ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
GBE1	1,4-alpha-glucan branching enzyme 1(GBE1)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0006091~generation of precursor metabolites and energy,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003844~1,4-alpha-glucan branching enzyme activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0030246~carbohydrate binding,GO:0043169~cation binding,	IPR004193:Glycoside hydrolase, family 13, N-terminal,IPR006047:Glycosyl hydrolase, family 13, catalytic domain,IPR006048:Alpha-amylase, C-terminal all beta,IPR006407:1,4-alpha-glucan-branching enzyme,IPR013780:Glycosyl hydrolase, family 13, all-beta,IPR013781:Glycoside hydrolase, catalytic domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015902:Glycoside hydrolase, family 13,IPR017853:Glycoside hydrolase, superfamily,	hsa00500:Starch and sucrose metabolism,hsa01100:Metabolic pathways,	232500~Glycogen storage disease IV,263570~Polyglucosan body disease, adult form,	PIRSF000463:1,4-alpha-glucan branching enzyme,	SM00642:Aamy,	3D-structure,Acetylation,Complete proteome,Disease mutation,Glycogen biosynthesis,Glycogen storage disease,Glycosyltransferase,Neuropathy,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:1,4-alpha-glucan-branching enzyme,modified residue,sequence conflict,sequence variant,
HACL1	2-hydroxyacyl-CoA lyase 1(HACL1)	Homo sapiens				GO:0001561~fatty acid alpha-oxidation,GO:0051259~protein oligomerization,	GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,	GO:0000287~magnesium ion binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0016829~lyase activity,GO:0016830~carbon-carbon lyase activity,GO:0030976~thiamine pyrophosphate binding,GO:0042802~identical protein binding,GO:0048037~cofactor binding,	IPR011766:Thiamine pyrophosphate enzyme, C-terminal TPP-binding,IPR012000:Thiamine pyrophosphate enzyme, central domain,IPR012001:Thiamine pyrophosphate enzyme, N-terminal TPP-binding domain,	hsa04146:Peroxisome,				Alternative splicing,Complete proteome,Lyase,Magnesium,Metal-binding,Peroxisome,Phosphoprotein,Proteomics identification,Reference proteome,Thiamine pyrophosphate,	binding site:Thiamine pyrophosphate,chain:2-hydroxyacyl-CoA lyase 1,metal ion-binding site:Magnesium,modified residue,region of interest:Thiamine pyrophosphate binding,sequence conflict,short sequence motif:Microbody targeting signal,
DHCR24	24-dehydrocholesterol reductase(DHCR24)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0006915~apoptotic process,GO:0006979~response to oxidative stress,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0009725~response to hormone,GO:0009888~tissue development,GO:0030539~male genitalia development,GO:0031639~plasminogen activation,GO:0033489~cholesterol biosynthetic process via desmosterol,GO:0033490~cholesterol biosynthetic process via lathosterol,GO:0042987~amyloid precursor protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043588~skin development,GO:0055114~oxidation-reduction process,GO:0061024~membrane organization,GO:1901214~regulation of neuron death,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000246~delta24(24-1) sterol reductase activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0019899~enzyme binding,GO:0042605~peptide antigen binding,GO:0050614~delta24-sterol reductase activity,GO:0050660~flavin adenine dinucleotide binding,	IPR006094:FAD linked oxidase, N-terminal,IPR016166:FAD-binding, type 2,IPR016169:CO dehydrogenase flavoprotein-like, FAD-binding, subdomain 2,	hsa00100:Steroid biosynthesis,hsa01100:Metabolic pathways,	602398~Desmosterolosis,			Alternative splicing,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Disease mutation,Endoplasmic reticulum,FAD,Flavoprotein,Golgi apparatus,Lipid biosynthesis,Lipid metabolism,Membrane,NADP,Oxidoreductase,Proteomics identification,Reference proteome,Signal,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:24-dehydrocholesterol reductase,domain:FAD-binding PCMH-type,modified residue,nucleotide phosphate-binding region:FAD,sequence variant,signal peptide,site:Cleavage; by caspase,transmembrane region,
BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1(BPNT1)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0007399~nervous system development,GO:0016311~dephosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0008441~3'(2'),5'-bisphosphate nucleotidase activity,	IPR000760:Inositol monophosphatase,IPR020550:Inositol monophosphatase, conserved site,IPR020583:Inositol monophosphatase, metal-binding site,	hsa00920:Sulfur metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Hydrolase,Lithium,Magnesium,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,	binding site:Substrate,chain:3'(2'),5'-bisphosphate nucleotidase 1,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 1; via carbonyl oxygen,metal ion-binding site:Magnesium 2,modified residue,region of interest:Substrate binding,sequence conflict,splice variant,strand,turn,
HMGCS2	3-hydroxy-3-methylglutaryl-CoA synthase 2(HMGCS2)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0008299~isoprenoid biosynthetic process,GO:0046951~ketone body biosynthetic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0004421~hydroxymethylglutaryl-CoA synthase activity,	IPR000590:Hydroxymethylglutaryl-coenzyme A synthase, active site,IPR010122:Hydroxymethylglutaryl-CoA synthase, eukaryotic,IPR013528:Hydroxymethylglutaryl-coenzyme A synthase, N-terminal,IPR013746:Hydroxymethylglutaryl-coenzyme A synthase C-terminal,IPR016039:Thiolase-like,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,hsa00900:Terpenoid backbone biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	605911~HMG-CoA synthase-2 deficiency,			3D-structure,Acetylation,Alternative splicing,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Disease mutation,Lipid biosynthesis,Lipid metabolism,Mitochondrion,Phosphoprotein,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transferase,Transit peptide,	chain:Hydroxymethylglutaryl-CoA synthase, mitochondrial,helix,modified residue,sequence variant,strand,transit peptide:Mitochondrion,turn,
HIBCH	3-hydroxyisobutyryl-CoA hydrolase(HIBCH)	Homo sapiens			Lipid metabolism,	GO:0006574~valine catabolic process,GO:0006635~fatty acid beta-oxidation,GO:0009083~branched-chain amino acid catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0003860~3-hydroxyisobutyryl-CoA hydrolase activity,	IPR014748:Crontonase, C-terminal,	hsa00280:Valine, leucine and isoleucine degradation,hsa00410:beta-Alanine metabolism,hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,	250620~3-hydroxyisobutryl-CoA hydrolase deficiency,			3D-structure,Acetylation,Alternative splicing,Branched-chain amino acid catabolism,Complete proteome,Disease mutation,Hydrolase,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:3-hydroxyisobutyryl-CoA hydrolase, mitochondrial,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
HMGCL	3-hydroxymethyl-3-methylglutaryl-CoA lyase(HMGCL)	Homo sapiens				GO:0001889~liver development,GO:0006552~leucine catabolic process,GO:0006629~lipid metabolic process,GO:0006637~acyl-CoA metabolic process,GO:0007005~mitochondrion organization,GO:0007584~response to nutrient,GO:0042594~response to starvation,GO:0046951~ketone body biosynthetic process,GO:0051262~protein tetramerization,GO:0070542~response to fatty acid,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,	GO:0000062~fatty-acyl-CoA binding,GO:0000287~magnesium ion binding,GO:0004419~hydroxymethylglutaryl-CoA lyase activity,GO:0005102~receptor binding,GO:0016829~lyase activity,GO:0030145~manganese ion binding,GO:0031406~carboxylic acid binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR000138:Hydroxymethylglutaryl-CoA lyase, active site,IPR000891:Pyruvate carboxyltransferase,IPR013785:Aldolase-type TIM barrel,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,hsa01100:Metabolic pathways,hsa04146:Peroxisome,	246450~HMG-CoA lyase deficiency,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Lyase,Metal-binding,Mitochondrion,Peroxisome,Proteomics identification,Reference proteome,Transit peptide,	binding site:Substrate,chain:Hydroxymethylglutaryl-CoA lyase, mitochondrial,helix,metal ion-binding site:Divalent metal cation,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,turn,
OXCT2	3-oxoacid CoA-transferase 2(OXCT2)	Homo sapiens			Lipid metabolism,	GO:0008152~metabolic process,GO:0046952~ketone body catabolic process,	GO:0005739~mitochondrion,GO:0031514~motile cilium,	GO:0008260~3-oxoacid CoA-transferase activity,GO:0008410~CoA-transferase activity,	IPR004163:Coenzyme A transferase binding site,IPR004164:Coenzyme A transferase active site,IPR004165:Coenzyme A transferase family I,IPR012791:3-oxoacid CoA-transferase, subunit B,IPR012792:3-oxoacid CoA-transferase, subunit A,IPR014388:3-oxoacid CoA-transferase,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,		PIRSF000858:3-oxoacid CoA-transferase,	SM00882:SM00882,	Complete proteome,Mitochondrion,Polymorphism,Reference proteome,Transferase,Transit peptide,	chain:Succinyl-CoA:3-ketoacid-coenzyme A transferase 2, mitochondrial,region of interest:CoA-binding,sequence conflict,sequence variant,transit peptide:Mitochondrion,
HPDL	4-hydroxyphenylpyruvate dioxygenase like(HPDL)	Homo sapiens				GO:0009072~aromatic amino acid family metabolic process,GO:0055114~oxidation-reduction process,		GO:0003868~4-hydroxyphenylpyruvate dioxygenase activity,GO:0046872~metal ion binding,	IPR005956:4-hydroxyphenylpyruvate dioxygenase,			PIRSF009283:4-hydroxyphenylpyruvate dioxygenase,		Complete proteome,Dioxygenase,Iron,Metal-binding,Oxidoreductase,Reference proteome,	chain:4-hydroxyphenylpyruvate dioxygenase-like protein,
NT5DC2	5'-nucleotidase domain containing 2(NT5DC2)	Homo sapiens				GO:0016311~dephosphorylation,		GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,			PIRSF017434:cytosolic purine 5'-nucleotidase,		Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton donor,chain:5'-nucleotidase domain-containing protein 2,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,sequence conflict,sequence variant,splice variant,
NT5DC4	5'-nucleotidase domain containing 4(NT5DC4)	Homo sapiens				GO:0016311~dephosphorylation,		GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,			PIRSF017434:cytosolic purine 5'-nucleotidase,		Complete proteome,Hydrolase,Magnesium,Metal-binding,Reference proteome,	active site:Nucleophile,active site:Proton donor,chain:5'-nucleotidase domain-containing protein 4,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,
NT5C1A	5'-nucleotidase, cytosolic IA(NT5C1A)	Homo sapiens				GO:0006195~purine nucleotide catabolic process,GO:0009116~nucleoside metabolic process,GO:0009128~purine nucleoside monophosphate catabolic process,GO:0016311~dephosphorylation,GO:0046085~adenosine metabolic process,GO:0046135~pyrimidine nucleoside catabolic process,	GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0008253~5'-nucleotidase activity,	IPR010394:5-nucleotidase,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				Complete proteome,Cytoplasm,Hydrolase,Magnesium,Nucleotide metabolism,Nucleotide-binding,Reference proteome,	active site:Nucleophile,chain:Cytosolic 5'-nucleotidase 1A,sequence conflict,
NT5C1B	5'-nucleotidase, cytosolic IB(NT5C1B)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism / General function prediction only,	GO:0006195~purine nucleotide catabolic process,GO:0009117~nucleotide metabolic process,GO:0016311~dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0008253~5'-nucleotidase activity,	IPR010394:5-nucleotidase,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Magnesium,Nucleotide metabolism,Reference proteome,	active site:Nucleophile,active site:Proton acceptor,binding site:Substrate,chain:Cytosolic 5'-nucleotidase 1B,chain:Retinol dehydrogenase 14,compositionally biased region:Poly-Gln,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,nucleotide phosphate-binding region:NADP,sequence conflict,splice variant,
ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase(ATIC)	Homo sapiens				GO:0003360~brainstem development,GO:0006139~nucleobase-containing compound metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006189~'de novo' IMP biosynthetic process,GO:0009116~nucleoside metabolic process,GO:0009168~purine ribonucleoside monophosphate biosynthetic process,GO:0010035~response to inorganic substance,GO:0021549~cerebellum development,GO:0021987~cerebral cortex development,GO:0031100~organ regeneration,GO:0046452~dihydrofolate metabolic process,GO:0046654~tetrahydrofolate biosynthetic process,GO:0098609~cell-cell adhesion,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003937~IMP cyclohydrolase activity,GO:0004643~phosphoribosylaminoimidazolecarboxamide formyltransferase activity,GO:0042803~protein homodimerization activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002695:AICARFT/IMPCHase bienzyme,IPR011607:Methylglyoxal synthase-like domain,IPR016193:Cytidine deaminase-like,IPR024050:AICAR transformylase, insert domain,IPR024051:AICAR transformylase domain,	hsa00230:Purine metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	608688~AICA-ribosiduria due to ATIC deficiency,	PIRSF000414:bifunctional purine biosynthesis protein, PurH type,	SM00798:AICARFT_IMPCHas,SM00851:SM00851,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Epilepsy,Hydrolase,Multifunctional enzyme,Polymorphism,Proteomics identification,Purine biosynthesis,Reference proteome,Transferase,	active site:Proton acceptor,binding site:AICAR,binding site:AICAR; shared with dimeric partner,binding site:AICAR; via carbonyl oxygen,binding site:AICAR; via carbonyl oxygen; shared with dimeric partner,chain:Bifunctional purine biosynthesis protein PURH,helix,modified residue,nucleotide phosphate-binding region:IMP,region of interest:AICAR binding,sequence conflict,sequence variant,site:Transition state stabilizer,strand,turn,
HTR1F	5-hydroxytryptamine receptor 1F(HTR1F)	Homo sapiens				GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0042493~response to drug,GO:0051209~release of sequestered calcium ion into cytosol,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000450:5-Hydroxytryptamine 1F receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 1F,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
HTR2B	5-hydroxytryptamine receptor 2B(HTR2B)	Homo sapiens				GO:0001755~neural crest cell migration,GO:0001819~positive regulation of cytokine production,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002031~G-protein coupled receptor internalization,GO:0003007~heart morphogenesis,GO:0003300~cardiac muscle hypertrophy,GO:0006182~cGMP biosynthetic process,GO:0006874~cellular calcium ion homeostasis,GO:0006939~smooth muscle contraction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007507~heart development,GO:0007610~behavior,GO:0008284~positive regulation of cell proliferation,GO:0010507~negative regulation of autophagy,GO:0010513~positive regulation of phosphatidylinositol biosynthetic process,GO:0014033~neural crest cell differentiation,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014827~intestine smooth muscle contraction,GO:0016310~phosphorylation,GO:0019722~calcium-mediated signaling,GO:0042310~vasoconstriction,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043406~positive regulation of MAP kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0048598~embryonic morphogenesis,GO:0050715~positive regulation of cytokine secretion,GO:0050795~regulation of behavior,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051781~positive regulation of cell division,GO:0060548~negative regulation of cell death,GO:0070371~ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070528~protein kinase C signaling,GO:0071502~cellular response to temperature stimulus,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030425~dendrite,GO:0045202~synapse,	GO:0001965~G-protein alpha-subunit binding,GO:0004993~G-protein coupled serotonin receptor activity,GO:0005096~GTPase activator activity,GO:0008144~drug binding,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000482:5-Hydroxytryptamine 2B receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04540:Gap junction,hsa04726:Serotonergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,			SM01381:SM01381,	3D-structure,Behavior,Cell junction,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Synapse,Synaptosome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 2B,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,short sequence motif:PDZ-binding,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
HTR6	5-hydroxytryptamine receptor 6(HTR6)	Homo sapiens				GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0021795~cerebral cortex cell migration,GO:0032008~positive regulation of TOR signaling,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005929~cilium,GO:0030425~dendrite,	GO:0004969~histamine receptor activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0005515~protein binding,GO:0030594~neurotransmitter receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 6,disulfide bond,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MTR	5-methyltetrahydrofolate-homocysteine methyltransferase(MTR)	Homo sapiens				GO:0000096~sulfur amino acid metabolic process,GO:0007399~nervous system development,GO:0009086~methionine biosynthetic process,GO:0009235~cobalamin metabolic process,GO:0031103~axon regeneration,GO:0032259~methylation,GO:0042558~pteridine-containing compound metabolic process,GO:0048678~response to axon injury,GO:0071732~cellular response to nitric oxide,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008705~methionine synthase activity,GO:0008898~S-adenosylmethionine-homocysteine S-methyltransferase activity,GO:0031419~cobalamin binding,	IPR000489:Pterin-binding,IPR003726:Homocysteine S-methyltransferase,IPR003759:Cobalamin (vitamin B12)-binding module, cap domain,IPR004223:Vitamin B12-dependent methionine synthase, activation domain,IPR006158:Cobalamin (vitamin B12)-binding domain,IPR011005:Dihydropteroate synthase-like,IPR011822:5-methyltetrahydrofolate--homocysteine methyltransferase,	hsa00270:Cysteine and methionine metabolism,hsa00450:Selenocompound metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,hsa01230:Biosynthesis of amino acids,	250940~Homocystinuria-megaloblastic anemia, cblG complementation type,601634~Neural tube defects, folate-sensitive, susceptibility to,	PIRSF000381:cobalamin-dependent methionine synthase,	SM01018:SM01018,	3D-structure,Alternative splicing,Amino-acid biosynthesis,Cobalamin,Cobalt,Complete proteome,Cytoplasm,Disease mutation,Metal-binding,Methionine biosynthesis,Methyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Transferase,Zinc,	binding site:Cobalamin,binding site:Cobalamin; via carbonyl oxygen,binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,chain:Methionine synthase,domain:AdoMet activation,domain:B12-binding,domain:B12-binding N-terminal,domain:Hcy-binding,domain:Pterin-binding,helix,metal ion-binding site:Cobalt (cobalamin axial ligand),metal ion-binding site:Zinc,region of interest:Cobalamin-binding,region of interest:S-adenosyl-L-methionine binding,sequence variant,strand,turn,
PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2(PFKFB2)	Homo sapiens				GO:0006000~fructose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0006089~lactate metabolic process,GO:0006096~glycolytic process,GO:0009749~response to glucose,GO:0016311~dephosphorylation,GO:0032024~positive regulation of insulin secretion,GO:0033133~positive regulation of glucokinase activity,GO:0046835~carbohydrate phosphorylation,GO:0061621~canonical glycolysis,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0003873~6-phosphofructo-2-kinase activity,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, active site,IPR003094:Fructose-2,6-bisphosphatase,IPR013078:Histidine phosphatase superfamily, clade-1,IPR013079:6-phosphofructo-2-kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00051:Fructose and mannose metabolism,hsa04152:AMPK signaling pathway,hsa04919:Thyroid hormone signaling pathway,			SM00855:SM00855,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Kinase,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	active site:Proton donor,active site:Tele-phosphohistidine intermediate,binding site:Fructose-6-phosphate,chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 2,modified residue,nucleotide phosphate-binding region:ATP,region of interest:6-phosphofructo-2-kinase,region of interest:Fructose-2,6-bisphosphatase,sequence conflict,splice variant,
PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4(PFKFB4)	Homo sapiens				GO:0006000~fructose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0016311~dephosphorylation,GO:0046835~carbohydrate phosphorylation,GO:0061621~canonical glycolysis,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0003873~6-phosphofructo-2-kinase activity,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0005524~ATP binding,	IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, active site,IPR003094:Fructose-2,6-bisphosphatase,IPR013078:Histidine phosphatase superfamily, clade-1,IPR013079:6-phosphofructo-2-kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00051:Fructose and mannose metabolism,hsa04152:AMPK signaling pathway,			SM00855:SM00855,	Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Kinase,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	active site:Proton donor,active site:Tele-phosphohistidine intermediate,binding site:Fructose-6-phosphate,chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 4,modified residue,nucleotide phosphate-binding region:ATP,region of interest:6-phosphofructo-2-kinase,region of interest:Fructose-2,6-bisphosphatase,sequence variant,
ABHD14A-ACY1	ABHD14A-ACY1 readthrough(ABHD14A-ACY1)	Homo sapiens				GO:0006520~cellular amino acid metabolic process,GO:0043171~peptide catabolic process,	GO:0005737~cytoplasm,	GO:0004046~aminoacylase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0070573~metallodipeptidase activity,	IPR001261:ArgE/DapE/ACY1/CPG2/YscS, conserved site,IPR002933:Peptidase M20,IPR010159:N-acyl-L-amino-acid amidohydrolase,IPR011650:Peptidase M20, dimerisation domain,					Complete proteome,Reference proteome,Signal,
ABI3BP	ABI family member 3 binding protein(ABI3BP)	Homo sapiens				GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,	GO:0005614~interstitial matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0005518~collagen binding,GO:0008201~heparin binding,	IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,	Alternative splicing,Complete proteome,Glycoprotein,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Target of Nesh-SH3,compositionally biased region:Pro-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,
ABL2	ABL proto-oncogene 2, non-receptor tyrosine kinase(ABL2)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010506~regulation of autophagy,GO:0010863~positive regulation of phospholipase C activity,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030036~actin cytoskeleton organization,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0045087~innate immune response,GO:0051353~positive regulation of oxidoreductase activity,GO:0071300~cellular response to retinoic acid,GO:2000145~regulation of cell motility,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0000287~magnesium ion binding,GO:0003785~actin monomer binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030145~manganese ion binding,GO:0051015~actin filament binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015015:F-actin binding,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa05416:Viral myocarditis,	Leukemia, acute myeloid, with eosinophilia~Leukemia, acute myeloid, with eosinophilia,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,SM00808:FABD,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell adhesion,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Lipoprotein,Magnesium,Manganese,Metal-binding,Myristate,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase ABL2,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:Protein kinase,domain:SH2,domain:SH3,helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,region of interest:CAP,sequence conflict,sequence variant,short sequence motif:Kinase activation loop,short sequence motif:Nuclear localization signal,splice variant,strand,
ADAM17	ADAM metallopeptidase domain 17(ADAM17)	Homo sapiens		h_erbb4Pathway:g-Secretase mediated ErbB4 Signaling Pathway ,h_notchPathway:Proteolysis and Signaling Pathway of Notch ,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,		GO:0001666~response to hypoxia,GO:0001934~positive regulation of protein phosphorylation,GO:0002446~neutrophil mediated immunity,GO:0002467~germinal center formation,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0007155~cell adhesion,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0008284~positive regulation of cell proliferation,GO:0010820~positive regulation of T cell chemotaxis,GO:0030183~B cell differentiation,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031293~membrane protein intracellular domain proteolysis,GO:0031659~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,GO:0032496~response to lipopolysaccharide,GO:0032722~positive regulation of chemokine production,GO:0033025~regulation of mast cell apoptotic process,GO:0033077~T cell differentiation in thymus,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0033627~cell adhesion mediated by integrin,GO:0035313~wound healing, spreading of epidermal cells,GO:0035625~epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,GO:0042493~response to drug,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0048536~spleen development,GO:0048870~cell motility,GO:0050830~defense response to Gram-positive bacterium,GO:0051088~PMA-inducible membrane protein ectodomain proteolysis,GO:0051272~positive regulation of cellular component movement,GO:0055099~response to high density lipoprotein particle,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0032587~ruffle membrane,GO:0045121~membrane raft,	GO:0004222~metalloendopeptidase activity,GO:0005112~Notch binding,GO:0005138~interleukin-6 receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0030165~PDZ domain binding,GO:0046872~metal ion binding,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR024079:Metallopeptidase, catalytic domain,	hsa04330:Notch signaling pathway,hsa05010:Alzheimer's disease,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,	614328~Inflammatory skin and bowel disease, neonatal, 1,		SM00050:DISIN,	3D-structure,Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Notch signaling pathway,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,SH3-binding,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 17,compositionally biased region:Cys-rich,compositionally biased region:Poly-Val,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,modified residue,region of interest:Crambin-like,sequence conflict,sequence variant,short sequence motif:Cysteine switch,short sequence motif:SH3-binding,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ADAM23	ADAM metallopeptidase domain 23(ADAM23)	Homo sapiens				GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007417~central nervous system development,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Integrin,Membrane,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 23,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:May bind the integrin receptor,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ADAMTS9	ADAM metallopeptidase with thrombospondin type 1 motif 9(ADAMTS9)	Homo sapiens				GO:0006508~proteolysis,GO:0006516~glycoprotein catabolic process,GO:0007275~multicellular organism development,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0045636~positive regulation of melanocyte differentiation,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0009986~cell surface,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR012314:Peptidase M12B, GON-ADAMTSs,IPR013273:Peptidase M12B, ADAM-TS,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,	Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Endoplasmic reticulum,ER-Golgi transport,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Protein transport,Reference proteome,Repeat,Secreted,Signal,Transport,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 9,compositionally biased region:Cys-rich,compositionally biased region:Poly-Ser,disulfide bond,domain:Disintegrin,domain:GON,domain:Peptidase M12B,domain:TSP type-1 1,domain:TSP type-1 10,domain:TSP type-1 11,domain:TSP type-1 12,domain:TSP type-1 13,domain:TSP type-1 14,domain:TSP type-1 15,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,domain:TSP type-1 8,domain:TSP type-1 9,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,splice variant,
ADAMTSL4-AS1	ADAMTSL4 antisense RNA 1(ADAMTSL4-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein C1orf138,compositionally biased region:Pro-rich,sequence conflict,
ARF4	ADP ribosylation factor 4(ARF4)	Homo sapiens				GO:0006471~protein ADP-ribosylation,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007420~brain development,GO:0007612~learning,GO:0015031~protein transport,GO:0016477~cell migration,GO:0031584~activation of phospholipase D activity,GO:0043066~negative regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045176~apical protein localization,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048678~response to axon injury,GO:0060996~dendritic spine development,GO:0061512~protein localization to cilium,GO:2000377~regulation of reactive oxygen species metabolic process,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0032587~ruffle membrane,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Complete proteome,ER-Golgi transport,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ADP-ribosylation factor 4,helix,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,sequence variant,strand,turn,
ARL13B	ADP ribosylation factor like GTPase 13B(ARL13B)	Homo sapiens				GO:0001947~heart looping,GO:0007224~smoothened signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0009953~dorsal/ventral pattern formation,GO:0021532~neural tube patterning,GO:0021830~interneuron migration from the subpallium to the cortex,GO:0021943~formation of radial glial scaffolds,GO:0035058~nonmotile primary cilium assembly,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,GO:0070986~left/right axis specification,	GO:0005929~cilium,GO:0005930~axoneme,GO:0031514~motile cilium,GO:0060170~ciliary membrane,GO:0072372~primary cilium,	GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		612291~Joubert syndrome 8,			Alternative splicing,Cell membrane,Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Disease mutation,GTP-binding,Isopeptide bond,Joubert syndrome,Lipoprotein,Membrane,Nucleotide-binding,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:ADP-ribosylation factor-like protein 13B,compositionally biased region:Pro-rich,nucleotide phosphate-binding region:GTP,sequence variant,splice variant,
ARL5A	ADP ribosylation factor like GTPase 5A(ARL5A)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,	GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Alternative splicing,Complete proteome,GTP-binding,Lipoprotein,Myristate,Nucleotide-binding,Proteomics identification,Reference proteome,	binding site:GTP; via amide nitrogen,chain:ADP-ribosylation factor-like protein 5A,helix,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,strand,turn,
ARL6IP5	ADP ribosylation factor like GTPase 6 interacting protein 5(ARL6IP5)	Homo sapiens				GO:0002037~negative regulation of L-glutamate transport,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0010917~negative regulation of mitochondrial membrane potential,GO:0015813~L-glutamate transport,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR004895:Prenylated rab acceptor PRA1,					Acetylation,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Endoplasmic reticulum,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:PRA1 family protein 3,modified residue,region of interest:Targeting to endoplasmic reticulum membrane,sequence conflict,topological domain:Cytoplasmic,transmembrane region,
ARL6IP6	ADP ribosylation factor like GTPase 6 interacting protein 6(ARL6IP6)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:ADP-ribosylation factor-like protein 6- interacting protein 6,modified residue,sequence conflict,transmembrane region,
ARL8A	ADP ribosylation factor like GTPase 8A(ARL8A)	Homo sapiens				GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007264~small GTPase mediated signal transduction,GO:0051301~cell division,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0031902~late endosome membrane,GO:0051233~spindle midzone,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0043014~alpha-tubulin binding,GO:0048487~beta-tubulin binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Cell cycle,Cell division,Chromosome partition,Complete proteome,Endosome,GTP-binding,Lysosome,Membrane,Mitosis,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:ADP-ribosylation factor-like protein 8A,helix,nucleotide phosphate-binding region:GTP,region of interest:Mediates targeting to membranes,strand,turn,
ARL8B	ADP ribosylation factor like GTPase 8B(ARL8B)	Homo sapiens				GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007264~small GTPase mediated signal transduction,GO:0032418~lysosome localization,GO:0051301~cell division,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0031902~late endosome membrane,GO:0051233~spindle midzone,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0043014~alpha-tubulin binding,GO:0048487~beta-tubulin binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Endosome,GTP-binding,Lysosome,Membrane,Nucleotide-binding,Reference proteome,	chain:ADP-ribosylation factor-like protein 8B,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,region of interest:Mediates targeting to membranes,strand,turn,
ADPRHL2	ADP-ribosylhydrolase like 2(ADPRHL2)	Homo sapiens				GO:0071451~cellular response to superoxide,	GO:0005654~nucleoplasm,GO:0005759~mitochondrial matrix,	GO:0004649~poly(ADP-ribose) glycohydrolase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR005502:ADP-ribosylation/Crystallin J1,					3D-structure,Complete proteome,Cytoplasm,Hydrolase,Magnesium,Metal-binding,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transit peptide,	chain:Poly(ADP-ribose) glycohydrolase ARH3,compositionally biased region:Poly-Ala,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,mutagenesis site,sequence conflict,sequence variant,strand,turn,
AFF3	AF4/FMR2 family member 3(AFF3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0034612~response to tumor necrosis factor,GO:0035116~embryonic hindlimb morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003690~double-stranded DNA binding,	IPR007797:Transcription factor AF4/FMR2,					Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:AF4/FMR2 family member 3,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,
AKNAD1	AKNA domain containing 1(AKNAD1)	Homo sapiens					GO:0005737~cytoplasm,		IPR022150:Transcription factor, AT-hook-containing,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf62,sequence conflict,sequence variant,splice variant,
AKT3	AKT serine/threonine kinase 3(AKT3)	Homo sapiens				GO:0000002~mitochondrial genome maintenance,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0018105~peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04973:Carbohydrate digestion and absorption,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	615937~Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,		SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:RAC-gamma serine/threonine-protein kinase,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
ALG14	ALG14, UDP-N-acetylglucosaminyltransferase subunit(ALG14)	Homo sapiens				GO:0006488~dolichol-linked oligosaccharide biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0004577~N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,	IPR013969:Oligosaccharide biosynthesis protein Alg14-like,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	616227~Myasthenic syndrome, congenital, 15, without tubular aggregates,			Complete proteome,Congenital myasthenic syndrome,Disease mutation,Endoplasmic reticulum,Membrane,Nucleus,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:UDP-N-acetylglucosamine transferase subunit ALG14 homolog,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ALG6	ALG6, alpha-1,3-glucosyltransferase(ALG6)	Homo sapiens				GO:0006487~protein N-linked glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0006490~oligosaccharide-lipid intermediate biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004583~dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0042281~dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,GO:0046527~glucosyltransferase activity,	IPR004856:Glycosyl transferase, ALG6/ALG8,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	603147~Congenital disorder of glycosylation, type Ic,			Complete proteome,Congenital disorder of glycosylation,Disease mutation,Endoplasmic reticulum,Glycosyltransferase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:Dolichyl pyrophosphate Man9GlcNAc2 alpha- 1,3-glucosyltransferase,sequence conflict,sequence variant,transmembrane region,
ALMS1P1	ALMS1, centrosome and basal body associated protein pseudogene 1(ALMS1P1)	Homo sapiens													chain:Putative ALMS1-like protein,sequence variant,
ALMS1	ALMS1, centrosome and basal body associated protein(ALMS1)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0001736~establishment of planar polarity,GO:0006629~lipid metabolic process,GO:0007286~spermatid development,GO:0007605~sensory perception of sound,GO:0016197~endosomal transport,GO:0019722~calcium-mediated signaling,GO:0030728~ovulation,GO:0040015~negative regulation of multicellular organism growth,GO:0042384~cilium assembly,GO:0042593~glucose homeostasis,GO:0042632~cholesterol homeostasis,GO:0043066~negative regulation of apoptotic process,GO:0045444~fat cell differentiation,GO:0045598~regulation of fat cell differentiation,GO:0046548~retinal rod cell development,GO:0050673~epithelial cell proliferation,GO:0051492~regulation of stress fiber assembly,GO:0060122~inner ear receptor stereocilium organization,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0031514~motile cilium,GO:0036064~ciliary basal body,	GO:0005515~protein binding,GO:0051393~alpha-actinin binding,			203800~Alstrom syndrome,			Alternative splicing,Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Cone-rod dystrophy,Cytoplasm,Cytoskeleton,Deafness,Diabetes mellitus,Obesity,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Alstrom syndrome protein 1,compositionally biased region:Glu-rich,modified residue,region of interest:34 X 47 AA approximate tandem repeat,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:31,repeat:32,repeat:33,repeat:34,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,splice variant,
ALS2	ALS2, alsin Rho guanine nucleotide exchange factor(ALS2)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,Function unknown,	GO:0001662~behavioral fear response,GO:0001701~in utero embryonic development,GO:0001881~receptor recycling,GO:0006979~response to oxidative stress,GO:0007032~endosome organization,GO:0007409~axonogenesis,GO:0007528~neuromuscular junction development,GO:0007626~locomotory behavior,GO:0008104~protein localization,GO:0008219~cell death,GO:0016050~vesicle organization,GO:0016197~endosomal transport,GO:0016601~Rac protein signal transduction,GO:0035022~positive regulation of Rac protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0035249~synaptic transmission, glutamatergic,GO:0043547~positive regulation of GTPase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048812~neuron projection morphogenesis,GO:0051036~regulation of endosome size,GO:0071902~positive regulation of protein serine/threonine kinase activity,	GO:0001726~ruffle,GO:0005769~early endosome,GO:0005813~centrosome,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0031982~vesicle,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005087~Ran guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0017137~Rab GTPase binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0042803~protein homodimerization activity,GO:0043539~protein serine/threonine kinase activator activity,	IPR000219:Dbl homology (DH) domain,IPR000408:Regulator of chromosome condensation, RCC1,IPR003123:Vacuolar sorting protein 9,IPR003409:MORN motif,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,IPR011993:Pleckstrin homology-like domain,	hsa05014:Amyotrophic lateral sclerosis (ALS),	205100~Amyotrophic lateral sclerosis 2, juvenile,606353~Primary lateral sclerosis, juvenile,607225~Spastic paralysis, infantile onset ascending,		SM00698:MORN,	Acetylation,Alternative splicing,Amyotrophic lateral sclerosis,Complete proteome,Guanine-nucleotide releasing factor,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Alsin,domain:DH,domain:PH,domain:VPS9,modified residue,repeat:MORN 1,repeat:MORN 2,repeat:MORN 3,repeat:MORN 4,repeat:MORN 5,repeat:MORN 6,repeat:MORN 7,repeat:MORN 8,repeat:RCC1 1,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,sequence conflict,sequence variant,splice variant,
ALX3	ALX homeobox 3(ALX3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007389~pattern specification process,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0042981~regulation of apoptotic process,GO:0048701~embryonic cranial skeleton morphogenesis,	GO:0005634~nucleus,	GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		136760~Frontonasal dysplasia 1,		SM00389:HOX,	Complete proteome,Developmental protein,Disease mutation,DNA-binding,Homeobox,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein aristaless-like 3,DNA-binding region:Homeobox,sequence conflict,sequence variant,
AMMECR1L	AMMECR1 like(AMMECR1L)	Homo sapiens							IPR002733:AMMECR1 domain,IPR023473:AMMECR1,IPR027485:AMMECR1, N-terminal,					Complete proteome,Phosphoprotein,Reference proteome,	chain:AMMECR1-like protein,domain:AMMECR1,modified residue,
AAK1	AP2 associated kinase 1(AAK1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006897~endocytosis,GO:0032880~regulation of protein localization,GO:0045747~positive regulation of Notch signaling pathway,GO:0046777~protein autophosphorylation,GO:0050821~protein stabilization,GO:2000369~regulation of clathrin-mediated endocytosis,	GO:0005737~cytoplasm,GO:0005905~clathrin-coated pit,GO:0019897~extrinsic component of plasma membrane,GO:0030136~clathrin-coated vesicle,GO:0031252~cell leading edge,GO:0043195~terminal bouton,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005112~Notch binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0035612~AP-2 adaptor complex binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR026105:BMP-2-inducible protein kinase,				SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell membrane,Coated pit,Complete proteome,Endocytosis,Kinase,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:AP2-associated protein kinase 1,compositionally biased region:Gln-rich,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ala,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
APITD1-CORT	APITD1-CORT readthrough(APITD1-CORT)	Homo sapiens				GO:0000712~resolution of meiotic recombination intermediates,GO:0006281~DNA repair,GO:0006312~mitotic recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0031297~replication fork processing,GO:0031398~positive regulation of protein ubiquitination,GO:0034080~CENP-A containing nucleosome assembly,GO:0036297~interstrand cross-link repair,GO:0051301~cell division,GO:0051382~kinetochore assembly,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0043240~Fanconi anaemia nuclear complex,GO:0071821~FANCM-MHF complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,	IPR009072:Histone-fold,IPR018142:Somatostatin/Cortistatin, C-terminal,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA damage,DNA repair,DNA-binding,Fanconi anemia,Kinetochore,Mitosis,Nucleus,Proteomics identification,Reference proteome,
ACTR1B	ARP1 actin-related protein 1 homolog B, centractin beta(ACTR1B)	Homo sapiens				GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005869~dynactin complex,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0070062~extracellular exosome,GO:1990752~microtubule end,	GO:0005515~protein binding,GO:0005524~ATP binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020902:Actin/actin-like conserved site,				SM00268:ACTIN,	Acetylation,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nitration,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Beta-centractin,modified residue,sequence variant,
ACTR2	ARP2 actin related protein 2 homolog(ACTR2)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_rhoPathway:Rho cell motility signaling pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0006928~movement of cell or subcellular component,GO:0007163~establishment or maintenance of cell polarity,GO:0008356~asymmetric cell division,GO:0016344~meiotic chromosome movement towards spindle pole,GO:0016482~cytosolic transport,GO:0033206~meiotic cytokinesis,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042384~cilium assembly,GO:0048013~ephrin receptor signaling pathway,GO:0051653~spindle localization,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005885~Arp2/3 protein complex,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030478~actin cap,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0005200~structural constituent of cytoskeleton,GO:0005524~ATP binding,GO:0051015~actin filament binding,	IPR004000:Actin-related protein,IPR020902:Actin/actin-like conserved site,IPR027306:Actin-related protein 2 (Arp2),				SM00268:ACTIN,	Acetylation,Actin-binding,Alternative splicing,ATP-binding,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Actin-related protein 2,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,
ACTR3	ARP3 actin related protein 3 homolog(ACTR3)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_rhoPathway:Rho cell motility signaling pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0006928~movement of cell or subcellular component,GO:0007163~establishment or maintenance of cell polarity,GO:0008356~asymmetric cell division,GO:0016344~meiotic chromosome movement towards spindle pole,GO:0033206~meiotic cytokinesis,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048013~ephrin receptor signaling pathway,GO:0051653~spindle localization,GO:0060271~cilium morphogenesis,	GO:0005829~cytosol,GO:0005885~Arp2/3 protein complex,GO:0005903~brush border,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0070062~extracellular exosome,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0051015~actin filament binding,	IPR004000:Actin-related protein,IPR015623:Actin-related protein 3 (Arp3),IPR020902:Actin/actin-like conserved site,				SM00268:ACTIN,	Acetylation,Actin-binding,ATP-binding,Cell projection,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Actin-related protein 3,modified residue,
ARPC4-TTLL3	ARPC4-TTLL3 readthrough(ARPC4-TTLL3)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0030041~actin filament polymerization,GO:0034314~Arp2/3 complex-mediated actin nucleation,	GO:0005737~cytoplasm,GO:0005885~Arp2/3 protein complex,		IPR004344:Tubulin-tyrosine ligase,IPR008384:ARP2/3 complex, 20kDa subunit (P20-Arc),					Actin-binding,Complete proteome,Cytoplasm,Cytoskeleton,Reference proteome,
ARV1	ARV1 homolog, fatty acid homeostasis modulator(ARV1)	Homo sapiens				GO:0006665~sphingolipid metabolic process,GO:0006695~cholesterol biosynthetic process,GO:0008206~bile acid metabolic process,GO:0016125~sterol metabolic process,GO:0030301~cholesterol transport,GO:0032366~intracellular sterol transport,GO:0090181~regulation of cholesterol metabolic process,GO:0097036~regulation of plasma membrane sterol distribution,	GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0032541~cortical endoplasmic reticulum,	GO:0015248~sterol transporter activity,	IPR007290:Arv1 protein,					Complete proteome,Lipid metabolism,Membrane,Polymorphism,Proteomics identification,Reference proteome,Sphingolipid metabolism,Transmembrane,Transmembrane helix,	chain:Protein arv1,sequence conflict,sequence variant,transmembrane region,
ASH1L	ASH1 like histone lysine methyltransferase(ASH1L)	Homo sapiens				GO:0002674~negative regulation of acute inflammatory response,GO:0006323~DNA packaging,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0032635~interleukin-6 production,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043409~negative regulation of MAPK cascade,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051568~histone H3-K4 methylation,GO:0097676~histone H3-K36 dimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005923~bicellular tight junction,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001025:Bromo adjacent homology (BAH) domain,IPR001214:SET domain,IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR003616:Post-SET domain,IPR006560:AWS,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017956:AT hook, DNA-binding motif,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	hsa00310:Lysine degradation,			SM00249:PHD,SM00297:BROMO,SM00317:SET,SM00384:AT_hook,SM00439:BAH,SM00570:AWS,	3D-structure,Acetylation,Activator,Alternative splicing,Bromodomain,Cell junction,Chromatin regulator,Chromosome,Complete proteome,Isopeptide bond,Metal-binding,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Tight junction,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	chain:Probable histone-lysine N- methyltransferase ASH1L,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,DNA-binding region:A.T hook 3,domain:AWS,domain:BAH,domain:Bromo,domain:Post-SET,domain:SET,modified residue,sequence conflict,sequence variant,zinc finger region:PHD-type,
AHDC1	AT-hook DNA binding motif containing 1(AHDC1)	Homo sapiens						GO:0003677~DNA binding,			615829~Xia-Gibbs syndrome,			Acetylation,Complete proteome,DNA-binding,Mental retardation,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:A.T hook DNA-binding motif-containing protein 1,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,modified residue,sequence conflict,sequence variant,
AHCTF1	AT-hook containing transcription factor 1(AHCTF1)	Homo sapiens				GO:0000910~cytokinesis,GO:0006355~regulation of transcription, DNA-templated,GO:0007062~sister chromatid cohesion,GO:0015031~protein transport,GO:0051028~mRNA transport,GO:0051292~nuclear pore complex assembly,	GO:0000777~condensed chromosome kinetochore,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR025151:ELYS-like domain,					Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,DNA-binding,Kinetochore,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Translocation,Transport,	chain:Protein ELYS,DNA-binding region:A.T hook,modified residue,region of interest:Mediates transcriptional activity,region of interest:Necessary for cytoplasmic localization,region of interest:Necessary for nuclear localization,sequence conflict,sequence variant,splice variant,
ARID1A	AT-rich interaction domain 1A(ARID1A)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001843~neural tube closure,GO:0003205~cardiac chamber development,GO:0003408~optic cup formation involved in camera-type eye development,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016569~covalent chromatin modification,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030900~forebrain development,GO:0042766~nucleosome mobilization,GO:0042921~glucocorticoid receptor signaling pathway,GO:0043044~ATP-dependent chromatin remodeling,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048096~chromatin-mediated maintenance of transcription,GO:0055007~cardiac muscle cell differentiation,GO:0060674~placenta blood vessel development,GO:1901998~toxin transport,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0031491~nucleosome binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021906:Protein of unknown function DUF3518,		614607~Mental retardation, autosomal dominant 14,		SM00501:BRIGHT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,Direct protein sequencing,DNA-binding,Mental retardation,Methylation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:AT-rich interactive domain-containing protein 1A,compositionally biased region:Gln-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ser,domain:ARID,helix,modified residue,mutagenesis site,sequence conflict,short sequence motif:LXXLL,splice variant,strand,turn,
ARID4B	AT-rich interaction domain 4B(ARID4B)	Homo sapiens				GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007283~spermatogenesis,GO:0016575~histone deacetylation,GO:0034773~histone H4-K20 trimethylation,GO:0036124~histone H3-K9 trimethylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0097368~establishment of Sertoli cell barrier,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR002999:Tudor domain,IPR012603:RBB1NT,IPR016197:Chromo domain-like,IPR025995:RNA binding activity-knot of a chromodomain,				SM00333:TUDOR,SM00501:BRIGHT,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:AT-rich interactive domain-containing protein 4B,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:ARID,modified residue,region of interest:Antigenic epitope,sequence conflict,splice variant,
ABCA12	ATP binding cassette subfamily A member 12(ABCA12)	Homo sapiens				GO:0006869~lipid transport,GO:0010875~positive regulation of cholesterol efflux,GO:0019725~cellular homeostasis,GO:0031424~keratinization,GO:0032940~secretion by cell,GO:0033700~phospholipid efflux,GO:0035627~ceramide transport,GO:0043129~surfactant homeostasis,GO:0045055~regulated exocytosis,GO:0048286~lung alveolus development,GO:0055085~transmembrane transport,GO:0055088~lipid homeostasis,GO:0061436~establishment of skin barrier,GO:0072659~protein localization to plasma membrane,GO:2000010~positive regulation of protein localization to cell surface,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0097209~epidermal lamellar body,	GO:0005102~receptor binding,GO:0005215~transporter activity,GO:0005319~lipid transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0034040~lipid-transporting ATPase activity,GO:0034191~apolipoprotein A-I receptor binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	242500~Ichthyosis, autosomal recessive 4B (harlequin),601277~Ichthyosis, congenital, autosomal recessive 4A,		SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Ichthyosis,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 12,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
ABCA4	ATP binding cassette subfamily A member 4(ABCA4)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0006649~phospholipid transfer to membrane,GO:0006810~transport,GO:0006869~lipid transport,GO:0007601~visual perception,GO:0007603~phototransduction, visible light,GO:0045332~phospholipid translocation,GO:0045494~photoreceptor cell maintenance,GO:0055085~transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0097381~photoreceptor disc membrane,	GO:0005215~transporter activity,GO:0005395~eye pigment precursor transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0090555~phosphatidylethanolamine-translocating ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005951:Rim ABC transporter,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	153800~Macular degeneration, age-related, 2,248200~Fundus flavimaculatus,248200~Retinal dystrophy, early-onset severe,248200~Stargardt disease 1,601718~Retinitis pigmentosa 19,604116~Cone-rod dystrophy 3,		SM00382:AAA,	Age-related macular degeneration,ATP-binding,Complete proteome,Cone-rod dystrophy,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Retinitis pigmentosa,Sensory transduction,Stargardt disease,Transmembrane,Transmembrane helix,Transport,Vision,	chain:Retinal-specific ATP-binding cassette transporter,disulfide bond,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Extracellular,transmembrane region,
ABCB10	ATP binding cassette subfamily B member 10(ABCB10)	Homo sapiens				GO:0006810~transport,GO:0055085~transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0032592~integral component of mitochondrial membrane,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042803~protein homodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	3D-structure,Acetylation,ATP-binding,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Polymorphism,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family B member 10, mitochondrial,domain:ABC transmembrane type-1,domain:ABC transporter,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transit peptide:Mitochondrion,transmembrane region,
ABCB11	ATP binding cassette subfamily B member 11(ABCB11)	Homo sapiens		h_mrpPathway:Multi-Drug Resistance Factors,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Defense mechanisms,	GO:0006699~bile acid biosynthetic process,GO:0006810~transport,GO:0015721~bile acid and bile salt transport,GO:0015722~canalicular bile acid transport,GO:0035725~sodium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045177~apical part of cell,GO:0046581~intercellular canaliculus,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0008554~sodium-exporting ATPase activity, phosphorylative mechanism,GO:0015126~canalicular bile acid transmembrane transporter activity,GO:0015432~bile acid-exporting ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,	601847~Cholestasis, progressive familial intrahepatic 2,605479~Cholestasis, benign recurrent intrahepatic, 2,		SM00382:AAA,	ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Intrahepatic cholestasis,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Bile salt export pump,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,region of interest:Interaction with HAX1,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ABCB6	ATP binding cassette subfamily B member 6 (Langereis blood group)(ABCB6)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006779~porphyrin-containing compound biosynthetic process,GO:0006810~transport,GO:0006879~cellular iron ion homeostasis,GO:0007420~brain development,GO:0015886~heme transport,GO:0043588~skin development,GO:0055085~transmembrane transport,	GO:0000139~Golgi membrane,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0031307~integral component of mitochondrial outer membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0015232~heme transporter activity,GO:0015439~heme-transporting ATPase activity,GO:0015562~efflux transmembrane transporter activity,GO:0020037~heme binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	111600~Blood group, Langereis system,609153~Pseudohyperkalemia, familial, 2, due to red cell leak,614497~Microphthalmia, isolated, with coloboma 7,615402~Dyschromatosis universalis hereditaria 3,		SM00382:AAA,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Dyskeratosis congenita,Endoplasmic reticulum,Endosome,Golgi apparatus,Membrane,Microphthalmia,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family B member 6, mitochondrial,domain:ABC transmembrane type-1,domain:ABC transporter,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,transmembrane region,
ABCD3	ATP binding cassette subfamily D member 3(ABCD3)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006633~fatty acid biosynthetic process,GO:0006635~fatty acid beta-oxidation,GO:0007031~peroxisome organization,GO:0014070~response to organic cyclic compound,GO:0015910~peroxisomal long-chain fatty acid import,GO:0042493~response to drug,GO:0042760~very long-chain fatty acid catabolic process,GO:0055085~transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005324~long-chain fatty acid transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005283:Peroxysomal long chain fatty acyl transporter,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04146:Peroxisome,	616278~Bile acid synthesis defect, congenital, 5,		SM00382:AAA,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Peroxisome,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family D member 3,domain:ABC transmembrane type-1,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PEX19,region of interest:Targeting to peroxisomes,sequence conflict,sequence variant,splice variant,transmembrane region,
ABCG8	ATP binding cassette subfamily G member 8(ABCG8)	Homo sapiens				GO:0007584~response to nutrient,GO:0007588~excretion,GO:0010949~negative regulation of intestinal phytosterol absorption,GO:0015914~phospholipid transport,GO:0015918~sterol transport,GO:0030299~intestinal cholesterol absorption,GO:0033344~cholesterol efflux,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0045796~negative regulation of intestinal cholesterol absorption,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0043235~receptor complex,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017127~cholesterol transporter activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0046982~protein heterodimerization activity,	IPR003439:ABC transporter-like,IPR013525:ABC-2 type transporter,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04975:Fat digestion and absorption,hsa04976:Bile secretion,	210250~Sitosterolemia,611465~Gallbladder disease 4,			3D-structure,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family G member 8,domain:ABC transmembrane type-2,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9)(ATP5G3)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005741~mitochondrial outer membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0016021~integral component of membrane,GO:0045263~proton-transporting ATP synthase complex, coupling factor F(o),	GO:0005215~transporter activity,GO:0008289~lipid binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR000454:ATPase, F0 complex, subunit C,IPR002379:V-ATPase proteolipid subunit C-like domain,IPR020537:ATPase, F0 complex, subunit C, DCCD-binding site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				CF(0),Complete proteome,Hydrogen ion transport,Ion transport,Lipid-binding,Membrane,Mitochondrion,Polymorphism,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP synthase lipid-binding protein, mitochondrial,sequence variant,site:Reversibly protonated during proton transport,transit peptide:Mitochondrion,transmembrane region,
AGBL4	ATP/GTP binding protein like 4(AGBL4)	Homo sapiens			Amino acid transport and metabolism,	GO:0006508~proteolysis,GO:0035608~protein deglutamylation,GO:0035609~C-terminal protein deglutamylation,GO:0035610~protein side chain deglutamylation,GO:0051607~defense response to virus,	GO:0005794~Golgi apparatus,GO:0005814~centriole,GO:0005829~cytosol,GO:0036064~ciliary basal body,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,	IPR000834:Peptidase M14, carboxypeptidase A,				SM00631:Zn_pept,	Alternative splicing,Carboxypeptidase,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Zinc,	active site:Nucleophile,chain:Cytosolic carboxypeptidase 6,metal ion-binding site:Zinc,sequence variant,
AGBL5	ATP/GTP binding protein like 5(AGBL5)	Homo sapiens				GO:0006508~proteolysis,GO:0035608~protein deglutamylation,GO:0035611~protein branching point deglutamylation,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030496~midbody,GO:0072686~mitotic spindle,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,	IPR000834:Peptidase M14, carboxypeptidase A,					Alternative splicing,Carboxypeptidase,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Metal-binding,Metalloprotease,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Zinc,	chain:Cytosolic carboxypeptidase-like protein 5,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,sequence conflict,sequence variant,splice variant,
ATP13A2	ATPase 13A2(ATP13A2)	Homo sapiens				GO:0006812~cation transport,GO:0006874~cellular calcium ion homeostasis,GO:0006879~cellular iron ion homeostasis,GO:0006882~cellular zinc ion homeostasis,GO:0010821~regulation of mitochondrion organization,GO:0016241~regulation of macroautophagy,GO:0016243~regulation of autophagosome size,GO:0030003~cellular cation homeostasis,GO:0033157~regulation of intracellular protein transport,GO:0034220~ion transmembrane transport,GO:0034599~cellular response to oxidative stress,GO:0046777~protein autophosphorylation,GO:0050714~positive regulation of protein secretion,GO:0052548~regulation of endopeptidase activity,GO:0055069~zinc ion homeostasis,GO:0071287~cellular response to manganese ion,GO:0071294~cellular response to zinc ion,GO:0098655~cation transmembrane transport,GO:1901215~negative regulation of neuron death,GO:1903146~regulation of mitophagy,GO:1903543~positive regulation of exosomal secretion,GO:1904714~regulation of chaperone-mediated autophagy,GO:1905037~autophagosome organization,GO:1905122~polyamine import,GO:1905123~regulation of glucosylceramidase activity,GO:1905165~regulation of lysosomal protein catabolic process,GO:1905166~negative regulation of lysosomal protein catabolic process,GO:1990938~peptidyl-aspartic acid autophosphorylation,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005776~autophagosome,GO:0005887~integral component of plasma membrane,GO:0012506~vesicle membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0031982~vesicle,GO:0032585~multivesicular body membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043202~lysosomal lumen,GO:1905103~integral component of lysosomal membrane,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016887~ATPase activity,GO:0019829~cation-transporting ATPase activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,GO:0070300~phosphatidic acid binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,GO:1903135~cupric ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR006544:Cation-transporting P-type ATPase, subfamily  V,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,		606693~Ceroid lipofuscinosis, neuronal, 12,606693~Kufor-Rakeb syndrome,			Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Hydrolase,Lysosome,Magnesium,Membrane,Metal-binding,Neurodegeneration,Neuronal ceroid lipofuscinosis,Nucleotide-binding,Parkinsonism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	active site:4-aspartylphosphate intermediate,chain:Probable cation-transporting ATPase 13A2,metal ion-binding site:Magnesium,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ATP6V1B1	ATPase H+ transporting V1 subunit B1(ATP6V1B1)	Homo sapiens				GO:0001503~ossification,GO:0006885~regulation of pH,GO:0007588~excretion,GO:0007605~sensory perception of sound,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0042472~inner ear morphogenesis,GO:0045851~pH reduction,GO:0046034~ATP metabolic process,GO:0055074~calcium ion homeostasis,GO:0090383~phagosome acidification,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005902~microvillus,GO:0012505~endomembrane system,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0032403~protein complex binding,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005723:ATPase, V1 complex, subunit B,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR022879:V-type ATP synthase regulatory subunit B/beta,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,	267300~Renal tubular acidosis with deafness,			Complete proteome,Deafness,Disease mutation,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit B, kidney isoform,mutagenesis site,sequence conflict,sequence variant,short sequence motif:PDZ-binding,
ATP6V1C2	ATPase H+ transporting V1 subunit C2(ATP6V1C2)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016241~regulation of macroautophagy,GO:0030177~positive regulation of Wnt signaling pathway,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0000221~vacuolar proton-transporting V-type ATPase, V1 domain,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0070062~extracellular exosome,	GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0046983~protein dimerization activity,	IPR004907:ATPase, V1 complex, subunit C,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Alternative splicing,Coiled coil,Complete proteome,Hydrogen ion transport,Ion transport,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit C 2,sequence variant,splice variant,
ATP6V1E2	ATPase H+ transporting V1 subunit E2(ATP6V1E2)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0001669~acrosomal vesicle,GO:0005829~cytosol,GO:0033178~proton-transporting two-sector ATPase complex, catalytic domain,	GO:0005515~protein binding,GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR002842:ATPase, V1/A1 complex, subunit E,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Coiled coil,Complete proteome,Hydrogen ion transport,Ion transport,Reference proteome,Transport,	chain:V-type proton ATPase subunit E 2,modified residue,
ATP1A2	ATPase Na+/K+ transporting subunit alpha 2(ATP1A2)	Homo sapiens				GO:0001504~neurotransmitter uptake,GO:0002026~regulation of the force of heart contraction,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006883~cellular sodium ion homeostasis,GO:0006940~regulation of smooth muscle contraction,GO:0006942~regulation of striated muscle contraction,GO:0008217~regulation of blood pressure,GO:0008344~adult locomotory behavior,GO:0008542~visual learning,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0015991~ATP hydrolysis coupled proton transport,GO:0019229~regulation of vasoconstriction,GO:0030007~cellular potassium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0035094~response to nicotine,GO:0036376~sodium ion export from cell,GO:0040011~locomotion,GO:0045822~negative regulation of heart contraction,GO:0045988~negative regulation of striated muscle contraction,GO:0046034~ATP metabolic process,GO:0051481~negative regulation of cytosolic calcium ion concentration,GO:0051946~regulation of glutamate uptake involved in transmission of nerve impulse,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0055119~relaxation of cardiac muscle,GO:0060048~cardiac muscle contraction,GO:0071260~cellular response to mechanical stimulus,GO:0071383~cellular response to steroid hormone stimulus,GO:0086004~regulation of cardiac muscle cell contraction,GO:0086009~membrane repolarization,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:1903170~negative regulation of calcium ion transmembrane transport,GO:1903280~negative regulation of calcium:sodium antiporter activity,GO:1903416~response to glycoside,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005901~caveola,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030315~T-tubule,GO:0043197~dendritic spine,GO:0043209~myelin sheath,GO:0043231~intracellular membrane-bounded organelle,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0016887~ATPase activity,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0046872~metal ion binding,GO:0051087~chaperone binding,GO:1990239~steroid hormone binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	104290~Alternating hemiplegia of childhood,602481~Migraine, familial basilar,602481~Migraine, familial hemiplegic, 2,		SM00831:SM00831,	ATP-binding,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Potassium,Potassium transport,Proteomics identification,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sodium/potassium-transporting ATPase subunit alpha-2,metal ion-binding site:Magnesium,modified residue,region of interest:Interaction with phosphoinositide-3 kinase,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ATP1A4	ATPase Na+/K+ transporting subunit alpha 4(ATP1A4)	Homo sapiens				GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006883~cellular sodium ion homeostasis,GO:0007283~spermatogenesis,GO:0009566~fertilization,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0030007~cellular potassium ion homeostasis,GO:0030317~sperm motility,GO:0030641~regulation of cellular pH,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0042391~regulation of membrane potential,GO:1903779~regulation of cardiac conduction,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,			SM00831:SM00831,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Proteomics identification,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sodium/potassium-transporting ATPase subunit alpha-4,metal ion-binding site:Magnesium,modified residue,region of interest:Interaction with phosphoinositide-3 kinase,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ATP1B1	ATPase Na+/K+ transporting subunit beta 1(ATP1B1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006883~cellular sodium ion homeostasis,GO:0007155~cell adhesion,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010468~regulation of gene expression,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0030007~cellular potassium ion homeostasis,GO:0032781~positive regulation of ATPase activity,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0044861~protein transport into plasma membrane raft,GO:0046034~ATP metabolic process,GO:0050821~protein stabilization,GO:0050900~leukocyte migration,GO:0055119~relaxation of cardiac muscle,GO:0060048~cardiac muscle contraction,GO:0072659~protein localization to plasma membrane,GO:0086009~membrane repolarization,GO:0086013~membrane repolarization during cardiac muscle cell action potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:0090662~ATP hydrolysis coupled transmembrane transport,GO:1901018~positive regulation of potassium ion transmembrane transporter activity,GO:1903278~positive regulation of sodium ion export from cell,GO:1903281~positive regulation of calcium:sodium antiporter activity,GO:1903288~positive regulation of potassium ion import,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005901~caveola,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0042383~sarcolemma,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0001671~ATPase activator activity,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008144~drug binding,GO:0016887~ATPase activity,GO:0023026~MHC class II protein complex binding,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0051117~ATPase binding,	IPR000402:Sodium/potassium-transporting ATPase subunit beta,IPR015565:Sodium/potassium-transporting ATPase subunit beta, chordates,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	145500~Blood pressure regulation QTL,			Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Potassium,Potassium transport,Proteomics identification,Reference proteome,Signal-anchor,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit beta-1,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ATAD2B	ATPase family, AAA domain containing 2B(ATAD2B)	Homo sapiens				GO:0031936~negative regulation of chromatin silencing,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003682~chromatin binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR018359:Bromodomain, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00297:BROMO,SM00382:AAA,	3D-structure,Alternative splicing,ATP-binding,Bromodomain,Coiled coil,Complete proteome,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:ATPase family AAA domain-containing protein 2B,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,domain:Bromo,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,turn,
ATAD3A	ATPase family, AAA domain containing 3A(ATAD3A)	Homo sapiens			General function prediction only,	GO:0016049~cell growth,GO:0043066~negative regulation of apoptotic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0042645~mitochondrial nucleoid,	GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR021911:ATPase family AAA domain-containing protein 3, domain of unknown function DUF3523,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Direct protein sequencing,Membrane,Mitochondrion,Mitochondrion inner membrane,Mitochondrion nucleoid,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:ATPase family AAA domain-containing protein 3A,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
ATAD3C	ATPase family, AAA domain containing 3C(ATAD3C)	Homo sapiens						GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR021911:ATPase family AAA domain-containing protein 3, domain of unknown function DUF3523,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	ATP-binding,Complete proteome,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:ATPase family AAA domain-containing protein 3C,modified residue,nucleotide phosphate-binding region:ATP,
ATP8B2	ATPase phospholipid transporting 8B2(ATP8B2)	Homo sapiens				GO:0007030~Golgi organization,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,	GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Endoplasmic reticulum,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase ID,metal ion-binding site:Magnesium,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ATP2B2	ATPase plasma membrane Ca2+ transporting 2(ATP2B2)	Homo sapiens				GO:0006810~transport,GO:0006816~calcium ion transport,GO:0006996~organelle organization,GO:0007595~lactation,GO:0007605~sensory perception of sound,GO:0007626~locomotory behavior,GO:0008361~regulation of cell size,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021707~cerebellar granule cell differentiation,GO:0030182~neuron differentiation,GO:0034220~ion transmembrane transport,GO:0040011~locomotion,GO:0042428~serotonin metabolic process,GO:0045299~otolith mineralization,GO:0046068~cGMP metabolic process,GO:0048167~regulation of synaptic plasticity,GO:0050808~synapse organization,GO:0050885~neuromuscular process controlling balance,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051928~positive regulation of calcium ion transport,GO:0060088~auditory receptor cell stereocilium organization,GO:0070588~calcium ion transmembrane transport,GO:0090102~cochlea development,GO:1903779~regulation of cardiac conduction,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005929~cilium,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030054~cell junction,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0045202~synapse,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005388~calcium-transporting ATPase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0030165~PDZ domain binding,GO:0030899~calcium-dependent ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006408:Calcium-transporting P-type ATPase, subfamily IIB,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR022141:Calcium transporting P-type ATPase, C-terminal, plasma membrane,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,	601386~Deafness, autosomal recessive 12, modifier of,		SM00831:SM00831,	Alternative splicing,ATP-binding,Calcium,Calcium transport,Calmodulin-binding,Cell junction,Cell membrane,Complete proteome,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Plasma membrane calcium-transporting ATPase 2,compositionally biased region:Poly-Glu,metal ion-binding site:Magnesium,modified residue,region of interest:Calmodulin-binding subdomain A,region of interest:Calmodulin-binding subdomain B,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ATP2B4	ATPase plasma membrane Ca2+ transporting 4(ATP2B4)	Homo sapiens				GO:0003407~neural retina development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006874~cellular calcium ion homeostasis,GO:0007283~spermatogenesis,GO:0010751~negative regulation of nitric oxide mediated signal transduction,GO:0021766~hippocampus development,GO:0030317~sperm motility,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034220~ion transmembrane transport,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0051001~negative regulation of nitric-oxide synthase activity,GO:0051599~response to hydrostatic pressure,GO:0070588~calcium ion transmembrane transport,GO:0070885~negative regulation of calcineurin-NFAT signaling cascade,GO:0071872~cellular response to epinephrine stimulus,GO:0097553~calcium ion transmembrane import into cytosol,GO:0098703~calcium ion import across plasma membrane,GO:0098736~negative regulation of the force of heart contraction,GO:1900082~negative regulation of arginine catabolic process,GO:1901205~negative regulation of adrenergic receptor signaling pathway involved in heart process,GO:1901660~calcium ion export,GO:1902083~negative regulation of peptidyl-cysteine S-nitrosylation,GO:1902305~regulation of sodium ion transmembrane transport,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1903243~negative regulation of cardiac muscle hypertrophy in response to stress,GO:1903249~negative regulation of citrulline biosynthetic process,GO:1903779~regulation of cardiac conduction,GO:2000481~positive regulation of cAMP-dependent protein kinase activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0036126~sperm flagellum,GO:0043005~neuron projection,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0097228~sperm principal piece,	GO:0005388~calcium-transporting ATPase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0017080~sodium channel regulator activity,GO:0030165~PDZ domain binding,GO:0030346~protein phosphatase 2B binding,GO:0036487~nitric-oxide synthase inhibitor activity,GO:0046872~metal ion binding,GO:0050998~nitric-oxide synthase binding,GO:0097110~scaffold protein binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006408:Calcium-transporting P-type ATPase, subfamily IIB,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR022141:Calcium transporting P-type ATPase, C-terminal, plasma membrane,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,			SM00831:SM00831,	3D-structure,Alternative splicing,ATP-binding,Calcium,Calcium transport,Calmodulin-binding,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Plasma membrane calcium-transporting ATPase 4,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,helix,metal ion-binding site:Magnesium,modified residue,region of interest:Calmodulin-binding subdomain A,region of interest:Calmodulin-binding subdomain B,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ATRIP	ATR interacting protein(ATRIP)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0006260~DNA replication,GO:0036297~interstrand cross-link repair,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005654~nucleoplasm,	GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0070530~K63-linked polyubiquitin binding,		hsa03460:Fanconi anemia pathway,				3D-structure,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,DNA damage,DNA repair,Exonuclease,Hydrolase,Isopeptide bond,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:ATR-interacting protein,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,mutagenesis site,region of interest:Interaction with CINP,sequence conflict,sequence variant,short sequence motif:EEXXXDL motif,splice variant,
AGFG1	ArfGAP with FG repeats 1(AGFG1)	Homo sapiens				GO:0001675~acrosome assembly,GO:0006406~mRNA export from nucleus,GO:0007275~multicellular organism development,GO:0007289~spermatid nucleus differentiation,GO:0043547~positive regulation of GTPase activity,GO:0045109~intermediate filament organization,	GO:0005643~nuclear pore,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,	hsa05164:Influenza A,			SM00105:ArfGap,	3D-structure,Alternative splicing,Complete proteome,Cytoplasmic vesicle,Developmental protein,Differentiation,DNA-binding,Glycoprotein,Metal-binding,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Spermatogenesis,Transport,Zinc,Zinc-finger,	chain:Arf-GAP domain and FG repeats-containing protein 1,domain:Arf-GAP,glycosylation site:O-linked (GlcNAc),helix,modified residue,sequence conflict,splice variant,strand,turn,zinc finger region:C4-type,
AGAP1	ArfGAP with GTPase domain, ankyrin repeat and PH domain 1(AGAP1)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0005096~GTPase activator activity,GO:0005525~GTP binding,GO:0005543~phospholipid binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001806:Small GTPase superfamily,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,	Acetylation,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,GTP-binding,GTPase activation,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,Zinc,Zinc-finger,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1,domain:Arf-GAP,domain:PH,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,region of interest:Small GTPase-like,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,zinc finger region:C4-type,
ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2(ASAP2)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0043547~positive regulation of GTPase activity,	GO:0005886~plasma membrane,GO:0032580~Golgi cisterna membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,SM00326:SH3,	Alternative splicing,ANK repeat,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3 domain,Zinc,	chain:Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,compositionally biased region:Pro-rich,domain:Arf-GAP,domain:PH,domain:SH3,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,
ASAP3	ArfGAP with SH3 domain, ankyrin repeat and PH domain 3(ASAP3)	Homo sapiens				GO:0016477~cell migration,GO:0043547~positive regulation of GTPase activity,GO:0051492~regulation of stress fiber assembly,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005925~focal adhesion,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3,compositionally biased region:Poly-Ser,domain:Arf-GAP,domain:PH,helix,modified residue,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C4-type,
BTLA	B and T lymphocyte associated(BTLA)	Homo sapiens				GO:0002250~adaptive immune response,GO:0031295~T cell costimulation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:B- and T-lymphocyte attenuator,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
BCL11A	B-cell CLL/lymphoma 11A(BCL11A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0010977~negative regulation of neuron projection development,GO:0016925~protein sumoylation,GO:0030517~negative regulation of axon extension,GO:0032463~negative regulation of protein homooligomerization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048671~negative regulation of collateral sprouting,GO:0048672~positive regulation of collateral sprouting,GO:0050773~regulation of dendrite development,GO:2000171~negative regulation of dendrite development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:B-cell lymphoma/leukemia 11A,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
BCL9	B-cell CLL/lymphoma 9(BCL9)	Homo sapiens				GO:0014908~myotube differentiation involved in skeletal muscle regeneration,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035914~skeletal muscle cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060070~canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,	IPR015668:B Cell Lymphoma 9,IPR024670:B-cell lymphoma 9, beta-catenin binding domain,					3D-structure,Acetylation,Chromosomal rearrangement,Complete proteome,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Wnt signaling pathway,	chain:B-cell CLL/lymphoma 9 protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,helix,modified residue,region of interest:CTNNB1-binding,sequence conflict,sequence variant,strand,
BBX	BBX, HMG-box containing(BBX)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0060348~bone development,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR019102:HMG box transcription factor BBX, domain of unknown function DUF2028,				SM00398:HMG,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:HMG box transcription factor BBX,compositionally biased region:Lys-rich,compositionally biased region:Poly-Glu,DNA-binding region:HMG box,modified residue,sequence variant,splice variant,
MCL1	BCL2 family apoptosis regulator(MCL1)	Homo sapiens				GO:0001709~cell fate determination,GO:0007275~multicellular organism development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008637~apoptotic mitochondrial changes,GO:0010507~negative regulation of autophagy,GO:0019725~cellular homeostasis,GO:0034097~response to cytokine,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0071806~protein transmembrane transport,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:2000811~negative regulation of anoikis,GO:2001020~regulation of response to DNA damage stimulus,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016459~myosin complex,GO:0097136~Bcl-2 family protein complex,	GO:0005515~protein binding,GO:0015266~protein channel activity,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051434~BH3 domain binding,	IPR002475:Bcl2-like,IPR011992:EF-hand-like domain,IPR013281:Apoptosis regulator, Mcl-1,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR026298:Blc2 family,	hsa04151:PI3K-Akt signaling pathway,hsa05206:MicroRNAs in cancer,				3D-structure,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Direct protein sequencing,Isopeptide bond,Membrane,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Induced myeloid leukemia cell differentiation protein Mcl-1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,mutagenesis site,region of interest:PEST-like,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,site:Cleavage; by caspase-3,splice variant,transmembrane region,turn,
BCL2L11	BCL2 like 11(BCL2L11)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001782~B cell homeostasis,GO:0001783~B cell apoptotic process,GO:0001822~kidney development,GO:0001844~protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:0002262~myeloid cell homeostasis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007127~meiosis I,GO:0007160~cell-matrix adhesion,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0008584~male gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0030879~mammary gland development,GO:0032464~positive regulation of protein homooligomerization,GO:0034976~response to endoplasmic reticulum stress,GO:0035148~tube formation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0043583~ear development,GO:0045787~positive regulation of cell cycle,GO:0046620~regulation of organ growth,GO:0048066~developmental pigmentation,GO:0048070~regulation of developmental pigmentation,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048563~post-embryonic organ morphogenesis,GO:0060139~positive regulation of apoptotic process by virus,GO:0060154~cellular process regulating host cell cycle in response to virus,GO:0070242~thymocyte apoptotic process,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902263~apoptotic process involved in embryonic digit morphogenesis,GO:1903896~positive regulation of IRE1-mediated unfolded protein response,GO:2000271~positive regulation of fibroblast apoptotic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0005868~cytoplasmic dynein complex,GO:0012505~endomembrane system,GO:0019898~extrinsic component of membrane,GO:0097140~BIM-BCL-xl complex,GO:0097141~BIM-BCL-2 complex,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0045502~dynein binding,	IPR014771:Apoptosis, Bim N-terminal,IPR015040:Bcl-x interacting,IPR017288:Bcl-2-like protein 11,	hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05206:MicroRNAs in cancer,		PIRSF037827:Bcl-2-like protein 11,		3D-structure,Alternative splicing,Apoptosis,Complete proteome,Membrane,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Bcl-2-like protein 11,helix,modified residue,sequence conflict,short sequence motif:BH3,splice variant,
BCL2L15	BCL2 like 15(BCL2L15)	Homo sapiens				GO:0006915~apoptotic process,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005515~protein binding,						Alternative splicing,Apoptosis,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Bcl-2-like protein 15,sequence variant,
BCS1L	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone(BCS1L)	Homo sapiens				GO:0007005~mitochondrion organization,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0033617~mitochondrial respiratory chain complex IV assembly,GO:0034551~mitochondrial respiratory chain complex III assembly,	GO:0005739~mitochondrion,GO:0005750~mitochondrial respiratory chain complex III,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR014851:BCS1, N-terminal,IPR027243:Mitochondrial chaperone BCS1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		124000~Mitochondrial complex III deficiency, nuclear type 1,256000~Leigh syndrome,262000~Bjornstad syndrome,603358~GRACILE syndrome,		SM00382:AAA,SM01024:SM01024,	ATP-binding,Chaperone,Complete proteome,Deafness,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Mitochondrial chaperone BCS1,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transmembrane region,
BEND5	BEN domain containing 5(BEND5)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005794~Golgi apparatus,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR018379:BEN domain,				SM01025:SM01025,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:BEN domain-containing protein 5,domain:BEN,modified residue,sequence conflict,splice variant,
BRINP2	BMP/retinoic acid inducible neural specific 2(BRINP2)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0045666~positive regulation of neuron differentiation,GO:0045930~negative regulation of mitotic cell cycle,GO:0071300~cellular response to retinoic acid,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0030425~dendrite,GO:0043025~neuronal cell body,		IPR020864:Membrane attack complex component/perforin (MACPF) domain,				SM00457:MACPF,	Alternative splicing,Cell cycle,Complete proteome,Glycoprotein,Growth arrest,Polymorphism,Reference proteome,Secreted,Signal,	chain:Protein FAM5B,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
BRINP3	BMP/retinoic acid inducible neural specific 3(BRINP3)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0045666~positive regulation of neuron differentiation,GO:0045930~negative regulation of mitotic cell cycle,GO:0071300~cellular response to retinoic acid,	GO:0005576~extracellular region,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0030425~dendrite,GO:0043025~neuronal cell body,		IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR020864:Membrane attack complex component/perforin (MACPF) domain,				SM00457:MACPF,	Alternative splicing,Cell cycle,Complete proteome,Glycoprotein,Growth arrest,Mitochondrion,Reference proteome,Secreted,Signal,	chain:Protein FAM5C,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
BOK	BOK, BCL2 family apoptosis regulator(BOK)	Homo sapiens				GO:0001836~release of cytochrome c from mitochondria,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0010506~regulation of autophagy,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0048709~oligodendrocyte differentiation,GO:0051259~protein oligomerization,GO:0051402~neuron apoptotic process,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1900119~positive regulation of execution phase of apoptosis,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901382~regulation of chorionic trophoblast cell proliferation,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903899~positive regulation of PERK-mediated unfolded protein response,GO:1904708~regulation of granulosa cell apoptotic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005640~nuclear outer membrane,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0031966~mitochondrial membrane,GO:0032588~trans-Golgi network membrane,GO:0033106~cis-Golgi network membrane,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051400~BH domain binding,	IPR002475:Bcl2-like,IPR026298:Blc2 family,IPR026309:Bcl-2-related ovarian killer protein,					Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Endoplasmic reticulum,Endosome,Golgi apparatus,Isopeptide bond,Membrane,Mitochondrion,Mitochondrion inner membrane,Mitochondrion outer membrane,Nucleus,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Bcl-2-related ovarian killer protein,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,short sequence motif:BH4,
BARD1	BRCA1 associated RING domain 1(BARD1)	Homo sapiens		h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001894~tissue homeostasis,GO:0006260~DNA replication,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006974~cellular response to DNA damage stimulus,GO:0007050~cell cycle arrest,GO:0016567~protein ubiquitination,GO:0031441~negative regulation of mRNA 3'-end processing,GO:0042325~regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045732~positive regulation of protein catabolic process,GO:0046826~negative regulation of protein export from nucleus,GO:0085020~protein K6-linked ubiquitination,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031436~BRCA1-BARD1 complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070531~BRCA1-A complex,	GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019900~kinase binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR001357:BRCT domain,IPR001841:Zinc finger, RING-type,IPR002110:Ankyrin repeat,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR020683:Ankyrin repeat-containing domain,		114480~Breast cancer, susceptibility to,		SM00248:ANK,SM00292:BRCT,	3D-structure,Alternative splicing,ANK repeat,Complete proteome,DNA damage,DNA repair,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:BRCA1-associated RING domain protein 1,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:BRCT 1,domain:BRCT 2,helix,modified residue,region of interest:Interaction with BRCA1,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,strand,turn,zinc finger region:RING-type,
BAP1	BRCA1 associated protein 1(BAP1)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016579~protein deubiquitination,GO:0035520~monoubiquitinated protein deubiquitination,GO:0035522~monoubiquitinated histone H2A deubiquitination,GO:0051726~regulation of cell cycle,GO:0071108~protein K48-linked deubiquitination,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0035517~PR-DUB complex,	GO:0003682~chromatin binding,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008233~peptidase activity,	IPR001578:Peptidase C12, ubiquitin carboxyl-terminal hydrolase 1,		614327~Tumor predisposition syndrome,			Chromatin regulator,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase BAP1,modified residue,mutagenesis site,region of interest:Interaction with BRCA1,sequence variant,
BRK1	BRICK1, SCAR/WAVE actin nucleating complex subunit(BRK1)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0007015~actin filament organization,GO:0008284~positive regulation of cell proliferation,GO:0010592~positive regulation of lamellipodium assembly,GO:0016601~Rac protein signal transduction,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048870~cell motility,GO:0070207~protein homotrimerization,GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0030027~lamellipodium,GO:0031209~SCAR complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0048365~Rac GTPase binding,		hsa04810:Regulation of actin cytoskeleton,				3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Reference proteome,	chain:Probable protein BRICK1,modified residue,splice variant,
BROX	BRO1 domain and CAAX motif containing(BROX)	Homo sapiens					GO:0016020~membrane,GO:0070062~extracellular exosome,		IPR004328:BRO1 domain,				SM01041:SM01041,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Proteomics identification,Reference proteome,	chain:BRO1 domain-containing protein BROX,domain:BRO1,lipid moiety-binding region:S-farnesyl cysteine,modified residue,sequence conflict,
BTBD8	BTB domain containing 8(BTBD8)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,				SM00225:BTB,	Alternative splicing,Coiled coil,Complete proteome,Nucleus,Polymorphism,Reference proteome,Repeat,	chain:BTB/POZ domain-containing protein 8,domain:BTB 1,domain:BTB 2,sequence conflict,sequence variant,splice variant,
BUB1	BUB1 mitotic checkpoint serine/threonine kinase(BUB1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007062~sister chromatid cohesion,GO:0007063~regulation of sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0008283~cell proliferation,GO:0016032~viral process,GO:0051301~cell division,GO:0051983~regulation of chromosome segregation,GO:0071173~spindle assembly checkpoint,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000942~condensed nuclear chromosome outer kinetochore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013212:Mad3/BUB1 homology region 1,IPR015661:Mitotic checkpoint serine/threonine protein kinase Bub1/Mitotic spindle checkpoint component Mad3,IPR017441:Protein kinase, ATP binding site,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,	Colorectal cancer with chromosomal instability, somatic~Colorectal cancer with chromosomal instability, somatic,		SM00220:S_TKc,SM00777:Mad3_BUB1_I,	3D-structure,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Complete proteome,Host-virus interaction,Kinase,Kinetochore,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mitotic checkpoint serine/threonine- protein kinase BUB1,domain:CD1,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Essential for loading of BUBR1, MAD1L1 and MAD2L1 to kinetochores,region of interest:Necessary for interaction with BUB3,region of interest:Necessary for interaction with CASC5,region of interest:Necessary for kinetochore localization,sequence conflict,sequence variant,short sequence motif:KEN box 1,short sequence motif:KEN box 2,short sequence motif:Nuclear localization signal,strand,turn,
BARHL2	BarH like homeobox 2(BARHL2)	Homo sapiens				GO:0001709~cell fate determination,GO:0001764~neuron migration,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0030182~neuron differentiation,GO:0030516~regulation of axon extension,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,DNA-binding,Homeobox,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:BarH-like 2 homeobox protein,compositionally biased region:Gln/Pro-rich,DNA-binding region:Homeobox,
CCR2	C-C motif chemokine receptor 2(CCR2)	Homo sapiens				GO:0001974~blood vessel remodeling,GO:0002407~dendritic cell chemotaxis,GO:0002827~positive regulation of T-helper 1 type immune response,GO:0002829~negative regulation of type 2 immune response,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007259~JAK-STAT cascade,GO:0009611~response to wounding,GO:0010574~regulation of vascular endothelial growth factor production,GO:0010820~positive regulation of T cell chemotaxis,GO:0016032~viral process,GO:0016525~negative regulation of angiogenesis,GO:0019221~cytokine-mediated signaling pathway,GO:0019725~cellular homeostasis,GO:0032729~positive regulation of interferon-gamma production,GO:0032743~positive regulation of interleukin-2 production,GO:0035705~T-helper 17 cell chemotaxis,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043310~negative regulation of eosinophil degranulation,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0050729~positive regulation of inflammatory response,GO:0050870~positive regulation of T cell activation,GO:0070098~chemokine-mediated signaling pathway,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090265~positive regulation of immune complex clearance by monocytes and macrophages,GO:2000439~positive regulation of monocyte extravasation,GO:2000451~positive regulation of CD8-positive, alpha-beta T cell extravasation,GO:2000464~positive regulation of astrocyte chemotaxis,GO:2000473~positive regulation of hematopoietic stem cell migration,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0048471~perinuclear region of cytoplasm,	GO:0004950~chemokine receptor activity,GO:0016493~C-C chemokine receptor activity,GO:0031727~CCR2 chemokine receptor binding,GO:0042803~protein homodimerization activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002237:CC chemokine receptor 2,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,	HIV infection, susceptibility/resistance to~HIV infection, susceptibility/resistance to,		SM01381:SM01381,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Sulfation,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CCR3	C-C motif chemokine receptor 3(CCR3)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,	h_ccr3Pathway:CCR3 signaling in Eosinophils,h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,h_il5Pathway:IL 5 Signaling Pathway,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,		GO:0001938~positive regulation of endothelial cell proliferation,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006968~cellular defense response,GO:0007155~cell adhesion,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0016032~viral process,GO:0045766~positive regulation of angiogenesis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002238:CC chemokine receptor 3,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05203:Viral carcinogenesis,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 3,disulfide bond,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CCR9	C-C motif chemokine receptor 9(CCR9)	Homo sapiens				GO:0002305~CD8-positive, gamma-delta intraepithelial T cell differentiation,GO:0006935~chemotaxis,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004950~chemokine receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR004069:CC chemokine receptor 9,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 9,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CXCR2	C-X-C motif chemokine receptor 2(CXCR2)	Homo sapiens				GO:0002407~dendritic cell chemotaxis,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008284~positive regulation of cell proliferation,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0030593~neutrophil chemotaxis,GO:0030901~midbrain development,GO:0031623~receptor internalization,GO:0033030~negative regulation of neutrophil apoptotic process,GO:0038112~interleukin-8-mediated signaling pathway,GO:0042119~neutrophil activation,GO:0043117~positive regulation of vascular permeability,GO:0045766~positive regulation of angiogenesis,GO:0070098~chemokine-mediated signaling pathway,GO:0072173~metanephric tubule morphogenesis,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005622~intracellular,GO:0005623~cell,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042629~mast cell granule,	GO:0004871~signal transducer activity,GO:0004918~interleukin-8 receptor activity,GO:0005515~protein binding,GO:0016494~C-X-C chemokine receptor activity,GO:0019959~interleukin-8 binding,	IPR000057:CXC chemokine receptor 2,IPR000174:CXC chemokine receptor 1/2,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,				3D-structure,Cell membrane,Chemotaxis,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-X-C chemokine receptor type 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CX3CR1	C-X3-C motif chemokine receptor 1(CX3CR1)	Homo sapiens				GO:0002052~positive regulation of neuroblast proliferation,GO:0002282~microglial cell activation involved in immune response,GO:0002881~negative regulation of chronic inflammatory response to non-antigenic stimulus,GO:0006935~chemotaxis,GO:0006968~cellular defense response,GO:0007155~cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007613~memory,GO:0009611~response to wounding,GO:0016032~viral process,GO:0016525~negative regulation of angiogenesis,GO:0021795~cerebral cortex cell migration,GO:0030336~negative regulation of cell migration,GO:0045766~positive regulation of angiogenesis,GO:0048246~macrophage chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1900272~negative regulation of long-term synaptic potentiation,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0032809~neuronal cell body membrane,GO:0043005~neuron projection,GO:0048471~perinuclear region of cytoplasm,	GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016495~C-X3-C chemokine receptor activity,GO:0019960~C-X3-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR005387:CX3C chemokine receptor 1,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,	607339~Coronary artery disease, resistance to,609423~Rapid progression to AIDS from HIV1 infection,613784~Macular degeneration, age-related, 12,			Age-related macular degeneration,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:CX3C chemokine receptor 1,disulfide bond,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CMC1	C-X9-C motif containing 1(CMC1)	Homo sapiens					GO:0005739~mitochondrion,	GO:0046872~metal ion binding,	IPR013892:Cytochrome c oxidase biogenesis protein Cmc1-like,					Acetylation,Complete proteome,Copper,Disulfide bond,Metal-binding,Mitochondrion,Proteomics identification,Reference proteome,	chain:COX assembly mitochondrial protein homolog,modified residue,sequence conflict,
CLEC4F	C-type lectin domain family 4 member F(CLEC4F)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006897~endocytosis,	GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	Alternative splicing,Coiled coil,Complete proteome,Endocytosis,Glycoprotein,Lectin,Membrane,Polymorphism,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member F,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CLIP4	CAP-Gly domain containing linker protein family member 4(CLIP4)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR000938:CAP Gly-rich domain,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM01052:SM01052,	3D-structure,Alternative splicing,ANK repeat,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:CAP-Gly domain-containing linker protein 4,compositionally biased region:Ser-rich,domain:CAP-Gly 1,domain:CAP-Gly 2,domain:CAP-Gly 3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,splice variant,
CFLAR	CASP8 and FADD like apoptosis regulator(CFLAR)	Homo sapiens	36.Death_of_Key_Intracellular_Targets,86.Apoptosis_Nematode&_Vert,	h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007519~skeletal muscle tissue development,GO:0014732~skeletal muscle atrophy,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0014866~skeletal myofibril assembly,GO:0016032~viral process,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043403~skeletal muscle tissue regeneration,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060544~regulation of necroptotic process,GO:0097194~execution phase of apoptosis,GO:1901740~negative regulation of myoblast fusion,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0045121~membrane raft,GO:0097342~ripoptosome,	GO:0002020~protease binding,GO:0004197~cysteine-type endopeptidase activity,GO:0005123~death receptor binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0032403~protein complex binding,GO:0097200~cysteine-type endopeptidase activity involved in execution phase of apoptosis,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001875:Death effector domain,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,	hsa04064:NF-kappa B signaling pathway,hsa04210:Apoptosis,hsa04668:TNF signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),			SM00031:DED,SM00115:CASc,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Host-virus interaction,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:CASP8 and FADD-like apoptosis regulator subunit p12,chain:CASP8 and FADD-like apoptosis regulator subunit p43,domain:DED 1,domain:DED 2,helix,mutagenesis site,region of interest:Caspase,region of interest:Interaction with caspase-3,region of interest:Interaction with caspase-8,region of interest:Interaction with caspase-8 propeptide,region of interest:Interaction with caspase-8 subunits p18 and p10,region of interest:Interaction with FADD,region of interest:Interaction with TRAF1 and TRAF2,region of interest:Not proteolytically processed and involved in apoptosis inhibition,sequence conflict,sequence variant,splice variant,strand,turn,
CEBPZ	CCAAT/enhancer binding protein zeta(CEBPZ)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0044822~poly(A) RNA binding,	IPR005612:CCAAT-binding factor,IPR016024:Armadillo-type fold,					Acetylation,Activator,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:CCAAT/enhancer-binding protein zeta,modified residue,sequence conflict,sequence variant,
CNOT10	CCR4-NOT transcription complex subunit 10(CNOT10)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0031047~gene silencing by RNA,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,	GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,IPR019734:Tetratricopeptide repeat,	hsa03018:RNA degradation,			SM00028:TPR,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 10,modified residue,sequence conflict,sequence variant,splice variant,
CNOT11	CCR4-NOT transcription complex subunit 11(CNOT11)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008283~cell proliferation,GO:0031047~gene silencing by RNA,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0030014~CCR4-NOT complex,	GO:0005515~protein binding,	IPR019312:Protein of unknown function DUF2363,					Complete proteome,Cytoplasm,Methylation,Nucleus,Proteomics identification,Reference proteome,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:UPF0760 protein C2orf29,compositionally biased region:Gly-rich,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,sequence conflict,
CNOT9	CCR4-NOT transcription complex subunit 9(CNOT9)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006402~mRNA catabolic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007548~sex differentiation,GO:0017148~negative regulation of translation,GO:0019221~cytokine-mediated signaling pathway,GO:0031047~gene silencing by RNA,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:2000327~positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,GO:0030015~CCR4-NOT core complex,	GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,	IPR007216:Rcd1,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	hsa03018:RNA degradation,				3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:Cell differentiation protein RCD1 homolog,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,turn,
CD101	CD101 molecule(CD101)	Homo sapiens				GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0007166~cell surface receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0016812~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,	IPR002195:Dihydroorotase, conserved site,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00409:IG,	Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Immunoglobulin superfamily member 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:EWI motif,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD160	CD160 molecule(CD160)	Homo sapiens				GO:0006968~cellular defense response,GO:0007166~cell surface receptor signaling pathway,GO:0008283~cell proliferation,GO:0050776~regulation of immune response,GO:0050829~defense response to Gram-negative bacterium,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0046658~anchored component of plasma membrane,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0032393~MHC class I receptor activity,	IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,					Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,	chain:CD160 antigen,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,
CD1A	CD1a molecule(CD1A)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0030881~beta-2-microglobulin binding,GO:0030883~endogenous lipid antigen binding,GO:0030884~exogenous lipid antigen binding,GO:0071723~lipopeptide binding,	IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,	hsa04640:Hematopoietic cell lineage,			SM00407:IGc1,	3D-structure,Adaptive immunity,Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	binding site:Glycolipid,chain:T-cell surface glycoprotein CD1a,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Glycolipid binding,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CD200	CD200 molecule(CD200)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0008037~cell recognition,GO:0043031~negative regulation of macrophage activation,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:OX-2 membrane glycoprotein,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD200R1	CD200 receptor 1(CD200R1)	Homo sapiens				GO:0016032~viral process,GO:0050776~regulation of immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004872~receptor activity,GO:0005515~protein binding,	IPR007110:Immunoglobulin-like domain,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,					Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host-virus interaction,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Cell surface glycoprotein CD200 receptor 1,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD247	CD247 molecule(CD247)	Homo sapiens		h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_il17Pathway:IL 17 Signaling Pathway,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrmolecule:T Cell Receptor and CD3 Complex,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0007166~cell surface receptor signaling pathway,GO:0016032~viral process,GO:0031295~T cell costimulation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,GO:0050852~T cell receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042101~T cell receptor complex,GO:0042105~alpha-beta T cell receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR021663:T-cell surface glycoprotein CD3 zeta/eta subunit/High affinity IgE receptor gamma subunit,IPR024128:T-cell surface glycoprotein CD3 zeta/eta subunit,	hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),	610163~Immunodeficiency 25,		SM00077:ITAM,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Host-virus interaction,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD3 zeta chain,disulfide bond,domain:ITAM 1,domain:ITAM 2,domain:ITAM 3,helix,modified residue,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD28	CD28 molecule(CD28)	Homo sapiens	3.T_cell_receptor,50.Hypothesis_of_bronchial_asthma,55.Allergen_recognition_by_Th2_or_Th0_cell,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_th1th2Pathway:Th1/Th2 Differentiation,h_thelperPathway:T Helper Cell Surface Molecules,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0002863~positive regulation of inflammatory response to antigenic stimulus,GO:0006959~humoral immune response,GO:0007166~cell surface receptor signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0031295~T cell costimulation,GO:0032733~positive regulation of interleukin-10 production,GO:0032753~positive regulation of interleukin-4 production,GO:0042089~cytokine biosynthetic process,GO:0042102~positive regulation of T cell proliferation,GO:0045060~negative thymic T cell selection,GO:0045066~regulatory T cell differentiation,GO:0045070~positive regulation of viral genome replication,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045589~regulation of regulatory T cell differentiation,GO:0045727~positive regulation of translation,GO:0045840~positive regulation of mitotic nuclear division,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0050690~regulation of defense response to virus by virus,GO:0050852~T cell receptor signaling pathway,GO:0051897~positive regulation of protein kinase B signaling,GO:0097190~apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0098636~protein complex involved in cell adhesion,	GO:0002020~protease binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR007110:Immunoglobulin-like domain,IPR008093:T cell antigen CD28,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04660:T cell receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05162:Measles,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,			SM00406:IGv,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:T-cell-specific surface glycoprotein CD28,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD302	CD302 molecule(CD302)	Homo sapiens				GO:0006909~phagocytosis,	GO:0005902~microvillus,GO:0005938~cell cortex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030175~filopodium,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Lectin,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CD302 antigen,chain:Lymphocyte antigen 75,disulfide bond,domain:C-type lectin,domain:C-type lectin 1,domain:C-type lectin 10,domain:C-type lectin 2,domain:C-type lectin 3,domain:C-type lectin 4,domain:C-type lectin 5,domain:C-type lectin 6,domain:C-type lectin 7,domain:C-type lectin 8,domain:C-type lectin 9,domain:Fibronectin type-II,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD34	CD34 molecule(CD34)	Homo sapiens	7.IL17_hematopoesis,	h_il17Pathway:IL 17 Signaling Pathway,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,		GO:0001894~tissue homeostasis,GO:0001935~endothelial cell proliferation,GO:0003094~glomerular filtration,GO:0003158~endothelium development,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016337~single organismal cell-cell adhesion,GO:0030097~hemopoiesis,GO:0030195~negative regulation of blood coagulation,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032733~positive regulation of interleukin-10 production,GO:0035759~mesangial cell-matrix adhesion,GO:0038001~paracrine signaling,GO:0042482~positive regulation of odontogenesis,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0045766~positive regulation of angiogenesis,GO:0048870~cell motility,GO:0050776~regulation of immune response,GO:0050900~leukocyte migration,GO:0060290~transdifferentiation,GO:0061042~vascular wound healing,GO:0071425~hematopoietic stem cell proliferation,GO:0071636~positive regulation of transforming growth factor beta production,GO:0071657~positive regulation of granulocyte colony-stimulating factor production,GO:0071971~extracellular exosome assembly,GO:0072011~glomerular endothelium development,GO:0072089~stem cell proliferation,GO:0072254~metanephric glomerular mesangial cell differentiation,GO:1900035~negative regulation of cellular response to heat,GO:1900038~negative regulation of cellular response to hypoxia,GO:1900041~negative regulation of interleukin-2 secretion,GO:1900168~positive regulation of glial cell-derived neurotrophic factor secretion,GO:1901215~negative regulation of neuron death,GO:2001214~positive regulation of vasculogenesis,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009925~basal plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0036053~glomerular endothelium fenestra,GO:0045171~intercellular bridge,GO:0048471~perinuclear region of cytoplasm,	GO:0008134~transcription factor binding,GO:0030246~carbohydrate binding,GO:0043199~sulfate binding,	IPR008083:CD34 antigen,IPR013836:CD34/Podocalyxin,	hsa04514:Cell adhesion molecules (CAMs),hsa04640:Hematopoietic cell lineage,				Alternative splicing,Cell adhesion,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Hematopoietic progenitor cell antigen CD34,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD46	CD46 molecule(CD46)	Homo sapiens				GO:0002250~adaptive immune response,GO:0002456~T cell mediated immunity,GO:0006508~proteolysis,GO:0006958~complement activation, classical pathway,GO:0007338~single fertilization,GO:0008593~regulation of Notch signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030449~regulation of complement activation,GO:0032613~interleukin-10 production,GO:0032733~positive regulation of interleukin-10 production,GO:0035581~sequestering of extracellular ligand from receptor,GO:0042102~positive regulation of T cell proliferation,GO:0043086~negative regulation of catalytic activity,GO:0043382~positive regulation of memory T cell differentiation,GO:0045087~innate immune response,GO:0045591~positive regulation of regulatory T cell differentiation,GO:0045916~negative regulation of complement activation,GO:0046718~viral entry into host cell,GO:0071636~positive regulation of transforming growth factor beta production,	GO:0002079~inner acrosomal membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001848~complement binding,GO:0004175~endopeptidase activity,GO:0004857~enzyme inhibitor activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR000436:Sushi/SCR/CCP,IPR017341:Membrane cofactor protein, CD46,	hsa04610:Complement and coagulation cascades,hsa05162:Measles,	612922~Hemolytic uremic syndrome, atypical, susceptibility to, 2,	PIRSF037971:membrane cofactor protein, CD46 type,	SM00032:CCP,	3D-structure,Alternative splicing,Complement pathway,Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,Disulfide bond,Fertilization,Glycoprotein,Hemolytic uremic syndrome,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Sushi,Transmembrane,Transmembrane helix,	chain:Membrane cofactor protein,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD47	CD47 molecule(CD47)	Homo sapiens	66.Prot_Interac_w_integrin_domains,72.IAP_interaction_with_cell_death_pathways,74.CD47-IAP_with_avB3,83.Growth_factors_Survival_factors_Mitogens,			GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0008228~opsonization,GO:0008284~positive regulation of cell proliferation,GO:0009617~response to bacterium,GO:0022409~positive regulation of cell-cell adhesion,GO:0030198~extracellular matrix organization,GO:0050729~positive regulation of inflammatory response,GO:0050766~positive regulation of phagocytosis,GO:0050870~positive regulation of T cell activation,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0070053~thrombospondin receptor activity,	IPR006704:Leukocyte surface antigen CD47,IPR007110:Immunoglobulin-like domain,IPR013147:CD47 transmembrane,IPR013270:CD47 immunoglobulin-like,IPR013783:Immunoglobulin-like fold,	hsa04512:ECM-receptor interaction,				3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Leukocyte surface antigen CD47,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD48	CD48 molecule(CD48)	Homo sapiens				GO:0002819~regulation of adaptive immune response,GO:0006952~defense response,GO:0007165~signal transduction,GO:0042110~T cell activation,GO:0045576~mast cell activation,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0003823~antigen binding,GO:0004872~receptor activity,GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04650:Natural killer cell mediated cytotoxicity,			SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CD48 antigen,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,strand,turn,
CD53	CD53 molecule(CD53)	Homo sapiens				GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:1901741~positive regulation of myoblast fusion,	GO:0001772~immunological synapse,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,			PIRSF002419:tetraspanin,		Cell junction,Cell membrane,Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Leukocyte surface antigen CD53,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD55	CD55 molecule (Cromer blood group)(CD55)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006958~complement activation, classical pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007283~spermatogenesis,GO:0030449~regulation of complement activation,GO:0031664~regulation of lipopolysaccharide-mediated signaling pathway,GO:0035743~CD4-positive, alpha-beta T cell cytokine production,GO:0043434~response to peptide hormone,GO:0045087~innate immune response,GO:0045730~respiratory burst,GO:0045916~negative regulation of complement activation,GO:0046718~viral entry into host cell,GO:0060137~maternal process involved in parturition,GO:2000516~positive regulation of CD4-positive, alpha-beta T cell activation,GO:2000563~positive regulation of CD4-positive, alpha-beta T cell proliferation,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0030133~transport vesicle,GO:0031225~anchored component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,hsa05416:Viral myocarditis,	613793~Blood group Cromer,		SM00032:CCP,	3D-structure,Alternative splicing,Blood group antigen,Cell membrane,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement decay-accelerating factor,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated serine,modified residue,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
CD58	CD58 molecule(CD58)	Homo sapiens	7.IL17_hematopoesis,	h_il17Pathway:IL 17 Signaling Pathway,		GO:0007155~cell adhesion,GO:0016337~single organismal cell-cell adhesion,GO:0034113~heterotypic cell-cell adhesion,GO:0050900~leukocyte migration,GO:0071346~cellular response to interferon-gamma,GO:0071356~cellular response to tumor necrosis factor,GO:2000484~positive regulation of interleukin-8 secretion,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,	IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015714:Lymphocyte function associated antigen 3,	hsa04514:Cell adhesion molecules (CAMs),hsa05169:Epstein-Barr virus infection,				3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Lymphocyte function-associated antigen 3,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated asparagine,propeptide:Removed in mature form,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CD84	CD84 molecule(CD84)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006952~defense response,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0032685~negative regulation of granulocyte macrophage colony-stimulating factor production,GO:0032701~negative regulation of interleukin-18 production,GO:0033004~negative regulation of mast cell activation,GO:0043305~negative regulation of mast cell degranulation,GO:0045087~innate immune response,GO:0050900~leukocyte migration,GO:2001256~regulation of store-operated calcium entry,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:SLAM family member 5,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,short sequence motif:ITSM motif 1,short sequence motif:ITSM motif 2,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CD8B	CD8b molecule(CD8B)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0042110~T cell activation,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0042101~T cell receptor complex,	GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0042288~MHC class I protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04640:Hematopoietic cell lineage,hsa04660:T cell receptor signaling pathway,hsa05340:Primary immunodeficiency,			SM00406:IGv,SM00409:IG,	Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD8 beta chain,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD96	CD96 molecule(CD96)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0002534~cytokine production involved in inflammatory response,GO:0002728~negative regulation of natural killer cell cytokine production,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0032496~response to lipopolysaccharide,GO:0032689~negative regulation of interferon-gamma production,GO:0050776~regulation of immune response,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005912~adherens junction,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,		211750~C syndrome,		SM00409:IG,	Alternative splicing,Cell adhesion,Chromosomal rearrangement,Complete proteome,Craniosynostosis,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface protein tactile,compositionally biased region:Pro-rich,compositionally biased region:Pro/Ser/Thr-rich,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CLK1	CDC like kinase 1(CLK1)	Homo sapiens				GO:0008283~cell proliferation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0043484~regulation of RNA splicing,GO:0046777~protein autophosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity protein kinase CLK1,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
CDC42BPA	CDC42 binding protein kinase alpha(CDC42BPA)	Homo sapiens			DNA replication, recombination, and repair,Function unknown,	GO:0006468~protein phosphorylation,GO:0016477~cell migration,GO:0031032~actomyosin structure organization,GO:0031532~actin cytoskeleton reorganization,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005911~cell-cell junction,GO:0031252~cell leading edge,GO:0042641~actomyosin,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000095:PAK-box/P21-Rho-binding,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001180:Citron-like,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR014930:Myotonic dystrophy protein kinase, coiled coil,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,IPR020454:Diacylglycerol/phorbol-ester binding,IPR026611:Serine/threonine-protein kinase MRCK,				SM00036:CNH,SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,SM00285:PBD,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase MRCK alpha,domain:AGC-kinase C-terminal,domain:CNH,domain:CRIB,domain:PH,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,zinc finger region:Phorbol-ester/DAG-type,
CDC42EP3	CDC42 effector protein 3(CDC42EP3)	Homo sapiens				GO:0007165~signal transduction,GO:0007266~Rho protein signal transduction,GO:0008360~regulation of cell shape,GO:0030838~positive regulation of actin filament polymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0015629~actin cytoskeleton,	GO:0005096~GTPase activator activity,GO:0005519~cytoskeletal regulatory protein binding,GO:0017049~GTP-Rho binding,	IPR000095:PAK-box/P21-Rho-binding,				SM00285:PBD,	Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Cdc42 effector protein 3,domain:CRIB,modified residue,sequence conflict,
CDC42SE1	CDC42 small effector 1(CDC42SE1)	Homo sapiens				GO:0006909~phagocytosis,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0034260~negative regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,	GO:0005095~GTPase inhibitor activity,GO:0005198~structural molecule activity,	IPR000095:PAK-box/P21-Rho-binding,					Alternative splicing,Cell membrane,Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,Lipoprotein,Membrane,Palmitate,Phagocytosis,Reference proteome,	chain:CDC42 small effector protein 1,domain:CRIB,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,region of interest:Mediates phosphoinositide-binding,splice variant,
CEBPZOS	CEBPZ opposite strand(CEBPZOS)	Homo sapiens					GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,							Complete proteome,Membrane,Mitochondrion,Reference proteome,Transmembrane,Transmembrane helix,
CGGBP1	CGG triplet repeat binding protein 1(CGGBP1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,						Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:CGG triplet repeat-binding protein 1,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,
CMTM6	CKLF like MARVEL transmembrane domain containing 6(CMTM6)	Homo sapiens				GO:0006935~chemotaxis,	GO:0005615~extracellular space,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,	IPR008253:Marvel,					Acetylation,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:CKLF-like MARVEL transmembrane domain- containing protein 6,domain:MARVEL,modified residue,sequence variant,transmembrane region,
CMTM7	CKLF like MARVEL transmembrane domain containing 7(CMTM7)	Homo sapiens				GO:0002337~B-1a B cell differentiation,GO:0006935~chemotaxis,	GO:0005615~extracellular space,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005125~cytokine activity,	IPR008253:Marvel,					Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:CKLF-like MARVEL transmembrane domain- containing protein 7,domain:MARVEL,transmembrane region,
CMTM8	CKLF like MARVEL transmembrane domain containing 8(CMTM8)	Homo sapiens				GO:0001766~membrane raft polarization,GO:0006935~chemotaxis,GO:0008104~protein localization,GO:0042552~myelination,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0045121~membrane raft,	GO:0005125~cytokine activity,GO:0019911~structural constituent of myelin sheath,	IPR008253:Marvel,IPR013295:Myelin and lymphocyte (MAL) protein,					Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Cytoplasm,Membrane,Nucleus,Reference proteome,Transmembrane,Transmembrane helix,	chain:CKLF-like MARVEL transmembrane domain- containing protein 8,domain:MARVEL,sequence conflict,transmembrane region,
CBWD2	COBW domain containing 2(CBWD2)	Homo sapiens			General function prediction only,			GO:0005524~ATP binding,	IPR003495:CobW/HypB/UreG domain,IPR011629:Cobalamin (vitamin B12) biosynthesis CobW-like, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					ATP-binding,Complete proteome,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:COBW domain-containing protein 2,compositionally biased region:Poly-Glu,domain:CobW C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,
COPS8	COP9 signalosome subunit 8(COPS8)	Homo sapiens				GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0008285~negative regulation of cell proliferation,GO:0010387~COP9 signalosome assembly,GO:0010388~cullin deneddylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,						3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 8,domain:PCI,modified residue,
COPS9	COP9 signalosome subunit 9(COPS9)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0034644~cellular response to UV,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,	GO:0005515~protein binding,						Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Myeloma overexpressed gene 2 protein,compositionally biased region:Poly-Asp,splice variant,
CTDSPL	CTD small phosphatase like(CTDSPL)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006470~protein dephosphorylation,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0004721~phosphoprotein phosphatase activity,GO:0016791~phosphatase activity,GO:0046872~metal ion binding,	IPR004274:NLI interacting factor,IPR011948:Dullard phosphatase domain, eukaryotic,IPR023214:HAD-like domain,				SM00577:CPDc,	3D-structure,Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Nucleus,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	active site:4-aspartylphosphate intermediate,active site:Proton donor,chain:CTD small phosphatase-like protein,domain:FCP1 homology,helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,modified residue,sequence variant,site:Transition state stabilizer,splice variant,strand,turn,
CTPS1	CTP synthase 1(CTPS1)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0006241~CTP biosynthetic process,GO:0006541~glutamine metabolic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0042098~T cell proliferation,GO:0042100~B cell proliferation,GO:0042493~response to drug,GO:0044210~'de novo' CTP biosynthetic process,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0003883~CTP synthase activity,GO:0005524~ATP binding,GO:0042802~identical protein binding,	IPR004468:CTP synthase,IPR017456:CTP synthase, N-terminal,IPR017926:Glutamine amidotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,	615897~Immunodeficiency 24,			3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Glutamine amidotransferase,Immunity,Ligase,Nucleotide-binding,Phosphoprotein,Polymorphism,Pyrimidine biosynthesis,Reference proteome,	active site:For GATase activity,chain:CTP synthase 1,domain:Glutamine amidotransferase type-1,helix,modified residue,sequence conflict,sequence variant,strand,turn,
CTTNBP2NL	CTTNBP2 N-terminal like(CTTNBP2NL)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0032410~negative regulation of transporter activity,GO:0034763~negative regulation of transmembrane transport,	GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,	GO:0005515~protein binding,GO:0051721~protein phosphatase 2A binding,	IPR019131:Cortactin-binding protein-2, N-terminal,					Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:CTTNBP2 N-terminal-like protein,modified residue,sequence variant,
CSMD2	CUB and Sushi multiple domains 2(CSMD2)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR000436:Sushi/SCR/CCP,IPR000859:CUB domain,				SM00032:CCP,SM00042:CUB,	Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sushi,Transmembrane,Transmembrane helix,	chain:CUB and sushi domain-containing protein 2,disulfide bond,domain:CUB 1,domain:CUB 10,domain:CUB 11,domain:CUB 12,domain:CUB 13,domain:CUB 14,domain:CUB 2,domain:CUB 3,domain:CUB 4,domain:CUB 5,domain:CUB 6,domain:CUB 7,domain:CUB 8,domain:CUB 9,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 21,domain:Sushi 22,domain:Sushi 23,domain:Sushi 24,domain:Sushi 25,domain:Sushi 26,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CDCP1	CUB domain containing protein 1(CDCP1)	Homo sapiens					GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR000859:CUB domain,					Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:CUB domain-containing protein 1,disulfide bond,domain:CUB,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,site:Cleavage; by ST14/MT-SP1,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CDCP2	CUB domain containing protein 2(CDCP2)	Homo sapiens					GO:0005576~extracellular region,		IPR000859:CUB domain,				SM00042:CUB,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:CUB domain-containing protein 2,disulfide bond,domain:CUB 1,domain:CUB 2,domain:CUB 3,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
CWC22	CWC22 spliceosome associated protein homolog(CWC22)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016607~nuclear speck,GO:0071006~U2-type catalytic step 1 spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR003890:MIF4G-like, type 3,IPR003891:Initiation factor eIF-4 gamma, MA3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,				SM00543:MIF4G,SM00544:MA3,	3D-structure,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Spliceosome,	chain:Pre-mRNA-splicing factor CWC22 homolog,compositionally biased region:Arg-rich,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Ser-rich,domain:MI,domain:MIF4G,modified residue,sequence conflict,sequence variant,
CYP1B1-AS1	CYP1B1 antisense RNA 1(CYP1B1-AS1)	Homo sapiens													chain:Uncharacterized protein C2orf58,sequence variant,
CAMKV	CaM kinase like vesicle associated(CAMKV)	Homo sapiens				GO:0006468~protein phosphorylation,	GO:0005886~plasma membrane,GO:0030659~cytoplasmic vesicle membrane,	GO:0004672~protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR020636:Calcium/calmodulin-dependent/calcium-dependent protein kinase,				SM00220:S_TKc,	Alternative splicing,Calmodulin-binding,Cell membrane,Complete proteome,Cytoplasmic vesicle,Kinase,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:CaM kinase-like vesicle-associated protein,compositionally biased region:Ala-rich,domain:Protein kinase,modified residue,sequence conflict,sequence variant,splice variant,
CBLB	Cbl proto-oncogene B(CBLB)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006508~proteolysis,GO:0006607~NLS-bearing protein import into nucleus,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0023051~regulation of signaling,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0045121~membrane raft,	GO:0001784~phosphotyrosine binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0017124~SH3 domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0061630~ubiquitin protein ligase activity,	IPR000980:SH2 domain,IPR001841:Zinc finger, RING-type,IPR003153:Adaptor protein Cbl, N-terminal helical,IPR009060:UBA-like,IPR011992:EF-hand-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014741:Adaptor protein Cbl, EF hand-like,IPR014742:Adaptor protein Cbl, SH2-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR017907:Zinc finger, RING-type, conserved site,IPR024159:Adaptor protein Cbl, PTB domain,IPR024162:Adaptor protein Cbl,	hsa04012:ErbB signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05220:Chronic myeloid leukemia,			SM00165:UBA,SM00184:RING,	3D-structure,Alternative splicing,Calcium,Complete proteome,Cytoplasm,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	binding site:Phosphotyrosine,chain:E3 ubiquitin-protein ligase CBL-B,compositionally biased region:Pro-rich,domain:CBL N-terminal,domain:EF-hand-like 1,domain:EF-hand-like 2,domain:SH2; atypical,domain:UBA,helix,modified residue,mutagenesis site,region of interest:4H,region of interest:Interaction with SH3KBP1,region of interest:Interaction with VAV1,region of interest:Linker,sequence conflict,sequence variant,splice variant,turn,zinc finger region:RING-type,
D2HGDH	D-2-hydroxyglutarate dehydrogenase(D2HGDH)	Homo sapiens			Energy production and conversion,	GO:0006103~2-oxoglutarate metabolic process,GO:0010042~response to manganese ion,GO:0010043~response to zinc ion,GO:0019516~lactate oxidation,GO:0022904~respiratory electron transport chain,GO:0032025~response to cobalt ion,GO:0032026~response to magnesium ion,GO:0044267~cellular protein metabolic process,GO:0051592~response to calcium ion,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003824~catalytic activity,GO:0004458~D-lactate dehydrogenase (cytochrome) activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0050660~flavin adenine dinucleotide binding,GO:0051990~(R)-2-hydroxyglutarate dehydrogenase activity,GO:0071949~FAD binding,	IPR004113:FAD-linked oxidase, C-terminal,IPR006094:FAD linked oxidase, N-terminal,IPR016164:FAD-linked oxidase-like, C-terminal,IPR016166:FAD-binding, type 2,IPR016167:FAD-binding, type 2, subdomain 1,IPR016169:CO dehydrogenase flavoprotein-like, FAD-binding, subdomain 2,IPR016171:Vanillyl-alcohol oxidase, C-terminal subdomain 2,		600721~D-2-hydroxyglutaric aciduria,			Alternative splicing,Complete proteome,Disease mutation,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,Transit peptide,	chain:D-2-hydroxyglutarate dehydrogenase, mitochondrial,domain:FAD-binding PCMH-type,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
DAB1	DAB1, reelin adaptor protein(DAB1)	Homo sapiens		h_reelinPathway:Reelin Signaling Pathway,		GO:0007162~negative regulation of cell adhesion,GO:0007264~small GTPase mediated signal transduction,GO:0007494~midgut development,GO:0007628~adult walking behavior,GO:0016358~dendrite development,GO:0021517~ventral spinal cord development,GO:0021589~cerebellum structural organization,GO:0021813~cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,GO:0021942~radial glia guided migration of Purkinje cell,GO:0042493~response to drug,GO:0045666~positive regulation of neuron differentiation,GO:0045860~positive regulation of protein kinase activity,GO:0046426~negative regulation of JAK-STAT cascade,GO:0048712~negative regulation of astrocyte differentiation,GO:0050771~negative regulation of axonogenesis,GO:0051645~Golgi localization,GO:0097477~lateral motor column neuron migration,	GO:0005730~nucleolus,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005903~brush border,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0043548~phosphatidylinositol 3-kinase binding,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,				SM00462:PTB,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Disabled homolog 1,domain:PID,modified residue,sequence conflict,sequence variant,splice variant,
DZIP3	DAZ interacting zinc finger protein 3(DZIP3)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019902~phosphatase binding,GO:0031593~polyubiquitin binding,GO:0044822~poly(A) RNA binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Ligase,Metal-binding,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase DZIP3,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,mutagenesis site,sequence conflict,splice variant,zinc finger region:RING-type; atypical,
DCST1	DC-STAMP domain containing 1(DCST1)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR012858:Dendritic cell-specific transmembrane protein-like,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Metal-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:DC-STAMP domain-containing protein 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,zinc finger region:RING-type; degenerate,
DCST2	DC-STAMP domain containing 2(DCST2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR012858:Dendritic cell-specific transmembrane protein-like,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:DC-STAMP domain-containing protein 2,compositionally biased region:Pro-rich,glycosylation site:N-linked (GlcNAc...),splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DCAF17	DDB1 and CUL4 associated factor 17(DCAF17)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005730~nucleolus,GO:0016021~integral component of membrane,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,				241080~Woodhouse-Sakati syndrome,			Alternative splicing,Complete proteome,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	chain:DDB1- and CUL4-associated factor 17,compositionally biased region:Poly-Glu,sequence conflict,sequence variant,splice variant,transmembrane region,
DCAF6	DDB1 and CUL4 associated factor 6(DCAF6)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,	IPR000048:IQ motif, EF-hand binding site,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	3D-structure,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 6,domain:IQ,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence variant,splice variant,
DCAF8	DDB1 and CUL4 associated factor 8(DCAF8)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,		610100~Giant axonal neuropathy 2, autosomal dominant,		SM00320:WD40,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Methylation,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 8,modified residue,mutagenesis site,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,splice variant,
DDX1	DEAD-box helicase 1(DDX1)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006446~regulation of translational initiation,GO:0007275~multicellular organism development,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0032508~DNA duplex unwinding,GO:0043330~response to exogenous dsRNA,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0071920~cleavage body,GO:0072669~tRNA-splicing ligase complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008143~poly(A) binding,GO:0033677~DNA/RNA helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00449:SPRY,SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Activator,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,DNA-binding,Exonuclease,Helicase,Hydrolase,mRNA processing,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transcription,Transcription regulation,tRNA processing,	chain:ATP-dependent RNA helicase DDX1,domain:B30.2/SPRY,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAD box,
DDX18	DEAD-box helicase 18(DDX18)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,GO:0071392~cellular response to estradiol stimulus,	GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM01178:SM01178,	3D-structure,ATP-binding,Chromosome,Complete proteome,Direct protein sequencing,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:ATP-dependent RNA helicase DDX18,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
DDX59	DEAD-box helicase 59(DDX59)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001650:Helicase, C-terminal,IPR007529:Zinc finger, HIT-type,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		174300~Orofaciodigital syndrome V,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Alternative splicing,ATP-binding,Ciliopathy,Complete proteome,Cytoplasm,Disease mutation,Helicase,Hydrolase,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:Probable ATP-dependent RNA helicase DDX59,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,strand,zinc finger region:HIT-type,
DDX11L2	DEAD/H-box helicase 11 like 2(DDX11L2)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,		GO:0003676~nucleic acid binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,	IPR006555:ATP-dependent helicase, C-terminal,
DENND1B	DENN domain containing 1B(DENND1B)	Homo sapiens				GO:0015031~protein transport,GO:0032456~endocytic recycling,GO:0035745~T-helper 2 cell cytokine production,GO:0043547~positive regulation of GTPase activity,GO:0050776~regulation of immune response,GO:0050852~T cell receptor signaling pathway,	GO:0005829~cytosol,GO:0030136~clathrin-coated vesicle,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0017137~Rab GTPase binding,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	3D-structure,Alternative splicing,Asthma,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:DENN domain-containing protein 1B,domain:dDENN,domain:DENN,domain:uDENN,sequence conflict,sequence variant,splice variant,
DENND2C	DENN domain containing 2C(DENND2C)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,		GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Reference proteome,	chain:DENN domain-containing protein 2C,domain:dDENN,domain:DENN,domain:uDENN,sequence conflict,sequence variant,splice variant,
DENND6A	DENN domain containing 6A(DENND6A)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin,	GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,GO:0055037~recycling endosome,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR018307:Late secretory pathway protein AVL9,IPR024224:Uncharacterised protein family FAM116,					Complete proteome,Cytoplasm,Endosome,Guanine-nucleotide releasing factor,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Protein FAM116A,modified residue,sequence conflict,
DEPDC1	DEP domain containing 1(DEPDC1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000198:Rho GTPase-activating protein domain,IPR000591:DEP domain,IPR008936:Rho GTPase activation protein,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00049:DEP,	3D-structure,Alternative splicing,Complete proteome,GTPase activation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:DEP domain-containing protein 1A,domain:DEP,domain:Rho-GAP,helix,modified residue,sequence variant,splice variant,strand,
DHX30	DExH-box helicase 30(DHX30)	Homo sapiens				GO:0006396~RNA processing,GO:1902775~mitochondrial large ribosomal subunit assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Mitochondrion,Mitochondrion nucleoid,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,	chain:Putative ATP-dependent RNA helicase DHX30,compositionally biased region:Poly-Glu,domain:DRBM,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAH box,splice variant,strand,turn,
DHX57	DExH-box helicase 57(DHX57)	Homo sapiens				GO:0006396~RNA processing,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR006575:RWD domain,IPR007502:Helicase-associated domain,IPR009060:UBA-like,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00356:ZnF_C3H1,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Helicase,Hydrolase,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Zinc,Zinc-finger,	chain:Putative ATP-dependent RNA helicase DHX57,compositionally biased region:Gly-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:UBA,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEVH box,splice variant,zinc finger region:C3H1-type,
DHX9	DExH-box helicase 9(DHX9)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006396~RNA processing,GO:0032481~positive regulation of type I interferon production,GO:0032508~DNA duplex unwinding,GO:0048511~rhythmic process,GO:0070934~CRD-mediated mRNA stabilization,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070937~CRD-mediated mRNA stability complex,GO:0097165~nuclear stress granule,	GO:0001085~RNA polymerase II transcription factor binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003724~RNA helicase activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014720:Double-stranded RNA-binding-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00358:DSRM,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	3D-structure,Acetylation,Activator,Alternative splicing,ATP-binding,Biological rhythms,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Helicase,Hydrolase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,RNA-binding,	chain:ATP-dependent RNA helicase A,domain:DRBM 1,domain:DRBM 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with BRCA1,region of interest:Interaction with CREBBP,region of interest:MTAD,region of interest:NTD,sequence conflict,sequence variant,short sequence motif:DEIH box,short sequence motif:Nuclear localization signal,
DIRAS3	DIRAS family GTPase 3(DIRAS3)	Homo sapiens				GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0006349~regulation of gene expression by genetic imprinting,GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Cell membrane,Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Reference proteome,	chain:GTP-binding protein Di-Ras3,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,
DIS3L2	DIS3 like 3'-5' exoribonuclease 2(DIS3L2)	Homo sapiens				GO:0000291~nuclear-transcribed mRNA catabolic process, exonucleolytic,GO:0006364~rRNA processing,GO:0007067~mitotic nuclear division,GO:0008285~negative regulation of cell proliferation,GO:0010587~miRNA catabolic process,GO:0016075~rRNA catabolic process,GO:0019827~stem cell population maintenance,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0051301~cell division,GO:0051306~mitotic sister chromatid separation,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,GO:1990074~polyuridylation-dependent mRNA catabolic process,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0005844~polysome,	GO:0000175~3'-5'-exoribonuclease activity,GO:0000287~magnesium ion binding,GO:0004540~ribonuclease activity,GO:0005515~protein binding,GO:0008266~poly(U) RNA binding,	IPR012340:Nucleic acid-binding, OB-fold,IPR022966:Ribonuclease II/R, conserved site,		267000~Perlman syndrome,			Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Disease mutation,Exonuclease,Hydrolase,Magnesium,Metal-binding,Mitosis,Nuclease,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Tumor suppressor,	chain:DIS3-like exonuclease 2,modified residue,sequence conflict,sequence variant,splice variant,
DLGAP3	DLG associated protein 3(DLGAP3)	Homo sapiens				GO:0023052~signaling,	GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0045211~postsynaptic membrane,	GO:0001540~beta-amyloid binding,GO:0005515~protein binding,	IPR005026:Guanylate-kinase-associated protein,					Cell junction,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Postsynaptic cell membrane,Reference proteome,Synapse,	chain:Disks large-associated protein 3,compositionally biased region:Poly-His,modified residue,
DDI2	DNA damage inducible 1 homolog 2(DDI2)	Homo sapiens				GO:0006508~proteolysis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004190~aspartic-type endopeptidase activity,	IPR000626:Ubiquitin,IPR019103:Aspartic peptidase, DDI1-type,IPR021109:Aspartic peptidase,					3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Protein DDI1 homolog 2,domain:Ubiquitin-like,modified residue,splice variant,
DRAM2	DNA damage regulated autophagy modulator 2(DRAM2)	Homo sapiens				GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0007601~visual perception,GO:0010506~regulation of autophagy,GO:0045494~photoreceptor cell maintenance,	GO:0001917~photoreceptor inner segment,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043231~intracellular membrane-bounded organelle,		IPR019402:Frag1/DRAM/Sfk1,		616502~Cone-rod dystrophy 21,			Apoptosis,Autophagy,Cell membrane,Complete proteome,Cone-rod dystrophy,Disease mutation,Lysosome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:DNA damage-regulated autophagy modulator protein 2,modified residue,sequence conflict,transmembrane region,
DFFB	DNA fragmentation factor subunit beta(DFFB)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_setPathway:Granzyme A mediated Apoptosis Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006309~apoptotic DNA fragmentation,GO:0006915~apoptotic process,GO:0030263~apoptotic chromosome condensation,	GO:0000790~nuclear chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004536~deoxyribonuclease activity,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,	IPR003508:Caspase-activated nuclease CIDE-N,IPR015311:Apoptosis, DNA fragmentation factor 40kDa,	hsa04210:Apoptosis,			SM00266:CAD,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Hydrolase,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA fragmentation factor subunit beta,domain:CIDE-N,helix,sequence variant,splice variant,strand,turn,
DNMT3A	DNA methyltransferase 3 alpha(DNMT3A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0006306~DNA methylation,GO:0006346~methylation-dependent chromatin silencing,GO:0006349~regulation of gene expression by genetic imprinting,GO:0007283~spermatogenesis,GO:0007568~aging,GO:0009636~response to toxic substance,GO:0010212~response to ionizing radiation,GO:0010288~response to lead ion,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0010468~regulation of gene expression,GO:0010942~positive regulation of cell death,GO:0030182~neuron differentiation,GO:0032355~response to estradiol,GO:0033189~response to vitamin A,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0043045~DNA methylation involved in embryo development,GO:0043046~DNA methylation involved in gamete generation,GO:0044027~hypermethylation of CpG island,GO:0045814~negative regulation of gene expression, epigenetic,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046499~S-adenosylmethioninamine metabolic process,GO:0071230~cellular response to amino acid stimulus,GO:0071361~cellular response to ethanol,GO:0071456~cellular response to hypoxia,GO:0090116~C-5 methylation of cytosine,GO:0097284~hepatocyte apoptotic process,	GO:0000775~chromosome, centromeric region,GO:0000791~euchromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005720~nuclear heterochromatin,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0009008~DNA-methyltransferase activity,GO:0042802~identical protein binding,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0051718~DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates,	IPR000313:PWWP,IPR001525:C-5 cytosine methyltransferase,IPR018117:DNA methylase, C-5 cytosine-specific, active site,IPR025766:ADD domain,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,hsa05206:MicroRNAs in cancer,	615879~Tatton-Brown-Rahman syndrome,		SM00293:PWWP,	3D-structure,Alternative promoter usage,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Mental retardation,Metal-binding,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,S-adenosyl-L-methionine,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:DNA (cytosine-5)-methyltransferase 3A,domain:PWWP,helix,modified residue,mutagenesis site,region of interest:Interaction with DNMT1 and DNMT3B,region of interest:Interaction with the PRC2/EED-EZH2 complex,splice variant,strand,turn,zinc finger region:ADD-type,
DPH2	DPH2 homolog(DPH2)	Homo sapiens				GO:0017183~peptidyl-diphthamide biosynthetic process from peptidyl-histidine,	GO:0005829~cytosol,	GO:0005515~protein binding,GO:0090560~2-(3-amino-3-carboxypropyl)histidine synthase activity,	IPR010014:Diphthamide synthesis DHP2, eukaryotic,IPR016435:Diphthamide synthesis, eukaryotic DPH1/archaeal DPH2,					Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Diphthamide biosynthesis protein 2,modified residue,sequence conflict,
DNAJB4	DnaJ heat shock protein family (Hsp40) member B4(DNAJB4)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0009408~response to heat,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001623:DnaJ domain,IPR002939:Chaperone DnaJ, C-terminal,IPR008971:HSP40/DnaJ peptide-binding,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	Cell membrane,Chaperone,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Stress response,	chain:DnaJ homolog subfamily B member 4,domain:J,modified residue,
DNAJC10	DnaJ heat shock protein family (Hsp40) member C10(DNAJC10)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0032781~positive regulation of ATPase activity,GO:0034975~protein folding in endoplasmic reticulum,GO:0034976~response to endoplasmic reticulum stress,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,	GO:0005623~cell,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0034663~endoplasmic reticulum chaperone complex,	GO:0001671~ATPase activator activity,GO:0005515~protein binding,GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,GO:0016671~oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,GO:0030544~Hsp70 protein binding,GO:0051087~chaperone binding,GO:0051117~ATPase binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ domain,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR017937:Thioredoxin, conserved site,IPR021170:DnaJ homolog, subfamily C,	hsa04141:Protein processing in endoplasmic reticulum,		PIRSF037293:ER-resident protein ERdj5,	SM00271:DnaJ,	Alternative splicing,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Membrane,Oxidoreductase,Polymorphism,Proteomics identification,Redox-active center,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily C member 10,domain:J,domain:Thioredoxin 1,domain:Thioredoxin 2,domain:Thioredoxin 3,domain:Thioredoxin 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
DNAJC11	DnaJ heat shock protein family (Hsp40) member C11(DNAJC11)	Homo sapiens					GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001623:DnaJ domain,IPR018253:DnaJ domain, conserved site,IPR024586:DnaJ-like protein C11, C-terminal,				SM00271:DnaJ,	Acetylation,Alternative splicing,Chaperone,Coiled coil,Complete proteome,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily C member 11,domain:J,sequence conflict,sequence variant,splice variant,
DNAJC16	DnaJ heat shock protein family (Hsp40) member C16(DNAJC16)	Homo sapiens				GO:0045454~cell redox homeostasis,	GO:0005623~cell,GO:0016021~integral component of membrane,		IPR001623:DnaJ domain,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily C member 16,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,domain:J,domain:Thioredoxin,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DNAJC27	DnaJ heat shock protein family (Hsp40) member C27(DNAJC27)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071701~regulation of MAPK export from nucleus,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001623:DnaJ domain,IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00271:DnaJ,	3D-structure,Alternative splicing,Complete proteome,GTP-binding,Nucleotide-binding,Nucleus,Oncogene,Reference proteome,	chain:DnaJ homolog subfamily C member 27,domain:J,helix,nucleotide phosphate-binding region:GTP,splice variant,turn,
DNAJC6	DnaJ heat shock protein family (Hsp40) member C6(DNAJC6)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0072318~clathrin coat disassembly,GO:2000369~regulation of clathrin-mediated endocytosis,	GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0031982~vesicle,GO:0045202~synapse,	GO:0004725~protein tyrosine phosphatase activity,GO:0017124~SH3 domain binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001623:DnaJ domain,IPR014020:Tensin phosphatase, C2 domain,	hsa04144:Endocytosis,	615528~Parkinson disease 19, juvenile-onset,		SM00271:DnaJ,SM01326:SM01326,	Acetylation,Alternative splicing,Chaperone,Complete proteome,Hydrolase,Neurodegeneration,Parkinson disease,Parkinsonism,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Repeat,SH3-binding,	active site:Phosphocysteine intermediate,chain:Putative tyrosine-protein phosphatase auxilin,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,domain:C2 tensin-type,domain:J,domain:Phosphatase tensin-type,modified residue,region of interest:3 X 4 AA approximate tandem repeats,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,
DNAJC8	DnaJ heat shock protein family (Hsp40) member C8(DNAJC8)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0045171~intercellular bridge,		IPR001623:DnaJ domain,				SM00271:DnaJ,	Acetylation,Chaperone,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily C member 8,domain:J,modified residue,sequence conflict,
E2F6	E2F transcription factor 6(E2F6)	Homo sapiens				GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015633:E2F Family,IPR015635:Transcription factor E2F6,				SM01372:SM01372,	Alternative splicing,Cell cycle,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor E2F6,compositionally biased region:Poly-Glu,domain:Leucine-zipper,modified residue,mutagenesis site,region of interest:Dimerization,region of interest:Transcription repression,sequence conflict,short sequence motif:DEF box,splice variant,
ELF3	E74 like ETS transcription factor 3(ELF3)	Homo sapiens				GO:0001824~blastocyst development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007275~multicellular organism development,GO:0008544~epidermis development,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060056~mammary gland involution,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,				SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Inflammatory response,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ETS-related transcription factor Elf-3,DNA-binding region:ETS,domain:PNT,helix,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
EBNA1BP2	EBNA1 binding protein 2(EBNA1BP2)	Homo sapiens				GO:0006364~rRNA processing,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0034399~nuclear periphery,	GO:0044822~poly(A) RNA binding,	IPR008610:Eukaryotic rRNA processing,					Acetylation,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,	chain:Probable rRNA-processing protein EBP2,modified residue,sequence conflict,sequence variant,
EDARADD	EDAR associated death domain(EDARADD)	Homo sapiens				GO:0006096~glycolytic process,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0033209~tumor necrosis factor-mediated signaling pathway,	GO:0000015~phosphopyruvate hydratase complex,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0004634~phosphopyruvate hydratase activity,GO:0005515~protein binding,	IPR000488:Death domain,IPR000941:Enolase,IPR011029:Death-like domain,IPR020810:Enolase, C-terminal,IPR020811:Enolase, N-terminal,		614940~Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,614941~Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,	PIRSF001400:enolase,	SM01192:SM01192,SM01193:SM01193,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disease mutation,Ectodermal dysplasia,Polymorphism,Proteomics identification,Receptor,Reference proteome,	chain:Ectodysplasin-A receptor-associated adapter protein,domain:Death,sequence variant,splice variant,
EFCAB14	EF-hand calcium binding domain 14(EFCAB14)	Homo sapiens			Cell division and chromosome partitioning,			GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,					Calcium,Complete proteome,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:EF-hand domain-containing protein KIAA0494,domain:EF-hand 1,domain:EF-hand 2,modified residue,sequence variant,
EFCAB2	EF-hand calcium binding domain 2(EFCAB2)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	Alternative splicing,Complete proteome,Reference proteome,Repeat,	chain:EF-hand calcium-binding domain-containing protein 2,domain:EF-hand 1,domain:EF-hand 2,sequence conflict,splice variant,
EFCAB7	EF-hand calcium binding domain 7(EFCAB7)	Homo sapiens					GO:0072372~primary cilium,	GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	calcium-binding region:3,chain:EF-hand calcium-binding domain-containing protein 7,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,sequence variant,splice variant,
EFHB	EF-hand domain family member B(EFHB)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:EF-hand domain-containing family member B,domain:EF-hand 1,domain:EF-hand 2,sequence conflict,sequence variant,splice variant,
EFHD1	EF-hand domain family member D1(EFHD1)	Homo sapiens				GO:0031175~neuron projection development,	GO:0005743~mitochondrial inner membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	Alternative splicing,Calcium,Coiled coil,Complete proteome,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:EF-hand domain-containing protein D1,domain:EF-hand 1,domain:EF-hand 2,sequence variant,
EFHD2	EF-hand domain family member D2(EFHD2)	Homo sapiens				GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0045121~membrane raft,	GO:0005509~calcium ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	Acetylation,Calcium,Coiled coil,Complete proteome,Direct protein sequencing,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:EF-hand domain-containing protein D2,domain:EF-hand 1,domain:EF-hand 2,modified residue,
EFR3B	EFR3 homolog B(EFR3B)	Homo sapiens				GO:0046854~phosphatidylinositol phosphorylation,GO:0090002~establishment of protein localization to plasma membrane,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Protein EFR3 homolog B,modified residue,splice variant,
EFEMP1	EGF containing fibulin like extracellular matrix protein 1(EFEMP1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007601~visual perception,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0032331~negative regulation of chondrocyte differentiation,GO:0043010~camera-type eye development,GO:0048048~embryonic eye morphogenesis,GO:0048050~post-embryonic eye morphogenesis,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005006~epidermal growth factor-activated receptor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR026823:Complement Clr-like EGF domain,		126600~Doyne honeycomb degeneration of retina,		SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Disease mutation,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Growth factor,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:EGF-containing fibulin-like extracellular matrix protein 1,disulfide bond,domain:EGF-like 1; atypical,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
EOGT	EGF domain specific O-linked N-acetylglucosamine transferase(EOGT)	Homo sapiens				GO:0006493~protein O-linked glycosylation,	GO:0005788~endoplasmic reticulum lumen,	GO:0016262~protein N-acetylglucosaminyltransferase activity,	IPR007657:Glycosyltransferase AER61, uncharacterised,	hsa00514:Other types of O-glycan biosynthesis,	615297~Adams-Oliver syndrome 4,			Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Proteomics identification,Reference proteome,Signal,Transferase,	chain:Uncharacterized glycosyltransferase AER61,glycosylation site:N-linked (GlcNAc...),sequence conflict,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
EHBP1	EH domain binding protein 1(EHBP1)	Homo sapiens					GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR001715:Calponin homology domain,IPR019448:EEIG1/EHBP1 N-terminal domain,IPR022735:Domain of unknown function DUF3585,		611868~Prostate cancer, hereditary, 12,		SM00033:CH,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:EH domain-binding protein 1,compositionally biased region:Poly-Glu,domain:CH,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
EHD3	EH domain containing 3(EHD3)	Homo sapiens				GO:0001881~receptor recycling,GO:0007596~blood coagulation,GO:0032456~endocytic recycling,GO:0034498~early endosome to Golgi transport,GO:0042384~cilium assembly,GO:0051260~protein homooligomerization,GO:0055117~regulation of cardiac muscle contraction,GO:0060271~cilium morphogenesis,GO:0072661~protein targeting to plasma membrane,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:0090160~Golgi to lysosome transport,GO:1901387~positive regulation of voltage-gated calcium channel activity,GO:1903358~regulation of Golgi organization,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0010008~endosome membrane,GO:0020018~ciliary pocket membrane,GO:0030139~endocytic vesicle,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,	GO:0003676~nucleic acid binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,	IPR000261:EPS15 homology (EH),IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,			SM00027:EH,	Acetylation,Alternative splicing,ATP-binding,Calcium,Cell membrane,Cell projection,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Direct protein sequencing,Endosome,Isopeptide bond,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Protein transport,Reference proteome,Transport,Ubl conjugation,	binding site:ATP,chain:EH domain-containing protein 3,domain:EF-hand,domain:EH,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,
ELAVL4	ELAV like RNA binding protein 4(ELAVL4)	Homo sapiens				GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007612~learning,GO:0007626~locomotory behavior,GO:0048813~dendrite morphogenesis,		GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0017091~AU-rich element binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR006548:Splicing factor ELAV/HuD,IPR012677:Nucleotide-binding, alpha-beta plait,		Neuropathy, paraneoplastic sensory~Neuropathy, paraneoplastic sensory,		SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:ELAV-like protein 4,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,sequence variant,splice variant,strand,turn,
ELK4	ELK4, ETS transcription factor(ELK4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0030154~cell differentiation,GO:0070932~histone H3 deacetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa04010:MAPK signaling pathway,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,			SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ETS domain-containing protein Elk-4,DNA-binding region:ETS,helix,sequence conflict,splice variant,strand,turn,
ERC2	ELKS/RAB6-interacting/CAST family member 2(ERC2)	Homo sapiens					GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0030054~cell junction,GO:0030426~growth cone,GO:0042734~presynaptic membrane,GO:0048786~presynaptic active zone,	GO:0005515~protein binding,	IPR019323:CAZ complex, RIM-binding protein,					Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Synapse,Synaptosome,	chain:ERC protein 2,compositionally biased region:Poly-Gly,compositionally biased region:Poly-His,compositionally biased region:Poly-Lys,modified residue,sequence variant,
ELMOD3	ELMO domain containing 3(ELMOD3)	Homo sapiens					GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0032420~stereocilium,GO:0060091~kinocilium,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR006816:Engulfment/cell motility, ELMO,		615429~Deafness, autosomal recessive 88,			Alternative splicing,Cell projection,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Disease mutation,GTPase activation,Non-syndromic deafness,Polymorphism,Proteomics identification,Reference proteome,	chain:ELMO domain-containing protein 3,domain:ELMO,sequence conflict,sequence variant,splice variant,
EPHA10	EPH receptor A10(EPHA10)	Homo sapiens				GO:0018108~peptidyl-tyrosine phosphorylation,GO:0048013~ephrin receptor signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0005003~ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008979:Galactose-binding domain-like,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,			PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	chain:Ephrin type-A receptor 10,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EPHA2	EPH receptor A2(EPHA2)	Homo sapiens				GO:0001501~skeletal system development,GO:0001570~vasculogenesis,GO:0001649~osteoblast differentiation,GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:0006954~inflammatory response,GO:0007275~multicellular organism development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010591~regulation of lamellipodium assembly,GO:0014028~notochord formation,GO:0016032~viral process,GO:0016477~cell migration,GO:0016525~negative regulation of angiogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021915~neural tube development,GO:0030182~neuron differentiation,GO:0030216~keratinocyte differentiation,GO:0030316~osteoclast differentiation,GO:0032682~negative regulation of chemokine production,GO:0033598~mammary gland epithelial cell proliferation,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0036342~post-anal tail morphogenesis,GO:0043491~protein kinase B signaling,GO:0043535~regulation of blood vessel endothelial cell migration,GO:0045765~regulation of angiogenesis,GO:0046058~cAMP metabolic process,GO:0046849~bone remodeling,GO:0048013~ephrin receptor signaling pathway,GO:0048320~axial mesoderm formation,GO:0048870~cell motility,GO:0050830~defense response to Gram-positive bacterium,GO:0051898~negative regulation of protein kinase B signaling,GO:0060035~notochord cell development,GO:0060326~cell chemotaxis,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0070309~lens fiber cell morphogenesis,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070848~response to growth factor,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090630~activation of GTPase activity,GO:0098609~cell-cell adhesion,GO:1901491~negative regulation of lymphangiogenesis,GO:1904238~pericyte cell differentiation,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0030027~lamellipodium,GO:0031256~leading edge membrane,GO:0031258~lamellipodium membrane,GO:0032587~ruffle membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,	116600~Cataract 6, multiple types,	PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,Angiogenesis,Apoptosis,ATP-binding,Cataract,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Differentiation,Disease mutation,Disulfide bond,Glycoprotein,Host-virus interaction,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 2,compositionally biased region:Cys-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
EPHA3	EPH receptor A3(EPHA3)	Homo sapiens				GO:0007155~cell adhesion,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0032956~regulation of actin cytoskeleton organization,GO:0043087~regulation of GTPase activity,GO:0048013~ephrin receptor signaling pathway,GO:0051893~regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0071300~cellular response to retinoic acid,GO:0097155~fasciculation of sensory neuron axon,GO:0097156~fasciculation of motor neuron axon,	GO:0005576~extracellular region,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005003~ephrin receptor activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 3,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
EPHA4	EPH receptor A4(EPHA4)	Homo sapiens		h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,		GO:0007155~cell adhesion,GO:0007628~adult walking behavior,GO:0008045~motor neuron axon guidance,GO:0008347~glial cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021957~corticospinal tract morphogenesis,GO:0043087~regulation of GTPase activity,GO:0043507~positive regulation of JUN kinase activity,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,GO:0048681~negative regulation of axon regeneration,GO:0048710~regulation of astrocyte differentiation,GO:0050770~regulation of axonogenesis,GO:0050775~positive regulation of dendrite morphogenesis,GO:0061001~regulation of dendritic spine morphogenesis,GO:0072178~nephric duct morphogenesis,GO:0097155~fasciculation of sensory neuron axon,GO:0097156~fasciculation of motor neuron axon,GO:2001108~positive regulation of Rho guanyl-nucleotide exchange factor activity,	GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030424~axon,GO:0030425~dendrite,GO:0031594~neuromuscular junction,GO:0031901~early endosome membrane,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0044295~axonal growth cone,GO:0045211~postsynaptic membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042731~PH domain binding,GO:0042802~identical protein binding,GO:0046875~ephrin receptor binding,GO:0097161~DH domain binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00220:S_TKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Developmental protein,Endosome,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Synapse,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 4,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EPHA6	EPH receptor A6(EPHA6)	Homo sapiens				GO:0018108~peptidyl-tyrosine phosphorylation,GO:0048013~ephrin receptor signaling pathway,	GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 6,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,region of interest:Ephrin-binding,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EPHA8	EPH receptor A8(EPHA8)	Homo sapiens				GO:0006929~substrate-dependent cell migration,GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0016322~neuron remodeling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030155~regulation of cell adhesion,GO:0031175~neuron projection development,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0043410~positive regulation of MAPK cascade,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,GO:0071372~cellular response to follicle-stimulating hormone stimulus,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031901~early endosome membrane,GO:0043005~neuron projection,	GO:0005004~GPI-linked ephrin receptor activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR020691:Ephrin type-A receptor 8,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Developmental protein,Endosome,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 8,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EPHB2	EPH receptor B2(EPHB2)	Homo sapiens				GO:0001525~angiogenesis,GO:0001655~urogenital system development,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0007612~learning,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021631~optic nerve morphogenesis,GO:0021952~central nervous system projection neuron axonogenesis,GO:0022038~corpus callosum development,GO:0031290~retinal ganglion cell axon guidance,GO:0042472~inner ear morphogenesis,GO:0048013~ephrin receptor signaling pathway,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0048593~camera-type eye morphogenesis,GO:0050771~negative regulation of axonogenesis,GO:0050878~regulation of body fluid levels,GO:0051965~positive regulation of synapse assembly,GO:0060021~palate development,GO:0060996~dendritic spine development,GO:0060997~dendritic spine morphogenesis,GO:0071679~commissural neuron axon guidance,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0004713~protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008046~axon guidance receptor activity,GO:0042802~identical protein binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,	603688~Prostate cancer/brain cancer susceptibility, somatic,	PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Cell projection,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tumor suppressor,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-B receptor 2,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding (in isoform 2),signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EDEM3	ER degradation enhancing alpha-mannosidase like protein 3(EDEM3)	Homo sapiens				GO:0006491~N-glycan processing,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:1904380~endoplasmic reticulum mannose trimming,GO:1904382~mannose trimming involved in glycoprotein ERAD pathway,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0044322~endoplasmic reticulum quality control compartment,	GO:0004559~alpha-mannosidase activity,GO:0004569~glycoprotein endo-alpha-1,2-mannosidase activity,GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,	IPR001382:Glycoside hydrolase, family 47,IPR003137:Protease-associated domain, PA,	hsa04141:Protein processing in endoplasmic reticulum,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosidase,Hydrolase,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,Unfolded protein response,	chain:ER degradation-enhancing alpha- mannosidase-like 3,domain:PA,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,
EMC1	ER membrane protein complex subunit 1(EMC1)	Homo sapiens			Function unknown,	GO:0034975~protein folding in endoplasmic reticulum,	GO:0016021~integral component of membrane,GO:0072546~ER membrane protein complex,		IPR002372:Pyrrolo-quinoline quinone repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR011678:Domain of unknown function DUF1620,IPR026895:ER membrane protein complex subunit 1,IPR027295:Quinonprotein alcohol dehydrogenase-like domain,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA0090,domain:DUF1620,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ERRFI1	ERBB receptor feedback inhibitor 1(ERRFI1)	Homo sapiens				GO:0006950~response to stress,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0031953~negative regulation of protein autophosphorylation,GO:0032691~negative regulation of interleukin-1 beta production,GO:0032869~cellular response to insulin stimulus,GO:0032966~negative regulation of collagen biosynthetic process,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0042536~negative regulation of tumor necrosis factor biosynthetic process,GO:0043547~positive regulation of GTPase activity,GO:0043589~skin morphogenesis,GO:0045616~regulation of keratinocyte differentiation,GO:0048286~lung alveolus development,GO:0060426~lung vasculature development,GO:0060428~lung epithelium development,GO:0061469~regulation of type B pancreatic cell proliferation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071474~cellular hyperosmotic response,GO:0071549~cellular response to dexamethasone stimulus,GO:1903243~negative regulation of cardiac muscle hypertrophy in response to stress,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0031267~small GTPase binding,	IPR021619:EGFR receptor inhibitor Mig-6,					3D-structure,Acetylation,Cell membrane,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Tumor suppressor,	chain:ERBB receptor feedback inhibitor 1,modified residue,sequence conflict,sequence variant,turn,
ERI3	ERI1 exoribonuclease family member 3(ERI3)	Homo sapiens				GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),		GO:0003676~nucleic acid binding,GO:0004527~exonuclease activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR012337:Ribonuclease H-like domain,IPR013520:Exonuclease, RNase T/DNA polymerase III,				SM00479:EXOIII,	3D-structure,Alternative splicing,Amyloid,Complete proteome,Exonuclease,Hydrolase,Magnesium,Metal-binding,Nuclease,Prion,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:AMP,chain:ERI1 exoribonuclease 3,domain:Exonuclease,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,splice variant,
ETV3L	ETS variant 3 like(ETV3L)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00413:ETS,	Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:ETS translocation variant 3-like protein,compositionally biased region:Pro-rich,DNA-binding region:ETS,sequence variant,
EYA3	EYA transcriptional coactivator and phosphatase 3(EYA3)	Homo sapiens				GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007601~visual perception,GO:0009653~anatomical structure morphogenesis,GO:0010212~response to ionizing radiation,GO:0016576~histone dephosphorylation,GO:0030154~cell differentiation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0045739~positive regulation of DNA repair,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006545:EYA,					Acetylation,Activator,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Developmental protein,DNA damage,DNA repair,Hydrolase,Magnesium,Metal-binding,Nucleus,Phosphoprotein,Protein phosphatase,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	active site:Nucleophile,active site:Proton donor,chain:Eyes absent homolog 3,metal ion-binding site:Magnesium,modified residue,mutagenesis site,sequence conflict,splice variant,
FBXW12	F-box and WD repeat domain containing 12(FBXW12)	Homo sapiens					GO:0016021~integral component of membrane,		IPR001810:F-box domain, cyclin-like,IPR011044:Quinoprotein amine dehydrogenase, beta chain-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00256:FBOX,	Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation pathway,WD repeat,	chain:F-box/WD repeat-containing protein 12,domain:F-box,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,
FBXL2	F-box and leucine rich repeat protein 2(FBXL2)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0006513~protein monoubiquitination,GO:0010506~regulation of autophagy,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019005~SCF ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0019903~protein phosphatase binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,	IPR001611:Leucine-rich repeat,IPR001810:F-box domain, cyclin-like,IPR006553:Leucine-rich repeat, cysteine-containing subtype,				SM00256:FBOX,SM00367:LRR_CC,	Alternative splicing,Calcium,Calmodulin-binding,Complete proteome,Host-virus interaction,Leucine-rich repeat,Lipoprotein,Membrane,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 2,domain:F-box,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,
FBXO11	F-box protein 11(FBXO11)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007605~sensory perception of sound,GO:0016567~protein ubiquitination,GO:0035246~peptidyl-arginine N-methylation,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016274~protein-arginine N-methyltransferase activity,	IPR001810:F-box domain, cyclin-like,IPR003126:Zinc finger, N-recognin,IPR006626:Parallel beta-helix repeat,IPR006633:Carbohydrate-binding/sugar hydrolysis domain,IPR007742:Periplasmic copper-binding protein NosD, beta helix domain,IPR011050:Pectin lyase fold/virulence factor,IPR012334:Pectin lyase fold,IPR022441:Parallel beta-helix repeat-2,				SM00256:FBOX,SM00396:ZnF_UBR1,SM00710:PbH1,SM00722:CASH,	Alternative splicing,Chromosome,Complete proteome,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:F-box only protein 11,domain:F-box,repeat:PbH1 1,repeat:PbH1 10,repeat:PbH1 11,repeat:PbH1 12,repeat:PbH1 13,repeat:PbH1 14,repeat:PbH1 15,repeat:PbH1 16,repeat:PbH1 17,repeat:PbH1 18,repeat:PbH1 19,repeat:PbH1 2,repeat:PbH1 3,repeat:PbH1 4,repeat:PbH1 5,repeat:PbH1 6,repeat:PbH1 7,repeat:PbH1 8,repeat:PbH1 9,sequence conflict,sequence variant,splice variant,zinc finger region:UBR-type,
FBXO2	F-box protein 2(FBXO2)	Homo sapiens		h_eradPathway:ERï¿½associated degradation (ERAD) Pathway,		GO:0000209~protein polyubiquitination,GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0006516~glycoprotein catabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0031090~organelle membrane,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,GO:0001948~glycoprotein binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001810:F-box domain, cyclin-like,IPR007397:F-box associated (FBA) domain,IPR008979:Galactose-binding domain-like,	hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,			SM01198:SM01198,	Complete proteome,Cytoplasm,Endoplasmic reticulum,Lectin,Membrane,Microsome,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 2,domain:F-box,domain:FBA,sequence conflict,sequence variant,
FBXO28	F-box protein 28(FBXO28)	Homo sapiens					GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,	GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,					Alternative splicing,Centromere,Chromosome,Coiled coil,Complete proteome,Kinetochore,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 28,domain:F-box,modified residue,
FBXO36	F-box protein 36(FBXO36)	Homo sapiens				GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,			IPR001810:F-box domain, cyclin-like,				SM00256:FBOX,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 36,domain:F-box,sequence variant,
FBXO42	F-box protein 42(FBXO42)	Homo sapiens						GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR011498:Kelch repeat type 2,IPR015915:Kelch-type beta propeller,				SM00256:FBOX,	Complete proteome,Kelch repeat,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box only protein 42,domain:F-box,modified residue,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,sequence conflict,sequence variant,
FBXO44	F-box protein 44(FBXO44)	Homo sapiens					GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR007397:F-box associated (FBA) domain,IPR008979:Galactose-binding domain-like,				SM00256:FBOX,SM01198:SM01198,	3D-structure,Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 44,domain:F-box,domain:FBA,sequence conflict,splice variant,
F11R	F11 receptor(F11R)	Homo sapiens				GO:0001817~regulation of cytokine production,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0009314~response to radiation,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0031032~actomyosin structure organization,GO:0034260~negative regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0045777~positive regulation of blood pressure,GO:0046718~viral entry into host cell,GO:0050892~intestinal absorption,GO:0050900~leukocyte migration,GO:0070830~bicellular tight junction assembly,GO:0090002~establishment of protein localization to plasma membrane,GO:0090557~establishment of endothelial intestinal barrier,GO:0090559~regulation of membrane permeability,GO:0098609~cell-cell adhesion,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005923~bicellular tight junction,GO:0015630~microtubule cytoskeleton,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0031410~cytoplasmic vesicle,GO:0036057~slit diaphragm,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0005515~protein binding,GO:0030165~PDZ domain binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,			SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Tight junction,Transmembrane,Transmembrane helix,	chain:Junctional adhesion molecule A,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
FAM20B	FAM20B, glycosaminoglycan xylosylkinase(FAM20B)	Homo sapiens				GO:0016310~phosphorylation,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0046872~metal ion binding,	IPR009581:Domain of unknown function DUF1193,IPR024869:FAM20,					ATP-binding,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Kinase,Manganese,Membrane,Metal-binding,Nucleotide-binding,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Protein FAM20B,glycosylation site:N-linked (GlcNAc...),short sequence motif:Microbody targeting signal,signal peptide,
FANCD2OS	FANCD2 opposite strand(FANCD2OS)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein C3orf24,
FASTKD1	FAST kinase domains 1(FASTKD1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0045333~cellular respiration,	GO:0005739~mitochondrion,	GO:0004672~protein kinase activity,GO:0044822~poly(A) RNA binding,	IPR010622:FAST kinase leucine-rich,IPR013579:FAST kinase-like protein, subdomain 2,IPR013584:RAP domain,				SM00952:SM00952,	Acetylation,Alternative splicing,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:FAST kinase domain-containing protein 1,domain:RAP,modified residue,sequence conflict,sequence variant,splice variant,
FASTKD2	FAST kinase domains 2(FASTKD2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0045333~cellular respiration,GO:1902775~mitochondrial large ribosomal subunit assembly,	GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0004672~protein kinase activity,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR010622:FAST kinase leucine-rich,IPR013579:FAST kinase-like protein, subdomain 2,IPR013584:RAP domain,		220110~Mitochondrial complex IV deficiency,		SM00952:SM00952,	Alternative splicing,Complete proteome,Mitochondrion,Mitochondrion nucleoid,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA-binding,Transit peptide,	chain:FAST kinase domain-containing protein 2,domain:RAP,sequence variant,splice variant,
FRMD4B	FERM domain containing 4B(FRMD4B)	Homo sapiens				GO:0090162~establishment of epithelial cell polarity,	GO:0001726~ruffle,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,		IPR000299:FERM domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR021774:Protein of unknown function DUF3338,				SM00295:B41,SM01196:SM01196,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Proteomics identification,Reference proteome,	chain:FERM domain-containing protein 4B,domain:FERM,modified residue,
FARP2	FERM, ARH/RhoGEF and pleckstrin domain protein 2(FARP2)	Homo sapiens				GO:0007155~cell adhesion,GO:0016322~neuron remodeling,GO:0016601~Rac protein signal transduction,GO:0030316~osteoclast differentiation,GO:0031532~actin cytoskeleton reorganization,GO:0033623~regulation of integrin activation,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0071526~semaphorin-plexin signaling pathway,GO:0071800~podosome assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0019898~extrinsic component of membrane,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,	hsa04015:Rap1 signaling pathway,hsa04520:Adherens junction,			SM00233:PH,SM00295:B41,SM00325:RhoGEF,SM01195:SM01195,SM01196:SM01196,	Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:FERM, RhoGEF and pleckstrin domain- containing protein 2,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:DH,domain:FERM,domain:PH 1,domain:PH 2,modified residue,sequence variant,splice variant,
FGGY	FGGY carbohydrate kinase domain containing(FGGY)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0016310~phosphorylation,GO:0070050~neuron cellular homeostasis,	GO:0005737~cytoplasm,	GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,	IPR006003:Carbohydrate kinase, FGGY-related,IPR018484:Carbohydrate kinase, FGGY, N-terminal,IPR018485:Carbohydrate kinase, FGGY, C-terminal,			PIRSF000538:keto-sugar kinase,		Alternative splicing,Amyotrophic lateral sclerosis,Complete proteome,Kinase,Neurodegeneration,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:FGGY carbohydrate kinase domain- containing protein,sequence variant,splice variant,
FKBP7	FK506 binding protein 7(FKBP7)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0061077~chaperone-mediated protein folding,	GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005528~FK506 binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,					Alternative splicing,Calcium,Complete proteome,Endoplasmic reticulum,Glycoprotein,Isomerase,Metal-binding,Proteomics identification,Reference proteome,Repeat,Rotamase,Signal,	calcium-binding region:1,calcium-binding region:2,chain:FK506-binding protein 7,domain:EF-hand 1,domain:EF-hand 2,domain:PPIase FKBP-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
FLVCR1-AS1	FLVCR1 antisense RNA 1 (head to head)(FLVCR1-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein LQK1,
FOSL2	FOS like 2, AP-1 transcription factor subunit(FOSL2)	Homo sapiens		h_ranklPathway:Bone Remodelling,		GO:0003334~keratinocyte development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008219~cell death,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	hsa04380:Osteoclast differentiation,			SM00338:BRLZ,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Fos-related antigen 2,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,
FPGT-TNNI3K	FPGT-TNNI3K readthrough(FPGT-TNNI3K)	Homo sapiens				GO:0002027~regulation of heart rate,GO:0006468~protein phosphorylation,GO:0055117~regulation of cardiac muscle contraction,GO:0086069~bundle of His cell to Purkinje myocyte communication,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0031013~troponin I binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002110:Ankyrin repeat,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,ATP-binding,Cardiomyopathy,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,
FRG2C	FSHD region gene 2 family member C(FRG2C)	Homo sapiens					GO:0005634~nucleus,		IPR026245:Protein FRG2,					Complete proteome,Nucleus,Polymorphism,Reference proteome,	chain:Protein FRG2-like-2,sequence variant,
FYCO1	FYVE and coiled-coil domain containing 1(FYCO1)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006810~transport,GO:0072383~plus-end-directed vesicle transport along microtubule,GO:1901098~positive regulation of autophagosome maturation,	GO:0005764~lysosome,GO:0005770~late endosome,GO:0005776~autophagosome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR004012:RUN,IPR009038:GOLD,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,		610019~Cataract 18, autosomal recessive,		SM00064:FYVE,	3D-structure,Acetylation,Alternative splicing,Cataract,Coiled coil,Complete proteome,Cytoplasmic vesicle,Disease mutation,Endosome,Lysosome,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:FYVE and coiled-coil domain-containing protein 1,domain:GOLD,domain:RUN,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:FYVE-type,
FGD5	FYVE, RhoGEF and PH domain containing 5(FGD5)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0030036~actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0046847~filopodium assembly,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0030027~lamellipodium,GO:0032587~ruffle membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0031267~small GTPase binding,GO:0046872~metal ion binding,	IPR000219:Dbl homology (DH) domain,IPR000306:Zinc finger, FYVE-type,IPR001849:Pleckstrin homology domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR011993:Pleckstrin homology-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,				SM00064:FYVE,SM00233:PH,SM00325:RhoGEF,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Endoplasmic reticulum,Endosome,Golgi apparatus,Guanine-nucleotide releasing factor,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:FYVE, RhoGEF and PH domain-containing protein 5,compositionally biased region:Glu-rich,compositionally biased region:Poly-Lys,domain:DH,domain:PH 1,domain:PH 2,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:FYVE-type,
FANCD2	Fanconi anemia complementation group D2(FANCD2)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0006281~DNA repair,GO:0007129~synapsis,GO:0007276~gamete generation,GO:0010332~response to gamma radiation,GO:0034599~cellular response to oxidative stress,GO:0036297~interstrand cross-link repair,GO:0045589~regulation of regulatory T cell differentiation,GO:0048854~brain morphogenesis,GO:0050727~regulation of inflammatory response,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0097150~neuronal stem cell population maintenance,GO:2000348~regulation of CD40 signaling pathway,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0070182~DNA polymerase binding,		hsa03460:Fanconi anemia pathway,	227646~Fanconi anemia, complementation group D2,			Alternative splicing,Cell cycle,Complete proteome,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Fanconi anemia group D2 protein,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,mutagenesis site,region of interest:Interaction with BRCA2,region of interest:Interaction with FANCE,sequence conflict,sequence variant,splice variant,
FANCL	Fanconi anemia complementation group L(FANCL)	Homo sapiens				GO:0006281~DNA repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0007276~gamete generation,GO:0036297~interstrand cross-link repair,GO:0042127~regulation of cell proliferation,	GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043240~Fanconi anaemia nuclear complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019162:Fanconi anemia complex, subunit FancL, WD-repeat containing domain,IPR026848:E3 ubiquitin-protein ligase FANCL,	hsa03460:Fanconi anemia pathway,hsa04120:Ubiquitin mediated proteolysis,	614083~Fanconi anemia, complementation group L,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA damage,DNA repair,Fanconi anemia,Ligase,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase FANCL,mutagenesis site,sequence conflict,sequence variant,zinc finger region:RING-type,
FAAP20	Fanconi anemia core complex associated protein 20(FAAP20)	Homo sapiens				GO:0006974~cellular response to DNA damage stimulus,GO:0019985~translesion synthesis,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0030054~cell junction,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,GO:0031593~polyubiquitin binding,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,GO:0070530~K63-linked polyubiquitin binding,						3D-structure,Alternative splicing,Chromosome,Complete proteome,DNA damage,DNA repair,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Uncharacterized protein C1orf86,sequence conflict,sequence variant,splice variant,
FAF1	Fas associated factor 1(FAF1)	Homo sapiens		h_fasPathway:FAS signaling pathway ( CD95 ),		GO:0006915~apoptotic process,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0008219~cell death,GO:0010942~positive regulation of cell death,GO:0030155~regulation of cell adhesion,GO:0031334~positive regulation of protein complex assembly,GO:0042176~regulation of protein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045859~regulation of protein kinase activity,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031265~CD95 death-inducing signaling complex,GO:0034098~VCP-NPL4-UFD1 AAA ATPase complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0043130~ubiquitin binding,GO:0051059~NF-kappaB binding,	IPR001012:UBX,IPR006577:UAS,IPR012336:Thioredoxin-like fold,				SM00166:UBX,SM00594:UAS,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:FAS-associated factor 1,domain:UBX,helix,modified residue,sequence conflict,splice variant,strand,turn,
FCER1A	Fc fragment of IgE receptor Ia(FCER1A)	Homo sapiens		h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,		GO:0001812~positive regulation of type I hypersensitivity,GO:0001820~serotonin secretion,GO:0007257~activation of JUN kinase activity,GO:0019370~leukotriene biosynthetic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043306~positive regulation of mast cell degranulation,GO:0045401~positive regulation of interleukin-3 biosynthetic process,GO:0045425~positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050850~positive regulation of calcium-mediated signaling,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0019767~IgE receptor activity,GO:0019863~IgE binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04071:Sphingolipid signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa05310:Asthma,			SM00408:IGc2,SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,IgE-binding protein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:High affinity immunoglobulin epsilon receptor subunit alpha,disulfide bond,domain:Ig-like 1,domain:Ig-like 2,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCER1G	Fc fragment of IgE receptor Ig(FCER1G)	Homo sapiens		h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,		GO:0001798~positive regulation of type IIa hypersensitivity,GO:0001805~positive regulation of type III hypersensitivity,GO:0001812~positive regulation of type I hypersensitivity,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002283~neutrophil activation involved in immune response,GO:0002292~T cell differentiation involved in immune response,GO:0002431~Fc receptor mediated stimulatory signaling pathway,GO:0002554~serotonin secretion by platelet,GO:0006911~phagocytosis, engulfment,GO:0007229~integrin-mediated signaling pathway,GO:0007596~blood coagulation,GO:0010543~regulation of platelet activation,GO:0016064~immunoglobulin mediated immune response,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030168~platelet activation,GO:0030593~neutrophil chemotaxis,GO:0031623~receptor internalization,GO:0032733~positive regulation of interleukin-10 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032765~positive regulation of mast cell cytokine production,GO:0033026~negative regulation of mast cell apoptotic process,GO:0038094~Fc-gamma receptor signaling pathway,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I,GO:0042742~defense response to bacterium,GO:0043306~positive regulation of mast cell degranulation,GO:0045087~innate immune response,GO:0045576~mast cell activation,GO:0050766~positive regulation of phagocytosis,GO:0050900~leukocyte migration,GO:0071404~cellular response to low-density lipoprotein particle stimulus,GO:0072659~protein localization to plasma membrane,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0032998~Fc-epsilon receptor I complex,	GO:0005515~protein binding,GO:0019767~IgE receptor activity,GO:0019863~IgE binding,GO:0019864~IgG binding,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR021663:T-cell surface glycoprotein CD3 zeta/eta subunit/High affinity IgE receptor gamma subunit,	hsa04071:Sphingolipid signaling pathway,hsa04611:Platelet activation,hsa04650:Natural killer cell mediated cytotoxicity,hsa04664:Fc epsilon RI signaling pathway,hsa05152:Tuberculosis,hsa05310:Asthma,			SM00077:ITAM,	Cell membrane,Complete proteome,Disulfide bond,IgE-binding protein,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:High affinity immunoglobulin epsilon receptor subunit gamma,disulfide bond,domain:ITAM,modified residue,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCGR3A	Fc fragment of IgG receptor IIIa(FCGR3A)	Homo sapiens	56.Macrophage_regulation_of_CD4+T_cells,			GO:0006955~immune response,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0019864~IgG binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04650:Natural killer cell mediated cytotoxicity,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05322:Systemic lupus erythematosus,	615707~Immunodeficiency 20,		SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,IgG-binding protein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor III-A,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCGR3B	Fc fragment of IgG receptor IIIb(FCGR3B)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0006955~immune response,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0019864~IgG binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04650:Natural killer cell mediated cytotoxicity,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05322:Systemic lupus erythematosus,	Neutropenia, alloimmune neonatal~Neutropenia, alloimmune neonatal,		SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,IgG-binding protein,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor III-B,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,strand,
FCGR2A	Fc fragment of IgG receptor IIa(FCGR2A)	Homo sapiens				GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04611:Platelet activation,hsa04666:Fc gamma R-mediated phagocytosis,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05322:Systemic lupus erythematosus,	152700~Lupus nephritis, susceptibility to,219700~Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis,611162~Malaria, severe, susceptibility to,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,IgG-binding protein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor II-a,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCGR2B	Fc fragment of IgG receptor IIb(FCGR2B)	Homo sapiens		h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,		GO:0006955~immune response,GO:0007165~signal transduction,GO:0016032~viral process,GO:0050776~regulation of immune response,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04662:B cell receptor signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05162:Measles,	152700~Systemic lupus erythematosus, susceptibility to,611162~Malaria, resistance to,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Host-virus interaction,IgG-binding protein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor II-b,chain:Low affinity immunoglobulin gamma Fc region receptor II-c,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,short sequence motif:ITIM motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCGR2C	Fc fragment of IgG receptor IIc (gene/pseudogene)(FCGR2C)	Homo sapiens				GO:0006955~immune response,GO:0007165~signal transduction,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,	188030~Thrombocytopenic purpura, autoimmune,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,IgG-binding protein,Immunoglobulin domain,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor II-b,chain:Low affinity immunoglobulin gamma Fc region receptor II-c,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,short sequence motif:ITIM motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCGR1CP	Fc fragment of IgG receptor Ic, pseudogene(FCGR1CP)	Homo sapiens													chain:High affinity immunoglobulin gamma Fc receptor I,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Interaction with EPB41L2,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCMR	Fc fragment of IgM receptor(FCMR)	Homo sapiens				GO:0002376~immune system process,GO:0006968~cellular defense response,GO:0043066~negative regulation of apoptotic process,	GO:0005576~extracellular region,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Fas apoptotic inhibitory molecule 3,compositionally biased region:Arg-rich,disulfide bond,domain:Ig-like,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCRL2	Fc receptor like 2(FCRL2)	Homo sapiens				GO:0007267~cell-cell signaling,GO:0009967~positive regulation of signal transduction,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCRL3	Fc receptor like 3(FCRL3)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 3,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCRL4	Fc receptor like 4(FCRL4)	Homo sapiens				GO:0002250~adaptive immune response,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Adaptive immunity,Alternative splicing,Cell membrane,Chromosomal rearrangement,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 4,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,signal peptide,site:Breakpoint for insertion to form FCRL4- IGHA1 fusion protein,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCRL5	Fc receptor like 5(FCRL5)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 5,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Ig-like C2-type 8,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FCRLA	Fc receptor like A(FCRLA)	Homo sapiens				GO:0030154~cell differentiation,	GO:0005737~cytoplasm,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Direct protein sequencing,Disulfide bond,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	chain:Fc receptor-like A,compositionally biased region:Pro-rich,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,sequence conflict,sequence variant,signal peptide,splice variant,
GNL2	G protein nucleolar 2(GNL2)	Homo sapiens				GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR006073:GTP binding domain,IPR012971:Nucleolar GTP-binding protein 2, N-terminal domain,IPR023179:GTP-binding protein, orthogonal bundle domain,IPR024929:Nucleolar GTP-binding protein 2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03008:Ribosome biogenesis in eukaryotes,				Acetylation,Coiled coil,Complete proteome,GTP-binding,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,Transmembrane,Transmembrane helix,	chain:Nucleolar GTP-binding protein 2,compositionally biased region:Poly-Glu,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
GNL3	G protein nucleolar 3(GNL3)	Homo sapiens				GO:0008283~cell proliferation,GO:0032206~positive regulation of telomere maintenance,GO:0033235~positive regulation of protein sumoylation,GO:0042127~regulation of cell proliferation,GO:0042254~ribosome biogenesis,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904816~positive regulation of protein localization to chromosome, telomeric region,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR006073:GTP binding domain,IPR014813:Guanine nucleotide-binding protein-like 3, N-terminal domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03008:Ribosome biogenesis in eukaryotes,				Acetylation,Alternative splicing,Coiled coil,Complete proteome,GTP-binding,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Guanine nucleotide-binding protein-like 3,modified residue,nucleotide phosphate-binding region:GTP,region of interest:Acidic,region of interest:Basic,region of interest:Intermediate,sequence conflict,sequence variant,splice variant,
GNAI2	G protein subunit alpha i2(GNAI2)	Homo sapiens				GO:0000186~activation of MAPKK activity,GO:0001973~adenosine receptor signaling pathway,GO:0006457~protein folding,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007584~response to nutrient,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0035556~intracellular signal transduction,GO:0043434~response to peptide hormone,GO:0050805~negative regulation of synaptic transmission,GO:0051301~cell division,GO:0051924~regulation of calcium ion transport,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0030496~midbody,GO:0044297~cell body,GO:0045121~membrane raft,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04360:Axon guidance,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04971:Gastric acid secretion,hsa05012:Parkinson's disease,hsa05030:Cocaine addiction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05200:Pathways in cancer,	192605~Ventricular tachycardia, idiopathic,Pituitary ACTH-secreting adenoma~Pituitary ACTH-secreting adenoma,		SM00275:SM00275,	ADP-ribosylation,Alternative splicing,Cell cycle,Cell division,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Palmitate,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(i) subunit alpha-2,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,splice variant,
GNAI3	G protein subunit alpha i3(GNAI3)	Homo sapiens				GO:0006457~protein folding,GO:0006810~transport,GO:0006906~vesicle fusion,GO:0007049~cell cycle,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007212~dopamine receptor signaling pathway,GO:0046039~GTP metabolic process,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0042588~zymogen granule,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0019904~protein domain specific binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031821~G-protein coupled serotonin receptor binding,GO:0032794~GTPase activating protein binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04360:Axon guidance,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04971:Gastric acid secretion,hsa05012:Parkinson's disease,hsa05030:Cocaine addiction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05200:Pathways in cancer,	602483~Auriculocondylar syndrome 1,		SM00275:SM00275,	3D-structure,ADP-ribosylation,Cell cycle,Cell division,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Palmitate,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(k) subunit alpha,helix,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,strand,turn,
GNAT2	G protein subunit alpha transducin 2(GNAT2)	Homo sapiens				GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste,GO:0006457~protein folding,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007601~visual perception,GO:0007602~phototransduction,GO:0009642~response to light intensity,GO:0046549~retinal cone cell development,GO:0050908~detection of light stimulus involved in visual perception,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0042622~photoreceptor outer segment membrane,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0008020~G-protein coupled photoreceptor activity,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04744:Phototransduction,	613856~Achromatopsia-4,		SM00275:SM00275,	ADP-ribosylation,Complete proteome,GTP-binding,Lipoprotein,Magnesium,Metal-binding,Myristate,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Sensory transduction,Transducer,Vision,	chain:Guanine nucleotide-binding protein G(t) subunit alpha-2,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
GNB1	G protein subunit beta 1(GNB1)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,h_bArr-mapkPathway:Role of ï¿½-arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bArrestinPathway:ï¿½-arrestins in GPCR Desensitization,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_edg1Pathway:Phospholipids as signalling intermediaries,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gcrpathway:Corticosteroids and cardioprotection,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_gsPathway:Activation of cAMP-dependent protein kinase, PKA,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_tubbyPathway:G-Protein Signaling Through Tubby Proteins,		GO:0006457~protein folding,GO:0007165~signal transduction,GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007265~Ras protein signal transduction,GO:0008283~cell proliferation,GO:0010659~cardiac muscle cell apoptotic process,GO:0016056~rhodopsin mediated signaling pathway,GO:0030168~platelet activation,GO:0050909~sensory perception of taste,GO:0060041~retina development in camera-type eye,GO:0070208~protein heterotrimerization,GO:0071377~cellular response to glucagon stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071456~cellular response to hypoxia,GO:0071870~cellular response to catecholamine stimulus,	GO:0001917~photoreceptor inner segment,GO:0005622~intracellular,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0042622~photoreceptor outer segment membrane,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0070062~extracellular exosome,GO:0097381~photoreceptor disc membrane,GO:1903561~extracellular vesicle,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0030507~spectrin binding,GO:0031702~type 1 angiotensin receptor binding,GO:0032403~protein complex binding,GO:0047391~alkylglycerophosphoethanolamine phosphodiesterase activity,GO:0051020~GTPase binding,	IPR001632:G-protein, beta subunit,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016346:Guanine nucleotide-binding protein, beta subunit,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04744:Phototransduction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00320:WD40,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Mental retardation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transducer,WD repeat,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,strand,turn,
GNG12	G protein subunit gamma 12(GNG12)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0021987~cerebral cortex development,GO:0032496~response to lipopolysaccharide,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0030165~PDZ domain binding,GO:0042301~phosphate ion binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04810:Regulation of actin cytoskeleton,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Acetylation,Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Phosphoprotein,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,sequence conflict,
GNG4	G protein subunit gamma 4(GNG4)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0030308~negative regulation of cell growth,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,
GPBAR1	G protein-coupled bile acid receptor 1(GPBAR1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0038184~cell surface bile acid receptor signaling pathway,GO:2000810~regulation of bicellular tight junction assembly,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0038181~bile acid receptor activity,GO:0038182~G-protein coupled bile acid receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled bile acid receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR1	G protein-coupled receptor 1(GPR1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007218~neuropeptide signaling pathway,GO:0007268~chemical synaptic transmission,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0042923~neuropeptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002275:G protein-coupled receptor 1 orphan,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR137B	G protein-coupled receptor 137B(GPR137B)	Homo sapiens					GO:0005765~lysosomal membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,							Complete proteome,Glycoprotein,Lysosome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Integral membrane protein GPR137B,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR153	G protein-coupled receptor 153(GPR153)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,IPR022335:G protein-coupled receptor 153,IPR022347:G protein-coupled receptor 153/162,					Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 153,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR155	G protein-coupled receptor 155(GPR155)	Homo sapiens				GO:0035556~intracellular signal transduction,GO:0050890~cognition,GO:0055085~transmembrane transport,	GO:0005622~intracellular,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR000591:DEP domain,IPR004776:Auxin efflux carrier,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00049:DEP,	Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Integral membrane protein GPR155,compositionally biased region:Poly-Ile,domain:DEP,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,transmembrane region,
GPR157	G protein-coupled receptor 157(GPR157)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000832:GPCR, family 2, secretin-like,IPR017452:GPCR, rhodopsin-like, 7TM,IPR017981:GPCR, family 2-like,IPR022343:GCR1-cAMP receptor,					Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 157,compositionally biased region:Poly-Cys,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR161	G protein-coupled receptor 161(GPR161)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0030819~positive regulation of cAMP biosynthetic process,GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,	GO:0005929~cilium,GO:0016021~integral component of membrane,GO:0030666~endocytic vesicle membrane,GO:0055037~recycling endosome,GO:0060170~ciliary membrane,GO:0072372~primary cilium,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Alternative splicing,Cell membrane,Cell projection,Cilium,Complete proteome,Developmental protein,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 161,disulfide bond,glycosylation site:N-linked (GlcNAc...),splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR17	G protein-coupled receptor 17(GPR17)	Homo sapiens				GO:0002376~immune system process,GO:0002862~negative regulation of inflammatory response to antigenic stimulus,GO:0007186~G-protein coupled receptor signaling pathway,GO:0035025~positive regulation of Rho protein signal transduction,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004950~chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Uracil nucleotide/cysteinyl leukotriene receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR3	G protein-coupled receptor 3(GPR3)	Homo sapiens				GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0040020~regulation of meiotic nuclear division,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000723:G protein-coupled receptor 3/6/12 orphan,IPR000984:G protein-coupled receptor 3,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 3,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR35	G protein-coupled receptor 35(GPR35)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0035025~positive regulation of Rho protein signal transduction,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0070098~chemokine-mediated signaling pathway,GO:1901386~negative regulation of voltage-gated calcium channel activity,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016494~C-X-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 35,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR37L1	G protein-coupled receptor 37 like 1(GPR37L1)	Homo sapiens				GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0021940~positive regulation of cerebellar granule cell precursor proliferation,GO:0043410~positive regulation of MAPK cascade,GO:0045665~negative regulation of neuron differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048712~negative regulation of astrocyte differentiation,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0036505~prosaposin receptor activity,GO:0042277~peptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR003909:G protein-coupled receptor 37 orphan,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Endothelin B receptor-like protein 2,compositionally biased region:Cys-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR39	G protein-coupled receptor 39(GPR39)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0046872~metal ion binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,Zinc,	chain:G-protein coupled receptor 39,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc,modified residue,mutagenesis site,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR55	G protein-coupled receptor 55(GPR55)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0035025~positive regulation of Rho protein signal transduction,GO:0038171~cannabinoid signaling pathway,GO:0045453~bone resorption,GO:0045671~negative regulation of osteoclast differentiation,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004949~cannabinoid receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 55,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR75	G protein-coupled receptor 75(GPR75)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0070098~chemokine-mediated signaling pathway,GO:1901214~regulation of neuron death,	GO:0005887~integral component of plasma membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 75,compositionally biased region:Phe-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR88	G protein-coupled receptor 88(GPR88)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007626~locomotory behavior,GO:0019228~neuronal action potential,GO:0050885~neuromuscular process controlling balance,GO:0061743~motor learning,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0003774~motor activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Cytoplasm,G-protein coupled receptor,Glycoprotein,Membrane,Mental retardation,Nucleus,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 88,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPR89A	G protein-coupled receptor 89A(GPR89A)	Homo sapiens				GO:0006811~ion transport,GO:0007165~signal transduction,GO:0015031~protein transport,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0051452~intracellular pH reduction,GO:1903959~regulation of anion transmembrane transport,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0032580~Golgi cisterna membrane,	GO:0004871~signal transducer activity,GO:0005244~voltage-gated ion channel activity,GO:0008308~voltage-gated anion channel activity,	IPR015672:GPCR 89-related,IPR022535:Golgi pH regulator, conserved domain,IPR025969:Abscisic acid G-protein coupled receptor-like domain,					Alternative splicing,Complete proteome,Glycoprotein,Golgi apparatus,Ion channel,Ion transport,Membrane,Protein transport,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Protein GPR89,chain:Putative protein GPR89C,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,transmembrane region,
GPR89B	G protein-coupled receptor 89B(GPR89B)	Homo sapiens				GO:0006811~ion transport,GO:0015031~protein transport,GO:0034765~regulation of ion transmembrane transport,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0051452~intracellular pH reduction,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0032580~Golgi cisterna membrane,	GO:0004871~signal transducer activity,GO:0005244~voltage-gated ion channel activity,GO:0008308~voltage-gated anion channel activity,	IPR015672:GPCR 89-related,IPR022535:Golgi pH regulator, conserved domain,IPR025969:Abscisic acid G-protein coupled receptor-like domain,					Alternative splicing,Complete proteome,Glycoprotein,Golgi apparatus,Ion channel,Ion transport,Membrane,Protein transport,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Protein GPR89,chain:Putative protein GPR89C,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,transmembrane region,
GPATCH2	G-patch domain containing 2(GPATCH2)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,	GO:0005730~nucleolus,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,	IPR000467:G-patch domain,IPR026291:G patch domain-containing protein 2,				SM00443:G_patch,	Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Reference proteome,	chain:G patch domain-containing protein 2,domain:G-patch,modified residue,sequence conflict,splice variant,
GPSM2	G-protein signaling modulator 2(GPSM2)	Homo sapiens				GO:0000132~establishment of mitotic spindle orientation,GO:0007052~mitotic spindle organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0050790~regulation of catalytic activity,GO:0051661~maintenance of centrosome location,GO:0060487~lung epithelial cell differentiation,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0045177~apical part of cell,GO:0097431~mitotic spindle pole,	GO:0000166~nucleotide binding,GO:0001965~G-protein alpha-subunit binding,GO:0005092~GDP-dissociation inhibitor activity,GO:0005515~protein binding,GO:0030695~GTPase regulator activity,GO:0042802~identical protein binding,	IPR003109:GoLoco motif,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,		604213~Chudley-McCullough syndrome,		SM00028:TPR,SM00390:GoLoco,	3D-structure,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:G-protein-signaling modulator 2,domain:GoLoco 1,domain:GoLoco 2,domain:GoLoco 3,domain:GoLoco 4,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence conflict,
G0S2	G0/G1 switch 2(G0S2)	Homo sapiens				GO:0097191~extrinsic apoptotic signaling pathway,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005811~lipid particle,	GO:0005515~protein binding,	IPR016821:G0/G1 switch protein 2, putative,			PIRSF023925:G0/G1 switch protein 2,		Apoptosis,Complete proteome,Mitochondrion,Reference proteome,	chain:G0/G1 switch regulatory protein 2,
GABPB2	GA binding protein transcription factor beta subunit 2(GABPB2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:GA-binding protein subunit beta-2,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence conflict,sequence variant,
GATAD2B	GATA zinc finger domain containing 2B(GATAD2B)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0043044~ATP-dependent chromatin remodeling,	GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0016581~NuRD complex,GO:0016607~nuclear speck,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031492~nucleosomal DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,		615074~Mental retardation, autosomal dominant 18,			Coiled coil,Complete proteome,Isopeptide bond,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcriptional repressor p66-beta,modified residue,region of interest:CR1,region of interest:CR2,zinc finger region:GATA-type,
GPBP1L1	GC-rich promoter binding protein 1 like 1(GPBP1L1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,						Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Vasculin-like protein 1,modified residue,sequence conflict,sequence variant,
GCFC2	GC-rich sequence DNA-binding factor 2(GCFC2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000245~spliceosomal complex assembly,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0071008~U2-type post-mRNA release spliceosomal complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR012890:GC-rich sequence DNA-binding factor,IPR022783:GC-rich sequence DNA-binding factor domain,					Alternative splicing,Coiled coil,Complete proteome,DNA-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:GC-rich sequence DNA-binding factor,compositionally biased region:Poly-Ser,modified residue,sequence variant,splice variant,
GEN1	GEN1, Holliday junction 5' flap endonuclease(GEN1)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0010824~regulation of centrosome duplication,GO:0071139~resolution of recombination intermediates,GO:0071140~resolution of mitotic recombination intermediates,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0008821~crossover junction endodeoxyribonuclease activity,GO:0046872~metal ion binding,	IPR006084:XPG/Rad2 endonuclease,IPR006085:XPG N-terminal,IPR006086:XPG-I domain,IPR008918:Helix-hairpin-helix motif, class 2,IPR020045:5'-3' exonuclease, C-terminal domain,				SM00279:HhH2,SM00484:XPGI,SM00485:XPGN,	3D-structure,Complete proteome,DNA damage,DNA repair,Endonuclease,Hydrolase,Magnesium,Metal-binding,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Flap endonuclease GEN homolog 1,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,region of interest:I-domain,region of interest:N-domain,sequence variant,
GIPC2	GIPC PDZ domain containing family member 2(GIPC2)	Homo sapiens					GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001478:PDZ domain,IPR017379:Uncharacterised conserved protein UCP038083, PDZ,			PIRSF038083:uncharacterized protein with PDZ domain, GIPC type,	SM00228:PDZ,	3D-structure,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,	chain:PDZ domain-containing protein GIPC2,domain:PDZ,helix,sequence variant,strand,
GLI2	GLI family zinc finger 2(GLI2)	Homo sapiens		h_shhPathway:Sonic Hedgehog (Shh) Pathway,	Transcription / Cell division and chromosome partitioning,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0001822~kidney development,GO:0002062~chondrocyte differentiation,GO:0002076~osteoblast development,GO:0006366~transcription from RNA polymerase II promoter,GO:0007224~smoothened signaling pathway,GO:0007389~pattern specification process,GO:0007411~axon guidance,GO:0007418~ventral midline development,GO:0007442~hindgut morphogenesis,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009612~response to mechanical stimulus,GO:0009913~epidermal cell differentiation,GO:0009952~anterior/posterior pattern specification,GO:0009954~proximal/distal pattern formation,GO:0021508~floor plate formation,GO:0021513~spinal cord dorsal/ventral patterning,GO:0021517~ventral spinal cord development,GO:0021696~cerebellar cortex morphogenesis,GO:0021775~smoothened signaling pathway involved in ventral spinal cord interneuron specification,GO:0021776~smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,GO:0021938~smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,GO:0021965~spinal cord ventral commissure morphogenesis,GO:0021983~pituitary gland development,GO:0030324~lung development,GO:0030879~mammary gland development,GO:0030902~hindbrain development,GO:0032331~negative regulation of chondrocyte differentiation,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0035295~tube development,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0045666~positive regulation of neuron differentiation,GO:0045740~positive regulation of DNA replication,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048566~embryonic digestive tract development,GO:0048589~developmental growth,GO:0048666~neuron development,GO:0048754~branching morphogenesis of an epithelial tube,GO:0060032~notochord regression,GO:0060513~prostatic bud formation,GO:0060603~mammary gland duct morphogenesis,GO:0060831~smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:0071407~cellular response to organic cyclic compound,GO:0090103~cochlea morphogenesis,GO:0098586~cellular response to virus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005930~axoneme,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0031512~motile primary cilium,GO:0097542~ciliary tip,GO:0097546~ciliary base,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04340:Hedgehog signaling pathway,hsa04390:Hippo signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,	610829~Holoprosencephaly-9,615849~Culler-Jones syndrome,		SM00355:ZnF_C2H2,	Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,DNA-binding,Holoprosencephaly,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein GLI2,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
GLIS1	GLIS family zinc finger 1(GLIS1)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein GLIS1,compositionally biased region:Pro-rich,sequence conflict,sequence variant,short sequence motif:Bipartite nuclear localization signal,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2; atypical,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
GPN1	GPN-loop GTPase 1(GPN1)	Homo sapiens				GO:0044376~RNA polymerase II complex import to nucleus,GO:1990022~RNA polymerase III complex localization to nucleus,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR003593:AAA+ ATPase domain,IPR004130:Uncharacterised protein family, ATP binding,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,GTP-binding,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:GPN-loop GTPase 1,modified residue,nucleotide phosphate-binding region:GTP (Pootential),
GPN2	GPN-loop GTPase 2(GPN2)	Homo sapiens				GO:0044376~RNA polymerase II complex import to nucleus,GO:1990022~RNA polymerase III complex localization to nucleus,	GO:0005737~cytoplasm,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR004130:Uncharacterised protein family, ATP binding,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Acetylation,Complete proteome,GTP-binding,Hydrolase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:GPN-loop GTPase 2,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
GPR75-ASB3	GPR75-ASB3 readthrough(GPR75-ASB3)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0000151~ubiquitin ligase complex,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0031625~ubiquitin protein ligase binding,	IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00969:SM00969,	Alternative splicing,ANK repeat,Complete proteome,Reference proteome,Repeat,Ubl conjugation pathway,
GIGYF2	GRB10 interacting GYF protein 2(GIGYF2)	Homo sapiens				GO:0007631~feeding behavior,GO:0008344~adult locomotory behavior,GO:0009791~post-embryonic development,GO:0017148~negative regulation of translation,GO:0021522~spinal cord motor neuron differentiation,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0035264~multicellular organism growth,GO:0044267~cellular protein metabolic process,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048873~homeostasis of number of cells within a tissue,GO:0050881~musculoskeletal movement,GO:0050885~neuromuscular process controlling balance,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003169:GYF,		607688~Parkinson disease 11,		SM00444:GYF,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Methylation,Neurodegeneration,Parkinson disease,Parkinsonism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:PERQ amino acid-rich with GYF domain- containing protein 2,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,domain:GYF,modified residue,region of interest:Required for GRB10-binding,sequence conflict,sequence variant,splice variant,
GAREM2	GRB2 associated regulator of MAPK1 subtype 2(GAREM2)	Homo sapiens					GO:0070062~extracellular exosome,		IPR013761:Sterile alpha motif/pointed domain,IPR025946:CABIT domain,					Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:Protein FAM59B,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,domain:SAM,sequence conflict,splice variant,
GCC2	GRIP and coiled-coil domain containing 2(GCC2)	Homo sapiens				GO:0000042~protein targeting to Golgi,GO:0006622~protein targeting to lysosome,GO:0031023~microtubule organizing center organization,GO:0034067~protein localization to Golgi apparatus,GO:0034453~microtubule anchoring,GO:0034499~late endosome to Golgi transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0043001~Golgi to plasma membrane protein transport,GO:0070861~regulation of protein exit from endoplasmic reticulum,GO:0071955~recycling endosome to Golgi transport,GO:0090161~Golgi ribbon formation,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000237:GRIP,				SM00755:Grip,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:GRIP and coiled-coil domain-containing protein 2,compositionally biased region:Glu-rich,domain:GRIP,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
GULP1	GULP, engulfment adaptor PTB domain containing 1(GULP1)	Homo sapiens				GO:0006869~lipid transport,GO:0006911~phagocytosis, engulfment,GO:0006915~apoptotic process,GO:0007165~signal transduction,	GO:0005737~cytoplasm,	GO:0004871~signal transducer activity,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,				SM00462:PTB,	Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Lipid transport,Phagocytosis,Phosphoprotein,Proteomics identification,Reference proteome,Transport,	chain:PTB domain-containing engulfment adapter protein 1,domain:PID,modified residue,mutagenesis site,splice variant,
HLX	H2.0 like homeobox(HLX)	Homo sapiens			Transcription,	GO:0001889~liver development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007519~skeletal muscle tissue development,GO:0008284~positive regulation of cell proliferation,GO:0030154~cell differentiation,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045629~negative regulation of T-helper 2 cell differentiation,GO:0046622~positive regulation of organ growth,GO:0048484~enteric nervous system development,GO:0048557~embryonic digestive tract morphogenesis,	GO:0005634~nucleus,	GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000047:Helix-turn-helix motif,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,Differentiation,DNA-binding,Homeobox,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:H2.0-like homeobox protein,compositionally biased region:Poly-Gln,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,DNA-binding region:Homeobox,modified residue,sequence conflict,sequence variant,
HS1BP3	HCLS1 binding protein 3(HS1BP3)	Homo sapiens				GO:0042981~regulation of apoptotic process,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,	GO:0035091~phosphatidylinositol binding,	IPR001683:Phox homologous domain,				SM00312:PX,	Acetylation,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:HCLS1-binding protein 3,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,domain:PX,modified residue,sequence variant,
HEATR1	HEAT repeat containing 1(HEATR1)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0030686~90S preribosome,GO:0032040~small-subunit processome,GO:0034455~t-UTP complex,	GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR012954:BP28, C-terminal domain,IPR016024:Armadillo-type fold,IPR022125:U3 small nucleolar RNA-associated protein 10,	hsa03008:Ribosome biogenesis in eukaryotes,			SM01036:SM01036,	Acetylation,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,rRNA processing,	chain:HEAT repeat-containing protein 1,modified residue,repeat:HEAT,sequence variant,
HEATR5B	HEAT repeat containing 5B(HEATR5B)	Homo sapiens					GO:0016020~membrane,GO:0070062~extracellular exosome,		IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:HEAT repeat-containing protein 5B,modified residue,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,sequence conflict,sequence variant,splice variant,
HECW2	HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2(HECW2)	Homo sapiens				GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR000569:HECT,IPR001202:WW domain,				SM00119:HECTc,SM00239:C2,SM00456:WW,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:E3 ubiquitin-protein ligase HECW2,domain:C2,domain:HECT,domain:WW 1,domain:WW 2,modified residue,region of interest:Interaction with TP73,sequence conflict,splice variant,
HENMT1	HEN1 methyltransferase homolog 1(HENMT1)	Homo sapiens				GO:0001510~RNA methylation,GO:0006306~DNA methylation,GO:0006481~C-terminal protein methylation,GO:0018022~peptidyl-lysine methylation,GO:0030488~tRNA methylation,GO:0031047~gene silencing by RNA,GO:0031167~rRNA methylation,GO:0034587~piRNA metabolic process,GO:0035246~peptidyl-arginine N-methylation,GO:0080009~mRNA methylation,	GO:0043186~P granule,	GO:0000179~rRNA (adenine-N6,N6-)-dimethyltransferase activity,GO:0003723~RNA binding,GO:0004809~tRNA (guanine-N2-)-methyltransferase activity,GO:0005515~protein binding,GO:0008171~O-methyltransferase activity,GO:0008172~S-methyltransferase activity,GO:0008173~RNA methyltransferase activity,GO:0008174~mRNA methyltransferase activity,GO:0008425~2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,GO:0008650~rRNA (uridine-2'-O-)-methyltransferase activity,GO:0008988~rRNA (adenine-N6-)-methyltransferase activity,GO:0009008~DNA-methyltransferase activity,GO:0009019~tRNA (guanine-N1-)-methyltransferase activity,GO:0009383~rRNA (cytosine-C5-)-methyltransferase activity,GO:0016205~selenocysteine methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016428~tRNA (cytosine-5-)-methyltransferase activity,GO:0016435~rRNA (guanine) methyltransferase activity,GO:0018423~protein C-terminal leucine carboxyl O-methyltransferase activity,GO:0018707~1-phenanthrol methyltransferase activity,GO:0019702~protein-arginine N5-methyltransferase activity,GO:0030792~methylarsonite methyltransferase activity,GO:0034541~dimethylarsinite methyltransferase activity,GO:0034807~4,5-dihydroxybenzo(a)pyrene methyltransferase activity,GO:0034931~1-hydroxypyrene methyltransferase activity,GO:0034933~1-hydroxy-6-methoxypyrene methyltransferase activity,GO:0043770~demethylmenaquinone methyltransferase activity,GO:0043776~cobalt-precorrin-6B C5-methyltransferase activity,GO:0043777~cobalt-precorrin-7 C15-methyltransferase activity,GO:0043780~cobalt-precorrin-5B C1-methyltransferase activity,GO:0043782~cobalt-precorrin-3 C17-methyltransferase activity,GO:0043791~dimethylamine methyltransferase activity,GO:0043803~hydroxyneurosporene-O-methyltransferase activity,GO:0043827~tRNA (adenine-57, 58-N(1)-) methyltransferase activity,GO:0043833~methylamine-specific methylcobalamin:coenzyme M methyltransferase activity,GO:0043834~trimethylamine methyltransferase activity,GO:0043851~methanol-specific methylcobalamin:coenzyme M methyltransferase activity,GO:0043852~monomethylamine methyltransferase activity,GO:0046872~metal ion binding,GO:0051994~P-methyltransferase activity,GO:0052624~2-phytyl-1,4-naphthoquinone methyltransferase activity,GO:0052665~tRNA (uracil-2'-O-)-methyltransferase activity,GO:0052666~tRNA (cytosine-2'-O-)-methyltransferase activity,GO:0052667~phosphomethylethanolamine N-methyltransferase activity,GO:0052735~tRNA (cytosine-3-)-methyltransferase activity,GO:0070677~rRNA (cytosine-2'-O-)-methyltransferase activity,GO:0071424~rRNA (cytosine-N4-)-methyltransferase activity,GO:0080012~trihydroxyferuloyl spermidine O-methyltransferase activity,	IPR026610:3'-RNA ribose 2'-O-methyltransferase, Hen1,					3D-structure,Complete proteome,Cytoplasm,Metal-binding,Methyltransferase,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,RNA-mediated gene silencing,S-adenosyl-L-methionine,Transferase,	chain:UPF0486 protein C1orf59,sequence conflict,sequence variant,
HHLA2	HERV-H LTR-associating 2(HHLA2)	Homo sapiens				GO:0001819~positive regulation of cytokine production,GO:0031295~T cell costimulation,GO:0042104~positive regulation of activated T cell proliferation,	GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR003597:Immunoglobulin C1-set,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:HERV-H LTR-associating protein 2,disulfide bond,domain:Ig-like C1-type,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,transmembrane region,
HHLA3	HERV-H LTR-associating 3(HHLA3)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Reference proteome,	chain:HERV-H LTR-associating protein 3,sequence conflict,splice variant,
HFM1	HFM1, ATP dependent DNA helicase homolog(HFM1)	Homo sapiens			General function prediction only,	GO:0000712~resolution of meiotic recombination intermediates,		GO:0003676~nucleic acid binding,GO:0004386~helicase activity,GO:0005524~ATP binding,	IPR001650:Helicase, C-terminal,IPR004179:Sec63 domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		615724~Premature ovarian failure 9,		SM00487:DEXDc,SM00490:HELICc,SM00973:SM00973,	Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Helicase,Hydrolase,Meiosis,Nucleotide-binding,Polymorphism,Premature ovarian failure,Reference proteome,	chain:Probable ATP-dependent DNA helicase HFM1,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:SEC63,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,splice variant,
HHIPL2	HHIP like 2(HHIPL2)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0005975~carbohydrate metabolic process,GO:0055114~oxidation-reduction process,	GO:0005576~extracellular region,	GO:0005515~protein binding,GO:0016901~oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,GO:0048038~quinone binding,	IPR011041:Soluble quinoprotein glucose/sorbosone dehydrogenase,IPR011042:Six-bladed beta-propeller, TolB-like,IPR012938:Glucose/Sorbosone dehydrogenase,IPR018143:Folate receptor-like,					Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:HHIP-like protein 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
HIGD1A	HIG1 hypoxia inducible domain family member 1A(HIGD1A)	Homo sapiens				GO:0043066~negative regulation of apoptotic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0070469~respiratory chain,		IPR007667:Hypoxia induced protein, domain,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Reference proteome,Respiratory chain,Stress response,Transmembrane,Transmembrane helix,Transport,	chain:HIG1 domain family member 1A,domain:HIG1,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
HORMAD1	HORMA domain containing 1(HORMAD1)	Homo sapiens				GO:0001824~blastocyst development,GO:0007126~meiotic nuclear division,GO:0007130~synaptonemal complex assembly,GO:0007283~spermatogenesis,GO:0042138~meiotic DNA double-strand break formation,GO:0048477~oogenesis,GO:0051177~meiotic sister chromatid cohesion,GO:0051598~meiotic recombination checkpoint,GO:0060629~regulation of homologous chromosome segregation,	GO:0000795~synaptonemal complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,		IPR003511:DNA-binding HORMA,					Alternative splicing,Chromosome,Complete proteome,Differentiation,Meiosis,Nucleus,Oogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Spermatogenesis,	chain:HORMA domain-containing protein 1,domain:HORMA,sequence conflict,sequence variant,splice variant,
HSPE1-MOB4	HSPE1-MOB4 readthrough(HSPE1-MOB4)	Homo sapiens				GO:0006457~protein folding,	GO:0005737~cytoplasm,	GO:0005524~ATP binding,	IPR005301:Mob1/phocein,IPR011032:GroES-like,IPR018369:Chaperonin Cpn10, conserved site,IPR020818:Chaperonin Cpn10,				SM00883:SM00883,SM01388:SM01388,	Chaperone,Complete proteome,Reference proteome,
HEMK1	HemK methyltransferase family member 1(HEMK1)	Homo sapiens				GO:0006306~DNA methylation,GO:0006479~protein methylation,	GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,	IPR002052:DNA methylase, N-6 adenine-specific, conserved site,IPR002295:N6 adenine-specific DNA methyltransferase, D21 class,IPR004556:Modification methylase HemK,IPR007848:Methyltransferase small domain,IPR019874:Protein-(glutamine-N5) methyltransferase, release factor-specific,					Complete proteome,Methyltransferase,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:HemK methyltransferase family member 1,sequence variant,
HJURP	Holliday junction recognition protein(HJURP)	Homo sapiens				GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0034080~CENP-A containing nucleosome assembly,GO:0043254~regulation of protein complex assembly,GO:0051101~regulation of DNA binding,	GO:0000775~chromosome, centromeric region,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0042393~histone binding,GO:0042802~identical protein binding,	IPR018465:Centromere protein Scm3, N-terminal,IPR021052:Holliday junction recognition protein, HJURP,IPR022102:Holliday junction regulator protein family C-terminal,					3D-structure,Alternative splicing,Cell cycle,Centromere,Chaperone,Chromosome,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Holliday junction recognition protein,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
HTRA2	HtrA serine peptidase 2(HTRA2)	Homo sapiens				GO:0006508~proteolysis,GO:0006672~ceramide metabolic process,GO:0007005~mitochondrion organization,GO:0007568~aging,GO:0007628~adult walking behavior,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009635~response to herbicide,GO:0010942~positive regulation of cell death,GO:0016540~protein autoprocessing,GO:0019742~pentacyclic triterpenoid metabolic process,GO:0030900~forebrain development,GO:0034599~cellular response to oxidative stress,GO:0034605~cellular response to heat,GO:0035458~cellular response to interferon-beta,GO:0040014~regulation of multicellular organism growth,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0044257~cellular protein catabolic process,GO:0045786~negative regulation of cell cycle,GO:0048666~neuron development,GO:0071300~cellular response to retinoic acid,GO:0071363~cellular response to growth factor stimulus,GO:0097194~execution phase of apoptosis,GO:1901215~negative regulation of neuron death,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001269~positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0035631~CD40 receptor complex,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0051082~unfolded protein binding,	IPR001478:PDZ domain,IPR001940:Peptidase S1C,IPR009003:Trypsin-like cysteine/serine peptidase domain,	hsa05012:Parkinson's disease,	610297~Parkinson disease 13,		SM00228:PDZ,	3D-structure,Alternative splicing,Apoptosis,Autocatalytic cleavage,Complete proteome,Direct protein sequencing,Disease mutation,Hydrolase,Membrane,Mitochondrion,Neurodegeneration,Parkinson disease,Parkinsonism,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Transit peptide,Transmembrane,Transmembrane helix,Zymogen,	active site:Charge relay system,chain:Serine protease HTRA2, mitochondrial,domain:PDZ,helix,mutagenesis site,region of interest:Serine protease,sequence variant,short sequence motif:IAP-binding motif,splice variant,strand,transit peptide:Mitochondrion,transmembrane region,turn,
IBA57	IBA57 homolog, iron-sulfur cluster assembly(IBA57)	Homo sapiens			General function prediction only,	GO:0006783~heme biosynthetic process,GO:0016226~iron-sulfur cluster assembly,	GO:0005759~mitochondrial matrix,	GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR013977:Glycine cleavage T-protein, C-terminal barrel,IPR017703:YgfZ/GcvT conserved site,		615330~Multiple mitochondrial dysfunctions syndrome 3,616451~Spastic paraplegia 74, autosomal recessive,			Acetylation,Complete proteome,Disease mutation,Heme biosynthesis,Hereditary spastic paraplegia,Mitochondrion,Neurodegeneration,Polymorphism,Reference proteome,Transferase,Transit peptide,	chain:Putative transferase C1orf69, mitochondrial,sequence variant,transit peptide:Mitochondrion,
IKZF2	IKAROS family zinc finger 2(IKZF2)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Acetylation,Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein Helios,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
ILKAP	ILK associated serine/threonine phosphatase(ILKAP)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0007229~integrin-mediated signaling pathway,	GO:0005737~cytoplasm,	GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0043169~cation binding,GO:0046872~metal ion binding,	IPR000222:Protein phosphatase 2C, manganese/magnesium aspartate binding site,IPR001932:Protein phosphatase 2C (PP2C)-like,IPR015655:Protein phosphatase 2C,				SM00332:PP2Cc,	Acetylation,Complete proteome,Cytoplasm,Hydrolase,Integrin,Kinase,Magnesium,Manganese,Metal-binding,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Transferase,	chain:Integrin-linked kinase-associated serine/threonine phosphatase 2C,domain:PP2C-like,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 1; via carbonyl oxygen,metal ion-binding site:Manganese 2,modified residue,mutagenesis site,sequence variant,
INO80D	INO80 complex subunit D(INO80D)	Homo sapiens				GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,		IPR025927:Potential DNA-binding domain,					Alternative splicing,Complete proteome,DNA damage,DNA recombination,DNA repair,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:INO80 complex subunit D,compositionally biased region:Poly-Asp,sequence conflict,sequence variant,
IQSEC1	IQ motif and Sec7 domain 1(IQSEC1)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR000048:IQ motif, EF-hand binding site,IPR000904:SEC7-like,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,			SM00222:Sec7,SM00233:PH,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Lipid-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:IQ motif and SEC7 domain-containing protein 1,domain:IQ,domain:PH,domain:SEC7,modified residue,sequence conflict,sequence variant,splice variant,
IQCC	IQ motif containing C(IQCC)	Homo sapiens							IPR000048:IQ motif, EF-hand binding site,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:IQ domain-containing protein C,domain:IQ,sequence conflict,sequence variant,splice variant,
IQCF1	IQ motif containing F1(IQCF1)	Homo sapiens				GO:0060474~positive regulation of sperm motility involved in capacitation,GO:2000344~positive regulation of acrosome reaction,	GO:0001669~acrosomal vesicle,	GO:0005516~calmodulin binding,	IPR000048:IQ motif, EF-hand binding site,				SM00015:IQ,	Alternative splicing,Complete proteome,Cytoplasmic vesicle,Polymorphism,Reference proteome,Repeat,	chain:IQ domain-containing protein F1,domain:IQ 1,domain:IQ 2,sequence variant,splice variant,
IQCF2	IQ motif containing F2(IQCF2)	Homo sapiens						GO:0005515~protein binding,GO:0005516~calmodulin binding,	IPR000048:IQ motif, EF-hand binding site,				SM00015:IQ,	Complete proteome,Reference proteome,Repeat,	chain:IQ domain-containing protein F2,domain:IQ 1,domain:IQ 2,
IQGAP3	IQ motif containing GTPase activating protein 3(IQGAP3)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000187~activation of MAPK activity,GO:0007165~signal transduction,GO:0007265~Ras protein signal transduction,GO:0008361~regulation of cell size,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0043087~regulation of GTPase activity,GO:0070371~ERK1 and ERK2 cascade,GO:0071310~cellular response to organic substance,	GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0016328~lateral plasma membrane,	GO:0005516~calmodulin binding,GO:0017048~Rho GTPase binding,GO:0070856~myosin VI light chain binding,	IPR000048:IQ motif, EF-hand binding site,IPR000593:RasGAP protein, C-terminal,IPR001715:Calponin homology domain,IPR001936:Ras GTPase-activating protein,IPR008936:Rho GTPase activation protein,IPR023152:Ras GTPase-activating protein, conserved site,	hsa04810:Regulation of actin cytoskeleton,			SM00015:IQ,SM00033:CH,SM00323:RasGAP,	3D-structure,Calmodulin-binding,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Ras GTPase-activating-like protein IQGAP3,domain:CH,domain:IQ 1,domain:IQ 2,domain:IQ 3,domain:IQ 4,domain:Ras-GAP,modified residue,sequence conflict,sequence variant,
IQCA1	IQ motif containing with AAA domain 1(IQCA1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,			GO:0005524~ATP binding,	IPR000048:IQ motif, EF-hand binding site,IPR003959:ATPase, AAA-type, core,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Nucleotide-binding,Polymorphism,Reference proteome,	chain:IQ and AAA domain-containing protein 1,compositionally biased region:Lys-rich,domain:IQ,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
ISG15	ISG15 ubiquitin-like modifier(ISG15)	Homo sapiens				GO:0019941~modification-dependent protein catabolic process,GO:0019985~translesion synthesis,GO:0030501~positive regulation of bone mineralization,GO:0031397~negative regulation of protein ubiquitination,GO:0032020~ISG15-protein conjugation,GO:0032480~negative regulation of type I interferon production,GO:0032649~regulation of interferon-gamma production,GO:0034340~response to type I interferon,GO:0042742~defense response to bacterium,GO:0045071~negative regulation of viral genome replication,GO:0045648~positive regulation of erythrocyte differentiation,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0031386~protein tag,	IPR000626:Ubiquitin,IPR019956:Ubiquitin subgroup,	hsa04622:RIG-I-like receptor signaling pathway,	616126~Immunodeficiency 38,		SM00213:UBQ,	3D-structure,Antiviral defense,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Host-virus interaction,Immunity,Innate immunity,Isopeptide bond,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-nitrosylation,Secreted,Ubl conjugation pathway,	binding site:Activating enzyme,chain:Interferon-induced 17 kDa protein,chain:Ubiquitin cross-reactive protein,cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),domain:Ubiquitin-like 1,domain:Ubiquitin-like 2,helix,propeptide:Removed in mature form,region of interest:Involved in the ligation of specific target proteins,sequence conflict,sequence variant,strand,
IWS1	IWS1, SUPT6H interacting protein(IWS1)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010793~regulation of mRNA export from nucleus,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0050684~regulation of mRNA processing,GO:0051028~mRNA transport,GO:0090239~regulation of histone H4 acetylation,GO:2001253~regulation of histone H3-K36 trimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR017923:Transcription factor IIS, N-terminal,					Acetylation,Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transport,	chain:Protein IWS1 homolog,compositionally biased region:Glu-rich,domain:TFIIS N-terminal,modified residue,region of interest:3 X approximate tandem repeats,repeat:1,repeat:2,repeat:3; half-length,sequence conflict,sequence variant,splice variant,
JAK1	Janus kinase 1(JAK1)	Homo sapiens	12.IL-6_type_cytok-signal-transduct,48.mice_minus_JAKs_and_STATs,75.Stats_activators_of_Apoptosis,	h_egfPathway:EGF Signaling Pathway,h_ifnaPathway:IFN alpha signaling pathway,h_ifngPathway:IFN gamma signaling pathway ,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il4Pathway:IL 4 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_il7Pathway:IL-7 Signal Transduction,h_pdgfPathway:PDGF Signaling Pathway,h_stat3Pathway:Stat3 Signaling Pathway,		GO:0000165~MAPK cascade,GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038110~interleukin-2-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043547~positive regulation of GTPase activity,GO:0045087~innate immune response,GO:0046677~response to antibiotic,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060338~regulation of type I interferon-mediated signaling pathway,GO:1903672~positive regulation of sprouting angiogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005131~growth hormone receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,GO:0031625~ubiquitin protein ligase binding,GO:0031730~CCR5 chemokine receptor binding,GO:0046872~metal ion binding,	IPR000299:FERM domain,IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR016251:Tyrosine-protein kinase, non-receptor Jak/Tyk2,IPR017441:Protein kinase, ATP binding site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR020776:Tyrosine-protein kinase, non-receptor Jak1,	hsa04151:PI3K-Akt signaling pathway,hsa04380:Osteoclast differentiation,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04630:Jak-STAT signaling pathway,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05212:Pancreatic cancer,		PIRSF000636:tyrosine-protein kinase, Jak/Tyk2 type,	SM00219:TyrKc,SM00252:SH2,SM00295:B41,	3D-structure,Acetylation,ATP-binding,Coiled coil,Complete proteome,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH2 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase JAK1,domain:FERM,domain:Protein kinase 1,domain:Protein kinase 2,domain:SH2,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
KANSL1L	KAT8 regulatory NSL complex subunit 1 like(KANSL1L)	Homo sapiens				GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043984~histone H4-K16 acetylation,	GO:0000123~histone acetyltransferase complex,GO:0044545~NSL complex,	GO:0001047~core promoter binding,GO:0035035~histone acetyltransferase binding,GO:0043995~histone acetyltransferase activity (H4-K5 specific),GO:0043996~histone acetyltransferase activity (H4-K8 specific),GO:0046972~histone acetyltransferase activity (H4-K16 specific),	IPR026180:KAT8 regulatory NSL complex subunit 1,				SM01300:SM01300,	Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein C2orf67,modified residue,sequence conflict,splice variant,
KANSL3	KAT8 regulatory NSL complex subunit 3(KANSL3)	Homo sapiens				GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043984~histone H4-K16 acetylation,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0043995~histone acetyltransferase activity (H4-K5 specific),GO:0043996~histone acetyltransferase activity (H4-K8 specific),GO:0046972~histone acetyltransferase activity (H4-K16 specific),	IPR026555:KAT8 regulatory NSL complex subunit 3/Testis-expressed sequence 30 protein,					Alternative splicing,Chromatin regulator,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA1310,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,
KHDRBS1	KH RNA binding domain containing, signal transduction associated 1(KHDRBS1)	Homo sapiens		h_sam68Pathway:Regulation of Splicing through Sam68,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0006351~transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0008283~cell proliferation,GO:0009967~positive regulation of signal transduction,GO:0031647~regulation of protein stability,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045948~positive regulation of translational initiation,GO:0046831~regulation of RNA export from nucleus,GO:0046833~positive regulation of RNA export from nucleus,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070618~Grb2-Sos complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Complete proteome,Direct protein sequencing,Isopeptide bond,Membrane,Methylation,mRNA processing,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,SH3-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:KH domain-containing, RNA-binding, signal transduction-associated protein 1,compositionally biased region:Arg/Gly-rich,compositionally biased region:DMA/Gly-rich,compositionally biased region:Pro-rich,domain:KH,modified residue,splice variant,
KIAA0040	KIAA0040(KIAA0040)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA0040,sequence variant,
KIAA0319L	KIAA0319 like(KIAA0319L)	Homo sapiens					GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000601:PKD domain,IPR013980:Seven cysteines,IPR022409:PKD/Chitinase domain,				SM00089:PKD,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA0319-like,domain:MANSC,domain:PKD 1,domain:PKD 2,domain:PKD 3,domain:PKD 4,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KIAA0907	KIAA0907(KIAA0907)	Homo sapiens					GO:0005634~nucleus,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR004088:K Homology domain, type 1,					3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:UPF0469 protein KIAA0907,compositionally biased region:Pro-rich,helix,modified residue,splice variant,strand,turn,
KIAA1107	KIAA1107(KIAA1107)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1107,modified residue,sequence conflict,sequence variant,splice variant,
KIAA1143	KIAA1143(KIAA1143)	Homo sapiens						GO:0005515~protein binding,						Acetylation,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1143,modified residue,sequence variant,
KIAA1211L	KIAA1211 like(KIAA1211L)	Homo sapiens							IPR026713:Probable exonuclease mut-7 homolog, isoform 5,					Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C2orf55,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,
KIAA1324	KIAA1324(KIAA1324)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0009267~cellular response to starvation,GO:0044090~positive regulation of vacuole organization,GO:2000786~positive regulation of autophagosome assembly,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,	GO:0044822~poly(A) RNA binding,	IPR009011:Mannose-6-phosphate receptor binding domain,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,				SM01411:SM01411,	Alternative splicing,Autophagy,Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Golgi apparatus,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:UPF0577 protein KIAA1324,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KIAA1522	KIAA1522(KIAA1522)	Homo sapiens												Alternative splicing,Complete proteome,Lipoprotein,Methylation,Myristate,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1522,compositionally biased region:Poly-Arg,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,sequence variant,
KIAA1524	KIAA1524(KIAA1524)	Homo sapiens				GO:0007283~spermatogenesis,GO:0098609~cell-cell adhesion,GO:2000179~positive regulation of neural precursor cell proliferation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein CIP2A,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
KIAA1614	KIAA1614(KIAA1614)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1614,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,
KIAA1841	KIAA1841(KIAA1841)	Homo sapiens						GO:0003677~DNA binding,	IPR009057:Homeodomain-like,IPR021777:Protein of unknown function DUF3342,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1841,sequence conflict,splice variant,
KIAA2012	KIAA2012(KIAA2012)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Reference proteome,
KANK4	KN motif and ankyrin repeat domains 4(KANK4)	Homo sapiens			Cell division and chromosome partitioning,		GO:0005737~cytoplasm,		IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,IPR021939:Kank N-terminal motif,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:KN motif and ankyrin repeat domain- containing protein 4,compositionally biased region:Pro-rich,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence conflict,sequence variant,splice variant,
KRBOX1	KRAB box domain containing 1(KRBOX1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR001909:Krueppel-associated box,				SM00349:KRAB,	Alternative splicing,Complete proteome,Reference proteome,
KISS1	KiSS-1 metastasis-suppressor(KISS1)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0008285~negative regulation of cell proliferation,GO:0033686~positive regulation of luteinizing hormone secretion,GO:0043410~positive regulation of MAPK cascade,GO:0050806~positive regulation of synaptic transmission,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0060112~generation of ovulation cycle rhythm,GO:0060124~positive regulation of growth hormone secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0016324~apical plasma membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,	GO:0005515~protein binding,GO:0031773~kisspeptin receptor binding,	IPR020207:Metastasis-suppressor KiSS-1,		614842~Hypogonadotropic hypogonadism 13 with or without anosmia,			Amidation,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Hypogonadotropic hypogonadism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Metastasis-suppressor KiSS-1,modified residue,peptide:Kisspeptin-10,peptide:Kisspeptin-13,peptide:Kisspeptin-14,peptide:Metastin,region of interest:Essential for receptor binding and receptor activation,sequence conflict,sequence variant,signal peptide,site:Cleavage; by MMP2 and MMP9,
KLF11	Kruppel like factor 11(KLF11)	Homo sapiens			General function prediction only,	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:1901653~cellular response to peptide,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		610508~Maturity-onset diabetes of the young, type VII,		SM00355:ZnF_C2H2,	3D-structure,Activator,Alternative splicing,Apoptosis,Complete proteome,Diabetes mellitus,Disease mutation,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 11,helix,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
KLF17	Kruppel like factor 17(KLF17)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007276~gamete generation,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 17,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
KLF18	Kruppel like factor 18(KLF18)	Homo sapiens						GO:0003676~nucleic acid binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR011049:Serralysin-like metalloprotease, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,Reference proteome,
KLF7	Kruppel like factor 7(KLF7)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007411~axon guidance,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048813~dendrite morphogenesis,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 7,short sequence motif:Nuclear localization signal,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
LCK	LCK proto-oncogene, Src family tyrosine kinase(LCK)	Homo sapiens	3.T_cell_receptor,54.T-cell_anergy,63.LAT_couples_T-cell_receptor,67.Ikaros_and_signaling_inhibitors,81.Structure_of_Caps_and_SMACs,	h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_il2Pathway:IL 2 signaling pathway,h_il7Pathway:IL-7 Signal Transduction,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrPathway:T Cell Receptor Signaling Pathway,		GO:0006468~protein phosphorylation,GO:0006470~protein dephosphorylation,GO:0006882~cellular zinc ion homeostasis,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0030097~hemopoiesis,GO:0030168~platelet activation,GO:0030217~T cell differentiation,GO:0031295~T cell costimulation,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0045087~innate immune response,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050690~regulation of defense response to virus by virus,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050862~positive regulation of T cell receptor signaling pathway,GO:0050870~positive regulation of T cell activation,GO:0050900~leukocyte migration,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051249~regulation of lymphocyte activation,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000242~pericentriolar material,GO:0001772~immunological synapse,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0042169~SH2 domain binding,GO:0042609~CD4 receptor binding,GO:0042610~CD8 receptor binding,GO:0042802~identical protein binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0051117~ATPase binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa05166:HTLV-I infection,hsa05340:Primary immunodeficiency,	615758~Immunodeficiency 22,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,Host-virus interaction,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase LCK,domain:Protein kinase,domain:SH2,domain:SH3,helix,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PTPRH,region of interest:Interactions with CD4 and CD8,sequence conflict,sequence variant,splice variant,strand,turn,
LRP1B	LDL receptor related protein 1B(LRP1B)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0015031~protein transport,	GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0005509~calcium ion binding,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,IPR026823:Complement Clr-like EGF domain,				SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	Calcium,Complete proteome,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 1B,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:LDL-receptor class A 1,domain:LDL-receptor class A 10,domain:LDL-receptor class A 11,domain:LDL-receptor class A 12,domain:LDL-receptor class A 13,domain:LDL-receptor class A 14,domain:LDL-receptor class A 15,domain:LDL-receptor class A 16,domain:LDL-receptor class A 17,domain:LDL-receptor class A 18,domain:LDL-receptor class A 19,domain:LDL-receptor class A 2,domain:LDL-receptor class A 20,domain:LDL-receptor class A 21,domain:LDL-receptor class A 22,domain:LDL-receptor class A 23,domain:LDL-receptor class A 24,domain:LDL-receptor class A 25,domain:LDL-receptor class A 26,domain:LDL-receptor class A 27,domain:LDL-receptor class A 28,domain:LDL-receptor class A 29,domain:LDL-receptor class A 3,domain:LDL-receptor class A 30,domain:LDL-receptor class A 31,domain:LDL-receptor class A 32,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,domain:LDL-receptor class A 8,domain:LDL-receptor class A 9,glycosylation site:N-linked (GlcNAc...),repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 21,repeat:LDL-receptor class B 22,repeat:LDL-receptor class B 23,repeat:LDL-receptor class B 24,repeat:LDL-receptor class B 25,repeat:LDL-receptor class B 26,repeat:LDL-receptor class B 27,repeat:LDL-receptor class B 28,repeat:LDL-receptor class B 29,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 30,repeat:LDL-receptor class B 31,repeat:LDL-receptor class B 32,repeat:LDL-receptor class B 33,repeat:LDL-receptor class B 34,repeat:LDL-receptor class B 35,repeat:LDL-receptor class B 36,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRP2	LDL receptor related protein 2(LRP2)	Homo sapiens			Function unknown,	GO:0001523~retinoid metabolic process,GO:0003281~ventricular septum development,GO:0006486~protein glycosylation,GO:0006629~lipid metabolic process,GO:0006766~vitamin metabolic process,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0008283~cell proliferation,GO:0030900~forebrain development,GO:0035904~aorta development,GO:0042359~vitamin D metabolic process,GO:0042953~lipoprotein transport,GO:0060976~coronary vasculature development,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005905~clathrin-coated pit,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030139~endocytic vesicle,GO:0031526~brush border membrane,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0005041~low-density lipoprotein receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0042954~lipoprotein transporter activity,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR019825:Legume lectin, beta chain, Mn/Ca-binding site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,IPR026823:Complement Clr-like EGF domain,	hsa04340:Hedgehog signaling pathway,hsa04918:Thyroid hormone synthesis,	222448~Donnai-Barrow syndrome,		SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	3D-structure,Calcium,Coated pit,Complete proteome,Disease mutation,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Lipoprotein,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,SH3-binding,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 2,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12; calcium-binding,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15; calcium-binding,domain:EGF-like 16,domain:EGF-like 17,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6; calcium-binding,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:LDL-receptor class A 1,domain:LDL-receptor class A 10,domain:LDL-receptor class A 11,domain:LDL-receptor class A 12,domain:LDL-receptor class A 13,domain:LDL-receptor class A 14,domain:LDL-receptor class A 15,domain:LDL-receptor class A 16,domain:LDL-receptor class A 17,domain:LDL-receptor class A 18,domain:LDL-receptor class A 19,domain:LDL-receptor class A 2,domain:LDL-receptor class A 20,domain:LDL-receptor class A 21,domain:LDL-receptor class A 22,domain:LDL-receptor class A 23,domain:LDL-receptor class A 24,domain:LDL-receptor class A 25,domain:LDL-receptor class A 26,domain:LDL-receptor class A 27,domain:LDL-receptor class A 28,domain:LDL-receptor class A 29,domain:LDL-receptor class A 3,domain:LDL-receptor class A 30,domain:LDL-receptor class A 31,domain:LDL-receptor class A 32,domain:LDL-receptor class A 33,domain:LDL-receptor class A 34,domain:LDL-receptor class A 35,domain:LDL-receptor class A 36,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,domain:LDL-receptor class A 8,domain:LDL-receptor class A 9,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 21,repeat:LDL-receptor class B 22,repeat:LDL-receptor class B 23,repeat:LDL-receptor class B 24,repeat:LDL-receptor class B 25,repeat:LDL-receptor class B 26,repeat:LDL-receptor class B 27,repeat:LDL-receptor class B 28,repeat:LDL-receptor class B 29,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 30,repeat:LDL-receptor class B 31,repeat:LDL-receptor class B 32,repeat:LDL-receptor class B 33,repeat:LDL-receptor class B 34,repeat:LDL-receptor class B 35,repeat:LDL-receptor class B 36,repeat:LDL-receptor class B 37,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,short sequence motif:SH2-binding,short sequence motif:SH3-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRP8	LDL receptor related protein 8(LRP8)	Homo sapiens		h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development,h_reelinPathway:Reelin Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001523~retinoid metabolic process,GO:0006508~proteolysis,GO:0006629~lipid metabolic process,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0021541~ammon gyrus development,GO:0021987~cerebral cortex development,GO:0032793~positive regulation of CREB transcription factor activity,GO:0038026~reelin-mediated signaling pathway,GO:0042493~response to drug,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050804~modulation of synaptic transmission,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0071363~cellular response to growth factor stimulus,GO:0071397~cellular response to cholesterol,GO:1900006~positive regulation of dendrite development,	GO:0005576~extracellular region,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043235~receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005041~low-density lipoprotein receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008035~high-density lipoprotein particle binding,GO:0019894~kinesin binding,GO:0030229~very-low-density lipoprotein particle receptor activity,GO:0034185~apolipoprotein binding,GO:0038025~reelin receptor activity,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,		608446~Myocardial infarction, susceptibility to,		SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	3D-structure,Alternative splicing,Calcium,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Lipoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Low-density lipoprotein receptor-related protein 8,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,glycosylation site:N-linked (GlcNAc...),region of interest:Clustered O-linked oligosaccharides,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LEMD1	LEM domain containing 1(LEMD1)	Homo sapiens					GO:0016021~integral component of membrane,		IPR003887:LEM domain,IPR011015:LEM/LEM-like domain,				SM00540:LEM,	Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:LEM domain-containing protein 1,domain:LEM,sequence conflict,sequence variant,splice variant,transmembrane region,
LMCD1	LIM and cysteine rich domains 1(LMCD1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0010611~regulation of cardiac muscle hypertrophy,GO:0044267~cellular protein metabolic process,GO:0070886~positive regulation of calcineurin-NFAT signaling cascade,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031012~extracellular matrix,	GO:0003714~transcription corepressor activity,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR010442:PET domain,				SM00132:LIM,	Alternative splicing,Complete proteome,Cytoplasm,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,	chain:LIM and cysteine-rich domains protein 1,compositionally biased region:Cys-rich,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:PET,
LMO4	LIM domain only 4(LMO4)	Homo sapiens				GO:0001843~neural tube closure,GO:0003281~ventricular septum development,GO:0006366~transcription from RNA polymerase II promoter,GO:0021514~ventral spinal cord interneuron differentiation,GO:0021522~spinal cord motor neuron differentiation,GO:0021527~spinal cord association neuron differentiation,GO:0030334~regulation of cell migration,GO:0031333~negative regulation of protein complex assembly,GO:0033674~positive regulation of kinase activity,GO:0042659~regulation of cell fate specification,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048538~thymus development,GO:0050865~regulation of cell activation,	GO:0005667~transcription factor complex,GO:0031252~cell leading edge,	GO:0001158~enhancer sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Complete proteome,LIM domain,Metal-binding,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM domain transcription factor LMO4,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,
LIMD1	LIM domains containing 1(LIMD1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0002076~osteoblast development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008360~regulation of cell shape,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0035195~gene silencing by miRNA,GO:0035331~negative regulation of hippo signaling,GO:0045668~negative regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0016442~RISC complex,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,	hsa04390:Hippo signaling pathway,			SM00132:LIM,	Cell junction,Complete proteome,Cytoplasm,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Tumor suppressor,Zinc,	chain:LIM domain-containing protein 1,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,modified residue,region of interest:Interaction with RB1,region of interest:Mediates nuclear export,region of interest:Necessary for nuclear localization,sequence variant,
LHX4	LIM homeobox 4(LHX4)	Homo sapiens				GO:0001890~placenta development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008045~motor neuron axon guidance,GO:0009887~organ morphogenesis,GO:0021526~medial motor column neuron differentiation,GO:0043066~negative regulation of apoptotic process,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		262700~Pituitary hormone deficiency, combined, 4,		SM00132:LIM,SM00389:HOX,	Chromosomal rearrangement,Complete proteome,Disease mutation,DNA-binding,Dwarfism,Homeobox,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM/homeobox protein Lhx4,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,sequence conflict,sequence variant,
LHX8	LIM homeobox 8(LHX8)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007611~learning or memory,GO:0008585~female gonad development,GO:0021884~forebrain neuron development,GO:0042475~odontogenesis of dentin-containing tooth,	GO:0001674~female germ cell nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,				SM00132:LIM,SM00389:HOX,	Alternative splicing,Complete proteome,DNA-binding,Homeobox,LIM domain,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM/homeobox protein Lhx8,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,
LHX9	LIM homeobox 9(LHX9)	Homo sapiens				GO:0008045~motor neuron axon guidance,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0035262~gonad morphogenesis,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,				SM00132:LIM,SM00389:HOX,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Homeobox,LIM domain,Metal-binding,Nucleus,Reference proteome,Repeat,Zinc,	chain:LIM/homeobox protein Lhx9,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,helix,splice variant,
LMX1A	LIM homeobox transcription factor 1 alpha(LMX1A)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006351~transcription, DNA-templated,GO:0007411~axon guidance,GO:0007613~memory,GO:0007626~locomotory behavior,GO:0021542~dentate gyrus development,GO:0021549~cerebellum development,GO:0042048~olfactory behavior,GO:0045665~negative regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050808~synapse organization,GO:0071542~dopaminergic neuron differentiation,GO:1904948~midbrain dopaminergic neuron differentiation,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,				SM00132:LIM,SM00389:HOX,	Activator,Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Homeobox,LIM domain,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM homeobox transcription factor 1- alpha,compositionally biased region:Gln-rich,compositionally biased region:Poly-Gln,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,splice variant,
LIMS1	LIM zinc finger domain containing 1(LIMS1)	Homo sapiens				GO:0001837~epithelial to mesenchymal transition,GO:0007569~cell aging,GO:0010628~positive regulation of gene expression,GO:0010811~positive regulation of cell-substrate adhesion,GO:0034329~cell junction assembly,GO:0043547~positive regulation of GTPase activity,GO:0045184~establishment of protein localization,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050678~regulation of epithelial cell proliferation,GO:0051291~protein heterooligomerization,GO:0051894~positive regulation of focal adhesion assembly,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,	IPR001781:Zinc finger, LIM-type,IPR017351:PINCH,			PIRSF038003:PINCH protein,	SM00132:LIM,	3D-structure,Acetylation,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Direct protein sequencing,LIM domain,Membrane,Metal-binding,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:LIM and senescent cell antigen-like- containing domain protein 1,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:LIM zinc-binding 4,domain:LIM zinc-binding 5,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
LIMS2	LIM zinc finger domain containing 2(LIMS2)	Homo sapiens				GO:0016337~single organismal cell-cell adhesion,GO:0034329~cell junction assembly,GO:0043066~negative regulation of apoptotic process,GO:0045216~cell-cell junction organization,GO:2000178~negative regulation of neural precursor cell proliferation,GO:2000346~negative regulation of hepatocyte proliferation,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,	GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR017351:PINCH,			PIRSF038003:PINCH protein,	SM00132:LIM,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disease mutation,LIM domain,Limb-girdle muscular dystrophy,Membrane,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:LIM and senescent cell antigen-like- containing domain protein 2,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:LIM zinc-binding 4,domain:LIM zinc-binding 5,modified residue,sequence conflict,splice variant,
LIMS3	LIM zinc finger domain containing 3(LIMS3)	Homo sapiens					GO:0005737~cytoplasm,	GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR017351:PINCH,				SM00132:LIM,	Alternative splicing,Complete proteome,Cytoplasm,LIM domain,Metal-binding,Reference proteome,Zinc,	chain:LIM and senescent cell antigen-like- containing domain protein 3,domain:LIM zinc-binding,
LIMS4	LIM zinc finger domain containing 4(LIMS4)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR017351:PINCH,			PIRSF038003:PINCH protein,	SM00132:LIM,	Alternative splicing,Complete proteome,Cytoplasm,LIM domain,Metal-binding,Proteomics identification,Reference proteome,Zinc,
LIMS3-LOC440895	LIMS3-LOC440895 readthrough(LIMS3-LOC440895)	Homo sapiens													chain:LIM and senescent cell antigen-like- containing domain protein 3,domain:LIM zinc-binding,
L1TD1	LINE1 type transposase domain containing 1(L1TD1)	Homo sapiens				GO:0032197~transposition, RNA-mediated,	GO:0030529~intracellular ribonucleoprotein complex,	GO:0003727~single-stranded RNA binding,	IPR004244:Transposase, L1,					3D-structure,Acetylation,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:LINE-1 type transposase domain-containing protein 1,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,sequence conflict,sequence variant,
LONRF2	LON peptidase N-terminal domain and ring finger 2(LONRF2)	Homo sapiens			Coenzyme metabolism,Posttranslational modification, protein turnover, chaperones,	GO:0006508~proteolysis,		GO:0004176~ATP-dependent peptidase activity,GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR003111:Peptidase S16, lon N-terminal,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015947:PUA-like domain,IPR017907:Zinc finger, RING-type, conserved site,IPR019734:Tetratricopeptide repeat,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00028:TPR,SM00184:RING,SM00464:LON,	Alternative splicing,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Repeat,TPR repeat,Zinc,Zinc-finger,	chain:LON peptidase N-terminal domain and RING finger protein 2,compositionally biased region:Poly-Pro,domain:Lon,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type,
LRRFIP1	LRR binding FLII interacting protein 1(LRRFIP1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032481~positive regulation of type I interferon production,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,	GO:0003677~DNA binding,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR019139:Leucine-rich repeat flightless-interacting protein,					3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Leucine-rich repeat flightless- interacting protein 1,compositionally biased region:Lys-rich,modified residue,region of interest:DNA-binding,sequence conflict,sequence variant,splice variant,
LRRFIP2	LRR binding FLII interacting protein 2(LRRFIP2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006355~regulation of transcription, DNA-templated,GO:0016055~Wnt signaling pathway,		GO:0005515~protein binding,GO:0030275~LRR domain binding,	IPR019139:Leucine-rich repeat flightless-interacting protein,					Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Wnt signaling pathway,	chain:Leucine-rich repeat flightless- interacting protein 2,compositionally biased region:Ser-rich,modified residue,region of interest:DVL3-binding,sequence variant,splice variant,
LSM10	LSM10, U7 small nuclear RNA associated(LSM10)	Homo sapiens				GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0008334~histone mRNA metabolic process,GO:0008380~RNA splicing,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005683~U7 snRNP,GO:0015030~Cajal body,	GO:0005515~protein binding,GO:0071208~histone pre-mRNA DCP binding,GO:0071209~U7 snRNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,				SM00651:Sm,	Complete proteome,mRNA processing,mRNA splicing,Nucleus,Reference proteome,Ribonucleoprotein,RNA-binding,	chain:U7 snRNA-associated Sm-like protein LSm10,
LYPD1	LY6/PLAUR domain containing 1(LYPD1)	Homo sapiens				GO:0001662~behavioral fear response,GO:0001775~cell activation,GO:0007271~synaptic transmission, cholinergic,GO:0035094~response to nicotine,GO:0095500~acetylcholine receptor signaling pathway,GO:1903077~negative regulation of protein localization to plasma membrane,GO:2000272~negative regulation of receptor activity,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,	GO:0030550~acetylcholine receptor inhibitor activity,GO:0033130~acetylcholine receptor binding,						Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Signal,	chain:Ly6/PLAUR domain-containing protein 1,domain:UPAR/Ly6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,signal peptide,splice variant,
LYPD6	LY6/PLAUR domain containing 6(LYPD6)	Homo sapiens					GO:0005576~extracellular region,							Alternative splicing,Complete proteome,Direct protein sequencing,Glycoprotein,Reference proteome,Secreted,Signal,	chain:Ly6/PLAUR domain-containing protein 6,domain:UPAR/Ly6,glycosylation site:N-linked (GlcNAc...),signal peptide,
LYPD6B	LY6/PLAUR domain containing 6B(LYPD6B)	Homo sapiens					GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,							Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Proteomics identification,Reference proteome,Signal,	chain:Ly6/PLAUR domain-containing protein 6B,domain:UPAR/Ly6,lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,signal peptide,splice variant,
LY75-CD302	LY75-CD302 readthrough(LY75-CD302)	Homo sapiens				GO:0006897~endocytosis,GO:0006954~inflammatory response,GO:0006955~immune response,	GO:0005887~integral component of plasma membrane,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0030246~carbohydrate binding,	IPR000562:Fibronectin, type II, collagen-binding,IPR000772:Ricin B lectin domain,IPR001304:C-type lectin,IPR013806:Kringle-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Endocytosis,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,
LANCL1	LanC like 1(LANCL1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005887~integral component of plasma membrane,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017124~SH3 domain binding,GO:0043295~glutathione binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR007822:Lanthionine synthetase C-like,IPR012341:Six-hairpin glycosidase,IPR020464:LanC-like protein, eukaryotic,				SM01260:SM01260,	3D-structure,Acetylation,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Metal-binding,Proteomics identification,Reference proteome,Zinc,	binding site:Glutathione,chain:LanC-like protein 1,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Glutathione binding,strand,turn,
MPHOSPH10	M-phase phosphoprotein 10(MPHOSPH10)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0000375~RNA splicing, via transesterification reactions,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0008380~RNA splicing,GO:0010923~negative regulation of phosphatase activity,GO:0030490~maturation of SSU-rRNA,	GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0034457~Mpp10 complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR012173:U3 small nucleolar ribonucleoprotein complex, subunit Mpp10p,	hsa03008:Ribosome biogenesis in eukaryotes,		PIRSF017300:U3 small nucleolar ribonucleoprotein (snoRNP) complex, Mpp10p subunit,		Acetylation,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,rRNA processing,Ubl conjugation,	chain:U3 small nucleolar ribonucleoprotein protein mpp10,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,modified residue,sequence variant,
MAD2L2	MAD2 mitotic arrest deficient-like 2 (yeast)(MAD2L2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0007015~actin filament organization,GO:0007067~mitotic nuclear division,GO:0007094~mitotic spindle assembly checkpoint,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0042177~negative regulation of protein catabolic process,GO:0042276~error-prone translesion synthesis,GO:0042772~DNA damage response, signal transduction resulting in transcription,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1904667~negative regulation of ubiquitin protein ligase activity,GO:2000048~negative regulation of cell-cell adhesion mediated by cadherin,GO:2000678~negative regulation of transcription regulatory region DNA binding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005680~anaphase-promoting complex,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016035~zeta DNA polymerase complex,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0005515~protein binding,GO:0008432~JUN kinase binding,	IPR003511:DNA-binding HORMA,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,hsa05100:Bacterial invasion of epithelial cells,hsa05131:Shigellosis,				3D-structure,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,Mitosis,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Mitotic spindle assembly checkpoint protein MAD2B,domain:HORMA,sequence conflict,
MKNK1	MAP kinase interacting serine/threonine kinase 1(MKNK1)	Homo sapiens	107.mRNA_translation-protein_synthesis,	h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_mapkPathway:MAPKinase Signaling Pathway,h_mtorPathway:mTOR Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,		GO:0006417~regulation of translation,GO:0006468~protein phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0046777~protein autophosphorylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0009931~calcium-dependent protein serine/threonine kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04910:Insulin signaling pathway,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Translation regulation,	active site:Proton acceptor,binding site:ATP,chain:MAP kinase-interacting serine/threonine- protein kinase 1,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
MAP7D1	MAP7 domain containing 1(MAP7D1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005819~spindle,GO:0015630~microtubule cytoskeleton,	GO:0005198~structural molecule activity,	IPR008604:E-MAP-115,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:MAP7 domain-containing protein 1,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,splice variant,
MXD1	MAX dimerization protein 1(MXD1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Max dimerization protein 1,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,helix,short sequence motif:Nuclear localization signal,strand,
MDM4	MDM4, p53 regulator(MDM4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0042177~negative regulation of protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045023~G0 to G1 transition,GO:0050821~protein stabilization,GO:0071157~negative regulation of cell cycle arrest,GO:0071456~cellular response to hypoxia,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR001876:Zinc finger, RanBP2-type,IPR003121:SWIB/MDM2 domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015458:MDM4,IPR016495:p53 negative regulator Mdm2/Mdm4,	hsa04115:p53 signaling pathway,hsa05206:MicroRNAs in cancer,		PIRSF006748:p53 negative regulator Mdm2/Mdm4,PIRSF500699:p53 negative regulator Mdm4 [Parent=PIRSF006748],		3D-structure,Alternative splicing,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:Protein Mdm4,compositionally biased region:Asp/Glu-rich (acidic),domain:SWIB,helix,mutagenesis site,region of interest:Region II,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,zinc finger region:RanBP2-type,zinc finger region:RING-type,
MERTK	MER proto-oncogene, tyrosine kinase(MERTK)	Homo sapiens				GO:0001779~natural killer cell differentiation,GO:0006468~protein phosphorylation,GO:0006909~phagocytosis,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007283~spermatogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030168~platelet activation,GO:0032940~secretion by cell,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043277~apoptotic cell clearance,GO:0043491~protein kinase B signaling,GO:0050766~positive regulation of phagocytosis,GO:0050900~leukocyte migration,GO:0051250~negative regulation of lymphocyte activation,GO:0060041~retina development in camera-type eye,GO:0060068~vagina development,GO:2000107~negative regulation of leukocyte apoptotic process,	GO:0001750~photoreceptor outer segment,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016028~rhabdomere,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,		613862~Retinitis pigmentosa 38,		SM00060:FN3,SM00219:TyrKc,SM00409:IG,	3D-structure,ATP-binding,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Retinitis pigmentosa,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Mer,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
MIA3	MIA family member 3, ER export factor(MIA3)	Homo sapiens				GO:0002687~positive regulation of leukocyte migration,GO:0006887~exocytosis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007162~negative regulation of cell adhesion,GO:0015031~protein transport,GO:0030336~negative regulation of cell migration,GO:0042060~wound healing,GO:0042953~lipoprotein transport,GO:0090110~cargo loading into COPII-coated vesicle,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070971~endoplasmic reticulum exit site,	GO:0005515~protein binding,GO:0042954~lipoprotein transporter activity,	IPR001452:Src homology-3 domain,IPR011511:Variant SH3,					Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Exocytosis,Glycoprotein,Membrane,Methylation,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,SH3 domain,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Melanoma inhibitory activity protein 3,compositionally biased region:Pro-rich,domain:SH3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,topological domain:In membrane,transmembrane region,
MIER1	MIER1 transcriptional regulator(MIER1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0031937~positive regulation of chromatin silencing,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0003677~DNA binding,GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,				SM00717:SANT,SM01189:SM01189,	Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repressor,Signal,Transcription,Transcription regulation,Ubl conjugation,	chain:Mesoderm induction early response protein 1,compositionally biased region:Glu-rich,domain:ELM2,domain:SANT,modified residue,mutagenesis site,region of interest:Interaction with HDAC1,sequence conflict,splice variant,
MINOS1-NBL1	MINOS1-NBL1 readthrough(MINOS1-NBL1)	Homo sapiens				GO:0007399~nervous system development,GO:0030514~negative regulation of BMP signaling pathway,GO:0035582~sequestering of BMP in extracellular matrix,GO:0038098~sequestering of BMP from receptor via BMP binding,GO:0045666~positive regulation of neuron differentiation,GO:0048263~determination of dorsal identity,GO:0048812~neuron projection morphogenesis,GO:0090027~negative regulation of monocyte chemotaxis,	GO:0005615~extracellular space,GO:0061617~MICOS complex,	GO:0016015~morphogen activity,GO:0036122~BMP binding,GO:0042803~protein homodimerization activity,	IPR004133:DAN,IPR006207:Cystine knot, C-terminal,IPR007512:Protein of unknown function DUF543,IPR016728:Neuroblastoma suppressor of tumorigenicity 1,	hsa04350:TGF-beta signaling pathway,		PIRSF018557:DAN protein,	SM00041:CT,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Tumor suppressor,
MOB4	MOB family member 4, phocein(MOB4)	Homo sapiens				GO:0006810~transport,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0032580~Golgi cisterna membrane,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR005301:Mob1/phocein,				SM01388:SM01388,	Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Golgi apparatus,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transport,Zinc,	chain:Mps one binder kinase activator-like 3,metal ion-binding site:Zinc,modified residue,sequence conflict,splice variant,
MOB1A	MOB kinase activator 1A(MOB1A)	Homo sapiens				GO:0035329~hippo signaling,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR005301:Mob1/phocein,	hsa04390:Hippo signaling pathway,			SM01388:SM01388,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Metal-binding,Phosphoprotein,Reference proteome,Zinc,	chain:Mps one binder kinase activator-like 1B,helix,metal ion-binding site:Zinc,modified residue,sequence conflict,splice variant,strand,turn,
MOB3C	MOB kinase activator 3C(MOB3C)	Homo sapiens						GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR005301:Mob1/phocein,				SM01388:SM01388,	Complete proteome,Metal-binding,Proteomics identification,Reference proteome,Zinc,	chain:Mps one binder kinase activator-like 2C,metal ion-binding site:Zinc,
MON1A	MON1 homolog A, secretory trafficking associated(MON1A)	Homo sapiens				GO:0009306~protein secretion,GO:0016192~vesicle-mediated transport,GO:0043547~positive regulation of GTPase activity,	GO:0012505~endomembrane system,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR004353:Vacuolar fusion protein MON1,					Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Vacuolar fusion protein MON1 homolog A,modified residue,splice variant,
MORC1	MORC family CW-type zinc finger 1(MORC1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,	GO:0005634~nucleus,	GO:0008270~zinc ion binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR011124:Zinc finger, CW-type,					Alternative splicing,Coiled coil,Complete proteome,Developmental protein,Differentiation,Metal-binding,Nucleus,Polymorphism,Reference proteome,Spermatogenesis,Zinc,Zinc-finger,	chain:MORC family CW-type zinc finger protein 1,sequence variant,zinc finger region:CW-type,
MORN1	MORN repeat containing 1(MORN1)	Homo sapiens			Function unknown,				IPR003409:MORN motif,				SM00698:MORN,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:MORN repeat-containing protein 1,repeat:MORN 1,repeat:MORN 2,repeat:MORN 3,repeat:MORN 4,repeat:MORN 5,repeat:MORN 6,repeat:MORN 7,sequence variant,splice variant,
MPV17	MPV17, mitochondrial inner membrane protein(MPV17)	Homo sapiens				GO:0000002~mitochondrial genome maintenance,GO:0032836~glomerular basement membrane development,GO:0034614~cellular response to reactive oxygen species,GO:0042592~homeostatic process,GO:0048839~inner ear development,GO:2000377~regulation of reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0016021~integral component of membrane,		IPR007248:Mpv17/PMP22,	hsa04146:Peroxisome,	256810~Mitochondrial DNA depletion syndrome 6 (hepatocerebral type),			Complete proteome,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Neuropathy,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein Mpv17,sequence variant,transmembrane region,
MROH7-TTC4	MROH7-TTC4 readthrough (NMD candidate)(MROH7-TTC4)	Homo sapiens							IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Complete proteome,Reference proteome,
MYCBP	MYC binding protein(MYCBP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR026060:Associate of Myc 1,					3D-structure,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Mitochondrion,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:C-Myc-binding protein,helix,sequence conflict,strand,turn,
MYCNOS	MYCN opposite strand(MYCNOS)	Homo sapiens				GO:0007275~multicellular organism development,GO:0008284~positive regulation of cell proliferation,GO:0031647~regulation of protein stability,GO:0033673~negative regulation of kinase activity,GO:0043066~negative regulation of apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,						Complete proteome,Cytoplasm,Nucleus,Reference proteome,	chain:N-cym protein,compositionally biased region:Arg/Lys-rich (basic),sequence conflict,
MEAF6	MYST/Esa1 associated factor 6(MEAF6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016573~histone acetylation,GO:0043968~histone H2A acetylation,GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043983~histone H4-K12 acetylation,GO:0043984~histone H4-K16 acetylation,GO:0044154~histone H3-K14 acetylation,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000123~histone acetyltransferase complex,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0035267~NuA4 histone acetyltransferase complex,GO:0070776~MOZ/MORF histone acetyltransferase complex,	GO:0005515~protein binding,	IPR015418:Histone H4 acetyltransferase, NuA4 complex, Eaf6,					Acetylation,Activator,Alternative splicing,Centromere,Chromatin regulator,Chromosomal rearrangement,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Kinetochore,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Chromatin modification-related protein MEAF6,modified residue,sequence conflict,splice variant,
MEIS1	Meis homeobox 1(MEIS1)	Homo sapiens				GO:0001525~angiogenesis,GO:0002089~lens morphogenesis in camera-type eye,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007626~locomotory behavior,GO:0035855~megakaryocyte development,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060216~definitive hemopoiesis,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeodomain,IPR008422:Homeobox KN domain,IPR009057:Homeodomain-like,	hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05202:Transcriptional misregulation in cancer,			SM00389:HOX,	3D-structure,Activator,Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,	chain:Homeobox protein Meis1,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Asp,compositionally biased region:Ser/Thr-rich,DNA-binding region:Homeobox; TALE-type,region of interest:Required for transcriptional activation,splice variant,
MOV10	Mov10 RISC complex RNA helicase(MOV10)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0035195~gene silencing by miRNA,GO:0035279~mRNA cleavage involved in gene silencing by miRNA,GO:0048015~phosphatidylinositol-mediated signaling,	GO:0000932~cytoplasmic mRNA processing body,GO:0005615~extracellular space,GO:0005829~cytosol,	GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR026122:Putative helicase MOV-10/Armitage,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,RNA-mediated gene silencing,Transcription,Transcription regulation,	chain:Putative helicase MOV-10,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAG box,splice variant,
MYSM1	Myb like, SWIRM and MPN domains 1(MYSM1)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0030334~regulation of cell migration,GO:0035522~monoubiquitinated histone H2A deubiquitination,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051797~regulation of hair follicle development,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0008237~metallopeptidase activity,GO:0032403~protein complex binding,GO:0042393~histone binding,GO:0046872~metal ion binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR001005:SANT/Myb domain,IPR007526:SWIRM domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017884:SANT domain,				SM00232:JAB_MPN,SM00717:SANT,	3D-structure,Activator,Alternative splicing,Chromatin regulator,Complete proteome,DNA-binding,Hydrolase,Metal-binding,Metalloprotease,Nucleus,Phosphoprotein,Polymorphism,Protease,Reference proteome,Transcription,Transcription regulation,Ubl conjugation pathway,Zinc,	chain:Histone H2A deubiquitinase MYSM1,domain:MPN,domain:SANT,domain:SWIRM,helix,metal ion-binding site:Zinc; catalytic,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:JAMM motif,short sequence motif:LXXLL motif,splice variant,strand,turn,
NAGK	N-acetylglucosamine kinase(NAGK)	Homo sapiens				GO:0006044~N-acetylglucosamine metabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0006051~N-acetylmannosamine metabolic process,GO:0019262~N-acetylneuraminate catabolic process,GO:0046835~carbohydrate phosphorylation,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0009384~N-acylmannosamine kinase activity,GO:0045127~N-acetylglucosamine kinase activity,	IPR002731:ATPase, BadF/BadG/BcrA/BcrD type,	hsa00520:Amino sugar and nucleotide sugar metabolism,				3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	binding site:ATP,binding site:Substrate,chain:N-acetyl-D-glucosamine kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Substrate binding,sequence conflict,sequence variant,strand,turn,
NPL	N-acetylneuraminate pyruvate lyase(NPL)	Homo sapiens			Amino acid transport and metabolism / Cell envelope biogenesis, outer membrane,	GO:0005975~carbohydrate metabolic process,GO:0008152~metabolic process,GO:0019262~N-acetylneuraminate catabolic process,	GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008747~N-acetylneuraminate lyase activity,GO:0016829~lyase activity,GO:0042802~identical protein binding,	IPR002220:Dihydrodipicolinate synthetase-like,IPR005264:N-acetylneuraminate lyase,IPR013785:Aldolase-type TIM barrel,	hsa00520:Amino sugar and nucleotide sugar metabolism,		PIRSF001365:dihydrodipicolinate synthase,	SM01130:SM01130,	Alternative splicing,Carbohydrate metabolism,Complete proteome,Cytoplasm,Lyase,Proteomics identification,Reference proteome,Schiff base,	active site:Schiff-base intermediate with substrate,chain:N-acetylneuraminate lyase,region of interest:Substrate binding,sequence conflict,site:Involved in proton transfer during cleavage,splice variant,
NAT8	N-acetyltransferase 8 (putative)(NAT8)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0010628~positive regulation of gene expression,GO:0018003~peptidyl-lysine N6-acetylation,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0044267~cellular protein metabolic process,GO:0050435~beta-amyloid metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0070062~extracellular exosome,	GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0005515~protein binding,GO:0047198~cysteine-S-conjugate N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					Acyltransferase,Complete proteome,Endoplasmic reticulum,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Probable N-acetyltransferase 8,chain:Probable N-acetyltransferase 8B,domain:N-acetyltransferase,sequence conflict,sequence variant,transmembrane region,
NAT8B	N-acetyltransferase 8B (putative, gene/pseudogene)(NAT8B)	Homo sapiens				GO:0001702~gastrulation with mouth forming second,GO:0010628~positive regulation of gene expression,GO:0018003~peptidyl-lysine N6-acetylation,GO:0043066~negative regulation of apoptotic process,GO:0044267~cellular protein metabolic process,GO:0050435~beta-amyloid metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					Acyltransferase,Complete proteome,Endoplasmic reticulum,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Probable N-acetyltransferase 8,chain:Probable N-acetyltransferase 8B,domain:N-acetyltransferase,sequence conflict,sequence variant,transmembrane region,
NGLY1	N-glycanase 1(NGLY1)	Homo sapiens				GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0006516~glycoprotein catabolic process,GO:0006517~protein deglycosylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000224~peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR002931:Transglutaminase-like,IPR006588:Peptide N glycanase, PAW domain,IPR008979:Galactose-binding domain-like,IPR018997:PUB domain,	hsa04141:Protein processing in endoplasmic reticulum,	615273~Congenital disorder of deglycosylation,		SM00460:TGc,SM00580:PUG,SM00613:PAW,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	active site:Nucleophile,chain:Peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase,domain:PAW,domain:PUB,helix,metal ion-binding site:Zinc,modified residue,sequence variant,splice variant,strand,turn,
NMI	N-myc and STAT interactor(NMI)	Homo sapiens		h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,		GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007259~JAK-STAT cascade,GO:0045355~negative regulation of interferon-alpha biosynthetic process,GO:0045358~negative regulation of interferon-beta biosynthetic process,GO:0045824~negative regulation of innate immune response,GO:0060333~interferon-gamma-mediated signaling pathway,GO:1902524~positive regulation of protein K48-linked ubiquitination,GO:1903506~regulation of nucleic acid-templated transcription,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR009909:Nmi/IFP 35,IPR009938:Interferon induced 35kDa, N-terminal,					Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:N-myc-interactor,sequence conflict,sequence variant,
NADK	NAD kinase(NADK)	Homo sapiens				GO:0006741~NADP biosynthetic process,GO:0016310~phosphorylation,GO:0019674~NAD metabolic process,GO:0046034~ATP metabolic process,	GO:0005829~cytosol,	GO:0003951~NAD+ kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR002504:Inorganic polyphosphate/ATP-NAD kinase, predicted,IPR016064:ATP-NAD kinase-like domain,IPR017437:ATP-NAD kinase, PpnK-type, all-beta,IPR017438:Inorganic polyphosphate/ATP-NAD kinase, domain 1,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,ATP-binding,Complete proteome,Kinase,Metal-binding,NAD,NADP,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:NAD kinase,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,
NDUFAF7	NADH:ubiquinone oxidoreductase complex assembly factor 7(NDUFAF7)	Homo sapiens			Function unknown,	GO:0019918~peptidyl-arginine methylation, to symmetrical-dimethyl arginine,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0046034~ATP metabolic process,	GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0019899~enzyme binding,GO:0035243~protein-arginine omega-N symmetric methyltransferase activity,	IPR003788:Putative S-adenosyl-L-methionine-dependent methyltransferase MidA,					Alternative splicing,Complete proteome,Methyltransferase,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:Protein midA homolog, mitochondrial,sequence variant,splice variant,transit peptide:Mitochondrion,
NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1(NDUFS1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0008637~apoptotic mitochondrial changes,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042773~ATP synthesis coupled electron transport,GO:0045333~cellular respiration,GO:0046034~ATP metabolic process,GO:0051881~regulation of mitochondrial membrane potential,GO:0072593~reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0043209~myelin sheath,	GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051537~2 iron, 2 sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000283:NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site,IPR001041:2Fe-2S ferredoxin-type domain,IPR006656:Molybdopterin oxidoreductase,IPR006963:Molybdopterin oxidoreductase, 4Fe-4S domain,IPR010228:NADH:ubiquinone oxidoreductase, subunit G,IPR012675:Beta-grasp domain,IPR015405:NADH-quinone oxidoreductase, chain G, C-terminal,IPR019574:NADH:ubiquinone oxidoreductase, subunit G, iron-sulphur binding,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,		SM00929:SM00929,	2Fe-2S,4Fe-4S,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Electron transport,Iron,Iron-sulfur,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial,domain:2Fe-2S ferredoxin-type,metal ion-binding site:Iron-sulfur 1 (2Fe-2S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S); via pros nitrogen,metal ion-binding site:Iron-sulfur 3 (4Fe-4S),modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
NDUFA10	NADH:ubiquinone oxidoreductase subunit A10(NDUFA10)	Homo sapiens			Nucleotide transport and metabolism,	GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042493~response to drug,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0043209~myelin sheath,GO:0070469~respiratory chain,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR015828:NADH:ubiquinone oxidoreductase, 42kDa subunit,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	256000~Leigh syndrome,	PIRSF000543:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 10,		Alternative splicing,Complete proteome,Electron transport,FAD,Flavoprotein,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
NDUFS5	NADH:ubiquinone oxidoreductase subunit S5(NDUFS5)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR019342:NADH:ubiquinone oxidoreductase, iron-sulphur subunit 5,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Complete proteome,Disulfide bond,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Respiratory chain,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 5,
NCK2	NCK adaptor protein 2(NCK2)	Homo sapiens				GO:0001771~immunological synapse formation,GO:0007015~actin filament organization,GO:0007165~signal transduction,GO:0007172~signal complex assembly,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007176~regulation of epidermal growth factor-activated receptor activity,GO:0008285~negative regulation of cell proliferation,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0030032~lamellipodium assembly,GO:0030838~positive regulation of actin filament polymerization,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0036493~positive regulation of translation in response to endoplasmic reticulum stress,GO:0042102~positive regulation of T cell proliferation,GO:0042110~T cell activation,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0060996~dendritic spine development,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903898~negative regulation of PERK-mediated unfolded protein response,GO:1903912~negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,GO:1990441~negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0012506~vesicle membrane,GO:0045202~synapse,	GO:0005070~SH3/SH2 adaptor activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0030159~receptor signaling complex scaffold activity,GO:0032403~protein complex binding,GO:0097110~scaffold protein binding,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR017304:Cytoplasmic, NCK,	hsa04012:ErbB signaling pathway,hsa04360:Axon guidance,hsa04660:T cell receptor signaling pathway,hsa05130:Pathogenic Escherichia coli infection,		PIRSF037874:adapter protein NCK,	SM00252:SH2,SM00326:SH3,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Endoplasmic reticulum,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Translation regulation,	chain:Cytoplasmic protein NCK2,domain:SH2,domain:SH3 1,domain:SH3 2,domain:SH3 3,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
NCKAP1	NCK associated protein 1(NCKAP1)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,		GO:0006915~apoptotic process,GO:0007417~central nervous system development,GO:0010592~positive regulation of lamellipodium assembly,GO:0016032~viral process,GO:0016601~Rac protein signal transduction,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation,	GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0031209~SCAR complex,GO:0031258~lamellipodium membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0048365~Rac GTPase binding,	IPR019137:Nck-associated protein 1,	hsa04810:Regulation of actin cytoskeleton,				3D-structure,Acetylation,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Host-virus interaction,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Nck-associated protein 1,splice variant,transmembrane region,
NCKAP5	NCK associated protein 5(NCKAP5)	Homo sapiens							IPR026163:Nck-associated protein 5-like,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Nck-associated protein 5,compositionally biased region:Poly-Pro,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,
NCKIPSD	NCK interacting protein with SH3 domain(NCKIPSD)	Homo sapiens				GO:0006607~NLS-bearing protein import into nucleus,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0008180~COP9 signalosome,	GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0017124~SH3 domain binding,	IPR001452:Src homology-3 domain,IPR018556:Domain of unknown function DUF2013,				SM00326:SH3,	Alternative splicing,Chromosomal rearrangement,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH3 domain,SH3-binding,	chain:NCK-interacting protein with SH3 domain,compositionally biased region:Leu-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser/Thr-rich,domain:SH3,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form MLL- AF3P21 oncogene,splice variant,
NDC1	NDC1 transmembrane nucleoporin(NDC1)	Homo sapiens				GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0007077~mitotic nuclear envelope disassembly,GO:0007129~synapsis,GO:0007283~spermatogenesis,GO:0010827~regulation of glucose transport,GO:0015031~protein transport,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0019083~viral transcription,GO:0030474~spindle pole body duplication,GO:0031047~gene silencing by RNA,GO:0031081~nuclear pore distribution,GO:0051292~nuclear pore complex assembly,GO:0071790~establishment of spindle pole body localization to nuclear envelope,GO:0075733~intracellular transport of virus,GO:1900034~regulation of cellular response to heat,	GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005816~spindle pole body,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,GO:0070762~nuclear pore transmembrane ring,	GO:0017056~structural constituent of nuclear pore,	IPR019049:Nucleoporin protein Ndc1-Nup,	hsa03013:RNA transport,				Alternative splicing,Complete proteome,Membrane,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Translocation,Transmembrane,Transmembrane helix,Transport,	chain:Nucleoporin NDC1,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Perinuclear space,transmembrane region,
NECAP2	NECAP endocytosis associated 2(NECAP2)	Homo sapiens				GO:0006897~endocytosis,GO:0015031~protein transport,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0016020~membrane,GO:0030125~clathrin vesicle coat,		IPR011993:Pleckstrin homology-like domain,IPR012466:Adaptin ear-binding coat-associated protein 1 NECAP-1,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endocytosis,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Adaptin ear-binding coat-associated protein 2,sequence variant,short sequence motif:WXXF motif 1,short sequence motif:WXXF motif 2,splice variant,
NEXN-AS1	NEXN antisense RNA 1(NEXN-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C1orf118,compositionally biased region:Ala-rich,compositionally biased region:Pro-rich,
NKIRAS1	NFKB inhibitor interacting Ras like 1(NKIRAS1)	Homo sapiens				GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:NF-kappa-B inhibitor-interacting Ras-like protein 1,mutagenesis site,nucleotide phosphate-binding region:GTP,region of interest:Interactions with NFKBIA and NFKBIB,sequence conflict,short sequence motif:Effector region,
NFKBIZ	NFKB inhibitor zeta(NFKBIZ)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,	GO:0005634~nucleus,	GO:0003712~transcription cofactor activity,GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	hsa05202:Transcriptional misregulation in cancer,			SM00248:ANK,	Activator,Alternative splicing,ANK repeat,Complete proteome,Nucleus,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:NF-kappa-B inhibitor zeta,region of interest:Interaction with NFKB1/p50,region of interest:Required for transcriptional activity,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
NFU1	NFU1 iron-sulfur cluster scaffold(NFU1)	Homo sapiens				GO:0016226~iron-sulfur cluster assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001075:NIF system FeS cluster assembly, NifU, C-terminal,IPR014824:NIF system FeS cluster assembly, NifU-like scaffold, N-terminal,IPR017065:HIRA-interacting protein 5,		605711~Multiple mitochondrial dysfunctions syndrome 1,		SM00932:SM00932,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:NFU1 iron-sulfur cluster scaffold homolog, mitochondrial,region of interest:NifU,sequence conflict,sequence variant,transit peptide:Mitochondrion,
NAB1	NGFI-A binding protein 1(NAB1)	Homo sapiens				GO:0001958~endochondral ossification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007399~nervous system development,GO:0014037~Schwann cell differentiation,GO:0042552~myelination,GO:0045682~regulation of epidermis development,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000989~transcription factor activity, transcription factor binding,GO:0008134~transcription factor binding,	IPR006986:Nab1, C-terminal,IPR006988:Nab, N-terminal,IPR006989:NAB co-repressor, domain,					3D-structure,Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:NGFI-A-binding protein 1,helix,modified residue,region of interest:NCD1,region of interest:NCD2,region of interest:Necessary for nuclear localization,sequence conflict,splice variant,turn,
NEK10	NIMA related kinase 10(NEK10)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007017~microtubule-based process,GO:0007059~chromosome segregation,GO:0031954~positive regulation of protein autophosphorylation,GO:0043406~positive regulation of MAP kinase activity,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:1902749~regulation of cell cycle G2/M phase transition,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:1902911~protein kinase complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR017441:Protein kinase, ATP binding site,					Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek10,domain:Protein kinase,nucleotide phosphate-binding region:ATP,repeat:ARM,sequence conflict,sequence variant,splice variant,
NEK4	NIMA related kinase 4(NEK4)	Homo sapiens				GO:0000278~mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007067~mitotic nuclear division,GO:0023014~signal transduction by protein phosphorylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,GO:1900062~regulation of replicative cell aging,GO:2000772~regulation of cellular senescence,GO:2001020~regulation of response to DNA damage stimulus,	GO:0005737~cytoplasm,GO:0005929~cilium,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0030145~manganese ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Cell cycle,Cell division,Cell projection,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Methylation,Mitosis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek4,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
NEK7	NIMA related kinase 7(NEK7)	Homo sapiens				GO:0000910~cytokinesis,GO:0006468~protein phosphorylation,GO:0007346~regulation of mitotic cell cycle,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0051225~spindle assembly,GO:0051973~positive regulation of telomerase activity,GO:1904355~positive regulation of telomere capping,	GO:0000922~spindle pole,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005874~microtubule,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Magnesium,Metal-binding,Microtubule,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek7,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
NIPAL3	NIPA like domain containing 3(NIPAL3)	Homo sapiens				GO:0002377~immunoglobulin production,GO:0015693~magnesium ion transport,GO:1903830~magnesium ion transmembrane transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0015095~magnesium ion transmembrane transporter activity,	IPR008521:Magnesium transporter NIPA,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:NIPA-like protein 3,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),modified residue,splice variant,transmembrane region,
NLRC4	NLR family CARD domain containing 4(NLRC4)	Homo sapiens				GO:0002218~activation of innate immune response,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006954~inflammatory response,GO:0009966~regulation of signal transduction,GO:0016045~detection of bacterium,GO:0016567~protein ubiquitination,GO:0042742~defense response to bacterium,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0045087~innate immune response,GO:0050702~interleukin-1 beta secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051260~protein homooligomerization,GO:0070269~pyroptosis,GO:0090307~mitotic spindle assembly,GO:1990001~inhibition of cysteine-type endopeptidase activity involved in apoptotic process,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0072557~IPAF inflammasome complex,	GO:0000287~magnesium ion binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR001315:Caspase Recruitment,IPR007111:NACHT nucleoside triphosphatase,IPR011029:Death-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04621:NOD-like receptor signaling pathway,hsa05132:Salmonella infection,hsa05134:Legionellosis,	616050~Autoinflammation with infantile enterocolitis,616115~Familial cold autoinflammatory syndrome 4,			Alternative splicing,Apoptosis,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Immunity,Inflammatory response,Innate immunity,Leucine-rich repeat,Nucleotide-binding,Phosphoprotein,Reference proteome,Repeat,	chain:NLR family CARD domain-containing protein 4,domain:CARD,domain:NACHT,nucleotide phosphate-binding region:ATP,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,splice variant,
NLRP3	NLR family pyrin domain containing 3(NLRP3)	Homo sapiens				GO:0002674~negative regulation of acute inflammatory response,GO:0002830~positive regulation of type 2 immune response,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0009595~detection of biotic stimulus,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032611~interleukin-1 beta production,GO:0032621~interleukin-18 production,GO:0032736~positive regulation of interleukin-13 production,GO:0032753~positive regulation of interleukin-4 production,GO:0032754~positive regulation of interleukin-5 production,GO:0042347~negative regulation of NF-kappaB import into nucleus,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0044546~NLRP3 inflammasome complex assembly,GO:0045087~innate immune response,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050701~interleukin-1 secretion,GO:0050713~negative regulation of interleukin-1 beta secretion,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050728~negative regulation of inflammatory response,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051259~protein oligomerization,GO:0051607~defense response to virus,GO:0071222~cellular response to lipopolysaccharide,GO:2000321~positive regulation of T-helper 17 cell differentiation,GO:2000553~positive regulation of T-helper 2 cell cytokine production,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0072559~NLRP3 inflammasome complex,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0042834~peptidoglycan binding,GO:0043565~sequence-specific DNA binding,	IPR001611:Leucine-rich repeat,IPR004020:DAPIN domain,IPR007111:NACHT nucleoside triphosphatase,IPR011029:Death-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04621:NOD-like receptor signaling pathway,hsa05133:Pertussis,hsa05164:Influenza A,	120100~Familial cold-induced inflammatory syndrome 1,191900~Muckle-Wells syndrome,607115~CINCA syndrome,		SM01288:SM01288,SM01289:SM01289,	3D-structure,Activator,Alternative splicing,Amyloidosis,ATP-binding,Complete proteome,Cytoplasm,Deafness,Disease mutation,Disulfide bond,Endoplasmic reticulum,Immunity,Inflammasome,Inflammatory response,Innate immunity,Leucine-rich repeat,Nucleotide-binding,Nucleus,Reference proteome,Repeat,Secreted,Transcription,Transcription regulation,Ubl conjugation,	chain:NACHT, LRR and PYD domains-containing protein 3,compositionally biased region:Poly-Glu,domain:DAPIN,domain:NACHT,nucleotide phosphate-binding region:ATP,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,sequence conflict,sequence variant,splice variant,
NME7	NME/NM23 family member 7(NME7)	Homo sapiens				GO:0006165~nucleoside diphosphate phosphorylation,GO:0006183~GTP biosynthetic process,GO:0006228~UTP biosynthetic process,GO:0006241~CTP biosynthetic process,	GO:0005813~centrosome,	GO:0004550~nucleoside diphosphate kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001564:Nucleoside diphosphate kinase,IPR006602:Uncharacterised domain DM10,IPR010554:Protein of unknown function DUF1126,IPR011410:Nucleoside diphosphate kinase, NDK7,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,		PIRSF036503:nucleoside diphosphate kinase, NDK7 type,	SM00562:NDK,SM00676:DM10,	Alternative splicing,ATP-binding,Complete proteome,Kinase,Magnesium,Metal-binding,Nucleotide metabolism,Nucleotide-binding,Proteomics identification,Reference proteome,Transferase,	active site:Pros-phosphohistidine intermediate,binding site:ATP,chain:Nucleoside diphosphate kinase 7,domain:DM10,
NOC2L	NOC2 like nucleolar associated transcriptional repressor(NOC2L)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002903~negative regulation of B cell apoptotic process,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0031497~chromatin assembly,GO:0032066~nucleolus to nucleoplasm transport,GO:0034644~cellular response to UV,GO:0035067~negative regulation of histone acetylation,GO:0042273~ribosomal large subunit biogenesis,GO:1901796~regulation of signal transduction by p53 class mediator,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030690~Noc1p-Noc2p complex,GO:0030691~Noc2p-Noc3p complex,	GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0031491~nucleosome binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,GO:0070491~repressing transcription factor binding,	IPR005343:Nucleolar complex protein 2,IPR016024:Armadillo-type fold,					Apoptosis,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Nucleolar complex protein 2 homolog,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,
NSUN3	NOP2/Sun RNA methyltransferase family member 3(NSUN3)	Homo sapiens				GO:0031167~rRNA methylation,	GO:0005762~mitochondrial large ribosomal subunit,	GO:0003723~RNA binding,GO:0008168~methyltransferase activity,	IPR001678:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p,IPR023267:RNA (C5-cytosine) methyltransferase,					Complete proteome,Methyltransferase,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,S-adenosyl-L-methionine,Transferase,	active site:Nucleophile,binding site:S-adenosyl-L-methionine,chain:Putative methyltransferase NSUN3,region of interest:S-adenosyl-L-methionine binding,sequence variant,
NSUN4	NOP2/Sun RNA methyltransferase family member 4(NSUN4)	Homo sapiens				GO:0031167~rRNA methylation,GO:0042256~mature ribosome assembly,GO:0070131~positive regulation of mitochondrial translation,	GO:0005762~mitochondrial large ribosomal subunit,	GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0019843~rRNA binding,GO:0070181~small ribosomal subunit rRNA binding,	IPR001678:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p,IPR023267:RNA (C5-cytosine) methyltransferase,					3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Methyltransferase,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA processing,rRNA-binding,S-adenosyl-L-methionine,Transferase,Transit peptide,	active site:Nucleophile,binding site:S-adenosyl-L-methionine,chain:Putative methyltransferase NSUN4,region of interest:S-adenosyl-L-methionine binding,sequence variant,splice variant,
NOP58	NOP58 ribonucleoprotein(NOP58)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0000154~rRNA modification,GO:0006364~rRNA processing,GO:0006608~snRNP protein import into nucleus,GO:0016049~cell growth,GO:0016925~protein sumoylation,GO:0048254~snoRNA localization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016020~membrane,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,GO:0070761~pre-snoRNP complex,	GO:0001094~TFIID-class transcription factor binding,GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,	IPR002687:Nop domain,IPR012974:NOP5, N-terminal,IPR012976:NOSIC,	hsa03008:Ribosome biogenesis in eukaryotes,			SM00931:SM00931,	Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,Ubl conjugation,	chain:Nucleolar protein 58,compositionally biased region:Lys-rich,domain:Nop,modified residue,sequence conflict,sequence variant,
NPHS2	NPHS2, podocin(NPHS2)	Homo sapiens				GO:0007588~excretion,GO:0031532~actin cytoskeleton reorganization,GO:0072249~metanephric glomerular visceral epithelial cell development,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0031235~intrinsic component of the cytoplasmic side of the plasma membrane,GO:0036057~slit diaphragm,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001107:Band 7 protein,IPR001972:Stomatin,IPR018080:Band 7/stomatin-like, conserved site,		600995~Nephrotic syndrome, type 2,		SM00244:PHB,	Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Lipoprotein,Membrane,Palmitate,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Podocin,lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,splice variant,topological domain:Cytoplasmic,transmembrane region,
NSL1	NSL1, MIS12 kinetochore complex component(NSL1)	Homo sapiens				GO:0000070~mitotic sister chromatid segregation,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000444~MIS12/MIND type complex,GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR013950:Kinetochore Mis14,					3D-structure,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Complete proteome,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Kinetochore-associated protein NSL1 homolog,modified residue,sequence variant,
NT5C1B-RDH14	NT5C1B-RDH14 readthrough(NT5C1B-RDH14)	Homo sapiens				GO:0006195~purine nucleotide catabolic process,GO:0009117~nucleotide metabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0008253~5'-nucleotidase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR010394:5-nucleotidase,IPR016040:NAD(P)-binding domain,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Magnesium,Nucleotide metabolism,Reference proteome,
NUAK2	NUAK family kinase 2(NUAK2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0030036~actin cytoskeleton organization,GO:0035556~intracellular signal transduction,GO:0042149~cellular response to glucose starvation,GO:0043066~negative regulation of apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Acetylation,Apoptosis,ATP-binding,Complete proteome,Direct protein sequencing,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:NUAK family SNF1-like kinase 2,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,
NUF2	NUF2, NDC80 kinetochore complex component(NUF2)	Homo sapiens				GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,GO:0031262~Ndc80 complex,	GO:0005515~protein binding,	IPR005549:Kinetochore protein Nuf2,					3D-structure,Acetylation,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Kinetochore protein Nuf2,helix,modified residue,region of interest:Interaction with the C-terminus of NDC80 and the SPBC24-SPBC25 subcomplex,region of interest:Interaction with the N-terminus of NDC80,sequence variant,strand,
NKAIN1	Na+/K+ transporting ATPase interacting 1(NKAIN1)	Homo sapiens				GO:0002028~regulation of sodium ion transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0051117~ATPase binding,	IPR008516:Na,K-Atpase Interacting protein,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,transmembrane region,
OSGEPL1	O-sialoglycoprotein endopeptidase like 1(OSGEPL1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0002949~tRNA threonylcarbamoyladenosine modification,GO:0006508~proteolysis,	GO:0000408~EKC/KEOPS complex,GO:0005739~mitochondrion,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,GO:0061711~N(6)-L-threonylcarbamoyladenine synthase,	IPR000905:Gcp-like domain,IPR017861:Kae1/YgjD family,IPR022450:Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (YgjD),					Acetylation,Acyltransferase,Alternative splicing,Complete proteome,Metal-binding,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,tRNA processing,	chain:Probable O-sialoglycoprotein endopeptidase 2,metal ion-binding site:Zinc,modified residue,sequence conflict,sequence variant,splice variant,
OMA1	OMA1 zinc metallopeptidase(OMA1)	Homo sapiens				GO:0002024~diet induced thermogenesis,GO:0006006~glucose metabolic process,GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0006629~lipid metabolic process,GO:0006950~response to stress,GO:0010637~negative regulation of mitochondrial fusion,GO:0034982~mitochondrial protein processing,GO:0042407~cristae formation,GO:0097009~energy homeostasis,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,	IPR001915:Peptidase M48,					Alternative splicing,Complete proteome,Hydrolase,Membrane,Metal-binding,Metalloprotease,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Zinc,	chain:Metalloendopeptidase OMA1, mitochondrial,metal ion-binding site:Zinc; catalytic,sequence variant,splice variant,transit peptide:Mitochondrion,transmembrane region,
ORMDL1	ORMDL sphingolipid biosynthesis regulator 1(ORMDL1)	Homo sapiens				GO:0006672~ceramide metabolic process,GO:0090155~negative regulation of sphingolipid biosynthetic process,GO:0090156~cellular sphingolipid homeostasis,GO:1900060~negative regulation of ceramide biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0035339~SPOTS complex,		IPR007203:ORMDL,			PIRSF018147:endoplasmic reticulum protein, Orm1 type,		Complete proteome,Endoplasmic reticulum,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:ORM1-like protein 1,transmembrane region,
OTUD3	OTU deubiquitinase 3(OTUD3)	Homo sapiens				GO:0035871~protein K11-linked deubiquitination,GO:0044313~protein K6-linked deubiquitination,		GO:0004843~thiol-dependent ubiquitin-specific protease activity,	IPR003323:Ovarian tumour, otubain,					3D-structure,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:OTU domain-containing protein 3,domain:OTU,modified residue,sequence variant,
OTUD7B	OTU deubiquitinase 7B(OTUD7B)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002385~mucosal immune response,GO:0006955~immune response,GO:0032717~negative regulation of interleukin-8 production,GO:0035871~protein K11-linked deubiquitination,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0070536~protein K63-linked deubiquitination,GO:0071108~protein K48-linked deubiquitination,GO:0071947~protein deubiquitination involved in ubiquitin-dependent protein catabolic process,GO:1900181~negative regulation of protein localization to nucleus,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008270~zinc ion binding,GO:0070530~K63-linked polyubiquitin binding,GO:1990380~Lys48-specific deubiquitinase activity,	IPR002653:Zinc finger, A20-type,IPR003323:Ovarian tumour, otubain,				SM00259:ZnF_A20,	Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Immunity,Metal-binding,Nucleus,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:OTU domain-containing protein 7B,domain:OTU,modified residue,mutagenesis site,region of interest:Catalytic,region of interest:TRAF-binding,sequence conflict,short sequence motif:Nuclear localization signal,zinc finger region:A20-type,
OLA1	Obg like ATPase 1(OLA1)	Homo sapiens				GO:0046034~ATP metabolic process,GO:0098609~cell-cell adhesion,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016887~ATPase activity,GO:0043022~ribosome binding,GO:0043023~ribosomal large subunit binding,GO:0046872~metal ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR004396:Conserved hypothetical protein CHP00092,IPR006073:GTP binding domain,IPR012675:Beta-grasp domain,IPR012676:TGS-like,IPR013029:Domain of unknown function DUF933,IPR023192:TGS-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF006641:GTP-dependent nucleic acid-binding protein, EngD type,		3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Hydrolase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	binding site:ATP; via carbonyl oxygen,chain:Obg-like ATPase 1,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,
PASK	PAS domain containing serine/threonine kinase(PASK)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0010906~regulation of glucose metabolic process,GO:0043576~regulation of respiratory gaseous exchange,GO:0045719~negative regulation of glycogen biosynthetic process,GO:0045727~positive regulation of translation,GO:0046777~protein autophosphorylation,GO:0070092~regulation of glucagon secretion,GO:2000505~regulation of energy homeostasis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0035091~phosphatidylinositol binding,	IPR000014:PAS domain,IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00091:PAS,SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Lipid-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:PAS domain-containing serine/threonine- protein kinase,domain:PAS 1,domain:PAS 2,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
PATJ	PATJ, crumbs cell polarity complex component(PATJ)	Homo sapiens				GO:0035556~intracellular signal transduction,GO:0070830~bicellular tight junction assembly,	GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0016324~apical plasma membrane,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001478:PDZ domain,IPR004172:L27,IPR015132:L27-2,	hsa04390:Hippo signaling pathway,hsa04530:Tight junction,			SM00228:PDZ,SM00569:L27,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Tight junction,	chain:InaD-like protein,domain:L27,domain:PDZ 1,domain:PDZ 10,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,domain:PDZ 5,domain:PDZ 6,domain:PDZ 7,domain:PDZ 8,domain:PDZ 9,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
PBX1	PBX homeobox 1(PBX1)	Homo sapiens				GO:0001658~branching involved in ureteric bud morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0006694~steroid biosynthetic process,GO:0007548~sex differentiation,GO:0008284~positive regulation of cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0009954~proximal/distal pattern formation,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0030278~regulation of ossification,GO:0030325~adrenal gland development,GO:0030326~embryonic limb morphogenesis,GO:0035019~somatic stem cell population maintenance,GO:0035162~embryonic hemopoiesis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045665~negative regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048706~embryonic skeletal system development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeodomain,IPR005542:PBX,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,	hsa05202:Transcriptional misregulation in cancer,	Leukemia, acute pre-B-cell~Leukemia, acute pre-B-cell,		SM00389:HOX,	3D-structure,Activator,Alternative splicing,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,DNA-binding,Homeobox,Nucleus,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repressor,Sexual differentiation,Steroidogenesis,Transcription,Transcription regulation,	chain:Pre-B-cell leukemia transcription factor 1,compositionally biased region:Poly-Ala,DNA-binding region:Homeobox; TALE-type,helix,site:Breakpoint for translocation to form CAA67062A-PBX1 oncogene,splice variant,turn,
PDZK1P1	PDZ domain containing 1 pseudogene 1(PDZK1P1)	Homo sapiens							IPR001478:PDZ domain,				SM00228:PDZ,	Alternative splicing,Complete proteome,Reference proteome,Repeat,
PDZK1	PDZ domain containing 1(PDZK1)	Homo sapiens		h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors,		GO:0006810~transport,GO:0008283~cell proliferation,GO:0015879~carnitine transport,GO:0015893~drug transport,GO:0034767~positive regulation of ion transmembrane transport,GO:0044070~regulation of anion transport,GO:0090314~positive regulation of protein targeting to membrane,	GO:0005886~plasma membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0031528~microvillus membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005124~scavenger receptor binding,GO:0005215~transporter activity,GO:0005515~protein binding,GO:0030165~PDZ domain binding,GO:0032403~protein complex binding,	IPR001478:PDZ domain,				SM00228:PDZ,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Na(+)/H(+) exchange regulatory cofactor NHE-RF3,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,helix,modified residue,sequence conflict,strand,turn,
PDZRN3	PDZ domain containing ring finger 3(PDZRN3)	Homo sapiens				GO:0007528~neuromuscular junction development,GO:0016567~protein ubiquitination,	GO:0031594~neuromuscular junction,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001293:Zinc finger, TRAF-type,IPR001478:PDZ domain,IPR001841:Zinc finger, RING-type,IPR008974:TRAF-like,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013323:SIAH-type domain,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00228:PDZ,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:PDZ domain-containing RING finger protein 3,domain:PDZ 1,domain:PDZ 2,helix,sequence variant,splice variant,strand,zinc finger region:RING-type; degenerate,zinc finger region:TRAF-type,
PDZK1IP1	PDZK1 interacting protein 1(PDZK1IP1)	Homo sapiens					GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR026628:PDZK1-interacting protein 1 family,					Complete proteome,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:PDZK1-interacting protein 1,sequence conflict,transmembrane region,
PCNP	PEST proteolytic signal containing nuclear protein(PCNP)	Homo sapiens				GO:0007049~cell cycle,GO:0016567~protein ubiquitination,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,	GO:0005515~protein binding,						Acetylation,Alternative splicing,Cell cycle,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:PEST proteolytic signal-containing nuclear protein,modified residue,sequence conflict,splice variant,
PHF13	PHD finger protein 13(PHF13)	Homo sapiens				GO:0000278~mitotic cell cycle,GO:0007059~chromosome segregation,GO:0007076~mitotic chromosome condensation,GO:0016569~covalent chromatin modification,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0035064~methylated histone binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,	3D-structure,Cell cycle,Cell division,Chromatin regulator,Complete proteome,DNA condensation,Metal-binding,Mitosis,Nucleus,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:PHD finger protein 13,sequence variant,zinc finger region:PHD-type,
PHOSPHO2-KLHL23	PHOSPHO2-KLHL23 readthrough(PHOSPHO2-KLHL23)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Complete proteome,Kelch repeat,Reference proteome,Repeat,
PIK3CD-AS1	PIK3CD antisense RNA 1(PIK3CD-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C1orf200,sequence conflict,
PITHD1	PITH domain containing 1(PITHD1)	Homo sapiens				GO:0006974~cellular response to DNA damage stimulus,	GO:0005634~nucleus,		IPR008979:Galactose-binding domain-like,IPR010400:PITH domain,					Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:UPF0424 protein C1orf128,compositionally biased region:Poly-Gly,modified residue,splice variant,
PMF1-BGLAP	PMF1-BGLAP readthrough(PMF1-BGLAP)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000444~MIS12/MIND type complex,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005829~cytosol,	GO:0003713~transcription coactivator activity,GO:0043522~leucine zipper domain binding,	IPR007128:Nnf1,					Activator,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Kinetochore,Mitosis,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,
PMS1	PMS1 homolog 1, mismatch repair system component(PMS1)	Homo sapiens				GO:0006298~mismatch repair,GO:0042493~response to drug,	GO:0000795~synaptonemal complex,GO:0005634~nucleus,GO:0005712~chiasma,GO:0032389~MutLalpha complex,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0030983~mismatched DNA binding,	IPR002099:DNA mismatch repair protein,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR009071:High mobility group (HMG) box domain,IPR013507:DNA mismatch repair protein, C-terminal,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR014762:DNA mismatch repair, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,				SM00398:HMG,SM01340:SM01340,	3D-structure,Alternative splicing,Complete proteome,DNA damage,DNA repair,DNA-binding,Hereditary nonpolyposis colorectal cancer,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:PMS1 protein homolog 1,DNA-binding region:HMG box,helix,sequence variant,turn,
POTEE	POTE ankyrin domain family member E(POTEE)	Homo sapiens			General function prediction only,	GO:0001895~retina homeostasis,GO:0021762~substantia nigra development,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,		IPR002110:Ankyrin repeat,IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020683:Ankyrin repeat-containing domain,IPR020902:Actin/actin-like conserved site,				SM00248:ANK,SM00268:ACTIN,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Isopeptide bond,Reference proteome,Repeat,	chain:POTE ankyrin domain family member E,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,region of interest:Actin-like,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence conflict,splice variant,
POTEF	POTE ankyrin domain family member F(POTEF)	Homo sapiens			General function prediction only,	GO:0001895~retina homeostasis,	GO:0005615~extracellular space,GO:0005938~cell cortex,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,		IPR002110:Ankyrin repeat,IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020683:Ankyrin repeat-containing domain,IPR020902:Actin/actin-like conserved site,				SM00248:ANK,SM00268:ACTIN,	ANK repeat,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Reference proteome,Repeat,Ubl conjugation,	chain:POTE ankyrin domain family member F,modified residue,region of interest:Actin-like,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence conflict,
POTEI	POTE ankyrin domain family member I(POTEI)	Homo sapiens				GO:0001895~retina homeostasis,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,		IPR002110:Ankyrin repeat,IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020683:Ankyrin repeat-containing domain,IPR020902:Actin/actin-like conserved site,				SM00248:ANK,SM00268:ACTIN,	ANK repeat,Coiled coil,Complete proteome,Isopeptide bond,Reference proteome,Repeat,Ubl conjugation,
POTEJ	POTE ankyrin domain family member J(POTEJ)	Homo sapiens				GO:0001895~retina homeostasis,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,		IPR002110:Ankyrin repeat,IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020683:Ankyrin repeat-containing domain,IPR020902:Actin/actin-like conserved site,				SM00248:ANK,SM00268:ACTIN,	ANK repeat,Coiled coil,Complete proteome,Isopeptide bond,Reference proteome,Repeat,Ubl conjugation,
POTEKP	POTE ankyrin domain family member K, pseudogene(POTEKP)	Homo sapiens				GO:0002576~platelet degranulation,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020902:Actin/actin-like conserved site,				SM00268:ACTIN,	ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Methylation,Nucleotide-binding,Oxidation,Reference proteome,	chain:Beta-actin-like protein 3,sequence conflict,
POU1F1	POU class 1 homeobox 1(POU1F1)	Homo sapiens	92.Ancient_Host_Defense_Pathways,			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001708~cell fate specification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008340~determination of adult lifespan,GO:0030183~B cell differentiation,GO:0032962~positive regulation of inositol trisphosphate biosynthetic process,GO:0040018~positive regulation of multicellular organism growth,GO:0043567~regulation of insulin-like growth factor receptor signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051169~nuclear transport,GO:0060133~somatotropin secreting cell development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0043565~sequence-specific DNA binding,	IPR000327:POU-specific,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR013847:POU domain,IPR015586:Pituitary-specific positive transcription factor 1,IPR017970:Homeobox, conserved site,		613038~Pituitary hormone deficiency, combined, 1,		SM00352:POU,SM00389:HOX,	Activator,Alternative splicing,Complete proteome,Disease mutation,DNA-binding,Dwarfism,Homeobox,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Pituitary-specific positive transcription factor 1,DNA-binding region:Homeobox,domain:POU-specific,sequence variant,splice variant,
POU2F1	POU class 2 homeobox 1(POU2F1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005783~endoplasmic reticulum,GO:0043231~intracellular membrane-bounded organelle,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000327:POU-specific,IPR000972:Octamer-binding transcription factor,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR013847:POU domain,IPR017970:Homeobox, conserved site,				SM00352:POU,SM00389:HOX,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:POU domain, class 2, transcription factor 1,DNA-binding region:Homeobox,domain:POU-specific,helix,modified residue,sequence conflict,sequence variant,splice variant,
PERM1	PPARGC1 and ESRR induced regulator, muscle 1(PERM1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0014850~response to muscle activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,							Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Uncharacterized protein C1orf170,compositionally biased region:Pro-rich,sequence conflict,sequence variant,splice variant,
PQLC2	PQ loop repeat containing 2(PQLC2)	Homo sapiens				GO:0015809~arginine transport,GO:0015819~lysine transport,GO:0080144~amino acid homeostasis,GO:1903401~L-lysine transmembrane transport,GO:1903826~arginine transmembrane transport,GO:1990822~basic amino acid transmembrane transport,	GO:0005765~lysosomal membrane,GO:0016021~integral component of membrane,GO:0031301~integral component of organelle membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0015174~basic amino acid transmembrane transporter activity,GO:0015181~arginine transmembrane transporter activity,GO:0015189~L-lysine transmembrane transporter activity,	IPR006603:Cystinosin/ERS1p repeat,				SM00679:CTNS,	Alternative splicing,Amino-acid transport,Complete proteome,Glycoprotein,Lysosome,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:PQ-loop repeat-containing protein 2,domain:PQ-loop 1,domain:PQ-loop 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PQLC3	PQ loop repeat containing 3(PQLC3)	Homo sapiens				GO:0006488~dolichol-linked oligosaccharide biosynthetic process,	GO:0016021~integral component of membrane,		IPR006603:Cystinosin/ERS1p repeat,IPR016817:Mannose-P-dolichol utilization defect 1 protein,			PIRSF023381:mannose-P-dolichol utilization defect 1 protein,		Alternative splicing,Complete proteome,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:PQ-loop repeat-containing protein 3,signal peptide,transmembrane region,
PRDM16	PR/SET domain 16(PRDM16)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0022008~neurogenesis,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030853~negative regulation of granulocyte differentiation,GO:0034968~histone lysine methylation,GO:0035019~somatic stem cell population maintenance,GO:0043457~regulation of cellular respiration,GO:0043586~tongue development,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050872~white fat cell differentiation,GO:0050873~brown fat cell differentiation,GO:0060021~palate development,GO:0090336~positive regulation of brown fat cell differentiation,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0017053~transcriptional repressor complex,	GO:0003676~nucleic acid binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0033613~activating transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,	IPR001214:SET domain,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		615373~Cardiomyopathy, dilated, 1LL,615373~Left ventricular noncompaction 8,		SM00317:SET,SM00355:ZnF_C2H2,	3D-structure,Activator,Alternative promoter usage,Alternative splicing,Cardiomyopathy,Chromosomal rearrangement,Complete proteome,Differentiation,Disease mutation,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:PR domain zinc finger protein 16,compositionally biased region:Pro-rich,domain:SET,region of interest:Interaction with CTBP1 and CTBP2,region of interest:Mediates interaction with SKI and regulation of TGF-beta signaling,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 1; atypical,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7; atypical,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
PRDM2	PR/SET domain 2(PRDM2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008340~determination of adult lifespan,GO:0034968~histone lysine methylation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046872~metal ion binding,	IPR001214:SET domain,IPR007087:Zinc finger, C2H2,IPR009170:Predicted retinoblastoma binding protein (RIZ),IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			PIRSF002395:retinoblastoma binding protein (RIZ),	SM00317:SET,SM00355:ZnF_C2H2,	3D-structure,Activator,Alternative initiation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:PR domain zinc finger protein 2,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:SET,helix,modified residue,mutagenesis site,region of interest:Retinoblastoma protein binding,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7; atypical,zinc finger region:C2H2-type 8; atypical,
PRAMEF1	PRAME family member 1(PRAMEF1)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,	chain:PRAME family member 1,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence variant,
PRAMEF10	PRAME family member 10(PRAMEF10)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,	chain:PRAME family member 10,modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence variant,
PRAMEF11	PRAME family member 11(PRAMEF11)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 11,chain:PRAME family member 9/15,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
PRAMEF14	PRAME family member 14(PRAMEF14)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 14,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
PRAMEF15	PRAME family member 15(PRAMEF15)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 11,chain:PRAME family member 9/15,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
PRAMEF18	PRAME family member 18(PRAMEF18)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 18,chain:PRAME family member 3,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
PRAMEF19	PRAME family member 19(PRAMEF19)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 19,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
PRAMEF20	PRAME family member 20(PRAMEF20)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 20/21,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
PRAMEF4	PRAME family member 4(PRAMEF4)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,	chain:PRAME family member 4,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence variant,
PRAMEF5	PRAME family member 5(PRAMEF5)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 5,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence conflict,
PRAMEF6	PRAME family member 6(PRAMEF6)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 6,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence conflict,
PRAMEF7	PRAME family member 7(PRAMEF7)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:PRAME family member 7,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
PRAMEF9	PRAME family member 9(PRAMEF9)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Reference proteome,	chain:PRAME family member 11,chain:PRAME family member 9/15,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
PINK1	PTEN induced putative kinase 1(PINK1)	Homo sapiens				GO:0000422~mitophagy,GO:0001934~positive regulation of protein phosphorylation,GO:0002082~regulation of oxidative phosphorylation,GO:0006468~protein phosphorylation,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006950~response to stress,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0010310~regulation of hydrogen peroxide metabolic process,GO:0010629~negative regulation of gene expression,GO:0010821~regulation of mitochondrion organization,GO:0010952~positive regulation of peptidase activity,GO:0016050~vesicle organization,GO:0016236~macroautophagy,GO:0016239~positive regulation of macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0016310~phosphorylation,GO:0016567~protein ubiquitination,GO:0018105~peptidyl-serine phosphorylation,GO:0022904~respiratory electron transport chain,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0032148~activation of protein kinase B activity,GO:0032226~positive regulation of synaptic transmission, dopaminergic,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033603~positive regulation of dopamine secretion,GO:0034599~cellular response to oxidative stress,GO:0035307~positive regulation of protein dephosphorylation,GO:0035556~intracellular signal transduction,GO:0036289~peptidyl-serine autophosphorylation,GO:0038203~TORC2 signaling,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043254~regulation of protein complex assembly,GO:0043524~negative regulation of neuron apoptotic process,GO:0045727~positive regulation of translation,GO:0046329~negative regulation of JNK cascade,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0051881~regulation of mitochondrial membrane potential,GO:0051897~positive regulation of protein kinase B signaling,GO:0061136~regulation of proteasomal protein catabolic process,GO:0071456~cellular response to hypoxia,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:0090141~positive regulation of mitochondrial fission,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090258~negative regulation of mitochondrial fission,GO:0097237~cellular response to toxic substance,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:1900407~regulation of cellular response to oxidative stress,GO:1901727~positive regulation of histone deacetylase activity,GO:1902803~regulation of synaptic vesicle transport,GO:1902902~negative regulation of autophagosome assembly,GO:1902958~positive regulation of mitochondrial electron transport, NADH to ubiquinone,GO:1903146~regulation of mitophagy,GO:1903147~negative regulation of mitophagy,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:1903204~negative regulation of oxidative stress-induced neuron death,GO:1903214~regulation of protein targeting to mitochondrion,GO:1903298~negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,GO:1903384~negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,GO:1903751~negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,GO:1903852~positive regulation of cristae formation,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:1904544~positive regulation of free ubiquitin chain polymerization,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2001171~positive regulation of ATP biosynthetic process,	GO:0000151~ubiquitin ligase complex,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005742~mitochondrial outer membrane translocase complex,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0030424~axon,GO:0031307~integral component of mitochondrial outer membrane,GO:0031932~TORC2 complex,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,GO:0097413~Lewy body,GO:0097449~astrocyte projection,	GO:0000287~magnesium ion binding,GO:0002020~protease binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0010857~calcium-dependent protein kinase activity,GO:0016301~kinase activity,GO:0016504~peptidase activator activity,GO:0031625~ubiquitin protein ligase binding,GO:0043422~protein kinase B binding,GO:0055131~C3HC4-type RING finger domain binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,	hsa05012:Parkinson's disease,	605909~Parkinson disease 6, early onset,		SM00220:S_TKc,	Alternative splicing,ATP-binding,Autophagy,Complete proteome,Cytoplasm,Disease mutation,Kinase,Magnesium,Membrane,Metal-binding,Mitochondrion,Mitochondrion outer membrane,Neurodegeneration,Nucleotide-binding,Parkinson disease,Parkinsonism,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,Transit peptide,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase PINK1, mitochondrial,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transit peptide:Mitochondrion,transmembrane region,
PPFIA4	PTPRF interacting protein alpha 4(PPFIA4)	Homo sapiens				GO:0007269~neurotransmitter secretion,GO:0014047~glutamate secretion,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0009986~cell surface,GO:0045202~synapse,GO:0048786~presynaptic active zone,	GO:0005515~protein binding,	IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,				SM00454:SAM,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Liprin-alpha-4,domain:SAM 1,domain:SAM 2,domain:SAM 3,sequence conflict,splice variant,
PXK	PX domain containing serine/threonine kinase like(PXK)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0032780~negative regulation of ATPase activity,GO:0042391~regulation of membrane potential,GO:0043271~negative regulation of ion transport,GO:0050804~modulation of synaptic transmission,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005886~plasma membrane,GO:0043234~protein complex,	GO:0000166~nucleotide binding,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0035091~phosphatidylinositol binding,	IPR000719:Protein kinase, catalytic domain,IPR001683:Phox homologous domain,IPR003124:WH2 domain,IPR011009:Protein kinase-like domain,				SM00312:PX,	Actin-binding,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Kinase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:PX domain-containing protein kinase-like protein,domain:Protein kinase,domain:PX,domain:WH2,mutagenesis site,sequence conflict,sequence variant,splice variant,
PCP4L1	Purkinje cell protein 4 like 1(PCP4L1)	Homo sapiens												Complete proteome,Phosphoprotein,Reference proteome,	chain:Purkinje cell protein 4-like protein 1,domain:IQ,
RSPO1	R-spondin 1(RSPO1)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0002090~regulation of receptor internalization,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005576~extracellular region,GO:0005634~nucleus,	GO:0001664~G-protein coupled receptor binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008201~heparin binding,	IPR000884:Thrombospondin, type 1 repeat,IPR006212:Furin-like repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,		610644~Palmoplantar hyperkeratosis and true hermaphroditism,610644~Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal,		SM00209:TSP1,SM00261:FU,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Heparin-binding,Nucleus,Palmoplantar keratoderma,Reference proteome,Repeat,Secreted,Sensory transduction,Signal,Wnt signaling pathway,	chain:R-spondin-1,disulfide bond,domain:TSP type-1,glycosylation site:N-linked (GlcNAc...),repeat:FU 1,repeat:FU 2,sequence conflict,signal peptide,splice variant,
R3HDM1	R3H domain containing 1(R3HDM1)	Homo sapiens						GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR001374:Single-stranded nucleic acid binding R3H,IPR024771:SUZ domain,				SM00393:R3H,	Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:R3H domain-containing protein 1,compositionally biased region:Poly-Pro,domain:R3H,modified residue,sequence conflict,sequence variant,splice variant,
RABGAP1L	RAB GTPase activating protein 1 like(RABGAP1L)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0031338~regulation of vesicle fusion,GO:0032880~regulation of protein localization,GO:0090630~activation of GTPase activity,	GO:0005634~nucleus,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0072372~primary cilium,	GO:0005096~GTPase activator activity,GO:0017137~Rab GTPase binding,	IPR000195:Rab-GTPase-TBC domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR022164:Kinesin-like,				SM00164:TBC,SM00462:PTB,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,GTPase activation,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosomal frameshifting,Transmembrane,Transmembrane helix,	chain:RAB GTPase-activating protein 1-like,domain:PID,domain:Rab-GAP TBC,helix,modified residue,sequence conflict,sequence variant,splice variant,turn,
RABIF	RAB interacting factor(RABIF)	Homo sapiens				GO:0006892~post-Golgi vesicle-mediated transport,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0043547~positive regulation of GTPase activity,GO:0061025~membrane fusion,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR007515:Mss4,IPR011057:Mss4-like,IPR011323:Mss4/translationally controlled tumour-associated TCTP,					3D-structure,Acetylation,Complete proteome,Guanine-nucleotide releasing factor,Metal-binding,Protein transport,Reference proteome,Transport,Zinc,	chain:Guanine nucleotide exchange factor MSS4,helix,metal ion-binding site:Zinc,modified residue,sequence conflict,strand,turn,
RABL2A	RAB, member of RAS oncogene family-like 2A(RABL2A)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR013684:Mitochondrial Rho-like,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,GTP-binding,Nucleotide-binding,Reference proteome,	chain:Rab-like protein 2A,nucleotide phosphate-binding region:GTP,splice variant,
RAB10	RAB10, member RAS oncogene family(RAB10)	Homo sapiens				GO:0006893~Golgi to plasma membrane transport,GO:0007264~small GTPase mediated signal transduction,GO:0007409~axonogenesis,GO:0016192~vesicle-mediated transport,GO:0016197~endosomal transport,GO:0019882~antigen processing and presentation,GO:0030859~polarized epithelial cell differentiation,GO:0032869~cellular response to insulin stimulus,GO:0043001~Golgi to plasma membrane protein transport,GO:0045200~establishment of neuroblast polarity,GO:0061024~membrane organization,GO:0061467~basolateral protein localization,GO:0071786~endoplasmic reticulum tubular network organization,GO:0072659~protein localization to plasma membrane,GO:0090150~establishment of protein localization to membrane,GO:0097051~establishment of protein localization to endoplasmic reticulum membrane,GO:0098609~cell-cell adhesion,	GO:0000139~Golgi membrane,GO:0000145~exocyst,GO:0005622~intracellular,GO:0005768~endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005929~cilium,GO:0030659~cytoplasmic vesicle membrane,GO:0030670~phagocytic vesicle membrane,GO:0032593~insulin-responsive compartment,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,GO:0071782~endoplasmic reticulum tubular network,GO:0072372~primary cilium,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0031489~myosin V binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,hsa04152:AMPK signaling pathway,				3D-structure,Acetylation,Cell projection,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Endosome,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Nucleotide-binding,Prenylation,Protein transport,Reference proteome,Transport,	chain:Ras-related protein Rab-10,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,short sequence motif:Effector region,
RAB11FIP5	RAB11 family interacting protein 5(RAB11FIP5)	Homo sapiens				GO:0035773~insulin secretion involved in cellular response to glucose stimulus,GO:0045055~regulated exocytosis,GO:0070164~negative regulation of adiponectin secretion,GO:0071468~cellular response to acidic pH,GO:2000008~regulation of protein localization to cell surface,	GO:0000139~Golgi membrane,GO:0005741~mitochondrial outer membrane,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0030141~secretory granule,GO:0030658~transport vesicle membrane,GO:0031901~early endosome membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0043015~gamma-tubulin binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR019018:Rab-binding domain FIP-RBD,	hsa04144:Endocytosis,			SM00239:C2,	Complete proteome,Cytoplasm,Cytoplasmic vesicle,Endosome,Golgi apparatus,Membrane,Mitochondrion,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Rab11 family-interacting protein 5,domain:C2,domain:RBD-FIP,modified residue,sequence conflict,
RAB17	RAB17, member RAS oncogene family(RAB17)	Homo sapiens				GO:0002415~immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0030100~regulation of endocytosis,GO:0032401~establishment of melanosome localization,GO:0032402~melanosome transport,GO:0032456~endocytic recycling,GO:0042384~cilium assembly,GO:0045056~transcytosis,GO:0046847~filopodium assembly,GO:0050773~regulation of dendrite development,GO:0051489~regulation of filopodium assembly,GO:0051963~regulation of synapse assembly,GO:0060271~cilium morphogenesis,	GO:0005622~intracellular,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030139~endocytic vesicle,GO:0030425~dendrite,GO:0042470~melanosome,GO:0043025~neuronal cell body,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Cell projection,Complete proteome,Endosome,GTP-binding,Lipoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Prenylation,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Ras-related protein Rab-17,lipid moiety-binding region:S-geranylgeranyl cysteine,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,short sequence motif:Effector region,
RAB1A	RAB1A, member RAS oncogene family(RAB1A)	Homo sapiens		h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery,		GO:0000045~autophagosome assembly,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006897~endocytosis,GO:0006914~autophagy,GO:0007030~Golgi organization,GO:0007264~small GTPase mediated signal transduction,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0019068~virion assembly,GO:0030252~growth hormone secretion,GO:0032402~melanosome transport,GO:0034446~substrate adhesion-dependent cell spreading,GO:0042742~defense response to bacterium,GO:0047496~vesicle transport along microtubule,GO:0048208~COPII vesicle coating,GO:0060271~cilium morphogenesis,GO:0072606~interleukin-8 secretion,GO:0090110~cargo loading into COPII-coated vesicle,GO:0090557~establishment of endothelial intestinal barrier,GO:0098609~cell-cell adhesion,GO:1903020~positive regulation of glycoprotein metabolic process,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005769~early endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05134:Legionellosis,				3D-structure,Acetylation,Alternative splicing,Autophagy,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,Endosome,ER-Golgi transport,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Prenylation,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Ras-related protein Rab-1A,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,short sequence motif:Effector region,splice variant,strand,turn,
RAB3GAP2	RAB3 GTPase activating non-catalytic protein subunit 2(RAB3GAP2)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0097051~establishment of protein localization to endoplasmic reticulum membrane,GO:1903061~positive regulation of protein lipidation,GO:1903373~positive regulation of endoplasmic reticulum tubular network organization,GO:2000786~positive regulation of autophagosome assembly,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0043234~protein complex,	GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0017137~Rab GTPase binding,GO:0030234~enzyme regulator activity,GO:0046982~protein heterodimerization activity,	IPR026059:Rab3-GAP regulatory subunit,		212720~Martsolf syndrome,614225~Warburg micro syndrome 2,			Alternative splicing,Cataract,Complete proteome,Cytoplasm,Disease mutation,GTPase activation,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rab3 GTPase-activating protein non- catalytic subunit,modified residue,sequence conflict,sequence variant,splice variant,
RAB3GAP1	RAB3 GTPase activating protein catalytic subunit 1(RAB3GAP1)	Homo sapiens				GO:0007420~brain development,GO:0010628~positive regulation of gene expression,GO:0021854~hypothalamus development,GO:0034389~lipid particle organization,GO:0043010~camera-type eye development,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0048172~regulation of short-term neuronal synaptic plasticity,GO:0060079~excitatory postsynaptic potential,GO:0060325~face morphogenesis,GO:0061646~positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,GO:0097051~establishment of protein localization to endoplasmic reticulum membrane,GO:1903061~positive regulation of protein lipidation,GO:1903233~regulation of calcium ion-dependent exocytosis of neurotransmitter,GO:1903373~positive regulation of endoplasmic reticulum tubular network organization,GO:2000786~positive regulation of autophagosome assembly,	GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005811~lipid particle,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0071782~endoplasmic reticulum tubular network,GO:0098794~postsynapse,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0017137~Rab GTPase binding,	IPR026147:Rab3 GTPase-activating protein catalytic subunit,		600118~Warburg micro syndrome 1,			Alternative splicing,Complete proteome,Cytoplasm,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rab3 GTPase-activating protein catalytic subunit,modified residue,mutagenesis site,sequence variant,splice variant,
RAB3B	RAB3B, member RAS oncogene family(RAB3B)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0017157~regulation of exocytosis,GO:0018125~peptidyl-cysteine methylation,GO:0019882~antigen processing and presentation,GO:0051586~positive regulation of dopamine uptake involved in synaptic transmission,GO:0097494~regulation of vesicle size,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0030141~secretory granule,GO:0031982~vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0030742~GTP-dependent protein binding,GO:0031489~myosin V binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Cell membrane,Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Prenylation,Protein transport,Reference proteome,Transport,	chain:Ras-related protein Rab-3B,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,short sequence motif:Effector region,strand,turn,
RAB42	RAB42, member RAS oncogene family(RAB42)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0016020~membrane,	GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Reference proteome,	chain:Putative Ras-related protein Rab-42,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,
RAB4A	RAB4A, member RAS oncogene family(RAB4A)	Homo sapiens		h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery,		GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0019882~antigen processing and presentation,GO:0030100~regulation of endocytosis,GO:0032482~Rab protein signal transduction,GO:0032781~positive regulation of ATPase activity,	GO:0005622~intracellular,GO:0005768~endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031982~vesicle,GO:0032593~insulin-responsive compartment,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,	GO:0001671~ATPase activator activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008565~protein transporter activity,GO:0019003~GDP binding,GO:0019905~syntaxin binding,GO:0035255~ionotropic glutamate receptor binding,GO:0051117~ATPase binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,				3D-structure,Complete proteome,Cytoplasm,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Prenylation,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Ras-related protein Rab-4A,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,short sequence motif:Effector region,strand,turn,
RAB5A	RAB5A, member RAS oncogene family(RAB5A)	Homo sapiens		h_eea1Pathway:The role of FYVE-finger proteins in vesicle transport,h_ptdinsPathway:Phosphoinositides and their downstream targets.,h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery,		GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0007264~small GTPase mediated signal transduction,GO:0007596~blood coagulation,GO:0015031~protein transport,GO:0030100~regulation of endocytosis,GO:0036465~synaptic vesicle recycling,GO:0039694~viral RNA genome replication,GO:0045022~early endosome to late endosome transport,GO:0045921~positive regulation of exocytosis,GO:0051036~regulation of endosome size,GO:0051489~regulation of filopodium assembly,GO:2000286~receptor internalization involved in canonical Wnt signaling pathway,GO:2000300~regulation of synaptic vesicle exocytosis,GO:2000785~regulation of autophagosome assembly,	GO:0001726~ruffle,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0010008~endosome membrane,GO:0015629~actin cytoskeleton,GO:0030139~endocytic vesicle,GO:0030424~axon,GO:0030425~dendrite,GO:0030670~phagocytic vesicle membrane,GO:0036477~somatodendritic compartment,GO:0042470~melanosome,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0043679~axon terminus,GO:0045121~membrane raft,GO:0045335~phagocytic vesicle,GO:0070062~extracellular exosome,GO:0098559~cytoplasmic side of early endosome membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04014:Ras signaling pathway,hsa04144:Endocytosis,hsa04145:Phagosome,hsa04962:Vasopressin-regulated water reabsorption,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05146:Amoebiasis,hsa05152:Tuberculosis,				3D-structure,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Endocytosis,Endosome,GTP-binding,Lipoprotein,Membrane,Nucleotide-binding,Phagocytosis,Prenylation,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Ras-related protein Rab-5A,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,short sequence motif:Effector region,strand,turn,
RAD18	RAD18, E3 ubiquitin protein ligase(RAD18)	Homo sapiens				GO:0006281~DNA repair,GO:0006301~postreplication repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0042769~DNA damage response, detection of DNA damage,GO:0051865~protein autoubiquitination,GO:0051984~positive regulation of chromosome segregation,GO:0060548~negative regulation of cell death,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0035861~site of double-strand break,GO:0042405~nuclear inclusion body,GO:0097505~Rad6-Rad18 complex,	GO:0000403~Y-form DNA binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031593~polyubiquitin binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0043142~single-stranded DNA-dependent ATPase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR003034:SAP domain,IPR006642:Zinc finger, Rad18-type putative,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00513:SAP,SM00734:ZnF_Rad18,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,DNA repair,DNA-binding,Isopeptide bond,Ligase,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase RAD18,domain:SAP,modified residue,sequence conflict,sequence variant,zinc finger region:Rad18-type,zinc finger region:RING-type,
RAD51AP2	RAD51 associated protein 2(RAD51AP2)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:RAD51-associated protein 2,mutagenesis site,region of interest:Interaction with RAD51,sequence variant,
RAD54L	RAD54-like (S. cerevisiae)(RAD54L)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0000733~DNA strand renaturation,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0007126~meiotic nuclear division,GO:0008340~determination of adult lifespan,GO:0010212~response to ionizing radiation,GO:0042493~response to drug,GO:0051276~chromosome organization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0036310~annealing helicase activity,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03440:Homologous recombination,	114480~Breast cancer, invasive ductal,605027~Lymphoma, non-Hodgkin, somatic,Adenocarcinoma, colonic, somatic~Adenocarcinoma, colonic, somatic,		SM00487:DEXDc,SM00490:HELICc,	ATP-binding,Complete proteome,DNA damage,DNA repair,DNA-binding,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA repair and recombination protein RAD54-like,domain:Helicase ATP-binding,domain:Helicase C-terminal,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEGH box,
RAD54L2	RAD54-like 2 (S. cerevisiae)(RAD54L2)	Homo sapiens					GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	ATP-binding,Complete proteome,DNA-binding,Helicase,Hydrolase,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Ubl conjugation,	chain:Helicase ARIP4,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,
RANBP2	RAN binding protein 2(RANBP2)	Homo sapiens		h_npcPathway:Mechanism of Protein Import into the Nucleus,h_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression,h_ranPathway:Cycling of Ran in nucleocytoplasmic transport,		GO:0000413~protein peptidyl-prolyl isomerization,GO:0001975~response to amphetamine,GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0006457~protein folding,GO:0006607~NLS-bearing protein import into nucleus,GO:0007062~sister chromatid cohesion,GO:0007077~mitotic nuclear envelope disassembly,GO:0010827~regulation of glucose transport,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0019083~viral transcription,GO:0031047~gene silencing by RNA,GO:0033132~negative regulation of glucokinase activity,GO:0051642~centrosome localization,GO:0075733~intracellular transport of virus,GO:0090526~regulation of gluconeogenesis involved in cellular glucose homeostasis,GO:1900034~regulation of cellular response to heat,	GO:0005635~nuclear envelope,GO:0005642~annulate lamellae,GO:0005643~nuclear pore,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005875~microtubule associated complex,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0042405~nuclear inclusion body,GO:0044614~nuclear pore cytoplasmic filaments,GO:0044615~nuclear pore nuclear basket,GO:1990723~cytoplasmic periphery of the nuclear pore complex,	GO:0003723~RNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008536~Ran GTPase binding,GO:0016874~ligase activity,GO:0019789~SUMO transferase activity,GO:0032403~protein complex binding,	IPR000156:Ran binding domain,IPR001876:Zinc finger, RanBP2-type,IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR011990:Tetratricopeptide-like helical,IPR011993:Pleckstrin homology-like domain,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR022011:Nup358/RanBP2 E3 ligase domain,	hsa03013:RNA transport,	608033~Encephalopathy, acute, infection-induced, 3, susceptibility to,		SM00028:TPR,SM00160:RanBD,SM00547:ZnF_RBZ,	3D-structure,Acetylation,Complete proteome,Disulfide bond,Isopeptide bond,Ligase,Membrane,Metal-binding,Methylation,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,RNA-binding,TPR repeat,Translocation,Transport,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 SUMO-protein ligase RANBP2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:PPIase cyclophilin-type,domain:RanBD1 1,domain:RanBD1 2,domain:RanBD1 3,domain:RanBD1 4,helix,modified residue,mutagenesis site,region of interest:2 X 50 AA approximate repeats,region of interest:Interaction with SUMO1,region of interest:Interaction with sumoylated RANGAP1,region of interest:Interaction with UBE2I,region of interest:Required for E3 SUMO-ligase activity,repeat:1,repeat:2,repeat:TPR,sequence conflict,sequence variant,strand,turn,zinc finger region:RanBP2-type 1,zinc finger region:RanBP2-type 2,zinc finger region:RanBP2-type 3,zinc finger region:RanBP2-type 4,zinc finger region:RanBP2-type 5,zinc finger region:RanBP2-type 6,zinc finger region:RanBP2-type 7,zinc finger region:RanBP2-type 8,
RGPD1	RANBP2-like and GRIP domain containing 1(RGPD1)	Homo sapiens				GO:0000042~protein targeting to Golgi,	GO:0005622~intracellular,		IPR000156:Ran binding domain,IPR000237:GRIP,IPR011990:Tetratricopeptide-like helical,IPR011993:Pleckstrin homology-like domain,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa03013:RNA transport,			SM00028:TPR,SM00160:RanBD,SM00755:Grip,	Coiled coil,Complete proteome,Reference proteome,Repeat,TPR repeat,	chain:RANBP2-like and GRIP domain-containing protein 1,chain:RANBP2-like and GRIP domain-containing protein 2,compositionally biased region:Poly-Ser,domain:GRIP,domain:RanBD1 1,domain:RanBD1 2,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,splice variant,
RGPD2	RANBP2-like and GRIP domain containing 2(RGPD2)	Homo sapiens				GO:0000042~protein targeting to Golgi,	GO:0005622~intracellular,		IPR000156:Ran binding domain,IPR000237:GRIP,IPR011990:Tetratricopeptide-like helical,IPR011993:Pleckstrin homology-like domain,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa03013:RNA transport,			SM00028:TPR,SM00160:RanBD,SM00755:Grip,	Coiled coil,Complete proteome,Reference proteome,Repeat,TPR repeat,	chain:RANBP2-like and GRIP domain-containing protein 1,chain:RANBP2-like and GRIP domain-containing protein 2,compositionally biased region:Poly-Ser,domain:GRIP,domain:RanBD1 1,domain:RanBD1 2,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,splice variant,
RGPD3	RANBP2-like and GRIP domain containing 3(RGPD3)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0000042~protein targeting to Golgi,	GO:0005622~intracellular,		IPR000156:Ran binding domain,IPR000237:GRIP,IPR011990:Tetratricopeptide-like helical,IPR011993:Pleckstrin homology-like domain,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa03013:RNA transport,			SM00028:TPR,SM00160:RanBD,SM00755:Grip,	Coiled coil,Complete proteome,Reference proteome,Repeat,TPR repeat,	chain:RANBP2-like and GRIP domain-containing protein 4,chain:RANBP2-like and GRIP domain-containing protein 5,chain:RANBP2-like and GRIP domain-containing protein 6,chain:RANBP2-like and GRIP domain-containing protein 7,compositionally biased region:Poly-Ser,domain:GRIP,domain:RanBD1 1,domain:RanBD1 2,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,splice variant,
RGPD4	RANBP2-like and GRIP domain containing 4(RGPD4)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0000042~protein targeting to Golgi,	GO:0005622~intracellular,		IPR000156:Ran binding domain,IPR000237:GRIP,IPR011990:Tetratricopeptide-like helical,IPR011993:Pleckstrin homology-like domain,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa03013:RNA transport,			SM00028:TPR,SM00160:RanBD,SM00755:Grip,	Alternative splicing,Complete proteome,Reference proteome,Repeat,TPR repeat,	chain:RANBP2-like and GRIP domain-containing protein 4,chain:RANBP2-like and GRIP domain-containing protein 5,chain:RANBP2-like and GRIP domain-containing protein 6,chain:RANBP2-like and GRIP domain-containing protein 7,compositionally biased region:Poly-Ser,domain:GRIP,domain:RanBD1 1,domain:RanBD1 2,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,splice variant,
RGPD5	RANBP2-like and GRIP domain containing 5(RGPD5)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0000042~protein targeting to Golgi,	GO:0005622~intracellular,GO:0005737~cytoplasm,		IPR000156:Ran binding domain,IPR000237:GRIP,IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR011993:Pleckstrin homology-like domain,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa03013:RNA transport,			SM00028:TPR,SM00160:RanBD,SM00755:Grip,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Reference proteome,Repeat,TPR repeat,	chain:RANBP2-like and GRIP domain-containing protein 4,chain:RANBP2-like and GRIP domain-containing protein 5,chain:RANBP2-like and GRIP domain-containing protein 6,chain:RANBP2-like and GRIP domain-containing protein 7,compositionally biased region:Poly-Ser,domain:GRIP,domain:RanBD1 1,domain:RanBD1 2,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,splice variant,
RGPD8	RANBP2-like and GRIP domain containing 8(RGPD8)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0000042~protein targeting to Golgi,	GO:0005622~intracellular,GO:0005643~nuclear pore,	GO:0008536~Ran GTPase binding,	IPR000156:Ran binding domain,IPR000237:GRIP,IPR011990:Tetratricopeptide-like helical,IPR011993:Pleckstrin homology-like domain,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,	hsa03013:RNA transport,			SM00028:TPR,SM00160:RanBD,SM00755:Grip,	Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:RANBP2-like and GRIP domain-containing protein 4,chain:RANBP2-like and GRIP domain-containing protein 5,chain:RANBP2-like and GRIP domain-containing protein 6,chain:RANBP2-like and GRIP domain-containing protein 7,compositionally biased region:Poly-Ser,domain:GRIP,domain:RanBD1 1,domain:RanBD1 2,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,splice variant,
RAP1GAP	RAP1 GTPase activating protein(RAP1GAP)	Homo sapiens				GO:0007165~signal transduction,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0045665~negative regulation of neuron differentiation,GO:0051056~regulation of small GTPase mediated signal transduction,GO:1903697~negative regulation of microvillus assembly,GO:1904425~negative regulation of GTP binding,GO:1904442~negative regulation of thyroid gland epithelial cell proliferation,GO:1990792~cellular response to glial cell derived neurotrophic factor,	GO:0000139~Golgi membrane,GO:0005769~early endosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003924~GTPase activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017016~Ras GTPase binding,GO:0030695~GTPase regulator activity,GO:0042803~protein homodimerization activity,	IPR000331:Rap GTPase activating proteins domain,IPR003109:GoLoco motif,	hsa04015:Rap1 signaling pathway,			SM00390:GoLoco,	3D-structure,Alternative splicing,Complete proteome,Golgi apparatus,GTPase activation,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rap1 GTPase-activating protein 1,domain:GoLoco,domain:Rap-GAP,helix,modified residue,sequence variant,splice variant,strand,turn,
RAP1A	RAP1A, member of RAS oncogene family(RAP1A)	Homo sapiens		h_integrinPathway:Integrin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,		GO:0000186~activation of MAPKK activity,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0015031~protein transport,GO:0030033~microvillus assembly,GO:0032486~Rap protein signal transduction,GO:0032966~negative regulation of collagen biosynthetic process,GO:0035690~cellular response to drug,GO:0038180~nerve growth factor signaling pathway,GO:0043547~positive regulation of GTPase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046326~positive regulation of glucose import,GO:0050766~positive regulation of phagocytosis,GO:0050796~regulation of insulin secretion,GO:0061028~establishment of endothelial barrier,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071320~cellular response to cAMP,GO:0071333~cellular response to glucose stimulus,GO:0097327~response to antineoplastic agent,GO:0097421~liver regeneration,GO:1901888~regulation of cell junction assembly,GO:1990090~cellular response to nerve growth factor stimulus,GO:2000301~negative regulation of synaptic vesicle exocytosis,GO:2001214~positive regulation of vasculogenesis,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030054~cell junction,GO:0032045~guanyl-nucleotide exchange factor complex,GO:0043005~neuron projection,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008565~protein transporter activity,GO:0017016~Ras GTPase binding,GO:0017034~Rap guanyl-nucleotide exchange factor activity,GO:0032403~protein complex binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04972:Pancreatic secretion,hsa05211:Renal cell carcinoma,				3D-structure,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Endosome,GTP-binding,Lipoprotein,Membrane,Methylation,Neurogenesis,Nucleotide-binding,Prenylation,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Ras-related protein Rap-1A,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,strand,turn,
RORC	RAR related orphan receptor C(RORC)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006805~xenobiotic metabolic process,GO:0007623~circadian rhythm,GO:0010906~regulation of glucose metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0030522~intracellular receptor signaling pathway,GO:0032922~circadian regulation of gene expression,GO:0036315~cellular response to sterol,GO:0042093~T-helper cell differentiation,GO:0042753~positive regulation of circadian rhythm,GO:0043401~steroid hormone mediated signaling pathway,GO:0045598~regulation of fat cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048535~lymph node development,GO:0048541~Peyer's patch development,GO:0060612~adipose tissue development,GO:0060850~regulation of transcription involved in cell fate commitment,GO:0070244~negative regulation of thymocyte apoptotic process,GO:0072539~T-helper 17 cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008142~oxysterol binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0098531~transcription factor activity, direct ligand regulated sequence-specific DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003079:Nuclear receptor ROR,IPR013088:Zinc finger, NHR/GATA-type,	hsa04710:Circadian rhythm,hsa05321:Inflammatory bowel disease (IBD),	616622~Immunodeficiency 42,		SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Activator,Alternative promoter usage,Biological rhythms,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Metal-binding,Nucleus,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor ROR-gamma,compositionally biased region:Poly-Gln,DNA-binding region:Nuclear receptor,region of interest:Hinge,region of interest:Ligand-binding,region of interest:Modulating,splice variant,zinc finger region:NR C4-type,
RASGRP3	RAS guanyl releasing protein 3(RASGRP3)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0032045~guanyl-nucleotide exchange factor complex,GO:0048471~perinuclear region of cytoplasm,	GO:0004871~signal transducer activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017016~Ras GTPase binding,GO:0019900~kinase binding,GO:0019992~diacylglycerol binding,	IPR000651:Ras-like guanine nucleotide exchange factor, N-terminal,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR002048:EF-hand domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR020454:Diacylglycerol/phorbol-ester binding,IPR023578:Ras guanine nucleotide exchange factor, domain,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04662:B cell receptor signaling pathway,hsa05200:Pathways in cancer,			SM00054:EFh,SM00109:C1,SM00147:RasGEF,SM00229:RasGEFN,	Alternative splicing,Calcium,Complete proteome,Guanine-nucleotide releasing factor,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	calcium-binding region:1,calcium-binding region:2,chain:Ras guanyl-releasing protein 3,domain:EF-hand 1,domain:EF-hand 2,domain:N-terminal Ras-GEF,domain:Ras-GEF,sequence conflict,sequence variant,zinc finger region:Phorbol-ester/DAG-type,
RALB	RAS like proto-oncogene B(RALB)	Homo sapiens				GO:0000910~cytokinesis,GO:0001928~regulation of exocyst assembly,GO:0001934~positive regulation of protein phosphorylation,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0007265~Ras protein signal transduction,GO:0009267~cellular response to starvation,GO:0032091~negative regulation of protein binding,GO:0032092~positive regulation of protein binding,GO:0060178~regulation of exocyst localization,GO:0071360~cellular response to exogenous dsRNA,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:2000786~positive regulation of autophagosome assembly,	GO:0000145~exocyst,GO:0005622~intracellular,GO:0005776~autophagosome,GO:0005886~plasma membrane,GO:0030496~midbody,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0031625~ubiquitin protein ligase binding,GO:0051117~ATPase binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,				3D-structure,Alternative splicing,Apoptosis,Cell cycle,Cell division,Cell membrane,Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Proteomics identification,Reference proteome,	chain:Ras-related protein Ral-B,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,strand,turn,
RASAL2	RAS protein activator like 2(RASAL2)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007165~signal transduction,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0046580~negative regulation of Ras protein signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031235~intrinsic component of the cytoplasmic side of the plasma membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001849:Pleckstrin homology domain,IPR001936:Ras GTPase-activating protein,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR021887:Protein of unknown function DUF3498,IPR023152:Ras GTPase-activating protein, conserved site,	hsa04014:Ras signaling pathway,			SM00233:PH,SM00239:C2,SM00323:RasGAP,	Alternative splicing,Coiled coil,Complete proteome,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Ras GTPase-activating protein nGAP,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,domain:C2,domain:PH,domain:Ras-GAP,modified residue,sequence variant,
RBBP4	RB binding protein 4, chromatin remodeling factor(RBBP4)	Homo sapiens		h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,		GO:0006260~DNA replication,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0016575~histone deacetylation,GO:0031497~chromatin assembly,GO:0034080~CENP-A containing nucleosome assembly,GO:0043044~ATP-dependent chromatin remodeling,GO:0045814~negative regulation of gene expression, epigenetic,GO:0051726~regulation of cell cycle,GO:0060416~response to growth hormone,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0016589~NURF complex,GO:0033186~CAF-1 complex,GO:0035098~ESC/E(Z) complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008094~DNA-dependent ATPase activity,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0042826~histone deacetylase binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR022052:Histone-binding protein RBBP4,				SM00320:WD40,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Chromatin regulator,Complete proteome,Direct protein sequencing,DNA replication,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,WD repeat,	chain:Histone-binding protein RBBP4,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,strand,turn,
RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit(RBBP5)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0043627~response to estrogen,GO:0051568~histone H3-K4 methylation,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,GO:0048188~Set1C/COMPASS complex,GO:0071339~MLL1 complex,	GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0035064~methylated histone binding,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0044212~transcription regulatory region DNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	3D-structure,Alternative splicing,Chromatin regulator,Complete proteome,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,WD repeat,	chain:Retinoblastoma-binding protein 5,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,splice variant,
RCAN3	RCAN family member 3(RCAN3)	Homo sapiens				GO:0009653~anatomical structure morphogenesis,GO:0019722~calcium-mediated signaling,GO:0050790~regulation of catalytic activity,GO:0070884~regulation of calcineurin-NFAT signaling cascade,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008597~calcium-dependent protein serine/threonine phosphatase regulator activity,GO:0031013~troponin I binding,	IPR006931:Calcipressin,IPR012677:Nucleotide-binding, alpha-beta plait,					Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Calcipressin-3,modified residue,sequence variant,splice variant,
RCSD1	RCSD domain containing 1(RCSD1)	Homo sapiens				GO:0003009~skeletal muscle contraction,GO:0071474~cellular hyperosmotic response,	GO:0005884~actin filament,	GO:0051015~actin filament binding,	IPR007850:RCSD,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Capz-interacting protein,domain:RCSD,modified residue,sequence conflict,sequence variant,splice variant,
REL	REL proto-oncogene, NF-kB subunit(REL)	Homo sapiens	79.B_cell_Activation,			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0010629~negative regulation of gene expression,GO:0032688~negative regulation of interferon-beta production,GO:0034097~response to cytokine,GO:0038061~NIK/NF-kappaB signaling,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1901215~negative regulation of neuron death,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005829~cytosol,GO:0033256~I-kappaB/NF-kappaB complex,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR000451:NF-kappa-B/Rel/Dorsal,IPR002909:Cell surface receptor IPT/TIG,IPR008967:p53-like transcription factor, DNA-binding,IPR011539:Rel homology domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,	hsa04014:Ras signaling pathway,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,			SM00429:IPT,	Acetylation,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:C-Rel proto-oncogene protein,modified residue,region of interest:RHD,short sequence motif:Nuclear localization signal,
RSG1	REM2 and RAB like small GTPase 1(RSG1)	Homo sapiens				GO:0006887~exocytosis,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0017157~regulation of exocytosis,GO:0031338~regulation of vesicle fusion,GO:0034613~cellular protein localization,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0036064~ciliary basal body,	GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Cell projection,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Exocytosis,GTP-binding,Nucleotide-binding,Polymorphism,Protein transport,Reference proteome,Transport,	chain:Miro domain-containing protein C1orf89,domain:Miro,nucleotide phosphate-binding region:GTP,sequence variant,
RCOR3	REST corepressor 3(RCOR3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0017053~transcriptional repressor complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0044212~transcription regulatory region DNA binding,	IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,				SM00717:SANT,SM01189:SM01189,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:REST corepressor 3,compositionally biased region:Pro-rich,domain:ELM2,domain:SANT 1,domain:SANT 2,modified residue,sequence variant,splice variant,
REV1	REV1, DNA directed polymerase(REV1)	Homo sapiens				GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0009411~response to UV,GO:0019985~translesion synthesis,GO:0042276~error-prone translesion synthesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0016779~nucleotidyltransferase activity,GO:0017125~deoxycytidyl transferase activity,GO:0046872~metal ion binding,	IPR001126:DNA-repair protein, UmuC-like,IPR001357:BRCT domain,IPR012112:DNA repair protein, Rev1,IPR017961:DNA polymerase, Y-family, little finger domain,IPR025527:Domain of unknown function DUF4414,	hsa03460:Fanconi anemia pathway,		PIRSF036573:DNA repair protein, Rev1 type,	SM00292:BRCT,	3D-structure,Alternative splicing,Complete proteome,DNA damage,DNA repair,DNA synthesis,DNA-binding,Magnesium,Metal-binding,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,	binding site:dCTP,chain:DNA repair protein REV1,domain:BRCT,domain:UmuC,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,modified residue,mutagenesis site,nucleotide phosphate-binding region:dCTP binding,region of interest:Interaction with target DNA,region of interest:Protein interaction domain,sequence variant,short sequence motif:Nuclear localization signal,site:Interaction with target DNA,splice variant,strand,turn,
RFT1	RFT1 homolog(RFT1)	Homo sapiens				GO:0008643~carbohydrate transport,GO:0034203~glycolipid translocation,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005319~lipid transporter activity,	IPR007594:RFT1,		612015~Congenital disorder of glycosylation, type In,			Complete proteome,Congenital disorder of glycosylation,Disease mutation,Membrane,Polymorphism,Proteomics identification,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:Protein RFT1 homolog,sequence variant,transmembrane region,
RFX8	RFX family member 8, lacking RFX DNA binding domain(RFX8)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0031018~endocrine pancreas development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR003150:DNA-binding RFX-type winged-helix domain,IPR011991:Winged helix-turn-helix DNA-binding domain,					Alternative splicing,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Uncharacterized protein FLJ42986,sequence conflict,splice variant,
RTCA	RNA 3'-terminal phosphate cyclase(RTCA)	Homo sapiens				GO:0006396~RNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003723~RNA binding,GO:0003963~RNA-3'-phosphate cyclase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000228:RNA 3'-terminal phosphate cyclase,IPR013791:RNA 3'-terminal phosphate cyclase, insert domain,IPR013792:RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta,IPR017770:RNA 3'-terminal phosphate cyclase type 1,IPR020719:RNA 3'-terminal phosphate cyclase-like, conserved site,IPR023797:RNA 3'-terminal phosphate cyclase domain,			PIRSF005378:RNA 3'-terminal phosphate cyclase,		Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Ligase,Nucleotide-binding,Nucleus,Proteomics identification,Reference proteome,	chain:RNA 3'-terminal phosphate cyclase,sequence conflict,splice variant,
RBM15	RNA binding motif protein 15(RBM15)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0001569~patterning of blood vessels,GO:0007221~positive regulation of transcription of Notch receptor target,GO:0016032~viral process,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048536~spleen development,GO:0060412~ventricular septum morphogenesis,GO:0060674~placenta blood vessel development,	GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0031965~nuclear membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR010912:Spen paralogue/orthologue C-terminal, metazoa,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012921:Spen paralogue and orthologue SPOC, C-terminal,IPR016194:SPOC like C-terminal domain,		Megakaryoblastic leukemia, acute~Megakaryoblastic leukemia, acute,		SM00360:RRM,	Acetylation,Alternative initiation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Host-virus interaction,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,RNA-binding,	chain:Putative RNA-binding protein 15,compositionally biased region:Arg-rich,compositionally biased region:Gly/Ser-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:SPOC,modified residue,sequence conflict,site:Breakpoint for translocation to form RBM15-MKL1,splice variant,
RBM34	RNA binding motif protein 34(RBM34)	Homo sapiens					GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:RNA-binding protein 34,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,splice variant,
RBM44	RNA binding motif protein 44(RBM44)	Homo sapiens					GO:0005737~cytoplasm,GO:0045171~intercellular bridge,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0042803~protein homodimerization activity,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:RNA-binding protein 44,domain:RRM,sequence variant,
RBM45	RNA binding motif protein 45(RBM45)	Homo sapiens				GO:0007399~nervous system development,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:RNA-binding protein 45,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,splice variant,
RBM5	RNA binding motif protein 5(RBM5)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006915~apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR007087:Zinc finger, C2H2,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00443:G_patch,SM00547:ZnF_RBZ,	3D-structure,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spliceosome,Zinc,Zinc-finger,	chain:RNA-binding protein 5,domain:G-patch,domain:RRM 1,domain:RRM 2,modified residue,region of interest:Required for interaction with U2AF2,region of interest:Sufficient for interaction with ACIN1, PRPF8, SFRS3, SNRPB, SNRPN, SNRNP70 and SNRNP200,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type; atypical,zinc finger region:RanBP2-type,
RBM6	RNA binding motif protein 6(RBM6)	Homo sapiens			Function unknown,	GO:0006396~RNA processing,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00443:G_patch,	Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:RNA-binding protein 6,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,domain:G-patch,domain:RRM,modified residue,sequence conflict,sequence variant,
RBM8A	RNA binding motif protein 8A(RBM8A)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0006417~regulation of translation,GO:0008380~RNA splicing,GO:0031124~mRNA 3'-end processing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0035145~exon-exon junction complex,GO:0043025~neuronal cell body,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR008111:RNA-binding motif protein 8,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,hsa03040:Spliceosome,	274000~Thrombocytopenia-absent radius syndrome,		SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,mRNA processing,mRNA splicing,mRNA transport,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Translation regulation,Transport,Ubl conjugation,	chain:RNA-binding protein 8A,domain:RRM,helix,modified residue,mutagenesis site,sequence conflict,splice variant,strand,turn,
RBMXL1	RNA binding motif protein, X-linked like 1(RBMXL1)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012604:RBM1CTR,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03040:Spliceosome,			SM00360:RRM,SM00361:RRM_1,	Acetylation,Complete proteome,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Ubl conjugation,
RBMS1	RNA binding motif single stranded interacting protein 1(RBMS1)	Homo sapiens			General function prediction only,	GO:0006260~DNA replication,GO:0006396~RNA processing,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,DNA replication,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:RNA-binding motif, single-stranded- interacting protein 1,domain:RRM 1,domain:RRM 2,helix,modified residue,sequence conflict,splice variant,strand,turn,
RBMS3	RNA binding motif single stranded interacting protein 3(RBMS3)	Homo sapiens				GO:0045727~positive regulation of translation,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Complete proteome,Cytoplasm,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:RNA-binding motif, single-stranded- interacting protein 3,domain:RRM 1,domain:RRM 2,sequence conflict,splice variant,
RNPC3	RNA binding region (RNP1, RRM) containing 3(RNPC3)	Homo sapiens			General function prediction only,	GO:0000398~mRNA splicing, via spliceosome,GO:0008380~RNA splicing,GO:0032502~developmental process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005689~U12-type spliceosomal complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0030626~U12 snRNA binding,GO:0097157~pre-mRNA intronic binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spliceosome,	chain:RNA-binding protein 40,compositionally biased region:Pro-rich,domain:RRM 1,domain:RRM 2,helix,modified residue,region of interest:Necessary for binding to m(7)G-capped U12 snRNA,region of interest:Necessary for interaction with PDCD7,sequence conflict,strand,
POLR1A	RNA polymerase I subunit A(POLR1A)	Homo sapiens		h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,		GO:0006351~transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005736~DNA-directed RNA polymerase I complex,GO:0005737~cytoplasm,	GO:0001054~RNA polymerase I activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000722:RNA polymerase, alpha subunit,IPR006592:RNA polymerase, N-terminal,IPR007066:RNA polymerase Rpb1, domain 3,IPR007080:RNA polymerase Rpb1, domain 1,IPR007081:RNA polymerase Rpb1, domain 5,IPR007083:RNA polymerase Rpb1, domain 4,IPR015699:DNA-directed RNA pol I, largest subunit,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03020:RNA polymerase,	616462~Acrofacial dysostosis, Cincinnati type,		SM00663:RPOLA_N,	Coiled coil,Complete proteome,Disease mutation,DNA-directed RNA polymerase,Magnesium,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transferase,Zinc,	chain:DNA-directed RNA polymerase I subunit RPA1,metal ion-binding site:Magnesium; catalytic,metal ion-binding site:Zinc,modified residue,region of interest:Bridging helix,sequence conflict,sequence variant,
POLR1B	RNA polymerase I subunit B(POLR1B)	Homo sapiens		h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,	Transcription,	GO:0006351~transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0007566~embryo implantation,GO:0009303~rRNA transcription,GO:0017126~nucleologenesis,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005736~DNA-directed RNA polymerase I complex,GO:0005737~cytoplasm,	GO:0001054~RNA polymerase I activity,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0032549~ribonucleoside binding,GO:0046872~metal ion binding,	IPR007120:DNA-directed RNA polymerase, subunit 2, domain 6,IPR007121:RNA polymerase, beta subunit, conserved site,IPR007641:RNA polymerase Rpb2, domain 7,IPR007642:RNA polymerase Rpb2, domain 2,IPR007644:RNA polymerase, beta subunit, protrusion,IPR007645:RNA polymerase Rpb2, domain 3,IPR009674:RNA polymerase I, Rpa2 specific,IPR014724:RNA polymerase Rpb2, OB-fold,IPR015712:DNA-directed RNA polymerase, subunit 2,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03020:RNA polymerase,				Alternative splicing,Complete proteome,DNA-directed RNA polymerase,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transferase,Zinc,Zinc-finger,	chain:DNA-directed RNA polymerase I subunit RPA2,sequence conflict,sequence variant,splice variant,zinc finger region:C4-type,
RPAP2	RNA polymerase II associated protein 2(RPAP2)	Homo sapiens				GO:0009301~snRNA transcription,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0070940~dephosphorylation of RNA polymerase II C-terminal domain,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,	GO:0004722~protein serine/threonine phosphatase activity,GO:0008420~CTD phosphatase activity,GO:0046872~metal ion binding,	IPR007308:Protein of unknown function DUF408,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Nucleus,Phosphoprotein,Protein phosphatase,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:RNA polymerase II-associated protein 2,modified residue,sequence conflict,splice variant,transmembrane region,
POLR2D	RNA polymerase II subunit D(POLR2D)	Homo sapiens				GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000398~mRNA splicing, via spliceosome,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010467~gene expression,GO:0031047~gene silencing by RNA,GO:0031990~mRNA export from nucleus in response to heat stress,GO:0034402~recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,GO:0035019~somatic stem cell population maintenance,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0045948~positive regulation of translational initiation,GO:0050434~positive regulation of viral transcription,	GO:0000932~cytoplasmic mRNA processing body,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003727~single-stranded RNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0031369~translation initiation factor binding,	IPR002121:HRDC domain,IPR005574:RNA polymerase II, Rpb4,IPR006590:RNA polymerase II, Rpb4, core,IPR010997:HRDC-like,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03020:RNA polymerase,hsa05016:Huntington's disease,			SM00657:RPOL4c,	3D-structure,Complete proteome,DNA-directed RNA polymerase,Nucleus,Proteomics identification,Reference proteome,Transcription,	chain:DNA-directed RNA polymerase II subunit RPB4,helix,modified residue,strand,turn,
POLR3C	RNA polymerase III subunit C(POLR3C)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006383~transcription from RNA polymerase III promoter,GO:0032481~positive regulation of type I interferon production,GO:0032728~positive regulation of interferon-beta production,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005829~cytosol,	GO:0001056~RNA polymerase III activity,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,	IPR008806:RNA polymerase III Rpc82, C -terminal,IPR013197:RNA polymerase III subunit RPC82-related, helix-turn-helix,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03020:RNA polymerase,hsa04623:Cytosolic DNA-sensing pathway,				3D-structure,Antiviral defense,Complete proteome,DNA-directed RNA polymerase,Immunity,Innate immunity,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,	chain:DNA-directed RNA polymerase III subunit RPC3,modified residue,sequence conflict,sequence variant,
POLR3GL	RNA polymerase III subunit G like(POLR3GL)	Homo sapiens				GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0032481~positive regulation of type I interferon production,	GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005829~cytosol,	GO:0001056~RNA polymerase III activity,GO:0005515~protein binding,	IPR024661:DNA-directed RNA polymerase III, subunit Rpc31,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03020:RNA polymerase,hsa04623:Cytosolic DNA-sensing pathway,				Coiled coil,Complete proteome,Proteomics identification,Reference proteome,	chain:DNA-directed RNA polymerase III subunit RPC7-like,compositionally biased region:Glu-rich,modified residue,
RPUSD3	RNA pseudouridylate synthase domain containing 3(RPUSD3)	Homo sapiens				GO:0001522~pseudouridine synthesis,GO:0031119~tRNA pseudouridine synthesis,	GO:0005739~mitochondrion,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0009982~pseudouridine synthase activity,GO:0019239~deaminase activity,GO:0044822~poly(A) RNA binding,	IPR006145:Pseudouridine synthase, RsuA/RluB/C/D/E/F,IPR020103:Pseudouridine synthase, catalytic domain,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:RNA pseudouridylate synthase domain- containing protein 3,sequence variant,splice variant,
RNF103-CHMP3	RNF103-CHMP3 readthrough(RNF103-CHMP3)	Homo sapiens				GO:0000920~cell separation after cytokinesis,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0007034~vacuolar transport,GO:0007049~cell cycle,GO:0010824~regulation of centrosome duplication,GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0019058~viral life cycle,GO:0036258~multivesicular body assembly,GO:0039702~viral budding via host ESCRT complex,GO:0050792~regulation of viral process,GO:0051258~protein polymerization,GO:0051291~protein heterooligomerization,GO:0061763~multivesicular body-lysosome fusion,GO:0071985~multivesicular body sorting pathway,GO:0097352~autophagosome maturation,GO:1902187~negative regulation of viral release from host cell,GO:1902188~positive regulation of viral release from host cell,GO:2000641~regulation of early endosome to late endosome transport,	GO:0000815~ESCRT III complex,GO:0005622~intracellular,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,	GO:0031210~phosphatidylcholine binding,GO:0042803~protein homodimerization activity,GO:1990381~ubiquitin-specific protease binding,	IPR005024:Snf7,	hsa04144:Endocytosis,				3D-structure,Alternative splicing,Apoptosis,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Endosome,Isopeptide bond,Lipoprotein,Membrane,Myristate,Phosphoprotein,Protein transport,Reference proteome,Transport,Ubl conjugation,
RUFY4	RUN and FYVE domain containing 4(RUFY4)	Homo sapiens						GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR004012:RUN,IPR011011:Zinc finger, FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,				SM00593:RUN,	Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:RUN and FYVE domain-containing protein 4,domain:RUN,splice variant,zinc finger region:FYVE-type,
RUSC1	RUN and SH3 domain containing 1(RUSC1)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0009967~positive regulation of signal transduction,	GO:0005634~nucleus,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005874~microtubule,GO:0014069~postsynaptic density,GO:0015630~microtubule cytoskeleton,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030054~cell junction,GO:0031410~cytoplasmic vesicle,GO:0045211~postsynaptic membrane,	GO:0003779~actin binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR001452:Src homology-3 domain,IPR004012:RUN,				SM00326:SH3,SM00593:RUN,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endosome,Golgi apparatus,Membrane,Microtubule,Nucleus,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,SH3 domain,Synapse,Ubl conjugation,	chain:RUN and SH3 domain-containing protein 1,domain:RUN,domain:SH3,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
RUSC1-AS1	RUSC1 antisense RNA 1(RUSC1-AS1)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf104,compositionally biased region:Poly-Gly,sequence variant,splice variant,
RAF1	Raf-1 proto-oncogene, serine/threonine kinase(RAF1)	Homo sapiens	100.MAPK_signaling_cascades,102.Cholesterol_Stress_Response,104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,2.Cytokine_Receptors,54.T-cell_anergy,67.Ikaros_and_signaling_inhibitors,68.Mitogen_signaling_in_growth_control,83.Growth_factors_Survival_factors_Mitogens,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArr-mapkPathway:Role of ï¿½-arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_ceramidePathway:Ceramide Signaling Pathway,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_pdgfPathway:PDGF Signaling Pathway,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,		GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0001666~response to hypoxia,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0007190~activation of adenylate cyclase activity,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0030154~cell differentiation,GO:0030168~platelet activation,GO:0030878~thyroid gland development,GO:0031333~negative regulation of protein complex assembly,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034220~ion transmembrane transport,GO:0035019~somatic stem cell population maintenance,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0035773~insulin secretion involved in cellular response to glucose stimulus,GO:0035994~response to muscle stretch,GO:0042060~wound healing,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045104~intermediate filament cytoskeleton organization,GO:0045595~regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048538~thymus development,GO:0060324~face development,GO:0071550~death-inducing signaling complex assembly,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000145~regulation of cell motility,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031143~pseudopodium,	GO:0003676~nucleic acid binding,GO:0004519~endonuclease activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001427:Ribonuclease A,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR003116:Raf-like Ras-binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020454:Diacylglycerol/phorbol-ester binding,IPR023411:Ribonuclease A, active site,IPR023412:Ribonuclease A-domain,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05034:Alcoholism,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	611553~Noonan syndrome 5,611554~LEOPARD syndrome 2,615916~Cardiomyopathy, dilated, 1NN,		SM00092:RNAse_Pc,SM00109:C1,SM00220:S_TKc,SM00455:RBD,	3D-structure,Alternative splicing,ATP-binding,Cardiomyopathy,Cell membrane,Complete proteome,Cytoplasm,Deafness,Direct protein sequencing,Disease mutation,Disulfide bond,Endonuclease,Hydrolase,Kinase,Membrane,Metal-binding,Methylation,Mitochondrion,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:RAF proto-oncogene serine/threonine- protein kinase,domain:Protein kinase,domain:RBD,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:Phorbol-ester/DAG-type,
RALGPS2	Ral GEF with PH domain and SH3 binding motif 2(RALGPS2)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0032485~regulation of Ral protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR001849:Pleckstrin homology domain,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR011993:Pleckstrin homology-like domain,IPR023578:Ras guanine nucleotide exchange factor, domain,				SM00147:RasGEF,SM00233:PH,	Alternative splicing,Alzheimer disease,Cell membrane,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Ras-specific guanine nucleotide-releasing factor RalGPS2,domain:PH,domain:Ras-GEF,modified residue,region of interest:Required for stimulation of nucleotide exchange by RALA,sequence variant,short sequence motif:PXXP,splice variant,
RAPGEF4	Rap guanine nucleotide exchange factor 4(RAPGEF4)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0017156~calcium ion regulated exocytosis,GO:0017157~regulation of exocytosis,GO:0019933~cAMP-mediated signaling,GO:0030073~insulin secretion,GO:0043547~positive regulation of GTPase activity,GO:0050796~regulation of insulin secretion,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017016~Ras GTPase binding,GO:0030552~cAMP binding,	IPR000591:DEP domain,IPR000595:Cyclic nucleotide-binding domain,IPR000651:Ras-like guanine nucleotide exchange factor, N-terminal,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR014710:RmlC-like jelly roll fold,IPR018490:Cyclic nucleotide-binding-like,IPR019804:Ras guanine-nucleotide exchange factor, conserved site,IPR023578:Ras guanine nucleotide exchange factor, domain,	hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04670:Leukocyte transendothelial migration,hsa04911:Insulin secretion,			SM00049:DEP,SM00100:cNMP,SM00147:RasGEF,SM00229:RasGEFN,	Alternative promoter usage,Alternative splicing,cAMP,cAMP-binding,Complete proteome,Cytoplasm,Exocytosis,Guanine-nucleotide releasing factor,Membrane,Nucleotide-binding,Proteomics identification,Reference proteome,Repeat,	chain:Rap guanine nucleotide exchange factor 4,domain:DEP,domain:N-terminal Ras-GEF,domain:Ras-GEF,modified residue,nucleotide phosphate-binding region:cAMP 1,nucleotide phosphate-binding region:cAMP 2,sequence conflict,splice variant,
RAPH1	Ras association (RalGDS/AF-6) and pleckstrin homology domains 1(RAPH1)	Homo sapiens				GO:0007165~signal transduction,GO:0048675~axon extension,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,	GO:0005515~protein binding,	IPR000159:Ras-association,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00314:RA,	3D-structure,Acetylation,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Ras-associated and pleckstrin homology domains-containing protein 1,domain:PH,domain:Ras-associating,modified residue,sequence conflict,sequence variant,splice variant,
RASSF5	Ras association domain family member 5(RASSF5)	Homo sapiens				GO:0006915~apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0031398~positive regulation of protein ubiquitination,GO:0035556~intracellular signal transduction,GO:0042981~regulation of apoptotic process,GO:1900180~regulation of protein localization to nucleus,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0005515~protein binding,GO:0017016~Ras GTPase binding,GO:0046872~metal ion binding,	IPR000159:Ras-association,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR011524:SARAH domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa05200:Pathways in cancer,hsa05223:Non-small cell lung cancer,			SM00109:C1,SM00314:RA,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Metal-binding,Microtubule,Phosphoprotein,Proteomics identification,Reference proteome,Tumor suppressor,Zinc,Zinc-finger,	chain:Ras association domain-containing protein 5,domain:Ras-associating,domain:SARAH,modified residue,splice variant,zinc finger region:Phorbol-ester/DAG-type,
RIT1	Ras like without CAAX 1(RIT1)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		615355~Noonan syndrome 8,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,GTP-binding,Membrane,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:GTP-binding protein Rit1,mutagenesis site,nucleotide phosphate-binding region:GTP,
RRAGC	Ras related GTP binding C(RRAGC)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0007264~small GTPase mediated signal transduction,GO:0008380~RNA splicing,GO:0010506~regulation of autophagy,GO:0016049~cell growth,GO:0016236~macroautophagy,GO:0032006~regulation of TOR signaling,GO:0032008~positive regulation of TOR signaling,GO:0034198~cellular response to amino acid starvation,GO:0034613~cellular protein localization,GO:0043200~response to amino acid,GO:0071230~cellular response to amino acid stimulus,GO:1903432~regulation of TORC1 signaling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005829~cytosol,GO:0034448~EGO complex,GO:0043231~intracellular membrane-bounded organelle,GO:1990131~Gtr1-Gtr2 GTPase complex,	GO:0000287~magnesium ion binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0046982~protein heterodimerization activity,	IPR006762:Gtr1/RagA G protein,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04150:mTOR signaling pathway,				3D-structure,Acetylation,Complete proteome,Cytoplasm,Disease mutation,GTP-binding,Lysosome,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,	chain:Ras-related GTP-binding protein C,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,
RHCE	Rh blood group CcEe antigens(RHCE)	Homo sapiens				GO:0015695~organic cation transport,GO:0019740~nitrogen utilization,GO:0072488~ammonium transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008519~ammonium transmembrane transporter activity,	IPR001905:Ammonium transporter,IPR002229:Blood group Rhesus C/E/D polypeptide,IPR024041:Ammonium transporter AmtB-like domain,		111690~Blood group, Rhesus,Rh-null disease, amorph type~Rh-null disease, amorph type,			Alternative splicing,Blood group antigen,Complete proteome,Direct protein sequencing,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Blood group Rh(CE) polypeptide,sequence conflict,sequence variant,splice variant,transmembrane region,
RHD	Rh blood group D antigen(RHD)	Homo sapiens				GO:0015695~organic cation transport,GO:0019740~nitrogen utilization,GO:0072488~ammonium transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008519~ammonium transmembrane transporter activity,	IPR001905:Ammonium transporter,IPR002229:Blood group Rhesus C/E/D polypeptide,IPR024041:Ammonium transporter AmtB-like domain,		Rh-negative blood type~Rh-negative blood type,			Alternative splicing,Blood group antigen,Complete proteome,Direct protein sequencing,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Blood group Rh(D) polypeptide,sequence conflict,sequence variant,splice variant,transmembrane region,
RHBG	Rh family B glycoprotein (gene/pseudogene)(RHBG)	Homo sapiens				GO:0015695~organic cation transport,GO:0015696~ammonium transport,GO:0019740~nitrogen utilization,GO:0070634~transepithelial ammonium transport,GO:0072488~ammonium transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014731~spectrin-associated cytoskeleton,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0046658~anchored component of plasma membrane,	GO:0008519~ammonium transmembrane transporter activity,GO:0030506~ankyrin binding,	IPR001905:Ammonium transporter,IPR002229:Blood group Rhesus C/E/D polypeptide,IPR024041:Ammonium transporter AmtB-like domain,					Alternative splicing,Ammonia transport,Cell membrane,Complete proteome,Cytoplasmic vesicle,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Ammonium transporter Rh type B,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Interaction with ANK3,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ARHGAP15	Rho GTPase activating protein 15(ARHGAP15)	Homo sapiens				GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0005096~GTPase activator activity,	IPR000198:Rho GTPase-activating protein domain,IPR001849:Pleckstrin homology domain,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR015767:Rho GTPase activating,				SM00233:PH,SM00324:RhoGAP,	3D-structure,Complete proteome,Cytoplasm,GTPase activation,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Rho GTPase-activating protein 15,domain:PH,domain:Rho-GAP,helix,modified residue,sequence conflict,strand,turn,
ARHGAP25	Rho GTPase activating protein 25(ARHGAP25)	Homo sapiens				GO:0007165~signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,	GO:0005096~GTPase activator activity,	IPR000198:Rho GTPase-activating protein domain,IPR001849:Pleckstrin homology domain,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00324:RhoGAP,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rho GTPase-activating protein 25,domain:PH,domain:Rho-GAP,modified residue,sequence variant,splice variant,strand,
ARHGAP29	Rho GTPase activating protein 29(ARHGAP29)	Homo sapiens				GO:0007266~Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0030165~PDZ domain binding,GO:0046872~metal ion binding,	IPR000198:Rho GTPase-activating protein domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008936:Rho GTPase activation protein,				SM00109:C1,SM00324:RhoGAP,	Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,GTPase activation,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Rho GTPase-activating protein 29,domain:Rho-GAP,modified residue,region of interest:Interaction with PTPN13/PTPL1,sequence conflict,sequence variant,splice variant,zinc finger region:Phorbol-ester/DAG-type,
ARHGAP30	Rho GTPase activating protein 30(ARHGAP30)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,	GO:0005096~GTPase activator activity,	IPR000198:Rho GTPase-activating protein domain,IPR008936:Rho GTPase activation protein,				SM00324:RhoGAP,	Alternative splicing,Complete proteome,Cytoplasmic vesicle,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rho GTPase-activating protein 30,compositionally biased region:Glu-rich,domain:Rho-GAP,modified residue,sequence conflict,sequence variant,splice variant,
ROCK2	Rho associated coiled-coil containing protein kinase 2(ROCK2)	Homo sapiens		h_ccr3Pathway:CCR3 signaling in Eosinophils,	Cell division and chromosome partitioning,	GO:0000910~cytokinesis,GO:0001934~positive regulation of protein phosphorylation,GO:0006468~protein phosphorylation,GO:0006939~smooth muscle contraction,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007266~Rho protein signal transduction,GO:0010595~positive regulation of endothelial cell migration,GO:0010628~positive regulation of gene expression,GO:0010825~positive regulation of centrosome duplication,GO:0016525~negative regulation of angiogenesis,GO:0030155~regulation of cell adhesion,GO:0030866~cortical actin cytoskeleton organization,GO:0032956~regulation of actin cytoskeleton organization,GO:0035509~negative regulation of myosin-light-chain-phosphatase activity,GO:0039694~viral RNA genome replication,GO:0042752~regulation of circadian rhythm,GO:0045616~regulation of keratinocyte differentiation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048511~rhythmic process,GO:0051298~centrosome duplication,GO:0051492~regulation of stress fiber assembly,GO:0051893~regulation of focal adhesion assembly,GO:0071394~cellular response to testosterone stimulus,GO:0090002~establishment of protein localization to plasma membrane,GO:1903140~regulation of establishment of endothelial barrier,GO:1903347~negative regulation of bicellular tight junction assembly,GO:2000114~regulation of establishment of cell polarity,GO:2000145~regulation of cell motility,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0004674~protein serine/threonine kinase activity,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0017048~Rho GTPase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0072518~Rho-dependent protein serine/threonine kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR015008:Rho binding domain,IPR017441:Protein kinase, ATP binding site,IPR020684:Rho-associated protein kinase,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04510:Focal adhesion,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,hsa04921:Oxytocin signaling pathway,hsa05130:Pathogenic Escherichia coli infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,		PIRSF037568:Rho-associated protein kinase,	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	3D-structure,ATP-binding,Biological rhythms,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Rho-associated protein kinase 2,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,region of interest:RHOA binding,repeat:REM,sequence conflict,sequence variant,zinc finger region:Phorbol-ester/DAG-type,
RND3	Rho family GTPase 3(RND3)	Homo sapiens				GO:0007155~cell adhesion,GO:0007264~small GTPase mediated signal transduction,GO:0030036~actin cytoskeleton organization,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005925~focal adhesion,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Complete proteome,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Proteomics identification,Reference proteome,	chain:Rho-related GTP-binding protein RhoE,helix,lipid moiety-binding region:S-farnesyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,strand,turn,
ARHGEF10L	Rho guanine nucleotide exchange factor 10 like(ARHGEF10L)	Homo sapiens				GO:0032933~SREBP signaling pathway,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051496~positive regulation of stress fiber assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,	IPR000219:Dbl homology (DH) domain,IPR011993:Pleckstrin homology-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00325:RhoGEF,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rho guanine nucleotide exchange factor 10-like protein,domain:DH,modified residue,sequence conflict,sequence variant,splice variant,
ARHGEF11	Rho guanine nucleotide exchange factor 11(ARHGEF11)	Homo sapiens		h_rhoPathway:Rho cell motility signaling pathway,		GO:0000910~cytokinesis,GO:0001558~regulation of cell growth,GO:0006928~movement of cell or subcellular component,GO:0006941~striated muscle contraction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007266~Rho protein signal transduction,GO:0030010~establishment of cell polarity,GO:0030036~actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0001664~G-protein coupled receptor binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000219:Dbl homology (DH) domain,IPR001478:PDZ domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR015212:Regulator of G protein signalling-like fold,IPR016137:Regulator of G protein signalling superfamily,	hsa04270:Vascular smooth muscle contraction,hsa05200:Pathways in cancer,			SM00228:PDZ,SM00233:PH,SM00315:RGS,SM00325:RhoGEF,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,GTPase activation,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Rho guanine nucleotide exchange factor 11,compositionally biased region:Poly-Pro,domain:DH,domain:PDZ,domain:PH,domain:RGSL,helix,modified residue,sequence variant,strand,turn,
ARHGEF16	Rho guanine nucleotide exchange factor 16(ARHGEF16)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0060326~cell chemotaxis,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090630~activation of GTPase activity,GO:0098609~cell-cell adhesion,	GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017048~Rho GTPase binding,GO:0030165~PDZ domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000219:Dbl homology (DH) domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00325:RhoGEF,SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:Rho guanine nucleotide exchange factor 16,domain:DH,domain:PH,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
ARHGEF19	Rho guanine nucleotide exchange factor 19(ARHGEF19)	Homo sapiens				GO:0032956~regulation of actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0042060~wound healing,GO:0043547~positive regulation of GTPase activity,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,		GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000219:Dbl homology (DH) domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00325:RhoGEF,SM00326:SH3,	Alternative splicing,Complete proteome,GTPase activation,Guanine-nucleotide releasing factor,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:Rho guanine nucleotide exchange factor 19,domain:DH,domain:PH,domain:SH3,sequence variant,splice variant,
ARHGEF3	Rho guanine nucleotide exchange factor 3(ARHGEF3)	Homo sapiens				GO:0007266~Rho protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000219:Dbl homology (DH) domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rho guanine nucleotide exchange factor 3,domain:DH,domain:PH,sequence conflict,sequence variant,splice variant,
ARHGEF33	Rho guanine nucleotide exchange factor 33(ARHGEF33)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,		GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,				SM00325:RhoGEF,	Alternative splicing,Coiled coil,Complete proteome,Guanine-nucleotide releasing factor,Methylation,Reference proteome,
ARHGEF4	Rho guanine nucleotide exchange factor 4(ARHGEF4)	Homo sapiens				GO:0030032~lamellipodium assembly,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0046847~filopodium assembly,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0032587~ruffle membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,	hsa04810:Regulation of actin cytoskeleton,			SM00233:PH,SM00325:RhoGEF,SM00326:SH3,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Membrane,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,Transmembrane,Transmembrane helix,	chain:Rho guanine nucleotide exchange factor 4,domain:DH,domain:PH,domain:SH3,helix,sequence variant,splice variant,strand,turn,
ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2(ARHGEF2)	Homo sapiens		h_ptdinsPathway:Phosphoinositides and their downstream targets.,		GO:0000132~establishment of mitotic spindle orientation,GO:0000902~cell morphogenesis,GO:0006886~intracellular protein transport,GO:0007015~actin filament organization,GO:0007026~negative regulation of microtubule depolymerization,GO:0007067~mitotic nuclear division,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0042127~regulation of cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045087~innate immune response,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050768~negative regulation of neurogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051301~cell division,GO:0060546~negative regulation of necroptotic process,GO:0071225~cellular response to muramyl dipeptide,GO:0071356~cellular response to tumor necrosis factor,GO:0071474~cellular hyperosmotic response,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902219~negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005923~bicellular tight junction,GO:0005925~focal adhesion,GO:0014069~postsynaptic density,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0032587~ruffle membrane,GO:0043025~neuronal cell body,GO:0043198~dendritic shaft,GO:0043234~protein complex,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0017048~Rho GTPase binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0046872~metal ion binding,GO:0048365~Rac GTPase binding,	IPR000219:Dbl homology (DH) domain,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR011993:Pleckstrin homology-like domain,	hsa05130:Pathogenic Escherichia coli infection,			SM00109:C1,SM00233:PH,SM00325:RhoGEF,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Golgi apparatus,Guanine-nucleotide releasing factor,Immunity,Innate immunity,Membrane,Metal-binding,Microtubule,Mitosis,Phosphoprotein,Proteomics identification,Reference proteome,Tight junction,Zinc,Zinc-finger,	chain:Rho guanine nucleotide exchange factor 2,domain:DH,domain:PH,modified residue,mutagenesis site,sequence conflict,splice variant,zinc finger region:Phorbol-ester/DAG-type,
SAG	S-antigen visual arrestin(SAG)	Homo sapiens		h_rhodopsinPathway:Visual Signal Transduction,		GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007601~visual perception,GO:0016056~rhodopsin mediated signaling pathway,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0043086~negative regulation of catalytic activity,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005829~cytosol,	GO:0002046~opsin binding,GO:0004864~protein phosphatase inhibitor activity,GO:0051219~phosphoprotein binding,	IPR000698:Arrestin,IPR011021:Arrestin-like, N-terminal,IPR011022:Arrestin C-terminal-like domain,IPR014752:Arrestin, C-terminal,IPR014753:Arrestin, N-terminal,IPR014756:Immunoglobulin E-set,IPR017864:Arrestin, conserved site,		258100~Oguchi disease-1,613758~Retinitis pigmentosa 47,		SM01017:SM01017,	Autoimmune uveitis,Calcium,Complete proteome,Congenital stationary night blindness,Disulfide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Retinitis pigmentosa,Sensory transduction,Vision,	chain:S-arrestin,disulfide bond,sequence conflict,sequence variant,
SPHAR	S-phase response (cyclin related)(SPHAR)	Homo sapiens				GO:0006260~DNA replication,								Complete proteome,Reference proteome,	chain:Protein SPHAR,sequence conflict,
SRBD1	S1 RNA binding domain 1(SRBD1)	Homo sapiens			Transcription,	GO:0006139~nucleobase-containing compound metabolic process,		GO:0003723~RNA binding,	IPR003029:Ribosomal protein S1, RNA-binding domain,IPR006641:YqgF/RNase H-like domain,IPR010994:RuvA domain 2-like,IPR012337:Ribonuclease H-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR018974:Tex-like protein, N-terminal,IPR022967:RNA-binding domain, S1,IPR023097:Tex RuvX-like domain,IPR023319:Tex-like protein, HTH domain,IPR023323:Tex-like domain,				SM00316:SM00316,SM00732:YqgFc,	Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,Ubl conjugation,	chain:S1 RNA-binding domain-containing protein 1,compositionally biased region:Poly-Val,domain:S1 motif,modified residue,sequence conflict,sequence variant,splice variant,
S100A10	S100 calcium binding protein A10(S100A10)	Homo sapiens				GO:0001765~membrane raft assembly,GO:0006900~membrane budding,GO:0043547~positive regulation of GTPase activity,GO:0051099~positive regulation of binding,GO:0051290~protein heterotetramerization,GO:0051496~positive regulation of stress fiber assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0090002~establishment of protein localization to plasma membrane,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0016021~integral component of membrane,GO:0019897~extrinsic component of plasma membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,				SM01394:SM01394,	3D-structure,Acetylation,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein S100-A10,helix,modified residue,region of interest:Ancestral calcium site,strand,
S100A2	S100 calcium binding protein A2(S100A2)	Homo sapiens				GO:0043542~endothelial cell migration,		GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM01394:SM01394,	3D-structure,Calcium,Complete proteome,Direct protein sequencing,Metal-binding,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1; low affinity,calcium-binding region:2; high affinity,chain:Protein S100-A2,domain:EF-hand 1,domain:EF-hand 2,helix,sequence conflict,strand,turn,
S100A5	S100 calcium binding protein A5(S100A5)	Homo sapiens					GO:0005634~nucleus,GO:0043025~neuronal cell body,	GO:0005507~copper ion binding,GO:0005509~calcium ion binding,GO:0008270~zinc ion binding,GO:0042803~protein homodimerization activity,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,SM01394:SM01394,	3D-structure,Alternative splicing,Calcium,Complete proteome,Copper,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,	calcium-binding region:1; low affinity,calcium-binding region:2; high affinity,chain:Protein S100-A5,domain:EF-hand 1,domain:EF-hand 2,sequence variant,
S100A7	S100 calcium binding protein A7(S100A7)	Homo sapiens				GO:0000302~response to reactive oxygen species,GO:0001525~angiogenesis,GO:0008544~epidermis development,GO:0010820~positive regulation of T cell chemotaxis,GO:0030216~keratinocyte differentiation,GO:0032496~response to lipopolysaccharide,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0051238~sequestering of metal ion,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071624~positive regulation of granulocyte chemotaxis,GO:0090026~positive regulation of monocyte chemotaxis,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0050786~RAGE receptor binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM01394:SM01394,	3D-structure,Acetylation,Calcium,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Metal-binding,Polymorphism,Reference proteome,Repeat,Secreted,Zinc,	calcium-binding region:2; high affinity,chain:Protein S100-A7,disulfide bond,domain:EF-hand 1,domain:EF-hand 2,helix,metal ion-binding site:Zinc,modified residue,sequence variant,turn,
S100A8	S100 calcium binding protein A8(S100A8)	Homo sapiens				GO:0001816~cytokine production,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002526~acute inflammatory response,GO:0002544~chronic inflammatory response,GO:0002793~positive regulation of peptide secretion,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006954~inflammatory response,GO:0010043~response to zinc ion,GO:0014002~astrocyte development,GO:0018119~peptidyl-cysteine S-nitrosylation,GO:0030307~positive regulation of cell growth,GO:0030593~neutrophil chemotaxis,GO:0032119~sequestering of zinc ion,GO:0032496~response to lipopolysaccharide,GO:0032602~chemokine production,GO:0042060~wound healing,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0045471~response to ethanol,GO:0050729~positive regulation of inflammatory response,GO:0050832~defense response to fungus,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051493~regulation of cytoskeleton organization,GO:0070488~neutrophil aggregation,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,GO:0035662~Toll-like receptor 4 binding,GO:0050544~arachidonic acid binding,GO:0050786~RAGE receptor binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM01394:SM01394,	3D-structure,Antimicrobial,Apoptosis,Autophagy,Calcium,Cell membrane,Chemotaxis,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Immunity,Inflammatory response,Innate immunity,Membrane,Metal-binding,Reference proteome,Repeat,S-nitrosylation,Secreted,Zinc,	calcium-binding region:1; low affinity,calcium-binding region:2; high affinity,chain:Protein S100-A8,domain:EF-hand 1,domain:EF-hand 2,helix,mutagenesis site,sequence conflict,strand,
S100A9	S100 calcium binding protein A9(S100A9)	Homo sapiens				GO:0001816~cytokine production,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002793~positive regulation of peptide secretion,GO:0006417~regulation of translation,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0014002~astrocyte development,GO:0030194~positive regulation of blood coagulation,GO:0030307~positive regulation of cell growth,GO:0030593~neutrophil chemotaxis,GO:0031532~actin cytoskeleton reorganization,GO:0032119~sequestering of zinc ion,GO:0032602~chemokine production,GO:0035606~peptidyl-cysteine S-trans-nitrosylation,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0045113~regulation of integrin biosynthetic process,GO:0050729~positive regulation of inflammatory response,GO:0050832~defense response to fungus,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051493~regulation of cytoskeleton organization,GO:0070488~neutrophil aggregation,GO:0098869~cellular oxidant detoxification,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,GO:0016209~antioxidant activity,GO:0035662~Toll-like receptor 4 binding,GO:0050544~arachidonic acid binding,GO:0050786~RAGE receptor binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,SM01394:SM01394,	3D-structure,Antimicrobial,Antioxidant,Apoptosis,Autophagy,Calcium,Cell membrane,Chemotaxis,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Immunity,Inflammatory response,Innate immunity,Membrane,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,S-nitrosylation,Secreted,Zinc,	calcium-binding region:1; low affinity,calcium-binding region:2; high affinity,chain:Protein S100-A9,domain:EF-hand 1,domain:EF-hand 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,turn,
S100PBP	S100P binding protein(S100PBP)	Homo sapiens					GO:0005634~nucleus,	GO:0048306~calcium-dependent protein binding,	IPR026097:S100P-binding protein,					Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:S100P-binding protein,sequence conflict,splice variant,
SACM1L	SAC1 suppressor of actin mutations 1-like (yeast)(SACM1L)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0046856~phosphatidylinositol dephosphorylation,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0032281~AMPA glutamate receptor complex,	GO:0004438~phosphatidylinositol-3-phosphatase activity,GO:0005515~protein binding,GO:0016791~phosphatase activity,GO:0034593~phosphatidylinositol bisphosphate phosphatase activity,GO:0034596~phosphatidylinositol phosphate 4-phosphatase activity,GO:0042578~phosphoric ester hydrolase activity,GO:0043812~phosphatidylinositol-4-phosphate phosphatase activity,	IPR002013:Synaptojanin, N-terminal,					Acetylation,Alternative splicing,Complete proteome,Endoplasmic reticulum,Hydrolase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Phosphatidylinositide phosphatase SAC1,domain:SAC,modified residue,sequence conflict,sequence variant,transmembrane region,
SASS6	SAS-6 centriolar assembly protein(SASS6)	Homo sapiens				GO:0007099~centriole replication,GO:0051298~centrosome duplication,	GO:0005813~centrosome,GO:0005814~centriole,GO:0098536~deuterosome,	GO:0005515~protein binding,			616402~Microcephaly 14, primary, autosomal recessive,			Cell cycle,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Phosphoprotein,Polymorphism,Primary microcephaly,Reference proteome,Ubl conjugation,	chain:Spindle assembly abnormal protein 6 homolog,domain:PISA,modified residue,sequence variant,
SATB1	SATB homeobox 1(SATB1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0008544~epidermis development,GO:0016032~viral process,GO:0016571~histone methylation,GO:0043367~CD4-positive, alpha-beta T cell differentiation,GO:0043374~CD8-positive, alpha-beta T cell differentiation,GO:0050798~activated T cell proliferation,GO:0060004~reflex,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005720~nuclear heterochromatin,GO:0016363~nuclear matrix,GO:0016605~PML body,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,	IPR001356:Homeodomain,IPR003350:Homeodomain protein CUT,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,				SM00389:HOX,SM01109:SM01109,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Chromosomal rearrangement,Complete proteome,DNA-binding,Homeobox,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Signal,Transcription,Transcription regulation,Ubl conjugation,	binding site:Matrix attachment region (MAR) DNA,chain:DNA-binding protein SATB1,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:CUT 1,DNA-binding region:CUT 2,DNA-binding region:Homeobox,helix,modified residue,mutagenesis site,region of interest:Matrix attachment region (MAR) DNA- binding,region of interest:Nuclear matrix targeting sequence (NMTS),region of interest:PDZ-like dimerization domain,short sequence motif:Nuclear localization signal,short sequence motif:Protein interaction,site:Cleavage; by caspases,splice variant,
SATB2	SATB homeobox 2(SATB2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001764~neuron migration,GO:0002076~osteoblast development,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009880~embryonic pattern specification,GO:0016569~covalent chromatin modification,GO:0021902~commitment of neuronal cell to specific neuron type in forebrain,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048704~embryonic skeletal system morphogenesis,GO:0051216~cartilage development,GO:0060021~palate development,GO:0071310~cellular response to organic substance,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR003350:Homeodomain protein CUT,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,		612313~Glass syndrome,		SM00389:HOX,SM01109:SM01109,	3D-structure,Alternative splicing,Chromatin regulator,Chromosomal rearrangement,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Homeobox,Isopeptide bond,Mental retardation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:DNA-binding protein SATB2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:CUT 1,DNA-binding region:CUT 2,DNA-binding region:Homeobox,helix,modified residue,mutagenesis site,sequence variant,turn,
STIL	SCL/TAL1 interrupting locus(STIL)	Homo sapiens				GO:0000578~embryonic axis specification,GO:0001701~in utero embryonic development,GO:0001843~neural tube closure,GO:0001947~heart looping,GO:0007052~mitotic spindle organization,GO:0007224~smoothened signaling pathway,GO:0007368~determination of left/right symmetry,GO:0008283~cell proliferation,GO:0021915~neural tube development,GO:0030900~forebrain development,GO:0030903~notochord development,GO:0033504~floor plate development,GO:0035264~multicellular organism growth,GO:0043066~negative regulation of apoptotic process,GO:0046599~regulation of centriole replication,GO:0051298~centrosome duplication,GO:0071539~protein localization to centrosome,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR026123:SCL-interrupting locus protein,		612703~Microcephaly 7, primary, autosomal recessive,			3D-structure,Acetylation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Disease mutation,Mental retardation,Phosphoprotein,Polymorphism,Primary microcephaly,Proteomics identification,Proto-oncogene,Reference proteome,Ubl conjugation,	chain:SCL-interrupting locus protein,modified residue,region of interest:PIN1-binding,sequence conflict,sequence variant,splice variant,
SESTD1	SEC14 and spectrin domain containing 1(SESTD1)	Homo sapiens					GO:0034704~calcium channel complex,	GO:0001786~phosphatidylserine binding,GO:0005515~protein binding,GO:0005545~1-phosphatidylinositol binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0031210~phosphatidylcholine binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0070300~phosphatidic acid binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR001251:CRAL-TRIO domain,					Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:SEC14 domain and spectrin repeat- containing protein 1,domain:CRAL-TRIO,repeat:Spectrin 1,repeat:Spectrin 2,repeat:Spectrin 3,sequence conflict,sequence variant,
SEC16B	SEC16 homolog B, endoplasmic reticulum export factor(SEC16B)	Homo sapiens				GO:0007029~endoplasmic reticulum organization,GO:0007031~peroxisome organization,GO:0010628~positive regulation of gene expression,GO:0015031~protein transport,GO:0016559~peroxisome fission,GO:0048208~COPII vesicle coating,GO:0070863~positive regulation of protein exit from endoplasmic reticulum,GO:0070972~protein localization to endoplasmic reticulum,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,		IPR024340:Sec16, central conserved domain,IPR024880:COPII coat assembly protein, Sec16,					Alternative splicing,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Signal,Transport,	chain:Protein transport protein Sec16B,compositionally biased region:Poly-Ser,compositionally biased region:Tyr-rich,modified residue,region of interest:Required for endoplasmic reticulum localization,sequence conflict,sequence variant,splice variant,
SEC22B	SEC22 homolog B, vesicle trafficking protein (gene/pseudogene)(SEC22B)	Homo sapiens			Intracellular trafficking and secretion,	GO:0006810~transport,GO:0006887~exocytosis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0033043~regulation of organelle organization,GO:0045732~positive regulation of protein catabolic process,GO:0048208~COPII vesicle coating,GO:0048280~vesicle fusion with Golgi apparatus,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0031201~SNARE complex,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0042470~melanosome,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,GO:0019905~syntaxin binding,	IPR001388:Synaptobrevin,IPR010908:Longin domain,IPR011012:Longin-like domain,	hsa04130:SNARE interactions in vesicular transport,hsa04145:Phagosome,hsa05134:Legionellosis,			SM01270:SM01270,	3D-structure,Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,ER-Golgi transport,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Vesicle-trafficking protein SEC22b,domain:Longin,domain:v-SNARE coiled-coil homology,helix,modified residue,sequence variant,strand,topological domain:Cytoplasmic,transmembrane region,turn,
SEC22C	SEC22 homolog C, vesicle trafficking protein(SEC22C)	Homo sapiens				GO:0006810~transport,GO:0006887~exocytosis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0015031~protein transport,GO:0048280~vesicle fusion with Golgi apparatus,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031201~SNARE complex,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,	IPR010908:Longin domain,IPR011012:Longin-like domain,				SM01270:SM01270,	Alternative splicing,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Membrane,Protein transport,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Vesicle-trafficking protein SEC22c,domain:Longin,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
SERTAD2	SERTA domain containing 2(SERTAD2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030308~negative regulation of cell growth,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003713~transcription coactivator activity,	IPR009263:SERTA,					Complete proteome,Cytoplasm,Nucleus,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:SERTA domain-containing protein 2,domain:SERTA,
SERTAD4	SERTA domain containing 4(SERTAD4)	Homo sapiens					GO:0005634~nucleus,		IPR009263:SERTA,					Complete proteome,Reference proteome,	chain:SERTA domain-containing protein 4,compositionally biased region:Ser-rich,domain:SERTA,
SERTAD4-AS1	SERTAD4 antisense RNA 1(SERTAD4-AS1)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C1orf133,sequence variant,splice variant,
SMYD1	SET and MYND domain containing 1(SMYD1)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0007507~heart development,GO:0010831~positive regulation of myotube differentiation,GO:0034968~histone lysine methylation,GO:0035914~skeletal muscle cell differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046872~metal ion binding,	IPR001214:SET domain,IPR002893:Zinc finger, MYND-type,				SM00317:SET,	Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Methyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	chain:SET and MYND domain-containing protein 1,domain:SET,sequence variant,zinc finger region:MYND-type,
SMYD2	SET and MYND domain containing 2(SMYD2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007507~heart development,GO:0008285~negative regulation of cell proliferation,GO:0010452~histone H3-K36 methylation,GO:0018026~peptidyl-lysine monomethylation,GO:0018027~peptidyl-lysine dimethylation,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000993~RNA polymerase II core binding,GO:0002039~p53 binding,GO:0005515~protein binding,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046872~metal ion binding,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001214:SET domain,IPR002893:Zinc finger, MYND-type,IPR011990:Tetratricopeptide-like helical,				SM00317:SET,	3D-structure,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Metal-binding,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	chain:SET and MYND domain-containing protein 2,domain:SET,sequence variant,zinc finger region:MYND-type,
SMYD3	SET and MYND domain containing 3(SMYD3)	Homo sapiens				GO:0006334~nucleosome assembly,GO:0006469~negative regulation of protein kinase activity,GO:0014904~myotube cell development,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034968~histone lysine methylation,GO:0045184~establishment of protein localization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071549~cellular response to dexamethasone stimulus,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000993~RNA polymerase II core binding,GO:0001162~RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046872~metal ion binding,	IPR001214:SET domain,IPR002893:Zinc finger, MYND-type,IPR025805:Histone-lysine N-methyltransferase Smyd3,				SM00317:SET,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Membrane,Metal-binding,Methyltransferase,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:SET and MYND domain-containing protein 3,domain:SET,sequence conflict,splice variant,zinc finger region:MYND-type,
SETMAR	SET domain and mariner transposase fusion gene(SETMAR)	Homo sapiens				GO:0000729~DNA double-strand break processing,GO:0000737~DNA catabolic process, endonucleolytic,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0008283~cell proliferation,GO:0010452~histone H3-K36 methylation,GO:0015074~DNA integration,GO:0031297~replication fork processing,GO:0044774~mitotic DNA integrity checkpoint,GO:0051568~histone H3-K4 methylation,GO:0071157~negative regulation of cell cycle arrest,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:0097676~histone H3-K36 dimethylation,GO:2000373~positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,GO:2001251~negative regulation of chromosome organization,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0035861~site of double-strand break,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0042803~protein homodimerization activity,GO:0043566~structure-specific DNA binding,GO:0044547~DNA topoisomerase binding,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001214:SET domain,IPR001888:Transposase, type 1,IPR003616:Post-SET domain,IPR007728:Pre-SET domain,	hsa00310:Lysine degradation,			SM00317:SET,SM00468:PreSET,	3D-structure,Alternative splicing,Chromatin regulator,Chromosome,Complete proteome,DNA damage,DNA repair,DNA-binding,Endonuclease,Hydrolase,Magnesium,Metal-binding,Methylation,Methyltransferase,Multifunctional enzyme,Nuclease,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,Zinc,	chain:Histone-lysine N-methyltransferase SETMAR,DNA-binding region:H-T-H motif,domain:Post-SET,domain:Pre-SET,domain:SET,helix,metal ion-binding site:Magnesium,modified residue,mutagenesis site,region of interest:Histone-lysine N-methyltransferase,region of interest:Mariner transposase Hsmar1,sequence conflict,splice variant,strand,
SETDB1	SET domain bifurcated 1(SETDB1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007265~Ras protein signal transduction,GO:0033273~response to vitamin,GO:0034968~histone lysine methylation,GO:0045471~response to ethanol,GO:0090309~positive regulation of methylation-dependent chromatin silencing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:1990841~promoter-specific chromatin binding,	IPR001214:SET domain,IPR001739:Methyl-CpG DNA binding,IPR002999:Tudor domain,IPR003616:Post-SET domain,IPR007728:Pre-SET domain,IPR016177:DNA-binding, integrase-type,IPR025796:Histone-lysine N-methyltransferase SETDB1,	hsa00310:Lysine degradation,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00317:SET,SM00333:TUDOR,SM00391:MBD,SM00468:PreSET,	3D-structure,Alternative splicing,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Metal-binding,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,	chain:Histone-lysine N-methyltransferase SETDB1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:MBD,domain:Post-SET,domain:Pre-SET,domain:SET,domain:Tudor 1,domain:Tudor 2,helix,modified residue,mutagenesis site,sequence variant,splice variant,strand,turn,
SETD2	SET domain containing 2(SETD2)	Homo sapiens				GO:0001525~angiogenesis,GO:0001763~morphogenesis of a branching structure,GO:0001843~neural tube closure,GO:0006298~mismatch repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0010793~regulation of mRNA export from nucleus,GO:0030900~forebrain development,GO:0034728~nucleosome organization,GO:0035441~cell migration involved in vasculogenesis,GO:0048332~mesoderm morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048864~stem cell development,GO:0060039~pericardium development,GO:0060669~embryonic placenta morphogenesis,GO:0060977~coronary vasculature morphogenesis,GO:0097198~histone H3-K36 trimethylation,GO:0097676~histone H3-K36 dimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001202:WW domain,IPR001214:SET domain,IPR003616:Post-SET domain,IPR006560:AWS,IPR009078:Ferritin-like superfamily,IPR013257:SRI, Set2 Rpb1 interacting,	hsa00310:Lysine degradation,			SM00317:SET,SM00456:WW,SM00508:PostSET,SM00570:AWS,	3D-structure,Activator,Alternative splicing,Autism spectrum disorder,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Mental retardation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,	chain:Histone-lysine N-methyltransferase SETD2,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:AWS,domain:Post-SET,domain:SET,domain:WW,helix,modified residue,mutagenesis site,region of interest:Interaction with POLR2A,region of interest:Low charge region,sequence conflict,sequence variant,splice variant,strand,turn,
SETD5	SET domain containing 5(SETD5)	Homo sapiens							IPR001214:SET domain,		615761~Mental retardation, autosomal dominant 23,		SM00317:SET,	Alternative splicing,Autism,Autism spectrum disorder,Coiled coil,Complete proteome,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:SET domain-containing protein 5,compositionally biased region:Ser-rich,domain:SET,modified residue,sequence conflict,sequence variant,splice variant,
SFT2D2	SFT2 domain containing 2(SFT2D2)	Homo sapiens				GO:0006810~transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR007305:Vesicle transport protein, Got1/SFT2-like,IPR011691:Vesicle transport protein, SFT2-like,					Acetylation,Complete proteome,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Vesicle transport protein SFT2B,modified residue,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
SFT2D3	SFT2 domain containing 3(SFT2D3)	Homo sapiens				GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR007305:Vesicle transport protein, Got1/SFT2-like,IPR011691:Vesicle transport protein, SFT2-like,					Complete proteome,Membrane,Polymorphism,Protein transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Vesicle transport protein SFT2C,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
SH2D1B	SH2 domain containing 1B(SH2D1B)	Homo sapiens				GO:0002250~adaptive immune response,GO:0002366~leukocyte activation involved in immune response,GO:0002717~positive regulation of natural killer cell mediated immunity,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0050776~regulation of immune response,	GO:0005622~intracellular,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0030674~protein binding, bridging,	IPR000980:SH2 domain,	hsa04650:Natural killer cell mediated cytotoxicity,			SM00252:SH2,	Adaptive immunity,Alternative splicing,Complete proteome,Immunity,Innate immunity,Phosphoprotein,Polymorphism,Reference proteome,SH2 domain,	chain:SH2 domain-containing protein 1B,domain:SH2,sequence variant,splice variant,
SH2D2A	SH2 domain containing 2A(SH2D2A)	Homo sapiens				GO:0001525~angiogenesis,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0009967~positive regulation of signal transduction,GO:0030154~cell differentiation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,	IPR000980:SH2 domain,	hsa04370:VEGF signaling pathway,			SM00252:SH2,	Alternative splicing,Angiogenesis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Phosphoprotein,Polymorphism,Reference proteome,SH2 domain,SH3-binding,	chain:SH2 domain-containing protein 2A,compositionally biased region:Pro-rich,domain:SH2,modified residue,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,
SH2D5	SH2 domain containing 5(SH2D5)	Homo sapiens					GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0045211~postsynaptic membrane,		IPR000980:SH2 domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,				SM00462:PTB,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Membrane,Postsynaptic cell membrane,Proteomics identification,Reference proteome,SH2 domain,Synapse,	chain:SH2 domain-containing protein 5,domain:SH2,modified residue,
SH2D6	SH2 domain containing 6(SH2D6)	Homo sapiens				GO:0006955~immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,		IPR000980:SH2 domain,				SM00252:SH2,	Alternative splicing,Complete proteome,Reference proteome,SH2 domain,	chain:SH2 domain-containing protein 6,compositionally biased region:Pro-rich,domain:SH2,sequence conflict,splice variant,
SH3YL1	SH3 and SYLF domain containing 1(SH3YL1)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:1900027~regulation of ruffle assembly,	GO:0032587~ruffle membrane,	GO:0005515~protein binding,GO:0019902~phosphatase binding,GO:0035091~phosphatidylinositol binding,	IPR001452:Src homology-3 domain,IPR007461:Ysc84 actin-binding domain,				SM00326:SH3,	3D-structure,Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,SH3 domain,	chain:SH3 domain-containing YSC84-like protein 1,domain:SH3,helix,sequence conflict,splice variant,strand,
STAC	SH3 and cysteine rich domain(STAC)	Homo sapiens				GO:0006936~muscle contraction,GO:0007165~signal transduction,GO:0034605~cellular response to heat,GO:0035556~intracellular signal transduction,GO:1901385~regulation of voltage-gated calcium channel activity,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0030315~T-tubule,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001452:Src homology-3 domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR013315:Spectrin alpha chain, SH3 domain,				SM00109:C1,SM00326:SH3,	3D-structure,Complete proteome,Cytoplasm,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,Zinc,Zinc-finger,	chain:SH3 and cysteine-rich domain-containing protein,domain:SH3,sequence variant,strand,turn,zinc finger region:Phorbol-ester/DAG-type,
SGIP1	SH3 domain GRB2 like endophilin interacting protein 1(SGIP1)	Homo sapiens				GO:0002021~response to dietary excess,GO:0006897~endocytosis,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0097320~membrane tubulation,GO:2000253~positive regulation of feeding behavior,GO:2000507~positive regulation of energy homeostasis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0030122~AP-2 adaptor complex,GO:0030136~clathrin-coated vesicle,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008017~microtubule binding,GO:0017124~SH3 domain binding,	IPR018808:Muniscin C-terminal mu homology domain,					3D-structure,Alternative splicing,Coated pit,Complete proteome,Endocytosis,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:SH3-containing GRB2-like protein 3- interacting protein 1,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,
SH3BP4	SH3 domain binding protein 4(SH3BP4)	Homo sapiens				GO:0006897~endocytosis,GO:0008285~negative regulation of cell proliferation,GO:0010508~positive regulation of autophagy,GO:0030308~negative regulation of cell growth,GO:0032007~negative regulation of TOR signaling,GO:0034260~negative regulation of GTPase activity,GO:0043090~amino acid import,GO:0050790~regulation of catalytic activity,GO:0061462~protein localization to lysosome,GO:0071230~cellular response to amino acid stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005905~clathrin-coated pit,GO:0030136~clathrin-coated vesicle,GO:0070062~extracellular exosome,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005515~protein binding,GO:0017016~Ras GTPase binding,GO:0042802~identical protein binding,	IPR000906:ZU5,IPR001452:Src homology-3 domain,IPR011511:Variant SH3,				SM00326:SH3,	Alternative splicing,Coated pit,Complete proteome,Cytoplasmic vesicle,Endocytosis,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:SH3 domain-binding protein 4,domain:SH3,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
SH3BP5	SH3 domain binding protein 5(SH3BP5)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,GO:0061099~negative regulation of protein tyrosine kinase activity,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0004860~protein kinase inhibitor activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,	IPR007940:SH3-binding 5,					3D-structure,Alternative splicing,Coiled coil,Complete proteome,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,SH3-binding,	chain:SH3 domain-binding protein 5,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,modified residue,mutagenesis site,
SH3D21	SH3 domain containing 21(SH3D21)	Homo sapiens					GO:0070062~extracellular exosome,		IPR001452:Src homology-3 domain,IPR011511:Variant SH3,IPR013315:Spectrin alpha chain, SH3 domain,				SM00326:SH3,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,
SH3GLB1	SH3 domain containing GRB2 like endophilin B1(SH3GLB1)	Homo sapiens		h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,		GO:0006654~phosphatidic acid biosynthetic process,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0008654~phospholipid biosynthetic process,GO:0010508~positive regulation of autophagy,GO:0016241~regulation of macroautophagy,GO:0031647~regulation of protein stability,GO:0032461~positive regulation of protein oligomerization,GO:0032465~regulation of cytokinesis,GO:0032801~receptor catabolic process,GO:0034198~cellular response to amino acid starvation,GO:0042149~cellular response to glucose starvation,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0048102~autophagic cell death,GO:0051084~'de novo' posttranslational protein folding,GO:0051259~protein oligomerization,GO:0090148~membrane fission,GO:0098609~cell-cell adhesion,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1902254~negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1902255~positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1903527~positive regulation of membrane tubulation,GO:1903778~protein localization to vacuolar membrane,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2000786~positive regulation of autophagosome assembly,	GO:0000139~Golgi membrane,GO:0000421~autophagosome membrane,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030496~midbody,GO:0031410~cytoplasmic vesicle,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005504~fatty acid binding,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0042171~lysophosphatidic acid acyltransferase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,IPR004148:BAR domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,			SM00326:SH3,SM00721:BAR,	Acetylation,Alternative splicing,Apoptosis,Autophagy,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Golgi apparatus,Lipid-binding,Membrane,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Endophilin-B1,domain:BAR,domain:SH3,mutagenesis site,region of interest:Membrane-binding amphipathic helix,splice variant,
SH3RF3	SH3 domain containing ring finger 3(SH3RF3)	Homo sapiens						GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001452:Src homology-3 domain,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00326:SH3,	Complete proteome,Metal-binding,Phosphoprotein,Reference proteome,Repeat,SH3 domain,Zinc,Zinc-finger,	chain:SH3 domain-containing RING finger protein 3,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gly,domain:SH3 1,domain:SH3 2,domain:SH3 3,domain:SH3 4,modified residue,zinc finger region:RING-type,
SHCBP1L	SHC binding and spindle associated 1 like(SHCBP1L)	Homo sapiens				GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:2001252~positive regulation of chromosome organization,	GO:0005737~cytoplasm,GO:0072687~meiotic spindle,		IPR006626:Parallel beta-helix repeat,IPR006633:Carbohydrate-binding/sugar hydrolysis domain,IPR011050:Pectin lyase fold/virulence factor,IPR012334:Pectin lyase fold,				SM00710:PbH1,SM00722:CASH,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Spermatogenesis,	chain:Uncharacterized protein C1orf14,compositionally biased region:Poly-Ala,modified residue,repeat:PbH1 1,repeat:PbH1 2,repeat:PbH1 3,repeat:PbH1 4,sequence conflict,sequence variant,splice variant,
SHQ1	SHQ1, H/ACA ribonucleoprotein assembly factor(SHQ1)	Homo sapiens				GO:0000493~box H/ACA snoRNP assembly,GO:0022618~ribonucleoprotein complex assembly,GO:0043065~positive regulation of apoptotic process,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,GO:2000233~negative regulation of rRNA processing,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015030~Cajal body,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,	IPR007009:SHQ1 protein,IPR007052:CS-like domain,IPR008978:HSP20-like chaperone,					3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein SHQ1 homolog,compositionally biased region:Ser-rich,domain:CS,sequence conflict,sequence variant,
SKI	SKI proto-oncogene(SKI)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001843~neural tube closure,GO:0002089~lens morphogenesis in camera-type eye,GO:0006351~transcription, DNA-templated,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009948~anterior/posterior axis specification,GO:0010626~negative regulation of Schwann cell proliferation,GO:0014902~myotube differentiation,GO:0021772~olfactory bulb development,GO:0022011~myelination in peripheral nervous system,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030326~embryonic limb morphogenesis,GO:0030509~BMP signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0031064~negative regulation of histone deacetylation,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0043010~camera-type eye development,GO:0043388~positive regulation of DNA binding,GO:0043585~nose morphogenesis,GO:0045668~negative regulation of osteoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048147~negative regulation of fibroblast proliferation,GO:0048593~camera-type eye morphogenesis,GO:0048666~neuron development,GO:0048741~skeletal muscle fiber development,GO:0048870~cell motility,GO:0060021~palate development,GO:0060041~retina development in camera-type eye,GO:0060325~face morphogenesis,GO:0060349~bone morphogenesis,GO:0060395~SMAD protein signal transduction,GO:0070207~protein homotrimerization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016604~nuclear body,GO:0016605~PML body,GO:0017053~transcriptional repressor complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0031625~ubiquitin protein ligase binding,GO:0046332~SMAD binding,GO:0046811~histone deacetylase inhibitor activity,GO:0070491~repressing transcription factor binding,	IPR003380:Transforming protein Ski,IPR009061:DNA binding domain, putative,IPR010919:SAND domain-like,IPR014890:c-SKI SMAD4-binding domain,IPR023216:Transcription regulator SKI/SnoN,		182212~Shprintzen-Goldberg syndrome,		SM01046:SM01046,	3D-structure,Coiled coil,Complete proteome,Craniosynostosis,Disease mutation,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Repeat,	chain:Ski oncogene,helix,modified residue,strand,turn,
SLAMF6	SLAM family member 6(SLAMF6)	Homo sapiens				GO:0001779~natural killer cell differentiation,GO:0001787~natural killer cell proliferation,GO:0032729~positive regulation of interferon-gamma production,GO:0032740~positive regulation of interleukin-17 production,GO:0045087~innate immune response,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0050776~regulation of immune response,GO:0072540~T-helper 17 cell lineage commitment,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:SLAM family member 6,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
SLAMF7	SLAM family member 7(SLAMF7)	Homo sapiens				GO:0002250~adaptive immune response,GO:0007155~cell adhesion,GO:0030101~natural killer cell activation,GO:0042267~natural killer cell mediated cytotoxicity,GO:0050776~regulation of immune response,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,					Adaptive immunity,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:SLAM family member 7,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SRGAP2B	SLIT-ROBO Rho GTPase activating protein 2B(SRGAP2B)	Homo sapiens				GO:0007399~nervous system development,			IPR001060:FCH domain,				SM00055:FCH,	Coiled coil,Complete proteome,Neurogenesis,Reference proteome,
SRGAP3	SLIT-ROBO Rho GTPase activating protein 3(SRGAP3)	Homo sapiens				GO:0007165~signal transduction,GO:0030336~negative regulation of cell migration,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0048365~Rac GTPase binding,	IPR000198:Rho GTPase-activating protein domain,IPR001060:FCH domain,IPR001452:Src homology-3 domain,IPR008936:Rho GTPase activation protein,	hsa04360:Axon guidance,			SM00055:FCH,SM00324:RhoGAP,SM00326:SH3,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:SLIT-ROBO Rho GTPase-activating protein 3,domain:FCH,domain:Rho-GAP,domain:SH3,modified residue,sequence variant,splice variant,
SMG5	SMG5, nonsense mediated mRNA decay factor(SMG5)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006406~mRNA export from nucleus,GO:0032204~regulation of telomere maintenance,GO:0032210~regulation of telomere maintenance via telomerase,GO:0035303~regulation of dephosphorylation,GO:0043487~regulation of RNA stability,GO:0090501~RNA phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004540~ribonuclease activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0042162~telomeric DNA binding,GO:0042826~histone deacetylase binding,GO:0043021~ribonucleoprotein complex binding,GO:0051721~protein phosphatase 2A binding,GO:0070034~telomerase RNA binding,GO:0070182~DNA polymerase binding,	IPR002716:PIN domain,IPR011990:Tetratricopeptide-like helical,IPR018834:DNA/RNA-binding domain, Est1-type,IPR019458:Telomerase activating protein Est1,	hsa03015:mRNA surveillance pathway,			SM00670:PINc,	3D-structure,Acetylation,Coiled coil,Complete proteome,Cytoplasm,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Protein SMG5,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,domain:PINc,helix,mutagenesis site,sequence conflict,sequence variant,strand,
SMG7	SMG7, nonsense mediated mRNA decay factor(SMG7)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006406~mRNA export from nucleus,GO:0007004~telomere maintenance via telomerase,GO:0035303~regulation of dephosphorylation,GO:0043487~regulation of RNA stability,GO:0090501~RNA phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0045111~intermediate filament cytoskeleton,	GO:0004540~ribonuclease activity,GO:0005515~protein binding,GO:0042162~telomeric DNA binding,GO:0043021~ribonucleoprotein complex binding,GO:0051721~protein phosphatase 2A binding,GO:0070034~telomerase RNA binding,	IPR011990:Tetratricopeptide-like helical,IPR018834:DNA/RNA-binding domain, Est1-type,IPR019458:Telomerase activating protein Est1,	hsa03015:mRNA surveillance pathway,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Protein SMG7,compositionally biased region:Gln/Pro-rich,compositionally biased region:Ser-rich,helix,modified residue,mutagenesis site,repeat:TPR 1,repeat:TPR 2,sequence conflict,sequence variant,splice variant,strand,turn,
SNRK	SNF related kinase(SNRK)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0030099~myeloid cell differentiation,GO:0035556~intracellular signal transduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Kinase,Magnesium,Metal-binding,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:SNF-related serine/threonine-protein kinase,domain:Protein kinase,domain:UBA,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
SOS1	SOS Ras/Rac guanine nucleotide exchange factor 1(SOS1)	Homo sapiens	101.Gprot_coupled_Rec_MAP_Kinase,104.Insulin_signaling,108.Regulating_glucose_transport,2.Cytokine_Receptors,54.T-cell_anergy,63.LAT_couples_T-cell_receptor,67.Ikaros_and_signaling_inhibitors,68.Mitogen_signaling_in_growth_control,81.Structure_of_Caps_and_SMACs,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_crebPathway:Transcription factor CREB and its extracellular signals,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_ngfPathway:Nerve growth factor pathway (NGF),h_pdgfPathway:PDGF Signaling Pathway,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,		GO:0000165~MAPK cascade,GO:0001782~B cell homeostasis,GO:0001942~hair follicle development,GO:0003209~cardiac atrium morphogenesis,GO:0003344~pericardium morphogenesis,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007296~vitellogenesis,GO:0007411~axon guidance,GO:0008286~insulin receptor signaling pathway,GO:0033081~regulation of T cell differentiation in thymus,GO:0035023~regulation of Rho protein signal transduction,GO:0035264~multicellular organism growth,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0042129~regulation of T cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0050900~leukocyte migration,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0060021~palate development,GO:0061029~eyelid development in camera-type eye,GO:0061384~heart trabecula morphogenesis,GO:1904693~midbrain morphogenesis,GO:2000973~regulation of pro-B cell differentiation,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0043025~neuronal cell body,	GO:0003677~DNA binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0046982~protein heterodimerization activity,	IPR000219:Dbl homology (DH) domain,IPR000651:Ras-like guanine nucleotide exchange factor, N-terminal,IPR001849:Pleckstrin homology domain,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR007125:Histone core,IPR009072:Histone-fold,IPR011993:Pleckstrin homology-like domain,IPR019804:Ras guanine-nucleotide exchange factor, conserved site,IPR023578:Ras guanine nucleotide exchange factor, domain,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04320:Dorso-ventral axis formation,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa05034:Alcoholism,hsa05160:Hepatitis C,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05231:Choline metabolism in cancer,	135300~Fibromatosis, gingival, 1,610733~Noonan syndrome 4,		SM00147:RasGEF,SM00229:RasGEFN,SM00233:PH,SM00325:RhoGEF,	3D-structure,Alternative splicing,Complete proteome,Disease mutation,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Son of sevenless homolog 1,compositionally biased region:Poly-Pro,domain:DH,domain:N-terminal Ras-GEF,domain:PH,domain:Ras-GEF,helix,modified residue,sequence variant,strand,turn,
SP100	SP100 nuclear antigen(SP100)	Homo sapiens		h_pmlPathway:Regulation of transcriptional activity by PML,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000723~telomere maintenance,GO:0006351~transcription, DNA-templated,GO:0006954~inflammatory response,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0010596~negative regulation of endothelial cell migration,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0032526~response to retinoic acid,GO:0032897~negative regulation of viral transcription,GO:0034097~response to cytokine,GO:0034340~response to type I interferon,GO:0034341~response to interferon-gamma,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045765~regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046826~negative regulation of protein export from nucleus,GO:0048384~retinoic acid receptor signaling pathway,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051271~negative regulation of cellular component movement,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902044~regulation of Fas signaling pathway,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0030870~Mre11 complex,GO:0034399~nuclear periphery,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019900~kinase binding,GO:0019904~protein domain specific binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0070087~chromo shadow domain binding,	IPR000770:SAND domain,IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR004865:Sp100,IPR009071:High mobility group (HMG) box domain,IPR010919:SAND domain-like,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	hsa05168:Herpes simplex infection,hsa05203:Viral carcinogenesis,			SM00249:PHD,SM00258:SAND,SM00297:BROMO,SM00398:HMG,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Host-virus interaction,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Nuclear autoantigen Sp-100,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:HMG box 1,DNA-binding region:HMG box 2,domain:HSR,domain:SAND,helix,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,short sequence motif:PxVxL motif,splice variant,strand,turn,
SP140L	SP140 nuclear body protein like(SP140L)	Homo sapiens					GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,	IPR000770:SAND domain,IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR004865:Sp100,IPR010919:SAND domain-like,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00258:SAND,SM00297:BROMO,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Nuclear body protein SP140-like protein,domain:HSR,domain:SAND,sequence conflict,sequence variant,splice variant,zinc finger region:PHD-type; degenerate,
SP140	SP140 nuclear body protein(SP140)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006952~defense response,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016605~PML body,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000770:SAND domain,IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR004865:Sp100,IPR010919:SAND domain-like,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00258:SAND,SM00297:BROMO,	3D-structure,Alternative splicing,Bromodomain,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Nuclear body protein SP140,compositionally biased region:Poly-Tyr,domain:Bromo,domain:HSR,domain:SAND,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:PHD-type,
SPC25	SPC25, NDC80 kinetochore complex component(SPC25)	Homo sapiens				GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005829~cytosol,GO:0031262~Ndc80 complex,	GO:0005515~protein binding,	IPR013255:Chromosome segregation protein Spc25,					3D-structure,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Kinetochore protein Spc25,helix,modified residue,region of interest:Interaction with the C-terminus of SPBC24,region of interest:Interaction with the N-terminus of SPBC24,region of interest:Interaction with the NDC80-NUF2 subcomplex,turn,
SPEG	SPEG complex locus(SPEG)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007517~muscle organ development,GO:0008285~negative regulation of cell proliferation,GO:0042692~muscle cell differentiation,	GO:0005634~nucleus,	GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000048:IQ motif, EF-hand binding site,IPR000719:Protein kinase, catalytic domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR015726:Serine/threonine protein kinase, striated muscle-specific,IPR017441:Protein kinase, ATP binding site,		615959~Centronuclear myopathy 5,		SM00015:IQ,SM00060:FN3,SM00220:S_TKc,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative promoter usage,Alternative splicing,ATP-binding,Complete proteome,Differentiation,Disease mutation,Disulfide bond,Immunoglobulin domain,Kinase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Striated muscle preferentially expressed protein kinase,compositionally biased region:Arg-rich,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like 1,domain:Ig-like 2,domain:Ig-like 3,domain:Ig-like 4,domain:Ig-like 5,domain:Ig-like 6,domain:Ig-like 7,domain:Ig-like 8,domain:Ig-like 9,domain:Protein kinase 1,domain:Protein kinase 2,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,
SPHKAP	SPHK1 interactor, AKAP domain containing(SPHKAP)	Homo sapiens		h_edg1Pathway:Phospholipids as signalling intermediaries,		GO:0010738~regulation of protein kinase A signaling,	GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0051018~protein kinase A binding,	IPR008382:SPHK1-interactor/A-kinase anchor 110kDa,IPR018292:A-kinase anchor 110kDa, C-terminal,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,	chain:A-kinase anchor protein SPHKAP,region of interest:PKA-RII subunit binding domain,sequence conflict,sequence variant,splice variant,
SPOCD1	SPOC domain containing 1(SPOCD1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0010923~negative regulation of phosphatase activity,			IPR003618:Transcription elongation factor S-II, central domain,IPR012921:Spen paralogue and orthologue SPOC, C-terminal,				SM00510:TFS2M,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:SPOC domain-containing protein 1,domain:SPOC,domain:TFIIS central,sequence conflict,sequence variant,splice variant,
SUPT7L	SPT7-like STAGA complex gamma subunit(SUPT7L)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0043966~histone H3 acetylation,GO:0051457~maintenance of protein location in nucleus,	GO:0005634~nucleus,GO:0030914~STAGA complex,	GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,	IPR006565:Bromodomain transcription factor,				SM00576:BTP,	Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:STAGA complex 65 subunit gamma,modified residue,splice variant,
SCAP	SREBF chaperone(SCAP)	Homo sapiens		h_s1pPathway:SREBP control of lipid synthesis,		GO:0001666~response to hypoxia,GO:0007568~aging,GO:0008203~cholesterol metabolic process,GO:0032868~response to insulin,GO:0032933~SREBP signaling pathway,GO:0042304~regulation of fatty acid biosynthetic process,GO:0045541~negative regulation of cholesterol biosynthetic process,GO:0045716~positive regulation of low-density lipoprotein particle receptor biosynthetic process,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0015485~cholesterol binding,GO:0032403~protein complex binding,GO:0051082~unfolded protein binding,	IPR000731:Sterol-sensing domain,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Cholesterol metabolism,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Lipid metabolism,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Steroid metabolism,Sterol metabolism,Transmembrane,Transmembrane helix,WD repeat,	chain:Sterol regulatory element-binding protein cleavage-activating protein,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Pro,domain:SSD,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:ER export signal,region of interest:Interaction with SREBF2,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
SOX11	SRY-box 11(SOX11)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001822~kidney development,GO:0001841~neural tube formation,GO:0002089~lens morphogenesis in camera-type eye,GO:0003151~outflow tract morphogenesis,GO:0003211~cardiac ventricle formation,GO:0003357~noradrenergic neuron differentiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006412~translation,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014003~oligodendrocyte development,GO:0014009~glial cell proliferation,GO:0014032~neural crest cell development,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0021510~spinal cord development,GO:0021782~glial cell development,GO:0030182~neuron differentiation,GO:0030513~positive regulation of BMP signaling pathway,GO:0035332~positive regulation of hippo signaling,GO:0035914~skeletal muscle cell differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045778~positive regulation of ossification,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046887~positive regulation of hormone secretion,GO:0048485~sympathetic nervous system development,GO:0048557~embryonic digestive tract morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050769~positive regulation of neurogenesis,GO:0060022~hard palate development,GO:0060023~soft palate development,GO:0060174~limb bud formation,GO:0060253~negative regulation of glial cell proliferation,GO:0060412~ventricular septum morphogenesis,GO:0060425~lung morphogenesis,GO:0060548~negative regulation of cell death,GO:0060563~neuroepithelial cell differentiation,GO:0061029~eyelid development in camera-type eye,GO:0061053~somite development,GO:0061303~cornea development in camera-type eye,GO:0061386~closure of optic fissure,GO:0072395~signal transduction involved in cell cycle checkpoint,GO:2000648~positive regulation of stem cell proliferation,GO:2000678~negative regulation of transcription regulatory region DNA binding,GO:2001111~positive regulation of lens epithelial cell proliferation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001158~enhancer sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008135~translation factor activity, RNA binding,	IPR009071:High mobility group (HMG) box domain,		615866~Mental retardation, autosomal dominant, 27,		SM00398:HMG,	Complete proteome,Developmental protein,Differentiation,Disease mutation,DNA-binding,Mental retardation,Neurogenesis,Nucleus,Phosphoprotein,Reference proteome,Signal,Transcription,Transcription regulation,	chain:Transcription factor SOX-11,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,DNA-binding region:HMG box,modified residue,
SOX13	SRY-box 13(SOX13)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0009653~anatomical structure morphogenesis,GO:0045586~regulation of gamma-delta T cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR009071:High mobility group (HMG) box domain,				SM00398:HMG,	Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor Sox-13,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,DNA-binding region:HMG box,modified residue,sequence conflict,sequence variant,
SS18L2	SS18 like 2(SS18L2)	Homo sapiens							IPR007726:SSXT,					Complete proteome,Reference proteome,	chain:SS18-like protein 2,short sequence motif:SH2-binding,
SSU72	SSU72 homolog, RNA polymerase II CTD phosphatase(SSU72)	Homo sapiens				GO:0006369~termination of RNA polymerase II transcription,GO:0006378~mRNA polyadenylation,GO:0070940~dephosphorylation of RNA polymerase II C-terminal domain,	GO:0005737~cytoplasm,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,	GO:0005515~protein binding,GO:0008420~CTD phosphatase activity,	IPR006811:RNA polymerase II subunit A,	hsa03015:mRNA surveillance pathway,				3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,mRNA processing,Nucleus,Protein phosphatase,Reference proteome,	chain:RNA polymerase II subunit A C-terminal domain phosphatase SSU72,mutagenesis site,sequence conflict,splice variant,
SSX2IP	SSX family member 2 interacting protein(SSX2IP)	Homo sapiens				GO:0007155~cell adhesion,GO:0035020~regulation of Rac protein signal transduction,GO:0035735~intraciliary transport involved in cilium morphogenesis,GO:0042384~cilium assembly,GO:0051297~centrosome organization,GO:0060271~cilium morphogenesis,GO:2000145~regulation of cell motility,	GO:0005634~nucleus,GO:0005913~cell-cell adherens junction,GO:0031252~cell leading edge,GO:0034451~centriolar satellite,GO:0036064~ciliary basal body,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0019904~protein domain specific binding,	IPR021622:Afadin/alpha-actinin-binding,	hsa04520:Adherens junction,				Alternative splicing,Cell adhesion,Cell junction,Cell projection,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Afadin- and alpha-actinin-binding protein,modified residue,sequence conflict,sequence variant,splice variant,
ST3GAL3	ST3 beta-galactoside alpha-2,3-sialyltransferase 3(ST3GAL3)	Homo sapiens				GO:0001574~ganglioside biosynthetic process,GO:0006486~protein glycosylation,GO:0009311~oligosaccharide metabolic process,GO:0016266~O-glycan processing,GO:0018146~keratan sulfate biosynthetic process,GO:0018279~protein N-linked glycosylation via asparagine,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,GO:0032580~Golgi cisterna membrane,	GO:0003836~beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,GO:0008118~N-acetyllactosaminide alpha-2,3-sialyltransferase activity,GO:0008373~sialyltransferase activity,	IPR001675:Glycosyl transferase, family 29,IPR012163:Sialyltransferase,	hsa00514:Other types of O-glycan biosynthesis,hsa00533:Glycosaminoglycan biosynthesis - keratan sulfate,hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,	611090~Mental retardation, autosomal recessive 12,615006~Epileptic encephalopathy, early infantile, 15,	PIRSF005557:sialyltransferase,		Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Mental retardation,Proteomics identification,Reference proteome,Secreted,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,Transmembrane helixFT   VAR_SEQ     102    117       FSKPAP,	chain:CMP-N-acetylneuraminate-beta-1,4- galactoside alpha-2,3-sialyltransferase,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ST3GAL5	ST3 beta-galactoside alpha-2,3-sialyltransferase 5(ST3GAL5)	Homo sapiens				GO:0001574~ganglioside biosynthetic process,GO:0005975~carbohydrate metabolic process,GO:0006486~protein glycosylation,GO:0006688~glycosphingolipid biosynthetic process,GO:0009311~oligosaccharide metabolic process,GO:0018279~protein N-linked glycosylation via asparagine,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,	GO:0003836~beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,GO:0004513~neolactotetraosylceramide alpha-2,3-sialyltransferase activity,GO:0008373~sialyltransferase activity,GO:0047291~lactosylceramide alpha-2,3-sialyltransferase activity,	IPR001675:Glycosyl transferase, family 29,IPR012163:Sialyltransferase,	hsa00604:Glycosphingolipid biosynthesis - ganglio series,hsa01100:Metabolic pathways,	609056~Amish infantile epilepsy syndrome,	PIRSF005557:sialyltransferase,		Alternative splicing,Complete proteome,Disulfide bond,Epilepsy,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Mental retardation,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Lactosylceramide alpha-2,3- sialyltransferase,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ST3GAL6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6(ST3GAL6)	Homo sapiens				GO:0001574~ganglioside biosynthetic process,GO:0006464~cellular protein modification process,GO:0006486~protein glycosylation,GO:0006664~glycolipid metabolic process,GO:0009311~oligosaccharide metabolic process,GO:0018146~keratan sulfate biosynthetic process,GO:0018279~protein N-linked glycosylation via asparagine,GO:0071354~cellular response to interleukin-6,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,GO:0070062~extracellular exosome,	GO:0003836~beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,GO:0008373~sialyltransferase activity,GO:0052798~beta-galactoside alpha-2,3-sialyltransferase activity,	IPR001675:Glycosyl transferase, family 29,IPR012163:Sialyltransferase,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,		PIRSF005557:sialyltransferase,		Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Type 2 lactosamine alpha-2,3- sialyltransferase,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ST6GALNAC3	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3(ST6GALNAC3)	Homo sapiens				GO:0001574~ganglioside biosynthetic process,GO:0006486~protein glycosylation,GO:0006677~glycosylceramide metabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0009100~glycoprotein metabolic process,GO:0009311~oligosaccharide metabolic process,GO:0018279~protein N-linked glycosylation via asparagine,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0001665~alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,GO:0008373~sialyltransferase activity,	IPR001675:Glycosyl transferase, family 29,	hsa00604:Glycosphingolipid biosynthesis - ganglio series,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-N-acetylgalactosaminide alpha-2,6- sialyltransferase 3,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ST6GALNAC5	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5(ST6GALNAC5)	Homo sapiens				GO:0001574~ganglioside biosynthetic process,GO:0006486~protein glycosylation,GO:0006688~glycosphingolipid biosynthetic process,GO:0009311~oligosaccharide metabolic process,GO:0009312~oligosaccharide biosynthetic process,GO:0018279~protein N-linked glycosylation via asparagine,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0001665~alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,GO:0008373~sialyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,	IPR001675:Glycosyl transferase, family 29,	hsa00604:Glycosphingolipid biosynthesis - ganglio series,hsa01100:Metabolic pathways,				Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Proteomics identification,Reference proteome,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-N-acetylgalactosaminide alpha-2,6- sialyltransferase 5,compositionally biased region:Poly-Gln,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ST6GAL2	ST6 beta-galactoside alpha-2,6-sialyltransferase 2(ST6GAL2)	Homo sapiens				GO:0006486~protein glycosylation,GO:0007275~multicellular organism development,GO:0009311~oligosaccharide metabolic process,GO:0018279~protein N-linked glycosylation via asparagine,GO:0040007~growth,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0003835~beta-galactoside alpha-2,6-sialyltransferase activity,GO:0008373~sialyltransferase activity,GO:0008718~D-amino-acid dehydrogenase activity,	IPR001675:Glycosyl transferase, family 29,IPR011330:Glycoside hydrolase/deacetylase, beta/alpha-barrel,	hsa00510:N-Glycan biosynthesis,hsa00514:Other types of O-glycan biosynthesis,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Oxidoreductase,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-galactoside alpha-2,6- sialyltransferase 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
STAMBP	STAM binding protein(STAMBP)	Homo sapiens				GO:0000281~mitotic cytokinesis,GO:0007259~JAK-STAT cascade,GO:0008284~positive regulation of cell proliferation,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0016579~protein deubiquitination,GO:0043524~negative regulation of neuron apoptotic process,GO:0046580~negative regulation of Ras protein signal transduction,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0032154~cleavage furrow,GO:0070062~extracellular exosome,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0019904~protein domain specific binding,GO:0046872~metal ion binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR007330:MIT,IPR015063:Domain of unknown function DUF1873,	hsa04144:Endocytosis,	614261~Microcephaly-capillary malformation syndrome,		SM00232:JAB_MPN,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Endosome,Hydrolase,Membrane,Metal-binding,Metalloprotease,Nucleus,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,	chain:STAM-binding protein,compositionally biased region:Glu-rich,domain:MPN,metal ion-binding site:Zinc 1; catalytic,metal ion-binding site:Zinc 2,modified residue,mutagenesis site,region of interest:Interaction with CHMP3,region of interest:Interaction with STAM1,short sequence motif:JAMM motif,site:Indirect Zinc-binding,
STRADB	STE20-related kinase adaptor beta(STRADB)	Homo sapiens				GO:0000902~cell morphogenesis,GO:0006468~protein phosphorylation,GO:0006611~protein export from nucleus,GO:0007050~cell cycle arrest,GO:0032147~activation of protein kinase activity,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,	hsa04152:AMPK signaling pathway,			SM00220:S_TKc,	Alternative splicing,ATP-binding,Cell cycle,Complete proteome,Cytoplasm,Membrane,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	binding site:ATP,chain:STE20-related kinase adapter protein beta,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
STEAP3	STEAP3 metalloreductase(STEAP3)	Homo sapiens				GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0009306~protein secretion,GO:0015677~copper ion import,GO:0033572~transferrin transport,GO:0042981~regulation of apoptotic process,GO:0055072~iron ion homeostasis,GO:0055114~oxidation-reduction process,GO:0097461~ferric iron import into cell,	GO:0005737~cytoplasm,GO:0005771~multivesicular body,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0008823~cupric reductase activity,GO:0016723~oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,GO:0046872~metal ion binding,GO:0052851~ferric-chelate reductase (NADPH) activity,	IPR013130:Ferric reductase transmembrane component-like domain,IPR016040:NAD(P)-binding domain,	hsa04115:p53 signaling pathway,	615234~Anemia, hypochromic microcytic, with iron overload 2,			3D-structure,Alternative splicing,Apoptosis,Cell cycle,Complete proteome,Copper,Endosome,FAD,Flavoprotein,Glycoprotein,Heme,Ion transport,Iron,Iron transport,Membrane,Metal-binding,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Metalloreductase STEAP3,domain:Ferric oxidoreductase,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Iron (heme axial ligand),modified residue,sequence conflict,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
STON1-GTF2A1L	STON1-GTF2A1L readthrough(STON1-GTF2A1L)	Homo sapiens				GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006897~endocytosis,GO:0030100~regulation of endocytosis,	GO:0005672~transcription factor TFIIA complex,GO:0005737~cytoplasm,GO:0016020~membrane,		IPR004855:Transcription factor IIA, alpha/beta subunit,IPR009083:Transcription factor IIA, helical,IPR009088:Transcription factor IIA, beta-barrel,IPR012320:Stonin homology,IPR013028:Transcription factor IIA, alpha subunit, N-terminal,				SM01371:SM01371,	Alternative splicing,Complete proteome,Cytoplasm,Endocytosis,Membrane,Polymorphism,Reference proteome,	chain:Stonin-1,chain:TFIIA-alpha and beta-like factor,domain:MHD,domain:SHD,sequence conflict,sequence variant,
STT3B	STT3B, catalytic subunit of the oligosaccharyltransferase complex(STT3B)	Homo sapiens				GO:0006516~glycoprotein catabolic process,GO:0006986~response to unfolded protein,GO:0018279~protein N-linked glycosylation via asparagine,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0043686~co-translational protein modification,GO:0043687~post-translational protein modification,	GO:0005783~endoplasmic reticulum,GO:0008250~oligosaccharyltransferase complex,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004579~dolichyl-diphosphooligosaccharide-protein glycotransferase activity,	IPR003674:Oligosaccharyl transferase, STT3 subunit,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,hsa04141:Protein processing in endoplasmic reticulum,	615597~Congenital disorder of glycosylation, type Ix,			Acetylation,Complete proteome,Congenital disorder of glycosylation,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Phosphoprotein,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Dolichyl-diphosphooligosaccharide-- protein glycosyltransferase subunit STT3B,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,transmembrane region,
SENP7	SUMO1/sentrin specific peptidase 7(SENP7)	Homo sapiens				GO:0006508~proteolysis,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0005515~protein binding,GO:0008234~cysteine-type peptidase activity,	IPR003653:Peptidase C48, SUMO/Sentrin/Ubl1,					3D-structure,Alternative splicing,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Sentrin-specific protease 7,helix,modified residue,mutagenesis site,region of interest:Protease,sequence conflict,sequence variant,splice variant,strand,turn,
SUCO	SUN domain containing ossification factor(SUCO)	Homo sapiens				GO:0001503~ossification,GO:0007275~multicellular organism development,GO:0032967~positive regulation of collagen biosynthetic process,GO:0045669~positive regulation of osteoblast differentiation,GO:0046850~regulation of bone remodeling,	GO:0005791~rough endoplasmic reticulum,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030867~rough endoplasmic reticulum membrane,		IPR008979:Galactose-binding domain-like,IPR012919:Sad1/UNC-like, C-terminal,					Alternative splicing,Coiled coil,Complete proteome,Developmental protein,Endoplasmic reticulum,Glycoprotein,Membrane,Osteogenesis,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein C1orf9,domain:SUN,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,transmembrane region,
SZRD1	SUZ RNA binding domain containing 1(SZRD1)	Homo sapiens							IPR024642:SUZ-C domain,IPR024771:SUZ domain,					Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:UPF0485 protein C1orf144,modified residue,splice variant,
SMARCC1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1(SMARCC1)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,	Chromatin structure and dynamics / Transcription,General function prediction only,	GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0008286~insulin receptor signaling pathway,GO:0009887~organ morphogenesis,GO:0016569~covalent chromatin modification,GO:0030850~prostate gland development,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043044~ATP-dependent chromatin remodeling,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0001741~XY body,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0047485~protein N-terminus binding,	IPR000953:Chromo domain/shadow,IPR001005:SANT/Myb domain,IPR001357:BRCT domain,IPR007526:SWIRM domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017884:SANT domain,				SM00298:CHROMO,SM00717:SANT,	3D-structure,Acetylation,Chromatin regulator,Coiled coil,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:SWI/SNF complex subunit SMARCC1,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,domain:SANT,domain:SWIRM,helix,modified residue,sequence conflict,sequence variant,strand,
SMARCAL1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1(SMARCAL1)	Homo sapiens				GO:0000733~DNA strand renaturation,GO:0006259~DNA metabolic process,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006974~cellular response to DNA damage stimulus,GO:0031297~replication fork processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0035861~site of double-strand break,	GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0036310~annealing helicase activity,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR010003:HARP domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		242900~Schimke immunoosseous dysplasia,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,ATP-binding,Coiled coil,Complete proteome,Disease mutation,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:SWI/SNF-related matrix-associated actin- dependent regulator of chromatin subfamily A-like protein 1,domain:HARP 1,domain:HARP 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DESH box,
SWT1	SWT1, RNA endoribonuclease homolog(SWT1)	Homo sapiens				GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,		IPR002716:PIN domain,				SM00670:PINc,	Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf26,compositionally biased region:Poly-Ser,domain:PINc,sequence conflict,sequence variant,
SFMBT1	Scm-like with four mbt domains 1(SFMBT1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0016569~covalent chromatin modification,GO:0030154~cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048635~negative regulation of muscle organ development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042393~histone binding,	IPR001660:Sterile alpha motif domain,IPR004092:Mbt repeat,IPR013761:Sterile alpha motif/pointed domain,IPR021987:Protein of unknown function DUF3588,				SM00454:SAM,SM00561:MBT,	Alternative splicing,Chromatin regulator,Complete proteome,Differentiation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Spermatogenesis,Transcription,Transcription regulation,	chain:Scm-like with four MBT domains protein 1,domain:SAM,modified residue,region of interest:Antigenic epitope,repeat:MBT 1,repeat:MBT 2,repeat:MBT 3,repeat:MBT 4,sequence conflict,splice variant,
SAP130	Sin3A associated protein 130(SAP130)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0043966~histone H3 acetylation,	GO:0005654~nucleoplasm,GO:0030914~STAGA complex,GO:0070822~Sin3-type complex,	GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,	IPR024137:Histone deacetylase complex subunit SAP130,					Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Histone deacetylase complex subunit SAP130,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,modified residue,region of interest:Interactions with SIN3A and HDAC1,splice variant,
SSB	Sjogren syndrome antigen B(SSB)	Homo sapiens		h_RNApol3Pathway:RNA polymerase III transcription,		GO:0006396~RNA processing,GO:0006400~tRNA modification,GO:0008334~histone mRNA metabolic process,GO:0075522~IRES-dependent viral translational initiation,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002344:Lupus La protein,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014886:RNA-binding motif,	hsa05322:Systemic lupus erythematosus,			SM00360:RRM,SM00715:LA,	3D-structure,Acetylation,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Systemic lupus erythematosus,	chain:La 4.1 protein,chain:Lupus La protein,domain:HTH La-type RNA-binding,domain:RRM,helix,modified residue,sequence variant,strand,turn,
SNIP1	Smad nuclear interacting protein 1(SNIP1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,		614501~Psychomotor retardation, epilepsy, and craniofacial dysmorphism,		SM00240:FHA,	Coiled coil,Complete proteome,Disease mutation,Epilepsy,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,RNA-mediated gene silencing,Ubl conjugation,	chain:Smad nuclear-interacting protein 1,compositionally biased region:Arg-rich,compositionally biased region:Poly-Glu,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:FHA,modified residue,mutagenesis site,sequence conflict,
SP3	Sp3 transcription factor(SP3)	Homo sapiens		h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001503~ossification,GO:0001779~natural killer cell differentiation,GO:0001829~trophectodermal cell differentiation,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016925~protein sumoylation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030219~megakaryocyte differentiation,GO:0030224~monocyte differentiation,GO:0030324~lung development,GO:0030851~granulocyte differentiation,GO:0043353~enucleate erythrocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048706~embryonic skeletal system development,GO:0060136~embryonic process involved in female pregnancy,GO:0060216~definitive hemopoiesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016605~PML body,GO:0017053~transcriptional repressor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Acetylation,Activator,Alternative initiation,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcription factor Sp3,compositionally biased region:Ala-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,modified residue,mutagenesis site,region of interest:Repressor domain,region of interest:Transactivation domain (Gln-rich),sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
SPRTN	SprT-like N-terminal domain(SPRTN)	Homo sapiens				GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0019985~translesion synthesis,GO:0031398~positive regulation of protein ubiquitination,GO:0070987~error-free translesion synthesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,GO:0070530~K63-linked polyubiquitin binding,	IPR006640:Domain of unknown function SprT-like,IPR006642:Zinc finger, Rad18-type putative,		616200~Ruijs-Aalfs syndrome,		SM00731:SprT,SM00734:ZnF_Rad18,	3D-structure,Acetylation,Alternative splicing,Chromosome,Complete proteome,Disease mutation,DNA damage,DNA repair,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger RAD18 domain-containing protein C1orf124,compositionally biased region:Poly-Ser,modified residue,sequence variant,splice variant,zinc finger region:Rad18-type,
SHE	Src homology 2 domain containing E(SHE)	Homo sapiens				GO:0007165~signal transduction,GO:0009967~positive regulation of signal transduction,		GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR000980:SH2 domain,				SM00252:SH2,	Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,SH2 domain,Signal,	chain:SH2 domain-containing adapter protein E,compositionally biased region:Ser-rich,domain:SH2,
TRAT1	T cell receptor associated transmembrane adaptor 1(TRAT1)	Homo sapiens				GO:0001920~negative regulation of receptor recycling,GO:0002250~adaptive immune response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050852~T cell receptor signaling pathway,GO:0050862~positive regulation of T cell receptor signaling pathway,GO:0051051~negative regulation of transport,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0042101~T cell receptor complex,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR020399:T-cell receptor-associated transmembrane adapter 1,					Adaptive immunity,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Immunity,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:T-cell receptor-associated transmembrane adapter 1,disulfide bond,modified residue,mutagenesis site,region of interest:Interaction with PIK3R1,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TBX15	T-box 15(TBX15)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0048701~embryonic cranial skeleton morphogenesis,	GO:0005634~nucleus,GO:0070722~Tle3-Aes complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR001699:Transcription factor, T-box,IPR008967:p53-like transcription factor, DNA-binding,IPR018186:Transcription factor, T-box, conserved site,		260660~Cousin syndrome,		SM00425:TBOX,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:T-box transcription factor TBX15,DNA-binding region:T-box,sequence variant,
TBX19	T-box 19(TBX19)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009653~anatomical structure morphogenesis,GO:0021983~pituitary gland development,GO:0042127~regulation of cell proliferation,GO:0045165~cell fate commitment,GO:0045595~regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0001158~enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR001699:Transcription factor, T-box,IPR002070:Transcription factor, Brachyury,IPR008967:p53-like transcription factor, DNA-binding,IPR018186:Transcription factor, T-box, conserved site,		201400~Adrenocorticotropic hormone deficiency,		SM00425:TBOX,	Activator,Complete proteome,Disease mutation,DNA-binding,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:T-box transcription factor TBX19,DNA-binding region:T-box,sequence variant,
TBR1	T-box, brain 1(TBR1)	Homo sapiens				GO:0001661~conditioned taste aversion,GO:0006351~transcription, DNA-templated,GO:0007420~brain development,GO:0010092~specification of organ identity,GO:0021764~amygdala development,GO:0021902~commitment of neuronal cell to specific neuron type in forebrain,GO:0030902~hindbrain development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1902667~regulation of axon guidance,	GO:0005634~nucleus,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR001699:Transcription factor, T-box,IPR008967:p53-like transcription factor, DNA-binding,IPR018186:Transcription factor, T-box, conserved site,				SM00425:TBOX,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:T-box brain protein 1,compositionally biased region:Poly-Ala,DNA-binding region:T-box,sequence variant,
TCAIM	T-cell activation inhibitor, mitochondrial(TCAIM)	Homo sapiens					GO:0005739~mitochondrion,							Alternative splicing,Coiled coil,Complete proteome,Mitochondrion,Polymorphism,Reference proteome,	chain:Uncharacterized protein C3orf23,sequence conflict,sequence variant,splice variant,
TAL1	TAL bHLH transcription factor 1, erythroid differentiation factor(TAL1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001525~angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007626~locomotory behavior,GO:0021527~spinal cord association neuron differentiation,GO:0030097~hemopoiesis,GO:0030218~erythrocyte differentiation,GO:0030219~megakaryocyte differentiation,GO:0030220~platelet formation,GO:0030221~basophil differentiation,GO:0031334~positive regulation of protein complex assembly,GO:0035162~embryonic hemopoiesis,GO:0035855~megakaryocyte development,GO:0042127~regulation of cell proliferation,GO:0043249~erythrocyte maturation,GO:0045165~cell fate commitment,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045799~positive regulation of chromatin assembly or disassembly,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051781~positive regulation of cell division,GO:0060018~astrocyte fate commitment,GO:0060216~definitive hemopoiesis,GO:0060217~hemangioblast cell differentiation,GO:0060218~hematopoietic stem cell differentiation,GO:0060375~regulation of mast cell differentiation,GO:2000036~regulation of stem cell population maintenance,	GO:0000118~histone deacetylase complex,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0033193~Lsd1/2 complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0070888~E-box binding,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,		613065~Leukemia, T-cell acute lymphocytic, somatic,		SM00353:HLH,	3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,DNA-binding,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:T-cell acute lymphocytic leukemia protein 1,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,modified residue,splice variant,
TAMM41	TAM41 mitochondrial translocator assembly and maintenance homolog(TAMM41)	Homo sapiens				GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0032049~cardiolipin biosynthetic process,	GO:0031314~extrinsic component of mitochondrial inner membrane,	GO:0004605~phosphatidate cytidylyltransferase activity,	IPR015222:Mitochondrial matrix Mmp37,			PIRSF028840:mitochondrial import protein MMP37,		Alternative splicing,Complete proteome,Lipid biosynthesis,Lipid metabolism,Magnesium,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotidyltransferase,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:MMP37-like protein, mitochondrial,sequence variant,transit peptide:Mitochondrion,
TARBP1	TAR (HIV-1) RNA binding protein 1(TARBP1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030488~tRNA methylation,	GO:0005634~nucleus,	GO:0003723~RNA binding,GO:0016423~tRNA (guanine) methyltransferase activity,	IPR001537:tRNA/rRNA methyltransferase, SpoU,IPR016024:Armadillo-type fold,IPR025806:Probable methyltransferase TARBP1,					3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Methyltransferase,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,S-adenosyl-L-methionine,Transferase,	binding site:S-adenosyl-L-methionine; via amide nitrogen,binding site:S-adenosyl-L-methionine; via amide nitrogen and carbonyl oxygen,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,chain:Probable methyltransferase TARBP1,compositionally biased region:Ala-rich,helix,modified residue,sequence variant,strand,turn,
TARDBP	TAR DNA binding protein(TARDBP)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0030264~nuclear fragmentation involved in apoptotic nuclear change,GO:0032024~positive regulation of insulin secretion,GO:0034976~response to endoplasmic reticulum stress,GO:0043922~negative regulation by host of viral transcription,GO:0051726~regulation of cell cycle,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0071765~nuclear inner membrane organization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005726~perichromatin fibrils,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0035061~interchromatin granule,	GO:0000166~nucleotide binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,		612069~Amyotrophic lateral sclerosis 10, with or without FTD,612069~Frontotemporal lobar degeneration, TARDBP-related,		SM00360:RRM,	3D-structure,Alternative splicing,Amyotrophic lateral sclerosis,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Neurodegeneration,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:TAR DNA-binding protein 43,compositionally biased region:Gly-rich,domain:RRM 1,domain:RRM 2,helix,modified residue,mutagenesis site,sequence variant,strand,turn,
TMF1	TATA element modulatory factor 1(TMF1)	Homo sapiens				GO:0001675~acrosome assembly,GO:0001819~positive regulation of cytokine production,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007289~spermatid nucleus differentiation,GO:0010629~negative regulation of gene expression,GO:0030317~sperm motility,GO:0032275~luteinizing hormone secretion,GO:0033327~Leydig cell differentiation,GO:0042742~defense response to bacterium,GO:0043066~negative regulation of apoptotic process,GO:0061136~regulation of proteasomal protein catabolic process,GO:0071407~cellular response to organic cyclic compound,GO:2000845~positive regulation of testosterone secretion,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,	IPR022091:TATA element modulatory factor 1 TATA binding,IPR022092:TATA element modulatory factor 1 DNA binding,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Golgi apparatus,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:TATA element modulatory factor,modified residue,mutagenesis site,region of interest:Interaction with Elongin BC complex,sequence variant,splice variant,
TAF12	TATA-box binding protein associated factor 12(TAF12)	Homo sapiens				GO:0006352~DNA-templated transcription, initiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0043966~histone H3 acetylation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051123~RNA polymerase II transcriptional preinitiation complex assembly,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000124~SAGA complex,GO:0000125~PCAF complex,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0030914~STAGA complex,GO:0033276~transcription factor TFTC complex,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0017025~TBP-class protein binding,GO:0046982~protein heterodimerization activity,	IPR003228:Transcription initiation factor TFIID,IPR009072:Histone-fold,	hsa03022:Basal transcription factors,				3D-structure,Alternative initiation,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Transcription initiation factor TFIID subunit 12,helix,modified residue,splice variant,
TAF13	TATA-box binding protein associated factor 13(TAF13)	Homo sapiens				GO:0006352~DNA-templated transcription, initiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0046982~protein heterodimerization activity,	IPR003195:Transcription initiation factor IID, 18kDa subunit,IPR009072:Histone-fold,	hsa03022:Basal transcription factors,hsa05168:Herpes simplex infection,				3D-structure,Complete proteome,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Transcription initiation factor TFIID subunit 13,helix,turn,
TAF5L	TATA-box binding protein associated factor 5 like(TAF5L)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0043966~histone H3 acetylation,	GO:0030914~STAGA complex,GO:0033276~transcription factor TFTC complex,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR007582:TFIID subunit, WD40-associated region,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa03022:Basal transcription factors,hsa05168:Herpes simplex infection,			SM00320:WD40,	Alternative splicing,Complete proteome,Direct protein sequencing,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,WD repeat,	chain:TAF5-like RNA polymerase II p300/CBP- associated factor-associated factor 65 kDa subunit 5L,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,splice variant,
TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A(TAF1A)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006360~transcription from RNA polymerase I promoter,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0000120~RNA polymerase I transcription factor complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0015630~microtubule cytoskeleton,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR016629:RNA polymerase I, subunit A (TATA-binding protein-associated factor),			PIRSF015161:RNA polymerase I, subunit A (TATA-binding protein-associated factor),		Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:TATA box-binding protein-associated factor RNA polymerase I subunit A,sequence variant,splice variant,
TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B(TAF1B)	Homo sapiens				GO:0001189~RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005668~RNA polymerase transcription factor SL1 complex,GO:0070062~extracellular exosome,GO:0070860~RNA polymerase I core factor complex,	GO:0001164~RNA polymerase I CORE element sequence-specific DNA binding,GO:0001187~transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0017025~TBP-class protein binding,GO:0046872~metal ion binding,	IPR021752:Transcription initiation factor Rrn7,					Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:TATA box-binding protein-associated factor RNA polymerase I subunit B,modified residue,sequence conflict,sequence variant,splice variant,
TBC1D23	TBC1 domain family member 23(TBC1D23)	Homo sapiens				GO:0032680~regulation of tumor necrosis factor production,GO:0032755~positive regulation of interleukin-6 production,GO:0050727~regulation of inflammatory response,		GO:0005515~protein binding,	IPR000195:Rab-GTPase-TBC domain,IPR001763:Rhodanese-like domain,				SM00164:TBC,	Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:TBC1 domain family member 23,domain:Rab-GAP TBC,domain:Rhodanese,modified residue,sequence conflict,splice variant,
TBC1D5	TBC1 domain family member 5(TBC1D5)	Homo sapiens				GO:0002092~positive regulation of receptor internalization,GO:0006886~intracellular protein transport,GO:0006914~autophagy,GO:0010508~positive regulation of autophagy,GO:0031338~regulation of vesicle fusion,GO:0042147~retrograde transport, endosome to Golgi,GO:0042594~response to starvation,GO:0090630~activation of GTPase activity,GO:1902017~regulation of cilium assembly,	GO:0005776~autophagosome,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0030122~AP-2 adaptor complex,GO:0030904~retromer complex,GO:0031410~cytoplasmic vesicle,GO:1990316~ATG1/ULK1 kinase complex,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0035612~AP-2 adaptor complex binding,	IPR000195:Rab-GTPase-TBC domain,				SM00164:TBC,	Alternative splicing,Autophagy,Complete proteome,Cytoplasmic vesicle,Endosome,GTPase activation,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:TBC1 domain family member 5,domain:Rab-GAP TBC,modified residue,sequence variant,
TBC1D8	TBC1 domain family member 8(TBC1D8)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0008015~blood circulation,GO:0008284~positive regulation of cell proliferation,GO:0031338~regulation of vesicle fusion,GO:0090630~activation of GTPase activity,GO:1902017~regulation of cilium assembly,	GO:0005622~intracellular,GO:0012505~endomembrane system,GO:0016020~membrane,	GO:0005096~GTPase activator activity,GO:0017137~Rab GTPase binding,	IPR000195:Rab-GTPase-TBC domain,IPR004182:GRAM,IPR011992:EF-hand-like domain,				SM00164:TBC,SM00568:GRAM,	Alternative splicing,Coiled coil,Complete proteome,GTPase activation,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:TBC1 domain family member 8,domain:GRAM 1,domain:GRAM 2,domain:Rab-GAP TBC,sequence conflict,sequence variant,splice variant,
THADA	THADA, armadillo repeat containing(THADA)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR019442:Domain of unknown function DUF2428, death-receptor-like,					Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Thyroid adenoma-associated protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Lys,modified residue,sequence conflict,sequence variant,splice variant,
THAP3	THAP domain containing 3(THAP3)	Homo sapiens						GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006612:Zinc finger, C2CH-type,IPR026520:THAP domain-containing protein 3,				SM00692:DM3,SM00980:SM00980,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:THAP domain-containing protein 3,sequence conflict,splice variant,zinc finger region:THAP-type,
THAP4	THAP domain containing 4(THAP4)	Homo sapiens						GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR006612:Zinc finger, C2CH-type,IPR011038:Calycin-like,IPR014878:Domain of unknown function DUF1794,				SM00692:DM3,SM00980:SM00980,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Heme,Iron,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:THAP domain-containing protein 4,helix,metal ion-binding site:Iron (heme axial ligand),modified residue,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:THAP-type,
THOC7	THO complex 7(THOC7)	Homo sapiens				GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0031124~mRNA 3'-end processing,GO:0046784~viral mRNA export from host cell nucleus,	GO:0000346~transcription export complex,GO:0000347~THO complex,GO:0000445~THO complex part of transcription export complex,GO:0000446~nucleoplasmic THO complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR008501:THO complex subunit 7/Mft1,	hsa03013:RNA transport,				Acetylation,Coiled coil,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transport,	chain:THO complex subunit 7 homolog,modified residue,region of interest:Interaction with NIF3L1,region of interest:Interaction with THOC5,sequence conflict,
THUMPD2	THUMP domain containing 2(THUMPD2)	Homo sapiens				GO:0030488~tRNA methylation,		GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0016423~tRNA (guanine) methyltransferase activity,	IPR000241:Putative RNA methylase domain,IPR004114:THUMP,				SM00981:SM00981,	Alternative splicing,Complete proteome,Methyltransferase,Proteomics identification,Reference proteome,RNA-binding,Transferase,	chain:THUMP domain-containing protein 2,domain:THUMP,
TIA1	TIA1 cytotoxic granule associated RNA binding protein(TIA1)	Homo sapiens		h_WNVpathway:West Nile Virus,		GO:0006915~apoptotic process,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0017148~negative regulation of translation,GO:0042036~negative regulation of cytokine biosynthetic process,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:1903608~protein localization to cytoplasmic stress granule,GO:1904037~positive regulation of epithelial cell apoptotic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0097165~nuclear stress granule,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0017091~AU-rich element binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,		604454~Welander distal myopathy,		SM00360:RRM,SM00361:RRM_1,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Disease mutation,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Nucleolysin TIA-1 isoform p15,chain:Nucleolysin TIA-1 isoform p40,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,sequence conflict,splice variant,strand,
TIMP4	TIMP metallopeptidase inhibitor 4(TIMP4)	Homo sapiens		h_reckPathway:Inhibition of Matrix Metalloproteinases,		GO:0007219~Notch signaling pathway,GO:0007417~central nervous system development,GO:0010033~response to organic substance,GO:0010951~negative regulation of endopeptidase activity,GO:0032496~response to lipopolysaccharide,GO:0034097~response to cytokine,GO:0042493~response to drug,GO:0042698~ovulation cycle,GO:0043086~negative regulation of catalytic activity,GO:0043434~response to peptide hormone,GO:0051045~negative regulation of membrane protein ectodomain proteolysis,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0030017~sarcomere,	GO:0002020~protease binding,GO:0008191~metalloendopeptidase inhibitor activity,GO:0046872~metal ion binding,	IPR001134:Netrin domain,IPR001820:Proteinase inhibitor I35, tissue inhibitor of metalloproteinase,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR027465:Proteinase inhibitor I35, tissue inhibitor of metalloproteinase, C-terminal domain,				SM00206:NTR,	Complete proteome,Disulfide bond,Metal-binding,Metalloenzyme inhibitor,Metalloprotease inhibitor,Protease inhibitor,Reference proteome,Secreted,Signal,Zinc,	chain:Metalloproteinase inhibitor 4,disulfide bond,domain:NTR,metal ion-binding site:Zinc; via amide nitrogen and carbonyl oxygen; shared with metalloproteinase partner,region of interest:Involved in metalloproteinase-binding,signal peptide,
TM2D1	TM2 domain containing 1(TM2D1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0097190~apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0001540~beta-amyloid binding,GO:0004930~G-protein coupled receptor activity,	IPR007829:TM2,					Apoptosis,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:TM2 domain-containing protein 1,glycosylation site:N-linked (GlcNAc...),signal peptide,transmembrane region,
TMEM110-MUSTN1	TMEM110-MUSTN1 readthrough(TMEM110-MUSTN1)	Homo sapiens				GO:0002062~chondrocyte differentiation,GO:0035988~chondrocyte proliferation,GO:0042246~tissue regeneration,	GO:0005634~nucleus,GO:0016021~integral component of membrane,		IPR022127:Protein of unknown function DUF3661, vaculolar transmembrane,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
TMEM51-AS1	TMEM51 antisense RNA 1(TMEM51-AS1)	Homo sapiens													chain:Putative uncharacterized protein C1orf126,splice variant,
TMEM56-RWDD3	TMEM56-RWDD3 readthrough(TMEM56-RWDD3)	Homo sapiens					GO:0016021~integral component of membrane,		IPR006634:TRAM/LAG1/CLN8 homology domain,				SM00724:TLC,	Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
TNFAIP6	TNF alpha induced protein 6(TNFAIP6)	Homo sapiens				GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0030335~positive regulation of cell migration,GO:0030728~ovulation,GO:0050728~negative regulation of inflammatory response,	GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0005540~hyaluronic acid binding,	IPR000538:Link,IPR000859:CUB domain,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00042:CUB,SM00445:LINK,	3D-structure,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Signal,	chain:Tumor necrosis factor-inducible gene 6 protein,disulfide bond,domain:CUB,domain:Link,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,signal peptide,strand,
TRAF5	TNF receptor associated factor 5(TRAF5)	Homo sapiens	99.NF-kB_activation,	h_tall1Pathway:TACI and BCMA stimulation of B cell immune responses.,		GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0016567~protein ubiquitination,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0035631~CD40 receptor complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031625~ubiquitin protein ligase binding,GO:0031996~thioesterase binding,GO:0042802~identical protein binding,	IPR001293:Zinc finger, TRAF-type,IPR001841:Zinc finger, RING-type,IPR002083:MATH,IPR008974:TRAF-like,IPR012227:TNF receptor-associated factor TRAF,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013323:SIAH-type domain,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR027130:TNF receptor-associated factor 5,	hsa04064:NF-kappa B signaling pathway,hsa04668:TNF signaling pathway,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05222:Small cell lung cancer,		PIRSF015614:TNF receptor-associated factor (TRAF),	SM00061:MATH,SM00184:RING,	Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Polymorphism,Receptor,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:TNF receptor-associated factor 5,domain:MATH,sequence variant,zinc finger region:RING-type,zinc finger region:TRAF-type 1,zinc finger region:TRAF-type 2,
TNFRSF14	TNF receptor superfamily member 14(TNFRSF14)	Homo sapiens				GO:0002741~positive regulation of cytokine secretion involved in immune response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007275~multicellular organism development,GO:0031295~T cell costimulation,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0046642~negative regulation of alpha-beta T cell proliferation,GO:0046718~viral entry into host cell,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0097190~apoptotic signaling pathway,GO:2000406~positive regulation of T cell migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0001618~virus receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR001368:TNFR/NGFR cysteine-rich region,IPR022332:Tumour necrosis factor receptor 14,	hsa04060:Cytokine-cytokine receptor interaction,hsa05168:Herpes simplex infection,			SM00208:TNFR,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 14,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TNFRSF18	TNF receptor superfamily member 18(TNFRSF18)	Homo sapiens				GO:0002687~positive regulation of leukocyte migration,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0043066~negative regulation of apoptotic process,GO:0045785~positive regulation of cell adhesion,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0005031~tumor necrosis factor-activated receptor activity,	IPR001368:TNFR/NGFR cysteine-rich region,IPR022318:Tumour necrosis factor receptor 18,	hsa04060:Cytokine-cytokine receptor interaction,			SM00208:TNFR,	Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 18,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TNFRSF1B	TNF receptor superfamily member 1B(TNFRSF1B)	Homo sapiens	72.IAP_interaction_with_cell_death_pathways,	h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_keratinocytePathway:Keratinocyte Differentiation,h_nfkbPathway:NF-kB Signaling Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_relaPathway:Acetylation and Deacetylation of RelA in The Nucleus,h_soddPathway:SODD/TNFR1 Signaling Pathway,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tnfr2Pathway:TNFR2 Signaling Pathway,		GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007275~multicellular organism development,GO:0007568~aging,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0050728~negative regulation of inflammatory response,GO:0050779~RNA destabilization,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0071222~cellular response to lipopolysaccharide,GO:0071363~cellular response to growth factor stimulus,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043025~neuronal cell body,GO:0043196~varicosity,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,	IPR001368:TNFR/NGFR cysteine-rich region,IPR020411:Tumour necrosis factor receptor 1B,	hsa04060:Cytokine-cytokine receptor interaction,hsa04668:TNF signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),			SM00208:TNFR,	3D-structure,Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Pharmaceutical,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 1b, membrane form,chain:Tumor necrosis factor-binding protein 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,repeat:TNFR-Cys 4,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TNFRSF8	TNF receptor superfamily member 8(TNFRSF8)	Homo sapiens				GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008285~negative regulation of cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043065~positive regulation of apoptotic process,GO:0045556~positive regulation of TRAIL biosynthetic process,GO:0071260~cellular response to mechanical stimulus,GO:0097190~apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005887~integral component of plasma membrane,GO:0070062~extracellular exosome,	GO:0004888~transmembrane signaling receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,	IPR001368:TNFR/NGFR cysteine-rich region,IPR020416:Tumour necrosis factor receptor 8,	hsa04060:Cytokine-cytokine receptor interaction,			SM00208:TNFR,	3D-structure,Alternative initiation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 8,compositionally biased region:Pro/Ser/Thr-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,repeat:TNFR-Cys 4,repeat:TNFR-Cys 5,repeat:TNFR-Cys 6,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TNNI3K	TNNI3 interacting kinase(TNNI3K)	Homo sapiens			General function prediction only,	GO:0002027~regulation of heart rate,GO:0006468~protein phosphorylation,GO:0055117~regulation of cardiac muscle contraction,GO:0086069~bundle of His cell to Purkinje myocyte communication,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0031013~troponin I binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002110:Ankyrin repeat,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020683:Ankyrin repeat-containing domain,		616117~Cardiac conduction disease with or without dilated cardiomyopathy,		SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,ATP-binding,Cardiomyopathy,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Fucose-1-phosphate guanylyltransferase,chain:Serine/threonine-protein kinase TNNI3K,compositionally biased region:Poly-Ser,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,repeat:ANK 1,repeat:ANK 10,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,
TPRKB	TP53RK binding protein(TPRKB)	Homo sapiens				GO:0008033~tRNA processing,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR013926:CGI121/TPRKB,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Reference proteome,tRNA processing,	chain:TP53RK-binding protein,helix,modified residue,sequence conflict,splice variant,strand,
TP73-AS1	TP73 antisense RNA 1(TP73-AS1)	Homo sapiens					GO:0005576~extracellular region,							Complete proteome,Polymorphism,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein KIAA0495,sequence variant,signal peptide,
TANK	TRAF family member associated NFKB activator(TANK)	Homo sapiens		h_stressPathway:TNF/Stress Related Signaling,h_tnfr2Pathway:TNFR2 Signaling Pathway,		GO:0006508~proteolysis,GO:0006974~cellular response to DNA damage stimulus,GO:0007165~signal transduction,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071479~cellular response to ionizing radiation,GO:1903003~positive regulation of protein deubiquitination,GO:2000158~positive regulation of ubiquitin-specific protease activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043234~protein complex,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0035800~deubiquitinase activator activity,GO:0046872~metal ion binding,	IPR024581:Tbk1/Ikki binding domain,	hsa04622:RIG-I-like receptor signaling pathway,				3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA damage,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:TRAF family member-associated NF-kappa-B activator,modified residue,mutagenesis site,region of interest:TRAF family member interaction,sequence conflict,sequence variant,splice variant,strand,zinc finger region:C2H2-type,
TRAIP	TRAF interacting protein(TRAIP)	Homo sapiens				GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0016567~protein ubiquitination,GO:0032688~negative regulation of interferon-beta production,	GO:0005730~nucleolus,GO:0048471~perinuclear region of cytoplasm,	GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR009053:Prefoldin,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	3D-structure,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Dwarfism,Ligase,Mental retardation,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:TRAF-interacting protein,modified residue,region of interest:Interaction with CYLD,sequence conflict,zinc finger region:RING-type,
TRAF3IP1	TRAF3 interacting protein 1(TRAF3IP1)	Homo sapiens				GO:0001738~morphogenesis of a polarized epithelium,GO:0001822~kidney development,GO:0001933~negative regulation of protein phosphorylation,GO:0021532~neural tube patterning,GO:0031076~embryonic camera-type eye development,GO:0031333~negative regulation of protein complex assembly,GO:0032480~negative regulation of type I interferon production,GO:0032688~negative regulation of interferon-beta production,GO:0035050~embryonic heart tube development,GO:0036342~post-anal tail morphogenesis,GO:0042073~intraciliary transport,GO:0042384~cilium assembly,GO:0042733~embryonic digit morphogenesis,GO:0050687~negative regulation of defense response to virus,GO:0070507~regulation of microtubule cytoskeleton organization,GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005930~axoneme,GO:0030992~intraciliary transport particle B,GO:0035869~ciliary transition zone,GO:0036064~ciliary basal body,GO:0072372~primary cilium,GO:0097542~ciliary tip,GO:0097546~ciliary base,	GO:0005515~protein binding,GO:0008017~microtubule binding,	IPR018799:TRAF3-interacting protein 1,		616629~Senior-Loken syndrome 9,			3D-structure,Alternative splicing,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Leber congenital amaurosis,Nephronophthisis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Senior-Loken syndrome,	chain:TRAF3-interacting protein 1,compositionally biased region:Arg-rich,helix,modified residue,region of interest:Abolishes microtubules-binding when missing,region of interest:DISC1-interaction domain,sequence variant,splice variant,turn,
TRAF3IP3	TRAF3 interacting protein 3(TRAF3IP3)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:TRAF3-interacting JNK-activating modulator,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TFG	TRK-fused gene(TFG)	Homo sapiens				GO:0007165~signal transduction,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000270:Phox/Bem1p,	hsa05200:Pathways in cancer,hsa05216:Thyroid cancer,	604484~Hereditary motor and sensory neuropathy, Okinawa type,615658~Spastic paraplegia 57, autosomal recessive,		SM00666:PB1,	Acetylation,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Hereditary spastic paraplegia,Methylation,Neurodegeneration,Neuropathy,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Protein TFG,modified residue,sequence conflict,sequence variant,site:Breakpoint for translocation to form TRK- T3,
TROVE2	TROVE domain family member 2(TROVE2)	Homo sapiens				GO:0002520~immune system development,GO:0006383~transcription from RNA polymerase III promoter,GO:0007224~smoothened signaling pathway,GO:0009411~response to UV,GO:0060271~cilium morphogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0030620~U2 snRNA binding,GO:0046872~metal ion binding,	IPR002035:von Willebrand factor, type A,IPR008858:TROVE,	hsa05322:Systemic lupus erythematosus,				Acetylation,Alternative splicing,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Direct protein sequencing,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,	chain:60 kDa SS-A/Ro ribonucleoprotein,domain:TROVE,modified residue,sequence conflict,splice variant,
TATDN2	TatD DNase domain containing 2(TATDN2)	Homo sapiens				GO:0006308~DNA catabolic process,GO:0036498~IRE1-mediated unfolded protein response,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004536~deoxyribonuclease activity,GO:0016888~endodeoxyribonuclease activity, producing 5'-phosphomonoesters,GO:0046872~metal ion binding,	IPR001130:TatD family,IPR018228:Deoxyribonuclease, TatD-related, conserved site,					Complete proteome,Hydrolase,Metal-binding,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Putative deoxyribonuclease TATDN2,modified residue,sequence variant,
TATDN3	TatD DNase domain containing 3(TATDN3)	Homo sapiens				GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005634~nucleus,	GO:0004518~nuclease activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0046872~metal ion binding,	IPR001130:TatD family,			PIRSF005902:Mg-dependent DNase, TatD type,		3D-structure,Alternative splicing,Complete proteome,Hydrolase,Metal-binding,Nuclease,Nucleus,Proteomics identification,Reference proteome,	chain:Putative deoxyribonuclease TATDN3,splice variant,
TCTEX1D1	Tctex1 domain containing 1(TCTEX1D1)	Homo sapiens						GO:0005515~protein binding,	IPR005334:Tctex-1,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Tctex1 domain-containing protein 1,sequence variant,
TRABD2A	TraB domain containing 2A(TRABD2A)	Homo sapiens				GO:0006508~proteolysis,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032461~positive regulation of protein oligomerization,GO:0060322~head development,GO:1904808~positive regulation of protein oxidation,	GO:0005887~integral component of plasma membrane,GO:0031301~integral component of organelle membrane,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0017147~Wnt-protein binding,GO:0046872~metal ion binding,	IPR002816:Pheromone shutdown, TraB,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:UPF0632 protein B,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TRABD2B	TraB domain containing 2B(TRABD2B)	Homo sapiens				GO:0006508~proteolysis,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032461~positive regulation of protein oligomerization,GO:1904808~positive regulation of protein oxidation,	GO:0005887~integral component of plasma membrane,GO:0031301~integral component of organelle membrane,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0046872~metal ion binding,	IPR002816:Pheromone shutdown, TraB,					Cell membrane,Complete proteome,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Protease,Reference proteome,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:UPF0632 protein A,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
UHMK1	U2AF homology motif kinase 1(UHMK1)	Homo sapiens		h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,		GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0007050~cell cycle arrest,GO:0018105~peptidyl-serine phosphorylation,GO:0031175~neuron projection development,GO:0045948~positive regulation of translational initiation,GO:0046777~protein autophosphorylation,GO:0046825~regulation of protein export from nucleus,	GO:0005634~nucleus,GO:0030424~axon,GO:0032839~dendrite cytoplasm,GO:0035145~exon-exon junction complex,GO:0035770~ribonucleoprotein granule,GO:0071598~neuronal ribonucleoprotein granule,	GO:0003729~mRNA binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0043021~ribonucleoprotein complex binding,	IPR000504:RNA recognition motif domain,IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00220:S_TKc,SM00360:RRM,	Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Nucleus,Polymorphism,Reference proteome,RNA-binding,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Kist,domain:Protein kinase,domain:RRM,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
UBE2F-SCLY	UBE2F-SCLY readthrough (NMD candidate)(UBE2F-SCLY)	Homo sapiens							IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,					Complete proteome,Proteomics identification,Reference proteome,
UBXN11	UBX domain protein 11(UBXN11)	Homo sapiens				GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0005515~protein binding,GO:0043130~ubiquitin binding,	IPR001012:UBX,IPR012989:SEP domain,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:UBX domain-containing protein 11,compositionally biased region:Pro-rich,domain:SEP,domain:UBX,region of interest:3 X 8 AA tandem repeats of P-G-P-G-P-G-P- S,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,splice variant,
UBXN2A	UBX domain protein 2A(UBXN2A)	Homo sapiens				GO:0007030~Golgi organization,GO:0010468~regulation of gene expression,GO:0031396~regulation of protein ubiquitination,GO:0031468~nuclear envelope reassembly,GO:0042176~regulation of protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0061025~membrane fusion,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005801~cis-Golgi network,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0033130~acetylcholine receptor binding,GO:0043130~ubiquitin binding,	IPR001012:UBX,IPR012989:SEP domain,				SM00166:UBX,SM00553:SEP,	Alternative splicing,Complete proteome,Reference proteome,	chain:UBX domain-containing protein 2A,domain:SEP,domain:UBX,
UBXN4	UBX domain protein 4(UBXN4)	Homo sapiens				GO:0006986~response to unfolded protein,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0005515~protein binding,	IPR001012:UBX,IPR012336:Thioredoxin-like fold,				SM00166:UBX,	3D-structure,Complete proteome,Endoplasmic reticulum,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Unfolded protein response,	chain:UBX domain-containing protein 4,domain:UBX,modified residue,sequence variant,topological domain:Cytoplasmic,transmembrane region,
UGT1A10	UDP glucuronosyltransferase family 1 member A10(UGT1A10)	Homo sapiens				GO:0008152~metabolic process,GO:0009813~flavonoid biosynthetic process,GO:0045922~negative regulation of fatty acid metabolic process,GO:0051552~flavone metabolic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,GO:1904224~negative regulation of glucuronosyltransferase activity,GO:2001030~negative regulation of cellular glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0001972~retinoic acid binding,GO:0005080~protein kinase C binding,GO:0015020~glucuronosyltransferase activity,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
UGT1A3	UDP glucuronosyltransferase family 1 member A3(UGT1A3)	Homo sapiens				GO:0008152~metabolic process,GO:0009813~flavonoid biosynthetic process,GO:0042573~retinoic acid metabolic process,GO:0045922~negative regulation of fatty acid metabolic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,GO:1904224~negative regulation of glucuronosyltransferase activity,GO:2001030~negative regulation of cellular glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0001972~retinoic acid binding,GO:0015020~glucuronosyltransferase activity,GO:0016740~transferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
UGT1A4	UDP glucuronosyltransferase family 1 member A4(UGT1A4)	Homo sapiens				GO:0006789~bilirubin conjugation,GO:0008152~metabolic process,GO:0009813~flavonoid biosynthetic process,GO:0042167~heme catabolic process,GO:0045922~negative regulation of fatty acid metabolic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,GO:1904224~negative regulation of glucuronosyltransferase activity,GO:2001030~negative regulation of cellular glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0001972~retinoic acid binding,GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
UGT1A5	UDP glucuronosyltransferase family 1 member A5(UGT1A5)	Homo sapiens				GO:0008152~metabolic process,GO:0009813~flavonoid biosynthetic process,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,	GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0015020~glucuronosyltransferase activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
UGT1A6	UDP glucuronosyltransferase family 1 member A6(UGT1A6)	Homo sapiens				GO:0006805~xenobiotic metabolic process,GO:0008152~metabolic process,GO:0009813~flavonoid biosynthetic process,GO:0045922~negative regulation of fatty acid metabolic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,GO:1904224~negative regulation of glucuronosyltransferase activity,GO:2001030~negative regulation of cellular glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001972~retinoic acid binding,GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
UGT1A7	UDP glucuronosyltransferase family 1 member A7(UGT1A7)	Homo sapiens				GO:0006631~fatty acid metabolic process,GO:0007588~excretion,GO:0008152~metabolic process,GO:0009804~coumarin metabolic process,GO:0009813~flavonoid biosynthetic process,GO:0017144~drug metabolic process,GO:0042573~retinoic acid metabolic process,GO:0043086~negative regulation of catalytic activity,GO:0045922~negative regulation of fatty acid metabolic process,GO:0051552~flavone metabolic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,GO:1904224~negative regulation of glucuronosyltransferase activity,GO:2001030~negative regulation of cellular glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0001972~retinoic acid binding,GO:0004857~enzyme inhibitor activity,GO:0005080~protein kinase C binding,GO:0008144~drug binding,GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
UGT1A8	UDP glucuronosyltransferase family 1 member A8(UGT1A8)	Homo sapiens				GO:0006631~fatty acid metabolic process,GO:0008152~metabolic process,GO:0008202~steroid metabolic process,GO:0009804~coumarin metabolic process,GO:0017144~drug metabolic process,GO:0042573~retinoic acid metabolic process,GO:0043086~negative regulation of catalytic activity,GO:0045922~negative regulation of fatty acid metabolic process,GO:0045939~negative regulation of steroid metabolic process,GO:0051552~flavone metabolic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,GO:1904224~negative regulation of glucuronosyltransferase activity,GO:2001030~negative regulation of cellular glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0001972~retinoic acid binding,GO:0004857~enzyme inhibitor activity,GO:0005496~steroid binding,GO:0005504~fatty acid binding,GO:0008144~drug binding,GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
UGT1A9	UDP glucuronosyltransferase family 1 member A9(UGT1A9)	Homo sapiens				GO:0006805~xenobiotic metabolic process,GO:0008152~metabolic process,GO:0042573~retinoic acid metabolic process,GO:0045922~negative regulation of fatty acid metabolic process,GO:0051552~flavone metabolic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,GO:1904224~negative regulation of glucuronosyltransferase activity,GO:2001030~negative regulation of cellular glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001972~retinoic acid binding,GO:0004857~enzyme inhibitor activity,GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7(B3GNT7)	Homo sapiens				GO:0016266~O-glycan processing,GO:0018146~keratan sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0008532~N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00533:Glycosaminoglycan biosynthesis - keratan sulfate,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 7,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
UAP1	UDP-N-acetylglucosamine pyrophosphorylase 1(UAP1)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0006047~UDP-N-acetylglucosamine metabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0003977~UDP-N-acetylglucosamine diphosphorylase activity,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,	IPR002618:UTP--glucose-1-phosphate uridylyltransferase,	hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleotidyltransferase,Polymorphism,Reference proteome,Transferase,	binding site:Substrate,chain:UDP-N-acetylhexosamine pyrophosphorylase,helix,modified residue,sequence conflict,sequence variant,short sequence motif:Substrate binding,splice variant,strand,turn,
UGGT1	UDP-glucose glycoprotein glucosyltransferase 1(UGGT1)	Homo sapiens		h_eradPathway:ERï¿½associated degradation (ERAD) Pathway,		GO:0006486~protein glycosylation,GO:0018279~protein N-linked glycosylation via asparagine,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0051084~'de novo' posttranslational protein folding,GO:0071712~ER-associated misfolded protein catabolic process,GO:0097359~UDP-glucosylation,GO:1904380~endoplasmic reticulum mannose trimming,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0044322~endoplasmic reticulum quality control compartment,GO:0070062~extracellular exosome,	GO:0003980~UDP-glucose:glycoprotein glucosyltransferase activity,GO:0005515~protein binding,GO:0051082~unfolded protein binding,	IPR009448:UDP-glucose:Glycoprotein Glucosyltransferase,	hsa04141:Protein processing in endoplasmic reticulum,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transferase,	chain:UDP-glucose:glycoprotein glucosyltransferase 1,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Glucosyltransferase,sequence conflict,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
UGP2	UDP-glucose pyrophosphorylase 2(UGP2)	Homo sapiens				GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0006011~UDP-glucose metabolic process,GO:0006065~UDP-glucuronate biosynthetic process,GO:0008152~metabolic process,GO:0019255~glucose 1-phosphate metabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003983~UTP:glucose-1-phosphate uridylyltransferase activity,GO:0005515~protein binding,GO:0005536~glucose binding,GO:0032557~pyrimidine ribonucleotide binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0070569~uridylyltransferase activity,	IPR002618:UTP--glucose-1-phosphate uridylyltransferase,IPR016267:UTP--glucose-1-phosphate uridylyltransferase, subgroup,	hsa00040:Pentose and glucuronate interconversions,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,		PIRSF000806:UTP--glucose-1-phosphate uridylyltransferase,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Magnesium,Metal-binding,Nucleotidyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:UTP--glucose-1-phosphate uridylyltransferase,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
UXS1	UDP-glucuronate decarboxylase 1(UXS1)	Homo sapiens			Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism,	GO:0033320~UDP-D-xylose biosynthetic process,GO:0051262~protein tetramerization,	GO:0005739~mitochondrion,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,GO:0070062~extracellular exosome,	GO:0042803~protein homodimerization activity,GO:0048040~UDP-glucuronate decarboxylase activity,GO:0050662~coenzyme binding,GO:0070403~NAD+ binding,	IPR001509:NAD-dependent epimerase/dehydratase,IPR016040:NAD(P)-binding domain,IPR021761:UDP-glucuronate decarboxylase N-terminal,	hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Complete proteome,Decarboxylase,Glycoprotein,Golgi apparatus,Lyase,Membrane,NAD,Phosphoprotein,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	binding site:NAD,binding site:Substrate,chain:UDP-glucuronic acid decarboxylase 1,glycosylation site:N-linked (GlcNAc...),helix,nucleotide phosphate-binding region:NAD,nucleotide phosphate-binding region:Substrate,splice variant,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
URB2	URB2 ribosome biogenesis 2 homolog (S. cerevisiae)(URB2)	Homo sapiens				GO:0042254~ribosome biogenesis,	GO:0005730~nucleolus,GO:0016235~aggresome,		IPR018849:Nucleolar 27S pre-rRNA processing, Urb2/Npa2, C-terminal,					Complete proteome,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Unhealthy ribosome biogenesis protein 2 homolog,sequence variant,
UBIAD1	UbiA prenyltransferase domain containing 1(UBIAD1)	Homo sapiens				GO:0006744~ubiquinone biosynthetic process,GO:0009234~menaquinone biosynthetic process,GO:0042371~vitamin K biosynthetic process,GO:0042373~vitamin K metabolic process,GO:0098869~cellular oxidant detoxification,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,GO:0031966~mitochondrial membrane,	GO:0004659~prenyltransferase activity,GO:0005515~protein binding,GO:0016209~antioxidant activity,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,	IPR000537:UbiA prenyltransferase family,IPR026046:UbiA prenyltransferase domain containing protein 1,		121800~Corneal dystrophy, Schnyder type,	PIRSF005355:ubia prenyltransferase domain containing protein 1,		Acetylation,Alternative splicing,Complete proteome,Corneal dystrophy,Cytoplasm,Disease mutation,Endoplasmic reticulum,Golgi apparatus,Membrane,Menaquinone biosynthesis,Mitochondrion,Nucleus,Prenyltransferase,Reference proteome,Transferase,Transmembrane,Transmembrane helix,Ubiquinone biosynthesis,	chain:UbiA prenyltransferase domain-containing protein 1,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
VTCN1	V-set domain containing T cell activation inhibitor 1(VTCN1)	Homo sapiens				GO:0001562~response to protozoan,GO:0002250~adaptive immune response,GO:0042102~positive regulation of T cell proliferation,GO:0050868~negative regulation of T cell activation,GO:0072602~interleukin-4 secretion,GO:0072643~interferon-gamma secretion,GO:1900042~positive regulation of interleukin-2 secretion,	GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0005102~receptor binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Lipoprotein,Membrane,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:V-set domain-containing T-cell activation inhibitor 1,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
VANGL1	VANGL planar cell polarity protein 1(VANGL1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,	GO:0016021~integral component of membrane,GO:0016328~lateral plasma membrane,	GO:0005515~protein binding,	IPR009539:Strabismus,	hsa04310:Wnt signaling pathway,	182940~Neural tube defects, susceptibility to,600145~Caudal regression syndrome,	PIRSF007991:Vang-like protein,		Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Vang-like protein 1,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
VPS54	VPS54, GARP complex subunit(VPS54)	Homo sapiens				GO:0006896~Golgi to vacuole transport,GO:0007041~lysosomal transport,GO:0015031~protein transport,GO:0040007~growth,GO:0042147~retrograde transport, endosome to Golgi,GO:0048873~homeostasis of number of cells within a tissue,GO:0050881~musculoskeletal movement,GO:0060052~neurofilament cytoskeleton organization,	GO:0000938~GARP complex,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0032588~trans-Golgi network membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0019905~syntaxin binding,	IPR012501:Vps54-like,IPR019515:Vacuolar protein sorting-associated protein 54,					Alternative splicing,Coiled coil,Complete proteome,Golgi apparatus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Transport,	chain:Vacuolar protein sorting-associated protein 54,modified residue,sequence conflict,sequence variant,splice variant,
WASH2P	WAS protein family homolog 2 pseudogene(WASH2P)	Homo sapiens				GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0042147~retrograde transport, endosome to Golgi,	GO:0005769~early endosome,GO:0005770~late endosome,GO:0005776~autophagosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0071203~WASH complex,	GO:0043014~alpha-tubulin binding,	IPR003124:WH2 domain,IPR021854:WASH complex, WASD domain,					Actin-binding,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endosome,Isopeptide bond,Membrane,Protein transport,Reference proteome,Transport,Ubl conjugation,
WASF2	WAS protein family member 2(WASF2)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,		GO:0001525~angiogenesis,GO:0001667~ameboidal-type cell migration,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0010592~positive regulation of lamellipodium assembly,GO:0016032~viral process,GO:0016601~Rac protein signal transduction,GO:0030032~lamellipodium assembly,GO:0030036~actin cytoskeleton organization,GO:0030048~actin filament-based movement,GO:0035855~megakaryocyte development,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0051497~negative regulation of stress fiber assembly,GO:0072673~lamellipodium morphogenesis,GO:0098609~cell-cell adhesion,	GO:0001726~ruffle,GO:0005622~intracellular,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0031209~SCAR complex,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003124:WH2 domain,	hsa04520:Adherens junction,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05100:Bacterial invasion of epithelial cells,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05231:Choline metabolism in cancer,			SM00246:WH2,	3D-structure,Actin-binding,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Host-virus interaction,Phosphoprotein,Reference proteome,	chain:Wiskott-Aldrich syndrome protein family member 2,compositionally biased region:Poly-Pro,domain:WH2,helix,modified residue,
WIPF1	WAS/WASL interacting protein family member 1(WIPF1)	Homo sapiens				GO:0000147~actin cortical patch assembly,GO:0006461~protein complex assembly,GO:0006897~endocytosis,GO:0008154~actin polymerization or depolymerization,GO:0008360~regulation of cell shape,GO:0030048~actin filament-based movement,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0051127~positive regulation of actin nucleation,GO:0051666~actin cortical patch localization,GO:0051707~response to other organism,	GO:0001726~ruffle,GO:0005829~cytosol,GO:0005884~actin filament,GO:0015629~actin cytoskeleton,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030479~actin cortical patch,GO:0031410~cytoplasmic vesicle,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005522~profilin binding,GO:0017124~SH3 domain binding,GO:0051015~actin filament binding,	IPR003124:WH2 domain,	hsa04144:Endocytosis,	614493~Wiskott-Aldrich syndrome 2,		SM00246:WH2,	3D-structure,Actin-binding,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:WAS/WASL-interacting protein family member 1,compositionally biased region:Gly-rich,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:WH2,helix,modified residue,region of interest:Binds actin,repeat:XRSGPXPPXP motif 1,repeat:XRSGPXPPXP motif 2,repeat:XRSGPXPPXP motif 3,sequence conflict,sequence variant,splice variant,
WDTC1	WD and tetratricopeptide repeats 1(WDTC1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006006~glucose metabolic process,GO:0008361~regulation of cell size,GO:0016567~protein ubiquitination,GO:0032869~cellular response to insulin stimulus,GO:0035264~multicellular organism growth,GO:0043086~negative regulation of catalytic activity,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0055082~cellular chemical homeostasis,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0042393~histone binding,GO:0042826~histone deacetylase binding,	IPR001680:WD40 repeat,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,SM00320:WD40,	3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,Ubl conjugation pathway,WD repeat,	chain:WD and tetratricopeptide repeats protein 1,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,splice variant,
WDFY1	WD repeat and FYVE domain containing 1(WDFY1)	Homo sapiens				GO:0034141~positive regulation of toll-like receptor 3 signaling pathway,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,	GO:0005634~nucleus,GO:0005769~early endosome,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0005545~1-phosphatidylinositol binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR001680:WD40 repeat,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017455:Zinc finger, FYVE-related,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00064:FYVE,SM00320:WD40,	Complete proteome,Endosome,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,WD repeat,Zinc,Zinc-finger,	chain:WD repeat and FYVE domain-containing protein 1,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,zinc finger region:FYVE-type,
WDPCP	WD repeat containing planar cell polarity effector(WDPCP)	Homo sapiens				GO:0001736~establishment of planar polarity,GO:0001822~kidney development,GO:0002093~auditory receptor cell morphogenesis,GO:0007224~smoothened signaling pathway,GO:0010762~regulation of fibroblast migration,GO:0016476~regulation of embryonic cell shape,GO:0032185~septin cytoskeleton organization,GO:0032880~regulation of protein localization,GO:0042384~cilium assembly,GO:0042733~embryonic digit morphogenesis,GO:0043010~camera-type eye development,GO:0045184~establishment of protein localization,GO:0051893~regulation of focal adhesion assembly,GO:0055123~digestive system development,GO:0060021~palate development,GO:0060271~cilium morphogenesis,GO:0060541~respiratory system development,GO:0072358~cardiovascular system development,GO:0090521~glomerular visceral epithelial cell migration,GO:1900027~regulation of ruffle assembly,GO:2000114~regulation of establishment of cell polarity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005930~axoneme,GO:0005938~cell cortex,GO:0016324~apical plasma membrane,GO:0097541~axonemal basal plate,		IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR024511:Protein of unknown function DUF3312,		217085~Congenital heart defects, hamartomas of tongue, and polysyndactyly,615992~Bardet-Biedl syndrome 15,			Alternative splicing,Bardet-Biedl syndrome,Cell membrane,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Mental retardation,Obesity,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein C2orf86,repeat:WD 1,repeat:WD 2,sequence variant,splice variant,
WDR12	WD repeat domain 12(WDR12)	Homo sapiens				GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0007219~Notch signaling pathway,GO:0008283~cell proliferation,GO:0042273~ribosomal large subunit biogenesis,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0070545~PeBoW complex,	GO:0005515~protein binding,GO:0043021~ribonucleoprotein complex binding,	IPR001680:WD40 repeat,IPR012972:NLE,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00320:WD40,	Acetylation,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Ribosome biogenesis,rRNA processing,Ubl conjugation,WD repeat,	chain:Ribosome biogenesis protein WDR12,modified residue,region of interest:Sufficient for nucleolar localization,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,
WDR26	WD repeat domain 26(WDR26)	Homo sapiens					GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR006594:LisH dimerisation motif,IPR006595:CTLH, C-terminal LisH motif,IPR013979:Translation initiation factor, beta propellor-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR020472:G-protein beta WD-40 repeat,				SM00320:WD40,SM00668:CTLH,	Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 26,domain:CTLH,domain:LisH,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,splice variant,
WDR3	WD repeat domain 3(WDR3)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031965~nuclear membrane,GO:0032040~small-subunit processome,GO:0034388~Pwp2p-containing subcomplex of 90S preribosome,	GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR007148:Small-subunit processome, Utp12,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	hsa03008:Ribosome biogenesis in eukaryotes,			SM00320:WD40,	Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 3,modified residue,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 13,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence variant,
WDR33	WD repeat domain 33(WDR33)	Homo sapiens				GO:0006301~postreplication repair,GO:0006379~mRNA cleavage,GO:0006397~mRNA processing,GO:0007283~spermatogenesis,	GO:0005581~collagen trimer,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	hsa03015:mRNA surveillance pathway,			SM00320:WD40,	Acetylation,Alternative splicing,Collagen,Complete proteome,Isopeptide bond,Methylation,mRNA processing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,WD repeat,	chain:WD repeat-containing protein 33,domain:Collagen-like,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,
WDR35	WD repeat domain 35(WDR35)	Homo sapiens				GO:0035721~intraciliary retrograde transport,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,GO:0061512~protein localization to cilium,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005929~cilium,GO:0005930~axoneme,GO:0030991~intraciliary transport particle A,GO:0036064~ciliary basal body,GO:0072372~primary cilium,GO:0097542~ciliary tip,	GO:0035091~phosphatidylinositol binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017233:WD repeat protein 35,IPR017986:WD40-repeat-containing domain,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,		613610~Cranioectodermal dysplasia 2,614091~Short-rib thoracic dysplasia 7 with or without polydactyly,	PIRSF037536:WD repeat protein 35,	SM00320:WD40,	Alternative splicing,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Ectodermal dysplasia,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 35,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,splice variant,
WDR43	WD repeat domain 43(WDR43)	Homo sapiens				GO:0000003~reproduction,GO:0000132~establishment of mitotic spindle orientation,GO:0006364~rRNA processing,GO:0007097~nuclear migration,GO:0031023~microtubule organizing center organization,GO:0047496~vesicle transport along microtubule,GO:2000574~regulation of microtubule motor activity,	GO:0000776~kinetochore,GO:0001650~fibrillar center,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005813~centrosome,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005938~cell cortex,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0044822~poly(A) RNA binding,GO:0045502~dynein binding,	IPR001680:WD40 repeat,IPR007148:Small-subunit processome, Utp12,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	hsa03008:Ribosome biogenesis in eukaryotes,			SM00320:WD40,	Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,WD repeat,	chain:WD repeat-containing protein 43,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,
WDR47	WD repeat domain 47(WDR47)	Homo sapiens				GO:0007275~multicellular organism development,	GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR006594:LisH dimerisation motif,IPR006595:CTLH, C-terminal LisH motif,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,				SM00320:WD40,SM00667:LisH,SM00668:CTLH,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Microtubule,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 47,compositionally biased region:Gln-rich,domain:CTLH,domain:LisH,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,splice variant,
WDR48	WD repeat domain 48(WDR48)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0007283~spermatogenesis,GO:0007338~single fertilization,GO:0016032~viral process,GO:0016579~protein deubiquitination,GO:0035264~multicellular organism growth,GO:0043588~skin development,GO:0048568~embryonic organ development,GO:0048705~skeletal system morphogenesis,GO:0048872~homeostasis of number of cells,GO:0050679~positive regulation of epithelial cell proliferation,GO:0072520~seminiferous tubule development,GO:1902525~regulation of protein monoubiquitination,	GO:0005634~nucleus,GO:0005764~lysosome,GO:0005770~late endosome,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR021772:Protein of unknown function DUF3337,	hsa03460:Fanconi anemia pathway,			SM00320:WD40,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Endosome,Host-virus interaction,Lysosome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:WD repeat-containing protein 48,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,sequence conflict,splice variant,
WDR6	WD repeat domain 6(WDR6)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0010507~negative regulation of autophagy,	GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR011043:Galactose oxidase/kelch, beta-propeller,IPR011044:Quinoprotein amine dehydrogenase, beta chain-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	Acetylation,Cell cycle,Complete proteome,Cytoplasm,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 6,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,
WDR63	WD repeat domain 63(WDR63)	Homo sapiens			General function prediction only,				IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 63,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,splice variant,
WDR64	WD repeat domain 64(WDR64)	Homo sapiens							IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 64,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,sequence variant,splice variant,
WDR75	WD repeat domain 75(WDR75)	Homo sapiens			General function prediction only,	GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006364~rRNA processing,GO:0016573~histone acetylation,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000124~SAGA complex,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003712~transcription cofactor activity,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	hsa03008:Ribosome biogenesis in eukaryotes,			SM00320:WD40,	Acetylation,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,WD repeat,	chain:WD repeat-containing protein 75,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,
WDR78	WD repeat domain 78(WDR78)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,			IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 78,compositionally biased region:Glu-rich,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence variant,splice variant,
WDR82	WD repeat domain 82(WDR82)	Homo sapiens				GO:0051568~histone H3-K4 methylation,GO:0080182~histone H3-K4 trimethylation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0016021~integral component of membrane,GO:0035097~histone methyltransferase complex,GO:0048188~Set1C/COMPASS complex,GO:0072357~PTW/PP1 phosphatase complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0042800~histone methyltransferase activity (H3-K4 specific),	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa03015:mRNA surveillance pathway,			SM00320:WD40,	Complete proteome,Membrane,Nucleus,Proteomics identification,Reference proteome,Repeat,Transmembrane,WD repeat,	chain:WD repeat-containing protein 82,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,
WDR92	WD repeat domain 92(WDR92)	Homo sapiens				GO:0006915~apoptotic process,		GO:0005515~protein binding,GO:0043130~ubiquitin binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 92,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence variant,strand,turn,
WDSUB1	WD repeat, sterile alpha motif and U-box domain containing 1(WDSUB1)	Homo sapiens				GO:0016567~protein ubiquitination,		GO:0004842~ubiquitin-protein transferase activity,	IPR001660:Sterile alpha motif domain,IPR001680:WD40 repeat,IPR003613:U box domain,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013761:Sterile alpha motif/pointed domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00320:WD40,SM00454:SAM,SM00504:Ubox,	Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat, SAM and U-box domain- containing protein 1,domain:SAM,domain:U-box,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
WNT10A	Wnt family member 10A(WNT10A)	Homo sapiens				GO:0001942~hair follicle development,GO:0007275~multicellular organism development,GO:0010628~positive regulation of gene expression,GO:0014033~neural crest cell differentiation,GO:0016055~Wnt signaling pathway,GO:0030182~neuron differentiation,GO:0031069~hair follicle morphogenesis,GO:0042476~odontogenesis,GO:0042487~regulation of odontogenesis of dentin-containing tooth,GO:0043586~tongue development,GO:0043588~skin development,GO:0045165~cell fate commitment,GO:0048730~epidermis morphogenesis,GO:0048733~sebaceous gland development,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,	GO:0005109~frizzled binding,	IPR005817:Wnt,IPR013302:Wnt-10 protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	150400~Tooth agenesis, selective, 4,224750~Schopf-Schulz-Passarge syndrome,257980~Odontoonychodermal dysplasia,		SM00097:WNT1,	Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Ectodermal dysplasia,Extracellular matrix,Glycoprotein,Hypotrichosis,Lipoprotein,Palmoplantar keratoderma,Polymorphism,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-10a,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
WNT2B	Wnt family member 2B(WNT2B)	Homo sapiens				GO:0002062~chondrocyte differentiation,GO:0002088~lens development in camera-type eye,GO:0007275~multicellular organism development,GO:0008584~male gonad development,GO:0009267~cellular response to starvation,GO:0016055~Wnt signaling pathway,GO:0021871~forebrain regionalization,GO:0030182~neuron differentiation,GO:0045165~cell fate commitment,GO:0060070~canonical Wnt signaling pathway,GO:0060492~lung induction,GO:0060638~mesenchymal-epithelial cell signaling,GO:0061072~iris morphogenesis,GO:0061303~cornea development in camera-type eye,GO:0071425~hematopoietic stem cell proliferation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,	GO:0005109~frizzled binding,	IPR005817:Wnt,IPR009140:Wnt-2 protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,			SM00097:WNT1,	Alternative splicing,Complete proteome,Developmental protein,Disulfide bond,Extracellular matrix,Glycoprotein,Lipoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-2b,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
WNT3A	Wnt family member 3A(WNT3A)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0001819~positive regulation of cytokine production,GO:0001934~positive regulation of protein phosphorylation,GO:0001947~heart looping,GO:0002092~positive regulation of receptor internalization,GO:0003136~negative regulation of heart induction by canonical Wnt signaling pathway,GO:0007411~axon guidance,GO:0007416~synapse assembly,GO:0008284~positive regulation of cell proliferation,GO:0010387~COP9 signalosome assembly,GO:0010628~positive regulation of gene expression,GO:0010977~negative regulation of neuron projection development,GO:0016055~Wnt signaling pathway,GO:0021527~spinal cord association neuron differentiation,GO:0021766~hippocampus development,GO:0021846~cell proliferation in forebrain,GO:0021874~Wnt signaling pathway involved in forebrain neuroblast division,GO:0021904~dorsal/ventral neural tube patterning,GO:0030097~hemopoiesis,GO:0030182~neuron differentiation,GO:0030198~extracellular matrix organization,GO:0030879~mammary gland development,GO:0030890~positive regulation of B cell proliferation,GO:0032092~positive regulation of protein binding,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033278~cell proliferation in midbrain,GO:0034613~cellular protein localization,GO:0035413~positive regulation of catenin import into nucleus,GO:0035914~skeletal muscle cell differentiation,GO:0036342~post-anal tail morphogenesis,GO:0036465~synaptic vesicle recycling,GO:0042472~inner ear morphogenesis,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045599~negative regulation of fat cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048337~positive regulation of mesodermal cell fate specification,GO:0048343~paraxial mesodermal cell fate commitment,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048697~positive regulation of collateral sprouting in absence of injury,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050768~negative regulation of neurogenesis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060021~palate development,GO:0060070~canonical Wnt signaling pathway,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0061184~positive regulation of dermatome development,GO:0061317~canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0070527~platelet aggregation,GO:0071300~cellular response to retinoic acid,GO:0090245~axis elongation involved in somitogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1903078~positive regulation of protein localization to plasma membrane,GO:1904339~negative regulation of dopaminergic neuron differentiation,GO:1904427~positive regulation of calcium ion transmembrane transport,GO:1904886~beta-catenin destruction complex disassembly,GO:1904953~Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin,GO:2000081~positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,GO:2000179~positive regulation of neural precursor cell proliferation,GO:2000347~positive regulation of hepatocyte proliferation,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000727~positive regulation of cardiac muscle cell differentiation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030666~endocytic vesicle membrane,GO:0031901~early endosome membrane,GO:0070062~extracellular exosome,GO:0098793~presynapse,GO:1990851~Wnt-Frizzled-LRP5/6 complex,	GO:0003713~transcription coactivator activity,GO:0005102~receptor binding,GO:0005109~frizzled binding,GO:0005110~frizzled-2 binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0039706~co-receptor binding,GO:0048018~receptor agonist activity,	IPR005817:Wnt,IPR009141:Wnt-3 protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05217:Basal cell carcinoma,			SM00097:WNT1,	Alternative splicing,Complete proteome,Developmental protein,Disulfide bond,Extracellular matrix,Glycoprotein,Lipoprotein,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-3a,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,signal peptide,
WNT5A	Wnt family member 5A(WNT5A)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0001736~establishment of planar polarity,GO:0001756~somitogenesis,GO:0001837~epithelial to mesenchymal transition,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001947~heart looping,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002088~lens development in camera-type eye,GO:0002741~positive regulation of cytokine secretion involved in immune response,GO:0003323~type B pancreatic cell development,GO:0003402~planar cell polarity pathway involved in axis elongation,GO:0003408~optic cup formation involved in camera-type eye development,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007257~activation of JUN kinase activity,GO:0007275~multicellular organism development,GO:0007411~axon guidance,GO:0007416~synapse assembly,GO:0007442~hindgut morphogenesis,GO:0007494~midgut development,GO:0008584~male gonad development,GO:0008595~anterior/posterior axis specification, embryo,GO:0010033~response to organic substance,GO:0010595~positive regulation of endothelial cell migration,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0010820~positive regulation of T cell chemotaxis,GO:0010976~positive regulation of neuron projection development,GO:0016055~Wnt signaling pathway,GO:0021891~olfactory bulb interneuron development,GO:0030182~neuron differentiation,GO:0030216~keratinocyte differentiation,GO:0030324~lung development,GO:0030514~negative regulation of BMP signaling pathway,GO:0030825~positive regulation of cGMP metabolic process,GO:0032092~positive regulation of protein binding,GO:0032148~activation of protein kinase B activity,GO:0032729~positive regulation of interferon-gamma production,GO:0032755~positive regulation of interleukin-6 production,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034613~cellular protein localization,GO:0035567~non-canonical Wnt signaling pathway,GO:0036342~post-anal tail morphogenesis,GO:0036517~chemoattraction of serotonergic neuron axon,GO:0036518~chemorepulsion of dopaminergic neuron axon,GO:0038031~non-canonical Wnt signaling pathway via JNK cascade,GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway,GO:0042060~wound healing,GO:0042733~embryonic digit morphogenesis,GO:0043032~positive regulation of macrophage activation,GO:0043066~negative regulation of apoptotic process,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045165~cell fate commitment,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0045599~negative regulation of fat cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045766~positive regulation of angiogenesis,GO:0045778~positive regulation of ossification,GO:0045807~positive regulation of endocytosis,GO:0045836~positive regulation of meiotic nuclear division,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048022~negative regulation of melanin biosynthetic process,GO:0048146~positive regulation of fibroblast proliferation,GO:0048341~paraxial mesoderm formation,GO:0048570~notochord morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048806~genitalia development,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0048850~hypophysis morphogenesis,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050729~positive regulation of inflammatory response,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051216~cartilage development,GO:0051964~negative regulation of synapse assembly,GO:0060021~palate development,GO:0060028~convergent extension involved in axis elongation,GO:0060029~convergent extension involved in organogenesis,GO:0060065~uterus development,GO:0060067~cervix development,GO:0060068~vagina development,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0060157~urinary bladder development,GO:0060324~face development,GO:0060340~positive regulation of type I interferon-mediated signaling pathway,GO:0060599~lateral sprouting involved in mammary gland duct morphogenesis,GO:0060638~mesenchymal-epithelial cell signaling,GO:0060686~negative regulation of prostatic bud formation,GO:0060744~mammary gland branching involved in thelarche,GO:0060750~epithelial cell proliferation involved in mammary gland duct elongation,GO:0060760~positive regulation of response to cytokine stimulus,GO:0060762~regulation of branching involved in mammary gland duct morphogenesis,GO:0060775~planar cell polarity pathway involved in gastrula mediolateral intercalation,GO:0060809~mesodermal to mesenchymal transition involved in gastrulation,GO:0060907~positive regulation of macrophage cytokine production,GO:0061036~positive regulation of cartilage development,GO:0061347~planar cell polarity pathway involved in outflow tract morphogenesis,GO:0061348~planar cell polarity pathway involved in ventricular septum morphogenesis,GO:0061349~planar cell polarity pathway involved in cardiac right atrium morphogenesis,GO:0061350~planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,GO:0061354~planar cell polarity pathway involved in pericardium morphogenesis,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0071222~cellular response to lipopolysaccharide,GO:0071277~cellular response to calcium ion,GO:0071300~cellular response to retinoic acid,GO:0071346~cellular response to interferon-gamma,GO:0071425~hematopoietic stem cell proliferation,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072201~negative regulation of mesenchymal cell proliferation,GO:0090009~primitive streak formation,GO:0090037~positive regulation of protein kinase C signaling,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090103~cochlea morphogenesis,GO:0090179~planar cell polarity pathway involved in neural tube closure,GO:0090630~activation of GTPase activity,GO:0097325~melanocyte proliferation,GO:1900020~positive regulation of protein kinase C activity,GO:1902474~positive regulation of protein localization to synapse,GO:1903827~regulation of cellular protein localization,GO:1904861~excitatory synapse assembly,GO:1904862~inhibitory synapse assembly,GO:1904934~negative regulation of cell proliferation in midbrain,GO:1904938~planar cell polarity pathway involved in axon guidance,GO:1904953~Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,GO:1904955~planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin,GO:2000052~positive regulation of non-canonical Wnt signaling pathway,GO:2000484~positive regulation of interleukin-8 secretion,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0070062~extracellular exosome,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005109~frizzled binding,GO:0005110~frizzled-2 binding,GO:0005115~receptor tyrosine kinase-like orphan receptor binding,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0044212~transcription regulatory region DNA binding,GO:0048018~receptor agonist activity,GO:1902379~chemoattractant activity involved in axon guidance,	IPR005817:Wnt,IPR018161:Wnt protein, conserved site,IPR026538:Wnt-5a protein,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	180700~Robinow syndrome, autosomal dominant 1,		SM00097:WNT1,	Alternative splicing,Chondrogenesis,Complete proteome,Developmental protein,Differentiation,Disease mutation,Disulfide bond,Dwarfism,Extracellular matrix,Glycoprotein,Lipoprotein,Membrane,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Protein Wnt-5a,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,signal peptide,splice variant,
WNT7A	Wnt family member 7A(WNT7A)	Homo sapiens				GO:0000578~embryonic axis specification,GO:0001502~cartilage condensation,GO:0001525~angiogenesis,GO:0002062~chondrocyte differentiation,GO:0007269~neurotransmitter secretion,GO:0007409~axonogenesis,GO:0007416~synapse assembly,GO:0007548~sex differentiation,GO:0008105~asymmetric protein localization,GO:0009953~dorsal/ventral pattern formation,GO:0010595~positive regulation of endothelial cell migration,GO:0014719~skeletal muscle satellite cell activation,GO:0014834~skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,GO:0016055~Wnt signaling pathway,GO:0021707~cerebellar granule cell differentiation,GO:0021846~cell proliferation in forebrain,GO:0022009~central nervous system vasculogenesis,GO:0030010~establishment of cell polarity,GO:0031133~regulation of axon diameter,GO:0032355~response to estradiol,GO:0035019~somatic stem cell population maintenance,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035567~non-canonical Wnt signaling pathway,GO:0035659~Wnt signaling pathway involved in wound healing, spreading of epidermal cells,GO:0036465~synaptic vesicle recycling,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0043627~response to estrogen,GO:0045165~cell fate commitment,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0048103~somatic stem cell division,GO:0048864~stem cell development,GO:0050768~negative regulation of neurogenesis,GO:0051965~positive regulation of synapse assembly,GO:0060021~palate development,GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing,GO:0060066~oviduct development,GO:0060070~canonical Wnt signaling pathway,GO:0060997~dendritic spine morphogenesis,GO:0061038~uterus morphogenesis,GO:0070307~lens fiber cell development,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1902474~positive regulation of protein localization to synapse,GO:1904861~excitatory synapse assembly,GO:1904891~positive regulation of excitatory synapse assembly,GO:2000463~positive regulation of excitatory postsynaptic potential,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030666~endocytic vesicle membrane,GO:0070062~extracellular exosome,GO:0098793~presynapse,	GO:0005102~receptor binding,GO:0005109~frizzled binding,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0048018~receptor agonist activity,	IPR005817:Wnt,IPR013300:Wnt-7 protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	228930~Fuhrmann syndrome,276820~Ulna and fibula, absence of, with severe limb deficiency,		SM00097:WNT1,	3D-structure,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Extracellular matrix,Glycoprotein,Lipoprotein,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-7a,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
WNT9A	Wnt family member 9A(WNT9A)	Homo sapiens				GO:0007093~mitotic cell cycle checkpoint,GO:0007267~cell-cell signaling,GO:0007275~multicellular organism development,GO:0008285~negative regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0030182~neuron differentiation,GO:0032331~negative regulation of chondrocyte differentiation,GO:0035115~embryonic forelimb morphogenesis,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045165~cell fate commitment,GO:0045597~positive regulation of cell differentiation,GO:0045880~positive regulation of smoothened signaling pathway,GO:0048704~embryonic skeletal system morphogenesis,GO:0060070~canonical Wnt signaling pathway,GO:0061072~iris morphogenesis,GO:0061303~cornea development in camera-type eye,GO:0071300~cellular response to retinoic acid,GO:0072498~embryonic skeletal joint development,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0005109~frizzled binding,	IPR005817:Wnt,IPR013303:Wnt-9a protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,			SM00097:WNT1,	Complete proteome,Developmental protein,Disulfide bond,Extracellular matrix,Glycoprotein,Lipoprotein,Polymorphism,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-9a,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
XCL2	X-C motif chemokine ligand 2(XCL2)	Homo sapiens				GO:0002548~monocyte chemotaxis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008015~blood circulation,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,IPR008105:C chemokine ligand 1,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Polymorphism,Reference proteome,Secreted,Signal,	chain:Cytokine SCM-1 beta,disulfide bond,sequence variant,signal peptide,
XRCC5	X-ray repair cross complementing 5(XRCC5)	Homo sapiens		h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,		GO:0000723~telomere maintenance,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0032481~positive regulation of type I interferon production,GO:0032508~DNA duplex unwinding,GO:0042493~response to drug,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048660~regulation of smooth muscle cell proliferation,GO:0050769~positive regulation of neurogenesis,GO:0060218~hematopoietic stem cell differentiation,GO:0071398~cellular response to fatty acid,GO:0071475~cellular hyperosmotic salinity response,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0075713~establishment of integrated proviral latency,GO:1904430~negative regulation of t-circle formation,	GO:0000783~nuclear telomere cap complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043564~Ku70:Ku80 complex,GO:0070419~nonhomologous end joining complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0031625~ubiquitin protein ligase binding,GO:0042162~telomeric DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0044877~macromolecular complex binding,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,	IPR002035:von Willebrand factor, type A,IPR005160:Ku70/Ku80 C-terminal arm,IPR005161:Ku70/Ku80, N-terminal alpha/beta,IPR006164:Ku70/Ku80 beta-barrel domain,IPR014893:Ku, C-terminal,IPR016194:SPOC like C-terminal domain,IPR024193:Ku80,	hsa03450:Non-homologous end-joining,		PIRSF016570:Ku DNA-binding complex, Ku80 subunit [Parent=PIRSF800001],	SM00327:VWA,SM00559:Ku78,	3D-structure,Acetylation,Activator,ATP-binding,Chromosome,Complete proteome,Direct protein sequencing,DNA damage,DNA recombination,DNA repair,DNA-binding,Helicase,Hydrolase,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Systemic lupus erythematosus,Transcription,Transcription regulation,Ubl conjugation,	chain:ATP-dependent DNA helicase 2 subunit 2,compositionally biased region:Pro-rich,domain:Ku,domain:Leucine-zipper,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:EEXXXDL motif,strand,turn,
YTHDF2	YTH N6-methyladenosine RNA binding protein 2(YTHDF2)	Homo sapiens				GO:0006959~humoral immune response,GO:0043488~regulation of mRNA stability,GO:1903679~positive regulation of cap-independent translational initiation,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:1990247~N6-methyladenosine-containing RNA binding,	IPR007275:YTH domain,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:YTH domain family protein 2,domain:YTH,modified residue,sequence variant,splice variant,
YY1AP1	YY1 associated protein 1(YY1AP1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,						Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:GON-4-like protein,chain:YY1-associated protein 1,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Myb-like,modified residue,repeat:PAH 1,repeat:PAH 2,sequence conflict,sequence variant,splice variant,
YIPF4	Yip1 domain family member 4(YIPF4)	Homo sapiens					GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,	IPR006977:Yip1 domain,					Complete proteome,Golgi apparatus,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein YIPF4,transmembrane region,
ZFP69B	ZFP69 zinc finger protein B(ZFP69B)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 643,domain:KRAB,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZFP69	ZFP69 zinc finger protein(ZFP69)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 642,domain:KRAB,domain:SCAN box,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF670-ZNF695	ZNF670-ZNF695 readthrough (NMD candidate)(ZNF670-ZNF695)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,	GO:0003676~nucleic acid binding,	IPR001909:Krueppel-associated box,				SM00349:KRAB,	Complete proteome,Reference proteome,
ABHD10	abhydrolase domain containing 10(ABHD10)	Homo sapiens				GO:0019391~glucuronoside catabolic process,GO:0052695~cellular glucuronidation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0102390~mycophenolic acid acyl-glucuronide esterase activity,	IPR000073:Alpha/beta hydrolase fold-1,					Alternative splicing,Complete proteome,Hydrolase,Mitochondrion,Polymorphism,Reference proteome,Signal,Transit peptide,	active site:Charge relay system,chain:Abhydrolase domain-containing protein 10, mitochondrial,sequence variant,transit peptide:Mitochondrion,
ABHD14A	abhydrolase domain containing 14A(ABHD14A)	Homo sapiens					GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0016787~hydrolase activity,	IPR000073:Alpha/beta hydrolase fold-1,					Complete proteome,Cytoplasm,Glycoprotein,Hydrolase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Charge relay system,chain:Abhydrolase domain-containing protein 14A,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
ABHD14B	abhydrolase domain containing 14B(ABHD14B)	Homo sapiens				GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0016787~hydrolase activity,	IPR000073:Alpha/beta hydrolase fold-1,IPR026764:Abhydrolase domain-containing protein 14B,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	active site:Charge relay system,chain:Abhydrolase domain-containing protein 14B,helix,modified residue,splice variant,strand,
ABHD6	abhydrolase domain containing 6(ABHD6)	Homo sapiens				GO:0009395~phospholipid catabolic process,GO:0030336~negative regulation of cell migration,GO:0046464~acylglycerol catabolic process,GO:0046889~positive regulation of lipid biosynthetic process,GO:0060292~long term synaptic depression,GO:2000124~regulation of endocannabinoid signaling pathway,	GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0032281~AMPA glutamate receptor complex,GO:0070062~extracellular exosome,	GO:0004620~phospholipase activity,GO:0047372~acylglycerol lipase activity,	IPR000073:Alpha/beta hydrolase fold-1,IPR000639:Epoxide hydrolase-like,	hsa04723:Retrograde endocannabinoid signaling,				Complete proteome,Hydrolase,Membrane,Mitochondrion,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Charge relay system,chain:Monoacylglycerol lipase ABHD6,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ABI2	abl interactor 2(ABI2)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,		GO:0006928~movement of cell or subcellular component,GO:0007010~cytoskeleton organization,GO:0008154~actin polymerization or depolymerization,GO:0016032~viral process,GO:0016477~cell migration,GO:0016601~Rac protein signal transduction,GO:0018108~peptidyl-tyrosine phosphorylation,GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0031209~SCAR complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0017124~SH3 domain binding,GO:0019900~kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0048365~Rac GTPase binding,GO:0070064~proline-rich region binding,	IPR000727:Target SNARE coiled-coil domain,IPR001452:Src homology-3 domain,IPR012849:Abl-interactor, homeo-domain homologous domain,	hsa04810:Regulation of actin cytoskeleton,			SM00326:SH3,	3D-structure,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Host-virus interaction,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Abl interactor 2,compositionally biased region:Pro-rich,domain:SH3,domain:t-SNARE coiled-coil homology,modified residue,sequence conflict,splice variant,strand,
ASPM	abnormal spindle microtubule assembly(ASPM)	Homo sapiens			Cytoskeleton,	GO:0001764~neuron migration,GO:0002052~positive regulation of neuroblast proliferation,GO:0007051~spindle organization,GO:0007067~mitotic nuclear division,GO:0007283~spermatogenesis,GO:0008584~male gonad development,GO:0021873~forebrain neuroblast division,GO:0021987~cerebral cortex development,GO:0045665~negative regulation of neuron differentiation,GO:0045769~negative regulation of asymmetric cell division,GO:0048477~oogenesis,GO:0048589~developmental growth,GO:0051445~regulation of meiotic cell cycle,GO:0051653~spindle localization,GO:0051661~maintenance of centrosome location,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090306~spindle assembly involved in meiosis,GO:0097150~neuronal stem cell population maintenance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030496~midbody,GO:0036449~microtubule minus-end,GO:0072687~meiotic spindle,GO:0097431~mitotic spindle pole,	GO:0005516~calmodulin binding,	IPR000048:IQ motif, EF-hand binding site,IPR001715:Calponin homology domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		608716~Microcephaly 5, primary, autosomal recessive,		SM00015:IQ,SM00033:CH,	Alternative splicing,Calmodulin-binding,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Mental retardation,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Primary microcephaly,Proteomics identification,Reference proteome,Repeat,	chain:Abnormal spindle-like microcephaly- associated protein,domain:CH 1,domain:CH 2,domain:IQ 1,domain:IQ 10,domain:IQ 11,domain:IQ 12,domain:IQ 13,domain:IQ 14,domain:IQ 15,domain:IQ 16,domain:IQ 17,domain:IQ 18,domain:IQ 19,domain:IQ 2,domain:IQ 20,domain:IQ 21,domain:IQ 22,domain:IQ 23,domain:IQ 24,domain:IQ 25,domain:IQ 26,domain:IQ 27,domain:IQ 28,domain:IQ 29,domain:IQ 3,domain:IQ 30,domain:IQ 31,domain:IQ 32,domain:IQ 33,domain:IQ 34,domain:IQ 35,domain:IQ 36,domain:IQ 37,domain:IQ 38,domain:IQ 39,domain:IQ 4,domain:IQ 5,domain:IQ 6,domain:IQ 7,domain:IQ 8,domain:IQ 9,modified residue,sequence conflict,sequence variant,splice variant,
AIM2	absent in melanoma 2(AIM2)	Homo sapiens				GO:0002218~activation of innate immune response,GO:0002230~positive regulation of defense response to virus by host,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032461~positive regulation of protein oligomerization,GO:0032731~positive regulation of interleukin-1 beta production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0035458~cellular response to interferon-beta,GO:0035690~cellular response to drug,GO:0045087~innate immune response,GO:0050702~interleukin-1 beta secretion,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070269~pyroptosis,GO:2001056~positive regulation of cysteine-type endopeptidase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0097169~AIM2 inflammasome complex,	GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR004020:DAPIN domain,IPR004021:HIN-200/IF120x,IPR011029:Death-like domain,	hsa04623:Cytosolic DNA-sensing pathway,			SM01289:SM01289,	3D-structure,Apoptosis,Complete proteome,Cytoplasm,DNA-binding,Immunity,Inflammatory response,Innate immunity,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Interferon-inducible protein AIM2,compositionally biased region:Poly-Ile,domain:DAPIN,domain:HIN-200,sequence conflict,sequence variant,
ACP1	acid phosphatase 1, soluble(ACP1)	Homo sapiens				GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005737~cytoplasm,GO:0009898~cytoplasmic side of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003993~acid phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,GO:0005515~protein binding,	IPR002115:Protein-tyrosine phosphatase, low molecular weight, mammalian,IPR017867:Protein-tyrosine phosphatase, low molecular weight,IPR023485:Phosphotyrosine protein phosphatase I superfamily,				SM00226:LMWPc,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	active site:Nucleophile,active site:Proton donor,chain:Low molecular weight phosphotyrosine protein phosphatase,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
ACP6	acid phosphatase 6, lysophosphatidic(ACP6)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0006644~phospholipid metabolic process,GO:0016311~dephosphorylation,GO:2001311~lysobisphosphatidic acid metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003993~acid phosphatase activity,GO:0052642~lysophosphatidic acid phosphatase activity,	IPR000560:Histidine phosphatase superfamily, clade-2,					3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Hydrolase,Lipid metabolism,Mitochondrion,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	active site:Nucleophile,active site:Proton donor,chain:Lysophosphatidic acid phosphatase type 6,mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,
ASIC4	acid sensing ion channel subunit family member 4(ASIC4)	Homo sapiens				GO:0006810~transport,GO:0035725~sodium ion transmembrane transport,	GO:0005887~integral component of plasma membrane,	GO:0005216~ion channel activity,GO:0005272~sodium channel activity,GO:0015081~sodium ion transmembrane transporter activity,	IPR001873:Na+ channel, amiloride-sensitive,IPR020903:Na+ channel, amiloride-sensitive, conserved site,	hsa04750:Inflammatory mediator regulation of TRP channels,				Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Reference proteome,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Amiloride-sensitive cation channel 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ANP32E	acidic nuclear phosphoprotein 32 family member E(ANP32E)	Homo sapiens				GO:0006334~nucleosome assembly,GO:0006913~nucleocytoplasmic transport,GO:0016569~covalent chromatin modification,GO:0042981~regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0043486~histone exchange,	GO:0000812~Swr1 complex,GO:0005634~nucleus,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0019212~phosphatase inhibitor activity,GO:0042393~histone binding,	IPR001611:Leucine-rich repeat,IPR025875:Leucine rich repeat 4,					3D-structure,Acetylation,Alternative splicing,Chaperone,Chromatin regulator,Complete proteome,Cytoplasm,Leucine-rich repeat,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Acidic leucine-rich nuclear phosphoprotein 32 family member E,compositionally biased region:Asp/Glu-rich (highly acidic),modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,sequence conflict,
ADI1	acireductone dioxygenase 1(ADI1)	Homo sapiens				GO:0019509~L-methionine biosynthetic process from methylthioadenosine,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0010309~acireductone dioxygenase [iron(II)-requiring] activity,GO:0016491~oxidoreductase activity,	IPR004313:Acireductone dioxygenase ARD family,IPR011051:RmlC-like cupin domain,IPR014710:RmlC-like jelly roll fold,IPR027496:1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase, eukaryotes,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Amino-acid biosynthesis,Cell membrane,Complete proteome,Cytoplasm,Dioxygenase,Direct protein sequencing,Iron,Membrane,Metal-binding,Methionine biosynthesis,Nucleus,Oxidoreductase,Proteomics identification,Reference proteome,Signal,	chain:1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase,metal ion-binding site:Nickel,mutagenesis site,sequence conflict,splice variant,
ACTL8	actin like 8(ACTL8)	Homo sapiens				GO:0030855~epithelial cell differentiation,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0005515~protein binding,	IPR004000:Actin-related protein,				SM00268:ACTIN,	Complete proteome,Cytoplasm,Cytoskeleton,Polymorphism,Reference proteome,	chain:Actin-like protein 8,sequence variant,
ARPC2	actin related protein 2/3 complex subunit 2(ARPC2)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_rhoPathway:Rho cell motility signaling pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0006928~movement of cell or subcellular component,GO:0010592~positive regulation of lamellipodium assembly,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048013~ephrin receptor signaling pathway,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005885~Arp2/3 protein complex,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0031252~cell leading edge,GO:0036195~muscle cell projection membrane,GO:0043005~neuron projection,GO:0045202~synapse,GO:0070062~extracellular exosome,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0051015~actin filament binding,	IPR007188:ARP2/3 complex, 34kDa subunit (p34-Arc),	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05100:Bacterial invasion of epithelial cells,hsa05130:Pathogenic Escherichia coli infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,				Acetylation,Actin-binding,Cell junction,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Proteomics identification,Reference proteome,Synapse,Synaptosome,	chain:Actin-related protein 2/3 complex subunit 2,modified residue,sequence conflict,
ARPC4	actin related protein 2/3 complex subunit 4(ARPC4)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_rhoPathway:Rho cell motility signaling pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0030041~actin filament polymerization,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0045010~actin nucleation,GO:0048013~ephrin receptor signaling pathway,	GO:0005829~cytosol,GO:0005885~Arp2/3 protein complex,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0030674~protein binding, bridging,GO:0051015~actin filament binding,	IPR008384:ARP2/3 complex, 20kDa subunit (P20-Arc),	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05100:Bacterial invasion of epithelial cells,hsa05130:Pathogenic Escherichia coli infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,				Acetylation,Actin-binding,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Proteomics identification,Reference proteome,	chain:Actin-related protein 2/3 complex subunit 4,chain:Tubulin monoglycylase TTLL3,domain:TTL,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
ARPC5	actin related protein 2/3 complex subunit 5(ARPC5)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_rhoPathway:Rho cell motility signaling pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0006928~movement of cell or subcellular component,GO:0014909~smooth muscle cell migration,GO:0016477~cell migration,GO:0021769~orbitofrontal cortex development,GO:0030011~maintenance of cell polarity,GO:0030036~actin cytoskeleton organization,GO:0031023~microtubule organizing center organization,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048013~ephrin receptor signaling pathway,GO:0051639~actin filament network formation,GO:0097581~lamellipodium organization,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005885~Arp2/3 protein complex,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0043005~neuron projection,GO:0070062~extracellular exosome,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0051015~actin filament binding,	IPR006789:ARP2/3 complex, 16kDa subunit (p16-Arc),	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05100:Bacterial invasion of epithelial cells,hsa05130:Pathogenic Escherichia coli infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,				Acetylation,Actin-binding,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Actin-related protein 2/3 complex subunit 5,splice variant,
ACTA1	actin, alpha 1, skeletal muscle(ACTA1)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_agrPathway:Agrin in Postsynaptic Differentiation,h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,h_hsp27Pathway:Stress Induction of HSP Regulation,h_integrinPathway:Integrin Signaling Pathway,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mCalpainPathway:mCalpain and friends in Cell motility,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_no1Pathway:Actions of Nitric Oxide in the Heart,h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery,h_salmonellaPathway:How does salmonella hijack a cell,h_uCalpainPathway:uCalpain and friends in Cell spread,		GO:0006936~muscle contraction,GO:0009612~response to mechanical stimulus,GO:0009991~response to extracellular stimulus,GO:0010226~response to lithium ion,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0030049~muscle filament sliding,GO:0030240~skeletal muscle thin filament assembly,GO:0043503~skeletal muscle fiber adaptation,GO:0048545~response to steroid hormone,GO:0048741~skeletal muscle fiber development,GO:0090131~mesenchyme migration,	GO:0001725~stress fiber,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0005865~striated muscle thin filament,GO:0005884~actin filament,GO:0015629~actin cytoskeleton,GO:0030017~sarcomere,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0044297~cell body,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0017022~myosin binding,GO:0043531~ADP binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020902:Actin/actin-like conserved site,		161800~Myopathy, actin, congenital, with cores,161800~Myopathy, actin, congenital, with excess of thin myofilaments,161800~Nemaline myopathy 3, autosomal dominant or recessive,255310~Myopathy, congenital, with fiber-type disproportion 1,		SM00268:ACTIN,	3D-structure,Acetylation,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Isopeptide bond,Methylation,Muscle protein,Nemaline myopathy,Nucleotide-binding,Oxidation,Proteomics identification,Reference proteome,	chain:Actin, alpha skeletal muscle,modified residue,propeptide:Removed in mature form,sequence variant,
ACTG2	actin, gamma 2, smooth muscle, enteric(ACTG2)	Homo sapiens				GO:0006936~muscle contraction,GO:0010628~positive regulation of gene expression,GO:0090131~mesenchyme migration,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0032982~myosin filament,GO:0044297~cell body,GO:0070062~extracellular exosome,GO:0071944~cell periphery,GO:0072562~blood microparticle,	GO:0005524~ATP binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020902:Actin/actin-like conserved site,	hsa04270:Vascular smooth muscle contraction,	155310~Visceral myopathy,		SM00268:ACTIN,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Isopeptide bond,Muscle protein,Nucleotide-binding,Oxidation,Proteomics identification,Reference proteome,	chain:Actin, gamma-enteric smooth muscle,modified residue,propeptide:Removed in mature form,sequence conflict,
ACTN2	actinin alpha 2(ACTN2)	Homo sapiens		h_cell2cellPathway:Cell to Cell Adhesion Signaling,h_integrinPathway:Integrin Signaling Pathway,h_uCalpainPathway:uCalpain and friends in Cell spread,		GO:0000165~MAPK cascade,GO:0002576~platelet degranulation,GO:0007155~cell adhesion,GO:0030035~microspike assembly,GO:0030049~muscle filament sliding,GO:0042391~regulation of membrane potential,GO:0042981~regulation of apoptotic process,GO:0043267~negative regulation of potassium ion transport,GO:0043268~positive regulation of potassium ion transport,GO:0043547~positive regulation of GTPase activity,GO:0045214~sarcomere organization,GO:0048041~focal adhesion assembly,GO:0051289~protein homotetramerization,GO:0051695~actin filament uncapping,GO:0055013~cardiac muscle cell development,GO:0086097~phospholipase C-activating angiotensin-activated signaling pathway,GO:0090002~establishment of protein localization to plasma membrane,GO:1901017~negative regulation of potassium ion transmembrane transporter activity,GO:1901018~positive regulation of potassium ion transmembrane transporter activity,GO:1903506~regulation of nucleic acid-templated transcription,GO:2000009~negative regulation of protein localization to cell surface,GO:2000273~positive regulation of receptor activity,GO:2001137~positive regulation of endocytic recycling,GO:2001259~positive regulation of cation channel activity,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030018~Z disc,GO:0030175~filopodium,GO:0030864~cortical actin cytoskeleton,GO:0031093~platelet alpha granule lumen,GO:0031143~pseudopodium,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008092~cytoskeletal protein binding,GO:0008307~structural constituent of muscle,GO:0019904~protein domain specific binding,GO:0030274~LIM domain binding,GO:0030375~thyroid hormone receptor coactivator activity,GO:0031432~titin binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,GO:0046983~protein dimerization activity,GO:0051015~actin filament binding,GO:0051373~FATZ binding,GO:0070080~titin Z domain binding,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR002017:Spectrin repeat,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR014837:EF-hand, Ca insensitive,IPR018159:Spectrin/alpha-actinin,	hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,hsa05146:Amoebiasis,hsa05203:Viral carcinogenesis,hsa05322:Systemic lupus erythematosus,	612158~Cardiomyopathy, dilated, 1AA, with or without LVNC,612158~Cardiomyopathy, hypertrophic, 23, with or without LVNC,		SM00033:CH,SM00054:EFh,SM00150:SPEC,	3D-structure,Actin-binding,Alternative splicing,Calcium,Cardiomyopathy,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	calcium-binding region:1; possibly ancestral,calcium-binding region:2; possibly ancestral,chain:Alpha-actinin-2,domain:Actin-binding,domain:CH 1,domain:CH 2,domain:EF-hand 1,domain:EF-hand 2,helix,modified residue,repeat:Spectrin 1,repeat:Spectrin 2,repeat:Spectrin 3,repeat:Spectrin 4,sequence variant,strand,turn,
ALCAM	activated leukocyte cell adhesion molecule(ALCAM)	Homo sapiens				GO:0002250~adaptive immune response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007165~signal transduction,GO:0008045~motor neuron axon guidance,GO:0031290~retinal ganglion cell axon guidance,GO:0048846~axon extension involved in axon guidance,GO:1990138~neuron projection extension,	GO:0001772~immunological synapse,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0031226~intrinsic component of plasma membrane,GO:0042101~T cell receptor complex,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:CD166 antigen,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ATF2	activating transcription factor 2(ATF2)	Homo sapiens		h_41BBPathway:The 4-1BB-dependent immune response,h_alkPathway:ALK in cardiac myocytes,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_mapkPathway:MAPKinase Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pcafPathway:The information-processing pathway at the IFN-beta enhancer,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0003151~outflow tract morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006970~response to osmotic stress,GO:0006974~cellular response to DNA damage stimulus,GO:0009414~response to water deprivation,GO:0016573~histone acetylation,GO:0031573~intra-S DNA damage checkpoint,GO:0032915~positive regulation of transforming growth factor beta2 production,GO:0043525~positive regulation of neuron apoptotic process,GO:0045444~fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060612~adipose tissue development,GO:0097186~amelogenesis,GO:1902110~positive regulation of mitochondrial membrane permeability involved in apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0035861~site of double-strand break,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0008140~cAMP response element binding protein binding,GO:0019901~protein kinase binding,GO:0035497~cAMP response element binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR016378:Transcription factor, cyclic AMP-dependent,	hsa04010:MAPK signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04668:TNF signaling pathway,hsa04728:Dopaminergic synapse,hsa04911:Insulin secretion,hsa04915:Estrogen signaling pathway,hsa04918:Thyroid hormone synthesis,hsa04922:Glucagon signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05203:Viral carcinogenesis,		PIRSF003153:cyclic AMP-dependent transcription factor, CRE-BP1 type,	SM00338:BRLZ,	3D-structure,Acetylation,Activator,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA damage,DNA-binding,Membrane,Metal-binding,Mitochondrion,Mitochondrion outer membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	chain:Cyclic AMP-dependent transcription factor ATF-2,DNA-binding region:Basic motif,domain:Leucine-zipper,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C2H2-type,
ATF3	activating transcription factor 3(ATF3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006094~gluconeogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0034198~cellular response to amino acid starvation,GO:0035914~skeletal muscle cell differentiation,GO:0036499~PERK-mediated unfolded protein response,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061394~regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:1903984~positive regulation of TRAIL-activated apoptotic signaling pathway,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:1990622~CHOP-ATF3 complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	hsa05166:HTLV-I infection,			SM00338:BRLZ,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Cyclic AMP-dependent transcription factor ATF-3,DNA-binding region:Basic motif,domain:Leucine-zipper,sequence conflict,sequence variant,splice variant,
ATF6	activating transcription factor 6(ATF6)	Homo sapiens				GO:0001654~eye development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006457~protein folding,GO:0006950~response to stress,GO:0006990~positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,GO:0007165~signal transduction,GO:0007601~visual perception,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0036500~ATF6-mediated unfolded protein response,GO:0043065~positive regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0035497~cAMP response element binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,	hsa04141:Protein processing in endoplasmic reticulum,hsa05010:Alzheimer's disease,	616517~Achromatopsia 7,		SM00338:BRLZ,	Activator,Coiled coil,Complete proteome,Disease mutation,DNA-binding,Endoplasmic reticulum,Glycoprotein,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Signal-anchor,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Unfolded protein response,	chain:Cyclic AMP-dependent transcription factor ATF-6 alpha,chain:Processed cyclic AMP-dependent transcription factor ATF-6 alpha,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,DNA-binding region:Basic motif,domain:Leucine-zipper,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Transcription activation,sequence conflict,sequence variant,site:Cleavage; by PS1,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ACVR1	activin A receptor type 1(ACVR1)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0001569~patterning of blood vessels,GO:0001701~in utero embryonic development,GO:0001702~gastrulation with mouth forming second,GO:0001707~mesoderm formation,GO:0001755~neural crest cell migration,GO:0002526~acute inflammatory response,GO:0003143~embryonic heart tube morphogenesis,GO:0003148~outflow tract septum morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003183~mitral valve morphogenesis,GO:0003203~endocardial cushion morphogenesis,GO:0003274~endocardial cushion fusion,GO:0003289~atrial septum primum morphogenesis,GO:0006468~protein phosphorylation,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007281~germ cell development,GO:0007368~determination of left/right symmetry,GO:0007507~heart development,GO:0009968~negative regulation of signal transduction,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030278~regulation of ossification,GO:0030335~positive regulation of cell migration,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0032924~activin receptor signaling pathway,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0045669~positive regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051145~smooth muscle cell differentiation,GO:0060037~pharyngeal system development,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060412~ventricular septum morphogenesis,GO:0060923~cardiac muscle cell fate commitment,GO:0061312~BMP signaling pathway involved in heart development,GO:0061445~endocardial cushion cell fate commitment,GO:0071773~cellular response to BMP stimulus,GO:1905007~positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:2000017~positive regulation of determination of dorsal identity,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045177~apical part of cell,GO:0048179~activin receptor complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005025~transforming growth factor beta receptor activity, type I,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016361~activin receptor activity, type I,GO:0017046~peptide hormone binding,GO:0042803~protein homodimerization activity,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0048185~activin binding,GO:0050431~transforming growth factor beta binding,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003605:TGF beta receptor, GS motif,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,	135100~Fibrodysplasia ossificans progressiva,		SM00220:S_TKc,SM00467:GS,	3D-structure,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Activin receptor type-1,domain:GS,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ACVR1C	activin A receptor type 1C(ACVR1C)	Homo sapiens				GO:0002021~response to dietary excess,GO:0006468~protein phosphorylation,GO:0009749~response to glucose,GO:0019915~lipid storage,GO:0023014~signal transduction by protein phosphorylation,GO:0030154~cell differentiation,GO:0030262~apoptotic nuclear changes,GO:0032868~response to insulin,GO:0038092~nodal signaling pathway,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0046676~negative regulation of insulin secretion,GO:1901164~negative regulation of trophoblast cell migration,GO:1901383~negative regulation of chorionic trophoblast cell proliferation,	GO:0005886~plasma membrane,GO:0048179~activin receptor complex,	GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016361~activin receptor activity, type I,GO:0019838~growth factor binding,GO:0038100~nodal binding,GO:0046872~metal ion binding,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003605:TGF beta receptor, GS motif,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00220:S_TKc,SM00467:GS,	Alternative splicing,Apoptosis,ATP-binding,Complete proteome,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Activin receptor type-1C,domain:GS,domain:Protein kinase,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ACVR2A	activin A receptor type 2A(ACVR2A)	Homo sapiens				GO:0001702~gastrulation with mouth forming second,GO:0001934~positive regulation of protein phosphorylation,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007283~spermatogenesis,GO:0007368~determination of left/right symmetry,GO:0007498~mesoderm development,GO:0009952~anterior/posterior pattern specification,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0030510~regulation of BMP signaling pathway,GO:0032924~activin receptor signaling pathway,GO:0032927~positive regulation of activin receptor signaling pathway,GO:0042713~sperm ejaculation,GO:0043084~penile erection,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048706~embryonic skeletal system development,GO:0050999~regulation of nitric-oxide synthase activity,GO:0060011~Sertoli cell proliferation,GO:0071773~cellular response to BMP stimulus,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0034673~inhibin-betaglycan-ActRII complex,GO:0043235~receptor complex,	GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015026~coreceptor activity,GO:0017002~activin-activated receptor activity,GO:0019838~growth factor binding,GO:0030165~PDZ domain binding,GO:0034711~inhibin binding,GO:0043621~protein self-association,GO:0046872~metal ion binding,GO:0048185~activin binding,GO:0098821~BMP receptor activity,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Disulfide bond,Glycoprotein,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Activin receptor type-2A,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ACVR2B	activin A receptor type 2B(ACVR2B)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001702~gastrulation with mouth forming second,GO:0001822~kidney development,GO:0001946~lymphangiogenesis,GO:0001974~blood vessel remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0007165~signal transduction,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007368~determination of left/right symmetry,GO:0007498~mesoderm development,GO:0007507~heart development,GO:0009749~response to glucose,GO:0009791~post-embryonic development,GO:0009952~anterior/posterior pattern specification,GO:0023014~signal transduction by protein phosphorylation,GO:0030073~insulin secretion,GO:0030324~lung development,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0031016~pancreas development,GO:0032147~activation of protein kinase activity,GO:0032924~activin receptor signaling pathway,GO:0032927~positive regulation of activin receptor signaling pathway,GO:0035265~organ growth,GO:0042475~odontogenesis of dentin-containing tooth,GO:0045669~positive regulation of osteoblast differentiation,GO:0048617~embryonic foregut morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0060021~palate development,GO:0060836~lymphatic endothelial cell differentiation,GO:0060840~artery development,GO:0060841~venous blood vessel development,GO:0061298~retina vasculature development in camera-type eye,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0043235~receptor complex,	GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016362~activin receptor activity, type II,GO:0019838~growth factor binding,GO:0046872~metal ion binding,GO:0048185~activin binding,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,	613751~Heterotaxy, visceral, 4, autosomal,			3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Heterotaxy,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Activin receptor type-2B,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ACBD3	acyl-CoA binding domain containing 3(ACBD3)	Homo sapiens				GO:0006694~steroid biosynthetic process,GO:0006810~transport,	GO:0000139~Golgi membrane,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000062~fatty-acyl-CoA binding,GO:0005515~protein binding,GO:0034237~protein kinase A regulatory subunit binding,	IPR000582:Acyl-CoA-binding protein, ACBP,IPR009038:GOLD,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR022408:Acyl-CoA-binding protein, ACBP, conserved site,					3D-structure,Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Golgi apparatus,Lipid biosynthesis,Lipid metabolism,Membrane,Mitochondrion,Phosphoprotein,Polymorphism,Reference proteome,Steroid biosynthesis,	chain:Golgi resident protein GCP60,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,domain:ACB,domain:GOLD,modified residue,sequence conflict,sequence variant,
ACBD6	acyl-CoA binding domain containing 6(ACBD6)	Homo sapiens					GO:0005737~cytoplasm,	GO:0000062~fatty-acyl-CoA binding,GO:0008289~lipid binding,	IPR000582:Acyl-CoA-binding protein, ACBP,IPR002110:Ankyrin repeat,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	3D-structure,ANK repeat,Complete proteome,Cytoplasm,Lipid-binding,Phosphoprotein,Reference proteome,Repeat,	chain:Acyl-CoA-binding domain-containing protein 6,domain:ACB,helix,modified residue,repeat:ANK 1,repeat:ANK 2,turn,
ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain(ACADM)	Homo sapiens			Lipid metabolism,	GO:0001889~liver development,GO:0005978~glycogen biosynthetic process,GO:0006111~regulation of gluconeogenesis,GO:0006635~fatty acid beta-oxidation,GO:0009409~response to cold,GO:0009791~post-embryonic development,GO:0019254~carnitine metabolic process, CoA-linked,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0042594~response to starvation,GO:0045329~carnitine biosynthetic process,GO:0051791~medium-chain fatty acid metabolic process,GO:0051793~medium-chain fatty acid catabolic process,GO:0055007~cardiac muscle cell differentiation,GO:0055088~lipid homeostasis,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,GO:0030424~axon,GO:0070062~extracellular exosome,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0009055~electron carrier activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0042802~identical protein binding,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,GO:0070991~medium-chain-acyl-CoA dehydrogenase activity,	IPR006089:Acyl-CoA dehydrogenase, conserved site,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal,	hsa00071:Fatty acid degradation,hsa00280:Valine, leucine and isoleucine degradation,hsa00410:beta-Alanine metabolism,hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,	201450~Acyl-CoA dehydrogenase, medium chain, deficiency of,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,FAD,Fatty acid metabolism,Flavoprotein,Lipid metabolism,Mitochondrion,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	active site:Proton acceptor,binding site:Substrate,binding site:Substrate; via amide nitrogen,binding site:Substrate; via carbonyl oxygen,chain:Medium-chain specific acyl-CoA dehydrogenase, mitochondrial,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:FAD,region of interest:Substrate binding,sequence conflict,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
ACADL	acyl-CoA dehydrogenase, long chain(ACADL)	Homo sapiens			Lipid metabolism,	GO:0001659~temperature homeostasis,GO:0006635~fatty acid beta-oxidation,GO:0019254~carnitine metabolic process, CoA-linked,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0042413~carnitine catabolic process,GO:0042758~long-chain fatty acid catabolic process,GO:0044242~cellular lipid catabolic process,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0046322~negative regulation of fatty acid oxidation,GO:0051289~protein homotetramerization,GO:0055088~lipid homeostasis,GO:0055114~oxidation-reduction process,GO:0090181~regulation of cholesterol metabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031966~mitochondrial membrane,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0004466~long-chain-acyl-CoA dehydrogenase activity,GO:0009055~electron carrier activity,GO:0016401~palmitoyl-CoA oxidase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,	IPR006089:Acyl-CoA dehydrogenase, conserved site,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal,	hsa00071:Fatty acid degradation,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,				Acetylation,Complete proteome,FAD,Fatty acid metabolism,Flavoprotein,Lipid metabolism,Mitochondrion,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Transit peptide,	chain:Long-chain specific acyl-CoA dehydrogenase, mitochondrial,sequence variant,transit peptide:Mitochondrion,
ACOX2	acyl-CoA oxidase 2(ACOX2)	Homo sapiens				GO:0006635~fatty acid beta-oxidation,GO:0006699~bile acid biosynthetic process,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0055088~lipid homeostasis,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,GO:0043231~intracellular membrane-bounded organelle,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0003997~acyl-CoA oxidase activity,GO:0005102~receptor binding,GO:0009055~electron carrier activity,GO:0016402~pristanoyl-CoA oxidase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0033791~3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,	IPR002655:Acyl-CoA oxidase, C-terminal,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR012258:Acyl-CoA oxidase,IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal,	hsa00120:Primary bile acid biosynthesis,hsa01100:Metabolic pathways,hsa03320:PPAR signaling pathway,hsa04146:Peroxisome,		PIRSF000168:acyl-CoA oxidase,		Complete proteome,Direct protein sequencing,FAD,Fatty acid metabolism,Flavoprotein,Lipid metabolism,Oxidoreductase,Peroxisome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Peroxisomal acyl-coenzyme A oxidase 2,modified residue,short sequence motif:Microbody targeting signal,
ACOXL	acyl-CoA oxidase-like(ACOXL)	Homo sapiens				GO:0006635~fatty acid beta-oxidation,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0055088~lipid homeostasis,	GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0003997~acyl-CoA oxidase activity,GO:0009055~electron carrier activity,GO:0016402~pristanoyl-CoA oxidase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,	IPR002655:Acyl-CoA oxidase, C-terminal,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,					Alternative splicing,Complete proteome,FAD,Flavoprotein,Oxidoreductase,Polymorphism,Reference proteome,	chain:Acyl-coenzyme A oxidase-like protein,nucleotide phosphate-binding region:FAD,sequence conflict,sequence variant,splice variant,
ACSL3	acyl-CoA synthetase long-chain family member 3(ACSL3)	Homo sapiens				GO:0001676~long-chain fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0007420~brain development,GO:0007584~response to nutrient,GO:0008152~metabolic process,GO:0014070~response to organic cyclic compound,GO:0034379~very-low-density lipoprotein particle assembly,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042998~positive regulation of Golgi to plasma membrane protein transport,GO:0044539~long-chain fatty acid import,GO:0051047~positive regulation of secretion,GO:2001247~positive regulation of phosphatidylcholine biosynthetic process,	GO:0005741~mitochondrial outer membrane,GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005811~lipid particle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003824~catalytic activity,GO:0004467~long-chain fatty acid-CoA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0102391~decanoate--CoA ligase activity,	IPR000873:AMP-dependent synthetase/ligase,IPR020845:AMP-binding, conserved site,IPR025110:Domain of unknown function DUF4009,	hsa00061:Fatty acid biosynthesis,hsa00071:Fatty acid degradation,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,hsa04146:Peroxisome,hsa04920:Adipocytokine signaling pathway,				ATP-binding,Complete proteome,Endoplasmic reticulum,Fatty acid metabolism,Ligase,Lipid metabolism,Magnesium,Membrane,Microsome,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Long-chain-fatty-acid--CoA ligase 3,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,transmembrane region,
ACOT11	acyl-CoA thioesterase 11(ACOT11)	Homo sapiens				GO:0006631~fatty acid metabolic process,GO:0006637~acyl-CoA metabolic process,GO:0009266~response to temperature stimulus,GO:0009409~response to cold,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0008289~lipid binding,GO:0047617~acyl-CoA hydrolase activity,GO:0052689~carboxylic ester hydrolase activity,	IPR002913:START domain,IPR006683:Thioesterase superfamily,IPR023393:START-like domain,				SM00234:START,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Serine esterase,	binding site:Coenzyme A,chain:Acyl-coenzyme A thioesterase 11,domain:Acyl coenzyme A hydrolase 1,domain:Acyl coenzyme A hydrolase 2,domain:START,helix,modified residue,region of interest:Coenzyme A binding,sequence conflict,sequence variant,splice variant,strand,turn,
ACOT7	acyl-CoA thioesterase 7(ACOT7)	Homo sapiens				GO:0015937~coenzyme A biosynthetic process,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0036114~medium-chain fatty-acyl-CoA catabolic process,GO:0036116~long-chain fatty-acyl-CoA catabolic process,GO:0051792~medium-chain fatty acid biosynthetic process,GO:1900535~palmitic acid biosynthetic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000062~fatty-acyl-CoA binding,GO:0005515~protein binding,GO:0016290~palmitoyl-CoA hydrolase activity,GO:0036042~long-chain fatty acyl-CoA binding,GO:0042803~protein homodimerization activity,GO:0047617~acyl-CoA hydrolase activity,GO:0052689~carboxylic ester hydrolase activity,	IPR006683:Thioesterase superfamily,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Mitochondrion,Proteomics identification,Reference proteome,Repeat,Serine esterase,	chain:Cytosolic acyl coenzyme A thioester hydrolase,domain:Acyl coenzyme A hydrolase 1,domain:Acyl coenzyme A hydrolase 2,helix,modified residue,sequence conflict,splice variant,strand,
APEH	acylaminoacyl-peptide hydrolase(APEH)	Homo sapiens			Amino acid transport and metabolism,	GO:0006415~translational termination,GO:0006508~proteolysis,GO:0050435~beta-amyloid metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008242~omega peptidase activity,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR001375:Peptidase S9, prolyl oligopeptidase, catalytic domain,IPR002471:Peptidase S9, serine active site,IPR011042:Six-bladed beta-propeller, TolB-like,					Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Charge relay system,chain:Acylamino-acid-releasing enzyme,modified residue,sequence conflict,sequence variant,
ACYP2	acylphosphatase 2(ACYP2)	Homo sapiens				GO:0006796~phosphate-containing compound metabolic process,	GO:0005739~mitochondrion,	GO:0003998~acylphosphatase activity,GO:0005515~protein binding,	IPR001792:Acylphosphatase-like,IPR017968:Acylphosphatase, conserved site,IPR020456:Acylphosphatase,	hsa00620:Pyruvate metabolism,				Acetylation,Complete proteome,Direct protein sequencing,Hydrolase,Proteomics identification,Reference proteome,	chain:Acylphosphatase-2,domain:Acylphosphatase-like,modified residue,
APPL1	adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1(APPL1)	Homo sapiens			Signal transduction mechanisms,	GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0046324~regulation of glucose import,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0012506~vesicle membrane,GO:0016581~NuRD complex,GO:0031901~early endosome membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0043422~protein kinase B binding,	IPR001849:Pleckstrin homology domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,	616511~Maturity-onset diabetes of the young, type 14,		SM00233:PH,SM00462:PTB,	3D-structure,Cell cycle,Coiled coil,Complete proteome,Diabetes mellitus,Disease mutation,Endosome,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DCC-interacting protein 13-alpha,domain:PH,domain:PID,helix,modified residue,region of interest:Required for RAB5A binding,sequence variant,strand,turn,
AP1S3	adaptor related protein complex 1 sigma 3 subunit(AP1S3)	Homo sapiens				GO:0006605~protein targeting,GO:0006886~intracellular protein transport,GO:0016192~vesicle-mediated transport,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0050690~regulation of defense response to virus by virus,	GO:0000139~Golgi membrane,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005905~clathrin-coated pit,GO:0030117~membrane coat,GO:0030659~cytoplasmic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,	GO:0005515~protein binding,GO:0008565~protein transporter activity,	IPR000804:Clathrin adaptor complex, small chain,IPR011012:Longin-like domain,IPR016635:Adaptor protein complex, sigma subunit,IPR022775:AP complex, mu/sigma subunit,	hsa04142:Lysosome,	616106~Psoriasis 15, pustular, susceptibility to,	PIRSF015588:adaptor protein complex, sigma subunit,		3D-structure,Alternative splicing,Coated pit,Complete proteome,Cytoplasmic vesicle,Disease mutation,Golgi apparatus,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:AP-1 complex subunit sigma-3,splice variant,
AP4B1	adaptor related protein complex 4 beta 1 subunit(AP4B1)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0016192~vesicle-mediated transport,	GO:0005802~trans-Golgi network,GO:0005905~clathrin-coated pit,GO:0030117~membrane coat,GO:0030131~clathrin adaptor complex,GO:0031904~endosome lumen,GO:0032588~trans-Golgi network membrane,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0008565~protein transporter activity,	IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal,IPR011989:Armadillo-like helical,IPR012295:Beta2-adaptin/TBP, C-terminal domain,IPR015151:Beta-adaptin appendage, C-terminal subdomain,IPR016024:Armadillo-type fold,IPR016342:AP-1, 2,4 complex subunit beta,IPR026739:AP complex subunit beta,	hsa04142:Lysosome,	614066~Spastic paraplegia 47, autosomal recessive,	PIRSF002291:adaptor protein complex, beta subunit,	SM01020:SM01020,	3D-structure,Alternative splicing,Coated pit,Complete proteome,Golgi apparatus,Hereditary spastic paraplegia,Membrane,Neurodegeneration,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:AP-4 complex subunit beta-1,sequence conflict,sequence variant,
ASXL2	additional sex combs like 2, transcriptional regulator(ASXL2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway,GO:0045600~positive regulation of fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046872~metal ion binding,	IPR007759:DNA-directed RNA polymerase delta subunit,IPR024811:Polycomb protein ASX/ASX-like,IPR024817:ASX-like protein 2,IPR026905:Protein ASX-like, PHD domain,					Alternative splicing,Chromosomal rearrangement,Complete proteome,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Putative Polycomb group protein ASXL2,compositionally biased region:Ala-rich,compositionally biased region:Gly-rich,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form MYST3-ASXL2 protein,splice variant,zinc finger region:PHD-type; atypical,
ADD2	adducin 2(ADD2)	Homo sapiens				GO:0006461~protein complex assembly,GO:0030036~actin cytoskeleton organization,GO:0030097~hemopoiesis,GO:0032092~positive regulation of protein binding,GO:0051016~barbed-end actin filament capping,GO:0051017~actin filament bundle assembly,GO:0055085~transmembrane transport,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0008290~F-actin capping protein complex,GO:0014069~postsynaptic density,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005516~calmodulin binding,GO:0030507~spectrin binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051015~actin filament binding,	IPR001303:Class II aldolase/adducin N-terminal,				SM01007:SM01007,	Acetylation,Actin-binding,Alternative splicing,Calmodulin-binding,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Beta-adducin,modified residue,region of interest:Interaction with calmodulin,sequence variant,splice variant,
ADORA1	adenosine A1 receptor(ADORA1)	Homo sapiens				GO:0000186~activation of MAPKK activity,GO:0001659~temperature homeostasis,GO:0001666~response to hypoxia,GO:0001973~adenosine receptor signaling pathway,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0002674~negative regulation of acute inflammatory response,GO:0002686~negative regulation of leukocyte migration,GO:0002793~positive regulation of peptide secretion,GO:0003093~regulation of glomerular filtration,GO:0006612~protein targeting to membrane,GO:0006909~phagocytosis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0014050~negative regulation of glutamate secretion,GO:0016042~lipid catabolic process,GO:0032229~negative regulation of synaptic transmission, GABAergic,GO:0032244~positive regulation of nucleoside transport,GO:0032900~negative regulation of neurotrophin production,GO:0035307~positive regulation of protein dephosphorylation,GO:0035814~negative regulation of renal sodium excretion,GO:0042323~negative regulation of circadian sleep/wake cycle, non-REM sleep,GO:0043066~negative regulation of apoptotic process,GO:0043268~positive regulation of potassium ion transport,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045776~negative regulation of blood pressure,GO:0045777~positive regulation of blood pressure,GO:0045908~negative regulation of vasodilation,GO:0046888~negative regulation of hormone secretion,GO:0050890~cognition,GO:0050965~detection of temperature stimulus involved in sensory perception of pain,GO:0050995~negative regulation of lipid catabolic process,GO:0051930~regulation of sensory perception of pain,GO:0051967~negative regulation of synaptic transmission, glutamatergic,GO:0055118~negative regulation of cardiac muscle contraction,GO:0060079~excitatory postsynaptic potential,GO:0060087~relaxation of vascular smooth muscle,GO:0070256~negative regulation of mucus secretion,GO:0097190~apoptotic signaling pathway,GO:1900453~negative regulation of long term synaptic depression,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030673~axolemma,GO:0032279~asymmetric synapse,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0043197~dendritic spine,GO:0045211~postsynaptic membrane,GO:0048786~presynaptic active zone,	GO:0001609~G-protein coupled adenosine receptor activity,GO:0001664~G-protein coupled receptor binding,GO:0001883~purine nucleoside binding,GO:0004629~phospholipase C activity,GO:0005515~protein binding,GO:0031072~heat shock protein binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0032795~heterotrimeric G-protein binding,GO:0046982~protein heterodimerization activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001068:Adenosine A1 receptor,IPR001634:Adenosine receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa05032:Morphine addiction,			SM01381:SM01381,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Adenosine receptor A1,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ADORA3	adenosine A3 receptor(ADORA3)	Homo sapiens				GO:0001973~adenosine receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0001609~G-protein coupled adenosine receptor activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000466:Adenosine A3 receptor,IPR001634:Adenosine receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,			SM01381:SM01381,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Adenosine A3 receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence conflict,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ADAR	adenosine deaminase, RNA specific(ADAR)	Homo sapiens		h_antisensePathway:RNA polymerase III transcription,		GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0002244~hematopoietic progenitor cell differentiation,GO:0002566~somatic diversification of immune receptors via somatic mutation,GO:0006382~adenosine to inosine editing,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006606~protein import into nucleus,GO:0006611~protein export from nucleus,GO:0009615~response to virus,GO:0016553~base conversion or substitution editing,GO:0030218~erythrocyte differentiation,GO:0031054~pre-miRNA processing,GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA,GO:0035455~response to interferon-alpha,GO:0043066~negative regulation of apoptotic process,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0051607~defense response to virus,GO:0060216~definitive hemopoiesis,GO:0060337~type I interferon signaling pathway,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0061484~hematopoietic stem cell homeostasis,GO:0098586~cellular response to virus,GO:1900369~negative regulation of RNA interference,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0044530~supraspliceosomal complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003726~double-stranded RNA adenosine deaminase activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000607:Double-stranded RNA-specific adenosine deaminase (DRADA),IPR002466:Adenosine deaminase/editase,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR014720:Double-stranded RNA-binding-like domain,	hsa04623:Cytosolic DNA-sensing pathway,hsa05162:Measles,hsa05164:Influenza A,	127400~Dyschromatosis symmetrica hereditaria,615010~Aicardi-Goutieres syndrome 6,		SM00358:DSRM,SM00550:Zalpha,SM00552:ADEAMc,	3D-structure,Aicardi-Goutieres syndrome,Alternative promoter usage,Alternative splicing,Antiviral defense,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA-binding,Hydrolase,Immunity,Innate immunity,Isopeptide bond,Metal-binding,Methylation,mRNA processing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,Ubl conjugation,Zinc,	active site:Proton donor,chain:Double-stranded RNA-specific adenosine deaminase,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:A to I editase,domain:DRBM 1,domain:DRBM 2,domain:DRBM 3,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,repeat:DRADA 1,repeat:DRADA 2,sequence conflict,sequence variant,splice variant,strand,turn,
AMPD1	adenosine monophosphate deaminase 1(AMPD1)	Homo sapiens				GO:0010033~response to organic substance,GO:0032264~IMP salvage,GO:0043101~purine-containing compound salvage,	GO:0005829~cytosol,	GO:0003876~AMP deaminase activity,GO:0032036~myosin heavy chain binding,GO:0046872~metal ion binding,	IPR001365:Adenosine/AMP deaminase domain,IPR006329:AMP deaminase,IPR006650:Adenosine/AMP deaminase active site,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	615511~Myopathy due to myoadenylate deaminase deficiency,	PIRSF001251:AMP deaminase,		Alternative splicing,Complete proteome,Disease mutation,Hydrolase,Metal-binding,Nucleotide metabolism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	chain:AMP deaminase 1,sequence variant,
AMPD2	adenosine monophosphate deaminase 2(AMPD2)	Homo sapiens				GO:0006188~IMP biosynthetic process,GO:0032264~IMP salvage,GO:0042632~cholesterol homeostasis,GO:0043101~purine-containing compound salvage,GO:0046033~AMP metabolic process,GO:0046034~ATP metabolic process,GO:0046039~GTP metabolic process,GO:0052652~cyclic purine nucleotide metabolic process,GO:0072015~glomerular visceral epithelial cell development,GO:0097009~energy homeostasis,	GO:0005829~cytosol,	GO:0003876~AMP deaminase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001365:Adenosine/AMP deaminase domain,IPR006329:AMP deaminase,IPR006650:Adenosine/AMP deaminase active site,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	615686~Spastic paraplegia 63,615809~Pontocerebellar hypoplasia, type 9,	PIRSF001251:AMP deaminase,		3D-structure,Alternative splicing,Complete proteome,Disease mutation,Hereditary spastic paraplegia,Hydrolase,Metal-binding,Methylation,Neurodegeneration,Nucleotide metabolism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	chain:AMP deaminase 2,modified residue,sequence conflict,splice variant,
AHCYL1	adenosylhomocysteinase like 1(AHCYL1)	Homo sapiens				GO:0006378~mRNA polyadenylation,GO:0006611~protein export from nucleus,GO:0006730~one-carbon metabolic process,GO:0010765~positive regulation of sodium ion transport,GO:0019510~S-adenosylhomocysteine catabolic process,GO:0031440~regulation of mRNA 3'-end processing,GO:0032412~regulation of ion transmembrane transporter activity,GO:0033353~S-adenosylmethionine cycle,GO:0038166~angiotensin-activated signaling pathway,GO:0042045~epithelial fluid transport,GO:0044070~regulation of anion transport,GO:0051592~response to calcium ion,GO:1903779~regulation of cardiac conduction,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016324~apical plasma membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0004013~adenosylhomocysteinase activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,GO:0051287~NAD binding,	IPR000043:Adenosylhomocysteinase,IPR015878:S-adenosyl-L-homocysteine hydrolase, NAD binding domain,IPR016040:NAD(P)-binding domain,IPR020082:S-adenosyl-L-homocysteine hydrolase, conserved site,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,		PIRSF001109:adenosylhomocysteine hydrolase, SAHH type,	SM00996:SM00996,SM00997:SM00997,	3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Endoplasmic reticulum,Hydrolase,Membrane,Microsome,NAD,One-carbon metabolism,Phosphoprotein,Reference proteome,RNA-binding,	binding site:Substrate,chain:Putative adenosylhomocysteinase 2,modified residue,region of interest:NAD binding,region of interest:PDZ-binding,region of interest:PEST,sequence conflict,splice variant,
ADCY10	adenylate cyclase 10, soluble(ADCY10)	Homo sapiens			General function prediction only,	GO:0003351~epithelial cilium movement,GO:0006171~cAMP biosynthetic process,GO:0007283~spermatogenesis,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0071241~cellular response to inorganic substance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0015630~microtubule cytoskeleton,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0031514~motile cilium,GO:0043025~neuronal cell body,GO:0045177~apical part of cell,GO:0045178~basal part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0000287~magnesium ion binding,GO:0004016~adenylate cyclase activity,GO:0005524~ATP binding,GO:0030145~manganese ion binding,GO:0051117~ATPase binding,GO:0071890~bicarbonate binding,	IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase,IPR011990:Tetratricopeptide-like helical,IPR016577:Adenylate cylcase, type 10,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa04024:cAMP signaling pathway,hsa04713:Circadian entrainment,	143870~Hypercalciuria, absorptive, susceptibility to,	PIRSF011131:soluble adenylyl cyclase,		3D-structure,Alternative splicing,ATP-binding,cAMP biosynthesis,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Lyase,Magnesium,Manganese,Membrane,Metal-binding,Mitochondrion,Nucleotide-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Adenylate cyclase type 10,domain:Guanylate cyclase 1,domain:Guanylate cyclase 2,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,metal ion-binding site:Magnesium 2; via carbonyl oxygen,modified residue,sequence conflict,sequence variant,splice variant,
ADCY3	adenylate cyclase 3(ADCY3)	Homo sapiens				GO:0003091~renal water homeostasis,GO:0006171~cAMP biosynthetic process,GO:0007165~signal transduction,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007338~single fertilization,GO:0007340~acrosome reaction,GO:0007608~sensory perception of smell,GO:0008355~olfactory learning,GO:0009190~cyclic nucleotide biosynthetic process,GO:0019933~cAMP-mediated signaling,GO:0030317~sperm motility,GO:0034199~activation of protein kinase A activity,GO:0035556~intracellular signal transduction,GO:0071377~cellular response to glucagon stimulus,GO:1904322~cellular response to forskolin,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005929~cilium,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0004016~adenylate cyclase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016849~phosphorus-oxygen lyase activity,GO:0046872~metal ion binding,	IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase,IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site,	hsa00230:Purine metabolism,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04114:Oocyte meiosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04727:GABAergic synapse,hsa04740:Olfactory transduction,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04925:Aldosterone synthesis and secretion,hsa04962:Vasopressin-regulated water reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,hsa05032:Morphine addiction,hsa05110:Vibrio cholerae infection,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05414:Dilated cardiomyopathy,			SM00044:CYCc,	Alternative splicing,ATP-binding,Calmodulin-binding,cAMP biosynthesis,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Glycoprotein,Golgi apparatus,Isopeptide bond,Lyase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Olfaction,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sensory transduction,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Adenylate cyclase type 3,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,metal ion-binding site:Magnesium 2; via carbonyl oxygen,sequence variant,topological domain:Cytoplasmic,transmembrane region,
CAP1	adenylate cyclase associated protein 1(CAP1)	Homo sapiens	81.Structure_of_Caps_and_SMACs,	h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,		GO:0000902~cell morphogenesis,GO:0001667~ameboidal-type cell migration,GO:0006898~receptor-mediated endocytosis,GO:0007163~establishment or maintenance of cell polarity,GO:0007165~signal transduction,GO:0007190~activation of adenylate cyclase activity,GO:0008154~actin polymerization or depolymerization,GO:0030036~actin cytoskeleton organization,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030864~cortical actin cytoskeleton,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0008179~adenylate cyclase binding,	IPR001837:Adenylate cyclase-associated CAP,IPR006599:CARP motif,IPR013912:Adenylate cyclase-associated CAP, C-terminal,IPR013992:Adenylate cyclase-associated CAP, N-terminal,IPR016098:Cyclase-associated protein CAP/septum formation inhibitor MinC, C-terminal,IPR017901:C-CAP/cofactor C-like domain,IPR018106:CAP, conserved site,				SM00673:CARP,	3D-structure,Acetylation,Actin-binding,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Isopeptide bond,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Ubl conjugation,	chain:Adenylyl cyclase-associated protein 1,compositionally biased region:Ala/Pro/Ser-rich,compositionally biased region:Poly-Pro,domain:C-CAP/cofactor C-like,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
AK4	adenylate kinase 4(AK4)	Homo sapiens				GO:0001889~liver development,GO:0006139~nucleobase-containing compound metabolic process,GO:0006165~nucleoside diphosphate phosphorylation,GO:0006172~ADP biosynthetic process,GO:0007420~brain development,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0042493~response to drug,GO:0046033~AMP metabolic process,GO:0046034~ATP metabolic process,GO:0046039~GTP metabolic process,GO:0046940~nucleoside monophosphate phosphorylation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0004017~adenylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0019205~nucleobase-containing compound kinase activity,GO:0046899~nucleoside triphosphate adenylate kinase activity,GO:0050145~nucleoside phosphate kinase activity,	IPR000850:Adenylate kinase,IPR006259:Adenylate kinase subfamily,IPR007862:Adenylate kinase, active site lid domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				3D-structure,Acetylation,ATP-binding,Complete proteome,GTP-binding,Kinase,Mitochondrion,Nucleotide-binding,Proteomics identification,Reference proteome,Transferase,	binding site:AMP,chain:Adenylate kinase isoenzyme 4, mitochondrial,helix,nucleotide phosphate-binding region:AMP,nucleotide phosphate-binding region:ATP,sequence conflict,strand,turn,
AK5	adenylate kinase 5(AK5)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0006165~nucleoside diphosphate phosphorylation,GO:0006172~ADP biosynthetic process,GO:0006173~dADP biosynthetic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009220~pyrimidine ribonucleotide biosynthetic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0046034~ATP metabolic process,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,	GO:0004017~adenylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,GO:0019205~nucleobase-containing compound kinase activity,GO:0019206~nucleoside kinase activity,	IPR000850:Adenylate kinase,IPR003117:cAMP-dependent protein kinase, regulatory subunit, type I/II alpha/beta,IPR006267:Adenylate kinase, isozyme 1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transferase,	binding site:AMP,chain:Adenylate kinase isoenzyme 5,helix,nucleotide phosphate-binding region:AMP,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,
ADSS	adenylosuccinate synthase(ADSS)	Homo sapiens				GO:0002376~immune system process,GO:0006167~AMP biosynthetic process,GO:0006531~aspartate metabolic process,GO:0009168~purine ribonucleoside monophosphate biosynthetic process,GO:0014074~response to purine-containing compound,GO:0044208~'de novo' AMP biosynthetic process,GO:0046040~IMP metabolic process,GO:0060359~response to ammonium ion,GO:0071257~cellular response to electrical stimulus,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004019~adenylosuccinate synthase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0042301~phosphate ion binding,	IPR001114:Adenylosuccinate synthetase,IPR018220:Adenylosuccinate synthase, active site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,IPR027529:Adenylosuccinate synthetase isozyme 2, chordates,	hsa00230:Purine metabolism,hsa00250:Alanine, aspartate and glutamate metabolism,hsa01100:Metabolic pathways,			SM00788:Adenylsucc_synt,	3D-structure,Acetylation,Complete proteome,Cytoplasm,GTP-binding,Ligase,Magnesium,Metal-binding,Nucleotide-binding,Polymorphism,Purine biosynthesis,Reference proteome,	chain:Adenylosuccinate synthetase isozyme 2,helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,strand,turn,
AJAP1	adherens junctions associated protein 1(AJAP1)	Homo sapiens				GO:0007155~cell adhesion,	GO:0005912~adherens junction,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,							Cell adhesion,Cell junction,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Adherens junction-associated protein 1,compositionally biased region:Thr-rich,modified residue,mutagenesis site,region of interest:Targeting signals,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ADGRF3	adhesion G protein-coupled receptor F3(ADGRF3)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,				SM00303:GPS,	Alternative splicing,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 113,domain:GPS,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ADGRG7	adhesion G protein-coupled receptor G7(ADGRG7)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,	IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR017981:GPCR, family 2-like,				SM00303:GPS,	Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 128,domain:GPS,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ADGRL2	adhesion G protein-coupled receptor L2(ADGRL2)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016524~latrotoxin receptor activity,GO:0030246~carbohydrate binding,	IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR000922:D-galactoside/L-rhamnose binding SUEL lectin domain,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR003112:Olfactomedin-like,IPR003334:GPCR, family 2, latrophilin, C-terminal,IPR003924:GPCR, family 2, latrophilin,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,				SM00008:HormR,SM00284:OLF,SM00303:GPS,	Alternative splicing,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lectin,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Latrophilin-2,disulfide bond,domain:GPS,domain:Olfactomedin-like,domain:SUEL-type lectin,glycosylation site:N-linked (GlcNAc...),modified residue,signal peptide,site:Cleavage,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ADGRL4	adhesion G protein-coupled receptor L4(ADGRL4)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,	GO:0004930~G-protein coupled receptor activity,GO:0005509~calcium ion binding,GO:0046983~protein dimerization activity,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000203:GPS domain,IPR000742:Epidermal growth factor-like domain,IPR000832:GPCR, family 2, secretin-like,IPR001881:EGF-like calcium-binding,IPR013032:EGF-like, conserved site,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023413:Green fluorescent protein-like,				SM00179:EGF_CA,SM00181:EGF,SM00303:GPS,	Calcium,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:EGF, latrophilin and seven transmembrane domain-containing protein 1,compositionally biased region:Poly-Glu,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:GPS,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,site:Cleavage,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
AFTPH	aftiphilin(AFTPH)	Homo sapiens				GO:0015031~protein transport,GO:0046907~intracellular transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0030121~AP-1 adaptor complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0030276~clathrin binding,						Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Aftiphilin,modified residue,region of interest:Clathrin-binding,sequence conflict,sequence variant,short sequence motif:WXXF motif 1,short sequence motif:WXXF motif 2,short sequence motif:WXXF motif 3 (partial),short sequence motif:WXXF motif 4,splice variant,
AGMAT	agmatinase(AGMAT)	Homo sapiens				GO:0008295~spermidine biosynthetic process,GO:0033388~putrescine biosynthetic process from arginine,GO:0097055~agmatine biosynthetic process,	GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0008783~agmatinase activity,GO:0016813~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,GO:0046872~metal ion binding,	IPR005925:Agmatinase-related,IPR006035:Ureohydrolase,IPR020855:Ureohydrolase, manganese-binding site,IPR023696:Ureohydrolase domain,	hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,		PIRSF036979:ureohydrolase/formiminoglutamase/proclavaminate amidino hydrolase,		Acetylation,Complete proteome,Hydrolase,Manganese,Metal-binding,Mitochondrion,Polymorphism,Putrescine biosynthesis,Reference proteome,Spermidine biosynthesis,Transit peptide,	chain:Agmatinase, mitochondrial,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,sequence conflict,sequence variant,transit peptide:Mitochondrion,
AGRN	agrin(AGRN)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,		GO:0001523~retinoid metabolic process,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0030198~extracellular matrix organization,GO:0030203~glycosaminoglycan metabolic process,GO:0043113~receptor clustering,GO:0043547~positive regulation of GTPase activity,GO:0045162~clustering of voltage-gated sodium channels,GO:0045887~positive regulation of synaptic growth at neuromuscular junction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050808~synapse organization,GO:0051491~positive regulation of filopodium assembly,	GO:0005576~extracellular region,GO:0005605~basal lamina,GO:0005737~cytoplasm,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0031012~extracellular matrix,GO:0043202~lysosomal lumen,GO:0045202~synapse,GO:0070062~extracellular exosome,	GO:0002162~dystroglycan binding,GO:0005200~structural constituent of cytoskeleton,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0033691~sialic acid binding,GO:0035374~chondroitin sulfate binding,GO:0043236~laminin binding,GO:0043395~heparan sulfate proteoglycan binding,	IPR000082:SEA domain,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR002350:Kazal domain,IPR003645:Follistatin-like, N-terminal,IPR003884:Factor I / membrane attack complex,IPR004850:Agrin NtA,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04512:ECM-receptor interaction,	615120~Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects,		SM00057:FIMAC,SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,SM00200:SEA,SM00274:FOLN,SM00280:KAZAL,SM00282:LamG,	Alternative splicing,Calcium,Cell junction,Cell membrane,Complete proteome,Congenital myasthenic syndrome,Developmental protein,Differentiation,Disease mutation,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Heparan sulfate,Laminin EGF-like domain,Membrane,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Agrin,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:Kazal-like 1,domain:Kazal-like 2,domain:Kazal-like 3,domain:Kazal-like 4,domain:Kazal-like 5,domain:Kazal-like 6,domain:Kazal-like 7,domain:Kazal-like 8,domain:Kazal-like 9,domain:Laminin EGF-like 1,domain:Laminin EGF-like 2,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,domain:NtA,domain:SEA,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
AKIRIN1	akirin 1(AKIRIN1)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0031965~nuclear membrane,	GO:0005515~protein binding,	IPR024132:Akirin,					Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Akirin-1,compositionally biased region:Pro-rich,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,
AGXT	alanine-glyoxylate aminotransferase(AGXT)	Homo sapiens				GO:0007219~Notch signaling pathway,GO:0009436~glyoxylate catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0019265~glycine biosynthetic process, by transamination of glyoxylate,GO:0019448~L-cysteine catabolic process,GO:0042853~L-alanine catabolic process,GO:0042866~pyruvate biosynthetic process,GO:0046487~glyoxylate metabolic process,GO:0046724~oxalic acid secretion,GO:0051384~response to glucocorticoid,GO:0051591~response to cAMP,	GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,	GO:0004760~serine-pyruvate transaminase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008453~alanine-glyoxylate transaminase activity,GO:0008483~transaminase activity,GO:0016597~amino acid binding,GO:0030170~pyridoxal phosphate binding,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,	IPR000192:Aminotransferase, class V/Cysteine desulfurase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR020578:Aminotransferase class-V pyridoxal-phosphate binding site,IPR024169:Serine-pyruvate aminotransferase/2-aminoethylphosphonate-pyruvate transaminase,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00260:Glycine, serine and threonine metabolism,hsa00630:Glyoxylate and dicarboxylate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04146:Peroxisome,	259900~Hyperoxaluria, primary, type 1,	PIRSF000524:serine--pyruvate aminotransferase,		3D-structure,Acetylation,Aminotransferase,Complete proteome,Disease mutation,Mitochondrion,Peroxisome,Phosphoprotein,Polymorphism,Pyridoxal phosphate,Reference proteome,Transferase,	binding site:Substrate,chain:Serine--pyruvate aminotransferase,helix,modified residue,mutagenesis site,sequence variant,strand,turn,
ALDH4A1	aldehyde dehydrogenase 4 family member A1(ALDH4A1)	Homo sapiens		h_argininecPathway:Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline,		GO:0006537~glutamate biosynthetic process,GO:0006560~proline metabolic process,GO:0006561~proline biosynthetic process,GO:0006562~proline catabolic process,GO:0010133~proline catabolic process to glutamate,GO:0019470~4-hydroxyproline catabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003842~1-pyrroline-5-carboxylate dehydrogenase activity,GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0042802~identical protein binding,	IPR005931:1-pyrroline-5-carboxylate dehydrogenase,IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,	239510~Hyperprolinemia, type II,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Mitochondrion,NAD,Oxidoreductase,Phosphoprotein,Polymorphism,Proline metabolism,Proteomics identification,Reference proteome,Transit peptide,	active site:Nucleophile,active site:Proton acceptor,chain:Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,site:Transition state stabilizer,transit peptide:Mitochondrion,
ALDH9A1	aldehyde dehydrogenase 9 family member A1(ALDH9A1)	Homo sapiens				GO:0006081~cellular aldehyde metabolic process,GO:0042136~neurotransmitter biosynthetic process,GO:0042445~hormone metabolic process,GO:0045329~carnitine biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004028~3-chloroallyl aldehyde dehydrogenase activity,GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0019145~aminobutyraldehyde dehydrogenase activity,GO:0033737~1-pyrroline dehydrogenase activity,GO:0047105~4-trimethylammoniobutyraldehyde dehydrogenase activity,	IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	hsa00010:Glycolysis / Gluconeogenesis,hsa00053:Ascorbate and aldarate metabolism,hsa00071:Fatty acid degradation,hsa00280:Valine, leucine and isoleucine degradation,hsa00310:Lysine degradation,hsa00330:Arginine and proline metabolism,hsa00340:Histidine metabolism,hsa00380:Tryptophan metabolism,hsa00410:beta-Alanine metabolism,hsa00561:Glycerolipid metabolism,hsa00620:Pyruvate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,NAD,Oxidoreductase,Polymorphism,Reference proteome,	active site:Nucleophile,active site:Proton acceptor,chain:4-trimethylaminobutyraldehyde dehydrogenase,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,site:Transition state stabilizer,
AOX1	aldehyde oxidase 1(AOX1)	Homo sapiens				GO:0006954~inflammatory response,GO:0009115~xanthine catabolic process,GO:0042816~vitamin B6 metabolic process,GO:0055114~oxidation-reduction process,GO:0072593~reactive oxygen species metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004031~aldehyde oxidase activity,GO:0004854~xanthine dehydrogenase activity,GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0043546~molybdopterin cofactor binding,GO:0046872~metal ion binding,GO:0050660~flavin adenine dinucleotide binding,GO:0051287~NAD binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR000674:Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead,IPR001041:2Fe-2S ferredoxin-type domain,IPR002346:Molybdopterin dehydrogenase, FAD-binding,IPR002888:[2Fe-2S]-binding,IPR005107:CO dehydrogenase flavoprotein, C-terminal,IPR006058:2Fe-2S ferredoxin, iron-sulphur binding site,IPR008274:Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding,IPR012675:Beta-grasp domain,IPR014313:Aldehyde oxidase,IPR016166:FAD-binding, type 2,IPR016167:FAD-binding, type 2, subdomain 1,IPR016169:CO dehydrogenase flavoprotein-like, FAD-binding, subdomain 2,IPR016208:Aldehyde oxidase/xanthine dehydrogenase,IPR022407:Oxidoreductase, molybdopterin binding site,	hsa00280:Valine, leucine and isoleucine degradation,hsa00350:Tyrosine metabolism,hsa00380:Tryptophan metabolism,hsa00750:Vitamin B6 metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa00830:Retinol metabolism,hsa00982:Drug metabolism - cytochrome P450,hsa01100:Metabolic pathways,		PIRSF000127:xanthine dehydrogenase,	SM01008:SM01008,SM01092:SM01092,	2Fe-2S,3D-structure,Complete proteome,Cytoplasm,FAD,Flavoprotein,Iron,Iron-sulfur,Metal-binding,Molybdenum,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Aldehyde oxidase,domain:2Fe-2S ferredoxin-type,domain:FAD-binding PCMH-type,metal ion-binding site:Iron-sulfur (2Fe-2S),sequence conflict,sequence variant,
AKR1A1	aldo-keto reductase family 1 member A1(AKR1A1)	Homo sapiens				GO:0006006~glucose metabolic process,GO:0006081~cellular aldehyde metabolic process,GO:0019640~glucuronate catabolic process to xylulose 5-phosphate,GO:0019853~L-ascorbic acid biosynthetic process,GO:0042840~D-glucuronate catabolic process,GO:0046185~aldehyde catabolic process,GO:0055114~oxidation-reduction process,GO:1901687~glutathione derivative biosynthetic process,	GO:0005615~extracellular space,GO:0005829~cytosol,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0004032~alditol:NADP+ 1-oxidoreductase activity,GO:0004033~aldo-keto reductase (NADP) activity,GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0047939~L-glucuronate reductase activity,	IPR001395:Aldo/keto reductase,IPR018170:Aldo/keto reductase, conserved site,IPR020471:Aldo/keto reductase subgroup,IPR023210:NADP-dependent oxidoreductase domain,	hsa00010:Glycolysis / Gluconeogenesis,hsa00040:Pentose and glucuronate interconversions,hsa00561:Glycerolipid metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01220:Degradation of aromatic compounds,		PIRSF000097:aldo-keto reductase,		3D-structure,Acetylation,Complete proteome,Direct protein sequencing,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton donor,binding site:Substrate,chain:Alcohol dehydrogenase [NADP+],helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,site:Lowers pKa of active site Tyr,strand,
AKR7L	aldo-keto reductase family 7 like (gene/pseudogene)(AKR7L)	Homo sapiens				GO:0006805~xenobiotic metabolic process,GO:0055114~oxidation-reduction process,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004033~aldo-keto reductase (NADP) activity,	IPR001395:Aldo/keto reductase,IPR023210:NADP-dependent oxidoreductase domain,					Alternative splicing,Complete proteome,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Selenocysteine,	active site:Proton donor,binding site:NADP,binding site:Substrate,chain:Aflatoxin B1 aldehyde reductase member 4,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,site:Lowers pKa of active site Tyr,splice variant,
AKR7A3	aldo-keto reductase family 7 member A3(AKR7A3)	Homo sapiens				GO:0006081~cellular aldehyde metabolic process,GO:0006805~xenobiotic metabolic process,GO:0055114~oxidation-reduction process,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004033~aldo-keto reductase (NADP) activity,GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0042802~identical protein binding,	IPR001395:Aldo/keto reductase,IPR023210:NADP-dependent oxidoreductase domain,	hsa00980:Metabolism of xenobiotics by cytochrome P450,				3D-structure,Complete proteome,Cytoplasm,NAD,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,	active site:Proton donor,binding site:NADP,binding site:Substrate,chain:Aflatoxin B1 aldehyde reductase member 3,helix,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,site:Lowers pKa of active site Tyr,strand,turn,
ALPI	alkaline phosphatase, intestinal(ALPI)	Homo sapiens				GO:0016311~dephosphorylation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,	GO:0000287~magnesium ion binding,GO:0002020~protease binding,GO:0004035~alkaline phosphatase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001952:Alkaline phosphatase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR018299:Alkaline phosphatase, active site,	hsa00790:Folate biosynthesis,hsa01100:Metabolic pathways,			SM00098:alkPPc,	Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Magnesium,Membrane,Metal-binding,Polymorphism,Reference proteome,Signal,Transmembrane,Zinc,	active site:Phosphoserine intermediate,chain:Intestinal-type alkaline phosphatase,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated aspartate,metal ion-binding site:Magnesium,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,
ALPL	alkaline phosphatase, liver/bone/kidney(ALPL)	Homo sapiens		h_npp1Pathway:Regulators of Bone Mineralization,		GO:0001501~skeletal system development,GO:0001649~osteoblast differentiation,GO:0001958~endochondral ossification,GO:0003006~developmental process involved in reproduction,GO:0016311~dephosphorylation,GO:0032496~response to lipopolysaccharide,GO:0033280~response to vitamin D,GO:0046677~response to antibiotic,GO:0051384~response to glucocorticoid,GO:0071407~cellular response to organic cyclic compound,GO:0071529~cementum mineralization,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0065010~extracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004035~alkaline phosphatase activity,GO:0005515~protein binding,GO:0016462~pyrophosphatase activity,GO:0016791~phosphatase activity,GO:0046872~metal ion binding,	IPR001952:Alkaline phosphatase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR018299:Alkaline phosphatase, active site,	hsa00790:Folate biosynthesis,hsa01100:Metabolic pathways,	146300~Hypophosphatasia, adult,146300~Odontohypophosphatasia,241500~Hypophosphatasia, infantile,241510~Hypophosphatasia, childhood,		SM00098:alkPPc,	Alternative splicing,Biomineralization,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Magnesium,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Zinc,	active site:Phosphoserine intermediate,chain:Alkaline phosphatase, tissue-nonspecific isozyme,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,metal ion-binding site:Magnesium,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,
ALPPL2	alkaline phosphatase, placental like 2(ALPPL2)	Homo sapiens				GO:0016311~dephosphorylation,	GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,	GO:0004035~alkaline phosphatase activity,GO:0046872~metal ion binding,	IPR001952:Alkaline phosphatase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR018299:Alkaline phosphatase, active site,	hsa00790:Folate biosynthesis,hsa01100:Metabolic pathways,			SM00098:alkPPc,	Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Magnesium,Membrane,Metal-binding,Polymorphism,Reference proteome,Signal,Zinc,	active site:Phosphoserine intermediate,chain:Alkaline phosphatase, placental-like,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated aspartate,metal ion-binding site:Magnesium,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,
AGPS	alkylglycerone phosphate synthase(AGPS)	Homo sapiens			Energy production and conversion,	GO:0008610~lipid biosynthetic process,GO:0008611~ether lipid biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0008609~alkylglycerone-phosphate synthase activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0050660~flavin adenine dinucleotide binding,GO:0071949~FAD binding,	IPR004113:FAD-linked oxidase, C-terminal,IPR006094:FAD linked oxidase, N-terminal,IPR016164:FAD-linked oxidase-like, C-terminal,IPR016166:FAD-binding, type 2,IPR016167:FAD-binding, type 2, subdomain 1,IPR016169:CO dehydrogenase flavoprotein-like, FAD-binding, subdomain 2,IPR025650:Alkyldihydroxyacetonephosphate synthase,	hsa00565:Ether lipid metabolism,hsa01100:Metabolic pathways,hsa04146:Peroxisome,	600121~Chondrodysplasia punctata, rhizomelic, type 3,			Acetylation,Cataract,Complete proteome,Disease mutation,Dwarfism,FAD,Flavoprotein,Lipid biosynthesis,Lipid metabolism,Membrane,Peroxisome,Phosphoprotein,Proteomics identification,Reference proteome,Rhizomelic chondrodysplasia punctata,Transferase,Transit peptide,	chain:Alkyldihydroxyacetonephosphate synthase, peroxisomal,compositionally biased region:Poly-Ala,domain:FAD-binding PCMH-type,modified residue,sequence variant,transit peptide:Peroxisome,
ALLC	allantoicase(ALLC)	Homo sapiens				GO:0000256~allantoin catabolic process,		GO:0004037~allantoicase activity,	IPR005164:Allantoicase,IPR008979:Galactose-binding domain-like,IPR015908:Allantoicase domain,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,		PIRSF016516:allantoicase,		Alternative splicing,Complete proteome,Hydrolase,Reference proteome,	chain:Probable allantoicase,sequence conflict,splice variant,
A3GALT2	alpha 1,3-galactosyltransferase 2(A3GALT2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006688~glycosphingolipid biosynthetic process,GO:0009247~glycolipid biosynthetic process,GO:0030259~lipid glycosylation,	GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0031982~vesicle,GO:0032580~Golgi cisterna membrane,	GO:0001962~alpha-1,3-galactosyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0046872~metal ion binding,GO:0047276~N-acetyllactosaminide 3-alpha-galactosyltransferase activity,	IPR005076:Glycosyl transferase, family 6,					Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Metal-binding,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha 1,3-galactosyltransferase 2,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Manganese,signal peptide,
ACY1	aminoacylase 1(ACY1)	Homo sapiens			Amino acid transport and metabolism,	GO:0006508~proteolysis,GO:0006520~cellular amino acid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0043171~peptide catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004046~aminoacylase activity,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0070573~metallodipeptidase activity,	IPR001261:ArgE/DapE/ACY1/CPG2/YscS, conserved site,IPR002933:Peptidase M20,IPR010159:N-acyl-L-amino-acid amidohydrolase,IPR011650:Peptidase M20, dimerisation domain,	hsa00220:Arginine biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01210:2-Oxocarboxylic acid metabolism,hsa01230:Biosynthesis of amino acids,	609924~Aminoacylase 1 deficiency,	PIRSF036696:acyl-amino-acid amidohydrolase 1,		3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Metal-binding,Polymorphism,Reference proteome,Zinc,	active site:Proton acceptor,chain:Aminoacylase-1,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,sequence variant,strand,turn,
ACMSD	aminocarboxymuconate semialdehyde decarboxylase(ACMSD)	Homo sapiens				GO:0006568~tryptophan metabolic process,GO:0006569~tryptophan catabolic process,GO:0046874~quinolinate metabolic process,GO:0051259~protein oligomerization,GO:1904984~regulation of quinolinate biosynthetic process,GO:1905004~picolinic acid biosynthetic process,GO:1905012~regulation of 'de novo' NAD biosynthetic process from tryptophan,	GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001760~aminocarboxymuconate-semialdehyde decarboxylase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,	IPR006680:Amidohydrolase 1,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Complete proteome,Decarboxylase,Lyase,Membrane,Metal-binding,Reference proteome,Transmembrane,Transmembrane helix,Zinc,	binding site:Substrate,chain:2-amino-3-carboxymuconate-6-semialdehyde decarboxylase,metal ion-binding site:Zinc,modified residue,splice variant,
AMT	aminomethyltransferase(AMT)	Homo sapiens				GO:0006546~glycine catabolic process,GO:0019464~glycine decarboxylation via glycine cleavage system,GO:0032259~methylation,GO:0046487~glyoxylate metabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004047~aminomethyltransferase activity,GO:0008483~transaminase activity,	IPR006222:Glycine cleavage T-protein, N-terminal,IPR006223:Glycine cleavage system T protein,IPR013977:Glycine cleavage T-protein, C-terminal barrel,IPR027266:GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1,	hsa00260:Glycine, serine and threonine metabolism,hsa00630:Glyoxylate and dicarboxylate metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,	605899~Glycine encephalopathy,	PIRSF006487:aminomethyltransferase,		3D-structure,Alternative splicing,Aminotransferase,Complete proteome,Disease mutation,Methyltransferase,Mitochondrion,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:Aminomethyltransferase, mitochondrial,helix,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,turn,
AMY2A	amylase, alpha 2A (pancreatic)(AMY2A)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0016052~carbohydrate catabolic process,GO:0044245~polysaccharide digestion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004556~alpha-amylase activity,GO:0005509~calcium ion binding,GO:0031404~chloride ion binding,GO:0043169~cation binding,	IPR006046:Alpha amylase,IPR006047:Glycosyl hydrolase, family 13, catalytic domain,IPR006048:Alpha-amylase, C-terminal all beta,IPR013780:Glycosyl hydrolase, family 13, all-beta,IPR013781:Glycoside hydrolase, catalytic domain,IPR015902:Glycoside hydrolase, family 13,IPR017853:Glycoside hydrolase, superfamily,	hsa00500:Starch and sucrose metabolism,hsa01100:Metabolic pathways,hsa04973:Carbohydrate digestion and absorption,			SM00632:Aamy_C,SM00642:Aamy,	3D-structure,Alternative splicing,Calcium,Carbohydrate metabolism,Chloride,Complete proteome,Disulfide bond,Glycoprotein,Glycosidase,Hydrolase,Metal-binding,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	active site:Nucleophile,active site:Proton donor,binding site:Chloride,chain:Pancreatic alpha-amylase,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,mutagenesis site,signal peptide,strand,turn,
AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase(AGL)	Homo sapiens				GO:0005978~glycogen biosynthetic process,GO:0005980~glycogen catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043033~isoamylase complex,	GO:0004133~glycogen debranching enzyme activity,GO:0004134~4-alpha-glucanotransferase activity,GO:0004135~amylo-alpha-1,6-glucosidase activity,GO:0005515~protein binding,GO:0030247~polysaccharide binding,	IPR006421:Glycogen debranching enzyme, metazoa,IPR008928:Six-hairpin glycosidase-like,IPR010401:Amylo-alpha-1,6-glucosidase,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,	hsa00500:Starch and sucrose metabolism,hsa01100:Metabolic pathways,	232400~Glycogen storage disease IIIa,232400~Glycogen storage disease IIIb,			Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Glycogen biosynthesis,Glycogen storage disease,Glycosidase,Glycosyltransferase,Hydrolase,Multifunctional enzyme,Phosphoprotein,Polymorphism,Reference proteome,Transferase,Ubl conjugation,	chain:Glycogen debranching enzyme,modified residue,region of interest:4-alpha-glucanotransferase,region of interest:Amylo-1,6-glucosidase,sequence conflict,sequence variant,splice variant,
ALS2CR11	amyotrophic lateral sclerosis 2 chromosome region candidate 11(ALS2CR11)	Homo sapiens						GO:0005515~protein binding,	IPR000008:C2 calcium-dependent membrane targeting,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein,sequence variant,splice variant,
ALS2CR12	amyotrophic lateral sclerosis 2 chromosome region candidate 12(ALS2CR12)	Homo sapiens				GO:0043087~regulation of GTPase activity,	GO:0001520~outer dense fiber,GO:0005737~cytoplasm,GO:0035686~sperm fibrous sheath,	GO:0005515~protein binding,	IPR026674:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein,modified residue,sequence variant,
ANAPC1	anaphase promoting complex subunit 1(ANAPC1)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051301~cell division,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0051439~regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0070979~protein K11-linked ubiquitination,	GO:0005654~nucleoplasm,GO:0005680~anaphase-promoting complex,GO:0005829~cytosol,		IPR024990:Anaphase-promoting complex subunit 1,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04914:Progesterone-mediated oocyte maturation,hsa05166:HTLV-I infection,				3D-structure,Cell cycle,Cell division,Complete proteome,Mitosis,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Anaphase-promoting complex subunit 1,modified residue,repeat:PC 1,repeat:PC 2,repeat:PC 3,repeat:PC 4,sequence conflict,
ALK	anaplastic lymphoma receptor tyrosine kinase(ALK)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008283~cell proliferation,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0038061~NIK/NF-kappaB signaling,GO:0042981~regulation of apoptotic process,GO:0046777~protein autophosphorylation,GO:0048666~neuron development,GO:0051092~positive regulation of NF-kappaB transcription factor activity,	GO:0005622~intracellular,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0004704~NF-kappaB-inducing kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0042802~identical protein binding,	IPR000719:Protein kinase, catalytic domain,IPR000998:MAM domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR026830:ALK tyrosine kinase receptor,IPR026984:Leukocyte tyrosine kinase receptor,	hsa05223:Non-small cell lung cancer,	613014~Neuroblastoma, susceptibility to, 3,		SM00192:LDLa,SM00219:TyrKc,	3D-structure,ATP-binding,Cell membrane,Chromosomal rearrangement,Complete proteome,Disease mutation,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:ALK tyrosine kinase receptor,compositionally biased region:Gly-rich,domain:LDL-receptor class A,domain:MAM 1,domain:MAM 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
AUP1	ancient ubiquitous protein 1(AUP1)	Homo sapiens				GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030970~retrograde protein transport, ER to cytosol,GO:0050790~regulation of catalytic activity,	GO:0000839~Hrd1p ubiquitin ligase ERAD-L complex,GO:0016020~membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0043130~ubiquitin binding,GO:0097027~ubiquitin-protein transferase activator activity,	IPR003892:Ubiquitin system component Cue,				SM00546:CUE,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Endoplasmic reticulum,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	chain:Ancient ubiquitous protein 1,compositionally biased region:Poly-Phe,domain:CUE,helix,modified residue,sequence conflict,splice variant,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ANGEL2	angel homolog 2(ANGEL2)	Homo sapiens				GO:0045930~negative regulation of mitotic cell cycle,GO:0070935~3'-UTR-mediated mRNA stabilization,	GO:0005737~cytoplasm,GO:0015030~Cajal body,	GO:0003730~mRNA 3'-UTR binding,	IPR005135:Endonuclease/exonuclease/phosphatase,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein angel homolog 2,sequence variant,splice variant,
ANGPTL1	angiopoietin like 1(ANGPTL1)	Homo sapiens				GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,				SM00186:FBG,	Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Angiopoietin-related protein 1,disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),signal peptide,
ANGPTL3	angiopoietin like 3(ANGPTL3)	Homo sapiens				GO:0001525~angiogenesis,GO:0006071~glycerol metabolic process,GO:0006631~fatty acid metabolic process,GO:0006644~phospholipid metabolic process,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0008203~cholesterol metabolic process,GO:0009395~phospholipid catabolic process,GO:0009725~response to hormone,GO:0010519~negative regulation of phospholipase activity,GO:0019915~lipid storage,GO:0030335~positive regulation of cell migration,GO:0042632~cholesterol homeostasis,GO:0045766~positive regulation of angiogenesis,GO:0048844~artery morphogenesis,GO:0050996~positive regulation of lipid catabolic process,GO:0051005~negative regulation of lipoprotein lipase activity,GO:0055088~lipid homeostasis,GO:0055090~acylglycerol homeostasis,GO:0055091~phospholipid homeostasis,GO:0070328~triglyceride homeostasis,	GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0009986~cell surface,GO:0030027~lamellipodium,	GO:0004857~enzyme inhibitor activity,GO:0004859~phospholipase inhibitor activity,GO:0005178~integrin binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,		605019~Hypobetalipoproteinemia, familial, 2,		SM00186:FBG,	Angiogenesis,Cell adhesion,Cell projection,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Heparin-binding,Lipid metabolism,Polymorphism,Reference proteome,Secreted,Signal,	chain:Angiopoietin-related protein 3,disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
AGT	angiotensinogen(AGT)	Homo sapiens		h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),		GO:0001558~regulation of cell growth,GO:0001819~positive regulation of cytokine production,GO:0001822~kidney development,GO:0001974~blood vessel remodeling,GO:0002003~angiotensin maturation,GO:0002016~regulation of blood volume by renin-angiotensin,GO:0002018~renin-angiotensin regulation of aldosterone production,GO:0002019~regulation of renal output by angiotensin,GO:0002027~regulation of heart rate,GO:0002034~regulation of blood vessel size by renin-angiotensin,GO:0003014~renal system process,GO:0003051~angiotensin-mediated drinking behavior,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0003331~positive regulation of extracellular matrix constituent secretion,GO:0006883~cellular sodium ion homeostasis,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007199~G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007263~nitric oxide mediated signal transduction,GO:0007267~cell-cell signaling,GO:0007565~female pregnancy,GO:0007568~aging,GO:0008217~regulation of blood pressure,GO:0010535~positive regulation of activation of JAK2 kinase activity,GO:0010595~positive regulation of endothelial cell migration,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0010629~negative regulation of gene expression,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010873~positive regulation of cholesterol esterification,GO:0010951~negative regulation of endopeptidase activity,GO:0014061~regulation of norepinephrine secretion,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014824~artery smooth muscle contraction,GO:0014873~response to muscle activity involved in regulation of muscle adaptation,GO:0016525~negative regulation of angiogenesis,GO:0019229~regulation of vasoconstriction,GO:0030308~negative regulation of cell growth,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032930~positive regulation of superoxide anion generation,GO:0033864~positive regulation of NAD(P)H oxidase activity,GO:0034104~negative regulation of tissue remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0035411~catenin import into nucleus,GO:0035813~regulation of renal sodium excretion,GO:0035815~positive regulation of renal sodium excretion,GO:0038166~angiotensin-activated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042311~vasodilation,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045777~positive regulation of blood pressure,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045909~positive regulation of vasodilation,GO:0048144~fibroblast proliferation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048659~smooth muscle cell proliferation,GO:0050663~cytokine secretion,GO:0050729~positive regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051387~negative regulation of neurotrophin TRK receptor signaling pathway,GO:0051403~stress-activated MAPK cascade,GO:0051924~regulation of calcium ion transport,GO:0051969~regulation of transmission of nerve impulse,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0070371~ERK1 and ERK2 cascade,GO:0070471~uterine smooth muscle contraction,GO:0071260~cellular response to mechanical stimulus,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:1901201~regulation of extracellular matrix assembly,GO:1902632~positive regulation of membrane hyperpolarization,GO:1902828~positive regulation of L-arginine import into cell,GO:1903598~positive regulation of gap junction assembly,GO:1903779~regulation of cardiac conduction,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,GO:1905010~positive regulation of L-lysine import into cell,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000650~negative regulation of sodium ion transmembrane transporter activity,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0016176~superoxide-generating NADPH oxidase activator activity,GO:0017080~sodium channel regulator activity,GO:0031702~type 1 angiotensin receptor binding,GO:0031703~type 2 angiotensin receptor binding,GO:0048018~receptor agonist activity,	IPR000215:Serpin family,IPR000227:Angiotensinogen,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,	hsa04614:Renin-angiotensin system,hsa04924:Renin secretion,	145500~Hypertension, essential, susceptibility to,267430~Renal tubular dysgenesis,Preeclampsia, susceptibility to~Preeclampsia, susceptibility to,		SM00093:SERPIN,	3D-structure,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,Vasoactive,Vasoconstrictor,	chain:Angiotensinogen,glycosylation site:N-linked (GlcNAc...),modified residue,peptide:Angiotensin-1,peptide:Angiotensin-2,peptide:Angiotensin-3,sequence conflict,sequence variant,signal peptide,
ANKAR	ankyrin and armadillo repeat containing(ANKAR)	Homo sapiens					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,		IPR000225:Armadillo,IPR002110:Ankyrin repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR020683:Ankyrin repeat-containing domain,				SM00185:ARM,SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Ankyrin and armadillo repeat-containing protein,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,sequence conflict,sequence variant,splice variant,transmembrane region,
ANKMY1	ankyrin repeat and MYND domain containing 1(ANKMY1)	Homo sapiens			Function unknown,			GO:0046872~metal ion binding,	IPR002110:Ankyrin repeat,IPR002893:Zinc finger, MYND-type,IPR003409:MORN motif,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00698:MORN,	Alternative splicing,ANK repeat,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Ankyrin repeat and MYND domain-containing protein 1,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:MORN 1,repeat:MORN 2,repeat:MORN 3,sequence conflict,sequence variant,splice variant,zinc finger region:MYND-type,
ASB1	ankyrin repeat and SOCS box containing 1(ASB1)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0030539~male genitalia development,GO:0035556~intracellular signal transduction,GO:0042036~negative regulation of cytokine biosynthetic process,	GO:0005622~intracellular,		IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00969:SM00969,	ANK repeat,Complete proteome,Developmental protein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Ankyrin repeat and SOCS box protein 1,domain:SOCS box,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,
ASB14	ankyrin repeat and SOCS box containing 14(ASB14)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0031625~ubiquitin protein ligase binding,	IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00253:SOCS,SM00969:SM00969,	Alternative splicing,ANK repeat,Complete proteome,Reference proteome,Repeat,Signal,	chain:Ankyrin repeat and SOCS box protein 14,domain:SOCS box,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,splice variant,
ASB17	ankyrin repeat and SOCS box containing 17(ASB17)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,		IPR001496:SOCS protein, C-terminal,IPR020683:Ankyrin repeat-containing domain,				SM00969:SM00969,	ANK repeat,Complete proteome,Polymorphism,Reference proteome,Ubl conjugation pathway,	chain:Ankyrin repeat and SOCS box protein 17,domain:SOCS box,repeat:ANK,sequence variant,
ASB18	ankyrin repeat and SOCS box containing 18(ASB18)	Homo sapiens			General function prediction only,	GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0031625~ubiquitin protein ligase binding,	IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00969:SM00969,	Alternative splicing,ANK repeat,Complete proteome,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	chain:Ankyrin repeat and SOCS box protein 18,domain:SOCS box,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence variant,splice variant,
ASB3	ankyrin repeat and SOCS box containing 3(ASB3)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00969:SM00969,	Alternative splicing,ANK repeat,Complete proteome,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Ankyrin repeat and SOCS box protein 3,domain:SOCS box,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,splice variant,
ANKRD13C	ankyrin repeat domain 13C(ANKRD13C)	Homo sapiens				GO:0006621~protein retention in ER lumen,GO:0010869~regulation of receptor biosynthetic process,GO:2000209~regulation of anoikis,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005102~receptor binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,IPR021832:Ankyrin repeat domain-containing protein 13,				SM00248:ANK,	Alternative splicing,ANK repeat,Chaperone,Complete proteome,Endoplasmic reticulum,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 13C,compositionally biased region:Poly-Ala,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,splice variant,
ANKRD20A12P	ankyrin repeat domain 20 family member A12, pseudogene(ANKRD20A12P)	Homo sapiens												Coiled coil,Complete proteome,Reference proteome,
ANKRD20A8P	ankyrin repeat domain 20 family member A8, pseudogene(ANKRD20A8P)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 20A4,chain:Ankyrin repeat domain-containing protein 20B,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence conflict,splice variant,
ANKRD28	ankyrin repeat domain 28(ANKRD28)	Homo sapiens			General function prediction only,	GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative promoter usage,Alternative splicing,ANK repeat,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 12,repeat:ANK 13,repeat:ANK 14,repeat:ANK 15,repeat:ANK 16,repeat:ANK 17,repeat:ANK 18,repeat:ANK 19,repeat:ANK 2,repeat:ANK 20,repeat:ANK 21,repeat:ANK 22,repeat:ANK 23,repeat:ANK 24,repeat:ANK 25,repeat:ANK 26,repeat:ANK 27,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,splice variant,
ANKRD30BL	ankyrin repeat domain 30B like(ANKRD30BL)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Reference proteome,Repeat,
ANKRD35	ankyrin repeat domain 35(ANKRD35)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 35,compositionally biased region:Poly-Ala,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence conflict,sequence variant,
ANKRD36	ankyrin repeat domain 36(ANKRD36)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 36,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,splice variant,
ANKRD36B	ankyrin repeat domain 36B(ANKRD36B)	Homo sapiens						GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:UPF0634 protein B,sequence conflict,sequence variant,splice variant,
ANKRD36C	ankyrin repeat domain 36C(ANKRD36C)	Homo sapiens						GO:0008200~ion channel inhibitor activity,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:UPF0634 protein C,sequence conflict,splice variant,
ANKRD39	ankyrin repeat domain 39(ANKRD39)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 39,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence conflict,sequence variant,
ANKRD44	ankyrin repeat domain 44(ANKRD44)	Homo sapiens						GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Proteomics identification,Reference proteome,Repeat,	chain:Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 12,repeat:ANK 13,repeat:ANK 14,repeat:ANK 15,repeat:ANK 16,repeat:ANK 17,repeat:ANK 18,repeat:ANK 19,repeat:ANK 2,repeat:ANK 20,repeat:ANK 21,repeat:ANK 22,repeat:ANK 23,repeat:ANK 24,repeat:ANK 25,repeat:ANK 26,repeat:ANK 27,repeat:ANK 28,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,splice variant,
ANKRD45	ankyrin repeat domain 45(ANKRD45)	Homo sapiens						GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 45,compositionally biased region:Poly-Glu,repeat:ANK 1,repeat:ANK 2,splice variant,
ANKRD53	ankyrin repeat domain 53(ANKRD53)	Homo sapiens				GO:0007080~mitotic metaphase plate congression,GO:0031116~positive regulation of microtubule polymerization,GO:0051301~cell division,GO:0060236~regulation of mitotic spindle organization,GO:1902412~regulation of mitotic cytokinesis,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005819~spindle,	GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Mitosis,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 53,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence variant,splice variant,
ANXA4	annexin A4(ANXA4)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007219~Notch signaling pathway,GO:0030855~epithelial cell differentiation,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0043066~negative regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0050819~negative regulation of coagulation,GO:2000483~negative regulation of interleukin-8 secretion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0012506~vesicle membrane,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004859~phospholipase inhibitor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0042802~identical protein binding,GO:0048306~calcium-dependent protein binding,GO:0051059~NF-kappaB binding,	IPR001464:Annexin,IPR002391:Annexin, type IV,IPR002392:Annexin, type V,IPR018252:Annexin repeat, conserved site,IPR018502:Annexin repeat,				SM00335:ANX,	3D-structure,Acetylation,Alternative splicing,Annexin,Calcium,Calcium/phospholipid-binding,Complete proteome,Direct protein sequencing,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Annexin A4,helix,modified residue,repeat:Annexin 1,repeat:Annexin 2,repeat:Annexin 3,repeat:Annexin 4,sequence conflict,sequence variant,turn,
ANXA9	annexin A9(ANXA9)	Homo sapiens				GO:0007165~signal transduction,GO:0016337~single organismal cell-cell adhesion,	GO:0005829~cytosol,GO:0009986~cell surface,GO:0070062~extracellular exosome,	GO:0001786~phosphatidylserine binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0015464~acetylcholine receptor activity,GO:0042803~protein homodimerization activity,	IPR001464:Annexin,IPR009116:Annexin, type XXXI,IPR018252:Annexin repeat, conserved site,IPR018502:Annexin repeat,				SM00335:ANX,	Annexin,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:Annexin A9,modified residue,repeat:Annexin 1,repeat:Annexin 2,repeat:Annexin 3,repeat:Annexin 4,sequence variant,
ANO10	anoctamin 10(ANO10)	Homo sapiens				GO:0006812~cation transport,GO:0006821~chloride transport,GO:0034220~ion transmembrane transport,GO:0098655~cation transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005227~calcium activated cation channel activity,GO:0005229~intracellular calcium activated chloride channel activity,	IPR007632:Anoctamin/TMEM 16,		613728~Spinocerebellar ataxia, autosomal recessive 10,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Membrane,Neurodegeneration,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Anoctamin-10,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ANO7	anoctamin 7(ANO7)	Homo sapiens				GO:0006821~chloride transport,GO:0006869~lipid transport,GO:0034220~ion transmembrane transport,GO:0061588~calcium activated phospholipid scrambling,GO:0061589~calcium activated phosphatidylserine scrambling,GO:0061590~calcium activated phosphatidylcholine scrambling,GO:0061591~calcium activated galactosylceramide scrambling,GO:1902476~chloride transmembrane transport,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,	GO:0005229~intracellular calcium activated chloride channel activity,GO:0017128~phospholipid scramblase activity,GO:0046983~protein dimerization activity,	IPR007632:Anoctamin/TMEM 16,					Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Endoplasmic reticulum,Glycoprotein,Lipid transport,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Anoctamin-7,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ANTXR1	anthrax toxin receptor 1(ANTXR1)	Homo sapiens				GO:0001568~blood vessel development,GO:0007165~signal transduction,GO:0022414~reproductive process,GO:0031532~actin cytoskeleton reorganization,GO:0034446~substrate adhesion-dependent cell spreading,GO:1901202~negative regulation of extracellular matrix assembly,GO:1905050~positive regulation of metallopeptidase activity,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0031258~lamellipodium membrane,GO:0031527~filopodium membrane,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,	IPR002035:von Willebrand factor, type A,IPR008399:Anthrax toxin receptor, C-terminal,IPR008400:Anthrax toxin receptor, extracellular,IPR017360:Anthrax toxin receptor,		230740~GAPO syndrome,602089~Hemangioma, capillary infantile, susceptibility to,	PIRSF038023:anthrax toxin receptor,	SM00327:VWA,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Disulfide bond,Glycoprotein,Hypotrichosis,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Anthrax toxin receptor 1,compositionally biased region:Asp/Glu-rich (highly acidic),compositionally biased region:Pro-rich,domain:VWFA,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Divalent metal cation,modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
APH1A	aph-1 homolog A, gamma-secretase subunit(APH1A)	Homo sapiens				GO:0001656~metanephros development,GO:0006509~membrane protein ectodomain proteolysis,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0016485~protein processing,GO:0031293~membrane protein intracellular domain proteolysis,GO:0042987~amyloid precursor protein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0048013~ephrin receptor signaling pathway,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,GO:0070765~gamma-secretase complex,	GO:0004175~endopeptidase activity,GO:0005515~protein binding,	IPR009294:Gamma-secretase subunit Aph-1,	hsa04330:Notch signaling pathway,hsa05010:Alzheimer's disease,				3D-structure,Alternative splicing,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Membrane,Notch signaling pathway,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gamma-secretase subunit APH-1A,sequence conflict,splice variant,transmembrane region,
APOB	apolipoprotein B(APOB)	Homo sapiens			DNA replication, recombination, and repair,	GO:0001523~retinoid metabolic process,GO:0001701~in utero embryonic development,GO:0006642~triglyceride mobilization,GO:0006898~receptor-mediated endocytosis,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0008203~cholesterol metabolic process,GO:0009566~fertilization,GO:0009615~response to virus,GO:0009743~response to carbohydrate,GO:0009791~post-embryonic development,GO:0010269~response to selenium ion,GO:0010628~positive regulation of gene expression,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010884~positive regulation of lipid storage,GO:0010886~positive regulation of cholesterol storage,GO:0019433~triglyceride catabolic process,GO:0030301~cholesterol transport,GO:0030317~sperm motility,GO:0032496~response to lipopolysaccharide,GO:0033344~cholesterol efflux,GO:0034374~low-density lipoprotein particle remodeling,GO:0034379~very-low-density lipoprotein particle assembly,GO:0034383~low-density lipoprotein particle clearance,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042159~lipoprotein catabolic process,GO:0042632~cholesterol homeostasis,GO:0042953~lipoprotein transport,GO:0044257~cellular protein catabolic process,GO:0045540~regulation of cholesterol biosynthetic process,GO:0048844~artery morphogenesis,GO:0050900~leukocyte migration,GO:0071356~cellular response to tumor necrosis factor,GO:0071379~cellular response to prostaglandin stimulus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0015629~actin cytoskeleton,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031904~endosome lumen,GO:0034359~mature chylomicron,GO:0034360~chylomicron remnant,GO:0034361~very-low-density lipoprotein particle,GO:0034362~low-density lipoprotein particle,GO:0034363~intermediate-density lipoprotein particle,GO:0042627~chylomicron,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,GO:0070971~endoplasmic reticulum exit site,GO:0071682~endocytic vesicle lumen,	GO:0005319~lipid transporter activity,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008201~heparin binding,GO:0017127~cholesterol transporter activity,GO:0035473~lipase binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR001747:Lipid transport protein, N-terminal,IPR009454:Lipid transport, open beta-sheet,IPR011030:Vitellinogen, superhelical,IPR015255:Vitellinogen, open beta-sheet,IPR015816:Vitellinogen, beta-sheet N-terminal,IPR015817:Vitellinogen, open beta-sheet, subdomain 1,IPR015818:Vitellinogen, open beta-sheet, subdomain 2,IPR015819:Lipid transport protein, beta-sheet shell,IPR016024:Armadillo-type fold,IPR022176:Apolipoprotein B100 C-terminal,	hsa04975:Fat digestion and absorption,hsa04977:Vitamin digestion and absorption,	144010~Hypercholesterolemia, due to ligand-defective apo B,615558~Hypobetalipoproteinemia,		SM00638:LPD_N,SM01169:SM01169,	Acetylation,Atherosclerosis,Cholesterol metabolism,Chylomicron,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Heparin-binding,LDL,Lipid metabolism,Lipid transport,Lipoprotein,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA editing,Secreted,Signal,Steroid metabolism,Sterol metabolism,Transport,VLDL,	chain:Apolipoprotein B-100,chain:Apolipoprotein B-48,disulfide bond,domain:Vitellogenin,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:Basic (possible receptor binding region),region of interest:Heparin-binding,region of interest:LDL receptor binding,sequence conflict,sequence variant,signal peptide,
APLF	aprataxin and PNKP like factor(APLF)	Homo sapiens				GO:0000012~single strand break repair,GO:0006302~double-strand break repair,GO:0006974~cellular response to DNA damage stimulus,GO:0045191~regulation of isotype switching,GO:0051106~positive regulation of DNA ligation,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0035861~site of double-strand break,	GO:0000166~nucleotide binding,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0008408~3'-5' exonuclease activity,GO:0046872~metal ion binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,IPR019406:Zinc finger, C2H2, APLF-like,					3D-structure,ADP-ribosylation,Coiled coil,Complete proteome,Cytoplasm,DNA damage,DNA repair,Lyase,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Aprataxin and PNK-like factor,domain:FHA-like,modified residue,mutagenesis site,sequence conflict,sequence variant,zinc finger region:PBZ-type 1,zinc finger region:PBZ-type 2,
AQP10	aquaporin 10(AQP10)	Homo sapiens				GO:0006833~water transport,GO:0009636~response to toxic substance,GO:0009992~cellular water homeostasis,GO:0015793~glycerol transport,GO:0034219~carbohydrate transmembrane transport,GO:0034220~ion transmembrane transport,GO:0071918~urea transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0015204~urea transmembrane transporter activity,GO:0015250~water channel activity,GO:0015254~glycerol channel activity,GO:0015265~urea channel activity,	IPR000425:Major intrinsic protein,IPR022357:Major intrinsic protein, conserved site,IPR023271:Aquaporin-like,IPR026252:Aquaporin 10,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Aquaporin-10,sequence variant,short sequence motif:NPA 1,short sequence motif:NPA 2,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
AQP12B	aquaporin 12B(AQP12B)	Homo sapiens				GO:0006833~water transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005215~transporter activity,GO:0015250~water channel activity,	IPR000425:Major intrinsic protein,IPR016697:Aquaporin 11/12,IPR023265:Aquaporin 12,IPR023271:Aquaporin-like,			PIRSF017529:aquaporin, 11/12 types,		Alternative splicing,Complete proteome,Membrane,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Aquaporin-12B,short sequence motif:NPA 1,short sequence motif:NPA 2,splice variant,transmembrane region,
RSRP1	arginine and serine rich protein 1(RSRP1)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:UPF0471 protein C1orf63,compositionally biased region:Arg-rich,modified residue,sequence variant,splice variant,
RERE	arginine-glutamic acid dipeptide repeats(RERE)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006607~NLS-bearing protein import into nucleus,GO:0021691~cerebellar Purkinje cell layer maturation,GO:0021930~cerebellar granule cell precursor proliferation,GO:0021942~radial glia guided migration of Purkinje cell,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048755~branching morphogenesis of a nerve,GO:0048813~dendrite morphogenesis,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008267~poly-glutamine tract binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000679:Zinc finger, GATA-type,IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR001025:Bromo adjacent homology (BAH) domain,IPR002951:Atrophin-like,IPR009057:Homeodomain-like,IPR013088:Zinc finger, NHR/GATA-type,IPR017884:SANT domain,				SM00401:ZnF_GATA,SM00439:BAH,SM00717:SANT,SM01189:SM01189,	3D-structure,Acetylation,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Developmental protein,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Arginine-glutamic acid dipeptide repeats protein,compositionally biased region:Arg/Glu-rich (mixed charge),compositionally biased region:His-rich,compositionally biased region:Pro-rich,domain:BAH,domain:ELM2,domain:SANT,helix,modified residue,sequence conflict,splice variant,zinc finger region:GATA-type,
RNPEP	arginyl aminopeptidase(RNPEP)	Homo sapiens				GO:0006508~proteolysis,GO:0043171~peptide catabolic process,GO:0045776~negative regulation of blood pressure,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0030141~secretory granule,GO:0070062~extracellular exosome,	GO:0004177~aminopeptidase activity,GO:0004301~epoxide hydrolase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0042277~peptide binding,GO:0070006~metalloaminopeptidase activity,	IPR001930:Peptidase M1, alanine aminopeptidase/leukotriene A4 hydrolase,IPR014782:Peptidase M1, membrane alanine aminopeptidase, N-terminal,IPR015211:Peptidase M1, leukotriene A4 hydrolase, aminopeptidase C-terminal,IPR015571:Peptidase M1, aminopeptidase B,IPR016024:Armadillo-type fold,				SM01263:SM01263,	Acetylation,Aminopeptidase,Complete proteome,Hydrolase,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Signal,Zinc,	active site:Proton donor,chain:Aminopeptidase B,metal ion-binding site:Zinc; catalytic,modified residue,sequence conflict,sequence variant,
AGO3	argonaute 3, RISC catalytic component(AGO3)	Homo sapiens		h_dicerPathway:Dicer Pathway,		GO:0006402~mRNA catabolic process,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0010501~RNA secondary structure unwinding,GO:0010628~positive regulation of gene expression,GO:0031054~pre-miRNA processing,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0035278~miRNA mediated inhibition of translation,GO:0035279~mRNA cleavage involved in gene silencing by miRNA,GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA,GO:0048015~phosphatidylinositol-mediated signaling,GO:0072091~regulation of stem cell proliferation,GO:0090625~mRNA cleavage involved in gene silencing by siRNA,GO:1901224~positive regulation of NIK/NF-kappaB signaling,	GO:0000794~condensed nuclear chromosome,GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016442~RISC complex,GO:0035068~micro-ribonucleoprotein complex,GO:0070578~RISC-loading complex,	GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0035198~miRNA binding,GO:0044822~poly(A) RNA binding,	IPR003100:Argonaute/Dicer protein, PAZ,IPR003165:Stem cell self-renewal protein Piwi,IPR012337:Ribonuclease H-like domain,IPR014811:Domain of unknown function DUF1785,				SM00949:SM00949,SM00950:SM00950,SM01163:SM01163,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Initiation factor,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,RNA-mediated gene silencing,Translation regulation,	chain:Protein argonaute-3,domain:PAZ,domain:Piwi,sequence conflict,
AGO4	argonaute 4, RISC catalytic component(AGO4)	Homo sapiens		h_dicerPathway:Dicer Pathway,		GO:0006402~mRNA catabolic process,GO:0007130~synaptonemal complex assembly,GO:0007140~male meiosis,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0008584~male gonad development,GO:0010501~RNA secondary structure unwinding,GO:0010586~miRNA metabolic process,GO:0022604~regulation of cell morphogenesis,GO:0031054~pre-miRNA processing,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0035278~miRNA mediated inhibition of translation,GO:0035279~mRNA cleavage involved in gene silencing by miRNA,GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA,GO:0043066~negative regulation of apoptotic process,GO:0048015~phosphatidylinositol-mediated signaling,GO:0090625~mRNA cleavage involved in gene silencing by siRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016442~RISC complex,GO:0035068~micro-ribonucleoprotein complex,GO:0070578~RISC-loading complex,	GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0005515~protein binding,GO:0035198~miRNA binding,	IPR003100:Argonaute/Dicer protein, PAZ,IPR003165:Stem cell self-renewal protein Piwi,IPR012337:Ribonuclease H-like domain,IPR014811:Domain of unknown function DUF1785,				SM00949:SM00949,SM00950:SM00950,SM01163:SM01163,	Complete proteome,Cytoplasm,Reference proteome,Ribonucleoprotein,RNA-binding,RNA-mediated gene silencing,Translation regulation,	chain:Protein argonaute-4,domain:PAZ,domain:Piwi,modified residue,
ARIH2	ariadne RBR E3 ubiquitin protein ligase 2(ARIH2)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007275~multicellular organism development,GO:0016567~protein ubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0048588~developmental cell growth,GO:0070534~protein K63-linked ubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:0071425~hematopoietic stem cell proliferation,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031466~Cul5-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031624~ubiquitin conjugating enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR002867:Zinc finger, C6HC-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00647:IBR,	Complete proteome,Cytoplasm,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Protein ariadne-2 homolog,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,zinc finger region:IBR-type,zinc finger region:RING-type 1; atypical,zinc finger region:RING-type 2,
ARMC9	armadillo repeat containing 9(ARMC9)	Homo sapiens					GO:0070062~extracellular exosome,		IPR006594:LisH dimerisation motif,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,				SM00667:LisH,	Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:LisH domain-containing protein ARMC9,compositionally biased region:Poly-Ser,domain:LisH,sequence conflict,sequence variant,splice variant,
ARNT	aryl hydrocarbon receptor nuclear translocator(ARNT)	Homo sapiens		h_acrPathway:Ahr Signal Transduction Pathway,h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB,h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0001666~response to hypoxia,GO:0001892~embryonic placenta development,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006351~transcription, DNA-templated,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0030154~cell differentiation,GO:0030522~intracellular receptor signaling pathway,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0033235~positive regulation of protein sumoylation,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045821~positive regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046886~positive regulation of hormone biosynthetic process,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0004874~aryl hydrocarbon receptor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0017162~aryl hydrocarbon receptor binding,GO:0035326~enhancer binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR000014:PAS domain,IPR001067:Nuclear translocator,IPR001610:PAC motif,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013655:PAS fold-3,IPR013767:PAS fold,	hsa04066:HIF-1 signaling pathway,hsa05200:Pathways in cancer,hsa05204:Chemical carcinogenesis,hsa05211:Renal cell carcinoma,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Aryl hydrocarbon receptor nuclear translocator,compositionally biased region:Gln-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ser,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAC,domain:PAS 1,domain:PAS 2,helix,modified residue,sequence variant,splice variant,strand,turn,
ASNSD1	asparagine synthetase domain containing 1(ASNSD1)	Homo sapiens				GO:0006529~asparagine biosynthetic process,GO:0006541~glutamine metabolic process,	GO:0005829~cytosol,	GO:0004066~asparagine synthase (glutamine-hydrolyzing) activity,GO:0042803~protein homodimerization activity,	IPR001962:Asparagine synthase,IPR009053:Prefoldin,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR017932:Glutamine amidotransferase type 2 domain,					Amino-acid biosynthesis,Asparagine biosynthesis,Coiled coil,Complete proteome,Glutamine amidotransferase,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,chain:Asparagine synthetase domain-containing protein 1,domain:Asparagine synthetase,domain:Glutamine amidotransferase type-2,sequence variant,
DNPEP	aspartyl aminopeptidase(DNPEP)	Homo sapiens				GO:0006508~proteolysis,GO:0006518~peptide metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0072562~blood microparticle,	GO:0004177~aminopeptidase activity,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0070006~metalloaminopeptidase activity,	IPR001948:Peptidase M18,IPR023358:Peptidase M18, domain 2,					3D-structure,Acetylation,Aminopeptidase,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Metalloprotease,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Signal,Zinc,	chain:Aspartyl aminopeptidase,metal ion-binding site:Zinc,modified residue,sequence conflict,
DARS2	aspartyl-tRNA synthetase 2, mitochondrial(DARS2)	Homo sapiens				GO:0006418~tRNA aminoacylation for protein translation,GO:0043039~tRNA aminoacylation,GO:0070145~mitochondrial asparaginyl-tRNA aminoacylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0000049~tRNA binding,GO:0003676~nucleic acid binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004815~aspartate-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,GO:0050560~aspartate-tRNA(Asn) ligase activity,	IPR002312:Aspartyl/Asparaginyl-tRNA synthetase, class IIb,IPR004115:GAD domain,IPR004364:Aminoacyl-tRNA synthetase, class II (D/K/N),IPR004365:Nucleic acid binding, OB-fold, tRNA/helicase-type,IPR004524:Aspartate-tRNA ligase, class IIb, bacterial/mitochondrial-type,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR012340:Nucleic acid-binding, OB-fold,IPR018150:Aminoacyl-tRNA synthetase, class II (D/K/N)-like,	hsa00970:Aminoacyl-tRNA biosynthesis,	611105~Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,			3D-structure,Acetylation,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Disease mutation,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Reference proteome,Transit peptide,	chain:Aspartyl-tRNA synthetase, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
DARS	aspartyl-tRNA synthetase(DARS)	Homo sapiens				GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006422~aspartyl-tRNA aminoacylation,GO:0006461~protein complex assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0004046~aminoacylase activity,GO:0004815~aspartate-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR002312:Aspartyl/Asparaginyl-tRNA synthetase, class IIb,IPR004364:Aminoacyl-tRNA synthetase, class II (D/K/N),IPR004365:Nucleic acid binding, OB-fold, tRNA/helicase-type,IPR004523:Aspartyl-tRNA synthetases,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR012340:Nucleic acid-binding, OB-fold,IPR018150:Aminoacyl-tRNA synthetase, class II (D/K/N)-like,	hsa00970:Aminoacyl-tRNA biosynthesis,	615281~Hypomyelination with brainstem and spinal cord involvement and leg spasticity,			3D-structure,Acetylation,Alternative splicing,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Ligase,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,	chain:Aspartyl-tRNA synthetase, cytoplasmic,modified residue,region of interest:Binding site for the 3'-end of tRNA,sequence conflict,sequence variant,
ASTN1	astrotactin 1(ASTN1)	Homo sapiens				GO:0001764~neuron migration,GO:0007158~neuron cell-cell adhesion,GO:0007626~locomotory behavior,	GO:0005768~endosome,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030136~clathrin-coated vesicle,GO:0043204~perikaryon,		IPR000742:Epidermal growth factor-like domain,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR020864:Membrane attack complex component/perforin (MACPF) domain,IPR026995:Astrotactin,				SM00181:EGF,SM00457:MACPF,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Cytoplasmic vesicle,Disulfide bond,EGF-like domain,Endosome,Glycoprotein,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Astrotactin-1,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:Fibronectin type-III 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,transmembrane region,
ATXN7	ataxin 7(ATXN7)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006997~nucleus organization,GO:0007601~visual perception,GO:0016578~histone deubiquitination,GO:0042326~negative regulation of phosphorylation,GO:0043569~negative regulation of insulin-like growth factor receptor signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0016363~nuclear matrix,GO:0030914~STAGA complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR013243:SCA7 domain,		164500~Spinocerebellar ataxia 7,			3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Isopeptide bond,Neurodegeneration,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Spinocerebellar ataxia,Transcription,Transcription regulation,Triplet repeat expansion,Ubl conjugation,	chain:Ataxin-7,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:SCA7,modified residue,sequence conflict,sequence variant,splice variant,
ATL2	atlastin GTPase 2(ATL2)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007029~endoplasmic reticulum organization,GO:0007030~Golgi organization,GO:0051260~protein homooligomerization,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0042802~identical protein binding,	IPR003191:Guanylate-binding protein, C-terminal,IPR015894:Guanylate-binding protein, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,GTP-binding,Hydrolase,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Atlastin-2,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ATOH8	atonal bHLH transcription factor 8(ATOH8)	Homo sapiens				GO:0001704~formation of primary germ layer,GO:0001937~negative regulation of endothelial cell proliferation,GO:0006351~transcription, DNA-templated,GO:0007399~nervous system development,GO:0010595~positive regulation of endothelial cell migration,GO:0030154~cell differentiation,GO:0035148~tube formation,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051450~myoblast proliferation,GO:0060395~SMAD protein signal transduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0033613~activating transcription factor binding,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Neurogenesis,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Protein atonal homolog 8,compositionally biased region:Pro-rich,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,sequence variant,splice variant,
ACKR2	atypical chemokine receptor 2(ACKR2)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0070098~chemokine-mediated signaling pathway,	GO:0005769~early endosome,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0055037~recycling endosome,	GO:0004950~chemokine receptor activity,GO:0005044~scavenger receptor activity,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR001277:CXC chemokine receptor 4,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Inflammatory response,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Chemokine-binding protein 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
AUNIP	aurora kinase A and ninein interacting protein(AUNIP)	Homo sapiens				GO:0007051~spindle organization,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0005515~protein binding,						Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf135,modified residue,sequence variant,
ATG16L1	autophagy related 16 like 1(ATG16L1)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0015031~protein transport,GO:0016236~macroautophagy,GO:0039689~negative stranded viral RNA replication,GO:0051260~protein homooligomerization,	GO:0000421~autophagosome membrane,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0005930~axoneme,GO:0034045~pre-autophagosomal structure membrane,	GO:0005515~protein binding,GO:0019787~ubiquitin-like protein transferase activity,GO:0042802~identical protein binding,	IPR001680:WD40 repeat,IPR013923:Autophagy-related protein 16,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04140:Regulation of autophagy,	611081~Inflammatory bowel disease 10,		SM00320:WD40,	3D-structure,Alternative splicing,Autophagy,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,WD repeat,	chain:Autophagy-related protein 16-1,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
ATG3	autophagy related 3(ATG3)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006464~cellular protein modification process,GO:0006612~protein targeting to membrane,GO:0016236~macroautophagy,GO:0016567~protein ubiquitination,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0044804~nucleophagy,GO:0050765~negative regulation of phagocytosis,GO:1902017~regulation of cilium assembly,	GO:0000153~cytoplasmic ubiquitin ligase complex,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0016874~ligase activity,GO:0019776~Atg8 ligase activity,GO:0019777~Atg12 transferase activity,GO:0019787~ubiquitin-like protein transferase activity,GO:0019899~enzyme binding,	IPR007134:Autophagy-related protein 3, N-terminal,IPR007135:Autophagy-related protein 3,IPR019461:Autophagy-related protein 3, C-terminal,	hsa04140:Regulation of autophagy,				3D-structure,Acetylation,Alternative splicing,Autophagy,Complete proteome,Cytoplasm,Isopeptide bond,Ligase,Protein transport,Proteomics identification,Reference proteome,Transport,Ubl conjugation,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Autophagy-related protein 3,modified residue,mutagenesis site,splice variant,
ATG4B	autophagy related 4B cysteine peptidase(ATG4B)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006501~C-terminal protein lipidation,GO:0006508~proteolysis,GO:0006612~protein targeting to membrane,GO:0006914~autophagy,GO:0015031~protein transport,GO:0016236~macroautophagy,GO:0016485~protein processing,GO:0044804~nucleophagy,GO:0045732~positive regulation of protein catabolic process,GO:0051697~protein delipidation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0005515~protein binding,GO:0008234~cysteine-type peptidase activity,	IPR005078:Peptidase C54,	hsa04140:Regulation of autophagy,				3D-structure,Acetylation,Alternative splicing,Autophagy,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Phosphoprotein,Polymorphism,Protease,Protein transport,Proteomics identification,Reference proteome,Thiol protease,Transport,Ubl conjugation pathway,	active site:Nucleophile,chain:Cysteine protease ATG4B,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
ATG4C	autophagy related 4C cysteine peptidase(ATG4C)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006501~C-terminal protein lipidation,GO:0006508~proteolysis,GO:0006612~protein targeting to membrane,GO:0006914~autophagy,GO:0015031~protein transport,GO:0016485~protein processing,GO:0044804~nucleophagy,GO:0051697~protein delipidation,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004197~cysteine-type endopeptidase activity,GO:0008233~peptidase activity,	IPR005078:Peptidase C54,	hsa04140:Regulation of autophagy,				Acetylation,Autophagy,Complete proteome,Cytoplasm,Hydrolase,Phosphoprotein,Protease,Protein transport,Proteomics identification,Reference proteome,Thiol protease,Transport,Ubl conjugation pathway,	active site:Nucleophile,chain:Cysteine protease ATG4C,modified residue,
ATG7	autophagy related 7(ATG7)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0006497~protein lipidation,GO:0006501~C-terminal protein lipidation,GO:0006914~autophagy,GO:0006995~cellular response to nitrogen starvation,GO:0009267~cellular response to starvation,GO:0010508~positive regulation of autophagy,GO:0015031~protein transport,GO:0016236~macroautophagy,GO:0016239~positive regulation of macroautophagy,GO:0016567~protein ubiquitination,GO:0031401~positive regulation of protein modification process,GO:0034727~piecemeal microautophagy of nucleus,GO:0039521~suppression by virus of host autophagy,GO:0043065~positive regulation of apoptotic process,GO:0044805~late nucleophagy,GO:0045732~positive regulation of protein catabolic process,GO:0051607~defense response to virus,GO:0061025~membrane fusion,GO:0071455~cellular response to hyperoxia,GO:1903146~regulation of mitophagy,	GO:0000407~pre-autophagosomal structure,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005930~axoneme,	GO:0004839~ubiquitin activating enzyme activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008641~small protein activating enzyme activity,GO:0019778~Atg12 activating enzyme activity,GO:0019779~Atg8 activating enzyme activity,GO:0042803~protein homodimerization activity,	IPR000594:UBA/THIF-type NAD/FAD binding fold,IPR006285:Ubiquitin-like modifier-activating enzyme Atg7,IPR016040:NAD(P)-binding domain,	hsa04140:Regulation of autophagy,				Acetylation,Alternative splicing,Autophagy,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Autophagy-related protein 7,modified residue,sequence variant,splice variant,
ATG9A	autophagy related 9A(ATG9A)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006914~autophagy,GO:0015031~protein transport,GO:0034497~protein localization to pre-autophagosomal structure,GO:0034727~piecemeal microautophagy of nucleus,GO:0044805~late nucleophagy,	GO:0000407~pre-autophagosomal structure,GO:0000421~autophagosome membrane,GO:0005768~endosome,GO:0005770~late endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005802~trans-Golgi network,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,GO:0031902~late endosome membrane,GO:0055037~recycling endosome,	GO:0005515~protein binding,	IPR007241:Autophagy-related protein 9,					Acetylation,Alternative splicing,Autophagy,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Autophagy-related protein 9A,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
AIDA	axin interactor, dorsalization associated(AIDA)	Homo sapiens				GO:0009953~dorsal/ventral pattern formation,GO:0043496~regulation of protein homodimerization activity,GO:0043508~negative regulation of JUN kinase activity,GO:0046329~negative regulation of JNK cascade,GO:0048264~determination of ventral identity,	GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0035091~phosphatidylinositol binding,	IPR023421:Axin interactor, dorsalization-associated protein, N-terminal,IPR025939:Axin interactor dorsalization-associated protein, C-terminal domain,					Alternative splicing,Coiled coil,Complete proteome,Developmental protein,Phosphoprotein,Reference proteome,	chain:Axin interactor, dorsalization-associated protein,modified residue,region of interest:Axin-binding,sequence conflict,splice variant,
AXDND1	axonemal dynein light chain domain containing 1(AXDND1)	Homo sapiens							IPR019347:Axonemal dynein light chain,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf125,compositionally biased region:Glu-rich,modified residue,sequence variant,splice variant,
BIRC6	baculoviral IAP repeat containing 6(BIRC6)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007067~mitotic nuclear division,GO:0008284~positive regulation of cell proliferation,GO:0010951~negative regulation of endopeptidase activity,GO:0016567~protein ubiquitination,GO:0032465~regulation of cytokinesis,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0051301~cell division,GO:0060711~labyrinthine layer development,GO:0060712~spongiotrophoblast layer development,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0000922~spindle pole,GO:0005768~endosome,GO:0005802~trans-Golgi network,GO:0005815~microtubule organizing center,GO:0016020~membrane,GO:0030496~midbody,	GO:0004842~ubiquitin-protein transferase activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR001370:Baculoviral inhibition of apoptosis protein repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR022103:Protein of unknown function DUF3643,	hsa04120:Ubiquitin mediated proteolysis,			SM00238:BIR,	3D-structure,Apoptosis,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Endosome,Golgi apparatus,Membrane,Mitosis,Phosphoprotein,Protease inhibitor,Proteomics identification,Reference proteome,Thiol protease inhibitor,Transferase,Ubl conjugation,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Baculoviral IAP repeat-containing protein 6,compositionally biased region:Poly-Ala,helix,modified residue,region of interest:Ubiquitin-conjugating,repeat:BIR,sequence conflict,strand,turn,
BSND	barttin CLCNK type accessory beta subunit(BSND)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,GO:1903959~regulation of anion transmembrane transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016323~basolateral plasma membrane,GO:0043234~protein complex,	GO:0005247~voltage-gated chloride channel activity,GO:0005254~chloride channel activity,GO:0017081~chloride channel regulator activity,			602522~Bartter syndrome, type 4a,602522~Sensorineural deafness with mild renal dysfunction,			Bartter syndrome,Cell membrane,Complete proteome,Cytoplasm,Deafness,Disease mutation,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Barttin,mutagenesis site,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
BHLHE40	basic helix-loop-helix family member e40(BHLHE40)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032922~circadian regulation of gene expression,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,GO:0043425~bHLH transcription factor binding,GO:0043426~MRF binding,GO:0046982~protein heterodimerization activity,GO:0070888~E-box binding,	IPR003650:Orange,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa04710:Circadian rhythm,			SM00353:HLH,SM00511:ORANGE,	Biological rhythms,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Class E basic helix-loop-helix protein 40,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Orange,modified residue,
BZW1	basic leucine zipper and W2 domains 1(BZW1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003307:W2 domain,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,				SM00515:eIF5C,	Acetylation,Activator,Alternative splicing,Complete proteome,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Basic leucine zipper and W2 domain- containing protein 1,domain:W2,modified residue,splice variant,
BLZF1	basic leucine zipper nuclear factor 1(BLZF1)	Homo sapiens			DNA replication, recombination, and repair,	GO:0001558~regulation of cell growth,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007030~Golgi organization,GO:0008283~cell proliferation,GO:0016192~vesicle-mediated transport,GO:0043001~Golgi to plasma membrane protein transport,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005796~Golgi lumen,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,	IPR013183:DASH complex subunit Hsk3 like,IPR027095:Golgin-45,					ADP-ribosylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,ER-Golgi transport,Golgi apparatus,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,Ubl conjugation,	chain:Golgin-45,modified residue,region of interest:Essential for the interaction with GORASP2,sequence conflict,sequence variant,splice variant,
BTF3L4	basic transcription factor 3 like 4(BTF3L4)	Homo sapiens						GO:0005515~protein binding,	IPR002715:Nascent polypeptide-associated complex NAC domain,				SM01407:SM01407,	Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Transcription factor BTF3 homolog 4,domain:NAC-A/B,modified residue,
BSN	bassoon presynaptic cytomatrix protein(BSN)	Homo sapiens				GO:0007268~chemical synaptic transmission,GO:0007416~synapse assembly,GO:0035418~protein localization to synapse,	GO:0005634~nucleus,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0044306~neuron projection terminus,GO:0048786~presynaptic active zone,GO:0048788~cytoskeleton of presynaptic active zone,GO:0060076~excitatory synapse,	GO:0046872~metal ion binding,	IPR008899:Zinc finger, piccolo-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,					Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Glycoprotein,Lipoprotein,Metal-binding,Methylation,Myristate,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Synapse,Synaptosome,Zinc,Zinc-finger,	chain:Protein bassoon,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,glycosylation site:O-linked (GlcNAc),lipid moiety-binding region:N-myristoyl glycine,modified residue,region of interest:3 X 7 AA tandem repeats of K-A-S-P-[LQ]- [APS]-[KST],region of interest:5 X 2 AA tandem repeats of P-G,region of interest:7 X 2 AA tandem repeats of P-G,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,zinc finger region:C4-type,
B3GALNT2	beta-1,3-N-acetylgalactosaminyltransferase 2(B3GALNT2)	Homo sapiens				GO:0006486~protein glycosylation,GO:0006493~protein O-linked glycosylation,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0016021~integral component of membrane,	GO:0008375~acetylglucosaminyltransferase activity,GO:0008376~acetylgalactosaminyltransferase activity,GO:0008378~galactosyltransferase activity,	IPR002659:Glycosyl transferase, family 31,		615181~Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11,			Alternative splicing,Complete proteome,Congenital muscular dystrophy,Disease mutation,Dystroglycanopathy,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Golgi apparatus,Lissencephaly,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-GalNAc:beta-1,3-N- acetylgalactosaminyltransferase 2,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
B3GALT1	beta-1,3-galactosyltransferase 1(B3GALT1)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,		GO:0006486~protein glycosylation,GO:0009312~oligosaccharide biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0047275~glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,3-galactosyltransferase 1,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
B3GALT2	beta-1,3-galactosyltransferase 2(B3GALT2)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,		GO:0006486~protein glycosylation,GO:0009312~oligosaccharide biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0047275~glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,3-galactosyltransferase 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
B3GALT6	beta-1,3-galactosyltransferase 6(B3GALT6)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,GO:0006486~protein glycosylation,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0030203~glycosaminoglycan metabolic process,GO:0030206~chondroitin sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0005797~Golgi medial cisterna,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0035250~UDP-galactosyltransferase activity,GO:0047220~galactosylxylosylprotein 3-beta-galactosyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,	271640~Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures,615349~Ehlers-Danlos syndrome, progeroid type, 2,			Complete proteome,Disease mutation,Dwarfism,Ehlers-Danlos syndrome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,3-galactosyltransferase 6,compositionally biased region:Poly-Pro,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
B4GALT2	beta-1,4-galactosyltransferase 2(B4GALT2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006486~protein glycosylation,GO:0007613~memory,GO:0007626~locomotory behavior,GO:0008542~visual learning,GO:0018146~keratan sulfate biosynthetic process,GO:0021680~cerebellar Purkinje cell layer development,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0003831~beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,GO:0003945~N-acetyllactosamine synthase activity,GO:0004461~lactose synthase activity,GO:0008378~galactosyltransferase activity,GO:0046872~metal ion binding,	IPR003859:Galactosyltransferase, metazoa,	hsa00052:Galactose metabolism,hsa00510:N-Glycan biosynthesis,hsa00514:Other types of O-glycan biosynthesis,hsa00533:Glycosaminoglycan biosynthesis - keratan sulfate,hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Metal-binding,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,4-galactosyltransferase 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Manganese,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
BTD	biotinidase(BTD)	Homo sapiens				GO:0006768~biotin metabolic process,GO:0006807~nitrogen compound metabolic process,GO:0007417~central nervous system development,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0047708~biotinidase activity,	IPR003010:Carbon-nitrogen hydrolase,IPR012101:Biotinidase, eukaryotic,	hsa00780:Biotin metabolism,hsa01100:Metabolic pathways,hsa04977:Vitamin digestion and absorption,	253260~Biotinidase deficiency,	PIRSF011861:biotinidase, eukaryotic type,		Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Glycoprotein,Hydrolase,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	active site:Nucleophile,active site:Proton acceptor,chain:Biotinidase,domain:CN hydrolase,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
BMP8A	bone morphogenetic protein 8a(BMP8A)	Homo sapiens				GO:0001503~ossification,GO:0002024~diet induced thermogenesis,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0030509~BMP signaling pathway,GO:0040007~growth,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0046676~negative regulation of insulin secretion,GO:0048468~cell development,GO:0051216~cartilage development,GO:0060395~SMAD protein signal transduction,GO:2000505~regulation of energy homeostasis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0008083~growth factor activity,GO:0070700~BMP receptor binding,	IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR002405:Inhibin, alpha subunit,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,			SM00204:TGFB,	Chondrogenesis,Complete proteome,Cytokine,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Growth factor,Osteogenesis,Polymorphism,Reference proteome,Secreted,Signal,	chain:Bone morphogenetic protein 8A,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
BMP8B	bone morphogenetic protein 8b(BMP8B)	Homo sapiens				GO:0001501~skeletal system development,GO:0001503~ossification,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0030509~BMP signaling pathway,GO:0040007~growth,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048468~cell development,GO:0051216~cartilage development,GO:0060395~SMAD protein signal transduction,	GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0008083~growth factor activity,GO:0070700~BMP receptor binding,	IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR002405:Inhibin, alpha subunit,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,			SM00204:TGFB,	Alternative splicing,Chondrogenesis,Complete proteome,Cytokine,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Growth factor,Osteogenesis,Polymorphism,Reference proteome,Secreted,Signal,	chain:Bone morphogenetic protein 8B,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
BMPR2	bone morphogenetic protein receptor type 2(BMPR2)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,		GO:0001707~mesoderm formation,GO:0001893~maternal placenta development,GO:0001935~endothelial cell proliferation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001946~lymphangiogenesis,GO:0001974~blood vessel remodeling,GO:0002063~chondrocyte development,GO:0003085~negative regulation of systemic arterial blood pressure,GO:0003148~outflow tract septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003183~mitral valve morphogenesis,GO:0003186~tricuspid valve morphogenesis,GO:0003197~endocardial cushion development,GO:0003252~negative regulation of cell proliferation involved in heart valve morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007420~brain development,GO:0009267~cellular response to starvation,GO:0009952~anterior/posterior pattern specification,GO:0010595~positive regulation of endothelial cell migration,GO:0010634~positive regulation of epithelial cell migration,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0014916~regulation of lung blood pressure,GO:0023014~signal transduction by protein phosphorylation,GO:0030166~proteoglycan biosynthetic process,GO:0030308~negative regulation of cell growth,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0032924~activin receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045778~positive regulation of ossification,GO:0045906~negative regulation of vasoconstriction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048286~lung alveolus development,GO:0048738~cardiac muscle tissue development,GO:0048842~positive regulation of axon extension involved in axon guidance,GO:0060173~limb development,GO:0060350~endochondral bone morphogenesis,GO:0060412~ventricular septum morphogenesis,GO:0060413~atrial septum morphogenesis,GO:0060836~lymphatic endothelial cell differentiation,GO:0060840~artery development,GO:0060841~venous blood vessel development,GO:0061036~positive regulation of cartilage development,GO:0061298~retina vasculature development in camera-type eye,GO:0061626~pharyngeal arch artery morphogenesis,GO:0071773~cellular response to BMP stimulus,GO:0072577~endothelial cell apoptotic process,GO:1902731~negative regulation of chondrocyte proliferation,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0005911~cell-cell junction,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016324~apical plasma membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0044214~spanning component of plasma membrane,	GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016362~activin receptor activity, type II,GO:0019838~growth factor binding,GO:0036122~BMP binding,GO:0046872~metal ion binding,GO:0098821~BMP receptor activity,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR015770:Bone morphogenic protein type II receptor,IPR017441:Protein kinase, ATP binding site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05206:MicroRNAs in cancer,	178600~Pulmonary hypertension, familial primary, 1, with or without HHT,178600~Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated,265450~Pulmonary venoocclusive disease 1,			3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Bone morphogenetic protein receptor type- 2,compositionally biased region:Poly-Asn,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
BOLL	boule homolog, RNA binding protein(BOLL)	Homo sapiens				GO:0007126~meiotic nuclear division,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0045948~positive regulation of translational initiation,GO:0070935~3'-UTR-mediated mRNA stabilization,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008494~translation activator activity,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Proteomics identification,Reference proteome,RNA-binding,Spermatogenesis,Translation regulation,	chain:Protein boule-like,domain:DAZ-like,domain:RRM,sequence conflict,splice variant,
BRE	brain and reproductive organ-expressed (TNFRSF1A modulator)(BRE)	Homo sapiens				GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007067~mitotic nuclear division,GO:0007165~signal transduction,GO:0010212~response to ionizing radiation,GO:0016569~covalent chromatin modification,GO:0031572~G2 DNA damage checkpoint,GO:0045739~positive regulation of DNA repair,GO:0051301~cell division,GO:0070536~protein K63-linked deubiquitination,	GO:0000152~nuclear ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070531~BRCA1-A complex,GO:0070552~BRISC complex,	GO:0000268~peroxisome targeting sequence binding,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0031593~polyubiquitin binding,	IPR010358:Brain/reproductive organ-expressed protein,					Acetylation,Alternative splicing,Apoptosis,Cell cycle,Cell division,Chromatin regulator,Complete proteome,Cytoplasm,DNA damage,DNA repair,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:BRCA1-A complex subunit BRE,modified residue,region of interest:UEV-like 1,region of interest:UEV-like 2,sequence conflict,splice variant,
BCAR3	breast cancer anti-estrogen resistance 3(BCAR3)	Homo sapiens				GO:0002089~lens morphogenesis in camera-type eye,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0009967~positive regulation of signal transduction,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0042493~response to drug,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,	GO:0005070~SH3/SH2 adaptor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000980:SH2 domain,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR023578:Ras guanine nucleotide exchange factor, domain,				SM00147:RasGEF,SM00252:SH2,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Methylation,Phosphoprotein,Polymorphism,Reference proteome,SH2 domain,	chain:Breast cancer anti-estrogen resistance protein 3,compositionally biased region:Poly-Asp,domain:Ras-GEF,domain:SH2,modified residue,sequence variant,splice variant,
BCAN	brevican(BCAN)	Homo sapiens				GO:0001501~skeletal system development,GO:0007155~cell adhesion,GO:0007417~central nervous system development,GO:0021766~hippocampus development,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0030203~glycosaminoglycan metabolic process,GO:0030206~chondroitin sulfate biosynthetic process,GO:0030207~chondroitin sulfate catabolic process,GO:0030208~dermatan sulfate biosynthetic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005796~Golgi lumen,GO:0031225~anchored component of membrane,GO:0043202~lysosomal lumen,	GO:0005201~extracellular matrix structural constituent,GO:0005540~hyaluronic acid binding,GO:0030246~carbohydrate binding,	IPR000436:Sushi/SCR/CCP,IPR000538:Link,IPR000742:Epidermal growth factor-like domain,IPR001304:C-type lectin,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013032:EGF-like, conserved site,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00032:CCP,SM00034:CLECT,SM00181:EGF,SM00406:IGv,SM00409:IG,SM00445:LINK,	Alternative splicing,Complete proteome,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,GPI-anchor,Hyaluronic acid,Immunoglobulin domain,Lectin,Lipoprotein,Membrane,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Brevican core protein,compositionally biased region:Glu-rich,disulfide bond,domain:C-type lectin,domain:EGF-like,domain:Ig-like V-type,domain:Link 1,domain:Link 2,domain:Sushi,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
BIN1	bridging integrator 1(BIN1)	Homo sapiens	62.G1-phase_progression_by_Myc,			GO:0006897~endocytosis,GO:0006997~nucleus organization,GO:0008283~cell proliferation,GO:0016032~viral process,GO:0030100~regulation of endocytosis,GO:0042692~muscle cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0045664~regulation of neuron differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0051647~nucleus localization,GO:0060988~lipid tube assembly,GO:0071156~regulation of cell cycle arrest,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0030424~axon,GO:0031674~I band,GO:0033268~node of Ranvier,GO:0043194~axon initial segment,GO:0060987~lipid tube,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0048156~tau protein binding,GO:0051015~actin filament binding,GO:0070063~RNA polymerase binding,	IPR001452:Src homology-3 domain,IPR003005:Amphiphysin,IPR003023:Amphiphysin, isoform 2,IPR004148:BAR domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,	255200~Myopathy, centronuclear, autosomal recessive,		SM00326:SH3,SM00721:BAR,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disease mutation,Endocytosis,Host-virus interaction,Nucleus,Phosphoprotein,Reference proteome,SH3 domain,Tumor suppressor,	chain:Myc box-dependent-interacting protein 1,domain:BAR,domain:SH3,helix,modified residue,region of interest:Clathrin-binding,region of interest:Interaction with BIN2,sequence conflict,sequence variant,splice variant,strand,
BAZ2B	bromodomain adjacent to zinc finger domain 2B(BAZ2B)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001487:Bromodomain,IPR001739:Methyl-CpG DNA binding,IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016177:DNA-binding, integrase-type,IPR018359:Bromodomain, conserved site,IPR018501:DDT domain superfamily,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00297:BROMO,SM00391:MBD,SM00571:DDT,	3D-structure,Acetylation,Alternative splicing,Bromodomain,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Bromodomain adjacent to zinc finger domain protein 2B,compositionally biased region:Arg-rich,compositionally biased region:Asp-rich,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Lys-rich,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Bromo,domain:DDT,domain:MBD,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:PHD-type,
BRPF1	bromodomain and PHD finger containing 1(BRPF1)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0043966~histone H3 acetylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070776~MOZ/MORF histone acetyltransferase complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000313:PWWP,IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR007087:Zinc finger, C2H2,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR018359:Bromodomain, conserved site,IPR019542:Enhancer of polycomb-like, N-terminal,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00293:PWWP,SM00297:BROMO,	3D-structure,Acetylation,Activator,Alternative splicing,Bromodomain,Chromatin regulator,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Peregrin,domain:Bromo,domain:PWWP,helix,modified residue,region of interest:Interaction with MEAF6 and ING5,region of interest:Interaction with MYST3 and MYST4,region of interest:Required for RUNX1 and RUNX2 transcriptional activation,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C2H2-type,zinc finger region:C4-type,zinc finger region:PHD-type,
BRDT	bromodomain testis associated(BRDT)	Homo sapiens				GO:0001207~histone displacement,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007140~male meiosis,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0008380~RNA splicing,GO:0016569~covalent chromatin modification,GO:0030154~cell differentiation,GO:0043484~regulation of RNA splicing,GO:0051039~positive regulation of transcription involved in meiotic cell cycle,	GO:0005634~nucleus,	GO:0003713~transcription coactivator activity,GO:0042393~histone binding,GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR018359:Bromodomain, conserved site,IPR027353:NET domain,				SM00297:BROMO,	3D-structure,Activator,Alternative splicing,Bromodomain,Chromatin regulator,Coiled coil,Complete proteome,Differentiation,Meiosis,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Spermatogenesis,Transcription,Transcription regulation,	chain:Bromodomain testis-specific protein,compositionally biased region:Ser-rich,domain:Bromo 1,domain:Bromo 2,helix,sequence conflict,sequence variant,splice variant,
ARPP21	cAMP regulated phosphoprotein 21(ARPP21)	Homo sapiens				GO:0034605~cellular response to heat,	GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0005516~calmodulin binding,	IPR001374:Single-stranded nucleic acid binding R3H,IPR024771:SUZ domain,				SM00393:R3H,	Acetylation,Alternative splicing,Calmodulin-binding,Coiled coil,Complete proteome,Cytoplasm,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:cAMP-regulated phosphoprotein 21,compositionally biased region:Gln-rich,compositionally biased region:Ser-rich,domain:R3H,modified residue,sequence conflict,splice variant,
CREB1	cAMP responsive element binding protein 1(CREB1)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation,h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1,h_crebPathway:Transcription factor CREB and its extracellular signals,h_dreamPathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,h_huntingtonPathway:Inhibition of Huntington's disease neurodegeneration by histone deacetylase inhibitors,h_mapkPathway:MAPKinase Signaling Pathway,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,		GO:0001666~response to hypoxia,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007568~aging,GO:0007595~lactation,GO:0007613~memory,GO:0007623~circadian rhythm,GO:0008361~regulation of cell size,GO:0008542~visual learning,GO:0010033~response to organic substance,GO:0010629~negative regulation of gene expression,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0014823~response to activity,GO:0016032~viral process,GO:0021983~pituitary gland development,GO:0032916~positive regulation of transforming growth factor beta3 production,GO:0033363~secretory granule organization,GO:0033762~response to glucagon,GO:0034670~chemotaxis to arachidonic acid,GO:0035094~response to nicotine,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0040018~positive regulation of multicellular organism growth,GO:0042493~response to drug,GO:0042752~regulation of circadian rhythm,GO:0043065~positive regulation of apoptotic process,GO:0045600~positive regulation of fat cell differentiation,GO:0045672~positive regulation of osteoclast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045899~positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046887~positive regulation of hormone secretion,GO:0046889~positive regulation of lipid biosynthetic process,GO:0048145~regulation of fibroblast proliferation,GO:0050821~protein stabilization,GO:0055025~positive regulation of cardiac muscle tissue development,GO:0060251~regulation of glial cell proliferation,GO:0060430~lung saccule development,GO:0060509~Type I pneumocyte differentiation,GO:0071294~cellular response to zinc ion,GO:0071398~cellular response to fatty acid,GO:1900273~positive regulation of long-term synaptic potentiation,GO:1901215~negative regulation of neuron death,GO:1902065~response to L-glutamate,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990314~cellular response to insulin-like growth factor stimulus,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0005759~mitochondrial matrix,GO:0030424~axon,GO:1990589~ATF4-CREB1 transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0030544~Hsp70 protein binding,GO:0035035~histone acetyltransferase binding,GO:0035497~cAMP response element binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:1990763~arrestin family protein binding,	IPR001630:cAMP response element binding (CREB) protein,IPR003102:Coactivator CBP, pKID,IPR004827:Basic-leucine zipper domain,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04380:Osteoclast differentiation,hsa04612:Antigen processing and presentation,hsa04668:TNF signaling pathway,hsa04710:Circadian rhythm,hsa04713:Circadian entrainment,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04911:Insulin secretion,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04922:Glucagon signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04931:Insulin resistance,hsa04962:Vasopressin-regulated water reabsorption,hsa05016:Huntington's disease,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05203:Viral carcinogenesis,hsa05215:Prostate cancer,	612160~Histiocytoma, angiomatoid fibrous, somatic,		SM00338:BRLZ,	3D-structure,Activator,Alternative splicing,Biological rhythms,Chromosomal rearrangement,Coiled coil,Complete proteome,Differentiation,DNA-binding,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Cyclic AMP-responsive element-binding protein 1,DNA-binding region:Basic motif,domain:KID,domain:Leucine-zipper,modified residue,sequence conflict,site:Required for binding TORCs,splice variant,
CACHD1	cache domain containing 1(CACHD1)	Homo sapiens				GO:0006816~calcium ion transport,	GO:0016021~integral component of membrane,		IPR002035:von Willebrand factor, type A,IPR013608:VWA N-terminal,					Alternative splicing,Calcium,Calcium transport,Complete proteome,Glycoprotein,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:VWFA and cache domain-containing protein 1,compositionally biased region:Cys-rich,compositionally biased region:His-rich,domain:Cache 1,domain:Cache 2,domain:VWFA,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CELSR2	cadherin EGF LAG seven-pass G-type receptor 2(CELSR2)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007186~G-protein coupled receptor signaling pathway,GO:0016055~Wnt signaling pathway,GO:0021999~neural plate anterior/posterior regionalization,GO:0022407~regulation of cell-cell adhesion,GO:0048813~dendrite morphogenesis,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000203:GPS domain,IPR000742:Epidermal growth factor-like domain,IPR000832:GPCR, family 2, secretin-like,IPR001791:Laminin G domain,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR002126:Cadherin,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR017981:GPCR, family 2-like,IPR020894:Cadherin conserved site,				SM00008:HormR,SM00112:CA,SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,SM00282:LamG,SM00303:GPS,	Calcium,Cell membrane,Complete proteome,Developmental protein,Disulfide bond,EGF-like domain,G-protein coupled receptor,Glycoprotein,Hydroxylation,Laminin EGF-like domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Cadherin EGF LAG seven-pass G-type receptor 2,compositionally biased region:Poly-Glu,disulfide bond,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:GPS,domain:Laminin EGF-like,domain:Laminin G-like 1,domain:Laminin G-like 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CELSR3	cadherin EGF LAG seven-pass G-type receptor 3(CELSR3)	Homo sapiens				GO:0001764~neuron migration,GO:0001932~regulation of protein phosphorylation,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007413~axonal fasciculation,GO:0032880~regulation of protein localization,GO:0036514~dopaminergic neuron axon guidance,GO:0036515~serotonergic neuron axon guidance,GO:0042384~cilium assembly,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:1904938~planar cell polarity pathway involved in axon guidance,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000203:GPS domain,IPR000742:Epidermal growth factor-like domain,IPR000832:GPCR, family 2, secretin-like,IPR001791:Laminin G domain,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR002126:Cadherin,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,IPR020894:Cadherin conserved site,				SM00008:HormR,SM00112:CA,SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,SM00282:LamG,SM00303:GPS,	Alternative splicing,Calcium,Cell membrane,Complete proteome,Developmental protein,Disulfide bond,EGF-like domain,G-protein coupled receptor,Glycoprotein,Hydroxylation,Laminin EGF-like domain,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Cadherin EGF LAG seven-pass G-type receptor 3,chain:Solute carrier family 26 member 6,disulfide bond,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:GPS,domain:Laminin EGF-like,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:STAS,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CDHR4	cadherin related family member 4(CDHR4)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,	IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,				SM00112:CA,	Alternative splicing,Calcium,Cell adhesion,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cadherin-like protein 29,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CALCRL	calcitonin receptor like receptor(CALCRL)	Homo sapiens				GO:0001525~angiogenesis,GO:0006171~cAMP biosynthetic process,GO:0006816~calcium ion transport,GO:0007166~cell surface receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007507~heart development,GO:0015031~protein transport,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0031623~receptor internalization,GO:0045986~negative regulation of smooth muscle contraction,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0071329~cellular response to sucrose stimulus,	GO:0005764~lysosome,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0001605~adrenomedullin receptor activity,GO:0001635~calcitonin gene-related peptide receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004948~calcitonin receptor activity,GO:0005515~protein binding,GO:0008565~protein transporter activity,	IPR000832:GPCR, family 2, secretin-like,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR003287:GPCR, family 2, calcitonin receptor family,IPR003289:GPCR, family 2, calcitonin gene-related peptide, type 1 receptor,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04270:Vascular smooth muscle contraction,			SM00008:HormR,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Calcitonin gene-related peptide type 1 receptor,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CIB4	calcium and integrin binding family member 4(CIB4)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,			GO:0000287~magnesium ion binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Complete proteome,Magnesium,Metal-binding,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:Calcium and integrin-binding family member 4,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,sequence variant,
CAB39	calcium binding protein 39(CAB39)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0032147~activation of protein kinase activity,GO:0035556~intracellular signal transduction,GO:0051291~protein heterooligomerization,GO:0071476~cellular hypotonic response,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:1901017~negative regulation of potassium ion transmembrane transporter activity,GO:1901380~negative regulation of potassium ion transmembrane transport,GO:2000681~negative regulation of rubidium ion transport,GO:2000687~negative regulation of rubidium ion transmembrane transporter activity,	GO:0005829~cytosol,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:1902554~serine/threonine protein kinase complex,	GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0019900~kinase binding,GO:0030295~protein kinase activator activity,GO:0043539~protein serine/threonine kinase activator activity,	IPR011989:Armadillo-like helical,IPR013878:Mo25-like,IPR016024:Armadillo-type fold,	hsa04150:mTOR signaling pathway,hsa04152:AMPK signaling pathway,				3D-structure,Complete proteome,Cytoplasm,Proteomics identification,Reference proteome,	chain:Calcium-binding protein 39,helix,modified residue,turn,
CADPS	calcium dependent secretion activator(CADPS)	Homo sapiens				GO:0006887~exocytosis,GO:0015031~protein transport,GO:0016050~vesicle organization,GO:0016079~synaptic vesicle exocytosis,GO:0016082~synaptic vesicle priming,GO:0050432~catecholamine secretion,GO:1990504~dense core granule exocytosis,	GO:0005829~cytosol,GO:0030054~cell junction,GO:0030659~cytoplasmic vesicle membrane,GO:0098793~presynapse,	GO:0005515~protein binding,GO:0008289~lipid binding,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,	IPR001849:Pleckstrin homology domain,IPR010439:Calcium-dependent secretion activator,IPR011993:Pleckstrin homology-like domain,IPR014770:Munc13 homology 1,				SM00233:PH,SM01145:SM01145,	3D-structure,Alternative splicing,Calcium,Cell junction,Coiled coil,Complete proteome,Cytoplasmic vesicle,Exocytosis,Lipid-binding,Membrane,Metal-binding,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Synapse,Transport,	chain:Calcium-dependent secretion activator 1,domain:C2,domain:MHD1,domain:PH,helix,region of interest:Interaction with DRD2,region of interest:Mediates targeting and association with DCVs,sequence conflict,splice variant,strand,
CARF	calcium responsive transcription factor(CARF)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0035865~cellular response to potassium ion,GO:0061400~positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,GO:0071277~cellular response to calcium ion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,						Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein,sequence conflict,splice variant,
CACNA2D2	calcium voltage-gated channel auxiliary subunit alpha2delta 2(CACNA2D2)	Homo sapiens				GO:0007528~neuromuscular junction development,GO:0034765~regulation of ion transmembrane transport,GO:0040014~regulation of multicellular organism growth,GO:0046622~positive regulation of organ growth,GO:0048747~muscle fiber development,GO:0050796~regulation of insulin secretion,GO:0060024~rhythmic synaptic transmission,GO:0061337~cardiac conduction,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0046872~metal ion binding,	IPR002035:von Willebrand factor, type A,IPR013608:VWA N-terminal,IPR013680:Voltage-dependent calcium channel, alpha-2/delta subunit, conserved region,	hsa04010:MAPK signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04921:Oxytocin signaling pathway,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,			SM00327:VWA,	Alternative splicing,Calcium,Calcium channel,Calcium transport,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Voltage-dependent calcium channel subunit alpha-2-2,chain:Voltage-dependent calcium channel subunit alpha-2/delta-2,chain:Voltage-dependent calcium channel subunit delta-2,domain:Cache,domain:VWFA,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Divalent metal cation,sequence variant,short sequence motif:MIDAS-like motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CACNA2D3	calcium voltage-gated channel auxiliary subunit alpha2delta 3(CACNA2D3)	Homo sapiens				GO:0034765~regulation of ion transmembrane transport,GO:0051924~regulation of calcium ion transport,GO:0061337~cardiac conduction,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,	GO:0005244~voltage-gated ion channel activity,GO:0005246~calcium channel regulator activity,GO:0005262~calcium channel activity,GO:0046872~metal ion binding,	IPR002035:von Willebrand factor, type A,IPR013608:VWA N-terminal,IPR013680:Voltage-dependent calcium channel, alpha-2/delta subunit, conserved region,	hsa04010:MAPK signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04921:Oxytocin signaling pathway,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,			SM00327:VWA,	Alternative splicing,Calcium,Calcium channel,Calcium transport,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Voltage-dependent calcium channel subunit alpha-2-3,chain:Voltage-dependent calcium channel subunit alpha-2/delta-3,chain:Voltage-dependent calcium channel subunit delta-3,domain:Cache,domain:VWFA,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Divalent metal cation,short sequence motif:MIDAS-like motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CACNB4	calcium voltage-gated channel auxiliary subunit beta 4(CACNB4)	Homo sapiens				GO:0006810~transport,GO:0007268~chemical synaptic transmission,GO:0007528~neuromuscular junction development,GO:0051899~membrane depolarization,GO:0061337~cardiac conduction,GO:0070588~calcium ion transmembrane transport,GO:1901385~regulation of voltage-gated calcium channel activity,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0009898~cytoplasmic side of plasma membrane,GO:0045202~synapse,	GO:0005245~voltage-gated calcium channel activity,GO:0005262~calcium channel activity,	IPR000584:Voltage-dependent calcium channel, L-type, beta subunit,IPR001452:Src homology-3 domain,IPR008079:Voltage-dependent calcium channel, L-type, beta-3 subunit,IPR008145:Guanylate kinase/L-type calcium channel,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04921:Oxytocin signaling pathway,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	607682~Epilepsy, idiopathic generalized, susceptibility to, 9,607682~Epilepsy, juvenile myoclonic, susceptibility to, 6,613855~Episodic ataxia, type 5,		SM00072:GuKc,	3D-structure,Alternative splicing,Calcium,Calcium channel,Calcium transport,Complete proteome,Disease mutation,Epilepsy,Ion channel,Ion transport,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,Transport,Voltage-gated channel,	chain:Voltage-dependent L-type calcium channel subunit beta-4,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
CACNA1D	calcium voltage-gated channel subunit alpha1 D(CACNA1D)	Homo sapiens				GO:0006816~calcium ion transport,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007605~sensory perception of sound,GO:0050796~regulation of insulin secretion,GO:0051928~positive regulation of calcium ion transport,GO:0060372~regulation of atrial cardiac muscle cell membrane repolarization,GO:0061337~cardiac conduction,GO:0070509~calcium ion import,GO:0070588~calcium ion transmembrane transport,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0086046~membrane depolarization during SA node cell action potential,GO:0086091~regulation of heart rate by cardiac conduction,GO:1901016~regulation of potassium ion transmembrane transporter activity,GO:1901379~regulation of potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0030018~Z disc,GO:1990454~L-type voltage-gated calcium channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0008331~high voltage-gated calcium channel activity,GO:0030506~ankyrin binding,GO:0046872~metal ion binding,GO:0051393~alpha-actinin binding,GO:0086007~voltage-gated calcium channel activity involved in cardiac muscle cell action potential,GO:0086059~voltage-gated calcium channel activity involved SA node cell action potential,	IPR002077:Voltage-dependent calcium channel, alpha-1 subunit,IPR005446:Voltage-dependent calcium channel, L-type, alpha-1 subunit,IPR005452:Voltage-dependent calcium channel, L-type, alpha-1D subunit,IPR005821:Ion transport domain,IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04930:Type II diabetes mellitus,hsa04973:Carbohydrate digestion and absorption,hsa05010:Alzheimer's disease,hsa05031:Amphetamine addiction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	614896~Sinoatrial node dysfunction and deafness,615474~Primary aldosteronism, seizures, and neurologic abnormalities,		SM01062:SM01062,	3D-structure,Alternative splicing,Calcium,Calcium channel,Calcium transport,Coiled coil,Complete proteome,Deafness,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,Triplet repeat expansion,Voltage-gated channel,	chain:Voltage-dependent L-type calcium channel subunit alpha-1D,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Met,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Binding to the beta subunit,region of interest:Dihydropyridine binding,region of interest:Phenylalkylamine binding,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,site:Calcium ion selectivity and permeability,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CACNA1E	calcium voltage-gated channel subunit alpha1 E(CACNA1E)	Homo sapiens				GO:0006810~transport,GO:0007268~chemical synaptic transmission,GO:0034765~regulation of ion transmembrane transport,GO:0050796~regulation of insulin secretion,GO:0051899~membrane depolarization,GO:0070588~calcium ion transmembrane transport,GO:0086010~membrane depolarization during action potential,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0008331~high voltage-gated calcium channel activity,	IPR002048:EF-hand domain,IPR002077:Voltage-dependent calcium channel, alpha-1 subunit,IPR005449:Voltage-dependent calcium channel, R-type, alpha-1 subunit,IPR005821:Ion transport domain,IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04930:Type II diabetes mellitus,			SM01062:SM01062,	3D-structure,Alternative splicing,Calcium,Calcium channel,Calcium transport,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Voltage-dependent R-type calcium channel subunit alpha-1E,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Val,domain:EF-hand,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Binding to the beta subunit,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,site:Calcium ion selectivity and permeability,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CACNA1S	calcium voltage-gated channel subunit alpha1 S(CACNA1S)	Homo sapiens				GO:0006816~calcium ion transport,GO:0006936~muscle contraction,GO:0034765~regulation of ion transmembrane transport,GO:0061337~cardiac conduction,GO:0070588~calcium ion transmembrane transport,GO:0086010~membrane depolarization during action potential,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0030315~T-tubule,GO:0031674~I band,	GO:0005245~voltage-gated calcium channel activity,GO:0005515~protein binding,GO:0008331~high voltage-gated calcium channel activity,GO:0046872~metal ion binding,	IPR002077:Voltage-dependent calcium channel, alpha-1 subunit,IPR005446:Voltage-dependent calcium channel, L-type, alpha-1 subunit,IPR005450:Voltage-dependent calcium channel, L-type, alpha-1S subunit,IPR005821:Ion transport domain,IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04723:Retrograde endocannabinoid signaling,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa05010:Alzheimer's disease,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	170400~Hypokalemic periodic paralysis, type 1,188580~Thyrotoxic periodic paralysis, susceptibility to, 1,601887~Malignant hyperthermia susceptibility 5,		SM01062:SM01062,	3D-structure,Calcium,Calcium channel,Calcium transport,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Voltage-dependent L-type calcium channel subunit alpha-1S,compositionally biased region:Poly-Leu,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Binding to the beta subunit,region of interest:Dihydropyridine binding,region of interest:Phenylalkylamine binding,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,site:Calcium ion selectivity and permeability,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CAMK1G	calcium/calmodulin dependent protein kinase IG(CAMK1G)	Homo sapiens		h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_mitrPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_pgc1aPathway:Regulation of PGC-1a,		GO:0006468~protein phosphorylation,	GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0005954~calcium- and calmodulin-dependent protein kinase complex,GO:0043005~neuron projection,	GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020636:Calcium/calmodulin-dependent/calcium-dependent protein kinase,	hsa04921:Oxytocin signaling pathway,hsa04925:Aldosterone synthesis and secretion,			SM00220:S_TKc,	3D-structure,Allosteric enzyme,Alternative splicing,ATP-binding,Calmodulin-binding,Cell membrane,Complete proteome,Cytoplasm,Golgi apparatus,Kinase,Lipoprotein,Membrane,Nucleotide-binding,Polymorphism,Prenylation,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Calcium/calmodulin-dependent protein kinase type 1G,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Autoinhibitory domain,region of interest:Calmodulin-binding,sequence conflict,sequence variant,splice variant,strand,turn,
CACYBP	calcyclin binding protein(CACYBP)	Homo sapiens				GO:0007568~aging,GO:0045740~positive regulation of DNA replication,GO:0055007~cardiac muscle cell differentiation,GO:0060416~response to growth hormone,GO:0060548~negative regulation of cell death,GO:0071277~cellular response to calcium ion,	GO:0005641~nuclear envelope lumen,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0030877~beta-catenin destruction complex,GO:0043005~neuron projection,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR007052:CS-like domain,IPR007699:SGS,IPR008978:HSP20-like chaperone,IPR015120:Siah interacting protein, N-terminal,	hsa04310:Wnt signaling pathway,				3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:Calcyclin-binding protein,domain:CS,domain:SGS,helix,modified residue,mutagenesis site,region of interest:Interaction with S100A6,region of interest:Interaction with SIAH1,region of interest:Interaction with SKP1,sequence conflict,splice variant,strand,turn,
CALM2	calmodulin 2(CALM2)	Homo sapiens		h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation,h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gcrpathway:Corticosteroids and cardioprotection,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_mef2dPathway:Role of MEF2D in T-cell Apoptosis,h_ndkDynaminPathway:Endocytotic role of NDK, Phosphins and Dynamin,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_no1Pathway:Actions of Nitric Oxide in the Heart,h_nos1Pathway:Nitric Oxide Signaling Pathway,h_pgc1aPathway:Regulation of PGC-1a,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_tcrPathway:T Cell Receptor Signaling Pathway,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0000165~MAPK cascade,GO:0001975~response to amphetamine,GO:0002027~regulation of heart rate,GO:0002576~platelet degranulation,GO:0005513~detection of calcium ion,GO:0005980~glycogen catabolic process,GO:0006936~muscle contraction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0019722~calcium-mediated signaling,GO:0021762~substantia nigra development,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0030801~positive regulation of cyclic nucleotide metabolic process,GO:0031954~positive regulation of protein autophosphorylation,GO:0032465~regulation of cytokinesis,GO:0032516~positive regulation of phosphoprotein phosphatase activity,GO:0034220~ion transmembrane transport,GO:0035307~positive regulation of protein dephosphorylation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043388~positive regulation of DNA binding,GO:0043547~positive regulation of GTPase activity,GO:0043647~inositol phosphate metabolic process,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051343~positive regulation of cyclic-nucleotide phosphodiesterase activity,GO:0051412~response to corticosterone,GO:0051592~response to calcium ion,GO:0055117~regulation of cardiac muscle contraction,GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity,GO:0060315~negative regulation of ryanodine-sensitive calcium-release channel activity,GO:0060316~positive regulation of ryanodine-sensitive calcium-release channel activity,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:1901841~regulation of high voltage-gated calcium channel activity,GO:1901844~regulation of cell communication by electrical coupling involved in cardiac conduction,	GO:0000922~spindle pole,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0030017~sarcomere,GO:0030426~growth cone,GO:0031982~vesicle,GO:0034704~calcium channel complex,GO:0070062~extracellular exosome,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008440~inositol-1,4,5-trisphosphate 3-kinase activity,GO:0015276~ligand-gated ion channel activity,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0031432~titin binding,GO:0031996~thioesterase binding,GO:0031997~N-terminal myristoylation domain binding,GO:0043274~phospholipase binding,GO:0043539~protein serine/threonine kinase activator activity,GO:0044325~ion channel binding,GO:0072542~protein phosphatase activator activity,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04114:Oocyte meiosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04728:Dopaminergic synapse,hsa04740:Olfactory transduction,hsa04744:Phototransduction,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa05010:Alzheimer's disease,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05133:Pertussis,hsa05152:Tuberculosis,hsa05214:Glioma,	616249~Long QT syndrome 15,		SM00054:EFh,	3D-structure,Acetylation,Calcium,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Isopeptide bond,Kinase,Long QT syndrome,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,calcium-binding region:4,chain:Calmodulin,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,helix,modified residue,sequence conflict,sequence variant,strand,
CAMTA1	calmodulin binding transcription activator 1(CAMTA1)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050885~neuromuscular process controlling balance,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0043565~sequence-specific DNA binding,	IPR000048:IQ motif, EF-hand binding site,IPR002110:Ankyrin repeat,IPR002909:Cell surface receptor IPT/TIG,IPR005559:CG-1 DNA-binding domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR020683:Ankyrin repeat-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		614756~Cerebellar ataxia, nonprogressive, with mental retardation,		SM01076:SM01076,	3D-structure,Activator,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Mental retardation,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Calmodulin-binding transcription activator 1,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Val,DNA-binding region:CG-1,domain:IPT/TIG,domain:IQ 1,domain:IQ 2,domain:IQ 3,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,
CAMSAP2	calmodulin regulated spectrin associated protein family member 2(CAMSAP2)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0031175~neuron projection development,GO:0033043~regulation of organelle organization,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005874~microtubule,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0030507~spectrin binding,GO:0051011~microtubule minus-end binding,	IPR001715:Calponin homology domain,IPR011033:PRC-barrel-like,IPR014797:CKK domain,IPR022613:Calmodulin-regulated spectrin-associated protein, CH domain,				SM01051:SM01051,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Calmodulin-regulated spectrin-associated protein 2,domain:CKK,modified residue,sequence conflict,sequence variant,splice variant,
CAMKMT	calmodulin-lysine N-methyltransferase(CAMKMT)	Homo sapiens				GO:0007005~mitochondrion organization,GO:0018022~peptidyl-lysine methylation,GO:0022400~regulation of rhodopsin mediated signaling pathway,	GO:0005634~nucleus,GO:0005794~Golgi apparatus,GO:0005829~cytosol,	GO:0018025~calmodulin-lysine N-methyltransferase activity,	IPR019410:Nicotinamide N-methyltransferase-like,IPR025800:Calmodulin-lysine N-methyltransferase,	hsa00310:Lysine degradation,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Golgi apparatus,Methyltransferase,Nucleus,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:Uncharacterized protein C2orf34,sequence conflict,splice variant,
CAPN13	calpain 13(CAPN13)	Homo sapiens				GO:0006508~proteolysis,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR001300:Peptidase C2, calpain, catalytic domain,IPR011992:EF-hand-like domain,IPR022682:Peptidase C2, calpain, large subunit, domain III,IPR022684:Peptidase C2, calpain family,				SM00230:CysPc,	3D-structure,Alternative splicing,Complete proteome,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,	chain:Calpain-13,domain:Calpain catalytic,domain:EF-hand 1,domain:EF-hand 2,helix,sequence conflict,sequence variant,splice variant,
CAPN14	calpain 14(CAPN14)	Homo sapiens				GO:0006508~proteolysis,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR001300:Peptidase C2, calpain, catalytic domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022682:Peptidase C2, calpain, large subunit, domain III,IPR022683:Peptidase C2, calpain, domain III,IPR022684:Peptidase C2, calpain family,				SM00230:CysPc,SM00720:calpain_III,	Alternative splicing,Calcium,Complete proteome,Hydrolase,Metal-binding,Protease,Reference proteome,Repeat,Thiol protease,	chain:Calpain-14,domain:Calpain catalytic,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,region of interest:Domain III,region of interest:Domain IV,region of interest:Linker,splice variant,
CAPN2	calpain 2(CAPN2)	Homo sapiens		h_mCalpainPathway:mCalpain and friends in Cell motility,h_mef2dPathway:Role of MEF2D in T-cell Apoptosis,	Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0001666~response to hypoxia,GO:0001824~blastocyst development,GO:0006508~proteolysis,GO:0007520~myoblast fusion,GO:0016540~protein autoprocessing,GO:0022617~extracellular matrix disassembly,GO:0051493~regulation of cytoskeleton organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0071230~cellular response to amino acid stimulus,	GO:0000785~chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030425~dendrite,GO:0030864~cortical actin cytoskeleton,GO:0031143~pseudopodium,GO:0045121~membrane raft,GO:0070062~extracellular exosome,GO:0097038~perinuclear endoplasmic reticulum,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0008234~cysteine-type peptidase activity,GO:0046982~protein heterodimerization activity,	IPR000169:Cysteine peptidase, cysteine active site,IPR001300:Peptidase C2, calpain, catalytic domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022682:Peptidase C2, calpain, large subunit, domain III,IPR022683:Peptidase C2, calpain, domain III,IPR022684:Peptidase C2, calpain family,	hsa04141:Protein processing in endoplasmic reticulum,hsa04210:Apoptosis,hsa04510:Focal adhesion,hsa05010:Alzheimer's disease,			SM00230:CysPc,SM00720:calpain_III,	3D-structure,Acetylation,Alternative splicing,Calcium,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Membrane,Metal-binding,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,	calcium-binding region:1,calcium-binding region:2,chain:Calpain-2 catalytic subunit,domain:Calpain catalytic,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,helix,propeptide:Anchors to the small subunit,region of interest:Domain III,region of interest:Domain IV,region of interest:Linker,sequence conflict,sequence variant,strand,turn,
CAPN7	calpain 7(CAPN7)	Homo sapiens				GO:0010634~positive regulation of epithelial cell migration,GO:0097264~self proteolysis,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005515~protein binding,GO:0090541~MIT domain binding,	IPR001300:Peptidase C2, calpain, catalytic domain,IPR007330:MIT,IPR022682:Peptidase C2, calpain, large subunit, domain III,IPR022683:Peptidase C2, calpain, domain III,IPR022684:Peptidase C2, calpain family,				SM00230:CysPc,SM00720:calpain_III,SM00745:MIT,	3D-structure,Acetylation,Complete proteome,Hydrolase,Nucleus,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,	chain:Calpain-7,domain:Calpain catalytic,helix,region of interest:Domain III,region of interest:Domain N,strand,turn,
CAPN8	calpain 8(CAPN8)	Homo sapiens				GO:0006508~proteolysis,GO:0007586~digestion,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR001300:Peptidase C2, calpain, catalytic domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022682:Peptidase C2, calpain, large subunit, domain III,IPR022683:Peptidase C2, calpain, domain III,IPR022684:Peptidase C2, calpain family,				SM00230:CysPc,SM00720:calpain_III,	Autocatalytic cleavage,Calcium,Complete proteome,Cytoplasm,Golgi apparatus,Hydrolase,Metal-binding,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,
CAPN9	calpain 9(CAPN9)	Homo sapiens				GO:0006508~proteolysis,GO:0007586~digestion,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR001300:Peptidase C2, calpain, catalytic domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022682:Peptidase C2, calpain, large subunit, domain III,IPR022683:Peptidase C2, calpain, domain III,IPR022684:Peptidase C2, calpain family,				SM00054:EFh,SM00230:CysPc,SM00720:calpain_III,	3D-structure,Alternative splicing,Calcium,Complete proteome,Hydrolase,Metal-binding,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,	calcium-binding region:1,calcium-binding region:2,chain:Calpain-9,domain:Calpain catalytic,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,helix,region of interest:Domain III,region of interest:Domain IV,sequence variant,splice variant,strand,
CNN3	calponin 3(CNN3)	Homo sapiens			Cytoskeleton,	GO:0030855~epithelial cell differentiation,GO:0031032~actomyosin structure organization,GO:0032780~negative regulation of ATPase activity,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,	GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0008017~microtubule binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000557:Calponin repeat,IPR001715:Calponin homology domain,IPR001997:Calponin,IPR003096:Smooth muscle protein/calponin,				SM00033:CH,	Acetylation,Actin-binding,Alternative splicing,Calmodulin-binding,Complete proteome,Direct protein sequencing,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Calponin-3,compositionally biased region:Asp/Glu-rich (acidic),domain:CH,modified residue,repeat:Calponin-like 1,repeat:Calponin-like 2,repeat:Calponin-like 3,
CASQ2	calsequestrin 2(CASQ2)	Homo sapiens				GO:0002027~regulation of heart rate,GO:0005513~detection of calcium ion,GO:0006941~striated muscle contraction,GO:0010649~regulation of cell communication by electrical coupling,GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0034220~ion transmembrane transport,GO:0043267~negative regulation of potassium ion transport,GO:0045214~sarcomere organization,GO:0051208~sequestering of calcium ion,GO:0051258~protein polymerization,GO:0060048~cardiac muscle contraction,GO:0060306~regulation of membrane repolarization,GO:0060315~negative regulation of ryanodine-sensitive calcium-release channel activity,GO:0071313~cellular response to caffeine,GO:0086029~Purkinje myocyte to ventricular cardiac muscle cell signaling,GO:1901017~negative regulation of potassium ion transmembrane transporter activity,GO:1903779~regulation of cardiac conduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005891~voltage-gated calcium channel complex,GO:0014701~junctional sarcoplasmic reticulum membrane,GO:0016529~sarcoplasmic reticulum,GO:0030018~Z disc,GO:0030314~junctional membrane complex,GO:0033017~sarcoplasmic reticulum membrane,GO:0033018~sarcoplasmic reticulum lumen,GO:0034704~calcium channel complex,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0048306~calcium-dependent protein binding,	IPR001393:Calsequestrin,IPR012336:Thioredoxin-like fold,IPR018233:Calsequestrin, conserved site,		611938~Ventricular tachycardia, catecholaminergic polymorphic, 2,			3D-structure,Alternative splicing,Calcium,Complete proteome,Disease mutation,Glycoprotein,Metal-binding,Muscle protein,Phosphoprotein,Polymorphism,Reference proteome,Sarcoplasmic reticulum,Signal,	chain:Calsequestrin-2,compositionally biased region:Asp/Glu-rich (acidic),glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,
CLSTN1	calsyntenin 1(CLSTN1)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0050806~positive regulation of synaptic transmission,GO:0051965~positive regulation of synapse assembly,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0042995~cell projection,GO:0045211~postsynaptic membrane,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019894~kinesin binding,GO:0042988~X11-like protein binding,	IPR002126:Cadherin,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR026914:Calsyntenin,				SM00112:CA,	Alternative splicing,Calcium,Cell adhesion,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Membrane,Nucleus,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Calsyntenin-1,chain:CTF1-alpha,chain:Soluble Alc-alpha,compositionally biased region:Glu-rich (highly acidic),domain:Cadherin 1,domain:Cadherin 2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CNR2	cannabinoid receptor 2(CNR2)	Homo sapiens		h_cb1rPathway:Metabolism of Anandamide, an Endogenous Cannabinoid,		GO:0001975~response to amphetamine,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0019233~sensory perception of pain,GO:0030595~leukocyte chemotaxis,GO:0032229~negative regulation of synaptic transmission, GABAergic,GO:0032496~response to lipopolysaccharide,GO:0033004~negative regulation of mast cell activation,GO:0038171~cannabinoid signaling pathway,GO:0045759~negative regulation of action potential,GO:0050728~negative regulation of inflammatory response,GO:0051001~negative regulation of nitric-oxide synthase activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0043025~neuronal cell body,GO:0043204~perikaryon,	GO:0004949~cannabinoid receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001551:Cannabinoid receptor type 2,IPR002230:Cannabinoid receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,			SM01381:SM01381,	3D-structure,Cell membrane,Cell projection,Complete proteome,G-protein coupled receptor,Glycoprotein,Inflammatory response,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Cannabinoid receptor 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CAPZA1	capping actin protein of muscle Z-line alpha subunit 1(CAPZA1)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006928~movement of cell or subcellular component,GO:0007596~blood coagulation,GO:0045087~innate immune response,GO:0051016~barbed-end actin filament capping,GO:0098609~cell-cell adhesion,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0008290~F-actin capping protein complex,GO:0015629~actin cytoskeleton,GO:0070062~extracellular exosome,GO:0071203~WASH complex,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002189:WASH complex, F-actin capping protein, alpha subunit,IPR017865:F-actin capping protein, alpha subunit, conserved site,	hsa04144:Endocytosis,				3D-structure,Acetylation,Actin capping,Actin-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Phosphoprotein,Polymorphism,Reference proteome,	chain:F-actin-capping protein subunit alpha-1,modified residue,sequence conflict,
CAPZB	capping actin protein of muscle Z-line beta subunit(CAPZB)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0007010~cytoskeleton organization,GO:0007596~blood coagulation,GO:0010591~regulation of lamellipodium assembly,GO:0022604~regulation of cell morphogenesis,GO:0030032~lamellipodium assembly,GO:0030036~actin cytoskeleton organization,GO:0031115~negative regulation of microtubule polymerization,GO:0031175~neuron projection development,GO:0048747~muscle fiber development,GO:0051016~barbed-end actin filament capping,GO:0051490~negative regulation of filopodium assembly,GO:0090036~regulation of protein kinase C signaling,GO:0098609~cell-cell adhesion,	GO:0001669~acrosomal vesicle,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005903~brush border,GO:0005913~cell-cell adherens junction,GO:0008290~F-actin capping protein complex,GO:0014704~intercalated disc,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0030027~lamellipodium,GO:0030863~cortical cytoskeleton,GO:0070062~extracellular exosome,GO:0071203~WASH complex,	GO:0003779~actin binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001698:WASH complex, F-actin capping protein, beta subunit,IPR019771:F-actin capping protein, beta subunit, conserved site,	hsa04144:Endocytosis,				Acetylation,Actin capping,Actin-binding,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,	chain:F-actin-capping protein subunit beta,modified residue,splice variant,
CAPG	capping actin protein, gelsolin like(CAPG)	Homo sapiens				GO:0006461~protein complex assembly,GO:0022617~extracellular matrix disassembly,GO:0051016~barbed-end actin filament capping,GO:0071803~positive regulation of podosome assembly,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005913~cell-cell adherens junction,GO:0008290~F-actin capping protein complex,GO:0042470~melanosome,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,GO:0090543~Flemming body,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR007122:Villin/Gelsolin,IPR007123:Gelsolin domain,				SM00262:GEL,	3D-structure,Acetylation,Actin capping,Actin-binding,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,	chain:Macrophage-capping protein,helix,modified residue,repeat:Gelsolin-like 1,repeat:Gelsolin-like 2,repeat:Gelsolin-like 3,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
CPS1	carbamoyl-phosphate synthase 1(CPS1)	Homo sapiens				GO:0000050~urea cycle,GO:0005980~glycogen catabolic process,GO:0006207~'de novo' pyrimidine nucleobase biosynthetic process,GO:0006508~proteolysis,GO:0006526~arginine biosynthetic process,GO:0006541~glutamine metabolic process,GO:0006807~nitrogen compound metabolic process,GO:0007494~midgut development,GO:0009636~response to toxic substance,GO:0010043~response to zinc ion,GO:0014075~response to amine,GO:0019240~citrulline biosynthetic process,GO:0019433~triglyceride catabolic process,GO:0032094~response to food,GO:0032496~response to lipopolysaccharide,GO:0042493~response to drug,GO:0042594~response to starvation,GO:0043200~response to amino acid,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045909~positive regulation of vasodilation,GO:0046209~nitric oxide metabolic process,GO:0050667~homocysteine metabolic process,GO:0055081~anion homeostasis,GO:0060416~response to growth hormone,GO:0070365~hepatocyte differentiation,GO:0070409~carbamoyl phosphate biosynthetic process,GO:0071320~cellular response to cAMP,GO:0071377~cellular response to glucagon stimulus,GO:0071400~cellular response to oleic acid,GO:0071548~response to dexamethasone,	GO:0005730~nucleolus,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0042645~mitochondrial nucleoid,GO:0043234~protein complex,	GO:0004070~aspartate carbamoyltransferase activity,GO:0004087~carbamoyl-phosphate synthase (ammonia) activity,GO:0004088~carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,GO:0004151~dihydroorotase activity,GO:0004175~endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0016595~glutamate binding,GO:0032403~protein complex binding,GO:0046872~metal ion binding,GO:0072341~modified amino acid binding,	IPR002474:Carbamoyl-phosphate synthase, small subunit N-terminal domain,IPR005479:Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain,IPR005480:Carbamoyl-phosphate synthetase, large subunit oligomerisation domain,IPR005483:Carbamoyl-phosphate synthase large subunit, CPSase domain,IPR006274:Carbamoyl-phosphate synthase, small subunit,IPR006275:Carbamoyl-phosphate synthase, large subunit,IPR011607:Methylglyoxal synthase-like domain,IPR011761:ATP-grasp fold,IPR013815:ATP-grasp fold, subdomain 1,IPR013816:ATP-grasp fold, subdomain 2,IPR016185:Pre-ATP-grasp domain,IPR017926:Glutamine amidotransferase,	hsa00220:Arginine biosynthesis,hsa00250:Alanine, aspartate and glutamate metabolism,hsa00910:Nitrogen metabolism,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,hsa01230:Biosynthesis of amino acids,	237300~Carbamoylphosphate synthetase I deficiency,615371~Pulmonary hypertension, neonatal, susceptibility to,Venoocclusive disease after bone marrow transplantation~Venoocclusive disease after bone marrow transplantation,		SM00851:SM00851,SM01096:SM01096,SM01097:SM01097,	3D-structure,Acetylation,Allosteric enzyme,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Ligase,Mitochondrion,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transit peptide,Urea cycle,	chain:Carbamoyl-phosphate synthase [ammonia], mitochondrial,domain:ATP-grasp 1,domain:ATP-grasp 2,domain:Glutamine amidotransferase type-1,helix,modified residue,region of interest:Anthranilate phosphoribosyltransferase homolog,sequence conflict,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
CHST10	carbohydrate sulfotransferase 10(CHST10)	Homo sapiens				GO:0007155~cell adhesion,GO:0016051~carbohydrate biosynthetic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008146~sulfotransferase activity,GO:0016232~HNK-1 sulfotransferase activity,	IPR005331:Sulfotransferase,IPR018011:Carbohydrate sulfotransferase-related,					Carbohydrate metabolism,Complete proteome,Glycoprotein,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Carbohydrate sulfotransferase 10,glycosylation site:N-linked (GlcNAc...),mutagenesis site,nucleotide phosphate-binding region:PAPS,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
CA6	carbonic anhydrase 6(CA6)	Homo sapiens				GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste,GO:0006730~one-carbon metabolic process,GO:0015701~bicarbonate transport,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004089~carbonate dehydratase activity,GO:0008270~zinc ion binding,	IPR001148:Alpha carbonic anhydrase,IPR018338:Carbonic anhydrase, alpha-class, conserved site,IPR018428:Carbonic anhydrase, CA-VI,IPR023561:Carbonic anhydrase, alpha-class,	hsa00910:Nitrogen metabolism,			SM01057:SM01057,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Lyase,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Zinc,	chain:Carbonic anhydrase 6,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc; catalytic,sequence conflict,sequence variant,signal peptide,strand,
CPT2	carnitine palmitoyltransferase 2(CPT2)	Homo sapiens		h_cptPathway:Mitochondrial Carnitine Palmitoyltransferase (CPT) System,		GO:0006635~fatty acid beta-oxidation,GO:0006853~carnitine shuttle,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0004095~carnitine O-palmitoyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR000542:Acyltransferase ChoActase/COT/CPT,	hsa00071:Fatty acid degradation,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,	255110~Myopathy due to CPT II deficiency,600649~CPT deficiency, hepatic, type II,608836~CPT II deficiency, lethal neonatal,614212~Encephalopathy, acute, infection-induced, 4, susceptibility to,			Acetylation,Acyltransferase,Complete proteome,Direct protein sequencing,Disease mutation,Fatty acid metabolism,Lipid metabolism,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,Transport,	active site:Proton acceptor,binding site:Carnitine,chain:Carnitine O-palmitoyltransferase 2, mitochondrial,modified residue,region of interest:Coenzyme A binding,region of interest:Interaction with mitochondrial inner membrane,sequence variant,transit peptide:Mitochondrion,
CRTAP	cartilage associated protein(CRTAP)	Homo sapiens				GO:0007283~spermatogenesis,GO:0018400~peptidyl-proline hydroxylation to 3-hydroxy-L-proline,GO:0050821~protein stabilization,GO:0061077~chaperone-mediated protein folding,GO:1901874~negative regulation of post-translational protein modification,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0032991~macromolecular complex,	GO:0032403~protein complex binding,			610682~Osteogenesis imperfecta, type VII,			Complete proteome,Disease mutation,Dwarfism,Extracellular matrix,Glycoprotein,Hydroxylation,Osteogenesis imperfecta,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Cartilage-associated protein,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
CASP10	caspase 10(CASP10)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_d4gdiPathway:D4-GDI Signaling Pathway,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007166~cell surface receptor signaling pathway,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0030225~macrophage differentiation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0097190~apoptotic signaling pathway,	GO:0005829~cytosol,GO:0031265~CD95 death-inducing signaling complex,GO:0097342~ripoptosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0035877~death effector domain binding,GO:0097199~cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001875:Death effector domain,IPR002138:Peptidase C14, caspase non-catalytic subunit p10,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site,	hsa04210:Apoptosis,hsa04622:RIG-I-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05152:Tuberculosis,hsa05161:Hepatitis B,	603909~Autoimmune lymphoproliferative syndrome, type II,605027~Lymphoma, non-Hodgkin, somatic,613659~Gastric cancer, somatic,		SM00031:DED,SM00115:CASc,	Alternative splicing,Apoptosis,Complete proteome,Direct protein sequencing,Disease mutation,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Zymogen,	chain:Caspase-10 subunit p12,chain:Caspase-10 subunit p23/17,domain:DED 1,domain:DED 2,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
CASP8	caspase 8(CASP8)	Homo sapiens	150.caspase_and_NFKB_activation,39.Deg_of_Chromosomal_DNA,40.Deg_of_Chrom_DNA_TNF-ind_apoptosis,44.Sig_Trans_TNFR1-DR3-DR4_DR5,46.P13K_PTEN,72.IAP_interaction_with_cell_death_pathways,86.Apoptosis_Nematode&_Vert,	h_caspasePathway:Caspase Cascade in Apoptosis,h_ceramidePathway:Ceramide Signaling Pathway,h_d4gdiPathway:D4-GDI Signaling Pathway,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_soddPathway:SODD/TNFR1 Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0007166~cell surface receptor signaling pathway,GO:0009409~response to cold,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0010939~regulation of necrotic cell death,GO:0030101~natural killer cell activation,GO:0030225~macrophage differentiation,GO:0032025~response to cobalt ion,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0034612~response to tumor necrosis factor,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0036462~TRAIL-activated apoptotic signaling pathway,GO:0039650~suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045471~response to ethanol,GO:0045651~positive regulation of macrophage differentiation,GO:0045862~positive regulation of proteolysis,GO:0046677~response to antibiotic,GO:0051291~protein heterooligomerization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060715~syncytiotrophoblast cell differentiation involved in labyrinthine layer development,GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway,GO:0071260~cellular response to mechanical stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071550~death-inducing signaling complex assembly,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097194~execution phase of apoptosis,GO:0097202~activation of cysteine-type endopeptidase activity,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045121~membrane raft,GO:0097342~ripoptosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0005123~death receptor binding,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0035877~death effector domain binding,GO:0042802~identical protein binding,GO:0097110~scaffold protein binding,GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process,GO:0097199~cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001875:Death effector domain,IPR002138:Peptidase C14, caspase non-catalytic subunit p10,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site,	hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05016:Huntington's disease,hsa05134:Legionellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05416:Viral myocarditis,	114480~Breast cancer, protection against,114550~Hepatocellular carcinoma, somatic,211980~Lung cancer, protection against,607271~Autoimmune lymphoproliferative syndrome, type IIB,		SM00031:DED,SM00115:CASc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Host-virus interaction,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Zymogen,	chain:Caspase-8 subunit p10,chain:Caspase-8 subunit p18,domain:DED 1,domain:DED 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
CASP9	caspase 9(CASP9)	Homo sapiens	150.caspase_and_NFKB_activation,36.Death_of_Key_Intracellular_Targets,69.Survival_signaling_BH3-Bad,72.IAP_interaction_with_cell_death_pathways,86.Apoptosis_Nematode&_Vert,	h_aktPathway:AKT Signaling Pathway,h_caspasePathway:Caspase Cascade in Apoptosis,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_d4gdiPathway:D4-GDI Signaling Pathway,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_rasPathway:Ras Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_WNVpathway:West Nile Virus,		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007568~aging,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0030220~platelet formation,GO:0032025~response to cobalt ion,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0034349~glial cell apoptotic process,GO:0034644~cellular response to UV,GO:0042770~signal transduction in response to DNA damage,GO:0042981~regulation of apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0046677~response to antibiotic,GO:0071549~cellular response to dexamethasone stimulus,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:2001020~regulation of response to DNA damage stimulus,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0043293~apoptosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0008233~peptidase activity,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001315:Caspase Recruitment,IPR002138:Peptidase C14, caspase non-catalytic subunit p10,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site,IPR017350:Caspase, interleukin-1 beta convertase,	hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05134:Legionellosis,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05416:Viral myocarditis,		PIRSF038001:caspase, interleukin-1 beta convertase type,	SM00114:CARD,SM00115:CASc,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Zymogen,	chain:Caspase-9 subunit p10,chain:Caspase-9 subunit p35,domain:CARD,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
CASZ1	castor zinc finger 1(CASZ1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007417~central nervous system development,GO:0045664~regulation of neuron differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein castor homolog 1,compositionally biased region:Ala-rich,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,
CTNNA2	catenin alpha 2(CTNNA2)	Homo sapiens		h_cell2cellPathway:Cell to Cell Adhesion Signaling,		GO:0007010~cytoskeleton organization,GO:0007155~cell adhesion,GO:0007409~axonogenesis,GO:0016337~single organismal cell-cell adhesion,GO:0021942~radial glia guided migration of Purkinje cell,GO:0048813~dendrite morphogenesis,GO:0048854~brain morphogenesis,GO:0051149~positive regulation of muscle cell differentiation,GO:0051823~regulation of synapse structural plasticity,GO:0060134~prepulse inhibition,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0030027~lamellipodium,GO:0030424~axon,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000633:Vinculin, conserved site,IPR001033:Alpha-catenin,IPR006077:Vinculin/alpha-catenin,	hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04670:Leukocyte transendothelial migration,hsa05100:Bacterial invasion of epithelial cells,hsa05200:Pathways in cancer,hsa05213:Endometrial cancer,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),				Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Catenin alpha-2,modified residue,sequence conflict,splice variant,
CTNNB1	catenin beta 1(CTNNB1)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_cell2cellPathway:Cell to Cell Adhesion Signaling,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_wntPathway:WNT Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000578~embryonic axis specification,GO:0000904~cell morphogenesis involved in differentiation,GO:0001569~patterning of blood vessels,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001701~in utero embryonic development,GO:0001702~gastrulation with mouth forming second,GO:0001708~cell fate specification,GO:0001711~endodermal cell fate commitment,GO:0001764~neuron migration,GO:0001837~epithelial to mesenchymal transition,GO:0001840~neural plate development,GO:0002052~positive regulation of neuroblast proliferation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002089~lens morphogenesis in camera-type eye,GO:0003266~regulation of secondary heart field cardioblast proliferation,GO:0003338~metanephros morphogenesis,GO:0003340~negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006351~transcription, DNA-templated,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007268~chemical synaptic transmission,GO:0007398~ectoderm development,GO:0007403~glial cell fate determination,GO:0008285~negative regulation of cell proliferation,GO:0009948~anterior/posterior axis specification,GO:0009950~dorsal/ventral axis specification,GO:0009954~proximal/distal pattern formation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0016055~Wnt signaling pathway,GO:0016337~single organismal cell-cell adhesion,GO:0019827~stem cell population maintenance,GO:0021819~layer formation in cerebral cortex,GO:0022009~central nervous system vasculogenesis,GO:0030316~osteoclast differentiation,GO:0030521~androgen receptor signaling pathway,GO:0030539~male genitalia development,GO:0030902~hindbrain development,GO:0030997~regulation of centriole-centriole cohesion,GO:0031016~pancreas development,GO:0031069~hair follicle morphogenesis,GO:0031641~regulation of myelination,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032355~response to estradiol,GO:0032481~positive regulation of type I interferon production,GO:0033077~T cell differentiation in thymus,GO:0033234~negative regulation of protein sumoylation,GO:0034333~adherens junction assembly,GO:0034394~protein localization to cell surface,GO:0034613~cellular protein localization,GO:0035050~embryonic heart tube development,GO:0035112~genitalia morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035315~hair cell differentiation,GO:0035411~catenin import into nucleus,GO:0036023~embryonic skeletal limb joint morphogenesis,GO:0042129~regulation of T cell proliferation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042493~response to drug,GO:0042733~embryonic digit morphogenesis,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043410~positive regulation of MAPK cascade,GO:0043525~positive regulation of neuron apoptotic process,GO:0044334~canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,GO:0044336~canonical Wnt signaling pathway involved in negative regulation of apoptotic process,GO:0045453~bone resorption,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045671~negative regulation of osteoclast differentiation,GO:0045743~positive regulation of fibroblast growth factor receptor signaling pathway,GO:0045765~regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045976~negative regulation of mitotic cell cycle, embryonic,GO:0048096~chromatin-mediated maintenance of transcription,GO:0048145~regulation of fibroblast proliferation,GO:0048469~cell maturation,GO:0048489~synaptic vesicle transport,GO:0048538~thymus development,GO:0048599~oocyte development,GO:0048617~embryonic foregut morphogenesis,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0050767~regulation of neurogenesis,GO:0050808~synapse organization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051145~smooth muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051973~positive regulation of telomerase activity,GO:0060066~oviduct development,GO:0060070~canonical Wnt signaling pathway,GO:0060440~trachea formation,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060479~lung cell differentiation,GO:0060484~lung-associated mesenchyme development,GO:0060492~lung induction,GO:0060742~epithelial cell differentiation involved in prostate gland development,GO:0060769~positive regulation of epithelial cell proliferation involved in prostate gland development,GO:0060789~hair follicle placode formation,GO:0060916~mesenchymal cell proliferation involved in lung development,GO:0061154~endothelial tube morphogenesis,GO:0061198~fungiform papilla formation,GO:0061324~canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,GO:0061549~sympathetic ganglion development,GO:0061550~cranial ganglion development,GO:0070602~regulation of centromeric sister chromatid cohesion,GO:0071363~cellular response to growth factor stimulus,GO:0071681~cellular response to indole-3-methanol,GO:0072033~renal vesicle formation,GO:0072053~renal inner medulla development,GO:0072054~renal outer medulla development,GO:0072079~nephron tubule formation,GO:0072182~regulation of nephron tubule epithelial cell differentiation,GO:0090279~regulation of calcium ion import,GO:1901215~negative regulation of neuron death,GO:1904501~positive regulation of chromatin-mediated maintenance of transcription,GO:1904793~regulation of euchromatin binding,GO:1904796~regulation of core promoter binding,GO:1904798~positive regulation of core promoter binding,GO:1904837~beta-catenin-TCF complex assembly,GO:1904886~beta-catenin destruction complex disassembly,GO:1904888~cranial skeletal system development,GO:1904948~midbrain dopaminergic neuron differentiation,GO:1904954~canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,GO:1990403~embryonic brain development,GO:1990791~dorsal root ganglion development,GO:2000008~regulation of protein localization to cell surface,GO:2000017~positive regulation of determination of dorsal identity,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005719~nuclear euchromatin,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005916~fascia adherens,GO:0005923~bicellular tight junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0016600~flotillin complex,GO:0030018~Z disc,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030877~beta-catenin destruction complex,GO:0031528~microvillus membrane,GO:0032993~protein-DNA complex,GO:0034750~Scrib-APC-beta-catenin complex,GO:0043234~protein complex,GO:0044798~nuclear transcription factor complex,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0070369~beta-catenin-TCF7L2 complex,GO:0071664~catenin-TCF7L2 complex,GO:0071944~cell periphery,GO:1990907~beta-catenin-TCF complex,GO:1990909~Wnt signalosome,	GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0030331~estrogen receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0044212~transcription regulatory region DNA binding,GO:0044325~ion channel binding,GO:0045294~alpha-catenin binding,GO:0045296~cadherin binding,GO:0046332~SMAD binding,GO:0046982~protein heterodimerization activity,GO:0050681~androgen receptor binding,GO:0070411~I-SMAD binding,GO:0070491~repressing transcription factor binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1990188~euchromatin binding,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR013284:Beta-catenin,IPR016024:Armadillo-type fold,	hsa04015:Rap1 signaling pathway,hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04670:Leukocyte transendothelial migration,hsa04916:Melanogenesis,hsa04919:Thyroid hormone signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05130:Pathogenic Escherichia coli infection,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),	114500~Colorectal cancer, somatic,114550~Hepatocellular carcinoma, somatic,132600~Pilomatricoma, somatic,167000~Ovarian cancer, somatic,615075~Mental retardation, autosomal dominant 19,		SM00185:ARM,	3D-structure,Acetylation,Activator,Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Glycoprotein,Membrane,Mental retardation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-nitrosylation,Transcription,Transcription regulation,Ubl conjugation,Wnt signaling pathway,	chain:Catenin beta-1,helix,modified residue,mutagenesis site,region of interest:Interaction with SCRIB,repeat:ARM 1,repeat:ARM 10,repeat:ARM 11,repeat:ARM 12,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,repeat:ARM 9,sequence variant,splice variant,strand,turn,
CTNNBIP1	catenin beta interacting protein 1(CTNNBIP1)	Homo sapiens				GO:0001658~branching involved in ureteric bud morphogenesis,GO:0002528~regulation of vascular permeability involved in acute inflammatory response,GO:0009952~anterior/posterior pattern specification,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032091~negative regulation of protein binding,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045657~positive regulation of monocyte differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0060633~negative regulation of transcription initiation from RNA polymerase II promoter,GO:0072201~negative regulation of mesenchymal cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030877~beta-catenin destruction complex,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0070016~armadillo repeat domain binding,	IPR009428:Beta-catenin-interacting ICAT,	hsa04310:Wnt signaling pathway,				3D-structure,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Reference proteome,Wnt signaling pathway,	chain:Beta-catenin-interacting protein 1,helix,
CTSE	cathepsin E(CTSE)	Homo sapiens				GO:0007586~digestion,GO:0016540~protein autoprocessing,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030163~protein catabolic process,	GO:0005768~endosome,GO:0070062~extracellular exosome,	GO:0004190~aspartic-type endopeptidase activity,GO:0042803~protein homodimerization activity,	IPR001461:Peptidase A1,IPR001969:Peptidase aspartic, active site,IPR012848:Propeptide, peptidase A1,IPR021109:Aspartic peptidase,	hsa04142:Lysosome,				3D-structure,Alternative splicing,Aspartyl protease,Autocatalytic cleavage,Complete proteome,Direct protein sequencing,Disulfide bond,Endosome,Glycoprotein,Hydrolase,Polymorphism,Protease,Reference proteome,Signal,Zymogen,	chain:Cathepsin E form I,chain:Cathepsin E form II,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,propeptide:Activation peptide,sequence variant,signal peptide,splice variant,strand,turn,
CTSK	cathepsin K(CTSK)	Homo sapiens				GO:0001957~intramembranous ossification,GO:0002224~toll-like receptor signaling pathway,GO:0006508~proteolysis,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0045453~bone resorption,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0036021~endolysosome lumen,	GO:0001968~fibronectin binding,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008234~cysteine-type peptidase activity,GO:0043394~proteoglycan binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR013201:Proteinase inhibitor I29, cathepsin propeptide,IPR015644:Peptidase C1A, cathepsin K,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	hsa04142:Lysosome,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa05323:Rheumatoid arthritis,	265800~Pycnodysostosis,		SM00645:Pept_C1,SM00848:SM00848,	3D-structure,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Protease,Proteomics identification,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin K,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,strand,turn,
CTSS	cathepsin S(CTSS)	Homo sapiens				GO:0002224~toll-like receptor signaling pathway,GO:0002250~adaptive immune response,GO:0006508~proteolysis,GO:0006955~immune response,GO:0010447~response to acidic pH,GO:0016485~protein processing,GO:0019882~antigen processing and presentation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0034769~basement membrane disassembly,GO:0048002~antigen processing and presentation of peptide antigen,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0097067~cellular response to thyroid hormone stimulus,GO:2001259~positive regulation of cation channel activity,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0036021~endolysosome lumen,GO:0043202~lysosomal lumen,GO:0043231~intracellular membrane-bounded organelle,	GO:0001968~fibronectin binding,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005518~collagen binding,GO:0008234~cysteine-type peptidase activity,GO:0043236~laminin binding,GO:0043394~proteoglycan binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR013201:Proteinase inhibitor I29, cathepsin propeptide,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	hsa04142:Lysosome,hsa04145:Phagosome,hsa04612:Antigen processing and presentation,hsa05152:Tuberculosis,			SM00645:Pept_C1,SM00848:SM00848,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin S,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,strand,turn,
CATSPER4	cation channel sperm associated 4(CATSPER4)	Homo sapiens				GO:0007275~multicellular organism development,GO:0019228~neuronal action potential,GO:0030317~sperm motility,GO:0032570~response to progesterone,GO:0034765~regulation of ion transmembrane transport,GO:0035036~sperm-egg recognition,GO:0035725~sodium ion transmembrane transport,GO:0048240~sperm capacitation,GO:0060078~regulation of postsynaptic membrane potential,GO:0070588~calcium ion transmembrane transport,GO:0086010~membrane depolarization during action potential,	GO:0001669~acrosomal vesicle,GO:0005886~plasma membrane,GO:0036128~CatSper complex,GO:0097228~sperm principal piece,	GO:0005227~calcium activated cation channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005248~voltage-gated sodium channel activity,	IPR005821:Ion transport domain,					Alternative splicing,Calcium,Calcium channel,Calcium transport,Cell membrane,Cell projection,Cilium,Coiled coil,Complete proteome,Developmental protein,Differentiation,Flagellum,Ion channel,Ion transport,Membrane,Polymorphism,Reference proteome,Spermatogenesis,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Cation channel sperm-associated protein 4,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,topological domain:Pore forming,transmembrane region,
CADM2	cell adhesion molecule 2(CADM2)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0008037~cell recognition,GO:0034332~adherens junction organization,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0045202~synapse,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0042803~protein homodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003585:Neurexin/syndecan/glycophorin C,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,				SM00294:4.1m,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Cell adhesion molecule 2,compositionally biased region:Thr-rich,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CADM3	cell adhesion molecule 3(CADM3)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0008037~cell recognition,GO:0008104~protein localization,GO:0034332~adherens junction organization,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0042803~protein homodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003585:Neurexin/syndecan/glycophorin C,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00294:4.1m,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cell adhesion molecule 3,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CHL1	cell adhesion molecule L1 like(CHL1)	Homo sapiens				GO:0001764~neuron migration,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007411~axon guidance,GO:0008344~adult locomotory behavior,GO:0031103~axon regeneration,GO:0035640~exploration behavior,GO:0043524~negative regulation of neuron apoptotic process,GO:0050890~cognition,	GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0002020~protease binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR026966:Fibronectin type III C-terminal domain,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Extracellular matrix,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Neural cell adhesion molecule L1-like protein,chain:Processed neural cell adhesion molecule L1-like protein,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,short sequence motif:DGEA,short sequence motif:FIG[AQ]Y,signal peptide,site:Cleavage; by ADAM8,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CIDEC	cell death inducing DFFA like effector c(CIDEC)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0034389~lipid particle organization,GO:0042981~regulation of apoptotic process,GO:0097194~execution phase of apoptosis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005811~lipid particle,GO:0005829~cytosol,		IPR003508:Caspase-activated nuclease CIDE-N,		615238~Lipodystrophy, familial partial, type 5,		SM00266:CAD,	Activator,Alternative splicing,Apoptosis,Complete proteome,Endoplasmic reticulum,Lipid droplet,Nucleus,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Cell death activator CIDE-3,domain:CIDE-N,splice variant,
CDC14A	cell division cycle 14A(CDC14A)	Homo sapiens				GO:0007096~regulation of exit from mitosis,GO:0008283~cell proliferation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0042384~cilium assembly,GO:0051256~mitotic spindle midzone assembly,GO:0051301~cell division,GO:0071850~mitotic cell cycle arrest,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0072686~mitotic spindle,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR016130:Protein-tyrosine phosphatase, active site,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR026070:Tyrosine-protein phosphatase CDC14,	hsa04110:Cell cycle,			SM00195:DSPc,SM00404:PTPc_motif,	Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase CDC14A,mutagenesis site,region of interest:A,region of interest:B,region of interest:Linker,sequence conflict,sequence variant,splice variant,
CDC20	cell division cycle 20(CDC20)	Homo sapiens	84.Ubiquitination_Pathways_Cell_Cycle,			GO:0007049~cell cycle,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0008284~positive regulation of cell proliferation,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0031915~positive regulation of synaptic plasticity,GO:0040020~regulation of meiotic nuclear division,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0050773~regulation of dendrite development,GO:0051301~cell division,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0051439~regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0090129~positive regulation of synapse maturation,GO:1904668~positive regulation of ubiquitin protein ligase activity,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005680~anaphase-promoting complex,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0010997~anaphase-promoting complex binding,GO:0019899~enzyme binding,GO:0042826~histone deacetylase binding,GO:0097027~ubiquitin-protein transferase activator activity,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa05166:HTLV-I infection,hsa05203:Viral carcinogenesis,			SM00320:WD40,	3D-structure,Acetylation,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Isopeptide bond,Mitosis,Neurogenesis,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,WD repeat,	chain:Cell division cycle protein 20 homolog,modified residue,mutagenesis site,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,
CDC25A	cell division cycle 25A(CDC25A)	Homo sapiens	62.G1-phase_progression_by_Myc,	H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_srcRPTPPathway:Activation of Src by Protein-tyrosine phosphatase alpha,		GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0007067~mitotic nuclear division,GO:0008283~cell proliferation,GO:0009314~response to radiation,GO:0034644~cellular response to UV,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0051301~cell division,GO:0051726~regulation of cell cycle,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR000751:M-phase inducer phosphatase,IPR001763:Rhodanese-like domain,	hsa04110:Cell cycle,hsa04914:Progesterone-mediated oocyte maturation,hsa05206:MicroRNAs in cancer,			SM00450:RHOD,	3D-structure,Alternative splicing,Cell cycle,Cell division,Complete proteome,Hydrolase,Mitosis,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Ubl conjugation,	chain:M-phase inducer phosphatase 1,domain:Rhodanese,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Phosphodegron,splice variant,strand,turn,
CDC42	cell division cycle 42(CDC42)	Homo sapiens	101.Gprot_coupled_Rec_MAP_Kinase,82.TCR_and_Cap_or_SMAC,	h_agrPathway:Agrin in Postsynaptic Differentiation,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_rasPathway:Ras Signaling Pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0002040~sprouting angiogenesis,GO:0003161~cardiac conduction system development,GO:0003334~keratinocyte development,GO:0006897~endocytosis,GO:0007030~Golgi organization,GO:0007088~regulation of mitotic nuclear division,GO:0007097~nuclear migration,GO:0007163~establishment or maintenance of cell polarity,GO:0007264~small GTPase mediated signal transduction,GO:0007596~blood coagulation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016567~protein ubiquitination,GO:0021762~substantia nigra development,GO:0030036~actin cytoskeleton organization,GO:0030225~macrophage differentiation,GO:0030307~positive regulation of cell growth,GO:0031069~hair follicle morphogenesis,GO:0031274~positive regulation of pseudopodium assembly,GO:0031295~T cell costimulation,GO:0031333~negative regulation of protein complex assembly,GO:0031424~keratinization,GO:0031647~regulation of protein stability,GO:0032467~positive regulation of cytokinesis,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034332~adherens junction organization,GO:0034613~cellular protein localization,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0035264~multicellular organism growth,GO:0036336~dendritic cell migration,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0039694~viral RNA genome replication,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042176~regulation of protein catabolic process,GO:0043497~regulation of protein heterodimerization activity,GO:0043525~positive regulation of neuron apoptotic process,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045740~positive regulation of DNA replication,GO:0045859~regulation of protein kinase activity,GO:0046330~positive regulation of JNK cascade,GO:0046847~filopodium assembly,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048664~neuron fate determination,GO:0051017~actin filament bundle assembly,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051149~positive regulation of muscle cell differentiation,GO:0051301~cell division,GO:0051489~regulation of filopodium assembly,GO:0051683~establishment of Golgi localization,GO:0051835~positive regulation of synapse structural plasticity,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0060047~heart contraction,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0060501~positive regulation of epithelial cell proliferation involved in lung morphogenesis,GO:0060661~submandibular salivary gland formation,GO:0060684~epithelial-mesenchymal cell signaling,GO:0060789~hair follicle placode formation,GO:0071338~positive regulation of hair follicle cell proliferation,GO:0072384~organelle transport along microtubule,GO:0090135~actin filament branching,GO:0090136~epithelial cell-cell adhesion,GO:0090316~positive regulation of intracellular protein transport,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0000139~Golgi membrane,GO:0000322~storage vacuole,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030141~secretory granule,GO:0030175~filopodium,GO:0030496~midbody,GO:0031256~leading edge membrane,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043209~myelin sheath,GO:0045177~apical part of cell,GO:0051233~spindle midzone,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019901~protein kinase binding,GO:0030742~GTP-dependent protein binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0031996~thioesterase binding,GO:0034191~apolipoprotein A-I receptor binding,GO:0042802~identical protein binding,GO:0051022~Rho GDP-dissociation inhibitor binding,GO:0061630~ubiquitin protein ligase activity,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04660:T cell receptor signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04912:GnRH signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05100:Bacterial invasion of epithelial cells,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05130:Pathogenic Escherichia coli infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,	616737~Takenouchi-Kosaki syndrome,			3D-structure,Alternative splicing,Cell cycle,Cell division,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Direct protein sequencing,Disease mutation,Glycoprotein,GTP-binding,Lipoprotein,Membrane,Mental retardation,Methylation,Neurogenesis,Nucleotide-binding,Phosphoprotein,Prenylation,Proteomics identification,Reference proteome,	chain:Cell division control protein 42 homolog,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,splice variant,strand,turn,
CDC7	cell division cycle 7(CDC7)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000727~double-strand break repair via break-induced replication,GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0006909~phagocytosis,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0018105~peptidyl-serine phosphorylation,GO:0044770~cell cycle phase transition,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0045171~intercellular bridge,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04110:Cell cycle,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Cell cycle,Cell division,Complete proteome,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cell division cycle 7-related protein kinase,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
CDC73	cell division cycle 73(CDC73)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001711~endodermal cell fate commitment,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006378~mRNA polyadenylation,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010390~histone monoubiquitination,GO:0016055~Wnt signaling pathway,GO:0016570~histone modification,GO:0019827~stem cell population maintenance,GO:0030177~positive regulation of Wnt signaling pathway,GO:0031442~positive regulation of mRNA 3'-end processing,GO:0031648~protein destabilization,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0033523~histone H2B ubiquitination,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048147~negative regulation of fibroblast proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051301~cell division,GO:0071222~cellular response to lipopolysaccharide,GO:1904837~beta-catenin-TCF complex assembly,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016593~Cdc73/Paf1 complex,	GO:0000993~RNA polymerase II core binding,GO:0005515~protein binding,	IPR007852:RNA polymerase II accessory factor, Cdc73,		145000~Hyperparathyroidism, familial primary,145001~Hyperparathyroidism-jaw tumor syndrome,145001~Parathyroid adenoma with cystic changes,608266~Parathyroid carcinoma,			Acetylation,Cell cycle,Cell division,Complete proteome,Direct protein sequencing,Disease mutation,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,	chain:Parafibromin,compositionally biased region:Poly-Ile,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
CDCA7	cell division cycle associated 7(CDCA7)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0042127~regulation of cell proliferation,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,		IPR018866:Zinc-finger domain of monoamine-oxidase A repressor R1,					Alternative splicing,Apoptosis,Cell cycle,Cell division,Complete proteome,Cytoplasm,Disease mutation,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Cell division cycle-associated protein 7,compositionally biased region:Arg-rich,region of interest:Mediates transcriptional activity,sequence conflict,splice variant,
CGREF1	cell growth regulator with EF-hand domain 1(CGREF1)	Homo sapiens				GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0007155~cell adhesion,GO:0008285~negative regulation of cell proliferation,	GO:0005576~extracellular region,	GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,					Alternative splicing,Calcium,Cell adhesion,Cell cycle,Complete proteome,Growth arrest,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	calcium-binding region:1,calcium-binding region:2,chain:Cell growth regulator with EF hand domain protein 1,domain:EF-hand 1,domain:EF-hand 2,sequence conflict,sequence variant,signal peptide,
CREG2	cellular repressor of E1A stimulated genes 2(CREG2)	Homo sapiens				GO:0055114~oxidation-reduction process,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,	GO:0010181~FMN binding,GO:0016491~oxidoreductase activity,	IPR012349:FMN-binding split barrel,IPR014631:Cellular repressor of E1A-stimulated genes (CREG),			PIRSF036911:cellular repressor of E1A-stimulated protein,		Complete proteome,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Protein CREG2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,signal peptide,
CCSAP	centriole, cilia and spindle associated protein(CCSAP)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0045995~regulation of embryonic development,GO:0048666~neuron development,GO:0051301~cell division,GO:0060296~regulation of cilium beat frequency involved in ciliary motility,GO:1901673~regulation of mitotic spindle assembly,GO:1990755~mitotic spindle microtubule depolymerization,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005819~spindle,GO:0005929~cilium,GO:0005930~axoneme,GO:0030424~axon,GO:0035869~ciliary transition zone,GO:0036064~ciliary basal body,GO:0061673~mitotic spindle astral microtubule,GO:0072686~mitotic spindle,	GO:0008017~microtubule binding,						Acetylation,Alternative splicing,Cell cycle,Cell division,Cell projection,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Microtubule,Mitosis,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf96,compositionally biased region:Poly-Pro,modified residue,sequence conflict,sequence variant,splice variant,
CENPA	centromere protein A(CENPA)	Homo sapiens				GO:0000070~mitotic sister chromatid segregation,GO:0000132~establishment of mitotic spindle orientation,GO:0000281~mitotic cytokinesis,GO:0006334~nucleosome assembly,GO:0007062~sister chromatid cohesion,GO:0016032~viral process,GO:0034080~CENP-A containing nucleosome assembly,GO:0051382~kinetochore assembly,GO:0071459~protein localization to chromosome, centromeric region,	GO:0000775~chromosome, centromeric region,GO:0000778~condensed nuclear chromosome kinetochore,GO:0000780~condensed nuclear chromosome, centromeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0000939~condensed chromosome inner kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0019237~centromeric DNA binding,GO:0031492~nucleosomal DNA binding,GO:0046982~protein heterodimerization activity,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,				SM00428:H3,	3D-structure,ADP-ribosylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA-binding,Host-virus interaction,Kinetochore,Methylation,Mitosis,Nucleosome core,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Histone H3-like centromeric protein A,modified residue,mutagenesis site,region of interest:CATD,region of interest:H3-like,splice variant,
CENPL	centromere protein L(CENPL)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0034080~CENP-A containing nucleosome assembly,	GO:0000775~chromosome, centromeric region,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR025204:CENP-A-nucleosome distal centromere subunit  CENP-L,					Alternative splicing,Centromere,Chromosome,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Centromere protein L,sequence variant,splice variant,
CENPO	centromere protein O(CENPO)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0034080~CENP-A containing nucleosome assembly,	GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR018464:Centromere protein Cenp-O,					Alternative splicing,Centromere,Chromosome,Coiled coil,Complete proteome,Kinetochore,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Centromere protein O,modified residue,sequence conflict,sequence variant,splice variant,
CENPS	centromere protein S(CENPS)	Homo sapiens				GO:0000712~resolution of meiotic recombination intermediates,GO:0006281~DNA repair,GO:0006312~mitotic recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0031297~replication fork processing,GO:0031398~positive regulation of protein ubiquitination,GO:0034080~CENP-A containing nucleosome assembly,GO:0036297~interstrand cross-link repair,GO:0051301~cell division,GO:0051382~kinetochore assembly,	GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0043240~Fanconi anaemia nuclear complex,GO:0071821~FANCM-MHF complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR009072:Histone-fold,	hsa03460:Fanconi anemia pathway,				3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA damage,DNA repair,DNA-binding,Fanconi anemia,Kinetochore,Mitosis,Nucleus,Reference proteome,	chain:Centromere protein S,disulfide bond,peptide:Cortistatin-17,peptide:Cortistatin-29,signal peptide,splice variant,
CEP104	centrosomal protein 104(CEP104)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_setPathway:Granzyme A mediated Apoptosis Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,			GO:0000922~spindle pole,GO:0005814~centriole,GO:0005929~cilium,	GO:0005515~protein binding,GO:0016594~glycine binding,GO:0016595~glutamate binding,GO:0016596~thienylcyclohexylpiperidine binding,	IPR008979:Galactose-binding domain-like,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Cell projection,Ciliopathy,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Joubert syndrome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Uncharacterized protein KIAA0562,modified residue,repeat:HEAT 1,repeat:HEAT 2,sequence conflict,sequence variant,splice variant,
CEP170	centrosomal protein 170(CEP170)	Homo sapiens					GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005819~spindle,GO:0005874~microtubule,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0005515~protein binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,IPR026644:Centrosomal protein of 170kDa,				SM00240:FHA,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Centrosomal protein of 170 kDa,domain:FHA,modified residue,region of interest:Targeting to centrosomes,region of interest:Targeting to microtubules,sequence variant,splice variant,
CEP350	centrosomal protein 350(CEP350)	Homo sapiens			Cell division and chromosome partitioning,	GO:0034453~microtubule anchoring,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0016020~membrane,	GO:0005515~protein binding,GO:0008017~microtubule binding,	IPR000938:CAP Gly-rich domain,IPR025486:Domain of unknown function DUF4378,				SM01052:SM01052,	3D-structure,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Centrosome-associated protein 350,compositionally biased region:Ser-rich,domain:CAP-Gly,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,turn,
CEP68	centrosomal protein 68(CEP68)	Homo sapiens				GO:0010457~centriole-centriole cohesion,GO:0033365~protein localization to organelle,GO:0051297~centrosome organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0030054~cell junction,	GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,	IPR026696:A-kinase anchor protein 6/Centrosomal protein of 68kDa,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Centrosomal protein of 68 kDa,compositionally biased region:Poly-Ser,modified residue,sequence variant,splice variant,
CEP85	centrosomal protein 85(CEP85)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0007059~chromosome segregation,GO:0046602~regulation of mitotic centrosome separation,	GO:0000242~pericentriolar material,GO:0000922~spindle pole,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,	GO:0005515~protein binding,						Alternative splicing,Chromosome partition,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 21,modified residue,sequence conflict,sequence variant,splice variant,
CEP97	centrosomal protein 97(CEP97)	Homo sapiens			Function unknown,	GO:0030030~cell projection organization,GO:1901673~regulation of mitotic spindle assembly,GO:1902018~negative regulation of cilium assembly,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0005516~calmodulin binding,	IPR000048:IQ motif, EF-hand binding site,IPR001611:Leucine-rich repeat,					Alternative splicing,Calmodulin-binding,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Leucine-rich repeat,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Centrosomal protein of 97 kDa,domain:IQ,modified residue,region of interest:CEP110 binding,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence conflict,splice variant,
CERKL	ceramide kinase like(CERKL)	Homo sapiens				GO:0016310~phosphorylation,GO:0043066~negative regulation of apoptotic process,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,	GO:0016301~kinase activity,	IPR001206:Diacylglycerol kinase, catalytic domain,IPR016064:ATP-NAD kinase-like domain,		608380~Retinitis pigmentosa 26,			Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Endoplasmic reticulum,Golgi apparatus,Kinase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Retinitis pigmentosa,Transferase,	chain:Ceramide kinase-like protein,domain:DAGKc,mutagenesis site,sequence conflict,sequence variant,splice variant,
CERS2	ceramide synthase 2(CERS2)	Homo sapiens				GO:0030148~sphingolipid biosynthetic process,GO:0046513~ceramide biosynthetic process,GO:0048681~negative regulation of axon regeneration,GO:1900148~negative regulation of Schwann cell migration,GO:1905045~negative regulation of Schwann cell proliferation involved in axon regeneration,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0050291~sphingosine N-acyltransferase activity,	IPR001356:Homeodomain,IPR006634:TRAM/LAG1/CLN8 homology domain,IPR009057:Homeodomain-like,IPR016439:Longevity assurance, LAG1/LAC1,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04071:Sphingolipid signaling pathway,		PIRSF005225:longevity assurance protein LAG1/LAC1,	SM00724:TLC,	Complete proteome,DNA-binding,Endoplasmic reticulum,Glycoprotein,Homeobox,Lipid biosynthesis,Lipid metabolism,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:LAG1 longevity assurance homolog 2,DNA-binding region:Homeobox,domain:TLC,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
CERS6	ceramide synthase 6(CERS6)	Homo sapiens				GO:0030148~sphingolipid biosynthetic process,GO:0046513~ceramide biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0050291~sphingosine N-acyltransferase activity,	IPR001356:Homeodomain,IPR006634:TRAM/LAG1/CLN8 homology domain,IPR009057:Homeodomain-like,IPR016439:Longevity assurance, LAG1/LAC1,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04071:Sphingolipid signaling pathway,		PIRSF005225:longevity assurance protein LAG1/LAC1,	SM00724:TLC,	Alternative splicing,Complete proteome,DNA-binding,Endoplasmic reticulum,Glycoprotein,Homeobox,Lipid biosynthesis,Lipid metabolism,Membrane,Nucleus,Reference proteome,Transmembrane,Transmembrane helix,	chain:LAG1 longevity assurance homolog 6,DNA-binding region:Homeobox,domain:TLC,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
CPTP	ceramide-1-phosphate transfer protein(CPTP)	Homo sapiens				GO:0006687~glycosphingolipid metabolic process,GO:0046836~glycolipid transport,GO:1902389~ceramide 1-phosphate transport,	GO:0005634~nucleus,GO:0005640~nuclear outer membrane,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,	GO:0005543~phospholipid binding,GO:0005548~phospholipid transporter activity,GO:0017089~glycolipid transporter activity,GO:0051861~glycolipid binding,GO:1902387~ceramide 1-phosphate binding,GO:1902388~ceramide 1-phosphate transporter activity,	IPR014830:Glycolipid transfer protein domain,					3D-structure,Cell membrane,Complete proteome,Cytoplasm,Endosome,Golgi apparatus,Lipid transport,Lipid-binding,Membrane,Nucleus,Proteomics identification,Reference proteome,Transport,	chain:Glycolipid transfer protein domain- containing protein 1,
CRBN	cereblon(CRBN)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0032463~negative regulation of protein homooligomerization,GO:0034766~negative regulation of ion transmembrane transport,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0090073~positive regulation of protein homodimerization activity,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,	GO:0004176~ATP-dependent peptidase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR003111:Peptidase S16, lon N-terminal,IPR004910:Yippee-like protein,IPR015947:PUA-like domain,		607417~Mental retardation, autosomal recessive 2,		SM00464:LON,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Membrane,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,	chain:Protein cereblon,domain:Lon,sequence conflict,splice variant,
CCT3	chaperonin containing TCP1 subunit 3(CCT3)	Homo sapiens				GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0046931~pore complex assembly,GO:0050821~protein stabilization,GO:1901998~toxin transport,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0002199~zona pellucida receptor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005832~chaperonin-containing T-complex,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044183~protein binding involved in protein folding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012719:T-complex protein 1, gamma subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,					Acetylation,Alternative splicing,ATP-binding,Chaperone,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Isopeptide bond,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:T-complex protein 1 subunit gamma,disulfide bond,modified residue,sequence conflict,sequence variant,
CCT4	chaperonin containing TCP1 subunit 4(CCT4)	Homo sapiens	85.Nuc_Rec-Coact_Complex,	h_bcellsurvivalPathway:B Cell Survival Pathway,		GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0050821~protein stabilization,GO:0051973~positive regulation of telomerase activity,GO:0090666~scaRNA localization to Cajal body,GO:1901998~toxin transport,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0002199~zona pellucida receptor complex,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005832~chaperonin-containing T-complex,GO:0005874~microtubule,GO:0042470~melanosome,GO:0042995~cell projection,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012717:T-complex protein 1, delta subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,					Acetylation,Alternative splicing,ATP-binding,Cell projection,Chaperone,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,	chain:T-complex protein 1 subunit delta,modified residue,sequence conflict,sequence variant,
CCT7	chaperonin containing TCP1 subunit 7(CCT7)	Homo sapiens				GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0050821~protein stabilization,GO:1901998~toxin transport,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0002199~zona pellucida receptor complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005832~chaperonin-containing T-complex,GO:0005874~microtubule,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012720:T-complex protein 1, eta subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,					Acetylation,Alternative splicing,ATP-binding,Chaperone,Complete proteome,Cytoplasm,Direct protein sequencing,Methylation,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:T-complex protein 1 subunit eta,modified residue,sequence conflict,sequence variant,
CCT8P1	chaperonin containing TCP1 subunit 8 pseudogene 1(CCT8P1)	Homo sapiens													chain:T-complex protein 1 subunit theta,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,
CHMP3	charged multivesicular body protein 3(CHMP3)	Homo sapiens				GO:0000920~cell separation after cytokinesis,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0006997~nucleus organization,GO:0007049~cell cycle,GO:0007080~mitotic metaphase plate congression,GO:0010824~regulation of centrosome duplication,GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0019058~viral life cycle,GO:0036258~multivesicular body assembly,GO:0039702~viral budding via host ESCRT complex,GO:0050792~regulation of viral process,GO:0051258~protein polymerization,GO:0051291~protein heterooligomerization,GO:0061763~multivesicular body-lysosome fusion,GO:0071985~multivesicular body sorting pathway,GO:0097352~autophagosome maturation,GO:1901673~regulation of mitotic spindle assembly,GO:1902187~negative regulation of viral release from host cell,GO:1902188~positive regulation of viral release from host cell,GO:1903541~regulation of exosomal secretion,GO:2000641~regulation of early endosome to late endosome transport,	GO:0000815~ESCRT III complex,GO:0005622~intracellular,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0031210~phosphatidylcholine binding,GO:0042803~protein homodimerization activity,GO:1990381~ubiquitin-specific protease binding,	IPR005024:Snf7,	hsa04144:Endocytosis,				3D-structure,Alternative splicing,Apoptosis,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Endosome,Isopeptide bond,Lipoprotein,Membrane,Myristate,Phosphoprotein,Protein transport,Reference proteome,Transport,Ubl conjugation,	chain:Charged multivesicular body protein 3,chain:RING finger protein 103,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,mutagenesis site,region of interest:Interaction with STAMBP,region of interest:Interaction with VPS4A,region of interest:Intramolecular interaction with C- terminus,region of interest:Intramolecular interaction with N- terminus,sequence conflict,short sequence motif:MIT-interacting motif,strand,transmembrane region,turn,zinc finger region:RING-type,
CHN1	chimerin 1(CHN1)	Homo sapiens		h_rac1Pathway:Rac 1 cell motility signaling pathway,		GO:0007165~signal transduction,GO:0008045~motor neuron axon guidance,GO:0009967~positive regulation of signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0048013~ephrin receptor signaling pathway,GO:0050770~regulation of axonogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005070~SH3/SH2 adaptor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0046875~ephrin receptor binding,	IPR000198:Rho GTPase-activating protein domain,IPR000980:SH2 domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008936:Rho GTPase activation protein,IPR017356:N-chimaerin,IPR020454:Diacylglycerol/phorbol-ester binding,		604356~Duane retraction syndrome 2,	PIRSF038015:chimaerin,	SM00109:C1,SM00252:SH2,SM00324:RhoGAP,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,GTPase activation,Metal-binding,Neurogenesis,Phosphoprotein,Proteomics identification,Reference proteome,SH2 domain,Signal,Zinc,Zinc-finger,	chain:N-chimaerin,domain:Rho-GAP,domain:SH2,helix,modified residue,sequence variant,splice variant,turn,zinc finger region:Phorbol-ester/DAG-type,
CHIT1	chitinase 1(CHIT1)	Homo sapiens				GO:0000272~polysaccharide catabolic process,GO:0005975~carbohydrate metabolic process,GO:0006032~chitin catabolic process,GO:0006955~immune response,GO:0009617~response to bacterium,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004568~chitinase activity,GO:0008061~chitin binding,GO:0008843~endochitinase activity,	IPR001223:Glycoside hydrolase, family 18, catalytic domain,IPR001579:Glycoside hydrolase, chitinase active site,IPR002557:Chitin binding domain,IPR011583:Chitinase II,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,	hsa00520:Amino sugar and nucleotide sugar metabolism,	614122~Chitotriosidase deficiency,		SM00494:ChtBD2,SM00636:Glyco_18,	3D-structure,Alternative splicing,Carbohydrate metabolism,Chitin degradation,Chitin-binding,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Polymorphism,Polysaccharide degradation,Proteomics identification,Reference proteome,Secreted,Signal,	active site:Proton donor,chain:Chitotriosidase-1,disulfide bond,domain:Chitin-binding type-2,helix,sequence variant,signal peptide,splice variant,strand,turn,
CHI3L2	chitinase 3 like 2(CHI3L2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006032~chitin catabolic process,	GO:0005615~extracellular space,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004568~chitinase activity,GO:0008061~chitin binding,GO:0030246~carbohydrate binding,	IPR000677:2S globulin,IPR001223:Glycoside hydrolase, family 18, catalytic domain,IPR011583:Chitinase II,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,				SM00636:Glyco_18,	3D-structure,Alternative splicing,Chitin-binding,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Lectin,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Chitinase-3-like protein 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
CHIA	chitinase, acidic(CHIA)	Homo sapiens				GO:0000272~polysaccharide catabolic process,GO:0002532~production of molecular mediator involved in inflammatory response,GO:0005975~carbohydrate metabolic process,GO:0006030~chitin metabolic process,GO:0006032~chitin catabolic process,GO:0006037~cell wall chitin metabolic process,GO:0006915~apoptotic process,GO:0006955~immune response,GO:0007586~digestion,GO:0009620~response to fungus,GO:0090197~positive regulation of chemokine secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0003796~lysozyme activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004568~chitinase activity,GO:0008061~chitin binding,GO:0019900~kinase binding,GO:0030246~carbohydrate binding,	IPR001223:Glycoside hydrolase, family 18, catalytic domain,IPR001579:Glycoside hydrolase, chitinase active site,IPR002557:Chitin binding domain,IPR011583:Chitinase II,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,	hsa00520:Amino sugar and nucleotide sugar metabolism,			SM00494:ChtBD2,SM00636:Glyco_18,	3D-structure,Alternative splicing,Apoptosis,Carbohydrate metabolism,Chitin degradation,Chitin-binding,Complete proteome,Cytoplasm,Disulfide bond,Glycosidase,Hydrolase,Immunity,Inflammatory response,Polymorphism,Polysaccharide degradation,Reference proteome,Secreted,Signal,	active site:Proton donor,chain:Acidic mammalian chitinase,compositionally biased region:Poly-Ser,disulfide bond,domain:Chitin-binding type-2,helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
CTBS	chitobiase(CTBS)	Homo sapiens				GO:0006032~chitin catabolic process,GO:0009313~oligosaccharide catabolic process,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0070062~extracellular exosome,	GO:0004568~chitinase activity,GO:0008061~chitin binding,	IPR001223:Glycoside hydrolase, family 18, catalytic domain,IPR001579:Glycoside hydrolase, chitinase active site,IPR011583:Chitinase II,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,				SM00636:Glyco_18,	Complete proteome,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Polymorphism,Reference proteome,Signal,	active site:Proton donor,chain:Di-N-acetylchitobiase,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
CLCC1	chloride channel CLIC like 1(CLCC1)	Homo sapiens				GO:1902476~chloride transmembrane transport,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0034707~chloride channel complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0005254~chloride channel activity,	IPR009231:Chloride channel CLIC-like,					Alternative splicing,Chloride,Chloride channel,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Ion channel,Ion transport,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Chloride channel CLIC-like protein 1,modified residue,sequence variant,signal peptide,splice variant,transmembrane region,
CLCA2	chloride channel accessory 2(CLCA2)	Homo sapiens				GO:0006508~proteolysis,GO:0006810~transport,GO:0007155~cell adhesion,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009925~basal plasma membrane,GO:0030054~cell junction,	GO:0004222~metalloendopeptidase activity,GO:0005229~intracellular calcium activated chloride channel activity,GO:0005254~chloride channel activity,GO:0015276~ligand-gated ion channel activity,GO:0046872~metal ion binding,	IPR002035:von Willebrand factor, type A,IPR004727:Calcium-activated chloride channel protein,IPR013642:Chloride channel calcium-activated,	hsa04924:Renin secretion,hsa04972:Pancreatic secretion,			SM00327:VWA,	Autocatalytic cleavage,Calcium,Cell adhesion,Cell junction,Cell membrane,Chloride,Complete proteome,Glycoprotein,Hydrolase,Ion transport,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Transport,Zinc,	chain:Calcium-activated chloride channel regulator 2,chain:Calcium-activated chloride channel regulator 2, 109 kDa form,chain:Calcium-activated chloride channel regulator 2, 35 kDa form,domain:VWFA,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CLCA4	chloride channel accessory 4(CLCA4)	Homo sapiens				GO:0006508~proteolysis,GO:0006810~transport,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0005229~intracellular calcium activated chloride channel activity,GO:0005254~chloride channel activity,GO:0046872~metal ion binding,	IPR002035:von Willebrand factor, type A,IPR004727:Calcium-activated chloride channel protein,IPR013642:Chloride channel calcium-activated,	hsa04924:Renin secretion,hsa04972:Pancreatic secretion,			SM00327:VWA,	Alternative splicing,Autocatalytic cleavage,Cell membrane,Chloride,Complete proteome,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Transport,Zinc,	chain:Calcium-activated chloride channel regulator 4,chain:Calcium-activated chloride channel regulator 4, 110 kDa form,chain:Calcium-activated chloride channel regulator 4, 30 kDa form,domain:VWFA,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,transmembrane region,
CLIC4	chloride intracellular channel 4(CLIC4)	Homo sapiens				GO:0001525~angiogenesis,GO:0001886~endothelial cell morphogenesis,GO:0006749~glutathione metabolic process,GO:0006821~chloride transport,GO:0006915~apoptotic process,GO:0007035~vacuolar acidification,GO:0009566~fertilization,GO:0030154~cell differentiation,GO:0030216~keratinocyte differentiation,GO:0030336~negative regulation of cell migration,GO:0034765~regulation of ion transmembrane transport,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0035264~multicellular organism growth,GO:0048754~branching morphogenesis of an epithelial tube,GO:0051493~regulation of cytoskeleton organization,GO:0061299~retina vasculature morphogenesis in camera-type eye,GO:0071277~cellular response to calcium ion,GO:1902476~chloride transmembrane transport,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005911~cell-cell junction,GO:0009986~cell surface,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016363~nuclear matrix,GO:0030496~midbody,GO:0030659~cytoplasmic vesicle membrane,GO:0034707~chloride channel complex,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0005244~voltage-gated ion channel activity,GO:0005254~chloride channel activity,GO:0005515~protein binding,	IPR002946:Intracellular chloride channel,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,					3D-structure,Acetylation,Cell junction,Cell membrane,Chloride,Chloride channel,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Direct protein sequencing,Ion channel,Ion transport,Membrane,Mitochondrion,Nucleus,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Chloride intracellular channel protein 4,domain:GST C-terminal,helix,modified residue,region of interest:Required for insertion into the membrane,sequence conflict,strand,transmembrane region,turn,
CLCN6	chloride voltage-gated channel 6(CLCN6)	Homo sapiens				GO:0006821~chloride transport,GO:0006884~cell volume homeostasis,GO:0007165~signal transduction,GO:0009612~response to mechanical stimulus,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,GO:1903959~regulation of anion transmembrane transport,	GO:0005765~lysosomal membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,	GO:0005247~voltage-gated chloride channel activity,GO:0005524~ATP binding,GO:0015297~antiporter activity,GO:0031404~chloride ion binding,	IPR000644:Cystathionine beta-synthase, core,IPR001807:Chloride channel, voltage gated,IPR002248:Chloride channel ClC-6,IPR014743:Chloride channel, core,				SM00116:CBS,	Alternative splicing,Antiport,ATP-binding,CBS domain,Chloride,Complete proteome,Endosome,Glycoprotein,Ion transport,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	binding site:Chloride,binding site:Chloride; via amide nitrogen,chain:Chloride transport protein 6,compositionally biased region:Cys-rich,domain:CBS 1,domain:CBS 2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:In-membrane helix,region of interest:In-membrane loop between two helices,sequence variant,short sequence motif:Selectivity filter part_1,short sequence motif:Selectivity filter part_2,short sequence motif:Selectivity filter part_3,site:Mediates proton transfer from the outer aqueous phase to the interior of the protein; involved in linking H(+) and Cl(-) transport,site:Mediates proton transfer from the protein to the inner aqueous phase,splice variant,topological domain:Cytoplasmic,transmembrane region,
CLCNKA	chloride voltage-gated channel Ka(CLCNKA)	Homo sapiens				GO:0006810~transport,GO:0007588~excretion,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,GO:1903959~regulation of anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0034707~chloride channel complex,	GO:0005247~voltage-gated chloride channel activity,GO:0031404~chloride ion binding,GO:0046872~metal ion binding,	IPR000644:Cystathionine beta-synthase, core,IPR001807:Chloride channel, voltage gated,IPR002250:Chloride channel ClC-K,IPR014743:Chloride channel, core,		613090~Bartter syndrome, type 4b, digenic,		SM00116:CBS,	3D-structure,Alternative splicing,Bartter syndrome,Calcium,CBS domain,Chloride,Chloride channel,Complete proteome,Deafness,Disease mutation,Ion channel,Ion transport,Membrane,Metal-binding,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Chloride channel protein ClC-Ka,domain:CBS 1,domain:CBS 2,helix,modified residue,sequence conflict,sequence variant,strand,transmembrane region,turn,
CLCNKB	chloride voltage-gated channel Kb(CLCNKB)	Homo sapiens				GO:0006810~transport,GO:0007588~excretion,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,GO:1903959~regulation of anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0034707~chloride channel complex,	GO:0005247~voltage-gated chloride channel activity,GO:0031404~chloride ion binding,GO:0046872~metal ion binding,	IPR000644:Cystathionine beta-synthase, core,IPR001807:Chloride channel, voltage gated,IPR002250:Chloride channel ClC-K,IPR014743:Chloride channel, core,	hsa04966:Collecting duct acid secretion,	607364~Bartter syndrome, type 3,613090~Bartter syndrome, type 4b, digenic,		SM00116:CBS,	Alternative splicing,Bartter syndrome,Calcium,CBS domain,Cell membrane,Chloride,Chloride channel,Complete proteome,Deafness,Disease mutation,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Chloride channel protein ClC-Kb,domain:CBS 1,domain:CBS 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,transmembrane region,
CCK	cholecystokinin(CCK)	Homo sapiens				GO:0001662~behavioral fear response,GO:0001764~neuron migration,GO:0001836~release of cytochrome c from mitochondria,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007165~signal transduction,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007409~axonogenesis,GO:0008284~positive regulation of cell proliferation,GO:0014049~positive regulation of glutamate secretion,GO:0032099~negative regulation of appetite,GO:0032461~positive regulation of protein oligomerization,GO:0042755~eating behavior,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051901~positive regulation of mitochondrial depolarization,GO:0051930~regulation of sensory perception of pain,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0030424~axon,GO:0030425~dendrite,GO:0043194~axon initial segment,GO:0043195~terminal bouton,GO:0043203~axon hillock,GO:0043204~perikaryon,	GO:0005179~hormone activity,GO:0005184~neuropeptide hormone activity,	IPR001651:Gastrin/cholecystokinin peptide hormone,IPR013152:Gastrin/cholecystokinin, conserved site,IPR015499:Cholecystokinin,					Amidation,Cleavage on pair of basic residues,Complete proteome,Hormone,Polymorphism,Reference proteome,Secreted,Signal,Sulfation,	chain:Cholecystokinin,modified residue,mutagenesis site,peptide:Cholecystokinin-12,peptide:Cholecystokinin-18,peptide:Cholecystokinin-25,peptide:Cholecystokinin-33,peptide:Cholecystokinin-39,peptide:Cholecystokinin-5,peptide:Cholecystokinin-58,peptide:Cholecystokinin-58 desnonopeptide,peptide:Cholecystokinin-7,peptide:Cholecystokinin-8,sequence variant,signal peptide,
CHDH	choline dehydrogenase(CHDH)	Homo sapiens				GO:0019285~glycine betaine biosynthetic process from choline,GO:0042426~choline catabolic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,	GO:0005515~protein binding,GO:0008812~choline dehydrogenase activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0050660~flavin adenine dinucleotide binding,	IPR000172:Glucose-methanol-choline oxidoreductase, N-terminal,IPR007867:Glucose-methanol-choline oxidoreductase, C-terminal,IPR012132:Glucose-methanol-choline oxidoreductase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00260:Glycine, serine and threonine metabolism,hsa01100:Metabolic pathways,		PIRSF000137:glucose-methanol-choline oxidoreductase,		Acetylation,Complete proteome,FAD,Flavoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Choline dehydrogenase, mitochondrial,modified residue,nucleotide phosphate-binding region:FAD,sequence conflict,sequence variant,transit peptide:Mitochondrion,
CEPT1	choline/ethanolamine phosphotransferase 1(CEPT1)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0006657~CDP-choline pathway,GO:0008654~phospholipid biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0004142~diacylglycerol cholinephosphotransferase activity,GO:0004307~ethanolaminephosphotransferase activity,GO:0016780~phosphotransferase activity, for other substituted phosphate groups,GO:0046872~metal ion binding,	IPR000462:CDP-alcohol phosphatidyltransferase,IPR014472:Choline/ethanolamine phosphotransferase,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa01100:Metabolic pathways,		PIRSF015665:choline/ethanolaminephosphotransferase,		Complete proteome,Endoplasmic reticulum,Glycoprotein,Lipid biosynthesis,Lipid metabolism,Magnesium,Manganese,Membrane,Metal-binding,Nucleus,Phospholipid biosynthesis,Phospholipid metabolism,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Choline/ethanolaminephosphotransferase 1,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,transmembrane region,
CHRM3	cholinergic receptor muscarinic 3(CHRM3)	Homo sapiens				GO:0003056~regulation of vascular smooth muscle contraction,GO:0006464~cellular protein modification process,GO:0006939~smooth muscle contraction,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007197~adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,GO:0007207~phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007271~synaptic transmission, cholinergic,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0045987~positive regulation of smooth muscle contraction,GO:0046541~saliva secretion,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030425~dendrite,GO:0032279~asymmetric synapse,GO:0043679~axon terminus,GO:0045202~synapse,GO:0045211~postsynaptic membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0008144~drug binding,GO:0016907~G-protein coupled acetylcholine receptor activity,GO:0042166~acetylcholine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000995:Muscarinic acetylcholine receptor family,IPR001183:Muscarinic acetylcholine receptor M3,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04725:Cholinergic synapse,hsa04810:Regulation of actin cytoskeleton,hsa04911:Insulin secretion,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,	100100~Prune belly syndrome,		SM01381:SM01381,	3D-structure,Cell junction,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Synapse,Transducer,Transmembrane,Transmembrane helix,	chain:Muscarinic acetylcholine receptor M3,disulfide bond,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,short sequence motif:Basolateral sorting signal,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CHRNA1	cholinergic receptor nicotinic alpha 1 subunit(CHRNA1)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,h_botulinPathway:Blockade of Neurotransmitter Relase by Botulinum Toxin,h_no1Pathway:Actions of Nitric Oxide in the Heart,		GO:0003009~skeletal muscle contraction,GO:0006810~transport,GO:0007165~signal transduction,GO:0007271~synaptic transmission, cholinergic,GO:0007274~neuromuscular synaptic transmission,GO:0007528~neuromuscular junction development,GO:0019228~neuronal action potential,GO:0035094~response to nicotine,GO:0042391~regulation of membrane potential,GO:0046716~muscle cell cellular homeostasis,GO:0048630~skeletal muscle tissue growth,GO:0050881~musculoskeletal movement,GO:0050905~neuromuscular process,GO:0070050~neuron cellular homeostasis,GO:0098655~cation transmembrane transport,	GO:0005886~plasma membrane,GO:0005892~acetylcholine-gated channel complex,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0031594~neuromuscular junction,GO:0045211~postsynaptic membrane,	GO:0004889~acetylcholine-activated cation-selective channel activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015464~acetylcholine receptor activity,GO:0042166~acetylcholine binding,	IPR002394:Nicotinic acetylcholine receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,IPR027361:Nicotinic acetylcholine-gated receptor, transmembrane domain,	hsa04080:Neuroactive ligand-receptor interaction,	253290~Multiple pterygium syndrome, lethal type,601462~Myasthenic syndrome, congenital, 1A, slow-channel,608930~Myasthenic syndrome, congenital, 1B, fast-channel,			3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Congenital myasthenic syndrome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Acetylcholine receptor subunit alpha,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CHRND	cholinergic receptor nicotinic delta subunit(CHRND)	Homo sapiens				GO:0003009~skeletal muscle contraction,GO:0006810~transport,GO:0006811~ion transport,GO:0006936~muscle contraction,GO:0007165~signal transduction,GO:0007271~synaptic transmission, cholinergic,GO:0007274~neuromuscular synaptic transmission,GO:0035094~response to nicotine,GO:0042391~regulation of membrane potential,GO:0048630~skeletal muscle tissue growth,GO:0050881~musculoskeletal movement,GO:0050905~neuromuscular process,GO:0098655~cation transmembrane transport,	GO:0005886~plasma membrane,GO:0005892~acetylcholine-gated channel complex,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0045211~postsynaptic membrane,	GO:0004889~acetylcholine-activated cation-selective channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015464~acetylcholine receptor activity,GO:0042166~acetylcholine binding,	IPR002394:Nicotinic acetylcholine receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,IPR027361:Nicotinic acetylcholine-gated receptor, transmembrane domain,	hsa04080:Neuroactive ligand-receptor interaction,	253290~Multiple pterygium syndrome, lethal type,616321~Myasthenic syndrome, congenital, 3A, slow-channel,616322~Myasthenic syndrome, congenital, 3B, fast-channel,616323~Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency,			Alternative splicing,Cell junction,Cell membrane,Complete proteome,Congenital myasthenic syndrome,Disease mutation,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Acetylcholine receptor subunit delta,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CHRNG	cholinergic receptor nicotinic gamma subunit(CHRNG)	Homo sapiens		h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,		GO:0006810~transport,GO:0006936~muscle contraction,GO:0007165~signal transduction,GO:0007271~synaptic transmission, cholinergic,GO:0007274~neuromuscular synaptic transmission,GO:0035094~response to nicotine,GO:0098655~cation transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005892~acetylcholine-gated channel complex,GO:0030054~cell junction,GO:0045211~postsynaptic membrane,	GO:0004889~acetylcholine-activated cation-selective channel activity,GO:0005515~protein binding,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015464~acetylcholine receptor activity,GO:0042166~acetylcholine binding,	IPR002394:Nicotinic acetylcholine receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,IPR027361:Nicotinic acetylcholine-gated receptor, transmembrane domain,	hsa04080:Neuroactive ligand-receptor interaction,	253290~Multiple pterygium syndrome, lethal type,265000~Escobar syndrome,			Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Acetylcholine receptor subunit gamma,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CHPF	chondroitin polymerizing factor(CHPF)	Homo sapiens				GO:0030206~chondroitin sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0008376~acetylgalactosaminyltransferase activity,GO:0046872~metal ion binding,GO:0047238~glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,GO:0050510~N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008428:Chondroitin N-acetylgalactosaminyltransferase,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,hsa01100:Metabolic pathways,			SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Cytoplasm,Glycoprotein,Golgi apparatus,Membrane,Metal-binding,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Chondroitin sulfate synthase 2,compositionally biased region:Ala-rich,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Divalent metal cation,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
CSPG5	chondroitin sulfate proteoglycan 5(CSPG5)	Homo sapiens				GO:0007399~nervous system development,GO:0030154~cell differentiation,GO:0030203~glycosaminoglycan metabolic process,GO:0030206~chondroitin sulfate biosynthetic process,GO:0030207~chondroitin sulfate catabolic process,GO:0030208~dermatan sulfate biosynthetic process,GO:0040008~regulation of growth,GO:0046907~intracellular transport,GO:0050804~modulation of synaptic transmission,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0043202~lysosomal lumen,	GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR009505:Neural chondroitin sulphate proteoglycan cytoplasmic,IPR010555:Chondroitin sulphate attachment,					Alternative splicing,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,EGF-like domain,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Growth regulation,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Chondroitin sulfate proteoglycan 5,disulfide bond,domain:EGF-like,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),glycosylation site:O-linked (Xyl...) (chondroitin sulfate),region of interest:Interaction with GOPC,region of interest:Interaction with TNC and TNR,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CHD1L	chromodomain helicase DNA binding protein 1 like(CHD1L)	Homo sapiens				GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0006281~DNA repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006338~chromatin remodeling,GO:0006974~cellular response to DNA damage stimulus,GO:0033683~nucleotide-excision repair, DNA incision,GO:0070911~global genome nucleotide-excision repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR002589:Appr-1-p processing,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,DNA damage,DNA repair,Helicase,Hydrolase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Chromodomain-helicase-DNA-binding protein 1-like,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:Macro,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,splice variant,
CHD5	chromodomain helicase DNA binding protein 5(CHD5)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008285~negative regulation of cell proliferation,GO:0021895~cerebral cortex neuron differentiation,GO:0035093~spermatogenesis, exchange of chromosomal proteins,GO:0043967~histone H4 acetylation,GO:0060850~regulation of transcription involved in cell fate commitment,GO:0098532~histone H3-K27 trimethylation,GO:1901798~positive regulation of signal transduction by p53 class mediator,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0016020~membrane,GO:0016581~NuRD complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008270~zinc ion binding,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0061628~H3K27me3 modified histone binding,	IPR000330:SNF2-related,IPR000953:Chromo domain/shadow,IPR001650:Helicase, C-terminal,IPR001965:Zinc finger, PHD-type,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR009462:Domain of unknown function DUF1086,IPR009463:Domain of unknown function DUF1087,IPR011011:Zinc finger, FYVE/PHD-type,IPR012957:CHD, C-terminal 2,IPR012958:CHD, N-terminal,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR016197:Chromo domain-like,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR023780:Chromo domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00249:PHD,SM00298:CHROMO,SM00487:DEXDc,SM00490:HELICc,SM01146:SM01146,SM01147:SM01147,	ATP-binding,Chromatin regulator,Coiled coil,Complete proteome,Differentiation,DNA-binding,Helicase,Hydrolase,Metal-binding,Neurogenesis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Spermatogenesis,Transcription,Transcription regulation,Tumor suppressor,Zinc,Zinc-finger,	chain:Chromodomain-helicase-DNA-binding protein 5,compositionally biased region:Lys-rich,compositionally biased region:Pro-rich,domain:Chromo 1,domain:Chromo 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH box,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
C1orf100	chromosome 1 open reading frame 100(C1orf100)	Homo sapiens												Alternative splicing,Complete proteome,Reference proteome,	chain:Uncharacterized protein C1orf100,splice variant,
C1orf101	chromosome 1 open reading frame 101(C1orf101)	Homo sapiens					GO:0036128~CatSper complex,							Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C1orf101,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
C1orf105	chromosome 1 open reading frame 105(C1orf105)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf105,modified residue,sequence variant,
C1orf109	chromosome 1 open reading frame 109(C1orf109)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf109,splice variant,
C1orf112	chromosome 1 open reading frame 112(C1orf112)	Homo sapiens												Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf112,modified residue,sequence conflict,sequence variant,splice variant,
C1orf116	chromosome 1 open reading frame 116(C1orf116)	Homo sapiens					GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR026152:Specifically androgen-regulated gene protein,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Receptor,Reference proteome,	chain:Specifically androgen-regulated gene protein,compositionally biased region:Ala-rich,sequence variant,splice variant,
C1orf127	chromosome 1 open reading frame 127(C1orf127)	Homo sapiens				GO:0007368~determination of left/right symmetry,GO:0007507~heart development,								Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Signal,	chain:Uncharacterized protein C1orf127,compositionally biased region:Pro-rich,sequence conflict,sequence variant,splice variant,
C1orf131	chromosome 1 open reading frame 131(C1orf131)	Homo sapiens					GO:0005694~chromosome,	GO:0044822~poly(A) RNA binding,						Acetylation,Alternative splicing,Chromosome,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf131,compositionally biased region:Lys-rich,modified residue,sequence conflict,sequence variant,splice variant,
C1orf141	chromosome 1 open reading frame 141(C1orf141)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf141,sequence variant,splice variant,
C1orf146	chromosome 1 open reading frame 146(C1orf146)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein C1orf146,
C1orf158	chromosome 1 open reading frame 158(C1orf158)	Homo sapiens												Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf158,sequence variant,
C1orf159	chromosome 1 open reading frame 159(C1orf159)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C1orf159,compositionally biased region:Pro-rich,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,transmembrane region,
C1orf162	chromosome 1 open reading frame 162(C1orf162)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein C1orf162,sequence variant,splice variant,transmembrane region,
C1orf167	chromosome 1 open reading frame 167(C1orf167)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf167,compositionally biased region:Gln-rich,sequence variant,splice variant,
C1orf168	chromosome 1 open reading frame 168(C1orf168)	Homo sapiens				GO:0007165~signal transduction,			IPR001452:Src homology-3 domain,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf168,sequence conflict,sequence variant,splice variant,
C1orf185	chromosome 1 open reading frame 185(C1orf185)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C1orf185,transmembrane region,
C1orf189	chromosome 1 open reading frame 189(C1orf189)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Reference proteome,	chain:Uncharacterized protein C1orf189,
C1orf194	chromosome 1 open reading frame 194(C1orf194)	Homo sapiens							IPR022179:Protein of unknown function DUF3695,					Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf194,splice variant,
C1orf195	chromosome 1 open reading frame 195(C1orf195)	Homo sapiens												Alternative splicing,Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C1orf195,splice variant,
C1orf21	chromosome 1 open reading frame 21(C1orf21)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein C1orf21,modified residue,
C1orf216	chromosome 1 open reading frame 216(C1orf216)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Reference proteome,	chain:UPF0500 protein C1orf216,sequence conflict,
C1orf220	chromosome 1 open reading frame 220(C1orf220)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C1orf220,sequence conflict,sequence variant,
C1orf226	chromosome 1 open reading frame 226(C1orf226)	Homo sapiens												Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf226,modified residue,
C1orf228	chromosome 1 open reading frame 228(C1orf228)	Homo sapiens							IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Complete proteome,Reference proteome,	chain:Uncharacterized protein C1orf228,splice variant,
C1orf229	chromosome 1 open reading frame 229(C1orf229)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C1orf229,compositionally biased region:Poly-Ala,compositionally biased region:Pro-rich,
C1orf234	chromosome 1 open reading frame 234(C1orf234)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,
C1orf27	chromosome 1 open reading frame 27(C1orf27)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein odr-4 homolog,sequence conflict,sequence variant,splice variant,transmembrane region,
C1orf50	chromosome 1 open reading frame 50(C1orf50)	Homo sapiens						GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR019534:Protein of unknown function DUF2452,					Acetylation,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf50,sequence variant,
C1orf54	chromosome 1 open reading frame 54(C1orf54)	Homo sapiens					GO:0005576~extracellular region,							Complete proteome,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C1orf54,sequence conflict,signal peptide,
C1orf56	chromosome 1 open reading frame 56(C1orf56)	Homo sapiens					GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,							Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C1orf56,modified residue,signal peptide,splice variant,
C1orf64	chromosome 1 open reading frame 64(C1orf64)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C1orf64,sequence variant,
C1orf87	chromosome 1 open reading frame 87(C1orf87)	Homo sapiens							IPR011992:EF-hand-like domain,					Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf87,sequence variant,splice variant,
C1orf94	chromosome 1 open reading frame 94(C1orf94)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf94,compositionally biased region:Poly-Pro,sequence variant,
C2orf15	chromosome 2 open reading frame 15(C2orf15)	Homo sapiens						GO:0044822~poly(A) RNA binding,						Complete proteome,Reference proteome,	chain:Uncharacterized protein C2orf15,
C2orf16	chromosome 2 open reading frame 16(C2orf16)	Homo sapiens					GO:0005634~nucleus,GO:0070062~extracellular exosome,							Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:Uncharacterized protein C2orf16,compositionally biased region:Arg-rich,modified residue,region of interest:27 X 8 AA approximative tandem repeat of P-S-E-R-S-H-H-S,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,
C2orf27A	chromosome 2 open reading frame 27A(C2orf27A)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C2orf27,compositionally biased region:Poly-Pro,sequence conflict,sequence variant,splice variant,
C2orf27B	chromosome 2 open reading frame 27B(C2orf27B)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C2orf27,compositionally biased region:Poly-Pro,sequence conflict,sequence variant,splice variant,
C2orf40	chromosome 2 open reading frame 40(C2orf40)	Homo sapiens				GO:0008054~negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation,GO:0070314~G1 to G0 transition,GO:0090398~cellular senescence,	GO:0005615~extracellular space,GO:0030133~transport vesicle,							Cleavage on pair of basic residues,Complete proteome,Cytoplasmic vesicle,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	peptide:Augurin,sequence variant,signal peptide,
C2orf48	chromosome 2 open reading frame 48(C2orf48)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C2orf48,sequence variant,
C2orf49	chromosome 2 open reading frame 49(C2orf49)	Homo sapiens				GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0048598~embryonic morphogenesis,	GO:0005654~nucleoplasm,GO:0072669~tRNA-splicing ligase complex,		IPR024887:Ashwin,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Ashwin,modified residue,sequence variant,
C2orf54	chromosome 2 open reading frame 54(C2orf54)	Homo sapiens							IPR024809:Uncharacterised protein C2orf54,IPR024810:Mab-21 domain,				SM01265:SM01265,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C2orf54,modified residue,sequence conflict,sequence variant,splice variant,
C2orf61	chromosome 2 open reading frame 61(C2orf61)	Homo sapiens							IPR010736:Sperm-tail PG-rich repeat,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C2orf61,sequence variant,
C2orf69	chromosome 2 open reading frame 69(C2orf69)	Homo sapiens					GO:0005576~extracellular region,		IPR018881:Uncharacterised protein family UPF0565,					Complete proteome,Glycoprotein,Reference proteome,Secreted,Signal,	chain:UPF0565 protein C2orf69,glycosylation site:N-linked (GlcNAc...),signal peptide,
C2orf71	chromosome 2 open reading frame 71(C2orf71)	Homo sapiens				GO:0007601~visual perception,GO:0035845~photoreceptor cell outer segment organization,GO:0050896~response to stimulus,GO:1903546~protein localization to photoreceptor outer segment,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005929~cilium,GO:0072372~primary cilium,				613428~Retinitis pigmentosa 54,			Cell projection,Ciliopathy,Cilium,Complete proteome,Disease mutation,Lipoprotein,Myristate,Palmitate,Polymorphism,Reference proteome,Retinitis pigmentosa,Sensory transduction,Vision,	chain:Uncharacterized protein C2orf71,compositionally biased region:Pro-rich,modified residue,sequence variant,
C2orf72	chromosome 2 open reading frame 72(C2orf72)	Homo sapiens												Complete proteome,Reference proteome,
C2orf73	chromosome 2 open reading frame 73(C2orf73)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C2orf73,sequence variant,splice variant,
C2orf74	chromosome 2 open reading frame 74(C2orf74)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C2orf74,transmembrane region,
C2orf76	chromosome 2 open reading frame 76(C2orf76)	Homo sapiens							IPR018794:Uncharacterised protein family UPF0538,					Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:UPF0538 protein C2orf76,sequence variant,
C2orf78	chromosome 2 open reading frame 78(C2orf78)	Homo sapiens			Function unknown,									Coiled coil,Complete proteome,Reference proteome,
C2orf80	chromosome 2 open reading frame 80(C2orf80)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C2orf80,sequence variant,
C2orf88	chromosome 2 open reading frame 88(C2orf88)	Homo sapiens					GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0034237~protein kinase A regulatory subunit binding,						3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Lipoprotein,Membrane,Myristate,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein FLJ90687,chain:UPF0733 protein C2orf88,lipid moiety-binding region:N-myristoyl glycine,modified residue,sequence variant,signal peptide,
C2orf91	chromosome 2 open reading frame 91(C2orf91)	Homo sapiens												Complete proteome,Reference proteome,
C3orf20	chromosome 3 open reading frame 20(C3orf20)	Homo sapiens					GO:0005737~cytoplasm,GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C3orf20,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,modified residue,sequence variant,splice variant,transmembrane region,
C3orf35	chromosome 3 open reading frame 35(C3orf35)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:AP20 region protein 1,sequence conflict,sequence variant,splice variant,transmembrane region,
C3orf52	chromosome 3 open reading frame 52(C3orf52)	Homo sapiens					GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Alternative splicing,Complete proteome,Endoplasmic reticulum,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:TPA-induced transmembrane protein,sequence conflict,sequence variant,splice variant,transmembrane region,
C3orf62	chromosome 3 open reading frame 62(C3orf62)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C3orf62,sequence conflict,sequence variant,
C3orf67	chromosome 3 open reading frame 67(C3orf67)	Homo sapiens							IPR007714:Protein of unknown function DUF667,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C3orf67,sequence variant,splice variant,
C3orf84	chromosome 3 open reading frame 84(C3orf84)	Homo sapiens												Complete proteome,Reference proteome,
CELA2A	chymotrypsin like elastase family member 2A(CELA2A)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,		GO:0006508~proteolysis,	GO:0005615~extracellular space,GO:0036457~keratohyalin granule,	GO:0004252~serine-type endopeptidase activity,GO:0017171~serine hydrolase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00020:Tryp_SPc,	Complete proteome,Direct protein sequencing,Disulfide bond,Hydrolase,Polymorphism,Protease,Reference proteome,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Chymotrypsin-like elastase family member 2A,disulfide bond,domain:Peptidase S1,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,
CELA2B	chymotrypsin like elastase family member 2B(CELA2B)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,		GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00020:Tryp_SPc,	Complete proteome,Disulfide bond,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Chymotrypsin-like elastase family member 2B,disulfide bond,domain:Peptidase S1,propeptide:Activation peptide,sequence variant,signal peptide,
CELA3A	chymotrypsin like elastase family member 3A(CELA3A)	Homo sapiens				GO:0006508~proteolysis,GO:0007586~digestion,GO:0008203~cholesterol metabolic process,	GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00020:Tryp_SPc,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Chymotrypsin-like elastase family member 3A,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,
CELA3B	chymotrypsin like elastase family member 3B(CELA3B)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,		GO:0006508~proteolysis,GO:0008203~cholesterol metabolic process,	GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00020:Tryp_SPc,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Chymotrypsin-like elastase family member 3B,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,
CFAP221	cilia and flagella associated protein 221(CFAP221)	Homo sapiens				GO:0003341~cilium movement,GO:0060271~cilium morphogenesis,	GO:0005737~cytoplasm,GO:0005929~cilium,GO:0005930~axoneme,	GO:0005516~calmodulin binding,	IPR008962:PapD-like,					Alternative splicing,Calmodulin-binding,Cell projection,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein MGC33657,sequence variant,
CFAP36	cilia and flagella associated protein 36(CFAP36)	Homo sapiens					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0042995~cell projection,		IPR023379:ADP-ribosylation factor-like 2-binding protein, domain,					Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 104,modified residue,sequence variant,splice variant,
CFAP45	cilia and flagella associated protein 45(CFAP45)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005929~cilium,							Alternative splicing,Cell projection,Cilium,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 19, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
CFAP57	cilia and flagella associated protein 57(CFAP57)	Homo sapiens							IPR001680:WD40 repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 65,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CFAP65	cilia and flagella associated protein 65(CFAP65)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031514~motile cilium,	GO:0044822~poly(A) RNA binding,	IPR000535:Major sperm protein,IPR008962:PapD-like,					Alternative splicing,Cell membrane,Cell projection,Cilium,Coiled coil,Complete proteome,Flagellum,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Coiled-coil domain-containing protein 108,compositionally biased region:Glu-rich,domain:MSP,modified residue,sequence conflict,sequence variant,transmembrane region,
CFAP74	cilia and flagella associated protein 74(CFAP74)	Homo sapiens				GO:0035082~axoneme assembly,	GO:0005737~cytoplasm,GO:0005930~axoneme,							Alternative splicing,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1751,sequence conflict,sequence variant,splice variant,
CROCC2	ciliary rootlet coiled-coil, rootletin family member 2(CROCC2)	Homo sapiens												Coiled coil,Complete proteome,Reference proteome,
CROCCP2	ciliary rootlet coiled-coil, rootletin pseudogene 2(CROCCP2)	Homo sapiens				GO:0051297~centrosome organization,	GO:0035253~ciliary rootlet,		IPR026733:Rootletin,					Coiled coil,Complete proteome,Reference proteome,
CROCCP3	ciliary rootlet coiled-coil, rootletin pseudogene 3(CROCCP3)	Homo sapiens				GO:0051297~centrosome organization,	GO:0035253~ciliary rootlet,		IPR026733:Rootletin,					Coiled coil,Complete proteome,Reference proteome,
CROCC	ciliary rootlet coiled-coil, rootletin(CROCC)	Homo sapiens				GO:0007049~cell cycle,GO:0008104~protein localization,GO:0010457~centriole-centriole cohesion,GO:0010669~epithelial structure maintenance,GO:0032053~ciliary basal body organization,GO:0033365~protein localization to organelle,GO:0045494~photoreceptor cell maintenance,GO:0051297~centrosome organization,GO:0051656~establishment of organelle localization,	GO:0001917~photoreceptor inner segment,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0035253~ciliary rootlet,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0019894~kinesin binding,	IPR026733:Rootletin,					Alternative splicing,Cell cycle,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rootletin,compositionally biased region:Gln-rich,modified residue,sequence variant,splice variant,
CATIP	ciliogenesis associated TTC17 interacting protein(CATIP)	Homo sapiens				GO:0030041~actin filament polymerization,GO:0044782~cilium organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,	GO:0005515~protein binding,	IPR003117:cAMP-dependent protein kinase, regulatory subunit, type I/II alpha/beta,					Cell membrane,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Nucleus,Reference proteome,	chain:Uncharacterized protein C2orf62,
CIART	circadian associated repressor of transcription(CIART)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0032922~circadian regulation of gene expression,GO:0045475~locomotor rhythm,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0016605~PML body,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0005515~protein binding,GO:0070888~E-box binding,						Alternative splicing,Biological rhythms,Complete proteome,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Uncharacterized protein C1orf51,compositionally biased region:Ser-rich,sequence conflict,splice variant,
CLSPN	claspin(CLSPN)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0018105~peptidyl-serine phosphorylation,GO:0031572~G2 DNA damage checkpoint,GO:0032147~activation of protein kinase activity,GO:0033314~mitotic DNA replication checkpoint,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0010997~anaphase-promoting complex binding,	IPR024146:Claspin/Claspin-like,					Acetylation,Alternative splicing,Cell cycle,Coiled coil,Complete proteome,DNA damage,DNA repair,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Claspin,modified residue,mutagenesis site,repeat:CKB motif 1,repeat:CKB motif 2,repeat:CKB motif 3,sequence conflict,sequence variant,splice variant,
CLHC1	clathrin heavy chain linker domain containing 1(CLHC1)	Homo sapiens						GO:0005515~protein binding,	IPR012331:Clathrin, heavy chain, linker,IPR016024:Armadillo-type fold,IPR017212:Clathrin, heavy chain-related,			PIRSF037469:clathrin heavy chain-related protein,		Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C2orf63,sequence variant,splice variant,
CPSF3	cleavage and polyadenylation specific factor 3(CPSF3)	Homo sapiens		h_cpsfPathway:Polyadenylation of mRNA,	Translation, ribosomal structure and biogenesis,	GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006378~mRNA polyadenylation,GO:0006379~mRNA cleavage,GO:0006398~mRNA 3'-end processing by stem-loop binding and cleavage,GO:0006406~mRNA export from nucleus,GO:0031124~mRNA 3'-end processing,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005654~nucleoplasm,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0004521~endoribonuclease activity,GO:0005515~protein binding,GO:0008409~5'-3' exonuclease activity,GO:0046872~metal ion binding,	IPR001279:Beta-lactamase-like,IPR011108:RNA-metabolising metallo-beta-lactamase,IPR021718:Pre-mRNA 3'-end-processing endonuclease polyadenylation factor C-term,IPR022712:Beta-Casp domain,	hsa03015:mRNA surveillance pathway,			SM00849:SM00849,SM01027:SM01027,SM01098:SM01098,	3D-structure,Acetylation,Complete proteome,Endonuclease,Hydrolase,Isopeptide bond,Metal-binding,mRNA processing,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Ubl conjugation,Zinc,	active site:Proton donor,chain:Cleavage and polyadenylation specificity factor subunit 3,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,mutagenesis site,sequence variant,strand,turn,
CMSS1	cms1 ribosomal small subunit homolog (yeast)(CMSS1)	Homo sapiens			DNA replication, recombination, and repair / Transcription / Translation, ribosomal structure and biogenesis,		GO:0005634~nucleus,GO:0030686~90S preribosome,	GO:0044822~poly(A) RNA binding,	IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C3orf26,sequence variant,
F5	coagulation factor V(F5)	Homo sapiens		h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0002576~platelet degranulation,GO:0006508~proteolysis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007596~blood coagulation,GO:0008015~blood circulation,GO:0030168~platelet activation,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030134~ER to Golgi transport vesicle,GO:0031093~platelet alpha granule lumen,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:1903561~extracellular vesicle,	GO:0004252~serine-type endopeptidase activity,GO:0005507~copper ion binding,GO:0005515~protein binding,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR008972:Cupredoxin,IPR008979:Galactose-binding domain-like,IPR011707:Multicopper oxidase, type 3,IPR024715:Coagulation factor 5/8,	hsa04610:Complement and coagulation cascades,	188055~Thrombophilia due to activated protein C resistance,188055~Thrombophilia, susceptibility to, due to factor V Leiden,227400~Factor V deficiency,600880~Budd-Chiari syndrome,601367~Stroke, ischemic, susceptibility to,614389~Pregnancy loss, recurrent, susceptibility to, 1,	PIRSF000354:coagulation factor V/coagulation factor VIII,	SM00231:FA58C,	3D-structure,Blood coagulation,Calcium,Complete proteome,Copper,Disease mutation,Disulfide bond,Glycoprotein,Hemostasis,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sulfation,Thrombophilia,Zymogen,	chain:Coagulation factor V,chain:Coagulation factor V heavy chain,chain:Coagulation factor V light chain,disulfide bond,domain:F5/8 type A 1,domain:F5/8 type A 2,domain:F5/8 type A 3,domain:F5/8 type C 1,domain:F5/8 type C 2,domain:Plastocyanin-like 1,domain:Plastocyanin-like 2,domain:Plastocyanin-like 3,domain:Plastocyanin-like 4,domain:Plastocyanin-like 5,domain:Plastocyanin-like 6,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Copper,modified residue,propeptide:Activation peptide (connecting region),region of interest:2 X 17 AA tandem repeats,region of interest:35 X 9 AA approximate tandem repeats of [TNP]-L-S-P-D-L-S-Q-T,region of interest:B,repeat:1-1,repeat:1-2,repeat:2-1,repeat:2-10,repeat:2-11,repeat:2-12,repeat:2-13,repeat:2-14,repeat:2-15,repeat:2-16,repeat:2-17,repeat:2-18,repeat:2-19,repeat:2-2,repeat:2-20,repeat:2-21,repeat:2-22,repeat:2-23,repeat:2-24,repeat:2-25,repeat:2-26,repeat:2-27,repeat:2-28,repeat:2-29,repeat:2-3,repeat:2-30,repeat:2-31,repeat:2-32,repeat:2-33,repeat:2-34,repeat:2-35,repeat:2-4,repeat:2-5,repeat:2-6,repeat:2-7,repeat:2-8,repeat:2-9,sequence conflict,sequence variant,signal peptide,site:Cleavage; by activated protein C,site:Cleavage; by thrombin,strand,turn,
F13B	coagulation factor XIII B chain(F13B)	Homo sapiens				GO:0007596~blood coagulation,	GO:0005576~extracellular region,		IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,	613235~Factor XIIIB deficiency,		SM00032:CCP,	Blood coagulation,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemostasis,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Coagulation factor XIII B chain,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:Cell attachment site,signal peptide,
COPA	coatomer protein complex subunit alpha(COPA)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0030157~pancreatic juice secretion,	GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0030126~COPI vesicle coat,GO:0030133~transport vesicle,GO:0070062~extracellular exosome,	GO:0005179~hormone activity,GO:0005198~structural molecule activity,	IPR001680:WD40 repeat,IPR006692:Coatomer, WD associated region,IPR010714:Coatomer, alpha subunit, C-terminal,IPR011048:Cytochrome cd1-nitrite reductase-like, C-terminal haem d1,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016391:Coatomer alpha subunit,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,		616414~Autoimmune interstitial lung, joint, and kidney disease,	PIRSF003354:coatomer, alpha subunit,	SM00320:WD40,	Alternative splicing,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,ER-Golgi transport,Golgi apparatus,Hormone,Membrane,Methylation,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Repeat,RNA editing,Secreted,Transport,WD repeat,	chain:Coatomer subunit alpha,modified residue,peptide:Proxenin,peptide:Xenin,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,sequence variant,splice variant,
COQ10B	coenzyme Q10B(COQ10B)	Homo sapiens				GO:0006744~ubiquinone biosynthetic process,GO:0045333~cellular respiration,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0048039~ubiquinone binding,	IPR005031:Streptomyces cyclase/dehydrase,IPR023393:START-like domain,					Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Coenzyme Q-binding protein COQ10 homolog B, mitochondrial,sequence variant,transit peptide:Mitochondrion,
COQ8A	coenzyme Q8A(COQ8A)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006744~ubiquinone biosynthetic process,GO:0016310~phosphorylation,	GO:0005739~mitochondrion,GO:0016021~integral component of membrane,	GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0043531~ADP binding,	IPR004147:UbiB domain,IPR011009:Protein kinase-like domain,		612016~Coenzyme Q10 deficiency, primary, 4,			3D-structure,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Disease mutation,Kinase,Membrane,Mitochondrion,Neurodegeneration,Nucleotide-binding,Polymorphism,Reference proteome,Transferase,Transit peptide,Transmembrane,Transmembrane helix,Ubiquinone biosynthesis,	chain:Chaperone activity of bc1 complex-like, mitochondrial,domain:Protein kinase,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
CCDC12	coiled-coil domain containing 12(CCDC12)	Homo sapiens						GO:0005515~protein binding,	IPR013169:mRNA splicing factor, Cwf18,	hsa03040:Spliceosome,				Acetylation,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 12,modified residue,sequence conflict,
CCDC121	coiled-coil domain containing 121(CCDC121)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Reference proteome,	chain:Coiled-coil domain-containing protein 121,
CCDC13	coiled-coil domain containing 13(CCDC13)	Homo sapiens				GO:0006974~cellular response to DNA damage stimulus,GO:0031122~cytoplasmic microtubule organization,GO:0035058~nonmotile primary cilium assembly,	GO:0005813~centrosome,GO:0034451~centriolar satellite,GO:0042995~cell projection,	GO:0005515~protein binding,						Cell projection,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 13,sequence variant,
CCDC138	coiled-coil domain containing 138(CCDC138)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 138,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence variant,splice variant,
CCDC141	coiled-coil domain containing 141(CCDC141)	Homo sapiens				GO:0021799~cerebral cortex radially oriented cell migration,GO:0051642~centrosome localization,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,	GO:0005515~protein binding,	IPR002017:Spectrin repeat,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 141,domain:Ig-like,sequence variant,splice variant,
CCDC148	coiled-coil domain containing 148(CCDC148)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 148,compositionally biased region:Glu/Lys-rich,sequence conflict,sequence variant,splice variant,
CCDC150	coiled-coil domain containing 150(CCDC150)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 150,sequence conflict,sequence variant,splice variant,
CCDC173	coiled-coil domain containing 173(CCDC173)	Homo sapiens												Coiled coil,Complete proteome,Reference proteome,	chain:Uncharacterized protein C2orf77,compositionally biased region:Glu-rich,
CCDC18	coiled-coil domain containing 18(CCDC18)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 18,modified residue,sequence conflict,splice variant,
CCDC181	coiled-coil domain containing 181(CCDC181)	Homo sapiens					GO:0005654~nucleoplasm,		IPR026687:Uncharacterised protein C1orf114,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf114,compositionally biased region:Poly-Glu,sequence conflict,sequence variant,splice variant,
CCDC190	coiled-coil domain containing 190(CCDC190)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Reference proteome,	chain:Coiled-coil domain-containing protein C1orf110,sequence conflict,splice variant,
CCDC27	coiled-coil domain containing 27(CCDC27)	Homo sapiens												Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 27,compositionally biased region:Glu-rich,sequence conflict,sequence variant,
CCDC30	coiled-coil domain containing 30(CCDC30)	Homo sapiens					GO:0070062~extracellular exosome,							Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 30,sequence conflict,sequence variant,splice variant,
CCDC36	coiled-coil domain containing 36(CCDC36)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 36,modified residue,sequence variant,splice variant,
CCDC66	coiled-coil domain containing 66(CCDC66)	Homo sapiens				GO:0046548~retinal rod cell development,GO:0050908~detection of light stimulus involved in visual perception,GO:0060060~post-embryonic retina morphogenesis in camera-type eye,								Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 66,modified residue,sequence conflict,sequence variant,splice variant,
CCDC74B	coiled-coil domain containing 74B(CCDC74B)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 74B,sequence variant,splice variant,
CCDC80	coiled-coil domain containing 80(CCDC80)	Homo sapiens				GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,	GO:0005604~basement membrane,GO:0005614~interstitial matrix,GO:0016021~integral component of membrane,	GO:0001968~fibronectin binding,GO:0008201~heparin binding,	IPR025232:Domain of unknown function DUF4174,					Alternative splicing,Coiled coil,Complete proteome,Extracellular matrix,Isopeptide bond,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Coiled-coil domain-containing protein 80,compositionally biased region:Lys-rich,compositionally biased region:Thr-rich,sequence conflict,signal peptide,splice variant,
CCDC85A	coiled-coil domain containing 85A(CCDC85A)	Homo sapiens							IPR019359:Protein of unknown function DUF2216, coiled-coil,					Coiled coil,Complete proteome,Methylation,Reference proteome,	chain:Coiled-coil domain-containing protein 85A,compositionally biased region:Ala-rich,compositionally biased region:His-rich,
CCDC88A	coiled-coil domain containing 88A(CCDC88A)	Homo sapiens				GO:0001932~regulation of protein phosphorylation,GO:0006260~DNA replication,GO:0006275~regulation of DNA replication,GO:0010975~regulation of neuron projection development,GO:0016477~cell migration,GO:0030032~lamellipodium assembly,GO:0031929~TOR signaling,GO:0032148~activation of protein kinase B activity,GO:0032956~regulation of actin cytoskeleton organization,GO:0042127~regulation of cell proliferation,GO:0061024~membrane organization,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030027~lamellipodium,GO:0031410~cytoplasmic vesicle,	GO:0003779~actin binding,GO:0008017~microtubule binding,GO:0035091~phosphatidylinositol binding,GO:0042803~protein homodimerization activity,GO:0043422~protein kinase B binding,	IPR008636:HOOK/CCDC88,					Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,DNA replication,Membrane,Neurogenesis,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Girdin,modified residue,mutagenesis site,region of interest:Phosphoinositide-binding,sequence conflict,splice variant,
CCDC93	coiled-coil domain containing 93(CCDC93)	Homo sapiens				GO:0006893~Golgi to plasma membrane transport,GO:0015031~protein transport,	GO:0005769~early endosome,	GO:0005515~protein binding,	IPR019159:Protein of unknown function DUF2037,					Coiled coil,Complete proteome,Endosome,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Coiled-coil domain-containing protein 93,modified residue,sequence conflict,sequence variant,
CSDE1	cold shock domain containing E1(CSDE1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0008584~male gonad development,GO:0070966~nuclear-transcribed mRNA catabolic process, no-go decay,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0070937~CRD-mediated mRNA stability complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,IPR024642:SUZ-C domain,				SM00357:CSP,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Ubl conjugation,	chain:Cold shock domain-containing protein E1,domain:CSD 1,domain:CSD 2; truncated,domain:CSD 3,domain:CSD 4; truncated,domain:CSD 5,domain:CSD 6,domain:CSD 7,domain:CSD 8,domain:CSD 9,helix,modified residue,sequence conflict,splice variant,strand,turn,
COLGALT2	collagen beta(1-O)galactosyltransferase 2(COLGALT2)	Homo sapiens					GO:0005788~endoplasmic reticulum lumen,	GO:0005515~protein binding,GO:0016740~transferase activity,GO:0050211~procollagen galactosyltransferase activity,	IPR002654:Glycosyl transferase, family 25,	hsa00310:Lysine degradation,hsa00514:Other types of O-glycan biosynthesis,				Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,	chain:Procollagen galactosyltransferase 2,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,
COLQ	collagen like tail subunit of asymmetric acetylcholinesterase(COLQ)	Homo sapiens				GO:0001507~acetylcholine catabolic process in synaptic cleft,GO:0008105~asymmetric protein localization,GO:0008582~regulation of synaptic growth at neuromuscular junction,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,GO:0090150~establishment of protein localization to membrane,	GO:0005581~collagen trimer,GO:0005605~basal lamina,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0031594~neuromuscular junction,GO:0043083~synaptic cleft,	GO:0005515~protein binding,	IPR008160:Collagen triple helix repeat,IPR011936:Myxococcus cysteine-rich repeat,		603034~Myasthenic syndrome, congenital, 5,			3D-structure,Alternative splicing,Cell junction,Collagen,Complete proteome,Congenital myasthenic syndrome,Disease mutation,Disulfide bond,Neurotransmitter degradation,Polymorphism,Reference proteome,Repeat,Signal,Synapse,	chain:Acetylcholinesterase collagenic tail peptide,disulfide bond,domain:Collagen-like 1,domain:Collagen-like 2,region of interest:Heparan sulfate proteoglycan binding,region of interest:PRAD,sequence conflict,sequence variant,signal peptide,splice variant,
COL3A1	collagen type III alpha 1 chain(COL3A1)	Homo sapiens				GO:0001501~skeletal system development,GO:0007160~cell-matrix adhesion,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007507~heart development,GO:0007568~aging,GO:0009314~response to radiation,GO:0009612~response to mechanical stimulus,GO:0018149~peptide cross-linking,GO:0021987~cerebral cortex development,GO:0030168~platelet activation,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030574~collagen catabolic process,GO:0034097~response to cytokine,GO:0035025~positive regulation of Rho protein signal transduction,GO:0042060~wound healing,GO:0043206~extracellular fibril organization,GO:0043588~skin development,GO:0048565~digestive tract development,GO:0050776~regulation of immune response,GO:0050777~negative regulation of immune response,GO:0060414~aorta smooth muscle tissue morphogenesis,GO:0071230~cellular response to amino acid stimulus,GO:2001223~negative regulation of neuron migration,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005586~collagen type III trimer,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0005178~integrin binding,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0048407~platelet-derived growth factor binding,	IPR000885:Fibrillar collagen, C-terminal,IPR001007:von Willebrand factor, type C,IPR008160:Collagen triple helix repeat,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,	130050~Ehlers-Danlos syndrome, type IV,		SM00038:COLFI,SM00214:VWC,	3D-structure,Alternative splicing,Aortic aneurysm,Calcium,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Ehlers-Danlos syndrome,Extracellular matrix,Glycoprotein,Hydroxylation,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-1(III) chain,disulfide bond,domain:Fibrillar collagen NC1,domain:VWFC,glycosylation site:O-linked (Gal...),modified residue,propeptide:C-terminal propeptide,propeptide:N-terminal propeptide,region of interest:Nonhelical region (C-terminal),region of interest:Nonhelical region (N-terminal),region of interest:Triple-helical region,sequence conflict,sequence variant,signal peptide,splice variant,
COL4A3	collagen type IV alpha 3 chain(COL4A3)	Homo sapiens		h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,h_amiPathway:Acute Myocardial Infarction,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,h_npp1Pathway:Regulators of Bone Mineralization,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,h_vitCBPathway:Vitamin C in the Brain,		GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007605~sensory perception of sound,GO:0008015~blood circulation,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009749~response to glucose,GO:0010951~negative regulation of endopeptidase activity,GO:0016525~negative regulation of angiogenesis,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0032836~glomerular basement membrane development,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0072577~endothelial cell apoptotic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005587~collagen type IV trimer,GO:0005604~basement membrane,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0043231~intracellular membrane-bounded organelle,	GO:0005178~integrin binding,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0008191~metalloendopeptidase inhibitor activity,	IPR001442:Collagen IV, non-collagenous,IPR008160:Collagen triple helix repeat,IPR016187:C-type lectin fold,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	104200~Alport syndrome, autosomal dominant,141200~Hematuria, benign familial,203780~Alport syndrome, autosomal recessive,		SM00111:C4,	Alport syndrome,Alternative splicing,Basement membrane,Cell adhesion,Collagen,Complete proteome,Deafness,Direct protein sequencing,Disease mutation,Disulfide bond,Extracellular matrix,Glycoprotein,Hydroxylation,Isopeptide bond,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-3(IV) chain,chain:Tumstatin,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),cross-link:S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1533),cross-link:S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1651),disulfide bond,domain:Collagen IV NC1,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:7S domain,region of interest:Epitope recognized by Goodpasture antibodies,region of interest:Required for the anti-angiogenic activity of tumstatin,region of interest:Required for the anti-tumor cell activity of tumstatin,region of interest:Triple-helical region,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,site:Cleavage; by collagenase,splice variant,
COL4A4	collagen type IV alpha 4 chain(COL4A4)	Homo sapiens		h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,h_amiPathway:Acute Myocardial Infarction,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,h_npp1Pathway:Regulators of Bone Mineralization,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,h_vitCBPathway:Vitamin C in the Brain,		GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0032836~glomerular basement membrane development,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005587~collagen type IV trimer,GO:0005605~basal lamina,GO:0005788~endoplasmic reticulum lumen,	GO:0005201~extracellular matrix structural constituent,	IPR001442:Collagen IV, non-collagenous,IPR008160:Collagen triple helix repeat,IPR016187:C-type lectin fold,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	203780~Alport syndrome, autosomal recessive,Hematuria, familial benign~Hematuria, familial benign,		SM00111:C4,	Alport syndrome,Basement membrane,Collagen,Complete proteome,Deafness,Disease mutation,Disulfide bond,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-4(IV) chain,disulfide bond,domain:Collagen IV NC1,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:7S domain,region of interest:Triple-helical region,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,site:Cleavage; by collagenase,
COL9A2	collagen type IX alpha 2 chain(COL9A2)	Homo sapiens				GO:0001501~skeletal system development,GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005594~collagen type IX trimer,GO:0005788~endoplasmic reticulum lumen,	GO:0030020~extracellular matrix structural constituent conferring tensile strength,	IPR008160:Collagen triple helix repeat,	hsa04974:Protein digestion and absorption,	600204~Epiphyseal dysplasia, multiple, 2,603932~Intervertebral disc disease, susceptibility to,614284~Stickler syndrome, type V,			3D-structure,Collagen,Complete proteome,Deafness,Disease mutation,Disulfide bond,Dwarfism,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Stickler syndrome,	chain:Collagen alpha-2(IX) chain,disulfide bond,glycosylation site:O-linked (Xyl...) (glycosaminoglycan),region of interest:Nonhelical region 1 (NC1),region of interest:Nonhelical region 2 (NC2),region of interest:Nonhelical region 3 (NC3),region of interest:Nonhelical region 4 (NC4),region of interest:Triple-helical region 1 (COL1),region of interest:Triple-helical region 2 (COL2),region of interest:Triple-helical region 3 (COL3),region of interest:Triple-helical region 4 (COL4),sequence variant,signal peptide,
COL5A2	collagen type V alpha 2 chain(COL5A2)	Homo sapiens				GO:0001501~skeletal system development,GO:0001503~ossification,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030574~collagen catabolic process,GO:0043588~skin development,GO:0048592~eye morphogenesis,GO:0071230~cellular response to amino acid stimulus,GO:1903225~negative regulation of endodermal cell differentiation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005588~collagen type V trimer,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0005201~extracellular matrix structural constituent,GO:0046332~SMAD binding,GO:0046872~metal ion binding,	IPR000885:Fibrillar collagen, C-terminal,IPR001007:von Willebrand factor, type C,IPR008160:Collagen triple helix repeat,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,	130000~Ehlers-Danlos syndrome, classic type,		SM00038:COLFI,SM00214:VWC,	3D-structure,Calcium,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Ehlers-Danlos syndrome,Extracellular matrix,Glycoprotein,Hydroxylation,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-2(V) chain,domain:Fibrillar collagen NC1,domain:VWFC,glycosylation site:N-linked (GlcNAc...),modified residue,propeptide:C-terminal propeptide,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,
COL6A3	collagen type VI alpha 3 chain(COL6A3)	Homo sapiens				GO:0007155~cell adhesion,GO:0007517~muscle organ development,GO:0010951~negative regulation of endopeptidase activity,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005589~collagen type VI trimer,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,GO:0042383~sarcolemma,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002035:von Willebrand factor, type A,IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR003961:Fibronectin, type III,IPR008160:Collagen triple helix repeat,IPR013783:Immunoglobulin-like fold,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04974:Protein digestion and absorption,	158810~Bethlem myopathy 1,254090~Ullrich congenital muscular dystrophy 1,616411~Dystonia 27,		SM00131:KU,SM00327:VWA,	3D-structure,Alternative splicing,Cell adhesion,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Dystonia,Extracellular matrix,Glycoprotein,Hydroxylation,Phosphoprotein,Polymorphism,Protease inhibitor,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Collagen alpha-3(VI) chain,compositionally biased region:Ala-rich,compositionally biased region:Thr-rich,disulfide bond,domain:BPTI/Kunitz inhibitor,domain:Collagen-like 1,domain:Collagen-like 2,domain:Collagen-like 3,domain:Collagen-like 4,domain:Collagen-like 5,domain:Fibronectin type-III,domain:VWFA 1,domain:VWFA 10,domain:VWFA 11,domain:VWFA 12,domain:VWFA 2,domain:VWFA 3,domain:VWFA 4,domain:VWFA 5,domain:VWFA 6,domain:VWFA 7,domain:VWFA 8,domain:VWFA 9,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Gal...),helix,modified residue,region of interest:Nonhelical region,region of interest:Triple-helical region,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,site:Reactive bond,splice variant,strand,turn,
COL7A1	collagen type VII alpha 1 chain(COL7A1)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0010951~negative regulation of endopeptidase activity,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0035987~endodermal cell differentiation,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005590~collagen type VII trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0030134~ER to Golgi transport vesicle,GO:0031012~extracellular matrix,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002035:von Willebrand factor, type A,IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR003961:Fibronectin, type III,IPR008160:Collagen triple helix repeat,IPR013783:Immunoglobulin-like fold,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,	hsa04974:Protein digestion and absorption,	131705~Transient bullous of the newborn,131750~Epidermolysis bullosa dystrophica, AD,131850~Epidermolysis bullosa, pretibial,132000~EBD, Bart type,226600~EBD inversa,226600~Epidermolysis bullosa dystrophica, AR,604129~Epidermolysis bullosa pruriginosa,607523~Toenail dystrophy, isolated,EBD, localisata variant~EBD, localisata variant,		SM00060:FN3,SM00327:VWA,	Alternative splicing,Basement membrane,Cell adhesion,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Epidermolysis bullosa,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Collagen alpha-1(VII) chain,disulfide bond,domain:BPTI/Kunitz inhibitor,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,domain:VWFA 1,domain:VWFA 2,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Gal...),modified residue,region of interest:Interrupted collagenous region,region of interest:Nonhelical region (NC1),region of interest:Nonhelical region (NC2),region of interest:Triple-helical region,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,site:Reactive bond,splice variant,
COL8A1	collagen type VIII alpha 1 chain(COL8A1)	Homo sapiens				GO:0001525~angiogenesis,GO:0007155~cell adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0035987~endodermal cell differentiation,GO:0048593~camera-type eye morphogenesis,GO:0050673~epithelial cell proliferation,	GO:0005576~extracellular region,GO:0005591~collagen type VIII trimer,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,				SM00110:C1Q,	Angiogenesis,Basement membrane,Cell adhesion,Collagen,Complete proteome,Extracellular matrix,Hydroxylation,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-1(VIII) chain,chain:Vastatin,domain:C1q,region of interest:Nonhelical region (NC1),region of interest:Nonhelical region (NC2),region of interest:Triple-helical region (COL1),sequence conflict,signal peptide,
COL8A2	collagen type VIII alpha 2 chain(COL8A2)	Homo sapiens				GO:0001525~angiogenesis,GO:0016337~single organismal cell-cell adhesion,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0048593~camera-type eye morphogenesis,GO:0050673~epithelial cell proliferation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005604~basement membrane,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0005201~extracellular matrix structural constituent,GO:0030674~protein binding, bridging,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,		136800~Corneal dystrophy, Fuchs endothelial, 1,609140~Corneal dystrophy, posterior polymorphous 2,		SM00110:C1Q,	Angiogenesis,Basement membrane,Cell adhesion,Collagen,Complete proteome,Corneal dystrophy,Disease mutation,Extracellular matrix,Hydroxylation,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-2(VIII) chain,domain:C1q,region of interest:Nonhelical region (NC1),region of interest:Nonhelical region (NC2),region of interest:Triple-helical region,sequence conflict,sequence variant,signal peptide,
COL11A1	collagen type XI alpha 1 chain(COL11A1)	Homo sapiens				GO:0001502~cartilage condensation,GO:0001503~ossification,GO:0002063~chondrocyte development,GO:0006029~proteoglycan metabolic process,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030574~collagen catabolic process,GO:0035987~endodermal cell differentiation,GO:0035989~tendon development,GO:0042472~inner ear morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0055010~ventricular cardiac muscle tissue morphogenesis,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005592~collagen type XI trimer,GO:0005788~endoplasmic reticulum lumen,	GO:0005201~extracellular matrix structural constituent,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,GO:0050840~extracellular matrix binding,	IPR000885:Fibrillar collagen, C-terminal,IPR001791:Laminin G domain,IPR008160:Collagen triple helix repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,	154780~Marshall syndrome,228520~Fibrochondrogenesis 1,603932~Lumbar disc herniation, susceptibility to,604841~Stickler syndrome, type II,		SM00038:COLFI,SM00210:TSPN,SM00282:LamG,	Alternative splicing,Calcium,Cataract,Collagen,Complete proteome,Deafness,Direct protein sequencing,Disease mutation,Disulfide bond,Dwarfism,Ectodermal dysplasia,Extracellular matrix,Glycoprotein,Hydroxylation,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Stickler syndrome,	chain:Collagen alpha-1(XI) chain,domain:Fibrillar collagen NC1,domain:TSP N-terminal,glycosylation site:N-linked (GlcNAc...),modified residue,propeptide:C-terminal propeptide,propeptide:N-terminal propeptide,region of interest:Nonhelical region,region of interest:Nonhelical region (C-terminal),region of interest:Short nonhelical segment,region of interest:Telopeptide,region of interest:Triple-helical region,region of interest:Triple-helical region (interrupted),sequence conflict,sequence variant,signal peptide,splice variant,
COL16A1	collagen type XVI alpha 1 chain(COL16A1)	Homo sapiens				GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007565~female pregnancy,GO:0030198~extracellular matrix organization,GO:0033622~integrin activation,GO:0033627~cell adhesion mediated by integrin,GO:0051894~positive regulation of focal adhesion assembly,GO:0071230~cellular response to amino acid stimulus,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005597~collagen type XVI trimer,GO:0005788~endoplasmic reticulum lumen,	GO:0005178~integrin binding,GO:0005515~protein binding,	IPR001791:Laminin G domain,IPR008160:Collagen triple helix repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00210:TSPN,	Alternative splicing,Cell adhesion,Collagen,Complete proteome,Direct protein sequencing,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-1(XVI) chain,domain:TSP N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Nonhelical region 1 (NC1),region of interest:Nonhelical region 10 (NC10),region of interest:Nonhelical region 2 (NC2),region of interest:Nonhelical region 3 (NC3),region of interest:Nonhelical region 4 (NC4),region of interest:Nonhelical region 5 (NC5),region of interest:Nonhelical region 6 (NC6),region of interest:Nonhelical region 7 (NC7),region of interest:Nonhelical region 8 (NC8),region of interest:Nonhelical region 9 (NC9),region of interest:Triple-helical region 1 (COL1) with 2 imperfections,region of interest:Triple-helical region 2 (COL2) with 2 imperfections,region of interest:Triple-helical region 3 (COL3),region of interest:Triple-helical region 4 (COL4) with 2 imperfections,region of interest:Triple-helical region 5 (COL5) with 3 imperfections,region of interest:Triple-helical region 6 (COL6) with 1 imperfection,region of interest:Triple-helical region 7 (COL7) with 1 imperfection,region of interest:Triple-helical region 8 (COL8) with 1 imperfection,region of interest:Triple-helical region 9 (COL9) with 3 imperfections,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,
COL24A1	collagen type XXIV alpha 1 chain(COL24A1)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005788~endoplasmic reticulum lumen,	GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,	IPR000885:Fibrillar collagen, C-terminal,IPR001791:Laminin G domain,IPR008160:Collagen triple helix repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,			SM00038:COLFI,SM00210:TSPN,	Alternative splicing,Collagen,Complete proteome,Extracellular matrix,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-1(XXIV) chain,compositionally biased region:Poly-Tyr,domain:Collagen-like 1,domain:Collagen-like 10,domain:Collagen-like 11,domain:Collagen-like 12,domain:Collagen-like 13,domain:Collagen-like 14,domain:Collagen-like 15,domain:Collagen-like 16,domain:Collagen-like 17,domain:Collagen-like 2,domain:Collagen-like 3,domain:Collagen-like 4,domain:Collagen-like 5,domain:Collagen-like 6,domain:Collagen-like 7,domain:Collagen-like 8,domain:Collagen-like 9,domain:Fibrillar collagen NC1,domain:Laminin G-like,domain:TSP N-terminal,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
COLEC11	collectin subfamily member 11(COLEC11)	Homo sapiens				GO:0006508~proteolysis,GO:0006898~receptor-mediated endocytosis,GO:0006956~complement activation,GO:0007275~multicellular organism development,GO:0032502~developmental process,	GO:0005576~extracellular region,GO:0005581~collagen trimer,	GO:0004252~serine-type endopeptidase activity,GO:0005537~mannose binding,	IPR001304:C-type lectin,IPR008160:Collagen triple helix repeat,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04145:Phagosome,	265050~3MC syndrome 2,		SM00034:CLECT,	3D-structure,Alternative splicing,Calcium,Coiled coil,Collagen,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Lectin,Mannose-binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Collectin-11,disulfide bond,domain:C-type lectin,domain:Collagen-like,sequence conflict,sequence variant,signal peptide,splice variant,
CSF3R	colony stimulating factor 3 receptor(CSF3R)	Homo sapiens				GO:0006952~defense response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0030593~neutrophil chemotaxis,GO:0045637~regulation of myeloid cell differentiation,GO:0097186~amelogenesis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0051916~granulocyte colony-stimulating factor binding,	IPR003529:Long hematopoietin receptor, Gp130 family 2, conserved site,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR010457:Immunoglobulin C2-set-like, ligand-binding,IPR013783:Immunoglobulin-like fold,	hsa04060:Cytokine-cytokine receptor interaction,hsa04151:PI3K-Akt signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,hsa05200:Pathways in cancer,	162830~Neutrophilia, hereditary,		SM00060:FN3,	3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Granulocyte colony-stimulating factor receptor,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
C1QA	complement C1q A chain(C1QA)	Homo sapiens		h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,		GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0007267~cell-cell signaling,GO:0010039~response to iron ion,GO:0045087~innate immune response,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005602~complement component C1 complex,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,	613652~C1q deficiency,		SM00110:C1Q,	3D-structure,Collagen,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydroxylation,Immunity,Innate immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Complement C1q subcomponent subunit A,disulfide bond,domain:C1q,domain:Collagen-like,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Gal...),modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
C1QB	complement C1q B chain(C1QB)	Homo sapiens		h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,		GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0045087~innate immune response,GO:0048839~inner ear development,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005602~complement component C1 complex,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,	613652~C1q deficiency,		SM00110:C1Q,	3D-structure,Collagen,Complement pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydroxylation,Immunity,Innate immunity,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Secreted,Signal,	chain:Complement C1q subcomponent subunit B,disulfide bond,domain:C1q,domain:Collagen-like,glycosylation site:O-linked (Gal...),modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
C1QC	complement C1q C chain(C1QC)	Homo sapiens		h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,		GO:0006508~proteolysis,GO:0006955~immune response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0030853~negative regulation of granulocyte differentiation,GO:0045087~innate immune response,GO:0045650~negative regulation of macrophage differentiation,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,	613652~C1q deficiency,		SM00110:C1Q,	3D-structure,Collagen,Complement pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydroxylation,Immunity,Innate immunity,Reference proteome,Repeat,Secreted,Signal,	chain:Complement C1q subcomponent subunit C,disulfide bond,domain:C1q,domain:Collagen-like,glycosylation site:O-linked (Gal...),modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
CR1	complement C3b/C4b receptor 1 (Knops blood group)(CR1)	Homo sapiens		h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,		GO:0002430~complement receptor mediated signaling pathway,GO:0006958~complement activation, classical pathway,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,GO:0045957~negative regulation of complement activation, alternative pathway,GO:0045959~negative regulation of complement activation, classical pathway,GO:0046718~viral entry into host cell,GO:1900004~negative regulation of serine-type endopeptidase activity,GO:1900005~positive regulation of serine-type endopeptidase activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001851~complement component C3b binding,GO:0001855~complement component C4b binding,GO:0001861~complement component C4b receptor activity,GO:0004877~complement component C3b receptor activity,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05144:Malaria,hsa05152:Tuberculosis,	607486~Blood group, Knops system,611162~Malaria, severe, resistance to,CR1 deficiency~CR1 deficiency,SLE susceptibility~SLE susceptibility,		SM00032:CCP,	3D-structure,Blood group antigen,Complement pathway,Complete proteome,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Membrane,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Receptor,Reference proteome,Repeat,Signal,Sushi,Transmembrane,Transmembrane helix,	chain:Complement receptor type 1,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 21,domain:Sushi 22,domain:Sushi 23,domain:Sushi 24,domain:Sushi 25,domain:Sushi 26,domain:Sushi 27,domain:Sushi 28,domain:Sushi 29,domain:Sushi 3,domain:Sushi 30,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CR1L	complement C3b/C4b receptor 1 like(CR1L)	Homo sapiens					GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043235~receptor complex,		IPR000436:Sushi/SCR/CCP,				SM00032:CCP,	Alternative splicing,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement component receptor 1-like protein,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
CR2	complement C3d receptor 2(CR2)	Homo sapiens	6.CD23_engagement,	h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,		GO:0002430~complement receptor mediated signaling pathway,GO:0006955~immune response,GO:0006958~complement activation, classical pathway,GO:0030183~B cell differentiation,GO:0042100~B cell proliferation,GO:0045087~innate immune response,GO:0046718~viral entry into host cell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001848~complement binding,GO:0003677~DNA binding,GO:0004875~complement receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0042803~protein homodimerization activity,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,hsa04662:B cell receptor signaling pathway,hsa05169:Epstein-Barr virus infection,	610927~Systemic lupus erythematosus, susceptibility to, 9,614699~Immunodeficiency, common variable, 7,		SM00032:CCP,	3D-structure,Alternative splicing,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Sushi,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Complement receptor type 2,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
C8A	complement C8 alpha chain(C8A)	Homo sapiens		h_alternativePathway:Alternative Complement Pathway,h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,h_lectinPathway:Lectin Induced Complement Pathway,		GO:0006955~immune response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0019835~cytolysis,GO:0030449~regulation of complement activation,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0005615~extracellular space,GO:0016020~membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0001848~complement binding,GO:0032403~protein complex binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001862:Membrane attack complex component/perforin/complement C9,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR020863:Membrane attack complex component/perforin domain, conserved site,IPR020864:Membrane attack complex component/perforin (MACPF) domain,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05146:Amoebiasis,hsa05322:Systemic lupus erythematosus,	613790~C8 deficiency, type I,		SM00192:LDLa,SM00209:TSP1,SM00457:MACPF,	3D-structure,Cell membrane,Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Complete proteome,Cytolysis,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Immunity,Innate immunity,Membrane,Membrane attack complex,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane beta strand,	chain:Complement component C8 alpha chain,disulfide bond,domain:EGF-like,domain:LDL-receptor class A,domain:MACPF,domain:TSP type-1 1,domain:TSP type-1 2,glycosylation site:C-linked (Man),glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Not glycosylated,strand,turn,
C8B	complement C8 beta chain(C8B)	Homo sapiens				GO:0006955~immune response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0019835~cytolysis,GO:0030449~regulation of complement activation,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0005615~extracellular space,GO:0016020~membrane,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0032403~protein complex binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001862:Membrane attack complex component/perforin/complement C9,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR020863:Membrane attack complex component/perforin domain, conserved site,IPR020864:Membrane attack complex component/perforin (MACPF) domain,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05146:Amoebiasis,hsa05322:Systemic lupus erythematosus,	613789~C8 deficiency, type II,		SM00192:LDLa,SM00209:TSP1,SM00457:MACPF,	3D-structure,Complement alternate pathway,Complement pathway,Complete proteome,Cytolysis,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Immunity,Innate immunity,Membrane attack complex,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Complement component C8 beta chain,disulfide bond,domain:EGF-like,domain:LDL-receptor class A,domain:MACPF,domain:TSP type-1 1,domain:TSP type-1 2,glycosylation site:C-linked (Man),glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,
C4BPA	complement component 4 binding protein alpha(C4BPA)	Homo sapiens				GO:0006958~complement activation, classical pathway,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,GO:0045732~positive regulation of protein catabolic process,GO:0045959~negative regulation of complement activation, classical pathway,GO:1903027~regulation of opsonization,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0044216~other organism cell,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa05133:Pertussis,			SM00032:CCP,	3D-structure,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:C4b-binding protein alpha chain,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,strand,
C4BPB	complement component 4 binding protein beta(C4BPB)	Homo sapiens				GO:0006958~complement activation, classical pathway,GO:0007596~blood coagulation,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,GO:0045732~positive regulation of protein catabolic process,GO:0045959~negative regulation of complement activation, classical pathway,GO:1903027~regulation of opsonization,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0044216~other organism cell,	GO:0005515~protein binding,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa05133:Pertussis,			SM00032:CCP,	Alternative splicing,Complement pathway,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:C4b-binding protein beta chain,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
CFHR3	complement factor H related 3(CFHR3)	Homo sapiens					GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,		IPR000436:Sushi/SCR/CCP,		235400~Hemolytic uremic syndrome, atypical, susceptibility to,603075~Macular degeneration, age-related, reduced risk of,		SM00032:CCP,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H-related protein 3,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
CFHR4	complement factor H related 4(CFHR4)	Homo sapiens				GO:0006869~lipid transport,	GO:0005576~extracellular region,	GO:0005319~lipid transporter activity,	IPR000436:Sushi/SCR/CCP,				SM00032:CCP,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H-related protein 4,chain:complement factor H-related protein 4A,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
CFHR5	complement factor H related 5(CFHR5)	Homo sapiens				GO:0006957~complement activation, alternative pathway,	GO:0005576~extracellular region,		IPR000436:Sushi/SCR/CCP,		614809~Nephropathy due to CFHR5 deficiency,		SM00032:CCP,	Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemolytic uremic syndrome,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H-related protein 5,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
CFH	complement factor H(CFH)	Homo sapiens				GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0030449~regulation of complement activation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0008201~heparin binding,GO:0043395~heparan sulfate proteoglycan binding,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,	126700~Basal laminar drusen,235400~Hemolytic uremic syndrome, atypical, susceptibility to, 1,609814~Complement factor H deficiency,610698~Macular degeneration, age-related, 4,		SM00032:CCP,	3D-structure,Age-related macular degeneration,Alternative splicing,Complement alternate pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemolytic uremic syndrome,Immunity,Innate immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Not glycosylated,splice variant,strand,turn,
COG2	component of oligomeric golgi complex 2(COG2)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,	GO:0000139~Golgi membrane,GO:0005795~Golgi stack,GO:0005829~cytosol,GO:0016020~membrane,GO:0017119~Golgi transport complex,GO:0032588~trans-Golgi network membrane,	GO:0005515~protein binding,GO:0008565~protein transporter activity,GO:0032403~protein complex binding,	IPR009316:COG complex component, COG2,IPR024602:Conserved oligomeric Golgi complex, subunit 2, N-terminal,IPR024603:COG complex component, COG2, C-terminal,					Alternative splicing,Complete proteome,Golgi apparatus,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Conserved oligomeric Golgi complex subunit 2,sequence variant,
CNST	consortin, connexin sorting protein(CNST)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,GO:0042998~positive regulation of Golgi to plasma membrane protein transport,	GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0019902~phosphatase binding,GO:0071253~connexin binding,						Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Consortin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,transmembrane region,
CNTN2	contactin 2(CNTN2)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0001764~neuron migration,GO:0007155~cell adhesion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0007417~central nervous system development,GO:0007612~learning,GO:0007628~adult walking behavior,GO:0010954~positive regulation of protein processing,GO:0021853~cerebral cortex GABAergic interneuron migration,GO:0022010~central nervous system myelination,GO:0031133~regulation of axon diameter,GO:0031623~receptor internalization,GO:0045163~clustering of voltage-gated potassium channels,GO:0045665~negative regulation of neuron differentiation,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048710~regulation of astrocyte differentiation,GO:0060168~positive regulation of adenosine receptor signaling pathway,GO:0071205~protein localization to juxtaparanode region of axon,GO:0071206~establishment of protein localization to juxtaparanode region of axon,GO:0097090~presynaptic membrane organization,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0009986~cell surface,GO:0031225~anchored component of membrane,GO:0033268~node of Ranvier,GO:0043025~neuronal cell body,GO:0043209~myelin sheath,GO:0044224~juxtaparanode region of axon,GO:0045202~synapse,	GO:0001948~glycoprotein binding,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0043621~protein self-association,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),	615400~Epilepsy, myoclonic, familial adult, 5,		SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Epilepsy,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	chain:Contactin-2,compositionally biased region:Gly/Pro-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated asparagine,propeptide:Removed in mature form,sequence variant,short sequence motif:Cell attachment site,signal peptide,strand,
CNTN3	contactin 3(CNTN3)	Homo sapiens				GO:0007155~cell adhesion,GO:0007399~nervous system development,	GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Signal,	chain:Contactin-3,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,strand,
CNTN4	contactin 4(CNTN4)	Homo sapiens				GO:0007155~cell adhesion,GO:0007158~neuron cell-cell adhesion,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0007420~brain development,GO:0031175~neuron projection development,GO:0045665~negative regulation of neuron differentiation,GO:0048167~regulation of synaptic plasticity,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0030424~axon,GO:0031225~anchored component of membrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Chromosomal rearrangement,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Contactin-4,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,splice variant,
CNTN6	contactin 6(CNTN6)	Homo sapiens				GO:0007155~cell adhesion,GO:0007219~Notch signaling pathway,GO:0007417~central nervous system development,GO:0030182~neuron differentiation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,	GO:0005112~Notch binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Notch signaling pathway,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Contactin-6,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,modified residue,propeptide:Removed in mature form,sequence variant,signal peptide,
CNTNAP5	contactin associated protein like 5(CNTNAP5)	Homo sapiens				GO:0007155~cell adhesion,	GO:0016021~integral component of membrane,		IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR008979:Galactose-binding domain-like,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00181:EGF,SM00231:FA58C,SM00282:LamG,	Cell adhesion,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Contactin-associated protein-like 5,compositionally biased region:Poly-Ser,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:F5/8 type C,domain:Fibrinogen C-terminal,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,domain:Laminin G-like 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CPNE9	copine family member 9(CPNE9)	Homo sapiens				GO:1903861~positive regulation of dendrite extension,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,		IPR000008:C2 calcium-dependent membrane targeting,IPR002035:von Willebrand factor, type A,IPR010734:Copine,				SM00239:C2,SM00327:VWA,	Alternative splicing,Complete proteome,Differentiation,Glycoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Copine-9,compositionally biased region:Poly-Lys,domain:C2 1,domain:C2 2,domain:VWFA,glycosylation site:N-linked (GlcNAc...),
COMMD1	copper metabolism domain containing 1(COMMD1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006893~Golgi to plasma membrane transport,GO:0015031~protein transport,GO:0031398~positive regulation of protein ubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0048227~plasma membrane to endosome transport,GO:0055070~copper ion homeostasis,GO:1902306~negative regulation of sodium ion transmembrane transport,GO:2000009~negative regulation of protein localization to cell surface,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0010008~endosome membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031462~Cul2-RING ubiquitin ligase complex,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,	GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0070300~phosphatidic acid binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR017920:COMM domain,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Copper,Cytoplasm,Cytoplasmic vesicle,Endosome,Lipid-binding,Membrane,Metal-binding,Nucleus,Protein transport,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Transport,Ubl conjugation,Ubl conjugation pathway,	chain:COMM domain-containing protein 1,domain:COMM,helix,modified residue,strand,turn,
CPOX	coproporphyrinogen oxidase(CPOX)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,		GO:0006779~porphyrin-containing compound biosynthetic process,GO:0006782~protoporphyrinogen IX biosynthetic process,GO:0006783~heme biosynthetic process,GO:0010039~response to iron ion,GO:0010288~response to lead ion,GO:0017085~response to insecticide,GO:0046685~response to arsenic-containing substance,GO:0051597~response to methylmercury,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0016021~integral component of membrane,	GO:0004109~coproporphyrinogen oxidase activity,GO:0005212~structural constituent of eye lens,GO:0042803~protein homodimerization activity,	IPR001260:Coproporphyrinogen III oxidase, aerobic,IPR018375:Coproporphyrinogen III oxidase, conserved site,	hsa00860:Porphyrin and chlorophyll metabolism,hsa01100:Metabolic pathways,	121300~Coproporphyria,121300~Harderoporphyria,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,Heme biosynthesis,Membrane,Mitochondrion,Oxidoreductase,Phosphoprotein,Polymorphism,Porphyrin biosynthesis,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	active site:Proton donor,binding site:Substrate,chain:Coproporphyrinogen-III oxidase, mitochondrial,helix,modified residue,mutagenesis site,region of interest:Important for dimerization,region of interest:Substrate binding,sequence conflict,sequence variant,site:Important for dimerization,strand,transit peptide:Mitochondrion,turn,
COBLL1	cordon-bleu WH2 repeat protein like 1(COBLL1)	Homo sapiens				GO:0030041~actin filament polymerization,GO:0051639~actin filament network formation,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0003785~actin monomer binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003124:WH2 domain,IPR019025:Cordon-bleu domain,					3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Cordon-bleu protein-like 1,domain:WH2,helix,modified residue,sequence conflict,short sequence motif:KKRRAP 1,short sequence motif:KKRRAP 2,splice variant,strand,turn,
CIR1	corepressor interacting with RBPJ, 1(CIR1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0016607~nuclear speck,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,	IPR019339:CBF1-interacting co-repressor CIR, N-terminal domain,	hsa04330:Notch signaling pathway,			SM01083:SM01083,	Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Corepressor interacting with RBPJ 1,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Lys/Ser-rich,modified residue,region of interest:Interaction with RBPJ,region of interest:Interaction with RP9,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,
CNIH3	cornichon family AMPA receptor auxiliary protein 3(CNIH3)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0035249~synaptic transmission, glutamatergic,GO:0042391~regulation of membrane potential,GO:0048208~COPII vesicle coating,GO:2000311~regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0030054~cell junction,GO:0032281~AMPA glutamate receptor complex,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043198~dendritic shaft,GO:0045211~postsynaptic membrane,	GO:0016247~channel regulator activity,	IPR003377:Cornichon,				SM01398:SM01398,	Cell junction,Cell membrane,Complete proteome,Membrane,Postsynaptic cell membrane,Reference proteome,Synapse,Transmembrane,Transmembrane helix,	chain:Protein cornichon homolog 3,transmembrane region,
CNIH4	cornichon family AMPA receptor auxiliary protein 4(CNIH4)	Homo sapiens				GO:0006810~transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0031730~CCR5 chemokine receptor binding,	IPR003377:Cornichon,				SM01398:SM01398,	Alternative splicing,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Protein cornichon homolog 4,sequence variant,splice variant,transmembrane region,
CFC1	cripto, FRL-1, cryptic family 1(CFC1)	Homo sapiens				GO:0007368~determination of left/right symmetry,GO:0007369~gastrulation,GO:0038092~nodal signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,	GO:0038100~nodal binding,	IPR000742:Epidermal growth factor-like domain,IPR013032:EGF-like, conserved site,IPR019011:Cryptic/Cripto, CFC domain,		605376~Heterotaxy, visceral, 2, autosomal,			Cell membrane,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,EGF-like domain,Gastrulation,Glycoprotein,GPI-anchor,Heterotaxy,Lipoprotein,Membrane,Polymorphism,Reference proteome,Secreted,Signal,	chain:Cryptic protein,disulfide bond,domain:EGF-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
CRB1	crumbs 1, cell polarity complex component(CRB1)	Homo sapiens				GO:0006611~protein export from nucleus,GO:0007009~plasma membrane organization,GO:0007163~establishment or maintenance of cell polarity,GO:0007267~cell-cell signaling,GO:0042462~eye photoreceptor cell development,	GO:0005576~extracellular region,GO:0005622~intracellular,GO:0005902~microvillus,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR018097:EGF-like calcium-binding, conserved site,	hsa04390:Hippo signaling pathway,	172870~Pigmented paravenous chorioretinal atrophy,600105~Retinitis pigmentosa-12, autosomal recessive,613835~Leber congenital amaurosis 8,		SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	3D-structure,Alternative splicing,Calcium,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Leber congenital amaurosis,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Retinitis pigmentosa,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Crumbs homolog 1,disulfide bond,domain:EGF-like 1,domain:EGF-like 10; calcium-binding,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 16; calcium-binding,domain:EGF-like 17,domain:EGF-like 18,domain:EGF-like 19; calcium-binding,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:EGF-like 8,domain:EGF-like 9,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CRYBA2	crystallin beta A2(CRYBA2)	Homo sapiens				GO:0002088~lens development in camera-type eye,		GO:0005212~structural constituent of eye lens,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR001064:Beta/gamma crystallin,IPR011024:Gamma-crystallin-related,		115900~Cataract 42,		SM00247:XTALbg,	Cataract,Complete proteome,Disease mutation,Eye lens protein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Beta-crystallin A2,domain:Beta/gamma crystallin 'Greek key' 1,domain:Beta/gamma crystallin 'Greek key' 2,domain:Beta/gamma crystallin 'Greek key' 3,domain:Beta/gamma crystallin 'Greek key' 4,region of interest:Connecting peptide,region of interest:N-terminal arm,sequence conflict,
CRYBG3	crystallin beta-gamma domain containing 3(CRYBG3)	Homo sapiens						GO:0030246~carbohydrate binding,	IPR000772:Ricin B lectin domain,IPR001064:Beta/gamma crystallin,IPR011024:Gamma-crystallin-related,				SM00247:XTALbg,SM00458:RICIN,	Alternative splicing,Complete proteome,Lectin,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Beta/gamma crystallin domain-containing protein 3,domain:Beta/gamma crystallin 'Greek key' 1,domain:Beta/gamma crystallin 'Greek key' 2,domain:Beta/gamma crystallin 'Greek key' 3,domain:Beta/gamma crystallin 'Greek key' 4,domain:Beta/gamma crystallin 'Greek key' 5,domain:Beta/gamma crystallin 'Greek key' 6,domain:Beta/gamma crystallin 'Greek key' 7,domain:Beta/gamma crystallin 'Greek key' 8,domain:Beta/gamma crystallin 'Greek key' 9,domain:Ricin B-type lectin,sequence conflict,sequence variant,splice variant,
CRYGA	crystallin gamma A(CRYGA)	Homo sapiens				GO:0002088~lens development in camera-type eye,GO:0007601~visual perception,		GO:0005212~structural constituent of eye lens,	IPR001064:Beta/gamma crystallin,IPR011024:Gamma-crystallin-related,				SM00247:XTALbg,	3D-structure,Complete proteome,Eye lens protein,Polymorphism,Reference proteome,Repeat,	chain:Gamma-crystallin A,domain:Beta/gamma crystallin 'Greek key' 1,domain:Beta/gamma crystallin 'Greek key' 2,domain:Beta/gamma crystallin 'Greek key' 3,domain:Beta/gamma crystallin 'Greek key' 4,helix,region of interest:Connecting peptide,sequence variant,strand,turn,
CRYZ	crystallin zeta(CRYZ)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,	Energy production and conversion / General function prediction only,	GO:0007601~visual perception,GO:0042178~xenobiotic catabolic process,GO:0051289~protein homotetramerization,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003730~mRNA 3'-UTR binding,GO:0003960~NADPH:quinone reductase activity,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0070402~NADPH binding,GO:0070404~NADH binding,	IPR002085:Alcohol dehydrogenase superfamily, zinc-type,IPR002364:Quinone oxidoreductase/zeta-crystallin, conserved site,IPR011032:GroES-like,IPR013149:Alcohol dehydrogenase, C-terminal,IPR013154:Alcohol dehydrogenase GroES-like,IPR016040:NAD(P)-binding domain,IPR020843:Polyketide synthase, enoylreductase,				SM00829:SM00829,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Quinone oxidoreductase,helix,modified residue,sequence variant,strand,turn,
CUL3	cullin 3(CUL3)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0000278~mitotic cell cycle,GO:0001831~trophectodermal cellular morphogenesis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007050~cell cycle arrest,GO:0007080~mitotic metaphase plate congression,GO:0007229~integrin-mediated signaling pathway,GO:0007369~gastrulation,GO:0008054~negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation,GO:0008284~positive regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0016477~cell migration,GO:0016567~protein ubiquitination,GO:0017145~stem cell division,GO:0030030~cell projection organization,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0032467~positive regulation of cytokinesis,GO:0035024~negative regulation of Rho protein signal transduction,GO:0040016~embryonic cleavage,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043149~stress fiber assembly,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0044346~fibroblast apoptotic process,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0048208~COPII vesicle coating,GO:0072576~liver morphogenesis,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005827~polar microtubule,GO:0005829~cytosol,GO:0016020~membrane,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0070062~extracellular exosome,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0030332~cyclin binding,GO:0031208~POZ domain binding,GO:0031625~ubiquitin protein ligase binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0061630~ubiquitin protein ligase activity,	IPR001373:Cullin, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016157:Cullin, conserved site,IPR016158:Cullin homology,IPR016159:Cullin repeat-like-containing domain,IPR019559:Cullin protein, neddylation domain,	hsa04120:Ubiquitin mediated proteolysis,	614496~Pseudohypoaldosteronism, type IIE,		SM00182:CULLIN,SM00884:SM00884,	3D-structure,Acetylation,Alternative splicing,Cilium biogenesis/degradation,Complete proteome,Disease mutation,ER-Golgi transport,Golgi apparatus,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,Ubl conjugation,Ubl conjugation pathway,	chain:Cullin-3,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8),modified residue,sequence conflict,sequence variant,splice variant,
CAND2	cullin associated and neddylation dissociated 2 (putative)(CAND2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0010265~SCF complex assembly,GO:0016567~protein ubiquitination,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0005515~protein binding,GO:0017025~TBP-class protein binding,	IPR011989:Armadillo-like helical,IPR013932:TATA-binding protein interacting (TIP20),IPR016024:Armadillo-type fold,					Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Ubl conjugation,Ubl conjugation pathway,	chain:Cullin-associated NEDD8-dissociated protein 2,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,modified residue,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 11,repeat:HEAT 12,repeat:HEAT 13,repeat:HEAT 14,repeat:HEAT 15,repeat:HEAT 16,repeat:HEAT 17,repeat:HEAT 18,repeat:HEAT 19,repeat:HEAT 2,repeat:HEAT 20,repeat:HEAT 21,repeat:HEAT 22,repeat:HEAT 23,repeat:HEAT 24,repeat:HEAT 25,repeat:HEAT 26,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,sequence conflict,sequence variant,splice variant,
CNGA3	cyclic nucleotide gated channel alpha 3(CNGA3)	Homo sapiens				GO:0006810~transport,GO:0006812~cation transport,GO:0007165~signal transduction,GO:0007601~visual perception,GO:0031960~response to corticosteroid,GO:0032026~response to magnesium ion,GO:0042391~regulation of membrane potential,GO:0051591~response to cAMP,GO:0071805~potassium ion transmembrane transport,	GO:0005737~cytoplasm,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0042622~photoreceptor outer segment membrane,GO:0043204~perikaryon,GO:1902495~transmembrane transporter complex,	GO:0005216~ion channel activity,GO:0005222~intracellular cAMP activated cation channel activity,GO:0005223~intracellular cGMP activated cation channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0008022~protein C-terminus binding,GO:0015276~ligand-gated ion channel activity,GO:0030553~cGMP binding,	IPR000595:Cyclic nucleotide-binding domain,IPR005821:Ion transport domain,IPR014710:RmlC-like jelly roll fold,IPR018488:Cyclic nucleotide-binding, conserved site,IPR018490:Cyclic nucleotide-binding-like,	hsa04024:cAMP signaling pathway,hsa04740:Olfactory transduction,	216900~Achromatopsia-2,		SM00100:cNMP,	3D-structure,Alternative splicing,cGMP,cGMP-binding,Coiled coil,Complete proteome,Disease mutation,Ion channel,Ion transport,Leber congenital amaurosis,Ligand-gated ion channel,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Sensory transduction,Transmembrane,Transmembrane helix,Transport,Vision,	binding site:cGMP,chain:Cyclic nucleotide-gated cation channel alpha-3,nucleotide phosphate-binding region:cGMP,sequence variant,transmembrane region,
CCNT2	cyclin T2(CCNT2)	Homo sapiens			Cell division and chromosome partitioning / Transcription / DNA replication, recombination, and repair,Signal transduction mechanisms,	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007519~skeletal muscle tissue development,GO:0019085~early viral transcription,GO:0019086~late viral transcription,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051147~regulation of muscle cell differentiation,GO:0051301~cell division,GO:1901409~positive regulation of phosphorylation of RNA polymerase II C-terminal domain,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0048471~perinuclear region of cytoplasm,	GO:0001223~transcription coactivator binding,GO:0003682~chromatin binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0070063~RNA polymerase binding,GO:0097322~7SK snRNA binding,	IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,	hsa05202:Transcriptional misregulation in cancer,			SM00385:CYCLIN,	3D-structure,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cyclin,Cytoplasm,Host-virus interaction,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Cyclin-T2,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,helix,modified residue,mutagenesis site,sequence conflict,splice variant,turn,
CCNYL1	cyclin Y like 1(CCNYL1)	Homo sapiens				GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0007283~spermatogenesis,GO:0030317~sperm motility,	GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR006671:Cyclin, N-terminal,IPR012399:Cyclin Y,IPR013763:Cyclin-like,			PIRSF028934:uncharacterized protein with cyclin domain, CG14939 type,	SM00385:CYCLIN,	Alternative splicing,Complete proteome,Cyclin,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Cyclin-Y-like protein 1,domain:Cyclin N-terminal,modified residue,splice variant,
CNNM3	cyclin and CBS domain divalent metal cation transport mediator 3(CNNM3)	Homo sapiens			General function prediction only,	GO:0006811~ion transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR000644:Cystathionine beta-synthase, core,					Alternative splicing,CBS domain,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Metal transporter CNNM3,domain:CBS 1,domain:CBS 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,splice variant,transmembrane region,
CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4(CNNM4)	Homo sapiens				GO:0007601~visual perception,GO:0010960~magnesium ion homeostasis,GO:0015693~magnesium ion transport,GO:0035725~sodium ion transmembrane transport,GO:0050896~response to stimulus,GO:0070166~enamel mineralization,GO:1903830~magnesium ion transmembrane transport,	GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,	GO:0015081~sodium ion transmembrane transporter activity,GO:0015095~magnesium ion transmembrane transporter activity,	IPR000595:Cyclic nucleotide-binding domain,IPR000644:Cystathionine beta-synthase, core,IPR002550:Domain of unknown function DUF21,IPR014710:RmlC-like jelly roll fold,IPR018490:Cyclic nucleotide-binding-like,		217080~Jalili syndrome,			3D-structure,Alternative splicing,Amelogenesis imperfecta,Biomineralization,CBS domain,Cell membrane,Complete proteome,Cone-rod dystrophy,Disease mutation,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Sensory transduction,Transmembrane,Transmembrane helix,Transport,Vision,	chain:Metal transporter CNNM4,domain:CBS 1,domain:CBS 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,transmembrane region,
CDK11A	cyclin dependent kinase 11A(CDK11A)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,		GO:0001558~regulation of cell growth,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007067~mitotic nuclear division,GO:0050684~regulation of mRNA processing,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,				SM00220:S_TKc,	Alternative initiation,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Coiled coil,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,TransferaseFT                                MKTTSWLFQSHGSTEIP,	active site:Proton acceptor,binding site:ATP,chain:Cell division protein kinase 11A,chain:Cell division protein kinase 11B,compositionally biased region:Glu-rich,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
CDK11B	cyclin dependent kinase 11B(CDK11B)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,		GO:0001558~regulation of cell growth,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007067~mitotic nuclear division,GO:0008283~cell proliferation,GO:0050684~regulation of mRNA processing,GO:0051301~cell division,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0044822~poly(A) RNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,				SM00220:S_TKc,	Alternative initiation,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cell division protein kinase 11A,chain:Cell division protein kinase 11B,compositionally biased region:Glu-rich,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
CDK15	cyclin dependent kinase 15(CDK15)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0051726~regulation of cell cycle,		GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cell division protein kinase 15,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
CDK18	cyclin dependent kinase 18(CDK18)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0051726~regulation of cell cycle,		GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cell division protein kinase 18,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
CDKL4	cyclin dependent kinase like 4(CDKL4)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0051726~regulation of cell cycle,	GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cyclin-dependent kinase-like 4,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:[NKR]KIAxRE,
CTH	cystathionine gamma-lyase(CTH)	Homo sapiens		h_methioninePathway:Catabolic Pathways for Methionine, Isoleucine, Threonine and Valine,		GO:0000098~sulfur amino acid catabolic process,GO:0006534~cysteine metabolic process,GO:0018272~protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,GO:0019343~cysteine biosynthetic process via cystathionine,GO:0019344~cysteine biosynthetic process,GO:0019346~transsulfuration,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044524~protein sulfhydration,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051289~protein homotetramerization,GO:0070814~hydrogen sulfide biosynthetic process,GO:0071266~'de novo' L-methionine biosynthetic process,GO:1904831~positive regulation of aortic smooth muscle cell differentiation,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003962~cystathionine gamma-synthase activity,GO:0004123~cystathionine gamma-lyase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0016846~carbon-sulfur lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,GO:0044540~L-cystine L-cysteine-lyase (deaminating),GO:0047982~homocysteine desulfhydrase activity,GO:0080146~L-cysteine desulfhydrase activity,	IPR000277:Cys/Met metabolism, pyridoxal phosphate-dependent enzyme,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00260:Glycine, serine and threonine metabolism,hsa00270:Cysteine and methionine metabolism,hsa00450:Selenocompound metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01230:Biosynthesis of amino acids,	219500~Cystathioninuria,Homocysteine, total plasma, elevated~Homocysteine, total plasma, elevated,	PIRSF001434:cystathionine gamma-synthase,		3D-structure,Alternative splicing,Amino-acid biosynthesis,Calmodulin-binding,Complete proteome,Cysteine biosynthesis,Cytoplasm,Disease mutation,Lyase,Polymorphism,Pyridoxal phosphate,Reference proteome,	binding site:Substrate,chain:Cystathionine gamma-lyase,helix,modified residue,sequence variant,splice variant,strand,turn,
CSRP1	cysteine and glycine rich protein 1(CSRP1)	Homo sapiens				GO:0070527~platelet aggregation,	GO:0005634~nucleus,GO:0005925~focal adhesion,GO:0070062~extracellular exosome,	GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	Acetylation,Complete proteome,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:Cysteine and glycine-rich protein 1,compositionally biased region:Gly-rich,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,modified residue,sequence variant,short sequence motif:Nuclear localization signal,
CSRNP1	cysteine and serine rich nuclear protein 1(CSRNP1)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0009791~post-embryonic development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048705~skeletal system morphogenesis,GO:0060021~palate development,GO:0060325~face morphogenesis,	GO:0005634~nucleus,GO:0016021~integral component of membrane,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR023260:Cysteine/serine-rich nuclear protein family,					Activator,Apoptosis,Coiled coil,Complete proteome,DNA-binding,Membrane,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:Cysteine/serine-rich nuclear protein 1,compositionally biased region:Cys-rich,compositionally biased region:Ser-rich,sequence variant,
CSRNP3	cysteine and serine rich nuclear protein 3(CSRNP3)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0010923~negative regulation of phosphatase activity,GO:0043065~positive regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR023260:Cysteine/serine-rich nuclear protein family,					Activator,Alternative splicing,Apoptosis,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Cysteine/serine-rich nuclear protein 3,compositionally biased region:Cys-rich,compositionally biased region:Glu-rich,compositionally biased region:Ser-rich,modified residue,sequence variant,splice variant,
CRCT1	cysteine rich C-terminal 1(CRCT1)	Homo sapiens				GO:0018149~peptide cross-linking,GO:0030216~keratinocyte differentiation,	GO:0001533~cornified envelope,GO:0005737~cytoplasm,	GO:0005198~structural molecule activity,GO:0005515~protein binding,						Complete proteome,Polymorphism,Reference proteome,	chain:Cysteine-rich C-terminal protein 1,compositionally biased region:Cys-rich,sequence variant,
CYR61	cysteine rich angiogenic inducer 61(CYR61)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0001649~osteoblast differentiation,GO:0001934~positive regulation of protein phosphorylation,GO:0002041~intussusceptive angiogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003278~apoptotic process involved in heart morphogenesis,GO:0003281~ventricular septum development,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0008283~cell proliferation,GO:0009653~anatomical structure morphogenesis,GO:0010518~positive regulation of phospholipase activity,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0030513~positive regulation of BMP signaling pathway,GO:0033690~positive regulation of osteoblast proliferation,GO:0043066~negative regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0044319~wound healing, spreading of cells,GO:0045597~positive regulation of cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045860~positive regulation of protein kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060413~atrial septum morphogenesis,GO:0060548~negative regulation of cell death,GO:0060591~chondroblast differentiation,GO:0060710~chorio-allantoic fusion,GO:0060716~labyrinthine layer blood vessel development,GO:0061036~positive regulation of cartilage development,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0072593~reactive oxygen species metabolic process,GO:2000304~positive regulation of ceramide biosynthetic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,	GO:0000166~nucleotide binding,GO:0005178~integrin binding,GO:0005520~insulin-like growth factor binding,GO:0008201~heparin binding,GO:0050840~extracellular matrix binding,	IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR000884:Thrombospondin, type 1 repeat,IPR001007:von Willebrand factor, type C,IPR006207:Cystine knot, C-terminal,IPR006208:Cystine knot,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR012395:IGFBP-related, CNN,IPR017891:Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site,			PIRSF036495:IGFBP-related protein, CNN type,	SM00041:CT,SM00121:IB,SM00209:TSP1,SM00214:VWC,	3D-structure,Cell adhesion,Chemotaxis,Complete proteome,Disulfide bond,Growth factor binding,Heparin-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Protein CYR61,disulfide bond,domain:CTCK,domain:IGFBP N-terminal,domain:TSP type-1,domain:VWFC,region of interest:Heparin-binding,sequence conflict,sequence variant,signal peptide,
CRIM1	cysteine rich transmembrane BMP regulator 1(CRIM1)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0007399~nervous system development,GO:0010951~negative regulation of endopeptidase activity,GO:0048009~insulin-like growth factor receptor signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005010~insulin-like growth factor-activated receptor activity,GO:0005520~insulin-like growth factor binding,GO:0030165~PDZ domain binding,	IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR001007:von Willebrand factor, type C,IPR004094:Proteinase inhibitor I15, antistasin-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011061:Proteinase inhibitor I14/I15, hirudin/antistatin,IPR011390:Insulin-like growth factor binding protein-related protein (IGFBP-rP), MAC25,				SM00121:IB,SM00214:VWC,SM00215:VWC_out,	Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Cysteine-rich motor neuron 1 protein,chain:Processed cysteine-rich motor neuron 1 protein,domain:Antistasin-like 1,domain:Antistasin-like 2,domain:Antistasin-like 3,domain:Antistasin-like 4,domain:IGFBP N-terminal,domain:VWFC 1,domain:VWFC 2,domain:VWFC 3,domain:VWFC 4,domain:VWFC 5,domain:VWFC 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CRELD1	cysteine rich with EGF like domains 1(CRELD1)	Homo sapiens				GO:0003197~endocardial cushion development,GO:0003279~cardiac septum development,	GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR006212:Furin-like repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR021852:Domain of unknown function DUF3456,		606217~Atrioventricular septal defect, partial, with heterotaxy syndrome,606217~Atrioventricular septal defect, susceptibility to, 2,		SM00179:EGF_CA,SM00181:EGF,SM00261:FU,	Alternative splicing,Calcium,Complete proteome,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cysteine-rich with EGF-like domain protein 1,compositionally biased region:Pro-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,glycosylation site:N-linked (GlcNAc...),repeat:FU 1,repeat:FU 2,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CYS1	cystin 1(CYS1)	Homo sapiens					GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0060170~ciliary membrane,GO:0070062~extracellular exosome,GO:0072372~primary cilium,	GO:0005515~protein binding,						Cell membrane,Cell projection,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Lipoprotein,Membrane,Myristate,Reference proteome,	chain:Cystin-1,compositionally biased region:Poly-Arg,
CDA	cytidine deaminase(CDA)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0008655~pyrimidine-containing compound salvage,GO:0009972~cytidine deamination,GO:0019858~cytosine metabolic process,GO:0030308~negative regulation of cell growth,GO:0043097~pyrimidine nucleoside salvage,GO:0045980~negative regulation of nucleotide metabolic process,GO:0051289~protein homotetramerization,	GO:0005576~extracellular region,GO:0005829~cytosol,	GO:0001882~nucleoside binding,GO:0004126~cytidine deaminase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042803~protein homodimerization activity,	IPR002125:CMP/dCMP deaminase, zinc-binding,IPR006262:Cytidine deaminase, homotetrameric,IPR013171:Cytidine/deoxycytidylate deaminase, zinc-binding domain,IPR016192:APOBEC/CMP deaminase, zinc-binding,IPR016193:Cytidine deaminase-like,	hsa00240:Pyrimidine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,				3D-structure,Complete proteome,Hydrolase,Metal-binding,Polymorphism,Reference proteome,Zinc,	active site:Proton donor,chain:Cytidine deaminase,helix,metal ion-binding site:Zinc; catalytic,region of interest:Substrate binding,sequence variant,strand,turn,
CMPK1	cytidine/uridine monophosphate kinase 1(CMPK1)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0006165~nucleoside diphosphate phosphorylation,GO:0006207~'de novo' pyrimidine nucleobase biosynthetic process,GO:0006221~pyrimidine nucleotide biosynthetic process,GO:0006222~UMP biosynthetic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009220~pyrimidine ribonucleotide biosynthetic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0046940~nucleoside monophosphate phosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004127~cytidylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0004849~uridine kinase activity,GO:0005524~ATP binding,GO:0009041~uridylate kinase activity,GO:0019205~nucleobase-containing compound kinase activity,GO:0050145~nucleoside phosphate kinase activity,	IPR000850:Adenylate kinase,IPR006266:UMP-CMP kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,				3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Pyrimidine biosynthesis,Reference proteome,Signal,Transferase,	chain:UMP-CMP kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,site:Not acetylated,strand,turn,
CMPK2	cytidine/uridine monophosphate kinase 2(CMPK2)	Homo sapiens				GO:0006165~nucleoside diphosphate phosphorylation,GO:0006227~dUDP biosynthetic process,GO:0006233~dTDP biosynthetic process,GO:0006235~dTTP biosynthetic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0071222~cellular response to lipopolysaccharide,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004127~cytidylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0004798~thymidylate kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0033862~UMP kinase activity,	IPR014505:UMP-CMP kinase, mitochondrai,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,		PIRSF019736:thymidylate kinase, TKRP1 type,		Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Kinase,Mitochondrion,Nucleotide-binding,Polymorphism,Pyrimidine biosynthesis,Reference proteome,Transferase,Transit peptide,	chain:UMP-CMP kinase 2, mitochondrial,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
CYP1B1	cytochrome P450 family 1 subfamily B member 1(CYP1B1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0001525~angiogenesis,GO:0002930~trabecular meshwork development,GO:0006725~cellular aromatic compound metabolic process,GO:0006805~xenobiotic metabolic process,GO:0006809~nitric oxide biosynthetic process,GO:0007155~cell adhesion,GO:0007601~visual perception,GO:0008202~steroid metabolic process,GO:0008210~estrogen metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0009404~toxin metabolic process,GO:0009636~response to toxic substance,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0016125~sterol metabolic process,GO:0019369~arachidonic acid metabolic process,GO:0019373~epoxygenase P450 pathway,GO:0030199~collagen fibril organization,GO:0030336~negative regulation of cell migration,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0042572~retinol metabolic process,GO:0042574~retinal metabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043542~endothelial cell migration,GO:0045766~positive regulation of angiogenesis,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046466~membrane lipid catabolic process,GO:0048514~blood vessel morphogenesis,GO:0055114~oxidation-reduction process,GO:0061304~retinal blood vessel morphogenesis,GO:0070301~cellular response to hydrogen peroxide,GO:0071407~cellular response to organic cyclic compound,GO:0071603~endothelial cell-cell adhesion,GO:0097267~omega-hydroxylase P450 pathway,GO:2000377~regulation of reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,	hsa00140:Steroid hormone biosynthesis,hsa00380:Tryptophan metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa04913:Ovarian steroidogenesis,hsa05204:Chemical carcinogenesis,hsa05206:MicroRNAs in cancer,	231300~Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset,604229~Peters anomaly,			3D-structure,Complete proteome,Disease mutation,Endoplasmic reticulum,Glaucoma,Heme,Iron,Membrane,Metal-binding,Microsome,Mitochondrion,Monooxygenase,Oxidoreductase,Peters anomaly,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Cytochrome P450 1B1,metal ion-binding site:Iron (heme axial ligand),sequence variant,
CYP20A1	cytochrome P450 family 20 subfamily A member 1(CYP20A1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0055114~oxidation-reduction process,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,					Alternative splicing,Complete proteome,Heme,Iron,Membrane,Metal-binding,Monooxygenase,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Cytochrome P450 20A1,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,transmembrane region,
CYP26B1	cytochrome P450 family 26 subfamily B member 1(CYP26B1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0001709~cell fate determination,GO:0001768~establishment of T cell polarity,GO:0006766~vitamin metabolic process,GO:0006805~xenobiotic metabolic process,GO:0006954~inflammatory response,GO:0007140~male meiosis,GO:0007283~spermatogenesis,GO:0009954~proximal/distal pattern formation,GO:0010628~positive regulation of gene expression,GO:0030326~embryonic limb morphogenesis,GO:0034653~retinoic acid catabolic process,GO:0043587~tongue morphogenesis,GO:0045580~regulation of T cell differentiation,GO:0048384~retinoic acid receptor signaling pathway,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0055114~oxidation-reduction process,GO:0060349~bone morphogenesis,GO:0061436~establishment of skin barrier,GO:0070268~cornification,GO:0071300~cellular response to retinoic acid,GO:2001037~positive regulation of tongue muscle cell differentiation,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0031090~organelle membrane,	GO:0001972~retinoic acid binding,GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008401~retinoic acid 4-hydroxylase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,IPR002403:Cytochrome P450, E-class, group IV,IPR017972:Cytochrome P450, conserved site,	hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,	614416~Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies,			Alternative splicing,Complete proteome,Craniosynostosis,Disease mutation,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,Oxidoreductase,Polymorphism,Reference proteome,	chain:Cytochrome P450 26B1,metal ion-binding site:Iron (heme axial ligand),sequence variant,
CYP27A1	cytochrome P450 family 27 subfamily A member 1(CYP27A1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0006699~bile acid biosynthetic process,GO:0016125~sterol metabolic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,	hsa00120:Primary bile acid biosynthesis,hsa01100:Metabolic pathways,hsa03320:PPAR signaling pathway,	213700~Cerebrotendinous xanthomatosis,			3D-structure,Acetylation,Cataract,Complete proteome,Disease mutation,Heme,Iron,Membrane,Metal-binding,Mitochondrion,Monooxygenase,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Sterol 26-hydroxylase, mitochondrial,helix,metal ion-binding site:Iron (heme axial ligand),modified residue,region of interest:Sterol-binding,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,turn,
CYP27C1	cytochrome P450 family 27 subfamily C member 1(CYP27C1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0055114~oxidation-reduction process,	GO:0016020~membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,					Complete proteome,Heme,Iron,Membrane,Metal-binding,Monooxygenase,Oxidoreductase,Polymorphism,Reference proteome,	chain:Cytochrome P450 27C1,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,
CYP4A11	cytochrome P450 family 4 subfamily A member 11(CYP4A11)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0001676~long-chain fatty acid metabolic process,GO:0003091~renal water homeostasis,GO:0003095~pressure natriuresis,GO:0006631~fatty acid metabolic process,GO:0006691~leukotriene metabolic process,GO:0019369~arachidonic acid metabolic process,GO:0019373~epoxygenase P450 pathway,GO:0032305~positive regulation of icosanoid secretion,GO:0036101~leukotriene B4 catabolic process,GO:0055078~sodium ion homeostasis,GO:0055114~oxidation-reduction process,GO:0097267~omega-hydroxylase P450 pathway,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008392~arachidonic acid epoxygenase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0018685~alkane 1-monooxygenase activity,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0050051~leukotriene-B4 20-monooxygenase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR002402:Cytochrome P450, E-class, group II,IPR017972:Cytochrome P450, conserved site,					Alternative splicing,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	binding site:Heme (covalent; via 1 link),chain:Cytochrome P450 4A11,compositionally biased region:Poly-Leu,metal ion-binding site:Iron (heme axial ligand),mutagenesis site,sequence conflict,sequence variant,splice variant,
CYP4A22	cytochrome P450 family 4 subfamily A member 22(CYP4A22)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR002402:Cytochrome P450, E-class, group II,IPR017972:Cytochrome P450, conserved site,					Alternative splicing,Complete proteome,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	binding site:Heme (covalent; via 1 link),chain:Cytochrome P450 4A22,compositionally biased region:Poly-Leu,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,splice variant,
CYP4B1	cytochrome P450 family 4 subfamily B member 1(CYP4B1)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0018879~biphenyl metabolic process,GO:0018917~fluorene metabolic process,GO:0042738~exogenous drug catabolic process,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008144~drug binding,GO:0015643~toxic substance binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0018585~fluorene oxygenase activity,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,					Alternative splicing,Complete proteome,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	binding site:Heme (covalent; via 1 link),chain:Cytochrome P450 4B1,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,splice variant,
CYP4F30P	cytochrome P450 family 4 subfamily F member 30, pseudogene(CYP4F30P)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein C2orf14,chain:Uncharacterized protein C2orf14-like 1,chain:Uncharacterized protein C2orf14-like 2,
CYP4X1	cytochrome P450 family 4 subfamily X member 1(CYP4X1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0005506~iron ion binding,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,	hsa04726:Serotonergic synapse,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,Oxidoreductase,Reference proteome,Transmembrane,Transmembrane helix,	chain:Cytochrome P450 4X1,metal ion-binding site:Iron (heme axial ligand),
CYP4Z1	cytochrome P450 family 4 subfamily Z member 1(CYP4Z1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0005506~iron ion binding,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,					Complete proteome,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,Oxidoreductase,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Cytochrome P450 4Z1,metal ion-binding site:Iron (heme axial ligand),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
CYP4Z2P	cytochrome P450 family 4 subfamily Z member 2, pseudogene(CYP4Z2P)	Homo sapiens				GO:0055114~oxidation-reduction process,	GO:0016021~integral component of membrane,	GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,					Alternative splicing,Complete proteome,Membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Putative cytochrome P450 family member 4Z2,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
CYP8B1	cytochrome P450 family 8 subfamily B member 1(CYP8B1)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0006699~bile acid biosynthetic process,GO:0016125~sterol metabolic process,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008397~sterol 12-alpha-hydroxylase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0033778~7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,	IPR001128:Cytochrome P450,IPR002403:Cytochrome P450, E-class, group IV,IPR024204:Cytochrome P450, cholesterol 7-alpha-monooxygenase-type,	hsa00120:Primary bile acid biosynthesis,hsa01100:Metabolic pathways,hsa03320:PPAR signaling pathway,		PIRSF000047:cytochrome P450, CYP7A1 type,PIRSF500627:cytochrome P450 8B1 [Parent=PIRSF000047],		Complete proteome,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:7-alpha-hydroxycholest-4-en-3-one 12- alpha-hydroxylase,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,transmembrane region,
CYBRD1	cytochrome b reductase 1(CYBRD1)	Homo sapiens				GO:0006879~cellular iron ion homeostasis,GO:0010039~response to iron ion,GO:0055114~oxidation-reduction process,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031526~brush border membrane,GO:0070062~extracellular exosome,	GO:0000293~ferric-chelate reductase activity,GO:0005515~protein binding,GO:0016722~oxidoreductase activity, oxidizing metal ions,GO:0046872~metal ion binding,	IPR006593:Cytochrome b561/ferric reductase transmembrane,	hsa04978:Mineral absorption,			SM00665:B561,	Alternative splicing,Complete proteome,Electron transport,Glycoprotein,Heme,Iron,Membrane,Metal-binding,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Cytochrome b reductase 1,domain:Cytochrome b561,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Iron (heme axial ligand),modified residue,sequence conflict,sequence variant,transmembrane region,
CYB5RL	cytochrome b5 reductase like(CYB5RL)	Homo sapiens				GO:0015701~bicarbonate transport,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,	GO:0004128~cytochrome-b5 reductase activity, acting on NAD(P)H,GO:0016491~oxidoreductase activity,GO:0071949~FAD binding,	IPR001221:Phenol hydroxylase reductase,IPR001433:Oxidoreductase FAD/NAD(P)-binding,IPR001834:NADH:cytochrome b5 reductase (CBR),IPR008333:Oxidoreductase, FAD-binding domain,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,IPR019180:Oxidoreductase-like, N-terminal,	hsa00520:Amino sugar and nucleotide sugar metabolism,				Alternative splicing,Complete proteome,FAD,Flavoprotein,NAD,Oxidoreductase,Polymorphism,Reference proteome,	chain:NADH-cytochrome b5 reductase-like,domain:FAD-binding FR-type,nucleotide phosphate-binding region:FAD,sequence variant,splice variant,
CYB561D2	cytochrome b561 family member D2(CYB561D2)	Homo sapiens				GO:0055114~oxidation-reduction process,	GO:0016021~integral component of membrane,	GO:0046872~metal ion binding,	IPR006593:Cytochrome b561/ferric reductase transmembrane,				SM00665:B561,	Complete proteome,Direct protein sequencing,Electron transport,Heme,Iron,Membrane,Metal-binding,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Cytochrome b561 domain-containing protein 2,domain:Cytochrome b561,metal ion-binding site:Iron (heme axial ligand),topological domain:Cytoplasmic,transmembrane region,
COA6	cytochrome c oxidase assembly factor 6(COA6)	Homo sapiens				GO:0008535~respiratory chain complex IV assembly,GO:0042774~plasma membrane ATP synthesis coupled electron transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005886~plasma membrane,	GO:0004129~cytochrome-c oxidase activity,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR003213:Cytochrome c oxidase, subunit VIb,		616501~Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4,			Acetylation,Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Mitochondrion,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf31,splice variant,
COX5B	cytochrome c oxidase subunit 5B(COX5B)	Homo sapiens				GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,GO:0007585~respiratory gaseous exchange,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005751~mitochondrial respiratory chain complex IV,GO:0070062~extracellular exosome,	GO:0004129~cytochrome-c oxidase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR002124:Cytochrome c oxidase, subunit Vb,IPR020893:Cytochrome c oxidase, subunit Vb, zinc binding site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04260:Cardiac muscle contraction,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Complete proteome,Direct protein sequencing,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Transit peptide,Zinc,	chain:Cytochrome c oxidase subunit 5B, mitochondrial,metal ion-binding site:Zinc,modified residue,sequence conflict,transit peptide:Mitochondrion,
COX7A2L	cytochrome c oxidase subunit 7A2 like(COX7A2L)	Homo sapiens				GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,GO:1902600~hydrogen ion transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0016021~integral component of membrane,	GO:0004129~cytochrome-c oxidase activity,	IPR003177:Cytochrome c oxidase, subunit VIIa,IPR017267:Cytochrome c oxidase subunit VIIa-related, mitochondrial,	hsa00190:Oxidative phosphorylation,hsa04260:Cardiac muscle contraction,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF037710:cytochrome c oxidase subunit VIIa-related protein, mitochondrial type,		Acetylation,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	chain:Cytochrome c oxidase subunit 7A-related protein, mitochondrial,modified residue,sequence conflict,transit peptide:Mitochondrion,
CLASP1	cytoplasmic linker associated protein 1(CLASP1)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0006903~vesicle targeting,GO:0007020~microtubule nucleation,GO:0007026~negative regulation of microtubule depolymerization,GO:0007030~Golgi organization,GO:0007052~mitotic spindle organization,GO:0007062~sister chromatid cohesion,GO:0007163~establishment or maintenance of cell polarity,GO:0010458~exit from mitosis,GO:0010470~regulation of gastrulation,GO:0010634~positive regulation of epithelial cell migration,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0030953~astral microtubule organization,GO:0031023~microtubule organizing center organization,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0031116~positive regulation of microtubule polymerization,GO:0034453~microtubule anchoring,GO:0040001~establishment of mitotic spindle localization,GO:0045921~positive regulation of exocytosis,GO:0051294~establishment of spindle orientation,GO:0051301~cell division,GO:0051497~negative regulation of stress fiber assembly,GO:0051893~regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0090091~positive regulation of extracellular matrix disassembly,GO:0090162~establishment of epithelial cell polarity,GO:0090307~mitotic spindle assembly,GO:1903690~negative regulation of wound healing, spreading of epidermal cells,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005828~kinetochore microtubule,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0016020~membrane,GO:0030981~cortical microtubule cytoskeleton,GO:0031592~centrosomal corona,GO:0035371~microtubule plus-end,GO:0045180~basal cortex,GO:0070062~extracellular exosome,	GO:0002162~dystroglycan binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0043515~kinetochore binding,GO:0051010~microtubule plus-end binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,IPR024395:CLASP N-terminal domain,					3D-structure,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Kinetochore,Microtubule,Mitosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:CLIP-associating protein 1,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,modified residue,region of interest:Interaction with CLIP2,region of interest:Interaction with microtubules, MAPRE1 and MAPRE3,region of interest:Interaction with PHLDB2 and RSN,region of interest:Localization to kinetochores,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,sequence conflict,sequence variant,splice variant,
CLASP2	cytoplasmic linker associated protein 2(CLASP2)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0006903~vesicle targeting,GO:0007020~microtubule nucleation,GO:0007026~negative regulation of microtubule depolymerization,GO:0007030~Golgi organization,GO:0007052~mitotic spindle organization,GO:0007062~sister chromatid cohesion,GO:0007163~establishment or maintenance of cell polarity,GO:0010458~exit from mitosis,GO:0010470~regulation of gastrulation,GO:0010634~positive regulation of epithelial cell migration,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0030516~regulation of axon extension,GO:0031023~microtubule organizing center organization,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0031113~regulation of microtubule polymerization,GO:0032886~regulation of microtubule-based process,GO:0032956~regulation of actin cytoskeleton organization,GO:0034453~microtubule anchoring,GO:0035791~platelet-derived growth factor receptor-beta signaling pathway,GO:0045921~positive regulation of exocytosis,GO:0051301~cell division,GO:0051497~negative regulation of stress fiber assembly,GO:0051895~negative regulation of focal adhesion assembly,GO:0090002~establishment of protein localization to plasma membrane,GO:0090091~positive regulation of extracellular matrix disassembly,GO:1903690~negative regulation of wound healing, spreading of epidermal cells,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005815~microtubule organizing center,GO:0005828~kinetochore microtubule,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0016020~membrane,GO:0031252~cell leading edge,GO:0032587~ruffle membrane,GO:0044295~axonal growth cone,GO:0045180~basal cortex,GO:0072686~mitotic spindle,GO:1903754~cortical microtubule plus-end,	GO:0002162~dystroglycan binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0051010~microtubule plus-end binding,GO:0051015~actin filament binding,GO:1990782~protein tyrosine kinase binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,IPR024395:CLASP N-terminal domain,					3D-structure,Alternative splicing,Cell cycle,Cell division,Cell membrane,Cell projection,Centromere,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Kinetochore,Membrane,Microtubule,Mitosis,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:CLIP-associating protein 2,compositionally biased region:Poly-Leu,compositionally biased region:Ser-rich,modified residue,region of interest:Interaction with microtubules, MAPRE1 and MAPRE3,region of interest:Interaction with RSN and localization to the Golgi and kinetochores,region of interest:Required for cortical localization,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,sequence conflict,splice variant,
CKAP2L	cytoskeleton associated protein 2 like(CKAP2L)	Homo sapiens					GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,		IPR026165:Cytoskeleton-associated protein 2 family,		272440~Filippi syndrome,			Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Cytoskeleton-associated protein 2-like,modified residue,sequence conflict,sequence variant,splice variant,
DAP3	death associated protein 3(DAP3)	Homo sapiens				GO:0006915~apoptotic process,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,GO:0097190~apoptotic signaling pathway,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005761~mitochondrial ribosome,GO:0005763~mitochondrial small ribosomal subunit,GO:0015935~small ribosomal subunit,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR008092:Ribosomal protein S29, mitochondrial,IPR019368:Ribosomal protein S23/S29, mitochondrial,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:28S ribosomal protein S29, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
DAPL1	death associated protein like 1(DAPL1)	Homo sapiens				GO:0010507~negative regulation of autophagy,GO:0030154~cell differentiation,GO:0034198~cellular response to amino acid starvation,GO:0097190~apoptotic signaling pathway,	GO:0016021~integral component of membrane,	GO:0070513~death domain binding,	IPR017452:GPCR, rhodopsin-like, 7TM,IPR024130:DAP1/DAPL1,					Apoptosis,Complete proteome,Differentiation,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Death-associated protein-like 1,sequence variant,
DEDD	death effector domain containing(DEDD)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0042177~negative regulation of protein catabolic process,GO:0042981~regulation of apoptotic process,GO:0046697~decidualization,GO:1901837~negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,	GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001875:Death effector domain,IPR011029:Death-like domain,				SM00031:DED,	Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Death effector domain-containing protein,domain:DED,splice variant,
DCP1A	decapping mRNA 1A(DCP1A)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000290~deadenylation-dependent decapping of nuclear-transcribed mRNA,GO:0031087~deadenylation-independent decapping of nuclear-transcribed mRNA,GO:0043085~positive regulation of catalytic activity,GO:0043488~regulation of mRNA stability,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0016787~hydrolase activity,GO:0030234~enzyme regulator activity,GO:0042802~identical protein binding,	IPR010334:Dcp1-like decapping,IPR011993:Pleckstrin homology-like domain,	hsa03018:RNA degradation,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Methylation,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:mRNA-decapping enzyme 1A,modified residue,mutagenesis site,
DOCK10	dedicator of cytokinesis 10(DOCK10)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0030334~regulation of cell migration,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR001849:Pleckstrin homology domain,IPR010703:Dedicator of cytokinesis C-terminal,IPR011993:Pleckstrin homology-like domain,IPR021816:Dedicator of cytokinesis C/D, N-terminal,IPR026791:Dedicator of cytokinesis,IPR027007:DHR-1 domain,IPR027357:DHR-2 domain,				SM00233:PH,	Acetylation,Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Dedicator of cytokinesis protein 10,domain:DHR-1,domain:DHR-2,domain:PH,modified residue,sequence conflict,splice variant,
DOCK3	dedicator of cytokinesis 3(DOCK3)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,	IPR001452:Src homology-3 domain,IPR010703:Dedicator of cytokinesis C-terminal,IPR011511:Variant SH3,IPR016024:Armadillo-type fold,IPR026791:Dedicator of cytokinesis,IPR026800:Dedicator of cytokinesis B,IPR027007:DHR-1 domain,IPR027357:DHR-2 domain,				SM00326:SH3,	Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Phosphoprotein,Reference proteome,SH3 domain,SH3-binding,	chain:Dedicator of cytokinesis protein 3,compositionally biased region:Ser-rich,domain:DHR-1,domain:DHR-2,domain:SH3,modified residue,short sequence motif:SH3-binding,
DOCK7	dedicator of cytokinesis 7(DOCK7)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0007264~small GTPase mediated signal transduction,GO:0007409~axonogenesis,GO:0022027~interkinetic nuclear migration,GO:0031175~neuron projection development,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0045200~establishment of neuroblast polarity,GO:0050767~regulation of neurogenesis,GO:0090630~activation of GTPase activity,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,	GO:0005622~intracellular,GO:0005925~focal adhesion,GO:0008180~COP9 signalosome,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030426~growth cone,GO:0043005~neuron projection,GO:0045178~basal part of cell,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0048365~Rac GTPase binding,	IPR010703:Dedicator of cytokinesis C-terminal,IPR021816:Dedicator of cytokinesis C/D, N-terminal,IPR026791:Dedicator of cytokinesis,IPR027007:DHR-1 domain,IPR027357:DHR-2 domain,		615859~Epileptic encephalopathy, early infantile, 23,			Acetylation,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Developmental protein,Differentiation,Epilepsy,Guanine-nucleotide releasing factor,Membrane,Methylation,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Dedicator of cytokinesis protein 7,domain:DHR-1,domain:DHR-2,modified residue,sequence conflict,sequence variant,splice variant,
DHDDS	dehydrodolichyl diphosphate synthase subunit(DHDDS)	Homo sapiens				GO:0006486~protein glycosylation,GO:0006489~dolichyl diphosphate biosynthetic process,GO:0016094~polyprenol biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0002094~polyprenyltransferase activity,GO:0005515~protein binding,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,	IPR001441:Decaprenyl diphosphate synthase-like,IPR018520:Di-trans-poly-cis-decaprenylcistransferase-like, conserved site,	hsa00900:Terpenoid backbone biosynthesis,	613861~Retinitis pigmentosa 59,			Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Membrane,Polymorphism,Proteomics identification,Reference proteome,Retinitis pigmentosa,Transferase,	chain:Dehydrodolichyl diphosphate synthase,sequence conflict,sequence variant,splice variant,
DHRS3	dehydrogenase/reductase 3(DHRS3)	Homo sapiens			General function prediction only,	GO:0001523~retinoid metabolic process,GO:0003151~outflow tract morphogenesis,GO:0007601~visual perception,GO:0030278~regulation of ossification,GO:0042572~retinol metabolic process,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0055114~oxidation-reduction process,GO:0060021~palate development,GO:0060349~bone morphogenesis,GO:0060411~cardiac septum morphogenesis,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0042622~photoreceptor outer segment membrane,	GO:0000166~nucleotide binding,GO:0004745~retinol dehydrogenase activity,GO:0009055~electron carrier activity,GO:0052650~NADP-retinol dehydrogenase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,	hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Membrane,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:Substrate,chain:Short-chain dehydrogenase/reductase 3,sequence conflict,splice variant,transmembrane region,
DHRS9	dehydrogenase/reductase 9(DHRS9)	Homo sapiens			General function prediction only,	GO:0002138~retinoic acid biosynthetic process,GO:0008209~androgen metabolic process,GO:0030855~epithelial cell differentiation,GO:0042448~progesterone metabolic process,GO:0042572~retinol metabolic process,GO:0042904~9-cis-retinoic acid biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0031090~organelle membrane,	GO:0004022~alcohol dehydrogenase (NAD) activity,GO:0004745~retinol dehydrogenase activity,GO:0016854~racemase and epimerase activity,GO:0047035~testosterone dehydrogenase (NAD+) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,	hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Membrane,Microsome,NAD,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,	active site:Proton acceptor,binding site:NAD,binding site:Substrate,chain:Dehydrogenase/reductase SDR family member 9,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,signal peptide,splice variant,
DAZL	deleted in azoospermia like(DAZL)	Homo sapiens				GO:0001556~oocyte maturation,GO:0007147~female meiosis II,GO:0007275~multicellular organism development,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0045836~positive regulation of meiotic nuclear division,GO:0045948~positive regulation of translational initiation,GO:0070935~3'-UTR-mediated mRNA stabilization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008494~translation activator activity,GO:0042802~identical protein binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,		Spermatogenic failure, susceptibility to~Spermatogenic failure, susceptibility to,		SM00360:RRM,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Spermatogenesis,Translation regulation,	chain:Deleted in azoospermia-like,domain:DAZ-like,domain:RRM,region of interest:Homodimerization,sequence conflict,sequence variant,
DLEC1	deleted in lung and esophageal cancer 1(DLEC1)	Homo sapiens				GO:0008285~negative regulation of cell proliferation,	GO:0005737~cytoplasm,				133239~Esophageal cancer,211980~Lung cancer,			Alternative splicing,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Tumor suppressor,	chain:Deleted in lung and esophageal cancer protein 1,sequence conflict,sequence variant,splice variant,
DEGS1	delta 4-desaturase, sphingolipid 1(DEGS1)	Homo sapiens				GO:0006636~unsaturated fatty acid biosynthetic process,GO:0030148~sphingolipid biosynthetic process,GO:0046513~ceramide biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0009055~electron carrier activity,GO:0042284~sphingolipid delta-4 desaturase activity,	IPR005804:Fatty acid desaturase, type 1,IPR011388:Sphingolipid delta4-desaturase,IPR013866:Sphingolipid delta4-desaturase, N-terminal,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04071:Sphingolipid signaling pathway,		PIRSF017228:sphingolipid Delta-4 desaturase,	SM01269:SM01269,	Complete proteome,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Lipoprotein,Membrane,Mitochondrion,Myristate,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Sphingolipid delta(4)-desaturase DES1,modified residue,transmembrane region,
DNER	delta/notch like EGF repeat containing(DNER)	Homo sapiens				GO:0001764~neuron migration,GO:0006897~endocytosis,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0007416~synapse assembly,GO:0007417~central nervous system development,GO:0010001~glial cell differentiation,GO:0048741~skeletal muscle fiber development,	GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0004888~transmembrane signaling receptor activity,GO:0005112~Notch binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030276~clathrin binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00181:EGF,	Activator,Calcium,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Notch signaling pathway,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Delta and Notch-like epidermal growth factor-related receptor,disulfide bond,domain:EGF-like 1,domain:EGF-like 10; calcium-binding,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8; calcium-binding,domain:EGF-like 9,domain:Follistatin-like,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Interaction with AP1G1 and somatodendritic targeting,region of interest:Interaction with NOTCH1,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DTL	denticleless E3 ubiquitin protein ligase homolog(DTL)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006260~DNA replication,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0019985~translesion synthesis,GO:0031572~G2 DNA damage checkpoint,GO:0042769~DNA damage response, detection of DNA damage,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,GO:0031465~Cul4B-RING E3 ubiquitin ligase complex,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Acetylation,Alternative splicing,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,DNA replication,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,WD repeat,	chain:Denticleless protein homolog,modified residue,mutagenesis site,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,short sequence motif:DDB1-binding motif,short sequence motif:Nuclear localization signal,splice variant,
DGUOK	deoxyguanosine kinase(DGUOK)	Homo sapiens			Nucleotide transport and metabolism,	GO:0006468~protein phosphorylation,GO:0008617~guanosine metabolic process,GO:0009157~deoxyribonucleoside monophosphate biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0010977~negative regulation of neuron projection development,GO:0043101~purine-containing compound salvage,GO:0046070~dGTP metabolic process,GO:0046122~purine deoxyribonucleoside metabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0004138~deoxyguanosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019206~nucleoside kinase activity,	IPR002624:Deoxynucleoside kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,	251880~Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),	PIRSF000705:deoxynucleoside kinase,		3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Kinase,Mitochondrion,Neuropathy,Nucleotide-binding,Reference proteome,Transferase,Transit peptide,	chain:Deoxyguanosine kinase, mitochondrial,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
DNASE1L3	deoxyribonuclease 1 like 3(DNASE1L3)	Homo sapiens				GO:0006259~DNA metabolic process,GO:0006308~DNA catabolic process,GO:0006309~apoptotic DNA fragmentation,GO:0010623~programmed cell death involved in cell development,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,	GO:0003677~DNA binding,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0004536~deoxyribonuclease activity,GO:0005509~calcium ion binding,	IPR005135:Endonuclease/exonuclease/phosphatase,IPR016202:Deoxyribonuclease I-like,IPR018057:Deoxyribonuclease I, active site,		614420~Systemic lupus erythematosus 16,	PIRSF000988:deoxyribonuclease I,	SM00476:DNaseIc,	ADP-ribosylation,Alternative splicing,Apoptosis,Calcium,Complete proteome,Disulfide bond,Endonuclease,Endoplasmic reticulum,Hydrolase,Necrosis,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Systemic lupus erythematosus,	chain:Deoxyribonuclease gamma,disulfide bond,sequence variant,short sequence motif:Bipartite nuclear localization signal,short sequence motif:Nuclear localization signal,signal peptide,
DPT	dermatopontin(DPT)	Homo sapiens				GO:0007155~cell adhesion,GO:0008285~negative regulation of cell proliferation,GO:0030199~collagen fibril organization,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,		IPR026645:Dermatopontin family,					Cell adhesion,Complete proteome,Disulfide bond,Extracellular matrix,Polymorphism,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Secreted,Signal,Sulfation,	chain:Dermatopontin,disulfide bond,modified residue,region of interest:2 X 53-55 AA tandem repeats,region of interest:3 X 6 AA repeats of D-R-[EQ]-W-[NQK]- [FY],repeat:1-1,repeat:1-2,repeat:2-1,repeat:2-2,repeat:3-3,sequence conflict,sequence variant,signal peptide,
DES	desmin(DES)	Homo sapiens				GO:0006936~muscle contraction,GO:0007010~cytoskeleton organization,GO:0008016~regulation of heart contraction,GO:0030049~muscle filament sliding,GO:0045109~intermediate filament organization,	GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0005916~fascia adherens,GO:0014704~intercalated disc,GO:0030018~Z disc,GO:0031594~neuromuscular junction,GO:0042383~sarcolemma,GO:0045111~intermediate filament cytoskeleton,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0042802~identical protein binding,	IPR001664:Intermediate filament protein,IPR006821:Intermediate filament head, DNA-binding domain,IPR018039:Intermediate filament protein, conserved site,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	181400~Scapuloperoneal syndrome, neurogenic, Kaeser type,601419~Myopathy, myofibrillar, 1,604765~Cardiomyopathy, dilated, 1I,615325~Muscular dystrophy, limb-girdle, type 2R,		SM01391:SM01391,	ADP-ribosylation,Cardiomyopathy,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Desmin-related myopathy,Disease mutation,Intermediate filament,Limb-girdle muscular dystrophy,Membrane,Methylation,Muscle protein,Myofibrillar myopathy,Phosphoprotein,Polymorphism,Reference proteome,	chain:Desmin,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2A,region of interest:Coil 2B,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,
DESI2	desumoylating isopeptidase 2(DESI2)	Homo sapiens				GO:0006508~proteolysis,	GO:0005737~cytoplasm,	GO:0008233~peptidase activity,	IPR008580:Domain of unknown function DUF862, eukaryotic,				SM01179:SM01179,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Protease,Proteomics identification,Reference proteome,	chain:PPPDE peptidase domain-containing protein 1,domain:PPPDE peptidase,sequence conflict,splice variant,
DPPA4	developmental pluripotency associated 4(DPPA4)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0035019~somatic stem cell population maintenance,GO:0060484~lung-associated mesenchyme development,	GO:0005654~nucleoplasm,	GO:0005515~protein binding,	IPR025891:Developmental pluripotency-associated protein 2/4, C-terminal domain,IPR025892:Developmental pluripotency-associated protein 2/4, central domain,					Complete proteome,Developmental protein,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Developmental pluripotency-associated protein 4,sequence variant,
DGKD	diacylglycerol kinase delta(DGKD)	Homo sapiens				GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0010033~response to organic substance,GO:0015031~protein transport,GO:0016049~cell growth,GO:0019932~second-messenger-mediated signaling,GO:0030168~platelet activation,GO:0035556~intracellular signal transduction,GO:0046339~diacylglycerol metabolic process,GO:0046834~lipid phosphorylation,GO:0051260~protein homooligomerization,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,	GO:0004143~diacylglycerol kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019992~diacylglycerol binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000756:Diacylglycerol kinase, accessory domain,IPR001206:Diacylglycerol kinase, catalytic domain,IPR001660:Sterile alpha motif domain,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR011993:Pleckstrin homology-like domain,IPR013761:Sterile alpha motif/pointed domain,IPR016064:ATP-NAD kinase-like domain,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,hsa05231:Choline metabolism in cancer,			SM00045:DAGKa,SM00046:DAGKc,SM00109:C1,SM00233:PH,SM00454:SAM,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Endocytosis,Kinase,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Repeat,Transferase,Transport,Zinc,Zinc-finger,	chain:Diacylglycerol kinase delta,compositionally biased region:Pro-rich,domain:DAGKc,domain:PH,domain:SAM,helix,mutagenesis site,sequence conflict,splice variant,strand,turn,zinc finger region:Phorbol-ester/DAG-type 1,zinc finger region:Phorbol-ester/DAG-type 2,
DBI	diazepam binding inhibitor, acyl-CoA binding protein(DBI)	Homo sapiens				GO:0006810~transport,GO:0018345~protein palmitoylation,GO:0036151~phosphatidylcholine acyl-chain remodeling,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0070062~extracellular exosome,GO:0097038~perinuclear endoplasmic reticulum,	GO:0000062~fatty-acyl-CoA binding,GO:0008289~lipid binding,GO:0030156~benzodiazepine receptor binding,GO:0036042~long-chain fatty acyl-CoA binding,GO:0046983~protein dimerization activity,	IPR000582:Acyl-CoA-binding protein, ACBP,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR022408:Acyl-CoA-binding protein, ACBP, conserved site,	hsa03320:PPAR signaling pathway,				3D-structure,Acetylation,Alternative promoter usage,Alternative splicing,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Golgi apparatus,Lipid-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Selenium,Selenocysteine,Transport,	chain:Acyl-CoA-binding protein,domain:ACB,helix,modified residue,sequence variant,splice variant,turn,
DIEXF	digestive organ expansion factor homolog (zebrafish)(DIEXF)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0007275~multicellular organism development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0034511~U3 snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR010678:Digestive organ expansion factor, predicted,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Developmental protein,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Digestive organ expansion factor homolog,compositionally biased region:Glu-rich,compositionally biased region:Poly-Asp,modified residue,sequence conflict,sequence variant,
DBT	dihydrolipoamide branched chain transacylase E2(DBT)	Homo sapiens			Energy production and conversion,	GO:0008152~metabolic process,GO:0009083~branched-chain amino acid catabolic process,GO:0046487~glyoxylate metabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005947~mitochondrial alpha-ketoglutarate dehydrogenase complex,GO:0042645~mitochondrial nucleoid,	GO:0016746~transferase activity, transferring acyl groups,GO:0031625~ubiquitin protein ligase binding,GO:0043754~dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,	IPR000089:Biotin/lipoyl attachment,IPR001078:2-oxoacid dehydrogenase acyltransferase, catalytic domain,IPR003016:2-oxo acid dehydrogenase, lipoyl-binding site,IPR004167:E3 binding,IPR011053:Single hybrid motif,IPR015761:Lipoamide Acyltransferase,IPR023213:Chloramphenicol acetyltransferase-like domain,	hsa00280:Valine, leucine and isoleucine degradation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	248600~Maple syrup urine disease, type II,			3D-structure,Acetylation,Acyltransferase,Complete proteome,Direct protein sequencing,Disease mutation,Lipoyl,Maple syrup urine disease,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial,domain:Lipoyl-binding,helix,modified residue,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,turn,
DPYSL5	dihydropyrimidinase like 5(DPYSL5)	Homo sapiens				GO:0007165~signal transduction,GO:0007399~nervous system development,GO:0007411~axon guidance,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,	IPR006680:Amidohydrolase 1,IPR011059:Metal-dependent hydrolase, composite domain,IPR011778:Hydantoinase/dihydropyrimidinase,	hsa04360:Axon guidance,				3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Dihydropyrimidinase-related protein 5,modified residue,sequence conflict,
DPYD	dihydropyrimidine dehydrogenase(DPYD)	Homo sapiens			Nucleotide transport and metabolism,	GO:0006145~purine nucleobase catabolic process,GO:0006208~pyrimidine nucleobase catabolic process,GO:0006210~thymine catabolic process,GO:0006212~uracil catabolic process,GO:0006214~thymidine catabolic process,GO:0019483~beta-alanine biosynthetic process,GO:0046135~pyrimidine nucleoside catabolic process,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0017113~dihydropyrimidine dehydrogenase (NADP+) activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR005720:Dihydroorotate dehydrogenase domain,IPR009051:Alpha-helical ferredoxin,IPR013785:Aldolase-type TIM barrel,IPR017896:4Fe-4S ferredoxin-type, iron-sulpur binding domain,IPR017900:4Fe-4S ferredoxin, iron-sulphur binding, conserved site,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00240:Pyrimidine metabolism,hsa00410:beta-Alanine metabolism,hsa00770:Pantothenate and CoA biosynthesis,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,	274270~5-fluorouracil toxicity,274270~Dihydropyrimidine dehydrogenase deficiency,			4Fe-4S,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,FAD,Flavoprotein,FMN,Iron,Iron-sulfur,Metal-binding,NADP,Nucleotide-binding,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Dihydropyrimidine dehydrogenase [NADP+],domain:4Fe-4S ferredoxin-type 1,domain:4Fe-4S ferredoxin-type 2,domain:4Fe-4S ferredoxin-type 3,metal ion-binding site:Iron-sulfur 1 (4Fe-4S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S),modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:NADP,region of interest:Uracil binding,sequence conflict,sequence variant,
DDAH1	dimethylarginine dimethylaminohydrolase 1(DDAH1)	Homo sapiens			Amino acid transport and metabolism,	GO:0000052~citrulline metabolic process,GO:0003073~regulation of systemic arterial blood pressure,GO:0006527~arginine catabolic process,GO:0007263~nitric oxide mediated signal transduction,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045766~positive regulation of angiogenesis,GO:0050999~regulation of nitric-oxide synthase activity,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0016403~dimethylargininase activity,GO:0016597~amino acid binding,GO:0046872~metal ion binding,						3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Hydrolase,Metal-binding,Proteomics identification,Reference proteome,S-nitrosylation,Zinc,	binding site:Substrate,binding site:Substrate; via carbonyl oxygen,chain:N(G),N(G)-dimethylarginine dimethylaminohydrolase 1,helix,metal ion-binding site:Zinc,modified residue,strand,turn,
DPP4	dipeptidyl peptidase 4(DPP4)	Homo sapiens				GO:0001662~behavioral fear response,GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0008284~positive regulation of cell proliferation,GO:0010716~negative regulation of extracellular matrix disassembly,GO:0031295~T cell costimulation,GO:0033632~regulation of cell-cell adhesion mediated by integrin,GO:0035641~locomotory exploration behavior,GO:0036343~psychomotor behavior,GO:0042110~T cell activation,GO:0043542~endothelial cell migration,GO:0046718~viral entry into host cell,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030027~lamellipodium,GO:0030139~endocytic vesicle,GO:0031258~lamellipodium membrane,GO:0045121~membrane raft,GO:0046581~intercellular canaliculus,GO:0070062~extracellular exosome,GO:0071438~invadopodium membrane,	GO:0001618~virus receptor activity,GO:0002020~protease binding,GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR001375:Peptidase S9, prolyl oligopeptidase, catalytic domain,IPR002469:Peptidase S9B, dipeptidylpeptidase IV N-terminal,IPR002471:Peptidase S9, serine active site,	hsa04974:Protein digestion and absorption,				3D-structure,Aminopeptidase,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Protease,Proteomics identification,Receptor,Reference proteome,Secreted,Serine protease,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Charge relay system,chain:Dipeptidyl peptidase 4 membrane form,chain:Dipeptidyl peptidase 4 soluble form,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
DPP10	dipeptidyl peptidase like 10(DPP10)	Homo sapiens				GO:0006508~proteolysis,GO:0072659~protein localization to plasma membrane,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:1901379~regulation of potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008236~serine-type peptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0015459~potassium channel regulator activity,	IPR001375:Peptidase S9, prolyl oligopeptidase, catalytic domain,IPR002469:Peptidase S9B, dipeptidylpeptidase IV N-terminal,					3D-structure,Alternative splicing,Asthma,Cell membrane,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Inactive dipeptidyl peptidase 10,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Mediates effects on KCND2,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DPH5	diphthamide biosynthesis 5(DPH5)	Homo sapiens				GO:0017183~peptidyl-diphthamide biosynthetic process from peptidyl-histidine,GO:0032259~methylation,	GO:0005829~cytosol,	GO:0004164~diphthine synthase activity,	IPR000878:Tetrapyrrole methylase,IPR004551:Diphthine synthase,IPR014776:Tetrapyrrole methylase, subdomain 2,IPR014777:Tetrapyrrole methylase, subdomain 1,			PIRSF036432:diphthine synthase,		Alternative splicing,Complete proteome,Methyltransferase,Phosphoprotein,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:Diphthine synthase,sequence conflict,splice variant,
DDR2	discoidin domain receptor tyrosine kinase 2(DDR2)	Homo sapiens				GO:0001503~ossification,GO:0003416~endochondral bone growth,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0010715~regulation of extracellular matrix disassembly,GO:0010763~positive regulation of fibroblast migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030500~regulation of bone mineralization,GO:0031214~biomineral tissue development,GO:0035988~chondrocyte proliferation,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0045669~positive regulation of osteoblast differentiation,GO:0045860~positive regulation of protein kinase activity,GO:0046777~protein autophosphorylation,GO:0048146~positive regulation of fibroblast proliferation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0090091~positive regulation of extracellular matrix disassembly,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0005524~ATP binding,GO:0038062~protein tyrosine kinase collagen receptor activity,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR011009:Protein kinase-like domain,IPR020635:Tyrosine-protein kinase, catalytic domain,		271665~Spondylometaepiphyseal dysplasia, short limb-hand type,		SM00219:TyrKc,SM00231:FA58C,	3D-structure,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Dwarfism,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Osteogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Discoidin domain-containing receptor 2,disulfide bond,domain:F5/8 type C,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
DCBLD2	discoidin, CUB and LCCL domain containing 2(DCBLD2)	Homo sapiens				GO:0030308~negative regulation of cell growth,GO:0030522~intracellular receptor signaling pathway,GO:0042060~wound healing,	GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,	GO:0005515~protein binding,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000859:CUB domain,IPR004043:LCCL,IPR008979:Galactose-binding domain-like,				SM00042:CUB,SM00231:FA58C,SM00603:LCCL,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Discoidin, CUB and LCCL domain-containing protein 2,compositionally biased region:Poly-Pro,disulfide bond,domain:CUB,domain:F5/8 type C,domain:LCCL,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DVL1	dishevelled segment polarity protein 1(DVL1)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,h_alkPathway:ALK in cardiac myocytes,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_hesPathway:Segmentation Clock,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,h_wntPathway:WNT Signaling Pathway,		GO:0001505~regulation of neurotransmitter levels,GO:0001934~positive regulation of protein phosphorylation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0007269~neurotransmitter secretion,GO:0007411~axon guidance,GO:0007416~synapse assembly,GO:0007507~heart development,GO:0007528~neuromuscular junction development,GO:0010976~positive regulation of neuron projection development,GO:0016055~Wnt signaling pathway,GO:0021915~neural tube development,GO:0022007~convergent extension involved in neural plate elongation,GO:0030177~positive regulation of Wnt signaling pathway,GO:0031122~cytoplasmic microtubule organization,GO:0032091~negative regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034504~protein localization to nucleus,GO:0035176~social behavior,GO:0035372~protein localization to microtubule,GO:0035556~intracellular signal transduction,GO:0043113~receptor clustering,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048668~collateral sprouting,GO:0048675~axon extension,GO:0048813~dendrite morphogenesis,GO:0050808~synapse organization,GO:0050821~protein stabilization,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0060134~prepulse inhibition,GO:0060997~dendritic spine morphogenesis,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090103~cochlea morphogenesis,GO:0090179~planar cell polarity pathway involved in neural tube closure,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1902474~positive regulation of protein localization to synapse,GO:1903827~regulation of cellular protein localization,GO:1904886~beta-catenin destruction complex disassembly,GO:2000463~positive regulation of excitatory postsynaptic potential,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016328~lateral plasma membrane,GO:0030136~clathrin-coated vesicle,GO:0030424~axon,GO:0030426~growth cone,GO:0031410~cytoplasmic vesicle,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0098793~presynapse,GO:1990909~Wnt signalosome,	GO:0005109~frizzled binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0048365~Rac GTPase binding,	IPR000591:DEP domain,IPR001158:DIX domain,IPR001478:PDZ domain,IPR003351:Dishevelled protein domain,IPR008339:Dishevelled family,IPR008340:Dishevelled-1,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015506:Dishevelled-related protein,IPR024580:Dishevelled C-terminal,	hsa04310:Wnt signaling pathway,hsa04330:Notch signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,	616331~Robinow syndrome, autosomal dominant 2,		SM00021:DAX,SM00049:DEP,SM00228:PDZ,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Developmental protein,Dwarfism,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,Wnt signaling pathway,	chain:Segment polarity protein dishevelled homolog DVL-1,chain:Segment polarity protein dishevelled homolog DVL-1-like,compositionally biased region:Poly-Arg,domain:DEP,domain:DIX,domain:PDZ,modified residue,sequence conflict,splice variant,
DISP1	dispatched RND transporter family member 1(DISP1)	Homo sapiens				GO:0007224~smoothened signaling pathway,GO:0007225~patched ligand maturation,GO:0007368~determination of left/right symmetry,GO:0009880~embryonic pattern specification,GO:0009953~dorsal/ventral pattern formation,GO:0015833~peptide transport,GO:0050708~regulation of protein secretion,GO:0060539~diaphragm development,GO:0070207~protein homotrimerization,	GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,	GO:0005515~protein binding,GO:0015197~peptide transporter activity,	IPR000731:Sterol-sensing domain,IPR003392:Patched,					Complete proteome,Developmental protein,Glycoprotein,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein dispatched homolog 1,domain:SSD,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
DISP3	dispatched RND transporter family member 3(DISP3)	Homo sapiens			General function prediction only,	GO:0007224~smoothened signaling pathway,GO:0008203~cholesterol metabolic process,GO:0032368~regulation of lipid transport,GO:0042632~cholesterol homeostasis,GO:0045665~negative regulation of neuron differentiation,GO:0045834~positive regulation of lipid metabolic process,GO:2000179~positive regulation of neural precursor cell proliferation,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031965~nuclear membrane,		IPR000731:Sterol-sensing domain,IPR003392:Patched,					Alternative splicing,Cholesterol metabolism,Complete proteome,Cytoplasmic vesicle,Differentiation,Endoplasmic reticulum,Glycoprotein,Lipid metabolism,Membrane,Nucleus,Polymorphism,Reference proteome,Steroid metabolism,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:Patched domain-containing protein 2,domain:SSD,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DIRC1	disrupted in renal carcinoma 1(DIRC1)	Homo sapiens												Chromosomal rearrangement,Complete proteome,Polymorphism,Reference proteome,	chain:Disrupted in renal carcinoma protein 1,sequence variant,
DIRC3	disrupted in renal carcinoma 3(DIRC3)	Homo sapiens												Complete proteome,Reference proteome,
DISC1	disrupted in schizophrenia 1(DISC1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0001764~neuron migration,GO:0001954~positive regulation of cell-matrix adhesion,GO:0002052~positive regulation of neuroblast proliferation,GO:0021846~cell proliferation in forebrain,GO:0021852~pyramidal neuron migration,GO:0030177~positive regulation of Wnt signaling pathway,GO:0031929~TOR signaling,GO:0035058~nonmotile primary cilium assembly,GO:0045773~positive regulation of axon extension,GO:0051560~mitochondrial calcium ion homeostasis,GO:0051602~response to electrical stimulus,GO:0060070~canonical Wnt signaling pathway,GO:0060998~regulation of dendritic spine development,GO:0071539~protein localization to centrosome,GO:0090128~regulation of synapse maturation,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005813~centrosome,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0008021~synaptic vesicle,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030286~dynein complex,GO:0030424~axon,GO:0036064~ciliary basal body,GO:0044297~cell body,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0097546~ciliary base,	GO:0005515~protein binding,GO:0019894~kinesin binding,GO:0032403~protein complex binding,GO:0032947~protein complex scaffold,GO:0043565~sequence-specific DNA binding,	IPR002848:Translin,IPR009053:Prefoldin,IPR016068:Translin, N-terminal,IPR026081:Disrupted in schizophrenia 1,		181500~Schizoaffective disorder, susceptibility to,604906~Schizophrenia, susceptibility to,			Alternative splicing,Cell junction,Cell membrane,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Membrane,Microtubule,Neurogenesis,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Schizophrenia,Synapse,Wnt signaling pathway,	chain:Disrupted in schizophrenia 1 protein,mutagenesis site,region of interest:Interaction with ATF4 and ATF5,region of interest:Interaction with MAP1A,region of interest:Interaction with NDEL1 and PAFAH1B1,region of interest:Interaction with TRAF3IP1,region of interest:Required for localization to punctate cytoplasmic foci,sequence variant,splice variant,
DLX1	distal-less homeobox 1(DLX1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0009954~proximal/distal pattern formation,GO:0021544~subpallium development,GO:0021766~hippocampus development,GO:0021882~regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,GO:0021893~cerebral cortex GABAergic interneuron fate commitment,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043524~negative regulation of neuron apoptotic process,GO:0045746~negative regulation of Notch signaling pathway,GO:0048706~embryonic skeletal system development,GO:0048715~negative regulation of oligodendrocyte differentiation,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0043565~sequence-specific DNA binding,	IPR000047:Helix-turn-helix motif,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Homeobox protein DLX-1,DNA-binding region:Homeobox,sequence variant,
DLX2	distal-less homeobox 2(DLX2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007420~brain development,GO:0009954~proximal/distal pattern formation,GO:0021544~subpallium development,GO:0021766~hippocampus development,GO:0021772~olfactory bulb development,GO:0021882~regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,GO:0021893~cerebral cortex GABAergic interneuron fate commitment,GO:0042475~odontogenesis of dentin-containing tooth,GO:0045746~negative regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0048755~branching morphogenesis of a nerve,GO:0051216~cartilage development,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003727~single-stranded RNA binding,GO:0005515~protein binding,	IPR000047:Helix-turn-helix motif,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,IPR022135:Distal-less-like homeobox protein, N-terminal domain,				SM00389:HOX,	Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,	chain:Homeobox protein DLX-2,compositionally biased region:Poly-Gly,compositionally biased region:Poly-His,compositionally biased region:Poly-Ser,DNA-binding region:Homeobox,modified residue,
DCDC2B	doublecortin domain containing 2B(DCDC2B)	Homo sapiens				GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,	GO:0005515~protein binding,	IPR003533:Doublecortin domain,				SM00537:DCX,	Complete proteome,Reference proteome,Repeat,	chain:Doublecortin domain-containing protein 2B,domain:Doublecortin 1,domain:Doublecortin 2,
DCDC2C	doublecortin domain containing 2C(DCDC2C)	Homo sapiens				GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,		IPR003533:Doublecortin domain,				SM00537:DCX,	Complete proteome,Proteomics identification,Reference proteome,Repeat,
DCLK3	doublecortin like kinase 3(DCLK3)	Homo sapiens				GO:0018105~peptidyl-serine phosphorylation,GO:1900181~negative regulation of protein localization to nucleus,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020636:Calcium/calmodulin-dependent/calcium-dependent protein kinase,				SM00220:S_TKc,	ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase DCLK3,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence variant,
DR1	down-regulator of transcription 1(DR1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0043966~histone H3 acetylation,	GO:0005634~nucleus,GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0017025~TBP-class protein binding,GO:0046982~protein heterodimerization activity,	IPR003958:Transcription factor CBF/NF-Y/archaeal histone,IPR009072:Histone-fold,					3D-structure,Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Protein Dr1,compositionally biased region:Ala/Gln-rich,helix,modified residue,sequence variant,short sequence motif:Nuclear localization signal,strand,
DPY30	dpy-30, histone methyltransferase complex regulatory subunit(DPY30)	Homo sapiens				GO:0006348~chromatin silencing at telomere,GO:0006351~transcription, DNA-templated,GO:0016197~endosomal transport,GO:0051568~histone H3-K4 methylation,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,GO:0048188~Set1C/COMPASS complex,	GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR007858:Dpy-30 motif,					3D-structure,Acetylation,Chromatin regulator,Complete proteome,Golgi apparatus,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Protein dpy-30 homolog,helix,modified residue,turn,
DSTYK	dual serine/threonine and tyrosine protein kinase(DSTYK)	Homo sapiens				GO:0018108~peptidyl-tyrosine phosphorylation,GO:0033674~positive regulation of kinase activity,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045743~positive regulation of fibroblast growth factor receptor signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030054~cell junction,	GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,		610805~Congenital anomalies of kidney and urinary tract, susceptibility to,		SM00220:S_TKc,	Alternative splicing,ATP-binding,Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Kinase,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual serine/threonine and tyrosine protein kinase,compositionally biased region:Poly-Gly,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
DUSP19	dual specificity phosphatase 19(DUSP19)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0032147~activation of protein kinase activity,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0043410~positive regulation of MAPK cascade,GO:0043507~positive regulation of JUN kinase activity,GO:0043508~negative regulation of JUN kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046329~negative regulation of JNK cascade,GO:0046330~positive regulation of JNK cascade,		GO:0004725~protein tyrosine phosphatase activity,GO:0004860~protein kinase inhibitor activity,GO:0005078~MAP-kinase scaffold activity,GO:0005515~protein binding,GO:0008579~JUN kinase phosphatase activity,GO:0030295~protein kinase activator activity,GO:0031435~mitogen-activated protein kinase kinase kinase binding,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR020417:Atypical dual specificity phosphatase,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR024950:Dual specificity phosphatase,				SM00195:DSPc,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Hydrolase,Polymorphism,Protein phosphatase,Reference proteome,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase 19,domain:Tyrosine-protein phosphatase,sequence variant,splice variant,
DUSP23	dual specificity phosphatase 23(DUSP23)	Homo sapiens				GO:0016311~dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR016130:Protein-tyrosine phosphatase, active site,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,				SM00195:DSPc,SM00404:PTPc_motif,	3D-structure,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Polymorphism,Protein phosphatase,Reference proteome,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase 23,domain:Tyrosine-protein phosphatase,helix,sequence conflict,sequence variant,strand,turn,
DUSP27	dual specificity phosphatase 27 (putative)(DUSP27)	Homo sapiens				GO:0006470~protein dephosphorylation,		GO:0008138~protein tyrosine/serine/threonine phosphatase activity,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR020405:Atypical dual specificity phosphatase, subfamily A,IPR020417:Atypical dual specificity phosphatase,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR024950:Dual specificity phosphatase,				SM00195:DSPc,	Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Inactive dual specificity phosphatase 27,compositionally biased region:Ser-rich,domain:Tyrosine-protein phosphatase,sequence variant,
DCTN1	dynactin subunit 1(DCTN1)	Homo sapiens		h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007067~mitotic nuclear division,GO:0007399~nervous system development,GO:0010457~centriole-centriole cohesion,GO:0010970~establishment of localization by movement along microtubule,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0031116~positive regulation of microtubule polymerization,GO:0032402~melanosome transport,GO:0034454~microtubule anchoring at centrosome,GO:0036498~IRE1-mediated unfolded protein response,GO:0042147~retrograde transport, endosome to Golgi,GO:0051081~nuclear envelope disassembly,GO:0090063~positive regulation of microtubule nucleation,	GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005819~spindle,GO:0005829~cytosol,GO:0005869~dynactin complex,GO:0005874~microtubule,GO:0016020~membrane,GO:0030286~dynein complex,GO:0030904~retromer complex,GO:0031252~cell leading edge,GO:0035371~microtubule plus-end,	GO:0003774~motor activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0015631~tubulin binding,GO:0045502~dynein binding,	IPR000938:CAP Gly-rich domain,IPR022157:Dynein associated protein,	hsa04962:Vasopressin-regulated water reabsorption,hsa05016:Huntington's disease,	105400~Amyotrophic lateral sclerosis, susceptibility to,168605~Perry syndrome,607641~Neuropathy, distal hereditary motor, type VIIB,		SM01052:SM01052,	3D-structure,Alternative splicing,Amyotrophic lateral sclerosis,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Dynein,Microtubule,Neurodegeneration,Parkinsonism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,Ubl conjugation,	chain:Dynactin subunit 1,compositionally biased region:Ser-rich,domain:CAP-Gly,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
DNM3	dynamin 3(DNM3)	Homo sapiens				GO:0000266~mitochondrial fission,GO:0003374~dynamin polymerization involved in mitochondrial fission,GO:0006897~endocytosis,GO:0007416~synapse assembly,GO:0031623~receptor internalization,GO:0046847~filopodium assembly,GO:0051491~positive regulation of filopodium assembly,GO:0061002~negative regulation of dendritic spine morphogenesis,GO:0061025~membrane fusion,	GO:0001917~photoreceptor inner segment,GO:0005794~Golgi apparatus,GO:0005874~microtubule,GO:0014069~postsynaptic density,GO:0030424~axon,GO:0031966~mitochondrial membrane,GO:0043083~synaptic cleft,GO:0043197~dendritic spine,GO:0044327~dendritic spine head,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008017~microtubule binding,GO:0031798~type 1 metabotropic glutamate receptor binding,GO:0031802~type 5 metabotropic glutamate receptor binding,GO:0050998~nitric-oxide synthase binding,	IPR000375:Dynamin central domain,IPR001401:Dynamin, GTPase domain,IPR001849:Pleckstrin homology domain,IPR003130:Dynamin GTPase effector,IPR011993:Pleckstrin homology-like domain,IPR019762:Dynamin, GTPase region, conserved site,IPR020850:GTPase effector domain, GED,IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,hsa04721:Synaptic vesicle cycle,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa05100:Bacterial invasion of epithelial cells,			SM00053:DYNc,SM00233:PH,SM00302:GED,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Endocytosis,GTP-binding,Hydrolase,Microtubule,Motor protein,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Dynamin-3,domain:GED,domain:PH,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,splice variant,
DAW1	dynein assembly factor with WD repeats 1(DAW1)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0007368~determination of left/right symmetry,GO:0007507~heart development,	GO:0005929~cilium,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00320:WD40,	Alternative splicing,Cell projection,Cilium,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 69,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,sequence conflict,sequence variant,splice variant,
DNAH12	dynein axonemal heavy chain 12(DNAH12)	Homo sapiens			Cytoskeleton,	GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005929~cilium,GO:0030286~dynein complex,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+ ATPase domain,IPR004273:Dynein heavy chain domain,IPR011704:ATPase, dynein-related, AAA domain,IPR013602:Dynein heavy chain, domain-2,IPR024317:Dynein heavy chain, P-loop containing D4 domain,IPR024743:Dynein heavy chain, coiled coil stalk,IPR026983:Dynein heavy chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05016:Huntington's disease,			SM00382:AAA,	Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Dynein,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Axonemal dynein heavy chain 12-like protein,chain:Dynein heavy chain 12, axonemal,modified residue,nucleotide phosphate-binding region:ATP,region of interest:AAA 1,region of interest:AAA 2,region of interest:AAA 3,region of interest:AAA 4,region of interest:AAA 5,region of interest:Stalk,region of interest:Stem,sequence conflict,sequence variant,short sequence motif:CFDEFNR motif,short sequence motif:GPAGTGKT motif,splice variant,
DNAH14	dynein axonemal heavy chain 14(DNAH14)	Homo sapiens				GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005929~cilium,GO:0030286~dynein complex,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,	IPR004273:Dynein heavy chain domain,IPR013602:Dynein heavy chain, domain-2,IPR024317:Dynein heavy chain, P-loop containing D4 domain,IPR024743:Dynein heavy chain, coiled coil stalk,IPR026983:Dynein heavy chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05016:Huntington's disease,				Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Dynein,Glycoprotein,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:Dynein heavy chain 14, axonemal,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:GPAGTGKT motif,splice variant,
DNAH6	dynein axonemal heavy chain 6(DNAH6)	Homo sapiens		h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development,	Cytoskeleton,	GO:0001539~cilium or flagellum-dependent cell motility,GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005858~axonemal dynein complex,GO:0005874~microtubule,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+ ATPase domain,IPR004273:Dynein heavy chain domain,IPR011704:ATPase, dynein-related, AAA domain,IPR013602:Dynein heavy chain, domain-2,IPR024317:Dynein heavy chain, P-loop containing D4 domain,IPR024743:Dynein heavy chain, coiled coil stalk,IPR026980:Dynein heavy chain 6, axonemal,IPR026983:Dynein heavy chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05016:Huntington's disease,			SM00382:AAA,	Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Dynein,Microtubule,Motor protein,Nucleotide-binding,Proteomics identification,Reference proteome,Repeat,	chain:Dynein heavy chain 6, axonemal,nucleotide phosphate-binding region:ATP,region of interest:AAA 1,region of interest:AAA 2,region of interest:AAA 3,region of interest:AAA 4,region of interest:AAA 5,region of interest:AAA 6,region of interest:Stalk,region of interest:Stem,sequence conflict,splice variant,
DNAH7	dynein axonemal heavy chain 7(DNAH7)	Homo sapiens			Cytoskeleton,	GO:0003341~cilium movement,GO:0036159~inner dynein arm assembly,GO:0060285~cilium-dependent cell motility,	GO:0005737~cytoplasm,GO:0005858~axonemal dynein complex,GO:0005874~microtubule,GO:0005929~cilium,GO:0036156~inner dynein arm,	GO:0003777~microtubule motor activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR002048:EF-hand domain,IPR003593:AAA+ ATPase domain,IPR004273:Dynein heavy chain domain,IPR013602:Dynein heavy chain, domain-2,IPR018247:EF-Hand 1, calcium-binding site,IPR024317:Dynein heavy chain, P-loop containing D4 domain,IPR024743:Dynein heavy chain, coiled coil stalk,IPR026979:Dynein heavy chain 7, axonemal,IPR026983:Dynein heavy chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05016:Huntington's disease,			SM00382:AAA,	Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Dynein,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Reference proteome,Repeat,	chain:Dynein heavy chain 7, axonemal,nucleotide phosphate-binding region:ATP,region of interest:AAA 1,region of interest:AAA 2,region of interest:AAA 3,region of interest:AAA 4,region of interest:AAA 5,region of interest:AAA 6,region of interest:Stalk,region of interest:Stem,sequence conflict,sequence variant,splice variant,
DNALI1	dynein axonemal light intermediate chain 1(DNALI1)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0007338~single fertilization,	GO:0005737~cytoplasm,GO:0005858~axonemal dynein complex,GO:0005930~axoneme,GO:0030175~filopodium,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0045504~dynein heavy chain binding,	IPR019347:Axonemal dynein light chain,	hsa05016:Huntington's disease,				Alternative splicing,Coiled coil,Complete proteome,Dynein,Motor protein,Polymorphism,Reference proteome,	chain:Axonemal dynein light intermediate polypeptide 1,sequence conflict,sequence variant,
DYNC1I2	dynein cytoplasmic 1 intermediate chain 2(DYNC1I2)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007018~microtubule-based movement,GO:0016032~viral process,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005868~cytoplasmic dynein complex,GO:0005874~microtubule,GO:0031982~vesicle,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR025956:Cytoplasmic dynein 1 intermediate chain 1/2,	hsa04145:Phagosome,hsa04962:Vasopressin-regulated water reabsorption,hsa05132:Salmonella infection,			SM00320:WD40,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Dynein,Host-virus interaction,Microtubule,Motor protein,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transport,WD repeat,	chain:Cytoplasmic dynein 1 intermediate chain 2,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,splice variant,
DYNC1LI1	dynein cytoplasmic 1 light intermediate chain 1(DYNC1LI1)	Homo sapiens				GO:0006810~transport,GO:0007018~microtubule-based movement,GO:0007067~mitotic nuclear division,GO:0016032~viral process,GO:0051301~cell division,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000922~spindle pole,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005868~cytoplasmic dynein complex,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0044822~poly(A) RNA binding,GO:0045504~dynein heavy chain binding,	IPR008467:Dynein 1 light intermediate chain,IPR022780:Dynein family light intermediate chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04145:Phagosome,hsa04962:Vasopressin-regulated water reabsorption,hsa05132:Salmonella infection,				ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Dynein,Host-virus interaction,Kinetochore,Microtubule,Mitosis,Motor protein,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:Cytoplasmic dynein 1 light intermediate chain 1,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
DYNC2LI1	dynein cytoplasmic 2 light intermediate chain 1(DYNC2LI1)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007368~determination of left/right symmetry,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030030~cell projection organization,GO:0042384~cilium assembly,	GO:0005829~cytosol,GO:0005858~axonemal dynein complex,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0030990~intraciliary transport particle,GO:0031512~motile primary cilium,GO:0031514~motile cilium,GO:0036064~ciliary basal body,GO:0045177~apical part of cell,GO:0072372~primary cilium,GO:0097542~ciliary tip,	GO:0003774~motor activity,GO:0005515~protein binding,GO:0045504~dynein heavy chain binding,	IPR022780:Dynein family light intermediate chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04962:Vasopressin-regulated water reabsorption,				Alternative splicing,Cell projection,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Dynein,Microtubule,Motor protein,Polymorphism,Proteomics identification,Reference proteome,	chain:Cytoplasmic dynein 2 light intermediate chain 1,sequence conflict,sequence variant,splice variant,
DRC1	dynein regulatory complex subunit 1(DRC1)	Homo sapiens				GO:0007368~determination of left/right symmetry,GO:0007507~heart development,GO:0060285~cilium-dependent cell motility,GO:0070286~axonemal dynein complex assembly,GO:0071973~bacterial-type flagellum-dependent cell motility,	GO:0005737~cytoplasm,GO:0005930~axoneme,				615294~Ciliary dyskinesia, primary, 21,			Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Polymorphism,Primary ciliary dyskinesia,Reference proteome,	chain:UPF0407 protein C2orf39,compositionally biased region:Glu-rich,sequence variant,
DYSF	dysferlin(DYSF)	Homo sapiens				GO:0001778~plasma membrane repair,GO:0006906~vesicle fusion,GO:0006936~muscle contraction,	GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0030139~endocytic vesicle,GO:0030315~T-tubule,GO:0030659~cytoplasmic vesicle membrane,GO:0042383~sarcolemma,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR006614:Peroxin/Ferlin domain,IPR012560:Ferlin A-domain,IPR012561:Ferlin B-domain,IPR012968:FerIin domain,		253601~Muscular dystrophy, limb-girdle, type 2B,254130~Miyoshi muscular dystrophy 1,606768~Myopathy, distal, with anterior tibial onset,		SM00239:C2,SM00693:DysFN,SM00694:DysFC,SM01200:SM01200,SM01201:SM01201,SM01202:SM01202,	3D-structure,Alternative promoter usage,Alternative splicing,Calcium,Cell membrane,Complete proteome,Cytoplasmic vesicle,Disease mutation,Limb-girdle muscular dystrophy,Lipid-binding,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Dysferlin,compositionally biased region:Arg-rich,domain:C2 1,domain:C2 2,domain:C2 3,domain:C2 4,domain:C2 5,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DTNB	dystrobrevin beta(DTNB)	Homo sapiens					GO:0005737~cytoplasm,GO:0045202~synapse,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000433:Zinc finger, ZZ-type,IPR011992:EF-hand-like domain,IPR015153:EF-hand domain, type 1,IPR015154:EF-hand domain, type 2,IPR017432:Distrobrevin,			PIRSF038204:distrobrevin,	SM00291:ZnF_ZZ,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Dystrobrevin beta,region of interest:Syntrophin-binding region,splice variant,zinc finger region:ZZ-type,
DAG1	dystroglycan 1(DAG1)	Homo sapiens	10.Dysdap,63.LAT_couples_T-cell_receptor,82.TCR_and_Cap_or_SMAC,	h_agrPathway:Agrin in Postsynaptic Differentiation,		GO:0002011~morphogenesis of an epithelial sheet,GO:0006493~protein O-linked glycosylation,GO:0006509~membrane protein ectodomain proteolysis,GO:0006607~NLS-bearing protein import into nucleus,GO:0007016~cytoskeletal anchoring at plasma membrane,GO:0010470~regulation of gastrulation,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0016340~calcium-dependent cell-matrix adhesion,GO:0016476~regulation of embryonic cell shape,GO:0019048~modulation by virus of host morphology or physiology,GO:0021682~nerve maturation,GO:0022011~myelination in peripheral nervous system,GO:0030198~extracellular matrix organization,GO:0030336~negative regulation of cell migration,GO:0034453~microtubule anchoring,GO:0043409~negative regulation of MAPK cascade,GO:0043434~response to peptide hormone,GO:0046718~viral entry into host cell,GO:0051898~negative regulation of protein kinase B signaling,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060445~branching involved in salivary gland morphogenesis,GO:0071679~commissural neuron axon guidance,GO:0071711~basement membrane organization,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0009279~cell outer membrane,GO:0016010~dystrophin-associated glycoprotein complex,GO:0016011~dystroglycan complex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0033268~node of Ranvier,GO:0042383~sarcolemma,GO:0043034~costamere,GO:0045121~membrane raft,GO:0045211~postsynaptic membrane,GO:0070062~extracellular exosome,GO:0070938~contractile ring,	GO:0001618~virus receptor activity,GO:0002162~dystroglycan binding,GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008307~structural constituent of muscle,GO:0015631~tubulin binding,GO:0017166~vinculin binding,GO:0032403~protein complex binding,GO:0042169~SH2 domain binding,GO:0043237~laminin-1 binding,GO:0051393~alpha-actinin binding,	IPR006644:Dystroglycan-type cadherin-like,IPR008465:Dystroglycan,IPR013783:Immunoglobulin-like fold,IPR015919:Cadherin-like,IPR027468:Alpha-dystroglycan domain 2,	hsa04512:ECM-receptor interaction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,hsa05416:Viral myocarditis,	613818~Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9,616538~Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9,		SM00736:CADG,	3D-structure,Autocatalytic cleavage,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Disulfide bond,Dystroglycanopathy,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Limb-girdle muscular dystrophy,Lissencephaly,Membrane,Nucleus,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Alpha-dystroglycan,chain:Beta-dystroglycan,disulfide bond,domain:Peptidase S72,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (glycosaminoglycan),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DYTN	dystrotelin(DYTN)	Homo sapiens					GO:0005886~plasma membrane,	GO:0008270~zinc ion binding,	IPR000433:Zinc finger, ZZ-type,IPR011992:EF-hand-like domain,IPR015153:EF-hand domain, type 1,IPR015154:EF-hand domain, type 2,				SM00291:ZnF_ZZ,	Cell membrane,Coiled coil,Complete proteome,Membrane,Metal-binding,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Dystrotelin,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,sequence variant,zinc finger region:ZZ-type,
EML4	echinoderm microtubule associated protein like 4(EML4)	Homo sapiens			General function prediction only,	GO:0000226~microtubule cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007067~mitotic nuclear division,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,	GO:0008017~microtubule binding,	IPR001680:WD40 repeat,IPR005108:HELP,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	hsa05223:Non-small cell lung cancer,			SM00320:WD40,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Echinoderm microtubule-associated protein-like 4,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,sequence variant,
EML6	echinoderm microtubule associated protein like 6(EML6)	Homo sapiens					GO:0005737~cytoplasm,GO:0005874~microtubule,		IPR001680:WD40 repeat,IPR005108:HELP,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR011048:Cytochrome cd1-nitrite reductase-like, C-terminal haem d1,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,				SM00320:WD40,	Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Reference proteome,Repeat,WD repeat,	chain:Echinoderm microtubule-associated protein-like 6,compositionally biased region:Poly-Lys,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 13,repeat:WD 14,repeat:WD 15,repeat:WD 16,repeat:WD 17,repeat:WD 18,repeat:WD 19,repeat:WD 2,repeat:WD 20,repeat:WD 21,repeat:WD 22,repeat:WD 23,repeat:WD 24,repeat:WD 25,repeat:WD 26,repeat:WD 27,repeat:WD 28,repeat:WD 29,repeat:WD 3,repeat:WD 30,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,splice variant,
EVI5	ecotropic viral integration site 5(EVI5)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0007049~cell cycle,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0031338~regulation of vesicle fusion,GO:0042147~retrograde transport, endosome to Golgi,GO:0051301~cell division,GO:0090630~activation of GTPase activity,GO:1902017~regulation of cilium assembly,	GO:0005634~nucleus,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005829~cytosol,GO:0012505~endomembrane system,GO:0043231~intracellular membrane-bounded organelle,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017137~Rab GTPase binding,	IPR000195:Rab-GTPase-TBC domain,				SM00164:TBC,	Alternative splicing,Cell cycle,Cell division,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Ecotropic viral integration site 5 protein homolog,compositionally biased region:Ser-rich,domain:Rab-GAP TBC,modified residue,region of interest:Dimerization,region of interest:Interaction with alpha-tubulin, gamma- tubulin, BIRC5 and FBXO5,region of interest:Interaction with AURKB and INCENP,region of interest:Targeting to the centrosomes,sequence conflict,sequence variant,site:Breakpoint for translocation to form EVI5-TRNG10 fusion protein,
EDAR	ectodysplasin A receptor(EDAR)	Homo sapiens				GO:0001942~hair follicle development,GO:0006915~apoptotic process,GO:0008544~epidermis development,GO:0010628~positive regulation of gene expression,GO:0030154~cell differentiation,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043473~pigmentation,GO:0046330~positive regulation of JNK cascade,GO:0060662~salivary gland cavitation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0045177~apical part of cell,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,	IPR011029:Death-like domain,	hsa04060:Cytokine-cytokine receptor interaction,	129490~Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant,224900~Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive,612630~Hair morphology 1, hair thickness,			Alternative splicing,Apoptosis,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Ectodermal dysplasia,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member EDAR,disulfide bond,domain:Death,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENTPD3	ectonucleoside triphosphate diphosphohydrolase 3(ENTPD3)	Homo sapiens				GO:0009134~nucleoside diphosphate catabolic process,GO:0009143~nucleoside triphosphate catabolic process,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0017110~nucleoside-diphosphatase activity,GO:0017111~nucleoside-triphosphatase activity,	IPR000407:Nucleoside phosphatase GDA1/CD39,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa05169:Epstein-Barr virus infection,				Alternative splicing,ATP-binding,Calcium,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Magnesium,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Ectonucleoside triphosphate diphosphohydrolase 3,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EGLN1	egl-9 family hypoxia inducible factor 1(EGLN1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006879~cellular iron ion homeostasis,GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,GO:0030821~negative regulation of cAMP catabolic process,GO:0032364~oxygen homeostasis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045765~regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051344~negative regulation of cyclic-nucleotide phosphodiesterase activity,GO:0055008~cardiac muscle tissue morphogenesis,GO:0055114~oxidation-reduction process,GO:0060347~heart trabecula formation,GO:0060412~ventricular septum morphogenesis,GO:0060711~labyrinthine layer development,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0071731~response to nitric oxide,GO:1901214~regulation of neuron death,	GO:0005623~cell,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0019899~enzyme binding,GO:0031418~L-ascorbic acid binding,GO:0031543~peptidyl-proline dioxygenase activity,GO:0031545~peptidyl-proline 4-dioxygenase activity,	IPR002893:Zinc finger, MYND-type,IPR005123:Oxoglutarate/iron-dependent dioxygenase,IPR006620:Prolyl 4-hydroxylase, alpha subunit,	hsa04066:HIF-1 signaling pathway,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,	609070~Hemoglobin, high altitude adaptation,609820~Erythrocytosis, familial, 3,		SM00702:P4Hc,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Congenital erythrocytosis,Cytoplasm,Dioxygenase,Disease mutation,Iron,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,S-nitrosylation,Vitamin C,Zinc,Zinc-finger,	binding site:2-oxoglutarate,chain:Egl nine homolog 1,domain:Fe2OG dioxygenase,helix,metal ion-binding site:Iron,modified residue,mutagenesis site,sequence variant,splice variant,strand,turn,zinc finger region:MYND-type,
ENAH	enabled homolog (Drosophila)(ENAH)	Homo sapiens				GO:0007411~axon guidance,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030175~filopodium,GO:0045202~synapse,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0050699~WW domain binding,	IPR000697:EVH1,IPR011993:Pleckstrin homology-like domain,IPR014885:VASP tetramerisation,	hsa04810:Regulation of actin cytoskeleton,			SM00461:WH1,	3D-structure,Actin-binding,Alternative splicing,Cell junction,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH3-binding,Synapse,	chain:Protein enabled homolog,compositionally biased region:Pro-rich,domain:WH1,helix,modified residue,region of interest:9 X 5 AA tandem repeats of [LMQ]-E-[QR]- E-[QR],region of interest:EVH2,region of interest:EVH2 block A,region of interest:EVH2 block B,region of interest:EVH2 block C,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,short sequence motif:KLKR,splice variant,strand,turn,
ERLEC1	endoplasmic reticulum lectin 1(ERLEC1)	Homo sapiens				GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0036503~ERAD pathway,GO:1904153~negative regulation of retrograde protein transport, ER to cytosol,	GO:0005788~endoplasmic reticulum lumen,GO:0044322~endoplasmic reticulum quality control compartment,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0051082~unfolded protein binding,	IPR009011:Mannose-6-phosphate receptor binding domain,IPR012913:Glucosidase II beta subunit-like,	hsa04141:Protein processing in endoplasmic reticulum,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Polymorphism,Reference proteome,Repeat,Signal,	chain:Endoplasmic reticulum lectin 1,domain:PRKCSH 1,domain:PRKCSH 2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,
ERO1B	endoplasmic reticulum oxidoreductase 1 beta(ERO1B)	Homo sapiens				GO:0006457~protein folding,GO:0006464~cellular protein modification process,GO:0019471~4-hydroxyproline metabolic process,GO:0022417~protein maturation by protein folding,GO:0030070~insulin processing,GO:0030198~extracellular matrix organization,GO:0034975~protein folding in endoplasmic reticulum,GO:0042593~glucose homeostasis,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0003756~protein disulfide isomerase activity,GO:0005515~protein binding,GO:0015035~protein disulfide oxidoreductase activity,GO:0016491~oxidoreductase activity,GO:0016671~oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,GO:0051082~unfolded protein binding,	IPR007266:Endoplasmic reticulum oxidoreductin 1,	hsa04141:Protein processing in endoplasmic reticulum,		PIRSF017205:endoplasmic oxidoreductin,		Alternative splicing,Complete proteome,Disulfide bond,Electron transport,Endoplasmic reticulum,FAD,Flavoprotein,Glycoprotein,Membrane,Oxidoreductase,Polymorphism,Proteomics identification,Redox-active center,Reference proteome,Signal,Transport,	binding site:FAD,chain:ERO1-like protein beta,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
ENSA	endosulfine alpha(ENSA)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006810~transport,GO:0007067~mitotic nuclear division,GO:0007584~response to nutrient,GO:0009749~response to glucose,GO:0035308~negative regulation of protein dephosphorylation,GO:0043086~negative regulation of catalytic activity,GO:0050796~regulation of insulin secretion,GO:0051301~cell division,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004864~protein phosphatase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008200~ion channel inhibitor activity,GO:0008601~protein phosphatase type 2A regulator activity,GO:0019212~phosphatase inhibitor activity,GO:0019870~potassium channel inhibitor activity,GO:0019888~protein phosphatase regulator activity,GO:0051721~protein phosphatase 2A binding,	IPR006760:Endosulphine,					Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Mitosis,Phosphoprotein,Protein phosphatase inhibitor,Proteomics identification,Reference proteome,	chain:Alpha-endosulfine,modified residue,sequence conflict,splice variant,
EPAS1	endothelial PAS domain protein 1(EPAS1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0001892~embryonic placenta development,GO:0001974~blood vessel remodeling,GO:0002027~regulation of heart rate,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0007165~signal transduction,GO:0007601~visual perception,GO:0030218~erythrocyte differentiation,GO:0030324~lung development,GO:0035019~somatic stem cell population maintenance,GO:0042415~norepinephrine metabolic process,GO:0043129~surfactant homeostasis,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048625~myoblast fate commitment,GO:0055072~iron ion homeostasis,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0071456~cellular response to hypoxia,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0035035~histone acetyltransferase binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR000014:PAS domain,IPR001067:Nuclear translocator,IPR001610:PAC motif,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013767:PAS fold,IPR014887:HIF-1 alpha, transactivation domain, C-terminal,IPR021537:Hypoxia-inducible factor, alpha subunit,	hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,	611783~Erythrocytosis, familial, 4,		SM00086:PAC,SM00091:PAS,SM00353:HLH,	3D-structure,Activator,Angiogenesis,Complete proteome,Congenital erythrocytosis,Developmental protein,Differentiation,Disease mutation,DNA-binding,Hydroxylation,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Endothelial PAS domain-containing protein 1,compositionally biased region:Poly-Ser,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAC,domain:PAS 1,domain:PAS 2,helix,modified residue,mutagenesis site,region of interest:CTAD,region of interest:NTAD,sequence conflict,sequence variant,strand,turn,
ECE1	endothelin converting enzyme 1(ECE1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0001921~positive regulation of receptor recycling,GO:0003100~regulation of systemic arterial blood pressure by endothelin,GO:0007507~heart development,GO:0010814~substance P catabolic process,GO:0010815~bradykinin catabolic process,GO:0010816~calcitonin catabolic process,GO:0016485~protein processing,GO:0016486~peptide hormone processing,GO:0019229~regulation of vasoconstriction,GO:0034959~endothelin maturation,GO:0042447~hormone catabolic process,GO:0042733~embryonic digit morphogenesis,GO:0043583~ear development,GO:0060037~pharyngeal system development,	GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031302~intrinsic component of endosome membrane,GO:0031982~vesicle,GO:0033093~Weibel-Palade body,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0017046~peptide hormone binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR000718:Peptidase M13,IPR008753:Peptidase M13, N-terminal domain,IPR018497:Peptidase M13, C-terminal domain,IPR024079:Metallopeptidase, catalytic domain,		145500~Hypertension, essential, susceptibility to,613870~Hirschsprung disease, cardiac defects, and autonomic dysfunction,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Hirschsprung disease,Hydrolase,Membrane,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Proton donor,chain:Endothelin-converting enzyme 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc; catalytic,modified residue,mutagenesis site,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ECEL1	endothelin converting enzyme like 1(ECEL1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0003016~respiratory system process,GO:0006508~proteolysis,GO:0007218~neuropeptide signaling pathway,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,	IPR000718:Peptidase M13,IPR008753:Peptidase M13, N-terminal domain,IPR018497:Peptidase M13, C-terminal domain,IPR024079:Metallopeptidase, catalytic domain,		615065~Arthrogryposis, distal, type 5D,			Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	chain:Endothelin-converting enzyme-like 1,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
EN1	engrailed homeobox 1(EN1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0008344~adult locomotory behavior,GO:0009653~anatomical structure morphogenesis,GO:0009953~dorsal/ventral pattern formation,GO:0009954~proximal/distal pattern formation,GO:0021549~cerebellum development,GO:0030901~midbrain development,GO:0030917~midbrain-hindbrain boundary development,GO:0035115~embryonic forelimb morphogenesis,GO:0035176~social behavior,GO:0035264~multicellular organism growth,GO:0042756~drinking behavior,GO:0043473~pigmentation,GO:0043524~negative regulation of neuron apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048666~neuron development,GO:0061743~motor learning,GO:0071542~dopaminergic neuron differentiation,GO:1990403~embryonic brain development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,	IPR000747:Homeodomain engrailed,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR019549:Homeobox engrailed, C-terminal,IPR019737:Homeobox engrailed-type, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Reference proteome,	chain:Homeobox protein engrailed-1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,DNA-binding region:Homeobox,sequence conflict,
EPC2	enhancer of polycomb homolog 2(EPC2)	Homo sapiens				GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016573~histone acetylation,	GO:0032777~Piccolo NuA4 histone acetyltransferase complex,	GO:0004402~histone acetyltransferase activity,	IPR009607:Enhancer of polycomb, C-terminal,IPR019542:Enhancer of polycomb-like, N-terminal,IPR024943:Enhancer of polycomb protein,					Chromatin regulator,Complete proteome,DNA damage,DNA repair,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Enhancer of polycomb homolog 2,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ser,modified residue,sequence conflict,
ENO1	enolase 1(ENO1)	Homo sapiens		h_glycolysisPathway:Glycolysis Pathway,		GO:0006094~gluconeogenesis,GO:0006096~glycolytic process,GO:0006351~transcription, DNA-templated,GO:0009615~response to virus,GO:0030308~negative regulation of cell growth,GO:0045892~negative regulation of transcription, DNA-templated,GO:0061621~canonical glycolysis,GO:0098609~cell-cell adhesion,	GO:0000015~phosphopyruvate hydratase complex,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0031430~M band,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0004634~phosphopyruvate hydratase activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0051020~GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000941:Enolase,IPR020809:Enolase, conserved site,IPR020810:Enolase, C-terminal,IPR020811:Enolase, N-terminal,	hsa00010:Glycolysis / Gluconeogenesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01230:Biosynthesis of amino acids,hsa03018:RNA degradation,hsa04066:HIF-1 signaling pathway,	Enolase deficiency~Enolase deficiency,	PIRSF001400:enolase,	SM01192:SM01192,SM01193:SM01193,	3D-structure,Acetylation,Alternative initiation,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Glycolysis,Lyase,Magnesium,Membrane,Metal-binding,Nucleus,Phosphoprotein,Plasminogen activation,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	active site:Proton acceptor,active site:Proton donor,binding site:Substrate,chain:Alpha-enolase,helix,metal ion-binding site:Magnesium,modified residue,mutagenesis site,region of interest:Epitope recognized by CAR and healthy patient antibodies,region of interest:Epitope recognized by CAR antibodies,region of interest:Required for interaction with PLG,region of interest:Required for repression of c-myc promoter activity,region of interest:Substrate binding,sequence conflict,sequence variant,splice variant,strand,turn,
ECHDC2	enoyl-CoA hydratase domain containing 2(ECHDC2)	Homo sapiens			Lipid metabolism,	GO:0006635~fatty acid beta-oxidation,GO:0008152~metabolic process,	GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0004300~enoyl-CoA hydratase activity,	IPR001753:Crotonase superfamily,IPR014748:Crontonase, C-terminal,IPR018376:Enoyl-CoA hydratase/isomerase, conserved site,					Acetylation,Alternative splicing,Complete proteome,Fatty acid metabolism,Lipid metabolism,Lyase,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Enoyl-CoA hydratase domain-containing protein 2, mitochondrial,sequence conflict,sequence variant,site:Important for catalytic activity,splice variant,transit peptide:Mitochondrion,
EOMES	eomesodermin(EOMES)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001706~endoderm formation,GO:0001707~mesoderm formation,GO:0001714~endodermal cell fate specification,GO:0001829~trophectodermal cell differentiation,GO:0002250~adaptive immune response,GO:0002302~CD8-positive, alpha-beta T cell differentiation involved in immune response,GO:0006351~transcription, DNA-templated,GO:0007420~brain development,GO:0010002~cardioblast differentiation,GO:0019827~stem cell population maintenance,GO:0021772~olfactory bulb development,GO:0021796~cerebral cortex regionalization,GO:0021895~cerebral cortex neuron differentiation,GO:0032609~interferon-gamma production,GO:0035914~skeletal muscle cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060706~cell differentiation involved in embryonic placenta development,GO:0060809~mesodermal to mesenchymal transition involved in gastrulation,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001699:Transcription factor, T-box,IPR008967:p53-like transcription factor, DNA-binding,IPR018186:Transcription factor, T-box, conserved site,				SM00425:TBOX,	Activator,Adaptive immunity,Alternative splicing,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,DNA-binding,Gastrulation,Immunity,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Eomesodermin homolog,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Asn,compositionally biased region:Poly-Gly,DNA-binding region:T-box,region of interest:Required for transcription activation,sequence conflict,sequence variant,
EFNA3	ephrin A3(EFNA3)	Homo sapiens				GO:0007267~cell-cell signaling,GO:0007411~axon guidance,GO:0048013~ephrin receptor signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,	GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0046875~ephrin receptor binding,	IPR001799:Ephrin,IPR008972:Cupredoxin,IPR019765:Ephrin, conserved site,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Reference proteome,Signal,	chain:Ephrin-A3,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated glycine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,
EFNA4	ephrin A4(EFNA4)	Homo sapiens				GO:0007267~cell-cell signaling,GO:0007411~axon guidance,GO:0048013~ephrin receptor signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,	GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0046875~ephrin receptor binding,	IPR001799:Ephrin,IPR008972:Cupredoxin,IPR019765:Ephrin, conserved site,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,				Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Secreted,Signal,	chain:Ephrin-A4,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,signal peptide,splice variant,
EPS15	epidermal growth factor receptor pathway substrate 15(EPS15)	Homo sapiens		h_ndkDynaminPathway:Endocytotic role of NDK, Phosphins and Dynamin,		GO:0001921~positive regulation of receptor recycling,GO:0006895~Golgi to endosome transport,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0008283~cell proliferation,GO:0015031~protein transport,GO:0016050~vesicle organization,GO:0019065~receptor-mediated endocytosis of virus by host cell,GO:0032456~endocytic recycling,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0046718~viral entry into host cell,GO:0048268~clathrin coat assembly,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0005913~cell-cell adherens junction,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016235~aggresome,GO:0016324~apical plasma membrane,GO:0030122~AP-2 adaptor complex,GO:0031901~early endosome membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0060170~ciliary membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0031593~polyubiquitin binding,GO:0042802~identical protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000261:EPS15 homology (EH),IPR002048:EF-hand domain,IPR003903:Ubiquitin interacting motif,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa04144:Endocytosis,			SM00027:EH,SM00054:EFh,SM00726:UIM,	3D-structure,Acetylation,Alternative splicing,Calcium,Cell membrane,Chromosomal rearrangement,Coated pit,Coiled coil,Complete proteome,Cytoplasm,Endocytosis,Endosome,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,SH3-binding,Transport,Ubl conjugation,	calcium-binding region:1,calcium-binding region:2,chain:Epidermal growth factor receptor substrate 15,compositionally biased region:Pro-rich,domain:EF-hand 1,domain:EF-hand 2,domain:EH 1,domain:EH 2,domain:EH 3,helix,modified residue,mutagenesis site,region of interest:15 X 3 AA repeats of D-P-F,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,repeat:UIM 1,repeat:UIM 2,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,strand,turn,
EPCAM	epithelial cell adhesion molecule(EPCAM)	Homo sapiens				GO:0001657~ureteric bud development,GO:0008284~positive regulation of cell proliferation,GO:0023019~signal transduction involved in regulation of gene expression,GO:0043066~negative regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048863~stem cell differentiation,GO:0098609~cell-cell adhesion,GO:2000048~negative regulation of cell-cell adhesion mediated by cadherin,GO:2000147~positive regulation of cell motility,GO:2000648~positive regulation of stem cell proliferation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005923~bicellular tight junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000716:Thyroglobulin type-1,		613217~Diarrhea 5, with tufting enteropathy, congenital,613244~Colorectal cancer, hereditary nonpolyposis, type 8,		SM00211:TY,	3D-structure,Cell junction,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hereditary nonpolyposis colorectal cancer,Membrane,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Signal,Tight junction,Transmembrane,Transmembrane helix,Tumor antigen,	chain:Epithelial cell adhesion molecule,disulfide bond,domain:Thyroglobulin type-1,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial,modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EPHX1	epoxide hydrolase 1(EPHX1)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0006725~cellular aromatic compound metabolic process,GO:0006805~xenobiotic metabolic process,GO:0009636~response to toxic substance,GO:0014070~response to organic cyclic compound,GO:0019439~aromatic compound catabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0004301~epoxide hydrolase activity,GO:0016787~hydrolase activity,GO:0033961~cis-stilbene-oxide hydrolase activity,	IPR000639:Epoxide hydrolase-like,IPR010497:Epoxide hydrolase, N-terminal,IPR016292:Epoxide hydrolase,	hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa04976:Bile secretion,hsa05204:Chemical carcinogenesis,	189800~Preeclampsia, susceptibility to,607748~Hypercholanemia, familial,Diphenylhydantoin toxicity~Diphenylhydantoin toxicity,Fetal hydantoin syndrome~Fetal hydantoin syndrome,	PIRSF001112:epoxide hydrolase,		Aromatic hydrocarbons catabolism,Complete proteome,Detoxification,Direct protein sequencing,Endoplasmic reticulum,Hydrolase,Membrane,Methylation,Microsome,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Epoxide hydrolase 1,modified residue,sequence conflict,sequence variant,transmembrane region,
EPHX4	epoxide hydrolase 4(EPHX4)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0016787~hydrolase activity,	IPR000073:Alpha/beta hydrolase fold-1,IPR000639:Epoxide hydrolase-like,					Complete proteome,Hydrolase,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Nucleophile,active site:Proton acceptor,active site:Proton donor,chain:Epoxide hydrolase 4,sequence conflict,sequence variant,transmembrane region,
ERBB4	erb-b2 receptor tyrosine kinase 4(ERBB4)	Homo sapiens		h_erbb4Pathway:g-Secretase mediated ErbB4 Signaling Pathway ,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,		GO:0000165~MAPK cascade,GO:0001755~neural crest cell migration,GO:0001934~positive regulation of protein phosphorylation,GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007399~nervous system development,GO:0007507~heart development,GO:0007595~lactation,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009880~embryonic pattern specification,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021551~central nervous system morphogenesis,GO:0021889~olfactory bulb interneuron differentiation,GO:0030334~regulation of cell migration,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038128~ERBB2 signaling pathway,GO:0042523~positive regulation of tyrosine phosphorylation of Stat5 protein,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0045165~cell fate commitment,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060644~mammary gland epithelial cell differentiation,GO:0060749~mammary gland alveolus development,GO:0061026~cardiac muscle tissue regeneration,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:2000010~positive regulation of protein localization to cell surface,GO:2000145~regulation of cell motility,GO:2000366~positive regulation of STAT protein import into nucleus,GO:2001223~negative regulation of neuron migration,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0043235~receptor complex,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000494:EGF receptor, L domain,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR006211:Furin-like cysteine-rich domain,IPR006212:Furin-like repeat,IPR008266:Tyrosine-protein kinase, active site,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR016245:Tyrosine protein kinase, EGF/ERB/XmrK receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa05205:Proteoglycans in cancer,	615515~Amyotrophic lateral sclerosis 19,	PIRSF000619:tyrosine-protein kinase, EGF receptor type,	SM00219:TyrKc,SM00261:FU,	3D-structure,Activator,Alternative splicing,Amyotrophic lateral sclerosis,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Lactation,Membrane,Mitochondrion,Neurodegeneration,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transcription,Transcription regulation,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Receptor tyrosine-protein kinase erbB-4,compositionally biased region:Cys-rich,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:PDZ-binding,short sequence motif:WW-binding 1,short sequence motif:WW-binding 2,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ERMAP	erythroblast membrane associated protein (Scianna blood group)(ERMAP)	Homo sapiens					GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR001870:B30.2/SPRY domain,IPR003599:Immunoglobulin subtype,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,		111620~Blood group, Radin,111750~Blood group, Scianna system,		SM00406:IGv,SM00409:IG,SM00449:SPRY,SM00589:PRY,	Blood group antigen,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Erythroid membrane-associated protein,disulfide bond,domain:B30.2/SPRY,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EPB41L5	erythrocyte membrane protein band 4.1 like 5(EPB41L5)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001837~epithelial to mesenchymal transition,GO:0001839~neural plate morphogenesis,GO:0003383~apical constriction,GO:0006931~substrate-dependent cell migration, cell attachment to substrate,GO:0007398~ectoderm development,GO:0007492~endoderm development,GO:0007509~mesoderm migration involved in gastrulation,GO:0009826~unidimensional cell growth,GO:0010608~posttranscriptional regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0022408~negative regulation of cell-cell adhesion,GO:0031032~actomyosin structure organization,GO:0032091~negative regulation of protein binding,GO:0032092~positive regulation of protein binding,GO:0032525~somite rostral/caudal axis specification,GO:0048319~axial mesoderm morphogenesis,GO:0048339~paraxial mesoderm development,GO:0048617~embryonic foregut morphogenesis,GO:0051894~positive regulation of focal adhesion assembly,GO:0070201~regulation of establishment of protein localization,GO:0070986~left/right axis specification,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0019898~extrinsic component of membrane,GO:0032587~ruffle membrane,	GO:0005200~structural constituent of cytoskeleton,GO:0008092~cytoskeletal protein binding,GO:0019904~protein domain specific binding,	IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,				SM00295:B41,SM01195:SM01195,SM01196:SM01196,	Alternative splicing,Cell junction,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,	chain:Band 4.1-like protein 5,domain:FERM,modified residue,sequence variant,splice variant,
EPB41	erythrocyte membrane protein band 4.1(EPB41)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,		GO:0008015~blood circulation,GO:0030036~actin cytoskeleton organization,GO:0030866~cortical actin cytoskeleton organization,GO:0031032~actomyosin structure organization,GO:0032092~positive regulation of protein binding,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0008091~spectrin,GO:0014731~spectrin-associated cytoskeleton,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,GO:0030863~cortical cytoskeleton,GO:0043234~protein complex,	GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005545~1-phosphatidylinositol binding,GO:0030507~spectrin binding,	IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR007477:SAB domain,IPR008379:Band 4.1, C-terminal,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,		611804~Elliptocytosis-1,		SM00295:B41,SM01195:SM01195,SM01196:SM01196,	3D-structure,Actin-binding,Alternative splicing,Calmodulin-binding,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Elliptocytosis,Glycoprotein,Hereditary hemolytic anemia,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Pyropoikilocytosis,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein 4.1,domain:FERM,helix,modified residue,mutagenesis site,region of interest:Carboxyl-terminal (CTD),region of interest:Hydrophilic,region of interest:Spectrin--actin-binding,sequence conflict,sequence variant,splice variant,strand,turn,
ESPN	espin(ESPN)	Homo sapiens				GO:0007605~sensory perception of sound,GO:0007626~locomotory behavior,GO:0030046~parallel actin filament bundle assembly,GO:0051017~actin filament bundle assembly,GO:0051491~positive regulation of filopodium assembly,GO:0051494~negative regulation of cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005902~microvillus,GO:0005903~brush border,GO:0031941~filamentous actin,GO:0032426~stereocilium tip,	GO:0017124~SH3 domain binding,GO:0051015~actin filament binding,	IPR002110:Ankyrin repeat,IPR003124:WH2 domain,IPR020683:Ankyrin repeat-containing domain,		609006~Deafness, autosomal recessive 36,Deafness, neurosensory, without vestibular involvement, autosomal dominant~Deafness, neurosensory, without vestibular involvement, autosomal dominant,		SM00246:WH2,SM00248:ANK,	Actin-binding,Alternative splicing,ANK repeat,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Disease mutation,Hearing,Non-syndromic deafness,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Espin,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,domain:WH2,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,
ESPNL	espin-like(ESPNL)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Espin-like protein,compositionally biased region:Pro-rich,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,
ESRRG	estrogen related receptor gamma(ESRRG)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0043401~steroid hormone mediated signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048384~retinoic acid receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003708~retinoic acid receptor activity,GO:0005496~steroid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0050682~AF-2 domain binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003078:Retinoic acid receptor,IPR013088:Zinc finger, NHR/GATA-type,IPR024178:Oestrogen receptor/oestrogen-related receptor,IPR027289:Oestrogen-related receptor,			PIRSF002527:estrogen receptor-like nuclear receptor,PIRSF500939:estrogen-related receptor [Parent=PIRSF002527],	SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Estrogen-related receptor gamma,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Nuclear receptor,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:NR C4-type,
ETNK2	ethanolamine kinase 2(ETNK2)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001890~placenta development,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0009791~post-embryonic development,GO:0016310~phosphorylation,GO:0035264~multicellular organism growth,	GO:0005829~cytosol,	GO:0004305~ethanolamine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR011009:Protein kinase-like domain,	hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,				Alternative splicing,ATP-binding,Complete proteome,Kinase,Lipid biosynthesis,Lipid metabolism,Nucleotide-binding,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,	chain:Ethanolamine kinase 2,sequence conflict,sequence variant,
EIF2AK2	eukaryotic translation initiation factor 2 alpha kinase 2(EIF2AK2)	Homo sapiens		h_eif2Pathway:Regulation of eIF2,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_ranklPathway:Bone Remodelling,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_tollPathway:Toll-Like Receptor Pathway,		GO:0000186~activation of MAPKK activity,GO:0001819~positive regulation of cytokine production,GO:0006351~transcription, DNA-templated,GO:0006412~translation,GO:0006468~protein phosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0010998~regulation of translational initiation by eIF2 alpha phosphorylation,GO:0017148~negative regulation of translation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030683~evasion or tolerance by virus of host immune response,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0032722~positive regulation of chemokine production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0033689~negative regulation of osteoblast proliferation,GO:0034198~cellular response to amino acid starvation,GO:0035455~response to interferon-alpha,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0046777~protein autophosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051607~defense response to virus,GO:1900225~regulation of NLRP3 inflammasome complex assembly,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1901532~regulation of hematopoietic progenitor cell differentiation,GO:1902033~regulation of hematopoietic stem cell proliferation,GO:1902036~regulation of hematopoietic stem cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003725~double-stranded RNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008601~protein phosphatase type 2A regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0044822~poly(A) RNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR014720:Double-stranded RNA-binding-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04141:Protein processing in endoplasmic reticulum,hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,			SM00220:S_TKc,SM00358:DSRM,	3D-structure,Acetylation,Alternative splicing,Antiviral defense,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,Immunity,Innate immunity,Isopeptide bond,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Serine/threonine-protein kinase,Transcription,Transcription regulation,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Interferon-induced, double-stranded RNA- activated protein kinase,domain:DRBM 1,domain:DRBM 2,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:2 X 13 AA approximate repeats,repeat:1,repeat:2,sequence conflict,sequence variant,strand,turn,
EIF2AK3	eukaryotic translation initiation factor 2 alpha kinase 3(EIF2AK3)	Homo sapiens		h_eif2Pathway:Regulation of eIF2,	Function unknown,	GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001525~angiogenesis,GO:0002063~chondrocyte development,GO:0006468~protein phosphorylation,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006983~ER overload response,GO:0007029~endoplasmic reticulum organization,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0010998~regulation of translational initiation by eIF2 alpha phosphorylation,GO:0017148~negative regulation of translation,GO:0018105~peptidyl-serine phosphorylation,GO:0019722~calcium-mediated signaling,GO:0030073~insulin secretion,GO:0030282~bone mineralization,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031018~endocrine pancreas development,GO:0031642~negative regulation of myelination,GO:0032057~negative regulation of translational initiation in response to stress,GO:0034198~cellular response to amino acid starvation,GO:0034976~response to endoplasmic reticulum stress,GO:0036492~eiF2alpha phosphorylation in response to endoplasmic reticulum stress,GO:0036499~PERK-mediated unfolded protein response,GO:0042149~cellular response to glucose starvation,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0046777~protein autophosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0051260~protein homooligomerization,GO:0060734~regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,GO:0070417~cellular response to cold,GO:1900182~positive regulation of protein localization to nucleus,GO:1902235~regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1990737~response to manganese-induced endoplasmic reticulum stress,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003743~translation initiation factor activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019899~enzyme binding,GO:0019903~protein phosphatase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0051879~Hsp90 protein binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR017441:Protein kinase, ATP binding site,IPR027295:Quinonprotein alcohol dehydrogenase-like domain,	hsa04141:Protein processing in endoplasmic reticulum,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,	226980~Wolcott-Rallison syndrome,		SM00220:S_TKc,	3D-structure,ADP-ribosylation,ATP-binding,Complete proteome,Diabetes mellitus,Disease mutation,Endoplasmic reticulum,Glycoprotein,Initiation factor,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Signal,Stress response,Transferase,Translation regulation,Transmembrane,Transmembrane helix,Unfolded protein response,	active site:Proton acceptor,binding site:ATP,chain:Eukaryotic translation initiation factor 2-alpha kinase 3,compositionally biased region:Poly-Ala,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
EIF2B3	eukaryotic translation initiation factor 2B subunit gamma(EIF2B3)	Homo sapiens		h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0006413~translational initiation,GO:0009058~biosynthetic process,GO:0009408~response to heat,GO:0009749~response to glucose,GO:0014003~oligodendrocyte development,GO:0021766~hippocampus development,GO:0032057~negative regulation of translational initiation in response to stress,GO:0043434~response to peptide hormone,GO:0043547~positive regulation of GTPase activity,GO:0051716~cellular response to stimulus,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005851~eukaryotic translation initiation factor 2B complex,	GO:0003743~translation initiation factor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008135~translation factor activity, RNA binding,GO:0016779~nucleotidyltransferase activity,	IPR005835:Nucleotidyl transferase,IPR011004:Trimeric LpxA-like,	hsa03013:RNA transport,	603896~Leukoencephalopathy with vanishing white matter,			Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Initiation factor,Leukodystrophy,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,	chain:Translation initiation factor eIF-2B subunit gamma,modified residue,sequence conflict,sequence variant,splice variant,
EIF2D	eukaryotic translation initiation factor 2D(EIF2D)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0001731~formation of translation preinitiation complex,GO:0002192~IRES-dependent translational initiation,GO:0006886~intracellular protein transport,GO:0032790~ribosome disassembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0022627~cytosolic small ribosomal subunit,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0004872~receptor activity,	IPR001950:Translation initiation factor SUI1,IPR002478:Pseudouridine synthase/archaeosine transglycosylase,IPR003121:SWIB/MDM2 domain,IPR015947:PUA-like domain,				SM00359:PUA,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Initiation factor,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,	chain:Ligatin,domain:PUA,domain:SUI1,modified residue,sequence conflict,sequence variant,splice variant,
EIF4G3	eukaryotic translation initiation factor 4 gamma 3(EIF4G3)	Homo sapiens		h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_eifPathway:Eukaryotic protein translation,h_iresPathway:Internal Ribosome entry pathway,h_mtorPathway:mTOR Signaling Pathway,		GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0010507~negative regulation of autophagy,GO:0016032~viral process,	GO:0005829~cytosol,GO:0016281~eukaryotic translation initiation factor 4F complex,	GO:0000339~RNA cap binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0008135~translation factor activity, RNA binding,GO:0044822~poly(A) RNA binding,	IPR003307:W2 domain,IPR003890:MIF4G-like, type 3,IPR003891:Initiation factor eIF-4 gamma, MA3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	hsa03013:RNA transport,hsa05416:Viral myocarditis,			SM00515:eIF5C,SM00543:MIF4G,SM00544:MA3,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Host-virus interaction,Initiation factor,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Repeat,RNA-binding,Translation regulation,	chain:Eukaryotic translation initiation factor 4 gamma 3,domain:MI,domain:MIF4G,domain:W2,helix,modified residue,mutagenesis site,region of interest:eIF3/EIF4A-binding,region of interest:EIF4A-binding,region of interest:EIF4E-binding,region of interest:Necessary but not sufficient for MKNK1- binding,region of interest:PABPC1-binding,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,sequence conflict,sequence variant,site:Cleavage; by enterovirus/rhinovirus protease 2A,site:Cleavage; by foot-and-mouth disease virus leader protease,splice variant,turn,
EIF4E2	eukaryotic translation initiation factor 4E family member 2(EIF4E2)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0006413~translational initiation,GO:0017148~negative regulation of translation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005845~mRNA cap binding complex,	GO:0000339~RNA cap binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0008135~translation factor activity, RNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,	IPR001040:Translation Initiation factor eIF- 4e,IPR019770:Eukaryotic translation initiation factor 4E (eIF-4E), conserved site,IPR023398:Translation Initiation factor eIF- 4e-like  domain,	hsa03013:RNA transport,hsa04066:HIF-1 signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04910:Insulin signaling pathway,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Initiation factor,Isopeptide bond,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,Ubl conjugation,	chain:Eukaryotic translation initiation factor 4E type 2,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
EIF4E3	eukaryotic translation initiation factor 4E family member 3(EIF4E3)	Homo sapiens				GO:0006413~translational initiation,GO:0006417~regulation of translation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005845~mRNA cap binding complex,	GO:0003743~translation initiation factor activity,	IPR001040:Translation Initiation factor eIF- 4e,IPR023398:Translation Initiation factor eIF- 4e-like  domain,					Alternative splicing,Complete proteome,Initiation factor,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,	chain:Eukaryotic translation initiation factor 4E type 3,splice variant,
EIF5B	eukaryotic translation initiation factor 5B(EIF5B)	Homo sapiens				GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003743~translation initiation factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000795:Elongation factor, GTP-binding domain,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR005225:Small GTP-binding protein domain,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR023115:Translation initiation factor IF- 2, domain 3,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03013:RNA transport,				Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,GTP-binding,Hydrolase,Initiation factor,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,	chain:Eukaryotic translation initiation factor 5B,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Asp,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
EVA1A	eva-1 homolog A, regulator of programmed cell death(EVA1A)	Homo sapiens				GO:0006914~autophagy,GO:0006915~apoptotic process,	GO:0005765~lysosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,							Apoptosis,Autophagy,Complete proteome,Endoplasmic reticulum,Lysosome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM176A,region of interest:Necessary for the localization and biological activity,sequence conflict,sequence variant,transmembrane region,
EVX2	even-skipped homeobox 2(EVX2)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0035108~limb morphogenesis,	GO:0005654~nucleoplasm,	GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Reference proteome,	chain:Homeobox even-skipped homolog protein 2,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,DNA-binding region:Homeobox,
EXOC6B	exocyst complex component 6B(EXOC6B)	Homo sapiens				GO:0006904~vesicle docking involved in exocytosis,GO:0015031~protein transport,	GO:0000145~exocyst,	GO:0005515~protein binding,	IPR007225:Exocyst complex subunit Sec15-like,			PIRSF025007:exocyst complex, component Sec15,		Alternative splicing,Coiled coil,Complete proteome,Exocytosis,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Exocyst complex component 6B,
EXOC8	exocyst complex component 8(EXOC8)	Homo sapiens				GO:0001927~exocyst assembly,GO:0007032~endosome organization,GO:0015031~protein transport,GO:0016241~regulation of macroautophagy,GO:0022617~extracellular matrix disassembly,GO:0051601~exocyst localization,	GO:0000145~exocyst,GO:0005737~cytoplasm,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030426~growth cone,	GO:0005515~protein binding,GO:0017160~Ral GTPase binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR016159:Cullin repeat-like-containing domain,				SM00233:PH,	Cell projection,Complete proteome,Cytoplasm,Exocytosis,Phosphoprotein,Protein transport,Reference proteome,Transport,	chain:Exocyst complex component 8,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,domain:PH,modified residue,
EXO1	exonuclease 1(EXO1)	Homo sapiens				GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0002455~humoral immune response mediated by circulating immunoglobulin,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006310~DNA recombination,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0045190~isotype switching,GO:0051321~meiotic cell cycle,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004523~RNA-DNA hybrid ribonuclease activity,GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0008409~5'-3' exonuclease activity,GO:0035312~5'-3' exodeoxyribonuclease activity,GO:0045145~single-stranded DNA 5'-3' exodeoxyribonuclease activity,GO:0046872~metal ion binding,GO:0048256~flap endonuclease activity,GO:0051908~double-stranded DNA 5'-3' exodeoxyribonuclease activity,	IPR006084:XPG/Rad2 endonuclease,IPR006085:XPG N-terminal,IPR006086:XPG-I domain,IPR008918:Helix-hairpin-helix motif, class 2,IPR019974:XPG conserved site,IPR020045:5'-3' exonuclease, C-terminal domain,	hsa03430:Mismatch repair,			SM00279:HhH2,SM00484:XPGI,SM00485:XPGN,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,DNA damage,DNA excision,DNA repair,DNA-binding,Endonuclease,Excision nuclease,Exonuclease,Hydrolase,Immunity,Magnesium,Meiosis,Metal-binding,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Exonuclease 1,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,modified residue,mutagenesis site,region of interest:I-domain,region of interest:Interaction with MLH1,region of interest:Interaction with MSH2,region of interest:Interaction with MSH3,region of interest:N-domain,region of interest:Nuclear localization signal,sequence variant,splice variant,
EXOSC10	exosome component 10(EXOSC10)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000460~maturation of 5.8S rRNA,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0071028~nuclear mRNA surveillance,GO:0071034~CUT catabolic process,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071044~histone mRNA catabolic process,GO:0071048~nuclear retention of unspliced pre-mRNA at the site of transcription,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0000176~nuclear exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0035327~transcriptionally active chromatin,	GO:0000166~nucleotide binding,GO:0000175~3'-5'-exoribonuclease activity,GO:0004532~exoribonuclease activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR002121:HRDC domain,IPR002562:3'-5' exonuclease domain,IPR010997:HRDC-like,IPR012337:Ribonuclease H-like domain,IPR012588:Exosome-associated factor Rrp6, N-terminal,	hsa03018:RNA degradation,			SM00341:HRDC,SM00474:35EXOc,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Exonuclease,Exosome,Hydrolase,Isopeptide bond,Nonsense-mediated mRNA decay,Nuclease,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,rRNA processing,Ubl conjugation,	chain:Exosome component 10,domain:HRDC,helix,splice variant,strand,turn,
EXOSC7	exosome component 7(EXOSC7)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006401~RNA catabolic process,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034473~U1 snRNA 3'-end processing,GO:0034475~U4 snRNA 3'-end processing,GO:0034476~U5 snRNA 3'-end processing,GO:0043488~regulation of mRNA stability,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0071028~nuclear mRNA surveillance,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process,GO:0071042~nuclear polyadenylation-dependent mRNA catabolic process,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,	GO:0000175~3'-5'-exoribonuclease activity,GO:0003723~RNA binding,GO:0004532~exoribonuclease activity,GO:0005515~protein binding,GO:0017091~AU-rich element binding,	IPR001247:Exoribonuclease, phosphorolytic domain 1,IPR015847:Exoribonuclease, phosphorolytic domain 2,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027408:PNPase/RNase PH domain,	hsa03018:RNA degradation,				3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Exosome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,rRNA processing,	chain:Exosome complex exonuclease RRP42,helix,modified residue,sequence variant,strand,turn,
EXTL1	exostosin like glycosyltransferase 1(EXTL1)	Homo sapiens				GO:0001501~skeletal system development,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006486~protein glycosylation,GO:0015012~heparan sulfate proteoglycan biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0050508~glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,	IPR004263:Exostosin-like,IPR015338:EXTL2, alpha-1,4-N-acetylhexosaminyltransferase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,				Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Exostosin-like 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
EXTL2	exostosin like glycosyltransferase 2(EXTL2)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,GO:0006044~N-acetylglucosamine metabolic process,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0019276~UDP-N-acetylgalactosamine metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001888~glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,GO:0035248~alpha-1,4-N-acetylgalactosaminyltransferase activity,GO:0046872~metal ion binding,	IPR015338:EXTL2, alpha-1,4-N-acetylhexosaminyltransferase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,				Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Manganese,Membrane,Metal-binding,Proteomics identification,Reference proteome,Secreted,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Exostosin-like 2,chain:Processed exostosin-like 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Manganese; catalytic,site:Cleavage,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
XPO1	exportin 1(XPO1)	Homo sapiens		h_cremPathway:Regulation of Spermatogenesis by CREM,h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,	Nuclear structure / Intracellular trafficking and secretion,	GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006611~protein export from nucleus,GO:0006886~intracellular protein transport,GO:0007062~sister chromatid cohesion,GO:0010824~regulation of centrosome duplication,GO:0016032~viral process,GO:0034504~protein localization to nucleus,GO:0042176~regulation of protein catabolic process,GO:0042493~response to drug,GO:0043488~regulation of mRNA stability,GO:0046825~regulation of protein export from nucleus,GO:0051028~mRNA transport,GO:0075733~intracellular transport of virus,	GO:0000776~kinetochore,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005642~annulate lamellae,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015030~Cajal body,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003723~RNA binding,GO:0005049~nuclear export signal receptor activity,GO:0005215~transporter activity,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0008536~Ran GTPase binding,GO:0019904~protein domain specific binding,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR013598:Exportin-1/Importin-beta-like,IPR014877:CRM1 C-terminal domain,IPR016024:Armadillo-type fold,	hsa03008:Ribosome biogenesis in eukaryotes,hsa03013:RNA transport,hsa05164:Influenza A,hsa05166:HTLV-I infection,			SM00913:SM00913,SM01102:SM01102,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,mRNA transport,Nucleus,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transport,	chain:Exportin-1,domain:Importin N-terminal,helix,modified residue,mutagenesis site,region of interest:Interaction with HIV-1 Rev,region of interest:Interaction with Ran and nuclear export complex formation,region of interest:Interaction with RANBP3,region of interest:Necessary for HTLV-1 Rex multimerization,region of interest:Necessary for HTLV-1 Rex-mediated mRNA export,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,sequence conflict,strand,turn,
FAM102B	family with sequence similarity 102 member B(FAM102B)	Homo sapiens							IPR019448:EEIG1/EHBP1 N-terminal domain,					Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:Protein FAM102B,compositionally biased region:Poly-Lys,modified residue,splice variant,
FAM107A	family with sequence similarity 107 member A(FAM107A)	Homo sapiens				GO:0001558~regulation of cell growth,	GO:0005634~nucleus,GO:0043005~neuron projection,		IPR009533:Protein of unknown function DUF1151,					Alternative splicing,Coiled coil,Complete proteome,Growth regulation,Nucleus,Polymorphism,Reference proteome,	chain:Protein FAM107A,sequence variant,splice variant,
FAM117B	family with sequence similarity 117 member B(FAM117B)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR026641:Protein FAM117B,IPR026642:Glucocorticoid-induced transcript 1/FAM117,					Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:Protein FAM117B,compositionally biased region:Gly-rich,compositionally biased region:Poly-Pro,modified residue,sequence conflict,splice variant,
FAM126B	family with sequence similarity 126 member B(FAM126B)	Homo sapiens					GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR018619:Hyccin,					Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Protein FAM126B,modified residue,
FAM129A	family with sequence similarity 129 member A(FAM129A)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0034976~response to endoplasmic reticulum stress,GO:0045727~positive regulation of translation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR026088:Niban-like,					Complete proteome,Cytoplasm,Lipoprotein,Membrane,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Stress response,Translation regulation,	chain:Protein Niban,compositionally biased region:Glu-rich,modified residue,sequence conflict,sequence variant,
FAM131C	family with sequence similarity 131 member C(FAM131C)	Homo sapiens						GO:0005515~protein binding,	IPR026782:Protein FAM131,					Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM131C,compositionally biased region:Pro-rich,sequence conflict,sequence variant,
FAM134A	family with sequence similarity 134 member A(FAM134A)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein FAM134A,compositionally biased region:Gly-rich,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,transmembrane region,
FAM138B	family with sequence similarity 138 member B(FAM138B)	Homo sapiens													chain:Protein FAM138A/B/C/F,sequence conflict,
FAM150B	family with sequence similarity 150 member B(FAM150B)	Homo sapiens				GO:0010976~positive regulation of neuron projection development,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070378~positive regulation of ERK5 cascade,	GO:0005576~extracellular region,	GO:0005515~protein binding,GO:0030298~receptor signaling protein tyrosine kinase activator activity,GO:0030971~receptor tyrosine kinase binding,						Alternative splicing,Complete proteome,Reference proteome,Secreted,Signal,	chain:Protein FAM150B,signal peptide,splice variant,
FAM151A	family with sequence similarity 151 member A(FAM151A)	Homo sapiens					GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR019356:Protein of unknown function DUF2181,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM151A,sequence conflict,sequence variant,splice variant,transmembrane region,
FAM161A	family with sequence similarity 161 member A(FAM161A)	Homo sapiens				GO:0007601~visual perception,GO:0042384~cilium assembly,GO:0050896~response to stimulus,GO:0060271~cilium morphogenesis,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0032391~photoreceptor connecting cilium,GO:0036064~ciliary basal body,	GO:0005515~protein binding,	IPR019579:Uncharacterised protein family UPF0564,		606068~Retinitis pigmentosa 28,			Alternative splicing,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Polymorphism,Proteomics identification,Reference proteome,Retinitis pigmentosa,Sensory transduction,Vision,	chain:Protein FAM161A,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,sequence conflict,sequence variant,splice variant,
FAM163A	family with sequence similarity 163 member A(FAM163A)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0417 protein FAM163A,transmembrane region,
FAM168B	family with sequence similarity 168 member B(FAM168B)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,							Acetylation,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM168B,modified residue,sequence conflict,splice variant,
FAM171B	family with sequence similarity 171 member B(FAM171B)	Homo sapiens					GO:0016021~integral component of membrane,		IPR018890:Uncharacterised protein family FAM171,					Alternative splicing,Coiled coil,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein FAM171B,compositionally biased region:Gln-rich,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FAM177B	family with sequence similarity 177 member B(FAM177B)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM177B,compositionally biased region:Poly-Glu,sequence variant,splice variant,
FAM178B	family with sequence similarity 178 member B(FAM178B)	Homo sapiens							IPR026161:FAM178 family,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM178B,sequence variant,splice variant,
FAM189B	family with sequence similarity 189 member B(FAM189B)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0050699~WW domain binding,	IPR007237:CD20-like,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM189B,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),sequence variant,transmembrane region,
FAM19A1	family with sequence similarity 19 member A1, C-C motif chemokine like(FAM19A1)	Homo sapiens					GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,	GO:0005515~protein binding,	IPR020350:Chemokine-like protein, FAM19A2,					Complete proteome,Reference proteome,Secreted,Signal,	chain:Protein FAM19A1,sequence conflict,signal peptide,
FAM19A4	family with sequence similarity 19 member A4, C-C motif chemokine like(FAM19A4)	Homo sapiens				GO:0042391~regulation of membrane potential,GO:0051930~regulation of sensory perception of pain,	GO:0005576~extracellular region,	GO:0005515~protein binding,	IPR020350:Chemokine-like protein, FAM19A2,					Complete proteome,Reference proteome,Secreted,Signal,	chain:Protein FAM19A4,signal peptide,
FAM198A	family with sequence similarity 198 member A(FAM198A)	Homo sapiens					GO:0005576~extracellular region,							Complete proteome,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C3orf41,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
FAM208A	family with sequence similarity 208 member A(FAM208A)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0044822~poly(A) RNA binding,	IPR022188:Protein of unknown function DUF3715,					Acetylation,Alternative splicing,Chromosome,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Uncharacterized protein C3orf63,modified residue,sequence conflict,sequence variant,splice variant,
FAM228A	family with sequence similarity 228 member A(FAM228A)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:UPF0638 protein B,chain:UPF0638 protein C2orf84,sequence variant,splice variant,
FAM228B	family with sequence similarity 228 member B(FAM228B)	Homo sapiens				GO:0048741~skeletal muscle fiber development,								Alternative splicing,Complete proteome,Reference proteome,	chain:UPF0638 protein B,chain:UPF0638 protein C2orf84,sequence variant,splice variant,
FAM3D	family with sequence similarity 3 member D(FAM3D)	Homo sapiens				GO:0046676~negative regulation of insulin secretion,	GO:0005576~extracellular region,GO:0016021~integral component of membrane,	GO:0005125~cytokine activity,						Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Protein FAM3D,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
FAM41C	family with sequence similarity 41 member C(FAM41C)	Homo sapiens													chain:Putative protein FAM41C,
FAM43B	family with sequence similarity 43 member B(FAM43B)	Homo sapiens							IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,				SM00462:PTB,	Complete proteome,Reference proteome,	chain:Protein FAM43B,
FAM46C	family with sequence similarity 46 member C(FAM46C)	Homo sapiens						GO:0005515~protein binding,	IPR012937:Domain of unknown function DUF1693,				SM01153:SM01153,	Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM46C,sequence conflict,sequence variant,
FAM49A	family with sequence similarity 49 member A(FAM49A)	Homo sapiens					GO:0005622~intracellular,		IPR009828:Protein of unknown function DUF1394,					Complete proteome,Proteomics identification,Reference proteome,	chain:Protein FAM49A,
FAM69A	family with sequence similarity 69 member A(FAM69A)	Homo sapiens					GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,		IPR022049:Uncharacterised protein family FAM69,				SM01299:SM01299,	Alternative splicing,Complete proteome,Disulfide bond,Endoplasmic reticulum,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Protein FAM69A,splice variant,transmembrane region,
FAM76A	family with sequence similarity 76 member A(FAM76A)	Homo sapiens				GO:0016926~protein desumoylation,	GO:0005634~nucleus,	GO:0004175~endopeptidase activity,GO:0016929~SUMO-specific protease activity,						Alternative splicing,Coiled coil,Complete proteome,Proteomics identification,Reference proteome,	chain:Protein FAM76A,compositionally biased region:Poly-Ser,splice variant,
FAM78B	family with sequence similarity 78 member B(FAM78B)	Homo sapiens												Complete proteome,Reference proteome,	chain:Protein FAM78B,
FAM98A	family with sequence similarity 98 member A(FAM98A)	Homo sapiens					GO:0072669~tRNA-splicing ligase complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR018797:Uncharacterised protein family FAM98,					Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Protein FAM98A,compositionally biased region:Gly-rich,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Pro,
FUBP1	far upstream element binding protein 1(FUBP1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR015096:Domain of unknown function DUF1897,				SM00322:KH,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Far upstream element-binding protein 1,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
FDPS	farnesyl diphosphate synthase(FDPS)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0008299~isoprenoid biosynthetic process,GO:0016032~viral process,GO:0033384~geranyl diphosphate biosynthetic process,GO:0045337~farnesyl diphosphate biosynthetic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0004161~dimethylallyltranstransferase activity,GO:0004337~geranyltranstransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000092:Polyprenyl synthetase,IPR008949:Terpenoid synthase,	hsa00900:Terpenoid backbone biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa05164:Influenza A,hsa05166:HTLV-I infection,	616631~Porokeratosis 9, multiple types,			3D-structure,Acetylation,Alternative splicing,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Cytoplasm,Disease mutation,Host-virus interaction,Isoprene biosynthesis,Lipid biosynthesis,Lipid metabolism,Magnesium,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transferase,Transmembrane,Transmembrane helix,	binding site:Dimethylallyl diphosphate,binding site:Isopentenyl diphosphate,chain:Farnesyl pyrophosphate synthetase,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,metal ion-binding site:Magnesium 3,modified residue,sequence conflict,sequence variant,site:Important for determining product chain length,turn,
FABP3	fatty acid binding protein 3(FABP3)	Homo sapiens				GO:0006631~fatty acid metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0015909~long-chain fatty acid transport,GO:0019433~triglyceride catabolic process,GO:0032868~response to insulin,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0044539~long-chain fatty acid import,GO:0046320~regulation of fatty acid oxidation,GO:0055091~phospholipid homeostasis,GO:0070542~response to fatty acid,GO:0071073~positive regulation of phospholipid biosynthetic process,	GO:0005615~extracellular space,GO:0005829~cytosol,GO:0016528~sarcoplasm,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005324~long-chain fatty acid transporter activity,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0008289~lipid binding,GO:0036041~long-chain fatty acid binding,GO:0050543~icosatetraenoic acid binding,GO:0070538~oleic acid binding,	IPR000463:Cytosolic fatty-acid binding,IPR000566:Lipocalin/cytosolic fatty-acid binding protein domain,IPR011038:Calycin-like,IPR012674:Calycin,	hsa03320:PPAR signaling pathway,				3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Lipid-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	binding site:Fatty acid,chain:Fatty acid-binding protein, heart,helix,modified residue,sequence conflict,sequence variant,strand,
FAR2P1	fatty acyl-CoA reductase 2 pseudogene 1(FAR2P1)	Homo sapiens				GO:0055114~oxidation-reduction process,		GO:0080019~fatty-acyl-CoA reductase (alcohol-forming) activity,	IPR026055:Fatty acyl-CoA reductase,					Complete proteome,Reference proteome,	chain:Putative uncharacterized protein FLJ43933,
FLVCR1	feline leukemia virus subgroup C cellular receptor 1(FLVCR1)	Homo sapiens				GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0006810~transport,GO:0006839~mitochondrial transport,GO:0006879~cellular iron ion homeostasis,GO:0007275~multicellular organism development,GO:0015886~heme transport,GO:0030218~erythrocyte differentiation,GO:0035264~multicellular organism growth,GO:0042733~embryonic digit morphogenesis,GO:0043249~erythrocyte maturation,GO:0046620~regulation of organ growth,GO:0048536~spleen development,GO:0048704~embryonic skeletal system morphogenesis,GO:0055085~transmembrane transport,GO:0060323~head morphogenesis,GO:0097037~heme export,	GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0015232~heme transporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,		609033~Ataxia, posterior column, with retinitis pigmentosa,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Erythrocyte maturation,Glycoprotein,Membrane,Mitochondrion,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Retinitis pigmentosa,Transmembrane,Transmembrane helix,Transport,	chain:Feline leukemia virus subgroup C receptor-related protein 1,modified residue,sequence variant,transmembrane region,
FER1L5	fer-1 like family member 5(FER1L5)	Homo sapiens				GO:0007520~myoblast fusion,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR000008:C2 calcium-dependent membrane targeting,IPR006614:Peroxin/Ferlin domain,IPR012560:Ferlin A-domain,IPR012561:Ferlin B-domain,IPR012968:FerIin domain,				SM00239:C2,SM00693:DysFN,SM00694:DysFC,SM01200:SM01200,SM01201:SM01201,SM01202:SM01202,	Alternative splicing,Cell membrane,Complete proteome,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Fer-1-like protein 5,domain:C2 1,domain:C2 2,domain:C2 3,domain:C2 4,domain:C2 5,domain:C2 6,sequence conflict,sequence variant,splice variant,transmembrane region,
FAP	fibroblast activation protein alpha(FAP)	Homo sapiens				GO:0001525~angiogenesis,GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0010710~regulation of collagen catabolic process,GO:0010716~negative regulation of extracellular matrix disassembly,GO:0043542~endothelial cell migration,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051917~regulation of fibrinolysis,GO:0060244~negative regulation of cell proliferation involved in contact inhibition,GO:0071158~positive regulation of cell cycle arrest,GO:0071850~mitotic cell cycle arrest,GO:0097325~melanocyte proliferation,GO:1900119~positive regulation of execution phase of apoptosis,GO:1902362~melanocyte apoptotic process,GO:1903054~negative regulation of extracellular matrix organization,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0031258~lamellipodium membrane,GO:0032587~ruffle membrane,GO:0045177~apical part of cell,GO:0045178~basal part of cell,GO:0071438~invadopodium membrane,	GO:0002020~protease binding,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,	IPR001375:Peptidase S9, prolyl oligopeptidase, catalytic domain,IPR002469:Peptidase S9B, dipeptidylpeptidase IV N-terminal,IPR002471:Peptidase S9, serine active site,					3D-structure,Alternative splicing,Angiogenesis,Apoptosis,Cell adhesion,Cell junction,Cell membrane,Cell projection,Cleavage on pair of basic residues,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Charge relay system,binding site:Substrate,chain:Seprase,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
FMOD	fibromodulin(FMOD)	Homo sapiens		h_slrpPathway:Small Leucine-rich Proteoglycan (SLRP) molecules,		GO:0007181~transforming growth factor beta receptor complex assembly,GO:0007409~axonogenesis,GO:0018146~keratan sulfate biosynthetic process,GO:0030199~collagen fibril organization,GO:0035385~Roundabout signaling pathway,GO:0042340~keratan sulfate catabolic process,GO:0048846~axon extension involved in axon guidance,GO:0050770~regulation of axonogenesis,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0031012~extracellular matrix,GO:0043202~lysosomal lumen,	GO:0008201~heparin binding,GO:0048495~Roundabout binding,	IPR000372:Leucine-rich repeat-containing N-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR027215:Fibromodulin,				SM00013:LRRNT,SM00369:LRR_TYP,	Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Leucine-rich repeat,Proteoglycan,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Secreted,Signal,Sulfation,	chain:Fibromodulin,compositionally biased region:Cys-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...) (keratan sulfate),modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,signal peptide,site:Not sulfated,
FN1	fibronectin 1(FN1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001932~regulation of protein phosphorylation,GO:0002576~platelet degranulation,GO:0006953~acute-phase response,GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007161~calcium-independent cell-matrix adhesion,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0009611~response to wounding,GO:0010628~positive regulation of gene expression,GO:0010952~positive regulation of peptidase activity,GO:0018149~peptide cross-linking,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0033622~integrin activation,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0042060~wound healing,GO:0045773~positive regulation of axon extension,GO:0048146~positive regulation of fibroblast proliferation,GO:0050900~leukocyte migration,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:1904237~positive regulation of substrate-dependent cell migration, cell attachment to substrate,GO:2001202~negative regulation of transforming growth factor-beta secretion,	GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005578~proteinaceous extracellular matrix,GO:0005605~basal lamina,GO:0005615~extracellular space,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016324~apical plasma membrane,GO:0031012~extracellular matrix,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0002020~protease binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008201~heparin binding,GO:0016504~peptidase activator activity,GO:0042802~identical protein binding,	IPR000083:Fibronectin, type I,IPR000562:Fibronectin, type II, collagen-binding,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR013806:Kringle-like fold,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04810:Regulation of actin cytoskeleton,hsa05100:Bacterial invasion of epithelial cells,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05222:Small cell lung cancer,	601894~Glomerulopathy with fibronectin deposits 2,614101~Plasma fibronectin deficiency,		SM00058:FN1,SM00059:FN2,SM00060:FN3,	3D-structure,Acute phase,Alternative splicing,Angiogenesis,Cell adhesion,Cell shape,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Extracellular matrix,Glycoprotein,Heparin-binding,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Secreted,Signal,Sulfation,	chain:Anastellin,chain:Fibronectin,chain:Ugl-Y1,chain:Ugl-Y2,chain:Ugl-Y3,cross-link:Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?),disulfide bond,domain:Fibronectin type-I 1,domain:Fibronectin type-I 10,domain:Fibronectin type-I 11,domain:Fibronectin type-I 12,domain:Fibronectin type-I 2,domain:Fibronectin type-I 3,domain:Fibronectin type-I 4,domain:Fibronectin type-I 5,domain:Fibronectin type-I 6,domain:Fibronectin type-I 7,domain:Fibronectin type-I 8,domain:Fibronectin type-I 9,domain:Fibronectin type-II 1,domain:Fibronectin type-II 2,domain:Fibronectin type-III 1,domain:Fibronectin type-III 10,domain:Fibronectin type-III 11,domain:Fibronectin type-III 12; extra domain,domain:Fibronectin type-III 13,domain:Fibronectin type-III 14,domain:Fibronectin type-III 15,domain:Fibronectin type-III 16,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),helix,modified residue,mutagenesis site,region of interest:Binds to FBLN1,region of interest:Cell-attachment,region of interest:Collagen-binding,region of interest:Connecting strand 3 (CS-3) (V region),region of interest:Critical for collagen binding,region of interest:Fibrin- and heparin-binding 1,region of interest:Fibrin-binding 2,region of interest:Heparin-binding 2,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,site:Important for superfibronectin formation,site:Not glycosylated,splice variant,strand,turn,
FNDC4	fibronectin type III domain containing 4(FNDC4)	Homo sapiens					GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,	Complete proteome,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Fibronectin type III domain-containing protein 4,domain:Fibronectin type-III,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FNDC7	fibronectin type III domain containing 7(FNDC7)	Homo sapiens					GO:0005576~extracellular region,		IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,	Complete proteome,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Fibronectin type III domain-containing protein 7,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
FSIP2	fibrous sheath interacting protein 2(FSIP2)	Homo sapiens					GO:0005739~mitochondrion,							Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Fibrous sheath-interacting protein 2,chain:Uncharacterized protein FLJ44048,modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,splice variant,
FBLN2	fibulin 2(FBLN2)	Homo sapiens				GO:0010811~positive regulation of cell-substrate adhesion,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0050840~extracellular matrix binding,	IPR000020:Anaphylatoxin/fibulin,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR026823:Complement Clr-like EGF domain,				SM00104:ANATO,SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Fibulin-2,disulfide bond,domain:Anaphylatoxin-like 1,domain:Anaphylatoxin-like 2,domain:Anaphylatoxin-like 3,domain:EGF-like 10; calcium-binding,domain:EGF-like 1; calcium-binding,domain:EGF-like 2,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:EGF-like 9; calcium-binding,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Domain III,region of interest:N,region of interest:Subdomain NA (Cys-rich),region of interest:Subdomain NB (Cys-free),sequence conflict,sequence variant,signal peptide,
FBLN7	fibulin 7(FBLN7)	Homo sapiens				GO:0007155~cell adhesion,	GO:0005578~proteinaceous extracellular matrix,GO:0005925~focal adhesion,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0008201~heparin binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000436:Sushi/SCR/CCP,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00032:CCP,SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Cell adhesion,Coiled coil,Complete proteome,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Heparin-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Fibulin-7,disulfide bond,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:Sushi,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
FIGN	fidgetin, microtubule severing factor(FIGN)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0031122~cytoplasmic microtubule organization,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005874~microtubule,GO:0016363~nuclear matrix,	GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008568~microtubule-severing ATPase activity,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR015415:Vps4 oligomerisation, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	ATP-binding,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Fidgetin,compositionally biased region:Pro-rich,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
FLG	filaggrin(FLG)	Homo sapiens				GO:0007275~multicellular organism development,GO:0030216~keratinocyte differentiation,GO:0061436~establishment of skin barrier,	GO:0005634~nucleus,GO:0005882~intermediate filament,GO:0036457~keratohyalin granule,GO:0043231~intracellular membrane-bounded organelle,	GO:0005198~structural molecule activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR003303:Filaggrin,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,		146700~Ichthyosis vulgaris,605803~Dermatitis, atopic, susceptibility to, 2,		SM01394:SM01394,	3D-structure,Calcium,Citrullination,Coiled coil,Complete proteome,Developmental protein,Direct protein sequencing,Ichthyosis,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:filaggrin,compositionally biased region:Poly-Tyr,compositionally biased region:Ser-rich,domain:EF-hand 1,domain:EF-hand 2,modified residue,repeat:Filaggrin 1,repeat:Filaggrin 10,repeat:Filaggrin 11,repeat:Filaggrin 12,repeat:Filaggrin 13,repeat:Filaggrin 14,repeat:Filaggrin 15,repeat:Filaggrin 16,repeat:Filaggrin 17,repeat:Filaggrin 18,repeat:Filaggrin 19,repeat:Filaggrin 2,repeat:Filaggrin 20,repeat:Filaggrin 21,repeat:Filaggrin 22,repeat:Filaggrin 23,repeat:Filaggrin 3,repeat:Filaggrin 4,repeat:Filaggrin 5,repeat:Filaggrin 6,repeat:Filaggrin 7,repeat:Filaggrin 8,repeat:Filaggrin 9,sequence conflict,sequence variant,
FILIP1L	filamin A interacting protein 1 like(FILIP1L)	Homo sapiens					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,		IPR019131:Cortactin-binding protein-2, N-terminal,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Filamin A-interacting protein 1-like,modified residue,sequence conflict,sequence variant,splice variant,
FLNB	filamin B(FLNB)	Homo sapiens				GO:0003334~keratinocyte development,GO:0003382~epithelial cell morphogenesis,GO:0007016~cytoskeletal anchoring at plasma membrane,GO:0007165~signal transduction,GO:0007519~skeletal muscle tissue development,GO:0030036~actin cytoskeleton organization,GO:0030154~cell differentiation,GO:0098609~cell-cell adhesion,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0016021~integral component of membrane,GO:0030018~Z disc,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001298:Filamin/ABP280 repeat,IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,	hsa04010:MAPK signaling pathway,hsa04510:Focal adhesion,hsa05132:Salmonella infection,hsa05205:Proteoglycans in cancer,	108720~Atelosteogenesis, type I,108721~Atelosteogenesis, type III,112310~Boomerang dysplasia,150250~Larsen syndrome,272460~Spondylocarpotarsal synostosis syndrome,		SM00033:CH,SM00557:IG_FLMN,	3D-structure,Acetylation,Actin-binding,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Disease mutation,Dwarfism,Isopeptide bond,Myogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Filamin-B,domain:Actin-binding,domain:CH 1,domain:CH 2,helix,modified residue,region of interest:Hinge 1,region of interest:Hinge 2,region of interest:Interaction with FBLP1,region of interest:Interaction with FLNA 1,region of interest:Interaction with FLNA 2,region of interest:Interaction with INPPL1,region of interest:Interaction with the cytoplasmic tail of GP1BA,region of interest:Self-association site, tail,repeat:Filamin 1,repeat:Filamin 10,repeat:Filamin 11,repeat:Filamin 12,repeat:Filamin 13,repeat:Filamin 14,repeat:Filamin 15,repeat:Filamin 16,repeat:Filamin 17,repeat:Filamin 18,repeat:Filamin 19,repeat:Filamin 2,repeat:Filamin 20,repeat:Filamin 21,repeat:Filamin 22,repeat:Filamin 23,repeat:Filamin 24,repeat:Filamin 3,repeat:Filamin 4,repeat:Filamin 5,repeat:Filamin 6,repeat:Filamin 7,repeat:Filamin 8,repeat:Filamin 9,sequence conflict,sequence variant,splice variant,strand,turn,
FBLIM1	filamin binding LIM protein 1(FBLIM1)	Homo sapiens				GO:0008360~regulation of cell shape,GO:0016337~single organismal cell-cell adhesion,GO:0033623~regulation of integrin activation,GO:0034329~cell junction assembly,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0005938~cell cortex,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031005~filamin binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Alternative splicing,Cell adhesion,Cell junction,Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,LIM domain,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:Filamin-binding LIM protein 1,compositionally biased region:Pro-rich,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,mutagenesis site,region of interest:Filamin-binding,region of interest:PLEKHC1-binding,sequence variant,splice variant,strand,
FLAD1	flavin adenine dinucleotide synthetase 1(FLAD1)	Homo sapiens			General function prediction only,	GO:0006747~FAD biosynthetic process,GO:0006771~riboflavin metabolic process,GO:0008152~metabolic process,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0003824~catalytic activity,GO:0003919~FMN adenylyltransferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001453:Molybdopterin binding domain,IPR002500:Phosphoadenosine phosphosulphate reductase,IPR012183:FAD synthetase, molybdopterin binding,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,	hsa00740:Riboflavin metabolism,hsa01100:Metabolic pathways,		PIRSF036620:FAD synthetase with molybdopterin binding domain,	SM00852:SM00852,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,FAD,Flavoprotein,FMN,Mitochondrion,Nucleotide-binding,Nucleotidyltransferase,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:FAD synthetase,modified residue,region of interest:FAD synthetase,region of interest:Molybdenum cofactor biosynthesis protein- like,splice variant,
FMO1	flavin containing monooxygenase 1(FMO1)	Homo sapiens				GO:0006082~organic acid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0006970~response to osmotic stress,GO:0009404~toxin metabolic process,GO:0017144~drug metabolic process,GO:0032496~response to lipopolysaccharide,GO:0070995~NADPH oxidation,	GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0004497~monooxygenase activity,GO:0004499~N,N-dimethylaniline monooxygenase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR000960:Flavin monooxygenase FMO,IPR002253:Flavin monooxygenase (FMO) 1,IPR012143:Dimethylaniline monooxygenase, N-oxide-forming,IPR016040:NAD(P)-binding domain,IPR020946:Flavin monooxygenase-like,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00982:Drug metabolism - cytochrome P450,		PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming),		Acetylation,Alternative splicing,Complete proteome,Endoplasmic reticulum,FAD,Flavoprotein,Membrane,Microsome,Monooxygenase,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,	chain:Dimethylaniline monooxygenase [N-oxide- forming] 1,modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:NADP,sequence variant,
FMO3	flavin containing monooxygenase 3(FMO3)	Homo sapiens				GO:0006805~xenobiotic metabolic process,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0004499~N,N-dimethylaniline monooxygenase activity,GO:0034899~trimethylamine monooxygenase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR000960:Flavin monooxygenase FMO,IPR002255:Flavin monooxygenase (FMO) 3,IPR012143:Dimethylaniline monooxygenase, N-oxide-forming,IPR016040:NAD(P)-binding domain,IPR020946:Flavin monooxygenase-like,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00982:Drug metabolism - cytochrome P450,	602079~Trimethylaminuria,	PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming),		AAA86284),Complete proteome,Direct protein sequencing,Disease mutation,Endoplasmic reticulum,FAD,Flavoprotein,Membrane,Microsome,Monooxygenase,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,TransmembraneFT   CONFLICT    418    419       KW -> ANG (in Ref 1,	chain:Dimethylaniline monooxygenase [N-oxide- forming] 3,modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,
FMO5	flavin containing monooxygenase 5(FMO5)	Homo sapiens				GO:0017144~drug metabolic process,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0004499~N,N-dimethylaniline monooxygenase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR000960:Flavin monooxygenase FMO,IPR002257:Flavin monooxygenase (FMO) 5,IPR012143:Dimethylaniline monooxygenase, N-oxide-forming,IPR016040:NAD(P)-binding domain,IPR020946:Flavin monooxygenase-like,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00982:Drug metabolism - cytochrome P450,		PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming),		Alternative splicing,Complete proteome,Endoplasmic reticulum,FAD,Flavoprotein,Membrane,Methylation,Microsome,Monooxygenase,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Dimethylaniline monooxygenase [N-oxide- forming] 5,modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,
FMO6P	flavin containing monooxygenase 6 pseudogene(FMO6P)	Homo sapiens				GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0004497~monooxygenase activity,GO:0004499~N,N-dimethylaniline monooxygenase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR000960:Flavin monooxygenase FMO,IPR002255:Flavin monooxygenase (FMO) 3,IPR012143:Dimethylaniline monooxygenase, N-oxide-forming,IPR016040:NAD(P)-binding domain,IPR020946:Flavin monooxygenase-like,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,			PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming),		Complete proteome,Endoplasmic reticulum,FAD,Flavoprotein,Membrane,Microsome,Monooxygenase,NADP,Oxidoreductase,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,
FSHR	follicle stimulating hormone receptor(FSHR)	Homo sapiens		h_cremPathway:Regulation of Spermatogenesis by CREM,	Function unknown,	GO:0001545~primary ovarian follicle growth,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007283~spermatogenesis,GO:0007292~female gamete generation,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0009755~hormone-mediated signaling pathway,GO:0010738~regulation of protein kinase A signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0042699~follicle-stimulating hormone signaling pathway,GO:0045670~regulation of osteoclast differentiation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004963~follicle-stimulating hormone receptor activity,GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000372:Leucine-rich repeat-containing N-terminal,IPR002131:Glycoprotein hormone receptor,IPR002272:Follicle-stimulating hormone receptor,IPR017452:GPCR, rhodopsin-like, 7TM,IPR024635:Gonadotropin hormone receptor, transmembrane domain,IPR026906:Leucine rich repeat 5,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04913:Ovarian steroidogenesis,	233300~Ovarian dysgenesis 1,276400~Ovarian response to FSH stimulation,608115~Ovarian hyperstimulation syndrome,		SM00013:LRRNT,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,G-protein coupled receptor,Glycoprotein,Leucine-rich repeat,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Follicle-stimulating hormone receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
FHAD1	forkhead associated phosphopeptide binding domain 1(FHAD1)	Homo sapiens							IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,				SM00240:FHA,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Forkhead-associated domain-containing protein 1,compositionally biased region:Pro-rich,domain:FHA,sequence conflict,sequence variant,splice variant,
FOXD2	forkhead box D2(FOXD2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018122:Transcription factor, fork head, conserved site,				SM00339:FH,	Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Forkhead box protein D2,compositionally biased region:Ala-rich,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,DNA-binding region:Fork-head,sequence conflict,sequence variant,
FOXI3	forkhead box I3(FOXI3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018122:Transcription factor, fork head, conserved site,				SM00339:FH,	Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Forkhead box protein I3,compositionally biased region:Ala-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,DNA-binding region:Fork-head,
FOXJ3	forkhead box J3(FOXJ3)	Homo sapiens			Transcription,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018122:Transcription factor, fork head, conserved site,				SM00339:FH,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Forkhead box protein J3,DNA-binding region:Fork-head,modified residue,sequence conflict,sequence variant,splice variant,
FOXN2	forkhead box N2(FOXN2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030154~cell differentiation,GO:0035914~skeletal muscle cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0043231~intracellular membrane-bounded organelle,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018122:Transcription factor, fork head, conserved site,				SM00339:FH,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Forkhead box protein N2,DNA-binding region:Fork-head,splice variant,
FOXO6	forkhead box O6(FOXO6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007613~memory,GO:0060999~positive regulation of dendritic spine development,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa04068:FoxO signaling pathway,			SM00339:FH,	Activator,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Forkhead box protein O6,compositionally biased region:Ala-rich,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,DNA-binding region:Fork-head,modified residue,
FOXP1	forkhead box P1(FOXP1)	Homo sapiens			Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002329~pre-B cell differentiation,GO:0002639~positive regulation of immunoglobulin production,GO:0002903~negative regulation of B cell apoptotic process,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007519~skeletal muscle tissue development,GO:0008045~motor neuron axon guidance,GO:0010595~positive regulation of endothelial cell migration,GO:0021517~ventral spinal cord development,GO:0030316~osteoclast differentiation,GO:0032496~response to lipopolysaccharide,GO:0032680~regulation of tumor necrosis factor production,GO:0033152~immunoglobulin V(D)J recombination,GO:0035926~chemokine (C-C motif) ligand 2 secretion,GO:0036035~osteoclast development,GO:0042116~macrophage activation,GO:0042117~monocyte activation,GO:0042118~endothelial cell activation,GO:0045214~sarcomere organization,GO:0045655~regulation of monocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048745~smooth muscle tissue development,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050706~regulation of interleukin-1 beta secretion,GO:0050727~regulation of inflammatory response,GO:0055007~cardiac muscle cell differentiation,GO:0060043~regulation of cardiac muscle cell proliferation,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:0061140~lung secretory cell differentiation,GO:0061470~T follicular helper cell differentiation,GO:0072619~interleukin-21 secretion,GO:1900424~regulation of defense response to bacterium,GO:1901250~negative regulation of lung goblet cell differentiation,GO:1901256~regulation of macrophage colony-stimulating factor production,GO:1901509~regulation of endothelial tube morphogenesis,GO:2000727~positive regulation of cardiac muscle cell differentiation,GO:2001182~regulation of interleukin-12 secretion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0043621~protein self-association,GO:0046872~metal ion binding,GO:0050681~androgen receptor binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,		613670~Mental retardation with language impairment and with or without autistic features,		SM00339:FH,	3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,Disease mutation,DNA-binding,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Forkhead box protein P1,compositionally biased region:Gln-rich,DNA-binding region:Fork-head,domain:Leucine-zipper,modified residue,region of interest:CTBP1-binding,sequence conflict,site:Breakpoint for translocation to form PAX5-FOXP1,splice variant,zinc finger region:C2H2-type,
FTCDNL1	formiminotransferase cyclodeaminase N-terminal like(FTCDNL1)	Homo sapiens				GO:0008152~metabolic process,		GO:0005542~folic acid binding,GO:0016740~transferase activity,	IPR012886:Formiminotransferase, N-terminal subdomain,IPR022384:Formiminotransferas, N- and C-terminal subdomains,				SM01222:SM01222,	Complete proteome,Reference proteome,Signal,
FMN2	formin 2(FMN2)	Homo sapiens				GO:0006974~cellular response to DNA damage stimulus,GO:0007275~multicellular organism development,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0035556~intracellular signal transduction,GO:0040038~polar body extrusion after meiotic divisions,GO:0042177~negative regulation of protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045010~actin nucleation,GO:0046907~intracellular transport,GO:0048477~oogenesis,GO:0051295~establishment of meiotic spindle localization,GO:0051758~homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,GO:0070649~formin-nucleated actin cable assembly,GO:0071456~cellular response to hypoxia,	GO:0005730~nucleolus,GO:0005789~endoplasmic reticulum membrane,GO:0005819~spindle,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0030659~cytoplasmic vesicle membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,	IPR000591:DEP domain,IPR001265:Formin,IPR009408:Formin Homology 1,IPR015425:Actin-binding FH2,	hsa04320:Dorso-ventral axis formation,	616193~Mental retardation, autosomal recessive 47,		SM00498:FH2,	3D-structure,Actin-binding,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Developmental protein,DNA damage,Membrane,Mental retardation,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Stress response,Transport,	chain:Formin-2,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:FH1,domain:FH2,modified residue,sequence conflict,sequence variant,
FNBP1L	formin binding protein 1 like(FNBP1L)	Homo sapiens				GO:0006897~endocytosis,GO:0006900~membrane budding,GO:0006914~autophagy,GO:0010324~membrane invagination,GO:0016050~vesicle organization,GO:0030050~vesicle transport along actin filament,GO:0042384~cilium assembly,GO:0043547~positive regulation of GTPase activity,GO:0051491~positive regulation of filopodium assembly,GO:0072583~clathrin-mediated endocytosis,GO:0097320~membrane tubulation,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005802~trans-Golgi network,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005938~cell cortex,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0051020~GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001060:FCH domain,IPR001452:Src homology-3 domain,				SM00055:FCH,SM00326:SH3,	Alternative splicing,Autophagy,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endocytosis,Lipid-binding,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Formin-binding protein 1-like,domain:FCH,domain:SH3,modified residue,mutagenesis site,region of interest:Induction of membrane tubulation,region of interest:Interaction with CDC42,region of interest:Interaction with DAAM1, DIAPH1 and DIAPH2,region of interest:Interaction with DNM1,region of interest:Interaction with DNM2 and WASL,repeat:REM,splice variant,
FMNL2	formin like 2(FMNL2)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0022604~regulation of cell morphogenesis,GO:0030866~cortical actin cytoskeleton organization,GO:0098609~cell-cell adhesion,	GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,	GO:0003779~actin binding,GO:0017048~Rho GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR010472:Diaphanous FH3,IPR010473:Diaphanous GTPase-binding,IPR014767:Diaphanous autoregulatory,IPR014768:GTPase-binding/formin homology 3,IPR015425:Actin-binding FH2,IPR016024:Armadillo-type fold,IPR017987:Wilm's tumour protein,				SM00498:FH2,SM01139:SM01139,SM01140:SM01140,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Lipoprotein,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Formin-like protein 2,compositionally biased region:Pro-rich,domain:DAD,domain:FH2,domain:GBD/FH3,modified residue,sequence conflict,sequence variant,splice variant,
FHL2	four and a half LIM domains 2(FHL2)	Homo sapiens		h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009725~response to hormone,GO:0030521~androgen receptor signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0055014~atrial cardiac muscle cell development,GO:0055015~ventricular cardiac muscle cell development,GO:0060347~heart trabecula formation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0031430~M band,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0050681~androgen receptor binding,	IPR001781:Zinc finger, LIM-type,	hsa04380:Osteoclast differentiation,			SM00132:LIM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Four and a half LIM domains protein 2,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:LIM zinc-binding 4,helix,modified residue,sequence conflict,strand,turn,zinc finger region:C4-type,
FHL3	four and a half LIM domains 3(FHL3)	Homo sapiens				GO:0007517~muscle organ development,GO:0030036~actin cytoskeleton organization,	GO:0001725~stress fiber,GO:0005634~nucleus,GO:0005925~focal adhesion,GO:0030018~Z disc,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Acetylation,Complete proteome,LIM domain,Metal-binding,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Four and a half LIM domains protein 3,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:LIM zinc-binding 4,helix,sequence conflict,strand,turn,zinc finger region:C4-type,
FHIT	fragile histidine triad(FHIT)	Homo sapiens				GO:0006163~purine nucleotide metabolic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0009117~nucleotide metabolic process,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0047710~bis(5'-adenosyl)-triphosphatase activity,	IPR001310:Histidine triad (HIT) protein,IPR011146:HIT-like domain,IPR019808:Histidine triad, conserved site,	hsa00230:Purine metabolism,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,				3D-structure,Apoptosis,Chromosomal rearrangement,Complete proteome,Cytoplasm,Hydrolase,Manganese,Mitochondrion,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,	active site:Tele-AMP-histidine intermediate,binding site:Substrate,chain:Bis(5'-adenosyl)-triphosphatase,domain:HIT,helix,modified residue,mutagenesis site,region of interest:Binding to substrate; phosphate linker,short sequence motif:Histidine triad motif,strand,
FZD7	frizzled class receptor 7(FZD7)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010812~negative regulation of cell-substrate adhesion,GO:0014834~skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,GO:0019827~stem cell population maintenance,GO:0030182~neuron differentiation,GO:0033077~T cell differentiation in thymus,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035412~regulation of catenin import into nucleus,GO:0038031~non-canonical Wnt signaling pathway via JNK cascade,GO:0042327~positive regulation of phosphorylation,GO:0042666~negative regulation of ectodermal cell fate specification,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046330~positive regulation of JNK cascade,GO:0048103~somatic stem cell division,GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0060231~mesenchymal to epithelial transition,GO:0071300~cellular response to retinoic acid,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005109~frizzled binding,GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0030165~PDZ domain binding,GO:0042813~Wnt-activated receptor activity,	IPR000539:Frizzled protein,IPR015526:Frizzled/secreted frizzled-related protein,IPR017981:GPCR, family 2-like,IPR020067:Frizzled domain,IPR026552:Frizzled-7,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,			SM00063:FRI,SM01330:SM01330,	3D-structure,Cell membrane,Complete proteome,Developmental protein,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,Wnt signaling pathway,	chain:Frizzled-7,disulfide bond,domain:FZ,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Lys-Thr-X-X-X-Trp motif,short sequence motif:PDZ-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FRZB	frizzled-related protein(FRZB)	Homo sapiens				GO:0001501~skeletal system development,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0008285~negative regulation of cell proliferation,GO:0010721~negative regulation of cell development,GO:0014033~neural crest cell differentiation,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0035567~non-canonical Wnt signaling pathway,GO:0043065~positive regulation of apoptotic process,GO:0045600~positive regulation of fat cell differentiation,GO:0060029~convergent extension involved in organogenesis,GO:0061037~negative regulation of cartilage development,GO:0061053~somite development,GO:0070367~negative regulation of hepatocyte differentiation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090103~cochlea morphogenesis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0017147~Wnt-protein binding,GO:0042813~Wnt-activated receptor activity,	IPR001134:Netrin domain,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR015526:Frizzled/secreted frizzled-related protein,IPR018933:Netrin module, non-TIMP type,IPR020067:Frizzled domain,IPR026556:Secreted frizzled-related protein 3,		165720~Osteoarthritis susceptibility 1,		SM00063:FRI,SM00643:C345C,	Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Secreted frizzled-related protein 3,compositionally biased region:Ser-rich,disulfide bond,domain:FZ,domain:NTR,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
FPGT	fucose-1-phosphate guanylyltransferase(FPGT)	Homo sapiens			General function prediction only,	GO:0006004~fucose metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0005525~GTP binding,GO:0016772~transferase activity, transferring phosphorus-containing groups,GO:0016779~nucleotidyltransferase activity,GO:0047341~fucose-1-phosphate guanylyltransferase activity,	IPR011004:Trimeric LpxA-like,IPR012120:Fucose-1-phosphate guanylyltransferase,IPR012887:L-fucokinase,	hsa00051:Fructose and mannose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,		PIRSF036640:fucose-1-phosphate guanylyltransferase,		Alternative splicing,Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Nucleotidyltransferase,Polymorphism,Proteomics identification,Reference proteome,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Fucose-1-phosphate guanylyltransferase,chain:Serine/threonine-protein kinase TNNI3K,compositionally biased region:Poly-Ser,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,repeat:ANK 1,repeat:ANK 10,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,
FUCA1	fucosidase, alpha-L- 1, tissue(FUCA1)	Homo sapiens				GO:0006004~fucose metabolic process,GO:0006027~glycosaminoglycan catabolic process,GO:0016139~glycoside catabolic process,	GO:0005737~cytoplasm,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0004560~alpha-L-fucosidase activity,	IPR000933:Glycoside hydrolase, family 29,IPR013780:Glycosyl hydrolase, family 13, all-beta,IPR013781:Glycoside hydrolase, catalytic domain,IPR016286:Glycoside hydrolase, family 29, bacteria/metazoa/fungi,IPR017853:Glycoside hydrolase, superfamily,IPR018526:Glycoside hydrolase, family 29, conserved site,	hsa00511:Other glycan degradation,	230000~Fucosidosis,	PIRSF001092:alpha-L-fucosidase,	SM00812:Alpha_L_fucos,	Complete proteome,Disease mutation,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Phosphoprotein,Polymorphism,Reference proteome,Signal,	chain:Tissue alpha-L-fucosidase,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,site:May be important for catalysis,
GALM	galactose mutarotase(GALM)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006006~glucose metabolic process,GO:0006012~galactose metabolic process,GO:0033499~galactose catabolic process via UDP-galactose,	GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0004034~aldose 1-epimerase activity,GO:0016853~isomerase activity,GO:0030246~carbohydrate binding,	IPR008183:Aldose 1-/Glucose-6-phosphate 1-epimerase,IPR011013:Galactose mutarotase-like domain,IPR014718:Glycoside hydrolase-type carbohydrate-binding, subgroup,IPR015443:Aldose 1-epimerase,IPR018052:Aldose 1-epimerase, conserved site,	hsa00010:Glycolysis / Gluconeogenesis,hsa00052:Galactose metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,		PIRSF005096:aldose 1-epimerase,		3D-structure,Acetylation,Carbohydrate metabolism,Complete proteome,Cytoplasm,Isomerase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton acceptor,active site:Proton donor,binding site:Substrate,chain:Aldose 1-epimerase,helix,modified residue,mutagenesis site,region of interest:Substrate binding,sequence variant,strand,turn,
GLB1L	galactosidase beta 1 like(GLB1L)	Homo sapiens				GO:0005975~carbohydrate metabolic process,	GO:0005576~extracellular region,GO:0005773~vacuole,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004565~beta-galactosidase activity,	IPR001944:Glycoside hydrolase, family 35,IPR008979:Galactose-binding domain-like,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,IPR026283:Beta-galactosidase 1-like,			PIRSF006336:beta-galactosidase,		Alternative splicing,Complete proteome,Glycoprotein,Glycosidase,Hydrolase,Proteomics identification,Reference proteome,Secreted,Signal,	active site:Nucleophile,active site:Proton donor,chain:Beta-galactosidase-1-like protein,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,
GLB1	galactosidase beta 1(GLB1)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006027~glycosaminoglycan catabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0008152~metabolic process,GO:0019388~galactose catabolic process,GO:0042340~keratan sulfate catabolic process,GO:0044262~cellular carbohydrate metabolic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0043202~lysosomal lumen,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004308~exo-alpha-sialidase activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004565~beta-galactosidase activity,GO:0005515~protein binding,GO:0016936~galactoside binding,	IPR001944:Glycoside hydrolase, family 35,IPR008979:Galactose-binding domain-like,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,IPR019801:Glycoside hydrolase, family 35, conserved site,IPR025300:Beta-galactosidase jelly roll domain,IPR026283:Beta-galactosidase 1-like,	hsa00052:Galactose metabolism,hsa00511:Other glycan degradation,hsa00531:Glycosaminoglycan degradation,hsa00600:Sphingolipid metabolism,hsa00604:Glycosphingolipid biosynthesis - ganglio series,hsa01100:Metabolic pathways,hsa04142:Lysosome,	230500~GM1-gangliosidosis, type I,230600~GM1-gangliosidosis, type II,230650~GM1-gangliosidosis, type III,253010~Mucopolysaccharidosis type IVB (Morquio),	PIRSF006336:beta-galactosidase,		3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Gangliosidosis,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Mucopolysaccharidosis,Polymorphism,Proteomics identification,Reference proteome,Signal,Zymogen,	active site:Nucleophile,active site:Proton donor,chain:Beta-galactosidase,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
LGALS8	galectin 8(LGALS8)	Homo sapiens				GO:0098792~xenophagy,	GO:0005615~extracellular space,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001079:Galectin, carbohydrate recognition domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00276:GLECT,SM00908:SM00908,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Lectin,Polymorphism,Proteomics identification,Reference proteome,Repeat,	binding site:Carbohydrate,chain:Galectin-8,domain:Galectin 1,domain:Galectin 2,helix,region of interest:Beta-galactoside binding,sequence conflict,sequence variant,splice variant,strand,turn,
GABRD	gamma-aminobutyric acid type A receptor delta subunit(GABRD)	Homo sapiens				GO:0006810~transport,GO:0007165~signal transduction,GO:0007268~chemical synaptic transmission,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0034707~chloride channel complex,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,GO:0005515~protein binding,	IPR006028:Gamma-aminobutyric acid A receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR008098:Gamma-aminobutyric-acid A receptor delta subunit,IPR018000:Neurotransmitter-gated ion-channel, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04723:Retrograde endocannabinoid signaling,hsa04727:GABAergic synapse,hsa05032:Morphine addiction,hsa05033:Nicotine addiction,	613060~Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to,613060~Epilepsy, idiopathic generalized, 10,613060~Epilepsy, juvenile myoclonic, susceptibility to,			Cell junction,Cell membrane,Chloride,Chloride channel,Complete proteome,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Gamma-aminobutyric acid receptor subunit delta,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GABRR3	gamma-aminobutyric acid type A receptor rho3 subunit (gene/pseudogene)(GABRR3)	Homo sapiens				GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0034707~chloride channel complex,GO:0045211~postsynaptic membrane,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,GO:0019904~protein domain specific binding,	IPR006028:Gamma-aminobutyric acid A receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04723:Retrograde endocannabinoid signaling,hsa04727:GABAergic synapse,hsa05032:Morphine addiction,hsa05033:Nicotine addiction,				Cell junction,Cell membrane,Chloride,Chloride channel,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Postsynaptic cell membrane,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Gamma-aminobutyric acid receptor subunit rho-3,disulfide bond,glycosylation site:N-linked (GlcNAc...),region of interest:Interaction with SQSTM1,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GDAP2	ganglioside induced differentiation associated protein 2(GDAP2)	Homo sapiens				GO:0032526~response to retinoic acid,	GO:0005765~lysosomal membrane,	GO:0005515~protein binding,	IPR001251:CRAL-TRIO domain,IPR002589:Appr-1-p processing,				SM00506:A1pp,SM00516:SEC14,	3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Ganglioside-induced differentiation- associated protein 2,domain:CRAL-TRIO,domain:Macro,sequence variant,splice variant,
GJA5	gap junction protein alpha 5(GJA5)	Homo sapiens				GO:0001501~skeletal system development,GO:0001525~angiogenesis,GO:0003105~negative regulation of glomerular filtration,GO:0003151~outflow tract morphogenesis,GO:0003158~endothelium development,GO:0003161~cardiac conduction system development,GO:0003174~mitral valve development,GO:0003193~pulmonary valve formation,GO:0003281~ventricular septum development,GO:0003283~atrial septum development,GO:0003284~septum primum development,GO:0003294~atrial ventricular junction remodeling,GO:0006813~potassium ion transport,GO:0007154~cell communication,GO:0010643~cell communication by chemical coupling,GO:0010652~positive regulation of cell communication by chemical coupling,GO:0016264~gap junction assembly,GO:0030326~embryonic limb morphogenesis,GO:0035050~embryonic heart tube development,GO:0035922~foramen ovale closure,GO:0045776~negative regulation of blood pressure,GO:0045907~positive regulation of vasoconstriction,GO:0045909~positive regulation of vasodilation,GO:0048844~artery morphogenesis,GO:0051259~protein oligomerization,GO:0055085~transmembrane transport,GO:0055117~regulation of cardiac muscle contraction,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0060371~regulation of atrial cardiac muscle cell membrane depolarization,GO:0060373~regulation of ventricular cardiac muscle cell membrane depolarization,GO:0060412~ventricular septum morphogenesis,GO:0060413~atrial septum morphogenesis,GO:0086005~ventricular cardiac muscle cell action potential,GO:0086015~SA node cell action potential,GO:0086021~SA node cell to atrial cardiac muscle cell communication by electrical coupling,GO:0086044~atrial cardiac muscle cell to AV node cell communication by electrical coupling,GO:0086053~AV node cell to bundle of His cell communication by electrical coupling,GO:0086054~bundle of His cell to Purkinje myocyte communication by electrical coupling,GO:0086055~Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:0086091~regulation of heart rate by cardiac conduction,GO:0098904~regulation of AV node cell action potential,GO:0098905~regulation of bundle of His cell action potential,GO:0098906~regulation of Purkinje myocyte action potential,GO:0098910~regulation of atrial cardiac muscle cell action potential,GO:1900133~regulation of renin secretion into blood stream,GO:1900825~regulation of membrane depolarization during cardiac muscle cell action potential,GO:1990029~vasomotion,	GO:0005887~integral component of plasma membrane,GO:0005921~gap junction,GO:0005922~connexon complex,GO:0014704~intercalated disc,GO:0016021~integral component of membrane,GO:0042995~cell projection,	GO:0005243~gap junction channel activity,GO:0055077~gap junction hemi-channel activity,GO:0071253~connexin binding,GO:0086020~gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,GO:0086075~gap junction channel activity involved in cardiac conduction electrical coupling,GO:0086076~gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,GO:0086077~gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,GO:0086078~gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,GO:0086079~gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,	IPR000500:Connexin,IPR002264:Gap junction alpha-5 protein (Cx40),IPR013092:Connexin, N-terminal,IPR017990:Connexin, conserved site,IPR019570:Gap junction protein, cysteine-rich domain,		108770~Atrial standstill, digenic (GJA5/SCN5A),614049~Atrial fibrillation, familial, 11,		SM00037:CNX,SM01089:SM01089,	Atrial fibrillation,Cardiomyopathy,Cell junction,Cell membrane,Complete proteome,Disease mutation,Gap junction,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gap junction alpha-5 protein,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GJA9	gap junction protein alpha 9(GJA9)	Homo sapiens				GO:0007154~cell communication,	GO:0005922~connexon complex,GO:0016021~integral component of membrane,		IPR000500:Connexin,IPR013092:Connexin, N-terminal,IPR017990:Connexin, conserved site,IPR019570:Gap junction protein, cysteine-rich domain,				SM00037:CNX,SM01089:SM01089,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Gap junction,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gap junction alpha-9 protein,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GJB4	gap junction protein beta 4(GJB4)	Homo sapiens				GO:0007154~cell communication,GO:0007608~sensory perception of smell,GO:0042048~olfactory behavior,	GO:0005922~connexon complex,GO:0016021~integral component of membrane,		IPR000500:Connexin,IPR002270:Gap junction beta-4 protein (Cx31.1),IPR013092:Connexin, N-terminal,IPR017990:Connexin, conserved site,IPR019570:Gap junction protein, cysteine-rich domain,		133200~Erythrokeratodermia variabilis with erythema gyratum repens,		SM00037:CNX,SM01089:SM01089,	Cell junction,Cell membrane,Complete proteome,Disease mutation,Gap junction,Membrane,Palmoplantar keratoderma,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gap junction beta-4 protein,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GJB5	gap junction protein beta 5(GJB5)	Homo sapiens				GO:0007154~cell communication,GO:0008544~epidermis development,GO:0060707~trophoblast giant cell differentiation,GO:0060708~spongiotrophoblast differentiation,GO:0060713~labyrinthine layer morphogenesis,	GO:0005922~connexon complex,GO:0016021~integral component of membrane,		IPR000500:Connexin,IPR002271:Gap junction beta-5 protein (Cx30.3),IPR013092:Connexin, N-terminal,IPR017990:Connexin, conserved site,IPR019570:Gap junction protein, cysteine-rich domain,				SM00037:CNX,SM01089:SM01089,	Cell junction,Cell membrane,Complete proteome,Gap junction,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gap junction beta-5 protein,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GKN1	gastrokine 1(GKN1)	Homo sapiens				GO:0007586~digestion,GO:0042127~regulation of cell proliferation,GO:0051781~positive regulation of cell division,	GO:0005615~extracellular space,		IPR007084:BRICHOS domain,				SM01039:SM01039,	Complete proteome,Disulfide bond,Mitogen,Polymorphism,Reference proteome,Secreted,Signal,	chain:Gastrokine-1,domain:BRICHOS,sequence variant,signal peptide,
GKN2	gastrokine 2(GKN2)	Homo sapiens				GO:0042127~regulation of cell proliferation,	GO:0005615~extracellular space,GO:0045178~basal part of cell,		IPR007084:BRICHOS domain,				SM01039:SM01039,	Complete proteome,Direct protein sequencing,Disulfide bond,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Gastrokine-2,domain:BRICHOS,sequence conflict,sequence variant,signal peptide,
GEMIN6	gem nuclear organelle associated protein 6(GEMIN6)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0051170~nuclear import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,GO:0097504~Gemini of coiled bodies,	GO:0005515~protein binding,	IPR009422:Gemin6,	hsa03013:RNA transport,				3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Gem-associated protein 6,helix,modified residue,sequence variant,strand,turn,
GTF2A1L	general transcription factor IIA subunit 1 like(GTF2A1L)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0050890~cognition,	GO:0005672~transcription factor TFIIA complex,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR004855:Transcription factor IIA, alpha/beta subunit,IPR009083:Transcription factor IIA, helical,IPR009088:Transcription factor IIA, beta-barrel,IPR013028:Transcription factor IIA, alpha subunit, N-terminal,	hsa03022:Basal transcription factors,hsa05203:Viral carcinogenesis,			SM01371:SM01371,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Stonin-1,chain:TFIIA-alpha and beta-like factor,domain:MHD,domain:SHD,sequence conflict,sequence variant,
GTF2B	general transcription factor IIB(GTF2B)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,	Transcription,	GO:0006352~DNA-templated transcription, initiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0016032~viral process,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0050434~positive regulation of viral transcription,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,	GO:0001047~core promoter binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0017025~TBP-class protein binding,GO:0046966~thyroid hormone receptor binding,	IPR000812:Transcription factor TFIIB,IPR013137:Zinc finger, TFIIB-type,IPR013150:Transcription factor TFIIB, cyclin-like domain,IPR013763:Cyclin-like,IPR023486:Transcription factor TFIIB, conserved site,	hsa03022:Basal transcription factors,hsa05203:Viral carcinogenesis,			SM00385:CYCLIN,	3D-structure,Complete proteome,Host-virus interaction,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription initiation factor IIB,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,repeat:1,repeat:2,sequence variant,strand,turn,zinc finger region:TFIIB-type,
GTF3C2	general transcription factor IIIC subunit 2(GTF3C2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006383~transcription from RNA polymerase III promoter,GO:0042791~5S class rRNA transcription from RNA polymerase III type 1 promoter,GO:0042797~tRNA transcription from RNA polymerase III promoter,	GO:0000127~transcription factor TFIIIC complex,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,WD repeat,	chain:General transcription factor 3C polypeptide 2,compositionally biased region:Poly-Leu,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,sequence conflict,splice variant,
GTF3C3	general transcription factor IIIC subunit 3(GTF3C3)	Homo sapiens		h_RNApol3Pathway:RNA polymerase III transcription,		GO:0006351~transcription, DNA-templated,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006383~transcription from RNA polymerase III promoter,GO:0042791~5S class rRNA transcription from RNA polymerase III type 1 promoter,GO:0042797~tRNA transcription from RNA polymerase III promoter,	GO:0000127~transcription factor TFIIIC complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0000995~transcription factor activity, core RNA polymerase III binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Acetylation,Alternative splicing,Complete proteome,DNA-binding,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transcription,Transmembrane,Transmembrane helix,	chain:General transcription factor 3C polypeptide 3,compositionally biased region:Glu-rich,modified residue,repeat:TPR 1,repeat:TPR 10,repeat:TPR 11,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,sequence conflict,sequence variant,splice variant,
GGPS1	geranylgeranyl diphosphate synthase 1(GGPS1)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0006720~isoprenoid metabolic process,GO:0008299~isoprenoid biosynthetic process,GO:0033384~geranyl diphosphate biosynthetic process,GO:0033386~geranylgeranyl diphosphate biosynthetic process,GO:0045337~farnesyl diphosphate biosynthetic process,	GO:0005829~cytosol,	GO:0004161~dimethylallyltranstransferase activity,GO:0004311~farnesyltranstransferase activity,GO:0004337~geranyltranstransferase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000092:Polyprenyl synthetase,IPR008949:Terpenoid synthase,	hsa00900:Terpenoid backbone biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Isoprene biosynthesis,Magnesium,Metal-binding,Proteomics identification,Reference proteome,Transferase,	binding site:Dimethylallyl diphosphate,binding site:Isopentenyl diphosphate,chain:Geranylgeranyl pyrophosphate synthetase,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,metal ion-binding site:Magnesium 3,modified residue,sequence conflict,strand,
GMCL1	germ cell-less, spermatogenesis associated 1(GMCL1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0016363~nuclear matrix,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,				SM00225:BTB,SM00875:SM00875,	Complete proteome,Developmental protein,Differentiation,Nucleus,Phosphoprotein,Reference proteome,Spermatogenesis,	chain:Germ cell-less protein-like 1,chain:Germ cell-less protein-like 1-like,domain:BTB,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
GCSAML	germinal center associated signaling and motility like(GCSAML)	Homo sapiens				GO:0050855~regulation of B cell receptor signaling pathway,GO:2000401~regulation of lymphocyte migration,								Alternative splicing,Coiled coil,Complete proteome,Proteomics identification,Reference proteome,	chain:Putative uncharacterized protein C1orf150,splice variant,
GLMN	glomulin, FKBP associated protein(GLMN)	Homo sapiens				GO:0001570~vasculogenesis,GO:0001843~neural tube closure,GO:0031397~negative regulation of protein ubiquitination,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0040029~regulation of gene expression, epigenetic,GO:0042130~negative regulation of T cell proliferation,GO:0042327~positive regulation of phosphorylation,GO:0042692~muscle cell differentiation,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0050715~positive regulation of cytokine secretion,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0031462~Cul2-RING ubiquitin ligase complex,GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,	GO:0005171~hepatocyte growth factor receptor binding,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0055105~ubiquitin-protein transferase inhibitor activity,	IPR013877:YAP-binding/Alf4/Glomulin,IPR019516:Glomulin,		138000~Glomuvenous malformations,			3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Glomulin,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,modified residue,mutagenesis site,sequence variant,splice variant,
GCG	glucagon(GCG)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007631~feeding behavior,GO:0008283~cell proliferation,GO:0010737~protein kinase A signaling,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0032092~positive regulation of protein binding,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0035948~positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,GO:0042594~response to starvation,GO:0043066~negative regulation of apoptotic process,GO:0045860~positive regulation of protein kinase activity,GO:0050796~regulation of insulin secretion,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071377~cellular response to glucagon stimulus,GO:0090280~positive regulation of calcium ion import,GO:1900118~negative regulation of execution phase of apoptosis,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0005886~plasma membrane,GO:0034774~secretory granule lumen,	GO:0005102~receptor binding,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0031769~glucagon receptor binding,GO:0042802~identical protein binding,	IPR000532:Glucagon/GIP/secretin/VIP,IPR015550:Glucagon-like,	hsa04911:Insulin secretion,hsa04922:Glucagon signaling pathway,	Hyperproglucagonemia~Hyperproglucagonemia,		SM00070:GLUCA,	3D-structure,Amidation,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Hormone,Pharmaceutical,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,	helix,modified residue,peptide:Glicentin,peptide:Glicentin-related polypeptide,peptide:Glucagon,peptide:Glucagon-like peptide 1,peptide:Glucagon-like peptide 1(7-36),peptide:Glucagon-like peptide 1(7-37),peptide:Glucagon-like peptide 2,peptide:Oxyntomodulin,sequence conflict,sequence variant,signal peptide,site:Cleavage; by PCSK1,site:Cleavage; by PCSK1 and PCSK2,site:Cleavage; by PCSK2,turn,
GMEB1	glucocorticoid modulatory element binding protein 1(GMEB1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0046872~metal ion binding,	IPR000770:SAND domain,IPR010919:SAND domain-like,IPR024830:Glucocorticoid modulatory element-binding protein 1/2,				SM00258:SAND,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Zinc,	binding site:DNA,chain:Glucocorticoid modulatory element-binding protein 1,domain:SAND,helix,metal ion-binding site:Zinc,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
GXYLT2	glucoside xylosyltransferase 2(GXYLT2)	Homo sapiens				GO:0016266~O-glycan processing,	GO:0016021~integral component of membrane,	GO:0000107~imidazoleglycerol-phosphate synthase activity,GO:0018071~NAD(P)-cysteine ADP-ribosyltransferase activity,GO:0018121~NAD(P)-asparagine ADP-ribosyltransferase activity,GO:0018127~NAD(P)-serine ADP-ribosyltransferase activity,GO:0035252~UDP-xylosyltransferase activity,GO:0043867~7-cyano-7-deazaguanine tRNA-ribosyltransferase activity,GO:0044102~purine deoxyribosyltransferase activity,	IPR002495:Glycosyl transferase, family 8,	hsa00514:Other types of O-glycan biosynthesis,				Complete proteome,Glycoprotein,Glycosyltransferase,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Glucoside xylosyltransferase 2,compositionally biased region:Arg-rich,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GBA	glucosylceramidase beta(GBA)	Homo sapiens			Cell envelope biogenesis, outer membrane,	GO:0005975~carbohydrate metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006680~glucosylceramide catabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0007005~mitochondrion organization,GO:0009267~cellular response to starvation,GO:0009268~response to pH,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016239~positive regulation of macroautophagy,GO:0016241~regulation of macroautophagy,GO:0023021~termination of signal transduction,GO:0031175~neuron projection development,GO:0032268~regulation of cellular protein metabolic process,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032463~negative regulation of protein homooligomerization,GO:0032715~negative regulation of interleukin-6 production,GO:0033561~regulation of water loss via skin,GO:0033574~response to testosterone,GO:0035307~positive regulation of protein dephosphorylation,GO:0036473~cell death in response to oxidative stress,GO:0043243~positive regulation of protein complex disassembly,GO:0043407~negative regulation of MAP kinase activity,GO:0043589~skin morphogenesis,GO:0043627~response to estrogen,GO:0046512~sphingosine biosynthetic process,GO:0046513~ceramide biosynthetic process,GO:0050728~negative regulation of inflammatory response,GO:0051247~positive regulation of protein metabolic process,GO:0051384~response to glucocorticoid,GO:0071356~cellular response to tumor necrosis factor,GO:0097066~response to thyroid hormone,GO:1901215~negative regulation of neuron death,GO:1903052~positive regulation of proteolysis involved in cellular protein catabolic process,GO:1903061~positive regulation of protein lipidation,GO:1904457~positive regulation of neuronal action potential,GO:1905165~regulation of lysosomal protein catabolic process,	GO:0005615~extracellular space,GO:0005765~lysosomal membrane,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0004348~glucosylceramidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,	IPR001139:Glycoside hydrolase, family 30,IPR013780:Glycosyl hydrolase, family 13, all-beta,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,	hsa00511:Other glycan degradation,hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04142:Lysosome,	127750~Lewy body dementia, susceptibility to,168600~Parkinson disease, late-onset, susceptibility to,230800~Gaucher disease, type I,230900~Gaucher disease, type II,231000~Gaucher disease, type III,231005~Gaucher disease, type IIIC,608013~Gaucher disease, perinatal lethal,			3D-structure,Alternative initiation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Gaucher disease,Glycoprotein,Glycosidase,Hydrolase,Ichthyosis,Lipid metabolism,Lysosome,Membrane,Neurodegeneration,Parkinson disease,Parkinsonism,Pharmaceutical,Polymorphism,Proteomics identification,Reference proteome,Signal,Sphingolipid metabolism,	active site:Nucleophile,active site:Proton donor,chain:Glucosylceramidase,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
GAD1	glutamate decarboxylase 1(GAD1)	Homo sapiens				GO:0006538~glutamate catabolic process,GO:0006540~glutamate decarboxylation to succinate,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0009449~gamma-aminobutyric acid biosynthetic process,GO:0018352~protein-pyridoxal-5-phosphate linkage,GO:0019752~carboxylic acid metabolic process,GO:0042136~neurotransmitter biosynthetic process,GO:0042493~response to drug,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0012506~vesicle membrane,GO:0048786~presynaptic active zone,GO:0061202~clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,	GO:0004351~glutamate decarboxylase activity,GO:0005515~protein binding,GO:0016595~glutamate binding,GO:0016831~carboxy-lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,	IPR002129:Pyridoxal phosphate-dependent decarboxylase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR021115:Pyridoxal-phosphate binding site,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00410:beta-Alanine metabolism,hsa00430:Taurine and hypotaurine metabolism,hsa00650:Butanoate metabolism,hsa01100:Metabolic pathways,hsa04727:GABAergic synapse,hsa04940:Type I diabetes mellitus,	603513~Cerebral palsy, spastic quadriplegic, 1,			3D-structure,Alternative splicing,Complete proteome,Decarboxylase,Disease mutation,Lyase,Neurotransmitter biosynthesis,Phosphoprotein,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,	binding site:Substrate,chain:Glutamate decarboxylase 1,helix,modified residue,region of interest:Substrate binding,sequence conflict,sequence variant,splice variant,strand,turn,
GADL1	glutamate decarboxylase like 1(GADL1)	Homo sapiens			Amino acid transport and metabolism,	GO:0008652~cellular amino acid biosynthetic process,	GO:0005829~cytosol,	GO:0004068~aspartate 1-decarboxylase activity,GO:0004782~sulfinoalanine decarboxylase activity,GO:0016831~carboxy-lyase activity,GO:0030170~pyridoxal phosphate binding,	IPR002129:Pyridoxal phosphate-dependent decarboxylase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR021115:Pyridoxal-phosphate binding site,	hsa00410:beta-Alanine metabolism,hsa00430:Taurine and hypotaurine metabolism,hsa00770:Pantothenate and CoA biosynthesis,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Decarboxylase,Lyase,Pyridoxal phosphate,Reference proteome,	chain:Glutamate decarboxylase-like protein 1,modified residue,sequence conflict,splice variant,
GRIK3	glutamate ionotropic receptor kainate type subunit 3(GRIK3)	Homo sapiens				GO:0007196~adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,GO:0007215~glutamate receptor signaling pathway,GO:0007216~G-protein coupled glutamate receptor signaling pathway,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0042391~regulation of membrane potential,GO:0051967~negative regulation of synaptic transmission, glutamatergic,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0032839~dendrite cytoplasm,GO:0043195~terminal bouton,GO:0043204~perikaryon,GO:0045211~postsynaptic membrane,	GO:0001640~adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,GO:0001664~G-protein coupled receptor binding,GO:0004970~ionotropic glutamate receptor activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0008066~glutamate receptor activity,GO:0015276~ligand-gated ion channel activity,GO:0015277~kainate selective glutamate receptor activity,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR001828:Extracellular ligand-binding receptor,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,			SM00079:PBPe,SM00918:SM00918,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Isopeptide bond,Ligand-gated ion channel,Membrane,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,RNA editing,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Glutamate receptor, ionotropic kainate 3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GRM2	glutamate metabotropic receptor 2(GRM2)	Homo sapiens				GO:0007194~negative regulation of adenylate cyclase activity,GO:0007196~adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0014047~glutamate secretion,GO:0051966~regulation of synaptic transmission, glutamatergic,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0042734~presynaptic membrane,	GO:0001641~group II metabotropic glutamate receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005246~calcium channel regulator activity,GO:0005515~protein binding,GO:0008066~glutamate receptor activity,	IPR000162:GPCR, family 3, metabotropic glutamate receptor,IPR000337:GPCR, family 3,IPR001458:GPCR, family 3, metabotropic glutamate receptor 2,IPR001828:Extracellular ligand-binding receptor,IPR011500:GPCR, family 3, nine cysteines domain,IPR017978:GPCR, family 3, C-terminal,IPR017979:GPCR, family 3, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,hsa05030:Cocaine addiction,				3D-structure,Cell junction,Cell membrane,Cell projection,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Proteomics identification,Receptor,Reference proteome,Signal,Synapse,Transducer,Transmembrane,Transmembrane helix,	chain:Metabotropic glutamate receptor 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GRM7	glutamate metabotropic receptor 7(GRM7)	Homo sapiens				GO:0001661~conditioned taste aversion,GO:0001662~behavioral fear response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007196~adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007605~sensory perception of sound,GO:0007608~sensory perception of smell,GO:0007614~short-term memory,GO:0014050~negative regulation of glutamate secretion,GO:0019226~transmission of nerve impulse,GO:0030534~adult behavior,GO:0030818~negative regulation of cAMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0033555~multicellular organismal response to stress,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005938~cell cortex,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0032279~asymmetric synapse,GO:0042734~presynaptic membrane,GO:0043198~dendritic shaft,GO:0043235~receptor complex,GO:0045211~postsynaptic membrane,GO:0048786~presynaptic active zone,	GO:0001642~group III metabotropic glutamate receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005245~voltage-gated calcium channel activity,GO:0005246~calcium channel regulator activity,GO:0005509~calcium ion binding,GO:0008066~glutamate receptor activity,GO:0010855~adenylate cyclase inhibitor activity,GO:0016595~glutamate binding,GO:0030165~PDZ domain binding,GO:0070905~serine binding,	IPR000162:GPCR, family 3, metabotropic glutamate receptor,IPR000337:GPCR, family 3,IPR001828:Extracellular ligand-binding receptor,IPR001883:GPCR, family 3, metabotropic glutamate receptor 7,IPR011500:GPCR, family 3, nine cysteines domain,IPR017978:GPCR, family 3, C-terminal,IPR017979:GPCR, family 3, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,				3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Sensory transduction,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Metabotropic glutamate receptor 7,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GRIP2	glutamate receptor interacting protein 2(GRIP2)	Homo sapiens				GO:0007219~Notch signaling pathway,GO:0014824~artery smooth muscle contraction,GO:0015031~protein transport,GO:0045777~positive regulation of blood pressure,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0043198~dendritic shaft,GO:0045211~postsynaptic membrane,	GO:0030159~receptor signaling complex scaffold activity,	IPR001478:PDZ domain,				SM00228:PDZ,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Glutamate receptor-interacting protein 2,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,domain:PDZ 5,domain:PDZ 6,domain:PDZ 7,helix,sequence conflict,splice variant,strand,turn,
ERICH2	glutamate rich 2(ERICH2)	Homo sapiens						GO:0005515~protein binding,	IPR026703:Uncharacterised protein LOC285141,					Complete proteome,Reference proteome,
ERICH3	glutamate rich 3(ERICH3)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf173,compositionally biased region:Glu-rich,compositionally biased region:Poly-Arg,sequence conflict,sequence variant,splice variant,
GLS	glutaminase(GLS)	Homo sapiens		h_argininecPathway:Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline,		GO:0001967~suckling behavior,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0006537~glutamate biosynthetic process,GO:0006541~glutamine metabolic process,GO:0006543~glutamine catabolic process,GO:0007268~chemical synaptic transmission,GO:0008652~cellular amino acid biosynthetic process,GO:0014047~glutamate secretion,GO:0051289~protein homotetramerization,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0004359~glutaminase activity,GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR012338:Beta-lactamase/transpeptidase-like,IPR015868:Glutaminase,IPR020683:Ankyrin repeat-containing domain,	hsa00220:Arginine biosynthesis,hsa00250:Alanine, aspartate and glutamate metabolism,hsa00471:D-Glutamine and D-glutamate metabolism,hsa01100:Metabolic pathways,hsa04724:Glutamatergic synapse,hsa04727:GABAergic synapse,hsa04964:Proximal tubule bicarbonate reclamation,hsa05206:MicroRNAs in cancer,hsa05230:Central carbon metabolism in cancer,			SM00248:ANK,	3D-structure,Acetylation,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transit peptide,	chain:Glutaminase kidney isoform, mitochondrial,helix,modified residue,repeat:ANK,sequence conflict,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
QRICH1	glutamine rich 1(QRICH1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007010~cytoskeleton organization,GO:0007275~multicellular organism development,GO:0022604~regulation of cell morphogenesis,GO:0042981~regulation of apoptotic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001315:Caspase Recruitment,IPR011029:Death-like domain,IPR021893:Protein of unknown function DUF3504,					Acetylation,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Glutamine-rich protein 1,compositionally biased region:Gln-rich,domain:CARD,modified residue,sequence conflict,
GFPT1	glutamine--fructose-6-phosphate transaminase 1(GFPT1)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006002~fructose 6-phosphate metabolic process,GO:0006047~UDP-N-acetylglucosamine metabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0006112~energy reserve metabolic process,GO:0006541~glutamine metabolic process,GO:0032922~circadian regulation of gene expression,GO:0036498~IRE1-mediated unfolded protein response,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004360~glutamine-fructose-6-phosphate transaminase (isomerizing) activity,GO:0030246~carbohydrate binding,	IPR001347:Sugar isomerase (SIS),IPR005855:Glucosamine-fructose-6-phosphate aminotransferase, isomerising,IPR017932:Glutamine amidotransferase type 2 domain,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa04931:Insulin resistance,	610542~Myasthenia, congenital, 12, with tubular aggregates,			3D-structure,Alternative splicing,Aminotransferase,Biological rhythms,Complete proteome,Congenital myasthenic syndrome,Disease mutation,Glutamine amidotransferase,Phosphoprotein,Reference proteome,Repeat,Transferase,	active site:For GATase activity,chain:Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1,domain:Glutamine amidotransferase type-2,domain:SIS 1,domain:SIS 2,helix,modified residue,splice variant,strand,turn,
QPCT	glutaminyl-peptide cyclotransferase(QPCT)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0017186~peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,	GO:0070062~extracellular exosome,	GO:0008270~zinc ion binding,GO:0016603~glutaminyl-peptide cyclotransferase activity,	IPR007484:Peptidase M28,					3D-structure,Acyltransferase,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Transferase,Zinc,	active site:Proton acceptor,chain:Glutaminyl-peptide cyclotransferase,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc,mutagenesis site,sequence variant,signal peptide,splice variant,strand,turn,
QARS	glutaminyl-tRNA synthetase(QARS)	Homo sapiens				GO:0006418~tRNA aminoacylation for protein translation,GO:0006425~glutaminyl-tRNA aminoacylation,GO:0007420~brain development,GO:0045727~positive regulation of translation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004819~glutamine-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000924:Glutamyl/glutaminyl-tRNA synthetase, class Ib,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR004514:Glutamine-tRNA synthetase, class Ib,IPR007638:Glutaminyl-tRNA synthetase, class Ib, non-specific RNA-binding domain 2,IPR007639:Glutaminyl-tRNA synthetase, class Ib, non-specific RNA-binding domain, N-terminal,IPR011035:Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR020056:Ribosomal protein L25/Gln-tRNA synthetase, beta-barrel domain,IPR020058:Glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain,IPR020059:Glutamyl/glutaminyl-tRNA synthetase, class Ib, anti-codon binding domain,IPR020061:Glutamyl/glutaminyl-tRNA synthetase, class Ib, alpha-bundle domain,	hsa00970:Aminoacyl-tRNA biosynthesis,hsa01100:Metabolic pathways,	615760~Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy,			3D-structure,Acetylation,Alternative splicing,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Epilepsy,Ligase,Membrane,Nucleotide-binding,Phosphoprotein,Primary microcephaly,Protein biosynthesis,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	binding site:ATP,chain:Glutaminyl-tRNA synthetase,modified residue,short sequence motif:"HIGH" region,short sequence motif:"KMSKS" region,
EPRS	glutamyl-prolyl-tRNA synthetase(EPRS)	Homo sapiens				GO:0006418~tRNA aminoacylation for protein translation,GO:0006424~glutamyl-tRNA aminoacylation,GO:0006433~prolyl-tRNA aminoacylation,GO:0006461~protein complex assembly,GO:0017148~negative regulation of translation,GO:0071346~cellular response to interferon-gamma,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0097452~GAIT complex,	GO:0004818~glutamate-tRNA ligase activity,GO:0004827~proline-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0035613~RNA stem-loop binding,GO:0051020~GTPase binding,	IPR000738:WHEP-TRS,IPR000924:Glutamyl/glutaminyl-tRNA synthetase, class Ib,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR002314:Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain,IPR004046:Glutathione S-transferase, C-terminal,IPR004154:Anticodon-binding,IPR004499:Proline-tRNA ligase, class IIa, archaeal-type,IPR004526:Glutamyl-tRNA synthetase, class Ib, archaeal/eukaryotic cytosolic,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR009068:S15/NS1, RNA-binding,IPR010987:Glutathione S-transferase, C-terminal-like,IPR011035:Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR016061:Proline-tRNA ligase, class II, C-terminal,IPR017449:Prolyl-tRNA synthetase, class II,IPR020056:Ribosomal protein L25/Gln-tRNA synthetase, beta-barrel domain,IPR020058:Glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain,IPR020059:Glutamyl/glutaminyl-tRNA synthetase, class Ib, anti-codon binding domain,IPR020061:Glutamyl/glutaminyl-tRNA synthetase, class Ib, alpha-bundle domain,	hsa00860:Porphyrin and chlorophyll metabolism,hsa00970:Aminoacyl-tRNA biosynthesis,hsa01100:Metabolic pathways,			SM00946:SM00946,SM00991:SM00991,	3D-structure,Acetylation,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Ligase,Methylation,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Repeat,RNA-binding,Translation regulation,	binding site:ATP,chain:Bifunctional aminoacyl-tRNA synthetase,domain:WHEP-TRS 1,domain:WHEP-TRS 2,domain:WHEP-TRS 3,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:3 X 57 AA approximate repeats,region of interest:Charged,region of interest:Glutamyl-tRNA synthetase,region of interest:Prolyl-tRNA synthetase,sequence conflict,sequence variant,short sequence motif:"HIGH" region,short sequence motif:"KMSKS" region,
GSTM1	glutathione S-transferase mu 1(GSTM1)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0008152~metabolic process,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:0070458~cellular detoxification of nitrogen compound,GO:1901687~glutathione derivative biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004364~glutathione transferase activity,GO:0016740~transferase activity,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:Glutathione S-transferase, Mu class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase Mu 1,domain:GST C-terminal,domain:GST N-terminal,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
GSTM2	glutathione S-transferase mu 2(GSTM2)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006749~glutathione metabolic process,GO:0008152~metabolic process,GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0014809~regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:0043651~linoleic acid metabolic process,GO:0055119~relaxation of cardiac muscle,GO:0060315~negative regulation of ryanodine-sensitive calcium-release channel activity,GO:0060316~positive regulation of ryanodine-sensitive calcium-release channel activity,GO:0070458~cellular detoxification of nitrogen compound,GO:0071313~cellular response to caffeine,GO:0098869~cellular oxidant detoxification,GO:1901687~glutathione derivative biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016529~sarcoplasmic reticulum,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0004602~glutathione peroxidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:Glutathione S-transferase, Mu class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase Mu 2,domain:GST C-terminal,domain:GST N-terminal,helix,sequence conflict,sequence variant,strand,turn,
GSTM3	glutathione S-transferase mu 3(GSTM3)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0008065~establishment of blood-nerve barrier,GO:0008152~metabolic process,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:0043627~response to estrogen,GO:0070458~cellular detoxification of nitrogen compound,GO:1901687~glutathione derivative biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0035686~sperm fibrous sheath,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:Glutathione S-transferase, Mu class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase Mu 3,domain:GST C-terminal,domain:GST N-terminal,helix,sequence conflict,sequence variant,strand,
GSTM4	glutathione S-transferase mu 4(GSTM4)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0008152~metabolic process,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:1901687~glutathione derivative biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004364~glutathione transferase activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:Glutathione S-transferase, Mu class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase Mu 4,domain:GST C-terminal,domain:GST N-terminal,helix,sequence conflict,sequence variant,splice variant,strand,turn,
GPD1L	glycerol-3-phosphate dehydrogenase 1-like(GPD1L)	Homo sapiens				GO:0002027~regulation of heart rate,GO:0005975~carbohydrate metabolic process,GO:0006654~phosphatidic acid biosynthetic process,GO:0006734~NADH metabolic process,GO:0010765~positive regulation of sodium ion transport,GO:0019432~triglyceride biosynthetic process,GO:0019674~NAD metabolic process,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0046168~glycerol-3-phosphate catabolic process,GO:0055114~oxidation-reduction process,GO:0060373~regulation of ventricular cardiac muscle cell membrane depolarization,GO:0086005~ventricular cardiac muscle cell action potential,GO:0090038~negative regulation of protein kinase C signaling,GO:2000010~positive regulation of protein localization to cell surface,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009331~glycerol-3-phosphate dehydrogenase complex,GO:0070062~extracellular exosome,	GO:0004367~glycerol-3-phosphate dehydrogenase [NAD+] activity,GO:0017080~sodium channel regulator activity,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,GO:0051287~NAD binding,	IPR006109:Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal,IPR006168:Glycerol-3-phosphate dehydrogenase, NAD-dependent,IPR008927:6-phosphogluconate dehydrogenase, C-terminal-like,IPR011128:Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal,IPR013328:Dehydrogenase, multihelical,IPR016040:NAD(P)-binding domain,IPR017751:Glycerol-3-phosphate dehydrogenase, NAD-dependent, eukaryotic,	hsa00564:Glycerophospholipid metabolism,	611777~Brugada syndrome 2,	PIRSF000114:glycerol-3-phosphate dehydrogenase (NAD),		3D-structure,Brugada syndrome,Complete proteome,Cytoplasm,Disease mutation,NAD,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:NAD,binding site:NAD; via amide nitrogen,binding site:Substrate,chain:Glycerol-3-phosphate dehydrogenase 1-like protein,helix,nucleotide phosphate-binding region:NAD,region of interest:Substrate binding,sequence variant,strand,turn,
GPD2	glycerol-3-phosphate dehydrogenase 2(GPD2)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,	Energy production and conversion,	GO:0006072~glycerol-3-phosphate metabolic process,GO:0006094~gluconeogenesis,GO:0019563~glycerol catabolic process,GO:0035264~multicellular organism growth,GO:0043010~camera-type eye development,GO:0044255~cellular lipid metabolic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0009331~glycerol-3-phosphate dehydrogenase complex,GO:0016021~integral component of membrane,	GO:0004368~glycerol-3-phosphate dehydrogenase activity,GO:0005509~calcium ion binding,GO:0052591~sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,	IPR000447:FAD-dependent glycerol-3-phosphate dehydrogenase,IPR002048:EF-hand domain,IPR006076:FAD dependent oxidoreductase,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00564:Glycerophospholipid metabolism,	125853~Diabetes, type 2, susceptibility to,		SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,FAD,Flavoprotein,Membrane,Metal-binding,Mitochondrion,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transit peptide,Transmembrane,Transmembrane helix,	chain:Glycerol-3-phosphate dehydrogenase, mitochondrial,domain:EF-hand 1,domain:EF-hand 2,modified residue,nucleotide phosphate-binding region:FAD,sequence variant,splice variant,transit peptide:Mitochondrion,
GNPAT	glyceronephosphate O-acyltransferase(GNPAT)	Homo sapiens				GO:0006650~glycerophospholipid metabolic process,GO:0006654~phosphatidic acid biosynthetic process,GO:0007416~synapse assembly,GO:0007584~response to nutrient,GO:0008611~ether lipid biosynthetic process,GO:0021587~cerebellum morphogenesis,GO:0030913~paranodal junction assembly,GO:0042493~response to drug,GO:0042594~response to starvation,GO:0044255~cellular lipid metabolic process,GO:0061024~membrane organization,GO:0070542~response to fatty acid,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0016020~membrane,	GO:0005102~receptor binding,GO:0008374~O-acyltransferase activity,GO:0016287~glycerone-phosphate O-acyltransferase activity,GO:0016290~palmitoyl-CoA hydrolase activity,	IPR002123:Phospholipid/glycerol acyltransferase,IPR022284:Glycerol-3-phosphate O-acyltransferase,	hsa00564:Glycerophospholipid metabolism,hsa04146:Peroxisome,	222765~Chondrodysplasia punctata, rhizomelic, type 2,	PIRSF000437:glycerol-3-phosphate O-acyltransferase/dihydroxyacetone phosphate acyltransferase,PIRSF500063:dihydroxyacetone phosphate acyltransferase [Parent=PIRSF000437],	SM00563:PlsC,	Acetylation,Acyltransferase,Alternative splicing,Cataract,Complete proteome,Direct protein sequencing,Disease mutation,Dwarfism,Membrane,Peroxisome,Phosphoprotein,Proteomics identification,Reference proteome,Rhizomelic chondrodysplasia punctata,Transferase,	chain:Dihydroxyacetone phosphate acyltransferase,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,short sequence motif:HXXXXD motif,short sequence motif:Microbody targeting signal,
GYPC	glycophorin C (Gerbich blood group)(GYPC)	Homo sapiens					GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0030863~cortical cytoskeleton,	GO:0005515~protein binding,GO:0070492~oligosaccharide binding,	IPR001195:Glycophorin,IPR003585:Neurexin/syndecan/glycophorin C,	hsa05144:Malaria,	611162~Malaria, resistance to,616089~Blood group, Gerbich,	PIRSF002466:glycophorin,	SM00294:4.1m,	3D-structure,Alternative splicing,Blood group antigen,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Sialic acid,Transmembrane,Transmembrane helix,	chain:Glycophorin-C,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),modified residue,sequence variant,site:Not glycosylated; in variant Webb antigen,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPA33	glycoprotein A33(GPA33)	Homo sapiens				GO:0016337~single organismal cell-cell adhesion,	GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0009986~cell surface,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00408:IGc2,SM00409:IG,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Cell surface A33 antigen,compositionally biased region:Poly-Cys,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GLMP	glycosylated lysosomal membrane protein(GLMP)	Homo sapiens				GO:0030522~intracellular receptor signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0044212~transcription regulatory region DNA binding,						Alternative splicing,Complete proteome,Glycoprotein,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Lysosomal protein NCU-G1,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GLT8D1	glycosyltransferase 8 domain containing 1(GLT8D1)	Homo sapiens				GO:0000271~polysaccharide biosynthetic process,	GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0016757~transferase activity, transferring glycosyl groups,	IPR002495:Glycosyl transferase, family 8,					Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Glycosyltransferase 8 domain-containing protein 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GTDC1	glycosyltransferase like domain containing 1(GTDC1)	Homo sapiens						GO:0016757~transferase activity, transferring glycosyl groups,	IPR001296:Glycosyl transferase, family 1,IPR022701:Glycosyltransferase family 1, N-terminal,					Alternative splicing,Complete proteome,Glycosyltransferase,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glycosyltransferase-like domain- containing protein 1,sequence variant,splice variant,
GPC1	glypican 1(GPC1)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0007411~axon guidance,GO:0014037~Schwann cell differentiation,GO:0030200~heparan sulfate proteoglycan catabolic process,GO:0030203~glycosaminoglycan metabolic process,GO:0032288~myelin assembly,GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway,GO:2001016~positive regulation of skeletal muscle cell differentiation,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005768~endosome,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,GO:0043202~lysosomal lumen,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005507~copper ion binding,GO:0017134~fibroblast growth factor binding,GO:0043236~laminin binding,GO:0043395~heparan sulfate proteoglycan binding,	IPR001863:Glypican,IPR015502:Glypican-1,IPR019803:Glypican, conserved site,	hsa05205:Proteoglycans in cancer,				3D-structure,Alternative splicing,Cell membrane,Complete proteome,Copper,Direct protein sequencing,Disulfide bond,Endosome,Glycoprotein,GPI-anchor,Heparan sulfate,Lipoprotein,Membrane,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,S-nitrosylation,Secreted,Signal,Zinc,	chain:Glypican-1,chain:Secreted glypican-1,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (heparan sulfate),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,
GOLPH3L	golgi phosphoprotein 3 like(GOLPH3L)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007030~Golgi organization,GO:0043001~Golgi to plasma membrane protein transport,GO:0048193~Golgi vesicle transport,GO:0048194~Golgi vesicle budding,GO:0050714~positive regulation of protein secretion,	GO:0000139~Golgi membrane,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0031985~Golgi cisterna,GO:0032580~Golgi cisterna membrane,GO:0032588~trans-Golgi network membrane,	GO:0005515~protein binding,GO:0070273~phosphatidylinositol-4-phosphate binding,	IPR008628:Golgi phosphoprotein 3,					Alternative splicing,Complete proteome,Golgi apparatus,Lipid-binding,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Golgi phosphoprotein 3-like,
GORASP2	golgi reassembly stacking protein 2(GORASP2)	Homo sapiens				GO:0006996~organelle organization,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0005515~protein binding,	IPR001478:PDZ domain,IPR007583:GRASP55/65,IPR024958:GRASP55/65 PDZ-like domain,					3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Golgi apparatus,Lipoprotein,Membrane,Methylation,Myristate,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Golgi reassembly-stacking protein 2,compositionally biased region:Pro-rich,domain:PDZ,lipid moiety-binding region:N-myristoyl glycine,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
GOLT1A	golgi transport 1A(GOLT1A)	Homo sapiens				GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,		IPR007305:Vesicle transport protein, Got1/SFT2-like,					Complete proteome,Golgi apparatus,Membrane,Protein transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Vesicle transport protein GOT1A,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GOLGA4	golgin A4(GOLGA4)	Homo sapiens				GO:0000042~protein targeting to Golgi,GO:0016192~vesicle-mediated transport,GO:0043001~Golgi to plasma membrane protein transport,GO:0045773~positive regulation of axon extension,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0051020~GTPase binding,	IPR000237:GRIP,				SM00755:Grip,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Glycoprotein,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Golgin subfamily A member 4,compositionally biased region:Glu-rich,domain:GRIP,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
GORAB	golgin, RAB6 interacting(GORAB)	Homo sapiens				GO:0031069~hair follicle morphogenesis,GO:1901622~positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,	GO:0005515~protein binding,	IPR007033:Golgin, RAB6-interacting,		231070~Geroderma osteodysplasticum,			Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Dwarfism,Golgi apparatus,Polymorphism,Reference proteome,Signal,	chain:RAB6-interacting golgin,region of interest:Necessary for interaction with RCHY1,sequence conflict,sequence variant,splice variant,
GON4L	gon-4 like(GON4L)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,	IPR003822:Paired amphipathic helix,IPR009057:Homeodomain-like,IPR017877:Myb-like domain,					Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:GON-4-like protein,chain:YY1-associated protein 1,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Myb-like,modified residue,repeat:PAH 1,repeat:PAH 2,sequence conflict,sequence variant,splice variant,
GNRHR2	gonadotropin releasing hormone receptor 2 (pseudogene)(GNRHR2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0097211~cellular response to gonadotropin-releasing hormone,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004968~gonadotropin-releasing hormone receptor activity,GO:0042277~peptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001658:Gonadotrophin releasing hormone receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Phosphoprotein,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Putative gonadotropin-releasing hormone II receptor,glycosylation site:N-linked (GlcNAc...),splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GRHL1	grainyhead like transcription factor 1(GRHL1)	Homo sapiens				GO:0002934~desmosome organization,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0008544~epidermis development,GO:0045616~regulation of keratinocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061436~establishment of skin barrier,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR007604:CP2 transcription factor,					Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Grainyhead-like protein 1 homolog,modified residue,region of interest:Transcription activation,sequence conflict,sequence variant,splice variant,
GRHL3	grainyhead like transcription factor 3(GRHL3)	Homo sapiens				GO:0001736~establishment of planar polarity,GO:0001843~neural tube closure,GO:0006366~transcription from RNA polymerase II promoter,GO:0007389~pattern specification process,GO:0007398~ectoderm development,GO:0007417~central nervous system development,GO:0008544~epidermis development,GO:0032956~regulation of actin cytoskeleton organization,GO:0042060~wound healing,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061029~eyelid development in camera-type eye,GO:0061436~establishment of skin barrier,GO:0090103~cochlea morphogenesis,GO:0090179~planar cell polarity pathway involved in neural tube closure,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,	IPR007604:CP2 transcription factor,		606713~Van der Woude syndrome 2,			Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Grainyhead-like protein 3 homolog,region of interest:Transcription activation,sequence conflict,sequence variant,splice variant,
GREM2	gremlin 2, DAN family BMP antagonist(GREM2)	Homo sapiens				GO:0010172~embryonic body morphogenesis,GO:0019221~cytokine-mediated signaling pathway,GO:0030509~BMP signaling pathway,GO:0038098~sequestering of BMP from receptor via BMP binding,GO:0048263~determination of dorsal identity,GO:0060300~regulation of cytokine activity,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0008201~heparin binding,GO:0036122~BMP binding,GO:0042803~protein homodimerization activity,	IPR004133:DAN,IPR006207:Cystine knot, C-terminal,IPR017159:Gremlin precursor,			PIRSF037254:gremlin precursor,	SM00041:CT,	Complete proteome,Cytokine,Developmental protein,Disulfide bond,Glycoprotein,Heparin-binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Gremlin-2,disulfide bond,domain:CTCK,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
GDF7	growth differentiation factor 7(GDF7)	Homo sapiens				GO:0007411~axon guidance,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0021509~roof plate formation,GO:0021527~spinal cord association neuron differentiation,GO:0022612~gland morphogenesis,GO:0030509~BMP signaling pathway,GO:0030855~epithelial cell differentiation,GO:0030901~midbrain development,GO:0032924~activin receptor signaling pathway,GO:0040007~growth,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0045165~cell fate commitment,GO:0045666~positive regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048468~cell development,GO:0048608~reproductive structure development,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048853~forebrain morphogenesis,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060395~SMAD protein signal transduction,GO:0060571~morphogenesis of an epithelial fold,GO:2001051~positive regulation of tendon cell differentiation,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0042803~protein homodimerization activity,	IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,			SM00204:TGFB,	Cleavage on pair of basic residues,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Growth factor,Reference proteome,Secreted,Signal,	chain:Growth/differentiation factor 7,disulfide bond,glycosylation site:N-linked (GlcNAc...),signal peptide,
GFI1	growth factor independent 1 transcriptional repressor(GFI1)	Homo sapiens			General function prediction only,	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010956~negative regulation of calcidiol 1-monooxygenase activity,GO:0010957~negative regulation of vitamin D biosynthetic process,GO:0010977~negative regulation of neuron projection development,GO:0016032~viral process,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0034121~regulation of toll-like receptor signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051569~regulation of histone H3-K4 methylation,GO:0070105~positive regulation of interleukin-6-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,	GO:0005634~nucleus,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0017053~transcriptional repressor complex,	GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		607847~Neutropenia, nonimmune chronic idiopathic, of adults,613107~Neutropenia, severe congenital 2, autosomal dominant,		SM00355:ZnF_C2H2,	Complete proteome,Disease mutation,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein Gfi-1,compositionally biased region:Ala/Gly-rich,modified residue,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
GRB14	growth factor receptor bound protein 14(GRB14)	Homo sapiens				GO:0007165~signal transduction,GO:0009967~positive regulation of signal transduction,GO:0050900~leukocyte migration,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005070~SH3/SH2 adaptor activity,	IPR000159:Ras-association,IPR000980:SH2 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR015042:BPS (Between PH and SH2) domain,				SM00233:PH,SM00252:SH2,SM00314:RA,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Endosome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,	chain:Growth factor receptor-bound protein 14,domain:PH,domain:Ras-associating,domain:SH2,helix,modified residue,sequence conflict,strand,turn,
GREB1	growth regulation by estrogen in breast cancer 1(GREB1)	Homo sapiens		h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors,			GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,							Alternative splicing,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein GREB1,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,transmembrane region,
GBP1	guanylate binding protein 1(GBP1)	Homo sapiens				GO:0050848~regulation of calcium-mediated signaling,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0051607~defense response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1900041~negative regulation of interleukin-2 secretion,GO:1903076~regulation of protein localization to plasma membrane,GO:1903077~negative regulation of protein localization to plasma membrane,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0003779~actin binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019899~enzyme binding,GO:0019955~cytokine binding,GO:0030507~spectrin binding,GO:0042802~identical protein binding,GO:0051879~Hsp90 protein binding,	IPR003191:Guanylate-binding protein, C-terminal,IPR015894:Guanylate-binding protein, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Antiviral defense,Cell membrane,Complete proteome,Cytoplasm,Golgi apparatus,GTP-binding,Hydrolase,Immunity,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Polymorphism,Prenylation,Reference proteome,Secreted,	chain:Interferon-induced guanylate-binding protein 1,helix,lipid moiety-binding region:S-farnesyl cysteine,nucleotide phosphate-binding region:GTP,sequence variant,strand,turn,
GBP2	guanylate binding protein 2(GBP2)	Homo sapiens				GO:0006955~immune response,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,	GO:0000139~Golgi membrane,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR003191:Guanylate-binding protein, C-terminal,IPR015894:Guanylate-binding protein, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Cytoplasm,Golgi apparatus,GTP-binding,Hydrolase,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Polymorphism,Prenylation,Reference proteome,	chain:Interferon-induced guanylate-binding protein 2,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,sequence conflict,sequence variant,
GBP3	guanylate binding protein 3(GBP3)	Homo sapiens				GO:0051607~defense response to virus,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR003191:Guanylate-binding protein, C-terminal,IPR015894:Guanylate-binding protein, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Antiviral defense,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,GTP-binding,Hydrolase,Immunity,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:Guanylate-binding protein 3,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,transmembrane region,
GBP5	guanylate binding protein 5(GBP5)	Homo sapiens				GO:0006954~inflammatory response,GO:0045089~positive regulation of innate immune response,GO:0050702~interleukin-1 beta secretion,GO:0051289~protein homotetramerization,GO:0071346~cellular response to interferon-gamma,GO:0072616~interleukin-18 secretion,GO:1900017~positive regulation of cytokine production involved in inflammatory response,GO:1900227~positive regulation of NLRP3 inflammasome complex assembly,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0042802~identical protein binding,	IPR003191:Guanylate-binding protein, C-terminal,IPR015894:Guanylate-binding protein, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Antimicrobial,Complete proteome,Cytoplasm,Golgi apparatus,GTP-binding,Hydrolase,Immunity,Inflammatory response,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Polymorphism,Prenylation,Proteomics identification,Reference proteome,	chain:Guanylate-binding protein 5,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,sequence variant,
GBP7	guanylate binding protein 7(GBP7)	Homo sapiens					GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR003191:Guanylate-binding protein, C-terminal,IPR015894:Guanylate-binding protein, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Antimicrobial,Complete proteome,GTP-binding,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Guanylate-binding protein 7,nucleotide phosphate-binding region:GTP,sequence variant,transmembrane region,
GUCA1C	guanylate cyclase activator 1C(GUCA1C)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0007165~signal transduction,GO:0007601~visual perception,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0031284~positive regulation of guanylate cyclase activity,	GO:0097381~photoreceptor disc membrane,	GO:0005509~calcium ion binding,GO:0008048~calcium sensitive guanylate cyclase activator activity,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa04744:Phototransduction,			SM00054:EFh,	3D-structure,Alternative splicing,Calcium,Complete proteome,Lipoprotein,Metal-binding,Myristate,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Guanylyl cyclase-activating protein 3,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,helix,lipid moiety-binding region:N-myristoyl glycine,sequence variant,splice variant,strand,turn,
GUCA2A	guanylate cyclase activator 2A(GUCA2A)	Homo sapiens				GO:0031284~positive regulation of guanylate cyclase activity,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,	GO:0005179~hormone activity,GO:0030250~guanylate cyclase activator activity,	IPR000879:Guanylin,			PIRSF001849:guanylin,		3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Polymorphism,Reference proteome,Secreted,Signal,	chain:HMW-guanylin,disulfide bond,helix,peptide:Guanylin,signal peptide,strand,turn,
GUK1	guanylate kinase 1(GUK1)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,		GO:0006163~purine nucleotide metabolic process,GO:0006185~dGDP biosynthetic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0019673~GDP-mannose metabolic process,GO:0034436~glycoprotein transport,GO:0046034~ATP metabolic process,GO:0046037~GMP metabolic process,GO:0046054~dGMP metabolic process,GO:0046060~dATP metabolic process,GO:0046711~GDP biosynthetic process,GO:0046939~nucleotide phosphorylation,	GO:0005829~cytosol,	GO:0004385~guanylate kinase activity,GO:0005524~ATP binding,	IPR008144:Guanylate kinase,IPR008145:Guanylate kinase/L-type calcium channel,IPR017665:Guanylate kinase, sub-group,IPR020590:Guanylate kinase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,			SM00072:GuKc,	Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Kinase,Nucleotide-binding,Proteomics identification,Reference proteome,Transferase,	chain:Guanylate kinase,domain:Guanylate kinase-like,modified residue,nucleotide phosphate-binding region:ATP,
HSPD1	heat shock protein family D (Hsp60) member 1(HSPD1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0002236~detection of misfolded protein,GO:0002368~B cell cytokine production,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0002842~positive regulation of T cell mediated immune response to tumor cell,GO:0002931~response to ischemia,GO:0006458~'de novo' protein folding,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006986~response to unfolded protein,GO:0008637~apoptotic mitochondrial changes,GO:0009408~response to heat,GO:0009409~response to cold,GO:0014823~response to activity,GO:0016032~viral process,GO:0032496~response to lipopolysaccharide,GO:0032727~positive regulation of interferon-alpha production,GO:0032729~positive regulation of interferon-gamma production,GO:0032733~positive regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0032755~positive regulation of interleukin-6 production,GO:0033198~response to ATP,GO:0042026~protein refolding,GO:0042100~B cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043032~positive regulation of macrophage activation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0043627~response to estrogen,GO:0048291~isotype switching to IgG isotypes,GO:0050729~positive regulation of inflammatory response,GO:0050821~protein stabilization,GO:0050870~positive regulation of T cell activation,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0051131~chaperone-mediated protein complex assembly,GO:0051384~response to glucocorticoid,GO:0051604~protein maturation,GO:0071866~negative regulation of apoptotic process in bone marrow,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,GO:1904469~positive regulation of tumor necrosis factor secretion,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005769~early endosome,GO:0005782~peroxisomal matrix,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0009986~cell surface,GO:0016020~membrane,GO:0019907~cyclin-dependent protein kinase activating kinase holoenzyme complex,GO:0030061~mitochondrial crista,GO:0030135~coated vesicle,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0042588~zymogen granule,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0046696~lipopolysaccharide receptor complex,GO:0070062~extracellular exosome,	GO:0001530~lipopolysaccharide binding,GO:0002039~p53 binding,GO:0003688~DNA replication origin binding,GO:0003697~single-stranded DNA binding,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001844:Chaperonin Cpn60,IPR002423:Chaperonin Cpn60/TCP-1,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR018370:Chaperonin Cpn60, conserved site,IPR027409:GroEL-like apical domain,IPR027413:GroEL-like equatorial domain,	hsa03018:RNA degradation,hsa04940:Type I diabetes mellitus,hsa05134:Legionellosis,hsa05152:Tuberculosis,	605280~Spastic paraplegia 13, autosomal dominant,612233~Leukodystrophy, hypomyelinating, 4,			3D-structure,Acetylation,Alternative splicing,ATP-binding,Chaperone,Complete proteome,Direct protein sequencing,Disease mutation,Hereditary spastic paraplegia,Host-virus interaction,Leukodystrophy,Mitochondrion,Neurodegeneration,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Stress response,Transit peptide,	chain:60 kDa heat shock protein, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
HSPE1	heat shock protein family E (Hsp10) member 1(HSPE1)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0006457~protein folding,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006986~response to unfolded protein,GO:0051085~chaperone mediated protein folding requiring cofactor,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR011032:GroES-like,IPR018369:Chaperonin Cpn10, conserved site,IPR020818:Chaperonin Cpn10,				SM00883:SM00883,	3D-structure,Acetylation,Chaperone,Complete proteome,Direct protein sequencing,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Stress response,	chain:10 kDa heat shock protein, mitochondrial,modified residue,
HHAT	hedgehog acyltransferase(HHAT)	Homo sapiens				GO:0007224~smoothened signaling pathway,GO:0007275~multicellular organism development,GO:0018345~protein palmitoylation,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005525~GTP binding,GO:0008374~O-acyltransferase activity,GO:0016409~palmitoyltransferase activity,	IPR004299:Membrane bound O-acyl transferase, MBOAT,					Acyltransferase,Alternative splicing,Complete proteome,Developmental protein,Endoplasmic reticulum,GTP-binding,Lipoprotein,Membrane,Nucleotide-binding,Palmitate,Polymorphism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Protein-cysteine N-palmitoyltransferase HHAT,region of interest:GTP-binding,sequence conflict,sequence variant,splice variant,transmembrane region,
HMCN1	hemicentin 1(HMCN1)	Homo sapiens				GO:0007049~cell cycle,GO:0007601~visual perception,GO:0050896~response to stimulus,GO:0051301~cell division,	GO:0005604~basement membrane,GO:0005938~cell cortex,GO:0030054~cell junction,GO:0031012~extracellular matrix,GO:0032154~cleavage furrow,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR000884:Thrombospondin, type 1 repeat,IPR001881:EGF-like calcium-binding,IPR002035:von Willebrand factor, type A,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR006605:G2 nidogen/fibulin G2F,IPR007110:Immunoglobulin-like domain,IPR009017:Green fluorescent protein,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR018097:EGF-like calcium-binding, conserved site,IPR023413:Green fluorescent protein-like,IPR026823:Complement Clr-like EGF domain,		603075~Macular degeneration, age-related, 1,		SM00179:EGF_CA,SM00181:EGF,SM00209:TSP1,SM00406:IGv,SM00408:IGc2,SM00409:IG,SM00682:G2F,	Age-related macular degeneration,Alternative splicing,Basement membrane,Calcium,Cell cycle,Cell division,Cell junction,Complete proteome,Cytoplasm,Disease mutation,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Sensory transduction,Signal,Vision,	chain:Hemicentin-1,disulfide bond,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:Ig-like C2-type 1,domain:Ig-like C2-type 10,domain:Ig-like C2-type 11,domain:Ig-like C2-type 12,domain:Ig-like C2-type 13,domain:Ig-like C2-type 14,domain:Ig-like C2-type 15,domain:Ig-like C2-type 16,domain:Ig-like C2-type 17,domain:Ig-like C2-type 18,domain:Ig-like C2-type 19,domain:Ig-like C2-type 2,domain:Ig-like C2-type 20,domain:Ig-like C2-type 21,domain:Ig-like C2-type 22,domain:Ig-like C2-type 23,domain:Ig-like C2-type 24,domain:Ig-like C2-type 25,domain:Ig-like C2-type 26,domain:Ig-like C2-type 27,domain:Ig-like C2-type 28,domain:Ig-like C2-type 29,domain:Ig-like C2-type 3,domain:Ig-like C2-type 30,domain:Ig-like C2-type 31,domain:Ig-like C2-type 32,domain:Ig-like C2-type 33,domain:Ig-like C2-type 34,domain:Ig-like C2-type 35,domain:Ig-like C2-type 36,domain:Ig-like C2-type 37,domain:Ig-like C2-type 38,domain:Ig-like C2-type 39,domain:Ig-like C2-type 4,domain:Ig-like C2-type 40,domain:Ig-like C2-type 41,domain:Ig-like C2-type 42,domain:Ig-like C2-type 43,domain:Ig-like C2-type 44,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Ig-like C2-type 8,domain:Ig-like C2-type 9,domain:Nidogen G2 beta-barrel,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:VWFA,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
HS2ST1	heparan sulfate 2-O-sulfotransferase 1(HS2ST1)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,GO:0015014~heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,GO:0030202~heparin metabolic process,GO:0060676~ureteric bud formation,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004394~heparan sulfate 2-O-sulfotransferase activity,GO:0008146~sulfotransferase activity,	IPR005331:Sulfotransferase,IPR007734:Heparan sulphate 2-O-sulfotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,				Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Heparan sulfate 2-O-sulfotransferase 1,glycosylation site:N-linked (GlcNAc...),splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
HS6ST1	heparan sulfate 6-O-sulfotransferase 1(HS6ST1)	Homo sapiens				GO:0001525~angiogenesis,GO:0006024~glycosaminoglycan biosynthetic process,GO:0015015~heparan sulfate proteoglycan biosynthetic process, enzymatic modification,GO:0048286~lung alveolus development,GO:0048666~neuron development,GO:0060716~labyrinthine layer blood vessel development,	GO:0000139~Golgi membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0008146~sulfotransferase activity,GO:0017095~heparan sulfate 6-O-sulfotransferase activity,	IPR005331:Sulfotransferase,IPR010635:Heparan sulphate 6-sulfotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,	614880~Hypogonadotropic hypogonadism 15 with or without anosmia,			Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Glycoprotein,Hypogonadotropic hypogonadism,Kallmann syndrome,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Heparan-sulfate 6-O-sulfotransferase 1,compositionally biased region:Poly-Arg,glycosylation site:N-linked (GlcNAc...),region of interest:3'-phosphate binding,region of interest:5'-phosphosulfate-binding,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
HSPG2	heparan sulfate proteoglycan 2(HSPG2)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0001525~angiogenesis,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0030203~glycosaminoglycan metabolic process,GO:0042157~lipoprotein metabolic process,GO:0044267~cellular protein metabolic process,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0031012~extracellular matrix,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,	IPR000034:Laminin B type IV,IPR000082:SEA domain,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013032:EGF-like, conserved site,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa04512:ECM-receptor interaction,hsa05161:Hepatitis B,hsa05205:Proteoglycans in cancer,	224410~Dyssegmental dysplasia, Silverman-Handmaker type,255800~Schwartz-Jampel syndrome, type 1,		SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,SM00192:LDLa,SM00200:SEA,SM00281:LamB,SM00282:LamG,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Angiogenesis,Basement membrane,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Heparan sulfate,Immunoglobulin domain,Laminin EGF-like domain,Metal-binding,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Basement membrane-specific heparan sulfate proteoglycan core protein,chain:Endorepellin,chain:LG3 peptide,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 10,domain:Ig-like C2-type 11,domain:Ig-like C2-type 12,domain:Ig-like C2-type 13,domain:Ig-like C2-type 14,domain:Ig-like C2-type 15,domain:Ig-like C2-type 16,domain:Ig-like C2-type 17,domain:Ig-like C2-type 18,domain:Ig-like C2-type 19,domain:Ig-like C2-type 2,domain:Ig-like C2-type 20,domain:Ig-like C2-type 21,domain:Ig-like C2-type 22,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Ig-like C2-type 8,domain:Ig-like C2-type 9,domain:Laminin EGF-like 10,domain:Laminin EGF-like 11,domain:Laminin EGF-like 1; first part,domain:Laminin EGF-like 1; second part,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4; truncated,domain:Laminin EGF-like 5; first part,domain:Laminin EGF-like 5; second part,domain:Laminin EGF-like 6,domain:Laminin EGF-like 7,domain:Laminin EGF-like 8,domain:Laminin EGF-like 9; first part,domain:Laminin EGF-like 9; second part,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,domain:Laminin IV type A 1,domain:Laminin IV type A 2,domain:Laminin IV type A 3,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,domain:SEA,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (chondroitin sulfate),glycosylation site:O-linked (Xyl...) (heparan sulfate),mutagenesis site,region of interest:Mediates motor neuron attachment,sequence conflict,sequence variant,signal peptide,site:Cleavage; by BMP1,
HDGF	hepatoma-derived growth factor(HDGF)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0036498~IRE1-mediated unfolded protein response,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0000166~nucleotide binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0001222~transcription corepressor binding,GO:0003677~DNA binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0044822~poly(A) RNA binding,	IPR000313:PWWP,				SM00293:PWWP,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Growth factor,Heparin-binding,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	binding site:Heparin,chain:Hepatoma-derived growth factor,compositionally biased region:Glu-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:PWWP,helix,modified residue,sequence variant,short sequence motif:Bipartite nuclear localization signal,short sequence motif:Nuclear localization signal,strand,turn,
HES3	hes family bHLH transcription factor 3(HES3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0021555~midbrain-hindbrain boundary morphogenesis,GO:0021557~oculomotor nerve development,GO:0021558~trochlear nerve development,GO:0021575~hindbrain morphogenesis,GO:0030901~midbrain development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060164~regulation of timing of neuron differentiation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0008134~transcription factor binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Complete proteome,DNA-binding,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor HES-3,compositionally biased region:Pro-rich,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Orange,short sequence motif:WRPW motif,
HP1BP3	heterochromatin protein 1 binding protein 3(HP1BP3)	Homo sapiens				GO:0006334~nucleosome assembly,GO:0006355~regulation of transcription, DNA-templated,GO:0042127~regulation of cell proliferation,GO:0070828~heterochromatin organization,GO:0071456~cellular response to hypoxia,GO:0097298~regulation of nucleus size,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0031491~nucleosome binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00526:H15,	3D-structure,Acetylation,Alternative splicing,Chromosome,Coiled coil,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Heterochromatin protein 1-binding protein 3,compositionally biased region:Lys-rich,modified residue,sequence conflict,splice variant,
HNRNPA3	heterogeneous nuclear ribonucleoprotein A3(HNRNPA3)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0010467~gene expression,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0035770~ribonucleoprotein granule,GO:0043005~neuron projection,GO:0071013~catalytic step 2 spliceosome,GO:1990124~messenger ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0051033~RNA transmembrane transporter activity,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	hsa03040:Spliceosome,			SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein A3,compositionally biased region:Gly-rich,domain:RRM 1,domain:RRM 2,modified residue,splice variant,
HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1(HNRNPCL1)	Homo sapiens					GO:0005634~nucleus,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly,			PIRSF037992:heterogeneous nuclear ribonucleoprotein C, Raly type,	SM00360:RRM,	Coiled coil,Complete proteome,Nucleus,Polymorphism,Reference proteome,Ribonucleoprotein,RNA-binding,	chain:Heterogeneous nuclear ribonucleoprotein C-like 1,domain:RRM,modified residue,sequence variant,
HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2(HNRNPCL2)	Homo sapiens					GO:0005634~nucleus,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly,			PIRSF037992:heterogeneous nuclear ribonucleoprotein C, Raly type,	SM00360:RRM,	Coiled coil,Complete proteome,Nucleus,Reference proteome,Ribonucleoprotein,RNA-binding,	chain:Heterogeneous nuclear ribonucleoprotein C-like 1,domain:RRM,modified residue,sequence variant,
HNRNPCL4	heterogeneous nuclear ribonucleoprotein C-like 4(HNRNPCL4)	Homo sapiens					GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly,			PIRSF037992:heterogeneous nuclear ribonucleoprotein C, Raly type,	SM00360:RRM,	Coiled coil,Complete proteome,Nucleus,Reference proteome,RNA-binding,
HNRNPLL	heterogeneous nuclear ribonucleoprotein L like(HNRNPLL)	Homo sapiens				GO:0006397~mRNA processing,GO:0033120~positive regulation of RNA splicing,	GO:0005634~nucleus,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein L-like,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,domain:RRM 1,domain:RRM 2,domain:RRM 3,splice variant,
HNRNPR	heterogeneous nuclear ribonucleoprotein R(HNRNPR)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007623~circadian rhythm,GO:0010467~gene expression,GO:0043086~negative regulation of catalytic activity,GO:0061014~positive regulation of mRNA catabolic process,GO:0061157~mRNA destabilization,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0019013~viral nucleocapsid,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030529~intracellular ribonucleoprotein complex,GO:0043679~axon terminus,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006535:HnRNP R/Q splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,Isopeptide bond,Microsome,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein R,compositionally biased region:Asn/Gln-rich,compositionally biased region:Asp/Glu-rich (acidic),domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,region of interest:3 X 11 AA approximate repeats of D-D-Y-Y- G-Y-D-Y-H-D-Y,region of interest:RNA-binding RGG-box,repeat:1; approximate,repeat:2,repeat:3; approximate,short sequence motif:Nuclear localization signal,splice variant,strand,
HK2	hexokinase 2(HK2)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0001678~cellular glucose homeostasis,GO:0002931~response to ischemia,GO:0006096~glycolytic process,GO:0007595~lactation,GO:0008637~apoptotic mitochondrial changes,GO:0015758~glucose transport,GO:0035795~negative regulation of mitochondrial membrane permeability,GO:0046324~regulation of glucose import,GO:0046835~carbohydrate phosphorylation,GO:0051156~glucose 6-phosphate metabolic process,GO:0061621~canonical glycolysis,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:1904925~positive regulation of mitophagy in response to mitochondrial depolarization,GO:2000378~negative regulation of reactive oxygen species metabolic process,	GO:0005623~cell,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004340~glucokinase activity,GO:0004396~hexokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008865~fructokinase activity,GO:0019158~mannokinase activity,	IPR001312:Hexokinase,IPR019807:Hexokinase, conserved site,IPR022672:Hexokinase, N-terminal,IPR022673:Hexokinase, C-terminal,	hsa00010:Glycolysis / Gluconeogenesis,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa00524:Butirosin and neomycin biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04066:HIF-1 signaling pathway,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04973:Carbohydrate digestion and absorption,hsa05230:Central carbon metabolism in cancer,				3D-structure,Acetylation,Allosteric enzyme,ATP-binding,Complete proteome,Glycolysis,Kinase,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,	binding site:ATP,binding site:ATP 1,binding site:ATP 2,binding site:Glucose-6-phosphate 1,binding site:Glucose-6-phosphate 2,binding site:Substrate 1,binding site:Substrate 2,chain:Hexokinase-2,helix,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,region of interest:Catalytic,region of interest:Glucose-6-phosphate 1 binding,region of interest:Glucose-6-phosphate 2 binding,region of interest:Hydrophobic,region of interest:Regulatory,region of interest:Substrate 1 binding,region of interest:Substrate 2 binding,sequence conflict,sequence variant,strand,turn,
H6PD	hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase(H6PD)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0006006~glucose metabolic process,GO:0006098~pentose-phosphate shunt,GO:0055114~oxidation-reduction process,GO:0097305~response to alcohol,	GO:0005739~mitochondrion,GO:0005788~endoplasmic reticulum lumen,	GO:0004345~glucose-6-phosphate dehydrogenase activity,GO:0017057~6-phosphogluconolactonase activity,GO:0030246~carbohydrate binding,GO:0047936~glucose 1-dehydrogenase [NAD(P)] activity,GO:0050661~NADP binding,	IPR001282:Glucose-6-phosphate dehydrogenase,IPR005900:6-phosphogluconolactonase, DevB-type,IPR006148:Glucosamine/galactosamine-6-phosphate isomerase,IPR016040:NAD(P)-binding domain,IPR019796:Glucose-6-phosphate dehydrogenase, active site,IPR022674:Glucose-6-phosphate dehydrogenase, NAD-binding,IPR022675:Glucose-6-phosphate dehydrogenase, C-terminal,	hsa00030:Pentose phosphate pathway,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,	604931~Cortisone reductase deficiency 1,			Carbohydrate metabolism,Complete proteome,Disease mutation,Endoplasmic reticulum,Glucose metabolism,Glycoprotein,Hydrolase,Multifunctional enzyme,NAD,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Signal,	active site:Proton acceptor,binding site:NADP,binding site:Substrate,chain:GDH/6PGL endoplasmic bifunctional protein,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:6-phosphogluconolactonase,region of interest:Glucose 1-dehydrogenase,region of interest:Linker,sequence conflict,sequence variant,signal peptide,
HDLBP	high density lipoprotein binding protein(HDLBP)	Homo sapiens				GO:0006869~lipid transport,GO:0008203~cholesterol metabolic process,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0034364~high-density lipoprotein particle,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	3D-structure,Acetylation,Alternative splicing,Cholesterol metabolism,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,HDL,Lipid metabolism,Lipid transport,Lipoprotein,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Steroid metabolism,Sterol metabolism,Transport,	chain:Vigilin,domain:KH 1,domain:KH 10,domain:KH 11,domain:KH 12,domain:KH 13,domain:KH 14,domain:KH 2,domain:KH 3,domain:KH 4,domain:KH 5,domain:KH 6,domain:KH 7,domain:KH 8,domain:KH 9,helix,modified residue,sequence variant,strand,turn,
HMGB4	high mobility group box 4(HMGB4)	Homo sapiens					GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR009071:High mobility group (HMG) box domain,				SM00398:HMG,	Chromosome,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Repeat,	chain:High mobility group protein B4,DNA-binding region:HMG box 1,DNA-binding region:HMG box 2,sequence variant,
HPCAL1	hippocalcin like 1(HPCAL1)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,		GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Complete proteome,Lipoprotein,Membrane,Metal-binding,Myristate,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Hippocalcin-like protein 1,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,lipid moiety-binding region:N-myristoyl glycine,sequence conflict,
HPCAL4	hippocalcin like 4(HPCAL4)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0007165~signal transduction,GO:0007417~central nervous system development,	GO:0005622~intracellular,	GO:0005246~calcium channel regulator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0019904~protein domain specific binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Complete proteome,Lipoprotein,Metal-binding,Myristate,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Hippocalcin-like protein 4,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,lipid moiety-binding region:N-myristoyl glycine,sequence conflict,
HRH1	histamine receptor H1(HRH1)	Homo sapiens				GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007613~memory,GO:0008542~visual learning,GO:0019229~regulation of vasoconstriction,GO:0032962~positive regulation of inositol trisphosphate biosynthetic process,GO:0043114~regulation of vascular permeability,GO:0045907~positive regulation of vasoconstriction,GO:0048016~inositol phosphate-mediated signaling,GO:0048167~regulation of synaptic plasticity,GO:0048245~eosinophil chemotaxis,GO:0050804~modulation of synaptic transmission,GO:0071420~cellular response to histamine,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004969~histamine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000921:Histamine H1 receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04750:Inflammatory mediator regulation of TRP channels,			SM01381:SM01381,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Histamine H1 receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
HAT1	histone acetyltransferase 1(HAT1)	Homo sapiens				GO:0006323~DNA packaging,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006348~chromatin silencing at telomere,GO:0006475~internal protein amino acid acetylation,GO:0007584~response to nutrient,GO:0043967~histone H4 acetylation,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,	GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0010485~H4 histone acetyltransferase activity,GO:0042393~histone binding,	IPR016181:Acyl-CoA N-acyltransferase,IPR017380:Histone acetyltransferase type B, catalytic subunit,IPR019467:Histone acetyl transferase HAT1 N-terminal,	hsa05034:Alcoholism,		PIRSF038084:histone acetyltransferase type B, catalytic subunit,		3D-structure,Acetylation,Acyltransferase,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Histone acetyltransferase type B catalytic subunit,helix,modified residue,sequence variant,strand,turn,
HIST2H2AA3	histone cluster 2 H2A family member a3(HIST2H2AA3)	Homo sapiens				GO:0006342~chromatin silencing,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,			SM00414:H2A,	Acetylation,Chromosome,Citrullination,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Histone H2A type 2-A,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,mutagenesis site,
HIST2H2BD	histone cluster 2 H2B family member d (pseudogene)(HIST2H2BD)	Homo sapiens				GO:0006334~nucleosome assembly,	GO:0000788~nuclear nucleosome,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR000558:Histone H2B,IPR007125:Histone core,IPR009072:Histone-fold,				SM00427:H2B,	Acetylation,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Putative histone H2B type 2-D,modified residue,
HIST2H2BF	histone cluster 2 H2B family member f(HIST2H2BF)	Homo sapiens				GO:0006334~nucleosome assembly,	GO:0000788~nuclear nucleosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR000558:Histone H2B,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05203:Viral carcinogenesis,hsa05322:Systemic lupus erythematosus,			SM00427:H2B,	Acetylation,Alternative splicing,Chromosome,Complete proteome,DNA-binding,Glycoprotein,Isopeptide bond,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Histone H2B type 2-F,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,
HIST2H3PS2	histone cluster 2 H3 pseudogene 2(HIST2H3PS2)	Homo sapiens				GO:0006334~nucleosome assembly,	GO:0000786~nucleosome,GO:0005634~nucleus,	GO:0031492~nucleosomal DNA binding,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,				SM00428:H3,	3D-structure,Chromosome,Complete proteome,DNA-binding,Nucleosome core,Nucleus,Proteomics identification,Reference proteome,
HIST3H3	histone cluster 3 H3(HIST3H3)	Homo sapiens				GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006334~nucleosome assembly,GO:0016233~telomere capping,GO:0032460~negative regulation of protein oligomerization,GO:0051290~protein heterotetramerization,	GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0046982~protein heterodimerization activity,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,			SM00428:H3,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,DNA-binding,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Histone H3.1t,helix,modified residue,
HDAC1	histone deacetylase 1(HDAC1)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_huntingtonPathway:Inhibition of Huntington's disease neurodegeneration by histone deacetylase inhibitors,h_mef2dPathway:Role of MEF2D in T-cell Apoptosis,h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,h_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,h_wntPathway:WNT Signaling Pathway,	Chromatin structure and dynamics / Secondary metabolites biosynthesis, transport, and catabolism,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001975~response to amphetamine,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006346~methylation-dependent chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0007596~blood coagulation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009913~epidermal cell differentiation,GO:0010629~negative regulation of gene expression,GO:0010832~negative regulation of myotube differentiation,GO:0010870~positive regulation of receptor biosynthetic process,GO:0016032~viral process,GO:0016575~histone deacetylation,GO:0031000~response to caffeine,GO:0032496~response to lipopolysaccharide,GO:0032732~positive regulation of interleukin-1 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032922~circadian regulation of gene expression,GO:0034599~cellular response to oxidative stress,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042733~embryonic digit morphogenesis,GO:0043044~ATP-dependent chromatin remodeling,GO:0043066~negative regulation of apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0043922~negative regulation by host of viral transcription,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046676~negative regulation of insulin secretion,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0055093~response to hyperoxia,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:0060789~hair follicle placode formation,GO:0061029~eyelid development in camera-type eye,GO:0061198~fungiform papilla formation,GO:0070932~histone H3 deacetylation,GO:0070933~histone H4 deacetylation,GO:0071356~cellular response to tumor necrosis factor,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904837~beta-catenin-TCF complex assembly,GO:2000343~positive regulation of chemokine (C-X-C motif) ligand 2 production,GO:2000676~positive regulation of type B pancreatic cell apoptotic process,GO:2000757~negative regulation of peptidyl-lysine acetylation,	GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0043005~neuron projection,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0031492~nucleosomal DNA binding,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),GO:0033558~protein deacetylase activity,GO:0033613~activating transcription factor binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0047485~protein N-terminus binding,GO:0051059~NF-kappaB binding,GO:0070491~repressing transcription factor binding,	IPR000286:Histone deacetylase superfamily,IPR003084:Histone deacetylase,IPR023801:Histone deacetylase domain,	hsa04110:Cell cycle,hsa04330:Notch signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05016:Huntington's disease,hsa05034:Alcoholism,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05220:Chronic myeloid leukemia,		PIRSF037913:histone deacetylase class I, eukaryotic type,		3D-structure,Acetylation,Biological rhythms,Chromatin regulator,Complete proteome,Host-virus interaction,Hydrolase,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,S-nitrosylation,Transcription,Transcription regulation,Ubl conjugation,	chain:Histone deacetylase 1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),modified residue,mutagenesis site,region of interest:Histone deacetylase,sequence conflict,
HDAC11	histone deacetylase 11(HDAC11)	Homo sapiens				GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0014003~oligodendrocyte development,GO:0016575~histone deacetylation,GO:0070932~histone H3 deacetylation,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004407~histone deacetylase activity,GO:0008134~transcription factor binding,GO:0016787~hydrolase activity,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),	IPR000286:Histone deacetylase superfamily,IPR023801:Histone deacetylase domain,	hsa05034:Alcoholism,hsa05203:Viral carcinogenesis,				Alternative splicing,Chromatin regulator,Complete proteome,Hydrolase,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Histone deacetylase 11,region of interest:Histone deacetylase,sequence conflict,
HDAC4	histone deacetylase 4(HDAC4)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression,	Chromatin structure and dynamics / Secondary metabolites biosynthesis, transport, and catabolism,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0002076~osteoblast development,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006954~inflammatory response,GO:0007399~nervous system development,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010592~positive regulation of lamellipodium assembly,GO:0010832~negative regulation of myotube differentiation,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0014894~response to denervation involved in regulation of muscle adaptation,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016575~histone deacetylation,GO:0030183~B cell differentiation,GO:0033235~positive regulation of protein sumoylation,GO:0034983~peptidyl-lysine deacetylation,GO:0040029~regulation of gene expression, epigenetic,GO:0042113~B cell activation,GO:0042493~response to drug,GO:0043393~regulation of protein binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043525~positive regulation of neuron apoptotic process,GO:0045668~negative regulation of osteoblast differentiation,GO:0045820~negative regulation of glycolytic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048742~regulation of skeletal muscle fiber development,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0070555~response to interleukin-1,GO:0070932~histone H3 deacetylation,GO:0070933~histone H4 deacetylation,GO:0071260~cellular response to mechanical stimulus,GO:0071356~cellular response to tumor necrosis factor,GO:0071374~cellular response to parathyroid hormone stimulus,GO:1903428~positive regulation of reactive oxygen species biosynthetic process,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0017053~transcriptional repressor complex,GO:0030018~Z disc,GO:0031594~neuromuscular junction,GO:0031672~A band,GO:0042641~actomyosin,GO:0043234~protein complex,	GO:0001025~RNA polymerase III transcription factor binding,GO:0001047~core promoter binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0030955~potassium ion binding,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),GO:0033558~protein deacetylase activity,GO:0033613~activating transcription factor binding,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0070491~repressing transcription factor binding,	IPR000286:Histone deacetylase superfamily,IPR017320:Histone deacetylase class II, eukaryotic,IPR023801:Histone deacetylase domain,IPR024643:Histone deacetylase, glutamine rich N-terminal domain,	hsa05034:Alcoholism,hsa05203:Viral carcinogenesis,		PIRSF037911:histone deacetylase class II, eukaryotic type,		3D-structure,Alternative splicing,Autism spectrum disorder,Chromatin regulator,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Isopeptide bond,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,	chain:Histone deacetylase 4,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),helix,modified residue,mutagenesis site,region of interest:Histone deacetylase,region of interest:Interaction with MEF2A,sequence conflict,sequence variant,short sequence motif:Nuclear export signal,strand,turn,
HOXD10	homeobox D10(HOXD10)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007338~single fertilization,GO:0007519~skeletal muscle tissue development,GO:0008344~adult locomotory behavior,GO:0009952~anterior/posterior pattern specification,GO:0009954~proximal/distal pattern formation,GO:0021520~spinal cord motor neuron cell fate specification,GO:0030326~embryonic limb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048704~embryonic skeletal system morphogenesis,GO:0048935~peripheral nervous system neuron development,GO:0050905~neuromuscular process,	GO:0005634~nucleus,	GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,	hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,	192950~Charcot-Marie-Tooth disease, foot deformity of,192950~Vertical talus, congenital,		SM00389:HOX,	Complete proteome,Developmental protein,Disease mutation,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Hox-D10,DNA-binding region:Homeobox,sequence conflict,sequence variant,
HOXD11	homeobox D11(HOXD11)	Homo sapiens				GO:0001658~branching involved in ureteric bud morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0009953~dorsal/ventral pattern formation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,IPR021918:Domain of unknown function DUF3528, homeobox protein, eukaryotic,				SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Hox-D11,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,DNA-binding region:Homeobox,sequence conflict,sequence variant,
HOXD8	homeobox D8(HOXD8)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0008595~anterior/posterior axis specification, embryo,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048705~skeletal system morphogenesis,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001827:Homeobox protein, antennapedia type, conserved site,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Hox-D8,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,DNA-binding region:Homeobox,sequence conflict,
HIPK1	homeodomain interacting protein kinase 1(HIPK1)	Homo sapiens				GO:0001654~eye development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007224~smoothened signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0010842~retina layer formation,GO:0030182~neuron differentiation,GO:0034333~adherens junction assembly,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0045766~positive regulation of angiogenesis,GO:0048596~embryonic camera-type eye morphogenesis,GO:0060059~embryonic retina morphogenesis in camera-type eye,GO:0060216~definitive hemopoiesis,GO:0060235~lens induction in camera-type eye,GO:0061072~iris morphogenesis,GO:0072577~endothelial cell apoptotic process,GO:0097191~extrinsic apoptotic signaling pathway,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,DNA-binding,Homeobox,Isopeptide bond,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Signal,Transcription,Transcription regulation,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Homeodomain-interacting protein kinase 1,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with TP53,sequence conflict,sequence variant,splice variant,
HOOK1	hook microtubule tethering protein 1(HOOK1)	Homo sapiens				GO:0007032~endosome organization,GO:0007040~lysosome organization,GO:0007275~multicellular organism development,GO:0007286~spermatid development,GO:0008333~endosome to lysosome transport,GO:0015031~protein transport,GO:0045022~early endosome to late endosome transport,	GO:0005829~cytosol,GO:0005874~microtubule,GO:0030897~HOPS complex,GO:0070695~FHF complex,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0042802~identical protein binding,	IPR008636:HOOK/CCDC88,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Microtubule,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Spermatogenesis,Transport,	chain:Protein Hook homolog 1,modified residue,mutagenesis site,region of interest:Sufficient for interaction with AKTIP and VPS18,region of interest:Sufficient for interaction with microtubules,sequence variant,
HRNR	hornerin(HRNR)	Homo sapiens				GO:0031424~keratinization,GO:0043163~cell envelope organization,GO:0061436~establishment of skin barrier,	GO:0001533~cornified envelope,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030313~cell envelope,GO:0036457~keratohyalin granule,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM01394:SM01394,	Calcium,Complete proteome,Developmental protein,Keratinization,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:antimicrobial peptide E608,chain:Hornerin,domain:EF-hand 1,domain:EF-hand 2,modified residue,region of interest:S-100-like,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,
HIVEP3	human immunodeficiency virus type I enhancer binding protein 3(HIVEP3)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0035914~skeletal muscle cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription factor HIVEP3,compositionally biased region:Glu/Pro-rich,compositionally biased region:Ser-rich,modified residue,region of interest:6 X 4 AA tandem repeats of S-P-X-[RK],region of interest:Acidic 1,region of interest:Acidic 2,region of interest:Acidic 3,region of interest:No DNA binding activity or transactivation activity, but complete prevention of TRAF-dependent NF-Kappa-B activation; associates with TRAF2 and JUN,region of interest:ZAS1,region of interest:ZAS2,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3; degenerate,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
HAPLN2	hyaluronan and proteoglycan link protein 2(HAPLN2)	Homo sapiens				GO:0001501~skeletal system development,GO:0007155~cell adhesion,GO:0007417~central nervous system development,GO:0008065~establishment of blood-nerve barrier,GO:0085029~extracellular matrix assembly,	GO:0005578~proteinaceous extracellular matrix,	GO:0005201~extracellular matrix structural constituent,GO:0005540~hyaluronic acid binding,	IPR000538:Link,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00406:IGv,SM00409:IG,SM00445:LINK,	Complete proteome,Disulfide bond,Extracellular matrix,Hyaluronic acid,Immunoglobulin domain,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Hyaluronan and proteoglycan link protein 2,disulfide bond,domain:Ig-like V-type,domain:Link 1,domain:Link 2,signal peptide,
HSD3B1	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1(HSD3B1)	Homo sapiens			Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism,	GO:0006694~steroid biosynthetic process,GO:0006702~androgen biosynthetic process,GO:0006703~estrogen biosynthetic process,GO:0006704~glucocorticoid biosynthetic process,GO:0006705~mineralocorticoid biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030868~smooth endoplasmic reticulum membrane,	GO:0003854~3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0004769~steroid delta-isomerase activity,	IPR002225:3-beta hydroxysteroid dehydrogenase/isomerase,IPR016040:NAD(P)-binding domain,	hsa00140:Steroid hormone biosynthesis,hsa01100:Metabolic pathways,hsa04913:Ovarian steroidogenesis,hsa04925:Aldosterone synthesis and secretion,				Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Isomerase,Membrane,Mitochondrion,Multifunctional enzyme,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Steroidogenesis,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:NAD,chain:3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,sequence variant,transmembrane region,
HSD3B2	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2(HSD3B2)	Homo sapiens			Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism,	GO:0006694~steroid biosynthetic process,GO:0006702~androgen biosynthetic process,GO:0006704~glucocorticoid biosynthetic process,GO:0006705~mineralocorticoid biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030868~smooth endoplasmic reticulum membrane,GO:0031966~mitochondrial membrane,	GO:0003854~3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0004769~steroid delta-isomerase activity,GO:0016853~isomerase activity,	IPR002225:3-beta hydroxysteroid dehydrogenase/isomerase,IPR016040:NAD(P)-binding domain,	hsa00140:Steroid hormone biosynthesis,hsa01100:Metabolic pathways,hsa04913:Ovarian steroidogenesis,hsa04925:Aldosterone synthesis and secretion,	201810~3-beta-hydroxysteroid dehydrogenase, type II, deficiency,			Alternative splicing,Complete proteome,Congenital adrenal hyperplasia,Disease mutation,Endoplasmic reticulum,Isomerase,Membrane,Mitochondrion,Multifunctional enzyme,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Steroidogenesis,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:NAD,chain:3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,sequence conflict,sequence variant,splice variant,transmembrane region,
HAO2	hydroxyacid oxidase 2(HAO2)	Homo sapiens				GO:0019395~fatty acid oxidation,GO:0044255~cellular lipid metabolic process,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,GO:0070062~extracellular exosome,	GO:0003973~(S)-2-hydroxy-acid oxidase activity,GO:0005102~receptor binding,GO:0010181~FMN binding,GO:0016491~oxidoreductase activity,GO:0052852~very-long-chain-(S)-2-hydroxy-acid oxidase activity,GO:0052853~long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,GO:0052854~medium-chain-(S)-2-hydroxy-acid oxidase activity,	IPR000262:FMN-dependent dehydrogenase,IPR008259:FMN-dependent alpha-hydroxy acid dehydrogenase, active site,IPR012133:Alpha-hydroxy acid dehydrogenase, FMN-dependent,IPR013785:Aldolase-type TIM barrel,	hsa00630:Glyoxylate and dicarboxylate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04146:Peroxisome,		PIRSF000138:alpha-hydroxy acid dehydrogenase, FMN-dependent,		Alternative splicing,Complete proteome,Flavoprotein,FMN,Oxidoreductase,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:FMN,binding site:Substrate,chain:Hydroxyacid oxidase 2,domain:FMN hydroxy acid dehydrogenase,nucleotide phosphate-binding region:FMN,sequence conflict,sequence variant,short sequence motif:Microbody targeting signal,
HADHA	hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit(HADHA)	Homo sapiens				GO:0006631~fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0032868~response to insulin,GO:0035965~cardiolipin acyl-chain remodeling,GO:0042493~response to drug,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016507~mitochondrial fatty acid beta-oxidation multienzyme complex,GO:0031012~extracellular matrix,GO:0042645~mitochondrial nucleoid,	GO:0000062~fatty-acyl-CoA binding,GO:0003857~3-hydroxyacyl-CoA dehydrogenase activity,GO:0003985~acetyl-CoA C-acetyltransferase activity,GO:0003988~acetyl-CoA C-acyltransferase activity,GO:0004300~enoyl-CoA hydratase activity,GO:0005515~protein binding,GO:0016508~long-chain-enoyl-CoA hydratase activity,GO:0016509~long-chain-3-hydroxyacyl-CoA dehydrogenase activity,GO:0032403~protein complex binding,GO:0051287~NAD binding,	IPR001753:Crotonase superfamily,IPR006108:3-hydroxyacyl-CoA dehydrogenase, C-terminal,IPR006176:3-hydroxyacyl-CoA dehydrogenase, NAD binding,IPR006180:3-hydroxyacyl-CoA dehydrogenase, conserved site,IPR008927:6-phosphogluconate dehydrogenase, C-terminal-like,IPR012803:Fatty acid oxidation complex, alpha subunit, mitochondrial,IPR013328:Dehydrogenase, multihelical,IPR016040:NAD(P)-binding domain,IPR018376:Enoyl-CoA hydratase/isomerase, conserved site,	hsa00062:Fatty acid elongation,hsa00071:Fatty acid degradation,hsa00280:Valine, leucine and isoleucine degradation,hsa00310:Lysine degradation,hsa00380:Tryptophan metabolism,hsa00410:beta-Alanine metabolism,hsa00640:Propanoate metabolism,hsa00650:Butanoate metabolism,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01212:Fatty acid metabolism,	609015~Trifunctional protein deficiency,609016~Fatty liver, acute, of pregnancy,609016~HELLP syndrome, maternal, of pregnancy,609016~LCHAD deficiency,			Acetylation,Alternative splicing,Complete proteome,Disease mutation,Fatty acid metabolism,Lipid metabolism,Lyase,Methylation,Mitochondrion,Multifunctional enzyme,NAD,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Trifunctional enzyme subunit alpha, mitochondrial,modified residue,sequence conflict,sequence variant,site:Important for catalytic activity,transit peptide:Mitochondrion,
HADHB	hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit(HADHB)	Homo sapiens				GO:0006635~fatty acid beta-oxidation,GO:0008152~metabolic process,GO:0035965~cardiolipin acyl-chain remodeling,	GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0042645~mitochondrial nucleoid,GO:0070062~extracellular exosome,	GO:0003857~3-hydroxyacyl-CoA dehydrogenase activity,GO:0003988~acetyl-CoA C-acyltransferase activity,GO:0004300~enoyl-CoA hydratase activity,GO:0005515~protein binding,GO:0016509~long-chain-3-hydroxyacyl-CoA dehydrogenase activity,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0044822~poly(A) RNA binding,	IPR002155:Thiolase,IPR016039:Thiolase-like,IPR020610:Thiolase, active site,IPR020613:Thiolase, conserved site,IPR020615:Thiolase, acyl-enzyme intermediate active site,IPR020616:Thiolase, N-terminal,IPR020617:Thiolase, C-terminal,	hsa00062:Fatty acid elongation,hsa00071:Fatty acid degradation,hsa00280:Valine, leucine and isoleucine degradation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01212:Fatty acid metabolism,	609015~Trifunctional protein deficiency,			Acetylation,Acyltransferase,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Endoplasmic reticulum,Fatty acid metabolism,Lipid metabolism,Membrane,Mitochondrion,Mitochondrion inner membrane,Mitochondrion outer membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,	active site:Acyl-thioester intermediate,active site:Proton acceptor,chain:Trifunctional enzyme subunit beta, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
HYI	hydroxypyruvate isomerase (putative)(HYI)	Homo sapiens						GO:0005515~protein binding,GO:0008903~hydroxypyruvate isomerase activity,	IPR013022:Xylose isomerase-like, TIM barrel domain,IPR026040:Hydroxypyruvate isomerase-like,	hsa00630:Glyoxylate and dicarboxylate metabolism,hsa01100:Metabolic pathways,		PIRSF006241:hydroxypyruvate isomerase,		Alternative splicing,Complete proteome,Isomerase,Polymorphism,Proteomics identification,Reference proteome,	chain:Putative hydroxypyruvate isomerase,sequence conflict,sequence variant,splice variant,
HSD11B1	hydroxysteroid 11-beta dehydrogenase 1(HSD11B1)	Homo sapiens		h_vobesityPathway:Visceral Fat Deposits and the Metabolic Syndrome,	Cell envelope biogenesis, outer membrane,	GO:0006704~glucocorticoid biosynthetic process,GO:0030324~lung development,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003845~11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,GO:0016491~oxidoreductase activity,GO:0070524~11-beta-hydroxysteroid dehydrogenase (NADP+) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00140:Steroid hormone biosynthesis,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,	614662~Cortisone reductase deficiency 2,			3D-structure,Complete proteome,Endoplasmic reticulum,Glycoprotein,Lipid metabolism,Membrane,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Steroid metabolism,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:Substrate,chain:Corticosteroid 11-beta-dehydrogenase isozyme 1,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
IGSF21	immunoglobin superfamily member 21(IGSF21)	Homo sapiens					GO:0005576~extracellular region,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Immunoglobulin superfamily member 21,disulfide bond,domain:Ig-like 1,domain:Ig-like 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ILDR2	immunoglobulin like domain containing receptor 2(ILDR2)	Homo sapiens				GO:0009749~response to glucose,GO:0030073~insulin secretion,GO:0030154~cell differentiation,GO:0031016~pancreas development,GO:0048873~homeostasis of number of cells within a tissue,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008664:LISCH7,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Complete proteome,Disulfide bond,Endoplasmic reticulum,Immunoglobulin domain,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Immunoglobulin-like domain-containing receptor 2,compositionally biased region:Cys-rich,disulfide bond,domain:Ig-like V-type,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IGSF3	immunoglobulin superfamily member 3(IGSF3)	Homo sapiens				GO:0032808~lacrimal gland development,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,		149700~Lacrimal duct defect,		SM00406:IGv,SM00408:IGc2,SM00409:IG,	Alternative splicing,Chromosomal rearrangement,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Immunoglobulin superfamily member 3,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Ig-like C2-type 8,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:EWI motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IGSF9	immunoglobulin superfamily member 9(IGSF9)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0016358~dendrite development,GO:0050807~regulation of synapse organization,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0060077~inhibitory synapse,	GO:0098632~protein binding involved in cell-cell adhesion,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Protein turtle homolog A,compositionally biased region:Pro-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like 1,domain:Ig-like 2,domain:Ig-like 3,domain:Ig-like 4,domain:Ig-like 5,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IGFN1	immunoglobulin-like and fibronectin type III domain containing 1(IGFN1)	Homo sapiens					GO:0005634~nucleus,GO:0030018~Z disc,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Immunoglobulin domain,Nucleus,Polymorphism,Reference proteome,Repeat,	chain:Immunoglobulin-like and fibronectin type III domain-containing protein 1,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like 1,domain:Ig-like 2,domain:Ig-like 3,domain:Ig-like 4,domain:Ig-like 5,sequence variant,splice variant,
IPO9	importin 9(IPO9)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006606~protein import into nucleus,GO:0042991~transcription factor import into nucleus,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0008536~Ran GTPase binding,GO:0008565~protein transporter activity,GO:0042393~histone binding,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,				SM00913:SM00913,	Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Importin-9,domain:Importin N-terminal,modified residue,sequence conflict,
IHH	indian hedgehog(IHH)	Homo sapiens				GO:0001501~skeletal system development,GO:0001947~heart looping,GO:0007224~smoothened signaling pathway,GO:0007267~cell-cell signaling,GO:0007275~multicellular organism development,GO:0009968~negative regulation of signal transduction,GO:0016539~intein-mediated protein splicing,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032355~response to estradiol,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046639~negative regulation of alpha-beta T cell differentiation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051216~cartilage development,GO:0060135~maternal process involved in female pregnancy,GO:0061053~somite development,	GO:0005615~extracellular space,GO:0005886~plasma membrane,	GO:0005113~patched binding,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,	IPR000320:Hedgehog, N-terminal signaling domain,IPR001657:Hedgehog protein,IPR001767:Hint domain,IPR003586:Hint domain C-terminal,IPR003587:Hint domain N-terminal,IPR006141:Intein splice site,IPR009045:Hedgehog signalling/DD-peptidase zinc-binding domain,	hsa04340:Hedgehog signaling pathway,	112500~Brachydactyly, type A1,607778~Acrocapitofemoral dysplasia,	PIRSF009400:hedgehog protein,	SM00305:HintC,SM00306:HintN,	3D-structure,Autocatalytic cleavage,Calcium,Cell membrane,Complete proteome,Developmental protein,Disease mutation,Glycoprotein,Hydrolase,Lipoprotein,Membrane,Metal-binding,Palmitate,Protease,Reference proteome,Secreted,Signal,Zinc,	chain:Indian hedgehog protein,chain:Indian hedgehog protein C-product,chain:Indian hedgehog protein N-product,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:Cholesterol glycine ester,lipid moiety-binding region:N-palmitoyl cysteine,sequence conflict,sequence variant,signal peptide,site:Cleavage; by autolysis,site:Essential for auto-cleavage,site:Involved in auto-cleavage,site:Involved in cholesterol transfer,
ICOS	inducible T-cell costimulator(ICOS)	Homo sapiens		h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,		GO:0002517~T cell tolerance induction,GO:0006955~immune response,GO:0016337~single organismal cell-cell adhesion,GO:0031295~T cell costimulation,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,		IPR013106:Immunoglobulin V-set,	hsa04514:Cell adhesion molecules (CAMs),hsa04660:T cell receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05340:Primary immunodeficiency,	607594~Immunodeficiency, common variable, 1,			Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Inducible T-cell costimulator,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IVNS1ABP	influenza virus NS1A binding protein(IVNS1ABP)	Homo sapiens				GO:0006383~transcription from RNA polymerase III promoter,GO:0008380~RNA splicing,GO:0009615~response to virus,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,		IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,	hsa05164:Influenza A,		PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Complete proteome,Cytoplasm,Cytoskeleton,Host-virus interaction,Kelch repeat,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Influenza virus NS1A-binding protein,domain:BACK,domain:BTB,modified residue,mutagenesis site,region of interest:Sufficient for AHR interaction and signaling,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,
INHA	inhibin alpha subunit(INHA)	Homo sapiens				GO:0001501~skeletal system development,GO:0001541~ovarian follicle development,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0008584~male gonad development,GO:0009605~response to external stimulus,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0030154~cell differentiation,GO:0030218~erythrocyte differentiation,GO:0042127~regulation of cell proliferation,GO:0042326~negative regulation of phosphorylation,GO:0042541~hemoglobin biosynthetic process,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0045077~negative regulation of interferon-gamma biosynthetic process,GO:0045578~negative regulation of B cell differentiation,GO:0045650~negative regulation of macrophage differentiation,GO:0045786~negative regulation of cell cycle,GO:0046881~positive regulation of follicle-stimulating hormone secretion,GO:0046882~negative regulation of follicle-stimulating hormone secretion,GO:0048468~cell development,GO:0051726~regulation of cell cycle,GO:0060395~SMAD protein signal transduction,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0034673~inhibin-betaglycan-ActRII complex,GO:0043025~neuronal cell body,GO:0043512~inhibin A complex,GO:0043513~inhibin B complex,	GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0034711~inhibin binding,GO:0046982~protein heterodimerization activity,	IPR001839:Transforming growth factor-beta, C-terminal,IPR002405:Inhibin, alpha subunit,IPR015615:Transforming growth factor-beta-related,IPR017175:Inhibin, alpha subunit subgroup,IPR017948:Transforming growth factor beta, conserved site,			PIRSF037328:Inhibin alpha subunit [Parent=PIRSF800009],	SM00204:TGFB,	Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Hormone,Polymorphism,Reference proteome,Secreted,Signal,	chain:Inhibin alpha chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial,mutagenesis site,propeptide:Inhibin alpha N-terminal region,sequence conflict,sequence variant,signal peptide,site:Cleavage,
ID2	inhibitor of DNA binding 2, HLH protein(ID2)	Homo sapiens	71.Id_proteins_G0-to-S_cell_cycle,			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001656~metanephros development,GO:0001779~natural killer cell differentiation,GO:0001966~thigmotaxis,GO:0003149~membranous septum morphogenesis,GO:0003166~bundle of His development,GO:0006351~transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008344~adult locomotory behavior,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014003~oligodendrocyte development,GO:0019216~regulation of lipid metabolic process,GO:0021772~olfactory bulb development,GO:0032922~circadian regulation of gene expression,GO:0033598~mammary gland epithelial cell proliferation,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043353~enucleate erythrocyte differentiation,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045475~locomotor rhythm,GO:0045578~negative regulation of B cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045651~positive regulation of macrophage differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045777~positive regulation of blood pressure,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048469~cell maturation,GO:0048541~Peyer's patch development,GO:0048557~embryonic digestive tract morphogenesis,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048663~neuron fate commitment,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0060612~adipose tissue development,GO:0060749~mammary gland alveolus development,GO:0061030~epithelial cell differentiation involved in mammary gland alveolus development,GO:0061031~endodermal digestive tract morphogenesis,GO:0071158~positive regulation of cell cycle arrest,GO:0071285~cellular response to lithium ion,GO:0071931~positive regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0090398~cellular senescence,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0044325~ion channel binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR026052:DNA-binding protein inhibitor,	hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05202:Transcriptional misregulation in cancer,			SM00353:HLH,	3D-structure,Biological rhythms,Complete proteome,Cytoplasm,Developmental protein,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:DNA-binding protein inhibitor ID-2,domain:Helix-loop-helix motif,sequence conflict,
ING5	inhibitor of growth family member 5(ING5)	Homo sapiens			Chromatin structure and dynamics,	GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006473~protein acetylation,GO:0008285~negative regulation of cell proliferation,GO:0016573~histone acetylation,GO:0043065~positive regulation of apoptotic process,GO:0043966~histone H3 acetylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045926~negative regulation of growth,GO:1901796~regulation of signal transduction by p53 class mediator,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070776~MOZ/MORF histone acetyltransferase complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0035064~methylated histone binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR024610:Inhibitor of growth protein, N-terminal,				SM00249:PHD,SM01408:SM01408,	3D-structure,Acetylation,Activator,Alternative splicing,Chromatin regulator,Complete proteome,Metal-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Inhibitor of growth protein 5,helix,modified residue,splice variant,strand,turn,zinc finger region:PHD-type,
IKBKE	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon(IKBKE)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006955~immune response,GO:0007252~I-kappaB phosphorylation,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010884~positive regulation of lipid storage,GO:0032480~negative regulation of type I interferon production,GO:0034340~response to type I interferon,GO:0035456~response to interferon-beta,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0051260~protein homooligomerization,GO:0098586~cellular response to virus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0016605~PML body,GO:0031966~mitochondrial membrane,	GO:0004672~protein kinase activity,GO:0004704~NF-kappaB-inducing kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008384~IkappaB kinase activity,GO:0031625~ubiquitin protein ligase binding,GO:0036435~K48-linked polyubiquitin binding,GO:0070530~K63-linked polyubiquitin binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04620:Toll-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,			SM00220:S_TKc,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,DNA damage,Isopeptide bond,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Inhibitor of nuclear factor kappa-B kinase subunit epsilon,domain:Leucine-zipper,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
IMMT	inner membrane mitochondrial protein(IMMT)	Homo sapiens				GO:0042407~cristae formation,GO:0051560~mitochondrial calcium ion homeostasis,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043209~myelin sheath,GO:0061617~MICOS complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR019133:Mitochondrial inner membrane protein Mitofilin,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	chain:Mitochondrial inner membrane protein,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transmembrane region,
ITPRIPL1	inositol 1,4,5-trisphosphate receptor interacting protein-like 1(ITPRIPL1)	Homo sapiens					GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR024808:Inositol 1,4,5-triphosphate receptor-interacting protein-like 1,IPR024810:Mab-21 domain,IPR026250:Inositol 1,4,5-trisphosphate receptor-interacting protein,				SM01265:SM01265,	Alternative splicing,Coiled coil,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Inositol 1,4,5-triphosphate receptor- interacting protein-like 1,modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ITPR1	inositol 1,4,5-trisphosphate receptor type 1(ITPR1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006816~calcium ion transport,GO:0007165~signal transduction,GO:0009791~post-embryonic development,GO:0010506~regulation of autophagy,GO:0030168~platelet activation,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0042045~epithelial fluid transport,GO:0048016~inositol phosphate-mediated signaling,GO:0050796~regulation of insulin secretion,GO:0050849~negative regulation of calcium-mediated signaling,GO:0050882~voluntary musculoskeletal movement,GO:0051209~release of sequestered calcium ion into cytosol,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:1903779~regulation of cardiac conduction,	GO:0005637~nuclear inner membrane,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005955~calcineurin complex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016529~sarcoplasmic reticulum,GO:0031088~platelet dense granule membrane,GO:0031094~platelet dense tubular network,GO:0031095~platelet dense tubular network membrane,GO:0043234~protein complex,	GO:0005216~ion channel activity,GO:0005220~inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0015085~calcium ion transmembrane transporter activity,GO:0015278~calcium-release channel activity,GO:0019855~calcium channel inhibitor activity,GO:0035091~phosphatidylinositol binding,GO:0070679~inositol 1,4,5 trisphosphate binding,	IPR000493:Inositol 1,4,5-trisphosphate-binding protein receptor,IPR000699:Intracellular calcium-release channel,IPR005821:Ion transport domain,IPR013662:RyR/IP3R Homology associated domain,IPR014821:Inositol 1,4,5-trisphosphate/ryanodine receptor,IPR015925:Ryanodine receptor-related,IPR016024:Armadillo-type fold,IPR016093:MIR motif,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04114:Oocyte meiosis,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa05010:Alzheimer's disease,hsa05016:Huntington's disease,hsa05205:Proteoglycans in cancer,	117360~Spinocerebellar ataxia 29, congenital nonprogressive,606658~Spinocerebellar ataxia 15,		SM00472:MIR,	Alternative splicing,Apoptosis,Calcium,Calcium channel,Calcium transport,Coiled coil,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Ion channel,Ion transport,Isopeptide bond,Ligand-gated ion channel,Membrane,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Spinocerebellar ataxia,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Inositol 1,4,5-trisphosphate receptor type 1,domain:MIR 1,domain:MIR 2,domain:MIR 3,domain:MIR 4,domain:MIR 5,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Interaction with ERP44,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
IP6K1	inositol hexakisphosphate kinase 1(IP6K1)	Homo sapiens				GO:0043647~inositol phosphate metabolic process,GO:0046854~phosphatidylinositol phosphorylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000827~inositol-1,3,4,5,6-pentakisphosphate kinase activity,GO:0000828~inositol hexakisphosphate kinase activity,GO:0000829~inositol heptakisphosphate kinase activity,GO:0000832~inositol hexakisphosphate 5-kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008440~inositol-1,4,5-trisphosphate 3-kinase activity,GO:0052723~inositol hexakisphosphate 1-kinase activity,GO:0052724~inositol hexakisphosphate 3-kinase activity,GO:0052836~inositol 5-diphosphate pentakisphosphate 5-kinase activity,GO:0052839~inositol diphosphate tetrakisphosphate kinase activity,	IPR005522:Inositol polyphosphate kinase,	hsa04070:Phosphatidylinositol signaling system,				Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	chain:Inositol hexakisphosphate kinase 1,modified residue,region of interest:Substrate binding,
IP6K2	inositol hexakisphosphate kinase 2(IP6K2)	Homo sapiens				GO:0006817~phosphate ion transport,GO:0030308~negative regulation of cell growth,GO:0043065~positive regulation of apoptotic process,GO:0043647~inositol phosphate metabolic process,GO:0046854~phosphatidylinositol phosphorylation,GO:0060337~type I interferon signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0045111~intermediate filament cytoskeleton,	GO:0000827~inositol-1,3,4,5,6-pentakisphosphate kinase activity,GO:0000828~inositol hexakisphosphate kinase activity,GO:0000829~inositol heptakisphosphate kinase activity,GO:0000832~inositol hexakisphosphate 5-kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008440~inositol-1,4,5-trisphosphate 3-kinase activity,GO:0052723~inositol hexakisphosphate 1-kinase activity,GO:0052724~inositol hexakisphosphate 3-kinase activity,GO:0052836~inositol 5-diphosphate pentakisphosphate 5-kinase activity,GO:0052839~inositol diphosphate tetrakisphosphate kinase activity,	IPR005522:Inositol polyphosphate kinase,	hsa04070:Phosphatidylinositol signaling system,				Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Nucleus,Reference proteome,Transferase,	chain:Inositol hexakisphosphate kinase 2,region of interest:Substrate binding,sequence conflict,splice variant,
INPP1	inositol polyphosphate-1-phosphatase(INPP1)	Homo sapiens				GO:0006796~phosphate-containing compound metabolic process,GO:0007165~signal transduction,GO:0043647~inositol phosphate metabolic process,GO:0046854~phosphatidylinositol phosphorylation,GO:0046855~inositol phosphate dephosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0004441~inositol-1,4-bisphosphate 1-phosphatase activity,GO:0052829~inositol-1,3,4-trisphosphate 1-phosphatase activity,	IPR000760:Inositol monophosphatase,IPR020550:Inositol monophosphatase, conserved site,IPR020583:Inositol monophosphatase, metal-binding site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,				Complete proteome,Hydrolase,Lithium,Magnesium,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	binding site:Substrate,chain:Inositol polyphosphate 1-phosphatase,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 1; via carbonyl oxygen,metal ion-binding site:Magnesium 2,modified residue,region of interest:Substrate binding,sequence variant,
INPP5B	inositol polyphosphate-5-phosphatase B(INPP5B)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0007165~signal transduction,GO:0007283~spermatogenesis,GO:0030317~sperm motility,GO:0043547~positive regulation of GTPase activity,GO:0043647~inositol phosphate metabolic process,GO:0046856~phosphatidylinositol dephosphorylation,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0070613~regulation of protein processing,	GO:0005737~cytoplasm,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0031901~early endosome membrane,	GO:0004439~phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0052658~inositol-1,4,5-trisphosphate 5-phosphatase activity,GO:0052659~inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,	IPR000198:Rho GTPase-activating protein domain,IPR000300:Inositol polyphosphate-related phosphatase,IPR005135:Endonuclease/exonuclease/phosphatase,IPR008936:Rho GTPase activation protein,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,			SM00128:IPPc,SM00324:RhoGAP,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Endosome,Golgi apparatus,Hydrolase,Lipoprotein,Magnesium,Membrane,Metal-binding,Methylation,Polymorphism,Prenylation,Proteomics identification,Reference proteome,	chain:Type II inositol-1,4,5-trisphosphate 5- phosphatase,domain:Rho-GAP,sequence conflict,sequence variant,splice variant,
INPP5D	inositol polyphosphate-5-phosphatase D(INPP5D)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0008340~determination of adult lifespan,GO:0009968~negative regulation of signal transduction,GO:0016064~immunoglobulin mediated immune response,GO:0030889~negative regulation of B cell proliferation,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043647~inositol phosphate metabolic process,GO:0045409~negative regulation of interleukin-6 biosynthetic process,GO:0045579~positive regulation of B cell differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045656~negative regulation of monocyte differentiation,GO:0045659~negative regulation of neutrophil differentiation,GO:0045671~negative regulation of osteoclast differentiation,GO:0045779~negative regulation of bone resorption,GO:0046856~phosphatidylinositol dephosphorylation,GO:0050777~negative regulation of immune response,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0045121~membrane raft,	GO:0004445~inositol-polyphosphate 5-phosphatase activity,GO:0005515~protein binding,GO:0016314~phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,GO:0016787~hydrolase activity,GO:0017124~SH3 domain binding,GO:0034485~phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,GO:0051425~PTB domain binding,GO:0052659~inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,	IPR000300:Inositol polyphosphate-related phosphatase,IPR000980:SH2 domain,IPR005135:Endonuclease/exonuclease/phosphatase,	hsa00562:Inositol phosphate metabolism,hsa04070:Phosphatidylinositol signaling system,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,			SM00128:IPPc,SM00252:SH2,	3D-structure,Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Immunity,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3-binding,	chain:Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1,compositionally biased region:Pro-rich,domain:SH2,helix,modified residue,sequence conflict,sequence variant,short sequence motif:NPXY motif 1,short sequence motif:NPXY motif 2,short sequence motif:SH3-binding 1,short sequence motif:SH3-binding 2,short sequence motif:SH3-binding 3,splice variant,strand,
ITPKB	inositol-trisphosphate 3-kinase B(ITPKB)	Homo sapiens				GO:0000165~MAPK cascade,GO:0001932~regulation of protein phosphorylation,GO:0002262~myeloid cell homeostasis,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0032957~inositol trisphosphate metabolic process,GO:0033030~negative regulation of neutrophil apoptotic process,GO:0035726~common myeloid progenitor cell proliferation,GO:0043647~inositol phosphate metabolic process,GO:0045059~positive thymic T cell selection,GO:0045638~negative regulation of myeloid cell differentiation,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0071277~cellular response to calcium ion,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008440~inositol-1,4,5-trisphosphate 3-kinase activity,	IPR005522:Inositol polyphosphate kinase,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04070:Phosphatidylinositol signaling system,				Alternative splicing,ATP-binding,Calmodulin-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Transferase,	binding site:ATP,binding site:Substrate,chain:Inositol-trisphosphate 3-kinase B,compositionally biased region:Poly-Ser,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Calmodulin-binding,region of interest:Substrate binding,sequence conflict,sequence variant,splice variant,
INSIG2	insulin induced gene 2(INSIG2)	Homo sapiens				GO:0006641~triglyceride metabolic process,GO:0006695~cholesterol biosynthetic process,GO:0006991~response to sterol depletion,GO:0008203~cholesterol metabolic process,GO:0010894~negative regulation of steroid biosynthetic process,GO:0032868~response to insulin,GO:0032933~SREBP signaling pathway,GO:0042472~inner ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0060021~palate development,GO:0060363~cranial suture morphogenesis,GO:0070542~response to fatty acid,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0032937~SREBP-SCAP-Insig complex,	GO:0005515~protein binding,GO:0008134~transcription factor binding,	IPR025929:Insulin-induced protein family,					3D-structure,Cholesterol metabolism,Complete proteome,Endoplasmic reticulum,Lipid metabolism,Membrane,Proteomics identification,Reference proteome,Steroid metabolism,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:Insulin-induced gene 2 protein,mutagenesis site,transmembrane region,
IGFBP5	insulin like growth factor binding protein 5(IGFBP5)	Homo sapiens		h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis,		GO:0001558~regulation of cell growth,GO:0001649~osteoblast differentiation,GO:0006006~glucose metabolic process,GO:0007165~signal transduction,GO:0007565~female pregnancy,GO:0007568~aging,GO:0010906~regulation of glucose metabolic process,GO:0014912~negative regulation of smooth muscle cell migration,GO:0017148~negative regulation of translation,GO:0030336~negative regulation of cell migration,GO:0031069~hair follicle morphogenesis,GO:0035556~intracellular signal transduction,GO:0042593~glucose homeostasis,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0043569~negative regulation of insulin-like growth factor receptor signaling pathway,GO:0044267~cellular protein metabolic process,GO:0044342~type B pancreatic cell proliferation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045926~negative regulation of growth,GO:0048286~lung alveolus development,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0051146~striated muscle cell differentiation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060056~mammary gland involution,GO:0060416~response to growth hormone,GO:0071320~cellular response to cAMP,GO:0071407~cellular response to organic cyclic compound,GO:1901862~negative regulation of muscle tissue development,GO:1904205~negative regulation of skeletal muscle hypertrophy,	GO:0005576~extracellular region,GO:0005622~intracellular,GO:0016942~insulin-like growth factor binding protein complex,GO:0042567~insulin-like growth factor ternary complex,	GO:0001968~fibronectin binding,GO:0005515~protein binding,GO:0031994~insulin-like growth factor I binding,GO:0031995~insulin-like growth factor II binding,	IPR000716:Thyroglobulin type-1,IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR009168:Insulin-like growth factor binding protein,IPR012213:Insulin-like growth factor binding protein 5,IPR017891:Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site,IPR022321:Insulin-like growth factor-binding protein family 1-6, chordata,				SM00121:IB,SM00211:TY,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Insulin-like growth factor-binding protein 5,disulfide bond,domain:IGFBP N-terminal,domain:Thyroglobulin type-1,glycosylation site:O-linked (HexNAc...),helix,sequence variant,signal peptide,strand,
INSRR	insulin receptor related receptor(INSRR)	Homo sapiens				GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030238~male sex determination,GO:0031532~actin cytoskeleton reorganization,GO:0046777~protein autophosphorylation,GO:0071469~cellular response to alkaline pH,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043560~insulin receptor substrate binding,	IPR000494:EGF receptor, L domain,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR003961:Fibronectin, type III,IPR006211:Furin-like cysteine-rich domain,IPR006212:Furin-like repeat,IPR008266:Tyrosine-protein kinase, active site,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR013783:Immunoglobulin-like fold,IPR016246:Tyrosine-protein kinase, insulin-like receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04810:Regulation of actin cytoskeleton,hsa05215:Prostate cancer,		PIRSF000620:insulin receptor,	SM00060:FN3,SM00219:TyrKc,SM00261:FU,	ATP-binding,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Insulin receptor-related protein,chain:Insulin receptor-related protein alpha chain,chain:Insulin receptor-related protein beta chain,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IRS1	insulin receptor substrate 1(IRS1)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,107.mRNA_translation-protein_synthesis,108.Regulating_glucose_transport,158.14-3-3_signal_transduction,	h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_ghPathway:Growth Hormone Signaling Pathway,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il4Pathway:IL 4 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,		GO:0000165~MAPK cascade,GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0010907~positive regulation of glucose metabolic process,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0032868~response to insulin,GO:0032869~cellular response to insulin stimulus,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0042593~glucose homeostasis,GO:0043434~response to peptide hormone,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0046326~positive regulation of glucose import,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0046676~negative regulation of insulin secretion,GO:0046854~phosphatidylinositol phosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005899~insulin receptor complex,GO:0005901~caveola,GO:0043231~intracellular membrane-bounded organelle,	GO:0004871~signal transducer activity,GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005080~protein kinase C binding,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005515~protein binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0042169~SH2 domain binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR001849:Pleckstrin homology domain,IPR002404:Insulin receptor substrate-1, PTB,IPR011993:Pleckstrin homology-like domain,	hsa04022:cGMP-PKG signaling pathway,hsa04068:FoxO signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa05206:MicroRNAs in cancer,	125853~Diabetes mellitus, noninsulin-dependent,Coronary artery disease, susceptibility to~Coronary artery disease, susceptibility to,		SM00233:PH,SM00310:PTBI,	3D-structure,Complete proteome,Diabetes mellitus,Disease mutation,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Transducer,Ubl conjugation,	chain:Insulin receptor substrate 1,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:IRS-type PTB,domain:PH,helix,modified residue,mutagenesis site,region of interest:GRB2-binding,sequence conflict,sequence variant,short sequence motif:YXXM motif 1,short sequence motif:YXXM motif 2,short sequence motif:YXXM motif 3,short sequence motif:YXXM motif 4,short sequence motif:YXXM motif 5,short sequence motif:YXXM motif 6,short sequence motif:YXXM motif 7,short sequence motif:YXXM motif 8,short sequence motif:YXXM motif 9,strand,turn,
ITM2C	integral membrane protein 2C(ITM2C)	Homo sapiens				GO:0010977~negative regulation of neuron projection development,GO:0030182~neuron differentiation,GO:0042985~negative regulation of amyloid precursor protein biosynthetic process,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR007084:BRICHOS domain,				SM01039:SM01039,	Alternative splicing,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Glycoprotein,Lysosome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Integral membrane protein 2C,domain:BRICHOS,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,peptide:CT-BRI3,sequence conflict,sequence variant,site:Cleavage; by furin,splice variant,transmembrane region,
INTS3	integrator complex subunit 3(INTS3)	Homo sapiens				GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007093~mitotic cell cycle checkpoint,GO:0010212~response to ionizing radiation,GO:0016180~snRNA processing,GO:0042795~snRNA transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032039~integrator complex,GO:0070876~SOSS complex,	GO:0005515~protein binding,	IPR019333:Integrator complex subunit 3,					3D-structure,Acetylation,Alternative splicing,Complete proteome,DNA damage,DNA repair,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Integrator complex subunit 3,compositionally biased region:Ala/Gly-rich,modified residue,sequence conflict,splice variant,
INTS7	integrator complex subunit 7(INTS7)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0016180~snRNA processing,GO:0034472~snRNA 3'-end processing,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0071479~cellular response to ionizing radiation,	GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0032039~integrator complex,	GO:0005515~protein binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Chromosome,Complete proteome,DNA damage,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Integrator complex subunit 7,compositionally biased region:Gln-rich,modified residue,sequence conflict,sequence variant,splice variant,
ITGA4	integrin subunit alpha 4(ITGA4)	Homo sapiens		h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,h_lymphocytePathway:Adhesion Molecules on Lymphocyte,h_monocytePathway:Monocyte and its Surface Molecules,		GO:0003366~cell-matrix adhesion involved in ameboidal cell migration,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0030183~B cell differentiation,GO:0030198~extracellular matrix organization,GO:0034113~heterotypic cell-cell adhesion,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0043113~receptor clustering,GO:0050776~regulation of immune response,GO:0050900~leukocyte migration,GO:0050901~leukocyte tethering or rolling,GO:0050904~diapedesis,GO:0071345~cellular response to cytokine stimulus,GO:0090074~negative regulation of protein homodimerization activity,GO:0098657~import into cell,GO:1903238~positive regulation of leukocyte tethering or rolling,GO:1990771~clathrin-mediated extracellular exosome endocytosis,GO:2000406~positive regulation of T cell migration,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0034669~integrin alpha4-beta7 complex,GO:0070062~extracellular exosome,	GO:0001968~fibronectin binding,GO:0003823~antigen binding,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0019960~C-X3-C chemokine binding,GO:0046872~metal ion binding,GO:0050839~cell adhesion molecule binding,GO:1990405~protein antigen binding,	IPR000413:Integrin alpha chain,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04514:Cell adhesion molecules (CAMs),hsa04640:Hematopoietic cell lineage,hsa04670:Leukocyte transendothelial migration,hsa04672:Intestinal immune network for IgA production,hsa04810:Regulation of actin cytoskeleton,hsa05140:Leishmaniasis,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,			SM00191:Int_alpha,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Integrin,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-4,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence variant,short sequence motif:GFFKR motif,short sequence motif:SG1,signal peptide,site:Cleavage,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ITGA6	integrin subunit alpha 6(ITGA6)	Homo sapiens				GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0010668~ectodermal cell differentiation,GO:0010811~positive regulation of cell-substrate adhesion,GO:0016337~single organismal cell-cell adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0031581~hemidesmosome assembly,GO:0031589~cell-substrate adhesion,GO:0031668~cellular response to extracellular stimulus,GO:0033627~cell adhesion mediated by integrin,GO:0035878~nail development,GO:0042327~positive regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043588~skin development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046847~filopodium assembly,GO:0048565~digestive tract development,GO:0050873~brown fat cell differentiation,GO:0050900~leukocyte migration,GO:0071407~cellular response to organic cyclic compound,GO:0072001~renal system development,GO:0097186~amelogenesis,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005604~basement membrane,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030056~hemidesmosome,GO:0030175~filopodium,GO:0034676~integrin alpha6-beta4 complex,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0031994~insulin-like growth factor I binding,GO:0038132~neuregulin binding,GO:0043236~laminin binding,GO:0046872~metal ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000413:Integrin alpha chain,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04514:Cell adhesion molecules (CAMs),hsa04640:Hematopoietic cell lineage,hsa04810:Regulation of actin cytoskeleton,hsa05145:Toxoplasmosis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	226730~Epidermolysis bullosa, junctional, with pyloric stenosis,		SM00191:Int_alpha,	Alternative splicing,Calcium,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Epidermolysis bullosa,Glycoprotein,Integrin,Lipoprotein,Membrane,Metal-binding,Palmitate,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-6,chain:Integrin alpha-6 heavy chain,chain:Integrin alpha-6 light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),region of interest:Interaction with HPS5,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence conflict,short sequence motif:GFFKR motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ITGA9	integrin subunit alpha 9(ITGA9)	Homo sapiens				GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0030198~extracellular matrix organization,GO:0030593~neutrophil chemotaxis,GO:0042060~wound healing,	GO:0005886~plasma membrane,GO:0008305~integrin complex,GO:0009925~basal plasma membrane,GO:0034679~integrin alpha9-beta1 complex,	GO:0005518~collagen binding,GO:0043236~laminin binding,GO:0046872~metal ion binding,	IPR000413:Integrin alpha chain,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04514:Cell adhesion molecules (CAMs),hsa04810:Regulation of actin cytoskeleton,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,			SM00191:Int_alpha,	Calcium,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Integrin,Membrane,Metal-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-9,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence variant,short sequence motif:GFFKR motif,signal peptide,site:Cleavage,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ITGAV	integrin subunit alpha V(ITGAV)	Homo sapiens		h_edg1Pathway:Phospholipids as signalling intermediaries,		GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010888~negative regulation of lipid storage,GO:0016049~cell growth,GO:0016477~cell migration,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0031589~cell-substrate adhesion,GO:0032369~negative regulation of lipid transport,GO:0033627~cell adhesion mediated by integrin,GO:0033690~positive regulation of osteoblast proliferation,GO:0034113~heterotypic cell-cell adhesion,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0038027~apolipoprotein A-I-mediated signaling pathway,GO:0043277~apoptotic cell clearance,GO:0045715~negative regulation of low-density lipoprotein particle receptor biosynthetic process,GO:0045785~positive regulation of cell adhesion,GO:0046718~viral entry into host cell,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0050748~negative regulation of lipoprotein metabolic process,GO:0050764~regulation of phagocytosis,GO:0050900~leukocyte migration,GO:0050919~negative chemotaxis,GO:0052066~entry of symbiont into host cell by promotion of host phagocytosis,GO:0070371~ERK1 and ERK2 cascade,GO:0070588~calcium ion transmembrane transport,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:2000425~regulation of apoptotic cell clearance,GO:2000536~negative regulation of entry of bacterium into host cell,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031258~lamellipodium membrane,GO:0031527~filopodium membrane,GO:0031528~microvillus membrane,GO:0032587~ruffle membrane,GO:0034683~integrin alphav-beta3 complex,GO:0034684~integrin alphav-beta5 complex,GO:0034686~integrin alphav-beta8 complex,GO:0035867~alphav-beta3 integrin-IGF-1-IGF1R complex,GO:0045335~phagocytic vesicle,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001846~opsonin binding,GO:0001968~fibronectin binding,GO:0002020~protease binding,GO:0005080~protein kinase C binding,GO:0005245~voltage-gated calcium channel activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0017134~fibroblast growth factor binding,GO:0019960~C-X3-C chemokine binding,GO:0031994~insulin-like growth factor I binding,GO:0038132~neuregulin binding,GO:0046872~metal ion binding,GO:0050431~transforming growth factor beta binding,GO:0050840~extracellular matrix binding,GO:1990430~extracellular matrix protein binding,	IPR000413:Integrin alpha chain,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04145:Phagosome,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04514:Cell adhesion molecules (CAMs),hsa04810:Regulation of actin cytoskeleton,hsa04919:Thyroid hormone signaling pathway,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05222:Small cell lung cancer,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,			SM00191:Int_alpha,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Cell junction,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Integrin,Membrane,Metal-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-V,chain:Integrin alpha-V heavy chain,chain:Integrin alpha-V light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence conflict,sequence variant,short sequence motif:GFFKR motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ITGB1BP1	integrin subunit beta 1 binding protein 1(ITGB1BP1)	Homo sapiens	66.Prot_Interac_w_integrin_domains,			GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006469~negative regulation of protein kinase activity,GO:0006933~negative regulation of cell adhesion involved in substrate-bound cell migration,GO:0007160~cell-matrix adhesion,GO:0007219~Notch signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010595~positive regulation of endothelial cell migration,GO:0010764~negative regulation of fibroblast migration,GO:0015031~protein transport,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:0031214~biomineral tissue development,GO:0032091~negative regulation of protein binding,GO:0032148~activation of protein kinase B activity,GO:0033622~integrin activation,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0035148~tube formation,GO:0035556~intracellular signal transduction,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0043087~regulation of GTPase activity,GO:0043113~receptor clustering,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045747~positive regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050880~regulation of blood vessel size,GO:0051451~myoblast migration,GO:0051496~positive regulation of stress fiber assembly,GO:0051781~positive regulation of cell division,GO:0051894~positive regulation of focal adhesion assembly,GO:0051895~negative regulation of focal adhesion assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis,GO:0090314~positive regulation of protein targeting to membrane,GO:0090315~negative regulation of protein targeting to membrane,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:2001044~regulation of integrin-mediated signaling pathway,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008565~protein transporter activity,GO:0019901~protein kinase binding,GO:0032403~protein complex binding,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR019517:Integrin binding protein, ICAP-1,				SM00462:PTB,	3D-structure,Alternative splicing,Angiogenesis,Biomineralization,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Integrin,Membrane,Mitogen,Notch signaling pathway,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Integrin beta-1-binding protein 1,compositionally biased region:Ser/Thr-rich,domain:PID,helix,modified residue,mutagenesis site,sequence conflict,splice variant,strand,turn,
ITGB3BP	integrin subunit beta 3 binding protein(ITGB3BP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0034080~CENP-A containing nucleosome assembly,GO:0043065~positive regulation of apoptotic process,GO:0051301~cell division,	GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,	IPR009601:Nuclear receptor co-activator NRIF3,			PIRSF011860:nuclear receptor-interacting factor 3,		Activator,Alternative splicing,Apoptosis,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Integrin,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Centromere protein R,modified residue,mutagenesis site,region of interest:DD1,sequence variant,short sequence motif:LXXIL motif,short sequence motif:LXXLL motif,short sequence motif:Nuclear localization signal,splice variant,
ITGB6	integrin subunit beta 6(ITGB6)	Homo sapiens				GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0030198~extracellular matrix organization,GO:0033627~cell adhesion mediated by integrin,GO:0046718~viral entry into host cell,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0004872~receptor activity,GO:0005178~integrin binding,GO:0005515~protein binding,	IPR002035:von Willebrand factor, type A,IPR002369:Integrin beta subunit, N-terminal,IPR012896:Integrin beta subunit, tail,IPR013111:EGF, extracellular,IPR014836:Integrin beta subunit, cytoplasmic domain,IPR015436:Integrin beta-6 subunit,IPR015812:Integrin beta subunit,IPR016201:Plexin-like fold,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04810:Regulation of actin cytoskeleton,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	616221~Amelogenesis imperfecta, type IH,	PIRSF002512:integrin, beta subunit,	SM00187:INB,SM00423:PSI,SM01241:SM01241,SM01242:SM01242,	3D-structure,Alternative splicing,Amelogenesis imperfecta,Cell adhesion,Cell junction,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Integrin,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin beta-6,disulfide bond,domain:VWFA,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Cysteine-rich tandem repeats,region of interest:Interaction with HAX1,repeat:I,repeat:II,repeat:III,repeat:IV,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ITLN2	intelectin 2(ITLN2)	Homo sapiens					GO:0005576~extracellular region,	GO:0030246~carbohydrate binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,					Alternative splicing,Complete proteome,Lectin,Polymorphism,Reference proteome,Secreted,Signal,	chain:Intelectin-2,domain:Fibrinogen C-terminal,sequence variant,signal peptide,
ITIH1	inter-alpha-trypsin inhibitor heavy chain 1(ITIH1)	Homo sapiens				GO:0010951~negative regulation of endopeptidase activity,GO:0030212~hyaluronan metabolic process,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005509~calcium ion binding,	IPR002035:von Willebrand factor, type A,IPR010600:Inter-alpha-trypsin inhibitor heavy chain, C-terminal,IPR013694:VIT domain,				SM00327:VWA,SM00609:VIT,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Phosphoprotein,Polymorphism,Protease inhibitor,Proteoglycan,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:Inter-alpha-trypsin inhibitor heavy chain H1,disulfide bond,domain:VIT,domain:VWFA,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...) (complex),glycosylation site:O-linked (GalNAc...),glycosylation site:S-linked (Hex...),modified residue,region of interest:Hyaluronan-binding,sequence conflict,sequence variant,short sequence motif:Phagocytosis uptake signal,signal peptide,
IFI6	interferon alpha inducible protein 6(IFI6)	Homo sapiens				GO:0001836~release of cytochrome c from mitochondria,GO:0006955~immune response,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0051902~negative regulation of mitochondrial depolarization,GO:0060337~type I interferon signaling pathway,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR009311:Interferon-induced 6-16,					Alternative splicing,Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Interferon alpha-inducible protein 6,sequence conflict,signal peptide,splice variant,transmembrane region,
IFI44L	interferon induced protein 44 like(IFI44L)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0051607~defense response to virus,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005525~GTP binding,	IPR006073:GTP binding domain,IPR024644:Interferon-induced protein 44 family,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Antiviral defense,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,	chain:Interferon-induced protein 44-like,sequence conflict,sequence variant,splice variant,
IFIH1	interferon induced with helicase C domain 1(IFIH1)	Homo sapiens			DNA replication, recombination, and repair,	GO:0009597~detection of virus,GO:0009615~response to virus,GO:0016925~protein sumoylation,GO:0032480~negative regulation of type I interferon production,GO:0032727~positive regulation of interferon-alpha production,GO:0032728~positive regulation of interferon-beta production,GO:0034344~regulation of type III interferon production,GO:0039528~cytoplasmic pattern recognition receptor signaling pathway in response to virus,GO:0039530~MDA-5 signaling pathway,GO:0045087~innate immune response,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0043021~ribonucleoprotein complex binding,	IPR001650:Helicase, C-terminal,IPR006935:Helicase/UvrB domain,IPR011029:Death-like domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR021673:C-terminal domain of RIG-I,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04622:RIG-I-like receptor signaling pathway,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,	182250~Singleton-Merten syndrome 1,615846~Aicardi-Goutieres syndrome 7,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Aicardi-Goutieres syndrome,Alternative splicing,Antiviral defense,ATP-binding,Complete proteome,Cytoplasm,Diabetes mellitus,Disease mutation,Helicase,Host-virus interaction,Hydrolase,Immunity,Innate immunity,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,RNA-binding,Ubl conjugation,Zinc,	chain:Interferon-induced helicase C domain- containing protein 1,domain:CARD 1,domain:CARD 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,sequence conflict,sequence variant,site:Cleavage,splice variant,strand,turn,
IFNLR1	interferon lambda receptor 1(IFNLR1)	Homo sapiens				GO:0002385~mucosal immune response,GO:0008285~negative regulation of cell proliferation,GO:0019221~cytokine-mediated signaling pathway,GO:0034342~response to type III interferon,GO:0050691~regulation of defense response to virus by host,GO:0051607~defense response to virus,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0032002~interleukin-28 receptor complex,	GO:0004896~cytokine receptor activity,GO:0005515~protein binding,	IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,				3D-structure,Alternative splicing,Antiviral defense,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-28 receptor subunit alpha,disulfide bond,domain:Fibronectin type-III,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IRF2BP2	interferon regulatory factor 2 binding protein 2(IRF2BP2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0046872~metal ion binding,	IPR022750:Interferon regulatory factor 2-binding protein 1 & 2, zinc finger,					Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Interferon regulatory factor 2-binding protein 2,compositionally biased region:Pro-rich,modified residue,region of interest:Cys-rich,sequence conflict,sequence variant,splice variant,
IRF6	interferon regulatory factor 6(IRF6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0030216~keratinocyte differentiation,GO:0043616~keratinocyte proliferation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048468~cell development,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060644~mammary gland epithelial cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000975~regulatory region DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR001346:Interferon regulatory factor DNA-binding domain,IPR008984:SMAD/FHA domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017855:SMAD domain-like,IPR019471:Interferon regulatory factor-3,IPR019817:Interferon regulatory factor, conserved site,		119300~van der Woude syndrome,119500~Popliteal pterygium syndrome 1,608864~Orofacial cleft 6,		SM00348:IRF,SM01243:SM01243,	Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Disease mutation,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Interferon regulatory factor 6,DNA-binding region:Tryptophan pentad repeat,sequence variant,
IL1B	interleukin 1 beta(IL1B)	Homo sapiens		h_il1rPathway:Signal transduction through IL1R,h_il5Pathway:IL 5 Signaling Pathway,h_mspPathway:Msp/Ron Receptor Signaling Pathway,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0001660~fever generation,GO:0001934~positive regulation of protein phosphorylation,GO:0002711~positive regulation of T cell mediated immunity,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0007566~embryo implantation,GO:0008285~negative regulation of cell proliferation,GO:0009743~response to carbohydrate,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0010829~negative regulation of glucose transport,GO:0014805~smooth muscle adaptation,GO:0019221~cytokine-mediated signaling pathway,GO:0030213~hyaluronan biosynthetic process,GO:0030593~neutrophil chemotaxis,GO:0030730~sequestering of triglyceride,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0031622~positive regulation of fever generation,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032308~positive regulation of prostaglandin secretion,GO:0032611~interleukin-1 beta production,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032729~positive regulation of interferon-gamma production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0033129~positive regulation of histone phosphorylation,GO:0033198~response to ATP,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0035066~positive regulation of histone acetylation,GO:0035234~ectopic germ cell programmed cell death,GO:0035505~positive regulation of myosin light chain kinase activity,GO:0035690~cellular response to drug,GO:0042102~positive regulation of T cell proliferation,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043407~negative regulation of MAP kinase activity,GO:0043491~protein kinase B signaling,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045410~positive regulation of interleukin-6 biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045766~positive regulation of angiogenesis,GO:0045833~negative regulation of lipid metabolic process,GO:0045840~positive regulation of mitotic nuclear division,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046827~positive regulation of protein export from nucleus,GO:0050766~positive regulation of phagocytosis,GO:0050796~regulation of insulin secretion,GO:0050995~negative regulation of lipid catabolic process,GO:0050996~positive regulation of lipid catabolic process,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051781~positive regulation of cell division,GO:0060355~positive regulation of cell adhesion molecule production,GO:0060559~positive regulation of calcidiol 1-monooxygenase activity,GO:0070164~negative regulation of adiponectin secretion,GO:0070487~monocyte aggregation,GO:0071260~cellular response to mechanical stimulus,GO:0071310~cellular response to organic substance,GO:0071407~cellular response to organic cyclic compound,GO:0071639~positive regulation of monocyte chemotactic protein-1 production,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1903140~regulation of establishment of endothelial barrier,GO:2000778~positive regulation of interleukin-6 secretion,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0030141~secretory granule,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,GO:0005149~interleukin-1 receptor binding,GO:0019904~protein domain specific binding,	IPR000975:Interleukin-1,IPR003294:Interleukin-1, alpha/beta,IPR003296:Interleukin-1, beta IL1B,IPR003502:Interleukin-1 propeptide,IPR008996:Cytokine, IL-1-like,IPR020877:Interleukin-1 conserved site,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04640:Hematopoietic cell lineage,hsa04668:TNF signaling pathway,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04940:Type I diabetes mellitus,hsa05010:Alzheimer's disease,hsa05020:Prion diseases,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05321:Inflammatory bowel disease (IBD),hsa05323:Rheumatoid arthritis,hsa05332:Graft-versus-host disease,	137215~Gastric cancer risk after H. pylori infection,			3D-structure,Complete proteome,Cytokine,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Inflammatory response,Lysosome,Mitogen,Polymorphism,Proteomics identification,Pyrogen,Reference proteome,Secreted,	chain:Interleukin-1 beta,helix,sequence conflict,site:Involved in receptor binding,strand,turn,
IL1F10	interleukin 1 family member 10 (theta)(IL1F10)	Homo sapiens				GO:0019221~cytokine-mediated signaling pathway,	GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005149~interleukin-1 receptor binding,	IPR000975:Interleukin-1,IPR003297:Interleukin-1 receptor antagonist / Interleukin-36,IPR008996:Cytokine, IL-1-like,IPR027164:Interleukin-1 family member 10,					3D-structure,Alternative splicing,Complete proteome,Cytokine,Polymorphism,Reference proteome,Secreted,	chain:Interleukin-1 family member 10,sequence variant,splice variant,
IL1RN	interleukin 1 receptor antagonist(IL1RN)	Homo sapiens		h_il1rPathway:Signal transduction through IL1R,		GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0006629~lipid metabolic process,GO:0006953~acute-phase response,GO:0006955~immune response,GO:0030073~insulin secretion,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0051384~response to glucocorticoid,GO:2000660~negative regulation of interleukin-1-mediated signaling pathway,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,GO:0005149~interleukin-1 receptor binding,GO:0005150~interleukin-1, Type I receptor binding,GO:0005151~interleukin-1, Type II receptor binding,GO:0005152~interleukin-1 receptor antagonist activity,GO:0005515~protein binding,GO:0045352~interleukin-1 Type I receptor antagonist activity,GO:0045353~interleukin-1 Type II receptor antagonist activity,	IPR000975:Interleukin-1,IPR003297:Interleukin-1 receptor antagonist / Interleukin-36,IPR008996:Cytokine, IL-1-like,IPR020877:Interleukin-1 conserved site,IPR027166:Interleukin-1 receptor antagonist protein,		137215~Gastric cancer risk after H. pylori infection,612628~Microvascular complications of diabetes 4,612852~Interleukin 1 receptor antagonist deficiency,			3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Glycoprotein,Pharmaceutical,Polymorphism,Receptor,Reference proteome,Secreted,Signal,	chain:Interleukin-1 receptor antagonist protein,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,splice variant,strand,turn,
IRAK2	interleukin 1 receptor associated kinase 2(IRAK2)	Homo sapiens		h_il1rPathway:Signal transduction through IL1R,		GO:0000187~activation of MAPK activity,GO:0001959~regulation of cytokine-mediated signaling pathway,GO:0002224~toll-like receptor signaling pathway,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007254~JNK cascade,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0034162~toll-like receptor 9 signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway,GO:0070498~interleukin-1-mediated signaling pathway,GO:0070555~response to interleukin-1,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,	GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR000488:Death domain,IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR011029:Death-like domain,	hsa04722:Neurotrophin signaling pathway,hsa05152:Tuberculosis,				3D-structure,ATP-binding,Complete proteome,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,	chain:Interleukin-1 receptor-associated kinase- like 2,domain:Death,domain:Protein kinase,sequence variant,
IL1RL1	interleukin 1 receptor like 1(IL1RL1)	Homo sapiens				GO:0002826~negative regulation of T-helper 1 type immune response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0032689~negative regulation of interferon-gamma production,GO:0032754~positive regulation of interleukin-5 production,GO:0038172~interleukin-33-mediated signaling pathway,GO:0043032~positive regulation of macrophage activation,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050729~positive regulation of inflammatory response,GO:0090197~positive regulation of chemokine secretion,	GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0002113~interleukin-33 binding,GO:0002114~interleukin-33 receptor activity,GO:0004896~cytokine receptor activity,GO:0004908~interleukin-1 receptor activity,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR004074:Interleukin-1 receptor, type I/II,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,				SM00255:TIR,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-1 receptor-like 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:TIR,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL1RL2	interleukin 1 receptor like 2(IL1RL2)	Homo sapiens				GO:0006954~inflammatory response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0032755~positive regulation of interleukin-6 production,GO:0045087~innate immune response,GO:0045582~positive regulation of T cell differentiation,GO:0050727~regulation of inflammatory response,GO:0070498~interleukin-1-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004908~interleukin-1 receptor activity,GO:0004909~interleukin-1, Type I, activating receptor activity,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR003599:Immunoglobulin subtype,IPR004074:Interleukin-1 receptor, type I/II,IPR004076:Interleukin-1 receptor IL1R,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,				SM00255:TIR,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Inflammatory response,Innate immunity,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-1 receptor-like 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:TIR,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL1R1	interleukin 1 receptor type 1(IL1R1)	Homo sapiens	92.Ancient_Host_Defense_Pathways,99.NF-kB_activation,	h_il1rPathway:Signal transduction through IL1R,h_nfkbPathway:NF-kB Signaling Pathway,		GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0050727~regulation of inflammatory response,GO:0070498~interleukin-1-mediated signaling pathway,GO:0070555~response to interleukin-1,GO:2000391~positive regulation of neutrophil extravasation,GO:2000661~positive regulation of interleukin-1-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0002020~protease binding,GO:0004871~signal transducer activity,GO:0004888~transmembrane signaling receptor activity,GO:0004908~interleukin-1 receptor activity,GO:0004909~interleukin-1, Type I, activating receptor activity,GO:0005161~platelet-derived growth factor receptor binding,GO:0005515~protein binding,GO:0019966~interleukin-1 binding,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR003599:Immunoglobulin subtype,IPR004074:Interleukin-1 receptor, type I/II,IPR004076:Interleukin-1 receptor IL1R,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04640:Hematopoietic cell lineage,hsa04750:Inflammatory mediator regulation of TRP channels,hsa05146:Amoebiasis,hsa05166:HTLV-I infection,			SM00255:TIR,SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-1 receptor type 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:TIR,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
IL1R2	interleukin 1 receptor type 2(IL1R2)	Homo sapiens				GO:0006955~immune response,GO:0010955~negative regulation of protein processing,GO:0019221~cytokine-mediated signaling pathway,GO:0050712~negative regulation of interleukin-1 alpha secretion,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:2000660~negative regulation of interleukin-1-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004908~interleukin-1 receptor activity,GO:0004910~interleukin-1, Type II, blocking receptor activity,GO:0005515~protein binding,GO:0019966~interleukin-1 binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR004074:Interleukin-1 receptor, type I/II,IPR004077:Interleukin-1 receptor, type II,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,	hsa04060:Cytokine-cytokine receptor interaction,hsa04640:Hematopoietic cell lineage,hsa05146:Amoebiasis,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,			SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-1 receptor type 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL12RB2	interleukin 12 receptor subunit beta 2(IL12RB2)	Homo sapiens		h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_th1th2Pathway:Th1/Th2 Differentiation,		GO:0007166~cell surface receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0032609~interferon-gamma production,GO:0032729~positive regulation of interferon-gamma production,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004896~cytokine receptor activity,GO:0019901~protein kinase binding,	IPR003529:Long hematopoietin receptor, Gp130 family 2, conserved site,IPR003961:Fibronectin, type III,IPR010457:Immunoglobulin C2-set-like, ligand-binding,IPR013783:Immunoglobulin-like fold,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa05321:Inflammatory bowel disease (IBD),			SM00060:FN3,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-12 receptor subunit beta-2,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Required for STAT4 binding,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL17RB	interleukin 17 receptor B(IL17RB)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006952~defense response,GO:0019221~cytokine-mediated signaling pathway,GO:0050729~positive regulation of inflammatory response,GO:2000664~positive regulation of interleukin-5 secretion,GO:2000667~positive regulation of interleukin-13 secretion,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004896~cytokine receptor activity,GO:0030368~interleukin-17 receptor activity,	IPR013568:SEFIR,	hsa04060:Cytokine-cytokine receptor interaction,				Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-17 receptor B,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL17RC	interleukin 17 receptor C(IL17RC)	Homo sapiens				GO:0019221~cytokine-mediated signaling pathway,GO:0050832~defense response to fungus,GO:0071621~granulocyte chemotaxis,GO:1900017~positive regulation of cytokine production involved in inflammatory response,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,	GO:0005102~receptor binding,GO:0030368~interleukin-17 receptor activity,	IPR013568:SEFIR,		616445~Candidiasis, familial, 9,			Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-17 receptor C,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL17RD	interleukin 17 receptor D(IL17RD)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005887~integral component of plasma membrane,	GO:0030368~interleukin-17 receptor activity,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR013568:SEFIR,		615267~Hypogonadotropic hypogonadism 18 with or without anosmia,			Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Glycoprotein,Golgi apparatus,Hypogonadotropic hypogonadism,Kallmann syndrome,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-17 receptor D,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL17RE	interleukin 17 receptor E(IL17RE)	Homo sapiens				GO:0006954~inflammatory response,GO:0019221~cytokine-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0030368~interleukin-17 receptor activity,	IPR013568:SEFIR,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Glycoprotein,Inflammatory response,Membrane,Polymorphism,Receptor,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-17 receptor E,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL18R1	interleukin 18 receptor 1(IL18R1)	Homo sapiens		h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_th1th2Pathway:Th1/Th2 Differentiation,		GO:0006955~immune response,GO:0007165~signal transduction,GO:0030101~natural killer cell activation,GO:0032729~positive regulation of interferon-gamma production,GO:0035655~interleukin-18-mediated signaling pathway,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0045063~T-helper 1 cell differentiation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004908~interleukin-1 receptor activity,GO:0005515~protein binding,GO:0042008~interleukin-18 receptor activity,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR003599:Immunoglobulin subtype,IPR004074:Interleukin-1 receptor, type I/II,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,	hsa04060:Cytokine-cytokine receptor interaction,hsa04668:TNF signaling pathway,hsa05321:Inflammatory bowel disease (IBD),			SM00255:TIR,SM00409:IG,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-18 receptor 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:TIR,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL18RAP	interleukin 18 receptor accessory protein(IL18RAP)	Homo sapiens				GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0070301~cellular response to hydrogen peroxide,GO:0071345~cellular response to cytokine stimulus,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,	hsa04060:Cytokine-cytokine receptor interaction,hsa05321:Inflammatory bowel disease (IBD),			SM00255:TIR,SM00409:IG,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-18 receptor accessory protein,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:TIR,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL19	interleukin 19(IL19)	Homo sapiens				GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0042226~interleukin-6 biosynthetic process,GO:0046427~positive regulation of JAK-STAT cascade,GO:0072593~reactive oxygen species metabolic process,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005125~cytokine activity,	IPR009079:Four-helical cytokine-like, core,IPR012351:Four-helical cytokine, core,IPR020421:Interleukin-19,IPR020423:Interleukin-10, conserved site,IPR020443:Interleukin-10/19/20/24,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,				3D-structure,Alternative splicing,Apoptosis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Interleukin-19,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,turn,
IL22RA1	interleukin 22 receptor subunit alpha 1(IL22RA1)	Homo sapiens		h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,		GO:0019221~cytokine-mediated signaling pathway,GO:0050829~defense response to Gram-negative bacterium,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004904~interferon receptor activity,GO:0005515~protein binding,GO:0042015~interleukin-20 binding,	IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR015373:Interferon alpha/beta receptor, beta chain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,				3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-22 receptor subunit alpha-1,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
IL23R	interleukin 23 receptor(IL23R)	Homo sapiens				GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002230~positive regulation of defense response to virus by host,GO:0002827~positive regulation of T-helper 1 type immune response,GO:0006954~inflammatory response,GO:0010535~positive regulation of activation of JAK2 kinase activity,GO:0032496~response to lipopolysaccharide,GO:0032693~negative regulation of interleukin-10 production,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032729~positive regulation of interferon-gamma production,GO:0032735~positive regulation of interleukin-12 production,GO:0032740~positive regulation of interleukin-17 production,GO:0032819~positive regulation of natural killer cell proliferation,GO:0034341~response to interferon-gamma,GO:0038155~interleukin-23-mediated signaling pathway,GO:0042102~positive regulation of T cell proliferation,GO:0042104~positive regulation of activated T cell proliferation,GO:0042510~regulation of tyrosine phosphorylation of Stat1 protein,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042520~positive regulation of tyrosine phosphorylation of Stat4 protein,GO:0042523~positive regulation of tyrosine phosphorylation of Stat5 protein,GO:0043382~positive regulation of memory T cell differentiation,GO:0045672~positive regulation of osteoclast differentiation,GO:0050829~defense response to Gram-negative bacterium,GO:0051135~positive regulation of NK T cell activation,GO:2000318~positive regulation of T-helper 17 type immune response,GO:2000330~positive regulation of T-helper 17 cell lineage commitment,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:0072536~interleukin-23 receptor complex,	GO:0004896~cytokine receptor activity,GO:0005143~interleukin-12 receptor binding,GO:0005515~protein binding,GO:0042019~interleukin-23 binding,GO:0042020~interleukin-23 receptor activity,	IPR003532:Short hematopoietin receptor, family 2, conserved site,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa05321:Inflammatory bowel disease (IBD),	605606~Psoriasis, protection against,612261~Inflammatory bowel disease 17, protection against,			Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-23 receptor,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL36RN	interleukin 36 receptor antagonist(IL36RN)	Homo sapiens				GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0019732~antifungal humoral response,GO:0032700~negative regulation of interleukin-17 production,GO:0032715~negative regulation of interleukin-6 production,GO:0045087~innate immune response,GO:1902714~negative regulation of interferon-gamma secretion,	GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005149~interleukin-1 receptor binding,GO:0005152~interleukin-1 receptor antagonist activity,GO:0005515~protein binding,	IPR000975:Interleukin-1,IPR003297:Interleukin-1 receptor antagonist / Interleukin-36,IPR008996:Cytokine, IL-1-like,IPR020877:Interleukin-1 conserved site,IPR027171:Interleukin-36 receptor antagonist,		614204~Psoriasis 14, pustular,			3D-structure,Complete proteome,Cytokine,Disease mutation,Disulfide bond,Immunity,Innate immunity,Polymorphism,Proteomics identification,Reference proteome,Secreted,	chain:Interleukin-1 family member 5,disulfide bond,sequence variant,
IL36B	interleukin 36, beta(IL36B)	Homo sapiens				GO:0006954~inflammatory response,GO:0006955~immune response,GO:0019221~cytokine-mediated signaling pathway,GO:0032755~positive regulation of interleukin-6 production,GO:0045087~innate immune response,GO:0045582~positive regulation of T cell differentiation,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005149~interleukin-1 receptor binding,	IPR008996:Cytokine, IL-1-like,IPR027172:Interleukin-36 beta,					Alternative splicing,Complete proteome,Cytokine,Immunity,Inflammatory response,Innate immunity,Polymorphism,Reference proteome,Secreted,	chain:Interleukin-1 family member 8,sequence variant,splice variant,
IL5RA	interleukin 5 receptor subunit alpha(IL5RA)	Homo sapiens		h_il5Pathway:IL 5 Signaling Pathway,		GO:0000165~MAPK cascade,GO:0002437~inflammatory response to antigenic stimulus,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0032674~regulation of interleukin-5 production,GO:0038043~interleukin-5-mediated signaling pathway,GO:0043547~positive regulation of GTPase activity,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004896~cytokine receptor activity,GO:0004914~interleukin-5 receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR003532:Short hematopoietin receptor, family 2, conserved site,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR015321:Interleukin-6 receptor alpha chain, binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,				3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:interleukin-5 receptor  type 2,chain:Interleukin-5 receptor subunit alpha,chain:interleukin-5 receptor type 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL6R	interleukin 6 receptor(IL6R)	Homo sapiens		h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_il6Pathway:IL 6 signaling pathway,		GO:0002384~hepatic immune response,GO:0002446~neutrophil mediated immunity,GO:0002548~monocyte chemotaxis,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006953~acute-phase response,GO:0008284~positive regulation of cell proliferation,GO:0010536~positive regulation of activation of Janus kinase activity,GO:0019221~cytokine-mediated signaling pathway,GO:0031018~endocrine pancreas development,GO:0032717~negative regulation of interleukin-8 production,GO:0032722~positive regulation of chemokine production,GO:0032755~positive regulation of interleukin-6 production,GO:0032966~negative regulation of collagen biosynthetic process,GO:0034097~response to cytokine,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0043410~positive regulation of MAPK cascade,GO:0045669~positive regulation of osteoblast differentiation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0070102~interleukin-6-mediated signaling pathway,GO:0070120~ciliary neurotrophic factor-mediated signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005896~interleukin-6 receptor complex,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0070110~ciliary neurotrophic factor receptor complex,	GO:0004896~cytokine receptor activity,GO:0004897~ciliary neurotrophic factor receptor activity,GO:0004915~interleukin-6 receptor activity,GO:0005138~interleukin-6 receptor binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0019981~interleukin-6 binding,GO:0042803~protein homodimerization activity,GO:0070119~ciliary neurotrophic factor binding,	IPR003530:Long hematopoietin receptor, soluble alpha chain, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR015321:Interleukin-6 receptor alpha chain, binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04066:HIF-1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04932:Non-alcoholic fatty liver disease (NAFLD),	614689~Interleukin-6 receptor, soluble, serum level of, QTL,614752~Interleukin 6, serum level of, QTL,		SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-6 receptor subunit alpha,disulfide bond,domain:Fibronectin type-III,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,short sequence motif:WSXWS motif,signal peptide,site:Not glycosylated,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ILF2	interleukin enhancer binding factor 2(ILF2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006955~immune response,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR006116:2-5-oligoadenylate synthetase, N-terminal,IPR006561:DZF,				SM00572:DZF,	Activator,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Interleukin enhancer-binding factor 2,compositionally biased region:Poly-Glu,domain:DZF,modified residue,
IFFO2	intermediate filament family orphan 2(IFFO2)	Homo sapiens					GO:0005882~intermediate filament,	GO:0005198~structural molecule activity,	IPR001664:Intermediate filament protein,				SM01391:SM01391,	Coiled coil,Complete proteome,Reference proteome,	chain:Intermediate filament family orphan 2,
IMPG2	interphotoreceptor matrix proteoglycan 2(IMPG2)	Homo sapiens				GO:0007601~visual perception,	GO:0005578~proteinaceous extracellular matrix,GO:0016021~integral component of membrane,GO:0033165~interphotoreceptor matrix,GO:0043235~receptor complex,	GO:0005201~extracellular matrix structural constituent,GO:0005540~hyaluronic acid binding,GO:0008201~heparin binding,	IPR000082:SEA domain,IPR000742:Epidermal growth factor-like domain,IPR013032:EGF-like, conserved site,		613581~Retinitis pigmentosa 56,616152~Macular dystrophy, vitelliform, 5,		SM00200:SEA,	Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Heparin-binding,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Retinitis pigmentosa,Signal,Transmembrane,Transmembrane helix,	chain:Interphotoreceptor matrix proteoglycan 2,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:SEA 1,domain:SEA 2,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),region of interest:Hyaluronan-binding motif involved in chondroitin sulfate A- and C-binding,region of interest:Hyaluronan-binding motif involved in chondroitin sulfate A- and C-binding motif,region of interest:Hyaluronan-binding motif involved in chondroitin sulfate A-binding,region of interest:Hyaluronan-binding motif involved in chondroitin sulfate C-binding,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ITSN2	intersectin 2(ITSN2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006897~endocytosis,GO:0009967~positive regulation of signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:1903861~positive regulation of dendrite extension,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0070062~extracellular exosome,	GO:0005070~SH3/SH2 adaptor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000219:Dbl homology (DH) domain,IPR000261:EPS15 homology (EH),IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR002048:EF-hand domain,IPR011511:Variant SH3,IPR011992:EF-hand-like domain,IPR011993:Pleckstrin homology-like domain,IPR013315:Spectrin alpha chain, SH3 domain,IPR018247:EF-Hand 1, calcium-binding site,IPR027029:Intersectin-2,				SM00027:EH,SM00054:EFh,SM00233:PH,SM00239:C2,SM00325:RhoGEF,SM00326:SH3,	3D-structure,Alternative splicing,Calcium,Coiled coil,Complete proteome,Cytoplasm,Differentiation,Endocytosis,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:Intersectin-2,domain:C2,domain:DH,domain:EF-hand 1,domain:EH 1,domain:EH 2,domain:PH,domain:SH3 1,domain:SH3 2,domain:SH3 3,domain:SH3 4,domain:SH3 5,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,
IPP	intracisternal A particle-promoted polypeptide(IPP)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0003779~actin binding,GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011043:Galactose oxidase/kelch, beta-propeller,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Actin-binding,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Kelch repeat,Polymorphism,Reference proteome,Repeat,	chain:Actin-binding protein IPP,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence variant,
IFT57	intraflagellar transport 57(IFT57)	Homo sapiens				GO:0001843~neural tube closure,GO:0001947~heart looping,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007224~smoothened signaling pathway,GO:0042073~intraciliary transport,GO:0042384~cilium assembly,GO:0042981~regulation of apoptotic process,GO:0050680~negative regulation of epithelial cell proliferation,GO:0060271~cilium morphogenesis,GO:0060972~left/right pattern formation,	GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005929~cilium,GO:0005930~axoneme,GO:0030992~intraciliary transport particle B,GO:0032391~photoreceptor connecting cilium,GO:0036064~ciliary basal body,GO:0044292~dendrite terminus,GO:0072372~primary cilium,GO:0097542~ciliary tip,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR019530:Intra-flagellar transport protein 57,	hsa05016:Huntington's disease,				Apoptosis,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,DNA-binding,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Intraflagellar transport protein 57 homolog,mutagenesis site,region of interest:pDED,sequence conflict,
ICA1L	islet cell autoantigen 1 like(ICA1L)	Homo sapiens						GO:0005515~protein binding,GO:0019904~protein domain specific binding,	IPR006723:Islet cell autoantigen Ica1, C-terminal,IPR010504:Arfaptin homology (AH) domain,IPR024114:Islet cell autoantigen 1/Ica1-like,IPR027267:Arfaptin homology (AH) domain/BAR domain,				SM01015:SM01015,SM01237:SM01237,	Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Islet cell autoantigen 1-like protein,domain:AH,sequence conflict,splice variant,
IAH1	isoamyl acetate-hydrolyzing esterase 1 homolog(IAH1)	Homo sapiens				GO:0016042~lipid catabolic process,	GO:0070062~extracellular exosome,	GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,	IPR001087:Lipase, GDSL,					Alternative splicing,Complete proteome,Hydrolase,Lipid degradation,Lipid metabolism,Proteomics identification,Reference proteome,	active site:Nucleophile,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:Isoamyl acetate-hydrolyzing esterase 1 homolog,
IDH1	isocitrate dehydrogenase (NADP(+)) 1, cytosolic(IDH1)	Homo sapiens				GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006103~2-oxoglutarate metabolic process,GO:0006740~NADPH regeneration,GO:0006749~glutathione metabolic process,GO:0006979~response to oxidative stress,GO:0008585~female gonad development,GO:0048545~response to steroid hormone,GO:0060696~regulation of phospholipid catabolic process,GO:0071071~regulation of phospholipid biosynthetic process,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0005102~receptor binding,GO:0042803~protein homodimerization activity,GO:0050661~NADP binding,GO:0051287~NAD binding,GO:0051990~(R)-2-hydroxyglutarate dehydrogenase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR004790:Isocitrate dehydrogenase NADP-dependent,IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site,IPR024084:Isopropylmalate dehydrogenase-like domain,	hsa00020:Citrate cycle (TCA cycle),hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01210:2-Oxocarboxylic acid metabolism,hsa01230:Biosynthesis of amino acids,hsa04146:Peroxisome,	137800~Glioma, susceptibility to, somatic,	PIRSF000108:isocitrate dehydrogenase (NADP),	SM01329:SM01329,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Glyoxylate bypass,Magnesium,Manganese,Metal-binding,NADP,Oxidoreductase,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tricarboxylic acid cycle,	binding site:NADP,binding site:NADP; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:Isocitrate dehydrogenase [NADP] cytoplasmic,helix,metal ion-binding site:Magnesium or manganese,modified residue,nucleotide phosphate-binding region:NADP,region of interest:Substrate binding,sequence conflict,sequence variant,site:Critical for catalysis,strand,turn,
IARS2	isoleucyl-tRNA synthetase 2, mitochondrial(IARS2)	Homo sapiens				GO:0006418~tRNA aminoacylation for protein translation,GO:0006428~isoleucyl-tRNA aminoacylation,GO:0006450~regulation of translational fidelity,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0000049~tRNA binding,GO:0002161~aminoacyl-tRNA editing activity,GO:0004822~isoleucine-tRNA ligase activity,GO:0005524~ATP binding,	IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR002300:Aminoacyl-tRNA synthetase, class Ia,IPR002301:Isoleucine-tRNA ligase,IPR009008:Valyl/Leucyl/Isoleucyl-tRNA synthetase, class Ia, editing domain,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,IPR010663:Zinc finger, DNA glycosylase/AP lyase/isoleucyl tRNA synthetase,IPR013155:Valyl/Leucyl/Isoleucyl-tRNA synthetase, class I, anticodon-binding,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR023585:Isoleucine-tRNA ligase, type 1,	hsa00970:Aminoacyl-tRNA biosynthesis,	616007~Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia,			Acetylation,Aminoacyl-tRNA synthetase,ATP-binding,Cataract,Complete proteome,Deafness,Disease mutation,Ligase,Membrane,Mitochondrion,Neuropathy,Nucleotide-binding,Polymorphism,Protein biosynthesis,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	binding site:ATP,chain:Isoleucyl-tRNA synthetase, mitochondrial,modified residue,sequence conflict,sequence variant,short sequence motif:"HIGH" region,short sequence motif:"KMSKS" region,transit peptide:Mitochondrion,
JMJD4	jumonji domain containing 4(JMJD4)	Homo sapiens						GO:0005515~protein binding,	IPR003347:JmjC domain,				SM00558:JmjC,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:JmjC domain-containing protein 4,domain:JmjC,sequence conflict,sequence variant,splice variant,
KPNA6	karyopherin subunit alpha 6(KPNA6)	Homo sapiens			Intracellular trafficking and secretion,	GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing protein import into nucleus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060135~maternal process involved in female pregnancy,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0008565~protein transporter activity,	IPR000225:Armadillo,IPR002652:Importin-alpha, importin-beta-binding domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024931:Importin subunit alpha,			PIRSF005673:importin subunit alpha,	SM00185:ARM,	3D-structure,Acetylation,Complete proteome,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Importin subunit alpha-7,domain:IBB,modified residue,region of interest:NLS binding site (major),region of interest:NLS binding site (minor),repeat:ARM 10; atypical,repeat:ARM 1; truncated,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,repeat:ARM 9,short sequence motif:Nuclear localization signal,
KAZN	kazrin, periplakin interacting protein(KAZN)	Homo sapiens				GO:0031424~keratinization,	GO:0001533~cornified envelope,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0030057~desmosome,	GO:0005515~protein binding,	IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,				SM00454:SAM,	Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Keratinization,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Kazrin,compositionally biased region:Poly-Lys,domain:SAM 1,domain:SAM 2,domain:SAM 3,modified residue,region of interest:Interaction with PPL,sequence conflict,sequence variant,splice variant,
KLHDC7A	kelch domain containing 7A(KLHDC7A)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0016021~integral component of membrane,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR006652:Kelch repeat type 1,IPR015915:Kelch-type beta propeller,				SM00612:Kelch,	Complete proteome,Glycoprotein,Kelch repeat,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Kelch domain-containing protein 7A,compositionally biased region:Poly-Arg,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,sequence variant,transmembrane region,
KLHDC8B	kelch domain containing 8B(KLHDC8B)	Homo sapiens			Function unknown,		GO:0005737~cytoplasm,		IPR006652:Kelch repeat type 1,IPR015915:Kelch-type beta propeller,		236000~Hodgkin lymphoma, susceptibility to,		SM00612:Kelch,	Chromosomal rearrangement,Complete proteome,Cytoplasm,Kelch repeat,Reference proteome,Repeat,	chain:Kelch domain-containing protein 8B,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,repeat:Kelch 7,repeat:Kelch 8,
KLHDC9	kelch domain containing 9(KLHDC9)	Homo sapiens							IPR011043:Galactose oxidase/kelch, beta-propeller,IPR015915:Kelch-type beta propeller,					Alternative splicing,Complete proteome,Kelch repeat,Polymorphism,Reference proteome,Repeat,	chain:Kelch domain-containing protein 9,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,sequence conflict,sequence variant,splice variant,
KLHL12	kelch like family member 12(KLHL12)	Homo sapiens				GO:0006513~protein monoubiquitination,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0016055~Wnt signaling pathway,GO:0048208~COPII vesicle coating,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0000139~Golgi membrane,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0030134~ER to Golgi transport vesicle,GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	3D-structure,Alternative splicing,Complete proteome,Cytoplasmic vesicle,ER-Golgi transport,Kelch repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transport,Ubl conjugation pathway,Wnt signaling pathway,	chain:Kelch-like protein 12,domain:BTB,modified residue,region of interest:Interaction with DVL3,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,sequence variant,strand,turn,
KLHL17	kelch like family member 17(KLHL17)	Homo sapiens				GO:0007420~brain development,GO:0016567~protein ubiquitination,GO:0030036~actin cytoskeleton organization,	GO:0005615~extracellular space,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0032839~dendrite cytoplasm,GO:0043025~neuronal cell body,GO:0045211~postsynaptic membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0031208~POZ domain binding,GO:0032947~protein complex scaffold,GO:0051015~actin filament binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011043:Galactose oxidase/kelch, beta-propeller,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Actin-binding,Cell junction,Cell membrane,Complete proteome,Kelch repeat,Membrane,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Synapse,Ubl conjugation pathway,	chain:Kelch-like protein 17,compositionally biased region:Pro-rich,domain:BACK,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,
KLHL18	kelch like family member 18(KLHL18)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Alternative splicing,Complete proteome,Kelch repeat,Proteomics identification,Reference proteome,Repeat,	chain:Kelch-like protein 18,domain:BACK,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,splice variant,
KLHL20	kelch like family member 20(KLHL20)	Homo sapiens				GO:0006895~Golgi to endosome transport,GO:0007010~cytoskeleton organization,GO:0015031~protein transport,GO:0016567~protein ubiquitination,GO:0035455~response to interferon-alpha,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:1990390~protein K33-linked ubiquitination,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0016605~PML body,GO:0030424~axon,GO:0030425~dendrite,GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0019964~interferon-gamma binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Actin-binding,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Golgi apparatus,Kelch repeat,Nucleus,Protein transport,Reference proteome,Repeat,Transport,Ubl conjugation pathway,	chain:Kelch-like protein 20,domain:BACK,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,
KLHL21	kelch like family member 21(KLHL21)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0016567~protein ubiquitination,GO:0032465~regulation of cytokinesis,GO:0035853~chromosome passenger complex localization to spindle midzone,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005827~polar microtubule,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Kelch repeat,Mitosis,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Kelch-like protein 21,domain:BACK,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,splice variant,
KLHL23	kelch like family member 23(KLHL23)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0016021~integral component of membrane,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Complete proteome,Kelch repeat,Membrane,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Kelch-like protein 23,domain:BACK,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,
KLHL29	kelch like family member 29(KLHL29)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015916:Galactose oxidase, beta-propeller,				SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Alternative splicing,Complete proteome,Kelch repeat,Proteomics identification,Reference proteome,Repeat,	chain:Kelch-like protein 29,compositionally biased region:Pro-rich,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,splice variant,
KLHL30	kelch like family member 30(KLHL30)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Complete proteome,Kelch repeat,Reference proteome,Repeat,	chain:Kelch-like protein 30,domain:BACK,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,
KLHL40	kelch like family member 40(KLHL40)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0048741~skeletal muscle fiber development,	GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0031672~A band,GO:0031674~I band,	GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR017096:Kelch-like protein, gigaxonin,		615348~Nemaline myopathy 8, autosomal recessive,	PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,Kelch repeat,Nemaline myopathy,Polymorphism,Reference proteome,Repeat,	chain:Kelch repeat and BTB domain-containing protein 5,compositionally biased region:Poly-Lys,domain:BACK,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,sequence variant,splice variant,
KLHL41	kelch like family member 41(KLHL41)	Homo sapiens				GO:0006941~striated muscle contraction,GO:0016567~protein ubiquitination,GO:0030239~myofibril assembly,GO:0031275~regulation of lateral pseudopodium assembly,GO:0035914~skeletal muscle cell differentiation,GO:0045214~sarcomere organization,GO:0045661~regulation of myoblast differentiation,GO:0048741~skeletal muscle fiber development,GO:2000291~regulation of myoblast proliferation,GO:2001014~regulation of skeletal muscle cell differentiation,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0031143~pseudopodium,GO:0031430~M band,GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0033017~sarcoplasmic reticulum membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR017096:Kelch-like protein, gigaxonin,		615731~Nemaline myopathy 9,	PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Endoplasmic reticulum,Kelch repeat,Membrane,Nemaline myopathy,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Sarcoplasmic reticulum,Ubl conjugation,	chain:Kelch repeat and BTB domain-containing protein 10,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,sequence conflict,sequence variant,splice variant,
KBTBD8	kelch repeat and BTB domain containing 8(KBTBD8)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005794~Golgi apparatus,GO:0005819~spindle,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Kelch repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Kelch repeat and BTB domain-containing protein 8,domain:BACK,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,sequence variant,
KHK	ketohexokinase(KHK)	Homo sapiens				GO:0006000~fructose metabolic process,GO:0009744~response to sucrose,GO:0009749~response to glucose,GO:0009750~response to fructose,GO:0010043~response to zinc ion,GO:0032868~response to insulin,GO:0046835~carbohydrate phosphorylation,GO:0061624~fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004454~ketohexokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR011611:Carbohydrate kinase PfkB,	hsa00051:Fructose and mannose metabolism,hsa01100:Metabolic pathways,	229800~Fructosuria,			3D-structure,Alternative splicing,ATP-binding,Carbohydrate metabolism,Complete proteome,Disease mutation,Kinase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transferase,	binding site:ATP,binding site:D-fructose,binding site:D-fructose; via amide nitrogen,chain:Ketohexokinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,
KIRREL	kin of IRRE like (Drosophila)(KIRREL)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0007588~excretion,GO:0016337~single organismal cell-cell adhesion,GO:0030838~positive regulation of actin filament polymerization,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016021~integral component of membrane,GO:0031253~cell projection membrane,GO:0043198~dendritic shaft,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0017022~myosin binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Kin of IRRE-like protein 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KIDINS220	kinase D-interacting substrate 220kDa(KIDINS220)	Homo sapiens			General function prediction only,	GO:0000186~activation of MAPKK activity,GO:0001701~in utero embryonic development,GO:0010976~positive regulation of neuron projection development,GO:0038180~nerve growth factor signaling pathway,GO:0045859~regulation of protein kinase activity,GO:0048813~dendrite morphogenesis,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0005770~late endosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0016301~kinase activity,GO:0019887~protein kinase regulator activity,GO:0030165~PDZ domain binding,	IPR002110:Ankyrin repeat,IPR011646:KAP P-loop,IPR013761:Sterile alpha motif/pointed domain,IPR020683:Ankyrin repeat-containing domain,	hsa04722:Neurotrophin signaling pathway,			SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Endosome,Kinase,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Transmembrane,Transmembrane helix,	chain:Kinase D-interacting substrate of 220 kDa,domain:KAP NTPase,modified residue,region of interest:Mediates interaction with CRKL,region of interest:Mediates interaction with SNTA1,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 12,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KIFAP3	kinesin associated protein 3(KIFAP3)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007165~signal transduction,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0043066~negative regulation of apoptotic process,GO:0046587~positive regulation of calcium-dependent cell-cell adhesion,GO:0072383~plus-end-directed vesicle transport along microtubule,	GO:0000794~condensed nuclear chromosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,GO:0016939~kinesin II complex,GO:0030990~intraciliary transport particle,GO:0032391~photoreceptor connecting cilium,GO:0036064~ciliary basal body,GO:0070062~extracellular exosome,GO:0072372~primary cilium,GO:0097542~ciliary tip,GO:1990075~periciliary membrane compartment,	GO:0005515~protein binding,GO:0019894~kinesin binding,	IPR000225:Armadillo,IPR008658:Kinesin-associated protein 3,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,				SM00185:ARM,	Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Kinesin-associated protein 3,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,sequence conflict,sequence variant,
KIF14	kinesin family member 14(KIF14)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0007018~microtubule-based movement,GO:0007019~microtubule depolymerization,GO:0007080~mitotic metaphase plate congression,GO:0008284~positive regulation of cell proliferation,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0021685~cerebellar granular layer structural organization,GO:0021693~cerebellar Purkinje cell layer structural organization,GO:0021695~cerebellar cortex development,GO:0021766~hippocampus development,GO:0021772~olfactory bulb development,GO:0021846~cell proliferation in forebrain,GO:0021987~cerebral cortex development,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031641~regulation of myelination,GO:0032147~activation of protein kinase activity,GO:0032467~positive regulation of cytokinesis,GO:0032487~regulation of Rap protein signal transduction,GO:0033624~negative regulation of integrin activation,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043066~negative regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045184~establishment of protein localization,GO:0051301~cell division,GO:1902519~response to docetaxel trihydrate,GO:1903047~mitotic cell cycle process,GO:1903429~regulation of cell maturation,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0051233~spindle midzone,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,GO:0015631~tubulin binding,GO:0016887~ATPase activity,GO:0019901~protein kinase binding,GO:0030165~PDZ domain binding,	IPR000253:Forkhead-associated (FHA) domain,IPR001752:Kinesin, motor domain,IPR008984:SMAD/FHA domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		616258~Meckel syndrome 12,		SM00129:KISc,SM00240:FHA,	ATP-binding,Ciliopathy,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Meckel syndrome,Microtubule,Motor protein,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Kinesin-like protein KIF14,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:FHA,domain:Kinesin-motor,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Required for CIT-binding,region of interest:Required for PRC1-binding,sequence conflict,sequence variant,
KIF15	kinesin family member 15(KIF15)	Homo sapiens		h_ranMSPathway:Role of Ran in mitotic spindle regulation,	Cytoskeleton,	GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007018~microtubule-based movement,GO:0007067~mitotic nuclear division,GO:0008283~cell proliferation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,	GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005873~plus-end kinesin complex,GO:0005874~microtubule,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,	IPR001752:Kinesin, motor domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Motor protein,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Kinesin-like protein KIF15,domain:Kinesin-motor,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
KIF17	kinesin family member 17(KIF17)	Homo sapiens				GO:0007018~microtubule-based movement,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0022008~neurogenesis,GO:0030030~cell projection organization,GO:0031503~protein complex localization,	GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0030992~intraciliary transport particle B,GO:0032391~photoreceptor connecting cilium,GO:0036064~ciliary basal body,GO:0072372~primary cilium,GO:1990075~periciliary membrane compartment,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,	Alternative splicing,ATP-binding,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Kinesin-like protein KIF17,domain:Kinesin-motor,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
KIF1A	kinesin family member 1A(KIF1A)	Homo sapiens	28.KLFs_cytoplas_dynein_cargo_nerve_axons,30.Kinesin_superfamily_proteins,			GO:0007018~microtubule-based movement,GO:0008089~anterograde axonal transport,	GO:0005871~kinesin complex,GO:0005874~microtubule,GO:1904115~axon cytoplasm,	GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,	IPR000253:Forkhead-associated (FHA) domain,IPR001752:Kinesin, motor domain,IPR001849:Pleckstrin homology domain,IPR008984:SMAD/FHA domain,IPR011993:Pleckstrin homology-like domain,IPR019821:Kinesin, motor region, conserved site,IPR022140:Kinesin protein 1B,IPR022164:Kinesin-like,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		610357~Spastic paraplegia 30, autosomal recessive,614213~Neuropathy, hereditary sensory, type IIC,614255~Mental retardation, autosomal dominant 9,		SM00129:KISc,SM00233:PH,SM00240:FHA,	3D-structure,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Hereditary spastic paraplegia,Mental retardation,Microtubule,Motor protein,Neurodegeneration,Neuropathy,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Kinesin-like protein KIF1A,domain:FHA,domain:Kinesin-motor,domain:PH,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,
KIF1B	kinesin family member 1B(KIF1B)	Homo sapiens				GO:0006915~apoptotic process,GO:0007018~microtubule-based movement,GO:0007270~neuron-neuron synaptic transmission,GO:0007274~neuromuscular synaptic transmission,GO:0008089~anterograde axonal transport,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0047497~mitochondrion transport along microtubule,	GO:0005739~mitochondrion,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0043005~neuron projection,GO:1904115~axon cytoplasm,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,GO:0019894~kinesin binding,	IPR000253:Forkhead-associated (FHA) domain,IPR001752:Kinesin, motor domain,IPR001849:Pleckstrin homology domain,IPR008984:SMAD/FHA domain,IPR011993:Pleckstrin homology-like domain,IPR019821:Kinesin, motor region, conserved site,IPR022140:Kinesin protein 1B,IPR022164:Kinesin-like,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		118210~Charcot-Marie-Tooth disease, type 2A1,171300~Pheochromocytoma,256700~Neuroblastoma, susceptibility to, 1,		SM00129:KISc,SM00233:PH,SM00240:FHA,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Disease mutation,Microtubule,Mitochondrion,Motor protein,Neurodegeneration,Neuropathy,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Kinesin-like protein KIF1B,domain:FHA,domain:Kinesin-motor,domain:PH,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with KBP,sequence conflict,sequence variant,splice variant,strand,turn,
KIF21B	kinesin family member 21B(KIF21B)	Homo sapiens				GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,	IPR001680:WD40 repeat,IPR001752:Kinesin, motor domain,IPR009053:Prefoldin,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,SM00320:WD40,	Alternative splicing,ATP-binding,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Motor protein,Nucleotide-binding,Phosphoprotein,Reference proteome,Repeat,WD repeat,	chain:Kinesin-like protein KIF21B,domain:Kinesin-motor,modified residue,nucleotide phosphate-binding region:ATP,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,splice variant,
KIF26B	kinesin family member 26B(KIF26B)	Homo sapiens				GO:0007018~microtubule-based movement,GO:0007411~axon guidance,GO:0008104~protein localization,GO:0022409~positive regulation of cell-cell adhesion,GO:0030010~establishment of cell polarity,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0072092~ureteric bud invasion,	GO:0005737~cytoplasm,GO:0005871~kinesin complex,GO:0005874~microtubule,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,	IPR001752:Kinesin, motor domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Microtubule,Motor protein,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Kinesin-like protein KIF26B,compositionally biased region:Gly-rich,compositionally biased region:Ser-rich,domain:Kinesin-motor,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,
KIF2C	kinesin family member 2C(KIF2C)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007018~microtubule-based movement,GO:0007019~microtubule depolymerization,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007080~mitotic metaphase plate congression,GO:0008283~cell proliferation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051983~regulation of chromosome segregation,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0035371~microtubule plus-end,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019237~centromeric DNA binding,GO:0051010~microtubule plus-end binding,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Kinetochore,Microtubule,Mitosis,Motor protein,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	binding site:ATP,chain:Kinesin-like protein KIF2C,domain:Kinesin-motor,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Globular,region of interest:Negative regulator of microtubule-binding,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
KIF3C	kinesin family member 3C(KIF3C)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007018~microtubule-based movement,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0072384~organelle transport along microtubule,	GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0072372~primary cilium,GO:0097542~ciliary tip,	GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,	3D-structure,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:Kinesin-like protein KIF3C,compositionally biased region:Poly-Asn,compositionally biased region:Poly-Gly,domain:Kinesin-motor,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Globular,sequence conflict,sequence variant,strand,turn,
KIF5C	kinesin family member 5C(KIF5C)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006996~organelle organization,GO:0007018~microtubule-based movement,GO:0007411~axon guidance,GO:0008045~motor neuron axon guidance,GO:0008104~protein localization,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0051028~mRNA transport,	GO:0005737~cytoplasm,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0035253~ciliary rootlet,GO:0043005~neuron projection,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,hsa04728:Dopaminergic synapse,	615282~Cortical dysplasia, complex, with other brain malformations 2,		SM00129:KISc,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:Kinesin heavy chain isoform 5C,domain:Kinesin-motor,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Globular,region of interest:Microtubule-binding,sequence conflict,splice variant,
KIF9	kinesin family member 9(KIF9)	Homo sapiens				GO:0007018~microtubule-based movement,GO:0022617~extracellular matrix disassembly,GO:0071801~regulation of podosome assembly,GO:1903008~organelle disassembly,	GO:0002102~podosome,GO:0005737~cytoplasm,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0031982~vesicle,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,GO:0046983~protein dimerization activity,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,	3D-structure,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Motor protein,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,	chain:Kinesin-like protein KIF9,domain:Kinesin-motor,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
KYNU	kynureninase(KYNU)	Homo sapiens				GO:0006569~tryptophan catabolic process,GO:0009435~NAD biosynthetic process,GO:0019441~tryptophan catabolic process to kynurenine,GO:0019442~tryptophan catabolic process to acetyl-CoA,GO:0019805~quinolinate biosynthetic process,GO:0034341~response to interferon-gamma,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,GO:0034516~response to vitamin B6,GO:0043420~anthranilate metabolic process,GO:0097053~L-kynurenine catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0030170~pyridoxal phosphate binding,GO:0030429~kynureninase activity,GO:0042803~protein homodimerization activity,	IPR000192:Aminotransferase, class V/Cysteine desulfurase,IPR010111:Kynureninase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,	236800~Hydroxykynureninuria,	PIRSF038800:kynureninase,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Polymorphism,Proteomics identification,Pyridine nucleotide biosynthesis,Pyridoxal phosphate,Reference proteome,	binding site:Pyridoxal phosphate,binding site:Pyridoxal phosphate; via amide nitrogen,chain:Kynureninase,helix,modified residue,region of interest:Pyridoxal phosphate binding,sequence variant,strand,turn,
KMO	kynurenine 3-monooxygenase(KMO)	Homo sapiens				GO:0006569~tryptophan catabolic process,GO:0009651~response to salt stress,GO:0019441~tryptophan catabolic process to kynurenine,GO:0019674~NAD metabolic process,GO:0019805~quinolinate biosynthetic process,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,GO:0043420~anthranilate metabolic process,GO:0044550~secondary metabolite biosynthetic process,GO:0055114~oxidation-reduction process,GO:0070189~kynurenine metabolic process,	GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004502~kynurenine 3-monooxygenase activity,GO:0016174~NAD(P)H oxidase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0071949~FAD binding,	IPR002938:Monooxygenase, FAD-binding,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,IPR027545:Kynurenine 3-monooxygenase,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,FAD,Flavoprotein,Membrane,Mitochondrion,Mitochondrion outer membrane,Monooxygenase,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Pyridine nucleotide biosynthesis,Reference proteome,Transmembrane,Transmembrane helix,	chain:Kynurenine 3-monooxygenase,modified residue,sequence variant,splice variant,transmembrane region,
KYAT3	kynurenine aminotransferase 3(KYAT3)	Homo sapiens				GO:0006103~2-oxoglutarate metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0009058~biosynthetic process,GO:0070189~kynurenine metabolic process,GO:0097052~L-kynurenine metabolic process,	GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0016212~kynurenine-oxoglutarate transaminase activity,GO:0030170~pyridoxal phosphate binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0047315~kynurenine-glyoxylate transaminase activity,GO:0047804~cysteine-S-conjugate beta-lyase activity,	IPR004839:Aminotransferase, class I/classII,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00380:Tryptophan metabolism,hsa00450:Selenocompound metabolism,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Acetylation,Alternative splicing,Aminotransferase,Complete proteome,Lyase,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,	chain:Kynurenine--oxoglutarate transaminase 3,modified residue,sequence conflict,sequence variant,splice variant,
LCT	lactase(LCT)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0044245~polysaccharide digestion,GO:1901657~glycosyl compound metabolic process,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,	GO:0000016~lactase activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0008422~beta-glucosidase activity,GO:0017042~glycosylceramidase activity,	IPR001360:Glycoside hydrolase, family 1,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,IPR018120:Glycoside hydrolase, family 1, active site,	hsa00052:Galactose metabolism,hsa01100:Metabolic pathways,hsa04973:Carbohydrate digestion and absorption,	223000~Lactase deficiency, congenital,			Cell membrane,Complete proteome,Disease mutation,Glycosidase,Hydrolase,Membrane,Multifunctional enzyme,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Zymogen,	active site:Nucleophile,active site:Proton donor,chain:Lactase-phlorizin hydrolase,modified residue,propeptide:Beta-glucosidase,region of interest:4 X approximate repeats,repeat:1,repeat:2,repeat:3,repeat:4,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LTF	lactotransferrin(LTF)	Homo sapiens		h_AnthraxPathway:Anthrax Toxin Mechanism of Action,		GO:0001503~ossification,GO:0001817~regulation of cytokine production,GO:0001895~retina homeostasis,GO:0002227~innate immune response in mucosa,GO:0006351~transcription, DNA-templated,GO:0006508~proteolysis,GO:0006811~ion transport,GO:0006959~humoral immune response,GO:0019731~antibacterial humoral response,GO:0019732~antifungal humoral response,GO:0031665~negative regulation of lipopolysaccharide-mediated signaling pathway,GO:0032680~regulation of tumor necrosis factor production,GO:0032780~negative regulation of ATPase activity,GO:0033214~iron assimilation by chelation and transport,GO:0033690~positive regulation of osteoblast proliferation,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044267~cellular protein metabolic process,GO:0044793~negative regulation by host of viral process,GO:0045071~negative regulation of viral genome replication,GO:0045454~cell redox homeostasis,GO:0045669~positive regulation of osteoblast differentiation,GO:0048525~negative regulation of viral process,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060349~bone morphogenesis,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:1900159~positive regulation of bone mineralization involved in bone maturation,GO:1900229~negative regulation of single-species biofilm formation in or on host organism,GO:1902732~positive regulation of chondrocyte proliferation,GO:2000308~negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,GO:2001205~negative regulation of osteoclast development,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0030141~secretory granule,GO:0042581~specific granule,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0097013~phagocytic vesicle lumen,	GO:0003677~DNA binding,GO:0004252~serine-type endopeptidase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0043539~protein serine/threonine kinase activator activity,	IPR001156:Transferrin family,IPR016357:Transferrin,IPR018195:Transferrin family, iron binding site,			PIRSF002549:transferrin,PIRSF500683:lactoferrin [Parent=PIRSF002549],	SM00094:TR_FER,	3D-structure,Alternative promoter usage,Antibiotic,Antimicrobial,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,DNA-binding,Glycoprotein,Heparin-binding,Hydrolase,Immunity,Ion transport,Iron,Iron transport,Metal-binding,Nucleus,Osteogenesis,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease,Signal,Transcription,Transcription regulation,Transport,Ubl conjugation,	active site:Nucleophile,binding site:Carbonate 1,binding site:Carbonate 1; via amide nitrogen,binding site:Carbonate 2,binding site:Carbonate 2; via amide nitrogen,chain:Lactotransferrin,disulfide bond,domain:Transferrin-like 1,domain:Transferrin-like 2,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Iron 1,metal ion-binding site:Iron 2,modified residue,mutagenesis site,peptide:Kaliocin-1,peptide:Lactoferroxin-A,peptide:Lactoferroxin-B,peptide:Lactoferroxin-C,sequence conflict,sequence variant,signal peptide,strand,turn,
LAD1	ladinin 1(LAD1)	Homo sapiens				GO:0098609~cell-cell adhesion,	GO:0005604~basement membrane,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR017404:Ladinin 1,			PIRSF038144:ladinin 1,		Basement membrane,Complete proteome,Extracellular matrix,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,	chain:Ladinin-1,compositionally biased region:Poly-Arg,modified residue,region of interest:8 X SEK repeats,repeat:SEK 1,repeat:SEK 2,repeat:SEK 3,repeat:SEK 4,repeat:SEK 5,repeat:SEK 6,repeat:SEK 7,repeat:SEK 8,sequence variant,
LMNA	lamin A/C(LMNA)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0007077~mitotic nuclear envelope disassembly,GO:0007084~mitotic nuclear envelope reassembly,GO:0007517~muscle organ development,GO:0030334~regulation of cell migration,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0034504~protein localization to nucleus,GO:0035105~sterol regulatory element binding protein import into nucleus,GO:0036498~IRE1-mediated unfolded protein response,GO:0055015~ventricular cardiac muscle cell development,GO:0071456~cellular response to hypoxia,GO:0072201~negative regulation of mesenchymal cell proliferation,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0090343~positive regulation of cell aging,GO:1900180~regulation of protein localization to nucleus,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005638~lamin filament,GO:0005652~nuclear lamina,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0016607~nuclear speck,GO:0031012~extracellular matrix,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR001322:Lamin Tail Domain,IPR001664:Intermediate filament protein,IPR018039:Intermediate filament protein, conserved site,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	115200~Cardiomyopathy, dilated, 1A,151660~Lipodystrophy, familial partial, 2,159001~Muscular dystrophy, limb-girdle, type 1B,176670~Hutchinson-Gilford progeria,181350~Emery-Dreifuss muscular dystrophy 2, AD,212112~Malouf syndrome,248370~Mandibuloacral dysplasia,275210~Restrictive dermopathy, lethal,605588~Charcot-Marie-Tooth disease, type 2B1,610140~Heart-hand syndrome, Slovenian type,613205~Muscular dystrophy, congenital,616516~Emery-Dreifuss muscular dystrophy 3, AR,		SM01391:SM01391,	3D-structure,Acetylation,Alternative splicing,Cardiomyopathy,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Congenital muscular dystrophy,Direct protein sequencing,Disease mutation,Emery-Dreifuss muscular dystrophy,Intermediate filament,Isopeptide bond,Limb-girdle muscular dystrophy,Lipoprotein,Methylation,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Lamin-A/C,helix,lipid moiety-binding region:S-farnesyl cysteine,modified residue,mutagenesis site,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,sequence variant,short sequence motif:Nuclear localization signal,site:Heptad change of phase,site:Stutter,splice variant,strand,turn,
LBR	lamin B receptor(LBR)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0016126~sterol biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005635~nuclear envelope,GO:0005639~integral component of nuclear inner membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0044822~poly(A) RNA binding,GO:0050613~delta14-sterol reductase activity,GO:0070087~chromo shadow domain binding,	IPR001171:Ergosterol biosynthesis ERG4/ERG24,IPR002999:Tudor domain,IPR018083:Sterol reductase, conserved site,IPR019023:Lamin-B receptor of TUDOR domain,		169400~Pelger-Huet anomaly,215140~Greenberg skeletal dysplasia,613471~Reynolds syndrome,		SM00333:TUDOR,	3D-structure,Acetylation,Complete proteome,Disease mutation,DNA-binding,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Lamin-B receptor,modified residue,region of interest:Nucleoplasmic,sequence conflict,sequence variant,strand,transmembrane region,turn,
LAMB2	laminin subunit beta 2(LAMB2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0007528~neuromuscular junction development,GO:0007601~visual perception,GO:0014002~astrocyte development,GO:0014044~Schwann cell development,GO:0030198~extracellular matrix organization,GO:0048677~axon extension involved in regeneration,GO:0060041~retina development in camera-type eye,GO:0072249~metanephric glomerular visceral epithelial cell development,GO:0072274~metanephric glomerular basement membrane development,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005605~basal lamina,GO:0005608~laminin-3 complex,GO:0031012~extracellular matrix,GO:0043260~laminin-11 complex,GO:0045202~synapse,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005198~structural molecule activity,	IPR000742:Epidermal growth factor-like domain,IPR002049:EGF-like, laminin,IPR008211:Laminin, N-terminal,IPR013015:Laminin IV,IPR013032:EGF-like, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	609049~Pierson syndrome,614199~Nephrotic syndrome, type 5, with or without ocular abnormalities,		SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,	Basement membrane,Cell adhesion,Coiled coil,Complete proteome,Disease mutation,Disulfide bond,Extracellular matrix,Glycoprotein,Laminin EGF-like domain,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Laminin subunit beta-2,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 10,domain:Laminin EGF-like 11,domain:Laminin EGF-like 12,domain:Laminin EGF-like 13,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4,domain:Laminin EGF-like 5; truncated,domain:Laminin EGF-like 6,domain:Laminin EGF-like 7,domain:Laminin EGF-like 8,domain:Laminin EGF-like 9,domain:Laminin IV type B,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Domain alpha,region of interest:Domain I,region of interest:Domain II,sequence conflict,sequence variant,signal peptide,
LAMB3	laminin subunit beta 3(LAMB3)	Homo sapiens				GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0031581~hemidesmosome assembly,GO:0035987~endodermal cell differentiation,GO:0050873~brown fat cell differentiation,	GO:0005576~extracellular region,GO:0005610~laminin-5 complex,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0032403~protein complex binding,	IPR002049:EGF-like, laminin,IPR008211:Laminin, N-terminal,IPR008979:Galactose-binding domain-like,IPR013032:EGF-like, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	104530~Amelogenesis imperfecta, type IA,226650~Epidermolysis bullosa, junctional, non-Herlitz type,226700~Epidermolysis bullosa, junctional, Herlitz type,		SM00136:LamNT,SM00180:EGF_Lam,	Amelogenesis imperfecta,Basement membrane,Cell adhesion,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Epidermolysis bullosa,Extracellular matrix,Glycoprotein,Laminin EGF-like domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Laminin subunit beta-3,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4,domain:Laminin EGF-like 5,domain:Laminin EGF-like 6,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Domain alpha,region of interest:Domain I,region of interest:Domain II,sequence conflict,sequence variant,signal peptide,
LAMC1	laminin subunit gamma 1(LAMC1)	Homo sapiens		h_prionPathway:Prion Pathway,	DNA replication, recombination, and repair,	GO:0006461~protein complex assembly,GO:0007155~cell adhesion,GO:0007492~endoderm development,GO:0016477~cell migration,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0031581~hemidesmosome assembly,GO:0034446~substrate adhesion-dependent cell spreading,GO:0050679~positive regulation of epithelial cell proliferation,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005606~laminin-1 complex,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0043259~laminin-10 complex,GO:0043260~laminin-11 complex,GO:0070062~extracellular exosome,	GO:0005201~extracellular matrix structural constituent,	IPR000034:Laminin B type IV,IPR000742:Epidermal growth factor-like domain,IPR002049:EGF-like, laminin,IPR008211:Laminin, N-terminal,IPR008979:Galactose-binding domain-like,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05020:Prion diseases,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,			SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,SM00281:LamB,	Basement membrane,Cell adhesion,Coiled coil,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Laminin EGF-like domain,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Laminin subunit gamma-1,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 10,domain:Laminin EGF-like 11,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4,domain:Laminin EGF-like 5; first part,domain:Laminin EGF-like 5; second part,domain:Laminin EGF-like 6,domain:Laminin EGF-like 7,domain:Laminin EGF-like 8,domain:Laminin EGF-like 9,domain:Laminin IV type A,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Domain II and I,sequence conflict,sequence variant,signal peptide,
LAMC2	laminin subunit gamma 2(LAMC2)	Homo sapiens			Cell division and chromosome partitioning,Cell motility and secretion / Signal transduction mechanisms,	GO:0007155~cell adhesion,GO:0008284~positive regulation of cell proliferation,GO:0008544~epidermis development,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0031581~hemidesmosome assembly,	GO:0005576~extracellular region,GO:0005607~laminin-2 complex,GO:0005615~extracellular space,GO:0005938~cell cortex,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0008201~heparin binding,	IPR000034:Laminin B type IV,IPR000742:Epidermal growth factor-like domain,IPR002049:EGF-like, laminin,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	226650~Epidermolysis bullosa, junctional, non-Herlitz type,226700~Epidermolysis bullosa, junctional, Herlitz type,		SM00180:EGF_Lam,SM00181:EGF,SM00281:LamB,	Alternative splicing,Basement membrane,Cell adhesion,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,Epidermolysis bullosa,Extracellular matrix,Glycoprotein,Heparin-binding,Laminin EGF-like domain,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Laminin subunit gamma-2,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4; first part,domain:Laminin EGF-like 4; second part,domain:Laminin EGF-like 5,domain:Laminin EGF-like 6,domain:Laminin EGF-like 7,domain:Laminin EGF-like 8; truncated,domain:Laminin IV type A,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Domain II and I,sequence conflict,sequence variant,signal peptide,splice variant,
LELP1	late cornified envelope like proline rich 1(LELP1)	Homo sapiens				GO:0018149~peptide cross-linking,GO:0030216~keratinocyte differentiation,	GO:0001533~cornified envelope,GO:0005737~cytoplasm,	GO:0005198~structural molecule activity,	IPR026075:Small proline-rich protein/late cornified envelope protein,IPR026076:Late cornified envelope-like proline-rich protein 1,					Complete proteome,Reference proteome,	chain:Late cornified envelope-like proline-rich protein 1,compositionally biased region:Cys/Pro-rich,
LTBP1	latent transforming growth factor beta binding protein 1(LTBP1)	Homo sapiens				GO:0003281~ventricular septum development,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0035583~sequestering of TGFbeta in extracellular matrix,GO:0035904~aorta development,GO:0060976~coronary vasculature development,	GO:0001527~microfibril,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0043234~protein complex,	GO:0005024~transforming growth factor beta-activated receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0050431~transforming growth factor beta binding,GO:0050436~microfibril binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR017878:TB domain,IPR018097:EGF-like calcium-binding, conserved site,IPR026823:Complement Clr-like EGF domain,	hsa04350:TGF-beta signaling pathway,			SM00179:EGF_CA,SM00181:EGF,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Growth factor binding,Hydroxylation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Latent-transforming growth factor beta- binding protein 1,compositionally biased region:Pro-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 10; calcium-binding,domain:EGF-like 11; calcium-binding,domain:EGF-like 12; calcium-binding,domain:EGF-like 13; calcium-binding,domain:EGF-like 14; calcium-binding,domain:EGF-like 15; calcium-binding,domain:EGF-like 16; calcium-binding,domain:EGF-like 17,domain:EGF-like 18; calcium-binding,domain:EGF-like 2,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:EGF-like 9; calcium-binding,domain:TB 1,domain:TB 2,domain:TB 3,domain:TB 4,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,short sequence motif:Cell attachment site,signal peptide,splice variant,strand,turn,
LMAN2L	lectin, mannose binding 2 like(LMAN2L)	Homo sapiens				GO:0006457~protein folding,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007029~endoplasmic reticulum organization,GO:0007030~Golgi organization,GO:0015031~protein transport,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030134~ER to Golgi transport vesicle,	GO:0005537~mannose binding,GO:0046872~metal ion binding,	IPR005052:Legume-like lectin,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,					Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Lectin,Membrane,Mental retardation,Metal-binding,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:VIP36-like protein,disulfide bond,domain:L-type lectin-like,glycosylation site:N-linked (GlcNAc...) (high mannose),mutagenesis site,sequence conflict,short sequence motif:Endoplasmic reticular retention signal,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
LEFTY2	left-right determination factor 2(LEFTY2)	Homo sapiens				GO:0002576~platelet degranulation,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007275~multicellular organism development,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0016049~cell growth,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048468~cell development,GO:0060395~SMAD protein signal transduction,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0031093~platelet alpha granule lumen,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0008083~growth factor activity,	IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR003942:Left- Right determination factor,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04350:TGF-beta signaling pathway,	Left-right axis malformations~Left-right axis malformations,	PIRSF037402:lefty protein [Parent=PIRSF800009],	SM00204:TGFB,	Alternative splicing,Complete proteome,Cytokine,Developmental protein,Disease mutation,Disulfide bond,Glycoprotein,Growth factor,Heterotaxy,Polymorphism,Reference proteome,Secreted,Signal,	chain:Left-right determination factor 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),propeptide:Or 135,sequence conflict,sequence variant,signal peptide,
LMOD1	leiomodin 1(LMOD1)	Homo sapiens				GO:0006936~muscle contraction,GO:0007015~actin filament organization,GO:0030239~myofibril assembly,GO:0030838~positive regulation of actin filament polymerization,GO:0045010~actin nucleation,GO:0051694~pointed-end actin filament capping,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005865~striated muscle thin filament,GO:0005884~actin filament,GO:0016020~membrane,GO:0030016~myofibril,GO:0030017~sarcomere,	GO:0003779~actin binding,GO:0005523~tropomyosin binding,	IPR003124:WH2 domain,IPR004934:Tropomodulin,				SM00246:WH2,	3D-structure,Actin-binding,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Leiomodin-1,domain:WH2,region of interest:5 X 4 AA approximate tandem repeats,region of interest:8 X approximate tandem repeats,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,sequence conflict,sequence variant,splice variant,
LMOD3	leiomodin 3(LMOD3)	Homo sapiens				GO:0006936~muscle contraction,GO:0007015~actin filament organization,GO:0030239~myofibril assembly,GO:0051694~pointed-end actin filament capping,	GO:0005865~striated muscle thin filament,GO:0031430~M band,	GO:0003785~actin monomer binding,GO:0005523~tropomyosin binding,	IPR004934:Tropomodulin,		616165~Nemaline myopathy 10,			Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Nemaline myopathy,Polymorphism,Reference proteome,	chain:Leiomodin-3,compositionally biased region:Glu-rich,compositionally biased region:Poly-Pro,domain:WH2,sequence conflict,sequence variant,splice variant,
LEPROT	leptin receptor overlapping transcript(LEPROT)	Homo sapiens				GO:0032511~late endosome to vacuole transport via multivesicular body sorting pathway,GO:0046426~negative regulation of JAK-STAT cascade,GO:0060400~negative regulation of growth hormone receptor signaling pathway,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2000009~negative regulation of protein localization to cell surface,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,	GO:0005102~receptor binding,	IPR007262:Vacuolar protein sorting 55,					Complete proteome,Endosome,Golgi apparatus,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Leptin receptor gene-related protein,transmembrane region,
LEPR	leptin receptor(LEPR)	Homo sapiens		h_leptinPathway:Reversal of Insulin Resistance by Leptin,		GO:0001525~angiogenesis,GO:0006112~energy reserve metabolic process,GO:0006909~phagocytosis,GO:0007166~cell surface receptor signaling pathway,GO:0007275~multicellular organism development,GO:0008203~cholesterol metabolic process,GO:0010507~negative regulation of autophagy,GO:0019953~sexual reproduction,GO:0030217~T cell differentiation,GO:0033210~leptin-mediated signaling pathway,GO:0042593~glucose homeostasis,GO:0044321~response to leptin,GO:0045721~negative regulation of gluconeogenesis,GO:0046850~regulation of bone remodeling,GO:0051346~negative regulation of hydrolase activity,GO:0060259~regulation of feeding behavior,GO:0097009~energy homeostasis,GO:0098868~bone growth,GO:2000505~regulation of energy homeostasis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0043235~receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0038021~leptin receptor activity,	IPR003529:Long hematopoietin receptor, Gp130 family 2, conserved site,IPR003531:Short hematopoietin receptor, family 1, conserved site,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR010457:Immunoglobulin C2-set-like, ligand-binding,IPR013783:Immunoglobulin-like fold,IPR015752:Leptin receptor,	hsa04060:Cytokine-cytokine receptor interaction,hsa04080:Neuroactive ligand-receptor interaction,hsa04152:AMPK signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),	614963~Obesity, morbid, due to leptin receptor deficiency,		SM00060:FN3,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Obesity,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Leptin receptor,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Required for JAK2 activation,sequence conflict,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LURAP1	leucine rich adaptor protein 1(LURAP1)	Homo sapiens				GO:0001819~positive regulation of cytokine production,GO:0016477~cell migration,GO:0031032~actomyosin structure organization,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,	GO:0005737~cytoplasm,GO:0042641~actomyosin,	GO:0005515~protein binding,						Complete proteome,Cytoplasm,Leucine-rich repeat,Phosphoprotein,Reference proteome,Repeat,	chain:Uncharacterized protein C1orf190,modified residue,
LRPPRC	leucine rich pentatricopeptide repeat containing(LRPPRC)	Homo sapiens				GO:0000961~negative regulation of mitochondrial RNA catabolic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0047497~mitochondrion transport along microtubule,GO:0051028~mRNA transport,GO:0070129~regulation of mitochondrial translation,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0005640~nuclear outer membrane,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0042645~mitochondrial nucleoid,GO:0048471~perinuclear region of cytoplasm,	GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0048487~beta-tubulin binding,GO:0051015~actin filament binding,	IPR002885:Pentatricopeptide repeat,IPR011990:Tetratricopeptide-like helical,		220111~Leigh syndrome, French-Canadian type,			Acetylation,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Leigh syndrome,Membrane,Mitochondrion,mRNA transport,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,Transit peptide,Transport,	chain:Leucine-rich PPR motif-containing protein, mitochondrial,modified residue,region of interest:RNA-binding,repeat:PPR 1,repeat:PPR 10,repeat:PPR 11,repeat:PPR 12,repeat:PPR 13,repeat:PPR 14,repeat:PPR 15,repeat:PPR 16,repeat:PPR 17,repeat:PPR 18,repeat:PPR 19,repeat:PPR 2,repeat:PPR 20,repeat:PPR 3,repeat:PPR 4,repeat:PPR 5,repeat:PPR 6,repeat:PPR 7,repeat:PPR 8,repeat:PPR 9,sequence conflict,sequence variant,transit peptide:Mitochondrion,
LRRC2	leucine rich repeat containing 2(LRRC2)	Homo sapiens			Function unknown,				IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00369:LRR_TYP,	Complete proteome,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein 2,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,
LRRC38	leucine rich repeat containing 38(LRRC38)	Homo sapiens				GO:0006811~ion transport,GO:0007409~axonogenesis,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR000372:Leucine-rich repeat-containing N-terminal,IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,	Cell membrane,Complete proteome,Disulfide bond,Ion channel,Ion transport,Leucine-rich repeat,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Leucine-rich repeat-containing protein 38,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,sequence variant,signal peptide,transmembrane region,
LRRC39	leucine rich repeat containing 39(LRRC39)	Homo sapiens							IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR025875:Leucine rich repeat 4,				SM00369:LRR_TYP,	Alternative splicing,Coiled coil,Complete proteome,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein 39,compositionally biased region:Poly-Glu,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence variant,splice variant,
LRRC3B	leucine rich repeat containing 3B(LRRC3B)	Homo sapiens			Function unknown,		GO:0016021~integral component of membrane,		IPR000372:Leucine-rich repeat-containing N-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00013:LRRNT,SM00369:LRR_TYP,	Complete proteome,Glycoprotein,Leucine-rich repeat,Membrane,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat-containing protein 3B,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,signal peptide,transmembrane region,
LRRC40	leucine rich repeat containing 40(LRRC40)	Homo sapiens			Function unknown,		GO:0016020~membrane,		IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00369:LRR_TYP,	Complete proteome,Leucine-rich repeat,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein 40,modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 18,repeat:LRR 19,repeat:LRR 2,repeat:LRR 20,repeat:LRR 21,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,
LRRC41	leucine rich repeat containing 41(LRRC41)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0042803~protein homodimerization activity,	IPR026137:Leucine-rich repeat-containing  41,					Alternative splicing,Complete proteome,Leucine-rich repeat,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Leucine-rich repeat-containing protein 41,modified residue,region of interest:Interaction with Elongin BC complex,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,sequence conflict,sequence variant,splice variant,
LRRC42	leucine rich repeat containing 42(LRRC42)	Homo sapiens							IPR001611:Leucine-rich repeat,					Complete proteome,Leucine-rich repeat,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein 42,modified residue,repeat:LRR 1,repeat:LRR 2,sequence conflict,
LRRC47	leucine rich repeat containing 47(LRRC47)	Homo sapiens				GO:0006432~phenylalanyl-tRNA aminoacylation,	GO:0009328~phenylalanine-tRNA ligase complex,	GO:0003723~RNA binding,GO:0004826~phenylalanine-tRNA ligase activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR005146:B3/B4 tRNA-binding domain,				SM00369:LRR_TYP,SM00873:SM00873,	Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Leucine-rich repeat,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein 47,compositionally biased region:Poly-Ala,modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,sequence variant,
LRRC52	leucine rich repeat containing 52(LRRC52)	Homo sapiens			Function unknown,	GO:0006811~ion transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR000372:Leucine-rich repeat-containing N-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00013:LRRNT,SM00369:LRR_TYP,	Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Leucine-rich repeat,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Leucine-rich repeat-containing protein 52,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRRC7	leucine rich repeat containing 7(LRRC7)	Homo sapiens					GO:0005737~cytoplasm,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0045211~postsynaptic membrane,	GO:0005515~protein binding,	IPR001478:PDZ domain,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00228:PDZ,SM00369:LRR_TYP,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Leucine-rich repeat,Membrane,Methylation,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Synapse,	chain:Leucine-rich repeat-containing protein 7,domain:PDZ,modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 18,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,splice variant,
LRRC71	leucine rich repeat containing 71(LRRC71)	Homo sapiens							IPR001611:Leucine-rich repeat,					Alternative splicing,Complete proteome,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein C10orf92,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,sequence variant,splice variant,
LRRC8C	leucine rich repeat containing 8 family member C(LRRC8C)	Homo sapiens			Function unknown,	GO:0044070~regulation of anion transport,GO:0045444~fat cell differentiation,GO:0098656~anion transmembrane transport,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005225~volume-sensitive anion channel activity,GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR021040:Leucine-rich repeat-containing protein 8, N-terminal,IPR026906:Leucine rich repeat 5,				SM00369:LRR_TYP,	Acetylation,Cell membrane,Complete proteome,Endoplasmic reticulum,Glycoprotein,Ion channel,Ion transport,Leucine-rich repeat,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Leucine-rich repeat-containing protein 8C,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,transmembrane region,
LRRC8D	leucine rich repeat containing 8 family member D(LRRC8D)	Homo sapiens				GO:0044070~regulation of anion transport,GO:0098656~anion transmembrane transport,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005225~volume-sensitive anion channel activity,GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR021040:Leucine-rich repeat-containing protein 8, N-terminal,				SM00369:LRR_TYP,	Cell membrane,Complete proteome,Endoplasmic reticulum,Ion channel,Ion transport,Leucine-rich repeat,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Leucine-rich repeat-containing protein 8D,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence variant,transmembrane region,
LGR6	leucine rich repeat containing G protein-coupled receptor 6(LGR6)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030335~positive regulation of cell migration,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031982~vesicle,GO:0032588~trans-Golgi network membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000372:Leucine-rich repeat-containing N-terminal,IPR001611:Leucine-rich repeat,IPR002131:Glycoprotein hormone receptor,IPR003591:Leucine-rich repeat, typical subtype,				SM00013:LRRNT,SM00369:LRR_TYP,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Leucine-rich repeat,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,Tumor suppressor,Wnt signaling pathway,	chain:Leucine-rich repeat-containing G-protein coupled receptor 6,compositionally biased region:Poly-Gly,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRRN1	leucine rich repeat neuronal 1(LRRN1)	Homo sapiens				GO:0007409~axonogenesis,GO:0051965~positive regulation of synapse assembly,	GO:0016021~integral component of membrane,		IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00082:LRRCT,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Leucine-rich repeat,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat neuronal protein 1,disulfide bond,domain:Fibronectin type-III,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRRN2	leucine rich repeat neuronal 2(LRRN2)	Homo sapiens				GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007409~axonogenesis,	GO:0016021~integral component of membrane,	GO:0004872~receptor activity,	IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00082:LRRCT,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,	Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Leucine-rich repeat,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat neuronal protein 2,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRRTM4	leucine rich repeat transmembrane neuronal 4(LRRTM4)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0019221~cytokine-mediated signaling pathway,GO:0046426~negative regulation of JAK-STAT cascade,GO:0050808~synapse organization,	GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0045211~postsynaptic membrane,	GO:0004860~protein kinase inhibitor activity,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00369:LRR_TYP,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Glycoprotein,Leucine-rich repeat,Membrane,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat transmembrane neuronal protein 4,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRRIQ3	leucine rich repeats and IQ motif containing 3(LRRIQ3)	Homo sapiens						GO:0005515~protein binding,	IPR000048:IQ motif, EF-hand binding site,IPR001611:Leucine-rich repeat,IPR025875:Leucine rich repeat 4,					Alternative splicing,Coiled coil,Complete proteome,Leucine-rich repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Leucine-rich repeat and IQ domain- containing protein 3,domain:IQ,repeat:LRR 1,repeat:LRR 2,sequence conflict,sequence variant,splice variant,
LRIG1	leucine rich repeats and immunoglobulin like domains 1(LRIG1)	Homo sapiens				GO:0007605~sensory perception of sound,GO:0032474~otolith morphogenesis,GO:0060384~innervation,	GO:0016021~integral component of membrane,		IPR000372:Leucine-rich repeat-containing N-terminal,IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Leucine-rich repeat,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeats and immunoglobulin- like domains protein 1,compositionally biased region:Poly-Ser,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRIG2	leucine rich repeats and immunoglobulin like domains 2(LRIG2)	Homo sapiens			Function unknown,	GO:0007605~sensory perception of sound,GO:0010640~regulation of platelet-derived growth factor receptor signaling pathway,GO:0060384~innervation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,		615112~Urofacial syndrome 2,		SM00082:LRRCT,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,	Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Immunoglobulin domain,Leucine-rich repeat,Membrane,Phosphoprotein,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeats and immunoglobulin- like domains protein 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LRTM1	leucine rich repeats and transmembrane domains 1(LRTM1)	Homo sapiens			Function unknown,	GO:0006469~negative regulation of protein kinase activity,GO:0019221~cytokine-mediated signaling pathway,GO:0046426~negative regulation of JAK-STAT cascade,GO:0051965~positive regulation of synapse assembly,	GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0004860~protein kinase inhibitor activity,	IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00082:LRRCT,SM00369:LRR_TYP,	Alternative splicing,Complete proteome,Glycoprotein,Leucine-rich repeat,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat and transmembrane domain-containing protein 1,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LSMEM2	leucine rich single-pass membrane protein 2(LSMEM2)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C3orf45,transmembrane region,
LZIC	leucine zipper and CTNNBIP1 domain containing(LZIC)	Homo sapiens				GO:0010212~response to ionizing radiation,		GO:0008013~beta-catenin binding,	IPR009428:Beta-catenin-interacting ICAT,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein LZIC,sequence variant,
LUZP1	leucine zipper protein 1(LUZP1)	Homo sapiens				GO:0003281~ventricular septum development,GO:0021503~neural fold bending,GO:0060840~artery development,	GO:0005634~nucleus,GO:0016020~membrane,GO:0070062~extracellular exosome,		IPR026734:Leucine zipper protein 1,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Leucine zipper protein 1,modified residue,sequence conflict,sequence variant,splice variant,
LZTFL1	leucine zipper transcription factor like 1(LZTFL1)	Homo sapiens				GO:1903565~negative regulation of protein localization to cilium,GO:1903568~negative regulation of protein localization to ciliary membrane,	GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,	IPR026157:Leucine zipper transcription factor-like protein 1,		615994~Bardet-Biedl syndrome 17,			Alternative splicing,Bardet-Biedl syndrome,Ciliopathy,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Membrane,Obesity,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Leucine zipper transcription factor-like protein 1,sequence conflict,sequence variant,
LARS2	leucyl-tRNA synthetase 2, mitochondrial(LARS2)	Homo sapiens				GO:0006418~tRNA aminoacylation for protein translation,GO:0006429~leucyl-tRNA aminoacylation,GO:0006450~regulation of translational fidelity,GO:0032543~mitochondrial translation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0002161~aminoacyl-tRNA editing activity,GO:0004823~leucine-tRNA ligase activity,GO:0005524~ATP binding,	IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR002300:Aminoacyl-tRNA synthetase, class Ia,IPR002302:Leucine-tRNA ligase, bacterial/mitochondrial,IPR009008:Valyl/Leucyl/Isoleucyl-tRNA synthetase, class Ia, editing domain,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,IPR013155:Valyl/Leucyl/Isoleucyl-tRNA synthetase, class I, anticodon-binding,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,	hsa00970:Aminoacyl-tRNA biosynthesis,	615300~Perrault syndrome 4,			Acetylation,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Deafness,Disease mutation,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Transit peptide,	binding site:ATP,chain:Probable leucyl-tRNA synthetase, mitochondrial,modified residue,sequence variant,short sequence motif:"HIGH" region,short sequence motif:"KMSKS" region,transit peptide:Mitochondrion,
LNP1	leukemia NUP98 fusion partner 1(LNP1)	Homo sapiens												Chromosomal rearrangement,Complete proteome,Proteomics identification,Reference proteome,	chain:Leukemia NUP98 fusion partner 1,compositionally biased region:Poly-Asp,
LBH	limb bud and heart development(LBH)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0010468~regulation of gene expression,GO:0030193~regulation of blood coagulation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR013294:Limb-bud-and-heart,			PIRSF008130:uncharacterized conserved protein,		Complete proteome,Cytoplasm,Developmental protein,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Protein LBH,modified residue,sequence conflict,
LIN28A	lin-28 homolog A(LIN28A)	Homo sapiens			Posttranslational modification, protein turnover, chaperones / Intracellular trafficking and secretion,	GO:0006355~regulation of transcription, DNA-templated,GO:0007281~germ cell development,GO:0010587~miRNA catabolic process,GO:0017148~negative regulation of translation,GO:0019827~stem cell population maintenance,GO:0031054~pre-miRNA processing,GO:0031123~RNA 3'-end processing,GO:0035019~somatic stem cell population maintenance,GO:0045666~positive regulation of neuron differentiation,GO:0045686~negative regulation of glial cell differentiation,GO:0045727~positive regulation of translation,GO:0048863~stem cell differentiation,GO:0060964~regulation of gene silencing by miRNA,GO:1901724~positive regulation of cell proliferation involved in kidney development,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005791~rough endoplasmic reticulum,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,	GO:0002151~G-quadruplex RNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031369~translation initiation factor binding,GO:0035198~miRNA binding,GO:1990825~sequence-specific mRNA binding,	IPR001878:Zinc finger, CCHC-type,IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,				SM00343:ZnF_C2HC,SM00357:CSP,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Endoplasmic reticulum,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,Zinc,Zinc-finger,	chain:Protein lin-28 homolog A,domain:CSD,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,mutagenesis site,strand,turn,zinc finger region:CCHC-type 1,zinc finger region:CCHC-type 2,
LIN9	lin-9 DREAM MuvB core complex component(LIN9)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007049~cell cycle,GO:0051726~regulation of cell cycle,GO:0071897~DNA biosynthetic process,	GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,	GO:0005515~protein binding,	IPR010561:DIRP,				SM01135:SM01135,	Acetylation,Alternative splicing,Cell cycle,Coiled coil,Complete proteome,DNA synthesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Protein lin-9 homolog,modified residue,region of interest:Sufficient for interaction with RB1,sequence conflict,splice variant,
LDAH	lipid droplet associated hydrolase(LDAH)	Homo sapiens				GO:0016042~lipid catabolic process,GO:0019915~lipid storage,	GO:0005783~endoplasmic reticulum,GO:0005811~lipid particle,	GO:0016298~lipase activity,	IPR019363:Protein of unknown function DUF2305,					Alternative splicing,Complete proteome,Endoplasmic reticulum,Hydrolase,Lipid degradation,Lipid droplet,Lipid metabolism,Proteomics identification,Reference proteome,	chain:UPF0554 protein C2orf43,
LPIN1	lipin 1(LPIN1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006642~triglyceride mobilization,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0007077~mitotic nuclear envelope disassembly,GO:0009062~fatty acid catabolic process,GO:0016311~dephosphorylation,GO:0019432~triglyceride biosynthetic process,GO:0031100~organ regeneration,GO:0032869~cellular response to insulin stimulus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0003713~transcription coactivator activity,GO:0008195~phosphatidate phosphatase activity,	IPR007651:Lipin, N-terminal,IPR013209:LNS2, Lipin/Ned1/Smp2,IPR023214:HAD-like domain,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,	268200~Myoglobinuria, acute recurrent, autosomal recessive,		SM00775:LNS2,	Alternative splicing,Complete proteome,Cytoplasm,Endoplasmic reticulum,Fatty acid metabolism,Hydrolase,Isopeptide bond,Lipid metabolism,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Phosphatidate phosphatase LPIN1,compositionally biased region:Poly-Ser,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),modified residue,region of interest:C-LIP,region of interest:N-LIP,sequence variant,short sequence motif:DXDXT motif,short sequence motif:LXXIL motif,short sequence motif:Nuclear localization signal,
LHFPL4	lipoma HMGIC fusion partner-like 4(LHFPL4)	Homo sapiens					GO:0016021~integral component of membrane,		IPR019372:Lipoma HMGIC fusion partner-like protein,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Lipoma HMGIC fusion partner-like 4 protein,transmembrane region,
LIPT1	lipoyltransferase 1(LIPT1)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0006629~lipid metabolic process,GO:0009249~protein lipoylation,GO:0046487~glyoxylate metabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0016746~transferase activity, transferring acyl groups,GO:0016979~lipoate-protein ligase activity,GO:0017118~lipoyltransferase activity,	IPR004143:Biotin/lipoate A/B protein ligase,IPR004562:Lipoyltransferase/lipoate-protein ligase,	hsa00785:Lipoic acid metabolism,hsa01100:Metabolic pathways,	616299~Lipoyltransferase 1 deficiency,			Acyltransferase,Complete proteome,Disease mutation,Mitochondrion,Proteomics identification,Reference proteome,Transferase,Transit peptide,	binding site:Substrate,binding site:Substrate; via amide nitrogen and carbonyl oxygen,chain:Lipoyltransferase 1, mitochondrial,transit peptide:Mitochondrion,
LINC01106	long intergenic non-protein coding RNA 1106(LINC01106)	Homo sapiens													chain:Putative uncharacterized protein FLJ38359,
LINC01121	long intergenic non-protein coding RNA 1121(LINC01121)	Homo sapiens													chain:Putative uncharacterized protein UNQ6975/PRO21958,signal peptide,
LINC01140	long intergenic non-protein coding RNA 1140(LINC01140)	Homo sapiens													chain:Uncharacterized protein LOC339524,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Phe,compositionally biased region:Pro-rich,transmembrane region,
LINC01356	long intergenic non-protein coding RNA 1356(LINC01356)	Homo sapiens												Complete proteome,Reference proteome,
LINC00299	long intergenic non-protein coding RNA 299(LINC00299)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C2orf46,
LINC00467	long intergenic non-protein coding RNA 467(LINC00467)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C1orf97,compositionally biased region:Ser-rich,
LINC00471	long intergenic non-protein coding RNA 471(LINC00471)	Homo sapiens												Complete proteome,Reference proteome,
LINC00488	long intergenic non-protein coding RNA 488(LINC00488)	Homo sapiens													chain:Putative uncharacterized protein C3orf66,
LINC00862	long intergenic non-protein coding RNA 862(LINC00862)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
LINC00869	long intergenic non-protein coding RNA 869(LINC00869)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative protein FAM91A2,
LDLRAP1	low density lipoprotein receptor adaptor protein 1(LDLRAP1)	Homo sapiens				GO:0006810~transport,GO:0006898~receptor-mediated endocytosis,GO:0008203~cholesterol metabolic process,GO:0009967~positive regulation of signal transduction,GO:0031623~receptor internalization,GO:0042632~cholesterol homeostasis,GO:0042982~amyloid precursor protein metabolic process,GO:0043393~regulation of protein binding,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:0090118~receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport,GO:0090205~positive regulation of cholesterol metabolic process,	GO:0005769~early endosome,GO:0005829~cytosol,GO:0005883~neurofilament,GO:0009898~cytoplasmic side of plasma membrane,GO:0009925~basal plasma membrane,GO:0030121~AP-1 adaptor complex,GO:0030122~AP-2 adaptor complex,GO:0030424~axon,GO:0055037~recycling endosome,	GO:0001540~beta-amyloid binding,GO:0001784~phosphotyrosine binding,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0030159~receptor signaling complex scaffold activity,GO:0030276~clathrin binding,GO:0035591~signaling adaptor activity,GO:0035612~AP-2 adaptor complex binding,GO:0035615~clathrin adaptor activity,GO:0050750~low-density lipoprotein particle receptor binding,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,	hsa04144:Endocytosis,	603813~Hypercholesterolemia, familial, autosomal recessive,		SM00462:PTB,	3D-structure,Acetylation,Atherosclerosis,Cholesterol metabolism,Complete proteome,Cytoplasm,Disease mutation,Endocytosis,Hyperlipidemia,Lipid metabolism,Lipoprotein,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Steroid metabolism,Sterol metabolism,	chain:Low density lipoprotein receptor adapter protein 1,compositionally biased region:Poly-Gly,domain:PID,helix,modified residue,mutagenesis site,region of interest:AP-2 complex binding,sequence variant,short sequence motif:[DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif,short sequence motif:Clathrin box,
LNPK	lunapark, ER junction formation factor(LNPK)	Homo sapiens				GO:0007596~blood coagulation,GO:0032330~regulation of chondrocyte differentiation,GO:0035115~embryonic forelimb morphogenesis,GO:0042733~embryonic digit morphogenesis,GO:0060173~limb development,GO:0071786~endoplasmic reticulum tubular network organization,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0071782~endoplasmic reticulum tubular network,	GO:0046872~metal ion binding,	IPR019273:Domain of unknown function DUF2296,					Alternative splicing,Coiled coil,Complete proteome,Developmental protein,Endoplasmic reticulum,Lipoprotein,Membrane,Metal-binding,Myristate,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:Protein lunapark,compositionally biased region:Pro-rich,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LHCGR	luteinizing hormone/choriogonadotropin receptor(LHCGR)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0008584~male gonad development,GO:0009755~hormone-mediated signaling pathway,GO:0022602~ovulation cycle process,GO:0030539~male genitalia development,GO:0032962~positive regulation of inositol trisphosphate biosynthetic process,GO:0042700~luteinizing hormone signaling pathway,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0050890~cognition,GO:0071371~cellular response to gonadotropin stimulus,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004964~luteinizing hormone receptor activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0035472~choriogonadotropin hormone receptor activity,GO:0038106~choriogonadotropin hormone binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002131:Glycoprotein hormone receptor,IPR002273:Lutropin-choriogonadotropic hormone receptor,IPR017452:GPCR, rhodopsin-like, 7TM,IPR026906:Leucine rich repeat 5,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04913:Ovarian steroidogenesis,hsa04917:Prolactin signaling pathway,	176410~Leydig cell adenoma, somatic, with precocious puberty,176410~Precocious puberty, male,238320~Leydig cell hypoplasia with hypergonadotropic hypogonadism,238320~Leydig cell hypoplasia with pseudohermaphroditism,238320~Luteinizing hormone resistance, female,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,G-protein coupled receptor,Glycoprotein,Leucine-rich repeat,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Lutropin-choriogonadotropic hormone receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
LY75	lymphocyte antigen 75(LY75)	Homo sapiens				GO:0006897~endocytosis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0030246~carbohydrate binding,	IPR000562:Fibronectin, type II, collagen-binding,IPR000772:Ricin B lectin domain,IPR001304:C-type lectin,IPR013806:Kringle-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Endocytosis,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CD302 antigen,chain:Lymphocyte antigen 75,disulfide bond,domain:C-type lectin,domain:C-type lectin 1,domain:C-type lectin 10,domain:C-type lectin 2,domain:C-type lectin 3,domain:C-type lectin 4,domain:C-type lectin 5,domain:C-type lectin 6,domain:C-type lectin 7,domain:C-type lectin 8,domain:C-type lectin 9,domain:Fibronectin type-II,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LY9	lymphocyte antigen 9(LY9)	Homo sapiens				GO:0032740~positive regulation of interleukin-17 production,GO:0045087~innate immune response,GO:0072540~T-helper 17 cell lineage commitment,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Adaptive immunity,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-lymphocyte surface antigen Ly-9,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LEXM	lymphocyte expansion molecule(LEXM)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0035740~CD8-positive, alpha-beta T cell proliferation,GO:1903862~positive regulation of oxidative phosphorylation,	GO:0005739~mitochondrion,GO:0005761~mitochondrial ribosome,							Alternative splicing,Complete proteome,Mitochondrion,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf177,sequence conflict,sequence variant,splice variant,
LAX1	lymphocyte transmembrane adaptor 1(LAX1)	Homo sapiens				GO:0000188~inactivation of MAPK activity,GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0035556~intracellular signal transduction,GO:0042113~B cell activation,GO:0048305~immunoglobulin secretion,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050868~negative regulation of T cell activation,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0042169~SH2 domain binding,						Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Immunity,Membrane,Phosphoprotein,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Lymphocyte transmembrane adapter 1,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KAT2B	lysine acetyltransferase 2B(KAT2B)	Homo sapiens	85.Nuc_Rec-Coact_Complex,	h_pcafPathway:The information-processing pathway at the IFN-beta enhancer,h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0006338~chromatin remodeling,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006473~protein acetylation,GO:0007050~cell cycle arrest,GO:0007219~Notch signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0010835~regulation of protein ADP-ribosylation,GO:0016032~viral process,GO:0018076~N-terminal peptidyl-lysine acetylation,GO:0018393~internal peptidyl-lysine acetylation,GO:0018394~peptidyl-lysine acetylation,GO:0032869~cellular response to insulin stimulus,GO:0035948~positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,GO:0043966~histone H3 acetylation,GO:0043970~histone H3-K9 acetylation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,	GO:0000125~PCAF complex,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,GO:0031672~A band,GO:0031674~I band,GO:0042641~actomyosin,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016407~acetyltransferase activity,GO:0019901~protein kinase binding,GO:0032403~protein complex binding,GO:0042826~histone deacetylase binding,	IPR000182:GNAT domain,IPR001487:Bromodomain,IPR009464:PCAF, N-terminal,IPR016181:Acyl-CoA N-acyltransferase,IPR016376:Histone acetylase PCAF,IPR018359:Bromodomain, conserved site,	hsa04330:Notch signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05166:HTLV-I infection,hsa05203:Viral carcinogenesis,		PIRSF003048:histone acetylase PCAF,	SM00297:BROMO,	3D-structure,Activator,Acyltransferase,Biological rhythms,Bromodomain,Cell cycle,Complete proteome,Host-virus interaction,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Transferase,	chain:Histone acetyltransferase KAT2B,domain:Bromo,domain:N-acetyltransferase,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,turn,
KDM1A	lysine demethylase 1A(KDM1A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000380~alternative mRNA splicing, via spliceosome,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006482~protein demethylation,GO:0007596~blood coagulation,GO:0008283~cell proliferation,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0010725~regulation of primitive erythrocyte differentiation,GO:0010976~positive regulation of neuron projection development,GO:0016575~histone deacetylation,GO:0021983~pituitary gland development,GO:0021987~cerebral cortex development,GO:0030851~granulocyte differentiation,GO:0032091~negative regulation of protein binding,GO:0033169~histone H3-K9 demethylation,GO:0033184~positive regulation of histone ubiquitination,GO:0034644~cellular response to UV,GO:0034720~histone H3-K4 demethylation,GO:0035563~positive regulation of chromatin binding,GO:0042551~neuron maturation,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045793~positive regulation of cell size,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046098~guanine metabolic process,GO:0046886~positive regulation of hormone biosynthetic process,GO:0050768~negative regulation of neurogenesis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0055001~muscle cell development,GO:0055114~oxidation-reduction process,GO:0060992~response to fungicide,GO:0071320~cellular response to cAMP,GO:0071480~cellular response to gamma radiation,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1903827~regulation of cellular protein localization,GO:1990138~neuron projection extension,GO:2000179~positive regulation of neural precursor cell proliferation,GO:2000648~positive regulation of stem cell proliferation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0043234~protein complex,GO:1990391~DNA repair complex,	GO:0001085~RNA polymerase II transcription factor binding,GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016491~oxidoreductase activity,GO:0019899~enzyme binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0032451~demethylase activity,GO:0032452~histone demethylase activity,GO:0032453~histone demethylase activity (H3-K4 specific),GO:0032454~histone demethylase activity (H3-K9 specific),GO:0034648~histone demethylase activity (H3-dimethyl-K4 specific),GO:0042162~telomeric DNA binding,GO:0043426~MRF binding,GO:0044212~transcription regulatory region DNA binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050681~androgen receptor binding,GO:0061752~telomeric repeat-containing RNA binding,	IPR002937:Amine oxidase,IPR007526:SWIRM domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017366:Histone lysine-specific demethylase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,		616728~Cleft palate, psychomotor retardation, and distinctive facial features,	PIRSF038051:lysine-specific histone demethylase,		3D-structure,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Developmental protein,Direct protein sequencing,Disease mutation,FAD,Flavoprotein,Nucleus,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	binding site:FAD,chain:Lysine-specific histone demethylase 1,compositionally biased region:Ala-rich,compositionally biased region:Poly-Pro,domain:SWIRM,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:FAD,region of interest:Demethylase activity,sequence conflict,splice variant,strand,turn,
KDM3A	lysine demethylase 3A(KDM3A)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007290~spermatid nucleus elongation,GO:0009755~hormone-mediated signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0033169~histone H3-K9 demethylation,GO:0036123~histone H3-K9 dimethylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046293~formaldehyde biosynthetic process,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0055114~oxidation-reduction process,GO:2000036~regulation of stem cell population maintenance,GO:2000736~regulation of stem cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005506~iron ion binding,GO:0031490~chromatin DNA binding,GO:0032452~histone demethylase activity,GO:0032454~histone demethylase activity (H3-K9 specific),GO:0050681~androgen receptor binding,GO:0051213~dioxygenase activity,	IPR003347:JmjC domain,				SM00558:JmjC,	Acetylation,Activator,Chromatin regulator,Complete proteome,Cytoplasm,Differentiation,Dioxygenase,Iron,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Spermatogenesis,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Lysine-specific demethylase 3A,domain:JmjC,metal ion-binding site:Iron; catalytic,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:LXXLL motif,zinc finger region:C6-type,
KDM4A	lysine demethylase 4A(KDM4A)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0010507~negative regulation of autophagy,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0016032~viral process,GO:0016577~histone demethylation,GO:0031667~response to nutrient levels,GO:0045666~positive regulation of neuron differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048712~negative regulation of astrocyte differentiation,GO:0055114~oxidation-reduction process,GO:0060548~negative regulation of cell death,GO:0070544~histone H3-K36 demethylation,GO:1900113~negative regulation of histone H3-K9 trimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005721~pericentric heterochromatin,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031625~ubiquitin protein ligase binding,GO:0032452~histone demethylase activity,GO:0035064~methylated histone binding,GO:0051864~histone demethylase activity (H3-K36 specific),	IPR001965:Zinc finger, PHD-type,IPR002999:Tudor domain,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00249:PHD,SM00333:TUDOR,SM00545:JmjN,SM00558:JmjC,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,Dioxygenase,Host-virus interaction,Iron,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	binding site:Alpha-ketoglutarate,binding site:Histone H3-K4Me3,chain:Lysine-specific demethylase 4A,domain:JmjC,domain:JmjN,domain:Tudor 1,domain:Tudor 2,helix,metal ion-binding site:Iron; catalytic,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Interaction with NCOR1,sequence variant,strand,turn,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
KDM5B	lysine demethylase 5B(KDM5B)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007338~single fertilization,GO:0009791~post-embryonic development,GO:0010628~positive regulation of gene expression,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0034720~histone H3-K4 demethylation,GO:0034721~histone H3-K4 demethylation, trimethyl-H3-K4-specific,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0055114~oxidation-reduction process,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060763~mammary duct terminal end bud growth,GO:0060992~response to fungicide,GO:0061038~uterus morphogenesis,GO:0070306~lens fiber cell differentiation,GO:2000864~regulation of estradiol secretion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0032452~histone demethylase activity,GO:0032453~histone demethylase activity (H3-K4 specific),GO:0034647~histone demethylase activity (H3-trimethyl-K4 specific),GO:0034648~histone demethylase activity (H3-dimethyl-K4 specific),	IPR001606:ARID/BRIGHT DNA-binding domain,IPR001965:Zinc finger, PHD-type,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR004198:Zinc finger, C5HC2-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013637:Lysine-specific demethylase-like domain,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00501:BRIGHT,SM00545:JmjN,SM00558:JmjC,	3D-structure,Acetylation,Alternative splicing,Biological rhythms,Chromatin regulator,Complete proteome,Dioxygenase,Iron,Isopeptide bond,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Lysine-specific demethylase 5B,compositionally biased region:Poly-Lys,domain:ARID,domain:JmjC,domain:JmjN,modified residue,mutagenesis site,sequence conflict,splice variant,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,zinc finger region:PHD-type 3,
KRCC1	lysine rich coiled-coil 1(KRCC1)	Homo sapiens												Coiled coil,Complete proteome,Reference proteome,	chain:Lysine-rich coiled-coil protein 1,compositionally biased region:Lys-rich,
LCLAT1	lysocardiolipin acyltransferase 1(LCLAT1)	Homo sapiens				GO:0006654~phosphatidic acid biosynthetic process,GO:0007275~multicellular organism development,GO:0008152~metabolic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,GO:0035965~cardiolipin acyl-chain remodeling,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0005515~protein binding,GO:0008374~O-acyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR002123:Phospholipid/glycerol acyltransferase,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,			SM00563:PlsC,	Acetylation,Acyltransferase,Alternative splicing,Complete proteome,Developmental protein,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Lysocardiolipin acyltransferase 1,modified residue,mutagenesis site,sequence variant,short sequence motif:HXXXXD motif,splice variant,transmembrane region,
LPAR3	lysophosphatidic acid receptor 3(LPAR3)	Homo sapiens		h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,		GO:0000187~activation of MAPK activity,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007268~chemical synaptic transmission,GO:0032060~bleb assembly,GO:0048672~positive regulation of collateral sprouting,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0051928~positive regulation of calcium ion transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030424~axon,	GO:0001965~G-protein alpha-subunit binding,GO:0004930~G-protein coupled receptor activity,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0070915~lysophosphatidic acid receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR004065:Lysophosphatidic acid receptor,IPR005385:Lysophosphatidic acid receptor EDG-7,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04015:Rap1 signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04151:PI3K-Akt signaling pathway,hsa05200:Pathways in cancer,			SM01381:SM01381,	Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Lysophosphatidic acid receptor 3,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LPGAT1	lysophosphatidylglycerol acyltransferase 1(LPGAT1)	Homo sapiens				GO:0008654~phospholipid biosynthetic process,GO:0036148~phosphatidylglycerol acyl-chain remodeling,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0047144~2-acylglycerol-3-phosphate O-acyltransferase activity,	IPR002123:Phospholipid/glycerol acyltransferase,	hsa00564:Glycerophospholipid metabolism,			SM00563:PlsC,	Acyltransferase,Complete proteome,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Acyl-CoA:lysophosphatidylglycerol acyltransferase 1,short sequence motif:HXXXXD motif,transmembrane region,
LAPTM4A	lysosomal protein transmembrane 4 alpha(LAPTM4A)	Homo sapiens				GO:0006810~transport,	GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR004687:Lysosomal-associated transmembrane protein 4/5,IPR018396:Lysosomal-associated transmembrane protein, 4A/5,	hsa04142:Lysosome,				Acetylation,Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Lysosomal-associated transmembrane protein 4A,compositionally biased region:Poly-Pro,modified residue,transmembrane region,
LYST	lysosomal trafficking regulator(LYST)	Homo sapiens				GO:0007040~lysosome organization,GO:0015031~protein transport,GO:0030595~leukocyte chemotaxis,GO:0032438~melanosome organization,GO:0032510~endosome to lysosome transport via multivesicular body sorting pathway,GO:0033364~mast cell secretory granule organization,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042742~defense response to bacterium,GO:0042832~defense response to protozoan,GO:0043473~pigmentation,GO:0051607~defense response to virus,	GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,	GO:0005515~protein binding,	IPR000409:BEACH domain,IPR001680:WD40 repeat,IPR011993:Pleckstrin homology-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR023362:PH-BEACH domain,		214500~Chediak-Higashi syndrome,		SM00320:WD40,SM01026:SM01026,	Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,WD repeat,	chain:Lysosomal-trafficking regulator,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,domain:BEACH,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
LYG1	lysozyme g1(LYG1)	Homo sapiens				GO:0009253~peptidoglycan catabolic process,GO:0016998~cell wall macromolecule catabolic process,	GO:0005576~extracellular region,	GO:0003796~lysozyme activity,	IPR002152:Glycoside hydrolase, family 23,IPR023346:Lysozyme-like domain,			PIRSF001065:lysozyme g,		Complete proteome,Disulfide bond,Glycosidase,Hydrolase,Reference proteome,Secreted,Signal,	chain:Lysozyme g-like protein 1,disulfide bond,signal peptide,
MARCO	macrophage receptor with collagenous structure(MARCO)	Homo sapiens				GO:0002221~pattern recognition receptor signaling pathway,GO:0006898~receptor-mediated endocytosis,GO:0007166~cell surface receptor signaling pathway,GO:0043277~apoptotic cell clearance,GO:0045087~innate immune response,	GO:0005581~collagen trimer,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030666~endocytic vesicle membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005044~scavenger receptor activity,GO:0008329~signaling pattern recognition receptor activity,	IPR001190:Speract/scavenger receptor,IPR008160:Collagen triple helix repeat,IPR017448:Speract/scavenger receptor-related,	hsa04145:Phagosome,			SM00202:SR,	Alternative splicing,Collagen,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Macrophage receptor MARCO,disulfide bond,domain:Collagen-like,domain:SRCR,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MST1	macrophage stimulating 1(MST1)	Homo sapiens		h_mspPathway:Msp/Ron Receptor Signaling Pathway,		GO:0006508~proteolysis,GO:0007283~spermatogenesis,GO:0007566~embryo implantation,GO:0010628~positive regulation of gene expression,GO:0010758~regulation of macrophage chemotaxis,GO:0030317~sperm motility,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0045721~negative regulation of gluconeogenesis,GO:0046425~regulation of JAK-STAT cascade,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0060763~mammary duct terminal end bud growth,GO:0071456~cellular response to hypoxia,GO:1904036~negative regulation of epithelial cell apoptotic process,GO:2000479~regulation of cAMP-dependent protein kinase activity,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005773~vacuole,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,	IPR000001:Kringle,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR003609:Apple-like,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR013806:Kringle-like fold,IPR018056:Kringle, conserved site,IPR024174:Hepatocyte growth factor/macrophage stimulating protein 1,			PIRSF001152:hepatocyte growth factor/macrophage stimulating protein 1,	SM00020:Tryp_SPc,SM00130:KR,SM00473:PAN_AP,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Kringle,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease homolog,Signal,	chain:Hepatocyte growth factor-like protein,chain:Hepatocyte growth factor-like protein alpha chain,chain:Hepatocyte growth factor-like protein beta chain,disulfide bond,domain:Kringle 1,domain:Kringle 2,domain:Kringle 3,domain:Kringle 4,domain:PAN,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,turn,
MAEL	maelstrom spermatogenic transposon silencer(MAEL)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0007129~synapsis,GO:0007140~male meiosis,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009566~fertilization,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,GO:0043066~negative regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046620~regulation of organ growth,	GO:0000785~chromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030849~autosome,GO:0033391~chromatoid body,GO:0043186~P granule,GO:0048471~perinuclear region of cytoplasm,GO:0071547~piP-body,	GO:0003676~nucleic acid binding,GO:0043565~sequence-specific DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR024970:Maelstrom domain,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Meiosis,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-mediated gene silencing,Spermatogenesis,	chain:Protein maelstrom homolog,DNA-binding region:HMG box,helix,sequence variant,splice variant,
MROH2A	maestro heat like repeat family member 2A(MROH2A)	Homo sapiens							IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Complete proteome,Polymorphism,Reference proteome,Repeat,
MROH7	maestro heat like repeat family member 7(MROH7)	Homo sapiens					GO:0005615~extracellular space,GO:0016021~integral component of membrane,		IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C1orf175,compositionally biased region:Ser-rich,glycosylation site:N-linked (GlcNAc...),repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,sequence conflict,sequence variant,splice variant,transmembrane region,
MROH9	maestro heat like repeat family member 9(MROH9)	Homo sapiens							IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:Uncharacterized protein C1orf129,sequence conflict,sequence variant,
MAGOH	mago homolog, exon junction complex core component(MAGOH)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0006417~regulation of translation,GO:0031124~mRNA 3'-end processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0035145~exon-exon junction complex,GO:0071013~catalytic step 2 spliceosome,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004023:Mago nashi protein,	hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,hsa03040:Spliceosome,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,mRNA transport,Nonsense-mediated mRNA decay,Nucleus,Reference proteome,RNA-binding,Spliceosome,Translation regulation,Transport,	chain:Protein mago nashi homolog,helix,modified residue,mutagenesis site,strand,turn,
MFSD14A	major facilitator superfamily domain containing 14A(MFSD14A)	Homo sapiens				GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,	GO:0005215~transporter activity,	IPR001958:Tetracycline resistance protein, TetA/multidrug resistance protein MdtG,IPR005829:Sugar transporter, conserved site,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Hippocampus abundant transcript 1 protein,compositionally biased region:Poly-Lys,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MFSD4A	major facilitator superfamily domain containing 4A(MFSD4A)	Homo sapiens				GO:0055085~transmembrane transport,GO:1904659~glucose transmembrane transport,	GO:0016021~integral component of membrane,	GO:0005355~glucose transmembrane transporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Major facilitator superfamily domain- containing protein 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
MFSD6	major facilitator superfamily domain containing 6(MFSD6)	Homo sapiens					GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR020846:Major facilitator superfamily domain,IPR024989:Major facilitator superfamily associated domain,					Acetylation,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Major facilitator superfamily domain- containing protein 6,modified residue,sequence conflict,sequence variant,transmembrane region,
MR1	major histocompatibility complex, class I-related(MR1)	Homo sapiens				GO:0002367~cytokine production involved in immune response,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006955~immune response,GO:0007165~signal transduction,GO:0019882~antigen processing and presentation,GO:0032611~interleukin-1 beta production,GO:0032620~interleukin-17 production,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0042612~MHC class I protein complex,	GO:0003823~antigen binding,GO:0005515~protein binding,GO:0032393~MHC class I receptor activity,	IPR001039:MHC class I, alpha chain, alpha1/alpha2,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,MHC I,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Major histocompatibility complex class I- related gene protein,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Alpha-3,region of interest:Connecting peptide,region of interest:Ligand-binding,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MKRN2	makorin ring finger protein 2(MKRN2)	Homo sapiens			General function prediction only,	GO:0016567~protein ubiquitination,	GO:0005622~intracellular,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000571:Zinc finger, CCCH-type,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR026293:Makorin 2,				SM00184:RING,SM00356:ZnF_C3H1,	Alternative splicing,Complete proteome,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Probable E3 ubiquitin-protein ligase makorin-2,modified residue,region of interest:Makorin-type Cys-His,sequence conflict,sequence variant,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,zinc finger region:C3H1-type 3,zinc finger region:C3H1-type 4,zinc finger region:RING-type,
MALL	mal, T-cell differentiation protein like(MALL)	Homo sapiens				GO:0001766~membrane raft polarization,GO:0008104~protein localization,GO:0042552~myelination,GO:0042632~cholesterol homeostasis,	GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030136~clathrin-coated vesicle,GO:0031410~cytoplasmic vesicle,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0019911~structural constituent of myelin sheath,	IPR008253:Marvel,IPR013295:Myelin and lymphocyte (MAL) protein,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:MAL-like protein,domain:MARVEL,transmembrane region,
MDH1	malate dehydrogenase 1(MDH1)	Homo sapiens		h_malatePathway:Malate-aspartate shuttle,h_malatexPathway:Shuttle for transfer of acetyl groups from mitochondria to the cytosol,		GO:0005975~carbohydrate metabolic process,GO:0006094~gluconeogenesis,GO:0006099~tricarboxylic acid cycle,GO:0006107~oxaloacetate metabolic process,GO:0006108~malate metabolic process,GO:0006734~NADH metabolic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005829~cytosol,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004470~malic enzyme activity,GO:0005515~protein binding,GO:0016615~malate dehydrogenase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0030060~L-malate dehydrogenase activity,GO:0047860~diiodophenylpyruvate reductase activity,GO:0051287~NAD binding,	IPR001236:Lactate/malate dehydrogenase, N-terminal,IPR001252:Malate dehydrogenase, active site,IPR001557:L-lactate/malate dehydrogenase,IPR010945:Malate dehydrogenase, type 2,IPR011274:Malate dehydrogenase, NAD-dependent, cytosolic,IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal,IPR016040:NAD(P)-binding domain,IPR022383:Lactate/malate dehydrogenase, C-terminal,	hsa00020:Citrate cycle (TCA cycle),hsa00270:Cysteine and methionine metabolism,hsa00620:Pyruvate metabolism,hsa00630:Glyoxylate and dicarboxylate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04964:Proximal tubule bicarbonate reclamation,		PIRSF000102:L-lactate/malate dehydrogenase,		Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Methylation,NAD,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Tricarboxylic acid cycle,Ubl conjugation,	active site:Proton acceptor,binding site:NAD,binding site:Substrate,chain:Malate dehydrogenase, cytoplasmic,modified residue,nucleotide phosphate-binding region:NAD,
MDH1B	malate dehydrogenase 1B(MDH1B)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006099~tricarboxylic acid cycle,GO:0006107~oxaloacetate metabolic process,GO:0006108~malate metabolic process,GO:0006734~NADH metabolic process,	GO:0005737~cytoplasm,	GO:0016615~malate dehydrogenase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0030060~L-malate dehydrogenase activity,	IPR010945:Malate dehydrogenase, type 2,IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal,IPR016040:NAD(P)-binding domain,					Alternative splicing,Complete proteome,NAD,Oxidoreductase,Polymorphism,Reference proteome,Tricarboxylic acid cycle,	chain:Putative malate dehydrogenase 1B,sequence variant,splice variant,
MSL3P1	male-specific lethal 3 homolog (Drosophila) pseudogene 1(MSL3P1)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006342~chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0016575~histone deacetylation,GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,	GO:0035267~NuA4 histone acetyltransferase complex,		IPR008676:MRG,IPR026541:MRG domain,					Chromatin regulator,Complete proteome,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Putative male-specific lethal-3 protein- like 2,domain:Chromo,sequence variant,
MASP2	mannan binding lectin serine peptidase 2(MASP2)	Homo sapiens		h_compPathway:Complement Pathway,h_lectinPathway:Lectin Induced Complement Pathway,		GO:0001867~complement activation, lectin pathway,GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,	GO:0001855~complement component C4b binding,GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0048306~calcium-dependent protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000436:Sushi/SCR/CCP,IPR000742:Epidermal growth factor-like domain,IPR000859:CUB domain,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR001881:EGF-like calcium-binding,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR024175:Peptidase S1A, complement C1r/C1S/mannan-binding,	hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,	613791~MASP2 deficiency,	PIRSF001155:C1r-like complement-activating serine protease,	SM00020:Tryp_SPc,SM00032:CCP,SM00042:CUB,SM00179:EGF_CA,SM00181:EGF,	3D-structure,Alternative splicing,Autocatalytic cleavage,Calcium,Complement pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,EGF-like domain,Hydrolase,Hydroxylation,Immunity,Innate immunity,Metal-binding,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Sushi,	active site:Charge relay system,chain:Mannan-binding lectin serine protease 2,chain:Mannan-binding lectin serine protease 2 A chain,chain:Mannan-binding lectin serine protease 2 B chain,disulfide bond,domain:CUB 1,domain:CUB 2,domain:EGF-like; calcium-binding,domain:Peptidase S1,domain:Sushi 1,domain:Sushi 2,helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,site:Cleavage,splice variant,strand,turn,
MAN1A2	mannosidase alpha class 1A member 2(MAN1A2)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,h_eradPathway:ERï¿½associated degradation (ERAD) Pathway,		GO:0006491~N-glycan processing,GO:0007585~respiratory gaseous exchange,GO:0008152~metabolic process,GO:0048286~lung alveolus development,GO:1904381~Golgi apparatus mannose trimming,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,	IPR001382:Glycoside hydrolase, family 47,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,hsa04141:Protein processing in endoplasmic reticulum,				Acetylation,Calcium,Complete proteome,Disulfide bond,Glycoprotein,Glycosidase,Golgi apparatus,Hydrolase,Membrane,Metal-binding,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Mannosyl-oligosaccharide 1,2-alpha- mannosidase IB,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
MAN1C1	mannosidase alpha class 1C member 1(MAN1C1)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,h_eradPathway:ERï¿½associated degradation (ERAD) Pathway,		GO:0006487~protein N-linked glycosylation,GO:0006491~N-glycan processing,GO:0008152~metabolic process,GO:1904381~Golgi apparatus mannose trimming,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0030173~integral component of Golgi membrane,GO:0070062~extracellular exosome,	GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,	IPR001382:Glycoside hydrolase, family 47,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,hsa04141:Protein processing in endoplasmic reticulum,				Calcium,Complete proteome,Disulfide bond,Glycoprotein,Glycosidase,Golgi apparatus,Hydrolase,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Mannosyl-oligosaccharide 1,2-alpha- mannosidase IC,glycosylation site:N-linked (GlcNAc...),modified residue,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
MANEAL	mannosidase endo-alpha like(MANEAL)	Homo sapiens					GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0016798~hydrolase activity, acting on glycosyl bonds,	IPR026071:Glycosyl hydrolase family 99,					Alternative splicing,Complete proteome,Golgi apparatus,Hydrolase,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Glycoprotein endo-alpha-1,2-mannosidase- like protein,compositionally biased region:Poly-Arg,compositionally biased region:Pro-rich,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
MGAT4A	mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A(MGAT4A)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006491~N-glycan processing,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0008454~alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0046872~metal ion binding,	IPR006759:Glycosyl transferase, family 54,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,				Alternative splicing,Coiled coil,Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Metal-binding,Phosphoprotein,Reference proteome,Secreted,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-1,3-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase A,chain:Alpha-1,3-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase A soluble form,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
MGAT5	mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase(MGAT5)	Homo sapiens				GO:0006487~protein N-linked glycosylation,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0030144~alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,	IPR026116:Glycosyltransferase family 18,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-1,6-mannosylglycoprotein 6-beta-N- acetylglucosaminyltransferase A,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
MATN3	matrilin 3(MATN3)	Homo sapiens				GO:0001501~skeletal system development,GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002035:von Willebrand factor, type A,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR019466:Matrilin, coiled-coil trimerisation domain,		140600~Osteoarthritis susceptibility 2,607078~Epiphyseal dysplasia, multiple, 5,608728~Spondyloepimetaphyseal dysplasia,		SM00179:EGF_CA,SM00181:EGF,SM00327:VWA,SM01279:SM01279,	Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Disulfide bond,Dwarfism,EGF-like domain,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Matrilin-3,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:VWFA,modified residue,sequence variant,signal peptide,
MMP23B	matrix metallopeptidase 23B(MMP23B)	Homo sapiens				GO:0000003~reproduction,GO:0006508~proteolysis,	GO:0005578~proteinaceous extracellular matrix,GO:0005622~intracellular,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR001818:Peptidase M10, metallopeptidase,IPR003582:Metridin-like ShK toxin,IPR003599:Immunoglobulin subtype,IPR006026:Peptidase, metallopeptidase,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR021190:Peptidase M10A,IPR024079:Metallopeptidase, catalytic domain,				SM00235:ZnMc,SM00254:ShKT,SM00409:IG,	Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Hydrolase,Immunoglobulin domain,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Matrix metalloproteinase-23,chain:Matrix metalloproteinase-23, soluble form,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,modified residue,mutagenesis site,sequence variant,site:Cleavage; by furin-like protease,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MXRA8	matrix remodeling associated 8(MXRA8)	Homo sapiens				GO:0060857~establishment of glial blood-brain barrier,	GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Matrix-remodeling-associated protein 8,compositionally biased region:Poly-Arg,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MTOR	mechanistic target of rapamycin(MTOR)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,108.Regulating_glucose_transport,	h_bcellsurvivalPathway:B Cell Survival Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_mtorPathway:mTOR Signaling Pathway,h_stat3Pathway:Stat3 Signaling Pathway,		GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0003007~heart morphogenesis,GO:0003179~heart valve morphogenesis,GO:0005979~regulation of glycogen biosynthetic process,GO:0006112~energy reserve metabolic process,GO:0006207~'de novo' pyrimidine nucleobase biosynthetic process,GO:0006281~DNA repair,GO:0006468~protein phosphorylation,GO:0006914~autophagy,GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007281~germ cell development,GO:0007420~brain development,GO:0007569~cell aging,GO:0007584~response to nutrient,GO:0007616~long-term memory,GO:0008542~visual learning,GO:0009791~post-embryonic development,GO:0010507~negative regulation of autophagy,GO:0010592~positive regulation of lamellipodium assembly,GO:0010628~positive regulation of gene expression,GO:0010831~positive regulation of myotube differentiation,GO:0014042~positive regulation of neuron maturation,GO:0014736~negative regulation of muscle atrophy,GO:0016049~cell growth,GO:0016236~macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0021510~spinal cord development,GO:0030163~protein catabolic process,GO:0030838~positive regulation of actin filament polymerization,GO:0031295~T cell costimulation,GO:0031397~negative regulation of protein ubiquitination,GO:0031529~ruffle organization,GO:0031641~regulation of myelination,GO:0031669~cellular response to nutrient levels,GO:0031929~TOR signaling,GO:0031998~regulation of fatty acid beta-oxidation,GO:0032095~regulation of response to food,GO:0032868~response to insulin,GO:0032956~regulation of actin cytoskeleton organization,GO:0035176~social behavior,GO:0035264~multicellular organism growth,GO:0040007~growth,GO:0042060~wound healing,GO:0042220~response to cocaine,GO:0043087~regulation of GTPase activity,GO:0043200~response to amino acid,GO:0043278~response to morphine,GO:0043610~regulation of carbohydrate utilization,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045670~regulation of osteoclast differentiation,GO:0045727~positive regulation of translation,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0046777~protein autophosphorylation,GO:0046889~positive regulation of lipid biosynthetic process,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048255~mRNA stabilization,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050882~voluntary musculoskeletal movement,GO:0051496~positive regulation of stress fiber assembly,GO:0051534~negative regulation of NFAT protein import into nucleus,GO:0051897~positive regulation of protein kinase B signaling,GO:0055013~cardiac muscle cell development,GO:0060048~cardiac muscle contraction,GO:0060135~maternal process involved in female pregnancy,GO:0060252~positive regulation of glial cell proliferation,GO:0060999~positive regulation of dendritic spine development,GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development,GO:0071456~cellular response to hypoxia,GO:0090335~regulation of brown fat cell differentiation,GO:0090559~regulation of membrane permeability,GO:1900034~regulation of cellular response to heat,GO:1901216~positive regulation of neuron death,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1904000~positive regulation of eating behavior,GO:1904056~positive regulation of cholangiocyte proliferation,GO:1904058~positive regulation of sensory perception of pain,GO:1904193~negative regulation of cholangiocyte apoptotic process,GO:1904197~positive regulation of granulosa cell proliferation,GO:1904206~positive regulation of skeletal muscle hypertrophy,GO:1904213~negative regulation of iodide transmembrane transport,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0016605~PML body,GO:0030425~dendrite,GO:0031931~TORC1 complex,GO:0031932~TORC2 complex,GO:0043025~neuronal cell body,	GO:0001030~RNA polymerase III type 1 promoter DNA binding,GO:0001031~RNA polymerase III type 2 promoter DNA binding,GO:0001032~RNA polymerase III type 3 promoter DNA binding,GO:0001156~TFIIIC-class transcription factor binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0043022~ribosome binding,GO:0044877~macromolecular complex binding,GO:0051219~phosphoprotein binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR009076:Rapamycin-binding domain,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR011990:Tetratricopeptide-like helical,IPR014009:PIK-related kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR024585:Domain of unknown function DUF3385,  target of rapamycin protein,IPR026683:Serine/threonine-protein kinase TOR/Smg1,	hsa04012:ErbB signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05221:Acute myeloid leukemia,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	616638~Smith-Kingsmore syndrome,		SM00146:PI3Kc,SM01343:SM01343,SM01346:SM01346,	3D-structure,Acetylation,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Endoplasmic reticulum,Epilepsy,Golgi apparatus,Kinase,Lysosome,Membrane,Mental retardation,Microsome,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,TPR repeat,Transferase,	chain:Serine/threonine-protein kinase mTOR,domain:FAT,domain:FATC,domain:PI3K/PI4K,helix,modified residue,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,sequence conflict,sequence variant,
MED18	mediator complex subunit 18(MED18)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006369~termination of RNA polymerase II transcription,GO:0016567~protein ubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0016592~mediator complex,GO:0070847~core mediator complex,	GO:0001104~RNA polymerase II transcription cofactor activity,GO:0005515~protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR019095:Mediator complex, subunit Med18, metazoa/fungi,					Activator,Complete proteome,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Mediator of RNA polymerase II transcription subunit 18,modified residue,sequence conflict,
MED8	mediator complex subunit 8(MED8)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0016567~protein ubiquitination,	GO:0005654~nucleoplasm,GO:0016592~mediator complex,	GO:0001104~RNA polymerase II transcription cofactor activity,GO:0005515~protein binding,	IPR019364:Mediator complex, subunit Med8, fungi/metazoa,	hsa05168:Herpes simplex infection,				Activator,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation pathway,	chain:Mediator of RNA polymerase II transcription subunit 8,modified residue,mutagenesis site,region of interest:Interaction with the Elongin BC complex,sequence conflict,splice variant,
MEMO1	mediator of cell motility 1(MEMO1)	Homo sapiens				GO:0032886~regulation of microtubule-based process,GO:2000145~regulation of cell motility,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR002737:UPF0103/Mediator of ErbB2-driven cell motility (Memo-related),					3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:Protein MEMO1,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
M1AP	meiosis 1 associated protein(M1AP)	Homo sapiens				GO:0006396~RNA processing,GO:0007127~meiosis I,GO:0007283~spermatogenesis,GO:0007292~female gamete generation,GO:0030154~cell differentiation,GO:0031497~chromatin assembly,GO:0051308~male meiosis chromosome separation,	GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,						Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Polymorphism,Reference proteome,Spermatogenesis,	chain:Uncharacterized protein C2orf65,sequence variant,splice variant,
MITF	melanogenesis associated transcription factor(MITF)	Homo sapiens	53.Early-response_Tr_Fac_mast_cells,	h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0007275~multicellular organism development,GO:0010628~positive regulation of gene expression,GO:0016925~protein sumoylation,GO:0030318~melanocyte differentiation,GO:0042981~regulation of apoptotic process,GO:0045670~regulation of osteoclast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0097531~mast cell migration,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2001141~regulation of RNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR021802:Basic helix-loop-helix leucine zipper transcrition factor MiT/TFE,	hsa04380:Osteoclast differentiation,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05218:Melanoma,	103470~Waardenburg syndrome/ocular albinism, digenic,103500~Tietz albinism-deafness syndrome,193510~Waardenburg syndrome, type 2A,614456~Melanoma, cutaneous malignant, susceptibility to, 8,		SM00353:HLH,	3D-structure,Activator,Albinism,Alternative splicing,Coiled coil,Complete proteome,Deafness,Developmental protein,Disease mutation,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Waardenburg syndrome,	chain:Microphthalmia-associated transcription factor,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,mutagenesis site,region of interest:DNA binding regulation,region of interest:Transactivation,sequence variant,splice variant,
MLPH	melanophilin(MLPH)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0030050~vesicle transport along actin filament,	GO:0005622~intracellular,GO:0030425~dendrite,GO:0030864~cortical actin cytoskeleton,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0017022~myosin binding,GO:0017137~Rab GTPase binding,GO:0046872~metal ion binding,	IPR006788:Rab effector MyRIP/Melanophilin,IPR010911:Rab-binding domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,		609227~Griscelli syndrome, type 3,			Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Melanophilin,domain:RabBD,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,zinc finger region:FYVE-type,
MREG	melanoregulin(MREG)	Homo sapiens				GO:0030318~melanocyte differentiation,GO:0032402~melanosome transport,	GO:0016324~apical plasma membrane,GO:0042470~melanosome,GO:0043234~protein complex,							Alternative splicing,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Melanoregulin,compositionally biased region:Cys-rich,sequence conflict,sequence variant,splice variant,
MAGI1	membrane associated guanylate kinase, WW and PDZ domain containing 1(MAGI1)	Homo sapiens				GO:0006461~protein complex assembly,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0070997~neuron death,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005923~bicellular tight junction,GO:0030054~cell junction,GO:0042995~cell projection,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0032947~protein complex scaffold,GO:0051393~alpha-actinin binding,	IPR001202:WW domain,IPR001478:PDZ domain,IPR008144:Guanylate kinase,IPR008145:Guanylate kinase/L-type calcium channel,IPR014710:RmlC-like jelly roll fold,IPR020590:Guanylate kinase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04530:Tight junction,			SM00072:GuKc,SM00228:PDZ,SM00456:WW,	3D-structure,Alternative splicing,ATP-binding,Cell junction,Cell membrane,Coiled coil,Complete proteome,Membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Tight junction,	chain:Connector enhancer of kinase suppressor of ras 3,chain:Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,domain:CRIC,domain:DUF1170,domain:Guanylate kinase-like,domain:PDZ,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,domain:PDZ 5,domain:PDZ 6,domain:SAM,domain:WW 1,domain:WW 2,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with FCHSD2,sequence conflict,splice variant,strand,turn,
MAGI3	membrane associated guanylate kinase, WW and PDZ domain containing 3(MAGI3)	Homo sapiens				GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0016032~viral process,GO:0035556~intracellular signal transduction,GO:0046037~GMP metabolic process,GO:0046328~regulation of JNK cascade,GO:0046710~GDP metabolic process,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016020~membrane,	GO:0004385~guanylate kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0032947~protein complex scaffold,	IPR001202:WW domain,IPR001478:PDZ domain,IPR008144:Guanylate kinase,IPR008145:Guanylate kinase/L-type calcium channel,IPR020590:Guanylate kinase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,			SM00072:GuKc,SM00228:PDZ,SM00456:WW,	3D-structure,Alternative splicing,ATP-binding,Cell junction,Cell membrane,Complete proteome,Host-virus interaction,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Tight junction,Transferase,Ubl conjugation,	chain:Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,domain:Guanylate kinase-like,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,domain:PDZ 5,domain:PDZ 6,domain:WW 1,domain:WW 2,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with ADRB1 and TGFA,region of interest:Interaction with BAI1,region of interest:Interaction with LPAR2 and GRIN2B,region of interest:Interaction with PTEN,sequence conflict,splice variant,
MARCH4	membrane associated ring-CH-type finger 4(MARCH4)	Homo sapiens			RNA processing and modification,	GO:0016567~protein ubiquitination,	GO:0000139~Golgi membrane,GO:0005795~Golgi stack,GO:0005802~trans-Golgi network,GO:0016021~integral component of membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR011016:Zinc finger, RING-CH-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00744:RINGv,	Complete proteome,Golgi apparatus,Ligase,Membrane,Metal-binding,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase MARCH4,compositionally biased region:Pro-rich,signal peptide,transmembrane region,zinc finger region:RING-CH-type,
MARCH7	membrane associated ring-CH-type finger 7(MARCH7)	Homo sapiens				GO:0002643~regulation of tolerance induction,GO:0016567~protein ubiquitination,GO:0042130~negative regulation of T cell proliferation,		GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR011016:Zinc finger, RING-CH-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00744:RINGv,	Acetylation,Alternative splicing,Complete proteome,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase MARCH7,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,zinc finger region:RING-CH-type,
MBOAT2	membrane bound O-acyltransferase domain containing 2(MBOAT2)	Homo sapiens				GO:0008654~phospholipid biosynthetic process,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0004147~dihydrolipoamide branched chain acyltransferase activity,GO:0008951~palmitoleoyl [acyl-carrier-protein]-dependent acyltransferase activity,GO:0016406~carnitine O-acyltransferase activity,GO:0016412~serine O-acyltransferase activity,GO:0016413~O-acetyltransferase activity,GO:0016414~O-octanoyltransferase activity,GO:0016416~O-palmitoyltransferase activity,GO:0016418~S-acetyltransferase activity,GO:0016419~S-malonyltransferase activity,GO:0016454~C-palmitoyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0016749~N-succinyltransferase activity,GO:0016750~O-succinyltransferase activity,GO:0016751~S-succinyltransferase activity,GO:0016753~O-sinapoyltransferase activity,GO:0018030~peptidyl-lysine N6-myristoyltransferase activity,GO:0018031~peptidyl-lysine N6-palmitoyltransferase activity,GO:0018711~benzoyl acetate-CoA thiolase activity,GO:0018712~3-hydroxybutyryl-CoA thiolase activity,GO:0018713~3-ketopimelyl-CoA thiolase activity,GO:0019186~acyl-CoA N-acyltransferase activity,GO:0019705~protein-cysteine S-myristoyltransferase activity,GO:0032216~glucosaminyl-phosphotidylinositol O-acyltransferase activity,GO:0034737~ergosterol O-acyltransferase activity,GO:0034738~lanosterol O-acyltransferase activity,GO:0034848~naphthyl-2-oxomethyl-succinyl-CoA succinyl transferase activity,GO:0034851~2,4,4-trimethyl-3-oxopentanoyl-CoA 2-C-propanoyl transferase activity,GO:0034915~2-methylhexanoyl-CoA C-acetyltransferase activity,GO:0034919~butyryl-CoA 2-C-propionyltransferase activity,GO:0034945~2,6-dimethyl-5-methylene-3-oxo-heptanoyl-CoA C-acetyltransferase activity,GO:0043741~L-2-aminoadipate N-acetyltransferase activity,GO:0043806~keto acid formate lyase activity,GO:0043849~Ras palmitoyltransferase activity,GO:0046941~azetidine-2-carboxylic acid acetyltransferase activity,GO:0047144~2-acylglycerol-3-phosphate O-acyltransferase activity,GO:0052858~peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0090595~acetyl-CoA:L-lysine N6-acetyltransferase,	IPR004299:Membrane bound O-acyl transferase, MBOAT,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,				Acyltransferase,Complete proteome,Lipid biosynthesis,Lipid metabolism,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Lysophospholipid acyltransferase 2,sequence conflict,sequence variant,transmembrane region,
MMEL1	membrane metalloendopeptidase like 1(MMEL1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,	IPR000718:Peptidase M13,IPR008753:Peptidase M13, N-terminal domain,IPR018497:Peptidase M13, C-terminal domain,IPR024079:Metallopeptidase, catalytic domain,					Alternative splicing,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Proton donor,binding site:Substrate carboxyl,chain:Membrane metallo-endopeptidase-like 1,chain:Membrane metallo-endopeptidase-like 1, soluble form,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,sequence conflict,sequence variant,site:Cleavage,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
MPP4	membrane palmitoylated protein 4(MPP4)	Homo sapiens					GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,		IPR001452:Src homology-3 domain,IPR001478:PDZ domain,IPR004172:L27,IPR008144:Guanylate kinase,IPR008145:Guanylate kinase/L-type calcium channel,IPR014775:L27, C-terminal,IPR020590:Guanylate kinase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00072:GuKc,SM00228:PDZ,SM00326:SH3,SM00569:L27,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:MAGUK p55 subfamily member 4,domain:Guanylate kinase-like,domain:L27 1,domain:L27 2,domain:PDZ,domain:SH3,sequence conflict,sequence variant,splice variant,
MANF	mesencephalic astrocyte derived neurotrophic factor(MANF)	Homo sapiens				GO:0006986~response to unfolded protein,GO:0031175~neuron projection development,GO:0071542~dopaminergic neuron differentiation,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0048471~perinuclear region of cytoplasm,	GO:0008083~growth factor activity,GO:0044822~poly(A) RNA binding,	IPR011001:Saposin-like,IPR019345:Armet protein,					3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Sialic acid,Signal,Unfolded protein response,	chain:Mesencephalic astrocyte-derived neurotrophic factor,disulfide bond,helix,modified residue,sequence conflict,signal peptide,turn,
MTF1	metal regulatory transcription factor 1(MTF1)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006979~response to oxidative stress,GO:0010038~response to metal ion,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046686~response to cadmium ion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0035035~histone acetyltransferase binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Acetylation,Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Metal regulatory transcription factor 1,compositionally biased region:Pro-rich,sequence conflict,short sequence motif:Nuclear localization signal,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
MTF2	metal response element binding transcription factor 2(MTF2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0007379~segment specification,GO:0016569~covalent chromatin modification,GO:0019827~stem cell population maintenance,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048863~stem cell differentiation,GO:0061086~negative regulation of histone H3-K27 methylation,GO:0061087~positive regulation of histone H3-K27 methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0035098~ESC/E(Z) complex,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0035064~methylated histone binding,	IPR001965:Zinc finger, PHD-type,IPR002999:Tudor domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR025894:Polycomb-like MTF2 factor 2, C-terminal domain,				SM00249:PHD,SM00333:TUDOR,	Alternative splicing,Chromatin regulator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Metal-response element-binding transcription factor 2,modified residue,sequence variant,splice variant,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
MT1HL1	metallothionein 1H-like 1(MT1HL1)	Homo sapiens						GO:0046872~metal ion binding,	IPR000006:Metallothionein, vertebrate,IPR001368:TNFR/NGFR cysteine-rich region,IPR003019:Metallothionein superfamily, eukaryotic,IPR017854:Metallothionein domain,IPR023587:Metallothionein domain, vertebrate,					Acetylation,Complete proteome,Metal-binding,Metal-thiolate cluster,Reference proteome,
MTA3	metastasis associated 1 family member 3(MTA3)	Homo sapiens		h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors,		GO:0008284~positive regulation of cell proliferation,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0016575~histone deacetylation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008278~cohesin complex,GO:0016581~NuRD complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000679:Zinc finger, GATA-type,IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR001025:Bromo adjacent homology (BAH) domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,				SM00401:ZnF_GATA,SM00439:BAH,SM00717:SANT,SM01189:SM01189,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Metastasis-associated protein MTA3,domain:BAH,domain:ELM2,domain:SANT,sequence conflict,splice variant,zinc finger region:GATA-type; atypical,
MTX2	metaxin 2(MTX2)	Homo sapiens				GO:0006626~protein targeting to mitochondrion,GO:0006839~mitochondrial transport,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,	GO:0005515~protein binding,	IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,IPR019564:Mitochondrial outer membrane transport complex,  Sam37/metaxin,					Acetylation,Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion outer membrane,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Metaxin-2,
METAP1D	methionyl aminopeptidase type 1D, mitochondrial(METAP1D)	Homo sapiens				GO:0006508~proteolysis,GO:0018206~peptidyl-methionine modification,GO:0031365~N-terminal protein amino acid modification,GO:0070084~protein initiator methionine removal,	GO:0005739~mitochondrion,	GO:0004177~aminopeptidase activity,GO:0008235~metalloexopeptidase activity,GO:0046872~metal ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000994:Peptidase M24, structural domain,IPR001714:Peptidase M24, methionine aminopeptidase,IPR002467:Peptidase M24A, methionine aminopeptidase, subfamily 1,					Aminopeptidase,Complete proteome,Hydrolase,Metal-binding,Mitochondrion,Polymorphism,Protease,Reference proteome,Transit peptide,	binding site:Substrate,chain:Methionine aminopeptidase 1D, mitochondrial,metal ion-binding site:Cobalt 1,metal ion-binding site:Cobalt 2,sequence variant,transit peptide:Mitochondrion,
MBD5	methyl-CpG binding domain protein 5(MBD5)	Homo sapiens				GO:0007399~nervous system development,GO:0040014~regulation of multicellular organism growth,GO:0042593~glucose homeostasis,GO:0044708~single-organism behavior,GO:0060399~positive regulation of growth hormone receptor signaling pathway,	GO:0005634~nucleus,GO:0010369~chromocenter,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,	IPR000313:PWWP,IPR001739:Methyl-CpG DNA binding,IPR004918:Cdc37,IPR013873:Cdc37, C-terminal,IPR016177:DNA-binding, integrase-type,		156200~Mental retardation, autosomal dominant 1,		SM00391:MBD,SM01069:SM01069,	Alternative splicing,Chromosome,Complete proteome,Mental retardation,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Methyl-CpG-binding domain protein 5,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:MBD,domain:PWWP,sequence conflict,sequence variant,splice variant,
MTHFD2	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase(MTHFD2)	Homo sapiens			Coenzyme metabolism,	GO:0006730~one-carbon metabolic process,GO:0009396~folic acid-containing compound biosynthetic process,GO:0046653~tetrahydrofolate metabolic process,GO:0046655~folic acid metabolic process,GO:0055114~oxidation-reduction process,	GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0004329~formate-tetrahydrofolate ligase activity,GO:0004477~methenyltetrahydrofolate cyclohydrolase activity,GO:0004487~methylenetetrahydrofolate dehydrogenase (NAD+) activity,GO:0004488~methylenetetrahydrofolate dehydrogenase (NADP+) activity,GO:0042301~phosphate ion binding,	IPR000672:Tetrahydrofolate dehydrogenase/cyclohydrolase,IPR016040:NAD(P)-binding domain,IPR020630:Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain,IPR020631:Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain,IPR020867:Tetrahydrofolate dehydrogenase/cyclohydrolase, conserved site,	hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Hydrolase,Magnesium,Mitochondrion,Multifunctional enzyme,NAD,One-carbon metabolism,Oxidoreductase,Proteomics identification,Reference proteome,Transit peptide,	chain:Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial,modified residue,sequence conflict,transit peptide:Mitochondrion,
MTHFR	methylenetetrahydrofolate reductase(MTHFR)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006520~cellular amino acid metabolic process,GO:0006555~methionine metabolic process,GO:0008015~blood circulation,GO:0031060~regulation of histone methylation,GO:0033274~response to vitamin B2,GO:0035999~tetrahydrofolate interconversion,GO:0042493~response to drug,GO:0043200~response to amino acid,GO:0046500~S-adenosylmethionine metabolic process,GO:0046655~folic acid metabolic process,GO:0050667~homocysteine metabolic process,GO:0051593~response to folic acid,GO:0055114~oxidation-reduction process,GO:0070555~response to interleukin-1,GO:0070829~heterochromatin maintenance,	GO:0005829~cytosol,GO:0045202~synapse,	GO:0004489~methylenetetrahydrofolate reductase (NAD(P)H) activity,GO:0032403~protein complex binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,GO:0072341~modified amino acid binding,	IPR003171:Methylenetetrahydrofolate reductase,IPR004621:Eukaryotic-type methylenetetrahydrofolate reductase,	hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,	181500~Schizophrenia, susceptibility to,188050~Thromboembolism, susceptibility to,236250~Homocystinuria due to MTHFR deficiency,601634~Neural tube defects, susceptibility to,Vascular disease, susceptibility to~Vascular disease, susceptibility to,			Allosteric enzyme,Alternative splicing,Complete proteome,Disease mutation,FAD,Flavoprotein,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,	chain:Methylenetetrahydrofolate reductase,sequence variant,
MMADHC	methylmalonic aciduria and homocystinuria, cblD type(MMADHC)	Homo sapiens				GO:0009108~coenzyme biosynthetic process,GO:0009235~cobalamin metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR019362:Methylmalonic aciduria and homocystinuria type D protein,		277410~Homocystinuria, cblD type, variant 1,277410~Methylmalonic aciduria and homocystinuria, cblD type,277410~Methylmalonic aciduria, cblD type, variant 2,			3D-structure,Acetylation,Complete proteome,Cytoplasm,Disease mutation,Mitochondrion,Proteomics identification,Reference proteome,Transit peptide,	chain:Methylmalonic aciduria and homocystinuria type D protein, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
MCEE	methylmalonyl-CoA epimerase(MCEE)	Homo sapiens				GO:0019626~short-chain fatty acid catabolic process,GO:0046491~L-methylmalonyl-CoA metabolic process,	GO:0005759~mitochondrial matrix,	GO:0004493~methylmalonyl-CoA epimerase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR004360:Glyoxalase/fosfomycin resistance/dioxygenase domain,IPR017515:Methylmalonyl-CoA epimerase,	hsa00280:Valine, leucine and isoleucine degradation,hsa00630:Glyoxylate and dicarboxylate metabolism,hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,	251120~Methylmalonyl-CoA epimerase deficiency,			3D-structure,Acetylation,Cobalt,Complete proteome,Isomerase,Metal-binding,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Methylmalonyl-CoA epimerase, mitochondrial,compositionally biased region:Poly-Lys,modified residue,sequence variant,transit peptide:Mitochondrion,
METTL11B	methyltransferase like 11B(METTL11B)	Homo sapiens				GO:0006480~N-terminal protein amino acid methylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0071885~N-terminal protein N-methyltransferase activity,	IPR008576:Protein of unknown function DUF858, methyltransferase-like,					Complete proteome,Methyltransferase,Nucleus,Polymorphism,Reference proteome,S-adenosyl-L-methionine,Transferase,	binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,chain:Methyltransferase-like protein 11B,region of interest:S-adenosyl-L-methionine binding,sequence variant,
METTL13	methyltransferase like 13(METTL13)	Homo sapiens				GO:0032259~methylation,		GO:0005515~protein binding,GO:0008168~methyltransferase activity,	IPR013216:Methyltransferase type 11,					Acetylation,Alternative splicing,Complete proteome,Methyltransferase,Phosphoprotein,Polymorphism,Reference proteome,Transferase,	chain:Methyltransferase-like protein 13,modified residue,sequence conflict,sequence variant,splice variant,
METTL21A	methyltransferase like 21A(METTL21A)	Homo sapiens				GO:0006479~protein methylation,GO:0018022~peptidyl-lysine methylation,GO:0043462~regulation of ATPase activity,	GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0016279~protein-lysine N-methyltransferase activity,GO:0030544~Hsp70 protein binding,GO:0051117~ATPase binding,	IPR019410:Nicotinamide N-methyltransferase-like,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Methyltransferase,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:Protein FAM119A,sequence conflict,sequence variant,splice variant,transmembrane region,
METTL5	methyltransferase like 5(METTL5)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0032259~methylation,		GO:0003676~nucleic acid binding,GO:0008168~methyltransferase activity,	IPR002052:DNA methylase, N-6 adenine-specific, conserved site,IPR007848:Methyltransferase small domain,					Complete proteome,Methyltransferase,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Methyltransferase-like protein 5,sequence conflict,sequence variant,
METTL6	methyltransferase like 6(METTL6)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism / General function prediction only,	GO:0032259~methylation,		GO:0008168~methyltransferase activity,	IPR013216:Methyltransferase type 11,IPR013217:Methyltransferase type 12,IPR026113:Methyltransferase-like,			PIRSF037755:methyltransferase, METTL2 type,		Alternative splicing,Complete proteome,Methyltransferase,Proteomics identification,Reference proteome,Transferase,	chain:Methyltransferase-like protein 6,sequence conflict,splice variant,
METTL8	methyltransferase like 8(METTL8)	Homo sapiens				GO:0007519~skeletal muscle tissue development,GO:0032259~methylation,GO:0045444~fat cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004402~histone acetyltransferase activity,GO:0008168~methyltransferase activity,	IPR026113:Methyltransferase-like,			PIRSF037755:methyltransferase, METTL2 type,		Alternative splicing,Complete proteome,Cytoplasm,Methyltransferase,Nucleus,Proteomics identification,Reference proteome,Transferase,	chain:Methyltransferase-like protein 8,splice variant,
MIR128-1	microRNA 128-1(MIR128-1)	Homo sapiens								hsa05206:MicroRNAs in cancer,
MIR137	microRNA 137(MIR137)	Homo sapiens								hsa05206:MicroRNAs in cancer,
MFAP2	microfibrillar associated protein 2(MFAP2)	Homo sapiens				GO:0030198~extracellular matrix organization,GO:0048048~embryonic eye morphogenesis,GO:0048050~post-embryonic eye morphogenesis,	GO:0001527~microfibril,GO:0005576~extracellular region,		IPR003582:Metridin-like ShK toxin,IPR008673:Microfibril-associated glycoprotein,					Alternative splicing,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,Sulfation,	chain:Microfibrillar-associated protein 2,compositionally biased region:Gln/Glu-rich,disulfide bond,domain:SXC,modified residue,signal peptide,
MGST3	microsomal glutathione S-transferase 3(MGST3)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0007165~signal transduction,GO:0010243~response to organonitrogen compound,GO:0098869~cellular oxidant detoxification,GO:1901687~glutathione derivative biosynthetic process,	GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0004601~peroxidase activity,GO:0004602~glutathione peroxidase activity,GO:0005515~protein binding,GO:0016740~transferase activity,	IPR001129:Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein,IPR023352:Membrane associated eicosanoid/glutathione metabolism-like domain,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				Complete proteome,Endoplasmic reticulum,Lipoprotein,Membrane,Microsome,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Microsomal glutathione S-transferase 3,sequence variant,transmembrane region,
MARK1	microtubule affinity regulating kinase 1(MARK1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0001764~neuron migration,GO:0006468~protein phosphorylation,GO:0007010~cytoskeleton organization,GO:0016055~Wnt signaling pathway,GO:0030010~establishment of cell polarity,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,	GO:0000287~magnesium ion binding,GO:0001786~phosphatidylserine binding,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0016301~kinase activity,GO:0050321~tau-protein kinase activity,GO:0070300~phosphatidic acid binding,	IPR000719:Protein kinase, catalytic domain,IPR001772:Kinase associated domain 1 (KA1),IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR017441:Protein kinase, ATP binding site,				SM00165:UBA,SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Autism,Autism spectrum disorder,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Lipid-binding,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Wnt signaling pathway,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase MARK1,domain:KA1,domain:Protein kinase,domain:UBA,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
MAP1LC3C	microtubule associated protein 1 light chain 3 gamma(MAP1LC3C)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006995~cellular response to nitrogen starvation,GO:0016236~macroautophagy,	GO:0000421~autophagosome membrane,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0012505~endomembrane system,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0031625~ubiquitin protein ligase binding,	IPR004241:Autophagy protein Atg8 ubiquitin-like,					3D-structure,Autophagy,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Lipoprotein,Membrane,Microtubule,Reference proteome,Ubl conjugation pathway,	chain:Microtubule-associated proteins 1A/1B light chain 3C,lipid moiety-binding region:Phosphatidylethanolamine amidated glycine,mutagenesis site,propeptide:Removed in mature form,
MAP2	microtubule associated protein 2(MAP2)	Homo sapiens		h_akapcentrosomePathway:Protein Kinase A at the Centrosome,		GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0021954~central nervous system neuron development,GO:0031175~neuron projection development,GO:0048813~dendrite morphogenesis,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0043005~neuron projection,	GO:0002162~dystroglycan binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008017~microtubule binding,	IPR001084:Tau and MAP proteins tubulin-binding repeat,IPR013588:MAP2/Tau projection,IPR018459:RII binding domain,IPR027324:Microtubule associated protein MAP2/MAP4/Tau,					Alternative splicing,Calmodulin-binding,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Microtubule-associated protein 2,modified residue,region of interest:Calmodulin-binding,repeat:Tau/MAP 1,repeat:Tau/MAP 2,repeat:Tau/MAP 3,sequence conflict,sequence variant,splice variant,
MAP4	microtubule associated protein 4(MAP4)	Homo sapiens				GO:0007052~mitotic spindle organization,GO:0031175~neuron projection development,GO:0051012~microtubule sliding,GO:0051294~establishment of spindle orientation,GO:0051301~cell division,GO:1902856~negative regulation of nonmotile primary cilium assembly,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0005930~axoneme,GO:0014069~postsynaptic density,GO:0015630~microtubule cytoskeleton,GO:0043005~neuron projection,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0044822~poly(A) RNA binding,	IPR001084:Tau and MAP proteins tubulin-binding repeat,IPR027323:Microtubule-associated protein 4,IPR027324:Microtubule associated protein MAP2/MAP4/Tau,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Isopeptide bond,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Microtubule-associated protein 4,modified residue,mutagenesis site,region of interest:17 X 14 AA tandem repeats,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:2,repeat:26 residues 1,repeat:26 residues 2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8; truncated,repeat:9,repeat:Tau/MAP 1,repeat:Tau/MAP 2,repeat:Tau/MAP 3,repeat:Tau/MAP 4,sequence conflict,sequence variant,splice variant,
MAPRE3	microtubule associated protein RP/EB family member 3(MAPRE3)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,GO:1903033~positive regulation of microtubule plus-end binding,	GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,GO:0035371~microtubule plus-end,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0042802~identical protein binding,	IPR001715:Calponin homology domain,IPR004953:EB1, C-terminal,IPR027328:Microtubule-associated protein RP/EB,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Microtubule-associated protein RP/EB family member 3,domain:CH,domain:EB1 C-terminal,helix,modified residue,region of interest:APC-binding,region of interest:DCTN1-binding,sequence conflict,splice variant,turn,
MAST2	microtubule associated serine/threonine kinase 2(MAST2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007010~cytoskeleton organization,GO:0018105~peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0045075~regulation of interleukin-12 biosynthetic process,GO:0048515~spermatid differentiation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0019902~phosphatase binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001478:PDZ domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015022:Microtubule-associated serine/threonine-protein kinase, domain,IPR023142:Microtubule-associated serine/threonine-protein kinase, pre-PK domain,				SM00220:S_TKc,SM00228:PDZ,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Magnesium,Membrane,Metal-binding,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Microtubule-associated serine/threonine- protein kinase 2,domain:AGC-kinase C-terminal,domain:PDZ,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
MACF1	microtubule-actin crosslinking factor 1(MACF1)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0010632~regulation of epithelial cell migration,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0032886~regulation of microtubule-based process,GO:0042060~wound healing,GO:0043001~Golgi to plasma membrane protein transport,GO:0045773~positive regulation of axon extension,GO:0051893~regulation of focal adhesion assembly,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,GO:0032587~ruffle membrane,	GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001101:Plectin repeat,IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR002017:Spectrin repeat,IPR002048:EF-hand domain,IPR003108:Growth-arrest-specific protein 2 domain,IPR011992:EF-hand-like domain,IPR018159:Spectrin/alpha-actinin,IPR018247:EF-Hand 1, calcium-binding site,				SM00033:CH,SM00054:EFh,SM00150:SPEC,SM00243:GAS2,SM00250:PLEC,	3D-structure,Acetylation,Actin-binding,Alternative splicing,Calcium,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Leucine-rich repeat,Membrane,Metal-binding,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,Transmembrane,Transmembrane helix,Wnt signaling pathway,	calcium-binding region:1,calcium-binding region:2,chain:Microtubule-actin cross-linking factor 1, isoform 4,chain:Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,compositionally biased region:Poly-Ser,domain:Actin-binding,domain:CH 1,domain:CH 2,domain:EF-hand 1,domain:EF-hand 2,domain:SH3,modified residue,region of interest:4 X 4 AA tandem repeats of [GS]-S-R-[AR],repeat:Plectin 1,repeat:Plectin 10,repeat:Plectin 11,repeat:Plectin 12,repeat:Plectin 13,repeat:Plectin 14,repeat:Plectin 15,repeat:Plectin 16,repeat:Plectin 17,repeat:Plectin 18,repeat:Plectin 19,repeat:Plectin 2,repeat:Plectin 3,repeat:Plectin 4,repeat:Plectin 5,repeat:Plectin 6,repeat:Plectin 7,repeat:Plectin 8,repeat:Plectin 9,repeat:Spectrin 1,repeat:Spectrin 10,repeat:Spectrin 11,repeat:Spectrin 12,repeat:Spectrin 13,repeat:Spectrin 14,repeat:Spectrin 15,repeat:Spectrin 16,repeat:Spectrin 17,repeat:Spectrin 18,repeat:Spectrin 19,repeat:Spectrin 2,repeat:Spectrin 20,repeat:Spectrin 21,repeat:Spectrin 22,repeat:Spectrin 23,repeat:Spectrin 24,repeat:Spectrin 25,repeat:Spectrin 26,repeat:Spectrin 27,repeat:Spectrin 28,repeat:Spectrin 29,repeat:Spectrin 3,repeat:Spectrin 30,repeat:Spectrin 31,repeat:Spectrin 32,repeat:Spectrin 33,repeat:Spectrin 34,repeat:Spectrin 35,repeat:Spectrin 36,repeat:Spectrin 37,repeat:Spectrin 4,repeat:Spectrin 5,repeat:Spectrin 6,repeat:Spectrin 7,repeat:Spectrin 8,repeat:Spectrin 9,sequence conflict,sequence variant,splice variant,
MIIP	migration and invasion inhibitory protein(MIIP)	Homo sapiens				GO:0010972~negative regulation of G2/M transition of mitotic cell cycle,GO:0030336~negative regulation of cell migration,		GO:0005515~protein binding,						Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Migration and invasion-inhibitory protein,region of interest:Interaction with IGFBP2,sequence conflict,sequence variant,splice variant,
MIB2	mindbomb E3 ubiquitin protein ligase 2(MIB2)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0007219~Notch signaling pathway,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005829~cytosol,	GO:0003779~actin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000433:Zinc finger, ZZ-type,IPR001841:Zinc finger, RING-type,IPR002110:Ankyrin repeat,IPR010606:Mib-herc2,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR020683:Ankyrin repeat-containing domain,				SM00184:RING,SM00248:ANK,SM00291:ZnF_ZZ,	Acetylation,Actin-binding,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Endosome,Ligase,Metal-binding,Notch signaling pathway,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase MIB2,domain:MIB/HERC2 1,domain:MIB/HERC2 2,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type 1,zinc finger region:RING-type 2,zinc finger region:ZZ-type,
MCM6	minichromosome maintenance complex component 6(MCM6)	Homo sapiens		h_mcmPathway:CDK Regulation of DNA Replication,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0042555~MCM complex,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR004039:Rubredoxin-type fold,IPR008049:DNA replication licensing factor Mcm6,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03030:DNA replication,hsa04110:Cell cycle,	223100~Lactase persistence/nonpersistence,		SM00350:MCM,	3D-structure,Acetylation,ATP-binding,Cell cycle,Complete proteome,DNA replication,DNA-binding,Glycoprotein,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:DNA replication licensing factor Mcm6,domain:MCM,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
MSTO1	misato 1, mitochondrial distribution and morphology regulator(MSTO1)	Homo sapiens				GO:0007005~mitochondrion organization,GO:0048311~mitochondrion distribution,	GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,	GO:0003924~GTPase activity,	IPR003008:Tubulin/FtsZ, GTPase domain,IPR019605:Misato Segment II, myosin-like,					Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein misato homolog 1,modified residue,sequence conflict,sequence variant,splice variant,
MUL1	mitochondrial E3 ubiquitin protein ligase 1(MUL1)	Homo sapiens				GO:0000266~mitochondrial fission,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006996~organelle organization,GO:0007257~activation of JUN kinase activity,GO:0010637~negative regulation of mitochondrial fusion,GO:0010821~regulation of mitochondrion organization,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0030308~negative regulation of cell growth,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0033235~positive regulation of protein sumoylation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045824~negative regulation of innate immune response,GO:0050689~negative regulation of defense response to virus by host,GO:0050821~protein stabilization,GO:0051646~mitochondrion localization,GO:0051881~regulation of mitochondrial membrane potential,GO:0051898~negative regulation of protein kinase B signaling,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0071360~cellular response to exogenous dsRNA,GO:0071650~negative regulation of chemokine (C-C motif) ligand 5 production,GO:0090141~positive regulation of mitochondrial fission,GO:1901028~regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1903861~positive regulation of dendrite extension,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0031307~integral component of mitochondrial outer membrane,GO:0043025~neuronal cell body,	GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019789~SUMO transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR022170:E3 Ubiquitin ligase,					Apoptosis,Complete proteome,Isopeptide bond,Ligase,Membrane,Metal-binding,Mitochondrion,Mitochondrion outer membrane,Peroxisome,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Mitochondrial ubiquitin ligase activator of nfkb 1,mutagenesis site,sequence conflict,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,zinc finger region:RING-type,
MARC1	mitochondrial amidoxime reducing component 1(MARC1)	Homo sapiens			General function prediction only,	GO:0042126~nitrate metabolic process,GO:0051410~detoxification of nitrogen compound,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0003824~catalytic activity,GO:0008940~nitrate reductase activity,GO:0030151~molybdenum ion binding,GO:0030170~pyridoxal phosphate binding,GO:0043546~molybdopterin cofactor binding,	IPR005302:Molybdenum cofactor sulfurase, C-terminal,IPR005303:MOSC, N-terminal beta barrel,IPR011037:Pyruvate kinase-like, insert domain,					Alternative splicing,Complete proteome,Lipoprotein,Membrane,Mitochondrion,Mitochondrion outer membrane,Molybdenum,Myristate,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:MOSC domain-containing protein 1, mitochondrial,domain:MOSC,sequence variant,splice variant,transit peptide:Mitochondrion,
MARC2	mitochondrial amidoxime reducing component 2(MARC2)	Homo sapiens			General function prediction only,	GO:0042126~nitrate metabolic process,GO:0051410~detoxification of nitrogen compound,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0008940~nitrate reductase activity,GO:0030151~molybdenum ion binding,GO:0030170~pyridoxal phosphate binding,GO:0043546~molybdopterin cofactor binding,	IPR005302:Molybdenum cofactor sulfurase, C-terminal,IPR005303:MOSC, N-terminal beta barrel,IPR011037:Pyruvate kinase-like, insert domain,					Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,Membrane,Mitochondrion,Mitochondrion outer membrane,Molybdenum,Oxidoreductase,Peroxisome,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:MOSC domain-containing protein 2, mitochondrial,domain:MOSC,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
MFF	mitochondrial fission factor(MFF)	Homo sapiens				GO:0000266~mitochondrial fission,GO:0001836~release of cytochrome c from mitochondria,GO:0006626~protein targeting to mitochondrion,GO:0008053~mitochondrial fusion,GO:0010821~regulation of mitochondrion organization,GO:0016559~peroxisome fission,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0051260~protein homooligomerization,GO:0070584~mitochondrion morphogenesis,GO:0090141~positive regulation of mitochondrial fission,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090314~positive regulation of protein targeting to membrane,GO:1900063~regulation of peroxisome organization,	GO:0005741~mitochondrial outer membrane,GO:0005777~peroxisome,GO:0008021~synaptic vesicle,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0032592~integral component of mitochondrial membrane,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR008518:FATE/Miff/Tango-11,					Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasmic vesicle,Membrane,Mitochondrion,Mitochondrion outer membrane,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,	chain:Mitochondrial fission factor,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,
MTFR1L	mitochondrial fission regulator 1 like(MTFR1L)	Homo sapiens				GO:0000266~mitochondrial fission,GO:0009060~aerobic respiration,	GO:0005739~mitochondrion,	GO:0005515~protein binding,	IPR007972:Mitochondrial fission regulator 1,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Protein FAM54B,modified residue,sequence conflict,sequence variant,splice variant,
MINOS1	mitochondrial inner membrane organizing system 1(MINOS1)	Homo sapiens					GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0061617~MICOS complex,	GO:0005515~protein binding,	IPR007512:Protein of unknown function DUF543,					Acetylation,Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0327 protein C1orf151,transmembrane region,
MPC2	mitochondrial pyruvate carrier 2(MPC2)	Homo sapiens				GO:0006850~mitochondrial pyruvate transport,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0061732~mitochondrial acetyl-CoA biosynthetic process from pyruvate,GO:1902361~mitochondrial pyruvate transmembrane transport,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0050833~pyruvate transmembrane transporter activity,	IPR005336:Uncharacterised protein family UPF0041,					Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Brain protein 44,modified residue,
MRPL19	mitochondrial ribosomal protein L19(MRPL19)	Homo sapiens				GO:0006412~translation,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005634~nucleus,GO:0005743~mitochondrial inner membrane,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,GO:0031965~nuclear membrane,	GO:0003735~structural constituent of ribosome,	IPR001857:Ribosomal protein L19,IPR008991:Translation protein SH3-like domain,	hsa03010:Ribosome,				3D-structure,Complete proteome,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L19, mitochondrial,transit peptide:Mitochondrion,
MRPL33	mitochondrial ribosomal protein L33(MRPL33)	Homo sapiens				GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005743~mitochondrial inner membrane,GO:0005762~mitochondrial large ribosomal subunit,	GO:0003735~structural constituent of ribosome,	IPR001705:Ribosomal protein L33,IPR011332:Ribosomal protein, zinc-binding domain,	hsa03010:Ribosome,				3D-structure,Alternative splicing,Complete proteome,Mitochondrion,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:39S ribosomal protein L33, mitochondrial,
MRPL37	mitochondrial ribosomal protein L37(MRPL37)	Homo sapiens				GO:0006412~translation,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005761~mitochondrial ribosome,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR010793:Ribosomal protein L37/S30,					3D-structure,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L37, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
MRPL44	mitochondrial ribosomal protein L44(MRPL44)	Homo sapiens			Transcription,	GO:0006396~RNA processing,GO:0030422~production of siRNA involved in RNA interference,GO:0031053~primary miRNA processing,GO:0031054~pre-miRNA processing,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005634~nucleus,GO:0005743~mitochondrial inner membrane,GO:0005840~ribosome,	GO:0003725~double-stranded RNA binding,GO:0004525~ribonuclease III activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000999:Ribonuclease III domain,IPR014720:Double-stranded RNA-binding-like domain,		615395~Combined oxidative phosphorylation deficiency 16,			3D-structure,Complete proteome,Disease mutation,Endonuclease,Hydrolase,Mitochondrion,Nuclease,Polymorphism,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,Transit peptide,	chain:39S ribosomal protein L44, mitochondrial,domain:DRBM,domain:RNase III,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
MRPL55	mitochondrial ribosomal protein L55(MRPL55)	Homo sapiens				GO:0006412~translation,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005743~mitochondrial inner membrane,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,	IPR018615:Ribosomal protein L55, mitochondrial,					3D-structure,Alternative splicing,Complete proteome,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L55, mitochondrial,sequence variant,splice variant,transit peptide:Mitochondrion,
MRPS21	mitochondrial ribosomal protein S21(MRPS21)	Homo sapiens				GO:0006412~translation,GO:0032543~mitochondrial translation,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005743~mitochondrial inner membrane,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001911:Ribosomal protein S21,	hsa03010:Ribosome,				3D-structure,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:28S ribosomal protein S21, mitochondrial,sequence variant,
MRPS25	mitochondrial ribosomal protein S25(MRPS25)	Homo sapiens				GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,	IPR007741:Ribosomal protein/NADH dehydrogenase domain,IPR012336:Thioredoxin-like fold,				SM00916:SM00916,	3D-structure,Alternative splicing,Complete proteome,Mitochondrion,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:28S ribosomal protein S25, mitochondrial,
MRPS5	mitochondrial ribosomal protein S5(MRPS5)	Homo sapiens				GO:0006412~translation,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005763~mitochondrial small ribosomal subunit,GO:0022627~cytosolic small ribosomal subunit,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000851:Ribosomal protein S5,IPR005324:Ribosomal protein S5, C-terminal,IPR013810:Ribosomal protein S5, N-terminal,IPR014720:Double-stranded RNA-binding-like domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR018192:Ribosomal protein S5, N-terminal, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,	hsa03010:Ribosome,				3D-structure,Alternative splicing,Complete proteome,Mitochondrion,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:28S ribosomal protein S5, mitochondrial,domain:S5 DRBM,modified residue,splice variant,
MRPS9	mitochondrial ribosomal protein S9(MRPS9)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006412~translation,GO:0042769~DNA damage response, detection of DNA damage,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000754:Ribosomal protein S9,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020574:Ribosomal protein S9, conserved site,	hsa03010:Ribosome,				3D-structure,Acetylation,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:28S ribosomal protein S9, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
MECR	mitochondrial trans-2-enoyl-CoA reductase(MECR)	Homo sapiens			Energy production and conversion / General function prediction only,	GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0019166~trans-2-enoyl-CoA reductase (NADPH) activity,	IPR002085:Alcohol dehydrogenase superfamily, zinc-type,IPR011032:GroES-like,IPR013149:Alcohol dehydrogenase, C-terminal,IPR013154:Alcohol dehydrogenase GroES-like,IPR016040:NAD(P)-binding domain,IPR020843:Polyketide synthase, enoylreductase,	hsa00062:Fatty acid elongation,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,			SM00829:SM00829,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Mitochondrion,NADP,Nucleus,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Trans-2-enoyl-CoA reductase, mitochondrial,helix,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,
MTERF4	mitochondrial transcription termination factor 4(MTERF4)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006390~transcription from mitochondrial promoter,GO:0006626~protein targeting to mitochondrion,GO:0007507~heart development,GO:0008380~RNA splicing,GO:0032502~developmental process,GO:0032543~mitochondrial translation,GO:0043010~camera-type eye development,GO:0061668~mitochondrial ribosome assembly,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005762~mitochondrial large ribosomal subunit,	GO:0003690~double-stranded DNA binding,GO:0003727~single-stranded RNA binding,GO:0005515~protein binding,GO:0019843~rRNA binding,	IPR003690:Mitochodrial transcription termination factor-related,IPR016024:Armadillo-type fold,				SM00733:Mterf,	3D-structure,Complete proteome,Direct protein sequencing,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,rRNA processing,Transit peptide,	chain:mTERF domain-containing protein 2,sequence conflict,sequence variant,
MTIF2	mitochondrial translational initiation factor 2(MTIF2)	Homo sapiens				GO:0006446~regulation of translational initiation,GO:0032790~ribosome disassembly,GO:0070124~mitochondrial translational initiation,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,	GO:0003743~translation initiation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008135~translation factor activity, RNA binding,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,	IPR000178:Translation initiation factor aIF-2, bacterial-like,IPR000795:Elongation factor, GTP-binding domain,IPR005225:Small GTP-binding protein domain,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR023115:Translation initiation factor IF- 2, domain 3,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Coiled coil,Complete proteome,GTP-binding,Initiation factor,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Transit peptide,	chain:Translation initiation factor IF-2, mitochondrial,modified residue,nucleotide phosphate-binding region:GTP,region of interest:G-domain,sequence variant,transit peptide:Mitochondrion,
MFN2	mitofusin 2(MFN2)	Homo sapiens				GO:0001825~blastocyst formation,GO:0006626~protein targeting to mitochondrion,GO:0006915~apoptotic process,GO:0006986~response to unfolded protein,GO:0007006~mitochondrial membrane organization,GO:0007050~cell cycle arrest,GO:0007596~blood coagulation,GO:0008053~mitochondrial fusion,GO:0016236~macroautophagy,GO:0034497~protein localization to pre-autophagosomal structure,GO:0046580~negative regulation of Ras protein signal transduction,GO:0048593~camera-type eye morphogenesis,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0051646~mitochondrion localization,GO:0061734~parkin-mediated mitophagy in response to mitochondrial depolarization,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0015630~microtubule cytoskeleton,GO:0016021~integral component of membrane,GO:0031306~intrinsic component of mitochondrial outer membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0031625~ubiquitin protein ligase binding,	IPR006884:Fzo/mitofusin HR2 domain,IPR022812:Dynamin,IPR027089:Mitofusin-2,IPR027094:Mitofusin family,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		601152~Hereditary motor and sensory neuropathy VIA,609260~Charcot-Marie-Tooth disease, type 2A2,			Alternative splicing,Apoptosis,Autophagy,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Disease mutation,GTP-binding,Hydrolase,Membrane,Mitochondrion,Mitochondrion outer membrane,Neurodegeneration,Neuropathy,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,Unfolded protein response,	chain:Mitofusin-2,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,
MAP3K19	mitogen-activated protein kinase kinase kinase 19(MAP3K19)	Homo sapiens				GO:0023014~signal transduction by protein phosphorylation,GO:0030036~actin cytoskeleton organization,	GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:SPS1/STE20-related protein kinase YSK4,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
MAP3K2	mitogen-activated protein kinase kinase kinase 2(MAP3K2)	Homo sapiens	100.MAPK_signaling_cascades,	h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000186~activation of MAPKK activity,GO:0000187~activation of MAPK activity,GO:0006468~protein phosphorylation,GO:0007257~activation of JUN kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0071260~cellular response to mechanical stimulus,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,	IPR000270:Phox/Bem1p,IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04540:Gap junction,hsa04912:GnRH signaling pathway,			SM00220:S_TKc,SM00666:PB1,	3D-structure,ATP-binding,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase kinase kinase 2,domain:OPR,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,
MAP3K6	mitogen-activated protein kinase kinase kinase 6(MAP3K6)	Homo sapiens		h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000186~activation of MAPKK activity,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007257~activation of JUN kinase activity,	GO:0005622~intracellular,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013761:Sterile alpha motif/pointed domain,IPR017441:Protein kinase, ATP binding site,IPR025136:Domain of unknown function DUF4071,	hsa04010:MAPK signaling pathway,			SM00220:S_TKc,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase kinase kinase 6,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
MAP4K3	mitogen-activated protein kinase kinase kinase kinase 3(MAP4K3)	Homo sapiens		h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000185~activation of MAPKKK activity,GO:0006468~protein phosphorylation,GO:0007254~JNK cascade,GO:0009411~response to UV,GO:0034612~response to tumor necrosis factor,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008349~MAP kinase kinase kinase kinase activity,GO:0016301~kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR001180:Citron-like,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR021160:Mitogen-activated protein (MAP) kinase kinase kinase kinase,	hsa04010:MAPK signaling pathway,		PIRSF038172:mitogen-activated protein kinase kinase kinase kinase,	SM00036:CNH,SM00220:S_TKc,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase kinase kinase kinase 3,domain:CNH,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4(MAP4K4)	Homo sapiens		h_mapkPathway:MAPKinase Signaling Pathway,		GO:0006468~protein phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030033~microvillus assembly,GO:0035556~intracellular signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0046328~regulation of JNK cascade,GO:0061179~negative regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0070571~negative regulation of neuron projection regeneration,	GO:0005737~cytoplasm,	GO:0004111~creatine kinase activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001180:Citron-like,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,			SM00036:CNH,SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase kinase kinase kinase 4,domain:CNH,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
MAPKAPK2	mitogen-activated protein kinase-activated protein kinase 2(MAPKAPK2)	Homo sapiens	37.Akt-PKB_Effector_of_P13K_in_Vivo,	h_hsp27Pathway:Stress Induction of HSP Regulation,h_mapkPathway:MAPKinase Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0002224~toll-like receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006691~leukotriene metabolic process,GO:0006950~response to stress,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0007265~Ras protein signal transduction,GO:0018105~peptidyl-serine phosphorylation,GO:0031572~G2 DNA damage checkpoint,GO:0032496~response to lipopolysaccharide,GO:0032675~regulation of interleukin-6 production,GO:0032680~regulation of tumor necrosis factor production,GO:0034097~response to cytokine,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0038066~p38MAPK cascade,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043488~regulation of mRNA stability,GO:0044351~macropinocytosis,GO:0046777~protein autophosphorylation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048839~inner ear development,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:1900034~regulation of cellular response to heat,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0009931~calcium-dependent protein serine/threonine kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR027442:MAP kinase activated protein kinase, C-terminal domain,	hsa04010:MAPK signaling pathway,hsa04370:VEGF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa05203:Viral carcinogenesis,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,DNA damage,Isopeptide bond,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:MAP kinase-activated protein kinase 2,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
MIGA1	mitoguardin 1(MIGA1)	Homo sapiens				GO:0008053~mitochondrial fusion,	GO:0005741~mitochondrial outer membrane,GO:0016021~integral component of membrane,GO:0045203~integral component of cell outer membrane,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR019392:Protein of unknown function DUF2217,					Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM73A,splice variant,transmembrane region,
MZT2A	mitotic spindle organizing protein 2A(MZT2A)	Homo sapiens					GO:0005813~centrosome,GO:0005819~spindle,GO:0008274~gamma-tubulin ring complex,		IPR024332:MOZART2 family,					Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Protein FAM128A,modified residue,sequence conflict,
MZT2B	mitotic spindle organizing protein 2B(MZT2B)	Homo sapiens					GO:0005813~centrosome,GO:0005819~spindle,GO:0008274~gamma-tubulin ring complex,	GO:0005515~protein binding,	IPR024332:MOZART2 family,					Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein FAM128B,sequence variant,
MOGAT1	monoacylglycerol O-acyltransferase 1(MOGAT1)	Homo sapiens				GO:0006071~glycerol metabolic process,GO:0006651~diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0003846~2-acylglycerol O-acyltransferase activity,GO:0004144~diacylglycerol O-acyltransferase activity,	IPR007130:Diacylglycerol acyltransferase,	hsa00561:Glycerolipid metabolism,				Acyltransferase,Complete proteome,Endoplasmic reticulum,Glycerol metabolism,Glycoprotein,Lipid biosynthesis,Lipid metabolism,Membrane,Polymorphism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:2-acylglycerol O-acyltransferase 1,glycosylation site:N-linked (GlcNAc...),sequence variant,transmembrane region,
MUC1	mucin 1, cell surface associated(MUC1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007565~female pregnancy,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0016266~O-glycan processing,GO:0030855~epithelial cell differentiation,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0043618~regulation of transcription from RNA polymerase II promoter in response to stress,GO:0071300~cellular response to retinoic acid,GO:0090240~positive regulation of histone H4 acetylation,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,	GO:0000790~nuclear chromatin,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005796~Golgi lumen,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031982~vesicle,GO:0070062~extracellular exosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0002039~p53 binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,	IPR000082:SEA domain,IPR023217:Mucin-1,		174000~Medullary cystic kidney disease 1,		SM00200:SEA,	3D-structure,Alternative splicing,Autocatalytic cleavage,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Glycoprotein,Lipoprotein,Membrane,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Mucin-1,chain:Mucin-1 subunit alpha,chain:Mucin-1 subunit beta,domain:SEA,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:42 X 20 AA approximate tandem repeats of P-A-P-G-S-T-A-P-P-A-H-G-V-T-S-A-P-D-T-R,region of interest:Interaction with p53,region of interest:Required for interaction with beta- and gamma-catenins,region of interest:Required for interaction with GSK3B,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:31,repeat:32,repeat:33,repeat:34,repeat:35,repeat:36,repeat:37,repeat:38,repeat:39,repeat:4,repeat:40,repeat:41; approximate,repeat:42; approximate,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,short sequence motif:Interaction with GRB2,short sequence motif:Interaction with SRC and ESR1,short sequence motif:Required for interaction with AP1S2,signal peptide,site:Cleavage; by autolysis,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
MCOLN2	mucolipin 2(MCOLN2)	Homo sapiens				GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005262~calcium channel activity,	IPR013122:Polycystin cation channel, PKD1/PKD2,					Alternative splicing,Complete proteome,Ion channel,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Mucolipin-2,sequence variant,splice variant,transmembrane region,
MEGF6	multiple EGF like domains 6(MEGF6)	Homo sapiens					GO:0005576~extracellular region,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011489:EMI domain,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Multiple epidermal growth factor-like domains protein 6,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 16,domain:EGF-like 17,domain:EGF-like 18,domain:EGF-like 19,domain:EGF-like 20,domain:EGF-like 21,domain:EGF-like 22,domain:EGF-like 23,domain:EGF-like 24,domain:EGF-like 25,domain:EGF-like 26,domain:EGF-like 27,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5; calcium-binding,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8; calcium-binding,domain:EGF-like 9,domain:EMI,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
MLH1	mutL homolog 1(MLH1)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0000712~resolution of meiotic recombination intermediates,GO:0006298~mismatch repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0007060~male meiosis chromosome segregation,GO:0007129~synapsis,GO:0007283~spermatogenesis,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0016321~female meiosis chromosome segregation,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0043060~meiotic metaphase I plate congression,GO:0045141~meiotic telomere clustering,GO:0045190~isotype switching,GO:0045950~negative regulation of mitotic recombination,GO:0048477~oogenesis,GO:0051257~meiotic spindle midzone assembly,	GO:0000795~synaptonemal complex,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005712~chiasma,GO:0016020~membrane,GO:0032389~MutLalpha complex,	GO:0003682~chromatin binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032407~MutSalpha complex binding,	IPR002099:DNA mismatch repair protein,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR013507:DNA mismatch repair protein, C-terminal,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR014762:DNA mismatch repair, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,	hsa03430:Mismatch repair,hsa03460:Fanconi anemia pathway,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,	158320~Muir-Torre syndrome,276300~Mismatch repair cancer syndrome,609310~Colorectal cancer, hereditary nonpolyposis, type 2,		SM01340:SM01340,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Complete proteome,Disease mutation,DNA damage,DNA repair,Hereditary nonpolyposis colorectal cancer,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:DNA mismatch repair protein Mlh1,modified residue,region of interest:Interaction with EXO1,sequence conflict,sequence variant,
MSH2	mutS homolog 2(MSH2)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000710~meiotic mismatch repair,GO:0001701~in utero embryonic development,GO:0006119~oxidative phosphorylation,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006311~meiotic gene conversion,GO:0007050~cell cycle arrest,GO:0007131~reciprocal meiotic recombination,GO:0007281~germ cell development,GO:0008340~determination of adult lifespan,GO:0008584~male gonad development,GO:0010165~response to X-ray,GO:0010224~response to UV-B,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0019724~B cell mediated immunity,GO:0030183~B cell differentiation,GO:0031573~intra-S DNA damage checkpoint,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043524~negative regulation of neuron apoptotic process,GO:0043570~maintenance of DNA repeat elements,GO:0045128~negative regulation of reciprocal meiotic recombination,GO:0045190~isotype switching,GO:0045910~negative regulation of DNA recombination,GO:0051096~positive regulation of helicase activity,	GO:0000784~nuclear chromosome, telomeric region,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0032300~mismatch repair complex,GO:0032301~MutSalpha complex,GO:0032302~MutSbeta complex,	GO:0000287~magnesium ion binding,GO:0000400~four-way junction DNA binding,GO:0000403~Y-form DNA binding,GO:0000404~heteroduplex DNA loop binding,GO:0000406~double-strand/single-strand DNA junction binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016887~ATPase activity,GO:0019237~centromeric DNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032139~dinucleotide insertion or deletion binding,GO:0032142~single guanine insertion binding,GO:0032143~single thymine insertion binding,GO:0032181~dinucleotide repeat insertion binding,GO:0032357~oxidized purine DNA binding,GO:0032405~MutLalpha complex binding,GO:0042803~protein homodimerization activity,GO:0043531~ADP binding,	IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007695:DNA mismatch repair protein MutS-like, N-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007860:DNA mismatch repair protein MutS, connector domain,IPR007861:DNA mismatch repair protein MutS, clamp,IPR011184:DNA mismatch repair protein, MSH2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03430:Mismatch repair,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,	120435~Colorectal cancer, hereditary nonpolyposis, type 1,158320~Muir-Torre syndrome,276300~Mismatch repair cancer syndrome,	PIRSF005813:DNA mismatch repair protein, eukaryotic MSH2 type,	SM00533:MUTSd,SM00534:MUTSac,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Hereditary nonpolyposis colorectal cancer,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:DNA mismatch repair protein Msh2,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with EXO1,sequence variant,strand,turn,
MSH4	mutS homolog 4(MSH4)	Homo sapiens				GO:0000710~meiotic mismatch repair,GO:0001541~ovarian follicle development,GO:0006298~mismatch repair,GO:0007129~synapsis,GO:0007131~reciprocal meiotic recombination,GO:0007283~spermatogenesis,GO:0007292~female gamete generation,	GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0032300~mismatch repair complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030983~mismatched DNA binding,	IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007860:DNA mismatch repair protein MutS, connector domain,IPR007861:DNA mismatch repair protein MutS, clamp,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00533:MUTSd,SM00534:MUTSac,	ATP-binding,Complete proteome,DNA-binding,Meiosis,Nucleotide-binding,Polymorphism,Reference proteome,	chain:MutS protein homolog 4,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
MSH6	mutS homolog 6(MSH6)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000710~meiotic mismatch repair,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0007131~reciprocal meiotic recombination,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009411~response to UV,GO:0016032~viral process,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0043570~maintenance of DNA repeat elements,GO:0045190~isotype switching,GO:0045830~positive regulation of isotype switching,GO:0045910~negative regulation of DNA recombination,GO:0051096~positive regulation of helicase activity,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0000228~nuclear chromosome,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0032301~MutSalpha complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0000287~magnesium ion binding,GO:0000400~four-way junction DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032142~single guanine insertion binding,GO:0032143~single thymine insertion binding,GO:0032357~oxidized purine DNA binding,GO:0032405~MutLalpha complex binding,GO:0035064~methylated histone binding,GO:0042803~protein homodimerization activity,GO:0043531~ADP binding,	IPR000313:PWWP,IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007695:DNA mismatch repair protein MutS-like, N-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007860:DNA mismatch repair protein MutS, connector domain,IPR007861:DNA mismatch repair protein MutS, clamp,IPR016151:DNA mismatch repair protein MutS, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03430:Mismatch repair,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,	276300~Mismatch repair cancer syndrome,608089~Endometrial cancer, familial,614350~Colorectal cancer, hereditary nonpolyposis, type 5,		SM00293:PWWP,SM00533:MUTSd,SM00534:MUTSac,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromosome,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA-binding,Hereditary nonpolyposis colorectal cancer,Host-virus interaction,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA mismatch repair protein Msh6,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,domain:PWWP,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
MUTYH	mutY DNA glycosylase(MUTYH)	Homo sapiens			DNA replication, recombination, and repair,	GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006298~mismatch repair,GO:0045007~depurination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0019104~DNA N-glycosylase activity,GO:0032405~MutLalpha complex binding,GO:0032406~MutLbeta complex binding,GO:0032407~MutSalpha complex binding,GO:0032408~MutSbeta complex binding,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000086:NUDIX hydrolase domain,IPR000445:Helix-hairpin-helix motif,IPR003265:HhH-GPD domain,IPR003651:Endonuclease III-like, iron-sulphur cluster loop motif,IPR004035:Endonuclease III, iron-sulphur binding site,IPR004036:Endonuclease III, conserved site-2,IPR011257:DNA glycosylase,IPR015797:NUDIX hydrolase domain-like,IPR023170:Helix-turn-helix, base-excision DNA repair, C-terminal,	hsa03410:Base excision repair,	132600~Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas,608456~Adenomas, multiple colorectal,613659~Gastric cancer, somatic,		SM00478:ENDO3c,SM00525:FES,	3D-structure,4Fe-4S,Alternative splicing,Complete proteome,Disease mutation,DNA damage,DNA repair,Glycosidase,Hydrolase,Iron,Iron-sulfur,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:A/G-specific adenine DNA glycosylase,domain:Nudix hydrolase,helix,metal ion-binding site:Iron-sulfur (4Fe-4S),sequence variant,splice variant,strand,
MPZL1	myelin protein zero like 1(MPZL1)	Homo sapiens				GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007267~cell-cell signaling,	GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR000920:Myelin P0 protein,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00406:IGv,SM00409:IG,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Myelin protein zero-like protein 1,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MYT1L	myelin transcription factor 1 like(MYT1L)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007399~nervous system development,GO:0030154~cell differentiation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,	IPR002515:Zinc finger, C2HC-type,IPR013681:Myelin transcription factor 1,		616521~Mental retardation, autosomal dominant 39,			Alternative splicing,Autism spectrum disorder,Coiled coil,Complete proteome,Developmental protein,Differentiation,DNA-binding,Mental retardation,Metal-binding,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Myelin transcription factor 1-like protein,compositionally biased region:Asp/Glu-rich,compositionally biased region:Ser-rich,sequence conflict,splice variant,zinc finger region:C2HC-type 1,zinc finger region:C2HC-type 2,zinc finger region:C2HC-type 3,zinc finger region:C2HC-type 4,zinc finger region:C2HC-type 5,zinc finger region:C2HC-type 6,
MOBP	myelin-associated oligodendrocyte basic protein(MOBP)	Homo sapiens				GO:0007399~nervous system development,GO:0030050~vesicle transport along actin filament,	GO:0005739~mitochondrion,GO:0030864~cortical actin cytoskeleton,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0017022~myosin binding,GO:0017137~Rab GTPase binding,GO:0019911~structural constituent of myelin sheath,	IPR011011:Zinc finger, FYVE/PHD-type,IPR026666:Myelin-associated oligodendrocyte basic protein,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Myelin-associated oligodendrocyte basic protein,compositionally biased region:Pro-rich,region of interest:4 X 10 AA tandem repeats of P-R-S-P-P-R- S-E-R-Q,repeat:1,repeat:2,repeat:3,repeat:4,sequence conflict,splice variant,
MDS2	myelodysplastic syndrome 2 translocation associated(MDS2)	Homo sapiens					GO:0005615~extracellular space,							Chromosomal rearrangement,Complete proteome,Proto-oncogene,Reference proteome,
MNDA	myeloid cell nuclear differentiation antigen(MNDA)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006968~cellular defense response,GO:0006974~cellular response to DNA damage stimulus,GO:0030889~negative regulation of B cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0050853~B cell receptor signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0034399~nuclear periphery,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR004020:DAPIN domain,IPR004021:HIN-200/IF120x,				SM01289:SM01289,	3D-structure,Activator,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Myeloid cell nuclear differentiation antigen,domain:DAPIN,domain:HIN-200,helix,sequence variant,short sequence motif:Nuclear localization signal,turn,
MYOC	myocilin(MYOC)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014734~skeletal muscle hypertrophy,GO:0022011~myelination in peripheral nervous system,GO:0030335~positive regulation of cell migration,GO:0031175~neuron projection development,GO:0035024~negative regulation of Rho protein signal transduction,GO:0038031~non-canonical Wnt signaling pathway via JNK cascade,GO:0038133~ERBB2-ERBB3 signaling pathway,GO:0043408~regulation of MAPK cascade,GO:0045162~clustering of voltage-gated sodium channels,GO:0051492~regulation of stress fiber assembly,GO:0051496~positive regulation of stress fiber assembly,GO:0051497~negative regulation of stress fiber assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0051901~positive regulation of mitochondrial depolarization,GO:0060348~bone development,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005783~endoplasmic reticulum,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005929~cilium,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031012~extracellular matrix,GO:0031410~cytoplasmic vesicle,GO:0033268~node of Ranvier,GO:0070062~extracellular exosome,	GO:0001968~fibronectin binding,GO:0005109~frizzled binding,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,GO:0032027~myosin light chain binding,GO:0046872~metal ion binding,	IPR003112:Olfactomedin-like,		137750~Glaucoma 1A, primary open angle,		SM00284:OLF,	3D-structure,Calcium,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,Disulfide bond,Endoplasmic reticulum,Extracellular matrix,Glaucoma,Glycoprotein,Golgi apparatus,Lipoprotein,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Mitochondrion outer membrane,Palmitate,Polymorphism,Reference proteome,Secreted,Signal,	chain:Myocilin,disulfide bond,domain:Olfactomedin-like,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,short sequence motif:Microbody targeting signal,signal peptide,
MEF2D	myocyte enhancer factor 2D(MEF2D)	Homo sapiens		h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_mapkPathway:MAPKinase Signaling Pathway,h_mef2dPathway:Role of MEF2D in T-cell Apoptosis,h_mitrPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pgc1aPathway:Regulation of PGC-1a,		GO:0000165~MAPK cascade,GO:0001649~osteoblast differentiation,GO:0001958~endochondral ossification,GO:0002062~chondrocyte differentiation,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0007399~nervous system development,GO:0007512~adult heart development,GO:0007517~muscle organ development,GO:0035914~skeletal muscle cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0033613~activating transcription factor binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0046982~protein heterodimerization activity,	IPR002100:Transcription factor, MADS-box,IPR022102:Holliday junction regulator protein family C-terminal,	hsa04022:cGMP-PKG signaling pathway,			SM00432:MADS,	Acetylation,Activator,Alternative splicing,Apoptosis,Complete proteome,Developmental protein,Differentiation,DNA-binding,Isopeptide bond,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Myocyte-specific enhancer factor 2D,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Gln/Pro-rich,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,DNA-binding region:Mef2-type,domain:MADS-box,modified residue,mutagenesis site,region of interest:Beta domain,sequence variant,site:Cleavage,splice variant,
MYOG	myogenin(MYOG)	Homo sapiens				GO:0001503~ossification,GO:0007049~cell cycle,GO:0007519~skeletal muscle tissue development,GO:0008285~negative regulation of cell proliferation,GO:0009629~response to gravity,GO:0010831~positive regulation of myotube differentiation,GO:0014732~skeletal muscle atrophy,GO:0014737~positive regulation of muscle atrophy,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0014873~response to muscle activity involved in regulation of muscle adaptation,GO:0014878~response to electrical stimulus involved in regulation of muscle adaptation,GO:0014891~striated muscle atrophy,GO:0014894~response to denervation involved in regulation of muscle adaptation,GO:0035914~skeletal muscle cell differentiation,GO:0042693~muscle cell fate commitment,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043403~skeletal muscle tissue regeneration,GO:0045445~myoblast differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045820~negative regulation of glycolytic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048741~skeletal muscle fiber development,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0051149~positive regulation of muscle cell differentiation,GO:0071158~positive regulation of cell cycle arrest,GO:0071259~cellular response to magnetism,GO:0071285~cellular response to lithium ion,GO:0071300~cellular response to retinoic acid,GO:0071363~cellular response to growth factor stimulus,GO:0071392~cellular response to estradiol stimulus,GO:1901739~regulation of myoblast fusion,GO:1901741~positive regulation of myoblast fusion,GO:1903862~positive regulation of oxidative phosphorylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0032993~protein-DNA complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0070888~E-box binding,	IPR002546:Myogenic basic muscle-specific protein,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,SM00520:BASIC,	Activator,Cell cycle,Complete proteome,Developmental protein,Differentiation,DNA-binding,Myogenesis,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Myogenin,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,
MYOM3	myomesin 3(MYOM3)	Homo sapiens					GO:0031430~M band,	GO:0042803~protein homodimerization activity,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Immunoglobulin domain,Polymorphism,Reference proteome,Repeat,	chain:Myomesin-3,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,sequence conflict,sequence variant,splice variant,
MYO1B	myosin IB(MYO1B)	Homo sapiens				GO:0006892~post-Golgi vesicle-mediated transport,GO:0007015~actin filament organization,GO:0030048~actin filament-based movement,GO:0051017~actin filament bundle assembly,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005913~cell-cell adherens junction,GO:0010008~endosome membrane,GO:0016459~myosin complex,GO:0030175~filopodium,GO:0032588~trans-Golgi network membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0000146~microfilament motor activity,GO:0003774~motor activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0030898~actin-dependent ATPase activity,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000048:IQ motif, EF-hand binding site,IPR001609:Myosin head, motor domain,IPR010926:Myosin tail 2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00015:IQ,SM00242:MYSc,	Actin-binding,Alternative splicing,ATP-binding,Calmodulin-binding,Complete proteome,Isopeptide bond,Motor protein,Myosin,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Myosin-Ib,domain:IQ 1,domain:IQ 2,domain:IQ 3,domain:IQ 4,domain:IQ 5,domain:IQ 6,domain:Myosin head-like,sequence variant,splice variant,
MYO3B	myosin IIIB(MYO3B)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007601~visual perception,GO:0050896~response to stimulus,	GO:0005737~cytoplasm,GO:0016459~myosin complex,	GO:0003774~motor activity,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000048:IQ motif, EF-hand binding site,IPR000719:Protein kinase, catalytic domain,IPR001609:Myosin head, motor domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00015:IQ,SM00220:S_TKc,SM00242:MYSc,	Actin-binding,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Motor protein,Myosin,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sensory transduction,Serine/threonine-protein kinase,Transferase,Vision,	active site:Proton acceptor,binding site:ATP,chain:Myosin-IIIb,domain:IQ 1,domain:IQ 2,domain:Myosin head-like,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
MYRIP	myosin VIIA and Rab interacting protein(MYRIP)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0030050~vesicle transport along actin filament,GO:0032024~positive regulation of insulin secretion,	GO:0000145~exocyst,GO:0001750~photoreceptor outer segment,GO:0005622~intracellular,GO:0030133~transport vesicle,GO:0030864~cortical actin cytoskeleton,GO:0031045~dense core granule,GO:0042470~melanosome,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017022~myosin binding,GO:0017137~Rab GTPase binding,GO:0051018~protein kinase A binding,	IPR006788:Rab effector MyRIP/Melanophilin,IPR010911:Rab-binding domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,					Actin-binding,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Rab effector MyRIP,domain:RabBD,modified residue,region of interest:Actin-binding,region of interest:Myosin-binding,sequence conflict,sequence variant,zinc finger region:FYVE-type,
MYO7B	myosin VIIB(MYO7B)	Homo sapiens				GO:0030154~cell differentiation,GO:1904970~brush border assembly,	GO:0005856~cytoskeleton,GO:0005902~microvillus,GO:0005903~brush border,GO:0016459~myosin complex,GO:0070062~extracellular exosome,GO:0090651~apical cytoplasm,	GO:0003774~motor activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000048:IQ motif, EF-hand binding site,IPR000299:FERM domain,IPR000857:MyTH4 domain,IPR001452:Src homology-3 domain,IPR001609:Myosin head, motor domain,IPR011511:Variant SH3,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00015:IQ,SM00139:MyTH4,SM00242:MYSc,SM00295:B41,SM00326:SH3,	Actin-binding,Alternative splicing,ATP-binding,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Motor protein,Myosin,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:Myosin-VIIb,domain:FERM 1,domain:FERM 2,domain:IQ 1,domain:IQ 2,domain:IQ 3,domain:IQ 4,domain:IQ 5,domain:IQ 6,domain:Myosin head-like,domain:MyTH4 1,domain:MyTH4 2,domain:MyTH4 3,domain:SH3 1,domain:SH3 2,sequence conflict,sequence variant,splice variant,
MYBPHL	myosin binding protein H like(MYBPHL)	Homo sapiens						GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Immunoglobulin domain,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Myosin-binding protein H-like,disulfide bond,domain:Fibronectin type-III,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,sequence variant,
MYH15	myosin heavy chain 15(MYH15)	Homo sapiens				GO:0002074~extraocular skeletal muscle development,	GO:0030016~myofibril,GO:0032982~myosin filament,	GO:0003774~motor activity,GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,	IPR001609:Myosin head, motor domain,IPR002928:Myosin tail,IPR004009:Myosin, N-terminal, SH3-like,IPR027401:Myosin-like IQ motif-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04530:Tight junction,			SM00242:MYSc,	Actin-binding,ATP-binding,Calmodulin-binding,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Methylation,Motor protein,Muscle protein,Myosin,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Thick filament,Ubl conjugation,	chain:Myosin-15,domain:IQ,domain:Myosin head-like,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Actin-binding,sequence variant,
MYL1	myosin light chain 1(MYL1)	Homo sapiens				GO:0006936~muscle contraction,GO:0030049~muscle filament sliding,GO:0060048~cardiac muscle contraction,	GO:0005829~cytosol,GO:0005859~muscle myosin complex,GO:0030016~myofibril,GO:0030017~sarcomere,	GO:0005509~calcium ion binding,GO:0008307~structural constituent of muscle,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	Acetylation,Alternative splicing,Complete proteome,Methylation,Motor protein,Muscle protein,Myosin,Phosphoprotein,Reference proteome,Repeat,	chain:Myosin light chain 1/3, skeletal muscle isoform,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,modified residue,sequence conflict,splice variant,
MTMR14	myotubularin related protein 14(MTMR14)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0016236~macroautophagy,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0001726~ruffle,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0004438~phosphatidylinositol-3-phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0052629~phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,	IPR016130:Protein-tyrosine phosphatase, active site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,	160150~Centronuclear myopathy, autosomal, modifier of,			Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Glycoprotein,Hydrolase,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Signal,	chain:Myotubularin-related protein 14,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
NRDC	nardilysin convertase(NRDC)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006508~proteolysis,GO:0007528~neuromuscular junction development,GO:0008283~cell proliferation,GO:0016477~cell migration,GO:0016485~protein processing,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0052548~regulation of endopeptidase activity,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0009986~cell surface,	GO:0003824~catalytic activity,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,GO:0048408~epidermal growth factor binding,	IPR001431:Peptidase M16, zinc-binding site,IPR007863:Peptidase M16, C-terminal domain,IPR011237:Peptidase M16 domain,IPR011249:Metalloenzyme, LuxS/M16 peptidase-like,IPR011765:Peptidase M16, N-terminal,					Alternative splicing,Coiled coil,Complete proteome,Hydrolase,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,Zinc,	active site:Proton acceptor,chain:Nardilysin,compositionally biased region:Asp/Glu-rich (highly acidic),compositionally biased region:Poly-Glu,metal ion-binding site:Zinc,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
NPPA	natriuretic peptide A(NPPA)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_gcrpathway:Corticosteroids and cardioprotection,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),		GO:0001666~response to hypoxia,GO:0003085~negative regulation of systemic arterial blood pressure,GO:0006182~cGMP biosynthetic process,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007168~receptor guanylyl cyclase signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007565~female pregnancy,GO:0008217~regulation of blood pressure,GO:0010460~positive regulation of heart rate,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0030308~negative regulation of cell growth,GO:0032868~response to insulin,GO:0035994~response to muscle stretch,GO:0044267~cellular protein metabolic process,GO:0050880~regulation of blood vessel size,GO:0060372~regulation of atrial cardiac muscle cell membrane repolarization,GO:0060452~positive regulation of cardiac muscle contraction,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0071260~cellular response to mechanical stimulus,GO:1901841~regulation of high voltage-gated calcium channel activity,GO:1902261~positive regulation of delayed rectifier potassium channel activity,GO:1902514~regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,GO:1903766~positive regulation of potassium ion export across plasma membrane,GO:1903779~regulation of cardiac conduction,GO:1903815~negative regulation of collecting lymphatic vessel constriction,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0042629~mast cell granule,GO:0048471~perinuclear region of cytoplasm,	GO:0005102~receptor binding,GO:0005184~neuropeptide hormone activity,GO:0005515~protein binding,GO:0051428~peptide hormone receptor binding,GO:0071855~neuropeptide receptor binding,	IPR000663:Natriuretic peptide,IPR002407:Natriuretic peptide, atrial type,	hsa04066:HIF-1 signaling pathway,	612201~Atrial fibrillation, familial, 6,615745~Atrial standstill 2,		SM00183:NAT_PEP,	3D-structure,Atrial fibrillation,Cardiomyopathy,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Hormone,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Vasoactive,	disulfide bond,peptide:Atrial natriuretic factor,peptide:Cardiodilatin-related peptide,sequence conflict,sequence variant,signal peptide,strand,
NPPB	natriuretic peptide B(NPPB)	Homo sapiens	76.Sig_trans_Ca2_Calcineurin_NF-AT,	h_alkPathway:ALK in cardiac myocytes,		GO:0006182~cGMP biosynthetic process,GO:0007166~cell surface receptor signaling pathway,GO:0007168~receptor guanylyl cyclase signaling pathway,GO:0007589~body fluid secretion,GO:0008217~regulation of blood pressure,GO:0016525~negative regulation of angiogenesis,GO:0030308~negative regulation of cell growth,GO:0035810~positive regulation of urine volume,GO:0035815~positive regulation of renal sodium excretion,GO:0042312~regulation of vasodilation,GO:0043114~regulation of vascular permeability,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0043234~protein complex,	GO:0005102~receptor binding,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008613~diuretic hormone activity,	IPR000663:Natriuretic peptide,IPR002408:Natriuretic peptide, brain type,	hsa04022:cGMP-PKG signaling pathway,			SM00183:NAT_PEP,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hormone,Pharmaceutical,Polymorphism,Reference proteome,Secreted,Signal,Vasoactive,	chain:Natriuretic peptides B,disulfide bond,peptide:BNP(1-28),peptide:BNP(1-29),peptide:BNP(1-30),peptide:BNP(2-31),peptide:BNP(3-29),peptide:BNP(3-30),peptide:BNP(3-32),peptide:BNP(4-27),peptide:BNP(4-29),peptide:BNP(4-30),peptide:BNP(4-31),peptide:BNP(4-32),peptide:BNP(5-29),peptide:BNP(5-31),peptide:BNP(5-32),peptide:Brain natriuretic peptide 32,sequence variant,signal peptide,
NPPC	natriuretic peptide C(NPPC)	Homo sapiens				GO:0001503~ossification,GO:0001666~response to hypoxia,GO:0003418~growth plate cartilage chondrocyte differentiation,GO:0003419~growth plate cartilage chondrocyte proliferation,GO:0006182~cGMP biosynthetic process,GO:0007168~receptor guanylyl cyclase signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0009791~post-embryonic development,GO:0030814~regulation of cAMP metabolic process,GO:0030823~regulation of cGMP metabolic process,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0040014~regulation of multicellular organism growth,GO:0042493~response to drug,GO:0044702~single organism reproductive process,GO:0045471~response to ethanol,GO:0045669~positive regulation of osteoblast differentiation,GO:0045909~positive regulation of vasodilation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0050880~regulation of blood vessel size,GO:0051053~negative regulation of DNA metabolic process,GO:0051447~negative regulation of meiotic cell cycle,GO:1900194~negative regulation of oocyte maturation,GO:1903779~regulation of cardiac conduction,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0030141~secretory granule,	GO:0005102~receptor binding,GO:0005179~hormone activity,GO:0042803~protein homodimerization activity,GO:0051428~peptide hormone receptor binding,	IPR000663:Natriuretic peptide,IPR002406:Natriuretic peptide, C type,				SM00183:NAT_PEP,	3D-structure,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Hormone,Osteogenesis,Polymorphism,Reference proteome,Secreted,Signal,Vasoactive,	disulfide bond,peptide:CNP-22,peptide:CNP-29,peptide:CNP-53,sequence variant,signal peptide,turn,
NPR1	natriuretic peptide receptor 1(NPR1)	Homo sapiens				GO:0006182~cGMP biosynthetic process,GO:0006468~protein phosphorylation,GO:0007166~cell surface receptor signaling pathway,GO:0007168~receptor guanylyl cyclase signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007589~body fluid secretion,GO:0008217~regulation of blood pressure,GO:0009190~cyclic nucleotide biosynthetic process,GO:0016525~negative regulation of angiogenesis,GO:0030308~negative regulation of cell growth,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0035556~intracellular signal transduction,GO:0035810~positive regulation of urine volume,GO:0035815~positive regulation of renal sodium excretion,GO:0042312~regulation of vasodilation,GO:0042417~dopamine metabolic process,GO:0043114~regulation of vascular permeability,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:1903779~regulation of cardiac conduction,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008074~guanylate cyclase complex, soluble,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0000166~nucleotide binding,GO:0004016~adenylate cyclase activity,GO:0004383~guanylate cyclase activity,GO:0004672~protein kinase activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0016849~phosphorus-oxygen lyase activity,GO:0016941~natriuretic peptide receptor activity,GO:0017046~peptide hormone binding,GO:0019901~protein kinase binding,GO:0042562~hormone binding,	IPR000719:Protein kinase, catalytic domain,IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase,IPR001170:Natriuretic peptide receptor,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001828:Extracellular ligand-binding receptor,IPR011009:Protein kinase-like domain,IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site,	hsa00230:Purine metabolism,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,			SM00044:CYCc,	cGMP biosynthesis,Chloride,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,GTP-binding,Lyase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,Vasoactive,	binding site:Chloride,binding site:Chloride; via amide nitrogen,chain:Atrial natriuretic peptide receptor 1,disulfide bond,domain:Guanylate cyclase,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
NKTR	natural killer cell triggering receptor(NKTR)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0016020~membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016018~cyclosporin A binding,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,					3D-structure,Complete proteome,Cyclosporin,Isomerase,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Rotamase,Ubl conjugation,	chain:NK-tumor recognition protein,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Arg/Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:PPIase cyclophilin-type,helix,modified residue,region of interest:Arg/Ser tandem repeat-rich,sequence variant,strand,turn,
NEB	nebulin(NEB)	Homo sapiens				GO:0007517~muscle organ development,GO:0007525~somatic muscle development,GO:0030049~muscle filament sliding,GO:0030832~regulation of actin filament length,	GO:0005829~cytosol,GO:0005865~striated muscle thin filament,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008307~structural constituent of muscle,	IPR000900:Nebulin 35 residue motif,IPR001452:Src homology-3 domain,IPR013998:Nebulin,		256030~Nemaline myopathy 2, autosomal recessive,		SM00227:NEBU,SM00326:SH3,	3D-structure,Actin-binding,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Muscle protein,Nemaline myopathy,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:Nebulin,domain:SH3,region of interest:Interaction with SVIL,repeat:Nebulin 1,repeat:Nebulin 10,repeat:Nebulin 100,repeat:Nebulin 101,repeat:Nebulin 102,repeat:Nebulin 103,repeat:Nebulin 104,repeat:Nebulin 105,repeat:Nebulin 106,repeat:Nebulin 107,repeat:Nebulin 108,repeat:Nebulin 109,repeat:Nebulin 11,repeat:Nebulin 110,repeat:Nebulin 111,repeat:Nebulin 112,repeat:Nebulin 113,repeat:Nebulin 114,repeat:Nebulin 115,repeat:Nebulin 116,repeat:Nebulin 117,repeat:Nebulin 118,repeat:Nebulin 119,repeat:Nebulin 12,repeat:Nebulin 120,repeat:Nebulin 121,repeat:Nebulin 122,repeat:Nebulin 123,repeat:Nebulin 124,repeat:Nebulin 125,repeat:Nebulin 126,repeat:Nebulin 127,repeat:Nebulin 128,repeat:Nebulin 129,repeat:Nebulin 13,repeat:Nebulin 130,repeat:Nebulin 131,repeat:Nebulin 132,repeat:Nebulin 133,repeat:Nebulin 134,repeat:Nebulin 135,repeat:Nebulin 136,repeat:Nebulin 137,repeat:Nebulin 138,repeat:Nebulin 139,repeat:Nebulin 14,repeat:Nebulin 140,repeat:Nebulin 141,repeat:Nebulin 142,repeat:Nebulin 143,repeat:Nebulin 144,repeat:Nebulin 145,repeat:Nebulin 146,repeat:Nebulin 147,repeat:Nebulin 148,repeat:Nebulin 149,repeat:Nebulin 15,repeat:Nebulin 150,repeat:Nebulin 151,repeat:Nebulin 152,repeat:Nebulin 153,repeat:Nebulin 154,repeat:Nebulin 155,repeat:Nebulin 156,repeat:Nebulin 157,repeat:Nebulin 158,repeat:Nebulin 159,repeat:Nebulin 16,repeat:Nebulin 160,repeat:Nebulin 161,repeat:Nebulin 162,repeat:Nebulin 163,repeat:Nebulin 164,repeat:Nebulin 165,repeat:Nebulin 166,repeat:Nebulin 167,repeat:Nebulin 168,repeat:Nebulin 169,repeat:Nebulin 17,repeat:Nebulin 170,repeat:Nebulin 171,repeat:Nebulin 172,repeat:Nebulin 173,repeat:Nebulin 174,repeat:Nebulin 175,repeat:Nebulin 176,repeat:Nebulin 177,repeat:Nebulin 178,repeat:Nebulin 18,repeat:Nebulin 19,repeat:Nebulin 2,repeat:Nebulin 20,repeat:Nebulin 21,repeat:Nebulin 22,repeat:Nebulin 23,repeat:Nebulin 24,repeat:Nebulin 25,repeat:Nebulin 26,repeat:Nebulin 27,repeat:Nebulin 28,repeat:Nebulin 29,repeat:Nebulin 3,repeat:Nebulin 30,repeat:Nebulin 31,repeat:Nebulin 32,repeat:Nebulin 33,repeat:Nebulin 34,repeat:Nebulin 35,repeat:Nebulin 36,repeat:Nebulin 37,repeat:Nebulin 38,repeat:Nebulin 39,repeat:Nebulin 4,repeat:Nebulin 40,repeat:Nebulin 41,repeat:Nebulin 42,repeat:Nebulin 43,repeat:Nebulin 44,repeat:Nebulin 45,repeat:Nebulin 46,repeat:Nebulin 47,repeat:Nebulin 48,repeat:Nebulin 49,repeat:Nebulin 5,repeat:Nebulin 50,repeat:Nebulin 51,repeat:Nebulin 52,repeat:Nebulin 53,repeat:Nebulin 54,repeat:Nebulin 55,repeat:Nebulin 56,repeat:Nebulin 57,repeat:Nebulin 58,repeat:Nebulin 59,repeat:Nebulin 6,repeat:Nebulin 60,repeat:Nebulin 61,repeat:Nebulin 62,repeat:Nebulin 63,repeat:Nebulin 64,repeat:Nebulin 65,repeat:Nebulin 66,repeat:Nebulin 67,repeat:Nebulin 68,repeat:Nebulin 69,repeat:Nebulin 7,repeat:Nebulin 70,repeat:Nebulin 71,repeat:Nebulin 72,repeat:Nebulin 73,repeat:Nebulin 74,repeat:Nebulin 75,repeat:Nebulin 76,repeat:Nebulin 77,repeat:Nebulin 78,repeat:Nebulin 79,repeat:Nebulin 8,repeat:Nebulin 80,repeat:Nebulin 81,repeat:Nebulin 82,repeat:Nebulin 83,repeat:Nebulin 84,repeat:Nebulin 85,repeat:Nebulin 86,repeat:Nebulin 87,repeat:Nebulin 88,repeat:Nebulin 89,repeat:Nebulin 9,repeat:Nebulin 90,repeat:Nebulin 91,repeat:Nebulin 92,repeat:Nebulin 93,repeat:Nebulin 94,repeat:Nebulin 95,repeat:Nebulin 96,repeat:Nebulin 97,repeat:Nebulin 98,repeat:Nebulin 99,sequence conflict,sequence variant,strand,turn,
NECTIN3	nectin cell adhesion molecule 3(NECTIN3)	Homo sapiens				GO:0002089~lens morphogenesis in camera-type eye,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007286~spermatid development,GO:0008037~cell recognition,GO:0009566~fertilization,GO:0016337~single organismal cell-cell adhesion,GO:0034332~adherens junction organization,GO:0060042~retina morphogenesis in camera-type eye,GO:1902414~protein localization to cell junction,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0043296~apical junction complex,GO:0044291~cell-cell contact zone,GO:0045211~postsynaptic membrane,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04520:Adherens junction,			SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Poliovirus receptor-related protein 3,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
NECTIN4	nectin cell adhesion molecule 4(NECTIN4)	Homo sapiens				GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0008037~cell recognition,GO:0034332~adherens junction organization,GO:0046718~viral entry into host cell,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04520:Adherens junction,	613573~Ectodermal dysplasia-syndactyly syndrome 1,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Ectodermal dysplasia,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Poliovirus receptor-related protein 4,chain:Processed poliovirus receptor-related protein 4,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
NPHP1	nephrocystin 1(NPHP1)	Homo sapiens				GO:0007165~signal transduction,GO:0007588~excretion,GO:0007632~visual behavior,GO:0016337~single organismal cell-cell adhesion,GO:0030030~cell projection organization,GO:0030036~actin cytoskeleton organization,GO:0048515~spermatid differentiation,GO:0060041~retina development in camera-type eye,GO:1903348~positive regulation of bicellular tight junction assembly,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005923~bicellular tight junction,GO:0005929~cilium,GO:0016020~membrane,GO:0031514~motile cilium,GO:0032391~photoreceptor connecting cilium,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR001452:Src homology-3 domain,		256100~Nephronophthisis 1, juvenile,266900~Senior-Loken syndrome-1,609583~Joubert syndrome 4,		SM00326:SH3,	3D-structure,Alternative splicing,Cell junction,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Disease mutation,Joubert syndrome,Nephronophthisis,Phosphoprotein,Proteomics identification,Reference proteome,Senior-Loken syndrome,SH3 domain,Spermatogenesis,Tight junction,	chain:Nephrocystin-1,compositionally biased region:Glu-rich,domain:SH3,sequence variant,splice variant,strand,
NPHP4	nephrocystin 4(NPHP4)	Homo sapiens				GO:0007165~signal transduction,GO:0007632~visual behavior,GO:0016337~single organismal cell-cell adhesion,GO:0030036~actin cytoskeleton organization,GO:0030317~sperm motility,GO:0035329~hippo signaling,GO:0035845~photoreceptor cell outer segment organization,GO:0045494~photoreceptor cell maintenance,GO:0060041~retina development in camera-type eye,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1903348~positive regulation of bicellular tight junction assembly,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0031513~nonmotile primary cilium,GO:0032391~photoreceptor connecting cilium,GO:0035869~ciliary transition zone,GO:0097470~ribbon synapse,GO:0097546~ciliary base,	GO:0005198~structural molecule activity,GO:0005515~protein binding,			606966~Nephronophthisis 4,606996~Senior-Loken syndrome 4,			Alternative splicing,Cell junction,Cell projection,Ciliopathy,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Leber congenital amaurosis,Nephronophthisis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Senior-Loken syndrome,Tight junction,	chain:Nephrocystin-4,sequence variant,
NGF	nerve growth factor(NGF)	Homo sapiens	18.Cytokine_astocytes,	h_btg2Pathway:BTG family proteins and cell cycle regulation,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_ngfPathway:Nerve growth factor pathway (NGF),h_trkaPathway:Trka Receptor Signaling Pathway,		GO:0000186~activation of MAPKK activity,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007018~microtubule-based movement,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007267~cell-cell signaling,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010628~positive regulation of gene expression,GO:0032455~nerve growth factor processing,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045664~regulation of neuron differentiation,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048812~neuron projection morphogenesis,GO:0050772~positive regulation of axonogenesis,	GO:0005576~extracellular region,GO:0005768~endosome,GO:0005796~Golgi lumen,GO:0016023~cytoplasmic, membrane-bounded vesicle,	GO:0005163~nerve growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008191~metalloendopeptidase inhibitor activity,	IPR002072:Nerve growth factor-related,IPR019846:Nerve growth factor conserved site,IPR020408:Nerve growth factor-like,IPR020425:Nerve growth factor, beta subunit,IPR020437:Nerve growth factor, beta subunit, mammalian,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04722:Neurotrophin signaling pathway,hsa04750:Inflammatory mediator regulation of TRP channels,	608654~Neuropathy, hereditary sensory and autonomic, type V,	PIRSF001789:nerve growth factor, subunit beta,	SM00140:NGF,	3D-structure,Cleavage on pair of basic residues,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Growth factor,Metalloenzyme inhibitor,Metalloprotease inhibitor,Neurodegeneration,Neuropathy,Polymorphism,Protease inhibitor,Reference proteome,Secreted,Signal,	chain:Beta-nerve growth factor,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
NHLH2	nescient helix-loop-helix 2(NHLH2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007417~central nervous system development,GO:0007617~mating behavior,GO:0030154~cell differentiation,GO:0042698~ovulation cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Complete proteome,Developmental protein,Differentiation,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Helix-loop-helix protein 2,compositionally biased region:Poly-Arg,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,
NES	nestin(NES)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0030844~positive regulation of intermediate filament depolymerization,GO:0031076~embryonic camera-type eye development,GO:0032091~negative regulation of protein binding,GO:0043086~negative regulation of catalytic activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0048858~cell projection morphogenesis,GO:0072089~stem cell proliferation,GO:2000179~positive regulation of neural precursor cell proliferation,	GO:0005737~cytoplasm,GO:0005882~intermediate filament,GO:0031012~extracellular matrix,GO:0045111~intermediate filament cytoskeleton,	GO:0005198~structural molecule activity,GO:0019215~intermediate filament binding,	IPR001664:Intermediate filament protein,IPR018039:Intermediate filament protein, conserved site,				SM01391:SM01391,	Acetylation,Coiled coil,Complete proteome,Developmental protein,Intermediate filament,Isopeptide bond,Neurogenesis,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Nestin,modified residue,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2A,region of interest:Coil 2B,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,
NTNG1	netrin G1(NTNG1)	Homo sapiens				GO:0007409~axonogenesis,	GO:0046658~anchored component of plasma membrane,	GO:0005515~protein binding,	IPR000742:Epidermal growth factor-like domain,IPR002049:EGF-like, laminin,IPR008211:Laminin, N-terminal,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,	hsa04360:Axon guidance,hsa04514:Cell adhesion molecules (CAMs),			SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Laminin EGF-like domain,Lipoprotein,Membrane,Neurogenesis,Reference proteome,Repeat,Signal,	chain:Netrin-G1,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,signal peptide,splice variant,
NENF	neudesin neurotrophic factor(NENF)	Homo sapiens				GO:0032099~negative regulation of appetite,GO:0043410~positive regulation of MAPK cascade,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0012505~endomembrane system,GO:0016020~membrane,	GO:0008083~growth factor activity,GO:0046872~metal ion binding,	IPR001199:Cytochrome b5-like heme/steroid binding domain,				SM01117:SM01117,	Acetylation,Complete proteome,Heme,Iron,Metal-binding,Reference proteome,Secreted,Signal,	chain:Neudesin,domain:Cytochrome b5 heme-binding,modified residue,sequence conflict,signal peptide,
NEURL3	neuralized E3 ubiquitin protein ligase 3(NEURL3)	Homo sapiens				GO:0016567~protein ubiquitination,		GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR006573:NEUZ,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,SM00588:NEUZ,	Complete proteome,Ligase,Metal-binding,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase LINCR,domain:NHR,sequence conflict,zinc finger region:RING-type,
NEU2	neuraminidase 2(NEU2)	Homo sapiens				GO:0006687~glycosphingolipid metabolic process,GO:0006689~ganglioside catabolic process,GO:0009313~oligosaccharide catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004308~exo-alpha-sialidase activity,GO:0005515~protein binding,GO:0052794~exo-alpha-(2->3)-sialidase activity,GO:0052795~exo-alpha-(2->6)-sialidase activity,GO:0052796~exo-alpha-(2->8)-sialidase activity,	IPR011040:Sialidases,IPR026856:Sialidase family,IPR026945:Sialidase-2,	hsa00511:Other glycan degradation,hsa00600:Sphingolipid metabolism,				3D-structure,Carbohydrate metabolism,Complete proteome,Cytoplasm,Glycosidase,Hydrolase,Lipid degradation,Lipid metabolism,Polymorphism,Reference proteome,Repeat,	active site:Nucleophile,active site:Proton acceptor,binding site:Substrate,chain:Sialidase-2,helix,repeat:BNR 1,repeat:BNR 2,sequence variant,short sequence motif:FRIP motif,strand,turn,
NEU4	neuraminidase 4(NEU4)	Homo sapiens				GO:0006516~glycoprotein catabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0006689~ganglioside catabolic process,GO:0009313~oligosaccharide catabolic process,	GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0019866~organelle inner membrane,GO:0043202~lysosomal lumen,	GO:0004308~exo-alpha-sialidase activity,GO:0005515~protein binding,GO:0052794~exo-alpha-(2->3)-sialidase activity,GO:0052795~exo-alpha-(2->6)-sialidase activity,GO:0052796~exo-alpha-(2->8)-sialidase activity,	IPR011040:Sialidases,IPR026856:Sialidase family,IPR026946:Sialidase-4,	hsa00511:Other glycan degradation,hsa00600:Sphingolipid metabolism,				Alternative splicing,Carbohydrate metabolism,Complete proteome,Glycosidase,Hydrolase,Lipid degradation,Lipid metabolism,Lysosome,Membrane,Polymorphism,Reference proteome,Repeat,	active site:Nucleophile,active site:Proton acceptor,binding site:Substrate,chain:Sialidase-4,compositionally biased region:Pro-rich,repeat:BNR 1,repeat:BNR 2,repeat:BNR 3,sequence conflict,short sequence motif:FRIP motif,splice variant,
NRXN1	neurexin 1(NRXN1)	Homo sapiens				GO:0001525~angiogenesis,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007158~neuron cell-cell adhesion,GO:0007165~signal transduction,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0007411~axon guidance,GO:0007416~synapse assembly,GO:0007612~learning,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0021707~cerebellar granule cell differentiation,GO:0023041~neuronal signal transduction,GO:0030534~adult behavior,GO:0035176~social behavior,GO:0035418~protein localization to synapse,GO:0042297~vocal learning,GO:0045184~establishment of protein localization,GO:0050885~neuromuscular process controlling balance,GO:0051490~negative regulation of filopodium assembly,GO:0051965~positive regulation of synapse assembly,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0060134~prepulse inhibition,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0071625~vocalization behavior,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090126~protein complex assembly involved in synapse maturation,GO:0090129~positive regulation of synapse maturation,GO:0097091~synaptic vesicle clustering,GO:0097104~postsynaptic membrane assembly,GO:0097105~presynaptic membrane assembly,GO:0097112~gamma-aminobutyric acid receptor clustering,GO:0097114~NMDA glutamate receptor clustering,GO:0097116~gephyrin clustering involved in postsynaptic density assembly,GO:0097117~guanylate kinase-associated protein clustering,GO:0097118~neuroligin clustering involved in postsynaptic membrane assembly,GO:0097119~postsynaptic density protein 95 clustering,GO:0097120~receptor localization to synapse,GO:2000310~regulation of N-methyl-D-aspartate selective glutamate receptor activity,GO:2000311~regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000821~regulation of grooming behavior,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030139~endocytic vesicle,GO:0031965~nuclear membrane,GO:0031982~vesicle,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,GO:0043234~protein complex,GO:0044295~axonal growth cone,GO:0098793~presynapse,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005102~receptor binding,GO:0005246~calcium channel regulator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0033130~acetylcholine receptor binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,GO:0050839~cell adhesion molecule binding,GO:0097109~neuroligin family protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR003585:Neurexin/syndecan/glycophorin C,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR027158:Neurexin-1-alpha,	hsa04514:Cell adhesion molecules (CAMs),	614325~Pitt-Hopkins-like syndrome 2,614332~Schizophrenia, susceptibility to, 17,		SM00181:EGF,SM00282:LamG,SM00294:4.1m,	3D-structure,Alternative promoter usage,Alternative splicing,Angiogenesis,Calcium,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Neurexin-1-alpha,chain:Neurexin-1-beta,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Thr,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:Laminin G-like,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,domain:Laminin G-like 4,domain:Laminin G-like 5,domain:Laminin G-like 6,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
NXPH2	neurexophilin 2(NXPH2)	Homo sapiens				GO:0007218~neuropeptide signaling pathway,	GO:0005576~extracellular region,	GO:0005102~receptor binding,	IPR010450:Neurexophilin,IPR026845:Neurexophilin/NXPE,			PIRSF038019:neurexophilin,		Complete proteome,Glycoprotein,Reference proteome,Secreted,Signal,	chain:Neurexophilin-2,glycosylation site:N-linked (GlcNAc...),region of interest:II,region of interest:III,region of interest:IV (linker domain),region of interest:V (Cys-rich),sequence conflict,signal peptide,
NXPE3	neurexophilin and PC-esterase domain family member 3(NXPE3)	Homo sapiens					GO:0005576~extracellular region,		IPR014756:Immunoglobulin E-set,IPR026845:Neurexophilin/NXPE,					Complete proteome,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Protein FAM55C,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
NBEAL1	neurobeachin like 1(NBEAL1)	Homo sapiens					GO:0012505~endomembrane system,GO:0019898~extrinsic component of membrane,	GO:0005543~phospholipid binding,	IPR000409:BEACH domain,IPR001680:WD40 repeat,IPR011993:Pleckstrin homology-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,IPR023362:PH-BEACH domain,				SM00320:WD40,SM01026:SM01026,	Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein,chain:Neurobeachin-like protein 1,compositionally biased region:Ser-rich,domain:BEACH,repeat:WD 1,repeat:WD 2,sequence conflict,splice variant,
NBEAL2	neurobeachin like 2(NBEAL2)	Homo sapiens				GO:0030220~platelet formation,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,	GO:0005543~phospholipid binding,	IPR000409:BEACH domain,IPR001680:WD40 repeat,IPR011993:Pleckstrin homology-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,IPR023362:PH-BEACH domain,IPR026916:Neurobeachin-like protein,		139090~Gray platelet syndrome,		SM00320:WD40,SM01026:SM01026,	Alternative splicing,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Neurobeachin-like protein 2,compositionally biased region:Leu-rich,compositionally biased region:Pro-rich,domain:BEACH,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,splice variant,
NBL1	neuroblastoma 1, DAN family BMP antagonist(NBL1)	Homo sapiens				GO:0007399~nervous system development,GO:0030514~negative regulation of BMP signaling pathway,GO:0035582~sequestering of BMP in extracellular matrix,GO:0038098~sequestering of BMP from receptor via BMP binding,GO:0045666~positive regulation of neuron differentiation,GO:0048263~determination of dorsal identity,GO:0048812~neuron projection morphogenesis,GO:0090027~negative regulation of monocyte chemotaxis,	GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0016015~morphogen activity,GO:0036122~BMP binding,GO:0042803~protein homodimerization activity,	IPR004133:DAN,IPR006207:Cystine knot, C-terminal,IPR016728:Neuroblastoma suppressor of tumorigenicity 1,	hsa04350:TGF-beta signaling pathway,		PIRSF018557:DAN protein,	SM00041:CT,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Proteomics identification,Reference proteome,Secreted,Signal,Tumor suppressor,	chain:Neuroblastoma suppressor of tumorigenicity 1,compositionally biased region:Pro-rich,disulfide bond,domain:CTCK,signal peptide,splice variant,
NBAS	neuroblastoma amplified sequence(NBAS)	Homo sapiens				GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0015031~protein transport,GO:2000623~negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070939~Dsl1p complex,	GO:0000149~SNARE binding,	IPR011044:Quinoprotein amine dehydrogenase, beta chain-like,IPR013244:Secretory pathway Sec39,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,		614800~Short stature, optic nerve atrophy, and Pelger-Huet anomaly,616483~Infantile liver failure syndrome 2,			Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Dwarfism,Endoplasmic reticulum,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,WD repeat,	chain:Neuroblastoma-amplified sequence,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Thr,modified residue,repeat:WD 1,repeat:WD 2,sequence conflict,sequence variant,splice variant,
NBPF1	neuroblastoma breakpoint family member 1(NBPF1)	Homo sapiens			DNA replication, recombination, and repair,		GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Repeat,	chain:Neuroblastoma breakpoint family member 1,chain:Neuroblastoma breakpoint family member 10,chain:Neuroblastoma breakpoint family member 11,chain:Neuroblastoma breakpoint family member 12,chain:Neuroblastoma breakpoint family member 14,chain:Neuroblastoma breakpoint family member 15,chain:Neuroblastoma breakpoint family member 20,chain:Neuroblastoma breakpoint family member 8,chain:Neuroblastoma breakpoint family member 9,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,domain:NBPF 1,domain:NBPF 10,domain:NBPF 2,domain:NBPF 3,domain:NBPF 4,domain:NBPF 5,domain:NBPF 6,domain:NBPF 7,domain:NBPF 8,domain:NBPF 9,modified residue,sequence conflict,sequence variant,splice variant,
NBPF10	neuroblastoma breakpoint family member 10(NBPF10)	Homo sapiens			DNA replication, recombination, and repair,		GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0044822~poly(A) RNA binding,	IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Neuroblastoma breakpoint family member 1,chain:Neuroblastoma breakpoint family member 10,chain:Neuroblastoma breakpoint family member 11,chain:Neuroblastoma breakpoint family member 12,chain:Neuroblastoma breakpoint family member 14,chain:Neuroblastoma breakpoint family member 15,chain:Neuroblastoma breakpoint family member 20,chain:Neuroblastoma breakpoint family member 8,chain:Neuroblastoma breakpoint family member 9,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,domain:NBPF 1,domain:NBPF 10,domain:NBPF 2,domain:NBPF 3,domain:NBPF 4,domain:NBPF 5,domain:NBPF 6,domain:NBPF 7,domain:NBPF 8,domain:NBPF 9,modified residue,sequence conflict,sequence variant,splice variant,
NBPF11	neuroblastoma breakpoint family member 11(NBPF11)	Homo sapiens			DNA replication, recombination, and repair,		GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Reference proteome,Repeat,	chain:Neuroblastoma breakpoint family member 1,chain:Neuroblastoma breakpoint family member 10,chain:Neuroblastoma breakpoint family member 11,chain:Neuroblastoma breakpoint family member 12,chain:Neuroblastoma breakpoint family member 14,chain:Neuroblastoma breakpoint family member 15,chain:Neuroblastoma breakpoint family member 20,chain:Neuroblastoma breakpoint family member 8,chain:Neuroblastoma breakpoint family member 9,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,domain:NBPF 1,domain:NBPF 10,domain:NBPF 2,domain:NBPF 3,domain:NBPF 4,domain:NBPF 5,domain:NBPF 6,domain:NBPF 7,domain:NBPF 8,domain:NBPF 9,modified residue,sequence conflict,sequence variant,splice variant,
NBPF15	neuroblastoma breakpoint family member 15(NBPF15)	Homo sapiens			DNA replication, recombination, and repair,		GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Repeat,	chain:Neuroblastoma breakpoint family member 1,chain:Neuroblastoma breakpoint family member 10,chain:Neuroblastoma breakpoint family member 11,chain:Neuroblastoma breakpoint family member 12,chain:Neuroblastoma breakpoint family member 14,chain:Neuroblastoma breakpoint family member 15,chain:Neuroblastoma breakpoint family member 20,chain:Neuroblastoma breakpoint family member 8,chain:Neuroblastoma breakpoint family member 9,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,domain:NBPF 1,domain:NBPF 10,domain:NBPF 2,domain:NBPF 3,domain:NBPF 4,domain:NBPF 5,domain:NBPF 6,domain:NBPF 7,domain:NBPF 8,domain:NBPF 9,modified residue,sequence conflict,sequence variant,splice variant,
NBPF20	neuroblastoma breakpoint family member 20(NBPF20)	Homo sapiens					GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Coiled coil,Complete proteome,Reference proteome,
NBPF3	neuroblastoma breakpoint family member 3(NBPF3)	Homo sapiens				GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Repeat,	chain:Neuroblastoma breakpoint family member 3,compositionally biased region:Poly-Glu,domain:NBPF 1,domain:NBPF 2,domain:NBPF 3,domain:NBPF 4,domain:NBPF 5,sequence conflict,sequence variant,splice variant,
NBPF5P	neuroblastoma breakpoint family member 5, pseudogene(NBPF5P)	Homo sapiens					GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Coiled coil,Complete proteome,Cytoplasm,Reference proteome,
NBPF7	neuroblastoma breakpoint family member 7(NBPF7)	Homo sapiens					GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Repeat,	chain:Putative neuroblastoma breakpoint family member 7,compositionally biased region:Poly-Glu,domain:NBPF 1,domain:NBPF 2,sequence variant,
NFASC	neurofascin(NFASC)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,		GO:0002175~protein localization to paranode region of axon,GO:0007411~axon guidance,GO:0007422~peripheral nervous system development,GO:0019226~transmission of nerve impulse,GO:0030913~paranodal junction assembly,GO:0034113~heterotypic cell-cell adhesion,GO:0042552~myelination,GO:0045162~clustering of voltage-gated sodium channels,GO:0050808~synapse organization,GO:0071205~protein localization to juxtaparanode region of axon,GO:0072661~protein targeting to plasma membrane,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0033010~paranodal junction,GO:0033268~node of Ranvier,GO:0033270~paranode region of axon,GO:0043194~axon initial segment,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:0097454~Schwann cell microvillus,	GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0086080~protein binding involved in heterotypic cell-cell adhesion,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR026965:Neurofascin,IPR026966:Fibronectin type III C-terminal domain,	hsa04514:Cell adhesion molecules (CAMs),			SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Neurofascin,compositionally biased region:Thr-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
NMUR1	neuromedin U receptor 1(NMUR1)	Homo sapiens				GO:0006816~calcium ion transport,GO:0006821~chloride transport,GO:0006939~smooth muscle contraction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007218~neuropeptide signaling pathway,GO:0019722~calcium-mediated signaling,GO:0048016~inositol phosphate-mediated signaling,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0001607~neuromedin U receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0008188~neuropeptide receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR005390:Neuromedin U receptor,IPR005391:Neuromedin U receptor, type 1,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Neuromedin-U receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
NAV1	neuron navigator 1(NAV1)	Homo sapiens				GO:0001578~microtubule bundle formation,GO:0001764~neuron migration,	GO:0005737~cytoplasm,GO:0005874~microtubule,		IPR003593:AAA+ ATPase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Methylation,Microtubule,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Neuron navigator 1,modified residue,sequence conflict,sequence variant,splice variant,
NPAS2	neuronal PAS domain protein 2(NPAS2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007417~central nervous system development,GO:0007623~circadian rhythm,GO:0032922~circadian regulation of gene expression,GO:0045739~positive regulation of DNA repair,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051775~response to redox state,GO:0060548~negative regulation of cell death,GO:2001020~regulation of response to DNA damage stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,GO:0051879~Hsp90 protein binding,	IPR000014:PAS domain,IPR001067:Nuclear translocator,IPR001610:PAC motif,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013767:PAS fold,	hsa04710:Circadian rhythm,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	Activator,Biological rhythms,Complete proteome,DNA damage,DNA-binding,Heme,Iron,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Neuronal PAS domain-containing protein 2,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAC,domain:PAS 1,domain:PAS 2,sequence conflict,sequence variant,
NEUROD1	neuronal differentiation 1(NEUROD1)	Homo sapiens				GO:0003326~pancreatic A cell fate commitment,GO:0003329~pancreatic PP cell fate commitment,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006913~nucleocytoplasmic transport,GO:0007263~nitric oxide mediated signal transduction,GO:0009749~response to glucose,GO:0009952~anterior/posterior pattern specification,GO:0021542~dentate gyrus development,GO:0021549~cerebellum development,GO:0022008~neurogenesis,GO:0023019~signal transduction involved in regulation of gene expression,GO:0030073~insulin secretion,GO:0031018~endocrine pancreas development,GO:0035881~amacrine cell differentiation,GO:0035883~enteroendocrine cell differentiation,GO:0042493~response to drug,GO:0042593~glucose homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0045597~positive regulation of cell differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046426~negative regulation of JAK-STAT cascade,GO:0048562~embryonic organ morphogenesis,GO:0048666~neuron development,GO:0048839~inner ear development,GO:0050796~regulation of insulin secretion,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060730~regulation of intestinal epithelial structure maintenance,GO:0071156~regulation of cell cycle arrest,GO:0071333~cellular response to glucose stimulus,GO:2000675~negative regulation of type B pancreatic cell apoptotic process,GO:2000679~positive regulation of transcription regulatory region DNA binding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0070888~E-box binding,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR016637:Transcription factor, basic helix-loop-helix, NeuroD,IPR022575:Neurogenic differentiation factor, domain of unknown function,	hsa04950:Maturity onset diabetes of the young,	125853~Diabetes mellitus, noninsulin-dependent,606394~Maturity-onset diabetes of the young 6,	PIRSF015618:basic helix-loop-helix transcription factor NeuroD,	SM00353:HLH,	Activator,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Diabetes mellitus,Differentiation,Disease mutation,DNA-binding,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Neurogenic differentiation factor 1,compositionally biased region:Glu-rich (acidic),compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
NEGR1	neuronal growth regulator 1(NEGR1)	Homo sapiens				GO:0007626~locomotory behavior,GO:0007631~feeding behavior,GO:0010976~positive regulation of neuron projection development,GO:0016337~single organismal cell-cell adhesion,	GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Phosphoprotein,Reference proteome,Repeat,Signal,	chain:Neuronal growth regulator 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated glycine,modified residue,propeptide:Removed in mature form,sequence conflict,signal peptide,
NGEF	neuronal guanine nucleotide exchange factor(NGEF)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0048013~ephrin receptor signaling pathway,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0061002~negative regulation of dendritic spine morphogenesis,	GO:0005829~cytosol,GO:0016020~membrane,GO:0030426~growth cone,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,	hsa04360:Axon guidance,			SM00233:PH,SM00325:RhoGEF,SM00326:SH3,	Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Guanine-nucleotide releasing factor,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:Ephexin-1,compositionally biased region:Poly-Glu,domain:DH,domain:PH,domain:SH3,modified residue,region of interest:Regulatory region; modulates activity toward RHOA, RAC1 and CDC42,sequence conflict,sequence variant,splice variant,
NYAP2	neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2(NYAP2)	Homo sapiens				GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0048812~neuron projection morphogenesis,	GO:0005622~intracellular,	GO:0005515~protein binding,	IPR026722:Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1/2,IPR026723:Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2,					Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1486,compositionally biased region:Pro-rich,modified residue,sequence variant,splice variant,
NRP2	neuropilin 2(NRP2)	Homo sapiens				GO:0001525~angiogenesis,GO:0001938~positive regulation of endothelial cell proliferation,GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0007507~heart development,GO:0010595~positive regulation of endothelial cell migration,GO:0021612~facial nerve structural organization,GO:0021649~vestibulocochlear nerve structural organization,GO:0021675~nerve development,GO:0021828~gonadotrophin-releasing hormone neuronal migration to the hypothalamus,GO:0036486~ventral trunk neural crest cell migration,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048846~axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0061549~sympathetic ganglion development,GO:0061551~trigeminal ganglion development,GO:0097374~sensory neuron axon guidance,GO:0097490~sympathetic neuron projection extension,GO:0097491~sympathetic neuron projection guidance,GO:1901166~neural crest cell migration involved in autonomic nervous system development,GO:1902285~semaphorin-plexin signaling pathway involved in neuron projection guidance,GO:1903375~facioacoustic ganglion development,GO:1904835~dorsal root ganglion morphogenesis,	GO:0002116~semaphorin receptor complex,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,	GO:0004872~receptor activity,GO:0005021~vascular endothelial growth factor-activated receptor activity,GO:0008201~heparin binding,GO:0017154~semaphorin receptor activity,GO:0019838~growth factor binding,GO:0019955~cytokine binding,GO:0046872~metal ion binding,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000859:CUB domain,IPR000998:MAM domain,IPR008979:Galactose-binding domain-like,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR014648:Neuropilin,IPR022579:Neuropilin-1, C-terminal,IPR027143:Neuropilin-2,			PIRSF036960:neuropilin,	SM00042:CUB,SM00137:MAM,SM00231:FA58C,	3D-structure,Alternative splicing,Calcium,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Heparin-binding,Membrane,Metal-binding,Neurogenesis,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Neuropilin-2,compositionally biased region:Poly-Ser,disulfide bond,domain:CUB 1,domain:CUB 2,domain:F5/8 type C 1,domain:F5/8 type C 2,domain:MAM,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
NTRK1	neurotrophic receptor tyrosine kinase 1(NTRK1)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_trkaPathway:Trka Receptor Signaling Pathway,		GO:0000186~activation of MAPKK activity,GO:0001934~positive regulation of protein phosphorylation,GO:0006468~protein phosphorylation,GO:0007018~microtubule-based movement,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007411~axon guidance,GO:0007568~aging,GO:0007611~learning or memory,GO:0007623~circadian rhythm,GO:0008285~negative regulation of cell proliferation,GO:0009314~response to radiation,GO:0010623~programmed cell death involved in cell development,GO:0010976~positive regulation of neuron projection development,GO:0014823~response to activity,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021553~olfactory nerve development,GO:0030183~B cell differentiation,GO:0031667~response to nutrient levels,GO:0038180~nerve growth factor signaling pathway,GO:0042490~mechanoreceptor differentiation,GO:0042493~response to drug,GO:0043068~positive regulation of programmed cell death,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045471~response to ethanol,GO:0045766~positive regulation of angiogenesis,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046777~protein autophosphorylation,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048485~sympathetic nervous system development,GO:0048678~response to axon injury,GO:0050965~detection of temperature stimulus involved in sensory perception of pain,GO:0050966~detection of mechanical stimulus involved in sensory perception of pain,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051599~response to hydrostatic pressure,GO:0051602~response to electrical stimulus,GO:0051965~positive regulation of synapse assembly,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0060009~Sertoli cell development,GO:0060385~axonogenesis involved in innervation,GO:0061368~behavioral response to formalin induced pain,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071316~cellular response to nicotine,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0030424~axon,GO:0030425~dendrite,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,GO:0043025~neuronal cell body,GO:0043234~protein complex,GO:0043235~receptor complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005030~neurotrophin receptor activity,GO:0005166~neurotrophin p75 receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0010465~nerve growth factor receptor activity,GO:0019900~kinase binding,GO:0042803~protein homodimerization activity,GO:0043121~neurotrophin binding,GO:0048406~nerve growth factor binding,	IPR000483:Cysteine-rich flanking region, C-terminal,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001611:Leucine-rich repeat,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020461:Tyrosine-protein kinase, neurotrophic receptor, type 1,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR020777:Tyrosine-protein kinase, neurotrophic receptor,	hsa04010:MAPK signaling pathway,hsa04210:Apoptosis,hsa04722:Neurotrophin signaling pathway,hsa04750:Inflammatory mediator regulation of TRP channels,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05216:Thyroid cancer,hsa05230:Central carbon metabolism in cancer,	155240~Medullary thyroid carcinoma, familial,256800~Insensitivity to pain, congenital, with anhidrosis,		SM00082:LRRCT,SM00219:TyrKc,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,Disease mutation,Disulfide bond,Endosome,Glycoprotein,Immunoglobulin domain,Kinase,Leucine-rich repeat,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:High affinity nerve growth factor receptor,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with SQSTM1,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence conflict,sequence variant,signal peptide,site:Breakpoint for translocation to form TRK and TRK-T3,site:Breakpoint for translocation to form TRK- T1,site:Interaction with PLC-gamma-1,site:Interaction with SHC1,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
NCF2	neutrophil cytosolic factor 2(NCF2)	Homo sapiens		h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_rac1Pathway:Rac 1 cell motility signaling pathway,		GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006801~superoxide metabolic process,GO:0006968~cellular defense response,GO:0042554~superoxide anion generation,GO:0045087~innate immune response,GO:0045454~cell redox homeostasis,GO:0045730~respiratory burst,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0055114~oxidation-reduction process,	GO:0001669~acrosomal vesicle,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032010~phagolysosome,GO:0043020~NADPH oxidase complex,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0009055~electron carrier activity,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0048365~Rac GTPase binding,	IPR000270:Phox/Bem1p,IPR001452:Src homology-3 domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04670:Leukocyte transendothelial migration,hsa05140:Leishmaniasis,	233710~Chronic granulomatous disease due to deficiency of NCF-2,		SM00028:TPR,SM00326:SH3,SM00666:PB1,	3D-structure,Alternative splicing,Chronic granulomatous disease,Complete proteome,Cytoplasm,Disease mutation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,TPR repeat,	chain:Neutrophil cytosol factor 2,domain:OPR,domain:SH3 1,domain:SH3 2,helix,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence variant,strand,turn,
NEXN	nexilin F-actin binding protein(NEXN)	Homo sapiens				GO:0030334~regulation of cell migration,GO:0048739~cardiac muscle fiber development,GO:0051493~regulation of cytoskeleton organization,	GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0030018~Z disc,	GO:0008307~structural constituent of muscle,GO:0051015~actin filament binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,		613122~Cardiomyopathy, dilated, 1CC,613876~Cardiomyopathy, hypertrophic, 20,		SM00409:IG,	Actin-binding,Alternative splicing,Cardiomyopathy,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Immunoglobulin domain,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Nexilin,compositionally biased region:Glu-rich,domain:Ig-like,modified residue,sequence conflict,sequence variant,splice variant,
NCSTN	nicastrin(NCSTN)	Homo sapiens				GO:0002262~myeloid cell homeostasis,GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0016485~protein processing,GO:0031293~membrane protein intracellular domain proteolysis,GO:0042098~T cell proliferation,GO:0042987~amyloid precursor protein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0048013~ephrin receptor signaling pathway,GO:0050435~beta-amyloid metabolic process,GO:0050673~epithelial cell proliferation,	GO:0005765~lysosomal membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0005515~protein binding,	IPR008710:Nicastrin,	hsa04330:Notch signaling pathway,hsa05010:Alzheimer's disease,	142690~Acne inversa, familial, 1,			3D-structure,Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Membrane,Notch signaling pathway,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Nicastrin,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
NICN1	nicolin 1(NICN1)	Homo sapiens					GO:0005634~nucleus,GO:0005874~microtubule,							Alternative splicing,Complete proteome,Microtubule,Nucleus,Reference proteome,	chain:Nicolin-1,sequence conflict,splice variant,
NMNAT1	nicotinamide nucleotide adenylyltransferase 1(NMNAT1)	Homo sapiens				GO:0009435~NAD biosynthetic process,GO:0009611~response to wounding,GO:0019674~NAD metabolic process,GO:0034628~'de novo' NAD biosynthetic process from aspartate,GO:1990966~ATP generation from poly-ADP-D-ribose,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000309~nicotinamide-nucleotide adenylyltransferase activity,GO:0004515~nicotinate-nucleotide adenylyltransferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016779~nucleotidyltransferase activity,GO:0042802~identical protein binding,	IPR004821:Cytidyltransferase-like domain,IPR005248:Probable nicotinate-nucleotide adenylyltransferase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,	608553~Leber congenital amaurosis 9,			3D-structure,ATP-binding,Complete proteome,Direct protein sequencing,Disease mutation,Leber congenital amaurosis,Magnesium,NAD,Nucleotide-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Proteomics identification,Pyridine nucleotide biosynthesis,Reference proteome,Transferase,Zinc,	binding site:Substrate,chain:Nicotinamide mononucleotide adenylyltransferase 1,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:Nuclear localization signal,strand,turn,
NMNAT2	nicotinamide nucleotide adenylyltransferase 2(NMNAT2)	Homo sapiens				GO:0009435~NAD biosynthetic process,GO:0019674~NAD metabolic process,GO:0034628~'de novo' NAD biosynthetic process from aspartate,	GO:0000139~Golgi membrane,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0045202~synapse,	GO:0000309~nicotinamide-nucleotide adenylyltransferase activity,GO:0004515~nicotinate-nucleotide adenylyltransferase activity,GO:0005524~ATP binding,	IPR004821:Cytidyltransferase-like domain,IPR005248:Probable nicotinate-nucleotide adenylyltransferase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Golgi apparatus,Magnesium,NAD,Nucleotide-binding,Nucleotidyltransferase,Pyridine nucleotide biosynthesis,Reference proteome,Transferase,	binding site:Substrate,chain:Nicotinamide mononucleotide adenylyltransferase 2,mutagenesis site,nucleotide phosphate-binding region:ATP,splice variant,
NID1	nidogen 1(NID1)	Homo sapiens				GO:0007160~cell-matrix adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0032836~glomerular basement membrane development,GO:0071711~basement membrane organization,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005605~basal lamina,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0005509~calcium ion binding,GO:0005518~collagen binding,GO:0043236~laminin binding,GO:0043237~laminin-1 binding,GO:0043394~proteoglycan binding,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000716:Thyroglobulin type-1,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR003886:Nidogen, extracellular domain,IPR006605:G2 nidogen/fibulin G2F,IPR009017:Green fluorescent protein,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023413:Green fluorescent protein-like,IPR024731:EGF domain, merozoite surface protein 1-like,IPR026823:Complement Clr-like EGF domain,				SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00211:TY,SM00539:NIDO,SM00682:G2F,	3D-structure,Alternative splicing,Basement membrane,Calcium,Cell adhesion,Complete proteome,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Sulfation,	chain:Nidogen-1,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3; calcium-binding,domain:EGF-like 4,domain:EGF-like 5; calcium-binding,domain:EGF-like 6,domain:NIDO,domain:Nidogen G2 beta-barrel,domain:Thyroglobulin type-1,glycosylation site:N-linked (GlcNAc...),helix,modified residue,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,strand,turn,
NISCH	nischarin(NISCH)	Homo sapiens			Function unknown,	GO:0006006~glucose metabolic process,GO:0006915~apoptotic process,GO:0008217~regulation of blood pressure,GO:0016601~Rac protein signal transduction,GO:0030036~actin cytoskeleton organization,GO:0030336~negative regulation of cell migration,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0048243~norepinephrine secretion,	GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0055037~recycling endosome,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0035091~phosphatidylinositol binding,GO:0042802~identical protein binding,	IPR001611:Leucine-rich repeat,IPR001683:Phox homologous domain,				SM00312:PX,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Endosome,Leucine-rich repeat,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,	chain:Nischarin,compositionally biased region:Ala/Pro-rich,compositionally biased region:Glu-rich,domain:PX,modified residue,mutagenesis site,region of interest:Interaction with ITGA5,region of interest:Interaction with LIMK,region of interest:Interaction with PAK1,region of interest:Necessary for binding to phosphoinositide-3-P; not sufficient for targeting to endosomes,region of interest:Necessary for homooligomerization and targeting to endosomes,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence conflict,sequence variant,splice variant,
NOS1AP	nitric oxide synthase 1 adaptor protein(NOS1AP)	Homo sapiens				GO:0003062~regulation of heart rate by chemical signal,GO:0010628~positive regulation of gene expression,GO:0010750~positive regulation of nitric oxide mediated signal transduction,GO:0042981~regulation of apoptotic process,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0098901~regulation of cardiac muscle cell action potential,GO:1901381~positive regulation of potassium ion transmembrane transport,GO:1901841~regulation of high voltage-gated calcium channel activity,GO:1902261~positive regulation of delayed rectifier potassium channel activity,GO:1902514~regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,GO:1903762~positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,GO:2000170~positive regulation of peptidyl-cysteine S-nitrosylation,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005901~caveola,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0031965~nuclear membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0042383~sarcolemma,GO:0048471~perinuclear region of cytoplasm,GO:1902937~inward rectifier potassium channel complex,GO:1990454~L-type voltage-gated calcium channel complex,	GO:0005515~protein binding,GO:0050998~nitric-oxide synthase binding,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,	hsa04713:Circadian entrainment,			SM00462:PTB,	Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein,compositionally biased region:Poly-Gln,domain:PID,modified residue,region of interest:Interaction with NOS1,short sequence motif:PDZ-binding,
NOSTRIN	nitric oxide synthase trafficking(NOSTRIN)	Homo sapiens				GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050999~regulation of nitric-oxide synthase activity,	GO:0005634~nucleus,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030666~endocytic vesicle membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001060:FCH domain,IPR001452:Src homology-3 domain,IPR011072:HR1 rho-binding repeat,				SM00326:SH3,	3D-structure,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endocytosis,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:Nostrin,domain:FCH,domain:SH3,modified residue,sequence variant,splice variant,strand,
NIT2	nitrilase family member 2(NIT2)	Homo sapiens			General function prediction only,	GO:0006107~oxaloacetate metabolic process,GO:0006528~asparagine metabolic process,GO:0006541~glutamine metabolic process,GO:0006807~nitrogen compound metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0070062~extracellular exosome,	GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,GO:0050152~omega-amidase activity,	IPR003010:Carbon-nitrogen hydrolase,	hsa00250:Alanine, aspartate and glutamate metabolism,				Acetylation,Complete proteome,Cytoplasm,Hydrolase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton acceptor,chain:Omega-amidase NIT2,domain:CN hydrolase,modified residue,sequence variant,
NCAPH	non-SMC condensin I complex subunit H(NCAPH)	Homo sapiens				GO:0007076~mitotic chromosome condensation,GO:0051301~cell division,	GO:0000796~condensin complex,GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,	IPR022816:Condensin complex subunit 2/barren,			PIRSF017126:chromosome condensation complex condensin, subunit H,		Acetylation,Alternative splicing,Cell cycle,Cell division,Chromosome,Complete proteome,Cytoplasm,DNA condensation,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Condensin complex subunit 2,modified residue,sequence variant,
NCMAP	non-compact myelin associated protein(NCMAP)	Homo sapiens				GO:0031643~positive regulation of myelination,GO:0032290~peripheral nervous system myelin formation,	GO:0005887~integral component of plasma membrane,GO:0033270~paranode region of axon,GO:0043220~Schmidt-Lanterman incisure,	GO:0019911~structural constituent of myelin sheath,						Cell membrane,Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C1orf130,compositionally biased region:Poly-Val,transmembrane region,
NHEJ1	non-homologous end joining factor 1(NHEJ1)	Homo sapiens				GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0007417~central nervous system development,GO:0010212~response to ionizing radiation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0051351~positive regulation of ligase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032807~DNA ligase IV complex,GO:0070419~nonhomologous end joining complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0045027~DNA end binding,	IPR009089:DNA double-strand break repair and VJ recombination XRCC4, N-terminal,IPR015381:XLF/Cernunnos,	hsa03450:Non-homologous end-joining,	611291~Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation,			3D-structure,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SCID,	chain:Non-homologous end-joining factor 1,helix,sequence conflict,sequence variant,splice variant,strand,
NOTCH2NL	notch 2 N-terminal like(NOTCH2NL)	Homo sapiens				GO:0007219~Notch signaling pathway,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,	GO:0005576~extracellular region,GO:0005737~cytoplasm,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disulfide bond,EGF-like domain,Glycoprotein,Notch signaling pathway,Polymorphism,Reference proteome,Repeat,Secreted,	chain:Notch homolog 2 N-terminal-like protein,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5; calcium-binding,domain:EGF-like 6,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,
NOTCH2	notch 2(NOTCH2)	Homo sapiens		h_hesPathway:Segmentation Clock,		GO:0001709~cell fate determination,GO:0002315~marginal zone B cell differentiation,GO:0003184~pulmonary valve morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0007219~Notch signaling pathway,GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0016049~cell growth,GO:0019827~stem cell population maintenance,GO:0030097~hemopoiesis,GO:0030522~intracellular receptor signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046849~bone remodeling,GO:0050793~regulation of developmental process,GO:0060413~atrial septum morphogenesis,GO:0061314~Notch signaling involved in heart development,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004872~receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0038049~transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR000800:Notch domain,IPR001881:EGF-like calcium-binding,IPR002110:Ankyrin repeat,IPR008297:Notch,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR010660:Notch, NOD domain,IPR011656:Notch, NODP domain,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR020683:Ankyrin repeat-containing domain,IPR022336:Neurogenic locus Notch 2,IPR024600:Domain of unknown function DUF3454, notch,	hsa04320:Dorso-ventral axis formation,hsa04330:Notch signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05206:MicroRNAs in cancer,	102500~Hajdu-Cheney syndrome,610205~Alagille syndrome 2,	PIRSF002279:notch protein,	SM00004:NL,SM00179:EGF_CA,SM00181:EGF,SM00248:ANK,SM01334:SM01334,SM01338:SM01338,SM01339:SM01339,	3D-structure,Activator,ANK repeat,Calcium,Cell membrane,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Notch signaling pathway,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:Neurogenic locus notch homolog protein 2,chain:Notch 2 extracellular truncation,chain:Notch 2 intracellular domain,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11; calcium-binding,domain:EGF-like 12; calcium-binding,domain:EGF-like 13; calcium-binding,domain:EGF-like 14; calcium-binding,domain:EGF-like 15; calcium-binding,domain:EGF-like 16; calcium-binding,domain:EGF-like 17; calcium-binding,domain:EGF-like 18; calcium-binding,domain:EGF-like 19,domain:EGF-like 2,domain:EGF-like 20; calcium-binding,domain:EGF-like 21; calcium-binding,domain:EGF-like 22,domain:EGF-like 23; calcium-binding,domain:EGF-like 24; calcium-binding,domain:EGF-like 25; calcium-binding,domain:EGF-like 26; calcium-binding,domain:EGF-like 27; calcium-binding,domain:EGF-like 28,domain:EGF-like 29,domain:EGF-like 3,domain:EGF-like 30; calcium-binding,domain:EGF-like 31; calcium-binding,domain:EGF-like 32; calcium-binding,domain:EGF-like 33,domain:EGF-like 34,domain:EGF-like 35,domain:EGF-like 4,domain:EGF-like 5; calcium-binding,domain:EGF-like 6,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:EGF-like 9; calcium-binding,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Negative regulatory region (NRR),repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:LNR 1,repeat:LNR 2,repeat:LNR 3,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
NVL	nuclear VCP-like(NVL)	Homo sapiens				GO:0042254~ribosome biogenesis,GO:0051973~positive regulation of telomerase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:1990275~preribosome binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03008:Ribosome biogenesis in eukaryotes,			SM00382:AAA,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ribosome biogenesis,	chain:Nuclear valosin-containing protein-like,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
NASP	nuclear autoantigenic sperm protein(NASP)	Homo sapiens				GO:0001824~blastocyst development,GO:0006260~DNA replication,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0015031~protein transport,GO:0033574~response to testosterone,GO:0043486~histone exchange,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0051879~Hsp90 protein binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019544:Tetratricopeptide, SHNi-TPR domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Acetylation,Alternative splicing,Cell cycle,Coiled coil,Complete proteome,Cytoplasm,DNA replication,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transport,Ubl conjugation,	chain:Nuclear autoantigenic sperm protein,compositionally biased region:Glu-rich (acidic),modified residue,region of interest:Histone-binding,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
NUCKS1	nuclear casein kinase and cyclin dependent kinase substrate 1(NUCKS1)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0001678~cellular glucose homeostasis,GO:0006275~regulation of DNA replication,GO:0006325~chromatin organization,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0019046~release from viral latency,GO:0031297~replication fork processing,GO:0035822~gene conversion,GO:0036297~interstrand cross-link repair,GO:0043923~positive regulation by host of viral transcription,GO:0044829~positive regulation by host of viral genome replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046626~regulation of insulin receptor signaling pathway,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0060382~regulation of DNA strand elongation,GO:0071481~cellular response to X-ray,GO:1990968~modulation by host of RNA binding by virus,GO:1990969~modulation by host of viral RNA-binding transcription factor activity,	GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0008134~transcription factor binding,GO:0044822~poly(A) RNA binding,						Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Nuclear ubiquitous casein and cyclin- dependent kinases substrate,compositionally biased region:Lys-rich,compositionally biased region:Poly-Asp,modified residue,sequence conflict,sequence variant,splice variant,
NFIA	nuclear factor I A(NFIA)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0019079~viral genome replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060074~synapse maturation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0030054~cell junction,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,	IPR000647:CTF transcription factor/nuclear factor 1,IPR003619:MAD homology 1, Dwarfin-type,IPR019548:CTF transcription factor/nuclear factor 1, N-terminal,IPR019739:CTF transcription factor/nuclear factor 1, conserved site,IPR020604:CTF transcription factor/nuclear factor 1, DNA-binding domain,				SM00523:DWA,	Activator,Alternative splicing,Complete proteome,DNA replication,DNA-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Nuclear factor 1 A-type,DNA-binding region:CTF/NF-I,modified residue,sequence conflict,splice variant,
NFE2L2	nuclear factor, erythroid 2 like 2(NFE2L2)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,h_prionPathway:Prion Pathway,		GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007568~aging,GO:0010499~proteasomal ubiquitin-independent protein catabolic process,GO:0010628~positive regulation of gene expression,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010976~positive regulation of neuron projection development,GO:0016567~protein ubiquitination,GO:0030194~positive regulation of blood coagulation,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0034599~cellular response to oxidative stress,GO:0035690~cellular response to drug,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0036091~positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0036499~PERK-mediated unfolded protein response,GO:0042149~cellular response to glucose starvation,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045454~cell redox homeostasis,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045995~regulation of embryonic development,GO:0046326~positive regulation of glucose import,GO:0070301~cellular response to hydrogen peroxide,GO:0071356~cellular response to tumor necrosis factor,GO:0071456~cellular response to hypoxia,GO:0071498~cellular response to fluid shear stress,GO:0071499~cellular response to laminar fluid shear stress,GO:1902037~negative regulation of hematopoietic stem cell differentiation,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1903071~positive regulation of ER-associated ubiquitin-dependent protein catabolic process,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,GO:1903788~positive regulation of glutathione biosynthetic process,GO:1904753~negative regulation of vascular associated smooth muscle cell migration,GO:2000121~regulation of removal of superoxide radicals,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0032993~protein-DNA complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0001221~transcription cofactor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,	hsa04141:Protein processing in endoplasmic reticulum,			SM00338:BRLZ,	3D-structure,Acetylation,Activator,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear factor erythroid 2-related factor 2,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,
NRBP1	nuclear receptor binding protein 1(NRBP1)	Homo sapiens				GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0035556~intracellular signal transduction,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005938~cell cortex,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0048471~perinuclear region of cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR011009:Protein kinase-like domain,					Acetylation,Cell projection,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Nuclear receptor-binding protein,domain:Protein kinase,modified residue,sequence conflict,sequence variant,
NCOA1	nuclear receptor coactivator 1(NCOA1)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_PPARgPathway:Role of PPAR-gamma Coactivators in Obesity and Thermogenesis,h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000435~positive regulation of transcription from RNA polymerase II promoter by galactose,GO:0002155~regulation of thyroid hormone mediated signaling pathway,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007595~lactation,GO:0008584~male gonad development,GO:0015721~bile acid and bile salt transport,GO:0021549~cerebellum development,GO:0021766~hippocampus development,GO:0021854~hypothalamus development,GO:0021987~cerebral cortex development,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor signaling pathway,GO:0032355~response to estradiol,GO:0032526~response to retinoic acid,GO:0032570~response to progesterone,GO:0032870~cellular response to hormone stimulus,GO:0043065~positive regulation of apoptotic process,GO:0043967~histone H4 acetylation,GO:0044255~cellular lipid metabolic process,GO:0044849~estrous cycle,GO:0045666~positive regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045925~positive regulation of female receptivity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060179~male mating behavior,GO:0060713~labyrinthine layer morphogenesis,GO:1904017~cellular response to Thyroglobulin triiodothyronine,GO:2001038~regulation of cellular response to drug,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043005~neuron projection,	GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0019899~enzyme binding,GO:0030331~estrogen receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0032403~protein complex binding,GO:0033142~progesterone receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0046965~retinoid X receptor binding,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,GO:0050681~androgen receptor binding,	IPR000014:PAS domain,IPR008955:Nuclear receptor coactivator Src-1,IPR009110:Nuclear receptor coactivator, interlocking,IPR010011:Domain of unknown function DUF1518,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013767:PAS fold,IPR014920:Nuclear receptor coactivator, Ncoa-type, interlocking,IPR014935:Steroid receptor coactivator,IPR017426:Nuclear receptor coactivator,	hsa04919:Thyroid hormone signaling pathway,			SM00091:PAS,SM00353:HLH,SM01151:SM01151,	3D-structure,Acetylation,Activator,Acyltransferase,Alternative splicing,Chromosomal rearrangement,Complete proteome,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Ubl conjugation,	chain:Nuclear receptor coactivator 1,compositionally biased region:Gln-rich,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAS,helix,modified residue,mutagenesis site,region of interest:Interaction with CREBBP,region of interest:Interaction with STAT3,sequence conflict,sequence variant,short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,short sequence motif:LXXLL motif 3,short sequence motif:LXXLL motif 4,short sequence motif:LXXLL motif 5,short sequence motif:LXXLL motif 6,short sequence motif:LXXLL motif 7,site:Breakpoint for translocation to form PAX3-NCOA1 oncogene,splice variant,strand,turn,
NR1D2	nuclear receptor subfamily 1 group D member 2(NR1D2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0019216~regulation of lipid metabolic process,GO:0030522~intracellular receptor signaling pathway,GO:0042752~regulation of circadian rhythm,GO:0043401~steroid hormone mediated signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0050727~regulation of inflammatory response,GO:0055088~lipid homeostasis,GO:2000505~regulation of energy homeostasis,GO:2001014~regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0001046~core promoter sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,				SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Acetylation,Activator,Biological rhythms,Complete proteome,Disulfide bond,DNA-binding,Heme,Iron,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 1 group D member 2,compositionally biased region:Poly-Ser,DNA-binding region:Nuclear receptor,helix,modified residue,sequence conflict,sequence variant,strand,turn,zinc finger region:NR C4-type,
NR1I3	nuclear receptor subfamily 1 group I member 3(NR1I3)	Homo sapiens		h_acetaminophenPathway:Mechanism of Acetaminophen Activity and Toxicity,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0030521~androgen receptor signaling pathway,GO:0043401~steroid hormone mediated signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003713~transcription coactivator activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0004882~androgen receptor activity,GO:0004887~thyroid hormone receptor activity,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR001728:Thyroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,				SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 1 group I member 3,DNA-binding region:Nuclear receptor,helix,sequence variant,splice variant,strand,turn,zinc finger region:NR C4-type,
NR2C2	nuclear receptor subfamily 2 group C member 2(NR2C2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0021549~cerebellum development,GO:0030154~cell differentiation,GO:0038066~p38MAPK cascade,GO:0040019~positive regulation of embryonic development,GO:0043401~steroid hormone mediated signaling pathway,GO:0045663~positive regulation of myoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048520~positive regulation of behavior,GO:0051321~meiotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003713~transcription coactivator activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,				SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Differentiation,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repressor,Spermatogenesis,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 2 group C member 2,DNA-binding region:Nuclear receptor,modified residue,sequence conflict,zinc finger region:NR C4-type,
NR4A2	nuclear receptor subfamily 4 group A member 2(NR4A2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0001764~neuron migration,GO:0001975~response to amphetamine,GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0008344~adult locomotory behavior,GO:0009791~post-embryonic development,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021986~habenula development,GO:0030522~intracellular receptor signaling pathway,GO:0031668~cellular response to extracellular stimulus,GO:0034599~cellular response to oxidative stress,GO:0042053~regulation of dopamine metabolic process,GO:0042416~dopamine biosynthetic process,GO:0042551~neuron maturation,GO:0043085~positive regulation of catalytic activity,GO:0043401~steroid hormone mediated signaling pathway,GO:0043524~negative regulation of neuron apoptotic process,GO:0043576~regulation of respiratory gaseous exchange,GO:0045444~fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051866~general adaptation syndrome,GO:0060070~canonical Wnt signaling pathway,GO:0071376~cellular response to corticotropin-releasing hormone stimulus,GO:0071542~dopaminergic neuron differentiation,GO:1904948~midbrain dopaminergic neuron differentiation,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008270~zinc ion binding,GO:0035259~glucocorticoid receptor binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046965~retinoid X receptor binding,GO:0046982~protein heterodimerization activity,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003070:Orphan nuclear receptor,IPR003073:Orphan nuclear receptor, NURR type,IPR013088:Zinc finger, NHR/GATA-type,	hsa04925:Aldosterone synthesis and secretion,			SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 4 group A member 2,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,DNA-binding region:Nuclear receptor,helix,modified residue,region of interest:Ligand-binding,sequence conflict,strand,turn,zinc finger region:NR C4-type,
NR5A2	nuclear receptor subfamily 5 group A member 2(NR5A2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0008206~bile acid metabolic process,GO:0009755~hormone-mediated signaling pathway,GO:0009790~embryo development,GO:0009888~tissue development,GO:0030522~intracellular receptor signaling pathway,GO:0030855~epithelial cell differentiation,GO:0042127~regulation of cell proliferation,GO:0042592~homeostatic process,GO:0042632~cholesterol homeostasis,GO:0043401~steroid hormone mediated signaling pathway,GO:0045070~positive regulation of viral genome replication,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061113~pancreas morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,IPR016355:Steroidogenic factor 1,	hsa04950:Maturity onset diabetes of the young,		PIRSF002530:steroidogenic factor-like nuclear receptor,	SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Lipid-binding,Metal-binding,Nucleus,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	binding site:Lipid headgroup,chain:Nuclear receptor subfamily 5 group A member 2,DNA-binding region:Nuclear receptor,helix,mutagenesis site,region of interest:Ligand-binding,region of interest:Lipid binding,sequence conflict,short sequence motif:FTZ-F1 box,splice variant,strand,turn,zinc finger region:NR C4-type,
NFYC	nuclear transcription factor Y subunit gamma(NFYC)	Homo sapiens		h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation,	Transcription,	GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006457~protein folding,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016602~CCAAT-binding factor complex,GO:0032993~protein-DNA complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR003958:Transcription factor CBF/NF-Y/archaeal histone,IPR009072:Histone-fold,IPR027170:Transcriptional activator NFYC/HAP5 subunit,	hsa04612:Antigen processing and presentation,hsa05152:Tuberculosis,				3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Nuclear transcription factor Y subunit gamma,helix,sequence conflict,sequence variant,splice variant,strand,turn,
NABP1	nucleic acid binding protein 1(NABP1)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007093~mitotic cell cycle checkpoint,GO:0010212~response to ionizing radiation,GO:0042795~snRNA transcription from RNA polymerase II promoter,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070876~SOSS complex,	GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR012340:Nucleic acid-binding, OB-fold,					Alternative splicing,Complete proteome,DNA damage,DNA repair,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:SOSS complex subunit B2,DNA-binding region:OB,sequence variant,splice variant,
NOL10	nucleolar protein 10(NOL10)	Homo sapiens					GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR012580:NUC153,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Nucleolar protein 10,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,splice variant,
NOL9	nucleolar protein 9(NOL9)	Homo sapiens				GO:0000448~cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000460~maturation of 5.8S rRNA,GO:0006364~rRNA processing,GO:0016310~phosphorylation,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0051731~polynucleotide 5'-hydroxyl-kinase activity,						Acetylation,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,rRNA processing,Transferase,	chain:Nucleolar protein 9,modified residue,sequence variant,
NCL	nucleolin(NCL)	Homo sapiens		h_SARSpathway:SARS Coronavirus Protease,		GO:0001525~angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005938~cell cortex,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0042162~telomeric DNA binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa05130:Pathogenic Escherichia coli infection,			SM00360:RRM,SM00361:RRM_1,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Ubl conjugation,	chain:Nucleolin,compositionally biased region:Arg/Gly/Phe-rich,compositionally biased region:Asp/Glu-rich (acidic),domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,helix,modified residue,region of interest:8 X 8 AA tandem repeats of X-T-P-X-K-K-X- X,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5; truncated,repeat:6,repeat:7,repeat:8,sequence conflict,sequence variant,strand,
NUP133	nucleoporin 133(NUP133)	Homo sapiens				GO:0000972~transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006999~nuclear pore organization,GO:0007062~sister chromatid cohesion,GO:0007077~mitotic nuclear envelope disassembly,GO:0010827~regulation of glucose transport,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0019083~viral transcription,GO:0021915~neural tube development,GO:0022008~neurogenesis,GO:0031047~gene silencing by RNA,GO:0031081~nuclear pore distribution,GO:0048339~paraxial mesoderm development,GO:0061053~somite development,GO:0075733~intracellular transport of virus,GO:1900034~regulation of cellular response to heat,	GO:0000777~condensed chromosome kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005829~cytosol,GO:0016020~membrane,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,	GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0017056~structural constituent of nuclear pore,	IPR007187:Nucleoporin, Nup133/Nup155-like, C-terminal,IPR015943:WD40/YVTN repeat-like-containing domain,	hsa03013:RNA transport,				3D-structure,Acetylation,Centromere,Chromosome,Complete proteome,Kinetochore,Methylation,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Translocation,Transport,	chain:Nuclear pore complex protein Nup133,helix,modified residue,sequence conflict,sequence variant,strand,turn,
NUP210L	nucleoporin 210 like(NUP210L)	Homo sapiens				GO:0007286~spermatid development,GO:0060009~Sertoli cell development,	GO:0005643~nuclear pore,GO:0016021~integral component of membrane,		IPR003343:Bacterial Ig-like, group 2,IPR008964:Invasin/intimin cell-adhesion,	hsa03013:RNA transport,			SM00635:BID_2,	Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Nuclear pore membrane glycoprotein 210- like,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,transmembrane region,
NUP210	nucleoporin 210(NUP210)	Homo sapiens		h_npcPathway:Mechanism of Protein Import into the Nucleus,		GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0007077~mitotic nuclear envelope disassembly,GO:0010827~regulation of glucose transport,GO:0015031~protein transport,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0019083~viral transcription,GO:0031047~gene silencing by RNA,GO:0075733~intracellular transport of virus,GO:1900034~regulation of cellular response to heat,	GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0046983~protein dimerization activity,	IPR003343:Bacterial Ig-like, group 2,IPR008964:Invasin/intimin cell-adhesion,	hsa03013:RNA transport,			SM00635:BID_2,	Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Membrane,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Signal,Translocation,Transmembrane,Transmembrane helix,Transport,	chain:Nuclear pore membrane glycoprotein 210,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
NUP35	nucleoporin 35(NUP35)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0006607~NLS-bearing protein import into nucleus,GO:0006999~nuclear pore organization,GO:0007077~mitotic nuclear envelope disassembly,GO:0010827~regulation of glucose transport,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0019083~viral transcription,GO:0031047~gene silencing by RNA,GO:0055085~transmembrane transport,GO:0075733~intracellular transport of virus,GO:1900034~regulation of cellular response to heat,	GO:0005635~nuclear envelope,GO:0005652~nuclear lamina,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044613~nuclear pore central transport channel,GO:0044615~nuclear pore nuclear basket,GO:0045111~intermediate filament cytoskeleton,	GO:0000166~nucleotide binding,GO:0003697~single-stranded DNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0005543~phospholipid binding,	IPR007846:RNA-recognition motif (RRM) Nup35-type domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017389:Nucleoporin, NUP53,	hsa03013:RNA transport,		PIRSF038119:nucleoporin, NUP53 type,		3D-structure,Alternative splicing,Complete proteome,Membrane,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Translocation,Transport,	chain:Nucleoporin NUP53,domain:RRM Nup35-type,modified residue,sequence conflict,
NTPCR	nucleoside-triphosphatase, cancer-related(NTPCR)	Homo sapiens				GO:0016311~dephosphorylation,	GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0017111~nucleoside-triphosphatase activity,GO:0044822~poly(A) RNA binding,GO:0098519~nucleotide phosphatase activity, acting on free nucleotides,	IPR003593:AAA+ ATPase domain,IPR004948:Nucleoside-triphosphatase, THEP1 type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa00730:Thiamine metabolism,hsa01100:Metabolic pathways,			SM00382:AAA,	3D-structure,Acetylation,ATP-binding,Complete proteome,Hydrolase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:Nucleoside-triphosphatase C1orf57,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,strand,turn,
OBSL1	obscurin like 1(OBSL1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0007010~cytoskeleton organization,GO:0007030~Golgi organization,GO:0007088~regulation of mitotic nuclear division,GO:0034067~protein localization to Golgi apparatus,GO:0050775~positive regulation of dendrite morphogenesis,GO:0055003~cardiac myofibril assembly,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0014704~intercalated disc,GO:0030018~Z disc,GO:0031430~M band,GO:0048471~perinuclear region of cytoplasm,GO:1990393~3M complex,	GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0016301~kinase activity,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,		612921~3-M syndrome 2,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Disulfide bond,Dwarfism,Golgi apparatus,Immunoglobulin domain,Kinase,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transferase,
OBSCN	obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF(OBSCN)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007275~multicellular organism development,GO:0035023~regulation of Rho protein signal transduction,GO:0036309~protein localization to M-band,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045214~sarcomere organization,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,GO:0030016~myofibril,GO:0030018~Z disc,GO:0031430~M band,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008307~structural constituent of muscle,GO:0030506~ankyrin binding,GO:0031432~titin binding,GO:0046872~metal ion binding,	IPR000048:IQ motif, EF-hand binding site,IPR000219:Dbl homology (DH) domain,IPR000719:Protein kinase, catalytic domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,				SM00015:IQ,SM00060:FN3,SM00220:S_TKc,SM00233:PH,SM00325:RhoGEF,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,ATP-binding,Calmodulin-binding,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disulfide bond,Immunoglobulin domain,Kinase,Magnesium,Metal-binding,Muscle protein,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,SH3 domain,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Obscurin,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,disulfide bond,domain:DH,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like 1,domain:Ig-like 10,domain:Ig-like 11,domain:Ig-like 12,domain:Ig-like 13,domain:Ig-like 14,domain:Ig-like 15,domain:Ig-like 16,domain:Ig-like 17,domain:Ig-like 18,domain:Ig-like 19,domain:Ig-like 2,domain:Ig-like 20,domain:Ig-like 21,domain:Ig-like 22,domain:Ig-like 23,domain:Ig-like 24,domain:Ig-like 25,domain:Ig-like 26,domain:Ig-like 27,domain:Ig-like 28,domain:Ig-like 29,domain:Ig-like 3,domain:Ig-like 30,domain:Ig-like 31,domain:Ig-like 32,domain:Ig-like 33,domain:Ig-like 34,domain:Ig-like 35,domain:Ig-like 36,domain:Ig-like 37,domain:Ig-like 38,domain:Ig-like 39,domain:Ig-like 4,domain:Ig-like 40,domain:Ig-like 41,domain:Ig-like 42,domain:Ig-like 43,domain:Ig-like 44,domain:Ig-like 45,domain:Ig-like 46,domain:Ig-like 47,domain:Ig-like 48,domain:Ig-like 49,domain:Ig-like 5,domain:Ig-like 50,domain:Ig-like 51,domain:Ig-like 52,domain:Ig-like 53,domain:Ig-like 54,domain:Ig-like 55,domain:Ig-like 6,domain:Ig-like 7,domain:Ig-like 8,domain:Ig-like 9,domain:IQ,domain:PH,domain:Protein kinase 1,domain:Protein kinase 2,domain:SH3,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
OLFM3	olfactomedin 3(OLFM3)	Homo sapiens				GO:0042462~eye photoreceptor cell development,	GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0030054~cell junction,GO:0032281~AMPA glutamate receptor complex,GO:0045202~synapse,	GO:0005515~protein binding,	IPR003112:Olfactomedin-like,IPR011044:Quinoprotein amine dehydrogenase, beta chain-like,IPR022082:Neurogenesis glycoprotein,				SM00284:OLF,	Alternative splicing,Cell junction,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Reference proteome,Secreted,Signal,Synapse,	chain:Noelin-3,disulfide bond,domain:Olfactomedin-like,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,splice variant,
OLFML2B	olfactomedin like 2B(OLFML2B)	Homo sapiens				GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,	GO:0050840~extracellular matrix binding,	IPR003112:Olfactomedin-like,				SM00284:OLF,	Alternative splicing,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Olfactomedin-like protein 2B,compositionally biased region:Poly-Ala,disulfide bond,domain:Olfactomedin-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
OLFML3	olfactomedin like 3(OLFML3)	Homo sapiens				GO:0007275~multicellular organism development,	GO:1903561~extracellular vesicle,		IPR003112:Olfactomedin-like,				SM00284:OLF,	Alternative splicing,Coiled coil,Complete proteome,Developmental protein,Disulfide bond,Glycoprotein,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Olfactomedin-like protein 3,disulfide bond,domain:Olfactomedin-like,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
OR1C1	olfactory receptor family 1 subfamily C member 1(OR1C1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 1C1,disulfide bond,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR10J1	olfactory receptor family 10 subfamily J member 1(OR10J1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007338~single fertilization,GO:0007606~sensory perception of chemical stimulus,GO:0050907~detection of chemical stimulus involved in sensory perception,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 10J1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR10J4	olfactory receptor family 10 subfamily J member 4 (gene/pseudogene)(OR10J4)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050907~detection of chemical stimulus involved in sensory perception,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 10J4,disulfide bond,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR10K2	olfactory receptor family 10 subfamily K member 2(OR10K2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050907~detection of chemical stimulus involved in sensory perception,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 10K2,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR14A16	olfactory receptor family 14 subfamily A member 16(OR14A16)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,GO:0005549~odorant binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 14A16,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR14A2	olfactory receptor family 14 subfamily A member 2(OR14A2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,GO:0005549~odorant binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 14A2,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR14C36	olfactory receptor family 14 subfamily C member 36(OR14C36)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,GO:0005549~odorant binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 14C36,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2AJ1	olfactory receptor family 2 subfamily AJ member 1(OR2AJ1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2AJ1,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2B11	olfactory receptor family 2 subfamily B member 11(OR2B11)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2B11,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2C3	olfactory receptor family 2 subfamily C member 3(OR2C3)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2C3,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2G2	olfactory receptor family 2 subfamily G member 2(OR2G2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2G2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2G6	olfactory receptor family 2 subfamily G member 6(OR2G6)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2G6,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2L13	olfactory receptor family 2 subfamily L member 13(OR2L13)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,GO:0005515~protein binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2L13,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2L2	olfactory receptor family 2 subfamily L member 2(OR2L2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2L2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2L3	olfactory receptor family 2 subfamily L member 3(OR2L3)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2L3,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2L8	olfactory receptor family 2 subfamily L member 8 (gene/pseudogene)(OR2L8)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2L8,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2M3	olfactory receptor family 2 subfamily M member 3(OR2M3)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2M3,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T1	olfactory receptor family 2 subfamily T member 1(OR2T1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T11	olfactory receptor family 2 subfamily T member 11 (gene/pseudogene)(OR2T11)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T11,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T12	olfactory receptor family 2 subfamily T member 12(OR2T12)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T12,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T2	olfactory receptor family 2 subfamily T member 2(OR2T2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T2,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T27	olfactory receptor family 2 subfamily T member 27(OR2T27)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T27,chain:Olfactory receptor 2T7,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T33	olfactory receptor family 2 subfamily T member 33(OR2T33)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T33,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T35	olfactory receptor family 2 subfamily T member 35(OR2T35)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T35,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T4	olfactory receptor family 2 subfamily T member 4(OR2T4)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T4,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2T6	olfactory receptor family 2 subfamily T member 6(OR2T6)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T6,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2W3	olfactory receptor family 2 subfamily W member 3(OR2W3)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2T8,chain:Olfactory receptor 2W3,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR2W5	olfactory receptor family 2 subfamily W member 5 (gene/pseudogene)(OR2W5)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Putative olfactory receptor 2W5,disulfide bond,glycosylation site:N-linked (GlcNAc...),transmembrane region,
OR4F5	olfactory receptor family 4 subfamily F member 5(OR4F5)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050907~detection of chemical stimulus involved in sensory perception,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Olfaction,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 4F5,disulfide bond,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR5K3	olfactory receptor family 5 subfamily K member 3(OR5K3)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,GO:0005549~odorant binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 5K3,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR6K2	olfactory receptor family 6 subfamily K member 2(OR6K2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050907~detection of chemical stimulus involved in sensory perception,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 6K2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR6N1	olfactory receptor family 6 subfamily N member 1(OR6N1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 6N1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR6N2	olfactory receptor family 6 subfamily N member 2(OR6N2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050907~detection of chemical stimulus involved in sensory perception,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 6N2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR6P1	olfactory receptor family 6 subfamily P member 1(OR6P1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 6P1,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OR6Y1	olfactory receptor family 6 subfamily Y member 1(OR6Y1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 6Y1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OPRD1	opioid receptor delta 1(OPRD1)	Homo sapiens				GO:0000060~protein import into nucleus, translocation,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007268~chemical synaptic transmission,GO:0008344~adult locomotory behavior,GO:0010629~negative regulation of gene expression,GO:0019233~sensory perception of pain,GO:0032460~negative regulation of protein oligomerization,GO:0032793~positive regulation of CREB transcription factor activity,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0038003~opioid receptor signaling pathway,GO:0042755~eating behavior,GO:0051881~regulation of mitochondrial membrane potential,GO:0051924~regulation of calcium ion transport,GO:0051930~regulation of sensory perception of pain,GO:0071363~cellular response to growth factor stimulus,GO:0071456~cellular response to hypoxia,GO:0097237~cellular response to toxic substance,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0031226~intrinsic component of plasma membrane,GO:0031982~vesicle,GO:0032590~dendrite membrane,GO:0043005~neuron projection,GO:0043679~axon terminus,GO:0045121~membrane raft,GO:0045211~postsynaptic membrane,	GO:0004985~opioid receptor activity,GO:0005515~protein binding,GO:0038046~enkephalin receptor activity,GO:0042923~neuropeptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000321:Delta opioid receptor,IPR001418:Opioid receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,			SM01381:SM01381,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Delta-type opioid receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
OPN3	opsin 3(OPN3)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007602~phototransduction,GO:0009583~detection of light stimulus,GO:0009584~detection of visible light,GO:0018298~protein-chromophore linkage,GO:0042752~regulation of circadian rhythm,GO:0071482~cellular response to light stimulus,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0008020~G-protein coupled photoreceptor activity,GO:0009881~photoreceptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,IPR027430:Visual pigments (opsins) retinal binding site,					Alternative splicing,Chromophore,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Photoreceptor protein,Polymorphism,Receptor,Reference proteome,Retinal protein,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Opsin-3,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OPTC	opticin(OPTC)	Homo sapiens			Function unknown,		GO:0005578~proteinaceous extracellular matrix,	GO:0005201~extracellular matrix structural constituent,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00369:LRR_TYP,	Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Leucine-rich repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sulfation,	chain:Opticin,compositionally biased region:Cys-rich,compositionally biased region:Ser/Thr-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,sequence variant,signal peptide,
OSCP1	organic solute carrier partner 1(OSCP1)	Homo sapiens				GO:0006810~transport,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0009925~basal plasma membrane,		IPR019332:Organic solute carrier protein 1,					Alternative splicing,Cell membrane,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:Protein OSCP1,sequence conflict,sequence variant,splice variant,
ORC1	origin recognition complex subunit 1(ORC1)	Homo sapiens		h_mcmPathway:CDK Regulation of DNA Replication,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0006270~DNA replication initiation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000808~origin recognition complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005664~nuclear origin of replication recognition complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015163:CDC6, C-terminal domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04110:Cell cycle,	224690~Meier-Gorlin syndrome 1,		SM00382:AAA,SM00439:BAH,SM01074:SM01074,	Acetylation,ATP-binding,Complete proteome,Disease mutation,DNA replication,DNA-binding,Dwarfism,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Origin recognition complex subunit 1,domain:BAH,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
ORC4	origin recognition complex subunit 4(ORC4)	Homo sapiens		h_mcmPathway:CDK Regulation of DNA Replication,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0006270~DNA replication initiation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000808~origin recognition complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005664~nuclear origin of replication recognition complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003688~DNA replication origin binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR016527:Origin recognition complex, subunit 4,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04110:Cell cycle,	613800~Meier-Gorlin syndrome 2,	PIRSF007858:origin recognition complex, subunit 4,	SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Disease mutation,DNA replication,DNA-binding,Dwarfism,Methylation,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Origin recognition complex subunit 4,nucleotide phosphate-binding region:ATP,sequence variant,
OAZ3	ornithine decarboxylase antizyme 3(OAZ3)	Homo sapiens				GO:0006521~regulation of cellular amino acid metabolic process,GO:0006595~polyamine metabolic process,GO:0006596~polyamine biosynthetic process,GO:0007283~spermatogenesis,GO:0015847~putrescine transport,GO:0043086~negative regulation of catalytic activity,GO:0045732~positive regulation of protein catabolic process,GO:1902268~negative regulation of polyamine transmembrane transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0008073~ornithine decarboxylase inhibitor activity,GO:0015489~putrescine transmembrane transporter activity,	IPR002993:Ornithine decarboxylase antizyme,IPR016181:Acyl-CoA N-acyltransferase,					Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polyamine biosynthesis,Proteomics identification,Reference proteome,Ribosomal frameshifting,	chain:Ornithine decarboxylase antizyme 3,
OTX1	orthodenticle homeobox 1(OTX1)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0009952~anterior/posterior pattern specification,GO:0022037~metencephalon development,GO:0030901~midbrain development,GO:0042472~inner ear morphogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048852~diencephalon morphogenesis,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR003025:Transcription factor Otx,IPR003026:Transcription factor Otx1,IPR009057:Homeodomain-like,IPR013851:Transcription factor Otx, C-terminal,IPR017970:Homeobox, conserved site,	hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,Isopeptide bond,Nucleus,Reference proteome,Ubl conjugation,	chain:Homeobox protein OTX1,compositionally biased region:His-rich,DNA-binding region:Homeobox,
OTOF	otoferlin(OTOF)	Homo sapiens				GO:0007605~sensory perception of sound,GO:0016079~synaptic vesicle exocytosis,GO:0061025~membrane fusion,	GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0098793~presynapse,	GO:0005509~calcium ion binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR012561:Ferlin B-domain,IPR012968:FerIin domain,		601071~Auditory neuropathy, autosomal recessive, 1,601071~Deafness, autosomal recessive 9,		SM00239:C2,SM01201:SM01201,SM01202:SM01202,	Alternative splicing,Calcium,Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasmic vesicle,Deafness,Disease mutation,Endoplasmic reticulum,Hearing,Membrane,Neuropathy,Non-syndromic deafness,Polymorphism,Reference proteome,Repeat,Signal-anchor,Synapse,Transmembrane,Transmembrane helix,	chain:Otoferlin,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Lys,domain:C2 1,domain:C2 2,domain:C2 3,domain:C2 4,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OTOS	otospiralin(OTOS)	Homo sapiens				GO:0007605~sensory perception of sound,	GO:0005576~extracellular region,							Complete proteome,Polymorphism,Reference proteome,Secreted,Signal,	chain:Otospiralin,sequence variant,signal peptide,
ODF2L	outer dense fiber of sperm tails 2 like(ODF2L)	Homo sapiens					GO:0005813~centrosome,		IPR026099:Outer dense fibre protein 2-related,IPR026102:Outer dense fibre protein 2-like,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Outer dense fiber protein 2-like,sequence conflict,sequence variant,splice variant,
OVGP1	oviductal glycoprotein 1(OVGP1)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006032~chitin catabolic process,GO:0007339~binding of sperm to zona pellucida,GO:0007565~female pregnancy,GO:2000360~negative regulation of binding of sperm to zona pellucida,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030133~transport vesicle,GO:0035805~egg coat,GO:0098595~perivitelline space,	GO:0004568~chitinase activity,GO:0008061~chitin binding,	IPR001223:Glycoside hydrolase, family 18, catalytic domain,IPR011583:Chitinase II,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,				SM00636:Glyco_18,	Complete proteome,Cytoplasmic vesicle,Fertilization,Glycoprotein,Polymorphism,Reference proteome,Signal,	chain:Oviduct-specific glycoprotein,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
OXSR1	oxidative stress responsive 1(OXSR1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006979~response to oxidative stress,GO:0018107~peptidyl-threonine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0035556~intracellular signal transduction,GO:0071476~cellular hypotonic response,GO:1901017~negative regulation of potassium ion transmembrane transporter activity,GO:2000687~negative regulation of rubidium ion transmembrane transporter activity,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR024678:Serine/threonine-protein kinase OSR1/WNK, CCT domain,				SM00220:S_TKc,	3D-structure,Acetylation,ATP-binding,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase OSR1,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
OXNAD1	oxidoreductase NAD binding domain containing 1(OXNAD1)	Homo sapiens				GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,	GO:0016491~oxidoreductase activity,GO:0071949~FAD binding,	IPR001221:Phenol hydroxylase reductase,IPR001433:Oxidoreductase FAD/NAD(P)-binding,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,					Complete proteome,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Oxidoreductase NAD-binding domain- containing protein 1,domain:FAD-binding FR-type,nucleotide phosphate-binding region:NAD,sequence variant,signal peptide,
OSBPL10	oxysterol binding protein like 10(OSBPL10)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006869~lipid transport,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0001786~phosphatidylserine binding,GO:0015485~cholesterol binding,	IPR000648:Oxysterol-binding protein,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018494:Oxysterol-binding protein, conserved site,				SM00233:PH,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Lipid biosynthesis,Lipid metabolism,Lipid transport,Lipid-binding,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:Oxysterol-binding protein-related protein 10,domain:PH,modified residue,sequence variant,
OSBPL6	oxysterol binding protein like 6(OSBPL6)	Homo sapiens				GO:0006869~lipid transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031965~nuclear membrane,GO:0097038~perinuclear endoplasmic reticulum,	GO:0005515~protein binding,GO:0008289~lipid binding,	IPR000648:Oxysterol-binding protein,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018494:Oxysterol-binding protein, conserved site,				SM00233:PH,	Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Endoplasmic reticulum,Lipid transport,Lipid-binding,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transport,	chain:Oxysterol-binding protein-related protein 6,domain:PH,modified residue,sequence conflict,sequence variant,splice variant,
OSBPL9	oxysterol binding protein like 9(OSBPL9)	Homo sapiens				GO:0006869~lipid transport,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0031902~late endosome membrane,	GO:0008289~lipid binding,	IPR000648:Oxysterol-binding protein,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018494:Oxysterol-binding protein, conserved site,				SM00233:PH,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Endosome,Golgi apparatus,Lipid transport,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:Oxysterol-binding protein-related protein 9,domain:PH,modified residue,sequence conflict,splice variant,
PAX3	paired box 3(PAX3)	Homo sapiens		h_pmlPathway:Regulation of transcriptional activity by PML,		GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0007399~nervous system development,GO:0007517~muscle organ development,GO:0007605~sensory perception of sound,GO:0009887~organ morphogenesis,GO:0014029~neural crest formation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0071837~HMG box domain binding,	IPR001356:Homeodomain,IPR001523:Paired domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017970:Homeobox, conserved site,IPR022106:Paired box protein 7,		122880~Craniofacial-deafness-hand syndrome,148820~Waardenburg syndrome, type 3,193500~Waardenburg syndrome, type 1,268220~Rhabdomyosarcoma 2, alveolar,		SM00351:PAX,SM00389:HOX,	3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,Deafness,Developmental protein,Disease mutation,DNA-binding,Homeobox,Myogenesis,Neurogenesis,Nucleus,Paired box,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Waardenburg syndrome,	chain:Paired box protein Pax-3,DNA-binding region:Homeobox,domain:Paired,helix,sequence conflict,sequence variant,site:Breakpoint for translocation to form PAX3-NCOA1 oncogene,splice variant,
PAX7	paired box 7(PAX7)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0009653~anatomical structure morphogenesis,GO:0010453~regulation of cell fate commitment,GO:0014813~skeletal muscle satellite cell commitment,GO:0021527~spinal cord association neuron differentiation,GO:0021904~dorsal/ventral neural tube patterning,GO:0031062~positive regulation of histone methylation,GO:0043066~negative regulation of apoptotic process,GO:0043393~regulation of protein binding,GO:0043403~skeletal muscle tissue regeneration,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048663~neuron fate commitment,GO:0048706~embryonic skeletal system development,GO:0051216~cartilage development,GO:0060415~muscle tissue morphogenesis,GO:2000288~positive regulation of myoblast proliferation,	GO:0005634~nucleus,	GO:0000983~transcription factor activity, RNA polymerase II core promoter sequence-specific,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001523:Paired domain,IPR003654:OAR domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017970:Homeobox, conserved site,IPR022106:Paired box protein 7,		268220~Rhabdomyosarcoma 2, alveolar,		SM00351:PAX,SM00389:HOX,	Alternative splicing,Chromosomal rearrangement,Complete proteome,Developmental protein,DNA-binding,Homeobox,Myogenesis,Nucleus,Paired box,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Paired box protein Pax-7,compositionally biased region:Poly-Ala,DNA-binding region:Homeobox,domain:Paired,splice variant,
PAX8	paired box 8(PAX8)	Homo sapiens				GO:0001655~urogenital system development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006790~sulfur compound metabolic process,GO:0007275~multicellular organism development,GO:0007417~central nervous system development,GO:0009653~anatomical structure morphogenesis,GO:0030154~cell differentiation,GO:0030878~thyroid gland development,GO:0038194~thyroid-stimulating hormone signaling pathway,GO:0039003~pronephric field specification,GO:0042472~inner ear morphogenesis,GO:0042981~regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048793~pronephros development,GO:0071371~cellular response to gonadotropin stimulus,GO:0071599~otic vesicle development,GO:0072050~S-shaped body morphogenesis,GO:0072108~positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0072164~mesonephric tubule development,GO:0072207~metanephric epithelium development,GO:0072221~metanephric distal convoluted tubule development,GO:0072278~metanephric comma-shaped body morphogenesis,GO:0072284~metanephric S-shaped body morphogenesis,GO:0072289~metanephric nephron tubule formation,GO:0072305~negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,GO:0072307~regulation of metanephric nephron tubule epithelial cell differentiation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:1900212~negative regulation of mesenchymal cell apoptotic process involved in metanephros development,GO:1900215~negative regulation of apoptotic process involved in metanephric collecting duct development,GO:1900218~negative regulation of apoptotic process involved in metanephric nephron tubule development,GO:2000594~positive regulation of metanephric DCT cell differentiation,GO:2000611~positive regulation of thyroid hormone generation,GO:2000612~regulation of thyroid-stimulating hormone secretion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004996~thyroid-stimulating hormone receptor activity,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,	IPR001523:Paired domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR022130:Paired-box protein 2 C-terminal,	hsa04918:Thyroid hormone synthesis,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05216:Thyroid cancer,	218700~Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia,		SM00351:PAX,	3D-structure,Alternative splicing,Complete proteome,Congenital hypothyroidism,Developmental protein,Differentiation,Disease mutation,DNA-binding,Nucleus,Paired box,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Paired box protein Pax-8,compositionally biased region:Ser-rich,domain:Paired,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
PRRX1	paired related homeobox 1(PRRX1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0006355~regulation of transcription, DNA-templated,GO:0030326~embryonic limb morphogenesis,GO:0042472~inner ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048664~neuron fate determination,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048844~artery morphogenesis,GO:0051216~cartilage development,GO:0060021~palate development,GO:0070570~regulation of neuron projection regeneration,GO:0097150~neuronal stem cell population maintenance,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003713~transcription coactivator activity,GO:0043565~sequence-specific DNA binding,GO:0071837~HMG box domain binding,	IPR001356:Homeodomain,IPR003654:OAR domain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		202650~Agnathia-otocephaly complex,		SM00389:HOX,	Acetylation,Alternative splicing,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Paired mesoderm homeobox protein 1,DNA-binding region:Homeobox,modified residue,short sequence motif:OAR,splice variant,
PALMD	palmdelphin(PALMD)	Homo sapiens				GO:0008360~regulation of cell shape,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043197~dendritic spine,		IPR004965:Paralemmin,					Acetylation,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Palmdelphin,compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,splice variant,
PPT1	palmitoyl-protein thioesterase 1(PPT1)	Homo sapiens				GO:0002084~protein depalmitoylation,GO:0006898~receptor-mediated endocytosis,GO:0006907~pinocytosis,GO:0007042~lysosomal lumen acidification,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0007399~nervous system development,GO:0007420~brain development,GO:0007601~visual perception,GO:0007625~grooming behavior,GO:0008306~associative learning,GO:0008344~adult locomotory behavior,GO:0015031~protein transport,GO:0016042~lipid catabolic process,GO:0030149~sphingolipid catabolic process,GO:0030163~protein catabolic process,GO:0030308~negative regulation of cell growth,GO:0031579~membrane raft organization,GO:0032429~regulation of phospholipase A2 activity,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0043066~negative regulation of apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0044257~cellular protein catabolic process,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048549~positive regulation of pinocytosis,GO:0048666~neuron development,GO:0050803~regulation of synapse structure or activity,GO:0050896~response to stimulus,GO:0051181~cofactor transport,GO:0051186~cofactor metabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005764~lysosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043202~lysosomal lumen,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008474~palmitoyl-(protein) hydrolase activity,GO:0016290~palmitoyl-CoA hydrolase activity,	IPR002472:Palmitoyl protein thioesterase,	hsa00062:Fatty acid elongation,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,hsa04142:Lysosome,	256730~Ceroid lipofuscinosis, neuronal, 1,			3D-structure,Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Neurodegeneration,Neuronal ceroid lipofuscinosis,Polymorphism,Proteomics identification,Reference proteome,Secreted,Sensory transduction,Signal,Vision,	chain:Palmitoyl-protein thioesterase 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,
PANK4	pantothenate kinase 4(PANK4)	Homo sapiens				GO:0015937~coenzyme A biosynthetic process,GO:0016310~phosphorylation,	GO:0005737~cytoplasm,	GO:0004594~pantothenate kinase activity,GO:0005524~ATP binding,	IPR002791:Domain of unknown function DUF89,IPR004567:Type II pantothenate kinase,IPR015844:Pantothenate kinase, acetyl-CoA regulated, two-domain type,	hsa00770:Pantothenate and CoA biosynthesis,hsa01100:Metabolic pathways,		PIRSF036939:pantothenate kinase, acetyl-CoA regulated, two-domain type,		Acetylation,ATP-binding,Coenzyme A biosynthesis,Complete proteome,Cytoplasm,Kinase,Nitration,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Pantothenate kinase 4,modified residue,sequence variant,
PRCC	papillary renal cell carcinoma (translocation-associated)(PRCC)	Homo sapiens				GO:0007093~mitotic cell cycle checkpoint,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,	GO:0005515~protein binding,	IPR018800:Mitotic checkpoint protein PRCC, C-terminal,	hsa05202:Transcriptional misregulation in cancer,	605074~Renal cell carcinoma, papillary,			Cell cycle,Chromosomal rearrangement,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Proline-rich protein PRCC,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Thr,modified residue,sequence variant,
PAPPA2	pappalysin 2(PAPPA2)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006508~proteolysis,GO:0044267~cellular protein metabolic process,GO:0060349~bone morphogenesis,	GO:0005576~extracellular region,GO:0005622~intracellular,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000436:Sushi/SCR/CCP,IPR000800:Notch domain,IPR003961:Fibronectin, type III,IPR006558:LamG-like jellyroll fold,IPR008754:Peptidase M43, pregnancy-associated plasma-A,IPR011936:Myxococcus cysteine-rich repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR026918:Pappalysin-2,				SM00004:NL,SM00032:CCP,SM00560:LamGL,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Signal,Sushi,Zinc,Zymogen,	chain:Pappalysin-2,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Thr,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,mutagenesis site,region of interest:Metalloprotease,sequence conflict,sequence variant,signal peptide,splice variant,
PARD3B	par-3 family cell polarity regulator beta(PARD3B)	Homo sapiens				GO:0007049~cell cycle,GO:0051301~cell division,	GO:0005923~bicellular tight junction,GO:0012505~endomembrane system,GO:0016020~membrane,		IPR001478:PDZ domain,IPR021922:Protein of unknown function DUF3534,				SM00228:PDZ,	Alternative splicing,Cell cycle,Cell division,Cell junction,Coiled coil,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Tight junction,	chain:Partitioning defective 3 homolog B,compositionally biased region:Lys-rich,compositionally biased region:Poly-Pro,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,modified residue,sequence conflict,sequence variant,splice variant,
PTH2R	parathyroid hormone 2 receptor(PTH2R)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004991~parathyroid hormone receptor activity,GO:0005515~protein binding,	IPR000832:GPCR, family 2, secretin-like,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,			SM00008:HormR,	Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Parathyroid hormone 2 receptor,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PNKD	paroxysmal nonkinesigenic dyskinesia(PNKD)	Homo sapiens				GO:0019243~methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,GO:0032225~regulation of synaptic transmission, dopaminergic,GO:0042053~regulation of dopamine metabolic process,GO:0046929~negative regulation of neurotransmitter secretion,GO:0050884~neuromuscular process controlling posture,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0004416~hydroxyacylglutathione hydrolase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001279:Beta-lactamase-like,IPR017782:Hydroxyacylglutathione hydrolase,		118800~Paroxysmal nonkinesigenic dyskinesia,		SM00849:SM00849,	Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Dystonia,Hydrolase,Membrane,Metal-binding,Mitochondrion,Nucleus,Phosphoprotein,Reference proteome,Zinc,	chain:Probable hydrolase PNKD,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,region of interest:Substrate,sequence conflict,sequence variant,splice variant,
PNO1	partner of NOB1 homolog(PNO1)	Homo sapiens			General function prediction only,	GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,	GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	Acetylation,Complete proteome,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:RNA-binding protein pno1,domain:KH,modified residue,sequence variant,
PCNX2	pecanex homolog 2 (Drosophila)(PCNX2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007735:Pecanex,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Pecanex-like protein 2,compositionally biased region:Ser-rich,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,splice variant,transmembrane region,
PELI1	pellino E3 ubiquitin protein ligase 1(PELI1)	Homo sapiens				GO:0001819~positive regulation of cytokine production,GO:0008063~Toll signaling pathway,GO:0030890~positive regulation of B cell proliferation,GO:0031398~positive regulation of protein ubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032496~response to lipopolysaccharide,GO:0034141~positive regulation of toll-like receptor 3 signaling pathway,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,GO:0042130~negative regulation of T cell proliferation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043331~response to dsRNA,GO:0070936~protein K48-linked ubiquitination,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0016874~ligase activity,GO:0034450~ubiquitin-ubiquitin ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR006800:Pellino family,			PIRSF038886:pellino,		Complete proteome,Ligase,Phosphoprotein,Reference proteome,Ubl conjugation,Ubl conjugation pathway,	chain:Protein pellino homolog 1,sequence conflict,
PEF1	penta-EF-hand domain containing 1(PEF1)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0006508~proteolysis,GO:0051592~response to calcium ion,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Complete proteome,Cytoplasm,Membrane,Metal-binding,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:Peflin,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,domain:EF-hand 5,region of interest:9 X 9 AA approximate tandem repeat of [AP]-P-G-G-P-Y-G-G-P-P,region of interest:Required for interaction with PDCD6/ALG2,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,
PGLYRP4	peptidoglycan recognition protein 4(PGLYRP4)	Homo sapiens				GO:0002221~pattern recognition receptor signaling pathway,GO:0009253~peptidoglycan catabolic process,GO:0016045~detection of bacterium,GO:0045087~innate immune response,GO:0050830~defense response to Gram-positive bacterium,	GO:0005576~extracellular region,GO:0005622~intracellular,GO:0016020~membrane,	GO:0008270~zinc ion binding,GO:0008745~N-acetylmuramoyl-L-alanine amidase activity,GO:0016019~peptidoglycan receptor activity,GO:0042834~peptidoglycan binding,	IPR002502:N-acetylmuramoyl-L-alanine amidase domain,IPR006619:Peptidoglycan recognition protein family domain, metazoa/bacteria,IPR015510:Peptidoglycan recognition protein,				SM00644:Ami_2,SM00701:PGRP,	3D-structure,Alternative splicing,Antibiotic,Antimicrobial,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Polymorphism,Reference proteome,Secreted,Signal,	binding site:Murein,chain:Peptidoglycan recognition protein 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Interaction with murein,sequence variant,signal peptide,splice variant,strand,turn,
PADI1	peptidyl arginine deiminase 1(PADI1)	Homo sapiens				GO:0006325~chromatin organization,GO:0018101~protein citrullination,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004668~protein-arginine deiminase activity,GO:0005509~calcium ion binding,	IPR004303:Protein-arginine deiminase,IPR008972:Cupredoxin,IPR013530:Protein-arginine deiminase, C-terminal,IPR013732:Protein-arginine deiminase (PAD) N-terminal,IPR013733:Protein-arginine deiminase (PAD), central domain,			PIRSF001247:protein-arginine deiminase,		3D-structure,Calcium,Complete proteome,Cytoplasm,Hydrolase,Polymorphism,Reference proteome,	chain:Protein-arginine deiminase type-1,sequence conflict,sequence variant,
PADI2	peptidyl arginine deiminase 2(PADI2)	Homo sapiens				GO:0006325~chromatin organization,GO:0010848~regulation of chromatin disassembly,GO:0018101~protein citrullination,GO:0021762~substantia nigra development,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0036413~histone H3-R26 citrullination,GO:0048096~chromatin-mediated maintenance of transcription,GO:0070100~negative regulation of chemokine-mediated signaling pathway,GO:1901624~negative regulation of lymphocyte chemotaxis,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0035327~transcriptionally active chromatin,GO:0070062~extracellular exosome,	GO:0004668~protein-arginine deiminase activity,GO:0005509~calcium ion binding,GO:0030331~estrogen receptor binding,	IPR004303:Protein-arginine deiminase,IPR008972:Cupredoxin,IPR013530:Protein-arginine deiminase, C-terminal,IPR013732:Protein-arginine deiminase (PAD) N-terminal,IPR013733:Protein-arginine deiminase (PAD), central domain,			PIRSF001247:protein-arginine deiminase,		3D-structure,Alternative splicing,Calcium,Complete proteome,Cytoplasm,Hydrolase,Reference proteome,	chain:Protein-arginine deiminase type-2,sequence conflict,
PADI3	peptidyl arginine deiminase 3(PADI3)	Homo sapiens				GO:0006325~chromatin organization,GO:0018101~protein citrullination,	GO:0005829~cytosol,	GO:0004668~protein-arginine deiminase activity,GO:0005509~calcium ion binding,GO:0042802~identical protein binding,	IPR004303:Protein-arginine deiminase,IPR008972:Cupredoxin,IPR013530:Protein-arginine deiminase, C-terminal,IPR013732:Protein-arginine deiminase (PAD) N-terminal,IPR013733:Protein-arginine deiminase (PAD), central domain,			PIRSF001247:protein-arginine deiminase,		Calcium,Complete proteome,Cytoplasm,Hydrolase,Polymorphism,Reference proteome,	chain:Protein-arginine deiminase type-3,sequence conflict,sequence variant,
PADI4	peptidyl arginine deiminase 4(PADI4)	Homo sapiens				GO:0006325~chromatin organization,GO:0006334~nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006464~cellular protein modification process,GO:0018101~protein citrullination,GO:0019827~stem cell population maintenance,GO:0036413~histone H3-R26 citrullination,GO:0036414~histone citrullination,GO:0045087~innate immune response,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004668~protein-arginine deiminase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0016990~arginine deiminase activity,	IPR004303:Protein-arginine deiminase,IPR008972:Cupredoxin,IPR013530:Protein-arginine deiminase, C-terminal,IPR013732:Protein-arginine deiminase (PAD) N-terminal,IPR013733:Protein-arginine deiminase (PAD), central domain,		180300~Rheumatoid arthritis, susceptibility to,	PIRSF001247:protein-arginine deiminase,		3D-structure,Calcium,Chromatin regulator,Citrullination,Complete proteome,Cytoplasm,Hydrolase,Immunity,Innate immunity,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	binding site:Substrate,binding site:Substrate; via carbonyl oxygen,chain:Protein-arginine deiminase type-4,helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,metal ion-binding site:Calcium 4,metal ion-binding site:Calcium 4; via carbonyl oxygen,metal ion-binding site:Calcium 5,metal ion-binding site:Calcium 5; via carbonyl oxygen,mutagenesis site,sequence variant,strand,turn,
PADI6	peptidyl arginine deiminase 6(PADI6)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007028~cytoplasm organization,GO:0018101~protein citrullination,GO:0043143~regulation of translation by machinery localization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0045111~intermediate filament cytoskeleton,	GO:0004668~protein-arginine deiminase activity,GO:0005509~calcium ion binding,	IPR004303:Protein-arginine deiminase,IPR008972:Cupredoxin,IPR013530:Protein-arginine deiminase, C-terminal,IPR013732:Protein-arginine deiminase (PAD) N-terminal,IPR013733:Protein-arginine deiminase (PAD), central domain,			PIRSF001247:protein-arginine deiminase,		3D-structure,Calcium,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Reference proteome,	chain:Protein-arginine deiminase type-6,compositionally biased region:Poly-Leu,sequence conflict,
PPIAL4D	peptidylprolyl isomerase A like 4D(PPIAL4D)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0005737~cytoplasm,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,			PIRSF001467:peptidyl-prolyl cis-trans isomerase,		Complete proteome,Cytoplasm,Isomerase,Reference proteome,Rotamase,
PPIAL4E	peptidylprolyl isomerase A like 4E(PPIAL4E)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0005737~cytoplasm,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,			PIRSF001467:peptidyl-prolyl cis-trans isomerase,		Complete proteome,Cytoplasm,Isomerase,Reference proteome,Rotamase,	chain:Peptidylprolyl cis-trans isomerase A-like 4A,chain:Peptidylprolyl cis-trans isomerase A-like 4B,domain:PPIase cyclophilin-type,sequence conflict,
PPIAL4G	peptidylprolyl isomerase A like 4G(PPIAL4G)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0005737~cytoplasm,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,			PIRSF001467:peptidyl-prolyl cis-trans isomerase,		Complete proteome,Cytoplasm,Isomerase,Reference proteome,Rotamase,	chain:Peptidylprolyl cis-trans isomerase A-like 4A,chain:Peptidylprolyl cis-trans isomerase A-like 4B,domain:PPIase cyclophilin-type,sequence conflict,
PPIE	peptidylprolyl isomerase E(PPIE)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0000413~protein peptidyl-prolyl isomerization,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006457~protein folding,GO:0045070~positive regulation of viral genome replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0016018~cyclosporin A binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR016304:Cyclophilin-type peptidyl-prolyl cis-trans isomerase E,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,	hsa03040:Spliceosome,		PIRSF001475:peptidyl-prolyl cis-trans isomerase E,	SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Isomerase,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Rotamase,Spliceosome,	chain:Peptidyl-prolyl cis-trans isomerase E,compositionally biased region:Poly-Ala,domain:PPIase cyclophilin-type,domain:RRM,helix,sequence conflict,splice variant,strand,turn,
PPIG	peptidylprolyl isomerase G(PPIG)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0016018~cyclosporin A binding,GO:0044822~poly(A) RNA binding,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,					3D-structure,Alternative splicing,Complete proteome,Cyclosporin,Isomerase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Rotamase,	chain:Peptidyl-prolyl cis-trans isomerase G,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Asp/Glu/Ser-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Ser,domain:PPIase cyclophilin-type,helix,modified residue,sequence variant,splice variant,strand,turn,
PPIL3	peptidylprolyl isomerase like 3(PPIL3)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0016021~integral component of membrane,GO:0071013~catalytic step 2 spliceosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0016853~isomerase activity,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,			PIRSF001467:peptidyl-prolyl cis-trans isomerase,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Isomerase,Membrane,Methylation,mRNA processing,mRNA splicing,Polymorphism,Proteomics identification,Reference proteome,Rotamase,Spliceosome,Transmembrane,Transmembrane helix,	chain:Peptidyl-prolyl cis-trans isomerase-like 3,domain:PPIase cyclophilin-type,helix,sequence conflict,sequence variant,splice variant,strand,turn,
PER2	period circadian clock 2(PER2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002931~response to ischemia,GO:0005978~glycogen biosynthetic process,GO:0006094~gluconeogenesis,GO:0006351~transcription, DNA-templated,GO:0006631~fatty acid metabolic process,GO:0007623~circadian rhythm,GO:0019229~regulation of vasoconstriction,GO:0019249~lactate biosynthetic process,GO:0031397~negative regulation of protein ubiquitination,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0042754~negative regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050767~regulation of neurogenesis,GO:0050796~regulation of insulin secretion,GO:0050872~white fat cell differentiation,GO:0051726~regulation of cell cycle,GO:0051946~regulation of glutamate uptake involved in transmission of nerve impulse,GO:0070345~negative regulation of fat cell proliferation,GO:0070932~histone H3 deacetylation,GO:0097167~circadian regulation of translation,GO:2000678~negative regulation of transcription regulatory region DNA binding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043130~ubiquitin binding,	IPR000014:PAS domain,IPR013655:PAS fold-3,IPR022728:Period circadian-like, C-terminal,	hsa04710:Circadian rhythm,hsa04713:Circadian entrainment,hsa05168:Herpes simplex infection,hsa05202:Transcriptional misregulation in cancer,	604348~Advanced sleep phase syndrome, familial, 1,		SM00091:PAS,	Acetylation,Alternative splicing,Biological rhythms,Complete proteome,Cytoplasm,Disease mutation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Period circadian protein homolog 2,compositionally biased region:Poly-Arg,compositionally biased region:Pro-rich,domain:PAC,domain:PAS 1,domain:PAS 2,modified residue,mutagenesis site,region of interest:CRY binding domain,region of interest:CSNK1E binding domain,sequence variant,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,splice variant,
PER3	period circadian clock 3(PER3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0032922~circadian regulation of gene expression,GO:0045187~regulation of circadian sleep/wake cycle, sleep,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0019900~kinase binding,GO:0031625~ubiquitin protein ligase binding,	IPR000014:PAS domain,IPR013655:PAS fold-3,IPR015524:Period circadian protein 3,IPR022728:Period circadian-like, C-terminal,	hsa04710:Circadian rhythm,hsa04713:Circadian entrainment,hsa05168:Herpes simplex infection,			SM00091:PAS,	Alternative splicing,Biological rhythms,Complete proteome,Cytoplasm,Disease mutation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Period circadian protein homolog 3,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:PAC,domain:PAS 1,domain:PAS 2,region of interest:CRY binding domain,region of interest:CSNK1E binding domain,sequence conflict,sequence variant,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,
PXDN	peroxidasin(PXDN)	Homo sapiens				GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0006955~immune response,GO:0006979~response to oxidative stress,GO:0030198~extracellular matrix organization,GO:0042744~hydrogen peroxide catabolic process,GO:0055114~oxidation-reduction process,GO:0098869~cellular oxidant detoxification,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004601~peroxidase activity,GO:0005152~interleukin-1 receptor antagonist activity,GO:0005201~extracellular matrix structural constituent,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR000483:Cysteine-rich flanking region, C-terminal,IPR001007:von Willebrand factor, type C,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR010255:Haem peroxidase,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR019791:Haem peroxidase, animal, subgroup,		269400~Corneal opacification and other ocular anomalies,		SM00082:LRRCT,SM00214:VWC,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,	Alternative splicing,Calcium,Coiled coil,Complete proteome,Disease mutation,Disulfide bond,Extracellular matrix,Glycoprotein,Heme,Hydrogen peroxide,Immunoglobulin domain,Iron,Leucine-rich repeat,Metal-binding,Oxidoreductase,Peroxidase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	active site:Proton acceptor,binding site:Heme (covalent; via 2 links),chain:Peroxidasin homolog,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:VWFC,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,metal ion-binding site:Iron (heme axial ligand),modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence variant,signal peptide,site:Transition state stabilizer,splice variant,
PRDX1	peroxiredoxin 1(PRDX1)	Homo sapiens				GO:0000302~response to reactive oxygen species,GO:0001501~skeletal system development,GO:0001895~retina homeostasis,GO:0008283~cell proliferation,GO:0019430~removal of superoxide radicals,GO:0032872~regulation of stress-activated MAPK cascade,GO:0034101~erythrocyte homeostasis,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042744~hydrogen peroxide catabolic process,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,GO:0098609~cell-cell adhesion,	GO:0005615~extracellular space,GO:0005623~cell,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0031012~extracellular matrix,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004601~peroxidase activity,GO:0005515~protein binding,GO:0008379~thioredoxin peroxidase activity,GO:0016209~antioxidant activity,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0051920~peroxiredoxin activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000866:Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR019479:Peroxiredoxin, C-terminal,IPR024706:Peroxiredoxin, AhpC-type,	hsa04146:Peroxisome,		PIRSF000239:peroxiredoxin, AhpC type,		3D-structure,Acetylation,Antioxidant,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Isopeptide bond,Oxidoreductase,Peroxidase,Phosphoprotein,Polymorphism,Proteomics identification,Redox-active center,Reference proteome,Ubl conjugation,	active site:Cysteine sulfenic acid (-SOH) intermediate,chain:Peroxiredoxin-1,disulfide bond,domain:Thioredoxin,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,turn,
PEX13	peroxisomal biogenesis factor 13(PEX13)	Homo sapiens				GO:0001561~fatty acid alpha-oxidation,GO:0001764~neuron migration,GO:0001967~suckling behavior,GO:0007626~locomotory behavior,GO:0016560~protein import into peroxisome matrix, docking,GO:0021795~cerebral cortex cell migration,GO:0060152~microtubule-based peroxisome localization,	GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005779~integral component of peroxisomal membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,	IPR001452:Src homology-3 domain,IPR007223:Peroxin 13, N-terminal,	hsa04146:Peroxisome,	614883~Peroxisome biogenesis disorder 11A (Zellweger),614885~Peroxisome biogenesis disorder 11B,		SM00326:SH3,	Complete proteome,Disease mutation,Membrane,Peroxisome,Peroxisome biogenesis disorder,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,SH3 domain,Transmembrane,Transmembrane helix,Transport,Zellweger syndrome,	chain:Peroxisomal membrane protein PEX13,compositionally biased region:Poly-Pro,domain:SH3,region of interest:Interaction with PEX19,region of interest:Targeting to peroxisomes,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
PEX14	peroxisomal biogenesis factor 14(PEX14)	Homo sapiens				GO:0006461~protein complex assembly,GO:0007031~peroxisome organization,GO:0016558~protein import into peroxisome matrix,GO:0016560~protein import into peroxisome matrix, docking,GO:0016561~protein import into peroxisome matrix, translocation,GO:0032091~negative regulation of protein binding,GO:0034453~microtubule anchoring,GO:0036250~peroxisome transport along microtubule,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0044721~protein import into peroxisome matrix, substrate release,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051260~protein homooligomerization,GO:1901094~negative regulation of protein homotetramerization,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,	GO:0003714~transcription corepressor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0047485~protein N-terminus binding,GO:0048487~beta-tubulin binding,	IPR006785:Peroxisome membrane anchor protein Pex14p, N-terminal,IPR025655:Peroxisomal membrane protein 14,	hsa04146:Peroxisome,	614887~Peroxisome biogenesis disorder 13A (Zellweger),			3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Membrane,Peroxisome,Peroxisome biogenesis disorder,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Translocation,Transport,Zellweger syndrome,	chain:Peroxisomal membrane protein PEX14,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
PECR	peroxisomal trans-2-enoyl-CoA reductase(PECR)	Homo sapiens				GO:0006633~fatty acid biosynthetic process,GO:0033306~phytol metabolic process,GO:0044255~cellular lipid metabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005102~receptor binding,GO:0008670~2,4-dienoyl-CoA reductase (NADPH) activity,GO:0019166~trans-2-enoyl-CoA reductase (NADPH) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,	hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,hsa04146:Peroxisome,				3D-structure,Alternative splicing,Complete proteome,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,NADP,Oxidoreductase,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton acceptor,chain:Peroxisomal trans-2-enoyl-CoA reductase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,short sequence motif:Microbody targeting signal,splice variant,strand,turn,
PPARG	peroxisome proliferator activated receptor gamma(PPARG)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_PPARgPathway:Role of PPAR-gamma Coactivators in Obesity and Thermogenesis,h_pparPathway:Basic mechanism of action of PPARa, PPARb(d) and PPARg and effects on gene expression,h_vobesityPathway:Visceral Fat Deposits and the Metabolic Syndrome,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001890~placenta development,GO:0002674~negative regulation of acute inflammatory response,GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006629~lipid metabolic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007507~heart development,GO:0007584~response to nutrient,GO:0008217~regulation of blood pressure,GO:0009409~response to cold,GO:0009612~response to mechanical stimulus,GO:0010742~macrophage derived foam cell differentiation,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010871~negative regulation of receptor biosynthetic process,GO:0010887~negative regulation of cholesterol storage,GO:0010891~negative regulation of sequestering of triglyceride,GO:0015909~long-chain fatty acid transport,GO:0019395~fatty acid oxidation,GO:0030224~monocyte differentiation,GO:0030308~negative regulation of cell growth,GO:0030855~epithelial cell differentiation,GO:0031000~response to caffeine,GO:0031100~organ regeneration,GO:0032526~response to retinoic acid,GO:0032869~cellular response to insulin stimulus,GO:0032966~negative regulation of collagen biosynthetic process,GO:0033189~response to vitamin A,GO:0033993~response to lipid,GO:0035357~peroxisome proliferator activated receptor signaling pathway,GO:0035902~response to immobilization stress,GO:0042493~response to drug,GO:0042593~glucose homeostasis,GO:0042594~response to starvation,GO:0042752~regulation of circadian rhythm,GO:0042953~lipoprotein transport,GO:0043401~steroid hormone mediated signaling pathway,GO:0043627~response to estrogen,GO:0045087~innate immune response,GO:0045165~cell fate commitment,GO:0045600~positive regulation of fat cell differentiation,GO:0045713~low-density lipoprotein particle receptor biosynthetic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046321~positive regulation of fatty acid oxidation,GO:0048469~cell maturation,GO:0048511~rhythmic process,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0050872~white fat cell differentiation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051974~negative regulation of telomerase activity,GO:0055088~lipid homeostasis,GO:0055098~response to low-density lipoprotein particle,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0060336~negative regulation of interferon-gamma-mediated signaling pathway,GO:0060694~regulation of cholesterol transporter activity,GO:0060850~regulation of transcription involved in cell fate commitment,GO:0071300~cellular response to retinoic acid,GO:0071306~cellular response to vitamin E,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071455~cellular response to hyperoxia,GO:1901558~response to metformin,GO:2000230~negative regulation of pancreatic stellate cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0001046~core promoter sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0004955~prostaglandin receptor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008144~drug binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0019903~protein phosphatase binding,GO:0030331~estrogen receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0033613~activating transcription factor binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046965~retinoid X receptor binding,GO:0050544~arachidonic acid binding,GO:0051393~alpha-actinin binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003074:Peroxisome proliferator-activated receptor,IPR003077:Peroxisome proliferator-activated receptor, gamma,IPR013088:Zinc finger, NHR/GATA-type,IPR022590:Peroxisome proliferator-activated receptor gamma, N-terminal,	hsa03320:PPAR signaling pathway,hsa04152:AMPK signaling pathway,hsa04380:Osteoclast differentiation,hsa05016:Huntington's disease,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05216:Thyroid cancer,	125853~Diabetes, type 2,601665~Obesity, severe,604367~Insulin resistance, severe, digenic,604367~Lipodystrophy, familial partial, type 3,609338~Carotid intimal medial thickness 1,Obesity, resistance to~Obesity, resistance to,		SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Activator,Alternative splicing,Biological rhythms,Complete proteome,Cytoplasm,Diabetes mellitus,Disease mutation,DNA-binding,Glycoprotein,Metal-binding,Nucleus,Obesity,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	binding site:Synthetic agonist,chain:Peroxisome proliferator-activated receptor gamma,DNA-binding region:Nuclear receptor,helix,modified residue,region of interest:Interaction with FAM120B,region of interest:Ligand-binding,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:NR C4-type,
FARSB	phenylalanyl-tRNA synthetase beta subunit(FARSB)	Homo sapiens				GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006432~phenylalanyl-tRNA aminoacylation,GO:0051290~protein heterotetramerization,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0009328~phenylalanine-tRNA ligase complex,GO:0016020~membrane,	GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0004826~phenylalanine-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR004531:Phenylalanyl-tRNA synthetase, class IIc, beta subunit, archae/euk cytosolic,IPR005146:B3/B4 tRNA-binding domain,IPR005147:tRNA synthetase, B5-domain,IPR009061:DNA binding domain, putative,IPR020825:Phenylalanyl-tRNA synthetase, B3/B4,	hsa00970:Aminoacyl-tRNA biosynthesis,			SM00873:SM00873,SM00874:SM00874,	3D-structure,Alternative splicing,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Ligase,Nucleotide-binding,Polymorphism,Protein biosynthesis,Reference proteome,	chain:Phenylalanyl-tRNA synthetase beta chain,modified residue,sequence conflict,
PDCL3	phosducin like 3(PDCL3)	Homo sapiens				GO:0001525~angiogenesis,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006457~protein folding,GO:0006915~apoptotic process,GO:0008616~queuosine biosynthetic process,GO:0016032~viral process,GO:0045766~positive regulation of angiogenesis,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008479~queuine tRNA-ribosyltransferase activity,GO:0043184~vascular endothelial growth factor receptor 2 binding,GO:0044183~protein binding involved in protein folding,	IPR006442:Type II toxin-antitoxin system, antitoxin Phd/YefM,IPR012336:Thioredoxin-like fold,IPR024253:Phosducin, thioredoxin-like domain,					Angiogenesis,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Host-virus interaction,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Phosducin-like protein 3,modified residue,
PDC	phosducin(PDC)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007601~visual perception,GO:0007602~phototransduction,GO:0008616~queuosine biosynthetic process,GO:0043086~negative regulation of catalytic activity,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004859~phospholipase inhibitor activity,GO:0008479~queuine tRNA-ribosyltransferase activity,	IPR001200:Phosducin,IPR012336:Thioredoxin-like fold,IPR023196:Phosducin N-terminal domain,IPR024253:Phosducin, thioredoxin-like domain,					Alternative splicing,Cell projection,Cilium,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Reference proteome,Sensory transduction,Vision,	chain:Phosducin,modified residue,sequence conflict,
PDCL3P4	phosducin-like 3 pseudogene 4(PDCL3P4)	Homo sapiens													chain:Phosducin-like protein 3,modified residue,
PHACTR4	phosphatase and actin regulator 4(PHACTR4)	Homo sapiens				GO:0001755~neural crest cell migration,GO:0001843~neural tube closure,GO:0007266~Rho protein signal transduction,GO:0030036~actin cytoskeleton organization,GO:0043085~positive regulation of catalytic activity,GO:0048484~enteric nervous system development,GO:0051726~regulation of cell cycle,GO:0061386~closure of optic fissure,GO:2001045~negative regulation of integrin-mediated signaling pathway,	GO:0005737~cytoplasm,GO:0030027~lamellipodium,	GO:0003779~actin binding,GO:0004864~protein phosphatase inhibitor activity,GO:0008157~protein phosphatase 1 binding,GO:0008599~protein phosphatase type 1 regulator activity,GO:0071862~protein phosphatase type 1 activator activity,GO:0072542~protein phosphatase activator activity,	IPR004018:RPEL repeat,				SM00707:RPEL,	Actin-binding,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Developmental protein,Neurogenesis,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Phosphatase and actin regulator 4,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,modified residue,repeat:RPEL 1,repeat:RPEL 2,repeat:RPEL 3,sequence conflict,splice variant,
PHOSPHO2	phosphatase, orphan 2(PHOSPHO2)	Homo sapiens				GO:0016311~dephosphorylation,		GO:0005515~protein binding,GO:0016791~phosphatase activity,GO:0033883~pyridoxal phosphatase activity,GO:0046872~metal ion binding,	IPR006383:HAD-superfamily hydrolase, subfamily IB, PSPase-like,IPR006384:Pyridoxal phosphate phosphatase-related,IPR016965:Phosphatase PHOSPHO-type,IPR023214:HAD-like domain,	hsa00750:Vitamin B6 metabolism,hsa01100:Metabolic pathways,		PIRSF031051:pyridoxal phosphate phosphatase, PHOSPHO2 type,		Complete proteome,Hydrolase,Magnesium,Metal-binding,Polymorphism,Pyridoxal phosphate,Reference proteome,	active site:Nucleophile,active site:Proton donor,binding site:Substrate,chain:Pyridoxal phosphate phosphatase PHOSPHO2,metal ion-binding site:Magnesium,sequence variant,
PI4KB	phosphatidylinositol 4-kinase beta(PI4KB)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0006898~receptor-mediated endocytosis,GO:0007165~signal transduction,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005768~endosome,GO:0005829~cytosol,GO:0030867~rough endoplasmic reticulum membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004430~1-phosphatidylinositol 4-kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0071889~14-3-3 protein binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR001263:Phosphoinositide 3-kinase, accessory (PIK) domain,IPR011009:Protein kinase-like domain,IPR015433:Phosphatidylinositol Kinase,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,			SM00146:PI3Kc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,Golgi apparatus,Kinase,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	chain:Phosphatidylinositol 4-kinase beta,domain:PI3K/PI4K,modified residue,sequence conflict,splice variant,
PIGF	phosphatidylinositol glycan anchor biosynthesis class F(PIGF)	Homo sapiens				GO:0006506~GPI anchor biosynthetic process,GO:0016254~preassembly of GPI anchor in ER membrane,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004307~ethanolaminephosphotransferase activity,GO:0016491~oxidoreductase activity,	IPR009580:GPI biosynthesis protein Pig-F,	hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Endoplasmic reticulum,GPI-anchor biosynthesis,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Phosphatidylinositol-glycan biosynthesis class F protein,splice variant,transmembrane region,
PIGK	phosphatidylinositol glycan anchor biosynthesis class K(PIGK)	Homo sapiens				GO:0006508~proteolysis,GO:0016255~attachment of GPI anchor to protein,GO:0034394~protein localization to cell surface,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0042765~GPI-anchor transamidase complex,	GO:0003756~protein disulfide isomerase activity,GO:0003923~GPI-anchor transamidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0034235~GPI anchor binding,	IPR001096:Peptidase C13, legumain,	hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,hsa01100:Metabolic pathways,		PIRSF019663:transamidase/peptidase, legumain type,PIRSF500138:glycosylphosphatidylinositol:protein transamidase, catalytic/GPI8 component [Parent=PIRSF019663],		Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,GPI-anchor biosynthesis,Hydrolase,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,Thiol protease,Transmembrane,Transmembrane helix,	chain:GPI-anchor transamidase,disulfide bond,mutagenesis site,region of interest:Essential for GPI attachment,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
PIGV	phosphatidylinositol glycan anchor biosynthesis class V(PIGV)	Homo sapiens				GO:0006506~GPI anchor biosynthetic process,GO:0016254~preassembly of GPI anchor in ER membrane,GO:0097502~mannosylation,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031501~mannosyltransferase complex,	GO:0000030~mannosyltransferase activity,GO:0004376~glycolipid mannosyltransferase activity,GO:0004584~dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,	IPR007315:GPI mannosyltransferase 2,	hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,hsa01100:Metabolic pathways,	239300~Hyperphosphatasia with mental retardation syndrome 1,			Complete proteome,Disease mutation,Endoplasmic reticulum,Glycosyltransferase,GPI-anchor biosynthesis,Membrane,Mental retardation,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:GPI mannosyltransferase 2,mutagenesis site,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
PLCXD2	phosphatidylinositol specific phospholipase C X domain containing 2(PLCXD2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0007165~signal transduction,GO:0016042~lipid catabolic process,	GO:0005634~nucleus,	GO:0004871~signal transducer activity,GO:0008081~phosphoric diester hydrolase activity,	IPR000909:Phospholipase C, phosphatidylinositol-specific , X domain,IPR017946:PLC-like phosphodiesterase, TIM beta/alpha-barrel domain,				SM00148:PLCXc,	Alternative splicing,Complete proteome,Hydrolase,Lipid degradation,Lipid metabolism,Nucleus,Reference proteome,Transducer,	chain:PI-PLC X domain-containing protein 2,chain:Pleckstrin homology-like domain family B member 2,domain:PH,domain:PI-PLC X-box,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
PIK3CD	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta(PIK3CD)	Homo sapiens				GO:0001779~natural killer cell differentiation,GO:0001816~cytokine production,GO:0002250~adaptive immune response,GO:0002551~mast cell chemotaxis,GO:0002679~respiratory burst involved in defense response,GO:0006468~protein phosphorylation,GO:0006661~phosphatidylinositol biosynthetic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0010628~positive regulation of gene expression,GO:0010818~T cell chemotaxis,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016310~phosphorylation,GO:0030101~natural killer cell activation,GO:0030217~T cell differentiation,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0035747~natural killer cell chemotaxis,GO:0035754~B cell chemotaxis,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0043303~mast cell degranulation,GO:0045087~innate immune response,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0060374~mast cell differentiation,GO:0072672~neutrophil extravasation,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0042629~mast cell granule,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0035004~phosphatidylinositol 3-kinase activity,GO:0035005~1-phosphatidylinositol-4-phosphate 3-kinase activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR000341:Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain,IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR001263:Phosphoinositide 3-kinase, accessory (PIK) domain,IPR002420:Phosphatidylinositol 3-kinase C2 (PI3K C2) domain,IPR003113:Phosphatidylinositol 3-kinase adaptor-binding (PI3K ABD) domain,IPR011009:Protein kinase-like domain,IPR015433:Phosphatidylinositol Kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,	hsa00562:Inositol phosphate metabolism,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05100:Bacterial invasion of epithelial cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	615513~Immunodeficiency 14,		SM00142:PI3K_C2,SM00143:PI3K_p85B,SM00144:PI3K_rbd,SM00145:PI3Ka,SM00146:PI3Kc,	3D-structure,Adaptive immunity,Alternative splicing,ATP-binding,Chemotaxis,Complete proteome,Cytoplasm,Differentiation,Direct protein sequencing,Disease mutation,Immunity,Inflammatory response,Innate immunity,Kinase,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	chain:Phosphatidylinositol-4,5-bisphosphate 3- kinase catalytic subunit delta isoform,domain:PI3K/PI4K,modified residue,mutagenesis site,sequence conflict,
PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta(PIK3C2B)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0009267~cellular response to starvation,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0043491~protein kinase B signaling,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:1905037~autophagosome organization,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0030139~endocytic vesicle,	GO:0001727~lipid kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0035005~1-phosphatidylinositol-4-phosphate 3-kinase activity,GO:0035091~phosphatidylinositol binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000341:Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain,IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR001263:Phosphoinositide 3-kinase, accessory (PIK) domain,IPR001683:Phox homologous domain,IPR002420:Phosphatidylinositol 3-kinase C2 (PI3K C2) domain,IPR011009:Protein kinase-like domain,IPR015433:Phosphatidylinositol Kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,			SM00142:PI3K_C2,SM00144:PI3K_rbd,SM00145:PI3Ka,SM00146:PI3Kc,SM00239:C2,SM00312:PX,	ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Endoplasmic reticulum,Kinase,Membrane,Microsome,Nucleotide-binding,Nucleus,Proteomics identification,Reference proteome,Transferase,	chain:Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit beta,compositionally biased region:Pro-rich,domain:C2,domain:PI3K/PI4K,domain:PX,modified residue,region of interest:Interaction with GRB2,sequence conflict,
PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha(PIP5K1A)	Homo sapiens		h_rhoPathway:Rho cell motility signaling pathway,		GO:0006650~glycerophospholipid metabolic process,GO:0006661~phosphatidylinositol biosynthetic process,GO:0006909~phagocytosis,GO:0007165~signal transduction,GO:0008654~phospholipid biosynthetic process,GO:0010761~fibroblast migration,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016477~cell migration,GO:0030216~keratinocyte differentiation,GO:0031532~actin cytoskeleton reorganization,GO:0046854~phosphatidylinositol phosphorylation,GO:0048041~focal adhesion assembly,GO:0060326~cell chemotaxis,GO:0072661~protein targeting to plasma membrane,GO:0090630~activation of GTPase activity,GO:0097178~ruffle assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016607~nuclear speck,GO:0030027~lamellipodium,GO:0032587~ruffle membrane,	GO:0000285~1-phosphatidylinositol-3-phosphate 5-kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016307~phosphatidylinositol phosphate kinase activity,GO:0016308~1-phosphatidylinositol-4-phosphate 5-kinase activity,GO:0019900~kinase binding,GO:0052810~1-phosphatidylinositol-5-kinase activity,GO:0052811~1-phosphatidylinositol-3-phosphate 4-kinase activity,GO:0052812~phosphatidylinositol-3,4-bisphosphate 5-kinase activity,	IPR002498:Phosphatidylinositol-4-phosphate 5-kinase, core,IPR023610:Phosphatidylinositol-4-phosphate 5-kinase,IPR027483:Phosphatidylinositol-4-phosphate 5-kinase, C-terminal,IPR027484:Phosphatidylinositol-4-phosphate 5-kinase, N-terminal domain,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05231:Choline metabolism in cancer,			SM00330:PIPKc,	Alternative splicing,ATP-binding,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Isopeptide bond,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Ubl conjugation,	chain:Phosphatidylinositol-4-phosphate 5-kinase type-1 alpha,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:PIPK,modified residue,splice variant,
PDE11A	phosphodiesterase 11A(PDE11A)	Homo sapiens				GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0046069~cGMP catabolic process,	GO:0005829~cytosol,GO:0043204~perikaryon,	GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0004118~cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,GO:0030552~cAMP binding,GO:0030553~cGMP binding,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003018:GAF domain,IPR003607:HD/PDEase domain,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,hsa05032:Morphine addiction,	610475~Pigmented nodular adrenocortical disease, primary, 2,		SM00065:GAF,SM00471:HDc,	Allosteric enzyme,Alternative splicing,cAMP,cGMP,Complete proteome,Cushing syndrome,Cytoplasm,Hydrolase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	active site:Proton donor,binding site:cAMP or cGMP,chain:Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A,domain:GAF 1,domain:GAF 2,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,modified residue,mutagenesis site,region of interest:Catalytic,sequence variant,splice variant,
PDE12	phosphodiesterase 12(PDE12)	Homo sapiens				GO:0006397~mRNA processing,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0005759~mitochondrial matrix,	GO:0004535~poly(A)-specific ribonuclease activity,GO:0046872~metal ion binding,	IPR005135:Endonuclease/exonuclease/phosphatase,					3D-structure,Alternative splicing,Complete proteome,Exonuclease,Hydrolase,Magnesium,Metal-binding,Mitochondrion,mRNA processing,Nuclease,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:2',5'-phosphodiesterase 12,sequence variant,splice variant,
PDE1A	phosphodiesterase 1A(PDE1A)	Homo sapiens				GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0034391~regulation of smooth muscle cell apoptotic process,GO:0046069~cGMP catabolic process,GO:0048660~regulation of smooth muscle cell proliferation,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0043025~neuronal cell body,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0004117~calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,GO:0005516~calmodulin binding,GO:0030553~cGMP binding,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,GO:0048101~calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003607:HD/PDEase domain,IPR013706:3'5'-cyclic nucleotide phosphodiesterase N-terminal,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,hsa04020:Calcium signaling pathway,hsa04742:Taste transduction,hsa04924:Renin secretion,hsa05032:Morphine addiction,			SM00471:HDc,	3D-structure,Alternative splicing,Calmodulin-binding,cAMP,cGMP,Complete proteome,Hydrolase,Metal-binding,Reference proteome,	active site:Proton donor,chain:Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,region of interest:Calmodulin-binding,region of interest:Catalytic,splice variant,strand,turn,
PDE4B	phosphodiesterase 4B(PDE4B)	Homo sapiens				GO:0001780~neutrophil homeostasis,GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0030593~neutrophil chemotaxis,GO:0032729~positive regulation of interferon-gamma production,GO:0032743~positive regulation of interleukin-2 production,GO:0035690~cellular response to drug,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0071222~cellular response to lipopolysaccharide,GO:0071872~cellular response to epinephrine stimulus,GO:0086004~regulation of cardiac muscle cell contraction,GO:1901841~regulation of high voltage-gated calcium channel activity,GO:1901898~negative regulation of relaxation of cardiac muscle,	GO:0000930~gamma-tubulin complex,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005891~voltage-gated calcium channel complex,GO:0008021~synaptic vesicle,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030018~Z disc,GO:0043197~dendritic spine,GO:0071944~cell periphery,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0030552~cAMP binding,GO:0044325~ion channel binding,GO:0046872~metal ion binding,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003607:HD/PDEase domain,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,hsa04024:cAMP signaling pathway,hsa05032:Morphine addiction,			SM00471:HDc,	3D-structure,Alternative splicing,cAMP,Complete proteome,Hydrolase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton donor,binding site:cAMP,chain:cAMP-specific 3',5'-cyclic phosphodiesterase 4B,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,modified residue,nucleotide phosphate-binding region:cAMP,sequence variant,site:Binds AMP, but not cAMP,splice variant,strand,turn,
PDE4DIP	phosphodiesterase 4D interacting protein(PDE4DIP)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0043623~cellular protein complex assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0030016~myofibril,	GO:0005515~protein binding,GO:0019899~enzyme binding,	IPR005454:Profilin, chordates,IPR005455:Profilin,IPR010630:Neuroblastoma breakpoint family (NBPF) domain,IPR012943:Spindle associated,				SM01148:SM01148,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Myomegalin,domain:NBPF,sequence conflict,sequence variant,site:Breakpoint for insertion to form PDE4DIP- PDGFRB fusion protein,splice variant,
PDE6D	phosphodiesterase 6D(PDE6D)	Homo sapiens				GO:0007601~visual perception,GO:0034260~negative regulation of GTPase activity,GO:0050896~response to stimulus,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0072372~primary cilium,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0005095~GTPase inhibitor activity,GO:0005515~protein binding,GO:0017137~Rab GTPase binding,	IPR008015:GMP phosphodiesterase, delta subunit,IPR014756:Immunoglobulin E-set,IPR017287:Retinal rod rhodopsin-sensitive cGMP 3', 5'-cyclic phosphodiesterase, delta subunit,	hsa00230:Purine metabolism,	615665~Joubert syndrome 22,	PIRSF037825:retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase, delta subunit,		3D-structure,Cell projection,cGMP,Ciliopathy,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Joubert syndrome,Membrane,Proteomics identification,Reference proteome,Sensory transduction,Vision,	chain:Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta,helix,sequence conflict,strand,turn,
PGM1	phosphoglucomutase 1(PGM1)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0005978~glycogen biosynthetic process,GO:0005980~glycogen catabolic process,GO:0006006~glucose metabolic process,GO:0006094~gluconeogenesis,GO:0006096~glycolytic process,GO:0019388~galactose catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004614~phosphoglucomutase activity,GO:0005515~protein binding,GO:0016868~intramolecular transferase activity, phosphotransferases,	IPR005841:Alpha-D-phosphohexomutase superfamily,IPR005843:Alpha-D-phosphohexomutase, C-terminal,IPR005844:Alpha-D-phosphohexomutase, alpha/beta/alpha domain I,IPR005845:Alpha-D-phosphohexomutase, alpha/beta/alpha domain II,IPR005846:Alpha-D-phosphohexomutase, alpha/beta/alpha domain III,IPR016055:Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III,IPR016066:Alpha-D-phosphohexomutase, conserved site,	hsa00010:Glycolysis / Gluconeogenesis,hsa00030:Pentose phosphate pathway,hsa00052:Galactose metabolism,hsa00230:Purine metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	614921~Congenital disorder of glycosylation, type It,			3D-structure,Acetylation,Alternative splicing,Carbohydrate metabolism,Complete proteome,Congenital disorder of glycosylation,Cytoplasm,Disease mutation,Glucose metabolism,Glycogen storage disease,Isomerase,Magnesium,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,	active site:Phosphoserine intermediate,chain:Phosphoglucomutase-1,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via phosphate group,modified residue,sequence conflict,sequence variant,splice variant,
PGD	phosphogluconate dehydrogenase(PGD)	Homo sapiens				GO:0006098~pentose-phosphate shunt,GO:0009051~pentose-phosphate shunt, oxidative branch,GO:0019322~pentose biosynthetic process,GO:0019521~D-gluconate metabolic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004616~phosphogluconate dehydrogenase (decarboxylating) activity,	IPR006113:6-phosphogluconate dehydrogenase, decarboxylating,IPR006114:6-phosphogluconate dehydrogenase, C-terminal,IPR006115:6-phosphogluconate dehydrogenase, NADP-binding,IPR006184:6-phosphogluconate-binding site,IPR008927:6-phosphogluconate dehydrogenase, C-terminal-like,IPR012284:Fibritin/6-phosphogluconate dehydrogenase, C-terminal extension,IPR013328:Dehydrogenase, multihelical,IPR016040:NAD(P)-binding domain,	hsa00030:Pentose phosphate pathway,hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,		PIRSF000109:phosphogluconate dehydrogenase (decarboxylating),	SM01350:SM01350,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Gluconate utilization,NADP,Oxidoreductase,Pentose shunt,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:6-phosphogluconate dehydrogenase, decarboxylating,helix,modified residue,sequence conflict,sequence variant,strand,turn,
PHGDH	phosphoglycerate dehydrogenase(PHGDH)	Homo sapiens				GO:0006541~glutamine metabolic process,GO:0006544~glycine metabolic process,GO:0006564~L-serine biosynthetic process,GO:0006566~threonine metabolic process,GO:0007420~brain development,GO:0009070~serine family amino acid biosynthetic process,GO:0009448~gamma-aminobutyric acid metabolic process,GO:0010468~regulation of gene expression,GO:0019530~taurine metabolic process,GO:0021510~spinal cord development,GO:0021782~glial cell development,GO:0021915~neural tube development,GO:0031175~neuron projection development,GO:0055114~oxidation-reduction process,GO:0070314~G1 to G0 transition,	GO:0005829~cytosol,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004617~phosphoglycerate dehydrogenase activity,GO:0009055~electron carrier activity,GO:0051287~NAD binding,	IPR006139:D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain,IPR006140:D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding,IPR006236:D-3-phosphoglycerate dehydrogenase,IPR016040:NAD(P)-binding domain,	hsa00260:Glycine, serine and threonine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01230:Biosynthesis of amino acids,	256520~Neu-Laxova syndrome 1,601815~Phosphoglycerate dehydrogenase deficiency,			3D-structure,Acetylation,Amino-acid biosynthesis,Complete proteome,Direct protein sequencing,Disease mutation,Isopeptide bond,NAD,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Serine biosynthesis,Signal,Ubl conjugation,	active site:Proton donor,binding site:NAD,binding site:NAD; via carbonyl oxygen,chain:D-3-phosphoglycerate dehydrogenase,helix,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,strand,turn,
PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing(PIKFYVE)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0006898~receptor-mediated endocytosis,GO:0032288~myelin assembly,GO:0034504~protein localization to nucleus,GO:0035556~intracellular signal transduction,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0042147~retrograde transport, endosome to Golgi,GO:0046854~phosphatidylinositol phosphorylation,GO:1904562~phosphatidylinositol 5-phosphate metabolic process,GO:2000785~regulation of autophagosome assembly,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0010008~endosome membrane,GO:0012506~vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0000285~1-phosphatidylinositol-3-phosphate 5-kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016308~1-phosphatidylinositol-4-phosphate 5-kinase activity,GO:0043813~phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR000591:DEP domain,IPR002423:Chaperonin Cpn60/TCP-1,IPR002498:Phosphatidylinositol-4-phosphate 5-kinase, core,IPR011011:Zinc finger, FYVE/PHD-type,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027483:Phosphatidylinositol-4-phosphate 5-kinase, C-terminal,IPR027484:Phosphatidylinositol-4-phosphate 5-kinase, N-terminal domain,	hsa00562:Inositol phosphate metabolism,hsa04070:Phosphatidylinositol signaling system,hsa04145:Phagosome,hsa04810:Regulation of actin cytoskeleton,	121850~Corneal fleck dystrophy,		SM00049:DEP,SM00064:FYVE,SM00330:PIPKc,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Corneal dystrophy,Disease mutation,Endosome,Kinase,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Zinc,Zinc-finger,	chain:1-phosphatidylinositol-3-phosphate 5- kinase,domain:DEP,domain:PIPK,modified residue,region of interest:Catalytic,sequence variant,zinc finger region:FYVE-type,
PIK3R3	phosphoinositide-3-kinase regulatory subunit 3(PIK3R3)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006661~phosphatidylinositol biosynthetic process,GO:0008286~insulin receptor signaling pathway,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0043551~regulation of phosphatidylinositol 3-kinase activity,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005829~cytosol,GO:0005942~phosphatidylinositol 3-kinase complex,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,	IPR000980:SH2 domain,IPR001720:PI3 kinase, P85 regulatory subunit,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05100:Bacterial invasion of epithelial cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,			SM00252:SH2,	Alternative splicing,Coiled coil,Complete proteome,Kinase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH2 domain,Transferase,	chain:Phosphatidylinositol 3-kinase regulatory subunit gamma,compositionally biased region:Pro-rich,domain:SH2 1,domain:SH2 2,modified residue,sequence conflict,sequence variant,splice variant,
PLA2G2C	phospholipase A2 group IIC(PLA2G2C)	Homo sapiens				GO:0006644~phospholipid metabolic process,GO:0016042~lipid catabolic process,GO:0050482~arachidonic acid secretion,	GO:0005576~extracellular region,	GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,	IPR001211:Phospholipase A2,IPR016090:Phospholipase A2 domain,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04972:Pancreatic secretion,hsa04975:Fat digestion and absorption,			SM00085:PA2c,	Calcium,Complete proteome,Disulfide bond,Hydrolase,Lipid metabolism,Metal-binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Putative inactive group IIC secretory phospholipase A2,disulfide bond,metal ion-binding site:Calcium; via carbonyl oxygen,sequence conflict,sequence variant,signal peptide,
PLA2G4A	phospholipase A2 group IVA(PLA2G4A)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,		GO:0006644~phospholipid metabolic process,GO:0006654~phosphatidic acid biosynthetic process,GO:0006663~platelet activating factor biosynthetic process,GO:0006690~icosanoid metabolic process,GO:0009395~phospholipid catabolic process,GO:0019369~arachidonic acid metabolic process,GO:0035965~cardiolipin acyl-chain remodeling,GO:0036148~phosphatidylglycerol acyl-chain remodeling,GO:0036149~phosphatidylinositol acyl-chain remodeling,GO:0036150~phosphatidylserine acyl-chain remodeling,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0042127~regulation of cell proliferation,GO:0046456~icosanoid biosynthetic process,GO:0050482~arachidonic acid secretion,GO:0071236~cellular response to antibiotic,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008970~phosphatidylcholine 1-acylhydrolase activity,GO:0046872~metal ion binding,GO:0047498~calcium-dependent phospholipase A2 activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR002642:Lysophospholipase, catalytic domain,IPR016035:Acyl transferase/acyl hydrolase/lysophospholipase,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04370:VEGF signaling pathway,hsa04611:Platelet activation,hsa04664:Fc epsilon RI signaling pathway,hsa04724:Glutamatergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04921:Oxytocin signaling pathway,hsa05231:Choline metabolism in cancer,	Phospholipase A2, group IV A, deficiency of~Phospholipase A2, group IV A, deficiency of,		SM00022:PLAc,SM00239:C2,	3D-structure,Calcium,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,Hydrolase,Lipid degradation,Lipid metabolism,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,	chain:Cytosolic phospholipase A2,domain:C2,domain:PLA2c,helix,modified residue,mutagenesis site,region of interest:Phospholipid binding,sequence variant,strand,turn,
PLA2G5	phospholipase A2 group V(PLA2G5)	Homo sapiens				GO:0006644~phospholipid metabolic process,GO:0006654~phosphatidic acid biosynthetic process,GO:0006663~platelet activating factor biosynthetic process,GO:0010518~positive regulation of phospholipase activity,GO:0016042~lipid catabolic process,GO:0019370~leukotriene biosynthetic process,GO:0034097~response to cytokine,GO:0036148~phosphatidylglycerol acyl-chain remodeling,GO:0036149~phosphatidylinositol acyl-chain remodeling,GO:0036150~phosphatidylserine acyl-chain remodeling,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0050482~arachidonic acid secretion,GO:0051591~response to cAMP,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005576~extracellular region,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,GO:0008201~heparin binding,GO:0047498~calcium-dependent phospholipase A2 activity,	IPR001211:Phospholipase A2,IPR016090:Phospholipase A2 domain,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04972:Pancreatic secretion,hsa04975:Fat digestion and absorption,	228980~Fleck retina, familial benign,		SM00085:PA2c,	3D-structure,Calcium,Complete proteome,Disease mutation,Disulfide bond,Hydrolase,Lipid degradation,Lipid metabolism,Metal-binding,Reference proteome,Secreted,Signal,	chain:Calcium-dependent phospholipase A2,disulfide bond,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,signal peptide,
PLA2R1	phospholipase A2 receptor 1(PLA2R1)	Homo sapiens				GO:0001816~cytokine production,GO:0006898~receptor-mediated endocytosis,GO:0007165~signal transduction,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0072593~reactive oxygen species metabolic process,GO:0090238~positive regulation of arachidonic acid secretion,GO:0090399~replicative senescence,GO:0090403~oxidative stress-induced premature senescence,GO:1900138~negative regulation of phospholipase A2 activity,GO:1900139~negative regulation of arachidonic acid secretion,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0030246~carbohydrate binding,GO:0043274~phospholipase binding,	IPR000562:Fibronectin, type II, collagen-binding,IPR000772:Ricin B lectin domain,IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04145:Phagosome,hsa05152:Tuberculosis,			SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Lectin,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Secretory phospholipase A2 receptor,chain:Soluble secretory phospholipase A2 receptor,disulfide bond,domain:C-type lectin 1,domain:C-type lectin 2,domain:C-type lectin 3,domain:C-type lectin 4,domain:C-type lectin 5,domain:C-type lectin 6,domain:C-type lectin 7,domain:C-type lectin 8,domain:Fibronectin type-II,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Endocytosis signal,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PLB1	phospholipase B1(PLB1)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0006629~lipid metabolic process,GO:0016042~lipid catabolic process,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0042572~retinol metabolic process,GO:2000344~positive regulation of acrosome reaction,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,	GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0016298~lipase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0050253~retinyl-palmitate esterase activity,	IPR001087:Lipase, GDSL,IPR008265:Lipase, GDSL, active site,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04977:Vitamin digestion and absorption,				Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Hydrolase,Lipid degradation,Lipid metabolism,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Nucleophile,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:Phospholipase B1, membrane-associated,glycosylation site:N-linked (GlcNAc...),region of interest:4 X 308-326 AA approximate repeats,region of interest:Necessary for membrane localization,repeat:1,repeat:2,repeat:3,repeat:4,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PLCD1	phospholipase C delta 1(PLCD1)	Homo sapiens		h_plcdPathway:Phospholipase C d1 in phospholipid associated cell signaling,		GO:0001525~angiogenesis,GO:0006644~phospholipid metabolic process,GO:0016042~lipid catabolic process,GO:0035556~intracellular signal transduction,GO:0042127~regulation of cell proliferation,GO:0043647~inositol phosphate metabolic process,GO:0060716~labyrinthine layer blood vessel development,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0001786~phosphatidylserine binding,GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,GO:0032794~GTPase activating protein binding,GO:0070300~phosphatidic acid binding,GO:1901981~phosphatidylinositol phosphate binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000909:Phospholipase C, phosphatidylinositol-specific , X domain,IPR001192:Phosphoinositide phospholipase C,IPR001711:Phospholipase C, phosphatidylinositol-specific, Y domain,IPR001849:Pleckstrin homology domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR011993:Pleckstrin homology-like domain,IPR015359:Phospholipase C, phosphoinositol-specific, EF-hand-like,IPR017946:PLC-like phosphodiesterase, TIM beta/alpha-barrel domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04919:Thyroid hormone signaling pathway,	151600~Nail disorder, nonsyndromic congenital, 3, (leukonychia),		SM00054:EFh,SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	Alternative splicing,Calcium,Complete proteome,Disease mutation,Glycoprotein,Hydrolase,Lipid degradation,Lipid metabolism,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transducer,	binding site:Substrate,calcium-binding region:1,calcium-binding region:2,chain:1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1,domain:C2,domain:EF-hand 1,domain:EF-hand 2,domain:PH,domain:PI-PLC X-box,domain:PI-PLC Y-box,metal ion-binding site:Calcium 1; catalytic,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,region of interest:Substrate binding,sequence conflict,sequence variant,
PLCD4	phospholipase C delta 4(PLCD4)	Homo sapiens				GO:0007340~acrosome reaction,GO:0016042~lipid catabolic process,GO:0035556~intracellular signal transduction,GO:0046488~phosphatidylinositol metabolic process,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0031965~nuclear membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004629~phospholipase C activity,GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000909:Phospholipase C, phosphatidylinositol-specific , X domain,IPR001192:Phosphoinositide phospholipase C,IPR001711:Phospholipase C, phosphatidylinositol-specific, Y domain,IPR001849:Pleckstrin homology domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR011993:Pleckstrin homology-like domain,IPR015359:Phospholipase C, phosphoinositol-specific, EF-hand-like,IPR017946:PLC-like phosphodiesterase, TIM beta/alpha-barrel domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04919:Thyroid hormone signaling pathway,			SM00054:EFh,SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	Alternative splicing,Calcium,Complete proteome,Cytoplasm,Endoplasmic reticulum,Hydrolase,Lipid degradation,Lipid metabolism,Membrane,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transducer,	binding site:Substrate,calcium-binding region:1,calcium-binding region:2,chain:1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-4,compositionally biased region:Glu-rich,compositionally biased region:Poly-Lys,domain:C2,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:PH,domain:PI-PLC X-box,domain:PI-PLC Y-box,metal ion-binding site:Calcium 1; catalytic,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,region of interest:Substrate binding,sequence conflict,short sequence motif:PDZ-binding,splice variant,
PLCH2	phospholipase C eta 2(PLCH2)	Homo sapiens				GO:0016042~lipid catabolic process,GO:0035556~intracellular signal transduction,GO:0043647~inositol phosphate metabolic process,GO:0046488~phosphatidylinositol metabolic process,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004629~phospholipase C activity,GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000909:Phospholipase C, phosphatidylinositol-specific , X domain,IPR001192:Phosphoinositide phospholipase C,IPR001711:Phospholipase C, phosphatidylinositol-specific, Y domain,IPR001849:Pleckstrin homology domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR011993:Pleckstrin homology-like domain,IPR015359:Phospholipase C, phosphoinositol-specific, EF-hand-like,IPR017946:PLC-like phosphodiesterase, TIM beta/alpha-barrel domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,			SM00054:EFh,SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	Alternative splicing,Calcium,Cell membrane,Complete proteome,Cytoplasm,Hydrolase,Lipid degradation,Lipid metabolism,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transducer,	binding site:Substrate,chain:1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-2,domain:C2,domain:EF-hand 1,domain:EF-hand 2,domain:PH,domain:PI-PLC X-box,domain:PI-PLC Y-box,metal ion-binding site:Calcium 1; catalytic,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,modified residue,region of interest:Necessary for plasma membrane localization,sequence conflict,splice variant,
PLCL1	phospholipase C like 1(PLCL1)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0016042~lipid catabolic process,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:1900122~positive regulation of receptor binding,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004629~phospholipase C activity,GO:0004871~signal transducer activity,GO:0050811~GABA receptor binding,GO:0070679~inositol 1,4,5 trisphosphate binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000909:Phospholipase C, phosphatidylinositol-specific , X domain,IPR001192:Phosphoinositide phospholipase C,IPR001711:Phospholipase C, phosphatidylinositol-specific, Y domain,IPR001849:Pleckstrin homology domain,IPR011992:EF-hand-like domain,IPR011993:Pleckstrin homology-like domain,IPR015359:Phospholipase C, phosphoinositol-specific, EF-hand-like,IPR017946:PLC-like phosphodiesterase, TIM beta/alpha-barrel domain,	hsa04727:GABAergic synapse,			SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Lipid degradation,Lipid metabolism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transducer,	chain:Inactive phospholipase C-like protein 1,domain:C2,domain:PH,domain:PI-PLC X-box,domain:PI-PLC Y-box,modified residue,region of interest:Interaction with GABA A beta subunit,region of interest:Interaction with PPP1C,sequence conflict,sequence variant,splice variant,
PLCL2	phospholipase C like 2(PLCL2)	Homo sapiens				GO:0002322~B cell proliferation involved in immune response,GO:0002337~B-1a B cell differentiation,GO:0006629~lipid metabolic process,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0016042~lipid catabolic process,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0050859~negative regulation of B cell receptor signaling pathway,GO:1900122~positive regulation of receptor binding,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004871~signal transducer activity,GO:0050811~GABA receptor binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000909:Phospholipase C, phosphatidylinositol-specific , X domain,IPR001192:Phosphoinositide phospholipase C,IPR001711:Phospholipase C, phosphatidylinositol-specific, Y domain,IPR001849:Pleckstrin homology domain,IPR011992:EF-hand-like domain,IPR011993:Pleckstrin homology-like domain,IPR015359:Phospholipase C, phosphoinositol-specific, EF-hand-like,IPR017946:PLC-like phosphodiesterase, TIM beta/alpha-barrel domain,				SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Lipid degradation,Lipid metabolism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transducer,	chain:Inactive phospholipase C-like protein 2,compositionally biased region:Gly-rich,domain:C2,domain:PH,domain:PI-PLC X-box,domain:PI-PLC Y-box,modified residue,sequence variant,splice variant,
PLD5	phospholipase D family member 5(PLD5)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0003824~catalytic activity,	IPR001736:Phospholipase D/Transphosphatidylase,				SM00155:PLDc,	Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Inactive phospholipase D5,domain:PLD phosphodiesterase 1,domain:PLD phosphodiesterase 2,glycosylation site:N-linked (GlcNAc...),splice variant,transmembrane region,
PLPP3	phospholipid phosphatase 3(PLPP3)	Homo sapiens				GO:0001568~blood vessel development,GO:0001702~gastrulation with mouth forming second,GO:0001933~negative regulation of protein phosphorylation,GO:0006470~protein dephosphorylation,GO:0006629~lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0008354~germ cell migration,GO:0030111~regulation of Wnt signaling pathway,GO:0030148~sphingolipid biosynthetic process,GO:0034109~homotypic cell-cell adhesion,GO:0044328~canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,GO:0044329~canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,GO:0044330~canonical Wnt signaling pathway involved in positive regulation of wound healing,GO:0046839~phospholipid dephosphorylation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060020~Bergmann glial cell differentiation,GO:1902068~regulation of sphingolipid mediated signaling pathway,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005912~adherens junction,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004721~phosphoprotein phosphatase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008195~phosphatidate phosphatase activity,GO:0042392~sphingosine-1-phosphate phosphatase activity,GO:0042577~lipid phosphatase activity,	IPR000326:Phosphatidic acid phosphatase type 2/haloperoxidase,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04666:Fc gamma R-mediated phagocytosis,hsa04975:Fat digestion and absorption,hsa05231:Choline metabolism in cancer,			SM00014:acidPPc,	Cell membrane,Complete proteome,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Lipid phosphate phosphohydrolase 3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
PLPPR5	phospholipid phosphatase related 5(PLPPR5)	Homo sapiens				GO:0006644~phospholipid metabolic process,GO:0007165~signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0046839~phospholipid dephosphorylation,GO:0051491~positive regulation of filopodium assembly,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0042577~lipid phosphatase activity,	IPR000326:Phosphatidic acid phosphatase type 2/haloperoxidase,				SM00014:acidPPc,	Alternative splicing,Cell membrane,Complete proteome,Hydrolase,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Lipid phosphate phosphatase-related protein type 5,splice variant,transmembrane region,
PMVK	phosphomevalonate kinase(PMVK)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0016126~sterol biosynthetic process,GO:0016310~phosphorylation,GO:0019287~isopentenyl diphosphate biosynthetic process, mevalonate pathway,GO:0070723~response to cholesterol,	GO:0005737~cytoplasm,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004631~phosphomevalonate kinase activity,GO:0005524~ATP binding,	IPR005919:Higher eukaryotic phosphomevalonate kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00900:Terpenoid backbone biosynthesis,hsa01100:Metabolic pathways,hsa04146:Peroxisome,	175800~Porokeratosis 1, multiple types,	PIRSF036639:phosphomevalonate kinase, animal type,		3D-structure,ATP-binding,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Disease mutation,Kinase,Lipid biosynthesis,Lipid metabolism,Nucleotide-binding,Peroxisome,Polymorphism,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transferase,	binding site:ATP,binding site:Substrate,chain:Phosphomevalonate kinase,helix,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:Microbody targeting signal,strand,turn,
PID1	phosphotyrosine interaction domain containing 1(PID1)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006112~energy reserve metabolic process,GO:0010628~positive regulation of gene expression,GO:0010635~regulation of mitochondrial fusion,GO:0044320~cellular response to leptin stimulus,GO:0045444~fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0051881~regulation of mitochondrial membrane potential,GO:0070346~positive regulation of fat cell proliferation,GO:0070584~mitochondrion morphogenesis,GO:0071345~cellular response to cytokine stimulus,GO:0071354~cellular response to interleukin-6,GO:0071356~cellular response to tumor necrosis factor,GO:0071398~cellular response to fatty acid,GO:0090005~negative regulation of establishment of protein localization to plasma membrane,GO:0090298~negative regulation of mitochondrial DNA replication,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2001170~negative regulation of ATP biosynthetic process,GO:2001171~positive regulation of ATP biosynthetic process,GO:2001274~negative regulation of glucose import in response to insulin stimulus,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,				SM00462:PTB,	Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,	chain:PTB-containing, cubilin and LRP1- interacting protein,domain:PID,modified residue,sequence variant,splice variant,
PGBD2	piggyBac transposable element derived 2(PGBD2)	Homo sapiens												Alternative splicing,Complete proteome,Reference proteome,	chain:PiggyBac transposable element-derived protein 2,splice variant,
PGBD5	piggyBac transposable element derived 5(PGBD5)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:PiggyBac transposable element-derived protein 5,sequence variant,transmembrane region,
PKP1	plakophilin 1(PKP1)	Homo sapiens				GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0016337~single organismal cell-cell adhesion,GO:0045110~intermediate filament bundle assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0030057~desmosome,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0019215~intermediate filament binding,GO:0030280~structural constituent of epidermis,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,		604536~Ectodermal dysplasia/skin fragility syndrome,		SM00185:ARM,	3D-structure,Alternative splicing,Cell adhesion,Cell junction,Complete proteome,Developmental protein,Ectodermal dysplasia,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Plakophilin-1,helix,modified residue,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,repeat:ARM 9,sequence conflict,sequence variant,splice variant,strand,turn,
PKP4	plakophilin 4(PKP4)	Homo sapiens				GO:0007043~cell-cell junction assembly,GO:0007267~cell-cell signaling,GO:0016337~single organismal cell-cell adhesion,GO:0030155~regulation of cell adhesion,GO:0032467~positive regulation of cytokinesis,GO:0043547~positive regulation of GTPase activity,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0009898~cytoplasmic side of plasma membrane,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030057~desmosome,GO:0030496~midbody,GO:0044291~cell-cell contact zone,GO:0048471~perinuclear region of cytoplasm,GO:0051233~spindle midzone,GO:0072686~mitotic spindle,	GO:0005515~protein binding,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,				SM00185:ARM,	Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Membrane,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Plakophilin-4,compositionally biased region:Poly-Lys,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,repeat:ARM 9,sequence variant,splice variant,
PLGLA	plasminogen-like A (pseudogene)(PLGLA)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_fibrinolysisPathway:Fibrinolysis Pathway,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,			GO:0005576~extracellular region,		IPR003609:Apple-like,IPR016351:Plasminogen-related,			PIRSF002483:plasminogen-related protein,	SM00473:PAN_AP,	Complete proteome,Disulfide bond,Reference proteome,Secreted,Signal,	chain:Plasminogen-related protein A,disulfide bond,domain:PAN,signal peptide,
PLGLB1	plasminogen-like B1(PLGLB1)	Homo sapiens					GO:0005576~extracellular region,		IPR003609:Apple-like,IPR016351:Plasminogen-related,			PIRSF002483:plasminogen-related protein,	SM00473:PAN_AP,	Complete proteome,Disulfide bond,Reference proteome,Secreted,Signal,	chain:Plasminogen-related protein B,disulfide bond,domain:PAN,signal peptide,
PAFAH2	platelet activating factor acetylhydrolase 2(PAFAH2)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0016042~lipid catabolic process,GO:0043066~negative regulation of apoptotic process,	GO:0005737~cytoplasm,	GO:0003847~1-alkyl-2-acetylglycerophosphocholine esterase activity,GO:0005543~phospholipid binding,	IPR005065:Platelet-activating factor acetylhydrolase,IPR016715:PAF acetylhydrolase,	hsa00565:Ether lipid metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,		PIRSF018169:PAF acetylhydrolase,		Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Lipid degradation,Lipid metabolism,Proteomics identification,Reference proteome,	active site:Charge relay system,active site:Nucleophile,chain:Platelet-activating factor acetylhydrolase 2, cytoplasmic,modified residue,sequence conflict,
PTAFR	platelet activating factor receptor(PTAFR)	Homo sapiens				GO:0001816~cytokine production,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007567~parturition,GO:0009609~response to symbiotic bacterium,GO:0010863~positive regulation of phospholipase C activity,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032959~inositol trisphosphate biosynthetic process,GO:0035589~G-protein coupled purinergic nucleotide receptor signaling pathway,GO:0043315~positive regulation of neutrophil degranulation,GO:0045056~transcytosis,GO:0045410~positive regulation of interleukin-6 biosynthetic process,GO:0045727~positive regulation of translation,GO:0045776~negative regulation of blood pressure,GO:0045907~positive regulation of vasoconstriction,GO:0045909~positive regulation of vasodilation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060732~positive regulation of inositol phosphate biosynthetic process,GO:0071258~cellular response to gravity,GO:0071320~cellular response to cAMP,GO:0071398~cellular response to fatty acid,GO:0071548~response to dexamethasone,GO:1902943~positive regulation of voltage-gated chloride channel activity,GO:1903238~positive regulation of leukocyte tethering or rolling,GO:1904058~positive regulation of sensory perception of pain,GO:1904300~positive regulation of transcytosis,GO:1904303~positive regulation of maternal process involved in parturition,GO:1904306~positive regulation of gastro-intestinal system smooth muscle contraction,GO:1904317~cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,	GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0001530~lipopolysaccharide binding,GO:0001875~lipopolysaccharide receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004992~platelet activating factor receptor activity,GO:0005543~phospholipid binding,GO:0045028~G-protein coupled purinergic nucleotide receptor activity,GO:0051019~mitogen-activated protein kinase binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002282:Platelet-activating factor receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa05150:Staphylococcus aureus infection,				3D-structure,Cell membrane,Chemotaxis,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Platelet-activating factor receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PEAR1	platelet endothelial aggregation receptor 1(PEAR1)	Homo sapiens				GO:0043654~recognition of apoptotic cell,GO:0045746~negative regulation of Notch signaling pathway,	GO:0001891~phagocytic cup,GO:0016021~integral component of membrane,		IPR000742:Epidermal growth factor-like domain,IPR002049:EGF-like, laminin,IPR011489:EMI domain,IPR013032:EGF-like, conserved site,				SM00180:EGF_Lam,SM00181:EGF,	Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Platelet endothelial aggregation receptor 1,compositionally biased region:Pro-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:EMI,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,transmembrane region,
PSD4	pleckstrin and Sec7 domain containing 4(PSD4)	Homo sapiens				GO:0032012~regulation of ARF protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005543~phospholipid binding,	IPR000904:SEC7-like,IPR001605:Pleckstrin homology domain, spectrin-type,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,			SM00222:Sec7,SM00233:PH,	Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Guanine-nucleotide releasing factor,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:PH and SEC7 domain-containing protein 4,domain:PH,domain:SEC7,modified residue,sequence conflict,sequence variant,splice variant,
PLEKHM2	pleckstrin homology and RUN domain containing M2(PLEKHM2)	Homo sapiens				GO:0007030~Golgi organization,GO:0032418~lysosome localization,GO:0032880~regulation of protein localization,GO:1903527~positive regulation of membrane tubulation,	GO:0010008~endosome membrane,	GO:0005515~protein binding,GO:0019894~kinesin binding,	IPR001849:Pleckstrin homology domain,IPR004012:RUN,IPR011993:Pleckstrin homology-like domain,	hsa05132:Salmonella infection,			SM00233:PH,SM00593:RUN,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Pleckstrin homology domain-containing family M member 2,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Lys,domain:PH,domain:RUN,helix,modified residue,mutagenesis site,region of interest:Interaction with KIF5B,region of interest:Interaction with sifA,sequence conflict,sequence variant,strand,
PLEKHG5	pleckstrin homology and RhoGEF domain containing G5(PLEKHG5)	Homo sapiens				GO:0007165~signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0035767~endothelial cell chemotaxis,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0030027~lamellipodium,GO:0030139~endocytic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0004871~signal transducer activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,	hsa05200:Pathways in cancer,	611067~Spinal muscular atrophy, distal, autosomal recessive, 4,615376~Charcot-Marie-Tooth disease, recessive intermediate C,		SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Cell junction,Cell membrane,Cell projection,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Membrane,Neurodegeneration,Neuropathy,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Pleckstrin homology domain-containing family G member 5,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,domain:DH,domain:PH,modified residue,sequence conflict,sequence variant,splice variant,
PLEKHA3	pleckstrin homology domain containing A3(PLEKHA3)	Homo sapiens					GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0005543~phospholipid binding,GO:0005545~1-phosphatidylinositol binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	3D-structure,Complete proteome,Golgi apparatus,Lipid-binding,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Pleckstrin homology domain-containing family A member 3,domain:PH,modified residue,sequence conflict,
PLEKHA6	pleckstrin homology domain containing A6(PLEKHA6)	Homo sapiens							IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	3D-structure,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Pleckstrin homology domain-containing family A member 6,compositionally biased region:Pro-rich,domain:PH,helix,modified residue,sequence variant,strand,turn,
PLEKHB2	pleckstrin homology domain containing B2(PLEKHB2)	Homo sapiens				GO:0045595~regulation of cell differentiation,	GO:0016021~integral component of membrane,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	3D-structure,Alternative splicing,Complete proteome,Endosome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Pleckstrin homology domain-containing family B member 2,domain:PH,sequence conflict,splice variant,
PLEKHM3	pleckstrin homology domain containing M3(PLEKHM3)	Homo sapiens						GO:0046872~metal ion binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR025258:Domain of unknown function DUF4206,				SM00233:PH,SM01175:SM01175,	Alternative splicing,Complete proteome,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Pleckstrin homology domain-containing family M member 3,compositionally biased region:Poly-Gln,domain:PH 1,domain:PH 2,modified residue,splice variant,zinc finger region:Phorbol-ester/DAG-type,
PLEKHN1	pleckstrin homology domain containing N1(PLEKHN1)	Homo sapiens					GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Alternative splicing,Cell membrane,Complete proteome,Lipoprotein,Membrane,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Pleckstrin homology domain-containing family N member 1,domain:PH 1,domain:PH 2,modified residue,sequence conflict,sequence variant,splice variant,
PLEKHO1	pleckstrin homology domain containing O1(PLEKHO1)	Homo sapiens				GO:0007520~myoblast fusion,GO:0008360~regulation of cell shape,GO:0051451~myoblast migration,GO:0072673~lamellipodium morphogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0032587~ruffle membrane,GO:0036195~muscle cell projection membrane,	GO:0005515~protein binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	binding site:Capping protein,chain:Pleckstrin homology domain-containing family O member 1,domain:PH,modified residue,mutagenesis site,region of interest:Interaction with ATM, CKIP, IFP35 and NMI,region of interest:Interaction with capping proteins (CPs),region of interest:Negative regulator of AP-1 activity,sequence conflict,sequence variant,site:Cleavage; by caspase-3,splice variant,
PHLDA3	pleckstrin homology like domain family A member 3(PHLDA3)	Homo sapiens				GO:0009653~anatomical structure morphogenesis,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043065~positive regulation of apoptotic process,GO:0051898~negative regulation of protein kinase B signaling,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Apoptosis,Complete proteome,Cytoplasm,Membrane,Polymorphism,Reference proteome,Tumor suppressor,	chain:Pleckstrin homology-like domain family A member 3,domain:PH,sequence conflict,sequence variant,
PHLDB2	pleckstrin homology like domain family B member 2(PHLDB2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0000226~microtubule cytoskeleton organization,GO:0010470~regulation of gastrulation,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0045184~establishment of protein localization,GO:0051497~negative regulation of stress fiber assembly,GO:0051895~negative regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0098609~cell-cell adhesion,GO:1903690~negative regulation of wound healing, spreading of epidermal cells,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0031252~cell leading edge,GO:0045111~intermediate filament cytoskeleton,GO:0045180~basal cortex,	GO:0005515~protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:PI-PLC X domain-containing protein 2,chain:Pleckstrin homology-like domain family B member 2,domain:PH,domain:PI-PLC X-box,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
PLEKHH2	pleckstrin homology, MyTH4 and FERM domain containing H2(PLEKHH2)	Homo sapiens				GO:0030835~negative regulation of actin filament depolymerization,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0030864~cortical actin cytoskeleton,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000299:FERM domain,IPR000857:MyTH4 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,				SM00139:MyTH4,SM00233:PH,SM00295:B41,	Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Pleckstrin homology domain-containing family H member 2,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:FERM,domain:MyTH4,domain:PH 1,domain:PH 2,sequence conflict,sequence variant,splice variant,transmembrane region,
PLEK	pleckstrin(PLEK)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0002576~platelet degranulation,GO:0006904~vesicle docking involved in exocytosis,GO:0007229~integrin-mediated signaling pathway,GO:0010572~positive regulation of platelet activation,GO:0010920~negative regulation of inositol phosphate biosynthetic process,GO:0010925~positive regulation of inositol-polyphosphate 5-phosphatase activity,GO:0030030~cell projection organization,GO:0030836~positive regulation of actin filament depolymerization,GO:0030845~phospholipase C-inhibiting G-protein coupled receptor signaling pathway,GO:0030866~cortical actin cytoskeleton organization,GO:0031529~ruffle organization,GO:0031532~actin cytoskeleton reorganization,GO:0032233~positive regulation of actin filament bundle assembly,GO:0033625~positive regulation of integrin activation,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0046488~phosphatidylinositol metabolic process,GO:0050849~negative regulation of calcium-mediated signaling,GO:0060305~regulation of cell diameter,GO:0070493~thrombin receptor signaling pathway,GO:0070527~platelet aggregation,GO:0070528~protein kinase C signaling,GO:0070560~protein secretion by platelet,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0032587~ruffle membrane,	GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,	IPR000591:DEP domain,IPR001849:Pleckstrin homology domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR011993:Pleckstrin homology-like domain,				SM00049:DEP,SM00233:PH,	3D-structure,Acetylation,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Pleckstrin,domain:DEP,domain:PH 1,domain:PH 2,helix,modified residue,sequence conflict,sequence variant,strand,turn,
PLXNA2	plexin A2(PLXNA2)	Homo sapiens				GO:0001756~somitogenesis,GO:0021785~branchiomotor neuron axon guidance,GO:0021915~neural tube development,GO:0021935~cerebellar granule cell precursor tangential migration,GO:0030334~regulation of cell migration,GO:0048841~regulation of axon extension involved in axon guidance,GO:0051642~centrosome localization,GO:0060037~pharyngeal system development,GO:0060174~limb bud formation,GO:0071526~semaphorin-plexin signaling pathway,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,	GO:0002116~semaphorin receptor complex,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0005515~protein binding,GO:0017154~semaphorin receptor activity,	IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR002909:Cell surface receptor IPT/TIG,IPR008936:Rho GTPase activation protein,IPR013548:Plexin, cytoplasmic RasGAP domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,	hsa04360:Axon guidance,			SM00423:PSI,SM00429:IPT,SM00630:Sema,	3D-structure,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Plexin-A2,domain:IPT/TIG 1,domain:IPT/TIG 2,domain:IPT/TIG 3,domain:IPT/TIG 4,domain:Sema,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PDPN	podoplanin(PDPN)	Homo sapiens				GO:0000902~cell morphogenesis,GO:0001946~lymphangiogenesis,GO:0006693~prostaglandin metabolic process,GO:0006833~water transport,GO:0006865~amino acid transport,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0008360~regulation of cell shape,GO:0015884~folic acid transport,GO:0016337~single organismal cell-cell adhesion,GO:0030168~platelet activation,GO:0030324~lung development,GO:0048286~lung alveolus development,GO:0048870~cell motility,GO:0051272~positive regulation of cellular component movement,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0001726~ruffle,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0031258~lamellipodium membrane,GO:0031527~filopodium membrane,GO:0031528~microvillus membrane,GO:0032587~ruffle membrane,	GO:0005372~water transmembrane transporter activity,GO:0008517~folic acid transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015250~water channel activity,	IPR008783:Podoplanin,					3D-structure,Alternative splicing,Cell membrane,Cell projection,Cell shape,Complete proteome,Developmental protein,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Sialic acid,Signal,Transmembrane,Transmembrane helix,	chain:Podoplanin,glycosylation site:O-linked (GalNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
POGK	pogo transposable element with KRAB domain(POGK)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001909:Krueppel-associated box,IPR004875:DDE superfamily endonuclease, CENP-B-like,IPR006600:HTH CenpB-type DNA-binding domain,IPR009057:Homeodomain-like,IPR018586:Brinker DNA-binding domain,				SM00349:KRAB,SM00674:CENPB,	Coiled coil,Complete proteome,Developmental protein,DNA-binding,Isopeptide bond,Nucleus,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Pogo transposable element with KRAB domain,compositionally biased region:Poly-Glu,domain:DDE,domain:HTH CENPB-type,domain:KRAB,modified residue,
POGZ	pogo transposable element with ZNF domain(POGZ)	Homo sapiens				GO:0007064~mitotic sister chromatid cohesion,GO:0051301~cell division,GO:0051382~kinetochore assembly,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR004875:DDE superfamily endonuclease, CENP-B-like,IPR006600:HTH CenpB-type DNA-binding domain,IPR007087:Zinc finger, C2H2,IPR009057:Homeodomain-like,IPR015880:Zinc finger, C2H2-like,		616364~Mental retardation, autosomal dominant 37,		SM00355:ZnF_C2H2,SM00674:CENPB,	3D-structure,Alternative splicing,Autism spectrum disorder,Cell cycle,Cell division,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Pogo transposable element with ZNF domain,compositionally biased region:Pro-rich,domain:DDE,domain:HTH CENPB-type,helix,modified residue,sequence conflict,sequence variant,splice variant,turn,zinc finger region:C2H2-type 1; atypical,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
PAIP2B	poly(A) binding protein interacting protein 2B(PAIP2B)	Homo sapiens				GO:0045947~negative regulation of translational initiation,	GO:0005737~cytoplasm,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0005515~protein binding,	IPR009818:Ataxin-2, C-terminal,					Acetylation,Complete proteome,Reference proteome,Repressor,Translation regulation,Ubl conjugation,	chain:Polyadenylate-binding protein-interacting protein 2B,modified residue,
PARP1	poly(ADP-ribose) polymerase 1(PARP1)	Homo sapiens	39.Deg_of_Chromosomal_DNA,	h_aifPathway:Opposing roles of AIF in Apoptosis and Cell Survival,h_caspasePathway:Caspase Cascade in Apoptosis,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_d4gdiPathway:D4-GDI Signaling Pathway,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0000724~double-strand break repair via homologous recombination,GO:0006273~lagging strand elongation,GO:0006281~DNA repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006302~double-strand break repair,GO:0006366~transcription from RNA polymerase II promoter,GO:0006471~protein ADP-ribosylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007005~mitochondrion organization,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0010332~response to gamma radiation,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0010990~regulation of SMAD protein complex assembly,GO:0016540~protein autoprocessing,GO:0016925~protein sumoylation,GO:0023019~signal transduction involved in regulation of gene expression,GO:0030225~macrophage differentiation,GO:0032042~mitochondrial DNA metabolic process,GO:0032869~cellular response to insulin stimulus,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0033683~nucleotide-excision repair, DNA incision,GO:0034599~cellular response to oxidative stress,GO:0036211~protein modification process,GO:0042769~DNA damage response, detection of DNA damage,GO:0043504~mitochondrial DNA repair,GO:0044030~regulation of DNA methylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051103~DNA ligation involved in DNA repair,GO:0051901~positive regulation of mitochondrial depolarization,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0070212~protein poly-ADP-ribosylation,GO:0070911~global genome nucleotide-excision repair,GO:0071294~cellular response to zinc ion,GO:1901216~positive regulation of neuron death,GO:1903376~regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903827~regulation of cellular protein localization,GO:1904044~response to aldosterone,GO:1904357~negative regulation of telomere maintenance via telomere lengthening,GO:1904646~cellular response to beta-amyloid,GO:1904762~positive regulation of myofibroblast differentiation,GO:1990966~ATP generation from poly-ADP-D-ribose,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2001170~negative regulation of ATP biosynthetic process,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0003910~DNA ligase (ATP) activity,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030331~estrogen receptor binding,GO:0042802~identical protein binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0047485~protein N-terminus binding,GO:0051287~NAD binding,GO:0070412~R-SMAD binding,	IPR001357:BRCT domain,IPR001510:Zinc finger, PARP-type,IPR004102:Poly(ADP-ribose) polymerase, regulatory domain,IPR008288:NAD+ ADP-ribosyltransferase,IPR008893:WGR domain,IPR012317:Poly(ADP-ribose) polymerase, catalytic domain,IPR012982:PADR1,	hsa03410:Base excision repair,		PIRSF000489:poly(ADP-ribose) polymerase,	SM00292:BRCT,SM00773:WGR,SM01335:SM01335,SM01336:SM01336,	3D-structure,Acetylation,ADP-ribosylation,Coiled coil,Complete proteome,Direct protein sequencing,DNA damage,DNA repair,DNA-binding,Glycosyltransferase,Isopeptide bond,Metal-binding,NAD,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:Poly [ADP-ribose] polymerase 1,domain:BRCT,domain:PARP alpha-helical,domain:PARP catalytic,helix,modified residue,mutagenesis site,region of interest:Automodification domain,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,zinc finger region:PARP-type 1,zinc finger region:PARP-type 2,
PARP3	poly(ADP-ribose) polymerase family member 3(PARP3)	Homo sapiens				GO:0000723~telomere maintenance,GO:0006273~lagging strand elongation,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006471~protein ADP-ribosylation,GO:0051103~DNA ligation involved in DNA repair,GO:0051106~positive regulation of DNA ligation,GO:0060236~regulation of mitotic spindle organization,GO:1990166~protein localization to site of double-strand break,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0035861~site of double-strand break,	GO:0003824~catalytic activity,GO:0003910~DNA ligase (ATP) activity,GO:0003950~NAD+ ADP-ribosyltransferase activity,	IPR004102:Poly(ADP-ribose) polymerase, regulatory domain,IPR008893:WGR domain,IPR012317:Poly(ADP-ribose) polymerase, catalytic domain,	hsa03410:Base excision repair,			SM00773:WGR,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Glycosyltransferase,NAD,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Poly [ADP-ribose] polymerase 3,domain:PARP alpha-helical,domain:PARP catalytic,helix,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
PCBP1	poly(rC) binding protein 1(PCBP1)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0010467~gene expression,GO:0039694~viral RNA genome replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:0098847~sequence-specific single stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	hsa03040:Spliceosome,			SM00322:KH,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Viral RNA replication,	chain:Poly(rC)-binding protein 1,domain:KH 1,domain:KH 2,domain:KH 3,helix,modified residue,sequence conflict,strand,
PCBP4	poly(rC) binding protein 4(PCBP4)	Homo sapiens				GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007050~cell cycle arrest,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0043488~regulation of mRNA stability,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,	chain:Poly(rC)-binding protein 4,domain:KH 1,domain:KH 2,domain:KH 3,sequence variant,splice variant,
PMF1	polyamine modulated factor 1(PMF1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000444~MIS12/MIND type complex,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005829~cytosol,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043522~leucine zipper domain binding,	IPR007128:Nnf1,					Activator,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Kinetochore,Mitosis,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Osteocalcin,chain:Polyamine-modulated factor 1,disulfide bond,domain:Gla,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 3,modified residue,sequence conflict,sequence variant,signal peptide,site:Not hydroxylated,splice variant,
PBRM1	polybromo 1(PBRM1)	Homo sapiens			Chromatin structure and dynamics / Transcription,	GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007067~mitotic nuclear division,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,	GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR001487:Bromodomain,IPR009071:High mobility group (HMG) box domain,IPR018359:Bromodomain, conserved site,				SM00297:BROMO,SM00398:HMG,SM00439:BAH,	3D-structure,Acetylation,Alternative splicing,Bromodomain,Chromatin regulator,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,	chain:Protein polybromo-1,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,DNA-binding region:HMG box,domain:BAH 1,domain:BAH 2,domain:Bromo 1,domain:Bromo 2,domain:Bromo 3,domain:Bromo 4,domain:Bromo 5,domain:Bromo 6,helix,modified residue,sequence conflict,splice variant,turn,
PHC2	polyhomeotic homolog 2(PHC2)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0016925~protein sumoylation,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,	IPR001660:Sterile alpha motif domain,IPR012313:Zinc finger, FCS-type,IPR013761:Sterile alpha motif/pointed domain,				SM00454:SAM,	Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Polyhomeotic-like protein 2,compositionally biased region:Gln-rich,compositionally biased region:Ser-rich,domain:SAM,modified residue,sequence conflict,sequence variant,short sequence motif:HD1,splice variant,zinc finger region:FCS-type,
PIGR	polymeric immunoglobulin receptor(PIGR)	Homo sapiens				GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste,GO:0001895~retina homeostasis,GO:0002415~immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0038093~Fc receptor signaling pathway,GO:0043113~receptor clustering,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0001792~polymeric immunoglobulin receptor activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04672:Intestinal immune network for IgA production,			SM00406:IGv,SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Polymeric immunoglobulin receptor,chain:Secretory component,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,domain:Ig-like V-type 3,domain:Ig-like V-type 4,domain:Ig-like V-type 5,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
GALNT13	polypeptide N-acetylgalactosaminyltransferase 13(GALNT13)	Homo sapiens				GO:0006486~protein glycosylation,GO:0016266~O-glycan processing,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR000772:Ricin B lectin domain,IPR001173:Glycosyl transferase, family 2,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,			SM00458:RICIN,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Lectin,Manganese,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Polypeptide N- acetylgalactosaminyltransferase 1,chain:Polypeptide N- acetylgalactosaminyltransferase 1 soluble form,chain:Polypeptide N- acetylgalactosaminyltransferase 13,disulfide bond,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),region of interest:Catalytic subdomain A,region of interest:Catalytic subdomain B,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GALNT14	polypeptide N-acetylgalactosaminyltransferase 14(GALNT14)	Homo sapiens				GO:0006486~protein glycosylation,GO:0016266~O-glycan processing,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR000772:Ricin B lectin domain,IPR001173:Glycosyl transferase, family 2,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,			SM00458:RICIN,	Alternative splicing,Complete proteome,Disulfide bond,Glycosyltransferase,Golgi apparatus,Lectin,Manganese,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Polypeptide N- acetylgalactosaminyltransferase 14,disulfide bond,domain:Ricin B-type lectin,region of interest:Catalytic subdomain A,region of interest:Catalytic subdomain B,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GALNT15	polypeptide N-acetylgalactosaminyltransferase 15(GALNT15)	Homo sapiens				GO:0006486~protein glycosylation,GO:0016266~O-glycan processing,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,	GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR000772:Ricin B lectin domain,IPR001173:Glycosyl transferase, family 2,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,			SM00458:RICIN,	Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Lectin,Manganese,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Polypeptide N- acetylgalactosaminyltransferase-like protein 2,disulfide bond,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),region of interest:Catalytic subdomain A,region of interest:Catalytic subdomain B,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GALNT2	polypeptide N-acetylgalactosaminyltransferase 2(GALNT2)	Homo sapiens				GO:0002378~immunoglobulin biosynthetic process,GO:0006486~protein glycosylation,GO:0006493~protein O-linked glycosylation,GO:0016266~O-glycan processing,GO:0018242~protein O-linked glycosylation via serine,GO:0018243~protein O-linked glycosylation via threonine,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,GO:0032580~Golgi cisterna membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0005515~protein binding,GO:0016757~transferase activity, transferring glycosyl groups,GO:0030145~manganese ion binding,GO:0030246~carbohydrate binding,	IPR000772:Ricin B lectin domain,IPR001173:Glycosyl transferase, family 2,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,			SM00458:RICIN,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycosyltransferase,Golgi apparatus,Lectin,Manganese,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Polypeptide N- acetylgalactosaminyltransferase 2,chain:Polypeptide N- acetylgalactosaminyltransferase 2 soluble form,disulfide bond,domain:Ricin B-type lectin,helix,region of interest:Catalytic subdomain A,region of interest:Catalytic subdomain B,sequence conflict,sequence variant,site:Not glycosylated,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
GALNT3	polypeptide N-acetylgalactosaminyltransferase 3(GALNT3)	Homo sapiens			Cell envelope biogenesis, outer membrane,	GO:0005975~carbohydrate metabolic process,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0016266~O-glycan processing,GO:0018242~protein O-linked glycosylation via serine,GO:0018243~protein O-linked glycosylation via threonine,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0005509~calcium ion binding,GO:0016740~transferase activity,GO:0030145~manganese ion binding,GO:0030246~carbohydrate binding,	IPR000772:Ricin B lectin domain,IPR001173:Glycosyl transferase, family 2,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,	211900~Tumoral calcinosis, hyperphosphatemic, familial,		SM00458:RICIN,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Lectin,Manganese,Membrane,Metal-binding,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Polypeptide N- acetylgalactosaminyltransferase 3,disulfide bond,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),region of interest:Catalytic subdomain A,region of interest:Catalytic subdomain B,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GALNT5	polypeptide N-acetylgalactosaminyltransferase 5(GALNT5)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,GO:0016266~O-glycan processing,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0016740~transferase activity,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR000772:Ricin B lectin domain,IPR001173:Glycosyl transferase, family 2,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,			SM00458:RICIN,	Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Lectin,Manganese,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Polypeptide N- acetylgalactosaminyltransferase 5,disulfide bond,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),region of interest:Catalytic subdomain A,region of interest:Catalytic subdomain B,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
PTBP2	polypyrimidine tract binding protein 2(PTBP2)	Homo sapiens				GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0021510~spinal cord development,GO:0021549~cerebellum development,GO:0033119~negative regulation of RNA splicing,GO:2000177~regulation of neural precursor cell proliferation,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0030426~growth cone,GO:0043025~neuronal cell body,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,	chain:Polypyrimidine tract-binding protein 2,compositionally biased region:Poly-Ala,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,helix,modified residue,splice variant,strand,turn,
PNPT1	polyribonucleotide nucleotidyltransferase 1(PNPT1)	Homo sapiens				GO:0000957~mitochondrial RNA catabolic process,GO:0000958~mitochondrial mRNA catabolic process,GO:0000962~positive regulation of mitochondrial RNA catabolic process,GO:0000964~mitochondrial RNA 5'-end processing,GO:0000965~mitochondrial RNA 3'-end processing,GO:0006396~RNA processing,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0034599~cellular response to oxidative stress,GO:0035458~cellular response to interferon-beta,GO:0035927~RNA import into mitochondrion,GO:0035928~rRNA import into mitochondrion,GO:0043457~regulation of cellular respiration,GO:0043631~RNA polyadenylation,GO:0045926~negative regulation of growth,GO:0051260~protein homooligomerization,GO:0061014~positive regulation of mRNA catabolic process,GO:0070207~protein homotrimerization,GO:0070584~mitochondrion morphogenesis,GO:0071042~nuclear polyadenylation-dependent mRNA catabolic process,GO:0071850~mitotic cell cycle arrest,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,GO:0097222~mitochondrial mRNA polyadenylation,GO:2000627~positive regulation of miRNA catabolic process,GO:2000772~regulation of cellular senescence,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0016020~membrane,GO:0045025~mitochondrial degradosome,	GO:0000175~3'-5'-exoribonuclease activity,GO:0003723~RNA binding,GO:0004654~polyribonucleotide nucleotidyltransferase activity,GO:0005515~protein binding,GO:0008266~poly(U) RNA binding,GO:0034046~poly(G) binding,GO:0035198~miRNA binding,GO:0044822~poly(A) RNA binding,	IPR001247:Exoribonuclease, phosphorolytic domain 1,IPR003029:Ribosomal protein S1, RNA-binding domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR012162:Polyribonucleotide nucleotidyltransferase,IPR012340:Nucleic acid-binding, OB-fold,IPR015847:Exoribonuclease, phosphorolytic domain 2,IPR015848:Polynucleotide phosphorylase, phosphorolytic RNA-binding, bacterial/organelle-type,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR022967:RNA-binding domain, S1,IPR027408:PNPase/RNase PH domain,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03018:RNA degradation,	614932~Combined oxidative phosphorylation deficiency 13,614934~Deafness, autosomal recessive 70,	PIRSF005499:polyribonucleotide nucleotidyltransferase,	SM00316:SM00316,SM00322:KH,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Deafness,Disease mutation,Exonuclease,Hydrolase,Membrane,Mitochondrion,mRNA processing,Non-syndromic deafness,Nuclease,Nucleotidyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transferase,Transit peptide,Transport,	chain:Polyribonucleotide nucleotidyltransferase 1, mitochondrial,domain:KH,domain:S1 motif,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
PGAP1	post-GPI attachment to proteins 1(PGAP1)	Homo sapiens				GO:0007605~sensory perception of sound,GO:0009880~embryonic pattern specification,GO:0009948~anterior/posterior axis specification,GO:0015031~protein transport,GO:0015798~myo-inositol transport,GO:0016255~attachment of GPI anchor to protein,GO:0021871~forebrain regionalization,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004518~nuclease activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0042578~phosphoric ester hydrolase activity,	IPR012908:GPI inositol-deacylase PGAP1-like,	hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,hsa01100:Metabolic pathways,	615802~Mental retardation, autosomal recessive 42,			Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Hydrolase,Membrane,Mental retardation,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:GPI inositol-deacylase,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
KCNN3	potassium calcium-activated channel subfamily N member 3(KCNN3)	Homo sapiens				GO:0071805~potassium ion transmembrane transport,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043025~neuronal cell body,	GO:0005516~calmodulin binding,GO:0016286~small conductance calcium-activated potassium channel activity,	IPR004178:Calmodulin-binding domain,IPR013099:Ion transport 2,IPR015449:Potassium channel, calcium-activated, SK,	hsa04911:Insulin secretion,			SM01053:SM01053,	Alternative splicing,Calmodulin-binding,Coiled coil,Complete proteome,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Small conductance calcium-activated potassium channel protein 3,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,region of interest:Calmodulin-binding,sequence conflict,sequence variant,transmembrane region,
KCMF1	potassium channel modulatory factor 1(KCMF1)	Homo sapiens						GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR000433:Zinc finger, ZZ-type,IPR007087:Zinc finger, C2H2,IPR008598:Drought induced 19/ RING finger protein 114,IPR015880:Zinc finger, C2H2-like,				SM00291:ZnF_ZZ,SM00355:ZnF_C2H2,	Acetylation,Coiled coil,Complete proteome,Ligase,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase KCMF1,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,modified residue,sequence conflict,zinc finger region:C2H2-type,zinc finger region:ZZ-type,
KCTD3	potassium channel tetramerization domain containing 3(KCTD3)	Homo sapiens				GO:0051260~protein homooligomerization,			IPR000210:BTB/POZ-like,IPR001680:WD40 repeat,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR011333:BTB/POZ fold,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00225:BTB,SM00320:WD40,	Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:BTB/POZ domain-containing protein KCTD3,domain:BTB,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,splice variant,
KCNT2	potassium sodium-activated channel subfamily T member 2(KCNT2)	Homo sapiens				GO:0071805~potassium ion transmembrane transport,	GO:0008076~voltage-gated potassium channel complex,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005249~voltage-gated potassium channel activity,GO:0005524~ATP binding,GO:0015269~calcium-activated potassium channel activity,	IPR003929:Potassium channel, calcium-activated, BK, alpha subunit,IPR013099:Ion transport 2,IPR016040:NAD(P)-binding domain,					Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Potassium,Potassium channel,Potassium transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Potassium channel subfamily T member 2,domain:RCK N-terminal,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,region of interest:Pore-forming, in membrane,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KCNK1	potassium two pore domain channel subfamily K member 1(KCNK1)	Homo sapiens				GO:0006813~potassium ion transport,GO:0030322~stabilization of membrane potential,GO:0035094~response to nicotine,GO:0035725~sodium ion transmembrane transport,GO:0060075~regulation of resting membrane potential,GO:0061337~cardiac conduction,GO:0071805~potassium ion transmembrane transport,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0030054~cell junction,GO:0030425~dendrite,GO:0031526~brush border membrane,GO:0034705~potassium channel complex,GO:0043204~perikaryon,GO:0045202~synapse,GO:0055037~recycling endosome,GO:1902937~inward rectifier potassium channel complex,	GO:0005242~inward rectifier potassium channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005267~potassium channel activity,GO:0005272~sodium channel activity,GO:0022841~potassium ion leak channel activity,	IPR001779:Two pore domain potassium channel, TWIK-1,IPR003092:Two pore domain potassium channel, TASK family,IPR003280:Two pore domain potassium channel,IPR005408:Two pore domain potassium channel, TWIK family,IPR013099:Ion transport 2,			PIRSF038061:potassium channel, subfamily K type,		3D-structure,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasmic vesicle,Disulfide bond,Endosome,Glycoprotein,Ion channel,Ion transport,Isopeptide bond,Membrane,Phosphoprotein,Potassium,Potassium channel,Potassium transport,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Potassium channel subfamily K member 1,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Pore-forming 1,region of interest:Pore-forming 2,topological domain:Cytoplasmic,transmembrane region,
KCNK12	potassium two pore domain channel subfamily K member 12(KCNK12)	Homo sapiens				GO:0030322~stabilization of membrane potential,GO:0034765~regulation of ion transmembrane transport,GO:0071805~potassium ion transmembrane transport,	GO:0005887~integral component of plasma membrane,	GO:0005244~voltage-gated ion channel activity,GO:0022841~potassium ion leak channel activity,	IPR003280:Two pore domain potassium channel,IPR005410:Two pore domain potassium channel, THIK,IPR013099:Ion transport 2,					Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium channel subfamily K member 12,compositionally biased region:Poly-Cys,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Pore-forming 1,region of interest:Pore-forming 2,topological domain:Cytoplasmic,transmembrane region,
KCNK2	potassium two pore domain channel subfamily K member 2(KCNK2)	Homo sapiens				GO:0003231~cardiac ventricle development,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007613~memory,GO:0009612~response to mechanical stimulus,GO:0010942~positive regulation of cell death,GO:0030322~stabilization of membrane potential,GO:0048678~response to axon injury,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0071456~cellular response to hypoxia,GO:0071805~potassium ion transmembrane transport,GO:0090102~cochlea development,GO:1900039~positive regulation of cellular response to hypoxia,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043025~neuronal cell body,GO:0044305~calyx of Held,GO:0097449~astrocyte projection,	GO:0005267~potassium channel activity,GO:0015271~outward rectifier potassium channel activity,GO:0019870~potassium channel inhibitor activity,GO:0022841~potassium ion leak channel activity,	IPR003280:Two pore domain potassium channel,IPR003976:Two pore domain potassium channel, TREK,IPR013099:Ion transport 2,	hsa04971:Gastric acid secretion,				3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Potassium channel subfamily K member 2,glycosylation site:N-linked (GlcNAc...),region of interest:Essential for chloroform and halothane sensitivity,region of interest:Pore-forming 1,region of interest:Pore-forming 2,region of interest:Required for basal channel activity,sequence conflict,splice variant,topological domain:Cytoplasmic,transmembrane region,
KCNK3	potassium two pore domain channel subfamily K member 3(KCNK3)	Homo sapiens				GO:0006813~potassium ion transport,GO:0007268~chemical synaptic transmission,GO:0007420~brain development,GO:0030322~stabilization of membrane potential,GO:0034220~ion transmembrane transport,GO:0042493~response to drug,GO:0051481~negative regulation of cytosolic calcium ion concentration,GO:0061337~cardiac conduction,GO:0071294~cellular response to zinc ion,GO:0071456~cellular response to hypoxia,GO:0071805~potassium ion transmembrane transport,GO:0090102~cochlea development,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005216~ion channel activity,GO:0005252~open rectifier potassium channel activity,GO:0005267~potassium channel activity,GO:0008022~protein C-terminus binding,GO:0022841~potassium ion leak channel activity,GO:0042803~protein homodimerization activity,GO:0044548~S100 protein binding,GO:0046982~protein heterodimerization activity,	IPR003092:Two pore domain potassium channel, TASK family,IPR003280:Two pore domain potassium channel,IPR005406:Two pore domain potassium channel, TASK-1,IPR013099:Ion transport 2,	hsa04925:Aldosterone synthesis and secretion,	615344~Pulmonary hypertension, primary, 4,	PIRSF038061:potassium channel, subfamily K type,		Cell membrane,Complete proteome,Disease mutation,Glycoprotein,Ion channel,Ion transport,Membrane,Potassium,Potassium channel,Potassium transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Potassium channel subfamily K member 3,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Pore-forming 1,region of interest:Pore-forming 2,topological domain:Cytoplasmic,transmembrane region,
KCNIP3	potassium voltage-gated channel interacting protein 3(KCNIP3)	Homo sapiens		h_dreamPathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM,	Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006886~intracellular protein transport,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0061337~cardiac conduction,GO:0071805~potassium ion transmembrane transport,GO:0072659~protein localization to plasma membrane,GO:1901379~regulation of potassium ion transmembrane transport,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0030425~dendrite,GO:0032993~protein-DNA complex,GO:0043679~axon terminus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005244~voltage-gated ion channel activity,GO:0005267~potassium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0015459~potassium channel regulator activity,GO:0043565~sequence-specific DNA binding,GO:0044325~ion channel binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	3D-structure,Alternative splicing,Apoptosis,Calcium,Cell membrane,Complete proteome,Cytoplasm,Endoplasmic reticulum,Golgi apparatus,Ion channel,Ion transport,Isopeptide bond,Lipoprotein,Membrane,Metal-binding,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Transport,Ubl conjugation,Voltage-gated channel,	calcium-binding region:1,calcium-binding region:2,chain:Calsenilin,domain:EF-hand 1; degenerate,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:Interaction with KCND2,sequence conflict,sequence variant,splice variant,strand,
KCNG3	potassium voltage-gated channel modifier subfamily G member 3(KCNG3)	Homo sapiens				GO:0034765~regulation of ion transmembrane transport,GO:0051260~protein homooligomerization,GO:0071805~potassium ion transmembrane transport,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,	GO:0005251~delayed rectifier potassium channel activity,GO:0005515~protein binding,	IPR000210:BTB/POZ-like,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR003968:Potassium channel, voltage dependent, Kv,IPR003971:Potassium channel, voltage dependent, Kv9,IPR005821:Ion transport domain,IPR011333:BTB/POZ fold,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,				SM00225:BTB,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Ion channel,Ion transport,Membrane,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily G member 3,region of interest:Segment H5 (pore-forming),short sequence motif:Selectivity filter,splice variant,topological domain:Cytoplasmic,transmembrane region,
KCNS3	potassium voltage-gated channel modifier subfamily S member 3(KCNS3)	Homo sapiens				GO:0006813~potassium ion transport,GO:0034765~regulation of ion transmembrane transport,GO:0050796~regulation of insulin secretion,GO:0051260~protein homooligomerization,GO:0071805~potassium ion transmembrane transport,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral component of membrane,	GO:0005249~voltage-gated potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,GO:0015459~potassium channel regulator activity,	IPR000210:BTB/POZ-like,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR003968:Potassium channel, voltage dependent, Kv,IPR003971:Potassium channel, voltage dependent, Kv9,IPR005821:Ion transport domain,IPR011333:BTB/POZ fold,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,				SM00225:BTB,	Cell membrane,Complete proteome,Ion channel,Ion transport,Membrane,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily S member 3,region of interest:Segment H5 (pore-forming),sequence conflict,sequence variant,short sequence motif:Selectivity filter,topological domain:Cytoplasmic,transmembrane region,
KCNA10	potassium voltage-gated channel subfamily A member 10(KCNA10)	Homo sapiens				GO:0006813~potassium ion transport,GO:0034765~regulation of ion transmembrane transport,GO:0051260~protein homooligomerization,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral component of membrane,	GO:0005221~intracellular cyclic nucleotide activated cation channel activity,GO:0005251~delayed rectifier potassium channel activity,	IPR000210:BTB/POZ-like,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR003968:Potassium channel, voltage dependent, Kv,IPR003972:Potassium channel, voltage dependent, Kv1,IPR005821:Ion transport domain,IPR011333:BTB/POZ fold,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,				SM00225:BTB,	Complete proteome,Glycoprotein,Ion channel,Ion transport,Lipoprotein,Membrane,Palmitate,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily A member 10,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,short sequence motif:Selectivity filter,transmembrane region,
KCNA2	potassium voltage-gated channel subfamily A member 2(KCNA2)	Homo sapiens		h_bArr-mapkPathway:Role of ï¿½-arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bArrestinPathway:ï¿½-arrestins in GPCR Desensitization,		GO:0006813~potassium ion transport,GO:0014059~regulation of dopamine secretion,GO:0019228~neuronal action potential,GO:0019233~sensory perception of pain,GO:0021633~optic nerve structural organization,GO:0034765~regulation of ion transmembrane transport,GO:0045188~regulation of circadian sleep/wake cycle, non-REM sleep,GO:0051260~protein homooligomerization,GO:0071805~potassium ion transmembrane transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0031258~lamellipodium membrane,GO:0032809~neuronal cell body membrane,GO:0042734~presynaptic membrane,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0044224~juxtaparanode region of axon,	GO:0005249~voltage-gated potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,GO:0005267~potassium channel activity,GO:0005515~protein binding,GO:0015271~outward rectifier potassium channel activity,GO:0019894~kinesin binding,	IPR000210:BTB/POZ-like,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR003968:Potassium channel, voltage dependent, Kv,IPR003972:Potassium channel, voltage dependent, Kv1,IPR004049:Potassium channel, voltage dependent, Kv1.2,IPR005821:Ion transport domain,IPR011333:BTB/POZ fold,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,		616366~Epileptic encephalopathy, early infantile, 32,		SM00225:BTB,	Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Disease mutation,Endoplasmic reticulum,Epilepsy,Glycoprotein,Ion channel,Ion transport,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Potassium,Potassium channel,Potassium transport,Reference proteome,Synapse,Synaptosome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily A member 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,short sequence motif:PDZ-binding,short sequence motif:Selectivity filter,transmembrane region,
KCNAB2	potassium voltage-gated channel subfamily A regulatory beta subunit 2(KCNAB2)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0050905~neuromuscular process,GO:0055114~oxidation-reduction process,GO:0070995~NADPH oxidation,GO:0071805~potassium ion transmembrane transport,GO:1901379~regulation of potassium ion transmembrane transport,GO:2000008~regulation of protein localization to cell surface,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0043679~axon terminus,GO:0044224~juxtaparanode region of axon,GO:1990031~pinceau fiber,	GO:0004033~aldo-keto reductase (NADP) activity,GO:0005249~voltage-gated potassium channel activity,GO:0015459~potassium channel regulator activity,	IPR001395:Aldo/keto reductase,IPR005399:Potassium channel, voltage-dependent, beta subunit, KCNAB-related,IPR005401:Potassium channel, voltage-dependent, beta subunit, KCNAB2,IPR005983:Potassium channel, voltage-dependent, beta subunit, KCNAB,IPR023210:NADP-dependent oxidoreductase domain,					3D-structure,Acetylation,Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Ion channel,Ion transport,Membrane,Methylation,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Proteomics identification,Reference proteome,Synapse,Synaptosome,Transport,Voltage-gated channel,	binding site:NADP,chain:Voltage-gated potassium channel subunit beta-2,helix,modified residue,nucleotide phosphate-binding region:NADP,sequence variant,splice variant,strand,turn,
KCNC4	potassium voltage-gated channel subfamily C member 4(KCNC4)	Homo sapiens				GO:0006813~potassium ion transport,GO:0007268~chemical synaptic transmission,GO:0034765~regulation of ion transmembrane transport,GO:0046928~regulation of neurotransmitter secretion,GO:0051260~protein homooligomerization,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0031594~neuromuscular junction,GO:0043679~axon terminus,	GO:0005249~voltage-gated potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,GO:0005267~potassium channel activity,	IPR000210:BTB/POZ-like,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR003968:Potassium channel, voltage dependent, Kv,IPR003974:Potassium channel, voltage dependent, Kv3,IPR005405:Potassium channel, voltage dependent, Kv3.4,IPR005821:Ion transport domain,IPR011333:BTB/POZ fold,IPR021105:Potassium channel, voltage dependent, Kv3, inactivation domain,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,				SM00225:BTB,	3D-structure,Alternative splicing,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily C member 4,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Inactivation gate,sequence conflict,sequence variant,short sequence motif:Selectivity filter,splice variant,topological domain:Cytoplasmic,transmembrane region,
KCND3	potassium voltage-gated channel subfamily D member 3(KCND3)	Homo sapiens				GO:0006813~potassium ion transport,GO:0034765~regulation of ion transmembrane transport,GO:0051260~protein homooligomerization,GO:0061337~cardiac conduction,GO:0071435~potassium ion export,GO:0086009~membrane repolarization,GO:0086013~membrane repolarization during cardiac muscle cell action potential,GO:0086091~regulation of heart rate by cardiac conduction,GO:0097623~potassium ion export across plasma membrane,GO:0098915~membrane repolarization during ventricular cardiac muscle cell action potential,GO:0099625~ventricular cardiac muscle cell membrane repolarization,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0030425~dendrite,GO:0042383~sarcolemma,	GO:0005249~voltage-gated potassium channel activity,GO:0005250~A-type (transient outward) potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,GO:0005515~protein binding,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0086008~voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,GO:1902282~voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,	IPR000210:BTB/POZ-like,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR003968:Potassium channel, voltage dependent, Kv,IPR003975:Potassium channel, voltage dependent, Kv4,IPR004056:Potassium channel, voltage dependent, Kv4.3,IPR005821:Ion transport domain,IPR011333:BTB/POZ fold,IPR021645:Shal-type voltage-gated potassium channels,IPR024587:Potassium channel, voltage dependent, Kv4, C-terminal,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,		607346~Spinocerebellar ataxia 19,616399~Brugada syndrome 9,		SM00225:BTB,	3D-structure,Alternative splicing,Brugada syndrome,Cell membrane,Cell projection,Complete proteome,Disease mutation,Ion channel,Ion transport,Membrane,Metal-binding,Neurodegeneration,Phosphoprotein,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Signal,Spinocerebellar ataxia,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,Zinc,	chain:Potassium voltage-gated channel subfamily D member 3,helix,metal ion-binding site:Zinc,modified residue,region of interest:Interaction with KCNIP2,region of interest:Segment H5 (pore-forming),sequence conflict,sequence variant,short sequence motif:Selectivity filter,splice variant,strand,topological domain:Cytoplasmic,transmembrane region,turn,
KCNH1	potassium voltage-gated channel subfamily H member 1(KCNH1)	Homo sapiens				GO:0000160~phosphorelay signal transduction system,GO:0001964~startle response,GO:0006813~potassium ion transport,GO:0007520~myoblast fusion,GO:0023014~signal transduction by protein phosphorylation,GO:0034765~regulation of ion transmembrane transport,GO:0042127~regulation of cell proliferation,GO:0042391~regulation of membrane potential,GO:0048015~phosphatidylinositol-mediated signaling,GO:0071277~cellular response to calcium ion,GO:0071805~potassium ion transmembrane transport,	GO:0005637~nuclear inner membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0030673~axolemma,GO:0031901~early endosome membrane,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0000155~phosphorelay sensor kinase activity,GO:0005249~voltage-gated potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0019901~protein kinase binding,GO:0030551~cyclic nucleotide binding,GO:0042802~identical protein binding,GO:0044325~ion channel binding,GO:0046982~protein heterodimerization activity,GO:0071889~14-3-3 protein binding,GO:1902936~phosphatidylinositol bisphosphate binding,	IPR000014:PAS domain,IPR000595:Cyclic nucleotide-binding domain,IPR000700:PAS-associated, C-terminal,IPR001610:PAC motif,IPR003938:Potassium channel, voltage-dependent, EAG/ELK/ERG,IPR003949:Potassium channel, voltage-dependent, EAG,IPR005821:Ion transport domain,IPR014710:RmlC-like jelly roll fold,IPR018490:Cyclic nucleotide-binding-like,		135500~Zimmermann-Laband syndrome 1,611816~Temple-Baraitser syndrome,		SM00086:PAC,SM00100:cNMP,	3D-structure,Alternative splicing,Calmodulin-binding,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Endosome,Epilepsy,Glycoprotein,Ion channel,Ion transport,Membrane,Mental retardation,Nucleus,Phosphoprotein,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily H member 1,domain:PAC,domain:PAS,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:cNMP,region of interest:CAD (involved in subunit assembly),region of interest:Calmodulin-binding,region of interest:Segment H5 (pore-forming),short sequence motif:Selectivity filter,splice variant,topological domain:Cytoplasmic,transmembrane region,
KCNH7	potassium voltage-gated channel subfamily H member 7(KCNH7)	Homo sapiens				GO:0034765~regulation of ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005249~voltage-gated potassium channel activity,	IPR000014:PAS domain,IPR000595:Cyclic nucleotide-binding domain,IPR003938:Potassium channel, voltage-dependent, EAG/ELK/ERG,IPR003967:Potassium channel, voltage-dependent, ERG,IPR005821:Ion transport domain,IPR014710:RmlC-like jelly roll fold,IPR018490:Cyclic nucleotide-binding-like,				SM00100:cNMP,	Alternative splicing,Coiled coil,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Potassium,Potassium channel,Potassium transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily H member 7,domain:PAC,domain:PAS,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:cNMP,region of interest:Segment H5 (pore-forming),sequence conflict,sequence variant,short sequence motif:Selectivity filter,splice variant,topological domain:Cytoplasmic,transmembrane region,
KCNH8	potassium voltage-gated channel subfamily H member 8(KCNH8)	Homo sapiens				GO:0000160~phosphorelay signal transduction system,GO:0023014~signal transduction by protein phosphorylation,GO:0034765~regulation of ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0071805~potassium ion transmembrane transport,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0000155~phosphorelay sensor kinase activity,GO:0005249~voltage-gated potassium channel activity,	IPR000014:PAS domain,IPR000595:Cyclic nucleotide-binding domain,IPR000700:PAS-associated, C-terminal,IPR001610:PAC motif,IPR003938:Potassium channel, voltage-dependent, EAG/ELK/ERG,IPR003950:Potassium channel, voltage-dependent, ELK,IPR005821:Ion transport domain,IPR014710:RmlC-like jelly roll fold,IPR018490:Cyclic nucleotide-binding-like,				SM00086:PAC,SM00100:cNMP,	Alternative splicing,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Potassium,Potassium channel,Potassium transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily H member 8,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,domain:PAC,domain:PAS,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:cNMP,region of interest:Segment H5 (pore-forming),sequence conflict,sequence variant,short sequence motif:Selectivity filter,topological domain:Cytoplasmic,transmembrane region,
KCNJ10	potassium voltage-gated channel subfamily J member 10(KCNJ10)	Homo sapiens				GO:0006813~potassium ion transport,GO:0007601~visual perception,GO:0007628~adult walking behavior,GO:0010107~potassium ion import,GO:0022010~central nervous system myelination,GO:0034765~regulation of ion transmembrane transport,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0051935~glutamate reuptake,GO:0055075~potassium ion homeostasis,GO:0060075~regulation of resting membrane potential,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0098793~presynapse,	GO:0005242~inward rectifier potassium channel activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015272~ATP-activated inward rectifier potassium channel activity,GO:0015467~G-protein activated inward rectifier potassium channel activity,	IPR003269:Potassium channel, inwardly rectifying, Kir1.2,IPR013518:Potassium channel, inwardly rectifying, Kir, cytoplasmic,IPR014756:Immunoglobulin E-set,IPR016449:Potassium channel, inwardly rectifying, Kir,	hsa04971:Gastric acid secretion,	600791~Enlarged vestibular aqueduct, digenic,612780~SESAME syndrome,	PIRSF005465:G protein-activated inward rectifier potassium channel,		ATP-binding,Cell membrane,Complete proteome,Deafness,Disease mutation,Epilepsy,Ion channel,Ion transport,Membrane,Mental retardation,Nucleotide-binding,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:ATP-sensitive inward rectifier potassium channel 10,nucleotide phosphate-binding region:ATP,region of interest:H5 (pore-forming helix),sequence conflict,sequence variant,short sequence motif:Selectivity filter,site:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KCNJ3	potassium voltage-gated channel subfamily J member 3(KCNJ3)	Homo sapiens				GO:0006813~potassium ion transport,GO:0010107~potassium ion import,GO:0034765~regulation of ion transmembrane transport,GO:0051602~response to electrical stimulus,GO:0086091~regulation of heart rate by cardiac conduction,GO:0098914~membrane repolarization during atrial cardiac muscle cell action potential,GO:0098915~membrane repolarization during ventricular cardiac muscle cell action potential,GO:0099625~ventricular cardiac muscle cell membrane repolarization,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030315~T-tubule,	GO:0005242~inward rectifier potassium channel activity,GO:0005515~protein binding,GO:0015467~G-protein activated inward rectifier potassium channel activity,GO:0086089~voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,GO:1902282~voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,	IPR003274:Potassium channel, inwardly rectifying, Kir3.1,IPR013518:Potassium channel, inwardly rectifying, Kir, cytoplasmic,IPR014756:Immunoglobulin E-set,IPR016449:Potassium channel, inwardly rectifying, Kir,	hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04915:Estrogen signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05032:Morphine addiction,		PIRSF005465:G protein-activated inward rectifier potassium channel,		Alternative splicing,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:G protein-activated inward rectifier potassium channel 1,modified residue,region of interest:H5 (pore-forming helix),sequence conflict,sequence variant,short sequence motif:Selectivity filter,site:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KCNQ4	potassium voltage-gated channel subfamily Q member 4(KCNQ4)	Homo sapiens		h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,		GO:0006813~potassium ion transport,GO:0007605~sensory perception of sound,GO:0034765~regulation of ion transmembrane transport,GO:0042472~inner ear morphogenesis,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0009925~basal plasma membrane,GO:0016021~integral component of membrane,	GO:0005249~voltage-gated potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,GO:0005267~potassium channel activity,GO:0005515~protein binding,	IPR003937:Potassium channel, voltage dependent, KCNQ,IPR005821:Ion transport domain,IPR013821:Potassium channel, voltage dependent, KCNQ, C-terminal,IPR015573:Potassium channel, voltage dependent, KCNQ4,	hsa04725:Cholinergic synapse,	600101~Deafness, autosomal dominant 2A,			3D-structure,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Deafness,Disease mutation,Hearing,Ion channel,Ion transport,Membrane,Non-syndromic deafness,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily KQT member 4,helix,region of interest:Segment H5 (pore-forming),sequence variant,short sequence motif:Selectivity filter,splice variant,transmembrane region,
PRPF3	pre-mRNA processing factor 3(PRPF3)	Homo sapiens				GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0043234~protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR002483:PWI domain,IPR010541:Domain of unknown function DUF1115,IPR013881:Pre-mRNA-splicing factor 3,IPR027104:U4/U6 small nuclear ribonucleoprotein Prp3,	hsa03040:Spliceosome,	601414~Retinitis pigmentosa 18,		SM00311:PWI,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Retinitis pigmentosa,Spliceosome,Ubl conjugation,	chain:U4/U6 small nuclear ribonucleoprotein PRP3,compositionally biased region:Poly-Val,domain:PWI,helix,modified residue,sequence conflict,sequence variant,splice variant,turn,
PRPF40A	pre-mRNA processing factor 40 homolog A(PRPF40A)	Homo sapiens			RNA processing and modification,	GO:0000398~mRNA splicing, via spliceosome,GO:0007010~cytoskeleton organization,GO:0007049~cell cycle,GO:0008360~regulation of cell shape,GO:0016477~cell migration,GO:0032465~regulation of cytokinesis,GO:0051301~cell division,	GO:0005654~nucleoplasm,GO:0005685~U1 snRNP,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0071004~U2-type prespliceosome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0070064~proline-rich region binding,	IPR001202:WW domain,IPR002713:FF domain,	hsa03040:Spliceosome,			SM00441:FF,SM00456:WW,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Pre-mRNA-processing factor 40 homolog A,domain:FF 1,domain:FF 2,domain:FF 3,domain:FF 4,domain:FF 5,domain:WW 1,domain:WW 2,helix,modified residue,sequence conflict,splice variant,strand,turn,
PCYOX1	prenylcysteine oxidase 1(PCYOX1)	Homo sapiens			Coenzyme metabolism,	GO:0030327~prenylated protein catabolic process,GO:0030328~prenylcysteine catabolic process,GO:0030329~prenylcysteine metabolic process,GO:0055114~oxidation-reduction process,GO:1902476~chloride transmembrane transport,	GO:0005764~lysosome,GO:0005774~vacuolar membrane,GO:0005886~plasma membrane,GO:0034361~very-low-density lipoprotein particle,GO:0070062~extracellular exosome,	GO:0001735~prenylcysteine oxidase activity,GO:0008555~chloride-transporting ATPase activity,	IPR010795:Prenylcysteine lyase,IPR017046:Prenylcysteine oxidase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00900:Terpenoid backbone biosynthesis,hsa01130:Biosynthesis of antibiotics,		PIRSF036292:prenylcysteine oxidase,		Alternative splicing,Complete proteome,Direct protein sequencing,FAD,Flavoprotein,Glycoprotein,Isopeptide bond,Lysosome,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Prenylcysteine oxidase 1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
PSEN2	presenilin 2(PSEN2)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,		GO:0001666~response to hypoxia,GO:0006509~membrane protein ectodomain proteolysis,GO:0006816~calcium ion transport,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0016485~protein processing,GO:0031293~membrane protein intracellular domain proteolysis,GO:0035556~intracellular signal transduction,GO:0042987~amyloid precursor protein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0048013~ephrin receptor signaling pathway,GO:0050435~beta-amyloid metabolic process,	GO:0000139~Golgi membrane,GO:0000776~kinetochore,GO:0005622~intracellular,GO:0005637~nuclear inner membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005938~cell cortex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030018~Z disc,GO:0043025~neuronal cell body,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0004175~endopeptidase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0005515~protein binding,	IPR001108:Peptidase A22A, presenilin,IPR001493:Peptidase A22A, presenilin 2,IPR006639:Peptidase A22, presenilin signal peptide,	hsa04330:Notch signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa05010:Alzheimer's disease,	606889~Alzheimer disease-4,613697~Cardiomyopathy, dilated, 1V,		SM00730:PSN,	Alternative splicing,Alzheimer disease,Amyloidosis,Cardiomyopathy,Complete proteome,Disease mutation,Endoplasmic reticulum,Golgi apparatus,Hydrolase,Membrane,Neurodegeneration,Notch signaling pathway,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Presenilin-2 CTF subunit,chain:Presenilin-2 NTF subunit,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:PAL,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
PRICKLE2	prickle planar cell polarity protein 2(PRICKLE2)	Homo sapiens				GO:0060071~Wnt signaling pathway, planar cell polarity pathway,	GO:0005737~cytoplasm,GO:0031965~nuclear membrane,	GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR010442:PET domain,	hsa04310:Wnt signaling pathway,	613832~Epilepsy, progressive myoclonic 5,		SM00132:LIM,	Complete proteome,Disease mutation,Epilepsy,LIM domain,Lipoprotein,Membrane,Metal-binding,Methylation,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Prenylation,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:Prickle-like protein 2,compositionally biased region:Arg-rich,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:PET,lipid moiety-binding region:S-farnesyl cysteine,modified residue,
PLOD1	procollagen-lysine,2-oxoglutarate 5-dioxygenase 1(PLOD1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006464~cellular protein modification process,GO:0008544~epidermis development,GO:0046947~hydroxylysine biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0030867~rough endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0005506~iron ion binding,GO:0008475~procollagen-lysine 5-dioxygenase activity,GO:0031418~L-ascorbic acid binding,GO:0042803~protein homodimerization activity,	IPR001006:Procollagen-lysine 5-dioxygenase,IPR005123:Oxoglutarate/iron-dependent dioxygenase,IPR006620:Prolyl 4-hydroxylase, alpha subunit,	hsa00310:Lysine degradation,	225400~Ehlers-Danlos syndrome, type VI,		SM00702:P4Hc,	Alternative splicing,Complete proteome,Dioxygenase,Direct protein sequencing,Disease mutation,Ehlers-Danlos syndrome,Endoplasmic reticulum,Glycoprotein,Iron,Membrane,Metal-binding,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,Vitamin C,	chain:Procollagen-lysine,2-oxoglutarate 5- dioxygenase 1,domain:Fe2OG dioxygenase,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Iron,mutagenesis site,sequence variant,signal peptide,
PAQR6	progestin and adipoQ receptor family member 6(PAQR6)	Homo sapiens				GO:0043401~steroid hormone mediated signaling pathway,GO:0048545~response to steroid hormone,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0003707~steroid hormone receptor activity,GO:0005496~steroid binding,	IPR004254:Hly-III-related,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Progestin and adipoQ receptor family member 6,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PDCD6IP	programmed cell death 6 interacting protein(PDCD6IP)	Homo sapiens				GO:0000920~cell separation after cytokinesis,GO:0006915~apoptotic process,GO:0006997~nucleus organization,GO:0007049~cell cycle,GO:0007080~mitotic metaphase plate congression,GO:0010824~regulation of centrosome duplication,GO:0015031~protein transport,GO:0019058~viral life cycle,GO:0036258~multivesicular body assembly,GO:0039702~viral budding via host ESCRT complex,GO:0090611~ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,GO:1901673~regulation of mitotic spindle assembly,GO:1903543~positive regulation of exosomal secretion,GO:1903551~regulation of extracellular exosome assembly,GO:1903553~positive regulation of extracellular exosome assembly,	GO:0001772~immunological synapse,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:0070971~endoplasmic reticulum exit site,GO:1903561~extracellular vesicle,	GO:0005515~protein binding,GO:0031871~proteinase activated receptor binding,GO:0042803~protein homodimerization activity,GO:0048306~calcium-dependent protein binding,	IPR004328:BRO1 domain,IPR025304:ALIX V-shaped domain,	hsa04144:Endocytosis,			SM01041:SM01041,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Host-virus interaction,Methylation,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Secreted,Transport,	chain:Programmed cell death 6-interacting protein,compositionally biased region:Pro-rich,domain:BRO1,helix,modified residue,mutagenesis site,region of interest:Essential to promote virus budding,region of interest:Interaction with CEP55,region of interest:Interaction with CHMP4A, CHMP4B and CHMP4C,region of interest:Interaction with EIAV p9,region of interest:Interaction with TSG101,region of interest:Self-association,sequence conflict,sequence variant,strand,turn,
PROK2	prokineticin 2(PROK2)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0001525~angiogenesis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007218~neuropeptide signaling pathway,GO:0007283~spermatogenesis,GO:0007623~circadian rhythm,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0019233~sensory perception of pain,GO:0043066~negative regulation of apoptotic process,GO:0045765~regulation of angiogenesis,GO:0045987~positive regulation of smooth muscle contraction,	GO:0005576~extracellular region,GO:0005623~cell,	GO:0001664~G-protein coupled receptor binding,	IPR009523:Prokineticin,IPR023569:Prokineticin domain,		610628~Hypogonadotropic hypogonadism 4 with or without anosmia,			Alternative splicing,Biological rhythms,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Hypogonadotropic hypogonadism,Kallmann syndrome,Neuropeptide,Reference proteome,Secreted,Signal,	chain:Prokineticin-2,disulfide bond,sequence variant,signal peptide,splice variant,
PRLH	prolactin releasing hormone(PRLH)	Homo sapiens				GO:0001894~tissue homeostasis,GO:0002023~reduction of food intake in response to dietary excess,GO:0006112~energy reserve metabolic process,GO:0006629~lipid metabolic process,GO:0007186~G-protein coupled receptor signaling pathway,GO:0009749~response to glucose,GO:0032868~response to insulin,GO:0040014~regulation of multicellular organism growth,GO:0045444~fat cell differentiation,GO:0048483~autonomic nervous system development,	GO:0005576~extracellular region,GO:0005737~cytoplasm,	GO:0005179~hormone activity,GO:0005184~neuropeptide hormone activity,GO:0031861~prolactin-releasing peptide receptor binding,	IPR026194:Prolactin-releasing peptide,					Amidation,Cleavage on pair of basic residues,Complete proteome,Hormone,Reference proteome,Secreted,Signal,	modified residue,peptide:Prolactin-releasing peptide PrRP20,peptide:Prolactin-releasing peptide PrRP31,signal peptide,
PRELP	proline and arginine rich end leucine rich repeat protein(PRELP)	Homo sapiens				GO:0001501~skeletal system development,GO:0007409~axonogenesis,GO:0007569~cell aging,GO:0018146~keratan sulfate biosynthetic process,GO:0042340~keratan sulfate catabolic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0031012~extracellular matrix,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005201~extracellular matrix structural constituent,GO:0008201~heparin binding,	IPR000372:Leucine-rich repeat-containing N-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR027216:Prolargin,				SM00013:LRRNT,SM00369:LRR_TYP,	Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Prolargin,compositionally biased region:Cys-rich,compositionally biased region:Poly-Leu,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence variant,signal peptide,
PRR9	proline rich 9(PRR9)	Homo sapiens				GO:0018149~peptide cross-linking,GO:0030216~keratinocyte differentiation,	GO:0001533~cornified envelope,GO:0005737~cytoplasm,	GO:0005198~structural molecule activity,	IPR026075:Small proline-rich protein/late cornified envelope protein,					Complete proteome,Reference proteome,	chain:Proline-rich protein 9,compositionally biased region:Cys-rich,
PRRC2C	proline rich coiled-coil 2C(PRRC2C)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,	GO:0016020~membrane,	GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,	IPR009738:BAT2, N-terminal,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:BAT2 domain-containing protein 1,compositionally biased region:Ala-rich,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,
PNRC2	proline rich nuclear receptor coactivator 2(PNRC2)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0031087~deadenylation-independent decapping of nuclear-transcribed mRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,	GO:0005515~protein binding,	IPR026780:Proline-rich nuclear receptor coactivator 1/2,IPR026781:Proline-rich nuclear receptor coactivator 2,					3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Nonsense-mediated mRNA decay,Nucleus,Receptor,Reference proteome,Transcription,Transcription regulation,	chain:Proline-rich nuclear receptor coactivator 2,mutagenesis site,short sequence motif:SH3-binding,splice variant,
P3H1	prolyl 3-hydroxylase 1(P3H1)	Homo sapiens				GO:0006457~protein folding,GO:0008285~negative regulation of cell proliferation,GO:0018126~protein hydroxylation,GO:0019511~peptidyl-proline hydroxylation,GO:0032963~collagen metabolic process,GO:0050708~regulation of protein secretion,GO:0050821~protein stabilization,GO:0055114~oxidation-reduction process,GO:0060348~bone development,GO:0061077~chaperone-mediated protein folding,GO:1901874~negative regulation of post-translational protein modification,	GO:0005578~proteinaceous extracellular matrix,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0032991~macromolecular complex,GO:0070062~extracellular exosome,	GO:0005506~iron ion binding,GO:0005518~collagen binding,GO:0019797~procollagen-proline 3-dioxygenase activity,GO:0031418~L-ascorbic acid binding,GO:0032403~protein complex binding,	IPR005123:Oxoglutarate/iron-dependent dioxygenase,IPR006620:Prolyl 4-hydroxylase, alpha subunit,IPR011990:Tetratricopeptide-like helical,		610915~Osteogenesis imperfecta, type VIII,		SM00702:P4Hc,	Alternative splicing,Coiled coil,Complete proteome,Dioxygenase,Dwarfism,Endoplasmic reticulum,Extracellular matrix,Glycoprotein,Iron,Metal-binding,Osteogenesis imperfecta,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,TPR repeat,Vitamin C,	chain:Prolyl 3-hydroxylase 1,domain:Fe2OG dioxygenase,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Iron,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
P4HTM	prolyl 4-hydroxylase, transmembrane(P4HTM)	Homo sapiens				GO:0045646~regulation of erythrocyte differentiation,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005506~iron ion binding,GO:0005509~calcium ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0031418~L-ascorbic acid binding,	IPR002048:EF-hand domain,IPR005123:Oxoglutarate/iron-dependent dioxygenase,IPR006620:Prolyl 4-hydroxylase, alpha subunit,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00702:P4Hc,	Alternative splicing,Calcium,Complete proteome,Dioxygenase,Endoplasmic reticulum,Glycoprotein,Iron,Membrane,Metal-binding,Oxidoreductase,Proteomics identification,Reference proteome,Repeat,Signal-anchor,Transmembrane,Transmembrane helix,Vitamin C,	binding site:2-oxoglutarate,calcium-binding region:1,calcium-binding region:2,chain:Transmembrane prolyl 4-hydroxylase,domain:EF-hand 1,domain:EF-hand 2,domain:Fe2OG dioxygenase,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Iron,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
PREPL	prolyl endopeptidase-like(PREPL)	Homo sapiens			Amino acid transport and metabolism,	GO:0006508~proteolysis,	GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,	GO:0004252~serine-type endopeptidase activity,GO:0070008~serine-type exopeptidase activity,	IPR001375:Peptidase S9, prolyl oligopeptidase, catalytic domain,IPR002470:Peptidase S9A, prolyl oligopeptidase,IPR023302:Peptidase S9A, oligopeptidase, N-terminal,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Protease,Proteomics identification,Reference proteome,Serine protease,	active site:Charge relay system,chain:Prolyl endopeptidase-like,mutagenesis site,sequence conflict,splice variant,
PROX1	prospero homeobox 1(PROX1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001709~cell fate determination,GO:0001822~kidney development,GO:0001889~liver development,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001946~lymphangiogenesis,GO:0002088~lens development in camera-type eye,GO:0002194~hepatocyte cell migration,GO:0006351~transcription, DNA-templated,GO:0007420~brain development,GO:0007623~circadian rhythm,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0010595~positive regulation of endothelial cell migration,GO:0021516~dorsal spinal cord development,GO:0021542~dentate gyrus development,GO:0021707~cerebellar granule cell differentiation,GO:0021915~neural tube development,GO:0030182~neuron differentiation,GO:0030240~skeletal muscle thin filament assembly,GO:0030324~lung development,GO:0030910~olfactory placode formation,GO:0031016~pancreas development,GO:0031667~response to nutrient levels,GO:0042752~regulation of circadian rhythm,GO:0043049~otic placode formation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045071~negative regulation of viral genome replication,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046619~optic placode formation involved in camera-type eye formation,GO:0048845~venous blood vessel morphogenesis,GO:0055005~ventricular cardiac myofibril assembly,GO:0055007~cardiac muscle cell differentiation,GO:0055009~atrial cardiac muscle tissue morphogenesis,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0060042~retina morphogenesis in camera-type eye,GO:0060059~embryonic retina morphogenesis in camera-type eye,GO:0060214~endocardium formation,GO:0060298~positive regulation of sarcomere organization,GO:0060412~ventricular septum morphogenesis,GO:0060414~aorta smooth muscle tissue morphogenesis,GO:0060421~positive regulation of heart growth,GO:0060836~lymphatic endothelial cell differentiation,GO:0060849~regulation of transcription involved in lymphatic endothelial cell fate commitment,GO:0061114~branching involved in pancreas morphogenesis,GO:0070309~lens fiber cell morphogenesis,GO:0070365~hepatocyte differentiation,GO:0070858~negative regulation of bile acid biosynthetic process,GO:0072574~hepatocyte proliferation,GO:0090425~acinar cell differentiation,GO:0097150~neuronal stem cell population maintenance,GO:1901978~positive regulation of cell cycle checkpoint,GO:2000179~positive regulation of neural precursor cell proliferation,GO:2000979~positive regulation of forebrain neuron differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0001046~core promoter sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0044212~transcription regulatory region DNA binding,GO:0050692~DBD domain binding,GO:0050693~LBD domain binding,	IPR009057:Homeodomain-like,IPR023082:Homeo-prospero domain,					3D-structure,Biological rhythms,Complete proteome,Developmental protein,DNA-binding,Homeobox,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Prospero homeobox protein 1,compositionally biased region:Poly-Gln,DNA-binding region:Prospero-type homeobox,modified residue,region of interest:Prospero-like,sequence conflict,sequence variant,
PTGER3	prostaglandin E receptor 3(PTGER3)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008219~cell death,GO:0014827~intestine smooth muscle contraction,GO:0031622~positive regulation of fever generation,GO:0060455~negative regulation of gastric acid secretion,	GO:0005635~nuclear envelope,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004957~prostaglandin E receptor activity,	IPR000265:Prostanoid EP3 receptor,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001244:Prostaglandin DP receptor,IPR001481:Prostanoid EP3 receptor, type 2,IPR008365:Prostanoid receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04923:Regulation of lipolysis in adipocytes,hsa05200:Pathways in cancer,				Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Prostaglandin E2 receptor EP3 subtype,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PTGFR	prostaglandin F receptor(PTGFR)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007567~parturition,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0043066~negative regulation of apoptotic process,GO:0071799~cellular response to prostaglandin D stimulus,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004958~prostaglandin F receptor activity,	IPR000141:Prostaglandin F receptor,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR008365:Prostanoid receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Prostaglandin F2-alpha receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PTGFRN	prostaglandin F2 receptor inhibitor(PTGFRN)	Homo sapiens				GO:0034389~lipid particle organization,	GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00409:IG,	Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Prostaglandin F2 receptor negative regulator,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,short sequence motif:Endoplasmic reticular retention signal,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PRSS38	protease, serine 38(PRSS38)	Homo sapiens				GO:0006508~proteolysis,	GO:0005576~extracellular region,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Reference proteome,Secreted,Serine protease,Signal,	active site:Charge relay system,chain:Serine protease MPN2,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,
PSMD1	proteasome 26S subunit, non-ATPase 1(PSMD1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006521~regulation of cellular amino acid metabolic process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042176~regulation of protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005838~proteasome regulatory particle,GO:0008540~proteasome regulatory particle, base subcomplex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0022624~proteasome accessory complex,GO:0034515~proteasome storage granule,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0030234~enzyme regulator activity,	IPR002015:Proteasome/cyclosome, regulatory subunit,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR016642:26S proteasome regulatory complex, non-ATPase subcomplex, Rpn2/Psmd1 subunit,	hsa03050:Proteasome,hsa05169:Epstein-Barr virus infection,		PIRSF015947:26S proteasome regulatory complex, non-ATPase subcomplex, Rpn2/Psmd1 subunit,		3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Membrane,Phosphoprotein,Proteasome,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:26S proteasome non-ATPase regulatory subunit 1,compositionally biased region:Poly-Glu,modified residue,repeat:PC 1,repeat:PC 10,repeat:PC 2,repeat:PC 3,repeat:PC 4,repeat:PC 5,repeat:PC 6,repeat:PC 7,repeat:PC 8,repeat:PC 9,sequence conflict,splice variant,
PSMD14	proteasome 26S subunit, non-ATPase 14(PSMD14)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0000724~double-strand break repair via homologous recombination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006521~regulation of cellular amino acid metabolic process,GO:0010950~positive regulation of endopeptidase activity,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0045471~response to ethanol,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0061136~regulation of proteasomal protein catabolic process,GO:0070536~protein K63-linked deubiquitination,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0008541~proteasome regulatory particle, lid subcomplex,GO:0022624~proteasome accessory complex,GO:0031597~cytosolic proteasome complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,GO:0061133~endopeptidase activator activity,GO:0070628~proteasome binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR024969:Rpn11/EIF3F C-terminal domain,	hsa03050:Proteasome,hsa05169:Epstein-Barr virus infection,			SM00232:JAB_MPN,	3D-structure,Complete proteome,Direct protein sequencing,DNA damage,DNA repair,Hydrolase,Metal-binding,Metalloprotease,Phosphoprotein,Protease,Proteasome,Proteomics identification,Reference proteome,Ubl conjugation pathway,Zinc,	chain:26S proteasome non-ATPase regulatory subunit 14,domain:MPN,metal ion-binding site:Zinc; catalytic,modified residue,short sequence motif:JAMM motif,
PSMD4	proteasome 26S subunit, non-ATPase 4(PSMD4)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006521~regulation of cellular amino acid metabolic process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043248~proteasome assembly,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0008540~proteasome regulatory particle, base subcomplex,GO:0022624~proteasome accessory complex,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0031593~polyubiquitin binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR002035:von Willebrand factor, type A,IPR003903:Ubiquitin interacting motif,IPR027040:Proteasome subunit Rpn10,	hsa03050:Proteasome,hsa05169:Epstein-Barr virus infection,			SM00327:VWA,SM00726:UIM,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Phosphoprotein,Proteasome,Proteomics identification,Reference proteome,Repeat,	chain:26S proteasome non-ATPase regulatory subunit 4,compositionally biased region:Poly-Ala,domain:VWFA,helix,modified residue,region of interest:Essential for ubiquitin-binding,repeat:UIM 1,repeat:UIM 2,splice variant,strand,
PSMD6	proteasome 26S subunit, non-ATPase 6(PSMD6)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006508~proteolysis,GO:0006521~regulation of cellular amino acid metabolic process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005838~proteasome regulatory particle,GO:0022624~proteasome accessory complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0016887~ATPase activity,	IPR000717:Proteasome component (PCI) domain,IPR011990:Tetratricopeptide-like helical,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR019585:26S proteasome, regulatory subunit Rpn7,	hsa03050:Proteasome,hsa05169:Epstein-Barr virus infection,			SM00088:PINT,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Proteasome,Proteomics identification,Reference proteome,	chain:26S proteasome non-ATPase regulatory subunit 6,domain:PCI,
PSME4	proteasome activator subunit 4(PSME4)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006281~DNA repair,GO:0006521~regulation of cellular amino acid metabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007275~multicellular organism development,GO:0010499~proteasomal ubiquitin-independent protein catabolic process,GO:0010952~positive regulation of peptidase activity,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0035093~spermatogenesis, exchange of chromosomal proteins,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0016607~nuclear speck,GO:1990111~spermatoproteasome complex,	GO:0005515~protein binding,GO:0016504~peptidase activator activity,GO:0070577~lysine-acetylated histone binding,GO:0070628~proteasome binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021843:Protein of unknown function DUF3437,	hsa03050:Proteasome,				Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA damage,DNA repair,Nucleus,Phosphoprotein,Polymorphism,Proteasome,Proteomics identification,Reference proteome,Repeat,Spermatogenesis,	chain:Proteasome activator complex subunit 4,modified residue,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,sequence conflict,sequence variant,splice variant,
PSMA5	proteasome subunit alpha 5(PSMA5)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006521~regulation of cellular amino acid metabolic process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0019773~proteasome core complex, alpha-subunit complex,GO:0070062~extracellular exosome,	GO:0004298~threonine-type endopeptidase activity,GO:0005515~protein binding,	IPR000426:Proteasome, alpha-subunit, N-terminal domain,IPR001353:Proteasome, subunit alpha/beta,IPR023332:Proteasome A-type subunit,	hsa03050:Proteasome,			SM00948:SM00948,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Glycoprotein,Hydrolase,Nucleus,Phosphoprotein,Protease,Proteasome,Reference proteome,Threonine protease,	chain:Proteasome subunit alpha type-5,modified residue,sequence conflict,
PSMB2	proteasome subunit beta 2(PSMB2)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006521~regulation of cellular amino acid metabolic process,GO:0010243~response to organonitrogen compound,GO:0014070~response to organic cyclic compound,GO:0016032~viral process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004298~threonine-type endopeptidase activity,GO:0005515~protein binding,	IPR001353:Proteasome, subunit alpha/beta,IPR016050:Proteasome, beta-type subunit, conserved site,IPR023333:Proteasome B-type subunit,	hsa03050:Proteasome,				3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,Hydrolase,Nucleus,Protease,Proteasome,Proteomics identification,Reference proteome,Threonine protease,	chain:Proteasome subunit beta type-2,modified residue,
PSMB4	proteasome subunit beta 4(PSMB4)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0002862~negative regulation of inflammatory response to antigenic stimulus,GO:0006521~regulation of cellular amino acid metabolic process,GO:0016032~viral process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0070062~extracellular exosome,	GO:0001530~lipopolysaccharide binding,GO:0004298~threonine-type endopeptidase activity,GO:0005515~protein binding,	IPR001353:Proteasome, subunit alpha/beta,IPR016050:Proteasome, beta-type subunit, conserved site,IPR016295:Proteasome endopeptidase complex, beta subunit,IPR023333:Proteasome B-type subunit,	hsa03050:Proteasome,		PIRSF001213:proteasome endopeptidase complex, beta subunit,		3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteasome,Reference proteome,Threonine protease,Zymogen,	chain:Proteasome subunit beta type-4,modified residue,sequence conflict,sequence variant,
PROC	protein C, inactivator of coagulation factors Va and VIIIa(PROC)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,		GO:0006465~signal peptide processing,GO:0006508~proteolysis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007596~blood coagulation,GO:0017187~peptidyl-glutamic acid carboxylation,GO:0030195~negative regulation of blood coagulation,GO:0043066~negative regulation of apoptotic process,GO:0050728~negative regulation of inflammatory response,GO:0050819~negative regulation of coagulation,GO:0050900~leukocyte migration,GO:1903142~positive regulation of establishment of endothelial barrier,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,	GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0016787~hydrolase activity,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000294:Gamma-carboxyglutamic acid-rich (GLA) domain,IPR000742:Epidermal growth factor-like domain,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR001881:EGF-like calcium-binding,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR012224:Peptidase S1A, coagulation factor VII/IX/X/C/Z,IPR013032:EGF-like, conserved site,IPR017857:Coagulation factor, subgroup, Gla domain,IPR018097:EGF-like calcium-binding, conserved site,IPR018114:Peptidase S1, trypsin family, active site,	hsa04610:Complement and coagulation cascades,	176860~Thrombophilia due to protein C deficiency, autosomal dominant,612304~Thrombophilia due to protein C deficiency, autosomal recessive,	PIRSF001143:coagulation factor X,	SM00020:Tryp_SPc,SM00069:GLA,SM00179:EGF_CA,SM00181:EGF,	3D-structure,Alternative splicing,Blood coagulation,Calcium,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,EGF-like domain,Endoplasmic reticulum,Gamma-carboxyglutamic acid,Glycoprotein,Golgi apparatus,Hemostasis,Hydrolase,Hydroxylation,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease,Signal,Thrombophilia,Zymogen,	active site:Charge relay system,chain:Vitamin K-dependent protein C,chain:Vitamin K-dependent protein C heavy chain,chain:Vitamin K-dependent protein C light chain,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:Gla,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial; atypical,helix,modified residue,peptide:Activation peptide,sequence conflict,sequence variant,signal peptide,site:Cleavage; by thrombin,strand,turn,
POMGNT1	protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)(POMGNT1)	Homo sapiens				GO:0006486~protein glycosylation,GO:0006493~protein O-linked glycosylation,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0008375~acetylglucosaminyltransferase activity,GO:0047223~beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,	IPR004139:Glycosyl transferase, family 13,		253280~Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3,613151~Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3,613157~Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3,			3D-structure,Alternative splicing,Complete proteome,Congenital muscular dystrophy,Disease mutation,Dystroglycanopathy,Glycosyltransferase,Golgi apparatus,Isopeptide bond,Limb-girdle muscular dystrophy,Lissencephaly,Manganese,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Retinitis pigmentosa,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Protein O-linked-mannose beta-1,2-N- acetylglucosaminyltransferase 1,compositionally biased region:Poly-Arg,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
POMGNT2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)(POMGNT2)	Homo sapiens				GO:0001764~neuron migration,GO:0006493~protein O-linked glycosylation,GO:0035269~protein O-linked mannosylation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0008375~acetylglucosaminyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0097363~protein O-GlcNAc transferase activity,	IPR003961:Fibronectin, type III,IPR007657:Glycosyltransferase AER61, uncharacterised,IPR013783:Immunoglobulin-like fold,		614830~Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8,			Complete proteome,Congenital muscular dystrophy,Disease mutation,Dystroglycanopathy,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Lissencephaly,Membrane,Reference proteome,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Uncharacterized glycosyltransferase AGO61,glycosylation site:N-linked (GlcNAc...),signal peptide,
PROS1	protein S (alpha)(PROS1)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,		GO:0002576~platelet degranulation,GO:0006465~signal peptide processing,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007596~blood coagulation,GO:0010951~negative regulation of endopeptidase activity,GO:0017187~peptidyl-glutamic acid carboxylation,GO:0030195~negative regulation of blood coagulation,GO:0030449~regulation of complement activation,GO:0042730~fibrinolysis,GO:0050900~leukocyte migration,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005789~endoplasmic reticulum membrane,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004866~endopeptidase inhibitor activity,GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000294:Gamma-carboxyglutamic acid-rich (GLA) domain,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017857:Coagulation factor, subgroup, Gla domain,IPR018097:EGF-like calcium-binding, conserved site,	hsa04610:Complement and coagulation cascades,	612336~Thrombophilia due to protein S deficiency, autosomal dominant,614514~Thrombophilia due to protein S deficiency, autosomal recessive,		SM00069:GLA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	3D-structure,Blood coagulation,Calcium,Cleavage on pair of basic residues,Complete proteome,Disease mutation,Disulfide bond,EGF-like domain,Fibrinolysis,Gamma-carboxyglutamic acid,Glycoprotein,Hemostasis,Hydroxylation,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Thrombophilia,Transmembrane,Transmembrane helix,Zymogen,	chain:protein S,chain:Vitamin K-dependent protein S,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:Gla,domain:Laminin G-like 1,domain:Laminin G-like 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,region of interest:Thrombin-sensitive,sequence conflict,sequence variant,signal peptide,site:Not glycosylated; in variant Heerlen,strand,turn,
PRKRA	protein activator of interferon induced protein kinase EIF2AK2(PRKRA)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006955~immune response,GO:0008285~negative regulation of cell proliferation,GO:0009615~response to virus,GO:0030422~production of siRNA involved in RNA interference,GO:0031047~gene silencing by RNA,GO:0031054~pre-miRNA processing,GO:0034599~cellular response to oxidative stress,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0042473~outer ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0043085~positive regulation of catalytic activity,GO:0048705~skeletal system morphogenesis,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0016301~kinase activity,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR014720:Double-stranded RNA-binding-like domain,		612067~Dystonia 16,		SM00358:DSRM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Dystonia,Kinase,Parkinsonism,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,Transferase,	chain:Interferon-inducible double stranded RNA- dependent protein kinase activator A,domain:DRBM 1,domain:DRBM 2,domain:DRBM 3,helix,modified residue,mutagenesis site,region of interest:Sufficient for self-association and interaction with TARBP2,sequence conflict,sequence variant,splice variant,strand,
PDIA6	protein disulfide isomerase family A member 6(PDIA6)	Homo sapiens	84.Ubiquitination_Pathways_Cell_Cycle,			GO:0006457~protein folding,GO:0034976~response to endoplasmic reticulum stress,GO:0036498~IRE1-mediated unfolded protein response,GO:0043277~apoptotic cell clearance,GO:0045454~cell redox homeostasis,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0034663~endoplasmic reticulum chaperone complex,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0003756~protein disulfide isomerase activity,GO:0005515~protein binding,	IPR005788:Disulphide isomerase,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR017937:Thioredoxin, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,				3D-structure,Alternative splicing,Cell membrane,Chaperone,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Isomerase,Membrane,Phosphoprotein,Polymorphism,Redox-active center,Reference proteome,Repeat,Signal,	active site:Nucleophile,chain:Protein disulfide-isomerase A6,compositionally biased region:Asp/Glu-rich (acidic),disulfide bond,domain:Thioredoxin 1,domain:Thioredoxin 2,helix,modified residue,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,site:Contributes to redox potential value,site:Lowers pKa of C-terminal Cys of first active site,site:Lowers pKa of C-terminal Cys of second active site,splice variant,strand,turn,
PRKAA2	protein kinase AMP-activated catalytic subunit alpha 2(PRKAA2)	Homo sapiens		h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_leptinPathway:Reversal of Insulin Resistance by Leptin,		GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006633~fatty acid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0006853~carnitine shuttle,GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0008610~lipid biosynthetic process,GO:0010508~positive regulation of autophagy,GO:0014850~response to muscle activity,GO:0016055~Wnt signaling pathway,GO:0016236~macroautophagy,GO:0016239~positive regulation of macroautophagy,GO:0016241~regulation of macroautophagy,GO:0031669~cellular response to nutrient levels,GO:0032007~negative regulation of TOR signaling,GO:0035404~histone-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0035690~cellular response to drug,GO:0042149~cellular response to glucose starvation,GO:0042304~regulation of fatty acid biosynthetic process,GO:0042593~glucose homeostasis,GO:0042752~regulation of circadian rhythm,GO:0043066~negative regulation of apoptotic process,GO:0045821~positive regulation of glycolytic process,GO:0048511~rhythmic process,GO:0055089~fatty acid homeostasis,GO:0071380~cellular response to prostaglandin E stimulus,GO:1901796~regulation of signal transduction by p53 class mediator,GO:2000505~regulation of energy homeostasis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031588~nucleotide-activated protein kinase complex,	GO:0003682~chromatin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004679~AMP-activated protein kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0035174~histone serine kinase activity,GO:0046872~metal ion binding,GO:0047322~[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,GO:0050405~[acetyl-CoA carboxylase] kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04068:FoxO signaling pathway,hsa04140:Regulation of autophagy,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04710:Circadian rhythm,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05410:Hypertrophic cardiomyopathy (HCM),			SM00220:S_TKc,	3D-structure,ATP-binding,Autophagy,Biological rhythms,Cholesterol biosynthesis,Cholesterol metabolism,Chromatin regulator,Complete proteome,Cytoplasm,Fatty acid biosynthesis,Fatty acid metabolism,Kinase,Lipid biosynthesis,Lipid metabolism,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transcription,Transcription regulation,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation,Wnt signaling pathway,	active site:Proton acceptor,binding site:ATP,chain:5'-AMP-activated protein kinase catalytic subunit alpha-2,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
PRKCD	protein kinase C delta(PRKCD)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_keratinocytePathway:Keratinocyte Differentiation,		GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007202~activation of phospholipase C activity,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0010469~regulation of receptor activity,GO:0016064~immunoglobulin mediated immune response,GO:0016572~histone phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0023021~termination of signal transduction,GO:0030168~platelet activation,GO:0030837~negative regulation of actin filament polymerization,GO:0032079~positive regulation of endodeoxyribonuclease activity,GO:0032091~negative regulation of protein binding,GO:0032147~activation of protein kinase activity,GO:0032613~interleukin-10 production,GO:0032615~interleukin-12 production,GO:0032930~positive regulation of superoxide anion generation,GO:0032956~regulation of actin cytoskeleton organization,GO:0034351~negative regulation of glial cell apoptotic process,GO:0035307~positive regulation of protein dephosphorylation,GO:0035556~intracellular signal transduction,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042100~B cell proliferation,GO:0042119~neutrophil activation,GO:0042307~positive regulation of protein import into nucleus,GO:0042742~defense response to bacterium,GO:0043407~negative regulation of MAP kinase activity,GO:0043488~regulation of mRNA stability,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050728~negative regulation of inflammatory response,GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation,GO:0050821~protein stabilization,GO:0051490~negative regulation of filopodium assembly,GO:0060326~cell chemotaxis,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0070301~cellular response to hydrogen peroxide,GO:0071447~cellular response to hydroperoxide,GO:0090331~negative regulation of platelet aggregation,GO:0090398~cellular senescence,GO:1900163~positive regulation of phospholipid scramblase activity,GO:1904385~cellular response to angiotensin,GO:2000304~positive regulation of ceramide biosynthetic process,GO:2000753~positive regulation of glucosylceramide catabolic process,GO:2000755~positive regulation of sphingomyelin catabolic process,GO:2001022~positive regulation of response to DNA damage stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0004699~calcium-independent protein kinase C activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008047~enzyme activator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0043560~insulin receptor substrate binding,GO:0046872~metal ion binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR014376:Protein kinase C, delta/epsilon/eta/theta types,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,IPR020454:Diacylglycerol/phorbol-ester binding,IPR027436:Protein kinase C, delta,	hsa04062:Chemokine signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04666:Fc gamma R-mediated phagocytosis,hsa04722:Neurotrophin signaling pathway,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,	615559~Autoimmune lymphoproliferative syndrome, type III,	PIRSF000551:protein kinase C, delta/epsilon/eta/theta types,PIRSF501104:protein kinase C delta type [Parent=PIRSF000551],	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,	3D-structure,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell membrane,Complete proteome,Cytoplasm,Kinase,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,Tumor suppressor,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Protein kinase C delta type,domain:AGC-kinase C-terminal,domain:C2,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,site:Interaction with phosphotyrosine- containing peptide,strand,turn,zinc finger region:Phorbol-ester/DAG-type 1,zinc finger region:Phorbol-ester/DAG-type 2,
PRKCE	protein kinase C epsilon(PRKCE)	Homo sapiens		h_akapcentrosomePathway:Protein Kinase A at the Centrosome,h_FlumazenilPathway:Cardiac Protection Against ROS ,h_keratinocytePathway:Keratinocyte Differentiation,h_ptdinsPathway:Phosphoinositides and their downstream targets.,		GO:0002281~macrophage activation involved in immune response,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007202~activation of phospholipase C activity,GO:0010634~positive regulation of epithelial cell migration,GO:0010763~positive regulation of fibroblast migration,GO:0010811~positive regulation of cell-substrate adhesion,GO:0018105~peptidyl-serine phosphorylation,GO:0030168~platelet activation,GO:0030838~positive regulation of actin filament polymerization,GO:0031397~negative regulation of protein ubiquitination,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032024~positive regulation of insulin secretion,GO:0032230~positive regulation of synaptic transmission, GABAergic,GO:0032467~positive regulation of cytokinesis,GO:0035556~intracellular signal transduction,GO:0035641~locomotory exploration behavior,GO:0035669~TRAM-dependent toll-like receptor 4 signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043278~response to morphine,GO:0043410~positive regulation of MAPK cascade,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050996~positive regulation of lipid catabolic process,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051279~regulation of release of sequestered calcium ion into cytosol,GO:0051301~cell division,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0070257~positive regulation of mucus secretion,GO:0071361~cellular response to ethanol,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071456~cellular response to hypoxia,GO:0090303~positive regulation of wound healing,GO:2000273~positive regulation of receptor activity,GO:2000650~negative regulation of sodium ion transmembrane transporter activity,GO:2001031~positive regulation of cellular glucuronidation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,GO:0071944~cell periphery,	GO:0003785~actin monomer binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0004699~calcium-independent protein kinase C activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008047~enzyme activator activity,GO:0019899~enzyme binding,GO:0030546~receptor activator activity,GO:0035276~ethanol binding,GO:0046872~metal ion binding,GO:0071889~14-3-3 protein binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR014376:Protein kinase C, delta/epsilon/eta/theta types,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,IPR020454:Diacylglycerol/phorbol-ester binding,IPR027274:Protein kinase C, epsilon,	hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04530:Tight junction,hsa04666:Fc gamma R-mediated phagocytosis,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04925:Aldosterone synthesis and secretion,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa05206:MicroRNAs in cancer,		PIRSF000551:protein kinase C, delta/epsilon/eta/theta types,PIRSF501106:protein kinase C epsilon type [Parent=PIRSF000551],	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00239:C2,	3D-structure,ATP-binding,Cell adhesion,Cell cycle,Cell division,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Immunity,Kinase,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Protein kinase C epsilon type,domain:AGC-kinase C-terminal,domain:C2,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,zinc finger region:Phorbol-ester/DAG-type 1,zinc finger region:Phorbol-ester/DAG-type 2,
PRKCZ	protein kinase C zeta(PRKCZ)	Homo sapiens		h_ptdinsPathway:Phosphoinositides and their downstream targets.,		GO:0000226~microtubule cytoskeleton organization,GO:0001954~positive regulation of cell-matrix adhesion,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007616~long-term memory,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0016477~cell migration,GO:0018105~peptidyl-serine phosphorylation,GO:0030010~establishment of cell polarity,GO:0031333~negative regulation of protein complex assembly,GO:0031532~actin cytoskeleton reorganization,GO:0031584~activation of phospholipase D activity,GO:0032148~activation of protein kinase B activity,GO:0032753~positive regulation of interleukin-4 production,GO:0035556~intracellular signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0046326~positive regulation of glucose import,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0047496~vesicle transport along microtubule,GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051291~protein heterooligomerization,GO:0051346~negative regulation of hydrolase activity,GO:0051899~membrane depolarization,GO:0060081~membrane hyperpolarization,GO:0060291~long-term synaptic potentiation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070528~protein kinase C signaling,GO:0072659~protein localization to plasma membrane,GO:1990138~neuron projection extension,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000553~positive regulation of T-helper 2 cell cytokine production,GO:2000664~positive regulation of interleukin-5 secretion,GO:2000667~positive regulation of interleukin-13 secretion,GO:2001181~positive regulation of interleukin-10 secretion,	GO:0005622~intracellular,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0016363~nuclear matrix,GO:0030054~cell junction,GO:0031252~cell leading edge,GO:0031941~filamentous actin,GO:0031982~vesicle,GO:0035748~myelin sheath abaxonal region,GO:0043203~axon hillock,GO:0045121~membrane raft,GO:0045179~apical cortex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015459~potassium channel regulator activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0043274~phospholipase binding,GO:0043560~insulin receptor substrate binding,GO:0046872~metal ion binding,GO:0071889~14-3-3 protein binding,	IPR000270:Phox/Bem1p,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR012233:Protein kinase C, zeta/iota,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,IPR020454:Diacylglycerol/phorbol-ester binding,	hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04144:Endocytosis,hsa04390:Hippo signaling pathway,hsa04530:Tight junction,hsa04611:Platelet activation,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,		PIRSF000554:protein kinase C, zeta/iota types,	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00666:PB1,	Alternative splicing,ATP-binding,Cell junction,Complete proteome,Cytoplasm,Endosome,Inflammatory response,Kinase,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Protein kinase C zeta type,domain:AGC-kinase C-terminal,domain:OPR,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with SQSTM1,sequence conflict,sequence variant,zinc finger region:Phorbol-ester/DAG-type,
PRKD3	protein kinase D3(PRKD3)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0018105~peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0089700~protein kinase D signaling,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0004697~protein kinase C activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR015727:Protein kinase C mu-related,IPR017441:Protein kinase, ATP binding site,IPR020454:Diacylglycerol/phorbol-ester binding,	hsa04015:Rap1 signaling pathway,hsa04925:Aldosterone synthesis and secretion,		PIRSF000552:protein kinase C, mu/nu/D2 types,	SM00109:C1,SM00220:S_TKc,SM00233:PH,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase D3,domain:PH,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,zinc finger region:Phorbol-ester/DAG-type 1,zinc finger region:Phorbol-ester/DAG-type 2,
PKN2	protein kinase N2(PKN2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0010631~epithelial cell migration,GO:0018105~peptidyl-serine phosphorylation,GO:0032467~positive regulation of cytokinesis,GO:0035556~intracellular signal transduction,GO:0043297~apical junction assembly,GO:0045070~positive regulation of viral genome replication,GO:0045931~positive regulation of mitotic cell cycle,GO:0051301~cell division,GO:0098609~cell-cell adhesion,GO:2000145~regulation of cell motility,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030496~midbody,GO:0032154~cleavage furrow,GO:0043234~protein complex,GO:0043296~apical junction complex,GO:0045111~intermediate filament cytoskeleton,GO:0048471~perinuclear region of cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0070063~RNA polymerase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000008:C2 calcium-dependent membrane targeting,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011072:HR1 rho-binding repeat,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04151:PI3K-Akt signaling pathway,hsa05132:Salmonella infection,			SM00133:S_TK_X,SM00220:S_TKc,SM00239:C2,SM00742:Hr1,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Cell adhesion,Cell cycle,Cell division,Cell junction,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transcription,Transcription regulation,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase N2,domain:AGC-kinase C-terminal,domain:C2,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,repeat:REM 1,repeat:REM 2,repeat:REM 3,sequence variant,
PRKACB	protein kinase cAMP-activated catalytic subunit beta(PRKACB)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics,h_akapcentrosomePathway:Protein Kinase A at the Centrosome,h_badPathway:Regulation of BAD phosphorylation,h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1,h_cftrPathway:Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway,h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_dreamPathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM,h_gata3Pathway:GATA3 participate in activating the Th2 cytokine genes expression,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_mCalpainPathway:mCalpain and friends in Cell motility,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_no1Pathway:Actions of Nitric Oxide in the Heart,h_nos1Pathway:Nitric Oxide Signaling Pathway,h_plcePathway:Phospholipase C-epsilon pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_shhPathway:Sonic Hedgehog (Shh) Pathway,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,		GO:0001843~neural tube closure,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0003091~renal water homeostasis,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007596~blood coagulation,GO:0034199~activation of protein kinase A activity,GO:0042157~lipoprotein metabolic process,GO:0051447~negative regulation of meiotic cell cycle,GO:0070613~regulation of protein processing,GO:0071377~cellular response to glucagon stimulus,GO:0097338~response to clozapine,GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,	GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005952~cAMP-dependent protein kinase complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0097546~ciliary base,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0004691~cAMP-dependent protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0031625~ubiquitin protein ligase binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04114:Oocyte meiosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04740:Olfactory transduction,hsa04742:Taste transduction,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04910:Insulin signaling pathway,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04962:Vasopressin-regulated water reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04976:Bile secretion,hsa05012:Parkinson's disease,hsa05020:Prion diseases,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05032:Morphine addiction,hsa05110:Vibrio cholerae infection,hsa05146:Amoebiasis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05414:Dilated cardiomyopathy,			SM00133:S_TK_X,SM00220:S_TKc,	Alternative splicing,ATP-binding,cAMP,Cell membrane,Complete proteome,Cytoplasm,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:cAMP-dependent protein kinase catalytic subunit beta,domain:AGC-kinase C-terminal,domain:Protein kinase,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
PRKAR2A	protein kinase cAMP-dependent type II regulatory subunit alpha(PRKAR2A)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics,h_akapcentrosomePathway:Protein Kinase A at the Centrosome,h_badPathway:Regulation of BAD phosphorylation,h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1,h_cftrPathway:Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway,h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_dreamPathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM,h_gata3Pathway:GATA3 participate in activating the Th2 cytokine genes expression,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_mCalpainPathway:mCalpain and friends in Cell motility,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_no1Pathway:Actions of Nitric Oxide in the Heart,h_nos1Pathway:Nitric Oxide Signaling Pathway,h_plcePathway:Phospholipase C-epsilon pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_shhPathway:Sonic Hedgehog (Shh) Pathway,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,		GO:0003091~renal water homeostasis,GO:0007596~blood coagulation,GO:0034199~activation of protein kinase A activity,GO:0035556~intracellular signal transduction,GO:0071377~cellular response to glucagon stimulus,GO:2000480~negative regulation of cAMP-dependent protein kinase activity,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005952~cAMP-dependent protein kinase complex,GO:0016020~membrane,GO:0031588~nucleotide-activated protein kinase complex,GO:0044853~plasma membrane raft,GO:0070062~extracellular exosome,GO:0097546~ciliary base,	GO:0004862~cAMP-dependent protein kinase inhibitor activity,GO:0005515~protein binding,GO:0008603~cAMP-dependent protein kinase regulator activity,GO:0016301~kinase activity,GO:0030552~cAMP binding,GO:0031625~ubiquitin protein ligase binding,GO:0034236~protein kinase A catalytic subunit binding,	IPR000595:Cyclic nucleotide-binding domain,IPR003117:cAMP-dependent protein kinase, regulatory subunit, type I/II alpha/beta,IPR012198:cAMP-dependent protein kinase regulatory subunit,IPR014710:RmlC-like jelly roll fold,IPR018488:Cyclic nucleotide-binding, conserved site,IPR018490:Cyclic nucleotide-binding-like,	hsa04910:Insulin signaling pathway,		PIRSF000548:cAMP-dependent protein kinase, regulatory subunit,	SM00100:cNMP,SM00394:RIIa,	3D-structure,Acetylation,Alternative splicing,cAMP,cAMP-binding,Cell membrane,Complete proteome,Cytoplasm,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transferase,	binding site:cAMP 1,binding site:cAMP 2,chain:cAMP-dependent protein kinase type II- alpha regulatory subunit,helix,modified residue,nucleotide phosphate-binding region:cAMP 1,nucleotide phosphate-binding region:cAMP 2,region of interest:Dimerization and phosphorylation,
PPP1CB	protein phosphatase 1 catalytic subunit beta(PPP1CB)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0005977~glycogen metabolic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005981~regulation of glycogen catabolic process,GO:0006470~protein dephosphorylation,GO:0030155~regulation of cell adhesion,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0051301~cell division,	GO:0000164~protein phosphatase type 1 complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0042587~glycogen granule,GO:0070062~extracellular exosome,GO:0070688~MLL5-L complex,GO:0072357~PTW/PP1 phosphatase complex,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,GO:0050115~myosin-light-chain-phosphatase activity,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,	hsa03015:mRNA surveillance pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04114:Oocyte meiosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04390:Hippo signaling pathway,hsa04510:Focal adhesion,hsa04611:Platelet activation,hsa04720:Long-term potentiation,hsa04728:Dopaminergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04931:Insulin resistance,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05168:Herpes simplex infection,hsa05205:Proteoglycans in cancer,			SM00156:PP2Ac,	Acetylation,Biological rhythms,Carbohydrate metabolism,Cell cycle,Cell division,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Glycogen metabolism,Hydrolase,Manganese,Metal-binding,Nucleus,Phosphoprotein,Protein phosphatase,Proteomics identification,Reference proteome,	active site:Proton donor,chain:Serine/threonine-protein phosphatase PP1- beta catalytic subunit,chain:Speedy protein A,metal ion-binding site:Iron,metal ion-binding site:Manganese,modified residue,region of interest:Speedy/Ringo box; required for cdk- binding,sequence conflict,splice variant,
PPP1R1C	protein phosphatase 1 regulatory inhibitor subunit 1C(PPP1R1C)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0007049~cell cycle,GO:0030307~positive regulation of cell growth,GO:0035556~intracellular signal transduction,GO:0051301~cell division,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0005737~cytoplasm,	GO:0004864~protein phosphatase inhibitor activity,GO:0004865~protein serine/threonine phosphatase inhibitor activity,	IPR008466:Protein phosphatase inhibitor, 1DARPP-32,					Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Phosphoprotein,Protein phosphatase inhibitor,Reference proteome,	chain:Protein phosphatase 1 regulatory subunit 1C,sequence conflict,splice variant,
PPP1R12B	protein phosphatase 1 regulatory subunit 12B(PPP1R12B)	Homo sapiens		h_ccr3Pathway:CCR3 signaling in Eosinophils,h_integrinPathway:Integrin Signaling Pathway,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_rhoPathway:Rho cell motility signaling pathway,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0006937~regulation of muscle contraction,GO:0007165~signal transduction,GO:0043085~positive regulation of catalytic activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016021~integral component of membrane,GO:0030018~Z disc,GO:0031672~A band,	GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0019208~phosphatase regulator activity,GO:0019901~protein kinase binding,	IPR002110:Ankyrin repeat,IPR017401:Protein phosphatase 1, regulatory subunit 12A/B/C, eukaryote,IPR020683:Ankyrin repeat-containing domain,	hsa04270:Vascular smooth muscle contraction,hsa04510:Focal adhesion,hsa04810:Regulation of actin cytoskeleton,hsa04921:Oxytocin signaling pathway,hsa05205:Proteoglycans in cancer,		PIRSF038141:protein phosphatase 1, regulatory subunits 12A/B/C, vertebrate type,	SM00248:ANK,	Alternative promoter usage,Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Protein phosphatase 1 regulatory subunit 12B,compositionally biased region:Glu-rich,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence variant,splice variant,
PPP1R21	protein phosphatase 1 regulatory subunit 21(PPP1R21)	Homo sapiens					GO:0016020~membrane,	GO:0019902~phosphatase binding,	IPR019343:Uncharacterised domain KLRAQ/TTKRSYEDQ, N-terminal,IPR019348:Uncharacterised domain KLRAQ/TTKRSYEDQ, C-terminal,				SM01254:SM01254,	Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:KLRAQ motif-containing protein 1,modified residue,sequence conflict,splice variant,
PPP1R7	protein phosphatase 1 regulatory subunit 7(PPP1R7)	Homo sapiens			Function unknown,	GO:0007059~chromosome segregation,GO:0035307~positive regulation of protein dephosphorylation,GO:0050790~regulation of catalytic activity,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008599~protein phosphatase type 1 regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0030234~enzyme regulator activity,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003603:U2A'/phosphoprotein 32 family A, C-terminal,IPR007632:Anoctamin/TMEM 16,IPR025875:Leucine rich repeat 4,				SM00369:LRR_TYP,SM00446:LRRcap,	Acetylation,Alternative splicing,Complete proteome,Leucine-rich repeat,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Protein phosphatase 1 regulatory subunit 7,modified residue,mutagenesis site,repeat:LRR 1,repeat:LRR 10,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,splice variant,
PPP1R8	protein phosphatase 1 regulatory subunit 8(PPP1R8)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006401~RNA catabolic process,GO:0008283~cell proliferation,GO:0008380~RNA splicing,GO:0035308~negative regulation of protein dephosphorylation,GO:0043086~negative regulation of catalytic activity,GO:0090501~RNA phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0004519~endonuclease activity,GO:0004865~protein serine/threonine phosphatase inhibitor activity,GO:0005515~protein binding,GO:0008599~protein phosphatase type 1 regulator activity,GO:0008995~ribonuclease E activity,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,				SM00240:FHA,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Endonuclease,Hydrolase,Magnesium,mRNA processing,mRNA splicing,Nuclease,Nucleus,Phosphoprotein,Protein phosphatase inhibitor,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Spliceosome,Transcription,Transcription regulation,	chain:Nuclear inhibitor of protein phosphatase 1,domain:FHA,modified residue,mutagenesis site,region of interest:Interaction with CDC5L, SF3B1 and MELK,region of interest:Interaction with EED,region of interest:Involved in PP-1 binding,region of interest:Involved in PP-1 inhibition,region of interest:RNA-binding,short sequence motif:Nuclear localization signal 1,short sequence motif:Nuclear localization signal 2,splice variant,
PPP2R5A	protein phosphatase 2 regulatory subunit B'alpha(PPP2R5A)	Homo sapiens				GO:0007165~signal transduction,GO:0035307~positive regulation of protein dephosphorylation,GO:0090005~negative regulation of establishment of protein localization to plasma membrane,GO:0090219~negative regulation of lipid kinase activity,	GO:0000159~protein phosphatase type 2A complex,GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030018~Z disc,GO:0031430~M band,	GO:0005515~protein binding,GO:0008601~protein phosphatase type 2A regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0019900~kinase binding,	IPR002554:Protein phosphatase 2A, regulatory B subunit, B56,IPR016024:Armadillo-type fold,	hsa03015:mRNA surveillance pathway,hsa04071:Sphingolipid signaling pathway,hsa04114:Oocyte meiosis,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04728:Dopaminergic synapse,		PIRSF028043:serine/threonine-protein phosphatase 2A, subunit B56,		Acetylation,Alternative splicing,Centromere,Chromosome,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Reference proteome,	chain:Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,compositionally biased region:Poly-Ser,modified residue,sequence conflict,
PP2D1	protein phosphatase 2C like domain containing 1(PP2D1)	Homo sapiens				GO:0006470~protein dephosphorylation,		GO:0004722~protein serine/threonine phosphatase activity,	IPR001932:Protein phosphatase 2C (PP2C)-like,IPR015655:Protein phosphatase 2C,				SM00332:PP2Cc,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,
PPP4R2	protein phosphatase 4 regulatory subunit 2(PPP4R2)	Homo sapiens				GO:0006397~mRNA processing,GO:0006464~cellular protein modification process,GO:0008380~RNA splicing,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0050790~regulation of catalytic activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030289~protein phosphatase 4 complex,	GO:0005515~protein binding,GO:0019888~protein phosphatase regulator activity,GO:0030362~protein phosphatase type 4 regulator activity,GO:0030674~protein binding, bridging,	IPR015267:Protein phosphatase 4 core regulatory subunit R2,					Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Serine/threonine-protein phosphatase 4 regulatory subunit 2,compositionally biased region:Glu-rich,modified residue,sequence variant,splice variant,
PPP4R3B	protein phosphatase 4 regulatory subunit 3B(PPP4R3B)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0019216~regulation of lipid metabolic process,GO:0045722~positive regulation of gluconeogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030289~protein phosphatase 4 complex,		IPR006887:Domain of unknown function DUF625,IPR011993:Pleckstrin homology-like domain,IPR016024:Armadillo-type fold,	hsa04922:Glucagon signaling pathway,				Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Serine/threonine-protein phosphatase 4 regulatory subunit 3B,compositionally biased region:Poly-Glu,domain:WH1,modified residue,sequence conflict,sequence variant,splice variant,
PPM1B	protein phosphatase, Mg2+/Mn2+ dependent 1B(PPM1B)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0006499~N-terminal protein myristoylation,GO:0032688~negative regulation of interferon-beta production,GO:0035970~peptidyl-threonine dephosphorylation,GO:0042347~negative regulation of NF-kappaB import into nucleus,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050687~negative regulation of defense response to virus,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0000287~magnesium ion binding,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0030145~manganese ion binding,	IPR000222:Protein phosphatase 2C, manganese/magnesium aspartate binding site,IPR001932:Protein phosphatase 2C (PP2C)-like,IPR012911:Protein serine/threonine phosphatase 2C, C-terminal,IPR015655:Protein phosphatase 2C,	hsa04010:MAPK signaling pathway,			SM00332:PP2Cc,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Isopeptide bond,Lipoprotein,Magnesium,Manganese,Membrane,Metal-binding,Myristate,Phosphoprotein,Protein phosphatase,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Protein phosphatase 1B,helix,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 1; via carbonyl oxygen,metal ion-binding site:Manganese 2,splice variant,strand,turn,
PTP4A2	protein tyrosine phosphatase type IVA, member 2(PTP4A2)	Homo sapiens				GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004727~prenylated protein tyrosine phosphatase activity,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,				SM00404:PTPc_motif,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Endosome,Hydrolase,Lipoprotein,Membrane,Methylation,Prenylation,Protein phosphatase,Proteomics identification,Reference proteome,	active site:Phosphocysteine intermediate,active site:Proton donor,binding site:Substrate,chain:Protein tyrosine phosphatase type IVA 2,disulfide bond,domain:Tyrosine-protein phosphatase,lipid moiety-binding region:S-farnesyl cysteine,mutagenesis site,region of interest:Phosphate binding,sequence conflict,splice variant,
PTPN14	protein tyrosine phosphatase, non-receptor type 14(PTPN14)	Homo sapiens				GO:0001946~lymphangiogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006470~protein dephosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0046825~regulation of protein export from nucleus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0003712~transcription cofactor activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000299:FERM domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014392:Protein-tyrosine phosphatase, non-receptor type-14, -21,IPR016130:Protein-tyrosine phosphatase, active site,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,		613611~Choanal atresia and lymphedema,	PIRSF000934:non-receptor tyrosine-protein phosphatase, 14/21 types,	SM00194:PTPc,SM00295:B41,SM00404:PTPc_motif,SM01196:SM01196,	3D-structure,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 14,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,domain:FERM,domain:Tyrosine-protein phosphatase,helix,modified residue,sequence conflict,sequence variant,strand,turn,
PTPN18	protein tyrosine phosphatase, non-receptor type 18(PTPN18)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,GO:0005515~protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR016130:Protein-tyrosine phosphatase, active site,				SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 18,domain:Tyrosine-protein phosphatase,helix,modified residue,sequence conflict,sequence variant,strand,turn,
PTPN22	protein tyrosine phosphatase, non-receptor type 22(PTPN22)	Homo sapiens				GO:0002230~positive regulation of defense response to virus by host,GO:0002685~regulation of leukocyte migration,GO:0006470~protein dephosphorylation,GO:0006914~autophagy,GO:0010507~negative regulation of autophagy,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030217~T cell differentiation,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032481~positive regulation of type I interferon production,GO:0032496~response to lipopolysaccharide,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032817~regulation of natural killer cell proliferation,GO:0034141~positive regulation of toll-like receptor 3 signaling pathway,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,GO:0034157~positive regulation of toll-like receptor 7 signaling pathway,GO:0034165~positive regulation of toll-like receptor 9 signaling pathway,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035549~positive regulation of interferon-beta secretion,GO:0035644~phosphoanandamide dephosphorylation,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043508~negative regulation of JUN kinase activity,GO:0045088~regulation of innate immune response,GO:0050852~T cell receptor signaling pathway,GO:0050855~regulation of B cell receptor signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0050868~negative regulation of T cell activation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070433~negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,GO:0071225~cellular response to muramyl dipeptide,GO:0071663~positive regulation of granzyme B production,GO:1900165~negative regulation of interleukin-6 secretion,GO:1901222~regulation of NIK/NF-kappaB signaling,GO:1902523~positive regulation of protein K63-linked ubiquitination,GO:1902715~positive regulation of interferon-gamma secretion,GO:1902741~positive regulation of interferon-alpha secretion,GO:1903753~negative regulation of p38MAPK cascade,GO:2000483~negative regulation of interleukin-8 secretion,GO:2000566~positive regulation of CD8-positive, alpha-beta T cell proliferation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0009898~cytoplasmic side of plasma membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0016791~phosphatase activity,GO:0017124~SH3 domain binding,GO:0019900~kinase binding,GO:0031625~ubiquitin protein ligase binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR016130:Protein-tyrosine phosphatase, active site,IPR016276:Non-receptor tyrosine-protein phosphatase, 8/22,		152700~Systemic lupus erythematosus susceptibility to,180300~Rheumatoid arthritis, susceptibility to,222100~Diabetes, type 1, susceptibility to,	PIRSF000930:non-receptor tyrosine-protein phosphatase, 8/22 types,	SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Autophagy,Complete proteome,Cytoplasm,Diabetes mellitus,Disease mutation,Disulfide bond,Hydrolase,Immunity,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,Systemic lupus erythematosus,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 22,domain:Tyrosine-protein phosphatase,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,
PTPN23	protein tyrosine phosphatase, non-receptor type 23(PTPN23)	Homo sapiens			Cell division and chromosome partitioning,	GO:0010633~negative regulation of epithelial cell migration,GO:0015031~protein transport,GO:0030334~regulation of cell migration,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0060271~cilium morphogenesis,GO:1903387~positive regulation of homophilic cell adhesion,GO:1903393~positive regulation of adherens junction organization,GO:2000643~positive regulation of early endosome to late endosome transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0036064~ciliary basal body,GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR004328:BRO1 domain,IPR016130:Protein-tyrosine phosphatase, active site,IPR025304:ALIX V-shaped domain,				SM00194:PTPc,SM00404:PTPc_motif,SM01041:SM01041,	3D-structure,Cell projection,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endosome,Hydrolase,Methylation,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Protein transport,Proteomics identification,Receptor,Reference proteome,Repeat,TPR repeat,Transport,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 23,compositionally biased region:Pro-rich,domain:BRO1,domain:Tyrosine-protein phosphatase,modified residue,region of interest:6 X 2 AA approximate tandem repeats of P- Q,region of interest:His,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:TPR 1,repeat:TPR 2,sequence conflict,sequence variant,
PTPN4	protein tyrosine phosphatase, non-receptor type 4(PTPN4)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0009898~cytoplasmic side of plasma membrane,GO:0019898~extrinsic component of membrane,	GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000299:FERM domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR000798:Ezrin/radixin/moesin like,IPR001478:PDZ domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR011993:Pleckstrin homology-like domain,IPR012151:Protein-tyrosine phosphatase, non-receptor type-3, -4,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR016130:Protein-tyrosine phosphatase, active site,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,			PIRSF000927:non-receptor tyrosine-protein phosphatase, 3/4 types,	SM00194:PTPc,SM00228:PDZ,SM00295:B41,SM00404:PTPc_motif,SM01195:SM01195,SM01196:SM01196,	3D-structure,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 4,domain:FERM,domain:PDZ,domain:Tyrosine-protein phosphatase,helix,sequence conflict,sequence variant,strand,turn,
PTPN7	protein tyrosine phosphatase, non-receptor type 7(PTPN7)	Homo sapiens		h_tcrPathway:T Cell Receptor Signaling Pathway,		GO:0006470~protein dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0009898~cytoplasmic side of plasma membrane,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR008356:Protein-tyrosine phosphatase, KIM-containing,IPR016130:Protein-tyrosine phosphatase, active site,	hsa04010:MAPK signaling pathway,			SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Oxidation,Phosphoprotein,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,	active site:Phosphocysteine intermediate,binding site:Substrate,chain:Tyrosine-protein phosphatase non-receptor type 7,domain:Tyrosine-protein phosphatase,helix,modified residue,mutagenesis site,region of interest:Interaction with MAP kinases,region of interest:Substrate binding,sequence conflict,splice variant,strand,
PTPRC	protein tyrosine phosphatase, receptor type C(PTPRC)	Homo sapiens		h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,		GO:0001915~negative regulation of T cell mediated cytotoxicity,GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0002244~hematopoietic progenitor cell differentiation,GO:0002378~immunoglobulin biosynthetic process,GO:0006469~negative regulation of protein kinase activity,GO:0006470~protein dephosphorylation,GO:0006933~negative regulation of cell adhesion involved in substrate-bound cell migration,GO:0007166~cell surface receptor signaling pathway,GO:0010332~response to gamma radiation,GO:0016311~dephosphorylation,GO:0030217~T cell differentiation,GO:0030890~positive regulation of B cell proliferation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0042100~B cell proliferation,GO:0042102~positive regulation of T cell proliferation,GO:0044770~cell cycle phase transition,GO:0045860~positive regulation of protein kinase activity,GO:0048539~bone marrow development,GO:0048864~stem cell development,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050857~positive regulation of antigen receptor-mediated signaling pathway,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051607~defense response to virus,GO:0051726~regulation of cell cycle,GO:2000473~positive regulation of hematopoietic stem cell migration,GO:2000648~positive regulation of stem cell proliferation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,IPR016335:Leukocyte common antigen,IPR024739:Protein tyrosine phosphatase, receptor type, N-terminal,	hsa04514:Cell adhesion molecules (CAMs),hsa04660:T cell receptor signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa05340:Primary immunodeficiency,	608971~Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive,609532~Hepatitic C virus, susceptibility to,	PIRSF002004:leukocyte common antigen,	SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Hydrolase,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,Repeat,SCID,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Leukocyte common antigen,chain:T200 leukocyte common antigen,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
PTPRF	protein tyrosine phosphatase, receptor type F(PTPRF)	Homo sapiens				GO:0007155~cell adhesion,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0007268~chemical synaptic transmission,GO:0016477~cell migration,GO:0031102~neuron projection regeneration,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0048679~regulation of axon regeneration,GO:1900121~negative regulation of receptor binding,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0008201~heparin binding,GO:0032403~protein complex binding,GO:0035373~chondroitin sulfate proteoglycan binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,	hsa04514:Cell adhesion molecules (CAMs),hsa04520:Adherens junction,hsa04910:Insulin signaling pathway,hsa04931:Insulin resistance,	616001~Breasts and/or nipples, aplasia or hypoplasia of, 2,		SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Heparin-binding,Hydrolase,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase F,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
PTPRG	protein tyrosine phosphatase, receptor type G(PTPRG)	Homo sapiens				GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007420~brain development,GO:0010633~negative regulation of epithelial cell migration,GO:0010977~negative regulation of neuron projection development,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:1903385~regulation of homophilic cell adhesion,	GO:0005615~extracellular space,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR001148:Alpha carbonic anhydrase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,				SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,SM01057:SM01057,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase gamma,domain:Alpha-carbonic anhydrase,domain:Fibronectin type-III,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,site:Ancestral active site,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
PTPRN	protein tyrosine phosphatase, receptor type N(PTPRN)	Homo sapiens				GO:0000302~response to reactive oxygen species,GO:0001553~luteinization,GO:0006351~transcription, DNA-templated,GO:0019221~cytokine-mediated signaling pathway,GO:0030073~insulin secretion,GO:0032868~response to insulin,GO:0035773~insulin secretion involved in cellular response to glucose stimulus,GO:0043627~response to estrogen,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051591~response to cAMP,GO:1904692~positive regulation of type B pancreatic cell proliferation,GO:1990502~dense core granule maturation,	GO:0005634~nucleus,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030141~secretory granule,GO:0030658~transport vesicle membrane,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0045202~synapse,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0030507~spectrin binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0051020~GTPase binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR016130:Protein-tyrosine phosphatase, active site,IPR021613:Protein-tyrosine phosphatase receptor IA-2,IPR024833:Regulated endocrine-specific protein 18,	hsa04940:Type I diabetes mellitus,			SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasmic vesicle,Diabetes mellitus,Direct protein sequencing,Disulfide bond,Endosome,Glycoprotein,Isopeptide bond,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Synapse,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase-like N,domain:Tyrosine-protein phosphatase,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,site:Cleavage,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
PTPRU	protein tyrosine phosphatase, receptor type U(PTPRU)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0007155~cell adhesion,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0016337~single organismal cell-cell adhesion,GO:0030154~cell differentiation,GO:0030336~negative regulation of cell migration,GO:0031100~organ regeneration,GO:0034109~homotypic cell-cell adhesion,GO:0034394~protein localization to cell surface,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0051384~response to glucocorticoid,GO:0060070~canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR000998:MAM domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,				SM00060:FN3,SM00137:MAM,SM00194:PTPc,SM00404:PTPc_motif,	Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Differentiation,Disulfide bond,Glycoprotein,Hydrolase,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase U,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type,domain:MAM,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Mediates interaction with CTNNB1,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PRG4	proteoglycan 4(PRG4)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006955~immune response,GO:0008283~cell proliferation,	GO:0005576~extracellular region,	GO:0005044~scavenger receptor activity,GO:0030247~polysaccharide binding,	IPR000585:Hemopexin-like domain,IPR001212:Somatomedin B domain,IPR018486:Hemopexin, conserved site,IPR018487:Hemopexin-like repeats,IPR020436:Somatomedin B, chordata,		208250~Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,		SM00120:HX,SM00201:SO,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Proteoglycan 4,chain:Proteoglycan 4 C-terminal part,compositionally biased region:Ser-rich,disulfide bond,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:SMB 1,domain:SMB 2,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:59 X 8 AA repeats of K-X-P-X-P-T-T-X,repeat:1,repeat:10,repeat:11; approximate,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16; approximate,repeat:17,repeat:18; approximate,repeat:19; approximate,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24; approximate,repeat:25,repeat:26; approximate,repeat:27,repeat:28,repeat:29,repeat:2; approximate,repeat:3,repeat:30,repeat:31,repeat:32,repeat:33; approximate,repeat:34,repeat:35; approximate,repeat:36; approximate,repeat:37; approximate,repeat:38; approximate,repeat:39,repeat:40,repeat:41,repeat:42; approximate,repeat:43; approximate,repeat:44,repeat:45; approximate,repeat:46; approximate,repeat:47; approximate,repeat:48; approximate,repeat:49,repeat:4; approximate,repeat:5,repeat:50,repeat:51; approximate,repeat:52,repeat:53; approximate,repeat:54; approximate,repeat:55; approximate,repeat:56; approximate,repeat:57,repeat:58,repeat:59; approximate,repeat:6; approximate,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,signal peptide,site:Cleavage; by subtilisin-like proprotein convertase 4,splice variant,
PTMA	prothymosin, alpha(PTMA)	Homo sapiens	61.Myc_network,			GO:0006351~transcription, DNA-templated,GO:0043486~histone exchange,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042393~histone binding,	IPR004931:Prothymosin/parathymosin,					3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Prothymosin alpha,compositionally biased region:Asp/Glu-rich (acidic),modified residue,peptide:Thymosin alpha-1,splice variant,
PPOX	protoporphyrinogen oxidase(PPOX)	Homo sapiens				GO:0006779~porphyrin-containing compound biosynthetic process,GO:0006782~protoporphyrinogen IX biosynthetic process,GO:0006783~heme biosynthetic process,GO:0042493~response to drug,GO:0055114~oxidation-reduction process,	GO:0005758~mitochondrial intermembrane space,GO:0031304~intrinsic component of mitochondrial inner membrane,GO:0031305~integral component of mitochondrial inner membrane,GO:0031966~mitochondrial membrane,	GO:0004729~oxygen-dependent protoporphyrinogen oxidase activity,GO:0016491~oxidoreductase activity,GO:0050660~flavin adenine dinucleotide binding,	IPR002937:Amine oxidase,IPR004572:Protoporphyrinogen oxidase,IPR016040:NAD(P)-binding domain,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,IPR027418:Protoporphyrinogen oxidase, C-terminal domain,	hsa00860:Porphyrin and chlorophyll metabolism,hsa01100:Metabolic pathways,	176200~Porphyria variegata,			3D-structure,Complete proteome,Disease mutation,FAD,Flavoprotein,Heme biosynthesis,Membrane,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Polymorphism,Porphyrin biosynthesis,Proteomics identification,Reference proteome,	chain:Protoporphyrinogen oxidase,nucleotide phosphate-binding region:FAD,sequence variant,
PUS10	pseudouridylate synthase 10(PUS10)	Homo sapiens				GO:0001522~pseudouridine synthesis,GO:0031119~tRNA pseudouridine synthesis,		GO:0003723~RNA binding,GO:0009982~pseudouridine synthase activity,	IPR020103:Pseudouridine synthase, catalytic domain,					3D-structure,Coiled coil,Complete proteome,Isomerase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,tRNA processing,	active site:Nucleophile,binding site:Substrate,chain:Putative tRNA pseudouridine synthase Pus10,helix,modified residue,region of interest:RNA binding forefinger loop,region of interest:RNA binding thumb loop,sequence conflict,sequence variant,strand,turn,
PUM1	pumilio RNA binding family member 1(PUM1)	Homo sapiens				GO:0007283~spermatogenesis,GO:0008344~adult locomotory behavior,GO:0010608~posttranscriptional regulation of gene expression,GO:0016441~posttranscriptional gene silencing,GO:0043488~regulation of mRNA stability,GO:0048863~stem cell differentiation,GO:0051726~regulation of cell cycle,GO:0051983~regulation of chromosome segregation,GO:0060964~regulation of gene silencing by miRNA,GO:0061157~mRNA destabilization,GO:1900246~positive regulation of RIG-I signaling pathway,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001313:Pumilio RNA-binding repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,				SM00025:Pumilio,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spermatogenesis,Translation regulation,	chain:Pumilio homolog 1,compositionally biased region:Ala-rich,compositionally biased region:Gln-rich,compositionally biased region:Ser-rich,domain:PUM-HD,helix,modified residue,mutagenesis site,repeat:Pumilio 1,repeat:Pumilio 2,repeat:Pumilio 3,repeat:Pumilio 4,repeat:Pumilio 5,repeat:Pumilio 6,repeat:Pumilio 7,repeat:Pumilio 8,sequence conflict,splice variant,turn,
PUM2	pumilio RNA binding family member 2(PUM2)	Homo sapiens				GO:0010608~posttranscriptional regulation of gene expression,GO:0034063~stress granule assembly,GO:0043488~regulation of mRNA stability,GO:0051983~regulation of chromosome segregation,GO:0060964~regulation of gene silencing by miRNA,GO:1900246~positive regulation of RIG-I signaling pathway,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001313:Pumilio RNA-binding repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,				SM00025:Pumilio,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Translation regulation,	chain:Pumilio homolog 2,compositionally biased region:Ala-rich,compositionally biased region:Gln-rich,compositionally biased region:Ser-rich,domain:PUM-HD,modified residue,repeat:Pumilio 1,repeat:Pumilio 2,repeat:Pumilio 3,repeat:Pumilio 4,repeat:Pumilio 5,repeat:Pumilio 6,repeat:Pumilio 7,repeat:Pumilio 8,sequence variant,splice variant,
PHTF1	putative homeodomain transcription factor 1(PHTF1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005801~cis-Golgi network,GO:0016021~integral component of membrane,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR021980:Transcription factor homeodomain, male germ-cell,					Alternative splicing,Complete proteome,DNA-binding,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:Putative homeodomain transcription factor 1,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,sequence conflict,splice variant,
PYHIN1	pyrin and HIN domain family member 1(PYHIN1)	Homo sapiens				GO:0007049~cell cycle,	GO:0016607~nuclear speck,		IPR004020:DAPIN domain,IPR004021:HIN-200/IF120x,				SM01289:SM01289,	Alternative splicing,Cell cycle,Complete proteome,Nucleus,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Pyrin and HIN domain-containing protein 1,domain:DAPIN,domain:HIN-200,splice variant,
PDK1	pyruvate dehydrogenase kinase 1(PDK1)	Homo sapiens				GO:0006006~glucose metabolic process,GO:0006468~protein phosphorylation,GO:0008283~cell proliferation,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0010510~regulation of acetyl-CoA biosynthetic process from pyruvate,GO:0010906~regulation of glucose metabolic process,GO:0097411~hypoxia-inducible factor-1alpha signaling pathway,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005967~mitochondrial pyruvate dehydrogenase complex,	GO:0004672~protein kinase activity,GO:0004740~pyruvate dehydrogenase (acetyl-transferring) kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR005467:Signal transduction histidine kinase, core,IPR018955:Branched-chain alpha-ketoacid dehydrogenase kinase/Pyruvate dehydrogenase kinase, N-terminal,	hsa04066:HIF-1 signaling pathway,hsa05230:Central carbon metabolism in cancer,			SM00387:HATPase_c,	3D-structure,Alternative splicing,ATP-binding,Carbohydrate metabolism,Complete proteome,Glucose metabolism,Kinase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Pyruvate,Reference proteome,Transferase,Transit peptide,	binding site:ATP,chain:[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial,domain:Histidine kinase,helix,nucleotide phosphate-binding region:ATP,sequence variant,strand,transit peptide:Mitochondrion,turn,
PKLR	pyruvate kinase, liver and RBC(PKLR)	Homo sapiens		h_glycolysisPathway:Glycolysis Pathway,		GO:0001666~response to hypoxia,GO:0006754~ATP biosynthetic process,GO:0007584~response to nutrient,GO:0009408~response to heat,GO:0009749~response to glucose,GO:0010226~response to lithium ion,GO:0032869~cellular response to insulin stimulus,GO:0033198~response to ATP,GO:0042866~pyruvate biosynthetic process,GO:0051591~response to cAMP,GO:0061621~canonical glycolysis,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004743~pyruvate kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0030955~potassium ion binding,	IPR001697:Pyruvate kinase,IPR011037:Pyruvate kinase-like, insert domain,IPR015793:Pyruvate kinase, barrel,IPR015794:Pyruvate kinase, alpha/beta,IPR015795:Pyruvate kinase, C-terminal,IPR015806:Pyruvate kinase, beta-barrel insert domain,IPR015813:Pyruvate/Phosphoenolpyruvate kinase-like domain,IPR018209:Pyruvate kinase, active site,	hsa00010:Glycolysis / Gluconeogenesis,hsa00230:Purine metabolism,hsa00620:Pyruvate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01230:Biosynthesis of amino acids,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04950:Maturity onset diabetes of the young,	102900~Adenosine triphosphate, elevated, of erythrocytes,266200~Pyruvate kinase deficiency,			3D-structure,Acetylation,Allosteric enzyme,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Glycolysis,Hereditary hemolytic anemia,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Potassium,Proteomics identification,Pyruvate,Reference proteome,Transferase,	binding site:Allosteric activator,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:Pyruvate kinase isozymes R/L,helix,metal ion-binding site:Magnesium,metal ion-binding site:Potassium,modified residue,region of interest:Allosteric activator binding,sequence conflict,sequence variant,site:Transition state stabilizer,splice variant,strand,turn,
RBSN	rabenosyn, RAB effector(RBSN)	Homo sapiens				GO:0000011~vacuole inheritance,GO:0006895~Golgi to endosome transport,GO:0006896~Golgi to vacuole transport,GO:0006897~endocytosis,GO:0007596~blood coagulation,GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0034058~endosomal vesicle fusion,GO:0034498~early endosome to Golgi transport,GO:0090160~Golgi to lysosome transport,GO:1903358~regulation of Golgi organization,	GO:0005768~endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0010009~cytoplasmic side of endosome membrane,GO:0031901~early endosome membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017137~Rab GTPase binding,GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR007087:Zinc finger, C2H2,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,IPR021565:FYVE-finger-containing Rab5 effector protein rabenosyn-5,	hsa04144:Endocytosis,			SM00064:FYVE,	3D-structure,Acetylation,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Endosome,Lipoprotein,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,Zinc,Zinc-finger,	chain:Rabenosyn-5,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,helix,modified residue,mutagenesis site,region of interest:Necessary for the correct targeting to endosomes,region of interest:Necessary for the interaction with EHD1,region of interest:Necessary for the interaction with RAB4A,region of interest:Necessary for the interaction with RAB5A,repeat:UIM,sequence conflict,sequence variant,zinc finger region:C2H2-type,zinc finger region:FYVE-type,
RSAD2	radical S-adenosyl methionine domain containing 2(RSAD2)	Homo sapiens				GO:0009615~response to virus,GO:0034157~positive regulation of toll-like receptor 7 signaling pathway,GO:0034165~positive regulation of toll-like receptor 9 signaling pathway,GO:0035710~CD4-positive, alpha-beta T cell activation,GO:0043367~CD4-positive, alpha-beta T cell differentiation,GO:0045071~negative regulation of viral genome replication,GO:0050709~negative regulation of protein secretion,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,GO:2000553~positive regulation of T-helper 2 cell cytokine production,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005811~lipid particle,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0043621~protein self-association,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006638:Elongator protein 3/MiaB/NifB,IPR007197:Radical SAM,IPR013785:Aldolase-type TIM barrel,IPR026372:Antiviral radical SAM protein viperin,	hsa05164:Influenza A,			SM00729:Elp3,	4Fe-4S,Antiviral defense,Atherosclerosis,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Host-virus interaction,Immunity,Innate immunity,Iron,Iron-sulfur,Lipid droplet,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Mitochondrion outer membrane,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,	chain:Radical S-adenosyl methionine domain- containing protein 2,metal ion-binding site:Iron-sulfur (4Fe-4S-S-AdoMet),sequence conflict,sequence variant,
RFTN2	raftlin family member 2(RFTN2)	Homo sapiens				GO:0032596~protein transport into membrane raft,GO:0033227~dsRNA transport,GO:0043330~response to exogenous dsRNA,GO:0050851~antigen receptor-mediated signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0045121~membrane raft,							Cell membrane,Complete proteome,Lipoprotein,Membrane,Myristate,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Raftlin-2,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence conflict,
RFTN1	raftlin, lipid raft linker 1(RFTN1)	Homo sapiens				GO:0001765~membrane raft assembly,GO:0002457~T cell antigen processing and presentation,GO:0032596~protein transport into membrane raft,GO:0032620~interleukin-17 production,GO:0033227~dsRNA transport,GO:0034138~toll-like receptor 3 signaling pathway,GO:0040007~growth,GO:0043330~response to exogenous dsRNA,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:1903044~protein localization to membrane raft,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0003725~double-stranded RNA binding,						Cell membrane,Complete proteome,Lipoprotein,Membrane,Myristate,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Raftlin,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,sequence conflict,sequence variant,
RGL1	ral guanine nucleotide dissociation stimulator like 1(RGL1)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005829~cytosol,	GO:0008321~Ral guanyl-nucleotide exchange factor activity,	IPR000159:Ras-association,IPR000651:Ras-like guanine nucleotide exchange factor, N-terminal,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR019804:Ras guanine-nucleotide exchange factor, conserved site,IPR023578:Ras guanine nucleotide exchange factor, domain,	hsa04014:Ras signaling pathway,			SM00147:RasGEF,SM00229:RasGEFN,SM00314:RA,	Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Reference proteome,	chain:Ral guanine nucleotide dissociation stimulator-like 1,compositionally biased region:Ser-rich,domain:N-terminal Ras-GEF,domain:Ras-associating,domain:Ras-GEF,modified residue,sequence conflict,sequence variant,splice variant,
RHOA	ras homolog family member A(RHOA)	Homo sapiens	102.Cholesterol_Stress_Response,	h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,h_akapcentrosomePathway:Protein Kinase A at the Centrosome,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_integrinPathway:Integrin Signaling Pathway,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_par1pathway:Thrombin signaling and protease-activated receptors,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_rhoPathway:Rho cell motility signaling pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_uCalpainPathway:uCalpain and friends in Cell spread,		GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007266~Rho protein signal transduction,GO:0016032~viral process,GO:0016477~cell migration,GO:0021762~substantia nigra development,GO:0030036~actin cytoskeleton organization,GO:0030168~platelet activation,GO:0030334~regulation of cell migration,GO:0031532~actin cytoskeleton reorganization,GO:0032467~positive regulation of cytokinesis,GO:0032956~regulation of actin cytoskeleton organization,GO:0033688~regulation of osteoblast proliferation,GO:0035385~Roundabout signaling pathway,GO:0036089~cleavage furrow formation,GO:0038027~apolipoprotein A-I-mediated signaling pathway,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043149~stress fiber assembly,GO:0043297~apical junction assembly,GO:0043542~endothelial cell migration,GO:0043931~ossification involved in bone maturation,GO:0044319~wound healing, spreading of cells,GO:0045666~positive regulation of neuron differentiation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050771~negative regulation of axonogenesis,GO:0050772~positive regulation of axonogenesis,GO:0050919~negative chemotaxis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051496~positive regulation of stress fiber assembly,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0060193~positive regulation of lipase activity,GO:0061383~trabecula morphogenesis,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis,GO:0090307~mitotic spindle assembly,GO:0097498~endothelial tube lumen extension,GO:1902766~skeletal muscle satellite cell migration,GO:1903673~mitotic cleavage furrow formation,GO:2000145~regulation of cell motility,	GO:0005622~intracellular,GO:0005768~endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030496~midbody,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031982~vesicle,GO:0032154~cleavage furrow,GO:0043296~apical junction complex,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0017022~myosin binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04144:Endocytosis,hsa04270:Vascular smooth muscle contraction,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04360:Axon guidance,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04611:Platelet activation,hsa04660:T cell receptor signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04921:Oxytocin signaling pathway,hsa04972:Pancreatic secretion,hsa05100:Bacterial invasion of epithelial cells,hsa05130:Pathogenic Escherichia coli infection,hsa05133:Pertussis,hsa05152:Tuberculosis,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,				3D-structure,ADP-ribosylation,Cell cycle,Cell division,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Glycoprotein,GTP-binding,Host-virus interaction,Lipoprotein,Magnesium,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Prenylation,Proteomics identification,Proto-oncogene,Reference proteome,Ubl conjugation,	chain:Transforming protein RhoA,compositionally biased region:Arg/Lys-rich (basic),helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,site:Cleavage; by yopT,strand,turn,
RHOB	ras homolog family member B(RHOB)	Homo sapiens				GO:0000910~cytokinesis,GO:0001525~angiogenesis,GO:0006886~intracellular protein transport,GO:0006915~apoptotic process,GO:0007155~cell adhesion,GO:0007266~Rho protein signal transduction,GO:0008333~endosome to lysosome transport,GO:0010595~positive regulation of endothelial cell migration,GO:0030154~cell differentiation,GO:0030168~platelet activation,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0043065~positive regulation of apoptotic process,GO:0045766~positive regulation of angiogenesis,GO:0045786~negative regulation of cell cycle,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0061154~endothelial tube morphogenesis,GO:0070301~cellular response to hydrogen peroxide,GO:0071479~cellular response to ionizing radiation,	GO:0005634~nucleus,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0010008~endosome membrane,GO:0031902~late endosome membrane,GO:0032154~cleavage furrow,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,ADP-ribosylation,Angiogenesis,Apoptosis,Cell adhesion,Cell membrane,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Endosome,Glycoprotein,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Nucleus,Palmitate,Phosphoprotein,Prenylation,Protein transport,Reference proteome,Transport,Tumor suppressor,	chain:Rho-related GTP-binding protein RhoB,helix,lipid moiety-binding region:S-farnesyl cysteine; in plasma membrane form,lipid moiety-binding region:S-geranylgeranyl cysteine; in endosomal form,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,strand,turn,
RHOC	ras homolog family member C(RHOC)	Homo sapiens				GO:0000910~cytokinesis,GO:0007264~small GTPase mediated signal transduction,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043297~apical junction assembly,GO:0044319~wound healing, spreading of cells,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0060193~positive regulation of lipase activity,GO:1902766~skeletal muscle satellite cell migration,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0032154~cleavage furrow,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,ADP-ribosylation,Cell membrane,Complete proteome,Glycoprotein,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Polymorphism,Prenylation,Proteomics identification,Reference proteome,	chain:Rho-related GTP-binding protein RhoC,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,sequence variant,short sequence motif:Effector region,strand,turn,
RHOQ	ras homolog family member Q(RHOQ)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0008286~insulin receptor signaling pathway,GO:0008360~regulation of cell shape,GO:0030866~cortical actin cytoskeleton organization,GO:0032869~cellular response to insulin stimulus,GO:0032956~regulation of actin cytoskeleton organization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046039~GTP metabolic process,GO:0046326~positive regulation of glucose import,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051491~positive regulation of filopodium assembly,GO:0090005~negative regulation of establishment of protein localization to plasma membrane,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005522~profilin binding,GO:0005525~GTP binding,GO:0032427~GBD domain binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04910:Insulin signaling pathway,				3D-structure,Cell membrane,Complete proteome,Cytoplasm,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Proteomics identification,Reference proteome,	chain:Rho-related GTP-binding protein RhoQ,helix,lipid moiety-binding region:S-farnesyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,strand,turn,
RHOU	ras homolog family member U(RHOU)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0016601~Rac protein signal transduction,GO:0030036~actin cytoskeleton organization,GO:0051056~regulation of small GTPase mediated signal transduction,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000139~Golgi membrane,GO:0002102~podosome,GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0042995~cell projection,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Golgi apparatus,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,	chain:Rho-related GTP-binding protein RhoU,compositionally biased region:Gly-rich,helix,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,strand,turn,
RLF	rearranged L-myc fusion(RLF)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0015074~DNA integration,GO:0044030~regulation of DNA methylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051276~chromosome organization,GO:0097692~histone H3-K4 monomethylation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein Rlf,modified residue,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
REEP1	receptor accessory protein 1(REEP1)	Homo sapiens				GO:0032386~regulation of intracellular transport,GO:0051205~protein insertion into membrane,GO:0071786~endoplasmic reticulum tubular network organization,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0071782~endoplasmic reticulum tubular network,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0031849~olfactory receptor binding,	IPR004345:TB2/DP1/HVA22-related protein,		610250~Spastic paraplegia 31, autosomal dominant,614751~Neuronopathy, distal hereditary motor, type VB,			Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Hereditary spastic paraplegia,Membrane,Mitochondrion,Neurodegeneration,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Receptor expression-enhancing protein 1,compositionally biased region:Poly-Pro,modified residue,sequence variant,transmembrane region,
RAMP1	receptor activity modifying protein 1(RAMP1)	Homo sapiens				GO:0001525~angiogenesis,GO:0006816~calcium ion transport,GO:0006886~intracellular protein transport,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0015031~protein transport,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0031623~receptor internalization,GO:0060050~positive regulation of protein glycosylation,GO:0072659~protein localization to plasma membrane,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004872~receptor activity,GO:0004948~calcitonin receptor activity,GO:0005515~protein binding,GO:0008565~protein transporter activity,GO:0015026~coreceptor activity,GO:0031716~calcitonin receptor binding,	IPR006985:Receptor activity modifying protein,	hsa04270:Vascular smooth muscle contraction,				3D-structure,Complete proteome,Disulfide bond,Membrane,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Receptor activity-modifying protein 1,disulfide bond,helix,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
RTP5	receptor transporter protein 5 (putative)(RTP5)	Homo sapiens				GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste,GO:0006612~protein targeting to membrane,GO:0051205~protein insertion into membrane,	GO:0005622~intracellular,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0031849~olfactory receptor binding,	IPR026096:Receptor-transporting protein/CXXC-type zinc finger protein 11,IPR026689:CXXC-type zinc finger protein 11,IPR027377:Zinc-binding domain,				SM01328:SM01328,	Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C2orf85,sequence conflict,sequence variant,transmembrane region,
ROR1	receptor tyrosine kinase like orphan receptor 1(ROR1)	Homo sapiens				GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004672~protein kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0017147~Wnt-protein binding,GO:1904929~coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,	IPR000001:Kringle,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR013806:Kringle-like fold,IPR016247:Tyrosine-protein kinase, receptor ROR,IPR018056:Kringle, conserved site,IPR020067:Frizzled domain,			PIRSF000624:tyrosine-protein kinase transmembrane receptor ROR,	SM00130:KR,SM00408:IGc2,SM00409:IG,	Alternative splicing,ATP-binding,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Kinase,Kringle,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,Wnt signaling pathway,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase transmembrane receptor ROR1,compositionally biased region:Pro-rich,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:FZ,domain:Ig-like C2-type,domain:Kringle,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
REG1B	regenerating family member 1 beta(REG1B)	Homo sapiens				GO:0008283~cell proliferation,	GO:0070062~extracellular exosome,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	Complete proteome,Disulfide bond,Glycoprotein,Lectin,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Lithostathine-1-beta,disulfide bond,domain:C-type lectin,glycosylation site:O-linked (GalNAc...),modified residue,sequence variant,signal peptide,
REG3G	regenerating family member 3 gamma(REG3G)	Homo sapiens				GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006953~acute-phase response,GO:0010838~positive regulation of keratinocyte proliferation,GO:0045617~negative regulation of keratinocyte differentiation,GO:0050830~defense response to Gram-positive bacterium,GO:0090303~positive regulation of wound healing,	GO:0005576~extracellular region,GO:0005737~cytoplasm,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	Acute phase,Alternative splicing,Antimicrobial,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Inflammatory response,Lectin,Reference proteome,Secreted,Signal,	chain:Regenerating islet-derived protein 3- gamma,disulfide bond,domain:C-type lectin,sequence conflict,signal peptide,
REG4	regenerating family member 4(REG4)	Homo sapiens					GO:0005576~extracellular region,GO:0005737~cytoplasm,	GO:0005509~calcium ion binding,GO:0008201~heparin binding,GO:2001065~mannan binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Lectin,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Regenerating islet-derived protein 4,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
RIMS3	regulating synaptic membrane exocytosis 3(RIMS3)	Homo sapiens				GO:0017156~calcium ion regulated exocytosis,GO:0042391~regulation of membrane potential,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0030054~cell junction,GO:0048786~presynaptic active zone,	GO:0044325~ion channel binding,	IPR000008:C2 calcium-dependent membrane targeting,				SM00239:C2,	Alternative splicing,Cell junction,Complete proteome,Exocytosis,Neurotransmitter transport,Phosphoprotein,Reference proteome,Synapse,Transport,	chain:Regulating synaptic membrane exocytosis protein 3,domain:C2,modified residue,sequence conflict,
RPRD2	regulation of nuclear pre-mRNA domain containing 2(RPRD2)	Homo sapiens				GO:0042795~snRNA transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,		IPR006569:CID domain,IPR006903:RNA polymerase II-binding domain,IPR008942:ENTH/VHS,				SM00582:RPR,	3D-structure,Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Reference proteome,	chain:Regulation of nuclear pre-mRNA domain- containing protein 2,compositionally biased region:Gly/Ser-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:CID,modified residue,sequence conflict,sequence variant,splice variant,
RGS13	regulator of G-protein signaling 13(RGS13)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0043547~positive regulation of GTPase activity,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00315:RGS,	Complete proteome,Polymorphism,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 13,domain:RGS,sequence variant,
RGS18	regulator of G-protein signaling 18(RGS18)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00315:RGS,	3D-structure,Complete proteome,Cytoplasm,Phosphoprotein,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 18,domain:RGS,helix,sequence conflict,strand,turn,
RGS21	regulator of G-protein signaling 21(RGS21)	Homo sapiens				GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00315:RGS,	Complete proteome,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 21,domain:RGS,
RGS5	regulator of G-protein signaling 5(RGS5)	Homo sapiens				GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,		145500~Blood pressure regulation QTL,		SM00315:RGS,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Membrane,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 5,domain:RGS,helix,
RGS7	regulator of G-protein signaling 7(RGS7)	Homo sapiens				GO:0006457~protein folding,GO:0007186~G-protein coupled receptor signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,	GO:0004871~signal transducer activity,GO:0005096~GTPase activator activity,GO:0031681~G-protein beta-subunit binding,	IPR000591:DEP domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015898:G-protein gamma-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00049:DEP,SM00224:GGL,SM00315:RGS,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,GTPase activation,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal transduction inhibitor,Ubl conjugation,	chain:Regulator of G-protein signaling 7,domain:DEP,domain:G protein gamma,domain:RGS,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,turn,
RGS8	regulator of G-protein signaling 8(RGS8)	Homo sapiens				GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0060159~regulation of dopamine receptor signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0032809~neuronal cell body membrane,GO:0043204~perikaryon,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00315:RGS,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Complete proteome,GTPase activation,Membrane,Nucleus,Phosphoprotein,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 8,domain:RGS,helix,splice variant,turn,
RGSL1	regulator of G-protein signaling like 1(RGSL1)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005096~GTPase activator activity,	IPR016137:Regulator of G protein signalling superfamily,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Regulator of G-protein signaling protein- like,compositionally biased region:Poly-Ser,domain:RGS,sequence conflict,sequence variant,splice variant,transmembrane region,
RCC1	regulator of chromosome condensation 1(RCC1)	Homo sapiens		h_npcPathway:Mechanism of Protein Import into the Nucleus,h_ranMSPathway:Role of Ran in mitotic spindle regulation,h_ranPathway:Cycling of Ran in nucleocytoplasmic transport,	Cell division and chromosome partitioning / Cytoskeleton,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007088~regulation of mitotic nuclear division,GO:0016032~viral process,GO:0043547~positive regulation of GTPase activity,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0000790~nuclear chromatin,GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,	GO:0003682~chromatin binding,GO:0005087~Ran guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,					3D-structure,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Guanine-nucleotide releasing factor,Methylation,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Regulator of chromosome condensation,helix,modified residue,repeat:RCC1 1,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,repeat:RCC1 6,repeat:RCC1 7,strand,turn,
RCC2	regulator of chromosome condensation 2(RCC2)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007229~integrin-mediated signaling pathway,GO:0010762~regulation of fibroblast migration,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0030334~regulation of cell migration,GO:0034260~negative regulation of GTPase activity,GO:0045184~establishment of protein localization,GO:0048041~focal adhesion assembly,GO:0051301~cell division,GO:0051895~negative regulation of focal adhesion assembly,GO:0051987~positive regulation of attachment of spindle microtubules to kinetochore,GO:0072356~chromosome passenger complex localization to kinetochore,GO:0090630~activation of GTPase activity,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1900027~regulation of ruffle assembly,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0031901~early endosome membrane,GO:0034506~chromosome, centromeric core domain,GO:1990023~mitotic spindle midzone,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0031267~small GTPase binding,GO:0044822~poly(A) RNA binding,GO:0048365~Rac GTPase binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,					Acetylation,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Nucleus,Phosphoprotein,Reference proteome,Repeat,	chain:Protein RCC2,modified residue,repeat:RCC1 1,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,repeat:RCC1 6,repeat:RCC1 7,sequence conflict,
RMDN2	regulator of microtubule dynamics 2(RMDN2)	Homo sapiens					GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005874~microtubule,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Regulator of microtubule dynamics protein 2,sequence variant,splice variant,transmembrane region,
RIIAD1	regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1(RIIAD1)	Homo sapiens							IPR003117:cAMP-dependent protein kinase, regulatory subunit, type I/II alpha/beta,					Complete proteome,Reference proteome,	chain:RIIa domain-containing protein C1orf230,domain:RIIa,
RXFP4	relaxin/insulin like family peptide receptor 4(RXFP4)	Homo sapiens				GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:2000253~positive regulation of feeding behavior,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004945~angiotensin type II receptor activity,GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,	IPR000248:Angiotensin II receptor family,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Relaxin-3 receptor 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
REN	renin(REN)	Homo sapiens		h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,		GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0002003~angiotensin maturation,GO:0002018~renin-angiotensin regulation of aldosterone production,GO:0006508~proteolysis,GO:0008217~regulation of blood pressure,GO:0008584~male gonad development,GO:0009755~hormone-mediated signaling pathway,GO:0030163~protein catabolic process,GO:0032496~response to lipopolysaccharide,GO:0035690~cellular response to drug,GO:0035902~response to immobilization stress,GO:0042756~drinking behavior,GO:0043408~regulation of MAPK cascade,GO:0048469~cell maturation,GO:0050435~beta-amyloid metabolic process,GO:0051591~response to cAMP,GO:0070305~response to cGMP,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005886~plasma membrane,	GO:0004190~aspartic-type endopeptidase activity,GO:0005102~receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0008233~peptidase activity,	IPR001461:Peptidase A1,IPR001969:Peptidase aspartic, active site,IPR012848:Propeptide, peptidase A1,IPR021109:Aspartic peptidase,	hsa04614:Renin-angiotensin system,hsa04924:Renin secretion,	267430~Renal tubular dysgenesis,613092~Hyperuricemic nephropathy, familial juvenile 2,Hyperproreninemia~Hyperproreninemia,			3D-structure,Alternative splicing,Aspartyl protease,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Signal,Zymogen,	chain:Renin,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
RPA2	replication protein A2(RPA2)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0006260~DNA replication,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006298~mismatch repair,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0019985~translesion synthesis,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0033683~nucleotide-excision repair, DNA incision,GO:0036297~interstrand cross-link repair,GO:0042276~error-prone translesion synthesis,GO:0042769~DNA damage response, detection of DNA damage,GO:0070987~error-free translesion synthesis,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:2000001~regulation of DNA damage checkpoint,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0016605~PML body,GO:0035861~site of double-strand break,	GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0019903~protein phosphatase binding,GO:0031625~ubiquitin protein ligase binding,GO:0047485~protein N-terminus binding,	IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014646:Replication protein A, subunit RPA32,IPR014892:Replication protein A, C-terminal,	hsa03030:DNA replication,hsa03420:Nucleotide excision repair,hsa03430:Mismatch repair,hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,		PIRSF036949:replication protein A, RPA32 subunit,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,DNA damage,DNA recombination,DNA repair,DNA replication,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Replication protein A 32 kDa subunit,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Gly/Ser-rich,helix,modified residue,mutagenesis site,region of interest:Interaction with TIPIN,sequence variant,site:Not phosphorylated,splice variant,strand,turn,
RIF1	replication timing regulatory factor 1(RIF1)	Homo sapiens				GO:0006303~double-strand break repair via nonhomologous end joining,GO:0007049~cell cycle,GO:0019827~stem cell population maintenance,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,	GO:0000781~chromosome, telomeric region,GO:0001939~female pronucleus,GO:0001940~male pronucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005886~plasma membrane,		IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR022031:Rap1-interacting factor 1 N-terminal,	hsa04550:Signaling pathways regulating pluripotency of stem cells,				Alternative splicing,Cell cycle,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,	chain:Telomere-associated protein RIF1,modified residue,region of interest:Interaction with condensed chromosomes in telophase,sequence conflict,sequence variant,splice variant,
RER1	retention in endoplasmic reticulum sorting receptor 1(RER1)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,	GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,	GO:0033130~acetylcholine receptor binding,	IPR004932:Retrieval of early ER protein Rer1,			PIRSF016013:endoplasmic reticulum retrieval protein, Rer1p type,		Acetylation,Complete proteome,Golgi apparatus,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein RER1,modified residue,sequence conflict,transmembrane region,
RTN4	reticulon 4(RTN4)	Homo sapiens				GO:0006915~apoptotic process,GO:0007413~axonal fasciculation,GO:0021801~cerebral cortex radial glia guided migration,GO:0030308~negative regulation of cell growth,GO:0030334~regulation of cell migration,GO:0030517~negative regulation of axon extension,GO:0042981~regulation of apoptotic process,GO:0050771~negative regulation of axonogenesis,GO:0051292~nuclear pore complex assembly,GO:0060317~cardiac epithelial to mesenchymal transition,GO:0071786~endoplasmic reticulum tubular network organization,GO:0071787~endoplasmic reticulum tubular network assembly,GO:0098609~cell-cell adhesion,GO:2000172~regulation of branching morphogenesis of a nerve,	GO:0005622~intracellular,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003388:Reticulon,					3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Reticulon-4,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,domain:Reticulon,helix,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
RARB	retinoic acid receptor beta(RARB)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001657~ureteric bud development,GO:0002068~glandular epithelial cell development,GO:0003148~outflow tract septum morphogenesis,GO:0003406~retinal pigment epithelium development,GO:0003417~growth plate cartilage development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0021756~striatum development,GO:0031641~regulation of myelination,GO:0032331~negative regulation of chondrocyte differentiation,GO:0035116~embryonic hindlimb morphogenesis,GO:0035264~multicellular organism growth,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043401~steroid hormone mediated signaling pathway,GO:0045666~positive regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048048~embryonic eye morphogenesis,GO:0048384~retinoic acid receptor signaling pathway,GO:0048566~embryonic digestive tract development,GO:0055012~ventricular cardiac muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003708~retinoic acid receptor activity,GO:0008144~drug binding,GO:0008270~zinc ion binding,GO:0032403~protein complex binding,GO:0043565~sequence-specific DNA binding,GO:0046965~retinoid X receptor binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003078:Retinoic acid receptor,IPR013088:Zinc finger, NHR/GATA-type,	hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,	615524~Microphthalmia, syndromic 12,		SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Metal-binding,Microphthalmia,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Retinoic acid receptor beta,DNA-binding region:Nuclear receptor,helix,region of interest:Hinge,region of interest:Ligand-binding,region of interest:Modulating,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:NR C4-type,
RXRG	retinoid X receptor gamma(RXRG)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0043401~steroid hormone mediated signaling pathway,GO:0048384~retinoic acid receptor signaling pathway,GO:0051289~protein homotetramerization,GO:1901522~positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004886~9-cis retinoic acid receptor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000003:Retinoid X receptor/HNF4,IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,IPR021780:Nuclear/hormone receptor activator site AF-1,	hsa03320:PPAR signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05216:Thyroid cancer,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,			SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Complete proteome,DNA-binding,Metal-binding,Nucleus,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Retinoic acid receptor RXR-gamma,DNA-binding region:Nuclear receptor,helix,region of interest:Hinge,region of interest:Ligand-binding,region of interest:Modulating,strand,zinc finger region:NR C4-type,
RHBDD1	rhomboid domain containing 1(RHBDD1)	Homo sapiens				GO:0006915~apoptotic process,GO:0010954~positive regulation of protein processing,GO:0031293~membrane protein intracellular domain proteolysis,GO:0033619~membrane protein proteolysis,GO:0034620~cellular response to unfolded protein,GO:0034644~cellular response to UV,GO:0036503~ERAD pathway,GO:0043066~negative regulation of apoptotic process,GO:0043687~post-translational protein modification,GO:0045732~positive regulation of protein catabolic process,GO:0048515~spermatid differentiation,GO:0051047~positive regulation of secretion,GO:1904211~membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,GO:2000254~regulation of male germ cell proliferation,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0044322~endoplasmic reticulum quality control compartment,	GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,	IPR022764:Peptidase S54, rhomboid domain,					3D-structure,Alternative splicing,Apoptosis,Complete proteome,Differentiation,Endoplasmic reticulum,Hydrolase,Membrane,Mitochondrion,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Spermatogenesis,Transmembrane,Transmembrane helix,	active site:Nucleophile,chain:Rhomboid domain-containing protein 1,sequence conflict,sequence variant,splice variant,transmembrane region,
RHBDL2	rhomboid like 2(RHBDL2)	Homo sapiens				GO:0016485~protein processing,	GO:0005743~mitochondrial inner membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004252~serine-type endopeptidase activity,	IPR002610:Peptidase S54, rhomboid,IPR017213:Peptidase S54, rhomboid, metazoan,IPR022764:Peptidase S54, rhomboid domain,			PIRSF037470:rhomboid protein,		Alternative splicing,Cell membrane,Complete proteome,Hydrolase,Membrane,Polymorphism,Protease,Reference proteome,Serine protease,Transmembrane,Transmembrane helix,	active site:Nucleophile,chain:Rhomboid-related protein 2,compositionally biased region:Poly-Glu,mutagenesis site,sequence variant,splice variant,transmembrane region,
RBKS	ribokinase(RBKS)	Homo sapiens				GO:0019303~D-ribose catabolic process,GO:0046835~carbohydrate phosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0004747~ribokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019200~carbohydrate kinase activity,GO:0046872~metal ion binding,	IPR002139:Ribokinase,IPR002173:Carbohydrate/puine kinase, PfkB, conserved site,IPR011611:Carbohydrate kinase PfkB,IPR011877:Ribokinase, bacterial,	hsa00030:Pentose phosphate pathway,				3D-structure,Alternative splicing,ATP-binding,Carbohydrate metabolism,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Potassium,Proteomics identification,Reference proteome,Transferase,	chain:Ribokinase,helix,modified residue,sequence conflict,strand,turn,
RNASEH1	ribonuclease H1(RNASEH1)	Homo sapiens				GO:0006401~RNA catabolic process,GO:0043137~DNA replication, removal of RNA primer,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005737~cytoplasm,	GO:0000287~magnesium ion binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004523~RNA-DNA hybrid ribonuclease activity,GO:0004540~ribonuclease activity,	IPR002156:Ribonuclease H domain,IPR009027:Ribosomal protein L9/RNase H1, N-terminal,IPR011320:Ribonuclease H1, N-terminal,IPR012337:Ribonuclease H-like domain,IPR017067:Ribonuclease H1, eukaryote,	hsa03030:DNA replication,	616479~Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2,	PIRSF036852:ribonuclease H1, eukaryotic type,		3D-structure,Complete proteome,Cytoplasm,Disease mutation,Endonuclease,Hydrolase,Magnesium,Metal-binding,Nuclease,Polymorphism,Progressive external ophthalmoplegia,Reference proteome,	chain:Ribonuclease H1,domain:RNase H,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,sequence conflict,sequence variant,strand,turn,
RPP14	ribonuclease P/MRP subunit p14(RPP14)	Homo sapiens				GO:0001682~tRNA 5'-leader removal,GO:0006364~rRNA processing,GO:0006631~fatty acid metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003723~RNA binding,GO:0004526~ribonuclease P activity,GO:0016829~lyase activity,	IPR002539:MaoC-like domain,IPR002759:Ribonuclease P/MRP protein subunit,	hsa03013:RNA transport,				3D-structure,Complete proteome,Direct protein sequencing,Fatty acid metabolism,Hydrolase,Lipid metabolism,Lyase,Mitochondrion,Nucleus,Proteomics identification,Reference proteome,Signal,Transit peptide,tRNA processing,	chain:Ribonuclease P protein subunit p14,
RAVER2	ribonucleoprotein, PTB binding 2(RAVER2)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Ribonucleoprotein PTB-binding 2,compositionally biased region:Ala/Gly-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,splice variant,strand,
RRM2	ribonucleotide reductase regulatory subunit M2(RRM2)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0009186~deoxyribonucleoside diphosphate metabolic process,GO:0009263~deoxyribonucleotide biosynthetic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0051290~protein heterotetramerization,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005971~ribonucleoside-diphosphate reductase complex,	GO:0004748~ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR000358:Ribonucleotide reductase small subunit,IPR009078:Ferritin-like superfamily,IPR012348:Ribonucleotide reductase-related,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,hsa04115:p53 signaling pathway,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,DNA replication,Iron,Metal-binding,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Ribonucleoside-diphosphate reductase subunit M2,helix,metal ion-binding site:Iron 1,metal ion-binding site:Iron 2,modified residue,mutagenesis site,strand,turn,
RPIA	ribose 5-phosphate isomerase A(RPIA)	Homo sapiens				GO:0006098~pentose-phosphate shunt,GO:0009052~pentose-phosphate shunt, non-oxidative branch,	GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004751~ribose-5-phosphate isomerase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0048029~monosaccharide binding,	IPR004788:Ribose 5-phosphate isomerase, type A,IPR020672:Ribose-5-phosphate isomerase, type A, subgroup,	hsa00030:Pentose phosphate pathway,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01230:Biosynthesis of amino acids,	608611~Ribose 5-phosphate isomerase deficiency,			Complete proteome,Disease mutation,Isomerase,Membrane,Methylation,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Ribose-5-phosphate isomerase,sequence conflict,sequence variant,
RRP15	ribosomal RNA processing 15 homolog(RRP15)	Homo sapiens				GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0030687~preribosome, large subunit precursor,		IPR012459:Protein of unknown function DUF1665,					Acetylation,Citrullination,Coiled coil,Complete proteome,Isopeptide bond,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:RRP15-like protein,modified residue,sequence conflict,sequence variant,
RIMKLA	ribosomal modification protein rimK like family member A(RIMKLA)	Homo sapiens				GO:0006464~cellular protein modification process,	GO:0005737~cytoplasm,	GO:0003824~catalytic activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,GO:0072590~N-acetyl-L-aspartate-L-glutamate ligase activity,	IPR004666:Ribosomal S6 modification enzyme RimK/Lysine biosynthesis enzyme LysX,IPR011761:ATP-grasp fold,IPR013651:ATP-grasp fold, RimK-type,IPR013815:ATP-grasp fold, subdomain 1,IPR013816:ATP-grasp fold, subdomain 2,IPR016185:Pre-ATP-grasp domain,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa01100:Metabolic pathways,				ATP-binding,Complete proteome,Cytoplasm,Ligase,Magnesium,Manganese,Metal-binding,Nucleotide-binding,Phosphoprotein,Reference proteome,	chain:Ribosomal protein S6 modification-like protein A,domain:ATP-grasp,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,nucleotide phosphate-binding region:ATP,
RPL11	ribosomal protein L11(RPL11)	Homo sapiens				GO:0000027~ribosomal large subunit assembly,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006605~protein targeting,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,GO:0034504~protein localization to nucleus,GO:0042273~ribosomal large subunit biogenesis,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR002132:Ribosomal protein L5,IPR020929:Ribosomal protein L5, conserved site,IPR022803:Ribosomal protein L5 domain,	hsa03010:Ribosome,	612562~Diamond-Blackfan anemia 7,	PIRSF002161:ribosomal protein, L5p/L5a/L11e/organellar L5 types,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Diamond-Blackfan anemia,Direct protein sequencing,Disease mutation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,	chain:60S ribosomal protein L11,modified residue,sequence conflict,sequence variant,splice variant,
RPL14	ribosomal protein L14(RPL14)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,GO:0042273~ribosomal large subunit biogenesis,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002784:Ribosomal protein L14,IPR008991:Translation protein SH3-like domain,IPR014722:Ribosomal protein L2 domain 2,	hsa03010:Ribosome,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,Ribosomal protein,Triplet repeat expansion,Ubl conjugation,	chain:60S ribosomal protein L14,modified residue,region of interest:2 X 3 AA tandem repeats of K-[GA]-Q,region of interest:4 X 5 AA tandem repeats of Q-K-A-[PAS]-X,repeat:1-1,repeat:1-2,repeat:1-3,repeat:1-4,repeat:2-1,repeat:2-2,sequence conflict,sequence variant,
RPL21P28	ribosomal protein L21 pseudogene 28(RPL21P28)	Homo sapiens													chain:60S ribosomal protein L21,modified residue,sequence conflict,sequence variant,
RPL22	ribosomal protein L22(RPL22)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0002181~cytoplasmic translation,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,GO:0046632~alpha-beta T cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0044822~poly(A) RNA binding,	IPR002671:Ribosomal protein L22e,	hsa03010:Ribosome,				3D-structure,Complete proteome,Direct protein sequencing,Heparin-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,	chain:60S ribosomal protein L22,compositionally biased region:Asp/Glu-rich (highly acidic),
RPL24	ribosomal protein L24(RPL24)	Homo sapiens				GO:0000027~ribosomal large subunit assembly,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0007093~mitotic cell cycle checkpoint,GO:0010458~exit from mitosis,GO:0019083~viral transcription,GO:0021554~optic nerve development,GO:0031290~retinal ganglion cell axon guidance,GO:0060041~retina development in camera-type eye,GO:0098609~cell-cell adhesion,GO:1902626~assembly of large subunit precursor of preribosome,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000988:Ribosomal protein L24e-related,IPR011017:TRASH domain,IPR023442:Ribosomal protein L24e, conserved site,	hsa03010:Ribosome,			SM00746:TRASH,	3D-structure,Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:60S ribosomal protein L24,modified residue,site:Not acetylated,
RPL31	ribosomal protein L31(RPL31)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0002181~cytoplasmic translation,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,	GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000054:Ribosomal protein L31e,IPR020052:Ribosomal protein L31e, conserved site,IPR023621:Ribosomal protein L31e domain,	hsa03010:Ribosome,			SM01380:SM01380,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:60S ribosomal protein L31,modified residue,
RPL37A	ribosomal protein L37a(RPL37A)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR002674:Ribosomal protein L37ae,IPR011331:Ribosomal protein L37ae/L37e,IPR011332:Ribosomal protein, zinc-binding domain,	hsa03010:Ribosome,				3D-structure,Complete proteome,Metal-binding,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Zinc,Zinc-finger,	chain:60S ribosomal protein L37a,zinc finger region:C4-type,
RPL5	ribosomal protein L5(RPL5)	Homo sapiens				GO:0000027~ribosomal large subunit assembly,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0008097~5S rRNA binding,GO:0044822~poly(A) RNA binding,	IPR005485:Ribosomal protein L5 eukaryotic/L18 archaeal,IPR025607:Ribosomal protein L5 eukaryotic/L18 archaeal, C-terminal,	hsa03010:Ribosome,	612561~Diamond-Blackfan anemia 6,			3D-structure,Acetylation,Complete proteome,Cytoplasm,Diamond-Blackfan anemia,Direct protein sequencing,Disease mutation,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,Ubl conjugation,	chain:60S ribosomal protein L5,modified residue,sequence conflict,sequence variant,
RPS6KC1	ribosomal protein S6 kinase C1(RPS6KC1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007165~signal transduction,	GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005840~ribosome,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0035091~phosphatidylinositol binding,	IPR000719:Protein kinase, catalytic domain,IPR001683:Phox homologous domain,IPR007330:MIT,IPR011009:Protein kinase-like domain,				SM00220:S_TKc,SM00312:PX,SM00745:MIT,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,Ribosomal protein,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Ribosomal protein S6 kinase delta-1,domain:MIT,domain:Protein kinase 1,domain:Protein kinase 2,domain:PX,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
RPS8	ribosomal protein S8(RPS8)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001047:Ribosomal protein S8e,IPR018283:Ribosomal protein S8e, conserved site,IPR022309:Ribosomal protein S8e/ribosomal biogenesis NSA2,	hsa03010:Ribosome,				3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Lipoprotein,Membrane,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:40S ribosomal protein S8,modified residue,sequence variant,
RPSA	ribosomal protein SA(RPSA)	Homo sapiens		h_prionPathway:Prion Pathway,		GO:0000028~ribosomal small subunit assembly,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000461~endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006407~rRNA export from nucleus,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0007155~cell adhesion,GO:0016337~single organismal cell-cell adhesion,GO:0019083~viral transcription,GO:0030855~epithelial cell differentiation,GO:0046718~viral entry into host cell,	GO:0005604~basement membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030686~90S preribosome,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0003735~structural constituent of ribosome,GO:0005055~laminin receptor activity,GO:0005515~protein binding,GO:0043022~ribosome binding,GO:0043236~laminin binding,GO:0044822~poly(A) RNA binding,	IPR001865:Ribosomal protein S2,IPR005707:Ribosomal protein S2, eukaryotic/archaeal,IPR018130:Ribosomal protein S2, conserved site,IPR023591:Ribosomal protein S2, flavodoxin-like domain,IPR027498:Ribosomal protein S2, eukaryotic,IPR027504:40S ribosomal protein SA,	hsa03010:Ribosome,	271400~Asplenia, isolated congenital,			3D-structure,Acetylation,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Host cell receptor for virus entry,Host-virus interaction,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Ribonucleoprotein,Ribosomal protein,	chain:40S ribosomal protein SA,helix,modified residue,region of interest:Laminin-binding,repeat:[DE]-W-[ST] 1,repeat:[DE]-W-[ST] 2,repeat:[DE]-W-[ST] 3,repeat:[DE]-W-[ST] 4,repeat:[DE]-W-[ST] 5,sequence conflict,sequence variant,site:Cleavage; by ST3; site 1,site:Cleavage; by ST3; site 2,strand,turn,
RC3H1	ring finger and CCCH-type domains 1(RC3H1)	Homo sapiens				GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0001782~B cell homeostasis,GO:0002634~regulation of germinal center formation,GO:0002635~negative regulation of germinal center formation,GO:0010608~posttranscriptional regulation of gene expression,GO:0016567~protein ubiquitination,GO:0030889~negative regulation of B cell proliferation,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0042098~T cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0043029~T cell homeostasis,GO:0043488~regulation of mRNA stability,GO:0045623~negative regulation of T-helper cell differentiation,GO:0046007~negative regulation of activated T cell proliferation,GO:0048535~lymph node development,GO:0048536~spleen development,GO:0050856~regulation of T cell receptor signaling pathway,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0061470~T follicular helper cell differentiation,GO:0071347~cellular response to interleukin-1,GO:1901224~positive regulation of NIK/NF-kappaB signaling,	GO:0000932~cytoplasmic mRNA processing body,GO:0010494~cytoplasmic stress granule,	GO:0003730~mRNA 3'-UTR binding,GO:0008270~zinc ion binding,GO:0035613~RNA stem-loop binding,GO:0044822~poly(A) RNA binding,GO:0061630~ubiquitin protein ligase activity,	IPR000571:Zinc finger, CCCH-type,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00356:ZnF_C3H1,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Metal-binding,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Zinc,Zinc-finger,	chain:Roquin,compositionally biased region:Pro-rich,modified residue,sequence conflict,splice variant,zinc finger region:C3H1-type,zinc finger region:RING-type; degenerate,
RFWD2	ring finger and WD repeat domain 2(RFWD2)	Homo sapiens				GO:0010212~response to ionizing radiation,GO:0016567~protein ubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0016607~nuclear speck,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001594:Zinc finger, DHHC-type, palmitoyltransferase,IPR001680:WD40 repeat,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017907:Zinc finger, RING-type, conserved site,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04115:p53 signaling pathway,hsa04120:Ubiquitin mediated proteolysis,			SM00184:RING,SM00320:WD40,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Ligase,Membrane,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation,Ubl conjugation pathway,WD repeat,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase RFWD2,compositionally biased region:Ser-rich,mutagenesis site,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal 1,short sequence motif:Nuclear localization signal 2,splice variant,zinc finger region:RING-type,
RNF103	ring finger protein 103(RNF103)	Homo sapiens				GO:0007417~central nervous system development,GO:0016567~protein ubiquitination,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Complete proteome,Endoplasmic reticulum,Ligase,Membrane,Metal-binding,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Charged multivesicular body protein 3,chain:RING finger protein 103,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,mutagenesis site,region of interest:Interaction with STAMBP,region of interest:Interaction with VPS4A,region of interest:Intramolecular interaction with C- terminus,region of interest:Intramolecular interaction with N- terminus,sequence conflict,short sequence motif:MIT-interacting motif,strand,transmembrane region,turn,zinc finger region:RING-type,
RNF11	ring finger protein 11(RNF11)	Homo sapiens			DNA replication, recombination, and repair,	GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0051865~protein autoubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005769~early endosome,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Complete proteome,Cytoplasm,Direct protein sequencing,Endosome,Lipoprotein,Metal-binding,Myristate,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:RING finger protein 11,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:WW-binding,zinc finger region:RING-type,
RNF115	ring finger protein 115(RNF115)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0051865~protein autoubiquitination,GO:0070534~protein K63-linked ubiquitination,GO:0070936~protein K48-linked ubiquitination,	GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Acetylation,Complete proteome,Cytoplasm,Ligase,Metal-binding,Polymorphism,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:RING finger protein 115,modified residue,sequence conflict,sequence variant,zinc finger region:RING-type,
RNF123	ring finger protein 123(RNF123)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005737~cytoplasm,	GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00184:RING,SM00449:SPRY,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Ligase,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase RNF123,compositionally biased region:Poly-Ala,domain:B30.2/SPRY,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type,
RNF144A	ring finger protein 144A(RNF144A)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0000151~ubiquitin ligase complex,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031624~ubiquitin conjugating enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR002867:Zinc finger, C6HC-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00647:IBR,	3D-structure,Cell membrane,Complete proteome,Cytoplasmic vesicle,Membrane,Metal-binding,Polymorphism,Reference proteome,Repeat,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Probable E3 ubiquitin-protein ligase RNF144A,helix,sequence variant,strand,transmembrane region,turn,zinc finger region:IBR-type,zinc finger region:RING-type 1; atypical,zinc finger region:RING-type 2; degenerate,
RNF149	ring finger protein 149(RNF149)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0016567~protein ubiquitination,GO:0031647~regulation of protein stability,GO:0035690~cellular response to drug,GO:0043409~negative regulation of MAPK cascade,	GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR003137:Protease-associated domain, PA,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Complete proteome,Glycoprotein,Ligase,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase RNF149,domain:PA,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,transmembrane region,zinc finger region:RING-type; atypical,
RNF187	ring finger protein 187(RNF187)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051865~protein autoubiquitination,GO:0070936~protein K48-linked ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,				SM00184:RING,	Complete proteome,Cytoplasm,Isopeptide bond,Ligase,Metal-binding,Methylation,Nucleus,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Protein RNF187,
RNF19B	ring finger protein 19B(RNF19B)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0002250~adaptive immune response,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0044194~cytolytic granule,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031624~ubiquitin conjugating enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR002867:Zinc finger, C6HC-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,SM00647:IBR,	Adaptive immunity,Alternative splicing,Complete proteome,Immunity,Membrane,Metal-binding,Reference proteome,Repeat,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase RNF19B,compositionally biased region:Ala-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,sequence conflict,splice variant,transmembrane region,zinc finger region:IBR-type,zinc finger region:RING-type 1,zinc finger region:RING-type 2,
RNF2	ring finger protein 2(RNF2)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0001702~gastrulation with mouth forming second,GO:0006351~transcription, DNA-templated,GO:0007281~germ cell development,GO:0009948~anterior/posterior axis specification,GO:0016925~protein sumoylation,GO:0035518~histone H2A monoubiquitination,GO:0036353~histone H2A-K119 monoubiquitination,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,	GO:0000151~ubiquitin ligase complex,GO:0000791~euchromatin,GO:0001739~sex chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,GO:0071339~MLL1 complex,	GO:0003682~chromatin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,GO:0071535~RING-like zinc finger domain binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,	3D-structure,Acetylation,Alternative splicing,Chromosome,Complete proteome,Isopeptide bond,Ligase,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase RING2,helix,modified residue,mutagenesis site,region of interest:Interaction with HIP2,strand,turn,zinc finger region:RING-type,
RNF220	ring finger protein 220(RNF220)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0051865~protein autoubiquitination,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Ligase,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:RING finger protein 220,modified residue,sequence conflict,splice variant,zinc finger region:RING-type,
RSBN1	round spermatid basic protein 1(RSBN1)	Homo sapiens					GO:0005634~nucleus,		IPR026306:Round spermatid basic protein 1,					Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Round spermatid basic protein 1,compositionally biased region:His-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Lys,compositionally biased region:Pro-rich,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,
ROBO1	roundabout guidance receptor 1(ROBO1)	Homo sapiens				GO:0002042~cell migration involved in sprouting angiogenesis,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007507~heart development,GO:0016199~axon midline choice point recognition,GO:0021836~chemorepulsion involved in postnatal olfactory bulb interneuron migration,GO:0030336~negative regulation of cell migration,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035385~Roundabout signaling pathway,GO:0050772~positive regulation of axonogenesis,GO:0050925~negative regulation of negative chemotaxis,GO:0070100~negative regulation of chemokine-mediated signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0030424~axon,	GO:0005515~protein binding,GO:0008046~axon guidance receptor activity,GO:0030275~LRR domain binding,GO:0042802~identical protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04360:Axon guidance,			SM00060:FN3,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Chemotaxis,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Roundabout homolog 1,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ROBO2	roundabout guidance receptor 2(ROBO2)	Homo sapiens				GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001822~kidney development,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0016199~axon midline choice point recognition,GO:0021510~spinal cord development,GO:0021891~olfactory bulb interneuron development,GO:0031290~retinal ganglion cell axon guidance,GO:0032870~cellular response to hormone stimulus,GO:0035385~Roundabout signaling pathway,GO:0050772~positive regulation of axonogenesis,GO:0050925~negative regulation of negative chemotaxis,GO:0051964~negative regulation of synapse assembly,GO:0061364~apoptotic process involved in luteolysis,	GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030673~axolemma,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008046~axon guidance receptor activity,GO:0042802~identical protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR009138:Neural cell adhesion,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04360:Axon guidance,	610878~Vesicoureteral reflux 2,		SM00060:FN3,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Chemotaxis,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Roundabout homolog 2,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
RUNX3	runt related transcription factor 3(RUNX3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001503~ossification,GO:0002062~chondrocyte differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0030097~hemopoiesis,GO:0045595~regulation of cell differentiation,GO:0045786~negative regulation of cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048935~peripheral nervous system neuron development,GO:0050680~negative regulation of epithelial cell proliferation,GO:0071559~response to transforming growth factor beta,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000040:Acute myeloid leukemia 1 protein (AML1)/Runt,IPR008967:p53-like transcription factor, DNA-binding,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013524:Runt domain,IPR013711:Runx, C-terminal  domain,IPR027384:Runx, central domain,					Activator,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Runt-related transcription factor 3,compositionally biased region:Poly-Gly,compositionally biased region:Pro/Ser/Thr-rich,domain:Runt,modified residue,sequence conflict,splice variant,
RYR2	ryanodine receptor 2(RYR2)	Homo sapiens		h_no1Pathway:Actions of Nitric Oxide in the Heart,		GO:0001666~response to hypoxia,GO:0002027~regulation of heart rate,GO:0003143~embryonic heart tube morphogenesis,GO:0003220~left ventricular cardiac muscle tissue morphogenesis,GO:0003300~cardiac muscle hypertrophy,GO:0005513~detection of calcium ion,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0010460~positive regulation of heart rate,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0014850~response to muscle activity,GO:0019722~calcium-mediated signaling,GO:0030509~BMP signaling pathway,GO:0031000~response to caffeine,GO:0034220~ion transmembrane transport,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0035994~response to muscle stretch,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051284~positive regulation of sequestering of calcium ion,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051775~response to redox state,GO:0055117~regulation of cardiac muscle contraction,GO:0060048~cardiac muscle contraction,GO:0060070~canonical Wnt signaling pathway,GO:0060402~calcium ion transport into cytosol,GO:0070296~sarcoplasmic reticulum calcium ion transport,GO:0071313~cellular response to caffeine,GO:0071872~cellular response to epinephrine stimulus,GO:0072599~establishment of protein localization to endoplasmic reticulum,GO:0086005~ventricular cardiac muscle cell action potential,GO:0086029~Purkinje myocyte to ventricular cardiac muscle cell signaling,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:0097050~type B pancreatic cell apoptotic process,GO:0098735~positive regulation of the force of heart contraction,GO:0098904~regulation of AV node cell action potential,GO:0098907~regulation of SA node cell action potential,GO:0098910~regulation of atrial cardiac muscle cell action potential,GO:0098911~regulation of ventricular cardiac muscle cell action potential,GO:1901896~positive regulation of calcium-transporting ATPase activity,GO:1903779~regulation of cardiac conduction,	GO:0005623~cell,GO:0005790~smooth endoplasmic reticulum,GO:0005886~plasma membrane,GO:0014701~junctional sarcoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016529~sarcoplasmic reticulum,GO:0030018~Z disc,GO:0033017~sarcoplasmic reticulum membrane,GO:0034704~calcium channel complex,GO:0042383~sarcolemma,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005219~ryanodine-sensitive calcium-release channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0015278~calcium-release channel activity,GO:0019899~enzyme binding,GO:0034236~protein kinase A catalytic subunit binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0042802~identical protein binding,GO:0043621~protein self-association,GO:0043924~suramin binding,GO:0044325~ion channel binding,GO:0048763~calcium-induced calcium release activity,	IPR000699:Intracellular calcium-release channel,IPR001870:B30.2/SPRY domain,IPR002048:EF-hand domain,IPR003032:Ryanodine receptor Ryr,IPR003877:SPla/RYanodine receptor SPRY,IPR005821:Ion transport domain,IPR009460:Ryanodine Receptor TM 4-6,IPR011992:EF-hand-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013333:Ryanodine receptor,IPR013662:RyR/IP3R Homology associated domain,IPR014821:Inositol 1,4,5-trisphosphate/ryanodine receptor,IPR015925:Ryanodine receptor-related,IPR016093:MIR motif,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04713:Circadian entrainment,hsa04911:Insulin secretion,hsa04921:Oxytocin signaling pathway,hsa04972:Pancreatic secretion,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	600996~Arrhythmogenic right ventricular dysplasia 2,604772~Ventricular tachycardia, catecholaminergic polymorphic, 1,		SM00449:SPRY,SM00472:MIR,	3D-structure,Alternative splicing,Calcium,Calcium channel,Calcium transport,Calmodulin-binding,Cardiomyopathy,Coiled coil,Complete proteome,Developmental protein,Disease mutation,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Sarcoplasmic reticulum,Transmembrane,Transmembrane helix,Transport,	chain:Ryanodine receptor 2,compositionally biased region:Glu-rich (acidic),domain:B30.2/SPRY 1,domain:B30.2/SPRY 2,domain:B30.2/SPRY 3,domain:EF-hand 1,domain:EF-hand 2,domain:MIR 1,domain:MIR 2,domain:MIR 3,domain:MIR 4,domain:MIR 5,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:4 X approximate repeats,region of interest:Calmodulin-binding,region of interest:Modulator,repeat:1,repeat:2,repeat:3,repeat:4,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,transmembrane region,
SCCPDH	saccharopine dehydrogenase (putative)(SCCPDH)	Homo sapiens				GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005811~lipid particle,GO:0016020~membrane,GO:0030496~midbody,	GO:0016491~oxidoreductase activity,	IPR005097:Saccharopine dehydrogenase / Homospermidine synthase,IPR016040:NAD(P)-binding domain,					Acetylation,Complete proteome,Direct protein sequencing,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,	chain:Probable saccharopine dehydrogenase,modified residue,sequence conflict,sequence variant,
SLMAP	sarcolemma associated protein(SLMAP)	Homo sapiens				GO:0006936~muscle contraction,GO:0072659~protein localization to plasma membrane,GO:1900825~regulation of membrane depolarization during cardiac muscle cell action potential,GO:1902305~regulation of sodium ion transmembrane transport,GO:1905150~regulation of voltage-gated sodium channel activity,	GO:0005790~smooth endoplasmic reticulum,GO:0005815~microtubule organizing center,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0042383~sarcolemma,	GO:0005515~protein binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,				SM00240:FHA,	Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Sarcolemmal membrane-associated protein,domain:FHA,modified residue,region of interest:Necessary for targeting to centrosomes,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLFNL1	schlafen like 1(SLFNL1)	Homo sapiens						GO:0005524~ATP binding,	IPR007421:ATPase, AAA-4,					Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Schlafen-like protein 1,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
SCRN3	secernin 3(SCRN3)	Homo sapiens				GO:0006508~proteolysis,GO:0006887~exocytosis,		GO:0016805~dipeptidase activity,	IPR005322:Peptidase C69, dipeptidase A,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Secernin-3,sequence variant,
SPP2	secreted phosphoprotein 2(SPP2)	Homo sapiens				GO:0001501~skeletal system development,GO:0002576~platelet degranulation,GO:0010951~negative regulation of endopeptidase activity,GO:0046849~bone remodeling,	GO:0005576~extracellular region,GO:0031089~platelet dense granule lumen,GO:0070062~extracellular exosome,	GO:0004866~endopeptidase inhibitor activity,	IPR010892:Secreted phosphoprotein 24,					Complete proteome,Disulfide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Secreted phosphoprotein 24,disulfide bond,modified residue,sequence conflict,sequence variant,signal peptide,
SCTR	secretin receptor(SCTR)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007586~digestion,GO:0007588~excretion,	GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0015055~secretin receptor activity,	IPR000832:GPCR, family 2, secretin-like,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR002144:GPCR, family 2, secretin receptor,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,			SM00008:HormR,	Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Secretin receptor,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SCAMP3	secretory carrier membrane protein 3(SCAMP3)	Homo sapiens				GO:0006892~post-Golgi vesicle-mediated transport,GO:0015031~protein transport,GO:0032526~response to retinoic acid,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0031625~ubiquitin protein ligase binding,	IPR007273:SCAMP,					Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Secretory carrier-associated membrane protein 3,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,transmembrane region,
SZT2	seizure threshold 2 homolog (mouse)(SZT2)	Homo sapiens				GO:0007417~central nervous system development,GO:0009791~post-embryonic development,GO:0021540~corpus callosum morphogenesis,GO:0043473~pigmentation,GO:1901668~regulation of superoxide dismutase activity,	GO:0005777~peroxisome,GO:0070062~extracellular exosome,				615476~Epileptic encephalopathy, early infantile, 18,			Alternative splicing,Complete proteome,Epilepsy,Peroxisome,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein C1orf84,chain:Uncharacterized protein KIAA0467,compositionally biased region:His-rich,sequence conflict,splice variant,
SELP	selectin P(SELP)	Homo sapiens		h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_monocytePathway:Monocyte and its Surface Molecules,		GO:0002576~platelet degranulation,GO:0002687~positive regulation of leukocyte migration,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007159~leukocyte cell-cell adhesion,GO:0010572~positive regulation of platelet activation,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0032496~response to lipopolysaccharide,GO:0033623~regulation of integrin activation,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0050829~defense response to Gram-negative bacterium,GO:0050900~leukocyte migration,GO:0050901~leukocyte tethering or rolling,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031088~platelet dense granule membrane,GO:0031092~platelet alpha granule membrane,	GO:0001530~lipopolysaccharide binding,GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0033691~sialic acid binding,GO:0042806~fucose binding,GO:0043208~glycosphingolipid binding,GO:0048306~calcium-dependent protein binding,GO:0070492~oligosaccharide binding,	IPR000436:Sushi/SCR/CCP,IPR000742:Epidermal growth factor-like domain,IPR001304:C-type lectin,IPR002396:Selectin superfamily,IPR013032:EGF-like, conserved site,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04514:Cell adhesion molecules (CAMs),hsa05144:Malaria,hsa05150:Staphylococcus aureus infection,	147050~Atopy, susceptibility to,		SM00032:CCP,SM00034:CLECT,	3D-structure,Cell adhesion,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Lectin,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Sushi,Transmembrane,Transmembrane helix,	chain:P-selectin,disulfide bond,domain:C-type lectin,domain:EGF-like,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine; alternate,lipid moiety-binding region:S-stearoyl cysteine; alternate,region of interest:Interaction with SNX17,sequence variant,short sequence motif:Endocytosis signal,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
SELENBP1	selenium binding protein 1(SELENBP1)	Homo sapiens				GO:0015031~protein transport,	GO:0005615~extracellular space,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008430~selenium binding,	IPR008826:Selenium-binding protein,IPR015943:WD40/YVTN repeat-like-containing domain,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Nucleus,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Selenium,Transport,	chain:Selenium-binding protein 1,modified residue,sequence conflict,splice variant,
SCLY	selenocysteine lyase(SCLY)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0001887~selenium compound metabolic process,GO:0006520~cellular amino acid metabolic process,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0009000~selenocysteine lyase activity,GO:0016740~transferase activity,GO:0016829~lyase activity,	IPR000192:Aminotransferase, class V/Cysteine desulfurase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR016454:Cysteine desulfurase, NifS,	hsa00450:Selenocompound metabolism,hsa01100:Metabolic pathways,		PIRSF005572:cysteine desulfurase, NifS type,		3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Lyase,Phosphoprotein,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,	active site:Cysteine persulfide intermediate,chain:Selenocysteine lyase,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
SELENOF	selenoprotein F(SELENOF)	Homo sapiens				GO:0051084~'de novo' posttranslational protein folding,	GO:0005788~endoplasmic reticulum lumen,GO:0070062~extracellular exosome,	GO:0008430~selenium binding,	IPR012336:Thioredoxin-like fold,IPR014912:Sep15/SelM redox,					Alternative splicing,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Reference proteome,Selenocysteine,Signal,	chain:15 kDa selenoprotein,signal peptide,splice variant,
SELENOK	selenoprotein K(SELENOK)	Homo sapiens				GO:0002376~immune system process,GO:0006816~calcium ion transport,GO:0006979~response to oxidative stress,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0042802~identical protein binding,	IPR024491:Selenoprotein SelK/SelG,					Calcium,Calcium transport,Cell membrane,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Ion transport,Membrane,Polymorphism,Reference proteome,Selenocysteine,Transmembrane,Transmembrane helix,Transport,	chain:Selenoprotein K,sequence variant,
SELENON	selenoprotein N(SELENON)	Homo sapiens				GO:0003016~respiratory system process,GO:0007005~mitochondrion organization,GO:0014816~skeletal muscle satellite cell differentiation,GO:0014834~skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,GO:0014858~positive regulation of skeletal muscle cell proliferation,GO:0014873~response to muscle activity involved in regulation of muscle adaptation,GO:0033555~multicellular organismal response to stress,GO:0034599~cellular response to oxidative stress,GO:0048286~lung alveolus development,GO:0048741~skeletal muscle fiber development,GO:0055074~calcium ion homeostasis,GO:0055114~oxidation-reduction process,GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity,GO:0071313~cellular response to caffeine,GO:1902884~positive regulation of response to oxidative stress,	GO:0005789~endoplasmic reticulum membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,	IPR002048:EF-hand domain,		255310~Myopathy, congenital, with fiber-type disproportion,602771~Muscular dystrophy, rigid spine, 1,			Alternative splicing,Complete proteome,Desmin-related myopathy,Disease mutation,Endoplasmic reticulum,Glycoprotein,Membrane,Myofibrillar myopathy,Oxidoreductase,Reference proteome,Selenocysteine,Signal,	chain:Selenoprotein N,compositionally biased region:Ala-rich,domain:EF-hand,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
SEMA3F	semaphorin 3F(SEMA3F)	Homo sapiens				GO:0001755~neural crest cell migration,GO:0007411~axon guidance,GO:0021612~facial nerve structural organization,GO:0021637~trigeminal nerve structural organization,GO:0021675~nerve development,GO:0021785~branchiomotor neuron axon guidance,GO:0030335~positive regulation of cell migration,GO:0036486~ventral trunk neural crest cell migration,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0048846~axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0061549~sympathetic ganglion development,GO:0071526~semaphorin-plexin signaling pathway,GO:0097490~sympathetic neuron projection extension,GO:0097491~sympathetic neuron projection guidance,GO:1901166~neural crest cell migration involved in autonomic nervous system development,GO:1902285~semaphorin-plexin signaling pathway involved in neuron projection guidance,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,	GO:0005615~extracellular space,	GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semaphorin/CD100 antigen,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR027231:Semaphorin,	hsa04360:Axon guidance,			SM00408:IGc2,SM00409:IG,SM00423:PSI,SM00630:Sema,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Semaphorin-3F,compositionally biased region:Arg/Lys-rich (basic),disulfide bond,domain:Ig-like C2-type,domain:Sema,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
SEMA4A	semaphorin 4A(SEMA4A)	Homo sapiens				GO:0001525~angiogenesis,GO:0001755~neural crest cell migration,GO:0007409~axonogenesis,GO:0008360~regulation of cell shape,GO:0010594~regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0030335~positive regulation of cell migration,GO:0045063~T-helper 1 cell differentiation,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR027231:Semaphorin,	hsa04360:Axon guidance,	610282~Retinitis pigmentosa 35,610283~Cone-rod dystrophy 10,		SM00423:PSI,SM00630:Sema,	Adaptive immunity,Alternative splicing,Angiogenesis,Cell membrane,Complete proteome,Cone-rod dystrophy,Developmental protein,Differentiation,Disease mutation,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Neurogenesis,Polymorphism,Proteomics identification,Reference proteome,Retinitis pigmentosa,Signal,Transmembrane,Transmembrane helix,	chain:Semaphorin-4A,disulfide bond,domain:Ig-like C2-type,domain:PSI,domain:Sema,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SEMA4C	semaphorin 4C(SEMA4C)	Homo sapiens				GO:0001755~neural crest cell migration,GO:0001843~neural tube closure,GO:0021535~cell migration in hindbrain,GO:0021549~cerebellum development,GO:0030335~positive regulation of cell migration,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0042692~muscle cell differentiation,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005615~extracellular space,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0045211~postsynaptic membrane,	GO:0005515~protein binding,GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR027231:Semaphorin,	hsa04360:Axon guidance,			SM00409:IG,SM00423:PSI,SM00630:Sema,	Cell junction,Cell membrane,Complete proteome,Cytoplasmic vesicle,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Semaphorin-4C,compositionally biased region:Pro-rich,disulfide bond,domain:Ig-like C2-type,domain:PSI,domain:Sema,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SNTN	sentan, cilia apical structure protein(SNTN)	Homo sapiens					GO:0005929~cilium,		IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR026790:Sentan,				SM01394:SM01394,	Cell projection,Cilium,Complete proteome,Reference proteome,	chain:Sentan,
SEPT10	septin 10(SEPT10)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0007049~cell cycle,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0005515~protein binding,GO:0005525~GTP binding,	IPR016491:Septin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF006698:septin,		Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	binding site:GTP,binding site:GTP; via amide nitrogen and carbonyl oxygen,chain:Septin-10,modified residue,nucleotide phosphate-binding region:GTP,sequence variant,splice variant,
SEPT2	septin 2(SEPT2)	Homo sapiens				GO:0002036~regulation of L-glutamate transport,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007224~smoothened signaling pathway,GO:0031175~neuron projection development,GO:0032880~regulation of protein localization,GO:0042384~cilium assembly,GO:0050790~regulation of catalytic activity,GO:0051301~cell division,GO:0060271~cilium morphogenesis,GO:0098609~cell-cell adhesion,	GO:0000145~exocyst,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005913~cell-cell adherens junction,GO:0005930~axoneme,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0030496~midbody,GO:0031105~septin complex,GO:0031513~nonmotile primary cilium,GO:0032154~cleavage furrow,GO:0032391~photoreceptor connecting cilium,GO:0035869~ciliary transition zone,GO:0043209~myelin sheath,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0060170~ciliary membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005525~GTP binding,GO:0030234~enzyme regulator activity,GO:0032947~protein complex scaffold,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR008113:Septin 2,IPR016491:Septin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05100:Bacterial invasion of epithelial cells,		PIRSF006698:septin,		3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Cell membrane,Cell projection,Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,GTP-binding,Kinetochore,Membrane,Mitosis,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,	binding site:GTP,binding site:GTP; via amide nitrogen and carbonyl oxygen,chain:Septin-2,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,region of interest:Important for dimerization,sequence conflict,site:Important for dimerization,splice variant,strand,turn,
LOC100287497	septin 7 pseudogene(LOC100287497)	Homo sapiens													chain:Transmembrane protein FLJ23183,transmembrane region,
SRRM1	serine and arginine repetitive matrix 1(SRRM1)	Homo sapiens				GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0031124~mRNA 3'-end processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0071013~catalytic step 2 spliceosome,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR002483:PWI domain,	hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,			SM00311:PWI,	3D-structure,Acetylation,Alternative splicing,Citrullination,Coiled coil,Complete proteome,Direct protein sequencing,DNA-binding,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Ubl conjugation,	chain:Serine/arginine repetitive matrix protein 1,compositionally biased region:Ala-rich,compositionally biased region:Arg-rich,compositionally biased region:Lys-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:PWI,helix,modified residue,mutagenesis site,region of interest:Necessary for DNA and RNA-binding,region of interest:Necessary for mRNA 3'-end cleavage and cytoplasmic accumulation,region of interest:Necessary for speckles and matrix localization,sequence conflict,sequence variant,splice variant,strand,turn,
SRSF10	serine and arginine rich splicing factor 10(SRSF10)	Homo sapiens				GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006355~regulation of transcription, DNA-templated,GO:0006376~mRNA splice site selection,GO:0006406~mRNA export from nucleus,GO:0016482~cytosolic transport,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043679~axon terminus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0050733~RS domain binding,GO:0051082~unfolded protein binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03040:Spliceosome,			SM00360:RRM,	Alternative splicing,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Splicing factor, arginine/serine-rich 13A,compositionally biased region:Arg/Ser-rich (RS domain),domain:RRM,modified residue,splice variant,
SRSF11	serine and arginine rich splicing factor 11(SRSF11)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0031124~mRNA 3'-end processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Splicing factor, arginine/serine-rich 11,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,domain:RRM,modified residue,region of interest:10 X 8 AA approximate repeats of R-R-S-R- S-R-S-R,repeat:1,repeat:10,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,
SRSF4	serine and arginine rich splicing factor 4(SRSF4)	Homo sapiens				GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0031124~mRNA 3'-end processing,GO:0032868~response to insulin,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:1990825~sequence-specific mRNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03040:Spliceosome,hsa05168:Herpes simplex infection,			SM00360:RRM,	Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,	chain:Splicing factor, arginine/serine-rich 4,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Gly-rich (hinge region),domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,sequence variant,
SERINC2	serine incorporator 2(SERINC2)	Homo sapiens				GO:0006658~phosphatidylserine metabolic process,GO:0006665~sphingolipid metabolic process,GO:0015825~L-serine transport,GO:1904219~positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,GO:1904222~positive regulation of serine C-palmitoyltransferase activity,	GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0015194~L-serine transmembrane transporter activity,	IPR005016:TMS membrane protein/tumour differentially expressed protein,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Serine incorporator 2,sequence conflict,sequence variant,transmembrane region,
SPINK8	serine peptidase inhibitor, Kazal type 8 (putative)(SPINK8)	Homo sapiens				GO:0060046~regulation of acrosome reaction,GO:1900004~negative regulation of serine-type endopeptidase activity,	GO:0001669~acrosomal vesicle,GO:0005615~extracellular space,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002350:Kazal domain,				SM00280:KAZAL,	Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Protease inhibitor,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Serine protease inhibitor Kazal-type 8,disulfide bond,domain:Kazal-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,site:Reactive bond,
STK11IP	serine/threonine kinase 11 interacting protein(STK11IP)	Homo sapiens			Function unknown,	GO:0008104~protein localization,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0019901~protein kinase binding,	IPR001611:Leucine-rich repeat,					Alternative splicing,Complete proteome,Cytoplasm,Leucine-rich repeat,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Serine/threonine kinase 11-interacting protein,compositionally biased region:Glu-rich,modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence conflict,sequence variant,splice variant,
STK17B	serine/threonine kinase 17b(STK17B)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0035556~intracellular signal transduction,GO:0046777~protein autophosphorylation,GO:2000271~positive regulation of fibroblast apoptotic process,	GO:0005634~nucleus,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase 17B,compositionally biased region:Poly-Ser,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,
STK36	serine/threonine kinase 36(STK36)	Homo sapiens				GO:0003351~epithelial cilium movement,GO:0006468~protein phosphorylation,GO:0007228~positive regulation of hh target transcription factor activity,GO:0007420~brain development,GO:0009791~post-embryonic development,GO:0042384~cilium assembly,GO:0045880~positive regulation of smoothened signaling pathway,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0060271~cilium morphogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Developmental protein,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase 36,domain:Protein kinase,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
STK39	serine/threonine kinase 39(STK39)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006468~protein phosphorylation,GO:0006950~response to stress,GO:0008217~regulation of blood pressure,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0023016~signal transduction by trans-phosphorylation,GO:0032414~positive regulation of ion transmembrane transporter activity,GO:0035556~intracellular signal transduction,GO:0036438~maintenance of lens transparency,GO:0043268~positive regulation of potassium ion transport,GO:0046777~protein autophosphorylation,GO:0050727~regulation of inflammatory response,GO:0071476~cellular hypotonic response,GO:0090188~negative regulation of pancreatic juice secretion,GO:1901017~negative regulation of potassium ion transmembrane transporter activity,GO:1901380~negative regulation of potassium ion transmembrane transport,GO:2000021~regulation of ion homeostasis,GO:2000650~negative regulation of sodium ion transmembrane transporter activity,GO:2000681~negative regulation of rubidium ion transport,GO:2000687~negative regulation of rubidium ion transmembrane transporter activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0019898~extrinsic component of membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR024678:Serine/threonine-protein kinase OSR1/WNK, CCT domain,				SM00220:S_TKc,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:STE20/SPS1-related proline-alanine-rich protein kinase,compositionally biased region:Ala/Pro-rich,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:Caspase cleavage related site,short sequence motif:Nuclear localization signal,
STK40	serine/threonine kinase 40(STK40)	Homo sapiens				GO:0003016~respiratory system process,GO:0005977~glycogen metabolic process,GO:0006468~protein phosphorylation,GO:0010468~regulation of gene expression,GO:0035264~multicellular organism growth,GO:0043066~negative regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048286~lung alveolus development,GO:0060425~lung morphogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR024104:Pseudokinase tribbles family/serine-threonine-protein kinase 40,IPR024236:Serine/threonine-protein kinase 40,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase 40,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
SDCCAG8	serologically defined colon cancer antigen 8(SDCCAG8)	Homo sapiens			Cell division and chromosome partitioning,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0001764~neuron migration,GO:0030010~establishment of cell polarity,GO:0035148~tube formation,GO:0051297~centrosome organization,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0034451~centriolar satellite,	GO:0005515~protein binding,			613615~Senior-Loken syndrome 7,615993~Bardet-Biedl syndrome 16,			Alternative splicing,Bardet-Biedl syndrome,Cell junction,Ciliopathy,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Leber congenital amaurosis,Nephronophthisis,Obesity,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Senior-Loken syndrome,	chain:Serologically defined colon cancer antigen 8,compositionally biased region:Gln-rich,region of interest:Sufficient for homodimerization,sequence variant,splice variant,
SERPINC1	serpin family C member 1(SERPINC1)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,		GO:0002438~acute inflammatory response to antigenic stimulus,GO:0007584~response to nutrient,GO:0007595~lactation,GO:0007596~blood coagulation,GO:0010951~negative regulation of endopeptidase activity,GO:2000266~regulation of blood coagulation, intrinsic pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0002020~protease binding,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0008201~heparin binding,	IPR000215:Serpin family,IPR015555:Antithrombin-III,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,	hsa04610:Complement and coagulation cascades,	613118~Thrombophilia due to antithrombin III deficiency,		SM00093:SERPIN,	3D-structure,Blood coagulation,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemostasis,Heparin-binding,Phosphoprotein,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,Thrombophilia,	binding site:Heparin,chain:Antithrombin-III,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,site:Reactive bond,strand,turn,
SERPINE2	serpin family E member 2(SERPINE2)	Homo sapiens				GO:0007596~blood coagulation,GO:0008285~negative regulation of cell proliferation,GO:0010757~negative regulation of plasminogen activation,GO:0010766~negative regulation of sodium ion transport,GO:0010951~negative regulation of endopeptidase activity,GO:0010955~negative regulation of protein processing,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0021683~cerebellar granular layer morphogenesis,GO:0030195~negative regulation of blood coagulation,GO:0030308~negative regulation of cell growth,GO:0030334~regulation of cell migration,GO:0032940~secretion by cell,GO:0033363~secretory granule organization,GO:0042177~negative regulation of protein catabolic process,GO:0042628~mating plug formation,GO:0045861~negative regulation of proteolysis,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048505~regulation of timing of cell differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0060291~long-term synaptic potentiation,GO:0060384~innervation,GO:0061108~seminal vesicle epithelium development,GO:0090331~negative regulation of platelet aggregation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0031012~extracellular matrix,GO:0031091~platelet alpha granule,GO:0031232~extrinsic component of external side of plasma membrane,GO:0031594~neuromuscular junction,GO:1903561~extracellular vesicle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,	IPR000215:Serpin family,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,				SM00093:SERPIN,	3D-structure,Alternative splicing,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Glycoprotein,Heparin-binding,Neurogenesis,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:Glia-derived nexin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,site:Reactive bond,splice variant,
SARS	seryl-tRNA synthetase(SARS)	Homo sapiens				GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006434~seryl-tRNA aminoacylation,GO:0008033~tRNA processing,GO:0016259~selenocysteine metabolic process,GO:0097056~selenocysteinyl-tRNA(Sec) biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0004828~serine-tRNA ligase activity,GO:0005524~ATP binding,GO:0098619~selenocysteine-tRNA ligase activity,	IPR002314:Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain,IPR002317:Serine-tRNA ligase, type1,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR010978:tRNA-binding arm,IPR015866:Serine-tRNA synthetase, type1, N-terminal,	hsa00970:Aminoacyl-tRNA biosynthesis,				3D-structure,Acetylation,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Ligase,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,	binding site:ATP; via carbonyl oxygen and amide nitrogen,binding site:Serine,chain:Seryl-tRNA synthetase, cytoplasmic,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Serine binding,sequence conflict,
SESN2	sestrin 2(SESN2)	Homo sapiens				GO:0001932~regulation of protein phosphorylation,GO:0006635~fatty acid beta-oxidation,GO:0006914~autophagy,GO:0009749~response to glucose,GO:0016239~positive regulation of macroautophagy,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0032042~mitochondrial DNA metabolic process,GO:0032868~response to insulin,GO:0034599~cellular response to oxidative stress,GO:0036091~positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0043491~protein kinase B signaling,GO:0046323~glucose import,GO:0070328~triglyceride homeostasis,GO:0071230~cellular response to amino acid stimulus,GO:0071233~cellular response to leucine,GO:0072593~reactive oxygen species metabolic process,GO:0090526~regulation of gluconeogenesis involved in cellular glucose homeostasis,GO:0098869~cellular oxidant detoxification,GO:1900182~positive regulation of protein localization to nucleus,GO:1901031~regulation of response to reactive oxygen species,GO:1902010~negative regulation of translation in response to endoplasmic reticulum stress,GO:1904262~negative regulation of TORC1 signaling,GO:2000479~regulation of cAMP-dependent protein kinase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0031588~nucleotide-activated protein kinase complex,GO:0031932~TORC2 complex,GO:0061700~GATOR2 complex,GO:1990316~ATG1/ULK1 kinase complex,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005515~protein binding,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0032542~sulfiredoxin activity,GO:0070728~leucine binding,	IPR006730:PA26 p53-induced protein (sestrin),	hsa04115:p53 signaling pathway,				3D-structure,Acetylation,Complete proteome,Cytoplasm,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,	chain:Sestrin-2,sequence variant,
SCMH1	sex comb on midleg homolog 1 (Drosophila)(SCMH1)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0009653~anatomical structure morphogenesis,GO:0009952~anterior/posterior pattern specification,GO:0016458~gene silencing,GO:0016925~protein sumoylation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0010369~chromocenter,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR001660:Sterile alpha motif domain,IPR004092:Mbt repeat,IPR013761:Sterile alpha motif/pointed domain,IPR021987:Protein of unknown function DUF3588,				SM00454:SAM,SM00561:MBT,	3D-structure,Alternative splicing,Complete proteome,Developmental protein,Nucleus,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:Polycomb protein SCMH1,domain:SAM,helix,modified residue,repeat:MBT 1,repeat:MBT 2,sequence conflict,splice variant,strand,turn,
SHISA5	shisa family member 5(SHISA5)	Homo sapiens				GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0050699~WW domain binding,	IPR026910:Shisa family,	hsa04115:p53 signaling pathway,				Alternative splicing,Apoptosis,Complete proteome,Endoplasmic reticulum,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein shisa-5,compositionally biased region:Poly-Thr,compositionally biased region:Pro-rich,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SGO2	shugoshin 2(SGO2)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0051301~cell division,GO:0051754~meiotic sister chromatid cohesion, centromeric,	GO:0000775~chromosome, centromeric region,GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0030892~mitotic cohesin complex,	GO:0005515~protein binding,	IPR026706:Shugoshin-like 2,					Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Kinetochore,Meiosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Shugoshin-like 2,modified residue,sequence conflict,sequence variant,splice variant,
SFXN5	sideroflexin 5(SFXN5)	Homo sapiens				GO:0015746~citrate transport,GO:0034220~ion transmembrane transport,GO:0055072~iron ion homeostasis,	GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0015075~ion transmembrane transporter activity,GO:0015137~citrate transmembrane transporter activity,	IPR004686:Tricarboxylate/iron carrier,					Complete proteome,Ion transport,Iron,Iron transport,Membrane,Mitochondrion,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Sideroflexin-5,transmembrane region,
SIPA1L2	signal induced proliferation associated 1 like 2(SIPA1L2)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,		GO:0005096~GTPase activator activity,	IPR000331:Rap GTPase activating proteins domain,IPR001478:PDZ domain,IPR021818:Protein of unknown function DUF3401,	hsa04015:Rap1 signaling pathway,			SM00228:PDZ,	Alternative splicing,Coiled coil,Complete proteome,GTPase activation,Phosphoprotein,Polymorphism,Reference proteome,	chain:Signal-induced proliferation-associated 1-like protein 2,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:PDZ,domain:Rap-GAP,modified residue,sequence conflict,sequence variant,splice variant,
SPCS1	signal peptidase complex subunit 1(SPCS1)	Homo sapiens				GO:0006465~signal peptide processing,GO:0006508~proteolysis,GO:0045047~protein targeting to ER,	GO:0005787~signal peptidase complex,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0031090~organelle membrane,	GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0043022~ribosome binding,	IPR009542:Microsomal signal peptidase 12kDa subunit,	hsa03060:Protein export,				Complete proteome,Endoplasmic reticulum,Hydrolase,Membrane,Microsome,Protease,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Signal peptidase complex subunit 1,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
SRP9	signal recognition particle 9(SRP9)	Homo sapiens				GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0006616~SRP-dependent cotranslational protein targeting to membrane, translocation,GO:0045900~negative regulation of translational elongation,	GO:0005785~signal recognition particle receptor complex,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0005829~cytosol,GO:0048500~signal recognition particle,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0005047~signal recognition particle binding,GO:0005515~protein binding,GO:0008312~7S RNA binding,	IPR008832:Signal recognition particle, SRP9 subunit,IPR009018:Signal recognition particle, SRP9/SRP14 subunit,	hsa03060:Protein export,		PIRSF017029:signal recognition particle, 9 kDa protein,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Signal recognition particle,	chain:Signal recognition particle 9 kDa protein,helix,modified residue,site:Not acetylated,strand,turn,
SSR2	signal sequence receptor subunit 2(SSR2)	Homo sapiens				GO:0006613~cotranslational protein targeting to membrane,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,		IPR008856:Translocon-associated protein subunit beta,	hsa04141:Protein processing in endoplasmic reticulum,		PIRSF016400:translocon-associated protein, beta subunit,		Complete proteome,Endoplasmic reticulum,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Translocon-associated protein subunit beta,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
STAT1	signal transducer and activator of transcription 1(STAT1)	Homo sapiens	11.IL-6_gp130-Jak-STAT,12.IL-6_type_cytok-signal-transduct,17.Activators-CAM,2.Cytokine_Receptors,48.mice_minus_JAKs_and_STATs,75.Stats_activators_of_Apoptosis,	h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_egfPathway:EGF Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_ifnaPathway:IFN alpha signaling pathway,h_ifngPathway:IFN gamma signaling pathway ,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,h_mapkPathway:MAPKinase Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001937~negative regulation of endothelial cell proliferation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0003340~negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0007259~JAK-STAT cascade,GO:0007584~response to nutrient,GO:0008015~blood circulation,GO:0009612~response to mechanical stimulus,GO:0010742~macrophage derived foam cell differentiation,GO:0016525~negative regulation of angiogenesis,GO:0032869~cellular response to insulin stimulus,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034097~response to cytokine,GO:0035456~response to interferon-beta,GO:0035458~cellular response to interferon-beta,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042981~regulation of apoptotic process,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043434~response to peptide hormone,GO:0043542~endothelial cell migration,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046725~negative regulation by virus of viral protein levels in host cell,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051591~response to cAMP,GO:0051607~defense response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060338~regulation of type I interferon-mediated signaling pathway,GO:0061326~renal tubule development,GO:0071407~cellular response to organic cyclic compound,GO:0072136~metanephric mesenchymal cell proliferation involved in metanephros development,GO:0072162~metanephric mesenchymal cell differentiation,GO:0072308~negative regulation of metanephric nephron tubule epithelial cell differentiation,GO:0098609~cell-cell adhesion,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0030424~axon,GO:0030425~dendrite,GO:0048471~perinuclear region of cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000983~transcription factor activity, RNA polymerase II core promoter sequence-specific,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031730~CCR5 chemokine receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0051721~protein phosphatase 2A binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000980:SH2 domain,IPR001217:STAT transcription factor, core,IPR008967:p53-like transcription factor, DNA-binding,IPR011992:EF-hand-like domain,IPR012345:STAT transcription factor, DNA-binding, subdomain,IPR013799:STAT transcription factor, protein interaction,IPR013800:STAT transcription factor, all-alpha,IPR013801:STAT transcription factor, DNA-binding,IPR015988:STAT transcription factor, coiled coil,IPR022752:Signal transducer and activation of transcription 1, TAZ2 binding domain, C-terminal,	hsa04062:Chemokine signaling pathway,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,hsa05321:Inflammatory bowel disease (IBD),	613796~Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive,614162~Immunodeficiency 31C, autosomal dominant,614892~Immunodeficiency 31A, mycobacteriosis, autosomal dominant,		SM00964:SM00964,	3D-structure,Acetylation,Activator,Alternative splicing,Antiviral defense,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA-binding,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,Transcription,Transcription regulation,Ubl conjugation,	chain:Signal transducer and activator of transcription 1-alpha/beta,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:SH2,helix,modified residue,mutagenesis site,sequence variant,splice variant,strand,turn,
STAT4	signal transducer and activator of transcription 4(STAT4)	Homo sapiens	48.mice_minus_JAKs_and_STATs,80.T_cell_Activation,	h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,		GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007259~JAK-STAT cascade,GO:0019221~cytokine-mediated signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR000980:SH2 domain,IPR001217:STAT transcription factor, core,IPR008967:p53-like transcription factor, DNA-binding,IPR011992:EF-hand-like domain,IPR012345:STAT transcription factor, DNA-binding, subdomain,IPR013799:STAT transcription factor, protein interaction,IPR013800:STAT transcription factor, all-alpha,IPR013801:STAT transcription factor, DNA-binding,IPR015155:PLAA family ubiquitin binding, PFU,IPR015988:STAT transcription factor, coiled coil,	hsa04630:Jak-STAT signaling pathway,hsa05161:Hepatitis B,hsa05321:Inflammatory bowel disease (IBD),	612253~Systemic lupus erythematosus, susceptibility to, 11,		SM00964:SM00964,	Activator,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,Systemic lupus erythematosus,Transcription,Transcription regulation,	chain:Signal transducer and activator of transcription 4,domain:SH2,modified residue,sequence conflict,sequence variant,
STAM2	signal transducing adaptor molecule 2(STAM2)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0006914~autophagy,GO:0016197~endosomal transport,GO:0036258~multivesicular body assembly,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031901~early endosome membrane,GO:0033565~ESCRT-0 complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,	IPR001452:Src homology-3 domain,IPR002014:VHS,IPR003903:Ubiquitin interacting motif,IPR008942:ENTH/VHS,	hsa04144:Endocytosis,hsa04630:Jak-STAT signaling pathway,			SM00288:VHS,SM00326:SH3,SM00726:UIM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Endosome,Membrane,Phosphoprotein,Protein transport,Reference proteome,SH3 domain,Transport,	chain:Signal transducing adapter molecule 2,domain:ITAM,domain:SH3,domain:VHS,helix,modified residue,region of interest:Interaction with HGS,region of interest:Interaction with USP8,repeat:UIM,sequence conflict,short sequence motif:PxVxL motif,splice variant,strand,turn,
SLAMF1	signaling lymphocytic activation molecule family member 1(SLAMF1)	Homo sapiens				GO:0001779~natural killer cell differentiation,GO:0001787~natural killer cell proliferation,GO:0002277~myeloid dendritic cell activation involved in immune response,GO:0002725~negative regulation of T cell cytokine production,GO:0006909~phagocytosis,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0031338~regulation of vesicle fusion,GO:0032695~negative regulation of interleukin-12 production,GO:0032715~negative regulation of interleukin-6 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0035744~T-helper 1 cell cytokine production,GO:0042104~positive regulation of activated T cell proliferation,GO:0045087~innate immune response,GO:0046330~positive regulation of JNK cascade,GO:0046649~lymphocyte activation,GO:0046718~viral entry into host cell,GO:0050790~regulation of catalytic activity,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1902714~negative regulation of interferon-gamma secretion,GO:1902715~positive regulation of interferon-gamma secretion,GO:2000349~negative regulation of CD40 signaling pathway,	GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0045335~phagocytic vesicle,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0003823~antigen binding,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,	IPR007110:Immunoglobulin-like domain,IPR010407:Signaling lymphocytic activation molecule, N-terminal,	hsa05162:Measles,				3D-structure,Adaptive immunity,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Phagocytosis,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Signaling lymphocytic activation molecule,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,short sequence motif:SH2-binding,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SSBP3	single stranded DNA binding protein 3(SSBP3)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0008284~positive regulation of cell proliferation,GO:0021501~prechordal plate formation,GO:0021547~midbrain-hindbrain boundary initiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060322~head development,GO:0060323~head morphogenesis,GO:2000744~positive regulation of anterior head development,	GO:0005634~nucleus,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,	IPR006594:LisH dimerisation motif,IPR008116:Sequence-specific single-strand DNA-binding protein,				SM00667:LisH,	Acetylation,Alternative splicing,Complete proteome,DNA-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Single-stranded DNA-binding protein 3,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,domain:LisH,modified residue,splice variant,
SMAP2	small ArfGAP2(SMAP2)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,	hsa04144:Endocytosis,			SM00105:ArfGap,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,GTPase activation,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Stromal membrane-associated protein 2,compositionally biased region:Met-rich,domain:Arf-GAP,helix,modified residue,region of interest:Interaction with clathrin heavy chains,region of interest:Interaction with PICALM,sequence variant,splice variant,strand,turn,zinc finger region:C4-type,
SMIM1	small integral membrane protein 1 (Vel blood group)(SMIM1)	Homo sapiens					GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,				615264~Blood group, Vel system,			Blood group antigen,Complete proteome,Direct protein sequencing,Disulfide bond,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein LOC388588,modified residue,transmembrane region,
SMIM12	small integral membrane protein 12(SMIM12)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C1orf212,sequence variant,transmembrane region,
SMIM4	small integral membrane protein 4(SMIM4)	Homo sapiens					GO:0005739~mitochondrion,GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0640 protein,transmembrane region,
SNRNP40	small nuclear ribonucleoprotein U5 subunit 40(SNRNP40)	Homo sapiens				GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0008380~RNA splicing,	GO:0005654~nucleoplasm,GO:0005682~U5 snRNP,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005737~cytoplasm,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa03040:Spliceosome,			SM00320:WD40,	3D-structure,Alternative splicing,Complete proteome,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Reference proteome,Repeat,Spliceosome,Ubl conjugation,WD repeat,	chain:U5 small nuclear ribonucleoprotein 40 kDa protein,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,
SNRPE	small nuclear ribonucleoprotein polypeptide E(SNRPE)	Homo sapiens		h_smPathway:Spliceosomal Assembly,		GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0008334~histone mRNA metabolic process,GO:0042633~hair cycle,GO:0051170~nuclear import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005829~cytosol,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0070062~extracellular exosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027078:Small nuclear ribonucleoprotein E,	hsa03040:Spliceosome,	615059~Hypotrichosis 11,		SM00651:Sm,	3D-structure,Complete proteome,Cytoplasm,Disease mutation,Hypotrichosis,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:Small nuclear ribonucleoprotein E,
SNRPG	small nuclear ribonucleoprotein polypeptide G(SNRPG)	Homo sapiens		h_smPathway:Spliceosomal Assembly,		GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0008334~histone mRNA metabolic process,GO:0008380~RNA splicing,GO:0051170~nuclear import,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005829~cytosol,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034709~methylosome,GO:0034719~SMN-Sm protein complex,GO:0043186~P granule,GO:0071004~U2-type prespliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR017132:U6 snRNA-associated Sm-like protein LSm7,	hsa03040:Spliceosome,		PIRSF037188:U6 snRNA-associated Sm-like protein LSm7,	SM00651:Sm,	3D-structure,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:Small nuclear ribonucleoprotein G,
SNHG12	small nucleolar RNA host gene 12(SNHG12)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein SNHG12,
SNORA25	small nucleolar RNA, H/ACA box 25(SNORA25)	Homo sapiens													chain:TATA box-binding protein-associated factor RNA polymerase I subunit D,modified residue,sequence conflict,
SPRR1B	small proline rich protein 1B(SPRR1B)	Homo sapiens				GO:0008544~epidermis development,GO:0018149~peptide cross-linking,GO:0030216~keratinocyte differentiation,GO:0031424~keratinization,	GO:0001533~cornified envelope,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,GO:0030674~protein binding, bridging,	IPR003302:Cornifin (SPRR1),IPR026075:Small proline-rich protein/late cornified envelope protein,					Complete proteome,Cytoplasm,Direct protein sequencing,Keratinization,Polymorphism,Reference proteome,Repeat,	chain:Cornifin-B,region of interest:2 X 12 AA approximate repeats,region of interest:6 X 8 AA approximate tandem repeats,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,sequence variant,
SPRR2D	small proline rich protein 2D(SPRR2D)	Homo sapiens				GO:0008544~epidermis development,GO:0018149~peptide cross-linking,GO:0030216~keratinocyte differentiation,GO:0031424~keratinization,	GO:0001533~cornified envelope,GO:0005737~cytoplasm,	GO:0005198~structural molecule activity,	IPR026075:Small proline-rich protein/late cornified envelope protein,					Complete proteome,Cytoplasm,Keratinization,Polymorphism,Reference proteome,Repeat,	chain:Small proline-rich protein 2D,region of interest:3 X 9 AA tandem repeats of P-K-C-P-[EQ]- P-C-P-[PS],repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,
SPRR3	small proline rich protein 3(SPRR3)	Homo sapiens				GO:0008544~epidermis development,GO:0018149~peptide cross-linking,GO:0030216~keratinocyte differentiation,GO:0031424~keratinization,GO:0042060~wound healing,	GO:0001533~cornified envelope,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR026075:Small proline-rich protein/late cornified envelope protein,					Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Keratinization,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Small proline-rich protein 3,region of interest:14 X 8 AA approximate tandem repeats,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,
SUMO1	small ubiquitin-like modifier 1(SUMO1)	Homo sapiens		h_ctbp1Pathway:SUMOylation as a mechanism to modulate CtBP-dependent gene responses,h_parkinPathway:Role of Parkin in the Ubiquitin-Proteasomal Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression,h_sumoPathway:Basic Mechanisms of SUMOylation,		GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006355~regulation of transcription, DNA-templated,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0030578~PML body organization,GO:0031334~positive regulation of protein complex assembly,GO:0031647~regulation of protein stability,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032880~regulation of protein localization,GO:0034605~cellular response to heat,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045759~negative regulation of action potential,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050821~protein stabilization,GO:0060021~palate development,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0070911~global genome nucleotide-excision repair,GO:0071276~cellular response to cadmium ion,GO:0086004~regulation of cardiac muscle cell contraction,GO:0090204~protein localization to nuclear pore,GO:1901896~positive regulation of calcium-transporting ATPase activity,GO:1902260~negative regulation of delayed rectifier potassium channel activity,	GO:0000792~heterochromatin,GO:0001650~fibrillar center,GO:0001741~XY body,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016604~nuclear body,GO:0016605~PML body,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0045202~synapse,GO:0097165~nuclear stress granule,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0015459~potassium channel regulator activity,GO:0031386~protein tag,GO:0031625~ubiquitin protein ligase binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,	IPR000626:Ubiquitin,IPR022617:Small ubiquitin-related modifier, SUMO,	hsa03013:RNA transport,	613705~Orofacial cleft 10,		SM00213:UBQ,	3D-structure,Acetylation,Alternative splicing,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Host-virus interaction,Isopeptide bond,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,	chain:Small ubiquitin-related modifier 1,cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),domain:Ubiquitin-like,helix,modified residue,mutagenesis site,sequence conflict,site:Interaction with PIAS2,strand,turn,
SVBP	small vasohibin binding protein(SVBP)	Homo sapiens				GO:0009306~protein secretion,GO:0010596~negative regulation of endothelial cell migration,GO:0031397~negative regulation of protein ubiquitination,	GO:0005576~extracellular region,GO:0045177~apical part of cell,							Coiled coil,Complete proteome,Reference proteome,Secreted,	chain:Coiled-coil domain-containing protein 23,
SCNN1D	sodium channel epithelial 1 delta subunit(SCNN1D)	Homo sapiens				GO:0006814~sodium ion transport,GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0050896~response to stimulus,GO:0050909~sensory perception of taste,	GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005272~sodium channel activity,GO:0005515~protein binding,GO:0015280~ligand-gated sodium channel activity,	IPR001873:Na+ channel, amiloride-sensitive,IPR004724:Epithelial sodium channel,IPR020903:Na+ channel, amiloride-sensitive, conserved site,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Reference proteome,Sensory transduction,Sodium,Sodium channel,Sodium transport,Taste,Transmembrane,Transmembrane helix,Transport,	chain:Amiloride-sensitive sodium channel subunit delta,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SCN1A	sodium voltage-gated channel alpha subunit 1(SCN1A)	Homo sapiens				GO:0006814~sodium ion transport,GO:0007628~adult walking behavior,GO:0019227~neuronal action potential propagation,GO:0019228~neuronal action potential,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0050884~neuromuscular process controlling posture,GO:0050966~detection of mechanical stimulus involved in sensory perception of pain,GO:0060078~regulation of postsynaptic membrane potential,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0014704~intercalated disc,GO:0016021~integral component of membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0033268~node of Ranvier,GO:0043025~neuronal cell body,GO:0043194~axon initial segment,	GO:0005216~ion channel activity,GO:0005248~voltage-gated sodium channel activity,	IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR008051:Voltage gated sodium channel, alpha-1 subunit,IPR010526:Sodium ion transport-associated,IPR024583:Domain of unknown function DUF3451,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04728:Dopaminergic synapse,	604403~Epilepsy, generalized, with febrile seizures plus, type 2,604403~Febrile seizures, familial, 3A,607208~Dravet syndrome,609634~Migraine, familial hemiplegic, 3,			Alternative splicing,Autism,Autism spectrum disorder,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Epilepsy,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Sodium channel protein type 1 subunit alpha,glycosylation site:N-linked (GlcNAc...),repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,splice variant,transmembrane region,
SCN10A	sodium voltage-gated channel alpha subunit 10(SCN10A)	Homo sapiens				GO:0002027~regulation of heart rate,GO:0007600~sensory perception,GO:0019228~neuronal action potential,GO:0019233~sensory perception of pain,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042475~odontogenesis of dentin-containing tooth,GO:0055117~regulation of cardiac muscle contraction,GO:0060078~regulation of postsynaptic membrane potential,GO:0060371~regulation of atrial cardiac muscle cell membrane depolarization,GO:0086010~membrane depolarization during action potential,GO:0086016~AV node cell action potential,GO:0086043~bundle of His cell action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0070062~extracellular exosome,GO:0071439~clathrin complex,	GO:0005248~voltage-gated sodium channel activity,GO:0044325~ion channel binding,	IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR010526:Sodium ion transport-associated,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,		615551~Episodic pain syndrome, familial, 2,			Cell membrane,Complete proteome,Disease mutation,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,Voltage-gated channel,	chain:Sodium channel protein type 10 subunit alpha,domain:IQ,glycosylation site:N-linked (GlcNAc...),repeat:I,repeat:II,repeat:III,repeat:IV,sequence variant,transmembrane region,
SCN11A	sodium voltage-gated channel alpha subunit 11(SCN11A)	Homo sapiens				GO:0006814~sodium ion transport,GO:0019228~neuronal action potential,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042493~response to drug,GO:0051930~regulation of sensory perception of pain,GO:0060078~regulation of postsynaptic membrane potential,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0044299~C-fiber,GO:0070062~extracellular exosome,	GO:0005248~voltage-gated sodium channel activity,	IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR010526:Sodium ion transport-associated,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,		615548~Neuropathy, hereditary sensory and autonomic, type VII,615552~Episodic pain syndrome, familial, 3,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Glycoprotein,Ion channel,Ion transport,Membrane,Neurodegeneration,Neuropathy,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Sodium channel protein type 11 subunit alpha,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,splice variant,transmembrane region,
SCN2A	sodium voltage-gated channel alpha subunit 2(SCN2A)	Homo sapiens				GO:0006814~sodium ion transport,GO:0019228~neuronal action potential,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042552~myelination,GO:0060078~regulation of postsynaptic membrane potential,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0031226~intrinsic component of plasma membrane,GO:0033268~node of Ranvier,GO:0034706~sodium channel complex,	GO:0005216~ion channel activity,GO:0005248~voltage-gated sodium channel activity,	IPR000048:IQ motif, EF-hand binding site,IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR010526:Sodium ion transport-associated,IPR024583:Domain of unknown function DUF3451,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,		607745~Seizures, benign familial infantile, 3,613721~Epileptic encephalopathy, early infantile, 11,		SM00015:IQ,	3D-structure,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,Voltage-gated channel,	chain:Sodium channel protein type 2 subunit alpha,domain:IQ,glycosylation site:N-linked (GlcNAc...),helix,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,splice variant,strand,transmembrane region,
SCN3A	sodium voltage-gated channel alpha subunit 3(SCN3A)	Homo sapiens				GO:0006814~sodium ion transport,GO:0019228~neuronal action potential,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0060078~regulation of postsynaptic membrane potential,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005216~ion channel activity,GO:0005248~voltage-gated sodium channel activity,	IPR000048:IQ motif, EF-hand binding site,IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR010526:Sodium ion transport-associated,IPR024583:Domain of unknown function DUF3451,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,					Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,Voltage-gated channel,	chain:Sodium channel protein type 3 subunit alpha,domain:IQ,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,splice variant,transmembrane region,
SCN5A	sodium voltage-gated channel alpha subunit 5(SCN5A)	Homo sapiens				GO:0002027~regulation of heart rate,GO:0003231~cardiac ventricle development,GO:0003360~brainstem development,GO:0006814~sodium ion transport,GO:0010765~positive regulation of sodium ion transport,GO:0014894~response to denervation involved in regulation of muscle adaptation,GO:0019228~neuronal action potential,GO:0021537~telencephalon development,GO:0021549~cerebellum development,GO:0035725~sodium ion transmembrane transport,GO:0042475~odontogenesis of dentin-containing tooth,GO:0045760~positive regulation of action potential,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051899~membrane depolarization,GO:0060048~cardiac muscle contraction,GO:0060078~regulation of postsynaptic membrane potential,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0060371~regulation of atrial cardiac muscle cell membrane depolarization,GO:0060372~regulation of atrial cardiac muscle cell membrane repolarization,GO:0060373~regulation of ventricular cardiac muscle cell membrane depolarization,GO:0061337~cardiac conduction,GO:0071277~cellular response to calcium ion,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086004~regulation of cardiac muscle cell contraction,GO:0086005~ventricular cardiac muscle cell action potential,GO:0086010~membrane depolarization during action potential,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0086014~atrial cardiac muscle cell action potential,GO:0086015~SA node cell action potential,GO:0086016~AV node cell action potential,GO:0086043~bundle of His cell action potential,GO:0086045~membrane depolarization during AV node cell action potential,GO:0086046~membrane depolarization during SA node cell action potential,GO:0086047~membrane depolarization during Purkinje myocyte cell action potential,GO:0086048~membrane depolarization during bundle of His cell action potential,GO:0086067~AV node cell to bundle of His cell communication,GO:0086091~regulation of heart rate by cardiac conduction,GO:0098912~membrane depolarization during atrial cardiac muscle cell action potential,GO:1902305~regulation of sodium ion transmembrane transport,	GO:0001518~voltage-gated sodium channel complex,GO:0005622~intracellular,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0009986~cell surface,GO:0014704~intercalated disc,GO:0016021~integral component of membrane,GO:0016328~lateral plasma membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0042383~sarcolemma,	GO:0005216~ion channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0017080~sodium channel regulator activity,GO:0017134~fibroblast growth factor binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0030506~ankyrin binding,GO:0031625~ubiquitin protein ligase binding,GO:0044325~ion channel binding,GO:0050998~nitric-oxide synthase binding,GO:0086006~voltage-gated sodium channel activity involved in cardiac muscle cell action potential,GO:0086060~voltage-gated sodium channel activity involved in AV node cell action potential,GO:0086061~voltage-gated sodium channel activity involved in bundle of His cell action potential,GO:0086062~voltage-gated sodium channel activity involved in Purkinje myocyte action potential,GO:0086063~voltage-gated sodium channel activity involved in SA node cell action potential,GO:0097110~scaffold protein binding,	IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR008053:Voltage gated sodium channel, alpha-5 subunit,IPR010526:Sodium ion transport-associated,IPR024583:Domain of unknown function DUF3451,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04261:Adrenergic signaling in cardiomyocytes,	113900~Heart block, nonprogressive,113900~Heart block, progressive, type IA,272120~Sudden infant death syndrome, susceptibility to,601144~Brugada syndrome 1,601154~Cardiomyopathy, dilated, 1E,603829~Ventricular fibrillation, familial, 1,603830~Long QT syndrome-3,608567~Sick sinus syndrome 1,614022~Atrial fibrillation, familial, 10,			3D-structure,Alternative splicing,Atrial fibrillation,Brugada syndrome,Calmodulin-binding,Cardiomyopathy,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Glycoprotein,Ion channel,Ion transport,Long QT syndrome,Membrane,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,Voltage-gated channel,	chain:Sodium channel protein type 5 subunit alpha,domain:IQ,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,region of interest:Interaction with NEDD4, NEDD4L and WWP2,sequence conflict,sequence variant,splice variant,strand,transmembrane region,turn,
SCN7A	sodium voltage-gated channel alpha subunit 7(SCN7A)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006936~muscle contraction,GO:0019228~neuronal action potential,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0055078~sodium ion homeostasis,GO:0060078~regulation of postsynaptic membrane potential,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0097386~glial cell projection,	GO:0005248~voltage-gated sodium channel activity,	IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR010526:Sodium ion transport-associated,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04261:Adrenergic signaling in cardiomyocytes,				Cell membrane,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Sodium channel protein type 7 subunit alpha,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,transmembrane region,
SCN9A	sodium voltage-gated channel alpha subunit 9(SCN9A)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006954~inflammatory response,GO:0009636~response to toxic substance,GO:0009791~post-embryonic development,GO:0019228~neuronal action potential,GO:0019233~sensory perception of pain,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0048266~behavioral response to pain,GO:0060078~regulation of postsynaptic membrane potential,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005887~integral component of plasma membrane,GO:0042995~cell projection,	GO:0005248~voltage-gated sodium channel activity,GO:0031402~sodium ion binding,	IPR000048:IQ motif, EF-hand binding site,IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR010526:Sodium ion transport-associated,IPR024583:Domain of unknown function DUF3451,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,		133020~Erythermalgia, primary,133020~Small fiber neuropathy,243000~HSAN2D, autosomal recessive,243000~Insensitivity to pain, congenital,607208~Dravet syndrome, modifier of,613863~Epilepsy, generalized, with febrile seizures plus, type 7,613863~Febrile seizures, familial, 3B,Paroxysmal extreme pain disorder, 167400,~Paroxysmal extreme pain disorder, 167400,,		SM00015:IQ,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Disease mutation,Epilepsy,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,Voltage-gated channel,	chain:Sodium channel protein type 9 subunit alpha,domain:IQ,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,splice variant,transmembrane region,
SLC1A4	solute carrier family 1 member 4(SLC1A4)	Homo sapiens				GO:0006865~amino acid transport,GO:0006868~glutamine transport,GO:0015808~L-alanine transport,GO:0015811~L-cystine transport,GO:0015824~proline transport,GO:0015825~L-serine transport,GO:0015826~threonine transport,GO:0034589~hydroxyproline transport,GO:0035249~synaptic transmission, glutamatergic,GO:0035524~proline transmembrane transport,GO:0050890~cognition,GO:1902476~chloride transmembrane transport,	GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0042470~melanosome,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0005254~chloride channel activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015180~L-alanine transmembrane transporter activity,GO:0015184~L-cystine transmembrane transporter activity,GO:0015186~L-glutamine transmembrane transporter activity,GO:0015193~L-proline transmembrane transporter activity,GO:0015194~L-serine transmembrane transporter activity,GO:0015195~L-threonine transmembrane transporter activity,GO:0015293~symporter activity,GO:0034590~L-hydroxyproline transmembrane transporter activity,	IPR001991:Sodium:dicarboxylate symporter,IPR018107:Sodium:dicarboxylate symporter, conserved site,		616657~Spastic tetraplegia, thin corpus callosum, and progressive microcephaly,			Acetylation,Alternative splicing,Complete proteome,Disease mutation,Epilepsy,Glycoprotein,Membrane,Mental retardation,Phosphoprotein,Polymorphism,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Neutral amino acid transporter A,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC1A7	solute carrier family 1 member 7(SLC1A7)	Homo sapiens				GO:0006811~ion transport,GO:0006835~dicarboxylic acid transport,GO:0014047~glutamate secretion,GO:0089711~L-glutamate transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005313~L-glutamate transmembrane transporter activity,GO:0005314~high-affinity glutamate transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015293~symporter activity,	IPR001991:Sodium:dicarboxylate symporter,IPR018107:Sodium:dicarboxylate symporter, conserved site,	hsa04724:Glutamatergic synapse,				Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Excitatory amino acid transporter 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC11A1	solute carrier family 11 member 1(SLC11A1)	Homo sapiens				GO:0000060~protein import into nucleus, translocation,GO:0001818~negative regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0002309~T cell proliferation involved in immune response,GO:0002369~T cell cytokine production,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0002827~positive regulation of T-helper 1 type immune response,GO:0006826~iron ion transport,GO:0006828~manganese ion transport,GO:0006876~cellular cadmium ion homeostasis,GO:0006879~cellular iron ion homeostasis,GO:0006909~phagocytosis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007035~vacuolar acidification,GO:0009617~response to bacterium,GO:0010628~positive regulation of gene expression,GO:0015707~nitrite transport,GO:0032147~activation of protein kinase activity,GO:0032496~response to lipopolysaccharide,GO:0032623~interleukin-2 production,GO:0032632~interleukin-3 production,GO:0032729~positive regulation of interferon-gamma production,GO:0034341~response to interferon-gamma,GO:0042060~wound healing,GO:0042116~macrophage activation,GO:0042742~defense response to bacterium,GO:0042832~defense response to protozoan,GO:0043091~L-arginine import,GO:0045342~MHC class II biosynthetic process,GO:0045454~cell redox homeostasis,GO:0045730~respiratory burst,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048002~antigen processing and presentation of peptide antigen,GO:0048255~mRNA stabilization,GO:0050766~positive regulation of phagocytosis,GO:0050829~defense response to Gram-negative bacterium,GO:0055072~iron ion homeostasis,GO:0060586~multicellular organismal iron ion homeostasis,GO:0070574~cadmium ion transmembrane transport,GO:0070839~divalent metal ion export,GO:0071421~manganese ion transmembrane transport,	GO:0005764~lysosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009279~cell outer membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0031902~late endosome membrane,GO:0070821~tertiary granule membrane,	GO:0005215~transporter activity,GO:0005384~manganese ion transmembrane transporter activity,GO:0042803~protein homodimerization activity,GO:0046915~transition metal ion transmembrane transporter activity,GO:0051139~metal ion:proton antiporter activity,	IPR001046:Natural resistance-associated macrophage like,	hsa04142:Lysosome,	607948~Mycobacterium tuberculosis, susceptibility to infection by,610446~Buruli ulcer, susceptibility to,			Alternative splicing,Complete proteome,Glycoprotein,Ion transport,Iron,Iron transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Natural resistance-associated macrophage protein 1,compositionally biased region:Pro/Ser-rich,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC16A1	solute carrier family 16 member 1(SLC16A1)	Homo sapiens				GO:0006090~pyruvate metabolic process,GO:0006629~lipid metabolic process,GO:0015718~monocarboxylic acid transport,GO:0015728~mevalonate transport,GO:0032094~response to food,GO:0035879~plasma membrane lactate transport,GO:0042593~glucose homeostasis,GO:0050796~regulation of insulin secretion,GO:0050900~leukocyte migration,GO:0051297~centrosome organization,GO:0051780~behavioral response to nutrient,GO:0071407~cellular response to organic cyclic compound,	GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015129~lactate transmembrane transporter activity,GO:0015130~mevalonate transmembrane transporter activity,GO:0015293~symporter activity,GO:0042803~protein homodimerization activity,GO:0097159~organic cyclic compound binding,	IPR004743:Monocarboxylate transporter,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,		245340~Erythrocyte lactate transporter defect,610021~Hyperinsulinemic hypoglycemia, familial, 7,616095~Monocarboxylate transporter 1 deficiency,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Monocarboxylate transporter 1,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC16A14	solute carrier family 16 member 14(SLC16A14)	Homo sapiens				GO:0015718~monocarboxylic acid transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015293~symporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Membrane,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Monocarboxylate transporter 14,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC16A4	solute carrier family 16 member 4(SLC16A4)	Homo sapiens				GO:0015718~monocarboxylic acid transport,GO:0035879~plasma membrane lactate transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015129~lactate transmembrane transporter activity,GO:0015293~symporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Cell membrane,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Monocarboxylate transporter 5,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC19A2	solute carrier family 19 member 2(SLC19A2)	Homo sapiens				GO:0006810~transport,GO:0015884~folic acid transport,GO:0015888~thiamine transport,GO:0042723~thiamine-containing compound metabolic process,GO:0071934~thiamine transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0008517~folic acid transporter activity,GO:0015234~thiamine transmembrane transporter activity,GO:0015403~thiamine uptake transmembrane transporter activity,	IPR002666:Reduced folate carrier,IPR020846:Major facilitator superfamily domain,	hsa04977:Vitamin digestion and absorption,	249270~Thiamine-responsive megaloblastic anemia syndrome,	PIRSF028739:folate/thiamine transporter,PIRSF500794:thiamine transporter 1 [Parent=PIRSF028739],		Acetylation,Alternative splicing,Complete proteome,Deafness,Diabetes mellitus,Disease mutation,Glycoprotein,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Thiamine transporter 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC19A3	solute carrier family 19 member 3(SLC19A3)	Homo sapiens				GO:0006810~transport,GO:0042723~thiamine-containing compound metabolic process,GO:0071934~thiamine transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0015234~thiamine transmembrane transporter activity,GO:0015403~thiamine uptake transmembrane transporter activity,	IPR002666:Reduced folate carrier,IPR020846:Major facilitator superfamily domain,	hsa04977:Vitamin digestion and absorption,	607483~Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2),	PIRSF028739:folate/thiamine transporter,PIRSF500795:thiamine transporter 2 [Parent=PIRSF028739],		Complete proteome,Disease mutation,Glycoprotein,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Thiamine transporter 2,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC2A1	solute carrier family 2 member 1(SLC2A1)	Homo sapiens	105.Signaling_glucose_uptake,	h_vitCBPathway:Vitamin C in the Brain,		GO:0005989~lactose biosynthetic process,GO:0006461~protein complex assembly,GO:0006970~response to osmotic stress,GO:0015758~glucose transport,GO:0019852~L-ascorbic acid metabolic process,GO:0042149~cellular response to glucose starvation,GO:0042908~xenobiotic transport,GO:0050796~regulation of insulin secretion,GO:0070837~dehydroascorbic acid transport,GO:1904659~glucose transmembrane transport,	GO:0000139~Golgi membrane,GO:0001939~female pronucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030496~midbody,GO:0030864~cortical actin cytoskeleton,GO:0042470~melanosome,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005355~glucose transmembrane transporter activity,GO:0005515~protein binding,GO:0019900~kinase binding,GO:0022857~transmembrane transporter activity,GO:0022891~substrate-specific transmembrane transporter activity,GO:0033300~dehydroascorbic acid transporter activity,GO:0042802~identical protein binding,GO:0042910~xenobiotic transporter activity,GO:0043621~protein self-association,GO:0055056~D-glucose transmembrane transporter activity,	IPR002439:Glucose transporter, type 1 (GLUT1),IPR003663:Sugar/inositol transporter,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR020846:Major facilitator superfamily domain,	hsa04066:HIF-1 signaling pathway,hsa04911:Insulin secretion,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04976:Bile secretion,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05230:Central carbon metabolism in cancer,	601042~Dystonia 9,606777~GLUT1 deficiency syndrome 1, infantile onset, severe,608885~Stomatin-deficient cryohydrocytosis with neurologic defects,612126~GLUT1 deficiency syndrome 2, childhood onset,614847~Epilepsy, idiopathic generalized, susceptibility to, 12,			3D-structure,Acetylation,Cataract,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Dystonia,Epilepsy,Glycoprotein,Hereditary hemolytic anemia,Membrane,Mental retardation,Phosphoprotein,Proteomics identification,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 2, facilitated glucose transporter member 1,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Defines substrate specificity,sequence conflict,sequence variant,site:Not glycosylated,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
SLC2A5	solute carrier family 2 member 5(SLC2A5)	Homo sapiens				GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0005975~carbohydrate metabolic process,GO:0008643~carbohydrate transport,GO:0008645~hexose transport,GO:0009750~response to fructose,GO:0015755~fructose transport,GO:0015758~glucose transport,GO:0071332~cellular response to fructose stimulus,GO:1904659~glucose transmembrane transport,GO:1990539~fructose import across plasma membrane,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0042383~sarcolemma,GO:0070062~extracellular exosome,	GO:0005353~fructose transmembrane transporter activity,GO:0005355~glucose transmembrane transporter activity,GO:0022891~substrate-specific transmembrane transporter activity,GO:0070061~fructose binding,	IPR002442:Fructose transporter, type 5 (GLUT5),IPR003663:Sugar/inositol transporter,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR020846:Major facilitator superfamily domain,	hsa04973:Carbohydrate digestion and absorption,				3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 2, facilitated glucose transporter member 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC20A1	solute carrier family 20 member 1(SLC20A1)	Homo sapiens				GO:0006796~phosphate-containing compound metabolic process,GO:0006810~transport,GO:0006811~ion transport,GO:0006817~phosphate ion transport,GO:0007165~signal transduction,GO:0035435~phosphate ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044341~sodium-dependent phosphate transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0005315~inorganic phosphate transmembrane transporter activity,GO:0005316~high-affinity inorganic phosphate:sodium symporter activity,GO:0005436~sodium:phosphate symporter activity,GO:0015319~sodium:inorganic phosphate symporter activity,GO:0015321~sodium-dependent phosphate transmembrane transporter activity,	IPR001204:Phosphate transporter,					Complete proteome,Membrane,Phosphate transport,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-dependent phosphate transporter 1,modified residue,mutagenesis site,region of interest:A,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC22A14	solute carrier family 22 member 14(SLC22A14)	Homo sapiens				GO:0015695~organic cation transport,GO:0055085~transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0015101~organic cation transmembrane transporter activity,GO:0022857~transmembrane transporter activity,GO:0022891~substrate-specific transmembrane transporter activity,	IPR005828:General substrate transporter,IPR020846:Major facilitator superfamily domain,					Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Solute carrier family 22 member 14,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC22A15	solute carrier family 22 member 15(SLC22A15)	Homo sapiens				GO:0006811~ion transport,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,	GO:0022857~transmembrane transporter activity,GO:0022891~substrate-specific transmembrane transporter activity,	IPR005828:General substrate transporter,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Complete proteome,Glycoprotein,Ion transport,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 22 member 15,compositionally biased region:Poly-Glu,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,transmembrane region,
SLC23A3	solute carrier family 23 member 3(SLC23A3)	Homo sapiens				GO:0055085~transmembrane transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005215~transporter activity,	IPR006043:Xanthine/uracil/vitamin C permease,					Alternative splicing,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Solute carrier family 23 member 3,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC25A12	solute carrier family 25 member 12(SLC25A12)	Homo sapiens				GO:0006094~gluconeogenesis,GO:0006412~translation,GO:0015810~aspartate transport,GO:0015813~L-glutamate transport,GO:0043490~malate-aspartate shuttle,GO:0051592~response to calcium ion,GO:0089711~L-glutamate transmembrane transport,GO:0089712~L-aspartate transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0043209~myelin sheath,	GO:0003735~structural constituent of ribosome,GO:0005313~L-glutamate transmembrane transporter activity,GO:0005509~calcium ion binding,GO:0015172~acidic amino acid transmembrane transporter activity,GO:0015183~L-aspartate transmembrane transporter activity,	IPR002048:EF-hand domain,IPR002067:Mitochondrial carrier protein,IPR011992:EF-hand-like domain,IPR018108:Mitochondrial substrate/solute carrier,IPR018247:EF-Hand 1, calcium-binding site,IPR023395:Mitochondrial carrier domain,		612949~Hypomyelination, global cerebral,		SM00054:EFh,	3D-structure,Acetylation,Alternative splicing,Calcium,Complete proteome,Disease mutation,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Calcium-binding mitochondrial carrier protein Aralar1,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence conflict,sequence variant,transmembrane region,
SLC25A20	solute carrier family 25 member 20(SLC25A20)	Homo sapiens		h_cptPathway:Mitochondrial Carnitine Palmitoyltransferase (CPT) System,		GO:0006412~translation,GO:0006810~transport,GO:0006853~carnitine shuttle,GO:1902616~acyl carnitine transmembrane transport,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0003735~structural constituent of ribosome,GO:0015227~acyl carnitine transmembrane transporter activity,	IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,		212138~Carnitine-acylcarnitine translocase deficiency,			Acetylation,Complete proteome,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Mitochondrial carnitine/acylcarnitine carrier protein,modified residue,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Mitochondrial matrix,transmembrane region,
SLC25A24	solute carrier family 25 member 24(SLC25A24)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0006412~translation,GO:0006839~mitochondrial transport,GO:0010941~regulation of cell death,GO:0015867~ATP transport,GO:0034599~cellular response to oxidative stress,GO:0055085~transmembrane transport,GO:0071277~cellular response to calcium ion,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0003735~structural constituent of ribosome,GO:0005347~ATP transmembrane transporter activity,GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR002067:Mitochondrial carrier protein,IPR002167:Graves disease carrier protein,IPR011992:EF-hand-like domain,IPR018108:Mitochondrial substrate/solute carrier,IPR018247:EF-Hand 1, calcium-binding site,IPR023395:Mitochondrial carrier domain,				SM00054:EFh,	3D-structure,Acetylation,Alternative splicing,Calcium,Complete proteome,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Calcium-binding mitochondrial carrier protein SCaMC-1,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,modified residue,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence conflict,splice variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transmembrane region,
SLC25A26	solute carrier family 25 member 26(SLC25A26)	Homo sapiens				GO:0006412~translation,GO:0006810~transport,GO:0006811~ion transport,GO:0015805~S-adenosyl-L-methionine transport,GO:1901962~S-adenosyl-L-methionine transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0000095~S-adenosyl-L-methionine transmembrane transporter activity,GO:0003735~structural constituent of ribosome,	IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,					Alternative splicing,Complete proteome,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Transmembrane,Transmembrane helix,Transport,	chain:S-adenosylmethionine mitochondrial carrier protein,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence conflict,sequence variant,splice variant,transmembrane region,
SLC25A33	solute carrier family 25 member 33(SLC25A33)	Homo sapiens				GO:0000002~mitochondrial genome maintenance,GO:0002082~regulation of oxidative phosphorylation,GO:0006264~mitochondrial DNA replication,GO:0006390~transcription from mitochondrial promoter,GO:0006412~translation,GO:0006864~pyrimidine nucleotide transport,GO:0007005~mitochondrion organization,GO:0008284~positive regulation of cell proliferation,GO:0030307~positive regulation of cell growth,GO:0031930~mitochondria-nucleus signaling pathway,GO:0032869~cellular response to insulin stimulus,GO:0034551~mitochondrial respiratory chain complex III assembly,GO:0051881~regulation of mitochondrial membrane potential,GO:0071156~regulation of cell cycle arrest,GO:1903426~regulation of reactive oxygen species biosynthetic process,GO:1990314~cellular response to insulin-like growth factor stimulus,GO:1990519~mitochondrial pyrimidine nucleotide import,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0003735~structural constituent of ribosome,GO:0015218~pyrimidine nucleotide transmembrane transporter activity,	IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,					Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 25 member 33,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence variant,transmembrane region,
SLC25A38	solute carrier family 25 member 38(SLC25A38)	Homo sapiens				GO:0006412~translation,GO:0006783~heme biosynthetic process,GO:0006810~transport,GO:0030218~erythrocyte differentiation,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0003735~structural constituent of ribosome,GO:0005215~transporter activity,	IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,		205950~Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive,			Complete proteome,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 25 member 38,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence conflict,sequence variant,transmembrane region,
SLC26A6	solute carrier family 26 member 6(SLC26A6)	Homo sapiens				GO:0006811~ion transport,GO:0006821~chloride transport,GO:0008272~sulfate transport,GO:0015701~bicarbonate transport,GO:0015724~formate transport,GO:0015797~mannitol transport,GO:0019532~oxalate transport,GO:0030321~transepithelial chloride transport,GO:0038166~angiotensin-activated signaling pathway,GO:0042045~epithelial fluid transport,GO:0042391~regulation of membrane potential,GO:0046724~oxalic acid secretion,GO:0048240~sperm capacitation,GO:0050892~intestinal absorption,GO:0051453~regulation of intracellular pH,GO:0051454~intracellular pH elevation,GO:0070528~protein kinase C signaling,GO:0070633~transepithelial transport,GO:0071320~cellular response to cAMP,GO:0071332~cellular response to fructose stimulus,GO:0071346~cellular response to interferon-gamma,GO:1902358~sulfate transmembrane transport,GO:1902476~chloride transmembrane transport,GO:2001150~positive regulation of dipeptide transmembrane transport,	GO:0005622~intracellular,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0012506~vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031526~brush border membrane,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0034707~chloride channel complex,GO:0097225~sperm midpiece,	GO:0005254~chloride channel activity,GO:0005452~inorganic anion exchanger activity,GO:0008271~secondary active sulfate transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015108~chloride transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015301~anion:anion antiporter activity,GO:0015499~formate transmembrane transporter activity,GO:0015562~efflux transmembrane transporter activity,GO:0015659~formate uptake transmembrane transporter activity,GO:0015660~formate efflux transmembrane transporter activity,GO:0019531~oxalate transmembrane transporter activity,GO:0030165~PDZ domain binding,	IPR001902:Sulphate anion transporter,IPR002645:STAS domain,IPR011547:Sulphate transporter,IPR018045:Sulphate anion transporter, conserved site,	hsa04978:Mineral absorption,				Alternative splicing,Anion exchange,Antiport,Cell membrane,Chloride,Chloride channel,Coiled coil,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Ion channel,Ion transport,Membrane,Microsome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Cadherin EGF LAG seven-pass G-type receptor 3,chain:Solute carrier family 26 member 6,disulfide bond,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:GPS,domain:Laminin EGF-like,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:STAS,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC26A9	solute carrier family 26 member 9(SLC26A9)	Homo sapiens				GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0010628~positive regulation of gene expression,GO:0015701~bicarbonate transport,GO:0019532~oxalate transport,GO:0042391~regulation of membrane potential,GO:0051453~regulation of intracellular pH,GO:1902358~sulfate transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0005254~chloride channel activity,GO:0008271~secondary active sulfate transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015301~anion:anion antiporter activity,GO:0019531~oxalate transmembrane transporter activity,GO:0051117~ATPase binding,	IPR001902:Sulphate anion transporter,IPR002645:STAS domain,IPR011547:Sulphate transporter,	hsa04978:Mineral absorption,				Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Solute carrier family 26 member 9,compositionally biased region:Poly-Val,domain:STAS,sequence conflict,sequence variant,transmembrane region,
SLC27A3	solute carrier family 27 member 3(SLC27A3)	Homo sapiens				GO:0001676~long-chain fatty acid metabolic process,	GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0000166~nucleotide binding,GO:0004467~long-chain fatty acid-CoA ligase activity,GO:0031957~very long-chain fatty acid-CoA ligase activity,	IPR000873:AMP-dependent synthetase/ligase,IPR020845:AMP-binding, conserved site,IPR025110:Domain of unknown function DUF4009,	hsa04931:Insulin resistance,				Alternative splicing,Complete proteome,Fatty acid metabolism,Ligase,Lipid metabolism,Membrane,Mitochondrion,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Long-chain fatty acid transport protein 3,nucleotide phosphate-binding region:AMP,sequence conflict,sequence variant,splice variant,transmembrane region,
SLC3A1	solute carrier family 3 member 1(SLC3A1)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006865~amino acid transport,GO:0015802~basic amino acid transport,GO:0015811~L-cystine transport,GO:1990822~basic amino acid transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0005774~vacuolar membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031526~brush border membrane,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0015171~amino acid transmembrane transporter activity,GO:0015174~basic amino acid transmembrane transporter activity,GO:0015184~L-cystine transmembrane transporter activity,GO:0046982~protein heterodimerization activity,	IPR006047:Glycosyl hydrolase, family 13, catalytic domain,IPR013781:Glycoside hydrolase, catalytic domain,IPR015902:Glycoside hydrolase, family 13,IPR017853:Glycoside hydrolase, superfamily,	hsa04974:Protein digestion and absorption,	220100~Cystinuria,		SM00642:Aamy,	Alternative splicing,Amino-acid transport,Complete proteome,Cystinuria,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Signal-anchor,Transmembrane,Transmembrane helix,Transport,	chain:Neutral and basic amino acid transport protein rBAT,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC30A1	solute carrier family 30 member 1(SLC30A1)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0006829~zinc II ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006882~cellular zinc ion homeostasis,GO:0010043~response to zinc ion,GO:0046929~negative regulation of neurotransmitter secretion,GO:0061088~regulation of sequestering of zinc ion,GO:0070509~calcium ion import,GO:0070574~cadmium ion transmembrane transport,GO:0071577~zinc II ion transmembrane transport,GO:0071584~negative regulation of zinc ion transmembrane import,GO:0071585~detoxification of cadmium ion,GO:0090281~negative regulation of calcium ion import,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030315~T-tubule,GO:0031965~nuclear membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0005515~protein binding,GO:0008324~cation transmembrane transporter activity,GO:0019855~calcium channel inhibitor activity,	IPR002524:Cation efflux protein,IPR027469:Cation efflux protein transmembrane domain,	hsa04978:Mineral absorption,				Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,Zinc,Zinc transport,	chain:Zinc transporter 1,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:6 X 2 AA approximate repeats of H-G,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC30A10	solute carrier family 30 member 10(SLC30A10)	Homo sapiens				GO:0006828~manganese ion transport,GO:0010043~response to zinc ion,GO:0061088~regulation of sequestering of zinc ion,GO:0071577~zinc II ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,	IPR002524:Cation efflux protein,IPR027469:Cation efflux protein transmembrane domain,		613280~Hypermanganesemia with dystonia, polycythemia, and cirrhosis,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Dystonia,Ion transport,Membrane,Parkinsonism,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,Zinc,Zinc transport,	chain:Zinc transporter 10,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Val,modified residue,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC30A6	solute carrier family 30 member 6(SLC30A6)	Homo sapiens				GO:0010043~response to zinc ion,GO:0061088~regulation of sequestering of zinc ion,GO:0071577~zinc II ion transmembrane transport,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,	IPR002524:Cation efflux protein,IPR027469:Cation efflux protein transmembrane domain,					Alternative splicing,Complete proteome,Golgi apparatus,Ion transport,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Zinc,Zinc transport,	chain:Zinc transporter 6,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC30A7	solute carrier family 30 member 7(SLC30A7)	Homo sapiens				GO:0010043~response to zinc ion,GO:0032119~sequestering of zinc ion,GO:0061088~regulation of sequestering of zinc ion,GO:0071577~zinc II ion transmembrane transport,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031982~vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005385~zinc ion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,	IPR002524:Cation efflux protein,IPR027469:Cation efflux protein transmembrane domain,					Complete proteome,Golgi apparatus,Ion transport,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Zinc,Zinc transport,	chain:Zinc transporter 7,region of interest:His-rich loop,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC35A3	solute carrier family 35 member A3(SLC35A3)	Homo sapiens				GO:0006047~UDP-N-acetylglucosamine metabolic process,GO:0008643~carbohydrate transport,GO:0015788~UDP-N-acetylglucosamine transport,GO:0015992~proton transport,GO:1990569~UDP-N-acetylglucosamine transmembrane transport,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0005351~sugar:proton symporter activity,GO:0005462~UDP-N-acetylglucosamine transmembrane transporter activity,GO:0005515~protein binding,	IPR007271:Nucleotide-sugar transporter,		615553~Arthrogryposis, mental retardation, and seizures,	PIRSF005799:nucleotide-sugar transporter,		Alternative splicing,Autism spectrum disorder,Complete proteome,Epilepsy,Golgi apparatus,Membrane,Mental retardation,Proteomics identification,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:UDP-N-acetylglucosamine transporter,splice variant,transmembrane region,
SLC35A5	solute carrier family 35 member A5(SLC35A5)	Homo sapiens				GO:0008643~carbohydrate transport,GO:0015992~proton transport,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0005351~sugar:proton symporter activity,	IPR007271:Nucleotide-sugar transporter,			PIRSF005799:nucleotide-sugar transporter,		Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:Probable UDP-sugar transporter protein SLC35A5,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,transmembrane region,
SLC35D1	solute carrier family 35 member D1(SLC35D1)	Homo sapiens				GO:0006065~UDP-glucuronate biosynthetic process,GO:0008643~carbohydrate transport,GO:0015787~UDP-glucuronic acid transport,GO:0030206~chondroitin sulfate biosynthetic process,GO:0048706~embryonic skeletal system development,GO:0090481~pyrimidine nucleotide-sugar transmembrane transport,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005461~UDP-glucuronic acid transmembrane transporter activity,GO:0015165~pyrimidine nucleotide-sugar transmembrane transporter activity,	IPR004853:Domain of unknown function DUF250,		269250~Schneckenbecken dysplasia,			Alternative splicing,Complete proteome,Endoplasmic reticulum,Membrane,Polymorphism,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:UDP-glucuronic acid/UDP-N- acetylgalactosamine transporter,sequence variant,transmembrane region,
SLC35E2	solute carrier family 35 member E2(SLC35E2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR004853:Domain of unknown function DUF250,					Alternative splicing,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Solute carrier family 35 member E2,sequence conflict,splice variant,transmembrane region,
SLC35E2B	solute carrier family 35 member E2B(SLC35E2B)	Homo sapiens					GO:0016021~integral component of membrane,		IPR004853:Domain of unknown function DUF250,					Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Solute carrier family 35 member E2,sequence conflict,splice variant,transmembrane region,
SLC35F3	solute carrier family 35 member F3(SLC35F3)	Homo sapiens				GO:0015888~thiamine transport,	GO:0016021~integral component of membrane,		IPR000620:Drug/metabolite transporter,IPR026505:Solute carrier family 35 member F3/F4,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 35 member F3,sequence variant,splice variant,transmembrane region,
SLC35F5	solute carrier family 35 member F5(SLC35F5)	Homo sapiens			Carbohydrate transport and metabolism / Amino acid transport and metabolism / General function prediction only,	GO:0006810~transport,	GO:0016021~integral component of membrane,		IPR000620:Drug/metabolite transporter,					Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 35 member F5,compositionally biased region:Poly-Leu,domain:DUF6,sequence conflict,splice variant,transmembrane region,
SLC35F6	solute carrier family 35 member F6(SLC35F6)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005765~lysosomal membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR009262:Protein of unknown function DUF914, eukaryotic,IPR012404:Uncharacterised conserved protein UCP036436, nucleotide-sugar transporter-related,			PIRSF036436:permease related to nucleotide-sugar transporters,		Complete proteome,Glycoprotein,Lysosome,Membrane,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Transmembrane protein C2orf18,domain:DUF6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,transmembrane region,
SLC38A11	solute carrier family 38 member 11(SLC38A11)	Homo sapiens				GO:0003333~amino acid transmembrane transport,GO:0006814~sodium ion transport,	GO:0005783~endoplasmic reticulum,GO:0016021~integral component of membrane,	GO:0015171~amino acid transmembrane transporter activity,	IPR013057:Amino acid transporter, transmembrane,					Alternative splicing,Amino-acid transport,Complete proteome,Glycoprotein,Ion transport,Membrane,Polymorphism,Reference proteome,Signal,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Putative sodium-coupled neutral amino acid transporter 11,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC38A3	solute carrier family 38 member 3(SLC38A3)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006865~amino acid transport,GO:0006867~asparagine transport,GO:0006868~glutamine transport,GO:0007420~brain development,GO:0007565~female pregnancy,GO:0015808~L-alanine transport,GO:0015817~histidine transport,GO:0051365~cellular response to potassium ion starvation,GO:0061402~positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,GO:0089709~L-histidine transmembrane transport,GO:2000487~positive regulation of glutamine transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,	GO:0005290~L-histidine transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015180~L-alanine transmembrane transporter activity,GO:0015182~L-asparagine transmembrane transporter activity,GO:0015186~L-glutamine transmembrane transporter activity,GO:0015293~symporter activity,GO:0015297~antiporter activity,	IPR013057:Amino acid transporter, transmembrane,	hsa04724:Glutamatergic synapse,hsa04727:GABAergic synapse,hsa04964:Proximal tubule bicarbonate reclamation,				Amino-acid transport,Antiport,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-coupled neutral amino acid transporter 3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,transmembrane region,
SLC39A10	solute carrier family 39 member 10(SLC39A10)	Homo sapiens				GO:0002903~negative regulation of B cell apoptotic process,GO:0006882~cellular zinc ion homeostasis,GO:0030890~positive regulation of B cell proliferation,GO:0050861~positive regulation of B cell receptor signaling pathway,GO:0071578~zinc II ion transmembrane import,GO:1903615~positive regulation of protein tyrosine phosphatase activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005385~zinc ion transmembrane transporter activity,	IPR003689:Zinc/iron permease,					Alternative splicing,Complete proteome,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,Zinc,Zinc transport,	chain:Zinc transporter ZIP10,compositionally biased region:His-rich,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
SLC4A1AP	solute carrier family 4 member 1 adaptor protein(SLC4A1AP)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,IPR014720:Double-stranded RNA-binding-like domain,				SM00240:FHA,	3D-structure,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Kanadaptin,compositionally biased region:Glu-rich,domain:FHA,modified residue,sequence conflict,sequence variant,
SLC4A10	solute carrier family 4 member 10(SLC4A10)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006821~chloride transport,GO:0007399~nervous system development,GO:0009416~response to light stimulus,GO:0009791~post-embryonic development,GO:0015701~bicarbonate transport,GO:0021860~pyramidal neuron development,GO:0035264~multicellular organism growth,GO:0035641~locomotory exploration behavior,GO:0048854~brain morphogenesis,GO:0051453~regulation of intracellular pH,GO:0098656~anion transmembrane transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0043025~neuronal cell body,GO:0097440~apical dendrite,GO:0097441~basilar dendrite,GO:0097442~CA3 pyramidal cell dendrite,	GO:0005452~inorganic anion exchanger activity,GO:0008509~anion transmembrane transporter activity,GO:0015293~symporter activity,GO:0015301~anion:anion antiporter activity,	IPR003020:Bicarbonate transporter, eukaryotic,IPR003024:Sodium bicarbonate cotransporter,IPR011531:Bicarbonate transporter, C-terminal,IPR013769:Band 3 cytoplasmic domain,IPR016152:Phosphotransferase/anion transporter,					Alternative splicing,Antiport,Cell membrane,Complete proteome,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-driven chloride bicarbonate exchanger,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC4A5	solute carrier family 4 member 5(SLC4A5)	Homo sapiens				GO:0002064~epithelial cell development,GO:0003014~renal system process,GO:0003073~regulation of systemic arterial blood pressure,GO:0010468~regulation of gene expression,GO:0015698~inorganic anion transport,GO:0015701~bicarbonate transport,GO:0033326~cerebrospinal fluid secretion,GO:0035725~sodium ion transmembrane transport,GO:0048311~mitochondrion distribution,GO:0051453~regulation of intracellular pH,GO:0060041~retina development in camera-type eye,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,	GO:0005452~inorganic anion exchanger activity,GO:0008509~anion transmembrane transporter activity,GO:0008510~sodium:bicarbonate symporter activity,GO:0015301~anion:anion antiporter activity,	IPR003020:Bicarbonate transporter, eukaryotic,IPR003024:Sodium bicarbonate cotransporter,IPR011531:Bicarbonate transporter, C-terminal,IPR013769:Band 3 cytoplasmic domain,IPR016152:Phosphotransferase/anion transporter,	hsa04976:Bile secretion,				Alternative splicing,Anion exchange,Cell membrane,Complete proteome,Disulfide bond,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Electrogenic sodium bicarbonate cotransporter 4,compositionally biased region:Gly-rich,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC4A7	solute carrier family 4 member 7(SLC4A7)	Homo sapiens				GO:0015698~inorganic anion transport,GO:0015701~bicarbonate transport,GO:0035725~sodium ion transmembrane transport,GO:0051453~regulation of intracellular pH,GO:0060117~auditory receptor cell development,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0032420~stereocilium,GO:0045202~synapse,	GO:0005452~inorganic anion exchanger activity,GO:0008509~anion transmembrane transporter activity,GO:0008510~sodium:bicarbonate symporter activity,	IPR003020:Bicarbonate transporter, eukaryotic,IPR003024:Sodium bicarbonate cotransporter,IPR011531:Bicarbonate transporter, C-terminal,IPR013769:Band 3 cytoplasmic domain,IPR016152:Phosphotransferase/anion transporter,					Alternative splicing,Cell membrane,Cell projection,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium bicarbonate cotransporter 3,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:CA2-binding,sequence variant,short sequence motif:PDZ-binding,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC41A1	solute carrier family 41 member 1(SLC41A1)	Homo sapiens				GO:0010961~cellular magnesium ion homeostasis,GO:0015693~magnesium ion transport,GO:0035725~sodium ion transmembrane transport,GO:0055085~transmembrane transport,GO:0070838~divalent metal ion transport,GO:0071286~cellular response to magnesium ion,GO:1903830~magnesium ion transmembrane transport,	GO:0005623~cell,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0043234~protein complex,	GO:0015095~magnesium ion transmembrane transporter activity,GO:0022892~substrate-specific transporter activity,GO:0061768~magnesium:sodium antiporter activity,GO:0072509~divalent inorganic cation transmembrane transporter activity,	IPR006667:SLC41 divalent cation transporters, integral membrane domain,					Cell membrane,Complete proteome,Ion transport,Magnesium,Membrane,Phosphoprotein,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 41 member 1,sequence conflict,transmembrane region,
SLC44A3	solute carrier family 44 member 3(SLC44A3)	Homo sapiens				GO:0006656~phosphatidylcholine biosynthetic process,GO:0015871~choline transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0015220~choline transmembrane transporter activity,	IPR007603:Choline transporter-like,	hsa05231:Choline metabolism in cancer,				Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Choline transporter-like protein 3,compositionally biased region:Cys-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,transmembrane region,
SLC44A5	solute carrier family 44 member 5(SLC44A5)	Homo sapiens				GO:0006656~phosphatidylcholine biosynthetic process,GO:0015871~choline transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0015220~choline transmembrane transporter activity,	IPR007603:Choline transporter-like,	hsa05231:Choline metabolism in cancer,				Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Choline transporter-like protein 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC45A1	solute carrier family 45 member 1(SLC45A1)	Homo sapiens				GO:0008643~carbohydrate transport,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,	GO:0015293~symporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Complete proteome,Membrane,Phosphoprotein,Reference proteome,Sugar transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Proton-associated sugar transporter A,sequence conflict,transmembrane region,
SLC45A3	solute carrier family 45 member 3(SLC45A3)	Homo sapiens				GO:0010907~positive regulation of glucose metabolic process,GO:0015770~sucrose transport,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0048713~regulation of oligodendrocyte differentiation,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,	GO:0008506~sucrose:proton symporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,	hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,				Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 45 member 3,compositionally biased region:Poly-Pro,transmembrane region,
SLC5A6	solute carrier family 5 member 6(SLC5A6)	Homo sapiens			General function prediction only,	GO:0006768~biotin metabolic process,GO:0006810~transport,GO:0006814~sodium ion transport,GO:0015878~biotin transport,GO:0015887~pantothenate transmembrane transport,GO:0015939~pantothenate metabolic process,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0012506~vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031526~brush border membrane,	GO:0005215~transporter activity,GO:0008523~sodium-dependent multivitamin transmembrane transporter activity,	IPR001734:Sodium/solute symporter,IPR018212:Sodium/solute symporter, conserved site,	hsa04977:Vitamin digestion and absorption,				Biotin,Complete proteome,Glycoprotein,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-dependent multivitamin transporter,glycosylation site:N-linked (GlcNAc...),sequence variant,transmembrane region,
SLC5A7	solute carrier family 5 member 7(SLC5A7)	Homo sapiens				GO:0006814~sodium ion transport,GO:0007269~neurotransmitter secretion,GO:0007271~synaptic transmission, cholinergic,GO:0007274~neuromuscular synaptic transmission,GO:0008292~acetylcholine biosynthetic process,GO:0015871~choline transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043204~perikaryon,GO:0045202~synapse,GO:0098793~presynapse,	GO:0005215~transporter activity,GO:0005307~choline:sodium symporter activity,GO:0015220~choline transmembrane transporter activity,GO:0033265~choline binding,	IPR001734:Sodium/solute symporter,	hsa04725:Cholinergic synapse,hsa05231:Choline metabolism in cancer,	158580~Neuronopathy, distal hereditary motor, type VIIA,			Complete proteome,Glycoprotein,Ion transport,Membrane,Neurodegeneration,Neurotransmitter biosynthesis,Phosphoprotein,Polymorphism,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:High affinity choline transporter 1,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC5A9	solute carrier family 5 member 9(SLC5A9)	Homo sapiens				GO:0006814~sodium ion transport,GO:0055085~transmembrane transport,GO:1904659~glucose transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005362~low-affinity glucose:sodium symporter activity,GO:0015293~symporter activity,	IPR001734:Sodium/solute symporter,IPR018212:Sodium/solute symporter, conserved site,					Alternative splicing,Complete proteome,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/glucose cotransporter 4,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC6A1	solute carrier family 6 member 1(SLC6A1)	Homo sapiens			General function prediction only,	GO:0006810~transport,GO:0006836~neurotransmitter transport,GO:0007268~chemical synaptic transmission,GO:0007612~learning,GO:0009636~response to toxic substance,GO:0009744~response to sucrose,GO:0010288~response to lead ion,GO:0014054~positive regulation of gamma-aminobutyric acid secretion,GO:0014074~response to purine-containing compound,GO:0015812~gamma-aminobutyric acid transport,GO:0032229~negative regulation of synaptic transmission, GABAergic,GO:0032355~response to estradiol,GO:0042220~response to cocaine,GO:0051260~protein homooligomerization,GO:0051592~response to calcium ion,GO:0051939~gamma-aminobutyric acid import,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0043005~neuron projection,	GO:0005328~neurotransmitter:sodium symporter activity,GO:0005332~gamma-aminobutyric acid:sodium symporter activity,GO:0046872~metal ion binding,	IPR000175:Sodium:neurotransmitter symporter,IPR002980:Sodium:neurotransmitter symporter, GABA, GAT-1,	hsa04727:GABAergic synapse,	616421~Myoclonic-atonic epilepsy,			Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Membrane,Metal-binding,Neurotransmitter transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium- and chloride-dependent GABA transporter 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:PDZ-binding,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC6A11	solute carrier family 6 member 11(SLC6A11)	Homo sapiens			General function prediction only,	GO:0006836~neurotransmitter transport,GO:0007268~chemical synaptic transmission,GO:0007420~brain development,GO:0015812~gamma-aminobutyric acid transport,GO:0042493~response to drug,GO:0055085~transmembrane transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,	GO:0005328~neurotransmitter:sodium symporter activity,GO:0005332~gamma-aminobutyric acid:sodium symporter activity,GO:0042165~neurotransmitter binding,	IPR000175:Sodium:neurotransmitter symporter,IPR002982:Sodium:neurotransmitter symporter, GABA, GAT-3,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Neurotransmitter transport,Phosphoprotein,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium- and chloride-dependent GABA transporter 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC6A17	solute carrier family 6 member 17(SLC6A17)	Homo sapiens				GO:0003333~amino acid transmembrane transport,GO:0006836~neurotransmitter transport,GO:0007420~brain development,GO:0015804~neutral amino acid transport,GO:0015816~glycine transport,GO:0015820~leucine transport,GO:0015824~proline transport,GO:0032328~alanine transport,	GO:0005887~integral component of plasma membrane,GO:0008021~synaptic vesicle,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,	GO:0005328~neurotransmitter:sodium symporter activity,GO:0015171~amino acid transmembrane transporter activity,	IPR000175:Sodium:neurotransmitter symporter,IPR002438:Sodium:neurotransmitter symporter, orphan,		616269~Mental retardation, autosomal recessive 48,			Cell junction,Complete proteome,Cytoplasmic vesicle,Disease mutation,Glycoprotein,Membrane,Mental retardation,Neurotransmitter transport,Phosphoprotein,Polymorphism,Reference proteome,Symport,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Orphan sodium- and chloride-dependent neurotransmitter transporter NTT4,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC6A20	solute carrier family 6 member 20(SLC6A20)	Homo sapiens				GO:0003333~amino acid transmembrane transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015816~glycine transport,GO:0015824~proline transport,GO:0036233~glycine import,GO:0060012~synaptic transmission, glycinergic,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016324~apical plasma membrane,	GO:0005328~neurotransmitter:sodium symporter activity,GO:0005515~protein binding,GO:0015171~amino acid transmembrane transporter activity,GO:0015375~glycine:sodium symporter activity,	IPR000175:Sodium:neurotransmitter symporter,IPR002438:Sodium:neurotransmitter symporter, orphan,		138500~Hyperglycinuria,242600~Iminoglycinuria, digenic,			Alternative splicing,Amino-acid transport,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium- and chloride-dependent transporter XTRP3,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC6A6	solute carrier family 6 member 6(SLC6A6)	Homo sapiens			General function prediction only,	GO:0003333~amino acid transmembrane transport,GO:0006520~cellular amino acid metabolic process,GO:0006810~transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015734~taurine transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005328~neurotransmitter:sodium symporter activity,GO:0005369~taurine:sodium symporter activity,GO:0015171~amino acid transmembrane transporter activity,	IPR000175:Sodium:neurotransmitter symporter,IPR002434:Sodium:neurotransmitter symporter, taurine,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Neurotransmitter transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium- and chloride-dependent taurine transporter,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC6A9	solute carrier family 6 member 9(SLC6A9)	Homo sapiens			General function prediction only,	GO:0003333~amino acid transmembrane transport,GO:0006810~transport,GO:0015816~glycine transport,GO:0036233~glycine import,GO:0060012~synaptic transmission, glycinergic,GO:0061537~glycine secretion, neurotransmission,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0098793~presynapse,	GO:0005283~sodium:amino acid symporter activity,GO:0005328~neurotransmitter:sodium symporter activity,GO:0015375~glycine:sodium symporter activity,	IPR000175:Sodium:neurotransmitter symporter,IPR003028:Sodium:neurotransmitter symporter, glycine, type 1,					Alternative splicing,Amino-acid transport,Complete proteome,Membrane,Neurotransmitter transport,Phosphoprotein,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium- and chloride-dependent glycine transporter 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC8A1	solute carrier family 8 member A1(SLC8A1)	Homo sapiens				GO:0002026~regulation of the force of heart contraction,GO:0002027~regulation of heart rate,GO:0002028~regulation of sodium ion transport,GO:0006811~ion transport,GO:0006883~cellular sodium ion homeostasis,GO:0006936~muscle contraction,GO:0007154~cell communication,GO:0007584~response to nutrient,GO:0009749~response to glucose,GO:0010649~regulation of cell communication by electrical coupling,GO:0010763~positive regulation of fibroblast migration,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0014829~vascular smooth muscle contraction,GO:0021537~telencephalon development,GO:0030501~positive regulation of bone mineralization,GO:0033198~response to ATP,GO:0034614~cellular response to reactive oxygen species,GO:0035725~sodium ion transmembrane transport,GO:0035902~response to immobilization stress,GO:0035994~response to muscle stretch,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0044557~relaxation of smooth muscle,GO:0051481~negative regulation of cytosolic calcium ion concentration,GO:0055013~cardiac muscle cell development,GO:0055074~calcium ion homeostasis,GO:0055119~relaxation of cardiac muscle,GO:0060048~cardiac muscle contraction,GO:0060401~cytosolic calcium ion transport,GO:0060402~calcium ion transport into cytosol,GO:0070509~calcium ion import,GO:0070588~calcium ion transmembrane transport,GO:0071313~cellular response to caffeine,GO:0071320~cellular response to cAMP,GO:0071436~sodium ion export,GO:0071456~cellular response to hypoxia,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:0097369~sodium ion import,GO:0098735~positive regulation of the force of heart contraction,GO:1901660~calcium ion export,GO:1903779~regulation of cardiac conduction,	GO:0005739~mitochondrion,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0042383~sarcolemma,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,	GO:0005432~calcium:sodium antiporter activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008092~cytoskeletal protein binding,GO:0030506~ankyrin binding,GO:0044325~ion channel binding,	IPR001623:DnaJ domain,IPR002987:Sodium/calcium exchanger, isoform 1,IPR003644:Na-Ca exchanger/integrin-beta4,IPR004836:Sodium/calcium exchanger protein,IPR004837:Sodium/calcium exchanger membrane region,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04974:Protein digestion and absorption,			SM00237:Calx_beta,	Alternative splicing,Antiport,Calcium,Calcium transport,Calmodulin-binding,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/calcium exchanger 1,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Phe,domain:Calx-beta 1,domain:Calx-beta 2,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Calmodulin-binding,repeat:Alpha-1,repeat:Alpha-2,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC9A1	solute carrier family 9 member A1(SLC9A1)	Homo sapiens				GO:0006811~ion transport,GO:0006883~cellular sodium ion homeostasis,GO:0006885~regulation of pH,GO:0010447~response to acidic pH,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0016049~cell growth,GO:0016477~cell migration,GO:0030011~maintenance of cell polarity,GO:0030214~hyaluronan catabolic process,GO:0030307~positive regulation of cell growth,GO:0032869~cellular response to insulin stimulus,GO:0035794~positive regulation of mitochondrial membrane permeability,GO:0035994~response to muscle stretch,GO:0042493~response to drug,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045760~positive regulation of action potential,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051259~protein oligomerization,GO:0051453~regulation of intracellular pH,GO:0051492~regulation of stress fiber assembly,GO:0051533~positive regulation of NFAT protein import into nucleus,GO:0051893~regulation of focal adhesion assembly,GO:0051930~regulation of sensory perception of pain,GO:0055007~cardiac muscle cell differentiation,GO:0070886~positive regulation of calcineurin-NFAT signaling cascade,GO:0070997~neuron death,GO:0071236~cellular response to antibiotic,GO:0071257~cellular response to electrical stimulus,GO:0071260~cellular response to mechanical stimulus,GO:0071436~sodium ion export,GO:0071456~cellular response to hypoxia,GO:0071468~cellular response to acidic pH,GO:0071805~potassium ion transmembrane transport,GO:0071872~cellular response to epinephrine stimulus,GO:0086003~cardiac muscle cell contraction,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:0086092~regulation of the force of heart contraction by cardiac conduction,GO:0098719~sodium ion import across plasma membrane,GO:0098735~positive regulation of the force of heart contraction,GO:1902600~hydrogen ion transmembrane transport,GO:1903281~positive regulation of calcium:sodium antiporter activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0014704~intercalated disc,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030027~lamellipodium,GO:0030315~T-tubule,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0090533~cation-transporting ATPase complex,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0015299~solute:proton antiporter activity,GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,GO:0030346~protein phosphatase 2B binding,GO:0030674~protein binding, bridging,GO:0032947~protein complex scaffold,GO:0048306~calcium-dependent protein binding,GO:0086040~sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,	IPR001970:Na+/H+ exchanger, isoform 1 (NHE1),IPR004709:Na+/H+ exchanger,IPR006153:Cation/H+ exchanger,IPR018422:Cation/H+ exchanger, CPA1 family,	hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04810:Regulation of actin cytoskeleton,hsa04919:Thyroid hormone signaling pathway,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,hsa05205:Proteoglycans in cancer,	616291~Lichtenstein-Knorr syndrome,			3D-structure,Alternative splicing,Antiport,Calmodulin-binding,Cell membrane,Coiled coil,Complete proteome,Deafness,Disease mutation,Endoplasmic reticulum,Glycoprotein,Ion transport,Membrane,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Sodium/hydrogen exchanger 1,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,region of interest:H10 hydrophobic,region of interest:Interaction with CHP2,sequence variant,site:Channel pore-lining,site:Not glycosylated,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC9A2	solute carrier family 9 member A2(SLC9A2)	Homo sapiens				GO:0006811~ion transport,GO:0008104~protein localization,GO:0051453~regulation of intracellular pH,GO:0071805~potassium ion transmembrane transport,GO:0098719~sodium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,	IPR001953:Na+/H+ exchanger, isoform 2 (NHE2),IPR004709:Na+/H+ exchanger,IPR006153:Cation/H+ exchanger,IPR018422:Cation/H+ exchanger, CPA1 family,					Antiport,Complete proteome,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/hydrogen exchanger 2,glycosylation site:N-linked (GlcNAc...),region of interest:A (M1) hydrophobic,region of interest:B (M2) hydrophobic,region of interest:L, hydrophobic,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC9A4	solute carrier family 9 member A4(SLC9A4)	Homo sapiens				GO:0001696~gastric acid secretion,GO:0002064~epithelial cell development,GO:0006811~ion transport,GO:0051453~regulation of intracellular pH,GO:0071805~potassium ion transmembrane transport,GO:0098719~sodium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,	GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,	IPR001953:Na+/H+ exchanger, isoform 2 (NHE2),IPR004709:Na+/H+ exchanger,IPR006153:Cation/H+ exchanger,IPR018422:Cation/H+ exchanger, CPA1 family,	hsa04971:Gastric acid secretion,				Antiport,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/hydrogen exchanger 4,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),glycosylation site:N-linked (GlcNAc...),region of interest:A (M1) hydrophobic,region of interest:B (M2) hydrophobic,region of interest:L, hydrophobic,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC9C1	solute carrier family 9 member C1(SLC9C1)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0030317~sperm motility,GO:0051453~regulation of intracellular pH,GO:0071805~potassium ion transmembrane transport,GO:0098719~sodium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031514~motile cilium,	GO:0005216~ion channel activity,GO:0015299~solute:proton antiporter activity,GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,	IPR000595:Cyclic nucleotide-binding domain,IPR005821:Ion transport domain,IPR006153:Cation/H+ exchanger,IPR014710:RmlC-like jelly roll fold,IPR018422:Cation/H+ exchanger, CPA1 family,IPR018490:Cyclic nucleotide-binding-like,					Alternative splicing,Antiport,Cell membrane,Cell projection,Cilium,Complete proteome,Developmental protein,Differentiation,Flagellum,Glycoprotein,Ion transport,Membrane,Polymorphism,Reference proteome,Sodium,Sodium transport,Spermatogenesis,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/hydrogen exchanger 10,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:cNMP,region of interest:Ion transport-like,sequence conflict,sequence variant,splice variant,transmembrane region,
SLC9C2	solute carrier family 9 member C2 (putative)(SLC9C2)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0051453~regulation of intracellular pH,GO:0071805~potassium ion transmembrane transport,GO:0098719~sodium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0015299~solute:proton antiporter activity,GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,	IPR000595:Cyclic nucleotide-binding domain,IPR006153:Cation/H+ exchanger,IPR014710:RmlC-like jelly roll fold,IPR018422:Cation/H+ exchanger, CPA1 family,IPR018490:Cyclic nucleotide-binding-like,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,					Antiport,Complete proteome,Glycoprotein,Ion transport,Membrane,Polymorphism,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/hydrogen exchanger 11,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:cNMP,region of interest:Ion transport-like,sequence variant,transmembrane region,
SORT1	sortilin 1(SORT1)	Homo sapiens				GO:0001503~ossification,GO:0006895~Golgi to endosome transport,GO:0006897~endocytosis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007275~multicellular organism development,GO:0008333~endosome to lysosome transport,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010468~regulation of gene expression,GO:0014902~myotube differentiation,GO:0016050~vesicle organization,GO:0032509~endosome transport via multivesicular body sorting pathway,GO:0032868~response to insulin,GO:0038180~nerve growth factor signaling pathway,GO:0045599~negative regulation of fat cell differentiation,GO:0046323~glucose import,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048227~plasma membrane to endosome transport,GO:0051005~negative regulation of lipoprotein lipase activity,GO:1904037~positive regulation of epithelial cell apoptotic process,	GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030136~clathrin-coated vesicle,GO:0030140~trans-Golgi network transport vesicle,GO:0030425~dendrite,GO:0031410~cytoplasmic vesicle,GO:0031965~nuclear membrane,GO:0032580~Golgi cisterna membrane,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0010465~nerve growth factor receptor activity,GO:0019899~enzyme binding,GO:0030379~neurotensin receptor activity, non-G-protein coupled,GO:0048406~nerve growth factor binding,	IPR002860:BNR repeat,IPR006581:VPS10,IPR015943:WD40/YVTN repeat-like-containing domain,	hsa04142:Lysosome,hsa04722:Neurotrophin signaling pathway,	613589~Low density lipoprotein cholesterol level QTL6,		SM00602:VPS10,	3D-structure,Alternative splicing,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Endocytosis,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Lysosome,Membrane,Nucleus,Osteogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Sortilin,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,propeptide:Removed in mature form,region of interest:Golgi to endosome transport and interactions with GGA1 and GGA2,region of interest:Interactions with LRPAP1 and NGFB,region of interest:Intrachain binding of the propeptide and the extracellular domain,repeat:BNR 1,repeat:BNR 2,repeat:BNR 3,repeat:BNR 4,repeat:BNR 5,repeat:BNR 6,repeat:BNR 7,repeat:BNR 8,repeat:BNR 9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
SNX7	sorting nexin 7(SNX7)	Homo sapiens			Intracellular trafficking and secretion / General function prediction only,	GO:0006897~endocytosis,GO:0015031~protein transport,GO:0016050~vesicle organization,	GO:0005768~endosome,GO:0019898~extrinsic component of membrane,GO:0030659~cytoplasmic vesicle membrane,	GO:0005515~protein binding,GO:0035091~phosphatidylinositol binding,	IPR001683:Phox homologous domain,				SM00312:PX,	3D-structure,Alternative splicing,Complete proteome,Cytoplasmic vesicle,Lipid-binding,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Sorting nexin-7,domain:PX,helix,sequence conflict,sequence variant,splice variant,strand,
SNX27	sorting nexin family member 27(SNX27)	Homo sapiens				GO:0001770~establishment of natural killer cell polarity,GO:0006886~intracellular protein transport,GO:0007165~signal transduction,GO:0008333~endosome to lysosome transport,GO:0016197~endosomal transport,GO:1990126~retrograde transport, endosome to plasma membrane,	GO:0001772~immunological synapse,GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0030904~retromer complex,GO:0031901~early endosome membrane,GO:0071203~WASH complex,	GO:0005515~protein binding,GO:0032266~phosphatidylinositol-3-phosphate binding,	IPR000159:Ras-association,IPR001478:PDZ domain,IPR001683:Phox homologous domain,				SM00228:PDZ,SM00312:PX,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Endosome,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Sorting nexin-27,domain:PDZ,domain:PX,domain:Ras-associating,sequence conflict,sequence variant,splice variant,
SPAST	spastin(SPAST)	Homo sapiens				GO:0000281~mitotic cytokinesis,GO:0001578~microtubule bundle formation,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007409~axonogenesis,GO:0008089~anterograde axonal transport,GO:0008152~metabolic process,GO:0010458~exit from mitosis,GO:0019896~axonal transport of mitochondrion,GO:0031117~positive regulation of microtubule depolymerization,GO:0031122~cytoplasmic microtubule organization,GO:0031468~nuclear envelope reassembly,GO:0032467~positive regulation of cytokinesis,GO:0032506~cytokinetic process,GO:0034214~protein hexamerization,GO:0051013~microtubule severing,GO:0051228~mitotic spindle disassembly,GO:0051260~protein homooligomerization,GO:0090148~membrane fission,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0005813~centrosome,GO:0005819~spindle,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0016021~integral component of membrane,GO:0030496~midbody,GO:0031410~cytoplasmic vesicle,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071782~endoplasmic reticulum tubular network,GO:1904115~axon cytoplasm,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008568~microtubule-severing ATPase activity,GO:0043014~alpha-tubulin binding,GO:0048487~beta-tubulin binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR007330:MIT,IPR015415:Vps4 oligomerisation, C-terminal,IPR017179:Spastin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		182601~Spastic paraplegia 4, autosomal dominant,	PIRSF037338:spastin,	SM00382:AAA,SM00745:MIT,	3D-structure,Allosteric enzyme,Alternative initiation,Alternative promoter usage,Alternative splicing,ATP-binding,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Disease mutation,Endoplasmic reticulum,Endosome,Hereditary spastic paraplegia,Hydrolase,Lipid droplet,Membrane,Microtubule,Neurodegeneration,Neurogenesis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Spastin,domain:MIT,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Required for interaction with ATL1,region of interest:Required for interaction with microtubules,region of interest:Required for interaction with microtubules and microtubule severing,region of interest:Required for interaction with RTN1,region of interest:Required for interaction with SSNA1 and microtubules,region of interest:Required for midbody localization,region of interest:Required for nuclear localization,region of interest:Sufficient for interaction with CHMP1B,region of interest:Sufficient for interaction with microtubules,region of interest:Sufficient for microtubule severing,sequence variant,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,splice variant,transmembrane region,
SPTA1	spectrin alpha, erythrocytic 1(SPTA1)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0000165~MAPK cascade,GO:0002260~lymphocyte homeostasis,GO:0006779~porphyrin-containing compound biosynthetic process,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007009~plasma membrane organization,GO:0007015~actin filament organization,GO:0007411~axon guidance,GO:0008360~regulation of cell shape,GO:0030097~hemopoiesis,GO:0032092~positive regulation of protein binding,GO:0042102~positive regulation of T cell proliferation,GO:0043547~positive regulation of GTPase activity,GO:0051693~actin filament capping,	GO:0005829~cytosol,GO:0008091~spectrin,GO:0014731~spectrin-associated cytoskeleton,GO:0015629~actin cytoskeleton,GO:0030424~axon,GO:0031235~intrinsic component of the cytoplasmic side of the plasma membrane,GO:0032437~cuticular plate,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005200~structural constituent of cytoskeleton,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,GO:0051015~actin filament binding,	IPR001452:Src homology-3 domain,IPR002017:Spectrin repeat,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013315:Spectrin alpha chain, SH3 domain,IPR014837:EF-hand, Ca insensitive,IPR018159:Spectrin/alpha-actinin,		130600~Elliptocytosis-2,266140~Pyropoikilocytosis,270970~Spherocytosis, type 3,		SM00150:SPEC,SM00326:SH3,	3D-structure,Actin capping,Actin-binding,Alternative splicing,Calcium,Cell shape,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Elliptocytosis,Hereditary hemolytic anemia,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Pyropoikilocytosis,Reference proteome,Repeat,SH3 domain,	calcium-binding region:1,calcium-binding region:2,chain:Spectrin alpha chain, erythrocyte,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:SH3,helix,repeat:Spectrin 1,repeat:Spectrin 10,repeat:Spectrin 11,repeat:Spectrin 12,repeat:Spectrin 13,repeat:Spectrin 14,repeat:Spectrin 15,repeat:Spectrin 16,repeat:Spectrin 17,repeat:Spectrin 18,repeat:Spectrin 19,repeat:Spectrin 2,repeat:Spectrin 20,repeat:Spectrin 21,repeat:Spectrin 3,repeat:Spectrin 4,repeat:Spectrin 5,repeat:Spectrin 6,repeat:Spectrin 7,repeat:Spectrin 8,repeat:Spectrin 9,sequence conflict,sequence variant,splice variant,strand,
SPTBN1	spectrin beta, non-erythrocytic 1(SPTBN1)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,		GO:0000165~MAPK cascade,GO:0000281~mitotic cytokinesis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007009~plasma membrane organization,GO:0007010~cytoskeleton organization,GO:0007182~common-partner SMAD protein phosphorylation,GO:0007184~SMAD protein import into nucleus,GO:0007411~axon guidance,GO:0043001~Golgi to plasma membrane protein transport,GO:0043547~positive regulation of GTPase activity,GO:0051693~actin filament capping,GO:0071709~membrane assembly,GO:0072661~protein targeting to plasma membrane,GO:0098609~cell-cell adhesion,GO:1900042~positive regulation of interleukin-2 secretion,GO:1903076~regulation of protein localization to plasma membrane,GO:1903078~positive regulation of protein localization to plasma membrane,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0008091~spectrin,GO:0014069~postsynaptic density,GO:0014731~spectrin-associated cytoskeleton,GO:0030673~axolemma,GO:0031430~M band,GO:0032437~cuticular plate,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005543~phospholipid binding,GO:0030506~ankyrin binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0051020~GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001605:Pleckstrin homology domain, spectrin-type,IPR001715:Calponin homology domain,IPR001849:Pleckstrin homology domain,IPR002017:Spectrin repeat,IPR011993:Pleckstrin homology-like domain,IPR016343:Spectrin, beta subunit,IPR018159:Spectrin/alpha-actinin,			PIRSF002297:spectrin, beta subunit,	SM00033:CH,SM00150:SPEC,SM00233:PH,	3D-structure,Acetylation,Actin capping,Actin-binding,Alternative splicing,Calmodulin-binding,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Spectrin beta chain, brain 1,domain:Actin-binding,domain:CH 1,domain:CH 2,domain:PH,glycosylation site:O-linked (GlcNAc),helix,modified residue,region of interest:Interaction with ANK2,repeat:Spectrin 1,repeat:Spectrin 10,repeat:Spectrin 11,repeat:Spectrin 12,repeat:Spectrin 13,repeat:Spectrin 14,repeat:Spectrin 15,repeat:Spectrin 16,repeat:Spectrin 17,repeat:Spectrin 2,repeat:Spectrin 3,repeat:Spectrin 4,repeat:Spectrin 5,repeat:Spectrin 6,repeat:Spectrin 7,repeat:Spectrin 8,repeat:Spectrin 9,sequence conflict,sequence variant,splice variant,strand,turn,
SPDYA	speedy/RINGO cell cycle regulator family member A(SPDYA)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0006974~cellular response to DNA damage stimulus,GO:0007140~male meiosis,GO:0007275~multicellular organism development,GO:0008284~positive regulation of cell proliferation,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,	GO:0005634~nucleus,	GO:0019901~protein kinase binding,	IPR020984:Cell cycle regulatory protein, Spy1,	hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,				Alternative splicing,Cell cycle,Complete proteome,Developmental protein,DNA damage,Nucleus,Phosphoprotein,Reference proteome,	active site:Proton donor,chain:Serine/threonine-protein phosphatase PP1- beta catalytic subunit,chain:Speedy protein A,metal ion-binding site:Iron,metal ion-binding site:Manganese,modified residue,region of interest:Speedy/Ringo box; required for cdk- binding,sequence conflict,splice variant,
SPEN	spen family transcriptional repressor(SPEN)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0007219~Notch signaling pathway,GO:0016032~viral process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050769~positive regulation of neurogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR010912:Spen paralogue/orthologue C-terminal, metazoa,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012921:Spen paralogue and orthologue SPOC, C-terminal,IPR016194:SPOC like C-terminal domain,				SM00360:RRM,	3D-structure,Activator,Coiled coil,Complete proteome,DNA-binding,Host-virus interaction,Methylation,Notch signaling pathway,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,	chain:Msx2-interacting protein,compositionally biased region:Arg-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,compositionally biased region:Tyr-rich,domain:RID,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,domain:SPOC,helix,modified residue,region of interest:Interaction with MSX2,region of interest:Interaction with RBPSUH,sequence conflict,sequence variant,strand,turn,
SPAG16	sperm associated antigen 16(SPAG16)	Homo sapiens				GO:0007288~sperm axoneme assembly,GO:0035082~axoneme assembly,GO:0042384~cilium assembly,GO:0051012~microtubule sliding,GO:0060271~cilium morphogenesis,GO:0060294~cilium movement involved in cell motility,GO:0097231~cell motility in response to calcium ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005930~axoneme,GO:0031514~motile cilium,GO:1990716~axonemal central apparatus,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00320:WD40,	Alternative splicing,Cell projection,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Flagellum,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Sperm-associated antigen 16 protein,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
SPAG17	sperm associated antigen 17(SPAG17)	Homo sapiens				GO:0003351~epithelial cilium movement,GO:1904158~axonemal central apparatus assembly,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0031514~motile cilium,GO:1990716~axonemal central apparatus,		IPR026173:Sperm-associated antigen 17,					Cell projection,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Flagellum,Microtubule,Polymorphism,Reference proteome,	chain:Sperm-associated antigen 17,compositionally biased region:Lys-rich,repeat:LRR 1,repeat:LRR 2,sequence conflict,sequence variant,
SSFA2	sperm specific antigen 2(SSFA2)	Homo sapiens					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005102~receptor binding,GO:0051015~actin filament binding,	IPR026648:Sperm-specific antigen 2,				SM01257:SM01257,	Actin-binding,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Sperm-specific antigen 2,modified residue,sequence conflict,sequence variant,splice variant,
STPG1	sperm tail PG-rich repeat containing 1(STPG1)	Homo sapiens				GO:0006915~apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR010736:Sperm-tail PG-rich repeat,					Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:UPF0490 protein C1orf201,modified residue,sequence conflict,sequence variant,splice variant,
SPATA1	spermatogenesis associated 1(SPATA1)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,
SPATA17	spermatogenesis associated 17(SPATA17)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005516~calmodulin binding,	IPR000048:IQ motif, EF-hand binding site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00015:IQ,	Calmodulin-binding,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Repeat,	chain:Spermatogenesis-associated protein 17,domain:IQ 1,domain:IQ 2,domain:IQ 3,modified residue,sequence variant,
SPATA21	spermatogenesis associated 21(SPATA21)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Coiled coil,Complete proteome,Metal-binding,Polymorphism,Reference proteome,	chain:Spermatogenesis-associated protein 21,compositionally biased region:Pro-rich,domain:EF-hand,sequence variant,
SPATA3	spermatogenesis associated 3(SPATA3)	Homo sapiens					GO:0016021~integral component of membrane,		IPR026717:Spermatogenesis-associated protein 3,					Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Spermatogenesis-associated protein 3,sequence conflict,
SPATA45	spermatogenesis associated 45(SPATA45)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:UPF0732 protein C1orf227,sequence variant,
SPATA6	spermatogenesis associated 6(SPATA6)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0044458~motile cilium assembly,	GO:0005576~extracellular region,GO:0097224~sperm connecting piece,	GO:0032027~myosin light chain binding,	IPR027207:Spermatogenesis-associated protein 6,					Alternative splicing,Cell projection,Complete proteome,Developmental protein,Differentiation,Glycoprotein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Spermatogenesis,	chain:Spermatogenesis-associated protein 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
SPATS2L	spermatogenesis associated serine rich 2 like(SPATS2L)	Homo sapiens					GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0044822~poly(A) RNA binding,	IPR009060:UBA-like,IPR009816:Protein of unknown function DUF1387,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:SPATS2-like protein,modified residue,sequence conflict,splice variant,
SMPD4	sphingomyelin phosphodiesterase 4(SMPD4)	Homo sapiens				GO:0006685~sphingomyelin catabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0046475~glycerophospholipid catabolic process,GO:0046513~ceramide biosynthetic process,GO:0071356~cellular response to tumor necrosis factor,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0016021~integral component of membrane,	GO:0004767~sphingomyelin phosphodiesterase activity,GO:0046872~metal ion binding,GO:0050290~sphingomyelin phosphodiesterase D activity,	IPR024129:Sphingomyelin phosphodiesterase 4,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Hydrolase,Magnesium,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Sphingomyelin phosphodiesterase 4,modified residue,sequence conflict,splice variant,transmembrane region,
SMPDL3B	sphingomyelin phosphodiesterase acid like 3B(SMPDL3B)	Homo sapiens				GO:0006685~sphingomyelin catabolic process,GO:0006954~inflammatory response,GO:0034122~negative regulation of toll-like receptor signaling pathway,GO:0045087~innate immune response,GO:0046466~membrane lipid catabolic process,GO:0050728~negative regulation of inflammatory response,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0004767~sphingomyelin phosphodiesterase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0016787~hydrolase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0046872~metal ion binding,	IPR004843:Metallophosphoesterase domain,IPR017064:Acid sphingomyelinase-like phosphodiesterase, predicted,			PIRSF036767:acid sphingomyelinase-like phosphodiesterase,		Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Glycosidase,GPI-anchor,Hydrolase,Immunity,Inflammatory response,Innate immunity,Lipid degradation,Lipid metabolism,Lipoprotein,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Zinc,	chain:Acid sphingomyelinase-like phosphodiesterase 3b,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
SGPP2	sphingosine-1-phosphate phosphatase 2(SGPP2)	Homo sapiens				GO:0006670~sphingosine metabolic process,GO:0016311~dephosphorylation,GO:0030148~sphingolipid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0042392~sphingosine-1-phosphate phosphatase activity,GO:0070780~dihydrosphingosine-1-phosphate phosphatase activity,	IPR000326:Phosphatidic acid phosphatase type 2/haloperoxidase,	hsa00600:Sphingolipid metabolism,hsa04071:Sphingolipid signaling pathway,			SM00014:acidPPc,	Alternative splicing,Complete proteome,Endoplasmic reticulum,Hydrolase,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Sphingosine-1-phosphate phosphatase 2,transmembrane region,
S1PR1	sphingosine-1-phosphate receptor 1(S1PR1)	Homo sapiens		h_edg1Pathway:Phospholipids as signalling intermediaries,		GO:0001525~angiogenesis,GO:0001955~blood vessel maturation,GO:0003245~cardiac muscle tissue growth involved in heart morphogenesis,GO:0003376~sphingosine-1-phosphate signaling pathway,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007420~brain development,GO:0016477~cell migration,GO:0019226~transmission of nerve impulse,GO:0030032~lamellipodium assembly,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030335~positive regulation of cell migration,GO:0030500~regulation of bone mineralization,GO:0030595~leukocyte chemotaxis,GO:0031532~actin cytoskeleton reorganization,GO:0043547~positive regulation of GTPase activity,GO:0045124~regulation of bone resorption,GO:0045446~endothelial cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050927~positive regulation of positive chemotaxis,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0051497~negative regulation of stress fiber assembly,GO:0061384~heart trabecula morphogenesis,GO:0072678~T cell migration,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0031226~intrinsic component of plasma membrane,GO:0045121~membrane raft,	GO:0001664~G-protein coupled receptor binding,GO:0004930~G-protein coupled receptor activity,GO:0038036~sphingosine-1-phosphate receptor activity,GO:0046625~sphingolipid binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000987:EDG-1 sphingosine 1-phosphate receptor,IPR004061:Sphingosine 1-phosphate receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,			SM01381:SM01381,	3D-structure,Acetylation,Angiogenesis,Cell membrane,Chemotaxis,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Sphingosine 1-phosphate receptor 1,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SPSB1	splA/ryanodine receptor domain and SOCS box containing 1(SPSB1)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001496:SOCS protein, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00449:SPRY,SM00969:SM00969,	3D-structure,Complete proteome,Cytoplasm,Phosphoprotein,Receptor,Reference proteome,Ubl conjugation pathway,	chain:SPRY domain-containing SOCS box protein 1,domain:B30.2/SPRY,domain:SOCS box,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
SF3A3	splicing factor 3a subunit 3(SF3A3)	Homo sapiens			RNA processing and modification,	GO:0000375~RNA splicing, via transesterification reactions,GO:0000389~mRNA 3'-splice site recognition,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR000690:Zinc finger, C2H2-type matrin,IPR021966:Splicing factor SF3a60 binding domain,IPR024598:Domain of unknown function DUF3449,	hsa03040:Spliceosome,				3D-structure,Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Glycoprotein,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Spliceosome,Zinc,Zinc-finger,	chain:Splicing factor 3A subunit 3,compositionally biased region:Poly-Glu,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,zinc finger region:Matrin-type,
SF3B1	splicing factor 3b subunit 1(SF3B1)	Homo sapiens			RNA processing and modification,	GO:0000245~spliceosomal complex assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0016607~nuclear speck,GO:0034693~U11/U12 snRNP,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR015016:Splicing factor 3B subunit 1,IPR016024:Armadillo-type fold,	hsa03040:Spliceosome,	614286~Myelodysplastic syndrome, somatic,			3D-structure,Acetylation,Alternative splicing,Citrullination,Coiled coil,Complete proteome,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Spliceosome,Ubl conjugation,	chain:Splicing factor 3B subunit 1,helix,modified residue,mutagenesis site,region of interest:Interaction with PPP1R8,region of interest:Interaction with SF3B14,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 11,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,sequence conflict,strand,
SF3B6	splicing factor 3b subunit 6(SF3B6)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0001825~blastocyst formation,	GO:0005654~nucleoplasm,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03040:Spliceosome,			SM00360:RRM,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Reference proteome,RNA-binding,Ubl conjugation,	chain:Pre-mRNA branch site protein p14,domain:RRM,helix,modified residue,strand,turn,
SPRED2	sprouty related EVH1 domain containing 2(SPRED2)	Homo sapiens				GO:0000188~inactivation of MAPK activity,GO:0007275~multicellular organism development,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009966~regulation of signal transduction,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0090311~regulation of protein deacetylation,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030658~transport vesicle membrane,	GO:0005173~stem cell factor receptor binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030291~protein serine/threonine kinase inhibitor activity,	IPR000697:EVH1,IPR007875:Sprouty,IPR011993:Pleckstrin homology-like domain,IPR023337:c-Kit-binding domain,				SM00461:WH1,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Sprouty-related, EVH1 domain-containing protein 2,domain:KBD,domain:SPR,domain:WH1,helix,modified residue,sequence conflict,strand,
SSUH2	ssu-2 homolog (C. elegans)(SSUH2)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,		GO:0005737~cytoplasm,							Alternative splicing,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,	chain:Uncharacterized protein C3orf32,compositionally biased region:Cys-rich,sequence variant,
STAB1	stabilin 1(STAB1)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0016525~negative regulation of angiogenesis,GO:0042742~defense response to bacterium,GO:0055114~oxidation-reduction process,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030666~endocytic vesicle membrane,	GO:0005041~low-density lipoprotein receptor activity,GO:0005044~scavenger receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005540~hyaluronic acid binding,GO:0015035~protein disulfide oxidoreductase activity,GO:0030169~low-density lipoprotein particle binding,	IPR000538:Link,IPR000742:Epidermal growth factor-like domain,IPR000782:FAS1 domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR013032:EGF-like, conserved site,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR023413:Green fluorescent protein-like,IPR024731:EGF domain, merozoite surface protein 1-like,				SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,SM00445:LINK,SM00554:FAS1,	Alternative splicing,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Inflammatory response,Laminin EGF-like domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Stabilin-1,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 16,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:FAS1 1,domain:FAS1 2,domain:FAS1 3,domain:FAS1 4,domain:FAS1 5,domain:FAS1 6,domain:FAS1 7,domain:Laminin EGF-like 1,domain:Laminin EGF-like 2,domain:Link,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SAMD11	sterile alpha motif domain containing 11(SAMD11)	Homo sapiens					GO:0005634~nucleus,	GO:0003713~transcription coactivator activity,	IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,IPR024830:Glucocorticoid modulatory element-binding protein 1/2,				SM00454:SAM,	Alternative promoter usage,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Sterile alpha motif domain-containing protein 11,domain:SAM,sequence conflict,splice variant,
SAMD13	sterile alpha motif domain containing 13(SAMD13)	Homo sapiens							IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,					Alternative splicing,Complete proteome,Reference proteome,	chain:Sterile alpha motif domain-containing protein 13,domain:SAM,splice variant,
SRD5A2	steroid 5 alpha-reductase 2(SRD5A2)	Homo sapiens				GO:0006694~steroid biosynthetic process,GO:0006702~androgen biosynthetic process,GO:0006706~steroid catabolic process,GO:0007267~cell-cell signaling,GO:0008209~androgen metabolic process,GO:0008584~male gonad development,GO:0018879~biphenyl metabolic process,GO:0018894~dibenzo-p-dioxin metabolic process,GO:0018963~phthalate metabolic process,GO:0021766~hippocampus development,GO:0021854~hypothalamus development,GO:0030154~cell differentiation,GO:0030539~male genitalia development,GO:0030540~female genitalia development,GO:0031667~response to nutrient levels,GO:0032354~response to follicle-stimulating hormone,GO:0033574~response to testosterone,GO:0042448~progesterone metabolic process,GO:0042493~response to drug,GO:0043434~response to peptide hormone,GO:0048545~response to steroid hormone,GO:0055114~oxidation-reduction process,GO:0060348~bone development,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0043025~neuronal cell body,GO:0070852~cell body fiber,	GO:0003865~3-oxo-5-alpha-steroid 4-dehydrogenase activity,GO:0009917~sterol 5-alpha reductase activity,GO:0033218~amide binding,GO:0047751~cholestenone 5-alpha-reductase activity,	IPR001104:3-oxo-5-alpha-steroid 4-dehydrogenase, C-terminal,IPR016636:3-oxo-5-alpha-steroid 4-dehydrogenase,	hsa00140:Steroid hormone biosynthesis,hsa05215:Prostate cancer,	264600~Pseudovaginal perineoscrotal hypospadias,	PIRSF015596:3-oxo-5-alpha-steroid 4-dehydrogenase 2,		Complete proteome,Differentiation,Disease mutation,Endoplasmic reticulum,Membrane,Microsome,NADP,Oxidoreductase,Polymorphism,Pseudohermaphroditism,Reference proteome,Sexual differentiation,Transmembrane,Transmembrane helix,	chain:3-oxo-5-alpha-steroid 4-dehydrogenase 2,sequence variant,transmembrane region,
SOAT1	sterol O-acyltransferase 1(SOAT1)	Homo sapiens				GO:0008203~cholesterol metabolic process,GO:0010742~macrophage derived foam cell differentiation,GO:0010878~cholesterol storage,GO:0033344~cholesterol efflux,GO:0034379~very-low-density lipoprotein particle assembly,GO:0034435~cholesterol esterification,GO:0042632~cholesterol homeostasis,GO:0042986~positive regulation of amyloid precursor protein biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000062~fatty-acyl-CoA binding,GO:0004772~sterol O-acyltransferase activity,GO:0005515~protein binding,GO:0008374~O-acyltransferase activity,GO:0015485~cholesterol binding,GO:0034736~cholesterol O-acyltransferase activity,	IPR004299:Membrane bound O-acyl transferase, MBOAT,IPR014371:Sterol O-acyltransferase, ACAT/DAG/ARE types,	hsa00100:Steroid biosynthesis,		PIRSF000439:sterol O-acyltransferase, ACAT/DAG/ARE types,PIRSF500230:sterol O-acyltransferase, ACAT type [Parent=PIRSF000439],		Acetylation,Acyltransferase,Alternative splicing,Cholesterol metabolism,Complete proteome,Disulfide bond,Endoplasmic reticulum,Lipid metabolism,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Steroid metabolism,Sterol metabolism,Transferase,Transmembrane,Transmembrane helix,	chain:Sterol O-acyltransferase 1,sequence variant,transmembrane region,
SCP2	sterol carrier protein 2(SCP2)	Homo sapiens				GO:0006694~steroid biosynthetic process,GO:0006699~bile acid biosynthetic process,GO:0006701~progesterone biosynthetic process,GO:0007031~peroxisome organization,GO:0008152~metabolic process,GO:0015914~phospholipid transport,GO:0015918~sterol transport,GO:0032385~positive regulation of intracellular cholesterol transport,GO:0032959~inositol trisphosphate biosynthetic process,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0036109~alpha-linolenic acid metabolic process,GO:0045940~positive regulation of steroid metabolic process,GO:0072659~protein localization to plasma membrane,GO:1901373~lipid hydroperoxide transport,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0000062~fatty-acyl-CoA binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008526~phosphatidylinositol transporter activity,GO:0015248~sterol transporter activity,GO:0015485~cholesterol binding,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0033814~propanoyl-CoA C-acyltransferase activity,GO:0036042~long-chain fatty acyl-CoA binding,GO:0050632~propionyl-CoA C2-trimethyltridecanoyltransferase activity,GO:0070538~oleic acid binding,	IPR002155:Thiolase,IPR003033:SCP2 sterol-binding domain,IPR016039:Thiolase-like,IPR020613:Thiolase, conserved site,IPR020615:Thiolase, acyl-enzyme intermediate active site,IPR020616:Thiolase, N-terminal,IPR020617:Thiolase, C-terminal,	hsa00120:Primary bile acid biosynthesis,hsa01100:Metabolic pathways,hsa03320:PPAR signaling pathway,hsa04146:Peroxisome,	613724~Leukoencephalopathy with dystonia and motor neuropathy,	PIRSF000429:acetyl-CoA acetyltransferase,		3D-structure,Acetylation,Acyltransferase,Alternative initiation,Alternative promoter usage,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Lipid transport,Lipid-binding,Mitochondrion,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transport,	chain:Non-specific lipid-transfer protein,domain:SCP2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Microbody targeting signal,splice variant,strand,turn,
STON1	stonin 1(STON1)	Homo sapiens				GO:0006897~endocytosis,GO:0030100~regulation of endocytosis,	GO:0005737~cytoplasm,GO:0016020~membrane,		IPR012320:Stonin homology,					Alternative splicing,Complete proteome,Cytoplasm,Endocytosis,Membrane,Polymorphism,Reference proteome,	chain:Stonin-1,chain:TFIIA-alpha and beta-like factor,domain:MHD,domain:SHD,sequence conflict,sequence variant,
STRIP1	striatin interacting protein 1(STRIP1)	Homo sapiens				GO:0022604~regulation of cell morphogenesis,GO:0030866~cortical actin cytoskeleton organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR012486:N1221-like,IPR021819:Protein of unknown function DUF3402,				SM01292:SM01292,SM01293:SM01293,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,	chain:Protein FAM40A,compositionally biased region:Pro-rich,modified residue,sequence conflict,splice variant,
STRN	striatin(STRN)	Homo sapiens				GO:0007626~locomotory behavior,GO:0008285~negative regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0016358~dendrite development,GO:0070830~bicellular tight junction assembly,	GO:0000159~protein phosphatase type 2A complex,GO:0005737~cytoplasm,GO:0005923~bicellular tight junction,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0045211~postsynaptic membrane,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0030331~estrogen receptor binding,GO:0032403~protein complex binding,GO:0051721~protein phosphatase 2A binding,GO:0070016~armadillo repeat domain binding,	IPR001680:WD40 repeat,IPR013258:Striatin, N-terminal,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00320:WD40,	Alternative splicing,Calmodulin-binding,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Reference proteome,Repeat,WD repeat,	chain:Striatin,modified residue,region of interest:Calmodulin-binding,region of interest:Caveolin-binding,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,splice variant,
SDF4	stromal cell derived factor 4(SDF4)	Homo sapiens				GO:0009650~UV protection,GO:0017156~calcium ion regulated exocytosis,GO:0021549~cerebellum development,GO:0045444~fat cell differentiation,GO:0045471~response to ethanol,GO:0070625~zymogen granule exocytosis,	GO:0005737~cytoplasm,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0032059~bleb,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0042802~identical protein binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR027240:Calcium-binding protein CAB45,				SM00054:EFh,	Alternative splicing,Calcium,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Exocytosis,Glycoprotein,Golgi apparatus,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,calcium-binding region:4,calcium-binding region:5,calcium-binding region:6,chain:45 kDa calcium-binding protein,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,domain:EF-hand 5,domain:EF-hand 6,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Necessary for intracellular retention in Golgi apparatus lumen,sequence conflict,sequence variant,signal peptide,splice variant,
SMC6	structural maintenance of chromosomes 6(SMC6)	Homo sapiens			Cell division and chromosome partitioning,	GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0016925~protein sumoylation,GO:0051984~positive regulation of chromosome segregation,GO:0071139~resolution of recombination intermediates,GO:0090398~cellular senescence,	GO:0000781~chromosome, telomeric region,GO:0000803~sex chromosome,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016605~PML body,GO:0016607~nuclear speck,GO:0030915~Smc5-Smc6 complex,GO:0035061~interchromatin granule,GO:0035861~site of double-strand break,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,	IPR003395:RecF/RecN/SMC,IPR027132:Structural maintenance of chromosomes protein 6,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,ATP-binding,Chromosome,Coiled coil,Complete proteome,DNA damage,DNA recombination,DNA repair,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,Ubl conjugation,	chain:Structural maintenance of chromosomes protein 6,compositionally biased region:Ala/Asp-rich (DA-box),modified residue,nucleotide phosphate-binding region:ATP,region of interest:Flexible hinge,sequence conflict,sequence variant,splice variant,
STUM	stum, mechanosensory transduction mediator homolog(STUM)	Homo sapiens					GO:0016021~integral component of membrane,		IPR026673:SPEC3/C1orf95,					Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized membrane protein C1orf95,transmembrane region,
SDHB	succinate dehydrogenase complex iron sulfur subunit B(SDHB)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0006099~tricarboxylic acid cycle,GO:0006105~succinate metabolic process,GO:0009060~aerobic respiration,GO:0022904~respiratory electron transport chain,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005749~mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),GO:0005886~plasma membrane,GO:0031966~mitochondrial membrane,GO:0045273~respiratory chain complex II,GO:0070062~extracellular exosome,	GO:0000104~succinate dehydrogenase activity,GO:0005515~protein binding,GO:0008177~succinate dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0048039~ubiquinone binding,GO:0051537~2 iron, 2 sulfur cluster binding,GO:0051538~3 iron, 4 sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001041:2Fe-2S ferredoxin-type domain,IPR004489:Succinate dehydrogenase/fumarate reductase iron-sulphur protein,IPR006058:2Fe-2S ferredoxin, iron-sulphur binding site,IPR009051:Alpha-helical ferredoxin,IPR012675:Beta-grasp domain,IPR017896:4Fe-4S ferredoxin-type, iron-sulpur binding domain,IPR017900:4Fe-4S ferredoxin, iron-sulphur binding, conserved site,IPR025192:Succinate dehydogenase/fumarate reductase N-terminal,	hsa00020:Citrate cycle (TCA cycle),hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	115310~Paragangliomas 4,171300~Pheochromocytoma,606764~Gastrointestinal stromal tumor,606864~Paraganglioma and gastric stromal sarcoma,612359~Cowden syndrome 2,			2Fe-2S,3Fe-4S,4Fe-4S,Acetylation,Complete proteome,Disease mutation,Electron transport,Iron,Iron-sulfur,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transport,Tricarboxylic acid cycle,	binding site:Ubiquinone; shared with DHSD,chain:Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial,domain:2Fe-2S ferredoxin-type,domain:4Fe-4S ferredoxin-type,metal ion-binding site:Iron-sulfur 1 (2Fe-2S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S),metal ion-binding site:Iron-sulfur 3 (3Fe-4S),sequence conflict,sequence variant,transit peptide:Mitochondrion,
SDHC	succinate dehydrogenase complex subunit C(SDHC)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0006099~tricarboxylic acid cycle,GO:0006121~mitochondrial electron transport, succinate to ubiquinone,GO:0009060~aerobic respiration,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005749~mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045273~respiratory chain complex II,GO:0045281~succinate dehydrogenase complex,	GO:0000104~succinate dehydrogenase activity,GO:0009055~electron carrier activity,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR000701:Succinate dehydrogenase/Fumarate reductase, transmembrane subunit,IPR014314:Succinate dehydrogenase, cytochrome b556 subunit,IPR018495:Succinate dehydrogenase, cytochrome b subunit, conserved site,	hsa00020:Citrate cycle (TCA cycle),hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	605373~Paragangliomas 3,606764~Gastrointestinal stromal tumor,606864~Paraganglioma and gastric stromal sarcoma,			Alternative splicing,Complete proteome,Electron transport,Heme,Iron,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,Tricarboxylic acid cycle,	chain:Succinate dehydrogenase cytochrome b560 subunit, mitochondrial,metal ion-binding site:Iron (heme axial ligand),transit peptide:Mitochondrion,transmembrane region,
SUCLG2	succinate-CoA ligase GDP-forming beta subunit(SUCLG2)	Homo sapiens				GO:0006099~tricarboxylic acid cycle,GO:0006104~succinyl-CoA metabolic process,GO:0006105~succinate metabolic process,GO:0008152~metabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005815~microtubule organizing center,GO:0005886~plasma membrane,GO:0045244~succinate-CoA ligase complex (GDP-forming),	GO:0003824~catalytic activity,GO:0004776~succinate-CoA ligase (GDP-forming) activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016874~ligase activity,GO:0019003~GDP binding,GO:0046982~protein heterodimerization activity,	IPR005809:Succinyl-CoA synthetase, beta subunit,IPR005811:ATP-citrate lyase/succinyl-CoA ligase,IPR013650:ATP-grasp fold, succinyl-CoA synthetase-type,IPR013815:ATP-grasp fold, subdomain 1,IPR013816:ATP-grasp fold, subdomain 2,IPR016102:Succinyl-CoA synthetase-like,IPR017866:Succinyl-CoA synthetase, beta subunit, conserved site,	hsa00020:Citrate cycle (TCA cycle),hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,		PIRSF001554:succinyl-CoA synthetase, beta subunit,		Acetylation,Alternative splicing,Complete proteome,GTP-binding,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Tricarboxylic acid cycle,	chain:Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial,domain:ATP-grasp,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
SUMF1	sulfatase modifying factor 1(SUMF1)	Homo sapiens				GO:0006687~glycosphingolipid metabolic process,GO:0043687~post-translational protein modification,GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0016491~oxidoreductase activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR005532:Formylglycine-generating sulphatase enzyme domain,IPR016187:C-type lectin fold,	hsa04142:Lysosome,	272200~Multiple sulfatase deficiency,			3D-structure,Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Ichthyosis,Leukodystrophy,Metachromatic leukodystrophy,Metal-binding,Mucopolysaccharidosis,Oxidoreductase,Polymorphism,Proteomics identification,Redox-active center,Reference proteome,Signal,	active site:Proton acceptor,chain:Sulfatase-modifying factor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,mutagenesis site,region of interest:Interaction with sulfatases,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
SULT1C2	sulfotransferase family 1C member 2(SULT1C2)	Homo sapiens				GO:0009308~amine metabolic process,GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process,GO:0051923~sulfation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004062~aryl sulfotransferase activity,GO:0005515~protein binding,GO:0008146~sulfotransferase activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	active site:Proton acceptor,chain:Sulfotransferase 1C2,helix,nucleotide phosphate-binding region:PAPS,sequence variant,splice variant,strand,turn,
SULT1C3	sulfotransferase family 1C member 3(SULT1C3)	Homo sapiens				GO:0006790~sulfur compound metabolic process,	GO:0005737~cytoplasm,	GO:0004027~alcohol sulfotransferase activity,GO:0004062~aryl sulfotransferase activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Transferase,	active site:Proton acceptor,chain:Sulfotransferase 1C3,helix,nucleotide phosphate-binding region:PAPS,sequence variant,splice variant,strand,turn,
SULT6B1	sulfotransferase family 6B member 1(SULT6B1)	Homo sapiens					GO:0005737~cytoplasm,	GO:0001517~N-acetylglucosamine 6-O-sulfotransferase activity,GO:0001537~N-acetylgalactosamine 4-O-sulfotransferase activity,GO:0004394~heparan sulfate 2-O-sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0016232~HNK-1 sulfotransferase activity,GO:0017095~heparan sulfate 6-O-sulfotransferase activity,GO:0018721~trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity,GO:0018722~1-phenanthrol sulfotransferase activity,GO:0018723~3-phenanthrol sulfotransferase activity,GO:0018724~4-phenanthrol sulfotransferase activity,GO:0018725~trans-3,4-dihydrodiolphenanthrene sulfotransferase activity,GO:0018726~9-phenanthrol sulfotransferase activity,GO:0018727~2-phenanthrol sulfotransferase activity,GO:0034930~1-hydroxypyrene sulfotransferase activity,GO:0050694~galactose 3-O-sulfotransferase activity,GO:0050698~proteoglycan sulfotransferase activity,GO:0051922~cholesterol sulfotransferase activity,GO:0080131~hydroxyjasmonate sulfotransferase activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,Transferase,	active site:Proton acceptor,chain:Sulfotransferase 6B1,nucleotide phosphate-binding region:PAPS,sequence variant,splice variant,
ST7L	suppression of tumorigenicity 7 like(ST7L)	Homo sapiens				GO:0030308~negative regulation of cell growth,	GO:0016021~integral component of membrane,		IPR007311:ST7,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Suppressor of tumorigenicity 7 protein- like,sequence conflict,sequence variant,splice variant,transmembrane region,
SOCS5	suppressor of cytokine signaling 5(SOCS5)	Homo sapiens				GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0007259~JAK-STAT cascade,GO:0009968~negative regulation of signal transduction,GO:0016049~cell growth,GO:0016567~protein ubiquitination,GO:0019221~cytokine-mediated signaling pathway,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032715~negative regulation of interleukin-6 production,GO:0040008~regulation of growth,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045629~negative regulation of T-helper 2 cell differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0050728~negative regulation of inflammatory response,GO:0071638~negative regulation of monocyte chemotactic protein-1 production,GO:1904988~negative regulation of endothelial cell activation,	GO:0005737~cytoplasm,	GO:0004860~protein kinase inhibitor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,	IPR000980:SH2 domain,IPR001496:SOCS protein, C-terminal,IPR022252:Suppressor of cytokine signalling,	hsa04630:Jak-STAT signaling pathway,hsa04917:Prolactin signaling pathway,			SM00252:SH2,SM00253:SOCS,SM00969:SM00969,	Complete proteome,Growth regulation,Reference proteome,SH2 domain,Signal transduction inhibitor,Ubl conjugation pathway,	chain:Suppressor of cytokine signaling 5,domain:SH2,domain:SOCS box,sequence conflict,
SFTPB	surfactant protein B(SFTPB)	Homo sapiens				GO:0006665~sphingolipid metabolic process,GO:0007585~respiratory gaseous exchange,GO:0009887~organ morphogenesis,GO:0043085~positive regulation of catalytic activity,GO:0044267~cellular protein metabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005764~lysosome,GO:0005771~multivesicular body,GO:0005789~endoplasmic reticulum membrane,GO:0042599~lamellar body,GO:0045334~clathrin-coated endocytic vesicle,GO:0097208~alveolar lamellar body,GO:0097486~multivesicular body lumen,	GO:0001664~G-protein coupled receptor binding,GO:0008047~enzyme activator activity,	IPR003119:Saposin type A,IPR007856:Saposin-like type B, 1,IPR008138:Saposin-like type B, 2,IPR008139:Saposin B,IPR008373:Saposin,IPR011001:Saposin-like,		265120~Surfactant metabolism dysfunction, pulmonary, 1,		SM00162:SAPA,SM00741:SapB,	3D-structure,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Gaseous exchange,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Surface film,	chain:Pulmonary surfactant-associated protein B,disulfide bond,domain:Saposin A-type,domain:Saposin B-type 1,domain:Saposin B-type 2,domain:Saposin B-type 3,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,
SUSD4	sushi domain containing 4(SUSD4)	Homo sapiens				GO:0006958~complement activation, classical pathway,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,GO:0045957~negative regulation of complement activation, alternative pathway,GO:0045959~negative regulation of complement activation, classical pathway,	GO:0005576~extracellular region,GO:0016021~integral component of membrane,		IPR000436:Sushi/SCR/CCP,				SM00032:CCP,	Alternative splicing,Complement pathway,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Membrane,Reference proteome,Repeat,Secreted,Signal,Sushi,Transmembrane,Transmembrane helix,	chain:Sushi domain-containing protein 4,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SUSD5	sushi domain containing 5(SUSD5)	Homo sapiens				GO:0007155~cell adhesion,GO:0007219~Notch signaling pathway,	GO:0016021~integral component of membrane,	GO:0005540~hyaluronic acid binding,	IPR000436:Sushi/SCR/CCP,IPR000538:Link,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00445:LINK,	Complete proteome,Disulfide bond,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Sushi,Transmembrane,Transmembrane helix,	chain:Sushi domain-containing protein 5,disulfide bond,domain:Link,domain:Sushi,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SNED1	sushi, nidogen and EGF like domains 1(SNED1)	Homo sapiens				GO:0007160~cell-matrix adhesion,	GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000436:Sushi/SCR/CCP,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR003886:Nidogen, extracellular domain,IPR003961:Fibronectin, type III,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013783:Immunoglobulin-like fold,IPR018097:EGF-like calcium-binding, conserved site,				SM00032:CCP,SM00060:FN3,SM00179:EGF_CA,SM00181:EGF,SM00539:NIDO,	Alternative splicing,Calcium,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Sushi, nidogen and EGF-like domain- containing protein 1,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11; calcium-binding,domain:EGF-like 12; calcium-binding,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4; calcium-binding,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Follistatin-like 1,domain:Follistatin-like 2,domain:NIDO,domain:Sushi,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
SYDE2	synapse defective Rho GTPase homolog 2(SYDE2)	Homo sapiens				GO:0007165~signal transduction,GO:0043087~regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0090630~activation of GTPase activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR000198:Rho GTPase-activating protein domain,IPR008936:Rho GTPase activation protein,				SM00324:RhoGAP,	Alternative splicing,Complete proteome,GTPase activation,Phosphoprotein,Polymorphism,Reference proteome,	chain:Rho GTPase-activating protein SYDE2,domain:C2,domain:Rho-GAP,modified residue,sequence conflict,sequence variant,splice variant,
SYN2	synapsin II(SYN2)	Homo sapiens				GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,	GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0031201~SNARE complex,GO:0043209~myelin sheath,GO:0045202~synapse,	GO:0003824~catalytic activity,GO:0005524~ATP binding,	IPR001359:Synapsin,IPR013815:ATP-grasp fold, subdomain 1,IPR013816:ATP-grasp fold, subdomain 2,IPR016185:Pre-ATP-grasp domain,IPR019735:Synapsin, conserved site,IPR019736:Synapsin, phosphorylation site,IPR020897:Synapsin, pre-ATP-grasp domain,IPR020898:Synapsin, ATP-binding domain,		181500~Schizophrenia, susceptibility to,			Alternative splicing,Cell junction,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Synapse,	chain:Synapsin-2,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,modified residue,region of interest:A,region of interest:B; linker,region of interest:C; actin-binding and synaptic-vesicle binding,region of interest:E,region of interest:G; Pro-rich linker,region of interest:H; Pro/Ser-rich linker,sequence conflict,sequence variant,splice variant,
SYCP1	synaptonemal complex protein 1(SYCP1)	Homo sapiens				GO:0000711~meiotic DNA repair synthesis,GO:0007129~synapsis,GO:0007130~synaptonemal complex assembly,GO:0007131~reciprocal meiotic recombination,GO:0007283~spermatogenesis,GO:0032880~regulation of protein localization,GO:0035092~sperm chromatin condensation,GO:0051026~chiasma assembly,GO:0051301~cell division,GO:0051878~lateral element assembly,	GO:0000775~chromosome, centromeric region,GO:0000795~synaptonemal complex,GO:0000801~central element,GO:0000802~transverse filament,GO:0001673~male germ cell nucleus,	GO:0003677~DNA binding,	IPR008827:Synaptonemal complex 1,IPR024835:Synaptonemal complex protein 2/protein 2-like,					3D-structure,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Meiosis,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Synaptonemal complex protein 1,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Asp/Glu-rich (acidic),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
SYNPR	synaptoporin(SYNPR)	Homo sapiens				GO:0006810~transport,	GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030285~integral component of synaptic vesicle membrane,GO:0043005~neuron projection,	GO:0005215~transporter activity,GO:0005515~protein binding,	IPR001285:Synaptophysin/synaptoporin,IPR008253:Marvel,					Alternative splicing,Cell junction,Complete proteome,Cytoplasmic vesicle,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Synaptosome,Transmembrane,Transmembrane helix,	chain:Synaptoporin,domain:MARVEL,glycosylation site:N-linked (GlcNAc...),region of interest:5 X approximate repeats,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
SNAP47	synaptosome associated protein 47(SNAP47)	Homo sapiens				GO:0016082~synaptic vesicle priming,GO:0031629~synaptic vesicle fusion to presynaptic active zone membrane,GO:0060291~long-term synaptic potentiation,	GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0030425~dendrite,GO:0031083~BLOC-1 complex,GO:0031201~SNARE complex,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,GO:0098793~presynapse,	GO:0005484~SNAP receptor activity,GO:0005515~protein binding,GO:0019905~syntaxin binding,	IPR000727:Target SNARE coiled-coil domain,IPR004182:GRAM,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Synaptosomal-associated protein 47,domain:t-SNARE coiled-coil homology 1,domain:t-SNARE coiled-coil homology 2,sequence conflict,sequence variant,splice variant,
SYT11	synaptotagmin 11(SYT11)	Homo sapiens				GO:0001778~plasma membrane repair,GO:0006906~vesicle fusion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0046929~negative regulation of neurotransmitter secretion,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0050765~negative regulation of phagocytosis,GO:0051289~protein homotetramerization,GO:1900165~negative regulation of interleukin-6 secretion,GO:1900243~negative regulation of synaptic vesicle endocytosis,GO:1900424~regulation of defense response to bacterium,GO:1904468~negative regulation of tumor necrosis factor secretion,GO:1905154~negative regulation of membrane invagination,GO:1905162~regulation of phagosome maturation,GO:1905171~positive regulation of protein localization to phagocytic vesicle,GO:1990927~calcium ion regulated lysosome exocytosis,	GO:0001891~phagocytic cup,GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008021~synaptic vesicle,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030424~axon,GO:0030672~synaptic vesicle membrane,GO:0032009~early phagosome,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0044297~cell body,GO:0045335~phagocytic vesicle,GO:0048787~presynaptic active zone membrane,GO:0055037~recycling endosome,GO:0060076~excitatory synapse,GO:0060077~inhibitory synapse,GO:0098793~presynapse,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,GO:0031369~translation initiation factor binding,GO:0031625~ubiquitin protein ligase binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0048487~beta-tubulin binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,				SM00239:C2,	Calcium,Cell junction,Complete proteome,Cytoplasmic vesicle,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Synapse,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Synaptotagmin-11,domain:C2 1,domain:C2 2,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 3,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
SYT14	synaptotagmin 14(SYT14)	Homo sapiens				GO:0006906~vesicle fusion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,	IPR000008:C2 calcium-dependent membrane targeting,		614229~Spinocerebellar ataxia, autosomal recessive 11,		SM00239:C2,	Alternative splicing,Complete proteome,Disease mutation,Membrane,Neurodegeneration,Polymorphism,Reference proteome,Repeat,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Synaptotagmin-14,domain:C2 1,domain:C2 2,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SYT2	synaptotagmin 2(SYT2)	Homo sapiens				GO:0006906~vesicle fusion,GO:0007269~neurotransmitter secretion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0048488~synaptic vesicle endocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:1903861~positive regulation of dendrite extension,	GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0042584~chromaffin granule membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,GO:0043533~inositol 1,3,4,5 tetrakisphosphate binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,		616040~Myasthenic syndrome, congenital, 7, presynaptic,		SM00239:C2,	Calcium,Cell junction,Complete proteome,Congenital myasthenic syndrome,Cytoplasmic vesicle,Differentiation,Disease mutation,Glycoprotein,Membrane,Metal-binding,Phosphoprotein,Reference proteome,Repeat,Synapse,Transmembrane,Transmembrane helix,	chain:Synaptotagmin-2,domain:C2 1,domain:C2 2,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,region of interest:Phospholipid binding,sequence conflict,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
SYT6	synaptotagmin 6(SYT6)	Homo sapiens				GO:0006906~vesicle fusion,GO:0007340~acrosome reaction,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0060478~acrosomal vesicle exocytosis,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0070382~exocytic vesicle,GO:0097038~perinuclear endoplasmic reticulum,	GO:0001786~phosphatidylserine binding,GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,GO:0042803~protein homodimerization activity,GO:0048306~calcium-dependent protein binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,				SM00239:C2,	Alternative splicing,Calcium,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Disulfide bond,Membrane,Metal-binding,Phosphoprotein,Reference proteome,Repeat,Synapse,Transmembrane,Transmembrane helix,	chain:Synaptotagmin-6,domain:C2 1,domain:C2 2,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 3,splice variant,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
SYNC	syncoilin, intermediate filament protein(SYNC)	Homo sapiens		h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,		GO:0045103~intermediate filament-based process,	GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0030018~Z disc,GO:0031594~neuromuscular junction,GO:0042383~sarcolemma,GO:0048471~perinuclear region of cytoplasm,	GO:0005198~structural molecule activity,	IPR001664:Intermediate filament protein,				SM01391:SM01391,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Intermediate filament,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Syncoilin,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,
SDC1	syndecan 1(SDC1)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0001657~ureteric bud development,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0006954~inflammatory response,GO:0009636~response to toxic substance,GO:0016477~cell migration,GO:0030203~glycosaminoglycan metabolic process,GO:0042060~wound healing,GO:0042157~lipoprotein metabolic process,GO:0042476~odontogenesis,GO:0042542~response to hydrogen peroxide,GO:0048627~myoblast development,GO:0051384~response to glucocorticoid,GO:0051591~response to cAMP,GO:0051592~response to calcium ion,GO:0055002~striated muscle cell development,GO:0060009~Sertoli cell development,GO:0060070~canonical Wnt signaling pathway,GO:1903543~positive regulation of exosomal secretion,GO:1903553~positive regulation of extracellular exosome assembly,	GO:0005737~cytoplasm,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0043202~lysosomal lumen,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,	IPR001050:Syndecan,IPR003585:Neurexin/syndecan/glycophorin C,	hsa04512:ECM-receptor interaction,hsa04514:Cell adhesion molecules (CAMs),hsa05144:Malaria,hsa05205:Proteoglycans in cancer,			SM00294:4.1m,	3D-structure,Complete proteome,Glycoprotein,Heparan sulfate,Membrane,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Syndecan-1,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (chondroitin sulfate),glycosylation site:O-linked (Xyl...) (heparan sulfate),modified residue,sequence conflict,sequence variant,signal peptide,site:Cleavage of ectodomain,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SDC3	syndecan 3(SDC3)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0016477~cell migration,GO:0030203~glycosaminoglycan metabolic process,	GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043202~lysosomal lumen,		IPR001050:Syndecan,IPR003585:Neurexin/syndecan/glycophorin C,	hsa04514:Cell adhesion molecules (CAMs),	601665~Obesity, association with,		SM00294:4.1m,	Complete proteome,Glycoprotein,Heparan sulfate,Membrane,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Syndecan-3,compositionally biased region:Ser/Thr-rich (mucin-like),glycosylation site:O-linked (Xyl...) (glycosaminoglycan),modified residue,sequence variant,site:Cleavage of ectodomain,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
STX12	syntaxin 12(STX12)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0006886~intracellular protein transport,GO:0006906~vesicle fusion,GO:0016192~vesicle-mediated transport,GO:0033344~cholesterol efflux,GO:0048278~vesicle docking,GO:0050821~protein stabilization,GO:0061025~membrane fusion,	GO:0000139~Golgi membrane,GO:0000407~pre-autophagosomal structure,GO:0005622~intracellular,GO:0010008~endosome membrane,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031083~BLOC-1 complex,GO:0031201~SNARE complex,GO:0031982~vesicle,GO:0045121~membrane raft,GO:0045335~phagocytic vesicle,GO:0070062~extracellular exosome,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,	IPR000727:Target SNARE coiled-coil domain,IPR006011:Syntaxin, N-terminal,IPR006012:Syntaxin/epimorphin, conserved site,IPR010989:t-SNARE,	hsa04145:Phagosome,			SM00397:t_SNARE,SM00503:SynN,	3D-structure,Acetylation,Coiled coil,Complete proteome,Endosome,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Syntaxin-12,domain:t-SNARE coiled-coil homology,helix,modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
STX19	syntaxin 19(STX19)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0031629~synaptic vesicle fusion to presynaptic active zone membrane,GO:0048278~vesicle docking,	GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016021~integral component of membrane,GO:0031201~SNARE complex,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,	IPR000727:Target SNARE coiled-coil domain,IPR006011:Syntaxin, N-terminal,IPR006012:Syntaxin/epimorphin, conserved site,IPR010989:t-SNARE,IPR015708:Syntaxin-3,	hsa04130:SNARE interactions in vesicular transport,			SM00397:t_SNARE,	Coiled coil,Complete proteome,Membrane,Reference proteome,	chain:Syntaxin-19,compositionally biased region:Cys-rich,domain:t-SNARE coiled-coil homology,
STX6	syntaxin 6(STX6)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0006906~vesicle fusion,GO:0007032~endosome organization,GO:0032456~endocytic recycling,GO:0032880~regulation of protein localization,GO:0042147~retrograde transport, endosome to Golgi,GO:0048193~Golgi vesicle transport,GO:0048278~vesicle docking,GO:0090161~Golgi ribbon formation,GO:1903827~regulation of cellular protein localization,	GO:0000139~Golgi membrane,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030136~clathrin-coated vesicle,GO:0031201~SNARE complex,GO:0032588~trans-Golgi network membrane,GO:0043195~terminal bouton,GO:0045335~phagocytic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0005484~SNAP receptor activity,GO:0005515~protein binding,GO:0019905~syntaxin binding,	IPR000727:Target SNARE coiled-coil domain,IPR006012:Syntaxin/epimorphin, conserved site,IPR010989:t-SNARE,IPR015260:Syntaxin 6, N-terminal,	hsa04130:SNARE interactions in vesicular transport,			SM00397:t_SNARE,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Golgi apparatus,Membrane,Phosphoprotein,Protein transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Syntaxin-6,domain:t-SNARE coiled-coil homology,helix,modified residue,sequence conflict,topological domain:Cytoplasmic,transmembrane region,
STXBP3	syntaxin binding protein 3(STXBP3)	Homo sapiens			Intracellular trafficking and secretion,	GO:0006904~vesicle docking involved in exocytosis,GO:0007420~brain development,GO:0015758~glucose transport,GO:0022615~protein to membrane docking,GO:0030073~insulin secretion,GO:0032868~response to insulin,GO:0043312~neutrophil degranulation,GO:0045955~negative regulation of calcium ion-dependent exocytosis,GO:0051291~protein heterooligomerization,GO:0070527~platelet aggregation,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031091~platelet alpha granule,GO:0042581~specific granule,GO:0070062~extracellular exosome,GO:0070820~tertiary granule,	GO:0005515~protein binding,GO:0017075~syntaxin-1 binding,GO:0019905~syntaxin binding,	IPR001619:Sec1-like protein,IPR027482:Sec1-like, domain 2,			PIRSF005715:vesicle trafficking protein, VPS45/Sec1 type,		Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Transport,	chain:Syntaxin-binding protein 3,modified residue,sequence conflict,sequence variant,
SNTG2	syntrophin gamma 2(SNTG2)	Homo sapiens				GO:0007417~central nervous system development,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016013~syntrophin complex,GO:0042383~sarcolemma,	GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0030165~PDZ domain binding,GO:0097109~neuroligin family protein binding,	IPR001478:PDZ domain,IPR011993:Pleckstrin homology-like domain,IPR015482:Syntrophin,				SM00228:PDZ,	Actin-binding,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Polymorphism,Reference proteome,	chain:Gamma-2-syntrophin,compositionally biased region:Poly-Pro,domain:PDZ,domain:PH,sequence variant,
TRIT1	tRNA isopentenyltransferase 1(TRIT1)	Homo sapiens				GO:0006400~tRNA modification,GO:0008033~tRNA processing,GO:0009058~biosynthetic process,GO:0070900~mitochondrial tRNA modification,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003676~nucleic acid binding,GO:0004161~dimethylallyltranstransferase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0052381~tRNA dimethylallyltransferase activity,	IPR002648:Isopentenyl transferase,IPR003604:Zinc finger, U1-type,IPR018022:tRNA delta(2)-isopentenylpyrophosphate transferase,IPR022755:Zinc finger, double-stranded RNA binding,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa01100:Metabolic pathways,			SM00451:ZnF_U1,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Metal-binding,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,tRNA processing,Zinc,Zinc-finger,	chain:tRNA isopentenyltransferase, mitochondrial,modified residue,region of interest:Interaction with isopentenylpyrophosphate transferase,region of interest:Interaction with substrate tRNA,region of interest:Substrate binding,sequence conflict,sequence variant,site:Interaction with substrate tRNA,splice variant,transit peptide:Mitochondrion,zinc finger region:Matrin-type,
TRMT13	tRNA methyltransferase 13 homolog(TRMT13)	Homo sapiens				GO:0030488~tRNA methylation,		GO:0008168~methyltransferase activity,GO:0008175~tRNA methyltransferase activity,GO:0046872~metal ion binding,	IPR007871:Methyltransferase TRM13,IPR021721:Zinc finger, CCCH-type, TRM13,IPR022776:TRM13/UPF0224 family, U11-48K-like CHHC zinc finger domain,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Methyltransferase,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,tRNA processing,Zinc,Zinc-finger,	chain:tRNA guanosine-2'-O-methyltransferase TRM13 homolog,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:CHHC-type,
TRMT61B	tRNA methyltransferase 61B(TRMT61B)	Homo sapiens				GO:0031167~rRNA methylation,GO:0051260~protein homooligomerization,GO:0070901~mitochondrial tRNA methylation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031515~tRNA (m1A) methyltransferase complex,	GO:0005515~protein binding,GO:0016429~tRNA (adenine-N1-)-methyltransferase activity,GO:0016433~rRNA (adenine) methyltransferase activity,	IPR014816:tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit GCD14,					3D-structure,Complete proteome,Methyltransferase,Mitochondrion,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,Transit peptide,tRNA processing,	binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via amide nitrogen,chain:Potential tRNA (adenine-N(1)-)- methyltransferase catalytic subunit TRMT61B,helix,region of interest:S-adenosyl-L-methionine binding,sequence conflict,strand,turn,
TRNT1	tRNA nucleotidyl transferase 1(TRNT1)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0001680~tRNA 3'-terminal CCA addition,GO:0006396~RNA processing,GO:0006626~protein targeting to mitochondrion,GO:0042780~tRNA 3'-end processing,GO:1990180~mitochondrial tRNA 3'-end processing,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0004810~tRNA adenylyltransferase activity,GO:0005524~ATP binding,GO:0016779~nucleotidyltransferase activity,GO:0034062~RNA polymerase activity,GO:0052927~CTP:tRNA cytidylyltransferase activity,GO:0052928~CTP:3'-cytidine-tRNA cytidylyltransferase activity,GO:0052929~ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,	IPR002646:Poly A polymerase, head domain,	hsa03013:RNA transport,	616084~Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay,			3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Disulfide bond,Magnesium,Mitochondrion,Nucleotide-binding,Nucleotidyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transferase,Transit peptide,tRNA processing,	chain:tRNA-nucleotidyltransferase 1, mitochondrial,disulfide bond,helix,modified residue,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
TRNAU1AP	tRNA selenocysteine 1 associated protein 1(TRNAU1AP)	Homo sapiens				GO:0001514~selenocysteine incorporation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Protein biosynthesis,Reference proteome,Repeat,RNA-binding,	chain:tRNA selenocysteine 1-associated protein 1,compositionally biased region:Tyr-rich,domain:RRM 1,domain:RRM 2,helix,splice variant,strand,turn,
TSEN15	tRNA splicing endonuclease subunit 15(TSEN15)	Homo sapiens				GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006397~mRNA processing,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000213~tRNA-intron endonuclease activity,	IPR006677:tRNA intron endonuclease, catalytic domain-like,IPR018593:tRNA-splicing endonuclease subunit Sen15,					3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Endonuclease,Hydrolase,mRNA processing,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,tRNA processing,	chain:tRNA-splicing endonuclease subunit SEN15,helix,sequence variant,strand,turn,
TSEN2	tRNA splicing endonuclease subunit 2(TSEN2)	Homo sapiens				GO:0000379~tRNA-type intron splice site recognition and cleavage,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006397~mRNA processing,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0000214~tRNA-intron endonuclease complex,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0000213~tRNA-intron endonuclease activity,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0016829~lyase activity,	IPR006676:tRNA-splicing endonuclease,IPR006677:tRNA intron endonuclease, catalytic domain-like,IPR006678:tRNA intron endonuclease, N-terminal,IPR011856:tRNA endonuclease-like domain,IPR016589:tRNA-splicing endonuclease, SEN2 subunit,		612389~Pontocerebellar hypoplasia type 2B,	PIRSF011789:tRNA-splicing endonuclease, SEN2 subunit,		Alternative splicing,Complete proteome,Endonuclease,Hydrolase,Lyase,mRNA processing,Neurodegeneration,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Pontocerebellar hypoplasia,Proteomics identification,Reference proteome,tRNA processing,	chain:tRNA-splicing endonuclease subunit Sen2,modified residue,sequence variant,splice variant,
TYW3	tRNA-yW synthesizing protein 3 homolog(TYW3)	Homo sapiens				GO:0008033~tRNA processing,GO:0032259~methylation,		GO:0008168~methyltransferase activity,	IPR003827:tRNA wybutosine-synthesizing protein,					Alternative splicing,Complete proteome,Methyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,tRNA processing,	chain:tRNA wybutosine-synthesizing protein 3 homolog,modified residue,sequence conflict,sequence variant,
TACR1	tachykinin receptor 1(TACR1)	Homo sapiens				GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007217~tachykinin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0009582~detection of abiotic stimulus,GO:0045987~positive regulation of smooth muscle contraction,GO:0048265~response to pain,GO:0070472~regulation of uterine smooth muscle contraction,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004995~tachykinin receptor activity,GO:0005515~protein binding,GO:0016496~substance P receptor activity,	IPR000046:Neurokinin NK1 receptor,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001681:Neurokinin receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa05162:Measles,				3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	binding site:Antagonist CP 96345,chain:Substance-P receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TOE1	target of EGR1, member 1 (nuclear)(TOE1)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016607~nuclear speck,	GO:0000175~3'-5'-exoribonuclease activity,GO:0003676~nucleic acid binding,GO:0004535~poly(A)-specific ribonuclease activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR006941:Ribonuclease CAF1,IPR012337:Ribonuclease H-like domain,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Target of EGR1 protein 1,helix,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,zinc finger region:C3H1-type,
TAS1R1	taste 1 receptor member 1(TAS1R1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0050912~detection of chemical stimulus involved in sensory perception of taste,GO:0050917~sensory perception of umami taste,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0008527~taste receptor activity,GO:0046982~protein heterodimerization activity,	IPR000337:GPCR, family 3,IPR001828:Extracellular ligand-binding receptor,IPR011500:GPCR, family 3, nine cysteines domain,IPR017978:GPCR, family 3, C-terminal,IPR017979:GPCR, family 3, conserved site,	hsa04742:Taste transduction,				Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Sensory transduction,Signal,Taste,Transducer,Transmembrane,Transmembrane helix,	chain:Taste receptor type 1 member 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TNN	tenascin N(TNN)	Homo sapiens				GO:0007160~cell-matrix adhesion,GO:0007409~axonogenesis,GO:0016049~cell growth,GO:0016477~cell migration,	GO:0005578~proteinaceous extracellular matrix,GO:0009986~cell surface,	GO:0005178~integrin binding,GO:0042802~identical protein binding,	IPR000742:Epidermal growth factor-like domain,IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR003961:Fibronectin, type III,IPR013032:EGF-like, conserved site,IPR013783:Immunoglobulin-like fold,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05206:MicroRNAs in cancer,			SM00060:FN3,SM00181:EGF,SM00186:FBG,	Complete proteome,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Tenascin-N,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:Fibrinogen C-terminal,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
TNR	tenascin R(TNR)	Homo sapiens				GO:0007155~cell adhesion,GO:0007158~neuron cell-cell adhesion,GO:0007411~axon guidance,GO:0008306~associative learning,GO:0022029~telencephalon cell migration,GO:0022408~negative regulation of cell-cell adhesion,GO:0030198~extracellular matrix organization,GO:0035641~locomotory exploration behavior,GO:0048692~negative regulation of axon extension involved in regeneration,GO:0050767~regulation of neurogenesis,GO:0050805~negative regulation of synaptic transmission,GO:0050808~synapse organization,GO:0050885~neuromuscular process controlling balance,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060291~long-term synaptic potentiation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0045121~membrane raft,GO:0072534~perineuronal net,		IPR000742:Epidermal growth factor-like domain,IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR003961:Fibronectin, type III,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR013783:Immunoglobulin-like fold,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05206:MicroRNAs in cancer,			SM00060:FN3,SM00181:EGF,SM00186:FBG,	Alternative splicing,Cell adhesion,Coiled coil,Complete proteome,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Repeat,Secreted,Sialic acid,Signal,	chain:Tenascin-R,compositionally biased region:Cys-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:Fibrinogen C-terminal,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
TNS1	tensin 1(TNS1)	Homo sapiens		h_integrinPathway:Integrin Signaling Pathway,		GO:0007044~cell-substrate junction assembly,GO:0010761~fibroblast migration,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0009986~cell surface,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000980:SH2 domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR013625:Tensin phosphotyrosine-binding domain,IPR014020:Tensin phosphatase, C2 domain,				SM00109:C1,SM00252:SH2,SM00404:PTPc_motif,SM00462:PTB,SM01326:SM01326,	Actin-binding,Alternative splicing,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,	chain:Tensin-1,compositionally biased region:Gln-rich,compositionally biased region:Ser-rich,domain:C2 tensin-type,domain:Phosphatase tensin-type,domain:SH2,modified residue,sequence conflict,sequence variant,
TDGF1	teratocarcinoma-derived growth factor 1(TDGF1)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0001763~morphogenesis of a branching structure,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0008595~anterior/posterior axis specification, embryo,GO:0009790~embryo development,GO:0009966~regulation of signal transduction,GO:0010595~positive regulation of endothelial cell migration,GO:0018105~peptidyl-serine phosphorylation,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0030879~mammary gland development,GO:0035019~somatic stem cell population maintenance,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0043066~negative regulation of apoptotic process,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0071346~cellular response to interferon-gamma,GO:0071354~cellular response to interleukin-6,GO:0071356~cellular response to tumor necrosis factor,GO:0071364~cellular response to epidermal growth factor stimulus,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0019897~extrinsic component of plasma membrane,GO:0031225~anchored component of membrane,GO:0045121~membrane raft,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR000742:Epidermal growth factor-like domain,IPR013032:EGF-like, conserved site,IPR017047:Teratocarcinoma-derived growth factor Cripto,IPR019011:Cryptic/Cripto, CFC domain,		Forebrain defects~Forebrain defects,	PIRSF036301:growth factor Cripto,		Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,GPI-anchor,Growth factor,Lipoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Teratocarcinoma-derived growth factor 1,chain:Teratocarcinoma-derived growth factor 2,disulfide bond,domain:EGF-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
TOPAZ1	testis and ovary specific PAZ domain containing 1(TOPAZ1)	Homo sapiens				GO:0007286~spermatid development,GO:1901995~positive regulation of meiotic cell cycle phase transition,	GO:0005829~cytosol,	GO:0046872~metal ion binding,						Complete proteome,Cytoplasm,Metal-binding,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Uncharacterized protein C3orf77,sequence conflict,sequence variant,
TEX261	testis expressed 261(TEX261)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,	GO:0030134~ER to Golgi transport vesicle,GO:0030173~integral component of Golgi membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0097020~COPII adaptor activity,	IPR007277:Transmembrane adaptor Erv26,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein TEX261,transmembrane region,
TEX35	testis expressed 35(TEX35)	Homo sapiens					GO:0005634~nucleus,GO:0015630~microtubule cytoskeleton,							Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf49,sequence conflict,sequence variant,splice variant,
TEX37	testis expressed 37(TEX37)	Homo sapiens					GO:0005634~nucleus,	GO:0005515~protein binding,						Complete proteome,Nucleus,Polymorphism,Reference proteome,	chain:Protein TSC21,sequence variant,
TSGA10	testis specific 10(TSGA10)	Homo sapiens				GO:0007283~spermatogenesis,GO:0030031~cell projection assembly,	GO:0005737~cytoplasm,GO:0031514~motile cilium,GO:0031965~nuclear membrane,GO:0043005~neuron projection,	GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Testis-specific gene 10 protein,modified residue,region of interest:Interaction with HIF1A,sequence conflict,
TESK2	testis-specific kinase 2(TESK2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007283~spermatogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030036~actin cytoskeleton organization,GO:0048041~focal adhesion assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,					Alternative splicing,ATP-binding,Complete proteome,Kinase,Magnesium,Manganese,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity testis-specific protein kinase 2,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
TET3	tet methylcytosine dioxygenase 3(TET3)	Homo sapiens				GO:0006211~5-methylcytosine catabolic process,GO:0006493~protein O-linked glycosylation,GO:0019511~peptidyl-proline hydroxylation,GO:0044727~DNA demethylation of male pronucleus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070989~oxidative demethylation,GO:0080111~DNA demethylation,GO:0080182~histone H3-K4 trimethylation,	GO:0001939~female pronucleus,GO:0001940~male pronucleus,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000907~sulfonate dioxygenase activity,GO:0003677~DNA binding,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0018602~2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity,GO:0019798~procollagen-proline dioxygenase activity,GO:0034792~hypophosphite dioxygenase activity,GO:0043734~DNA-N1-methyladenine dioxygenase activity,GO:0052634~C-19 gibberellin 2-beta-dioxygenase activity,GO:0052635~C-20 gibberellin 2-beta-dioxygenase activity,GO:0070579~methylcytosine dioxygenase activity,	IPR002857:Zinc finger, CXXC-type,IPR024779:2OGFeDO domain, nucleic acid-modifying type,				SM01333:SM01333,	3D-structure,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Developmental protein,Dioxygenase,DNA-binding,Iron,Isopeptide bond,Metal-binding,Nucleus,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,	binding site:2-oxoglutarate,chain:Probable methylcytosine dioxygenase TET3,metal ion-binding site:Iron; catalytic,sequence variant,splice variant,
TPRXL	tetrapeptide repeat homeobox like(TPRXL)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative protein TPRXL,compositionally biased region:Ser-rich,
TSPAN2	tetraspanin 2(TSPAN2)	Homo sapiens				GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0007420~brain development,GO:0014002~astrocyte development,GO:0014005~microglia development,GO:0042552~myelination,GO:0048709~oligodendrocyte differentiation,GO:0061564~axon development,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043209~myelin sheath,	GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,			PIRSF002419:tetraspanin,		Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Tetraspanin-2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TRANK1	tetratricopeptide repeat and ankyrin repeat containing 1(TRANK1)	Homo sapiens							IPR002110:Ankyrin repeat,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR020683:Ankyrin repeat-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00028:TPR,SM00248:ANK,	ANK repeat,Coiled coil,Complete proteome,Polymorphism,Reference proteome,Repeat,Signal,TPR repeat,	chain:Lupus brain antigen 1 homolog,compositionally biased region:Glu-rich,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence conflict,sequence variant,
TTC13	tetratricopeptide repeat domain 13(TTC13)	Homo sapiens			Intracellular trafficking and secretion,				IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,Repeat,Signal,TPR repeat,	chain:Tetratricopeptide repeat protein 13,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,sequence conflict,splice variant,
TTC21A	tetratricopeptide repeat domain 21A(TTC21A)	Homo sapiens				GO:0035721~intraciliary retrograde transport,GO:0060271~cilium morphogenesis,GO:0061512~protein localization to cilium,	GO:0005929~cilium,GO:0030991~intraciliary transport particle A,		IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 21A,repeat:TPR 1,repeat:TPR 10,repeat:TPR 11,repeat:TPR 12,repeat:TPR 13,repeat:TPR 14,repeat:TPR 15,repeat:TPR 16,repeat:TPR 17,repeat:TPR 18,repeat:TPR 19,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,sequence conflict,sequence variant,splice variant,
TTC21B	tetratricopeptide repeat domain 21B(TTC21B)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007224~smoothened signaling pathway,GO:0008589~regulation of smoothened signaling pathway,GO:0021591~ventricular system development,GO:0021798~forebrain dorsal/ventral pattern formation,GO:0035721~intraciliary retrograde transport,GO:0035735~intraciliary transport involved in cilium morphogenesis,GO:0060271~cilium morphogenesis,GO:0061512~protein localization to cilium,	GO:0000790~nuclear chromatin,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0030991~intraciliary transport particle A,GO:0072372~primary cilium,GO:0097542~ciliary tip,		IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,		613819~Short-rib thoracic dysplasia 4 with or without polydactyly,613820~Nephronophthisis 12,		SM00028:TPR,	Alternative splicing,Bardet-Biedl syndrome,Cell projection,Ciliopathy,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Joubert syndrome,Meckel syndrome,Mental retardation,Nephronophthisis,Obesity,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 21B,repeat:TPR 1,repeat:TPR 10,repeat:TPR 11,repeat:TPR 12,repeat:TPR 13,repeat:TPR 14,repeat:TPR 15,repeat:TPR 16,repeat:TPR 17,repeat:TPR 18,repeat:TPR 19,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,sequence conflict,sequence variant,splice variant,
TTC24	tetratricopeptide repeat domain 24(TTC24)	Homo sapiens							IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR024812:Tetratricopeptide repeat protein 24,				SM00028:TPR,	Complete proteome,Polymorphism,Reference proteome,Repeat,TPR repeat,
TTC27	tetratricopeptide repeat domain 27(TTC27)	Homo sapiens							IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 27,repeat:HAT 1,repeat:HAT 2,repeat:HAT 3,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,sequence conflict,sequence variant,
TTC34	tetratricopeptide repeat domain 34(TTC34)	Homo sapiens							IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Complete proteome,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 34,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,
TTC39A	tetratricopeptide repeat domain 39A(TTC39A)	Homo sapiens							IPR011990:Tetratricopeptide-like helical,IPR019412:Outer membrane protein, IML2, mitochondrial/Tetratricopeptide repeat protein 39,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Alternative splicing,Coiled coil,Complete proteome,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 39A,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,splice variant,
TTC4	tetratricopeptide repeat domain 4(TTC4)	Homo sapiens							IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Acetylation,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 4,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,sequence variant,
TTC7A	tetratricopeptide repeat domain 7A(TTC7A)	Homo sapiens				GO:0006879~cellular iron ion homeostasis,GO:0030097~hemopoiesis,GO:0090002~establishment of protein localization to plasma membrane,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,IPR026900:Tetratricopeptide repeat protein 7,		243150~Gastrointestinal defects and immunodeficiency syndrome,		SM00028:TPR,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 7A,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,sequence conflict,sequence variant,splice variant,
TANC1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1(TANC1)	Homo sapiens				GO:0007520~myoblast fusion,GO:0008542~visual learning,GO:0097062~dendritic spine maintenance,	GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043679~axon terminus,GO:0045211~postsynaptic membrane,		IPR002110:Ankyrin repeat,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR020683:Ankyrin repeat-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00028:TPR,SM00248:ANK,	Acetylation,Alternative splicing,ANK repeat,Cell junction,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Synapse,TPR repeat,	chain:Protein TANC1,compositionally biased region:Ser-rich,modified residue,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence variant,splice variant,
THEM4	thioesterase superfamily member 4(THEM4)	Homo sapiens				GO:0006631~fatty acid metabolic process,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0043491~protein kinase B signaling,GO:1902108~regulation of mitochondrial membrane permeability involved in apoptotic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0032587~ruffle membrane,	GO:0016290~palmitoyl-CoA hydrolase activity,GO:0047617~acyl-CoA hydrolase activity,	IPR006683:Thioesterase superfamily,	hsa04151:PI3K-Akt signaling pathway,				3D-structure,Acetylation,Apoptosis,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Fatty acid metabolism,Hydrolase,Lipid metabolism,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Thioesterase superfamily member 4,sequence variant,
TXNDC12	thioredoxin domain containing 12(TXNDC12)	Homo sapiens				GO:0030154~cell differentiation,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,	GO:0005788~endoplasmic reticulum lumen,	GO:0005515~protein binding,GO:0015037~peptide disulfide oxidoreductase activity,GO:0019153~protein-disulfide reductase (glutathione) activity,	IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR017937:Thioredoxin, conserved site,	hsa00480:Glutathione metabolism,				3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Oxidoreductase,Proteomics identification,Redox-active center,Reference proteome,Signal,	binding site:FAD,binding site:FAD; via amide nitrogen and carbonyl oxygen,binding site:FAD; via carbonyl oxygen,chain:Apoptosis-inducing factor 1, mitochondrial,chain:Thioredoxin domain-containing protein 12,disulfide bond,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:FAD,region of interest:FAD-dependent oxidoreductase,sequence conflict,short sequence motif:Nuclear localization signal,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,strand,transit peptide:Mitochondrion,turn,
TXNDC9	thioredoxin domain containing 9(TXNDC9)	Homo sapiens				GO:0008616~queuosine biosynthetic process,GO:0045454~cell redox homeostasis,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005913~cell-cell adherens junction,GO:0030496~midbody,	GO:0005515~protein binding,GO:0008479~queuine tRNA-ribosyltransferase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Thioredoxin domain-containing protein 9,domain:Thioredoxin,modified residue,sequence conflict,sequence variant,
THNSL2	threonine synthase like 2(THNSL2)	Homo sapiens			Amino acid transport and metabolism,	GO:0009071~serine family amino acid catabolic process,GO:0009088~threonine biosynthetic process,GO:0016311~dephosphorylation,GO:0046360~2-oxobutyrate biosynthetic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0004795~threonine synthase activity,GO:0005125~cytokine activity,GO:0016829~lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0070905~serine binding,	IPR001926:Tryptophan synthase beta subunit-like PLP-dependent enzymes superfamily,IPR004450:Threonine synthase-like,					Alternative splicing,Complete proteome,Cytokine,Lyase,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Secreted,	chain:Threonine synthase-like 2,modified residue,sequence conflict,sequence variant,splice variant,
TARS2	threonyl-tRNA synthetase 2, mitochondrial (putative)(TARS2)	Homo sapiens				GO:0006435~threonyl-tRNA aminoacylation,GO:0070159~mitochondrial threonyl-tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003723~RNA binding,GO:0004829~threonine-tRNA ligase activity,GO:0005524~ATP binding,	IPR002314:Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain,IPR002320:Threonine-tRNA ligase, class IIa,IPR004095:TGS,IPR004154:Anticodon-binding,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR012675:Beta-grasp domain,IPR012676:TGS-like,IPR012947:Threonyl/alanyl tRNA synthetase, SAD,IPR018163:Threonyl/alanyl tRNA synthetase, class II-like, putative editing domain,	hsa00970:Aminoacyl-tRNA biosynthesis,	615918~Combined oxidative phosphorylation deficiency 21,		SM00863:SM00863,	Alternative splicing,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Disease mutation,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,Transit peptide,	chain:Threonyl-tRNA synthetase, mitochondrial,sequence conflict,transit peptide:Mitochondrion,
THBS3	thrombospondin 3(THBS3)	Homo sapiens				GO:0003417~growth plate cartilage development,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0043931~ossification involved in bone maturation,GO:0060346~bone trabecula formation,	GO:0005576~extracellular region,GO:0048471~perinuclear region of cytoplasm,	GO:0005509~calcium ion binding,GO:0008201~heparin binding,	IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR003367:Thrombospondin, type 3-like repeat,IPR008859:Thrombospondin, C-terminal,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017897:Thrombospondin, type 3 repeat,IPR018097:EGF-like calcium-binding, conserved site,IPR024665:Thrombospondin/cartilage oligomeric matrix protein, coiled-coil domain,	hsa04145:Phagosome,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05144:Malaria,			SM00179:EGF_CA,SM00181:EGF,SM00210:TSPN,	Alternative splicing,Calcium,Cell adhesion,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	chain:Thrombospondin-3,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4,domain:TSP C-terminal,domain:TSP N-terminal,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:TSP type-3 1,repeat:TSP type-3 2,repeat:TSP type-3 3,repeat:TSP type-3 4,repeat:TSP type-3 5,repeat:TSP type-3 6,repeat:TSP type-3 7,repeat:TSP type-3 8,sequence variant,signal peptide,
THSD7B	thrombospondin type 1 domain containing 7B(THSD7B)	Homo sapiens					GO:0016021~integral component of membrane,		IPR000884:Thrombospondin, type 1 repeat,				SM00209:TSP1,	Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Thrombospondin type-1 domain-containing protein 7B,compositionally biased region:Poly-Pro,disulfide bond,domain:TSP type-1 1,domain:TSP type-1 10,domain:TSP type-1 11,domain:TSP type-1 12,domain:TSP type-1 13,domain:TSP type-1 14,domain:TSP type-1 15,domain:TSP type-1 16,domain:TSP type-1 17,domain:TSP type-1 18,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,domain:TSP type-1 8,domain:TSP type-1 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
THEMIS2	thymocyte selection associated family member 2(THEMIS2)	Homo sapiens				GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0050852~T cell receptor signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR025946:CABIT domain,					Alternative splicing,Complete proteome,Immunity,Inflammatory response,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein THEMIS2,compositionally biased region:Asp/Glu-rich,compositionally biased region:Poly-Glu,sequence conflict,sequence variant,splice variant,
THRAP3	thyroid hormone receptor associated protein 3(THRAP3)	Homo sapiens				GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0042753~positive regulation of circadian rhythm,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048255~mRNA stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016592~mediator complex,GO:0016607~nuclear speck,GO:0035145~exon-exon junction complex,GO:0070062~extracellular exosome,	GO:0001046~core promoter sequence-specific DNA binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0042809~vitamin D receptor binding,GO:0044822~poly(A) RNA binding,GO:0046966~thyroid hormone receptor binding,GO:0051219~phosphoprotein binding,	IPR026667:Thyroid hormone receptor-associated protein 3,					Acetylation,Activator,ADP-ribosylation,ATP-binding,Biological rhythms,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Thyroid hormone receptor-associated protein 3,compositionally biased region:Arg-rich,compositionally biased region:Ser-rich,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
THRB	thyroid hormone receptor beta(THRB)	Homo sapiens		h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007605~sensory perception of sound,GO:0007621~negative regulation of female receptivity,GO:0008016~regulation of heart contraction,GO:0008050~female courtship behavior,GO:0009887~organ morphogenesis,GO:0030522~intracellular receptor signaling pathway,GO:0043401~steroid hormone mediated signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060509~Type I pneumocyte differentiation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003714~transcription corepressor activity,GO:0004887~thyroid hormone receptor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,GO:0070324~thyroid hormone binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR001728:Thyroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,	hsa04080:Neuroactive ligand-receptor interaction,hsa04919:Thyroid hormone signaling pathway,	145650~Thyroid hormone resistance, selective pituitary,188570~Thyroid hormone resistance,274300~Thyroid hormone resistance, autosomal recessive,		SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Alternative splicing,Complete proteome,Deafness,Disease mutation,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Thyroid hormone receptor beta,DNA-binding region:Nuclear receptor,helix,region of interest:Ligand-binding,region of interest:Modulating,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:NR C4-type,
TRIP12	thyroid hormone receptor interactor 12(TRIP12)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009790~embryo development,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:1901315~negative regulation of histone H2A K63-linked ubiquitination,GO:2000780~negative regulation of double-strand break repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0046966~thyroid hormone receptor binding,	IPR000569:HECT,IPR004170:WWE domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	hsa04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,	Acetylation,Alternative splicing,Complete proteome,DNA damage,DNA repair,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase TRIP12,domain:HECT,domain:WWE,modified residue,region of interest:K-box,sequence conflict,
TPO	thyroid peroxidase(TPO)	Homo sapiens				GO:0006590~thyroid hormone generation,GO:0006979~response to oxidative stress,GO:0035162~embryonic hemopoiesis,GO:0042446~hormone biosynthetic process,GO:0042744~hydrogen peroxide catabolic process,GO:0055114~oxidation-reduction process,GO:0098869~cellular oxidant detoxification,	GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004447~iodide peroxidase activity,GO:0004601~peroxidase activity,GO:0005509~calcium ion binding,GO:0020037~heme binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000436:Sushi/SCR/CCP,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR010255:Haem peroxidase,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR019791:Haem peroxidase, animal, subgroup,	hsa00350:Tyrosine metabolism,hsa01100:Metabolic pathways,hsa04918:Thyroid hormone synthesis,hsa05320:Autoimmune thyroid disease,	274500~Thyroid dyshormonogenesis 2A,		SM00032:CCP,SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Congenital hypothyroidism,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Heme,Hydrogen peroxide,Iron,Membrane,Metal-binding,Oxidoreductase,Peroxidase,Polymorphism,Proteomics identification,Reference proteome,Signal,Sushi,Thyroid hormones biosynthesis,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:Heme (covalent; via 2 links),chain:Thyroid peroxidase,disulfide bond,domain:EGF-like; calcium-binding,domain:Sushi,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,signal peptide,site:Transition state stabilizer,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TFPI	tissue factor pathway inhibitor(TFPI)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,		GO:0007596~blood coagulation,GO:0007598~blood coagulation, extrinsic pathway,GO:0010951~negative regulation of endopeptidase activity,GO:0032355~response to estradiol,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0031090~organelle membrane,GO:0031225~anchored component of membrane,	GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0030414~peptidase inhibitor activity,	IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,	hsa04610:Complement and coagulation cascades,			SM00131:KU,	3D-structure,Alternative splicing,Blood coagulation,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Glycoprotein,GPI-anchor,Hemostasis,Lipoprotein,Membrane,Microsome,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Tissue factor pathway inhibitor,disulfide bond,domain:BPTI/Kunitz inhibitor 1,domain:BPTI/Kunitz inhibitor 2,domain:BPTI/Kunitz inhibitor 3,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),glycosylation site:O-linked (GalNAc...); partial,helix,mutagenesis site,sequence variant,signal peptide,site:Not glycosylated,site:Reactive bond,splice variant,strand,turn,
TTN	titin(TTN)	Homo sapiens				GO:0002576~platelet degranulation,GO:0003300~cardiac muscle hypertrophy,GO:0006936~muscle contraction,GO:0006941~striated muscle contraction,GO:0007076~mitotic chromosome condensation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030049~muscle filament sliding,GO:0030240~skeletal muscle thin filament assembly,GO:0030241~skeletal muscle myosin thick filament assembly,GO:0035995~detection of muscle stretch,GO:0045214~sarcomere organization,GO:0045859~regulation of protein kinase activity,GO:0048739~cardiac muscle fiber development,GO:0048769~sarcomerogenesis,GO:0050790~regulation of catalytic activity,GO:0051592~response to calcium ion,GO:0055003~cardiac myofibril assembly,GO:0055008~cardiac muscle tissue morphogenesis,GO:0060048~cardiac muscle contraction,	GO:0000794~condensed nuclear chromosome,GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005859~muscle myosin complex,GO:0005865~striated muscle thin filament,GO:0030018~Z disc,GO:0031430~M band,GO:0031674~I band,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008307~structural constituent of muscle,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0031433~telethonin binding,GO:0042802~identical protein binding,GO:0042805~actinin binding,GO:0043621~protein self-association,GO:0051015~actin filament binding,GO:0051371~muscle alpha-actinin binding,GO:0097493~structural molecule activity conferring elasticity,	IPR000719:Protein kinase, catalytic domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR004168:PPAK motif,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR015129:Titin Z,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,	600334~Tibial muscular dystrophy, tardive,603689~Myopathy, proximal, with early respiratory muscle involvement,604145~Cardiomyopathy, dilated, 1G,608807~Muscular dystrophy, limb-girdle, type 2J,611705~Myopathy, early-onset, with fatal cardiomyopathy,613765~Cardiomyopathy, familial hypertrophic, 9,		SM00060:FN3,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,ATP-binding,Calcium,Calmodulin-binding,Cardiomyopathy,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Disulfide bond,Immunoglobulin domain,Isopeptide bond,Kinase,Limb-girdle muscular dystrophy,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Titin,compositionally biased region:Ala-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 10,domain:Fibronectin type-III 100,domain:Fibronectin type-III 101,domain:Fibronectin type-III 102,domain:Fibronectin type-III 103,domain:Fibronectin type-III 104,domain:Fibronectin type-III 105,domain:Fibronectin type-III 106,domain:Fibronectin type-III 107,domain:Fibronectin type-III 108,domain:Fibronectin type-III 109,domain:Fibronectin type-III 11,domain:Fibronectin type-III 110,domain:Fibronectin type-III 111,domain:Fibronectin type-III 112,domain:Fibronectin type-III 113,domain:Fibronectin type-III 114,domain:Fibronectin type-III 115,domain:Fibronectin type-III 116,domain:Fibronectin type-III 117,domain:Fibronectin type-III 118,domain:Fibronectin type-III 119,domain:Fibronectin type-III 12,domain:Fibronectin type-III 120,domain:Fibronectin type-III 121,domain:Fibronectin type-III 122,domain:Fibronectin type-III 123,domain:Fibronectin type-III 124,domain:Fibronectin type-III 125,domain:Fibronectin type-III 126,domain:Fibronectin type-III 127,domain:Fibronectin type-III 128,domain:Fibronectin type-III 129,domain:Fibronectin type-III 13,domain:Fibronectin type-III 130,domain:Fibronectin type-III 131,domain:Fibronectin type-III 132,domain:Fibronectin type-III 14,domain:Fibronectin type-III 15,domain:Fibronectin type-III 16,domain:Fibronectin type-III 17,domain:Fibronectin type-III 18,domain:Fibronectin type-III 19,domain:Fibronectin type-III 2,domain:Fibronectin type-III 20,domain:Fibronectin type-III 21,domain:Fibronectin type-III 22,domain:Fibronectin type-III 23,domain:Fibronectin type-III 24,domain:Fibronectin type-III 25,domain:Fibronectin type-III 26,domain:Fibronectin type-III 27,domain:Fibronectin type-III 28,domain:Fibronectin type-III 29,domain:Fibronectin type-III 3,domain:Fibronectin type-III 30,domain:Fibronectin type-III 31,domain:Fibronectin type-III 32,domain:Fibronectin type-III 33,domain:Fibronectin type-III 34,domain:Fibronectin type-III 35,domain:Fibronectin type-III 36,domain:Fibronectin type-III 37,domain:Fibronectin type-III 38,domain:Fibronectin type-III 39,domain:Fibronectin type-III 4,domain:Fibronectin type-III 40,domain:Fibronectin type-III 41,domain:Fibronectin type-III 42,domain:Fibronectin type-III 43,domain:Fibronectin type-III 44,domain:Fibronectin type-III 45,domain:Fibronectin type-III 46,domain:Fibronectin type-III 47,domain:Fibronectin type-III 48,domain:Fibronectin type-III 49,domain:Fibronectin type-III 5,domain:Fibronectin type-III 50,domain:Fibronectin type-III 51,domain:Fibronectin type-III 52,domain:Fibronectin type-III 53,domain:Fibronectin type-III 54,domain:Fibronectin type-III 55,domain:Fibronectin type-III 56,domain:Fibronectin type-III 57,domain:Fibronectin type-III 58,domain:Fibronectin type-III 59,domain:Fibronectin type-III 6,domain:Fibronectin type-III 60,domain:Fibronectin type-III 61,domain:Fibronectin type-III 62,domain:Fibronectin type-III 63,domain:Fibronectin type-III 64,domain:Fibronectin type-III 65,domain:Fibronectin type-III 66,domain:Fibronectin type-III 67,domain:Fibronectin type-III 68,domain:Fibronectin type-III 69,domain:Fibronectin type-III 7,domain:Fibronectin type-III 70,domain:Fibronectin type-III 71,domain:Fibronectin type-III 72,domain:Fibronectin type-III 73,domain:Fibronectin type-III 74,domain:Fibronectin type-III 75,domain:Fibronectin type-III 76,domain:Fibronectin type-III 77,domain:Fibronectin type-III 78,domain:Fibronectin type-III 79,domain:Fibronectin type-III 8,domain:Fibronectin type-III 80,domain:Fibronectin type-III 81,domain:Fibronectin type-III 82,domain:Fibronectin type-III 83,domain:Fibronectin type-III 84,domain:Fibronectin type-III 85,domain:Fibronectin type-III 86,domain:Fibronectin type-III 87,domain:Fibronectin type-III 88,domain:Fibronectin type-III 89,domain:Fibronectin type-III 9,domain:Fibronectin type-III 90,domain:Fibronectin type-III 91,domain:Fibronectin type-III 92,domain:Fibronectin type-III 93,domain:Fibronectin type-III 94,domain:Fibronectin type-III 95,domain:Fibronectin type-III 96,domain:Fibronectin type-III 97,domain:Fibronectin type-III 98,domain:Fibronectin type-III 99,domain:Ig-like 1,domain:Ig-like 10,domain:Ig-like 100,domain:Ig-like 101,domain:Ig-like 102,domain:Ig-like 103,domain:Ig-like 104,domain:Ig-like 105,domain:Ig-like 106,domain:Ig-like 107,domain:Ig-like 108,domain:Ig-like 109,domain:Ig-like 11,domain:Ig-like 110,domain:Ig-like 111,domain:Ig-like 112,domain:Ig-like 113,domain:Ig-like 114,domain:Ig-like 115,domain:Ig-like 116,domain:Ig-like 117,domain:Ig-like 118,domain:Ig-like 119,domain:Ig-like 12,domain:Ig-like 120,domain:Ig-like 121,domain:Ig-like 122,domain:Ig-like 123,domain:Ig-like 124,domain:Ig-like 125,domain:Ig-like 126,domain:Ig-like 127,domain:Ig-like 128,domain:Ig-like 129,domain:Ig-like 13,domain:Ig-like 130,domain:Ig-like 131,domain:Ig-like 132,domain:Ig-like 133,domain:Ig-like 134,domain:Ig-like 135,domain:Ig-like 136,domain:Ig-like 137,domain:Ig-like 138,domain:Ig-like 139,domain:Ig-like 14,domain:Ig-like 140,domain:Ig-like 141,domain:Ig-like 142,domain:Ig-like 143,domain:Ig-like 144,domain:Ig-like 145,domain:Ig-like 146,domain:Ig-like 147,domain:Ig-like 148,domain:Ig-like 149,domain:Ig-like 15,domain:Ig-like 150,domain:Ig-like 151,domain:Ig-like 152,domain:Ig-like 16,domain:Ig-like 17,domain:Ig-like 18,domain:Ig-like 19,domain:Ig-like 2,domain:Ig-like 20,domain:Ig-like 21,domain:Ig-like 22,domain:Ig-like 23,domain:Ig-like 24,domain:Ig-like 25,domain:Ig-like 26,domain:Ig-like 27,domain:Ig-like 28,domain:Ig-like 29,domain:Ig-like 3,domain:Ig-like 30,domain:Ig-like 31,domain:Ig-like 32,domain:Ig-like 33,domain:Ig-like 34,domain:Ig-like 35,domain:Ig-like 36,domain:Ig-like 37,domain:Ig-like 38,domain:Ig-like 39,domain:Ig-like 4,domain:Ig-like 40,domain:Ig-like 41,domain:Ig-like 42,domain:Ig-like 43,domain:Ig-like 44,domain:Ig-like 45,domain:Ig-like 46,domain:Ig-like 47,domain:Ig-like 48,domain:Ig-like 49,domain:Ig-like 5,domain:Ig-like 50,domain:Ig-like 51,domain:Ig-like 52,domain:Ig-like 53,domain:Ig-like 54,domain:Ig-like 55,domain:Ig-like 56,domain:Ig-like 57,domain:Ig-like 58,domain:Ig-like 59,domain:Ig-like 6,domain:Ig-like 60,domain:Ig-like 61,domain:Ig-like 62,domain:Ig-like 63,domain:Ig-like 64,domain:Ig-like 65,domain:Ig-like 66,domain:Ig-like 67,domain:Ig-like 68,domain:Ig-like 69,domain:Ig-like 7,domain:Ig-like 70,domain:Ig-like 71,domain:Ig-like 72,domain:Ig-like 73,domain:Ig-like 74,domain:Ig-like 75,domain:Ig-like 76,domain:Ig-like 77,domain:Ig-like 78,domain:Ig-like 79,domain:Ig-like 8,domain:Ig-like 80,domain:Ig-like 81,domain:Ig-like 82,domain:Ig-like 83,domain:Ig-like 84,domain:Ig-like 85,domain:Ig-like 86,domain:Ig-like 87,domain:Ig-like 88,domain:Ig-like 89,domain:Ig-like 9,domain:Ig-like 90,domain:Ig-like 91,domain:Ig-like 92,domain:Ig-like 93,domain:Ig-like 94,domain:Ig-like 95,domain:Ig-like 96,domain:Ig-like 97,domain:Ig-like 98,domain:Ig-like 99,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:ZIS1,region of interest:ZIS5,repeat:Kelch 1,repeat:Kelch 10,repeat:Kelch 11,repeat:Kelch 12,repeat:Kelch 13,repeat:Kelch 14,repeat:Kelch 15,repeat:Kelch 16,repeat:Kelch 17,repeat:Kelch 18,repeat:Kelch 19,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,repeat:Kelch 7,repeat:Kelch 8,repeat:Kelch 9,repeat:PEVK 1,repeat:PEVK 10,repeat:PEVK 11,repeat:PEVK 12,repeat:PEVK 13,repeat:PEVK 14,repeat:PEVK 15,repeat:PEVK 16,repeat:PEVK 17,repeat:PEVK 18,repeat:PEVK 19,repeat:PEVK 2,repeat:PEVK 20,repeat:PEVK 21,repeat:PEVK 22,repeat:PEVK 23,repeat:PEVK 24,repeat:PEVK 25,repeat:PEVK 26,repeat:PEVK 27,repeat:PEVK 28,repeat:PEVK 29,repeat:PEVK 3,repeat:PEVK 30,repeat:PEVK 31,repeat:PEVK 4,repeat:PEVK 5,repeat:PEVK 6,repeat:PEVK 7,repeat:PEVK 8,repeat:PEVK 9,repeat:RCC1 1,repeat:RCC1 10,repeat:RCC1 11,repeat:RCC1 12,repeat:RCC1 13,repeat:RCC1 14,repeat:RCC1 15,repeat:RCC1 16,repeat:RCC1 17,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,repeat:RCC1 6,repeat:RCC1 7,repeat:RCC1 8,repeat:RCC1 9,repeat:TPR 1,repeat:TPR 10,repeat:TPR 11,repeat:TPR 12,repeat:TPR 13,repeat:TPR 14,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 13,repeat:WD 14,repeat:WD 15,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,repeat:Z-repeat 1,repeat:Z-repeat 2,repeat:Z-repeat 3,repeat:Z-repeat 4,repeat:Z-repeat 5,repeat:Z-repeat 6,repeat:Z-repeat 7,sequence conflict,sequence variant,splice variant,strand,turn,
TLR5	toll like receptor 5(TLR5)	Homo sapiens				GO:0001819~positive regulation of cytokine production,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006954~inflammatory response,GO:0008584~male gonad development,GO:0032757~positive regulation of interleukin-8 production,GO:0034123~positive regulation of toll-like receptor signaling pathway,GO:0034146~toll-like receptor 5 signaling pathway,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0050707~regulation of cytokine secretion,GO:0050829~defense response to Gram-negative bacterium,GO:0071222~cellular response to lipopolysaccharide,GO:0071260~cellular response to mechanical stimulus,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005149~interleukin-1 receptor binding,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR027176:Toll-like receptor 5,	hsa04620:Toll-like receptor signaling pathway,hsa05130:Pathogenic Escherichia coli infection,hsa05132:Salmonella infection,hsa05134:Legionellosis,hsa05321:Inflammatory bowel disease (IBD),	601744~Systemic lupus erythematosus, resistance to,601744~Systemic lupus erythematosus, susceptibility to, 1,608556~Legionaire disease, susceptibility to,615557~Melioidosis, susceptibility to,		SM00082:LRRCT,SM00255:TIR,SM00369:LRR_TYP,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Leucine-rich repeat,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Toll-like receptor 5,domain:TIR,glycosylation site:N-linked (GlcNAc...),helix,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TOP2B	topoisomerase (DNA) II beta(TOP2B)	Homo sapiens		h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000712~resolution of meiotic recombination intermediates,GO:0000819~sister chromatid segregation,GO:0001764~neuron migration,GO:0006265~DNA topological change,GO:0006268~DNA unwinding involved in DNA replication,GO:0006312~mitotic recombination,GO:0007409~axonogenesis,GO:0016925~protein sumoylation,GO:0030900~forebrain development,GO:0044774~mitotic DNA integrity checkpoint,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0009295~nucleoid,GO:0009330~DNA topoisomerase complex (ATP-hydrolyzing),	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003918~DNA topoisomerase type II (ATP-hydrolyzing) activity,GO:0005080~protein kinase C binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008301~DNA binding, bending,GO:0019899~enzyme binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR001241:DNA topoisomerase, type IIA,IPR002205:DNA topoisomerase, type IIA, subunit A/C-terminal,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR006171:Toprim domain,IPR012542:DTHCT,IPR013506:DNA topoisomerase, type IIA, subunit B, domain 2,IPR013757:Type IIA DNA topoisomerase subunit A, alpha-helical domain,IPR013758:DNA topoisomerase, type IIA, subunit A/ C-terminal, alpha-beta,IPR013759:DNA topoisomerase, type IIA, central domain,IPR013760:DNA topoisomerase, type IIA-like domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR018522:DNA topoisomerase, type IIA, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR024946:Arginine repressor C-terminal-like domain,				SM00433:TOP2c,SM00434:TOP4c,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,DNA-binding,Isomerase,Isopeptide bond,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Topoisomerase,Ubl conjugation,	active site:O-(5'-phospho-DNA)-tyrosine intermediate,chain:DNA topoisomerase 2-beta,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:Nuclear export signal,splice variant,
TOR1AIP1	torsin 1A interacting protein 1(TOR1AIP1)	Homo sapiens				GO:0032781~positive regulation of ATPase activity,GO:0034504~protein localization to nucleus,GO:0071763~nuclear membrane organization,	GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0016021~integral component of membrane,	GO:0001671~ATPase activator activity,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0008092~cytoskeletal protein binding,GO:0051117~ATPase binding,	IPR008662:Lamina-associated polypeptide 1C,					3D-structure,Alternative splicing,Coiled coil,Complete proteome,Glycoprotein,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Torsin-1A-interacting protein 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,topological domain:Lumenal,topological domain:Nuclear,transmembrane region,
TLK1	tousled like kinase 1(TLK1)	Homo sapiens				GO:0001672~regulation of chromatin assembly or disassembly,GO:0006468~protein phosphorylation,GO:0006886~intracellular protein transport,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0016569~covalent chromatin modification,GO:0035556~intracellular signal transduction,	GO:0005634~nucleus,	GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Acetylation,Alternative splicing,ATP-binding,Cell cycle,Chromatin regulator,Coiled coil,Complete proteome,DNA damage,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase tousled- like 1,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
TRAK1	trafficking kinesin protein 1(TRAK1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006493~protein O-linked glycosylation,GO:0006605~protein targeting,GO:0008333~endosome to lysosome transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005769~early endosome,	GO:0005515~protein binding,GO:0016740~transferase activity,GO:0050811~GABA receptor binding,	IPR006933:HAP1, N-terminal,IPR022154:Trafficking kinesin-binding protein domain,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Endosome,Glycoprotein,Mitochondrion,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	chain:Trafficking kinesin-binding protein 1,compositionally biased region:Poly-Ser,domain:HAP1 N-terminal,splice variant,
TRAK2	trafficking kinesin protein 2(TRAK2)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006493~protein O-linked glycosylation,GO:0006605~protein targeting,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005769~early endosome,GO:0005886~plasma membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0050811~GABA receptor binding,	IPR006933:HAP1, N-terminal,IPR022154:Trafficking kinesin-binding protein domain,	hsa01100:Metabolic pathways,hsa04727:GABAergic synapse,				Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Endosome,Glycoprotein,Mitochondrion,Phosphoprotein,Polymorphism,Reference proteome,Transport,	chain:Trafficking kinesin-binding protein 2,region of interest:Interaction with HGS,sequence conflict,sequence variant,
TRAPPC12	trafficking protein particle complex 12(TRAPPC12)	Homo sapiens				GO:0006508~proteolysis,GO:0016192~vesicle-mediated transport,GO:0051310~metaphase plate congression,GO:0090234~regulation of kinetochore assembly,GO:1902426~negative regulation of mitotic spindle assembly checkpoint,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,	GO:0004175~endopeptidase activity,GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Complete proteome,ER-Golgi transport,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transport,	chain:Tetratricopeptide repeat protein 15,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence conflict,sequence variant,
TRAPPC3	trafficking protein particle complex 3(TRAPPC3)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0048193~Golgi vesicle transport,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0030008~TRAPP complex,	GO:0005515~protein binding,	IPR007194:Transport protein particle (TRAPP) component,IPR016721:TRAPP I complex, Bet3,IPR024096:NO signalling/Golgi transport  ligand-binding domain,			PIRSF018293:TRAPP I complex, Bet3 subunit,		3D-structure,Alternative splicing,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Golgi apparatus,Lipoprotein,Palmitate,Proteomics identification,Reference proteome,Transport,	chain:Trafficking protein particle complex subunit 3,helix,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,strand,turn,
TGOLN2	trans-golgi network protein 2(TGOLN2)	Homo sapiens				GO:0006895~Golgi to endosome transport,	GO:0005654~nucleoplasm,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0030140~trans-Golgi network transport vesicle,GO:0032588~trans-Golgi network membrane,	GO:0005515~protein binding,	IPR026084:Trans-Golgi network integral membrane protein TGN38,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Trans-Golgi network integral membrane protein 2,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:14 X 14 AA tandem repeats,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal; in isoform TGN46 and isoform TGN48,short sequence motif:Endocytosis signal; in isoform TGN51,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TCEANC2	transcription elongation factor A N-terminal and central domain containing 2(TCEANC2)	Homo sapiens				GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type,IPR003618:Transcription elongation factor S-II, central domain,IPR017923:Transcription factor IIS, N-terminal,				SM00509:TFS2N,	Acetylation,Alternative splicing,Complete proteome,Nucleus,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf83,domain:TFIIS central,domain:TFIIS N-terminal,sequence conflict,splice variant,
TCEA3	transcription elongation factor A3(TCEA3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032784~regulation of DNA-templated transcription, elongation,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003746~translation elongation factor activity,GO:0008270~zinc ion binding,	IPR001222:Zinc finger, TFIIS-type,IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type,IPR003618:Transcription elongation factor S-II, central domain,IPR006289:Transcription elongation factor, TFIIS,IPR016492:Transcription elongation factor, TFIIS-related,IPR017923:Transcription factor IIS, N-terminal,			PIRSF006704:transcription elongation factor, IIS type,	SM00440:ZnF_C2C2,SM00509:TFS2N,SM00510:TFS2M,	Alternative splicing,Complete proteome,DNA-binding,Elongation factor,Metal-binding,Nucleus,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription elongation factor A protein 3,compositionally biased region:Ser-rich,domain:TFIIS central,domain:TFIIS N-terminal,zinc finger region:TFIIS-type,
TCF7L1	transcription factor 7 like 1(TCF7L1)	Homo sapiens				GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016055~Wnt signaling pathway,GO:0030111~regulation of Wnt signaling pathway,GO:0060070~canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008013~beta-catenin binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR013558:CTNNB1 binding, N-teminal,IPR024940:Transcription factor TCF/LEF,IPR027397:Catenin binding domain,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05221:Acute myeloid leukemia,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),			SM00398:HMG,	Activator,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Wnt signaling pathway,	chain:Transcription factor 7-like 1,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,DNA-binding region:HMG box,region of interest:CTNNB1-binding,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
TFB2M	transcription factor B2, mitochondrial(TFB2M)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006390~transcription from mitochondrial promoter,GO:0006391~transcription initiation from mitochondrial promoter,GO:0007005~mitochondrion organization,GO:0031167~rRNA methylation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0030054~cell junction,GO:0042645~mitochondrial nucleoid,	GO:0000179~rRNA (adenine-N6,N6-)-dimethyltransferase activity,GO:0003712~transcription cofactor activity,GO:0044822~poly(A) RNA binding,	IPR001737:Ribosomal RNA adenine methylase transferase,IPR016861:Mitochondrial dimethyladenosine transferase 2, mitochondrial precursor,IPR020598:Ribosomal RNA adenine methylase transferase, N-terminal,			PIRSF027833:mitochondrial dimethyladenosine transferase 2, mitochondrial precursor,	SM00650:rADc,	Complete proteome,Methyltransferase,Mitochondrion,Polymorphism,Reference proteome,RNA-binding,rRNA processing,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Transit peptide,	chain:Dimethyladenosine transferase 2, mitochondrial,mutagenesis site,sequence conflict,sequence variant,transit peptide:Mitochondrion,
TFCP2L1	transcription factor CP2 like 1(TFCP2L1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0002070~epithelial cell maturation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006694~steroid biosynthetic process,GO:0007028~cytoplasm organization,GO:0007431~salivary gland development,GO:0007565~female pregnancy,GO:0008340~determination of adult lifespan,GO:0045927~positive regulation of growth,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0043565~sequence-specific DNA binding,	IPR007604:CP2 transcription factor,IPR013761:Sterile alpha motif/pointed domain,					Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor CP2-like protein 1,region of interest:Mediate transcriptional repression,
TTF2	transcription termination factor 2(TTF2)	Homo sapiens				GO:0006353~DNA-templated transcription, termination,GO:0006355~regulation of transcription, DNA-templated,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0008023~transcription elongation factor complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0008270~zinc ion binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR010666:Zinc finger, GRF-type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04918:Thyroid hormone synthesis,			SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,DNA-binding,Helicase,Hydrolase,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Spliceosome,Transcription,Transcription regulation,Transcription termination,	chain:Transcription termination factor 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,splice variant,
TADA1	transcriptional adaptor 1(TADA1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0043966~histone H3 acetylation,	GO:0000124~SAGA complex,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0030914~STAGA complex,	GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,	IPR024738:Transcriptional coactivator Hfi1/Transcriptional adapter 1,					Complete proteome,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Transcriptional adapter 1-like protein,sequence variant,
TGFA	transforming growth factor alpha(TGFA)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0001525~angiogenesis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0042060~wound healing,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045840~positive regulation of mitotic nuclear division,GO:0048208~COPII vesicle coating,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051781~positive regulation of cell division,GO:0060749~mammary gland alveolus development,GO:0072574~hepatocyte proliferation,	GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0001948~glycoprotein binding,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR000742:Epidermal growth factor-like domain,IPR013032:EGF-like, conserved site,IPR015497:Epidermal growth factor receptor ligand,	hsa04012:ErbB signaling pathway,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05223:Non-small cell lung cancer,				3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Growth factor,Lipoprotein,Membrane,Mitogen,Palmitate,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Protransforming growth factor alpha,chain:transforming growth factor alpha,disulfide bond,domain:EGF-like,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
TGFB2	transforming growth factor beta 2(TGFB2)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_erythPathway:Erythrocyte Differentiation Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_il1rPathway:Signal transduction through IL1R,h_inflamPathway:Cytokines and Inflammatory Response,h_mapkPathway:MAPKinase Signaling Pathway,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_slrp2Pathway:Function of SLRP in Bone: An Integrated View,h_tgfbPathway:TGF beta signaling pathway,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0000902~cell morphogenesis,GO:0001501~skeletal system development,GO:0001502~cartilage condensation,GO:0001525~angiogenesis,GO:0001654~eye development,GO:0001666~response to hypoxia,GO:0001822~kidney development,GO:0001837~epithelial to mesenchymal transition,GO:0001843~neural tube closure,GO:0001942~hair follicle development,GO:0001974~blood vessel remodeling,GO:0002576~platelet degranulation,GO:0003007~heart morphogenesis,GO:0003148~outflow tract septum morphogenesis,GO:0003149~membranous septum morphogenesis,GO:0003179~heart valve morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003184~pulmonary valve morphogenesis,GO:0003203~endocardial cushion morphogenesis,GO:0003215~cardiac right ventricle morphogenesis,GO:0003222~ventricular trabecula myocardium morphogenesis,GO:0003274~endocardial cushion fusion,GO:0003289~atrial septum primum morphogenesis,GO:0003407~neural retina development,GO:0006468~protein phosphorylation,GO:0007050~cell cycle arrest,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007184~SMAD protein import into nucleus,GO:0007267~cell-cell signaling,GO:0007411~axon guidance,GO:0007435~salivary gland morphogenesis,GO:0007507~heart development,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008347~glial cell migration,GO:0008584~male gonad development,GO:0009611~response to wounding,GO:0009790~embryo development,GO:0010002~cardioblast differentiation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010693~negative regulation of alkaline phosphatase activity,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0010936~negative regulation of macrophage cytokine production,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016049~cell growth,GO:0016477~cell migration,GO:0023014~signal transduction by protein phosphorylation,GO:0030097~hemopoiesis,GO:0030199~collagen fibril organization,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0030326~embryonic limb morphogenesis,GO:0030593~neutrophil chemotaxis,GO:0031069~hair follicle morphogenesis,GO:0032147~activation of protein kinase activity,GO:0032570~response to progesterone,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0032909~regulation of transforming growth factor beta2 production,GO:0032956~regulation of actin cytoskeleton organization,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0035910~ascending aorta morphogenesis,GO:0042060~wound healing,GO:0042416~dopamine biosynthetic process,GO:0042476~odontogenesis,GO:0042493~response to drug,GO:0042637~catagen,GO:0042704~uterine wall breakdown,GO:0043525~positive regulation of neuron apoptotic process,GO:0045216~cell-cell junction organization,GO:0045726~positive regulation of integrin biosynthetic process,GO:0045778~positive regulation of ossification,GO:0045787~positive regulation of cell cycle,GO:0045823~positive regulation of heart contraction,GO:0046580~negative regulation of Ras protein signal transduction,GO:0048103~somatic stem cell division,GO:0048566~embryonic digestive tract development,GO:0048663~neuron fate commitment,GO:0048666~neuron development,GO:0048699~generation of neurons,GO:0048839~inner ear development,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050714~positive regulation of protein secretion,GO:0050777~negative regulation of immune response,GO:0050778~positive regulation of immune response,GO:0051781~positive regulation of cell division,GO:0051795~positive regulation of catagen,GO:0051891~positive regulation of cardioblast differentiation,GO:0060021~palate development,GO:0060038~cardiac muscle cell proliferation,GO:0060065~uterus development,GO:0060317~cardiac epithelial to mesenchymal transition,GO:0060325~face morphogenesis,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060395~SMAD protein signal transduction,GO:0060412~ventricular septum morphogenesis,GO:0060413~atrial septum morphogenesis,GO:0061037~negative regulation of cartilage development,GO:0061626~pharyngeal arch artery morphogenesis,GO:0070237~positive regulation of activation-induced cell death of T cells,GO:0090091~positive regulation of extracellular matrix disassembly,GO:0097191~extrinsic apoptotic signaling pathway,GO:1900182~positive regulation of protein localization to nucleus,GO:1902256~regulation of apoptotic process involved in outflow tract morphogenesis,GO:1903659~regulation of complement-dependent cytotoxicity,GO:1903701~substantia propria of cornea development,GO:1904426~positive regulation of GTP binding,GO:1904888~cranial skeletal system development,GO:1905006~negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:1905007~positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005768~endosome,GO:0030424~axon,GO:0031012~extracellular matrix,GO:0031093~platelet alpha granule lumen,GO:0043025~neuronal cell body,	GO:0001540~beta-amyloid binding,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005102~receptor binding,GO:0005114~type II transforming growth factor beta receptor binding,GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0034714~type III transforming growth factor beta receptor binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR003940:Transforming growth factor, beta 2,IPR015615:Transforming growth factor-beta-related,IPR016319:Transforming growth factor-beta,IPR017948:Transforming growth factor beta, conserved site,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04350:TGF-beta signaling pathway,hsa04380:Osteoclast differentiation,hsa04390:Hippo signaling pathway,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,hsa05321:Inflammatory bowel disease (IBD),hsa05323:Rheumatoid arthritis,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,	614816~Loeys-Dietz syndrome 4,	PIRSF001787:transforming growth factor-beta [Parent=PIRSF800009],	SM00204:TGFB,	3D-structure,Alternative splicing,Aortic aneurysm,Chromosomal rearrangement,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Growth factor,Mitogen,Polymorphism,Reference proteome,Secreted,Signal,	chain:Transforming growth factor beta-2,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,
TGFBR2	transforming growth factor beta receptor 2(TGFBR2)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_tgfbPathway:TGF beta signaling pathway,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0001568~blood vessel development,GO:0001569~patterning of blood vessels,GO:0001570~vasculogenesis,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001947~heart looping,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002088~lens development in camera-type eye,GO:0002651~positive regulation of tolerance induction to self antigen,GO:0002663~positive regulation of B cell tolerance induction,GO:0002666~positive regulation of T cell tolerance induction,GO:0003148~outflow tract septum morphogenesis,GO:0003149~membranous septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003186~tricuspid valve morphogenesis,GO:0003214~cardiac left ventricle morphogenesis,GO:0003274~endocardial cushion fusion,GO:0003430~growth plate cartilage chondrocyte growth,GO:0006468~protein phosphorylation,GO:0006898~receptor-mediated endocytosis,GO:0006915~apoptotic process,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007182~common-partner SMAD protein phosphorylation,GO:0007219~Notch signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007369~gastrulation,GO:0007420~brain development,GO:0007507~heart development,GO:0007566~embryo implantation,GO:0007568~aging,GO:0007584~response to nutrient,GO:0008284~positive regulation of cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009749~response to glucose,GO:0010468~regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030154~cell differentiation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031100~organ regeneration,GO:0032147~activation of protein kinase activity,GO:0035162~embryonic hemopoiesis,GO:0040008~regulation of growth,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0043011~myeloid dendritic cell differentiation,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0043627~response to estrogen,GO:0045766~positive regulation of angiogenesis,GO:0048545~response to steroid hormone,GO:0048565~digestive tract development,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0051138~positive regulation of NK T cell differentiation,GO:0060021~palate development,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060412~ventricular septum morphogenesis,GO:0060434~bronchus morphogenesis,GO:0060440~trachea formation,GO:0060443~mammary gland morphogenesis,GO:0060463~lung lobe morphogenesis,GO:0070723~response to cholesterol,GO:1905007~positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:1990086~lens fiber cell apoptotic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:0045121~membrane raft,GO:0070022~transforming growth factor beta receptor homodimeric complex,	GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005024~transforming growth factor beta-activated receptor activity,GO:0005026~transforming growth factor beta receptor activity, type II,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005539~glycosaminoglycan binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0034714~type III transforming growth factor beta receptor binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0050431~transforming growth factor beta binding,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015013:Transforming growth factor beta receptor 2 ectodomain,IPR017194:Transforming growth factor-beta receptor, type II,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,hsa04380:Osteoclast differentiation,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa05142:Chagas disease (American trypanosomiasis),hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,	133239~Esophageal cancer, somatic,610168~Loeys-Dietz syndrome 2,614331~Colorectal cancer, hereditary nonpolyposis, type 6,	PIRSF037393:transforming growth factor-beta receptor, type II,	SM00220:S_TKc,	3D-structure,Alternative splicing,Aortic aneurysm,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Growth regulation,Hereditary nonpolyposis colorectal cancer,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:TGF-beta receptor type-2,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
TGFBR3	transforming growth factor beta receptor 3(TGFBR3)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0001666~response to hypoxia,GO:0001837~epithelial to mesenchymal transition,GO:0001889~liver development,GO:0003007~heart morphogenesis,GO:0003150~muscular septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003223~ventricular compact myocardium morphogenesis,GO:0006955~immune response,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007181~transforming growth factor beta receptor complex assembly,GO:0016049~cell growth,GO:0016477~cell migration,GO:0030509~BMP signaling pathway,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031100~organ regeneration,GO:0032354~response to follicle-stimulating hormone,GO:0034695~response to prostaglandin E,GO:0034699~response to luteinizing hormone,GO:0035556~intracellular signal transduction,GO:0043393~regulation of protein binding,GO:0046328~regulation of JNK cascade,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051271~negative regulation of cellular component movement,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0060021~palate development,GO:0060038~cardiac muscle cell proliferation,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060216~definitive hemopoiesis,GO:0060317~cardiac epithelial to mesenchymal transition,GO:0060318~definitive erythrocyte differentiation,GO:0060347~heart trabecula formation,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060412~ventricular septum morphogenesis,GO:0060939~epicardium-derived cardiac fibroblast cell development,GO:0060979~vasculogenesis involved in coronary vascular morphogenesis,GO:0061384~heart trabecula morphogenesis,GO:0070372~regulation of ERK1 and ERK2 cascade,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0034673~inhibin-betaglycan-ActRII complex,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0005024~transforming growth factor beta-activated receptor activity,GO:0005114~type II transforming growth factor beta receptor binding,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0015026~coreceptor activity,GO:0017134~fibroblast growth factor binding,GO:0030165~PDZ domain binding,GO:0046332~SMAD binding,GO:0048185~activin binding,GO:0050431~transforming growth factor beta binding,GO:0070123~transforming growth factor beta receptor activity, type III,	IPR001507:Zona pellucida domain,IPR017977:Zona pellucida domain, conserved site,				SM00241:ZP,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteoglycan,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:TGF-beta receptor type III,domain:ZP,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (glycosaminoglycan),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TGFBRAP1	transforming growth factor beta receptor associated protein 1(TGFBRAP1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006886~intracellular protein transport,GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008333~endosome to lysosome transport,GO:0034058~endosomal vesicle fusion,	GO:0005769~early endosome,GO:0016020~membrane,GO:0033263~CORVET complex,	GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0046332~SMAD binding,	IPR000547:Clathrin, heavy chain/VPS, 7-fold repeat,IPR001180:Citron-like,IPR019452:Vacuolar sorting protein 39/Transforming growth factor beta receptor-associated domain 1,IPR019453:Vacuolar sorting protein 39/Transforming growth factor beta receptor-associated domain 2,					Complete proteome,Cytoplasm,Endosome,Polymorphism,Protein transport,Reference proteome,Transport,	chain:Transforming growth factor-beta receptor- associated protein 1,domain:CNH,modified residue,sequence conflict,sequence variant,
TAGLN2	transgelin 2(TAGLN2)	Homo sapiens			Cytoskeleton,	GO:0030855~epithelial cell differentiation,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0031982~vesicle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000557:Calponin repeat,IPR001715:Calponin homology domain,IPR003096:Smooth muscle protein/calponin,				SM00033:CH,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Transgelin-2,domain:CH,helix,modified residue,repeat:Calponin-like,sequence variant,strand,turn,
TAGLN3	transgelin 3(TAGLN3)	Homo sapiens			Cytoskeleton,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0007417~central nervous system development,	GO:0005634~nucleus,GO:0043209~myelin sheath,		IPR000557:Calponin repeat,IPR001715:Calponin homology domain,IPR003096:Smooth muscle protein/calponin,				SM00033:CH,	Complete proteome,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Transgelin-3,domain:CH,modified residue,repeat:Calponin-like,
TGM4	transglutaminase 4(TGM4)	Homo sapiens				GO:0018149~peptide cross-linking,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003810~protein-glutamine gamma-glutamyltransferase activity,GO:0046872~metal ion binding,	IPR001102:Transglutaminase, N-terminal,IPR002931:Transglutaminase-like,IPR008958:Transglutaminase, C-terminal,IPR013783:Immunoglobulin-like fold,IPR013808:Transglutaminase, conserved site,IPR014756:Immunoglobulin E-set,IPR023608:Protein-glutamine gamma-glutamyltransferase, eukaryota,			PIRSF000459:protein-glutamine gamma-glutamyltransferase/erythrocyte membrane protein band 4.2,	SM00460:TGc,	Acyltransferase,Calcium,Complete proteome,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Protein-glutamine gamma- glutamyltransferase 4,metal ion-binding site:Calcium,sequence conflict,sequence variant,
TRPM8	transient receptor potential cation channel subfamily M member 8(TRPM8)	Homo sapiens				GO:0006812~cation transport,GO:0006874~cellular calcium ion homeostasis,GO:0009409~response to cold,GO:0016048~detection of temperature stimulus,GO:0050951~sensory perception of temperature stimulus,GO:0050955~thermoception,GO:0051289~protein homotetramerization,GO:0070207~protein homotrimerization,GO:0070588~calcium ion transmembrane transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,	GO:0005216~ion channel activity,GO:0005262~calcium channel activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR005821:Ion transport domain,	hsa04750:Inflammatory mediator regulation of TRP channels,				Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Endoplasmic reticulum,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Sensory transduction,Transmembrane,Transmembrane helix,Transport,	chain:Transient receptor potential cation channel subfamily M member 8,region of interest:Epitope; activates specific cytotoxic T lymphocytes,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TKT	transketolase(TKT)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0005999~xylulose biosynthetic process,GO:0006098~pentose-phosphate shunt,GO:0008152~metabolic process,GO:0009052~pentose-phosphate shunt, non-oxidative branch,GO:0040008~regulation of growth,GO:0046166~glyceraldehyde-3-phosphate biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004802~transketolase activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0048037~cofactor binding,	IPR005474:Transketolase, N-terminal,IPR005475:Transketolase-like, pyrimidine-binding domain,IPR009014:Transketolase, C-terminal/Pyruvate-ferredoxin oxidoreductase, domain II,IPR020826:Transketolase binding site,	hsa00030:Pentose phosphate pathway,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01230:Biosynthesis of amino acids,			SM00861:SM00861,	3D-structure,Acetylation,Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,Magnesium,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Thiamine pyrophosphate,Transferase,	chain:Transketolase,metal ion-binding site:Calcium,modified residue,sequence conflict,sequence variant,
TSNAX	translin associated factor X(TSNAX)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0015031~protein transport,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,	GO:0005634~nucleus,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008565~protein transporter activity,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR002848:Translin,IPR016068:Translin, N-terminal,IPR016069:Translin, C-terminal,					3D-structure,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Golgi apparatus,Magnesium,Metal-binding,Nucleus,Reference proteome,Spermatogenesis,Ubl conjugation,	chain:Translin-associated protein X,modified residue,region of interest:Interaction with C1D,
TIMM17A	translocase of inner mitochondrial membrane 17 homolog A (yeast)(TIMM17A)	Homo sapiens				GO:0006626~protein targeting to mitochondrion,GO:0006886~intracellular protein transport,GO:0030150~protein import into mitochondrial matrix,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005744~mitochondrial inner membrane presequence translocase complex,GO:0016021~integral component of membrane,GO:0031305~integral component of mitochondrial inner membrane,	GO:0015266~protein channel activity,GO:0015450~P-P-bond-hydrolysis-driven protein transmembrane transporter activity,	IPR003397:Mitochondrial inner membrane translocase subunit Tim17/Tim22/Tim23/peroxisomal protein PMP24,IPR005678:Mitochondrial inner membrane translocase complex, subunit Tim17,					Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Protein transport,Reference proteome,Translocation,Transmembrane,Transmembrane helix,Transport,	chain:Mitochondrial import inner membrane translocase subunit Tim17-A,sequence variant,transmembrane region,
TOMM20	translocase of outer mitochondrial membrane 20(TOMM20)	Homo sapiens				GO:0006605~protein targeting,GO:0006626~protein targeting to mitochondrion,GO:0016031~tRNA import into mitochondrion,GO:0016236~macroautophagy,GO:0030150~protein import into mitochondrial matrix,GO:0070096~mitochondrial outer membrane translocase complex assembly,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005742~mitochondrial outer membrane translocase complex,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0031307~integral component of mitochondrial outer membrane,GO:0044233~ER-mitochondrion membrane contact site,	GO:0005515~protein binding,GO:0015266~protein channel activity,GO:0015450~P-P-bond-hydrolysis-driven protein transmembrane transporter activity,GO:0030943~mitochondrion targeting sequence binding,GO:0051082~unfolded protein binding,	IPR002056:Protein import receptor MAS20-related,IPR022422:Protein import receptor MAS20, metazoan,IPR023392:Mitochondrial outer membrane translocase complex, subunit Tom20 domain,			PIRSF037707:mitochondrial import receptor, TOM20 subunit,		3D-structure,Complete proteome,Isopeptide bond,Membrane,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Mitochondrial import receptor subunit TOM20 homolog,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,
TOMM70	translocase of outer mitochondrial membrane 70(TOMM70)	Homo sapiens				GO:0006626~protein targeting to mitochondrion,GO:0016236~macroautophagy,GO:0071806~protein transmembrane transport,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005742~mitochondrial outer membrane translocase complex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008320~protein transmembrane transporter activity,	IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Acetylation,Complete proteome,Membrane,Methylation,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Reference proteome,Repeat,TPR repeat,Transmembrane,Transmembrane helix,	chain:Mitochondrial import receptor subunit TOM70,modified residue,repeat:TPR 1,repeat:TPR 10,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,
TPR	translocated promoter region, nuclear basket protein(TPR)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000189~MAPK import into nucleus,GO:0006308~DNA catabolic process,GO:0006404~RNA import into nucleus,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006611~protein export from nucleus,GO:0006999~nuclear pore organization,GO:0007067~mitotic nuclear division,GO:0007077~mitotic nuclear envelope disassembly,GO:0007094~mitotic spindle assembly checkpoint,GO:0010793~regulation of mRNA export from nucleus,GO:0010827~regulation of glucose transport,GO:0010965~regulation of mitotic sister chromatid separation,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0019083~viral transcription,GO:0031047~gene silencing by RNA,GO:0031453~positive regulation of heterochromatin assembly,GO:0031647~regulation of protein stability,GO:0031990~mRNA export from nucleus in response to heat stress,GO:0034605~cellular response to heat,GO:0035457~cellular response to interferon-alpha,GO:0042306~regulation of protein import into nucleus,GO:0042307~positive regulation of protein import into nucleus,GO:0043578~nuclear matrix organization,GO:0045947~negative regulation of translational initiation,GO:0046825~regulation of protein export from nucleus,GO:0046827~positive regulation of protein export from nucleus,GO:0046832~negative regulation of RNA export from nucleus,GO:0051292~nuclear pore complex assembly,GO:0051301~cell division,GO:0070849~response to epidermal growth factor,GO:0075733~intracellular transport of virus,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,GO:0090316~positive regulation of intracellular protein transport,GO:1900034~regulation of cellular response to heat,GO:1901673~regulation of mitotic spindle assembly,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005868~cytoplasmic dynein complex,GO:0009318~exodeoxyribonuclease VII complex,GO:0019898~extrinsic component of membrane,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0042405~nuclear inclusion body,GO:0044615~nuclear pore nuclear basket,GO:0072686~mitotic spindle,	GO:0003682~chromatin binding,GO:0003729~mRNA binding,GO:0005215~transporter activity,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0008855~exodeoxyribonuclease VII activity,GO:0015631~tubulin binding,GO:0031072~heat shock protein binding,GO:0042803~protein homodimerization activity,GO:0043495~protein anchor,GO:0044822~poly(A) RNA binding,GO:0051019~mitogen-activated protein kinase binding,GO:0070840~dynein complex binding,	IPR003761:Exonuclease VII, small subunit,IPR012929:Tetratricopeptide, MLP1/MLP2-like,IPR015866:Serine-tRNA synthetase, type1, N-terminal,	hsa03013:RNA transport,hsa05200:Pathways in cancer,hsa05216:Thyroid cancer,				Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosomal rearrangement,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Kinetochore,Membrane,Methylation,Mitosis,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Proto-oncogene,Reference proteome,Translocation,Transport,	chain:Nucleoprotein TPR,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,site:Breakpoint for translocation to form TRK- T1,
TM4SF20	transmembrane 4 L six family member 20(TM4SF20)	Homo sapiens				GO:0045861~negative regulation of proteolysis,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR008661:L6 membrane,		615432~Specific language impairment 5,			Autism spectrum disorder,Complete proteome,Endoplasmic reticulum,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane 4 L6 family member 20,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMBIM1	transmembrane BAX inhibitor motif containing 1(TMBIM1)	Homo sapiens				GO:0043086~negative regulation of catalytic activity,GO:0090005~negative regulation of establishment of protein localization to plasma membrane,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902045~negative regulation of Fas signaling pathway,GO:2000504~positive regulation of blood vessel remodeling,	GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005123~death receptor binding,	IPR006214:Bax inhibitor 1-related,					Complete proteome,Endosome,Lysosome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane BAX inhibitor motif- containing protein 1,modified residue,sequence conflict,sequence variant,transmembrane region,
TMCC2	transmembrane and coiled-coil domain family 2(TMCC2)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR019394:Predicted transmembrane/coiled-coil 2 protein,					Alternative splicing,Coiled coil,Complete proteome,Membrane,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane and coiled-coil domains protein 2,modified residue,sequence conflict,transmembrane region,
TMCO1	transmembrane and coiled-coil domains 1(TMCO1)	Homo sapiens				GO:0006983~ER overload response,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0070588~calcium ion transmembrane transport,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005262~calcium channel activity,	IPR002809:Protein of unknown function DUF106, transmembrane,IPR008559:Uncharacterised conserved protein UCP023322, transmembrane eukaryotic,		213980~Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome,	PIRSF023322:transmembrane protein,	SM01415:SM01415,	Alternative splicing,Calcium,Calcium channel,Calcium transport,Coiled coil,Complete proteome,Disease mutation,Endoplasmic reticulum,Glaucoma,Golgi apparatus,Ion channel,Ion transport,Membrane,Mental retardation,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Transmembrane and coiled-coil domain- containing protein 1,compositionally biased region:Poly-Pro,modified residue,sequence conflict,splice variant,transmembrane region,
TMCO4	transmembrane and coiled-coil domains 4(TMCO4)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007941:Protein of unknown function DUF726,					Alternative splicing,Coiled coil,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane and coiled-coil domain- containing protein 4,sequence conflict,sequence variant,splice variant,transmembrane region,
TMIGD3	transmembrane and immunoglobulin domain containing 3(TMIGD3)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
TMIE	transmembrane inner ear(TMIE)	Homo sapiens				GO:0007605~sensory perception of sound,GO:0042472~inner ear morphogenesis,	GO:0016021~integral component of membrane,				600971~Deafness, autosomal recessive 6,			Complete proteome,Deafness,Disease mutation,Membrane,Non-syndromic deafness,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane inner ear expressed protein,compositionally biased region:Lys-rich,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMED5	transmembrane p24 trafficking protein 5(TMED5)	Homo sapiens				GO:0006810~transport,GO:0015031~protein transport,GO:0090161~Golgi ribbon formation,	GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0070971~endoplasmic reticulum exit site,	GO:0005515~protein binding,	IPR009038:GOLD,IPR015717:Transmembrane emp24 domain-containing protein,IPR015720:TMP21-related,				SM01190:SM01190,	Alternative splicing,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Transmembrane emp24 domain-containing protein 5,domain:GOLD,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
TMPRSS7	transmembrane protease, serine 7(TMPRSS7)	Homo sapiens				GO:0006508~proteolysis,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004252~serine-type endopeptidase activity,GO:0008236~serine-type peptidase activity,	IPR000082:SEA domain,IPR000859:CUB domain,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,				SM00020:Tryp_SPc,SM00042:CUB,SM00192:LDLa,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Protease,Reference proteome,Repeat,Serine protease,Signal-anchor,Transmembrane,Transmembrane helix,Zymogen,	active site:Charge relay system,chain:Transmembrane protease, serine 7,disulfide bond,domain:CUB 1,domain:CUB 2,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:Peptidase S1,sequence conflict,site:Cleavage,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM110	transmembrane protein 110(TMEM110)	Homo sapiens				GO:0032237~activation of store-operated calcium channel activity,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0051533~positive regulation of NFAT protein import into nucleus,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0032541~cortical endoplasmic reticulum,	GO:0005246~calcium channel regulator activity,GO:0005515~protein binding,	IPR022127:Protein of unknown function DUF3661, vaculolar transmembrane,					Complete proteome,Endoplasmic reticulum,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Musculoskeletal embryonic nuclear protein 1,chain:Transmembrane protein 110,short sequence motif:Nuclear localization signal,transmembrane region,
TMEM127	transmembrane protein 127(TMEM127)	Homo sapiens				GO:0007032~endosome organization,GO:0008285~negative regulation of cell proliferation,GO:0032007~negative regulation of TOR signaling,	GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0017137~Rab GTPase binding,			171300~Pheochromocytoma, susceptibility to,			Acetylation,Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Transmembrane protein 127,modified residue,transmembrane region,
TMEM131	transmembrane protein 131(TMEM131)	Homo sapiens					GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR008962:PapD-like,IPR022113:Protein of unknown function DUF3651, TMEM131,					Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 131,compositionally biased region:Lys-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,glycosylation site:N-linked (GlcNAc...),modified residue,transmembrane region,
TMEM163	transmembrane protein 163(TMEM163)	Homo sapiens					GO:0030054~cell junction,GO:0030285~integral component of synaptic vesicle membrane,GO:0031901~early endosome membrane,	GO:0008270~zinc ion binding,	IPR026765:Transmembrane protein 163,					Alternative splicing,Cell junction,Complete proteome,Cytoplasmic vesicle,Endosome,Membrane,Phosphoprotein,Reference proteome,Synapse,Transmembrane,Transmembrane helix,Zinc,	chain:Transmembrane protein 163,compositionally biased region:Pro-rich,modified residue,splice variant,transmembrane region,
TMEM177	transmembrane protein 177(TMEM177)	Homo sapiens					GO:0016021~integral component of membrane,		IPR026620:Transmembrane protein 177,					Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 177,sequence variant,transmembrane region,
TMEM178A	transmembrane protein 178A(TMEM178A)	Homo sapiens				GO:0045671~negative regulation of osteoclast differentiation,GO:0051480~regulation of cytosolic calcium ion concentration,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,		IPR004031:PMP-22/EMP/MP20/Claudin,					Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 178,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM18	transmembrane protein 18(TMEM18)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0016477~cell migration,	GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,	IPR026721:Transmembrane protein 18,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Membrane,Nucleus,Proteomics identification,Reference proteome,Transcription,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 18,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM182	transmembrane protein 182(TMEM182)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR004031:PMP-22/EMP/MP20/Claudin,IPR026763:Transmembrane protein 182,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 182,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM183A	transmembrane protein 183A(TMEM183A)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR026509:Transmembrane protein 183,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 183A,chain:Transmembrane protein 183B,sequence conflict,sequence variant,splice variant,transmembrane region,
TMEM198	transmembrane protein 198(TMEM198)	Homo sapiens				GO:0007275~multicellular organism development,GO:0016055~Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,		IPR025256:Domain of unknown function DUF4203,					Cell membrane,Complete proteome,Cytoplasmic vesicle,Developmental protein,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Transmembrane protein 198,compositionally biased region:Arg-rich,compositionally biased region:Leu-rich,transmembrane region,
TMEM201	transmembrane protein 201(TMEM201)	Homo sapiens				GO:0010761~fibroblast migration,GO:0030473~nuclear migration along microtubule,	GO:0005637~nuclear inner membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0005521~lamin binding,GO:0051015~actin filament binding,	IPR018617:Protein of unknown function DUF2349,IPR018861:Protein of unknown function DUF2448,					Acetylation,Alternative splicing,Complete proteome,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 201,compositionally biased region:Ser-rich,glycosylation site:N-linked (GlcNAc...),modified residue,splice variant,transmembrane region,
TMEM206	transmembrane protein 206(TMEM206)	Homo sapiens					GO:0009986~cell surface,GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 206,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM214	transmembrane protein 214(TMEM214)	Homo sapiens				GO:0006915~apoptotic process,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005881~cytoplasmic microtubule,GO:0016021~integral component of membrane,		IPR019308:Protein of unknown function DUF2359, TMEM214,					Acetylation,Alternative splicing,Apoptosis,Complete proteome,Endoplasmic reticulum,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 214,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
TMEM237	transmembrane protein 237(TMEM237)	Homo sapiens				GO:0006096~glycolytic process,GO:0030111~regulation of Wnt signaling pathway,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,	GO:0000015~phosphopyruvate hydratase complex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0035869~ciliary transition zone,	GO:0000287~magnesium ion binding,GO:0004634~phosphopyruvate hydratase activity,	IPR000941:Enolase,IPR020811:Enolase, N-terminal,		614424~Joubert syndrome 14,		SM01193:SM01193,	Alternative splicing,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Joubert syndrome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein,sequence conflict,splice variant,transmembrane region,
TMEM240	transmembrane protein 240(TMEM240)	Homo sapiens					GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0097060~synaptic membrane,				607454~Spinocerebellar ataxia 21,			Cell junction,Cell membrane,Complete proteome,Disease mutation,Membrane,Mental retardation,Neurodegeneration,Phosphoprotein,Reference proteome,Spinocerebellar ataxia,Synapse,Transmembrane,Transmembrane helix,	chain:Transmembrane protein C1orf70,transmembrane region,
TMEM247	transmembrane protein 247(TMEM247)	Homo sapiens					GO:0005783~endoplasmic reticulum,GO:0016021~integral component of membrane,							Coiled coil,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein ENSP00000343375,transmembrane region,
TMEM30CP	transmembrane protein 30C, pseudogene(TMEM30CP)	Homo sapiens					GO:0016021~integral component of membrane,		IPR005045:Protein of unknown function DUF284, transmembrane eukaryotic,					Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
TMEM35B	transmembrane protein 35B(TMEM35B)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,
TMEM37	transmembrane protein 37(TMEM37)	Homo sapiens				GO:0034765~regulation of ion transmembrane transport,GO:0070588~calcium ion transmembrane transport,	GO:0016021~integral component of membrane,	GO:0005244~voltage-gated ion channel activity,GO:0005262~calcium channel activity,						Calcium,Calcium channel,Calcium transport,Complete proteome,Ion channel,Ion transport,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Voltage-dependent calcium channel gamma- like subunit,transmembrane region,
TMEM39B	transmembrane protein 39B(TMEM39B)	Homo sapiens					GO:0016021~integral component of membrane,		IPR019397:Uncharacterised protein family TMEM39,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 39B,compositionally biased region:Ser-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,transmembrane region,
TMEM40	transmembrane protein 40(TMEM40)	Homo sapiens					GO:0016021~integral component of membrane,		IPR026181:Transmembrane protein 40,					Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 40,compositionally biased region:Ser-rich,modified residue,sequence conflict,splice variant,transmembrane region,
TMEM42	transmembrane protein 42(TMEM42)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 42,sequence conflict,transmembrane region,
TMEM43	transmembrane protein 43(TMEM43)	Homo sapiens				GO:0071763~nuclear membrane organization,	GO:0005639~integral component of nuclear inner membrane,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0043621~protein self-association,	IPR012430:Transmembrane protein 43 family,		604400~Arrhythmogenic right ventricular dysplasia 5,614302~Emery-Dreifuss muscular dystrophy 7, AD,			Acetylation,Cardiomyopathy,Complete proteome,Disease mutation,Emery-Dreifuss muscular dystrophy,Endoplasmic reticulum,Membrane,Nucleus,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 43,modified residue,sequence conflict,sequence variant,topological domain:Lumenal,topological domain:Nuclear,transmembrane region,
TMEM45A	transmembrane protein 45A(TMEM45A)	Homo sapiens					GO:0016021~integral component of membrane,		IPR006904:Protein of unknown function DUF716, TMEM45,					Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 45A,modified residue,transmembrane region,
TMEM51	transmembrane protein 51(TMEM51)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Complete proteome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 51,modified residue,sequence variant,transmembrane region,
TMEM52	transmembrane protein 52(TMEM52)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 52,sequence variant,signal peptide,splice variant,transmembrane region,
TMEM53	transmembrane protein 53(TMEM53)	Homo sapiens					GO:0005634~nucleus,GO:0016021~integral component of membrane,		IPR008547:Protein of unknown function DUF829, TMEM53,					Alternative splicing,Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 53,sequence conflict,splice variant,transmembrane region,
TMEM56	transmembrane protein 56(TMEM56)	Homo sapiens					GO:0016021~integral component of membrane,		IPR006634:TRAM/LAG1/CLN8 homology domain,				SM00724:TLC,	Acetylation,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 56,domain:TLC,modified residue,transmembrane region,
TMEM57	transmembrane protein 57(TMEM57)	Homo sapiens				GO:0007420~brain development,	GO:0005634~nucleus,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0031965~nuclear membrane,GO:0044306~neuron projection terminus,GO:0045202~synapse,		IPR019130:Macoilin,					Alternative splicing,Cell projection,Complete proteome,Glycoprotein,Membrane,Nucleus,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Macoilin,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,splice variant,transmembrane region,
TMEM59	transmembrane protein 59(TMEM59)	Homo sapiens				GO:0006508~proteolysis,GO:0006914~autophagy,GO:0010508~positive regulation of autophagy,GO:0010955~negative regulation of protein processing,GO:0090005~negative regulation of establishment of protein localization to plasma membrane,GO:0090285~negative regulation of protein glycosylation in Golgi,	GO:0000137~Golgi cis cisterna,GO:0000138~Golgi trans cisterna,GO:0000139~Golgi membrane,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005797~Golgi medial cisterna,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0005515~protein binding,	IPR022065:Uncharacterised protein family, TMEM59,					Autophagy,Cell membrane,Complete proteome,Endosome,Glycoprotein,Golgi apparatus,Lysosome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 59,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM61	transmembrane protein 61(TMEM61)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 61,sequence variant,transmembrane region,
TMEM63A	transmembrane protein 63A(TMEM63A)	Homo sapiens			Function unknown,	GO:0006811~ion transport,	GO:0005765~lysosomal membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,	IPR003864:Domain of unknown function DUF221,IPR012677:Nucleotide-binding, alpha-beta plait,IPR026957:Transmembrane protein 63,					Calcium,Complete proteome,Ion channel,Ion transport,Lysosome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Transmembrane protein 63A,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,transmembrane region,
TMEM78	transmembrane protein 78(TMEM78)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 78,sequence conflict,transmembrane region,
TMEM79	transmembrane protein 79(TMEM79)	Homo sapiens				GO:0002070~epithelial cell maturation,GO:0031069~hair follicle morphogenesis,GO:0042335~cuticle development,GO:0045055~regulated exocytosis,GO:0045684~positive regulation of epidermis development,GO:0061436~establishment of skin barrier,GO:0070268~cornification,	GO:0005765~lysosomal membrane,GO:0016021~integral component of membrane,GO:0032588~trans-Golgi network membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,						Complete proteome,Golgi apparatus,Lysosome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 79,modified residue,sequence variant,transmembrane region,
TMEM81	transmembrane protein 81(TMEM81)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007110:Immunoglobulin-like domain,					Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 81,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM87B	transmembrane protein 87B(TMEM87B)	Homo sapiens					GO:0016021~integral component of membrane,		IPR009637:Transmembrane receptor, eukaryota,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 87B,glycosylation site:N-linked (GlcNAc...),modified residue,signal peptide,splice variant,topological domain:Extracellular,transmembrane region,
TMEM88B	transmembrane protein 88B(TMEM88B)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 88B,compositionally biased region:Poly-Glu,transmembrane region,
TMEM89	transmembrane protein 89(TMEM89)	Homo sapiens					GO:0005634~nucleus,GO:0016021~integral component of membrane,							Complete proteome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 89,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM9	transmembrane protein 9(TMEM9)	Homo sapiens				GO:0006810~transport,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,		IPR008853:TMEM9,					Complete proteome,Endosome,Glycoprotein,Lysosome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Transmembrane protein 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEFF2	transmembrane protein with EGF like and two follistatin like domains 2(TMEFF2)	Homo sapiens				GO:0030336~negative regulation of cell migration,GO:0044319~wound healing, spreading of cells,GO:0045720~negative regulation of integrin biosynthetic process,GO:0051497~negative regulation of stress fiber assembly,	GO:0005576~extracellular region,GO:0016021~integral component of membrane,		IPR000742:Epidermal growth factor-like domain,IPR002350:Kazal domain,IPR013032:EGF-like, conserved site,				SM00280:KAZAL,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Tomoregulin-2,disulfide bond,domain:EGF-like,domain:Kazal-like 1,domain:Kazal-like 2,glycosylation site:N-linked (GlcNAc...),region of interest:Required for shedding,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMPPE	transmembrane protein with metallophosphoesterase domain(TMPPE)	Homo sapiens			General function prediction only,		GO:0016021~integral component of membrane,	GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR004843:Metallophosphoesterase domain,					Alternative splicing,Complete proteome,Hydrolase,Membrane,Metal-binding,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein with metallophosphoesterase domain,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,sequence conflict,splice variant,transmembrane region,
TCHHL1	trichohyalin like 1(TCHHL1)	Homo sapiens			General function prediction only,				IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,				SM01394:SM01394,	Complete proteome,Polymorphism,Reference proteome,	chain:Trichohyalin-like protein 1,domain:EF-hand,sequence variant,
TRIM11	tripartite motif containing 11(TRIM11)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0032897~negative regulation of viral transcription,GO:0045087~innate immune response,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046597~negative regulation of viral entry into host cell,GO:0046598~positive regulation of viral entry into host cell,GO:0050768~negative regulation of neurogenesis,GO:0051607~defense response to virus,GO:1902187~negative regulation of viral release from host cell,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019904~protein domain specific binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	Alternative splicing,Antiviral defense,Coiled coil,Complete proteome,Cytoplasm,Ligase,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 11,domain:B30.2/SPRY,sequence conflict,splice variant,zinc finger region:B box-type,zinc finger region:RING-type,
TRIM17	tripartite motif containing 17(TRIM17)	Homo sapiens				GO:0006914~autophagy,GO:0032880~regulation of protein localization,GO:0051865~protein autoubiquitination,	GO:0005622~intracellular,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	Alternative splicing,Coiled coil,Complete proteome,Ligase,Metal-binding,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase TRIM17,domain:B30.2/SPRY,zinc finger region:B box-type,zinc finger region:RING-type,
TRIM33	tripartite motif containing 33(TRIM33)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0016567~protein ubiquitination,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0070410~co-SMAD binding,GO:0070412~R-SMAD binding,	IPR000315:Zinc finger, B-box,IPR001487:Bromodomain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003649:B-box, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00249:PHD,SM00297:BROMO,SM00336:BBOX,SM00502:BBC,	3D-structure,Acetylation,Alternative splicing,Bromodomain,Chromosomal rearrangement,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Ligase,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase TRIM33,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Thr,domain:Bromo,modified residue,mutagenesis site,region of interest:Necessary for E3 ubiquitin-protein ligase activity and repression of SMAD4 signaling and transcriptional repression,region of interest:Necessary for oligomerization,sequence conflict,sequence variant,site:Breakpoint for translocation to form TRIM33-RET oncogene,splice variant,zinc finger region:B box-type 1,zinc finger region:B box-type 2,zinc finger region:PHD-type,zinc finger region:RING-type,
TRIM43	tripartite motif containing 43(TRIM43)	Homo sapiens					GO:0005622~intracellular,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,	Coiled coil,Complete proteome,Metal-binding,Reference proteome,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 43,chain:Tripartite motif-containing protein 43B,domain:B30.2/SPRY,zinc finger region:B box-type,zinc finger region:RING-type,
TRIM45	tripartite motif containing 45(TRIM45)	Homo sapiens				GO:0060348~bone development,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0045171~intercellular bridge,	GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001298:Filamin/ABP280 repeat,IPR001841:Zinc finger, RING-type,IPR003649:B-box, C-terminal,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00336:BBOX,SM00502:BBC,SM00557:IG_FLMN,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 45,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),repeat:Filamin,sequence variant,splice variant,strand,turn,zinc finger region:B box-type 1,zinc finger region:B box-type 2,zinc finger region:RING-type,
TRIM54	tripartite motif containing 54(TRIM54)	Homo sapiens				GO:0007017~microtubule-based process,GO:0007026~negative regulation of microtubule depolymerization,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0055001~muscle cell development,	GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0030018~Z disc,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017903:COS domain,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00336:BBOX,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Metal-binding,Microtubule,Reference proteome,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 54,domain:COS,region of interest:Mediates microtubule-binding and homooligomerization,sequence conflict,splice variant,zinc finger region:B box-type,zinc finger region:RING-type,
TRIM58	tripartite motif containing 58(TRIM58)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005622~intracellular,	GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	Coiled coil,Complete proteome,Ligase,Metal-binding,Polymorphism,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 58,domain:B30.2/SPRY,sequence conflict,sequence variant,zinc finger region:B box-type,zinc finger region:RING-type,
TRIM62	tripartite motif containing 62(TRIM62)	Homo sapiens				GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0016567~protein ubiquitination,GO:0032897~negative regulation of viral transcription,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0046596~regulation of viral entry into host cell,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060333~interferon-gamma-mediated signaling pathway,GO:1902186~regulation of viral release from host cell,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00449:SPRY,SM00589:PRY,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Ligase,Metal-binding,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 62,domain:B30.2/SPRY,sequence conflict,zinc finger region:B box-type,zinc finger region:RING-type,
TRIM67	tripartite motif containing 67(TRIM67)	Homo sapiens				GO:0010976~positive regulation of neuron projection development,GO:0046580~negative regulation of Ras protein signal transduction,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003649:B-box, C-terminal,IPR003877:SPla/RYanodine receptor SPRY,IPR003961:Fibronectin, type III,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR017903:COS domain,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,				SM00060:FN3,SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00502:BBC,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 67,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,domain:B30.2/SPRY,domain:COS,domain:Fibronectin type-III,sequence conflict,splice variant,zinc finger region:B box-type 1; degenerate,zinc finger region:B box-type 2,
TRIM71	tripartite motif containing 71(TRIM71)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0001843~neural tube closure,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010586~miRNA metabolic process,GO:0017148~negative regulation of translation,GO:0021915~neural tube development,GO:0035278~miRNA mediated inhibition of translation,GO:0051865~protein autoubiquitination,GO:0060964~regulation of gene silencing by miRNA,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0072089~stem cell proliferation,GO:2000177~regulation of neural precursor cell proliferation,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0000932~cytoplasmic mRNA processing body,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0030371~translation repressor activity,GO:0035198~miRNA binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Zinc finger, B-box,IPR001258:NHL repeat,IPR001298:Filamin/ABP280 repeat,IPR001841:Zinc finger, RING-type,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013017:NHL repeat, subgroup,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,IPR017907:Zinc finger, RING-type, conserved site,	hsa05206:MicroRNAs in cancer,			SM00184:RING,SM00336:BBOX,SM00557:IG_FLMN,	Acetylation,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Ligase,Metal-binding,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 71,compositionally biased region:His-rich,compositionally biased region:Ser-rich,repeat:Filamin,repeat:NHL 1,repeat:NHL 2,repeat:NHL 3,repeat:NHL 4,repeat:NHL 5,repeat:NHL 6,zinc finger region:B box-type 1; atypical,zinc finger region:B box-type 2,zinc finger region:RING-type,
TPM3	tropomyosin 3(TPM3)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0006936~muscle contraction,GO:0007015~actin filament organization,GO:0030049~muscle filament sliding,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005862~muscle thin filament tropomyosin,GO:0005884~actin filament,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008307~structural constituent of muscle,GO:0051015~actin filament binding,	IPR000533:Tropomyosin,	hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa05200:Pathways in cancer,hsa05216:Thyroid cancer,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,	255310~Myopathy, congenital, with fiber-type disproportion,609284~CAP myopathy 1,609284~Nemaline myopathy 1, autosomal dominant or recessive,			Acetylation,Actin-binding,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Isopeptide bond,Muscle protein,Nemaline myopathy,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Ubl conjugation,	chain:Tropomyosin alpha-3 chain,modified residue,sequence conflict,sequence variant,splice variant,
TNNC1	troponin C1, slow skeletal and cardiac type(TNNC1)	Homo sapiens				GO:0002086~diaphragm contraction,GO:0003009~skeletal muscle contraction,GO:0006937~regulation of muscle contraction,GO:0010038~response to metal ion,GO:0014883~transition between fast and slow fiber,GO:0030049~muscle filament sliding,GO:0032972~regulation of muscle filament sliding speed,GO:0043462~regulation of ATPase activity,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0060048~cardiac muscle contraction,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005861~troponin complex,GO:0015629~actin cytoskeleton,GO:0043292~contractile fiber,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0031013~troponin I binding,GO:0031014~troponin T binding,GO:0042803~protein homodimerization activity,GO:0048306~calcium-dependent protein binding,GO:0051015~actin filament binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa04020:Calcium signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,	611879~Cardiomyopathy, dilated, 1Z,613243~Cardiomyopathy, hypertrophic, 13,		SM00054:EFh,	3D-structure,Acetylation,Calcium,Cardiomyopathy,Complete proteome,Direct protein sequencing,Disease mutation,Metal-binding,Muscle protein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Troponin C, slow skeletal and cardiac muscles,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,helix,modified residue,sequence conflict,sequence variant,strand,turn,
TNNT2	troponin T2, cardiac type(TNNT2)	Homo sapiens				GO:0006937~regulation of muscle contraction,GO:0008016~regulation of heart contraction,GO:0030049~muscle filament sliding,GO:0032780~negative regulation of ATPase activity,GO:0032781~positive regulation of ATPase activity,GO:0032972~regulation of muscle filament sliding speed,GO:0051291~protein heterooligomerization,GO:0051592~response to calcium ion,GO:0051764~actin crosslink formation,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0060048~cardiac muscle contraction,	GO:0005829~cytosol,GO:0005861~troponin complex,GO:0005865~striated muscle thin filament,GO:0030017~sarcomere,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005523~tropomyosin binding,GO:0030172~troponin C binding,GO:0030674~protein binding, bridging,GO:0031013~troponin I binding,	IPR001978:Troponin,	hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,	115195~Cardiomyopathy, hypertrophic, 2,601494~Cardiomyopathy, dilated, 1D,601494~Left ventricular noncompaction 6,612422~Cardiomyopathy, familial restrictive, 3,			3D-structure,Acetylation,Alternative splicing,Cardiomyopathy,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Muscle protein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Troponin T, cardiac muscle,helix,modified residue,sequence conflict,sequence variant,splice variant,
WARS2	tryptophanyl tRNA synthetase 2, mitochondrial(WARS2)	Homo sapiens				GO:0001570~vasculogenesis,GO:0006418~tRNA aminoacylation for protein translation,GO:0006436~tryptophanyl-tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,	GO:0004830~tryptophan-tRNA ligase activity,GO:0005524~ATP binding,	IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR002305:Aminoacyl-tRNA synthetase, class Ic,IPR002306:Tryptophan-tRNA ligase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR024109:Tryptophan-tRNA ligase, bacterial-type,	hsa00970:Aminoacyl-tRNA biosynthesis,				Alternative splicing,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Ligase,Mitochondrion,Nucleotide-binding,Polymorphism,Protein biosynthesis,Reference proteome,Transit peptide,	chain:Tryptophanyl-tRNA synthetase, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,
TUBA3D	tubulin alpha 3d(TUBA3D)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR000217:Tubulin,IPR002452:Alpha tubulin,IPR003008:Tubulin/FtsZ, GTPase domain,IPR008280:Tubulin/FtsZ, C-terminal,IPR017975:Tubulin, conserved site,IPR018316:Tubulin/FtsZ, 2-layer sandwich domain,IPR023123:Tubulin, C-terminal,	hsa04145:Phagosome,hsa04540:Gap junction,hsa05130:Pathogenic Escherichia coli infection,			SM00864:SM00864,SM00865:SM00865,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Isopeptide bond,Methylation,Microtubule,Nitration,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Tubulin alpha-3C/D chain,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,site:Involved in polymerization,splice variant,
TUBA3E	tubulin alpha 3e(TUBA3E)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR000217:Tubulin,IPR002452:Alpha tubulin,IPR003008:Tubulin/FtsZ, GTPase domain,IPR008280:Tubulin/FtsZ, C-terminal,IPR017975:Tubulin, conserved site,IPR018316:Tubulin/FtsZ, 2-layer sandwich domain,IPR023123:Tubulin, C-terminal,	hsa04145:Phagosome,hsa04540:Gap junction,hsa05130:Pathogenic Escherichia coli infection,			SM00864:SM00864,SM00865:SM00865,	Acetylation,Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Microtubule,Nitration,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,	chain:Tubulin alpha-3E chain,modified residue,nucleotide phosphate-binding region:GTP,sequence variant,site:Involved in polymerization,
TUBA4B	tubulin alpha 4b(TUBA4B)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,	GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,	IPR000217:Tubulin,IPR002452:Alpha tubulin,IPR003008:Tubulin/FtsZ, GTPase domain,				SM00864:SM00864,	Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Microtubule,Nucleotide-binding,Reference proteome,	chain:Putative tubulin-like protein alpha-4B,nucleotide phosphate-binding region:GTP,sequence conflict,
TBCE	tubulin folding cofactor E(TBCE)	Homo sapiens			Function unknown,	GO:0000226~microtubule cytoskeleton organization,GO:0006457~protein folding,GO:0007023~post-chaperonin tubulin folding pathway,GO:0008344~adult locomotory behavior,GO:0009791~post-embryonic development,GO:0014889~muscle atrophy,GO:0048589~developmental growth,GO:0048936~peripheral nervous system neuron axonogenesis,	GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0051087~chaperone binding,	IPR000626:Ubiquitin,IPR000938:CAP Gly-rich domain,		241410~Hypoparathyroidism-retardation-dysmorphism syndrome,244460~Kenny-Caffey syndrome, type 1,		SM01052:SM01052,	3D-structure,Acetylation,Alternative splicing,Chaperone,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Dwarfism,Leucine-rich repeat,Mental retardation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Tubulin-specific chaperone E,domain:CAP-Gly,modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,sequence variant,
TTLL10	tubulin tyrosine ligase like 10(TTLL10)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0018094~protein polyglycylation,		GO:0005515~protein binding,GO:0005524~ATP binding,GO:0070735~protein-glycine ligase activity,	IPR004344:Tubulin-tyrosine ligase,					Alternative splicing,ATP-binding,Complete proteome,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Inactive polyglycylase TTLL10,compositionally biased region:Pro-rich,domain:TTL,mutagenesis site,sequence conflict,sequence variant,splice variant,
TTLL3	tubulin tyrosine ligase like 3(TTLL3)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0018094~protein polyglycylation,GO:0035082~axoneme assembly,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,	GO:0005524~ATP binding,GO:0070735~protein-glycine ligase activity,GO:0070736~protein-glycine ligase activity, initiating,	IPR004344:Tubulin-tyrosine ligase,					Alternative splicing,ATP-binding,Cell projection,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Ligase,Microtubule,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Actin-related protein 2/3 complex subunit 4,chain:Tubulin monoglycylase TTLL3,domain:TTL,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
TTLL4	tubulin tyrosine ligase like 4(TTLL4)	Homo sapiens				GO:0018095~protein polyglutamylation,GO:0018200~peptidyl-glutamic acid modification,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005929~cilium,	GO:0005524~ATP binding,GO:0015631~tubulin binding,GO:0070739~protein-glutamic acid ligase activity,	IPR004344:Tubulin-tyrosine ligase,IPR013816:ATP-grasp fold, subdomain 2,					ATP-binding,Cell projection,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Ligase,Microtubule,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Tubulin polyglutamylase TTLL4,domain:TTL,modified residue,sequence variant,
TTLL7	tubulin tyrosine ligase like 7(TTLL7)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0007399~nervous system development,GO:0018095~protein polyglutamylation,GO:0030154~cell differentiation,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005929~cilium,GO:0030425~dendrite,GO:0043204~perikaryon,	GO:0005524~ATP binding,GO:0043014~alpha-tubulin binding,GO:0048487~beta-tubulin binding,GO:0070740~tubulin-glutamic acid ligase activity,	IPR004344:Tubulin-tyrosine ligase,					3D-structure,Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Ligase,Microtubule,Neurogenesis,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Tubulin polyglutamylase TTLL7,domain:TTL,sequence conflict,splice variant,
TTL	tubulin tyrosine ligase(TTL)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0006464~cellular protein modification process,GO:0030516~regulation of axon extension,		GO:0004835~tubulin-tyrosine ligase activity,GO:0005524~ATP binding,	IPR004344:Tubulin-tyrosine ligase,					ATP-binding,Complete proteome,Ligase,Magnesium,Nucleotide-binding,Potassium,Reference proteome,	chain:Tubulin--tyrosine ligase,domain:TTL,sequence conflict,
TINAGL1	tubulointerstitial nephritis antigen like 1(TINAGL1)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0016197~endosomal transport,GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0008234~cysteine-type peptidase activity,GO:0030247~polysaccharide binding,GO:0043236~laminin binding,	IPR000668:Peptidase C1A, papain C-terminal,IPR001212:Somatomedin B domain,IPR013128:Peptidase C1A, papain,IPR025660:Cysteine peptidase, histidine active site,				SM00645:Pept_C1,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Tubulointerstitial nephritis antigen- like,disulfide bond,domain:SMB,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
TDRKH	tudor and KH domain containing(TDRKH)	Homo sapiens				GO:0007140~male meiosis,GO:0007283~spermatogenesis,GO:0009566~fertilization,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,	GO:0005739~mitochondrion,GO:0016021~integral component of membrane,GO:0071546~pi-body,GO:0071547~piP-body,	GO:0003723~RNA binding,	IPR002999:Tudor domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,SM00333:TUDOR,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Isopeptide bond,Membrane,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,Spermatogenesis,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Tudor and KH domain-containing protein,domain:KH 1,domain:KH 2,domain:Tudor,helix,sequence conflict,sequence variant,splice variant,
TDRD10	tudor domain containing 10(TDRD10)	Homo sapiens						GO:0000166~nucleotide binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR002999:Tudor domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,RNA-binding,	chain:Tudor domain-containing protein 10,domain:RRM,domain:Tudor,sequence conflict,sequence variant,splice variant,
TDRD5	tudor domain containing 5(TDRD5)	Homo sapiens				GO:0007286~spermatid development,GO:0030719~P granule organization,GO:0043046~DNA methylation involved in gamete generation,	GO:0033391~chromatoid body,GO:0071546~pi-body,		IPR002999:Tudor domain,IPR025605:OST-HTH/LOTUS domain,				SM00333:TUDOR,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Spermatogenesis,	chain:Tudor domain-containing protein 5,domain:Tudor,modified residue,sequence conflict,sequence variant,splice variant,
TUFT1	tuftelin 1(TUFT1)	Homo sapiens			Cell division and chromosome partitioning,	GO:0030282~bone mineralization,GO:0035556~intracellular signal transduction,GO:0042476~odontogenesis,	GO:0005576~extracellular region,GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0030345~structural constituent of tooth enamel,	IPR024846:Tuftelin,					Alternative splicing,Biomineralization,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Secreted,	chain:Tuftelin,sequence conflict,sequence variant,splice variant,
TNFSF4	tumor necrosis factor superfamily member 4(TNFSF4)	Homo sapiens		h_ox40Pathway:OX40 Signaling Pathway,		GO:0002215~defense response to nematode,GO:0002526~acute inflammatory response,GO:0002726~positive regulation of T cell cytokine production,GO:0002819~regulation of adaptive immune response,GO:0002830~positive regulation of type 2 immune response,GO:0002891~positive regulation of immunoglobulin mediated immune response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0008203~cholesterol metabolic process,GO:0008284~positive regulation of cell proliferation,GO:0009615~response to virus,GO:0032689~negative regulation of interferon-gamma production,GO:0032700~negative regulation of interleukin-17 production,GO:0032729~positive regulation of interferon-gamma production,GO:0032733~positive regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0032736~positive regulation of interleukin-13 production,GO:0032743~positive regulation of interleukin-2 production,GO:0032753~positive regulation of interleukin-4 production,GO:0032755~positive regulation of interleukin-6 production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0035709~memory T cell activation,GO:0035712~T-helper 2 cell activation,GO:0035713~response to nitrogen dioxide,GO:0035714~cellular response to nitrogen dioxide,GO:0035783~CD4-positive, alpha-beta T cell costimulation,GO:0042098~T cell proliferation,GO:0042102~positive regulation of T cell proliferation,GO:0042104~positive regulation of activated T cell proliferation,GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043382~positive regulation of memory T cell differentiation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045590~negative regulation of regulatory T cell differentiation,GO:0045626~negative regulation of T-helper 1 cell differentiation,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0050710~negative regulation of cytokine secretion,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050871~positive regulation of B cell activation,GO:0051024~positive regulation of immunoglobulin secretion,GO:0071222~cellular response to lipopolysaccharide,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071954~chemokine (C-C motif) ligand 11 production,GO:1900281~positive regulation of CD4-positive, alpha-beta T cell costimulation,GO:2000568~positive regulation of memory T cell activation,GO:2000570~positive regulation of T-helper 2 cell activation,GO:2000572~positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005164~tumor necrosis factor receptor binding,GO:0032813~tumor necrosis factor receptor superfamily binding,	IPR006052:Tumour necrosis factor,IPR008983:Tumour necrosis factor-like domain,IPR021184:Tumour necrosis factor, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,	608446~Myocardial infarction, susceptibility to,		SM00207:TNF,	3D-structure,Alternative splicing,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Membrane,Reference proteome,Signal-anchor,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor ligand superfamily member 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
TP53BP2	tumor protein p53 binding protein 2(TP53BP2)	Homo sapiens				GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0042981~regulation of apoptotic process,GO:0045786~negative regulation of cell cycle,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:1900119~positive regulation of execution phase of apoptosis,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901216~positive regulation of neuron death,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0048471~perinuclear region of cytoplasm,	GO:0002039~p53 binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0042802~identical protein binding,GO:0051059~NF-kappaB binding,	IPR001452:Src homology-3 domain,IPR002110:Ankyrin repeat,IPR013315:Spectrin alpha chain, SH3 domain,IPR020683:Ankyrin repeat-containing domain,	hsa04390:Hippo signaling pathway,			SM00248:ANK,SM00326:SH3,	3D-structure,Alternative splicing,ANK repeat,Apoptosis,Cell cycle,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH3 domain,SH3-binding,	chain:Apoptosis-stimulating of p53 protein 2,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:SH3,helix,modified residue,mutagenesis site,region of interest:Interaction with APPBP1,region of interest:Mediates interaction with APC2,repeat:ANK 1,repeat:ANK 2,short sequence motif:SH3-binding,splice variant,strand,turn,
TP53I3	tumor protein p53 inducible protein 3(TP53I3)	Homo sapiens				GO:0006739~NADP metabolic process,GO:0042981~regulation of apoptotic process,GO:0055114~oxidation-reduction process,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003960~NADPH:quinone reductase activity,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0042803~protein homodimerization activity,GO:0048038~quinone binding,GO:0070402~NADPH binding,	IPR002085:Alcohol dehydrogenase superfamily, zinc-type,IPR011032:GroES-like,IPR013149:Alcohol dehydrogenase, C-terminal,IPR013154:Alcohol dehydrogenase GroES-like,IPR014189:Quinone oxidoreductase PIG3,IPR016040:NAD(P)-binding domain,IPR020843:Polyketide synthase, enoylreductase,	hsa04115:p53 signaling pathway,			SM00829:SM00829,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,	binding site:NADP,chain:Quinone oxidoreductase PIG3,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,splice variant,strand,turn,
TP73	tumor protein p73(TP73)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000187~activation of MAPK activity,GO:0001822~kidney development,GO:0006298~mismatch repair,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007050~cell cycle arrest,GO:0007346~regulation of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010165~response to X-ray,GO:0010243~response to organonitrogen compound,GO:0010332~response to gamma radiation,GO:0010468~regulation of gene expression,GO:0016032~viral process,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0034644~cellular response to UV,GO:0042493~response to drug,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043508~negative regulation of JUN kinase activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0045665~negative regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0051262~protein tetramerization,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0071158~positive regulation of cell cycle arrest,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0030054~cell junction,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR001660:Sterile alpha motif domain,IPR002117:p53 tumour suppressor family,IPR008967:p53-like transcription factor, DNA-binding,IPR010991:p53, tetramerisation domain,IPR011615:p53, DNA-binding domain,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04115:p53 signaling pathway,hsa04390:Hippo signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa05162:Measles,	Neuroblastoma~Neuroblastoma,		SM00454:SAM,	3D-structure,Activator,Alternative promoter usage,Alternative splicing,Apoptosis,Cell cycle,Complete proteome,Cytoplasm,DNA-binding,Host-virus interaction,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Zinc,	chain:Tumor protein p73,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); in isoform Alpha,domain:SAM,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:DNA-binding,region of interest:Interaction with HIPK2,region of interest:Oligomerization,region of interest:Transactivation,short sequence motif:WW-binding,splice variant,turn,
TSSC1	tumor suppressing subtransferable candidate 1(TSSC1)	Homo sapiens							IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Acetylation,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Protein TSSC1,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,
TUSC2	tumor suppressor candidate 2(TUSC2)	Homo sapiens				GO:0001779~natural killer cell differentiation,GO:0006909~phagocytosis,GO:0006954~inflammatory response,GO:0007049~cell cycle,GO:0007267~cell-cell signaling,GO:0008283~cell proliferation,GO:0032618~interleukin-15 production,GO:0032700~negative regulation of interleukin-17 production,GO:0032733~positive regulation of interleukin-10 production,GO:0048469~cell maturation,GO:0051881~regulation of mitochondrial membrane potential,GO:0052567~response to defense-related host reactive oxygen species production,GO:0070945~neutrophil mediated killing of gram-negative bacterium,GO:0071609~chemokine (C-C motif) ligand 5 production,GO:2000377~regulation of reactive oxygen species metabolic process,	GO:0005739~mitochondrion,	GO:0005515~protein binding,						Cell cycle,Complete proteome,Lipoprotein,Myristate,Phosphoprotein,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Tumor suppressor candidate 2,lipid moiety-binding region:N-myristoyl glycine,modified residue,
TACSTD2	tumor-associated calcium signal transducer 2(TACSTD2)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007601~visual perception,GO:0008283~cell proliferation,GO:0010633~negative regulation of epithelial cell migration,GO:0050678~regulation of epithelial cell proliferation,GO:0051497~negative regulation of stress fiber assembly,GO:0060675~ureteric bud morphogenesis,GO:0090191~negative regulation of branching involved in ureteric bud morphogenesis,GO:0098609~cell-cell adhesion,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1900028~negative regulation of ruffle assembly,GO:2000146~negative regulation of cell motility,GO:2000738~positive regulation of stem cell differentiation,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005887~integral component of plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016328~lateral plasma membrane,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0005515~protein binding,	IPR000716:Thyroglobulin type-1,		204870~Corneal dystrophy, gelatinous drop-like,		SM00211:TY,	3D-structure,Amyloid,Amyloidosis,Complete proteome,Corneal dystrophy,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Reference proteome,Sensory transduction,Signal,Transmembrane,Transmembrane helix,Tumor antigen,Vision,	chain:Tumor-associated calcium signal transducer 2,disulfide bond,domain:Thyroglobulin type-1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TWF2	twinfilin actin binding protein 2(TWF2)	Homo sapiens				GO:0010592~positive regulation of lamellipodium assembly,GO:0010976~positive regulation of neuron projection development,GO:0030030~cell projection organization,GO:0030837~negative regulation of actin filament polymerization,GO:0032532~regulation of microvillus length,GO:0032956~regulation of actin cytoskeleton organization,GO:0042989~sequestering of actin monomers,GO:0045773~positive regulation of axon extension,GO:0051016~barbed-end actin filament capping,GO:0071300~cellular response to retinoic acid,GO:0071363~cellular response to growth factor stimulus,GO:0098609~cell-cell adhesion,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0030016~myofibril,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030426~growth cone,GO:0032420~stereocilium,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003785~actin monomer binding,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002108:Actin-binding, cofilin/tropomyosin type,				SM00102:ADF,	3D-structure,Acetylation,Actin-binding,Cell projection,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Twinfilin-2,domain:ADF-H 1,domain:ADF-H 2,helix,modified residue,sequence conflict,sequence variant,strand,
TWIST2	twist family bHLH transcription factor 2(TWIST2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0045668~negative regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa05205:Proteoglycans in cancer,	200110~Ablepharon-macrostomia syndrome,209885~Barber-Say syndrome,227260~Focal facial dermal dysplasia 3, Setleis type,		SM00353:HLH,	Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disease mutation,DNA-binding,Ectodermal dysplasia,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Twist-related protein 2,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,sequence conflict,
YWHAQ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta(YWHAQ)	Homo sapiens		h_g2Pathway:Cell Cycle: G2/M Checkpoint,		GO:0006605~protein targeting,GO:0007264~small GTPase mediated signal transduction,GO:0021762~substantia nigra development,GO:0034766~negative regulation of ion transmembrane transport,GO:0045892~negative regulation of transcription, DNA-templated,GO:0061024~membrane organization,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0019904~protein domain specific binding,GO:0044325~ion channel binding,GO:0047485~protein N-terminus binding,GO:0071889~14-3-3 protein binding,	IPR000308:14-3-3 protein,IPR023409:14-3-3 protein, conserved site,IPR023410:14-3-3 domain,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04151:PI3K-Akt signaling pathway,hsa04390:Hippo signaling pathway,hsa05161:Hepatitis B,hsa05203:Viral carcinogenesis,		PIRSF000868:14-3-3 protein,	SM00101:14_3_3,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,	chain:14-3-3 protein theta,helix,modified residue,sequence conflict,site:Interaction with phosphoserine on interacting protein,turn,
TIE1	tyrosine kinase with immunoglobulin like and EGF like domains 1(TIE1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001570~vasculogenesis,GO:0001701~in utero embryonic development,GO:0007165~signal transduction,GO:0007498~mesoderm development,GO:0016525~negative regulation of angiogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030336~negative regulation of cell migration,GO:0032526~response to retinoic acid,GO:0045026~plasma membrane fusion,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000742:Epidermal growth factor-like domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013032:EGF-like, conserved site,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,				SM00060:FN3,SM00181:EGF,SM00219:TyrKc,SM00409:IG,	Alternative splicing,Angiogenesis,ATP-binding,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase receptor Tie-1,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
UQCRC1	ubiquinol-cytochrome c reductase core protein I(UQCRC1)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,	General function prediction only,	GO:0006119~oxidative phosphorylation,GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c,GO:0009060~aerobic respiration,GO:0014823~response to activity,GO:0016485~protein processing,GO:0043279~response to alkaloid,GO:0055114~oxidation-reduction process,GO:1902600~hydrogen ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005750~mitochondrial respiratory chain complex III,GO:0043209~myelin sheath,	GO:0004222~metalloendopeptidase activity,GO:0008121~ubiquinol-cytochrome-c reductase activity,GO:0008270~zinc ion binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,	IPR007863:Peptidase M16, C-terminal domain,IPR011237:Peptidase M16 domain,IPR011249:Metalloenzyme, LuxS/M16 peptidase-like,IPR011765:Peptidase M16, N-terminal,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04260:Cardiac muscle contraction,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Reference proteome,Respiratory chain,Transit peptide,Transport,	chain:Cytochrome b-c1 complex subunit 1, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
UQCRHL	ubiquinol-cytochrome c reductase hinge protein like(UQCRHL)	Homo sapiens				GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c,GO:0009060~aerobic respiration,GO:1902600~hydrogen ion transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0005750~mitochondrial respiratory chain complex III,GO:0070469~respiratory chain,	GO:0008121~ubiquinol-cytochrome-c reductase activity,	IPR003422:Cytochrome b-c1 complex, subunit 6,IPR023184:Ubiquinol-cytochrome C reductase hinge domain,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04260:Cardiac muscle contraction,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF000019:ubiquinol-cytochrome-c reductase (cytochrome c1) (complex III), nonheme 11 kDa subunit,		Acetylation,Complete proteome,Disulfide bond,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transit peptide,Transport,	chain:Cytochrome b-c1 complex subunit 6, mitochondrial,compositionally biased region:Poly-Glu,disulfide bond,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
UQCRH	ubiquinol-cytochrome c reductase hinge protein(UQCRH)	Homo sapiens				GO:0006119~oxidative phosphorylation,GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c,GO:0009060~aerobic respiration,GO:0055114~oxidation-reduction process,GO:1902600~hydrogen ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005750~mitochondrial respiratory chain complex III,	GO:0005515~protein binding,GO:0008121~ubiquinol-cytochrome-c reductase activity,	IPR003422:Cytochrome b-c1 complex, subunit 6,IPR023184:Ubiquinol-cytochrome C reductase hinge domain,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04260:Cardiac muscle contraction,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF000019:ubiquinol-cytochrome-c reductase (cytochrome c1) (complex III), nonheme 11 kDa subunit,		Acetylation,Complete proteome,Disulfide bond,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Respiratory chain,Signal,Transit peptide,Transport,	chain:Cytochrome b-c1 complex subunit 6, mitochondrial,compositionally biased region:Poly-Glu,disulfide bond,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
UCHL5	ubiquitin C-terminal hydrolase L5(UCHL5)	Homo sapiens				GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0010951~negative regulation of endopeptidase activity,GO:0016579~protein deubiquitination,GO:0021670~lateral ventricle development,GO:0030901~midbrain development,GO:0048853~forebrain morphogenesis,GO:0061136~regulation of proteasomal protein catabolic process,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005829~cytosol,GO:0031011~Ino80 complex,GO:0031597~cytosolic proteasome complex,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0004866~endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0070628~proteasome binding,	IPR001578:Peptidase C12, ubiquitin carboxyl-terminal hydrolase 1,IPR017390:Ubiquitinyl hydrolase, UCH37 type,			PIRSF038120:ubiquitin carboxyl-terminal hydrolase, UCH37type,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA damage,DNA recombination,DNA repair,Hydrolase,Nucleus,Polymorphism,Protease,Proteasome,Proteomics identification,Reference proteome,Thiol protease,Transcription,Transcription regulation,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase isozyme L5,helix,modified residue,mutagenesis site,region of interest:Interaction with ADRM1,sequence conflict,sequence variant,splice variant,strand,turn,
UBAP2L	ubiquitin associated protein 2 like(UBAP2L)	Homo sapiens				GO:0007339~binding of sperm to zona pellucida,GO:0010628~positive regulation of gene expression,GO:0061484~hematopoietic stem cell homeostasis,	GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,GO:0005737~cytoplasm,GO:0031519~PcG protein complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR009060:UBA-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR022166:Protein of unknown function DUF3697, ubiquitin-associated protein 2,				SM00165:UBA,	Acetylation,Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Ubiquitin-associated protein 2-like,domain:UBA,modified residue,sequence conflict,sequence variant,splice variant,
UBE2E1	ubiquitin conjugating enzyme E2 E1(UBE2E1)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0010390~histone monoubiquitination,GO:0016567~protein ubiquitination,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0032020~ISG15-protein conjugation,GO:0033523~histone H2B ubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0051439~regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0070936~protein K48-linked ubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042296~ISG15 transferase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR023313:Ubiquitin-conjugating enzyme, active site,	hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,				3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Isopeptide bond,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,Ubl conjugation,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Ubiquitin-conjugating enzyme E2 E1,compositionally biased region:Poly-Ser,helix,modified residue,sequence variant,strand,turn,
UBE2E2	ubiquitin conjugating enzyme E2 E2(UBE2E2)	Homo sapiens		h_parkinPathway:Role of Parkin in the Ubiquitin-Proteasomal Pathway,		GO:0006974~cellular response to DNA damage stimulus,GO:0032020~ISG15-protein conjugation,GO:0070534~protein K63-linked ubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:0070979~protein K11-linked ubiquitination,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,		GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042296~ISG15 transferase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR023313:Ubiquitin-conjugating enzyme, active site,	hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,				3D-structure,Acetylation,ATP-binding,Complete proteome,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Ubiquitin-conjugating enzyme E2 E2,helix,modified residue,strand,turn,
UBE2E3	ubiquitin conjugating enzyme E2 E3(UBE2E3)	Homo sapiens				GO:0040008~regulation of growth,GO:0070534~protein K63-linked ubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:0070979~protein K11-linked ubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR023313:Ubiquitin-conjugating enzyme, active site,	hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,				Acetylation,ATP-binding,Complete proteome,Cytoplasm,Growth regulation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Ubiquitin-conjugating enzyme E2 E3,modified residue,mutagenesis site,sequence conflict,sequence variant,
UBE2F	ubiquitin conjugating enzyme E2 F (putative)(UBE2F)	Homo sapiens		h_parkinPathway:Role of Parkin in the Ubiquitin-Proteasomal Pathway,		GO:0006301~postreplication repair,GO:0045116~protein neddylation,GO:0070534~protein K63-linked ubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0019788~NEDD8 transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0061630~ubiquitin protein ligase activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR023313:Ubiquitin-conjugating enzyme, active site,	hsa04120:Ubiquitin mediated proteolysis,				3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Ligase,Nucleotide-binding,Proteomics identification,Reference proteome,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:NEDD8-conjugating enzyme UBE2F,helix,modified residue,region of interest:Interaction with UBA3,sequence conflict,splice variant,strand,turn,
UBE2J2	ubiquitin conjugating enzyme E2 J2(UBE2J2)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006986~response to unfolded protein,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000151~ubiquitin ligase complex,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,GO:0061630~ubiquitin protein ligase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,	hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,hsa05012:Parkinson's disease,				3D-structure,Alternative splicing,ATP-binding,Complete proteome,Endoplasmic reticulum,Membrane,Nucleotide-binding,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Unfolded protein response,	active site:Glycyl thioester intermediate,chain:Ubiquitin-conjugating enzyme E2 J2,helix,sequence conflict,splice variant,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
UBE2Q1	ubiquitin conjugating enzyme E2 Q1(UBE2Q1)	Homo sapiens				GO:0001967~suckling behavior,GO:0007566~embryo implantation,GO:0007617~mating behavior,GO:0009566~fertilization,GO:0016567~protein ubiquitination,GO:0061458~reproductive system development,GO:0070459~prolactin secretion,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0030175~filopodium,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,	hsa04120:Ubiquitin mediated proteolysis,				3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell projection,Complete proteome,Cytoplasm,Nucleotide-binding,Nucleus,Reference proteome,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Ubiquitin-conjugating enzyme E2 Q1,compositionally biased region:Gly-rich,helix,modified residue,sequence conflict,splice variant,strand,turn,
UBE2T	ubiquitin conjugating enzyme E2 T(UBE2T)	Homo sapiens				GO:0006281~DNA repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0035519~protein K29-linked ubiquitination,GO:0036297~interstrand cross-link repair,GO:0044314~protein K27-linked ubiquitination,GO:0051865~protein autoubiquitination,GO:0070534~protein K63-linked ubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:0070979~protein K11-linked ubiquitination,GO:0085020~protein K6-linked ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003682~chromatin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,GO:0061630~ubiquitin protein ligase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR023313:Ubiquitin-conjugating enzyme, active site,	hsa03460:Fanconi anemia pathway,	616435~Fanconi anemia, complementation group T,			3D-structure,ATP-binding,Complete proteome,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Transferase,Ubl conjugation,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Ubiquitin-conjugating enzyme E2 T,helix,modified residue,strand,turn,
UBE2U	ubiquitin conjugating enzyme E2 U (putative)(UBE2U)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0016574~histone ubiquitination,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0000790~nuclear chromatin,GO:0005737~cytoplasm,GO:0033503~HULC complex,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,GO:0061630~ubiquitin protein ligase activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR023313:Ubiquitin-conjugating enzyme, active site,	hsa04120:Ubiquitin mediated proteolysis,				3D-structure,Alternative splicing,ATP-binding,Complete proteome,Nucleotide-binding,Polymorphism,Reference proteome,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Ubiquitin-conjugating enzyme E2 U,helix,sequence variant,splice variant,strand,turn,
UBA3	ubiquitin like modifier activating enzyme 3(UBA3)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0007113~endomitotic cell cycle,GO:0038061~NIK/NF-kappaB signaling,GO:0045116~protein neddylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016881~acid-amino acid ligase activity,GO:0016922~ligand-dependent nuclear receptor binding,GO:0019781~NEDD8 activating enzyme activity,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,	IPR000594:UBA/THIF-type NAD/FAD binding fold,IPR014929:E2 binding,IPR016040:NAD(P)-binding domain,IPR023318:Ubiquitin activating enzyme, alpha domain,	hsa04120:Ubiquitin mediated proteolysis,			SM01181:SM01181,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell cycle,Complete proteome,Ligase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:NEDD8-activating enzyme E1 catalytic subunit,helix,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with NAE1,region of interest:Interaction with NEDD8,region of interest:Interaction with UBE2M core domain,region of interest:Interaction with UBE2M N-terminus,sequence conflict,sequence variant,site:Determines specificity for NEDD8,strand,turn,
UBA7	ubiquitin like modifier activating enzyme 7(UBA7)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0019985~translesion synthesis,GO:0032020~ISG15-protein conjugation,GO:0032480~negative regulation of type I interferon production,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0004839~ubiquitin activating enzyme activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019782~ISG15 activating enzyme activity,	IPR000011:Ubiquitin/SUMO-activating enzyme E1,IPR000594:UBA/THIF-type NAD/FAD binding fold,IPR016040:NAD(P)-binding domain,IPR018075:Ubiquitin-activating enzyme, E1,IPR018965:Ubiquitin-activating enzyme e1, C-terminal,IPR019572:Ubiquitin-activating enzyme,	hsa04120:Ubiquitin mediated proteolysis,hsa05012:Parkinson's disease,			SM00985:SM00985,	ATP-binding,Complete proteome,Direct protein sequencing,Ligase,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Ubiquitin-like modifier-activating enzyme 7,nucleotide phosphate-binding region:ATP,region of interest:2 approximate repeats,repeat:1-1,repeat:1-2,sequence conflict,sequence variant,
UBR3	ubiquitin protein ligase E3 component n-recognin 3 (putative)(UBR3)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001967~suckling behavior,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007608~sensory perception of smell,GO:0009790~embryo development,GO:0016567~protein ubiquitination,GO:0042048~olfactory behavior,GO:0071596~ubiquitin-dependent protein catabolic process via the N-end rule pathway,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR003126:Zinc finger, N-recognin,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00396:ZnF_UBR1,	Alternative splicing,Coiled coil,Complete proteome,Ligase,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase UBR3,compositionally biased region:Ala-rich,compositionally biased region:Cys-rich,sequence conflict,splice variant,transmembrane region,zinc finger region:RING-type; degenerate,zinc finger region:UBR-type,
UBR4	ubiquitin protein ligase E3 component n-recognin 4(UBR4)	Homo sapiens				GO:0016032~viral process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR003126:Zinc finger, N-recognin,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,IPR025704:E3 ubiquitin ligase, UBR4,	hsa05203:Viral carcinogenesis,			SM00396:ZnF_UBR1,	Acetylation,Alternative splicing,Calmodulin-binding,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Host-virus interaction,Ligase,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase UBR4,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,zinc finger region:UBR-type,
USP1	ubiquitin specific peptidase 1(USP1)	Homo sapiens				GO:0001501~skeletal system development,GO:0006282~regulation of DNA repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009411~response to UV,GO:0016579~protein deubiquitination,GO:0035520~monoubiquitinated protein deubiquitination,GO:0036297~interstrand cross-link repair,GO:0042769~DNA damage response, detection of DNA damage,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,	hsa03460:Fanconi anemia pathway,				Autocatalytic cleavage,Complete proteome,DNA damage,DNA repair,Hydrolase,Nucleus,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 1,modified residue,mutagenesis site,sequence conflict,site:Cleavage; by autolysis,
USP24	ubiquitin specific peptidase 24(USP24)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016477~cell migration,GO:0016579~protein deubiquitination,	GO:0005737~cytoplasm,	GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR009060:UBA-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR016024:Armadillo-type fold,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 24,compositionally biased region:Gly-rich,compositionally biased region:Ser-rich,domain:UBA,modified residue,sequence conflict,sequence variant,
USP33	ubiquitin specific peptidase 33(USP33)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006897~endocytosis,GO:0007411~axon guidance,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009267~cellular response to starvation,GO:0010506~regulation of autophagy,GO:0016477~cell migration,GO:0016579~protein deubiquitination,GO:0032091~negative regulation of protein binding,GO:0032092~positive regulation of protein binding,GO:0050821~protein stabilization,GO:0051298~centrosome duplication,GO:0070536~protein K63-linked deubiquitination,GO:0071108~protein K48-linked deubiquitination,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005776~autophagosome,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005925~focal adhesion,GO:0030891~VCB complex,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0001664~G-protein coupled receptor binding,GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017160~Ral GTPase binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0043130~ubiquitin binding,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR001607:Zinc finger, UBP-type,IPR006615:Peptidase C19, ubiquitin-specific peptidase, DUSP domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,				SM00290:ZnF_UBP,SM00695:DUSP,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Endocytosis,Golgi apparatus,Hydrolase,Metal-binding,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Ubiquitin carboxyl-terminal hydrolase 33,domain:DUSP 1,domain:DUSP 2,helix,modified residue,mutagenesis site,sequence conflict,splice variant,strand,turn,zinc finger region:UBP-type,
USP34	ubiquitin specific peptidase 34(USP34)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016055~Wnt signaling pathway,GO:0016578~histone deubiquitination,GO:0016579~protein deubiquitination,GO:0071108~protein K48-linked deubiquitination,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000124~SAGA complex,GO:0005829~cytosol,	GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR016024:Armadillo-type fold,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Alternative splicing,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,Wnt signaling pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 34,modified residue,sequence variant,splice variant,
USP37	ubiquitin specific peptidase 37(USP37)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007067~mitotic nuclear division,GO:0016579~protein deubiquitination,GO:0035871~protein K11-linked deubiquitination,GO:0051301~cell division,GO:0071108~protein K48-linked deubiquitination,	GO:0005634~nucleus,	GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR003903:Ubiquitin interacting motif,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,				SM00726:UIM,	3D-structure,Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Hydrolase,Mitosis,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Ubl conjugation,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 37,modified residue,repeat:UIM 1,repeat:UIM 2,repeat:UIM 3,sequence conflict,sequence variant,
USP39	ubiquitin specific peptidase 39(USP39)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0016579~protein deubiquitination,GO:0051301~cell division,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,	GO:0008270~zinc ion binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR001607:Zinc finger, UBP-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,	hsa03040:Spliceosome,			SM00290:ZnF_UBP,	3D-structure,Alternative splicing,Cell cycle,Cell division,Complete proteome,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Spliceosome,Zinc,Zinc-finger,	chain:U4/U6.U5 tri-snRNP-associated protein 2,compositionally biased region:Arg-rich,modified residue,sequence conflict,zinc finger region:UBP-type,
USP4	ubiquitin specific peptidase 4(USP4)	Homo sapiens				GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0034394~protein localization to cell surface,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005886~plasma membrane,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0031685~adenosine receptor binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR006615:Peptidase C19, ubiquitin-specific peptidase, DUSP domain,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,				SM00695:DUSP,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Thiol protease,Ubl conjugation,Ubl conjugation pathway,Zinc,	chain:Ubiquitin carboxyl-terminal hydrolase 4,domain:DUSP,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
USP40	ubiquitin specific peptidase 40(USP40)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Alternative splicing,Complete proteome,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 40,modified residue,sequence conflict,sequence variant,splice variant,
USP48	ubiquitin specific peptidase 48(USP48)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR000626:Ubiquitin,IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR006615:Peptidase C19, ubiquitin-specific peptidase, DUSP domain,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 48,domain:DUSP 1,domain:DUSP 2,domain:DUSP 3,domain:Ubiquitin-like,modified residue,sequence variant,splice variant,
UBE4B	ubiquitination factor E4B(UBE4B)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0003222~ventricular trabecula myocardium morphogenesis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0008626~granzyme-mediated apoptotic signaling pathway,GO:0009411~response to UV,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0031175~neuron projection development,GO:0034976~response to endoplasmic reticulum stress,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051865~protein autoubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0034450~ubiquitin-ubiquitin ligase activity,GO:0051117~ATPase binding,	IPR003613:U box domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019474:Ubiquitin conjugation factor E4, core,	hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,			SM00504:Ubox,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Ligase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:Ubiquitin conjugation factor E4 B,domain:U-box,modified residue,mutagenesis site,sequence variant,site:Cleavage; by caspase-3 and caspase-7,site:Cleavage; by caspase-6 and granzyme B,splice variant,
ULK4	unc-51 like kinase 4(ULK4)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0006468~protein phosphorylation,GO:0010975~regulation of neuron projection development,GO:0043408~regulation of MAPK cascade,GO:0046328~regulation of JNK cascade,GO:0090036~regulation of protein kinase C signaling,GO:1900744~regulation of p38MAPK cascade,GO:2001222~regulation of neuron migration,		GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	chain:Serine/threonine-protein kinase ULK4,compositionally biased region:Poly-Leu,domain:Protein kinase,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,sequence conflict,sequence variant,
UNC80	unc-80 homolog, NALCN activator(UNC80)	Homo sapiens				GO:0034220~ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Disease mutation,Membrane,Neurodegeneration,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein unc-80 homolog,compositionally biased region:Gly-rich,sequence conflict,sequence variant,splice variant,transmembrane region,
UNC93B3	unc-93 homolog B3 pseudogene (C. elegans)(UNC93B3)	Homo sapiens													chain:Protein unc-93 homolog B1,compositionally biased region:Poly-Glu,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,transmembrane region,
PP2672	uncharacterized LOC100130249(PP2672)	Homo sapiens												Complete proteome,Reference proteome,
LOC100130691	uncharacterized LOC100130691(LOC100130691)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein FLJ44553,sequence conflict,
LOC284581	uncharacterized LOC284581(LOC284581)	Homo sapiens													chain:Putative uncharacterized protein FLJ37107,transmembrane region,
LOC285095	uncharacterized LOC285095(LOC285095)	Homo sapiens												Complete proteome,Reference proteome,
FLJ33534	uncharacterized LOC285150(FLJ33534)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein FLJ33534,sequence variant,splice variant,
LOC440934	uncharacterized LOC440934(LOC440934)	Homo sapiens													chain:Cancer/testis antigen 75,
UBP1	upstream binding protein 1 (LBP-1a)(UBP1)	Homo sapiens				GO:0001525~angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0019079~viral genome replication,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0043565~sequence-specific DNA binding,	IPR007604:CP2 transcription factor,IPR013761:Sterile alpha motif/pointed domain,					Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Upstream-binding protein 1,sequence conflict,sequence variant,splice variant,
UOX	urate oxidase (pseudogene)(UOX)	Homo sapiens									Urate oxidase deficiency~Urate oxidase deficiency,
UPP2	uridine phosphorylase 2(UPP2)	Homo sapiens				GO:0009116~nucleoside metabolic process,GO:0009166~nucleotide catabolic process,GO:0043097~pyrimidine nucleoside salvage,GO:0044206~UMP salvage,GO:0046108~uridine metabolic process,GO:0046135~pyrimidine nucleoside catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0045098~type III intermediate filament,	GO:0004850~uridine phosphorylase activity,GO:0005515~protein binding,	IPR000845:Nucleoside phosphorylase domain,IPR010059:Uridine phosphorylase, eukaryotic,IPR018016:Nucleoside phosphorylase, conserved site,IPR018017:Nucleoside phosphorylase,	hsa00240:Pyrimidine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycosyltransferase,Polymorphism,Redox-active center,Reference proteome,Transferase,	chain:Uridine phosphorylase 2,sequence conflict,sequence variant,
UCK2	uridine-cytidine kinase 2(UCK2)	Homo sapiens			Nucleotide transport and metabolism,	GO:0006206~pyrimidine nucleobase metabolic process,GO:0006238~CMP salvage,GO:0016310~phosphorylation,GO:0043097~pyrimidine nucleoside salvage,GO:0044206~UMP salvage,GO:0044211~CTP salvage,	GO:0005829~cytosol,	GO:0004849~uridine kinase activity,GO:0005524~ATP binding,GO:0019206~nucleoside kinase activity,	IPR000764:Uridine kinase,IPR006083:Phosphoribulokinase/uridine kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00240:Pyrimidine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,				3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Reference proteome,Transferase,	binding site:ATP,binding site:Substrate,chain:Uridine-cytidine kinase 2,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,strand,turn,
UTS2	urotensin 2(UTS2)	Homo sapiens				GO:0001666~response to hypoxia,GO:0003105~negative regulation of glomerular filtration,GO:0006936~muscle contraction,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007268~chemical synaptic transmission,GO:0008217~regulation of blood pressure,GO:0010459~negative regulation of heart rate,GO:0010460~positive regulation of heart rate,GO:0010763~positive regulation of fibroblast migration,GO:0010841~positive regulation of circadian sleep/wake cycle, wakefulness,GO:0032224~positive regulation of synaptic transmission, cholinergic,GO:0032967~positive regulation of collagen biosynthetic process,GO:0033574~response to testosterone,GO:0035811~negative regulation of urine volume,GO:0035814~negative regulation of renal sodium excretion,GO:0042312~regulation of vasodilation,GO:0042493~response to drug,GO:0045597~positive regulation of cell differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045776~negative regulation of blood pressure,GO:0045777~positive regulation of blood pressure,GO:0045909~positive regulation of vasodilation,GO:0046005~positive regulation of circadian sleep/wake cycle, REM sleep,GO:0046676~negative regulation of insulin secretion,GO:0048146~positive regulation of fibroblast proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0005102~receptor binding,GO:0005179~hormone activity,	IPR001483:Urotensin II,					Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Hormone,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	disulfide bond,peptide:Urotensin-2,sequence variant,signal peptide,splice variant,
USH2A	usherin(USH2A)	Homo sapiens				GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0035315~hair cell differentiation,GO:0045184~establishment of protein localization,GO:0045494~photoreceptor cell maintenance,GO:0048496~maintenance of organ identity,GO:0050896~response to stimulus,GO:0050953~sensory perception of light stimulus,GO:0060113~inner ear receptor cell differentiation,	GO:0001917~photoreceptor inner segment,GO:0002142~stereocilia ankle link complex,GO:0005604~basement membrane,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0032391~photoreceptor connecting cilium,GO:0032421~stereocilium bundle,GO:0036064~ciliary basal body,GO:0060171~stereocilium membrane,GO:1990075~periciliary membrane compartment,GO:1990696~USH2 complex,	GO:0005515~protein binding,GO:0005518~collagen binding,GO:0017022~myosin binding,GO:0042803~protein homodimerization activity,	IPR001791:Laminin G domain,IPR002049:EGF-like, laminin,IPR003961:Fibronectin, type III,IPR006558:LamG-like jellyroll fold,IPR008211:Laminin, N-terminal,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR026915:Usherin,		276901~Usher syndrome, type 2A,613809~Retinitis pigmentosa 39,		SM00060:FN3,SM00136:LamNT,SM00180:EGF_Lam,SM00282:LamG,SM00560:LamGL,	Alternative splicing,Cell membrane,Cell projection,Complete proteome,Deafness,Disease mutation,Disulfide bond,Glycoprotein,Hearing,Laminin EGF-like domain,Membrane,Polymorphism,Reference proteome,Repeat,Retinitis pigmentosa,Secreted,Sensory transduction,Signal,Transmembrane,Transmembrane helix,Usher syndrome,Vision,	chain:Usherin,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 10,domain:Fibronectin type-III 11,domain:Fibronectin type-III 12,domain:Fibronectin type-III 13,domain:Fibronectin type-III 14,domain:Fibronectin type-III 15,domain:Fibronectin type-III 16,domain:Fibronectin type-III 17,domain:Fibronectin type-III 18,domain:Fibronectin type-III 19,domain:Fibronectin type-III 2,domain:Fibronectin type-III 20,domain:Fibronectin type-III 21,domain:Fibronectin type-III 22,domain:Fibronectin type-III 23,domain:Fibronectin type-III 24,domain:Fibronectin type-III 25,domain:Fibronectin type-III 26,domain:Fibronectin type-III 27,domain:Fibronectin type-III 28,domain:Fibronectin type-III 29,domain:Fibronectin type-III 3,domain:Fibronectin type-III 30,domain:Fibronectin type-III 31,domain:Fibronectin type-III 32,domain:Fibronectin type-III 33,domain:Fibronectin type-III 34,domain:Fibronectin type-III 35,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,domain:Laminin EGF-like 1,domain:Laminin EGF-like 10,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4,domain:Laminin EGF-like 5,domain:Laminin EGF-like 6,domain:Laminin EGF-like 7,domain:Laminin EGF-like 8,domain:Laminin EGF-like 9,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MYCN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog(MYCN)	Homo sapiens				GO:0001502~cartilage condensation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010942~positive regulation of cell death,GO:0030324~lung development,GO:0042733~embryonic digit morphogenesis,GO:0045607~regulation of auditory receptor cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048704~embryonic skeletal system morphogenesis,GO:0048712~negative regulation of astrocyte differentiation,GO:0048754~branching morphogenesis of an epithelial tube,GO:1903800~positive regulation of production of miRNAs involved in gene silencing by miRNA,GO:2000378~negative regulation of reactive oxygen species metabolic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0016021~integral component of membrane,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR002418:Transcription regulator Myc,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR012682:Transcription regulator Myc, N-terminal,	hsa05202:Transcriptional misregulation in cancer,	164280~Feingold syndrome,	PIRSF001705:myc protein,	SM00353:HLH,	Activator,Complete proteome,Disease mutation,DNA-binding,Membrane,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:N-myc proto-oncogene protein,compositionally biased region:Asp/Glu-rich (acidic),DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,sequence conflict,sequence variant,
VRK2	vaccinia related kinase 2(VRK2)	Homo sapiens			General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair,	GO:0006468~protein phosphorylation,GO:0008360~regulation of cell shape,GO:0016032~viral process,GO:0018105~peptidyl-serine phosphorylation,GO:0034599~cellular response to oxidative stress,GO:0043408~regulation of MAPK cascade,GO:0046777~protein autophosphorylation,GO:2000659~regulation of interleukin-1-mediated signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0043234~protein complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,				SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Endoplasmic reticulum,Host-virus interaction,Kinase,Membrane,Mitochondrion,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase VRK2,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,transmembrane region,turn,
VPS13D	vacuolar protein sorting 13 homolog D(VPS13D)	Homo sapiens			Intracellular trafficking and secretion,	GO:0006623~protein targeting to vacuole,GO:0045053~protein retention in Golgi apparatus,	GO:0005622~intracellular,GO:0019898~extrinsic component of membrane,GO:0070062~extracellular exosome,		IPR009060:UBA-like,IPR009543:Vacuolar protein sorting-associated protein 13 domain,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR026847:Vacuolar protein sorting-associated protein 13,IPR026854:Vacuolar protein sorting-associated protein 13A N-terminal domain,				SM00165:UBA,	Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Vacuolar protein sorting-associated protein 13D,domain:UBA,modified residue,sequence conflict,sequence variant,splice variant,
VPS45	vacuolar protein sorting 45 homolog(VPS45)	Homo sapiens			Intracellular trafficking and secretion,	GO:0006886~intracellular protein transport,GO:0006904~vesicle docking involved in exocytosis,GO:0007596~blood coagulation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR001619:Sec1-like protein,IPR027482:Sec1-like, domain 2,	hsa04144:Endocytosis,	615285~Neutropenia, severe congenital, 5, autosomal recessive,	PIRSF005715:vesicle trafficking protein, VPS45/Sec1 type,		Alternative splicing,Complete proteome,Disease mutation,Endosome,Golgi apparatus,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Vacuolar protein sorting-associated protein 45,sequence conflict,
VCAM1	vascular cell adhesion molecule 1(VCAM1)	Homo sapiens	17.Activators-CAM,18.Cytokine_astocytes,58.(CD40L)_immnosurveillance,96.Immune_injury_MS-lesions_genetic_environ,	h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,		GO:0001666~response to hypoxia,GO:0002526~acute inflammatory response,GO:0002544~chronic inflammatory response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007159~leukocyte cell-cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007568~aging,GO:0007584~response to nutrient,GO:0009308~amine metabolic process,GO:0010043~response to zinc ion,GO:0010212~response to ionizing radiation,GO:0016032~viral process,GO:0016337~single organismal cell-cell adhesion,GO:0022614~membrane to membrane docking,GO:0030183~B cell differentiation,GO:0030198~extracellular matrix organization,GO:0032496~response to lipopolysaccharide,GO:0035094~response to nicotine,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0042102~positive regulation of T cell proliferation,GO:0045471~response to ethanol,GO:0050776~regulation of immune response,GO:0050901~leukocyte tethering or rolling,GO:0055114~oxidation-reduction process,GO:0060326~cell chemotaxis,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0071356~cellular response to tumor necrosis factor,	GO:0002102~podosome,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030175~filopodium,GO:0042383~sarcolemma,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,GO:0071065~alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,	GO:0005178~integrin binding,GO:0008131~primary amine oxidase activity,GO:0050839~cell adhesion molecule binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal,IPR003989:Vascular cell adhesion molecule-1,IPR007110:Immunoglobulin-like domain,IPR008424:Immunoglobulin C2-set,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04064:NF-kappa B signaling pathway,hsa04514:Cell adhesion molecules (CAMs),hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05166:HTLV-I infection,			SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host-virus interaction,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Vascular cell adhesion protein 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
VIPR1	vasoactive intestinal peptide receptor 1(VIPR1)	Homo sapiens				GO:0006936~muscle contraction,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007268~chemical synaptic transmission,GO:0007586~digestion,GO:0008284~positive regulation of cell proliferation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004999~vasoactive intestinal polypeptide receptor activity,GO:0005515~protein binding,	IPR000832:GPCR, family 2, secretin-like,IPR001571:GPCR, family 2, vasoactive intestinal peptide receptor,IPR001771:GPCR, family 2, vasoactive intestinal peptide receptor 1,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,			SM00008:HormR,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Vasoactive intestinal polypeptide receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
VASH2	vasohibin 2(VASH2)	Homo sapiens				GO:0000768~syncytium formation by plasma membrane fusion,GO:0001938~positive regulation of endothelial cell proliferation,GO:0045026~plasma membrane fusion,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0060716~labyrinthine layer blood vessel development,	GO:0005576~extracellular region,GO:0005737~cytoplasm,							Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,Secreted,	chain:Vasohibin-2,splice variant,
VAV3	vav guanine nucleotide exchange factor 3(VAV3)	Homo sapiens				GO:0001525~angiogenesis,GO:0006906~vesicle fusion,GO:0006974~cellular response to DNA damage stimulus,GO:0007229~integrin-mediated signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0008361~regulation of cell size,GO:0009967~positive regulation of signal transduction,GO:0030032~lamellipodium assembly,GO:0030168~platelet activation,GO:0030593~neutrophil chemotaxis,GO:0030890~positive regulation of B cell proliferation,GO:0035023~regulation of Rho protein signal transduction,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042493~response to drug,GO:0043065~positive regulation of apoptotic process,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045785~positive regulation of cell adhesion,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005070~SH3/SH2 adaptor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0046872~metal ion binding,	IPR000219:Dbl homology (DH) domain,IPR000980:SH2 domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001452:Src homology-3 domain,IPR001715:Calponin homology domain,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR003096:Smooth muscle protein/calponin,IPR011511:Variant SH3,IPR011993:Pleckstrin homology-like domain,IPR022613:Calmodulin-regulated spectrin-associated protein, CH domain,	hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,			SM00033:CH,SM00109:C1,SM00233:PH,SM00252:SH2,SM00325:RhoGEF,SM00326:SH3,	3D-structure,Alternative promoter usage,Alternative splicing,Angiogenesis,Complete proteome,Guanine-nucleotide releasing factor,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Zinc,Zinc-finger,	chain:Guanine nucleotide exchange factor VAV3,domain:CH,domain:DH,domain:PH,domain:SH2,domain:SH3 1,domain:SH3 2,helix,modified residue,sequence conflict,sequence variant,splice variant,turn,zinc finger region:Phorbol-ester/DAG-type,
VAX2	ventral anterior homeobox 2(VAX2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007398~ectoderm development,GO:0007409~axonogenesis,GO:0007601~visual perception,GO:0009950~dorsal/ventral axis specification,GO:0016055~Wnt signaling pathway,GO:0030900~forebrain development,GO:0048048~embryonic eye morphogenesis,GO:0060041~retina development in camera-type eye,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0001162~RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0031490~chromatin DNA binding,	IPR000047:Helix-turn-helix motif,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Wnt signaling pathway,	chain:Ventral anterior homeobox 2,compositionally biased region:Gly-rich,DNA-binding region:Homeobox,sequence variant,
VAMP4	vesicle associated membrane protein 4(VAMP4)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0006887~exocytosis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0016192~vesicle-mediated transport,GO:0035493~SNARE complex assembly,GO:0043001~Golgi to plasma membrane protein transport,GO:0090161~Golgi ribbon formation,	GO:0000139~Golgi membrane,GO:0005764~lysosome,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0031201~SNARE complex,GO:0032588~trans-Golgi network membrane,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,	IPR001388:Synaptobrevin,	hsa04130:SNARE interactions in vesicular transport,				Alternative splicing,Coiled coil,Complete proteome,Golgi apparatus,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Vesicle-associated membrane protein 4,domain:v-SNARE coiled-coil homology,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
VAMP5	vesicle associated membrane protein 5(VAMP5)	Homo sapiens				GO:0006887~exocytosis,GO:0006906~vesicle fusion,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0016192~vesicle-mediated transport,GO:0030154~cell differentiation,GO:0043001~Golgi to plasma membrane protein transport,	GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0014704~intercalated disc,GO:0030659~cytoplasmic vesicle membrane,GO:0031201~SNARE complex,GO:0031301~integral component of organelle membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,	IPR001388:Synaptobrevin,	hsa04130:SNARE interactions in vesicular transport,				Cell membrane,Coiled coil,Complete proteome,Developmental protein,Differentiation,Golgi apparatus,Membrane,Myogenesis,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Vesicle-associated membrane protein 5,domain:v-SNARE coiled-coil homology,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
VAMP8	vesicle associated membrane protein 8(VAMP8)	Homo sapiens				GO:0006892~post-Golgi vesicle-mediated transport,GO:0006906~vesicle fusion,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0043308~eosinophil degranulation,GO:0043312~neutrophil degranulation,GO:0046718~viral entry into host cell,GO:0070254~mucus secretion,GO:0097352~autophagosome maturation,GO:1903076~regulation of protein localization to plasma membrane,GO:1903531~negative regulation of secretion by cell,GO:1903595~positive regulation of histamine secretion by mast cell,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030667~secretory granule membrane,GO:0031201~SNARE complex,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,GO:0031982~vesicle,GO:0035577~azurophil granule membrane,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,GO:0098594~mucin granule,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,GO:0019869~chloride channel inhibitor activity,	IPR001388:Synaptobrevin,IPR016444:Synaptobrevin, metazoa/fungi,	hsa04130:SNARE interactions in vesicular transport,hsa04611:Platelet activation,		PIRSF005409:synaptobrevin,		3D-structure,Acetylation,Autophagy,Cell membrane,Coiled coil,Complete proteome,Direct protein sequencing,Endosome,Lysosome,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Vesicle-associated membrane protein 8,domain:v-SNARE coiled-coil homology,modified residue,sequence conflict,site:Interaction with STX8,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
VGLL3	vestigial like family member 3(VGLL3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,	IPR006627:TDU repeat,IPR011520:Vestigial/tondu,				SM00711:TDU,	Alternative splicing,Complete proteome,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Transcription cofactor vestigial-like protein 3,compositionally biased region:His-rich,splice variant,
VGLL4	vestigial like family member 4(VGLL4)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0005515~protein binding,	IPR006627:TDU repeat,				SM00711:TDU,	Acetylation,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transcription cofactor vestigial-like protein 4,modified residue,sequence variant,splice variant,
VIL1	villin 1(VIL1)	Homo sapiens				GO:0001951~intestinal D-glucose absorption,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0008360~regulation of cell shape,GO:0009617~response to bacterium,GO:0010634~positive regulation of epithelial cell migration,GO:0030041~actin filament polymerization,GO:0030042~actin filament depolymerization,GO:0030335~positive regulation of cell migration,GO:0030836~positive regulation of actin filament depolymerization,GO:0030855~epithelial cell differentiation,GO:0032233~positive regulation of actin filament bundle assembly,GO:0032532~regulation of microvillus length,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0040018~positive regulation of multicellular organism growth,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045010~actin nucleation,GO:0051014~actin filament severing,GO:0051016~barbed-end actin filament capping,GO:0051125~regulation of actin nucleation,GO:0051693~actin filament capping,GO:0060327~cytoplasmic actin-based contraction involved in cell motility,GO:0061041~regulation of wound healing,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:1902896~terminal web assembly,GO:2000392~regulation of lamellipodium morphogenesis,GO:2000394~positive regulation of lamellipodium morphogenesis,	GO:0001726~ruffle,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005903~brush border,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0032432~actin filament bundle,GO:0032433~filopodium tip,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0035727~lysophosphatidic acid binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0051015~actin filament binding,	IPR003128:Villin headpiece,IPR007122:Villin/Gelsolin,IPR007123:Gelsolin domain,		Cholestasis, progressive canalicular~Cholestasis, progressive canalicular,		SM00153:VHP,SM00262:GEL,	3D-structure,Actin capping,Actin-binding,Alternative splicing,Apoptosis,Calcium,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Villin-1,domain:HP,helix,region of interest:Core,region of interest:Headpiece,region of interest:Polyphosphoinositide binding,repeat:Gelsolin-like 1,repeat:Gelsolin-like 2,repeat:Gelsolin-like 3,repeat:Gelsolin-like 4,repeat:Gelsolin-like 5,repeat:Gelsolin-like 6,sequence conflict,sequence variant,
VILL	villin like(VILL)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0051693~actin filament capping,	GO:0015629~actin cytoskeleton,	GO:0003779~actin binding,GO:0005200~structural constituent of cytoskeleton,	IPR003128:Villin headpiece,IPR007122:Villin/Gelsolin,IPR007123:Gelsolin domain,IPR015626:Villin-like protein,				SM00153:VHP,SM00262:GEL,	Actin capping,Actin-binding,Alternative splicing,Calcium,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Villin-like protein,domain:HP,repeat:Gelsolin-like 1,repeat:Gelsolin-like 2,repeat:Gelsolin-like 3,repeat:Gelsolin-like 4,repeat:Gelsolin-like 5,repeat:Gelsolin-like 6,sequence conflict,sequence variant,splice variant,
VSNL1	visinin like 1(VSNL1)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0045921~positive regulation of exocytosis,GO:0046676~negative regulation of insulin secretion,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Complete proteome,Lipoprotein,Metal-binding,Myristate,Polymorphism,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Visinin-like protein 1,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,lipid moiety-binding region:N-myristoyl glycine,sequence conflict,sequence variant,
VIT	vitrin(VIT)	Homo sapiens				GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,	GO:0005578~proteinaceous extracellular matrix,GO:0005614~interstitial matrix,	GO:0005539~glycosaminoglycan binding,	IPR002035:von Willebrand factor, type A,IPR004043:LCCL,				SM00327:VWA,SM00603:LCCL,	Alternative splicing,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Vitrin,compositionally biased region:Poly-Val,disulfide bond,domain:LCCL,domain:VWFA 1,domain:VWFA 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
VWA1	von Willebrand factor A domain containing 1(VWA1)	Homo sapiens				GO:0030198~extracellular matrix organization,GO:0048266~behavioral response to pain,	GO:0005604~basement membrane,GO:0005614~interstitial matrix,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0042802~identical protein binding,	IPR002035:von Willebrand factor, type A,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00327:VWA,	Alternative splicing,Basement membrane,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:von Willebrand factor A domain-containing protein 1,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:VWFA,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
VWA3B	von Willebrand factor A domain containing 3B(VWA3B)	Homo sapiens					GO:0005737~cytoplasm,		IPR002035:von Willebrand factor, type A,				SM00327:VWA,	Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Mental retardation,Neurodegeneration,Polymorphism,Proteomics identification,Reference proteome,	chain:von Willebrand factor A domain-containing protein 3B,domain:VWFA,sequence conflict,sequence variant,splice variant,
VWA5B1	von Willebrand factor A domain containing 5B1(VWA5B1)	Homo sapiens					GO:0005576~extracellular region,		IPR002035:von Willebrand factor, type A,IPR013694:VIT domain,				SM00327:VWA,	Alternative splicing,Complete proteome,Glycoprotein,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:von Willebrand factor A domain-containing protein 5B1,domain:VIT,domain:VWFA,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
VWC2L	von Willebrand factor C domain containing protein 2-like(VWC2L)	Homo sapiens				GO:0030514~negative regulation of BMP signaling pathway,GO:0045666~positive regulation of neuron differentiation,	GO:0005615~extracellular space,GO:0030054~cell junction,GO:0032281~AMPA glutamate receptor complex,GO:0045202~synapse,	GO:0005515~protein binding,	IPR001007:von Willebrand factor, type C,				SM00214:VWC,	Alternative splicing,Cell junction,Complete proteome,Developmental protein,Reference proteome,Repeat,Secreted,Signal,Synapse,	chain:von Willebrand factor C domain-containing protein 2-like,domain:VWFC 1,domain:VWFC 2,signal peptide,splice variant,
WLS	wntless Wnt ligand secretion mediator(WLS)	Homo sapiens				GO:0001707~mesoderm formation,GO:0006886~intracellular protein transport,GO:0009948~anterior/posterior axis specification,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030901~midbrain development,GO:0030902~hindbrain development,GO:0031017~exocrine pancreas development,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0061355~Wnt protein secretion,GO:0061357~positive regulation of Wnt protein secretion,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000139~Golgi membrane,GO:0005769~early endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030666~endocytic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0032590~dendrite membrane,GO:0032839~dendrite cytoplasm,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0031852~mu-type opioid receptor binding,	IPR009551:Protein wntless,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,Developmental protein,Endoplasmic reticulum,Endosome,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Integral membrane protein GPR177,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
XDH	xanthine dehydrogenase(XDH)	Homo sapiens		h_freePathway:Free Radical Induced Apoptosis,		GO:0001933~negative regulation of protein phosphorylation,GO:0001937~negative regulation of endothelial cell proliferation,GO:0006195~purine nucleotide catabolic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007595~lactation,GO:0009115~xanthine catabolic process,GO:0010629~negative regulation of gene expression,GO:0045602~negative regulation of endothelial cell differentiation,GO:0051898~negative regulation of protein kinase B signaling,GO:0055114~oxidation-reduction process,GO:1900745~positive regulation of p38MAPK cascade,GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2001213~negative regulation of vasculogenesis,	GO:0005615~extracellular space,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0016529~sarcoplasmic reticulum,	GO:0004854~xanthine dehydrogenase activity,GO:0004855~xanthine oxidase activity,GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0016903~oxidoreductase activity, acting on the aldehyde or oxo group of donors,GO:0042803~protein homodimerization activity,GO:0043546~molybdopterin cofactor binding,GO:0050660~flavin adenine dinucleotide binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR000674:Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead,IPR001041:2Fe-2S ferredoxin-type domain,IPR002346:Molybdopterin dehydrogenase, FAD-binding,IPR002888:[2Fe-2S]-binding,IPR005107:CO dehydrogenase flavoprotein, C-terminal,IPR006058:2Fe-2S ferredoxin, iron-sulphur binding site,IPR008274:Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding,IPR012675:Beta-grasp domain,IPR014307:Xanthine dehydrogenase, small subunit,IPR016166:FAD-binding, type 2,IPR016167:FAD-binding, type 2, subdomain 1,IPR016169:CO dehydrogenase flavoprotein-like, FAD-binding, subdomain 2,IPR016208:Aldehyde oxidase/xanthine dehydrogenase,IPR022407:Oxidoreductase, molybdopterin binding site,	hsa00230:Purine metabolism,hsa00232:Caffeine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa04146:Peroxisome,	278300~Xanthinuria, type I,	PIRSF000127:xanthine dehydrogenase,	SM01008:SM01008,SM01092:SM01092,	2Fe-2S,3D-structure,Complete proteome,Cytoplasm,Disease mutation,Disulfide bond,FAD,Flavoprotein,Glycoprotein,Iron,Iron-sulfur,Metal-binding,Molybdenum,NAD,Oxidoreductase,Peroxisome,Polymorphism,Reference proteome,Secreted,	active site:Proton acceptor,binding site:FAD,binding site:FAD; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:Xanthine dehydrogenase/oxidase,disulfide bond,domain:2Fe-2S ferredoxin-type,domain:FAD-binding PCMH-type,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Iron-sulfur (2Fe-2S) 1,metal ion-binding site:Iron-sulfur (2Fe-2S) 2,metal ion-binding site:Molybdenum,metal ion-binding site:Molybdenum; via amide nitrogen,metal ion-binding site:Molybdenum; via carbonyl oxygen,modified residue,mutagenesis site,nucleotide phosphate-binding region:FAD,sequence conflict,sequence variant,strand,turn,
XPR1	xenotropic and polytropic retrovirus receptor 1(XPR1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0009615~response to virus,GO:0030643~cellular phosphate ion homeostasis,GO:0035435~phosphate ion transmembrane transport,GO:0046718~viral entry into host cell,	GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0031226~intrinsic component of plasma membrane,	GO:0000822~inositol hexakisphosphate binding,GO:0001618~virus receptor activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0015114~phosphate ion transmembrane transporter activity,GO:0015562~efflux transmembrane transporter activity,	IPR004331:SPX, N-terminal,IPR004342:EXS, C-terminal,		616413~Basal ganglia calcification, idiopathic, 6,			3D-structure,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Host cell receptor for virus entry,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Xenotropic and polytropic retrovirus receptor 1,domain:EXS,domain:SPX,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
XIRP2	xin actin binding repeat containing 2(XIRP2)	Homo sapiens				GO:0003281~ventricular septum development,GO:0007507~heart development,GO:0030036~actin cytoskeleton organization,GO:0045216~cell-cell junction organization,GO:0055008~cardiac muscle tissue morphogenesis,	GO:0030018~Z disc,GO:0030054~cell junction,	GO:0003779~actin binding,GO:0051393~alpha-actinin binding,	IPR012510:Actin-binding, Xin repeat,					3D-structure,Actin-binding,Alternative splicing,Cell junction,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Xin actin-binding repeat-containing protein 2,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,repeat:Xin 1,repeat:Xin 10,repeat:Xin 11,repeat:Xin 12,repeat:Xin 13,repeat:Xin 14,repeat:Xin 15,repeat:Xin 16,repeat:Xin 17,repeat:Xin 18,repeat:Xin 19,repeat:Xin 2,repeat:Xin 20,repeat:Xin 21,repeat:Xin 22,repeat:Xin 23,repeat:Xin 24,repeat:Xin 25,repeat:Xin 26,repeat:Xin 27,repeat:Xin 28,repeat:Xin 3,repeat:Xin 4,repeat:Xin 5,repeat:Xin 6,repeat:Xin 7,repeat:Xin 8,repeat:Xin 9,sequence conflict,sequence variant,splice variant,
XYLB	xylulokinase(XYLB)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0005975~carbohydrate metabolic process,GO:0005997~xylulose metabolic process,GO:0005998~xylulose catabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0019640~glucuronate catabolic process to xylulose 5-phosphate,GO:0042732~D-xylose metabolic process,GO:0046835~carbohydrate phosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004856~xylulokinase activity,GO:0005524~ATP binding,	IPR018484:Carbohydrate kinase, FGGY, N-terminal,IPR018485:Carbohydrate kinase, FGGY, C-terminal,	hsa00040:Pentose and glucuronate interconversions,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,ATP-binding,Carbohydrate metabolism,Complete proteome,Kinase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transferase,Xylose metabolism,	chain:Xylulose kinase,sequence variant,
YPEL5	yippee like 5(YPEL5)	Homo sapiens						GO:0046872~metal ion binding,	IPR004910:Yippee-like protein,					Complete proteome,Metal-binding,Phosphoprotein,Reference proteome,Zinc,	chain:Protein yippee-like 5,
ZAP70	zeta chain of T cell receptor associated protein kinase 70(ZAP70)	Homo sapiens	3.T_cell_receptor,54.T-cell_anergy,63.LAT_couples_T-cell_receptor,82.TCR_and_Cap_or_SMAC,	h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrPathway:T Cell Receptor Signaling Pathway,		GO:0002250~adaptive immune response,GO:0002281~macrophage activation involved in immune response,GO:0002283~neutrophil activation involved in immune response,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030217~T cell differentiation,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0043306~positive regulation of mast cell degranulation,GO:0043366~beta selection,GO:0045059~positive thymic T cell selection,GO:0045060~negative thymic T cell selection,GO:0045087~innate immune response,GO:0045579~positive regulation of B cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0070489~T cell aggregation,GO:0072678~T cell migration,GO:0090330~regulation of platelet aggregation,	GO:0001772~immunological synapse,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0042101~T cell receptor complex,GO:0045121~membrane raft,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR012234:Tyrosine-protein kinase, non-receptor SYK/ZAP-70,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR023420:Tyrosine-protein kinase SYK/ZAP-70, inter-SH2 domain,	hsa04014:Ras signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa05340:Primary immunodeficiency,	269840~Selective T-cell defect,	PIRSF000604:tyrosine-protein kinase, SYK/ZAP-70 type,	SM00219:TyrKc,SM00252:SH2,	3D-structure,Acetylation,Adaptive immunity,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Immunity,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SCID,SH2 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase ZAP-70,domain:Protein kinase,domain:SH2 1,domain:SH2 2,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
ZBED6	zinc finger BED-type containing 6(ZBED6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,	IPR003656:Zinc finger, BED-type predicted,IPR008906:HAT dimerisation,IPR012337:Ribonuclease H-like domain,				SM00614:ZnF_BED,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,
ZC3H11A	zinc finger CCCH-type containing 11A(ZC3H11A)	Homo sapiens				GO:0006369~termination of RNA polymerase II transcription,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0031124~mRNA 3'-end processing,	GO:0000346~transcription export complex,GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Acetylation,Coiled coil,Complete proteome,Isopeptide bond,Metal-binding,mRNA transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transport,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 11A,compositionally biased region:Poly-Asp,modified residue,sequence conflict,sequence variant,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,zinc finger region:C3H1-type 3,
ZC3H12A	zinc finger CCCH-type containing 12A(ZC3H12A)	Homo sapiens				GO:0000294~nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,GO:0001525~angiogenesis,GO:0001933~negative regulation of protein phosphorylation,GO:0002230~positive regulation of defense response to virus by host,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0007399~nervous system development,GO:0010468~regulation of gene expression,GO:0010508~positive regulation of autophagy,GO:0010595~positive regulation of endothelial cell migration,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010656~negative regulation of muscle cell apoptotic process,GO:0010884~positive regulation of lipid storage,GO:0010942~positive regulation of cell death,GO:0016579~protein deubiquitination,GO:0030154~cell differentiation,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032715~negative regulation of interleukin-6 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0034599~cellular response to oxidative stress,GO:0042149~cellular response to glucose starvation,GO:0042307~positive regulation of protein import into nucleus,GO:0042347~negative regulation of NF-kappaB import into nucleus,GO:0043031~negative regulation of macrophage activation,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044828~negative regulation by host of viral genome replication,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0045600~positive regulation of fat cell differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050713~negative regulation of interleukin-1 beta secretion,GO:0051259~protein oligomerization,GO:0051607~defense response to virus,GO:0055118~negative regulation of cardiac muscle contraction,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0090501~RNA phosphodiester bond hydrolysis,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,GO:0098586~cellular response to virus,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1900119~positive regulation of execution phase of apoptosis,GO:1900165~negative regulation of interleukin-6 secretion,GO:1900745~positive regulation of p38MAPK cascade,GO:1902714~negative regulation of interferon-gamma secretion,GO:1903003~positive regulation of protein deubiquitination,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,GO:1903936~cellular response to sodium arsenite,GO:1904468~negative regulation of tumor necrosis factor secretion,GO:1904628~cellular response to phorbol 13-acetate 12-myristate,GO:1904637~cellular response to ionomycin,GO:1990869~cellular response to chemokine,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000627~positive regulation of miRNA catabolic process,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005791~rough endoplasmic reticulum,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030867~rough endoplasmic reticulum membrane,GO:0042406~extrinsic component of endoplasmic reticulum membrane,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0004521~endoribonuclease activity,GO:0004532~exoribonuclease activity,GO:0004540~ribonuclease activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0035198~miRNA binding,GO:0035613~RNA stem-loop binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0043022~ribosome binding,GO:0046872~metal ion binding,	IPR021869:Ribonuclease Zc3h12a-like,					3D-structure,Angiogenesis,Antiviral defense,Apoptosis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA damage,DNA-binding,Endonuclease,Endoplasmic reticulum,Hydrolase,Immunity,Inflammatory response,Magnesium,Membrane,Metal-binding,Neurogenesis,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,RNA-binding,Stress response,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Ribonuclease ZC3H12A,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,zinc finger region:C3H1-type,
ZC3H15	zinc finger CCCH-type containing 15(ZC3H15)	Homo sapiens			General function prediction only,	GO:0019221~cytokine-mediated signaling pathway,GO:0098609~cell-cell adhesion,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 15,modified residue,region of interest:Required for interaction with DRG1,sequence conflict,sequence variant,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,
ZC3H6	zinc finger CCCH-type containing 6(ZC3H6)	Homo sapiens						GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Coiled coil,Complete proteome,Metal-binding,Phosphoprotein,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 6,compositionally biased region:Pro-rich,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,zinc finger region:C3H1-type 3,
ZC3H8	zinc finger CCCH-type containing 8(ZC3H8)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0042796~snRNA transcription from RNA polymerase III promoter,GO:0043029~T cell homeostasis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0046677~response to antibiotic,GO:0070245~positive regulation of thymocyte apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0008023~transcription elongation factor complex,GO:0015030~Cajal body,GO:0035327~transcriptionally active chromatin,GO:0035363~histone locus body,	GO:0001162~RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Apoptosis,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 8,modified residue,sequence conflict,sequence variant,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,zinc finger region:C3H1-type 3,
ZCCHC11	zinc finger CCHC-type containing 11(ZCCHC11)	Homo sapiens			DNA replication, recombination, and repair,	GO:0001816~cytokine production,GO:0010586~miRNA metabolic process,GO:0010587~miRNA catabolic process,GO:0019827~stem cell population maintenance,GO:0031054~pre-miRNA processing,GO:0031123~RNA 3'-end processing,GO:0031664~regulation of lipopolysaccharide-mediated signaling pathway,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032755~positive regulation of interleukin-6 production,GO:0070102~interleukin-6-mediated signaling pathway,GO:0071044~histone mRNA catabolic process,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016779~nucleotidyltransferase activity,GO:0044822~poly(A) RNA binding,GO:0050265~RNA uridylyltransferase activity,	IPR001878:Zinc finger, CCHC-type,IPR002058:PAP/25A-associated,IPR002934:Nucleotidyl transferase domain,				SM00343:ZnF_C2HC,	Alternative splicing,Complete proteome,Cytoplasm,Magnesium,Manganese,Metal-binding,Methylation,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-mediated gene silencing,Transferase,Zinc,Zinc-finger,	chain:Terminal uridylyltransferase 4,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,zinc finger region:CCHC-type 1,zinc finger region:CCHC-type 2,zinc finger region:CCHC-type 3,
ZCCHC17	zinc finger CCHC-type containing 17(ZCCHC17)	Homo sapiens					GO:0005634~nucleus,GO:0005730~nucleolus,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0043231~intracellular membrane-bounded organelle,GO:0045111~intermediate filament cytoskeleton,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR001878:Zinc finger, CCHC-type,IPR003029:Ribosomal protein S1, RNA-binding domain,IPR012340:Nucleic acid-binding, OB-fold,IPR022967:RNA-binding domain, S1,				SM00316:SM00316,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Zinc,Zinc-finger,	chain:Nucleolar protein of 40 kDa,compositionally biased region:Lys-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,domain:S1 motif,helix,modified residue,sequence conflict,splice variant,strand,zinc finger region:CCHC-type,
ZCWPW2	zinc finger CW-type and PWWP domain containing 2(ZCWPW2)	Homo sapiens						GO:0008270~zinc ion binding,	IPR000313:PWWP,IPR011124:Zinc finger, CW-type,					3D-structure,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Zinc finger CW-type PWWP domain protein 2,domain:PWWP,sequence variant,zinc finger region:CW-type,
ZDHHC18	zinc finger DHHC-type containing 18(ZDHHC18)	Homo sapiens			General function prediction only,	GO:0018345~protein palmitoylation,GO:0034613~cellular protein localization,	GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0008270~zinc ion binding,GO:0016409~palmitoyltransferase activity,GO:0019706~protein-cysteine S-palmitoyltransferase activity,	IPR001594:Zinc finger, DHHC-type, palmitoyltransferase,					Acyltransferase,Alternative splicing,Complete proteome,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	active site:S-palmitoyl cysteine intermediate,chain:Palmitoyltransferase ZDHHC18,compositionally biased region:Pro-rich,modified residue,transmembrane region,zinc finger region:DHHC-type,
ZDHHC3	zinc finger DHHC-type containing 3(ZDHHC3)	Homo sapiens			General function prediction only,	GO:0006605~protein targeting,GO:0018345~protein palmitoylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008270~zinc ion binding,GO:0016409~palmitoyltransferase activity,GO:0019706~protein-cysteine S-palmitoyltransferase activity,	IPR001594:Zinc finger, DHHC-type, palmitoyltransferase,					Acyltransferase,Alternative splicing,Complete proteome,Golgi apparatus,Lipoprotein,Membrane,Palmitate,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Palmitoyltransferase ZDHHC3,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,zinc finger region:DHHC-type,
ZEB2	zinc finger E-box binding homeobox 2(ZEB2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007399~nervous system development,GO:0045636~positive regulation of melanocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048023~positive regulation of melanin biosynthetic process,GO:0048066~developmental pigmentation,GO:0050790~regulation of catalytic activity,GO:0097324~melanocyte migration,GO:1903056~regulation of melanosome organization,	GO:0005634~nucleus,	GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0019208~phosphatase regulator activity,GO:0046872~metal ion binding,	IPR001356:Homeodomain,IPR007087:Zinc finger, C2H2,IPR008598:Drought induced 19/ RING finger protein 114,IPR009057:Homeodomain-like,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa05206:MicroRNAs in cancer,	235730~Mowat-Wilson syndrome,		SM00355:ZnF_C2H2,SM00389:HOX,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,DNA-binding,Epilepsy,Hirschsprung disease,Homeobox,Isopeptide bond,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger E-box-binding homeobox 2,compositionally biased region:Glu-rich (acidic),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Homeobox; atypical,helix,modified residue,region of interest:SMAD-MH2 binding domain,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4; atypical,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7; atypical,
ZFYVE9	zinc finger FYVE-type containing 9(ZFYVE9)	Homo sapiens		h_tgfbPathway:TGF beta signaling pathway,		GO:0006508~proteolysis,GO:0006897~endocytosis,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007183~SMAD protein complex assembly,GO:0007184~SMAD protein import into nucleus,	GO:0005769~early endosome,GO:0031901~early endosome membrane,	GO:0005515~protein binding,GO:0005545~1-phosphatidylinositol binding,GO:0008236~serine-type peptidase activity,GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,IPR022557:Domain of unknown function DUF3480,IPR024608:Smad anchor for receptor activation, Smad-binding domain,	hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,			SM00064:FYVE,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Endosome,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Zinc,Zinc-finger,	chain:Zinc finger FYVE domain-containing protein 9,helix,mutagenesis site,region of interest:SBD,sequence variant,splice variant,strand,turn,zinc finger region:FYVE-type,
ZNHIT6	zinc finger HIT-type containing 6(ZNHIT6)	Homo sapiens				GO:0000492~box C/D snoRNP assembly,GO:0042254~ribosome biogenesis,GO:0048254~snoRNA localization,GO:0051259~protein oligomerization,	GO:0070062~extracellular exosome,GO:0070761~pre-snoRNP complex,	GO:0001094~TFIID-class transcription factor binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0051117~ATPase binding,	IPR007529:Zinc finger, HIT-type,					Alternative splicing,Complete proteome,Isopeptide bond,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Ribosome biogenesis,Ubl conjugation,Zinc,Zinc-finger,	chain:Box C/D snoRNA protein 1,compositionally biased region:Glu-rich,modified residue,sequence conflict,sequence variant,zinc finger region:HIT-type,
ZMYM1	zinc finger MYM-type containing 1(ZMYM1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0046983~protein dimerization activity,	IPR008906:HAT dimerisation,IPR010507:Zinc finger, MYM-type,IPR011017:TRASH domain,IPR012337:Ribonuclease H-like domain,IPR025398:Domain of unknown function DUF4371,				SM00746:TRASH,	Complete proteome,Isopeptide bond,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger MYM-type protein 1,compositionally biased region:Ser-rich,modified residue,sequence variant,zinc finger region:MYM-type 1,zinc finger region:MYM-type 2,zinc finger region:MYM-type 3,zinc finger region:MYM-type 4,zinc finger region:TTF-type,
ZMYM4	zinc finger MYM-type containing 4(ZMYM4)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007010~cytoskeleton organization,GO:0007275~multicellular organism development,GO:0022604~regulation of cell morphogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR010507:Zinc finger, MYM-type,IPR011017:TRASH domain,IPR021893:Protein of unknown function DUF3504,				SM00746:TRASH,	Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger MYM-type protein 4,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:MYM-type 1,zinc finger region:MYM-type 2,zinc finger region:MYM-type 3,zinc finger region:MYM-type 4,zinc finger region:MYM-type 5,zinc finger region:MYM-type 6,zinc finger region:MYM-type 7,zinc finger region:MYM-type 8,zinc finger region:MYM-type 9,
ZMYND12	zinc finger MYND-type containing 12(ZMYND12)	Homo sapiens					GO:0005622~intracellular,	GO:0046872~metal ion binding,	IPR002893:Zinc finger, MYND-type,IPR011990:Tetratricopeptide-like helical,					Complete proteome,Metal-binding,Polymorphism,Reference proteome,Repeat,TPR repeat,Zinc,Zinc-finger,	chain:Zinc finger MYND domain-containing protein 12,repeat:TPR 1,repeat:TPR 2,sequence conflict,sequence variant,zinc finger region:MYND-type,
ZRANB3	zinc finger RANBP2-type containing 3(ZRANB3)	Homo sapiens				GO:0000733~DNA strand renaturation,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0031297~replication fork processing,GO:0036292~DNA rewinding,GO:0045910~negative regulation of DNA recombination,GO:0048478~replication fork protection,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0043596~nuclear replication fork,	GO:0003676~nucleic acid binding,GO:0003678~DNA helicase activity,GO:0004386~helicase activity,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0036310~annealing helicase activity,GO:0070530~K63-linked polyubiquitin binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR001876:Zinc finger, RanBP2-type,IPR002711:HNH endonuclease,IPR003615:HNH nuclease,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM00507:HNHc,SM00547:ZnF_RBZ,	Alternative splicing,ATP-binding,Chromosome,Complete proteome,DNA damage,DNA repair,Endonuclease,Helicase,Hydrolase,Isopeptide bond,Metal-binding,Multifunctional enzyme,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Zinc finger Ran-binding domain-containing protein 3,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH box,splice variant,zinc finger region:RanBP2-type,
ZSWIM2	zinc finger SWIM-type containing 2(ZSWIM2)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006915~apoptotic process,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,		GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0043621~protein self-association,GO:0061630~ubiquitin protein ligase activity,	IPR000433:Zinc finger, ZZ-type,IPR001841:Zinc finger, RING-type,IPR007527:Zinc finger, SWIM-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	3D-structure,Apoptosis,Complete proteome,Ligase,Metal-binding,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Zinc finger SWIM domain-containing protein 2,helix,strand,zinc finger region:RING-type 1,zinc finger region:RING-type 2,zinc finger region:SWIM-type,zinc finger region:ZZ-type,
ZSWIM5	zinc finger SWIM-type containing 5(ZSWIM5)	Homo sapiens					GO:0005615~extracellular space,	GO:0008270~zinc ion binding,	IPR007527:Zinc finger, SWIM-type,					Complete proteome,Metal-binding,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Zinc finger SWIM domain-containing protein 5,sequence variant,zinc finger region:SWIM-type,
ZZZ3	zinc finger ZZ-type containing 3(ZZZ3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,GO:0005730~nucleolus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000433:Zinc finger, ZZ-type,IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017930:Myb domain,				SM00717:SANT,	3D-structure,Acetylation,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:ZZ-type zinc finger-containing protein 3,DNA-binding region:H-T-H motif,domain:HTH myb-type,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,zinc finger region:ZZ-type,
ZBTB17	zinc finger and BTB domain containing 17(ZBTB17)	Homo sapiens	61.Myc_network,		General function prediction only,	GO:0001702~gastrulation with mouth forming second,GO:0006351~transcription, DNA-templated,GO:0007398~ectoderm development,GO:0036498~IRE1-mediated unfolded protein response,GO:0045786~negative regulation of cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005654~nucleoplasm,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04110:Cell cycle,hsa05202:Transcriptional misregulation in cancer,			SM00225:BTB,SM00355:ZnF_C2H2,	3D-structure,Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 17,domain:BTB,helix,region of interest:Interaction with HCFC1,region of interest:Interaction with MYC,sequence conflict,splice variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZBTB18	zinc finger and BTB domain containing 18(ZBTB18)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007519~skeletal muscle tissue development,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000228~nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0015630~microtubule cytoskeleton,GO:0045171~intercellular bridge,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		612337~Mental retardation, autosomal dominant 22,		SM00225:BTB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 238,domain:BTB,modified residue,region of interest:Binds DNMT3A,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
ZBTB37	zinc finger and BTB domain containing 37(ZBTB37)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 37,domain:BTB,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
ZBTB40	zinc finger and BTB domain containing 40(ZBTB40)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0030282~bone mineralization,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 40,domain:BTB,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11; atypical,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZBTB41	zinc finger and BTB domain containing 41(ZBTB41)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 41,domain:BTB,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZBTB47	zinc finger and BTB domain containing 47(ZBTB47)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 47,compositionally biased region:Pro-rich,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZBTB48	zinc finger and BTB domain containing 48(ZBTB48)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	3D-structure,Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 48,domain:BTB,helix,sequence conflict,sequence variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZBTB8OS	zinc finger and BTB domain containing 8 opposite strand(ZBTB8OS)	Homo sapiens				GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,	GO:0005654~nucleoplasm,GO:0070062~extracellular exosome,GO:0072669~tRNA-splicing ligase complex,	GO:0046872~metal ion binding,	IPR002804:Archease,IPR023572:Archease domain,					Acetylation,Alternative splicing,Calcium,Complete proteome,Metal-binding,Proteomics identification,Reference proteome,tRNA processing,	chain:Protein archease,modified residue,sequence conflict,splice variant,
ZBTB8A	zinc finger and BTB domain containing 8A(ZBTB8A)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 8A,compositionally biased region:Poly-Glu,domain:BTB,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,
ZBTB8B	zinc finger and BTB domain containing 8B(ZBTB8B)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Putative zinc finger and BTB domain- containing protein 8B,compositionally biased region:Poly-Ala,domain:BTB,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,
ZSCAN20	zinc finger and SCAN domain containing 20(ZSCAN20)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001005:SANT/Myb domain,IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00431:SCAN,SM00717:SANT,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger and SCAN domain-containing protein 20,domain:SCAN box,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF124	zinc finger protein 124(ZNF124)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 124,domain:KRAB,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,
ZNF142	zinc finger protein 142(ZNF142)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 142,modified residue,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 15,zinc finger region:C2H2-type 16,zinc finger region:C2H2-type 17,zinc finger region:C2H2-type 18,zinc finger region:C2H2-type 19,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 20,zinc finger region:C2H2-type 21,zinc finger region:C2H2-type 22,zinc finger region:C2H2-type 23,zinc finger region:C2H2-type 24,zinc finger region:C2H2-type 25,zinc finger region:C2H2-type 26,zinc finger region:C2H2-type 27,zinc finger region:C2H2-type 28,zinc finger region:C2H2-type 29,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 30,zinc finger region:C2H2-type 31,zinc finger region:C2H2-type 4; atypical,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF197	zinc finger protein 197(ZNF197)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,SM00431:SCAN,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 197,domain:KRAB,domain:SCAN box,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 15,zinc finger region:C2H2-type 16,zinc finger region:C2H2-type 17,zinc finger region:C2H2-type 18,zinc finger region:C2H2-type 19,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 20,zinc finger region:C2H2-type 21,zinc finger region:C2H2-type 22,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF2	zinc finger protein 2(ZNF2)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 2,domain:KRAB,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9; degenerate,
ZNF362	zinc finger protein 362(ZNF362)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 362,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
ZNF385B	zinc finger protein 385B(ZNF385B)	Homo sapiens				GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,	GO:0005634~nucleus,	GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,	IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00451:ZnF_U1,	Alternative splicing,Apoptosis,Complete proteome,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Zinc finger protein 385B,sequence conflict,sequence variant,splice variant,zinc finger region:Matrin-type 1,zinc finger region:Matrin-type 2,zinc finger region:Matrin-type 3,zinc finger region:Matrin-type 4,
ZNF385D	zinc finger protein 385D(ZNF385D)	Homo sapiens				GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,	GO:0005634~nucleus,	GO:0002039~p53 binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,	IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00451:ZnF_U1,	Complete proteome,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Zinc finger protein 385D,compositionally biased region:Poly-Ala,compositionally biased region:Thr-rich,sequence variant,zinc finger region:Matrin-type 1,zinc finger region:Matrin-type 2,zinc finger region:Matrin-type 3,
ZNF445	zinc finger protein 445(ZNF445)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,SM00431:SCAN,	Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 445,domain:KRAB,domain:SCAN box,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF496	zinc finger protein 496(ZNF496)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0016604~nuclear body,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043621~protein self-association,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00431:SCAN,	Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 496,domain:KRAB,domain:SCAN box,modified residue,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
ZNF501	zinc finger protein 501(ZNF501)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 501,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF512	zinc finger protein 512(ZNF512)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 512,helix,modified residue,sequence conflict,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3; atypical,zinc finger region:C2H2-type 4,
ZNF514	zinc finger protein 514(ZNF514)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 514,domain:KRAB,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,
ZNF589	zinc finger protein 589(ZNF589)	Homo sapiens			General function prediction only,	GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Zinc,Zinc-finger,	chain:Zinc finger protein 589,domain:KRAB,modified residue,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
ZNF619	zinc finger protein 619(ZNF619)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 619,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF620	zinc finger protein 620(ZNF620)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 620,domain:KRAB,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,
ZNF638	zinc finger protein 638(ZNF638)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR015880:Zinc finger, C2H2-like,IPR022755:Zinc finger, double-stranded RNA binding,				SM00355:ZnF_C2H2,SM00360:RRM,SM00451:ZnF_U1,	Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 638,compositionally biased region:Arg-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Lys,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:Matrin-type,
ZNF644	zinc finger protein 644(ZNF644)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		614167~Myopia 21, autosomal dominant,		SM00355:ZnF_C2H2,	Alternative splicing,Coiled coil,Complete proteome,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 644,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,
ZNF648	zinc finger protein 648(ZNF648)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 648,modified residue,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF654	zinc finger protein 654(ZNF654)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 654,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,modified residue,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
ZNF662	zinc finger protein 662(ZNF662)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 662,domain:KRAB,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,
ZNF670	zinc finger protein 670(ZNF670)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 670,domain:KRAB,modified residue,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9; degenerate,
ZNF672	zinc finger protein 672(ZNF672)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 672,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5; degenerate,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF678	zinc finger protein 678(ZNF678)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 678,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 15; degenerate,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF683	zinc finger protein 683(ZNF683)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001779~natural killer cell differentiation,GO:0002250~adaptive immune response,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0032823~regulation of natural killer cell differentiation,GO:0032826~regulation of natural killer cell differentiation involved in immune response,GO:0033082~regulation of extrathymic T cell differentiation,GO:0045087~innate immune response,GO:0051136~regulation of NK T cell differentiation,GO:1904628~cellular response to phorbol 13-acetate 12-myristate,GO:1904637~cellular response to ionomycin,	GO:0005634~nucleus,	GO:0001047~core promoter binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,GO:1990841~promoter-specific chromatin binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Adaptive immunity,Alternative splicing,Complete proteome,DNA-binding,Immunity,Innate immunity,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 683,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3; degenerate,zinc finger region:C2H2-type 4,
ZNF684	zinc finger protein 684(ZNF684)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 684,domain:KRAB,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,
ZNF692	zinc finger protein 692(ZNF692)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 692,helix,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
ZNF695	zinc finger protein 695(ZNF695)	Homo sapiens			General function prediction only,	GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Zinc finger protein 695,domain:KRAB,sequence variant,splice variant,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 1; atypical,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3; atypical,zinc finger region:C2H2-type 4; degenerate,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF697	zinc finger protein 697(ZNF697)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 697,compositionally biased region:Poly-Glu,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF717	zinc finger protein 717(ZNF717)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 717,domain:KRAB,modified residue,sequence conflict,sequence variant,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 15,zinc finger region:C2H2-type 16; degenerate,zinc finger region:C2H2-type 17; degenerate,zinc finger region:C2H2-type 18,zinc finger region:C2H2-type 19,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 20,zinc finger region:C2H2-type 21,zinc finger region:C2H2-type 22,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3; degenerate,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF804A	zinc finger protein 804A(ZNF804A)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR022755:Zinc finger, double-stranded RNA binding,					Complete proteome,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:Zinc finger protein 804A,sequence conflict,sequence variant,zinc finger region:C2H2-type,
ZNF806	zinc finger protein 806(ZNF806)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 285A,chain:Zinc finger protein 806,domain:KRAB,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 6; degenerate,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 8; degenerate,zinc finger region:C2H2-type 9,
ZKSCAN7	zinc finger with KRAB and SCAN domains 7(ZKSCAN7)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,SM00431:SCAN,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Putative zinc finger protein FLJ16720,chain:Zinc finger protein 167,domain:KRAB,domain:SCAN box,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 11; degenerate,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZMPSTE24	zinc metallopeptidase STE24(ZMPSTE24)	Homo sapiens				GO:0006508~proteolysis,GO:0006998~nuclear envelope organization,GO:0030327~prenylated protein catabolic process,GO:0071586~CAAX-box protein processing,	GO:0005637~nuclear inner membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0008235~metalloexopeptidase activity,GO:0046872~metal ion binding,	IPR001915:Peptidase M48,IPR027057:CAAX prenyl protease 1,	hsa00900:Terpenoid backbone biosynthesis,hsa01130:Biosynthesis of antibiotics,	275210~Restrictive dermopathy, lethal,608612~Mandibuloacral dysplasia with type B lipodystrophy,			3D-structure,Complete proteome,Disease mutation,Endoplasmic reticulum,Hydrolase,Membrane,Metal-binding,Metalloprotease,Nucleus,Polymorphism,Protease,Reference proteome,Transmembrane,Transmembrane helix,Zinc,	active site:Proton donor,chain:CAAX prenyl protease 1 homolog,metal ion-binding site:Zinc; catalytic,modified residue,sequence conflict,sequence variant,transmembrane region,
ZP4	zona pellucida glycoprotein 4(ZP4)	Homo sapiens				GO:0002922~positive regulation of humoral immune response,GO:0007339~binding of sperm to zona pellucida,GO:0010737~protein kinase A signaling,GO:0035556~intracellular signal transduction,GO:0042102~positive regulation of T cell proliferation,GO:0045860~positive regulation of protein kinase activity,GO:0060478~acrosomal vesicle exocytosis,GO:0070528~protein kinase C signaling,GO:2000344~positive regulation of acrosome reaction,GO:2000360~negative regulation of binding of sperm to zona pellucida,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0032190~acrosin binding,	IPR000519:P-type trefoil,IPR001507:Zona pellucida domain,IPR017957:P-type trefoil, conserved site,IPR017977:Zona pellucida domain, conserved site,				SM00018:PD,SM00241:ZP,	Cell membrane,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Fertilization,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Processed zona pellucida sperm-binding protein 4,chain:Zona pellucida sperm-binding protein 4,domain:P-type,domain:ZP,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),propeptide:Removed in mature form,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ZPLD1	zona pellucida like domain containing 1(ZPLD1)	Homo sapiens					GO:0016021~integral component of membrane,		IPR001507:Zona pellucida domain,				SM00241:ZP,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Zona pellucida-like domain-containing protein 1,domain:ZP,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ZYG11A	zyg-11 family member A, cell cycle regulator(ZYG11A)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0051438~regulation of ubiquitin-protein transferase activity,	GO:0031462~Cul2-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Protein zyg-11 homolog A,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,splice variant,
ZYG11B	zyg-11 family member B, cell cycle regulator(ZYG11B)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0051438~regulation of ubiquitin-protein transferase activity,	GO:0031462~Cul2-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR001611:Leucine-rich repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Complete proteome,Leucine-rich repeat,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Protein zyg-11 homolog B,mutagenesis site,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence conflict,splice variant,
